<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2025//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_250101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">31774957</PMID><DateCompleted><Year>2019</Year><Month>12</Month><Day>16</Day></DateCompleted><DateRevised><Year>2021</Year><Month>05</Month><Day>11</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1533-4406</ISSN><JournalIssue CitedMedium="Internet"><Volume>381</Volume><Issue>22</Issue><PubDate><Year>2019</Year><Month>Nov</Month><Day>28</Day></PubDate></JournalIssue><Title>The New England journal of medicine</Title><ISOAbbreviation>N Engl J Med</ISOAbbreviation></Journal><ArticleTitle>Diagnosis of Pulmonary Embolism with d-Dimer Adjusted to Clinical Probability.</ArticleTitle><Pagination><StartPage>2125</StartPage><EndPage>2134</EndPage><MedlinePgn>2125-2134</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1056/NEJMoa1909159</ELocationID><Abstract><AbstractText Label="BACKGROUND">Retrospective analyses suggest that pulmonary embolism is ruled out by a d-dimer level of less than 1000 ng per milliliter in patients with a low clinical pretest probability (C-PTP) and by a d-dimer level of less than 500 ng per milliliter in patients with a moderate C-PTP.</AbstractText><AbstractText Label="METHODS">We performed a prospective study in which pulmonary embolism was considered to be ruled out without further testing in outpatients with a low C-PTP and a d-dimer level of less than 1000 ng per milliliter or with a moderate C-PTP and a d-dimer level of less than 500 ng per milliliter. All other patients underwent chest imaging (usually computed tomographic pulmonary angiography). If pulmonary embolism was not diagnosed, patients did not receive anticoagulant therapy. All patients were followed for 3 months to detect venous thromboembolism.</AbstractText><AbstractText Label="RESULTS">A total of 2017 patients were enrolled and evaluated, of whom 7.4% had pulmonary embolism on initial diagnostic testing. Of the 1325 patients who had a low C-PTP (1285 patients) or moderate C-PTP (40 patients) and a negative d-dimer test (i.e., &lt;1000 or &lt;500 ng per milliliter, respectively), none had venous thromboembolism during follow-up (95% confidence interval [CI], 0.00 to 0.29%). These included 315 patients who had a low C-PTP and a d-dimer level of 500 to 999 ng per milliliter (95% CI, 0.00 to 1.20%). Of all 1863 patients who did not receive a diagnosis of pulmonary embolism initially and did not receive anticoagulant therapy, 1 patient (0.05%; 95% CI, 0.01 to 0.30) had venous thromboembolism. Our diagnostic strategy resulted in the use of chest imaging in 34.3% of patients, whereas a strategy in which pulmonary embolism is considered to be ruled out with a low C-PTP and a d-dimer level of less than 500 ng per milliliter would result in the use of chest imaging in 51.9% (difference, -17.6 percentage points; 95% CI, -19.2 to -15.9).</AbstractText><AbstractText Label="CONCLUSIONS">A combination of a low C-PTP and a d-dimer level of less than 1000 ng per milliliter identified a group of patients at low risk for pulmonary embolism during follow-up. (Funded by the Canadian Institutes of Health Research and others; PEGeD ClinicalTrials.gov number, NCT02483442.).</AbstractText><CopyrightInformation>Copyright &#xa9; 2019 Massachusetts Medical Society.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Kearon</LastName><ForeName>Clive</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>From the Departments of Medicine (C.K., K.W., S. Schulman, F.A.S., S. Sharma, S.M.B.), Health Research Methods, Evidence, and Impact (C.K., S.P., S. Schulman), and Oncology (S.P., L.R.-S., J.A.J.), McMaster University, Hamilton, ON, the Departments of Emergency Medicine (M.A.) and Medicine (A.H.), McGill University, Montreal, the Departments of Anesthesia (F.D.) and Family and Emergency Medicine (J.-F.D.), Sherbrooke University, Sherbrooke, QC, the Department of Medicine, University of Ottawa, Ottawa (G.L.G.), the Departments of Medicine and Epidemiology and Biostatistics, Western University, London, ON (A.L.-L.), and the Department of Medicine, University of Alberta, Edmonton (C.W.) - all in Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>de Wit</LastName><ForeName>Kerstin</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>From the Departments of Medicine (C.K., K.W., S. Schulman, F.A.S., S. Sharma, S.M.B.), Health Research Methods, Evidence, and Impact (C.K., S.P., S. Schulman), and Oncology (S.P., L.R.-S., J.A.J.), McMaster University, Hamilton, ON, the Departments of Emergency Medicine (M.A.) and Medicine (A.H.), McGill University, Montreal, the Departments of Anesthesia (F.D.) and Family and Emergency Medicine (J.-F.D.), Sherbrooke University, Sherbrooke, QC, the Department of Medicine, University of Ottawa, Ottawa (G.L.G.), the Departments of Medicine and Epidemiology and Biostatistics, Western University, London, ON (A.L.-L.), and the Department of Medicine, University of Alberta, Edmonton (C.W.) - all in Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Parpia</LastName><ForeName>Sameer</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>From the Departments of Medicine (C.K., K.W., S. Schulman, F.A.S., S. Sharma, S.M.B.), Health Research Methods, Evidence, and Impact (C.K., S.P., S. Schulman), and Oncology (S.P., L.R.-S., J.A.J.), McMaster University, Hamilton, ON, the Departments of Emergency Medicine (M.A.) and Medicine (A.H.), McGill University, Montreal, the Departments of Anesthesia (F.D.) and Family and Emergency Medicine (J.-F.D.), Sherbrooke University, Sherbrooke, QC, the Department of Medicine, University of Ottawa, Ottawa (G.L.G.), the Departments of Medicine and Epidemiology and Biostatistics, Western University, London, ON (A.L.-L.), and the Department of Medicine, University of Alberta, Edmonton (C.W.) - all in Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schulman</LastName><ForeName>Sam</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>From the Departments of Medicine (C.K., K.W., S. Schulman, F.A.S., S. Sharma, S.M.B.), Health Research Methods, Evidence, and Impact (C.K., S.P., S. Schulman), and Oncology (S.P., L.R.-S., J.A.J.), McMaster University, Hamilton, ON, the Departments of Emergency Medicine (M.A.) and Medicine (A.H.), McGill University, Montreal, the Departments of Anesthesia (F.D.) and Family and Emergency Medicine (J.-F.D.), Sherbrooke University, Sherbrooke, QC, the Department of Medicine, University of Ottawa, Ottawa (G.L.G.), the Departments of Medicine and Epidemiology and Biostatistics, Western University, London, ON (A.L.-L.), and the Department of Medicine, University of Alberta, Edmonton (C.W.) - all in Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Afilalo</LastName><ForeName>Marc</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>From the Departments of Medicine (C.K., K.W., S. Schulman, F.A.S., S. Sharma, S.M.B.), Health Research Methods, Evidence, and Impact (C.K., S.P., S. Schulman), and Oncology (S.P., L.R.-S., J.A.J.), McMaster University, Hamilton, ON, the Departments of Emergency Medicine (M.A.) and Medicine (A.H.), McGill University, Montreal, the Departments of Anesthesia (F.D.) and Family and Emergency Medicine (J.-F.D.), Sherbrooke University, Sherbrooke, QC, the Department of Medicine, University of Ottawa, Ottawa (G.L.G.), the Departments of Medicine and Epidemiology and Biostatistics, Western University, London, ON (A.L.-L.), and the Department of Medicine, University of Alberta, Edmonton (C.W.) - all in Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hirsch</LastName><ForeName>Andrew</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>From the Departments of Medicine (C.K., K.W., S. Schulman, F.A.S., S. Sharma, S.M.B.), Health Research Methods, Evidence, and Impact (C.K., S.P., S. Schulman), and Oncology (S.P., L.R.-S., J.A.J.), McMaster University, Hamilton, ON, the Departments of Emergency Medicine (M.A.) and Medicine (A.H.), McGill University, Montreal, the Departments of Anesthesia (F.D.) and Family and Emergency Medicine (J.-F.D.), Sherbrooke University, Sherbrooke, QC, the Department of Medicine, University of Ottawa, Ottawa (G.L.G.), the Departments of Medicine and Epidemiology and Biostatistics, Western University, London, ON (A.L.-L.), and the Department of Medicine, University of Alberta, Edmonton (C.W.) - all in Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Spencer</LastName><ForeName>Frederick A</ForeName><Initials>FA</Initials><AffiliationInfo><Affiliation>From the Departments of Medicine (C.K., K.W., S. Schulman, F.A.S., S. Sharma, S.M.B.), Health Research Methods, Evidence, and Impact (C.K., S.P., S. Schulman), and Oncology (S.P., L.R.-S., J.A.J.), McMaster University, Hamilton, ON, the Departments of Emergency Medicine (M.A.) and Medicine (A.H.), McGill University, Montreal, the Departments of Anesthesia (F.D.) and Family and Emergency Medicine (J.-F.D.), Sherbrooke University, Sherbrooke, QC, the Department of Medicine, University of Ottawa, Ottawa (G.L.G.), the Departments of Medicine and Epidemiology and Biostatistics, Western University, London, ON (A.L.-L.), and the Department of Medicine, University of Alberta, Edmonton (C.W.) - all in Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sharma</LastName><ForeName>Sangita</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>From the Departments of Medicine (C.K., K.W., S. Schulman, F.A.S., S. Sharma, S.M.B.), Health Research Methods, Evidence, and Impact (C.K., S.P., S. Schulman), and Oncology (S.P., L.R.-S., J.A.J.), McMaster University, Hamilton, ON, the Departments of Emergency Medicine (M.A.) and Medicine (A.H.), McGill University, Montreal, the Departments of Anesthesia (F.D.) and Family and Emergency Medicine (J.-F.D.), Sherbrooke University, Sherbrooke, QC, the Department of Medicine, University of Ottawa, Ottawa (G.L.G.), the Departments of Medicine and Epidemiology and Biostatistics, Western University, London, ON (A.L.-L.), and the Department of Medicine, University of Alberta, Edmonton (C.W.) - all in Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>D'Aragon</LastName><ForeName>Fr&#xe9;d&#xe9;rick</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>From the Departments of Medicine (C.K., K.W., S. Schulman, F.A.S., S. Sharma, S.M.B.), Health Research Methods, Evidence, and Impact (C.K., S.P., S. Schulman), and Oncology (S.P., L.R.-S., J.A.J.), McMaster University, Hamilton, ON, the Departments of Emergency Medicine (M.A.) and Medicine (A.H.), McGill University, Montreal, the Departments of Anesthesia (F.D.) and Family and Emergency Medicine (J.-F.D.), Sherbrooke University, Sherbrooke, QC, the Department of Medicine, University of Ottawa, Ottawa (G.L.G.), the Departments of Medicine and Epidemiology and Biostatistics, Western University, London, ON (A.L.-L.), and the Department of Medicine, University of Alberta, Edmonton (C.W.) - all in Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Deshaies</LastName><ForeName>Jean-Fran&#xe7;ois</ForeName><Initials>JF</Initials><AffiliationInfo><Affiliation>From the Departments of Medicine (C.K., K.W., S. Schulman, F.A.S., S. Sharma, S.M.B.), Health Research Methods, Evidence, and Impact (C.K., S.P., S. Schulman), and Oncology (S.P., L.R.-S., J.A.J.), McMaster University, Hamilton, ON, the Departments of Emergency Medicine (M.A.) and Medicine (A.H.), McGill University, Montreal, the Departments of Anesthesia (F.D.) and Family and Emergency Medicine (J.-F.D.), Sherbrooke University, Sherbrooke, QC, the Department of Medicine, University of Ottawa, Ottawa (G.L.G.), the Departments of Medicine and Epidemiology and Biostatistics, Western University, London, ON (A.L.-L.), and the Department of Medicine, University of Alberta, Edmonton (C.W.) - all in Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Le Gal</LastName><ForeName>Gregoire</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>From the Departments of Medicine (C.K., K.W., S. Schulman, F.A.S., S. Sharma, S.M.B.), Health Research Methods, Evidence, and Impact (C.K., S.P., S. Schulman), and Oncology (S.P., L.R.-S., J.A.J.), McMaster University, Hamilton, ON, the Departments of Emergency Medicine (M.A.) and Medicine (A.H.), McGill University, Montreal, the Departments of Anesthesia (F.D.) and Family and Emergency Medicine (J.-F.D.), Sherbrooke University, Sherbrooke, QC, the Department of Medicine, University of Ottawa, Ottawa (G.L.G.), the Departments of Medicine and Epidemiology and Biostatistics, Western University, London, ON (A.L.-L.), and the Department of Medicine, University of Alberta, Edmonton (C.W.) - all in Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lazo-Langner</LastName><ForeName>Alejandro</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>From the Departments of Medicine (C.K., K.W., S. Schulman, F.A.S., S. Sharma, S.M.B.), Health Research Methods, Evidence, and Impact (C.K., S.P., S. Schulman), and Oncology (S.P., L.R.-S., J.A.J.), McMaster University, Hamilton, ON, the Departments of Emergency Medicine (M.A.) and Medicine (A.H.), McGill University, Montreal, the Departments of Anesthesia (F.D.) and Family and Emergency Medicine (J.-F.D.), Sherbrooke University, Sherbrooke, QC, the Department of Medicine, University of Ottawa, Ottawa (G.L.G.), the Departments of Medicine and Epidemiology and Biostatistics, Western University, London, ON (A.L.-L.), and the Department of Medicine, University of Alberta, Edmonton (C.W.) - all in Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wu</LastName><ForeName>Cynthia</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>From the Departments of Medicine (C.K., K.W., S. Schulman, F.A.S., S. Sharma, S.M.B.), Health Research Methods, Evidence, and Impact (C.K., S.P., S. Schulman), and Oncology (S.P., L.R.-S., J.A.J.), McMaster University, Hamilton, ON, the Departments of Emergency Medicine (M.A.) and Medicine (A.H.), McGill University, Montreal, the Departments of Anesthesia (F.D.) and Family and Emergency Medicine (J.-F.D.), Sherbrooke University, Sherbrooke, QC, the Department of Medicine, University of Ottawa, Ottawa (G.L.G.), the Departments of Medicine and Epidemiology and Biostatistics, Western University, London, ON (A.L.-L.), and the Department of Medicine, University of Alberta, Edmonton (C.W.) - all in Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rudd-Scott</LastName><ForeName>Lisa</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>From the Departments of Medicine (C.K., K.W., S. Schulman, F.A.S., S. Sharma, S.M.B.), Health Research Methods, Evidence, and Impact (C.K., S.P., S. Schulman), and Oncology (S.P., L.R.-S., J.A.J.), McMaster University, Hamilton, ON, the Departments of Emergency Medicine (M.A.) and Medicine (A.H.), McGill University, Montreal, the Departments of Anesthesia (F.D.) and Family and Emergency Medicine (J.-F.D.), Sherbrooke University, Sherbrooke, QC, the Department of Medicine, University of Ottawa, Ottawa (G.L.G.), the Departments of Medicine and Epidemiology and Biostatistics, Western University, London, ON (A.L.-L.), and the Department of Medicine, University of Alberta, Edmonton (C.W.) - all in Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bates</LastName><ForeName>Shannon M</ForeName><Initials>SM</Initials><AffiliationInfo><Affiliation>From the Departments of Medicine (C.K., K.W., S. Schulman, F.A.S., S. Sharma, S.M.B.), Health Research Methods, Evidence, and Impact (C.K., S.P., S. Schulman), and Oncology (S.P., L.R.-S., J.A.J.), McMaster University, Hamilton, ON, the Departments of Emergency Medicine (M.A.) and Medicine (A.H.), McGill University, Montreal, the Departments of Anesthesia (F.D.) and Family and Emergency Medicine (J.-F.D.), Sherbrooke University, Sherbrooke, QC, the Department of Medicine, University of Ottawa, Ottawa (G.L.G.), the Departments of Medicine and Epidemiology and Biostatistics, Western University, London, ON (A.L.-L.), and the Department of Medicine, University of Alberta, Edmonton (C.W.) - all in Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Julian</LastName><ForeName>Jim A</ForeName><Initials>JA</Initials><AffiliationInfo><Affiliation>From the Departments of Medicine (C.K., K.W., S. Schulman, F.A.S., S. Sharma, S.M.B.), Health Research Methods, Evidence, and Impact (C.K., S.P., S. Schulman), and Oncology (S.P., L.R.-S., J.A.J.), McMaster University, Hamilton, ON, the Departments of Emergency Medicine (M.A.) and Medicine (A.H.), McGill University, Montreal, the Departments of Anesthesia (F.D.) and Family and Emergency Medicine (J.-F.D.), Sherbrooke University, Sherbrooke, QC, the Department of Medicine, University of Ottawa, Ottawa (G.L.G.), the Departments of Medicine and Epidemiology and Biostatistics, Western University, London, ON (A.L.-L.), and the Department of Medicine, University of Alberta, Edmonton (C.W.) - all in Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><CollectiveName>PEGeD Study Investigators</CollectiveName></Author></AuthorList><Language>eng</Language><DataBankList CompleteYN="Y"><DataBank><DataBankName>ClinicalTrials.gov</DataBankName><AccessionNumberList><AccessionNumber>NCT02483442</AccessionNumber></AccessionNumberList></DataBank></DataBankList><GrantList CompleteYN="Y"><Grant><GrantID>MOP-130249</GrantID><Agency>CIHR</Agency><Country>Canada</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>N Engl J Med</MedlineTA><NlmUniqueID>0255562</NlmUniqueID><ISSNLinking>0028-4793</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D005338">Fibrin Fibrinogen Degradation Products</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C036309">fibrin fragment D</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>N Engl J Med. 2020 Mar 12;382(11):1074. doi: 10.1056/NEJMc1917227.</RefSource><PMID Version="1">32160674</PMID></CommentsCorrections><CommentsCorrections RefType="CommentIn"><RefSource>N Engl J Med. 2020 Mar 12;382(11):1074-1075. doi: 10.1056/NEJMc1917227.</RefSource><PMID Version="1">32160675</PMID></CommentsCorrections><CommentsCorrections RefType="CommentIn"><RefSource>Ann Intern Med. 2020 Apr 21;172(8):JC47. doi: 10.7326/ACPJ202004210-047.</RefSource><PMID Version="1">32311731</PMID></CommentsCorrections><CommentsCorrections RefType="CommentIn"><RefSource>CJEM. 2020 Nov;22(6):774-775. doi: 10.1017/cem.2020.428.</RefSource><PMID Version="1">32684191</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000081415" MajorTopicYN="Y">Clinical Decision Rules</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000072226" MajorTopicYN="Y">Computed Tomography Angiography</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005338" MajorTopicYN="N">Fibrin Fibrinogen Degradation Products</DescriptorName><QualifierName UI="Q000032" MajorTopicYN="Y">analysis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011237" MajorTopicYN="N">Predictive Value of Tests</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011336" MajorTopicYN="N">Probability</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011655" MajorTopicYN="N">Pulmonary Embolism</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName></MeshHeading></MeshHeadingList><InvestigatorList><Investigator ValidYN="Y"><LastName>Gross</LastName><ForeName>P</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Iorio</LastName><ForeName>A</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Linkins</LastName><ForeName>L-A</ForeName><Initials>LA</Initials></Investigator><Investigator ValidYN="Y"><LastName>Weitz</LastName><ForeName>J</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bedek</LastName><ForeName>N</ForeName><Initials>N</Initials></Investigator><Investigator ValidYN="Y"><LastName>Dodds</LastName><ForeName>S</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Smale</LastName><ForeName>S</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Stevens</LastName><ForeName>P</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Webb</LastName><ForeName>C</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bhagirath</LastName><ForeName>V</ForeName><Initials>V</Initials></Investigator><Investigator ValidYN="Y"><LastName>Douketis</LastName><ForeName>J</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Eikelboom</LastName><ForeName>J</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Pai</LastName><ForeName>M</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Zondag</LastName><ForeName>M</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kahn</LastName><ForeName>S</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Tselios</LastName><ForeName>C</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Lim</LastName><ForeName>W</ForeName><Initials>W</Initials></Investigator><Investigator ValidYN="Y"><LastName>Patriquin</LastName><ForeName>C</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Siegal</LastName><ForeName>D</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Verhovsek</LastName><ForeName>M</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Glushchenko</LastName><ForeName>A</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kruja</LastName><ForeName>E</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Carbonneau</LastName><ForeName>E</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Lamontagne</LastName><ForeName>F</ForeName><Initials>F</Initials></Investigator><Investigator ValidYN="Y"><LastName>Marchand</LastName><ForeName>J</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Masse</LastName><ForeName>H M</ForeName><Initials>HM</Initials></Investigator><Investigator ValidYN="Y"><LastName>Carrier</LastName><ForeName>M</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Castellucci</LastName><ForeName>L</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Code</LastName><ForeName>C</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Duffett</LastName><ForeName>L</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Forgie</LastName><ForeName>M</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Gonsalves</LastName><ForeName>C</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Karovitch</LastName><ForeName>A</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Rodger</LastName><ForeName>M</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Scarvelis</LastName><ForeName>D</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Wells</LastName><ForeName>P</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Carr</LastName><ForeName>H</ForeName><Initials>H</Initials></Investigator><Investigator ValidYN="Y"><LastName>Clement</LastName><ForeName>A</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Mullen</LastName><ForeName>S</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Dreyer</LastName><ForeName>J</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Pillon</LastName><ForeName>S</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Columbus</LastName><ForeName>M</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Pallaveshi</LastName><ForeName>L</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Hnatiuk</LastName><ForeName>M</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Patterson</LastName><ForeName>J</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Sun</LastName><ForeName>L</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bellot</LastName><ForeName>P</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bhattacharya</LastName><ForeName>S</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Cairns</LastName><ForeName>R</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Cleary</LastName><ForeName>S</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Anand</LastName><ForeName>S</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Schulman</LastName><ForeName>S</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Rudd-Scott</LastName><ForeName>L</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>McGean</LastName><ForeName>E</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>McCarty</LastName><ForeName>D</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Singer</LastName><ForeName>J</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Rickles</LastName><ForeName>F</ForeName><Initials>F</Initials></Investigator><Investigator ValidYN="Y"><LastName>Sussman</LastName><ForeName>J</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ellis</LastName><ForeName>P</ForeName><Initials>P</Initials></Investigator></InvestigatorList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>11</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>11</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>12</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31774957</ArticleId><ArticleId IdType="doi">10.1056/NEJMoa1909159</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">29183076</PMID><DateCompleted><Year>2017</Year><Month>12</Month><Day>12</Day></DateCompleted><DateRevised><Year>2022</Year><Month>03</Month><Day>31</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1538-3598</ISSN><JournalIssue CitedMedium="Internet"><Volume>318</Volume><Issue>20</Issue><PubDate><Year>2017</Year><Month>Nov</Month><Day>28</Day></PubDate></JournalIssue><Title>JAMA</Title><ISOAbbreviation>JAMA</ISOAbbreviation></Journal><ArticleTitle>Association Between Wait Time and 30-Day Mortality in Adults Undergoing Hip Fracture Surgery.</ArticleTitle><Pagination><StartPage>1994</StartPage><EndPage>2003</EndPage><MedlinePgn>1994-2003</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1001/jama.2017.17606</ELocationID><Abstract><AbstractText Label="IMPORTANCE">Although wait times for hip fracture surgery have been linked to mortality and are being used as quality-of-care indicators worldwide, controversy exists about the duration of the wait that leads to complications.</AbstractText><AbstractText Label="OBJECTIVE">To use population-based wait-time data to identify the optimal time window in which to conduct hip fracture surgery before the risk of complications increases.</AbstractText><AbstractText Label="DESIGN, SETTING, AND PARTICIPANTS">Population-based, retrospective cohort study of adults undergoing hip fracture surgery between April 1, 2009, and March 31, 2014, at 72 hospitals in Ontario, Canada. Risk-adjusted restricted cubic splines modeled the probability of each complication according to wait time. The inflection point (in hours) when complications began to increase was used to define early and delayed surgery. To evaluate the robustness of this definition, outcomes among propensity-score matched early and delayed surgical patients were compared using percent absolute risk differences (RDs, with 95% CIs).</AbstractText><AbstractText Label="EXPOSURE">Time elapsed from hospital arrival to surgery (in hours).</AbstractText><AbstractText Label="MAIN OUTCOMES AND MEASURES">Mortality within 30 days. Secondary outcomes included a composite of mortality or other medical complications (myocardial infarction, deep vein thrombosis, pulmonary embolism, and pneumonia).</AbstractText><AbstractText Label="RESULTS">Among 42&#x202f;230 patients with hip fracture (mean [SD] age, 80.1 years [10.7], 70.5% women) who met study entry criteria, overall mortality at 30 days was 7.0%. The risk of complications increased when wait times were greater than 24 hours, irrespective of the complication considered. Compared with 13&#x202f;731 propensity-score matched patients who received surgery earlier, 13&#x202f;731 patients who received surgery after 24 hours had a significantly higher risk of 30-day mortality (898 [6.5%] vs 790 [5.8%]; % absolute RD, 0.79; 95% CI, 0.23-1.35) and the composite outcome (1680 [12.2%]) vs 1383 [10.1%]; % absolute RD, 2.16; 95% CI, 1.43-2.89).</AbstractText><AbstractText Label="CONCLUSIONS AND RELEVANCE">Among adults undergoing hip fracture surgery, increased wait time was associated with a greater risk of 30-day mortality and other complications. A wait time of 24 hours may represent a threshold defining higher risk.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Pincus</LastName><ForeName>Daniel</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Surgery, University of Toronto, Toronto, Ontario, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute for Clinical Evaluative Sciences, Toronto, Ontario, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, Ontario, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ravi</LastName><ForeName>Bheeshma</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Surgery, University of Toronto, Toronto, Ontario, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute for Clinical Evaluative Sciences, Toronto, Ontario, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Sunnybrook Health Sciences Centre, Department of Surgery, Toronto, Ontario, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wasserstein</LastName><ForeName>David</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Surgery, University of Toronto, Toronto, Ontario, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Sunnybrook Health Sciences Centre, Department of Surgery, Toronto, Ontario, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Huang</LastName><ForeName>Anjie</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, Ontario, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Paterson</LastName><ForeName>J Michael</ForeName><Initials>JM</Initials><AffiliationInfo><Affiliation>Institute for Clinical Evaluative Sciences, Toronto, Ontario, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, Ontario, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nathens</LastName><ForeName>Avery B</ForeName><Initials>AB</Initials><AffiliationInfo><Affiliation>Department of Surgery, University of Toronto, Toronto, Ontario, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute for Clinical Evaluative Sciences, Toronto, Ontario, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, Ontario, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Sunnybrook Health Sciences Centre, Department of Surgery, Toronto, Ontario, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kreder</LastName><ForeName>Hans J</ForeName><Initials>HJ</Initials><AffiliationInfo><Affiliation>Department of Surgery, University of Toronto, Toronto, Ontario, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute for Clinical Evaluative Sciences, Toronto, Ontario, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, Ontario, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Sunnybrook Health Sciences Centre, Department of Surgery, Toronto, Ontario, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jenkinson</LastName><ForeName>Richard J</ForeName><Initials>RJ</Initials><AffiliationInfo><Affiliation>Department of Surgery, University of Toronto, Toronto, Ontario, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, Ontario, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Sunnybrook Health Sciences Centre, Department of Surgery, Toronto, Ontario, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wodchis</LastName><ForeName>Walter P</ForeName><Initials>WP</Initials><AffiliationInfo><Affiliation>Institute for Clinical Evaluative Sciences, Toronto, Ontario, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, Ontario, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Toronto Rehabilitation Institute-University Health Network, Toronto, Ontario, Canada.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>JAMA</MedlineTA><NlmUniqueID>7501160</NlmUniqueID><ISSNLinking>0098-7484</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>JAMA. 2017 Nov 28;318(20):1981-1982. doi: 10.1001/jama.2017.17624.</RefSource><PMID Version="1">29183051</PMID></CommentsCorrections><CommentsCorrections RefType="CommentIn"><RefSource>Anaesthesist. 2018 Jun;67(6):458-460. doi: 10.1007/s00101-018-0449-y.</RefSource><PMID Version="1">29728710</PMID></CommentsCorrections><CommentsCorrections RefType="CommentIn"><RefSource>JAMA. 2018 Jun 5;319(21):2233. doi: 10.1001/jama.2018.4418.</RefSource><PMID Version="1">29872850</PMID></CommentsCorrections><CommentsCorrections RefType="CommentIn"><RefSource>JAMA. 2018 Jun 5;319(21):2234. doi: 10.1001/jama.2018.4422.</RefSource><PMID Version="1">29872851</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005500" MajorTopicYN="N">Follow-Up Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005593" MajorTopicYN="N">Fracture Fixation, Internal</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006620" MajorTopicYN="N">Hip Fractures</DescriptorName><QualifierName UI="Q000401" MajorTopicYN="Y">mortality</QualifierName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D057216" MajorTopicYN="N">Propensity Score</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D061665" MajorTopicYN="Y">Time-to-Treatment</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement><b>Conflict of Interest Disclosures:</b> All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest and none were reported.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2017</Year><Month>11</Month><Day>29</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2017</Year><Month>11</Month><Day>29</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2017</Year><Month>12</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2018</Year><Month>5</Month><Day>28</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29183076</ArticleId><ArticleId IdType="pmc">PMC5820694</ArticleId><ArticleId IdType="doi">10.1001/jama.2017.17606</ArticleId><ArticleId IdType="pii">2664460</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Leslie WD, O&#x2019;Donnell S, Lagac&#xe9; C, et al. ; Osteoporosis Surveillance Expert Working Group . Population-based Canadian hip fracture rates with international comparisons. Osteoporos Int. 2010;21(8):1317-1322.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5101056</ArticleId><ArticleId IdType="pubmed">19802507</ArticleId></ArticleIdList></Reference><Reference><Citation>Pincus D, Desai SJ, Wasserstein D, et al. . Outcomes of after-hours hip fracture surgery. J Bone Joint Surg Am. 2017;99(11):914-922.</Citation><ArticleIdList><ArticleId IdType="pubmed">28590376</ArticleId></ArticleIdList></Reference><Reference><Citation>Buse GL, Bhandari M, Sancheti P, et al. ; Hip Fracture Accelerated Surgical Treatment and Care Track (HIP ATTACK) Investigators . Accelerated care versus standard care among patients with hip fracture: the HIP ATTACK pilot trial. CMAJ. 2014;186(1):E52-E60.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3883849</ArticleId><ArticleId IdType="pubmed">24246589</ArticleId></ArticleIdList></Reference><Reference><Citation>Dy CJ, McCollister KE, Lubarsky DA, Lane JM. An economic evaluation of a systems-based strategy to expedite surgical treatment of hip fractures. J Bone Joint Surg Am. 2011;93(14):1326-1334.</Citation><ArticleIdList><ArticleId IdType="pubmed">21792499</ArticleId></ArticleIdList></Reference><Reference><Citation>Simunovic N, Devereaux PJ, Sprague S, et al. . Effect of early surgery after hip fracture on mortality and complications: systematic review and meta-analysis. CMAJ. 2010;182(15):1609-1616.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2952007</ArticleId><ArticleId IdType="pubmed">20837683</ArticleId></ArticleIdList></Reference><Reference><Citation>ACS TQIP Best Practices in Management of Orthopaedic Trauma 
2015; https://www.facs.org/quality-programs/trauma/tqip/best-practice. Accessed July 11, 2016.</Citation></Reference><Reference><Citation>Canadian Institute for Health Information  Wait times for priority procedures in Canada, 2017.  Ottawa, ON: CIHI; 2017. http://www.boneandjointcanada.com.</Citation></Reference><Reference><Citation>Royal College of Physicians National Hip Fracture Database Annual Report 2015. London, England: Royal College of Physicians; 2015.</Citation></Reference><Reference><Citation>Salas M, Hofman A, Stricker BH. Confounding by indication: an example of variation in the use of epidemiologic terminology. Am J Epidemiol. 1999;149(11):981-983.</Citation><ArticleIdList><ArticleId IdType="pubmed">10355372</ArticleId></ArticleIdList></Reference><Reference><Citation>Ryan DJ, Yoshihara H, Yoneoka D, Egol KA, Zuckerman JD. Delay in hip fracture surgery: an analysis of patient-specific and hospital-specific risk factors. J Orthop Trauma. 2015;29(8):343-348.</Citation><ArticleIdList><ArticleId IdType="pubmed">25714442</ArticleId></ArticleIdList></Reference><Reference><Citation>Fu MC, Boddapati V, Gausden EB, Samuel AM, Russell LA, Lane JM. Surgery for a fracture of the hip within 24 hours of admission is independently associated with reduced short-term post-operative complications. Bone Joint J. 2017;99-B(9):1216-1222.</Citation><ArticleIdList><ArticleId IdType="pubmed">28860403</ArticleId></ArticleIdList></Reference><Reference><Citation>Bretherton CP, Parker MJ. Early surgery for patients with a fracture of the hip decreases 30-day mortality. Bone Joint J. 2015;97-B(1):104-108.</Citation><ArticleIdList><ArticleId IdType="pubmed">25568422</ArticleId></ArticleIdList></Reference><Reference><Citation>Nyholm AM, Gromov K, Palm H, Brix M, Kallemose T, Troelsen A; Danish Fracture Database Collaborators . Time to surgery is associated with thirty-day and ninety-day mortality after proximal femoral fracture: a retrospective observational study on prospectively collected data from the Danish Fracture Database Collaborators. J Bone Joint Surg Am. 2015;97(16):1333-1339.</Citation><ArticleIdList><ArticleId IdType="pubmed">26290084</ArticleId></ArticleIdList></Reference><Reference><Citation>Sayers A, Whitehouse MR, Berstock JR, Harding KA, Kelly MB, Chesser TJ. The association between the day of the week of milestones in the care pathway of patients with hip fracture and 30-day mortality: findings from a prospective national registry&#x2014;the National Hip Fracture Database of England and Wales. BMC Med. 2017;15(1):62.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5367007</ArticleId><ArticleId IdType="pubmed">28343451</ArticleId></ArticleIdList></Reference><Reference><Citation>Dawson NV, Weiss R. Dichotomizing continuous variables in statistical analysis: a practice to avoid. Med Decis Making. 2012;32(2):225-226.</Citation><ArticleIdList><ArticleId IdType="pubmed">22457338</ArticleId></ArticleIdList></Reference><Reference><Citation>Frood J, Johnson T. Improving measures of hip fracture wait times: a focus on Ontario. Healthc Q. 2010;13(4):16-18.</Citation><ArticleIdList><ArticleId IdType="pubmed">24953803</ArticleId></ArticleIdList></Reference><Reference><Citation>Sheehan KJ, Sobolev B, Guy P, et al. ; Canadian Collaborative Study on Hip Fractures . Constructing an episode of care from acute hospitalization records for studying effects of timing of hip fracture surgery. J Orthop Res. 2016;34(2):197-204.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4995103</ArticleId><ArticleId IdType="pubmed">26228250</ArticleId></ArticleIdList></Reference><Reference><Citation>Schilling PL, Bozic KJ. Development and validation of perioperative risk-adjustment models for hip fracture repair, total hip arthroplasty, and total knee arthroplasty. J Bone Joint Surg Am. 2016;98(1):e2.</Citation><ArticleIdList><ArticleId IdType="pubmed">26738909</ArticleId></ArticleIdList></Reference><Reference><Citation>Deyo RA, Cherkin DC, Ciol MA. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol. 1992;45(6):613-619.</Citation><ArticleIdList><ArticleId IdType="pubmed">1607900</ArticleId></ArticleIdList></Reference><Reference><Citation>Weiner JP, Abrams C The Johns Hopkins ACG System: technical reference guide version 10.0. 2011. 
https://www.healthpartners.com/ucm/groups/public/@hp/@public/documents/documents/cntrb_035024.pdf. Accessed November 2, 2017.</Citation></Reference><Reference><Citation>Agabiti N, Picciotto S, Cesaroni G, et al. ; Italian Study Group on Inequalities in Health Care . The influence of socioeconomic status on utilization and outcomes of elective total hip replacement: a multicity population-based longitudinal study. Int J Qual Health Care. 2007;19(1):37-44.</Citation><ArticleIdList><ArticleId IdType="pubmed">17159197</ArticleId></ArticleIdList></Reference><Reference><Citation>Kralj B. Measuring &#x201c;Rurality&#x201d; for Purposes of Health Care Planning: An Empirical Measure for Ontario. Toronto, ON: Ontario Medical Association; 2005.</Citation></Reference><Reference><Citation>Sheehan KJ, Sobolev B, Guy P, et al. ; Canadian Collaborative Study of Hip Fractures . In-hospital mortality after hip fracture by treatment setting. CMAJ. 2016;188(17-18):1219-1225.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5135491</ArticleId><ArticleId IdType="pubmed">27754892</ArticleId></ArticleIdList></Reference><Reference><Citation>Moja L, Piatti A, Pecoraro V, et al. . Timing matters in hip fracture surgery: patients operated within 48 hours have better outcomes: a meta-analysis and meta-regression of over 190,000 patients. PLoS One. 2012;7(10):e46175.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3463569</ArticleId><ArticleId IdType="pubmed">23056256</ArticleId></ArticleIdList></Reference><Reference><Citation>Prasad V, Jena AB. Prespecified falsification end points: can they validate true observational associations? JAMA. 2013;309(3):241-242.</Citation><ArticleIdList><ArticleId IdType="pubmed">23321761</ArticleId></ArticleIdList></Reference><Reference><Citation>Marrie RA, Dawson NV, Garland A. Quantile regression and restricted cubic splines are useful for exploring relationships between continuous variables. J Clin Epidemiol. 2009;62(5):511-7.e1.</Citation><ArticleIdList><ArticleId IdType="pubmed">19135859</ArticleId></ArticleIdList></Reference><Reference><Citation>Ravi B, Jenkinson R, Austin PC, et al. . Relation between surgeon volume and risk of complications after total hip arthroplasty: propensity score matched cohort study. BMJ. 2014;348:g3284.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4032026</ArticleId><ArticleId IdType="pubmed">24859902</ArticleId></ArticleIdList></Reference><Reference><Citation>Austin PC. Comparing paired vs non-paired statistical methods of analyses when making inferences about absolute risk reductions in propensity-score matched samples. Stat Med. 2011;30(11):1292-1301.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3110307</ArticleId><ArticleId IdType="pubmed">21337595</ArticleId></ArticleIdList></Reference><Reference><Citation>Austin PC. Optimal caliper widths for propensity-score matching when estimating differences in means and differences in proportions in observational studies. Pharm Stat. 2011;10(2):150-161.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3120982</ArticleId><ArticleId IdType="pubmed">20925139</ArticleId></ArticleIdList></Reference><Reference><Citation>Brookhart MA, Schneeweiss S, Rothman KJ, Glynn RJ, Avorn J, St&#xfc;rmer T. Variable selection for propensity score models. Am J Epidemiol. 2006;163(12):1149-1156.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1513192</ArticleId><ArticleId IdType="pubmed">16624967</ArticleId></ArticleIdList></Reference><Reference><Citation>Austin PC. Balance diagnostics for comparing the distribution of baseline covariates between treatment groups in propensity-score matched samples. Stat Med. 2009;28(25):3083-3107.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3472075</ArticleId><ArticleId IdType="pubmed">19757444</ArticleId></ArticleIdList></Reference><Reference><Citation>Pincus D, Gomes T, Hellings C, et al. . A population-based assessment of the drug interaction between levothyroxine and warfarin. Clin Pharmacol Ther. 2012;92(6):766-770.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3711799</ArticleId><ArticleId IdType="pubmed">23093318</ArticleId></ArticleIdList></Reference><Reference><Citation>McIsaac DI, Abdulla K, Yang H, et al. . Association of delay of urgent or emergency surgery with mortality and use of health care resources: a propensity score-matched observational cohort study. CMAJ. 2017;189(27):E905-E912.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5505757</ArticleId><ArticleId IdType="pubmed">28694308</ArticleId></ArticleIdList></Reference><Reference><Citation>Uzoigwe CE, Burnand HGF, Cheesman CL, Aghedo DO, Faizi M, Middleton RG. Early and ultra-early surgery in hip fracture patients improves survival. Injury. 2013;44(6):726-729.</Citation><ArticleIdList><ArticleId IdType="pubmed">23010072</ArticleId></ArticleIdList></Reference><Reference><Citation>Sheehan KJ, Sobolev B, Chudyk A, Stephens T, Guy P. Patient and system factors of mortality after hip fracture: a scoping review. BMC Musculoskelet Disord. 2016;17(1):166.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4832537</ArticleId><ArticleId IdType="pubmed">27079195</ArticleId></ArticleIdList></Reference><Reference><Citation>Juurlink D, Preyra C, Croxford R, et al. . Canadian Institute for Health Information Discharge Abstract Database: A Validation Study. Toronto, ON: Institute for Clinical Evaluative Sciences; 2006.</Citation></Reference><Reference><Citation>Aggarwal A, Harris IA, Naylor JM. Patient preferences for emergency or planned hip fracture surgery: a cross-sectional study. J Orthop Surg Res. 2016;11(1):120.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5067889</ArticleId><ArticleId IdType="pubmed">27751182</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36925330</PMID><DateCompleted><Year>2023</Year><Month>04</Month><Day>14</Day></DateCompleted><DateRevised><Year>2023</Year><Month>04</Month><Day>18</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1471-6771</ISSN><JournalIssue CitedMedium="Internet"><Volume>130</Volume><Issue>5</Issue><PubDate><Year>2023</Year><Month>May</Month></PubDate></JournalIssue><Title>British journal of anaesthesia</Title><ISOAbbreviation>Br J Anaesth</ISOAbbreviation></Journal><ArticleTitle>Norepinephrine versus phenylephrine for treating hypotension during general anaesthesia in adult patients undergoing major noncardiac surgery: a multicentre, open-label, cluster-randomised, crossover, feasibility, and pilot trial.</ArticleTitle><Pagination><StartPage>519</StartPage><EndPage>527</EndPage><MedlinePgn>519-527</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.bja.2023.02.004</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0007-0912(23)00062-4</ELocationID><Abstract><AbstractText Label="BACKGROUND">Intraoperative hypotension is associated with postoperative complications. The use of vasopressors is often required to correct hypotension but the best vasopressor is unknown.</AbstractText><AbstractText Label="METHODS">A multicentre, cluster-randomised, crossover, feasibility and pilot trial was conducted across five hospitals in California. Phenylephrine (PE) vs norepinephrine (NE) infusion as the first-line vasopressor in patients under general anaesthesia alternated monthly at each hospital for 6 months. The primary endpoint was first-line vasopressor administration compliance of 80% or higher. Secondary endpoints were acute kidney injury (AKI), 30-day mortality, myocardial injury after noncardiac surgery (MINS), hospital length of stay, and rehospitalisation within 30 days.</AbstractText><AbstractText Label="RESULTS">A total of 3626 patients were enrolled over 6 months; 1809 patients were randomised in the NE group, 1817 in the PE group. Overall, 88.2% received the assigned first-line vasopressor. No drug infiltrations requiring treatment were reported in either group. Patients were median 63 yr old, 50% female, and 58% white. Randomisation in the NE group vs PE group did not reduce readmission within 30 days (adjusted odds ratio=0.92; 95% confidence interval, 0.6-1.39), 30-day mortality (1.01; 0.48-2.09), AKI (1.1; 0.92-1.31), or MINS (1.63; 0.84-3.16).</AbstractText><AbstractText Label="CONCLUSIONS">A large and diverse population undergoing major surgery under general anaesthesia was successfully enrolled and randomised to receive NE or PE infusion. This pilot and feasibility trial was not powered for adverse postoperative outcomes and a follow-up multicentre effectiveness trial is planned.</AbstractText><AbstractText Label="CLINICAL TRIAL REGISTRATION">NCT04789330 (ClinicalTrials.gov).</AbstractText><CopyrightInformation>Copyright &#xa9; 2023 The Author(s). Published by Elsevier Ltd.. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Legrand</LastName><ForeName>Matthieu</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Anesthesia and Perioperative Care, University of California, San Francisco, CA, USA; INI-CRCT Network, Nancy, France. Electronic address: Matthieu.Legrand@ucsf.edu.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kothari</LastName><ForeName>Rishi</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Anesthesia and Perioperative Care, University of California, San Francisco, CA, USA; Department of Anesthesiology and Perioperative Medicine, Thomas Jefferson University, Philadelphia, PA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fong</LastName><ForeName>Nicholas</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Anesthesia and Perioperative Care, University of California, San Francisco, CA, USA; School of Medicine, University of California, San Francisco, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Palaniappa</LastName><ForeName>Nandini</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Anesthesia and Perioperative Care, University of California, San Francisco, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Boldt</LastName><ForeName>David</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Anesthesia and Perioperative Care, University of California, Los Angeles, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Lee-Lynn</ForeName><Initials>LL</Initials><AffiliationInfo><Affiliation>Department of Anesthesia and Perioperative Care, University of California, San Francisco, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kurien</LastName><ForeName>Philip</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Anesthesia and Perioperative Care, University of California, San Francisco, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gabel</LastName><ForeName>Eilon</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Anesthesia and Perioperative Care, University of California, Los Angeles, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sturgess-DaPrato</LastName><ForeName>Jillene</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Anesthesia and Perioperative Care, University of California, San Francisco, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Harhay</LastName><ForeName>Michael O</ForeName><Initials>MO</Initials><AffiliationInfo><Affiliation>Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pirracchio</LastName><ForeName>Romain</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Anesthesia and Perioperative Care, University of California, San Francisco, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bokoch</LastName><ForeName>Michael P</ForeName><Initials>MP</Initials><AffiliationInfo><Affiliation>Department of Anesthesia and Perioperative Care, University of California, San Francisco, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><CollectiveName>VEGA-1 trial investigators</CollectiveName></Author></AuthorList><Language>eng</Language><DataBankList CompleteYN="Y"><DataBank><DataBankName>ClinicalTrials.gov</DataBankName><AccessionNumberList><AccessionNumber>NCT04789330</AccessionNumber></AccessionNumberList></DataBank></DataBankList><PublicationTypeList><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType><PublicationType UI="D016448">Multicenter Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>03</Month><Day>14</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Br J Anaesth</MedlineTA><NlmUniqueID>0372541</NlmUniqueID><ISSNLinking>0007-0912</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>1WS297W6MV</RegistryNumber><NameOfSubstance UI="D010656">Phenylephrine</NameOfSubstance></Chemical><Chemical><RegistryNumber>X4W3ENH1CV</RegistryNumber><NameOfSubstance UI="D009638">Norepinephrine</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D014662">Vasoconstrictor Agents</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010656" MajorTopicYN="N">Phenylephrine</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009638" MajorTopicYN="N">Norepinephrine</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010865" MajorTopicYN="N">Pilot Projects</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005240" MajorTopicYN="N">Feasibility Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007022" MajorTopicYN="Y">Hypotension</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014662" MajorTopicYN="N">Vasoconstrictor Agents</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000768" MajorTopicYN="N">Anesthesia, General</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D058186" MajorTopicYN="Y">Acute Kidney Injury</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">acute kidney injury</Keyword><Keyword MajorTopicYN="N">cluster-randomised crossover trial</Keyword><Keyword MajorTopicYN="N">intraoperative hypotension</Keyword><Keyword MajorTopicYN="N">noncardiac surgery</Keyword><Keyword MajorTopicYN="N">norepinephrine</Keyword><Keyword MajorTopicYN="N">phenylephrine</Keyword><Keyword MajorTopicYN="N">postoperative outcomes</Keyword><Keyword MajorTopicYN="N">vasopressor</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>12</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>2</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>2</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>4</Month><Day>14</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>3</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>3</Month><Day>16</Day><Hour>23</Hour><Minute>7</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36925330</ArticleId><ArticleId IdType="doi">10.1016/j.bja.2023.02.004</ArticleId><ArticleId IdType="pii">S0007-0912(23)00062-4</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">27966438</PMID><DateCompleted><Year>2017</Year><Month>08</Month><Day>03</Day></DateCompleted><DateRevised><Year>2022</Year><Month>03</Month><Day>31</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1872-9061</ISSN><JournalIssue CitedMedium="Internet"><Volume>74</Volume><Issue>10</Issue><PubDate><Year>2016</Year><Month>Dec</Month></PubDate></JournalIssue><Title>The Netherlands journal of medicine</Title><ISOAbbreviation>Neth J Med</ISOAbbreviation></Journal><ArticleTitle>Never ignore extremely elevated D-dimer levels: they are specific for serious illness.</ArticleTitle><Pagination><StartPage>443</StartPage><EndPage>448</EndPage><MedlinePgn>443-448</MedlinePgn></Pagination><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">D-dimer is routinely measured as part of the clinical diagnosis algorithms for venous thromboembolism (VTE). In these algorithms, low D- dimer cut-off values are used to generate a dichotomous test result that is sensitive, but very non-specific for VTE. A consequence of any test dichotomisation is loss of information that is hidden in the continuous spectrum of results. For D-dimer, the information conveyed by extremely elevated results may be particularly relevant. Our aim was to assess the differential diagnosis of extremely elevated D-dimer levels in a hospital setting.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Retrospective cohort study of patients &gt; 18 years with an extremely elevated (&gt; 5000 &#x3bc;g/l; &gt; 10x cut-off to exclude VTE) D-dimer test result. Electronic medical records were reviewed for diagnoses.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">A total of 759 extremely elevated D-dimer results were identified. After exclusion of 120 duplicate cases, 53 patients undergoing cardiopulmonary resuscitation, and 5 cases without diagnostic information, 581 cases were analysed. Their D-dimer ranged between 5030 and 239,000 &#x3bc;g/l, with a mean of 17,598 &#x3bc;g/l (SD 22,972 &#x3bc;g/l). Altogether, 89% of these patients had a diagnosis of VTE, sepsis and/or cancer. The prevalence was highest for pulmonary embolism (183 patients; 32%), followed by cancer (168 patients; 29%), sepsis (142 patients; 24%), trauma/surgery (142 patients; 24%), and deep vein thrombosis (73 patients; 13%).</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Although D-dimer testing has a reputation for being very non-specific, an extremely elevated D-dimer is uniquely associated with severe disease, mainly including VTE, sepsis and/or cancer. These results suggest that, even if sharply elevated D-dimers are a seemingly solitary finding, clinical suspicion of severe underlying disease should be maintained.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Schutte</LastName><ForeName>T</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, VU University Medical Center, Amsterdam, the Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Thijs</LastName><ForeName>A</ForeName><Initials>A</Initials></Author><Author ValidYN="Y"><LastName>Smulders</LastName><ForeName>Y M</ForeName><Initials>YM</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Neth J Med</MedlineTA><NlmUniqueID>0356133</NlmUniqueID><ISSNLinking>0300-2977</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D005338">Fibrin Fibrinogen Degradation Products</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C036309">fibrin fragment D</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003937" MajorTopicYN="N">Diagnosis, Differential</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005338" MajorTopicYN="N">Fibrin Fibrinogen Degradation Products</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009369" MajorTopicYN="N">Neoplasms</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011655" MajorTopicYN="N">Pulmonary Embolism</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012680" MajorTopicYN="N">Sensitivity and Specificity</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018805" MajorTopicYN="N">Sepsis</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020246" MajorTopicYN="N">Venous Thrombosis</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2016</Year><Month>12</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2016</Year><Month>12</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2017</Year><Month>8</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">27966438</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">24732175</PMID><DateCompleted><Year>2015</Year><Month>06</Month><Day>18</Day></DateCompleted><DateRevised><Year>2014</Year><Month>09</Month><Day>25</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1473-5733</ISSN><JournalIssue CitedMedium="Internet"><Volume>25</Volume><Issue>7</Issue><PubDate><Year>2014</Year><Month>Oct</Month></PubDate></JournalIssue><Title>Blood coagulation &amp; fibrinolysis : an international journal in haemostasis and thrombosis</Title><ISOAbbreviation>Blood Coagul Fibrinolysis</ISOAbbreviation></Journal><ArticleTitle>Testosterone, thrombophilia, thrombosis.</ArticleTitle><Pagination><StartPage>683</StartPage><EndPage>687</EndPage><MedlinePgn>683-7</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1097/MBC.0000000000000126</ELocationID><Abstract><AbstractText>We assessed previously undiagnosed thrombophilia-hypofibrinolysis in 11 testosterone (T)-taking men, five of whom developed deep venous thrombosis (DVT), four pulmonary embolism, one spinal cord infarction, and one osteonecrosis 3.5 months (median) after starting T gel (50-160&#x200a;mg/day) or T intramuscular (50-250&#x200a;mg/week). In the order of referral because of thrombosis after starting T, thrombophilia-hypofibrinolysis was studied in 11 men, and, separately, in two control groups without thrombosis - 44 healthy normal male controls and 39 healthy men taking T. Nine men had DVT or DVT-pulmonary embolism after 3.5 months (median) on T, one spinal cord infarction after 5 days on T, and one had osteonecrosis (knee and then hip osteonecrosis after 6 and 18 months on T). Four of the 11 men (36%) had high factor VIII (&#x2265;150%) vs. one of 42 (2%) controls (P&#x200a;=&#x200a;0.005), and vs. one of 25 (4%) T-controls, (P&#x200a;=&#x200a;0.023). Of the 11 men, two (18%) had factor V Leiden heterozygosity vs. none of 44 controls, (P&#x200a;=&#x200a;0.04) and vs. none of 39 T-controls(P&#x200a;=&#x200a;0.045). Of the 11 men, three had 4G4G plasminogen activator inhibitor-1 homozygosity, one prothrombin G20210A heterozygosity, one low protein S, and one high factor XI. When T was continued, second DVT-pulmonary embolism recurred in three of 11 men despite adequate anticoagulation. T interacts with thrombophilia-hypofibrinolysis leading to thrombosis. Men sustaining DVT-pulmonary embolism-osteonecrosis on T should be studied for thrombophilia. Continuation of T in thrombophilic men appears to be contraindicated because of recurrent thrombosis despite adequate anticoagulation. Before starting T, to prevent T-associated thrombosis, we recommend measures of factor V Leiden, factor VIII, and the prothrombin gene.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Glueck</LastName><ForeName>Charles J</ForeName><Initials>CJ</Initials><AffiliationInfo><Affiliation>aThrombosis Center bInternal Medicine Residency Program, Jewish Hospital of Cincinnati, Cincinnati, Ohio, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Friedman</LastName><ForeName>Joel</ForeName><Initials>J</Initials></Author><Author ValidYN="Y"><LastName>Hafeez</LastName><ForeName>Ahsan</ForeName><Initials>A</Initials></Author><Author ValidYN="Y"><LastName>Hassan</LastName><ForeName>Atif</ForeName><Initials>A</Initials></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Ping</ForeName><Initials>P</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Blood Coagul Fibrinolysis</MedlineTA><NlmUniqueID>9102551</NlmUniqueID><ISSNLinking>0957-5235</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>3XMK78S47O</RegistryNumber><NameOfSubstance UI="D013739">Testosterone</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001778" MajorTopicYN="N">Blood Coagulation Disorders</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000503" MajorTopicYN="Y">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016022" MajorTopicYN="N">Case-Control Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013739" MajorTopicYN="N">Testosterone</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="Y">administration &amp; dosage</QualifierName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019851" MajorTopicYN="N">Thrombophilia</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000503" MajorTopicYN="Y">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013927" MajorTopicYN="N">Thrombosis</DescriptorName><QualifierName UI="Q000139" MajorTopicYN="N">chemically induced</QualifierName><QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2014</Year><Month>4</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2014</Year><Month>4</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2015</Year><Month>6</Month><Day>19</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">24732175</ArticleId><ArticleId IdType="doi">10.1097/MBC.0000000000000126</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36512031</PMID><DateCompleted><Year>2023</Year><Month>06</Month><Day>01</Day></DateCompleted><DateRevised><Year>2025</Year><Month>06</Month><Day>23</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1863-9941</ISSN><JournalIssue CitedMedium="Internet"><Volume>49</Volume><Issue>3</Issue><PubDate><Year>2023</Year><Month>Jun</Month></PubDate></JournalIssue><Title>European journal of trauma and emergency surgery : official publication of the European Trauma Society</Title><ISOAbbreviation>Eur J Trauma Emerg Surg</ISOAbbreviation></Journal><ArticleTitle>Tranexamic acid in hip hemiarthroplasty surgery: a systematic review and meta-analysis.</ArticleTitle><Pagination><StartPage>1247</StartPage><EndPage>1258</EndPage><MedlinePgn>1247-1258</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s00068-022-02180-x</ELocationID><Abstract><AbstractText Label="PURPOSE" NlmCategory="OBJECTIVE">Anemia is one of the most common complications after hip fracture surgery. Tranexamic acid (TXA) has been considered effective in preventing anemia in total hip arthroplasty, but its role in hemiarthroplasty is debated. The aim of this systematic review was to investigate the efficacy and safety of perioperative TXA for hip hemiarthroplasty.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">A systematic literature search was performed to identify studies comparing adult patients who underwent hemiarthroplasty for a hip fracture with and without perioperative TXA. The primary outcome was transfusion rate. Secondary outcomes included postoperative hemoglobin, length of hospital stay, adverse events (i.e., deep venous thromboses and pulmonary embolism), and 30-day mortality.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">In total, 13 articles were included, comprising 54,843 patients of whom 14.1% received perioperative TXA. TXA was applied intravenous in ten studies, topical in two studies, one study investigated both. Pooled results showed a significant reduction in transfusion rate (pooled RR: 0.48, 95% CI 0.40-0.58, p&#x2009;&lt;&#x2009;0.01). Postoperative hemoglobin and length of stay were investigated in nine studies, pooled results showed significant improvement of both outcomes for patients that received TXA. Eleven studies investigated thromboembolic events, and there was no statistical difference in deep venous thromboses (pooled RR: 0.67, 95% CI 0.18-2.56, p&#x2009;=&#x2009;0.56) or pulmonary embolism (pooled RR: 1.10, 95% CI 0.45-2.68, p&#x2009;=&#x2009;0.83)&#xa0;among the two groups. There was a significant reduction in 30-day mortality for patients that received TXA.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">TXA can be considered effective and safe for&#xa0;patients undergoing hip hemiarthroplasty, with a reduction in transfusion rate and increase in postoperative hemoglobin, without increasing adverse events. Optimal timing, dosage, and type of administration of TXA remain unclear.</AbstractText><CopyrightInformation>&#xa9; 2022. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Augustinus</LastName><ForeName>Simone</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0002-0625-4349</Identifier><AffiliationInfo><Affiliation>Department of Trauma Surgery, OLVG Hospital, Jan Tooropstraat 164, 1061 AE, Amsterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mulders</LastName><ForeName>Marjolein A M</ForeName><Initials>MAM</Initials><AffiliationInfo><Affiliation>Department of Trauma Surgery, OLVG Hospital, Jan Tooropstraat 164, 1061 AE, Amsterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gardenbroek</LastName><ForeName>Tjibbe J</ForeName><Initials>TJ</Initials><AffiliationInfo><Affiliation>Department of Trauma Surgery, OLVG Hospital, Jan Tooropstraat 164, 1061 AE, Amsterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Goslings</LastName><ForeName>J Carel</ForeName><Initials>JC</Initials><AffiliationInfo><Affiliation>Department of Trauma Surgery, OLVG Hospital, Jan Tooropstraat 164, 1061 AE, Amsterdam, The Netherlands. j.c.goslings@olvg.nl.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>12</Month><Day>13</Day></ArticleDate></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>Eur J Trauma Emerg Surg</MedlineTA><NlmUniqueID>101313350</NlmUniqueID><ISSNLinking>1863-9933</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>6T84R30KC1</RegistryNumber><NameOfSubstance UI="D014148">Tranexamic Acid</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000933">Antifibrinolytic Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D006454">Hemoglobins</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014148" MajorTopicYN="Y">Tranexamic Acid</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000933" MajorTopicYN="Y">Antifibrinolytic Agents</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D062785" MajorTopicYN="Y">Hemiarthroplasty</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016063" MajorTopicYN="N">Blood Loss, Surgical</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011655" MajorTopicYN="Y">Pulmonary Embolism</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006454" MajorTopicYN="N">Hemoglobins</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000740" MajorTopicYN="Y">Anemia</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006620" MajorTopicYN="Y">Hip Fractures</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019644" MajorTopicYN="Y">Arthroplasty, Replacement, Hip</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020246" MajorTopicYN="Y">Venous Thrombosis</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Hemiarthroplasty</Keyword><Keyword MajorTopicYN="N">Hip fracture</Keyword><Keyword MajorTopicYN="N">Systematic review and meta-analysis</Keyword><Keyword MajorTopicYN="N">Tranexamic acid</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>7</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>11</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>6</Month><Day>1</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>12</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>12</Month><Day>13</Day><Hour>11</Hour><Minute>12</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36512031</ArticleId><ArticleId IdType="doi">10.1007/s00068-022-02180-x</ArticleId><ArticleId IdType="pii">10.1007/s00068-022-02180-x</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Brauer CA, Coca-Perraillon M, Cutler DM, Rosen AB. Incidence and mortality of hip fractures in the United States. JAMA. 2009;302(14):1573&#x2013;9. https://doi.org/10.1001/jama.2009.1462 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2009.1462</ArticleId><ArticleId IdType="pubmed">19826027</ArticleId><ArticleId IdType="pmc">4410861</ArticleId></ArticleIdList></Reference><Reference><Citation>Carpintero P, Caeiro JR, Carpintero R, Morales A, Silva S, Mesa M. Complications of hip fractures: a review. World J Orthop. 2014;5(4):402&#x2013;11. https://doi.org/10.5312/wjo.v5.i4.402 .</Citation><ArticleIdList><ArticleId IdType="doi">10.5312/wjo.v5.i4.402</ArticleId><ArticleId IdType="pubmed">25232517</ArticleId><ArticleId IdType="pmc">4133447</ArticleId></ArticleIdList></Reference><Reference><Citation>Foss NB, Kristensen MT, Kehlet H. Anaemia impedes functional mobility after hip fracture surgery. Age Ageing. 2008;37(2):173&#x2013;8. https://doi.org/10.1093/ageing/afm161 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ageing/afm161</ArticleId><ArticleId IdType="pubmed">18349013</ArticleId></ArticleIdList></Reference><Reference><Citation>Mosk CA, Mus M, Vroemen JP, et al. Dementia and delirium, the outcomes in elderly hip fracture patients. Clin Interv Aging. 2017;12:421&#x2013;30. https://doi.org/10.2147/CIA.S115945 .</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/CIA.S115945</ArticleId><ArticleId IdType="pubmed">28331300</ArticleId><ArticleId IdType="pmc">5354532</ArticleId></ArticleIdList></Reference><Reference><Citation>Vamvakas EC, Blajchman MA. Transfusion-related mortality: the ongoing risks of allogeneic blood transfusion and the available strategies for their prevention. Blood. 2009;113(15):3406&#x2013;17. https://doi.org/10.1182/blood-2008-10-167643 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/blood-2008-10-167643</ArticleId><ArticleId IdType="pubmed">19188662</ArticleId></ArticleIdList></Reference><Reference><Citation>Cuesta-Peredo D, Arteaga-Moreno F, Belenguer-Varea &#xc1;, et al. Influence of hospital adverse events and previous diagnoses on hospital care cost of patients with hip fracture. Arch Osteoporos. 2019;14(1):88. https://doi.org/10.1007/s11657-019-0638-6 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11657-019-0638-6</ArticleId><ArticleId IdType="pubmed">31402396</ArticleId></ArticleIdList></Reference><Reference><Citation>Fillingham YA, Ramkumar DB, Jevsevar DS, et al. The safety of tranexamic acid in total joint arthroplasty: a direct meta-analysis. J Arthroplasty. 2018;33(10):3070-3082.e1. https://doi.org/10.1016/j.arth.2018.03.031 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.arth.2018.03.031</ArticleId><ArticleId IdType="pubmed">29699826</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang X, Ma X-L, Ma J-X. Efficiency and safety of intravenous tranexamic acid in simultaneous bilateral total knee arthroplasty: a systematic review and meta-analysis. Orthop Surg. 2016;8(3):285&#x2013;93. https://doi.org/10.1111/os.12256 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/os.12256</ArticleId><ArticleId IdType="pubmed">27627710</ArticleId><ArticleId IdType="pmc">6584435</ArticleId></ArticleIdList></Reference><Reference><Citation>Sukeik M, Alshryda S, Haddad FS, Mason JM. Systematic review and meta-analysis of the use of tranexamic acid in total hip replacement. J Bone Jt Surg Br. 2011;93(1):39&#x2013;46. https://doi.org/10.1302/0301-620X.93B1.24984 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1302/0301-620X.93B1.24984</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang F, Zhang H, Zhang Z, Ma C, Feng X. Comparison of bipolar hemiarthroplasty and total hip arthroplasty for displaced femoral neck fractures in the healthy elderly: a meta-analysis. BMC Musculoskelet Disord. 2015;16:229. https://doi.org/10.1186/s12891-015-0696-x .</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12891-015-0696-x</ArticleId><ArticleId IdType="pubmed">26316274</ArticleId><ArticleId IdType="pmc">4552391</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith GH, Tsang J, Molyneux SG, White TO. The hidden blood loss after hip fracture. Injury. 2011;42(2):133&#x2013;5. https://doi.org/10.1016/j.injury.2010.02.015 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.injury.2010.02.015</ArticleId><ArticleId IdType="pubmed">20236640</ArticleId></ArticleIdList></Reference><Reference><Citation>Foss NB, Kehlet H. Hidden blood loss after surgery for hip fracture. J Bone Jt Surg Br. 2006;88(8):1053&#x2013;9. https://doi.org/10.1302/0301-620X.88B8.17534 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1302/0301-620X.88B8.17534</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee C, Freeman R, Edmondson M, Rogers BA. The efficacy of tranexamic acid in hip hemiarthroplasty surgery: an observational cohort study. Injury. 2015;46(10):1978&#x2013;82. https://doi.org/10.1016/j.injury.2015.06.039 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.injury.2015.06.039</ArticleId><ArticleId IdType="pubmed">26190627</ArticleId></ArticleIdList></Reference><Reference><Citation>Kwak DK, Jang CY, Kim DH, Rhyu SH, Hwang JH, Yoo JH. Topical tranexamic acid in elderly patients with femoral neck fractures treated with hemiarthroplasty: efficacy and safety? A case-control study. BMC Musculoskelet Disord. 2019;20(1):1&#x2013;9. https://doi.org/10.1186/s12891-019-2615-z .</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12891-019-2615-z</ArticleId></ArticleIdList></Reference><Reference><Citation>Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009;6(7): e1000097. https://doi.org/10.1371/journal.pmed.1000097 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pmed.1000097</ArticleId><ArticleId IdType="pubmed">19621072</ArticleId><ArticleId IdType="pmc">2707599</ArticleId></ArticleIdList></Reference><Reference><Citation>Sterne JAC, Savovi&#x107; J, Page MJ, et al. RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ. 2019;366: l4898. https://doi.org/10.1136/bmj.l4898 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.l4898</ArticleId><ArticleId IdType="pubmed">31462531</ArticleId></ArticleIdList></Reference><Reference><Citation>Slim K, Nini E, Forestier D, Kwiatkowski F, Panis Y, Chipponi J. Methodological index for non-randomized studies (minors): development and validation of a new instrument. ANZ J Surg. 2003;73(9):712&#x2013;6. https://doi.org/10.1046/j.1445-2197.2003.02748.x .</Citation><ArticleIdList><ArticleId IdType="doi">10.1046/j.1445-2197.2003.02748.x</ArticleId><ArticleId IdType="pubmed">12956787</ArticleId></ArticleIdList></Reference><Reference><Citation>Wan X, Wang W, Liu J, Tong T. Estimating the sample mean and standard deviation from the sample size, median, range and/or interquartile range. BMC Med Res Methodol. 2014;14:135. https://doi.org/10.1186/1471-2288-14-135 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2288-14-135</ArticleId><ArticleId IdType="pubmed">25524443</ArticleId><ArticleId IdType="pmc">4383202</ArticleId></ArticleIdList></Reference><Reference><Citation>Higgins JPT, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med. 2002;21(11):1539&#x2013;58. https://doi.org/10.1002/sim.1186 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/sim.1186</ArticleId><ArticleId IdType="pubmed">12111919</ArticleId></ArticleIdList></Reference><Reference><Citation>Narkbunnam R, Chompoonutprapa A, Ruangsomboon P, Udomkiat P, Chareancholvanich K, Pornrattanamaneewong C. Blood loss and transfusion rate compared among different dosing regimens of tranexamic acid administration in patients undergoing hip hemiarthroplasty for femoral neck fracture: a randomized controlled trial. Injury. 2021;52(10):2986&#x2013;90. https://doi.org/10.1016/j.injury.2021.08.001 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.injury.2021.08.001</ArticleId><ArticleId IdType="pubmed">34384597</ArticleId></ArticleIdList></Reference><Reference><Citation>Nikolaou VS, Masouros P, Floros T, Chronopoulos E, Skertsou M, Babis GC. Single dose of tranexamic acid effectively reduces blood loss and transfusion rates in elderly patients undergoing surgery for hip fracture: a randomized controlled trial. Bone Joint J. 2021;103-B(3):442&#x2013;448. https://doi.org/10.1302/0301-620X.103B3.BJJ-2020-1288.R1</Citation></Reference><Reference><Citation>Thipparampall AK, Gurajala I, Gopinath R. The effect of different dose regimens of tranexamic acid in reducing blood loss during hip surgery. Indian J Anaesth. 2017;61(3):235&#x2013;9. https://doi.org/10.4103/ija.IJA_495_16 .</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/ija.IJA_495_16</ArticleId><ArticleId IdType="pubmed">28405037</ArticleId><ArticleId IdType="pmc">5372404</ArticleId></ArticleIdList></Reference><Reference><Citation>Emara WM, Moez KK, Elkhouly AH. Topical versus intravenous tranexamic acid as a blood conservation intervention for reduction of post-operative bleeding in hemiarthroplasty. Anesth Essays Res. 2014;8(1):48&#x2013;53. https://doi.org/10.4103/0259-1162.128908 .</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/0259-1162.128908</ArticleId><ArticleId IdType="pubmed">25886103</ArticleId><ArticleId IdType="pmc">4173581</ArticleId></ArticleIdList></Reference><Reference><Citation>Ashkenazi I, Schermann H, Gold A, et al. Tranexamic acid in hip hemiarthroplasty. Injury. 2020;51(11):2658&#x2013;62. https://doi.org/10.1016/j.injury.2020.07.061 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.injury.2020.07.061</ArticleId><ArticleId IdType="pubmed">32763019</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheung ZB, Anthony SG, Forsh DA, et al. Utilization, effectiveness, and safety of tranexamic acid use in hip fracture surgery: a population-based study. J Orthop. 2020;20:167&#x2013;72. https://doi.org/10.1016/j.jor.2020.01.040 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jor.2020.01.040</ArticleId><ArticleId IdType="pubmed">32025142</ArticleId><ArticleId IdType="pmc">6997115</ArticleId></ArticleIdList></Reference><Reference><Citation>Kahan JB, Morris J, Li D, Moran J, O&#x2019;Connor MI. Expanded use of tranexamic acid is safe and decreases transfusion rates in patients with geriatric hip fractures. OTA Int Open Access J Orthop Trauma. 2021;4(4): e147. https://doi.org/10.1097/OI9.0000000000000147 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/OI9.0000000000000147</ArticleId></ArticleIdList></Reference><Reference><Citation>van Rijckevorsel VAJIM, Roukema GR, Kuijper TM, de Jong L. Clinical outcomes of tranexamic acid in acute hip hemiarthroplasties in frail geriatric patients. Orthop Traumatol Surg Res. 2022;108(5):103219. https://doi.org/10.1016/j.otsr.2022.103219 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.otsr.2022.103219</ArticleId><ArticleId IdType="pubmed">35093562</ArticleId></ArticleIdList></Reference><Reference><Citation>Viberg B, Gundtoft PH, Sch&#xf8;nnemann JO, et al. Is tranexamic acid use in patients with a hip fracture safe? Bone Jt J. 2021;103-B(3):449&#x2013;55. https://doi.org/10.1302/0301-620X.103B3.BJJ-2020-1375.R2 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1302/0301-620X.103B3.BJJ-2020-1375.R2</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie J, Hu Q, Huang Q, Chen G, Zhou Z, Pei F. Efficacy and safety of tranexamic acid in geriatric hip fracture with hemiarthroplasty: a retrospective cohort study. BMC Musculoskelet Disord. 2019;20(1):1&#x2013;9. https://doi.org/10.1186/s12891-019-2670-5 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12891-019-2670-5</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu W, Hui H, Zhang Y, Lin W, Fan Y. Intra-articular tranexamic acid injection during the hip hemi-arthroplasty in elderly patients: a retrospective study. Geriatr Orthop Surg Rehabil. 2018;9:215145931880385. https://doi.org/10.1177/2151459318803851 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/2151459318803851</ArticleId></ArticleIdList></Reference><Reference><Citation>Fillingham YA, Ramkumar DB, Jevsevar DS, et al. Tranexamic acid in total joint arthroplasty: the endorsed clinical practice guides of the American Association of Hip and Knee Surgeons, American Society of Regional Anesthesia and Pain Medicine, American Academy of Orthopaedic Surgeons, Hip Society, and. Reg Anesth Pain Med. 2019;44(1):7&#x2013;11. https://doi.org/10.1136/rapm-2018-000024 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/rapm-2018-000024</ArticleId><ArticleId IdType="pubmed">30640647</ArticleId></ArticleIdList></Reference><Reference><Citation>Shichman I, Shaked O, Ashkenazi I, Schwarzkopf R, Warschawski Y, Snir N. Tranexamic acid in non-elective primary total hip arthroplasty. Injury. 2021;52(6):1544&#x2013;8. https://doi.org/10.1016/j.injury.2020.10.056 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.injury.2020.10.056</ArticleId><ArticleId IdType="pubmed">33092856</ArticleId></ArticleIdList></Reference><Reference><Citation>Haj-Younes B, Sivakumar BS, Wang M, An VV, Lorentzos P, Adie S. Tranexamic acid in hip fracture surgery: a systematic review and meta-analysis. J Orthop Surg (Hong Kong). 2020;28(1):2309499019887995. https://doi.org/10.1177/2309499019887995 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/2309499019887995</ArticleId><ArticleId IdType="pubmed">31835969</ArticleId></ArticleIdList></Reference><Reference><Citation>Farrow LS, Smith TO, Ashcroft GP, Myint PK. A systematic review of tranexamic acid in hip fracture surgery. Br J Clin Pharmacol. 2016;82(6):1458&#x2013;70. https://doi.org/10.1111/bcp.13079 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/bcp.13079</ArticleId><ArticleId IdType="pubmed">27492116</ArticleId><ArticleId IdType="pmc">5099561</ArticleId></ArticleIdList></Reference><Reference><Citation>Qi Y-M, Wang H-P, Li Y-J, et al. The efficacy and safety of intravenous tranexamic acid in hip fracture surgery: a systematic review and meta-analysis. J Orthop Transl. 2019;19:1&#x2013;11. https://doi.org/10.1016/j.jot.2019.03.007 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jot.2019.03.007</ArticleId></ArticleIdList></Reference><Reference><Citation>Xing F, Chen W, Long C, Huang F, Wang G, Xiang Z. Postoperative outcomes of tranexamic acid use in geriatric trauma patients treated with proximal femoral intramedullary nails: a systematic review and meta-analysis. Orthop Traumatol Surg Res. 2020;106(1):117&#x2013;26. https://doi.org/10.1016/j.otsr.2019.10.015 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.otsr.2019.10.015</ArticleId><ArticleId IdType="pubmed">31928976</ArticleId></ArticleIdList></Reference><Reference><Citation>Luo X, Huang H, Tang X. Efficacy and safety of tranexamic acid for reducing blood loss in elderly patients with intertrochanteric fracture treated with intramedullary fixation surgery: a meta-analysis of randomized controlled trials. Acta Orthop Traumatol Turc. 2020;54(1):4&#x2013;14. https://doi.org/10.5152/j.aott.2020.01.88 .</Citation><ArticleIdList><ArticleId IdType="doi">10.5152/j.aott.2020.01.88</ArticleId><ArticleId IdType="pubmed">32175891</ArticleId><ArticleId IdType="pmc">7243694</ArticleId></ArticleIdList></Reference><Reference><Citation>Baruah RK, Borah PJ, Haque R. Use of tranexamic acid in dynamic hip screw plate fixation for trochanteric fractures. J Orthop Surg (Hong Kong). 2016;24(3):379&#x2013;82. https://doi.org/10.1177/1602400322 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1602400322</ArticleId><ArticleId IdType="pubmed">28031511</ArticleId></ArticleIdList></Reference><Reference><Citation>Yoon B-H, Kim T-Y, Ko YS, Lee Y-K, Ha Y-C, Koo K-H. Optimal use of tranexamic acid for total hip arthroplasty: a network meta-analysis. PLoS&#xa0;One. 2018;13(10): e0206480. https://doi.org/10.1371/journal.pone.0206480 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0206480</ArticleId><ArticleId IdType="pubmed">30379905</ArticleId><ArticleId IdType="pmc">6209331</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiong H, Liu Y, Zeng Y, Wu Y, Shen B. The efficacy and safety of combined administration of intravenous and topical tranexamic acid in primary total knee arthroplasty: a meta-analysis of randomized controlled trials. BMC Musculoskelet Disord. 2018;19(1):321. https://doi.org/10.1186/s12891-018-2181-9 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12891-018-2181-9</ArticleId><ArticleId IdType="pubmed">30193586</ArticleId><ArticleId IdType="pmc">6129000</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Z-J, Fu X, Xing D, Zhang H-F, Zang J-C, Ma X-L. Is tranexamic acid effective and safe in spinal surgery? A meta-analysis of randomized controlled trials. Eur Spine J Off Publ Eur Spine Soc Eur Spinal Deform Soc Eur Sect Cerv Spine Res Soc. 2013;22(9):1950&#x2013;7. https://doi.org/10.1007/s00586-013-2774-9 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00586-013-2774-9</ArticleId></ArticleIdList></Reference><Reference><Citation>Porter SB, Spaulding AC, Duncan CM, Wilke BK, Pagnano MW, Abdel MP. Tranexamic acid was not associated with increased complications in high-risk patients with hip fracture undergoing arthroplasty. J Bone Jt Surg Am. 2021;103(20):1880&#x2013;9. https://doi.org/10.2106/JBJS.21.00172 .</Citation><ArticleIdList><ArticleId IdType="doi">10.2106/JBJS.21.00172</ArticleId></ArticleIdList></Reference><Reference><Citation>Jules-Elysee KM, Tseng A, Sculco TP, et al. Comparison of topical and intravenous tranexamic acid for total knee replacement: a randomized double-blinded controlled study of effects on tranexamic acid levels and thrombogenic and inflammatory marker levels. J Bone Jt Surg Am. 2019;101(23):2120&#x2013;8. https://doi.org/10.2106/JBJS.19.00258 .</Citation><ArticleIdList><ArticleId IdType="doi">10.2106/JBJS.19.00258</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiganti M, Pipitone O, Than J, Stanley R, Passanise A, Krumrey J. A single dose versus two doses of tranexamic acid for extracapsular hip fractures. Cureus. 2022;14(1): e21239. https://doi.org/10.7759/cureus.21239 .</Citation><ArticleIdList><ArticleId IdType="doi">10.7759/cureus.21239</ArticleId><ArticleId IdType="pubmed">35174034</ArticleId><ArticleId IdType="pmc">8841038</ArticleId></ArticleIdList></Reference><Reference><Citation>Li C, Zhang W, Chang Q, Li Y. Combination effect of intraoperative and postoperative intravenous tranexamic acid in hip hemiarthroplasty. A propensity score matched analysis. Injury. 2022;53(10):3401&#x2013;6. https://doi.org/10.1016/j.injury.2022.07.033 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.injury.2022.07.033</ArticleId><ArticleId IdType="pubmed">35922338</ArticleId></ArticleIdList></Reference><Reference><Citation>Carson JL, Stanworth SJ, Dennis JA, et al. Transfusion thresholds for guiding red blood cell transfusion. Cochrane Database Syst Rev. 2021;12:CD002042. https://doi.org/10.1002/14651858.CD002042.pub5 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/14651858.CD002042.pub5</ArticleId><ArticleId IdType="pubmed">34932836</ArticleId></ArticleIdList></Reference><Reference><Citation>Sim YE, Sim S-ED, Seng C, Howe TS, Koh SB, Abdullah HR. Preoperative anemia, functional outcomes, and quality of life after hip fracture surgery. J Am Geriatr Soc. 2018;66(8):1524&#x2013;31. https://doi.org/10.1111/jgs.15428 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jgs.15428</ArticleId><ArticleId IdType="pubmed">30091139</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36788620</PMID><DateCompleted><Year>2023</Year><Month>02</Month><Day>16</Day></DateCompleted><DateRevised><Year>2025</Year><Month>06</Month><Day>26</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1749-799X</ISSN><JournalIssue CitedMedium="Internet"><Volume>18</Volume><Issue>1</Issue><PubDate><Year>2023</Year><Month>Feb</Month><Day>14</Day></PubDate></JournalIssue><Title>Journal of orthopaedic surgery and research</Title><ISOAbbreviation>J Orthop Surg Res</ISOAbbreviation></Journal><ArticleTitle>Venous thromboembolism after arthroscopic shoulder surgery: a systematic review.</ArticleTitle><Pagination><StartPage>103</StartPage><MedlinePgn>103</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">103</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s13018-023-03592-0</ELocationID><Abstract><AbstractText Label="PURPOSE" NlmCategory="OBJECTIVE">To summarize the incidence, risk factors, diagnosis methods, prophylaxis methods, and treatment of venous thromboembolism (VTE) following arthroscopic shoulder surgery.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Literature on VTE after arthroscopic shoulder surgeries was summarized, and all primary full-text articles reporting at least 1 case of deep vein thrombosis (DVT) or pulmonary embolism (PE) after arthroscopic shoulder surgeries were included. Articles were critically appraised and systematically analyzed to determine the incidence, risk factors, diagnosis, prophylaxis, and management of VTE following arthroscopic shoulder surgeries.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">This study included 42 articles in which the incidence of VTE ranges from 0 to 5.71% and the overall incidence was 0.26%. Most VTE events took place between the operation day and the 14th day after the operation (35/51). Possible risk factors included advanced age (&gt;&#x2009;70&#xa0;years), obesity (BMI&#x2009;&#x2265;&#x2009;30&#xa0;kg/m<sup>2</sup>), diabetes mellitus, thrombophilia, history of VTE, prolonged operation time, hormone use, and immobilization after surgery. The most common prophylaxis method was mechanical prophylaxis (13/15). No statistical difference was detected when chemoprophylaxis was applied. The management included heparinization followed by oral warfarin, warfarin alone and rivaroxaban, a direct oral anticoagulant.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Based on the included studies, the incidence rate of VTE after arthroscopic shoulder surgeries is relatively low. The risk factors for VTE are still unclear. CT/CTA and ultrasound were the mainstream diagnosis methods for PE and DVT, respectively. Current evidence shows that chemical prophylaxis did not deliver significant benefits, since none of the existing studies reported statistically different results. High-quality studies focusing on the prophylaxis and management of VTE population undergoing arthroscopic shoulder surgeries should be done in the future.</AbstractText><CopyrightInformation>&#xa9; 2023. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Li</LastName><ForeName>Tao</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Orthopedics, Orthopedic Research Institute, West China Hospital, Sichuan University, No. 37, Guoxue Road, Wuhou District, Chengdu, 610041, Sichuan Province, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Li</LastName><ForeName>Yinghao</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Orthopedics, Orthopedic Research Institute, West China Hospital, Sichuan University, No. 37, Guoxue Road, Wuhou District, Chengdu, 610041, Sichuan Province, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Linmin</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>West China School of Medicine, Sichuan University, Chengdu, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pang</LastName><ForeName>Long</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Orthopedics, Orthopedic Research Institute, West China Hospital, Sichuan University, No. 37, Guoxue Road, Wuhou District, Chengdu, 610041, Sichuan Province, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tang</LastName><ForeName>Xin</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Orthopedics, Orthopedic Research Institute, West China Hospital, Sichuan University, No. 37, Guoxue Road, Wuhou District, Chengdu, 610041, Sichuan Province, People's Republic of China. tangxin9388@163.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhu</LastName><ForeName>Jing</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Respiratory and Critical Care Medicine, West China Hospital, West China School of Nursing, Sichuan University, No. 37, Guoxue Road, Wuhou District, Chengdu, Sichuan Province, People's Republic of China. zhu-jing2008@163.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>82072514</GrantID><Agency>National Natural Science Foundation of China</Agency><Country/></Grant><Grant><GrantID>2021YFS0238</GrantID><Agency>Science &amp; Technology Department of Sichuan Province</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D000078182">Systematic Review</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>02</Month><Day>14</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>J Orthop Surg Res</MedlineTA><NlmUniqueID>101265112</NlmUniqueID><ISSNLinking>1749-799X</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>5Q7ZVV76EI</RegistryNumber><NameOfSubstance UI="D014859">Warfarin</NameOfSubstance></Chemical><Chemical><RegistryNumber>9NDF7JZ4M3</RegistryNumber><NameOfSubstance UI="D000069552">Rivaroxaban</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000925">Anticoagulants</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D054556" MajorTopicYN="Y">Venous Thromboembolism</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014859" MajorTopicYN="N">Warfarin</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012782" MajorTopicYN="N">Shoulder</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011655" MajorTopicYN="Y">Pulmonary Embolism</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000069552" MajorTopicYN="N">Rivaroxaban</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000925" MajorTopicYN="N">Anticoagulants</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015994" MajorTopicYN="N">Incidence</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Arthroscopic shoulder surgery</Keyword><Keyword MajorTopicYN="N">Prophylaxis</Keyword><Keyword MajorTopicYN="N">Systematic review</Keyword><Keyword MajorTopicYN="N">Venous thromboembolism</Keyword></KeywordList><CoiStatement>The authors declare that they have no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>9</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>2</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>2</Month><Day>15</Day><Hour>0</Hour><Minute>30</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>2</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>2</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>2</Month><Day>14</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36788620</ArticleId><ArticleId IdType="pmc">PMC9927062</ArticleId><ArticleId IdType="doi">10.1186/s13018-023-03592-0</ArticleId><ArticleId IdType="pii">10.1186/s13018-023-03592-0</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Urwin M, Symmons D, Allison T, Brammah T, Busby H, Roxby M, et al. Estimating the burden of musculoskeletal disorders in the community: the comparative prevalence of symptoms at different anatomical sites, and the relation to social deprivation. Ann Rheum Dis. 1998;57(11):649&#x2013;655. doi: 10.1136/ard.57.11.649.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/ard.57.11.649</ArticleId><ArticleId IdType="pmc">PMC1752494</ArticleId><ArticleId IdType="pubmed">9924205</ArticleId></ArticleIdList></Reference><Reference><Citation>Ropars M, Thomazeau H, Huten D. Clavicle fractures. Orthop Traumatol Surg Res. 2017;103(1s):S53&#x2013;S59. doi: 10.1016/j.otsr.2016.11.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.otsr.2016.11.007</ArticleId><ArticleId IdType="pubmed">28043849</ArticleId></ArticleIdList></Reference><Reference><Citation>Launonen AP, Lepola V, Saranko A, Flinkkil&#xe4; T, Laitinen M, Mattila VM. Epidemiology of proximal humerus fractures. Arch Osteoporos. 2015;10:209. doi: 10.1007/s11657-015-0209-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11657-015-0209-4</ArticleId><ArticleId IdType="pubmed">25675881</ArticleId></ArticleIdList></Reference><Reference><Citation>Thigpen CA, Shaffer MA, Gaunt BW, Leggin BG, Williams GR, Wilcox RB., 3rd The American Society of Shoulder and Elbow Therapists' consensus statement on rehabilitation following arthroscopic rotator cuff repair. J Shoulder Elbow Surg. 2016;25(4):521&#x2013;535. doi: 10.1016/j.jse.2015.12.018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jse.2015.12.018</ArticleId><ArticleId IdType="pubmed">26995456</ArticleId></ArticleIdList></Reference><Reference><Citation>Best MJ, Tanaka MJ. Multidirectional instability of the shoulder: treatment options and considerations. Sports Med Arthrosc Rev. 2018;26(3):113&#x2013;119. doi: 10.1097/JSA.0000000000000199.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/JSA.0000000000000199</ArticleId><ArticleId IdType="pubmed">30059445</ArticleId></ArticleIdList></Reference><Reference><Citation>Karakoc Y, Atalay &#xcf;B. Comparison of mini-open versus all-arthroscopic rotator cuff repair: retrospective analysis of a single center. Pan Afr Med J. 2020;37:132. doi: 10.11604/pamj.2020.37.132.19491.</Citation><ArticleIdList><ArticleId IdType="doi">10.11604/pamj.2020.37.132.19491</ArticleId><ArticleId IdType="pmc">PMC7757326</ArticleId><ArticleId IdType="pubmed">33425165</ArticleId></ArticleIdList></Reference><Reference><Citation>Black EM, Austin LS, Narzikul A, Seidl AJ, Martens K, Lazarus MD. Comparison of implant cost and surgical time in arthroscopic transosseous and transosseous equivalent rotator cuff repair. J Shoulder Elbow Surg. 2016;25(9):1449&#x2013;1456. doi: 10.1016/j.jse.2016.01.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jse.2016.01.003</ArticleId><ArticleId IdType="pubmed">27068378</ArticleId></ArticleIdList></Reference><Reference><Citation>Rubenstein WJ, Pean CA, Colvin AC. Shoulder arthroscopy in adults 60 or older: risk factors that correlate with postoperative complications in the first 30 days. Arthroscopy. 2017;33(1):49&#x2013;54. doi: 10.1016/j.arthro.2016.05.035.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.arthro.2016.05.035</ArticleId><ArticleId IdType="pubmed">27496681</ArticleId></ArticleIdList></Reference><Reference><Citation>Shields E, Thirukumaran C, Thorsness R, Noyes K, Voloshin I. An analysis of adult patient risk factors and complications within 30 days after arthroscopic shoulder surgery. Arthroscopy. 2015;31(5):807&#x2013;815. doi: 10.1016/j.arthro.2014.12.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.arthro.2014.12.011</ArticleId><ArticleId IdType="pubmed">25661861</ArticleId></ArticleIdList></Reference><Reference><Citation>Jensen AR, Cha PS, Devana SK, Ishmael C, Di Pauli von Treuheim T, D&#x2019;Oro A, et al. Evaluation of the trends, concomitant procedures, and complications with open and arthroscopic rotator cuff repairs in the medicare population. Orthop J Sports Med. 2017 doi: 10.1177/2325967117731310.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/2325967117731310</ArticleId><ArticleId IdType="pmc">PMC5639972</ArticleId><ArticleId IdType="pubmed">29051905</ArticleId></ArticleIdList></Reference><Reference><Citation>Kelly BC, Constantinescu DS, Vap AR. Arthroscopic and open or mini-open rotator cuff repair trends and complication rates among American board of orthopaedic surgeons part II examinees (2007&#x2013;2017) Arthroscopy. 2019;35(11):3019&#x2013;3024. doi: 10.1016/j.arthro.2019.06.022.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.arthro.2019.06.022</ArticleId><ArticleId IdType="pubmed">31699252</ArticleId></ArticleIdList></Reference><Reference><Citation>Rapp CM, Shields EJ, Wiater BP, Wiater JM. Venous thromboembolism after shoulder arthoplasty and arthroscopy. J Am Acad Orthop Surg. 2019;27(8):265&#x2013;274. doi: 10.5435/JAAOS-D-17-00763.</Citation><ArticleIdList><ArticleId IdType="doi">10.5435/JAAOS-D-17-00763</ArticleId><ArticleId IdType="pubmed">30480588</ArticleId></ArticleIdList></Reference><Reference><Citation>Kahn SR. The post-thrombotic syndrome. Hematol Am Soc Hematol Educ Program. 2016;2016(1):413&#x2013;418. doi: 10.1182/asheducation-2016.1.413.</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/asheducation-2016.1.413</ArticleId><ArticleId IdType="pmc">PMC6142466</ArticleId><ArticleId IdType="pubmed">27913509</ArticleId></ArticleIdList></Reference><Reference><Citation>Essien EO, Rali P, Mathai SC. Pulmonary embolism. Med Clin N Am. 2019;103(3):549&#x2013;564. doi: 10.1016/j.mcna.2018.12.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mcna.2018.12.013</ArticleId><ArticleId IdType="pubmed">30955521</ArticleId></ArticleIdList></Reference><Reference><Citation>Lung BE, Kanjiya S, Bisogno M, Komatsu DE, Wang ED. Risk factors for venous thromboembolism in total shoulder arthroplasty. JSES Open Access. 2019;3(3):183&#x2013;188. doi: 10.1016/j.jses.2019.07.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jses.2019.07.003</ArticleId><ArticleId IdType="pmc">PMC6834973</ArticleId><ArticleId IdType="pubmed">31709360</ArticleId></ArticleIdList></Reference><Reference><Citation>Kunutsor SK, Barrett MC, Whitehouse MR, Blom AW. Venous thromboembolism following 672,495 primary total shoulder and elbow replacements: meta-analyses of incidence, temporal trends and potential risk factors. Thromb Res. 2020;189:13&#x2013;23. doi: 10.1016/j.thromres.2020.02.018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.thromres.2020.02.018</ArticleId><ArticleId IdType="pubmed">32135385</ArticleId></ArticleIdList></Reference><Reference><Citation>Kolz JM, Aibinder WR, Adams RA, Cofield RH, Sperling JW. Symptomatic thromboembolic complications after shoulder arthroplasty: an update. J Bone Joint Surg Am. 2019;101(20):1845&#x2013;1851. doi: 10.2106/JBJS.18.01200.</Citation><ArticleIdList><ArticleId IdType="doi">10.2106/JBJS.18.01200</ArticleId><ArticleId IdType="pubmed">31626009</ArticleId></ArticleIdList></Reference><Reference><Citation>Tashjian RZ, Lilly DT, Isaacson AM, Georgopoulos CE, Bettwieser SP, Burks RT, et al. Incidence of and risk factors for symptomatic venous thromboembolism after shoulder arthroplasty. Am J Orthop (Belle Mead, NJ) 2016;45(6):E379&#x2013;E385.</Citation><ArticleIdList><ArticleId IdType="pubmed">27737296</ArticleId></ArticleIdList></Reference><Reference><Citation>Westermann RW, Pugely AJ, Ries Z, Amendola A, Martin CT, Gao Y, et al. Causes and predictors of 30-day readmission after shoulder and knee arthroscopy: an analysis of 15,167 cases. Arthroscopy. 2015;31(6):1035&#x2013;40.e1. doi: 10.1016/j.arthro.2015.03.029.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.arthro.2015.03.029</ArticleId><ArticleId IdType="pubmed">26048765</ArticleId></ArticleIdList></Reference><Reference><Citation>Rubenstein WJ, Lansdown DA, Feeley BT, Ma CB, Zhang AL. The impact of body mass index on complications after shoulder arthroscopy: Should surgery eligibility be determined by body mass index cutoffs? Arthroscopy. 2019;35(3):741&#x2013;746. doi: 10.1016/j.arthro.2018.10.136.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.arthro.2018.10.136</ArticleId><ArticleId IdType="pubmed">30704887</ArticleId></ArticleIdList></Reference><Reference><Citation>Hill JR, McKnight B, Pannell WC, Heckmann N, Sivasundaram L, Mostofi A, et al. Risk factors for 30-day readmission following shoulder arthroscopy. Arthroscopy. 2017;33(1):55&#x2013;61. doi: 10.1016/j.arthro.2016.06.048.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.arthro.2016.06.048</ArticleId><ArticleId IdType="pubmed">27641638</ArticleId></ArticleIdList></Reference><Reference><Citation>Cancienne JM, Burrus MT, Diduch DR, Werner BC. High altitude is an independent risk factor for venous thromboembolism following arthroscopic rotator cuff repair: a matched case-control study in medicare patients. J Shoulder Elbow Surg. 2017;26(1):7&#x2013;13. doi: 10.1016/j.jse.2016.06.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jse.2016.06.005</ArticleId><ArticleId IdType="pubmed">27528541</ArticleId></ArticleIdList></Reference><Reference><Citation>Slim K, Nini E, Forestier D, Kwiatkowski F, Panis Y, Chipponi J. Methodological index for non-randomized studies (minors): development and validation of a new instrument. ANZ J Surg. 2003;73(9):712&#x2013;716. doi: 10.1046/j.1445-2197.2003.02748.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1046/j.1445-2197.2003.02748.x</ArticleId><ArticleId IdType="pubmed">12956787</ArticleId></ArticleIdList></Reference><Reference><Citation>Takahashi H, Yamamoto N, Nagamoto H, Sano H, Tanaka M, Itoi E. Venous thromboembolism after elective shoulder surgery: a prospective cohort study of 175 patients. J Shoulder Elbow Surg. 2014;23(5):605&#x2013;612. doi: 10.1016/j.jse.2014.01.054.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jse.2014.01.054</ArticleId><ArticleId IdType="pubmed">24745310</ArticleId></ArticleIdList></Reference><Reference><Citation>Imberti D, Dentali F, Ivaldo N, Murena L, Paladini P, Castagna A, et al. Venous thromboembolism in patients undergoing shoulder arthroscopy: findings from the RECOS registry. Clin Appl Thromb Hemost. 2015;21(5):486&#x2013;488. doi: 10.1177/1076029614567311.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1076029614567311</ArticleId><ArticleId IdType="pubmed">25616489</ArticleId></ArticleIdList></Reference><Reference><Citation>Brislin KJ, Field LD, Savoie Iii FH. Complications after arthroscopic rotator cuff repair. Arthrosc J Arthrosc Relat Surg. 2007;23(2):124&#x2013;128. doi: 10.1016/j.arthro.2006.09.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.arthro.2006.09.001</ArticleId><ArticleId IdType="pubmed">17276218</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoxie SC, Sperling JW, Cofield RH. Pulmonary embolism following rotator cuff repair. Int J Shoulder Surg. 2008;2(3):49&#x2013;51. doi: 10.4103/0973-6042.42576.</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/0973-6042.42576</ArticleId><ArticleId IdType="pmc">PMC2840827</ArticleId><ArticleId IdType="pubmed">20300313</ArticleId></ArticleIdList></Reference><Reference><Citation>Randelli P, Castagna A, Cabitza F, Cabitza P, Arrigoni P, Denti M. Infectious and thromboembolic complications of arthroscopic shoulder surgery. J Shoulder Elbow Surg. 2010;19(1):97&#x2013;101. doi: 10.1016/j.jse.2009.04.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jse.2009.04.009</ArticleId><ArticleId IdType="pubmed">19559629</ArticleId></ArticleIdList></Reference><Reference><Citation>Jameson SS, James P, Howcroft DWJ, Serrano-Pedraza I, Rangan A, Reed MR, et al. Venous thromboembolic events are rare after shoulder surgery: analysis of a national database. J Shoulder Elbow Surg. 2011;20(5):764&#x2013;770. doi: 10.1016/j.jse.2010.11.034.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jse.2010.11.034</ArticleId><ArticleId IdType="pubmed">21420324</ArticleId></ArticleIdList></Reference><Reference><Citation>Martin CT, Gao Y, Pugely AJ, Wolf BR. 30-day morbidity and mortality after elective shoulder arthroscopy: a review of 9410 cases. J Shoulder Elbow Surg. 2013;22(12):1667&#x2013;75.e1. doi: 10.1016/j.jse.2013.06.022.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jse.2013.06.022</ArticleId><ArticleId IdType="pubmed">24060598</ArticleId></ArticleIdList></Reference><Reference><Citation>Rubenstein WJ, Lansdown DA, Feeley BT, Ma CB, Zhang AL. The impact of body mass index on complications after shoulder arthroscopy: Should surgery eligibility be determined by body mass index cutoffs? Arthrosc J Arthrosc Relat Surg. 2019;35(3):741&#x2013;746. doi: 10.1016/j.arthro.2018.10.136.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.arthro.2018.10.136</ArticleId><ArticleId IdType="pubmed">30704887</ArticleId></ArticleIdList></Reference><Reference><Citation>Yeung M, Shin JJ, Lesniak BP, Lin A. Complications of arthroscopic versus open biceps tenodesis in the setting of arthroscopic rotator cuff repairs: an analysis of the American board of orthopaedic surgery database. J Am Acad Orthop Surg. 2019;28:113&#x2013;120. doi: 10.5435/JAAOS-D-19-00252.</Citation><ArticleIdList><ArticleId IdType="doi">10.5435/JAAOS-D-19-00252</ArticleId><ArticleId IdType="pubmed">31977611</ArticleId></ArticleIdList></Reference><Reference><Citation>Flanigan DC, Muchow R, Orwin J, Graf B. Arthroscopy on anticoagulated patients: a retrospective evaluation of postoperative complications. Orthopedics. 2010;33(2):82&#x2013;86. doi: 10.3928/01477447-20100104-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.3928/01477447-20100104-8</ArticleId><ArticleId IdType="pubmed">20192141</ArticleId></ArticleIdList></Reference><Reference><Citation>Rangan A, Brealey SD, Keding A, Corbacho B, Northgraves M, Kottam L, et al. Management of adults with primary frozen shoulder in secondary care (UK FROST): a multicentre, pragmatic, three-arm, superiority randomised clinical trial. Lancet. 2020;396(10256):977&#x2013;989. doi: 10.1016/S0140-6736(20)31965-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)31965-6</ArticleId><ArticleId IdType="pubmed">33010843</ArticleId></ArticleIdList></Reference><Reference><Citation>Stone AV, Agarwalla A, Gowd AK, Jacobs CA, Macalena JA, Lesniak BP, et al. Oral contraceptive pills are not a risk factor for deep vein thrombosis or pulmonary embolism after arthroscopic shoulder surgery. Orthop J Sports Med. 2019;7(1):1&#x2013;5. doi: 10.1177/2325967118822970.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/2325967118822970</ArticleId><ArticleId IdType="pmc">PMC6350148</ArticleId><ArticleId IdType="pubmed">30729148</ArticleId></ArticleIdList></Reference><Reference><Citation>Mirzayan R, McCrum CL, Butler RK, Alluri RK. Risk factors for biceps related complications following arthroscopic tenotomy of the long head of the biceps tendon. Orthop J Sports Med. 2018;6(7):1&#x2013;2.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7052466</ArticleId><ArticleId IdType="pubmed">32166093</ArticleId></ArticleIdList></Reference><Reference><Citation>Owens BD, Williams AE, Wolf JM. Risk factors for surgical complications in rotator cuff repair in a veteran population. J Shoulder Elbow Surg. 2015;24(11):1707&#x2013;1712. doi: 10.1016/j.jse.2015.04.020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jse.2015.04.020</ArticleId><ArticleId IdType="pubmed">26164483</ArticleId></ArticleIdList></Reference><Reference><Citation>Sager B, Ahn J, Tran J, Khazzam M. Timing and risk factors for venous thromboembolism after rotator cuff repair in the 30-day perioperative period. Arthrosc J Arthrosc Relat Surg. 2019;35(11):3011&#x2013;3018. doi: 10.1016/j.arthro.2019.05.045.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.arthro.2019.05.045</ArticleId><ArticleId IdType="pubmed">31629586</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuremsky MA, Cain EL, Jr, Fleischli JE. Thromboembolic phenomena after arthroscopic shoulder surgery. Arthrosc J Arthrosc Relat Surg. 2011;27(12):1614&#x2013;1619. doi: 10.1016/j.arthro.2011.06.026.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.arthro.2011.06.026</ArticleId><ArticleId IdType="pubmed">21925830</ArticleId></ArticleIdList></Reference><Reference><Citation>Duralde XA, McClelland WB., Jr The clinical results of arthroscopic transtendinous repair of grade III partial articular-sided supraspinatus tendon tears. Arthroscopy. 2012;28(2):160&#x2013;168. doi: 10.1016/j.arthro.2011.08.286.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.arthro.2011.08.286</ArticleId><ArticleId IdType="pubmed">22078003</ArticleId></ArticleIdList></Reference><Reference><Citation>Schick CW, Westermann RW, Gao Y, Wolf BR, Group A. Thromboembolism following shoulder arthroscopy: a retrospective review. Orthop J Sports Med. 2014 doi: 10.1177/2325967114559506.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/2325967114559506</ArticleId><ArticleId IdType="pmc">PMC4555560</ArticleId><ArticleId IdType="pubmed">26535285</ArticleId></ArticleIdList></Reference><Reference><Citation>Alyea E, Gaston T, Austin LS, Wowkanech C, Cypel B, Pontes M, et al. The effectiveness of aspirin for venous thromboembolism prophylaxis for patients undergoing arthroscopic rotator cuff repair. Orthopedics. 2019;42(2):E187&#x2013;E192. doi: 10.3928/01477447-20181227-05.</Citation><ArticleIdList><ArticleId IdType="doi">10.3928/01477447-20181227-05</ArticleId><ArticleId IdType="pubmed">30602049</ArticleId></ArticleIdList></Reference><Reference><Citation>Burkhart SS. Deep venous thrombosis after shoulder arthroscopy. Arthrosc J Arthrosc Relat Surg Off Publ Arthrosc Assoc N Am Int Arthrosc Assoc. 1990;6(1):61&#x2013;63. doi: 10.1016/0749-8063(90)90100-R.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0749-8063(90)90100-R</ArticleId><ArticleId IdType="pubmed">2178620</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamamoto T, Tamai K, Akutsu M, Tomizawa K, Sukegawa T, Nohara Y. Pulmonary embolism after arthroscopic rotator cuff repair: a case report. Case Rep Orthop. 2013;2013:801752.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3600284</ArticleId><ArticleId IdType="pubmed">23533883</ArticleId></ArticleIdList></Reference><Reference><Citation>Polzhofer GK, Petersen W, Hassenpflug J. Thromboembolic complication after arthroscopic shoulder surgery. Arthroscopy. 2003;19(9):E129&#x2013;E132. doi: 10.1016/j.arthro.2003.09.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.arthro.2003.09.016</ArticleId><ArticleId IdType="pubmed">14608339</ArticleId></ArticleIdList></Reference><Reference><Citation>Cort&#xe9;s ZE, Hammerman SM, Gartsman GM. Pulmonary embolism after shoulder arthroscopy: Could patient positioning and traction make a difference? J Shoulder Elbow Surg. 2007;16(2):e16&#x2013;e17. doi: 10.1016/j.jse.2006.05.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jse.2006.05.009</ArticleId><ArticleId IdType="pubmed">17097309</ArticleId></ArticleIdList></Reference><Reference><Citation>Creighton RA, Cole BJ. Upper extremity deep venous thrombosis after shoulder arthroscopy: a case report. J Shoulder Elbow Surg. 2007;16(1):e20&#x2013;e22. doi: 10.1016/j.jse.2006.04.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jse.2006.04.002</ArticleId><ArticleId IdType="pubmed">16945557</ArticleId></ArticleIdList></Reference><Reference><Citation>Bongiovanni SL, Ranalletta M, Guala A, Maignon GD. Case reports: heritable thrombophilia associated with deep venous thrombosis after shoulder arthroscopy. Clin Orthop Relat Res. 2009;467(8):2196&#x2013;2199. doi: 10.1007/s11999-009-0895-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11999-009-0895-6</ArticleId><ArticleId IdType="pmc">PMC2706365</ArticleId><ArticleId IdType="pubmed">19452233</ArticleId></ArticleIdList></Reference><Reference><Citation>Hariri A, Nourissat G, Dumontier C, Doursounian L. Pulmonary embolism following thrombosis of the brachial vein after shoulder arthroscopy. A case report. Orthop Traumatol Surg Res. 2009;95(5):377&#x2013;379. doi: 10.1016/j.otsr.2009.03.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.otsr.2009.03.016</ArticleId><ArticleId IdType="pubmed">19576863</ArticleId></ArticleIdList></Reference><Reference><Citation>Dal Molin FF, Dal Molin SF. Thromboembolic complication after arthroscopic shoulder surgery. Rev Bras Ortop. 2010;45(3):312&#x2013;315.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4799102</ArticleId><ArticleId IdType="pubmed">27022559</ArticleId></ArticleIdList></Reference><Reference><Citation>Garofalo R, Notarnicola A, Moretti L, Moretti B, Marini S, Castagna A. Deep vein thromboembolism after arthroscopy of the shoulder: two case reports and a review of the literature. BMC Musculoskel Disord. 2010;11:65. doi: 10.1186/1471-2474-11-65.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2474-11-65</ArticleId><ArticleId IdType="pmc">PMC2858720</ArticleId><ArticleId IdType="pubmed">20377851</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim SJ, Yoo KY, Lee HG, Kim WM, Jeong CW, Lee HJ. Fatal pulmonary embolism caused by thrombosis of contralateral axillary vein after arthroscopic right rotator cuff repair. Korean J Anesthesiol. 2010;59:S172&#x2013;S175. doi: 10.4097/kjae.2010.59.S.S172.</Citation><ArticleIdList><ArticleId IdType="doi">10.4097/kjae.2010.59.S.S172</ArticleId><ArticleId IdType="pmc">PMC3030029</ArticleId><ArticleId IdType="pubmed">21286433</ArticleId></ArticleIdList></Reference><Reference><Citation>Delos D, Rodeo SA. Venous thrombosis after arthroscopic shoulder surgery: pacemaker leads as a possible cause: pacemaker leads as a possible cause. HSS J Musculoskel J Hosp Spec Surg. 2011;7(3):282&#x2013;285. doi: 10.1007/s11420-011-9215-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11420-011-9215-2</ArticleId><ArticleId IdType="pmc">PMC3192900</ArticleId><ArticleId IdType="pubmed">23024627</ArticleId></ArticleIdList></Reference><Reference><Citation>Laubscher PH, Ferguson MC. Venous thrombotic events in arthroscopic shoulder surgery&#x2014;a case report and review of the literature. SA Orthop J. 2011;10(2):78&#x2013;80.</Citation></Reference><Reference><Citation>Edgar R, Nagda S, Huffman R, Namdari S. Pulmonary embolism after shoulder arthroscopy. Orthopedics. 2012;35(11):e1673&#x2013;e1676. doi: 10.3928/01477447-20121023-31.</Citation><ArticleIdList><ArticleId IdType="doi">10.3928/01477447-20121023-31</ArticleId><ArticleId IdType="pubmed">23127464</ArticleId></ArticleIdList></Reference><Reference><Citation>Durant TJS, Cote MP, Arciero RA, Mazzocca AD. Fatal pulmonary embolism after arthroscopic rotator cuff repair: a case series. Muscles Ligaments Tendons J. 2014;4(2):232&#x2013;237. doi: 10.32098/mltj.02.2014.25.</Citation><ArticleIdList><ArticleId IdType="doi">10.32098/mltj.02.2014.25</ArticleId><ArticleId IdType="pmc">PMC4187592</ArticleId><ArticleId IdType="pubmed">25332941</ArticleId></ArticleIdList></Reference><Reference><Citation>Durant TJS, Swanson BT, Cote MP, Allen DA, Arciero RA, Mazzocca AD. Upper extremity deep venous thromboembolism following arthroscopic labral repair of the shoulder and biceps tenodesis: a case report. Int J Sports Phys Ther. 2014;9(3):377&#x2013;382.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4060316</ArticleId><ArticleId IdType="pubmed">24944857</ArticleId></ArticleIdList></Reference><Reference><Citation>Goldhaber NH, Lee CS. Isolated pulmonary embolism following shoulder arthroscopy. Case Rep Ortho. 2014;2014:279082.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4273471</ArticleId><ArticleId IdType="pubmed">25548699</ArticleId></ArticleIdList></Reference><Reference><Citation>Gwark JY, Koh J-S, Park HB. Pulmonary embolism after arthroscopic rotator cuff repair&#x2014;a case report. Clin Shoulder Elbow. 2014;17(1):31&#x2013;35. doi: 10.5397/CiSE.2014.17.1.31.</Citation><ArticleIdList><ArticleId IdType="doi">10.5397/CiSE.2014.17.1.31</ArticleId></ArticleIdList></Reference><Reference><Citation>Manaqibwala MI, Ghobrial IE, Curtis AS. Upper extremity thrombosis presenting as medial elbow pain after shoulder arthroscopy. Case Rep Orthop. 2014;2014:653146.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3977502</ArticleId><ArticleId IdType="pubmed">24772360</ArticleId></ArticleIdList></Reference><Reference><Citation>Matthews JM, Wessel SS, Pate RC, Chong AC. Pulmonary embolism after arthroscopic bankart and rotator cuff repair. Kansas J Med. 2017;10(2):43&#x2013;46. doi: 10.17161/kjm.v10i2.8652.</Citation><ArticleIdList><ArticleId IdType="doi">10.17161/kjm.v10i2.8652</ArticleId><ArticleId IdType="pmc">PMC5733415</ArticleId><ArticleId IdType="pubmed">29472967</ArticleId></ArticleIdList></Reference><Reference><Citation>Yagnatovsky M, Dai AZ, Zacchilli M, Jazrawi LM. Acute pulmonary embolism after arthroscopic glenoid labral repair and subacromial decompression: case report and review of the literature. Phys Sportsmed. 2018;46(1):135&#x2013;138. doi: 10.1080/00913847.2018.1419776.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/00913847.2018.1419776</ArticleId><ArticleId IdType="pubmed">29287491</ArticleId></ArticleIdList></Reference><Reference><Citation>Watanabe H, Nagase Y, Tamai K, Tanaka S. Pulmonary embolism associated with upper extremity deep venous thrombosis after shoulder arthroscopy: a case report. J Orthop Sci. 2019;24(4):746&#x2013;749. doi: 10.1016/j.jos.2017.01.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jos.2017.01.008</ArticleId><ArticleId IdType="pubmed">28209398</ArticleId></ArticleIdList></Reference><Reference><Citation>Chauhan A, Villacis D, Boente R, Romeo AA. Venous thromboembolism after arthroscopic rotator cuff repair in a patient with a negative presurgical SARS-CoV-2 test who developed symptomatic COVID-19 three days after surgery. J Shoulder Elbow Surg. 2021;30(5):e251&#x2013;e255. doi: 10.1016/j.jse.2021.02.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jse.2021.02.003</ArticleId><ArticleId IdType="pmc">PMC7901276</ArticleId><ArticleId IdType="pubmed">33636325</ArticleId></ArticleIdList></Reference><Reference><Citation>Ji L, Lyu C, Feng M, Qiang H. Asymptomatic pulmonary embolism after shoulder arthroscopy: case report and literature review. Orthop Surg. 2021;13(3):1119&#x2013;1125. doi: 10.1111/os.12982.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/os.12982</ArticleId><ArticleId IdType="pmc">PMC8126936</ArticleId><ArticleId IdType="pubmed">33719207</ArticleId></ArticleIdList></Reference><Reference><Citation>Dattani R, Smith CD, Patel VR. The venous thromboembolic complications of shoulder and elbow surgery: a systematic review. Bone Joint J. 2013;95(1):70&#x2013;74. doi: 10.1302/0301-620X.95B1.29854.</Citation><ArticleIdList><ArticleId IdType="doi">10.1302/0301-620X.95B1.29854</ArticleId><ArticleId IdType="pubmed">23307676</ArticleId></ArticleIdList></Reference><Reference><Citation>Greene JW, Deshmukh AJ, Cushner FD. Thromboembolic complications in arthroscopic surgery. Sports Med Arthrosc Rev. 2013;21(2):69&#x2013;74. doi: 10.1097/JSA.0b013e31828a7e76.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/JSA.0b013e31828a7e76</ArticleId><ArticleId IdType="pubmed">23649153</ArticleId></ArticleIdList></Reference><Reference><Citation>Aibinder WR, Sanchez-Sotelo J. Venous thromboembolism prophylaxis in shoulder surgery. Orthop Clin N Am. 2018;49(2):257. doi: 10.1016/j.ocl.2017.11.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ocl.2017.11.012</ArticleId><ArticleId IdType="pubmed">29499826</ArticleId></ArticleIdList></Reference><Reference><Citation>Heil J, Miesbach W, Vogl T, Bechstein WO, Reinisch A. Deep vein thrombosis of the upper extremity. Deutsches Arzteblatt Int. 2017;114(14):244&#x2013;249.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5415909</ArticleId><ArticleId IdType="pubmed">28446351</ArticleId></ArticleIdList></Reference><Reference><Citation>Afshari A, Ageno W, Ahmed A, Duranteau J, Faraoni D, Kozek-Langenecker S, et al. European guidelines on perioperative venous thromboembolism prophylaxis: executive summary. Eur J Anaesthesiol. 2018;35(2):77&#x2013;83. doi: 10.1097/EJA.0000000000000729.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/EJA.0000000000000729</ArticleId><ArticleId IdType="pubmed">29112553</ArticleId></ArticleIdList></Reference><Reference><Citation>Pandor A, Tonkins M, Goodacre S, Sworn K, Clowes M, Griffin XL, et al. Risk assessment models for venous thromboembolism in hospitalised adult patients: a systematic review. BMJ Open. 2021;11(7):e045672. doi: 10.1136/bmjopen-2020-045672.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjopen-2020-045672</ArticleId><ArticleId IdType="pmc">PMC8323381</ArticleId><ArticleId IdType="pubmed">34326045</ArticleId></ArticleIdList></Reference><Reference><Citation>Sch&#xfc;nemann HJ, Cushman M, Burnett AE, Kahn SR, Beyer-Westendorf J, Spencer FA, et al. American Society of Hematology 2018 guidelines for management of venous thromboembolism: prophylaxis for hospitalized and nonhospitalized medical patients. Blood Adv. 2018;2(22):3198&#x2013;3225. doi: 10.1182/bloodadvances.2018022954.</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/bloodadvances.2018022954</ArticleId><ArticleId IdType="pmc">PMC6258910</ArticleId><ArticleId IdType="pubmed">30482763</ArticleId></ArticleIdList></Reference><Reference><Citation>Anderson DR, Morgano GP, Bennett C, Dentali F, Francis CW, Garcia DA, et al. American Society of Hematology 2019 guidelines for management of venous thromboembolism: prevention of venous thromboembolism in surgical hospitalized patients. Blood Adv. 2019;3(23):3898&#x2013;3944. doi: 10.1182/bloodadvances.2019000975.</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/bloodadvances.2019000975</ArticleId><ArticleId IdType="pmc">PMC6963238</ArticleId><ArticleId IdType="pubmed">31794602</ArticleId></ArticleIdList></Reference><Reference><Citation>Ortel TL, Neumann I, Ageno W, Beyth R, Clark NP, Cuker A, et al. American Society of Hematology 2020 guidelines for management of venous thromboembolism: treatment of deep vein thrombosis and pulmonary embolism. Blood Adv. 2020;4(19):4693&#x2013;4738. doi: 10.1182/bloodadvances.2020001830.</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/bloodadvances.2020001830</ArticleId><ArticleId IdType="pmc">PMC7556153</ArticleId><ArticleId IdType="pubmed">33007077</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37865011</PMID><DateCompleted><Year>2023</Year><Month>12</Month><Day>05</Day></DateCompleted><DateRevised><Year>2025</Year><Month>07</Month><Day>24</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1879-0267</ISSN><JournalIssue CitedMedium="Internet"><Volume>54</Volume><Issue>12</Issue><PubDate><Year>2023</Year><Month>Dec</Month></PubDate></JournalIssue><Title>Injury</Title><ISOAbbreviation>Injury</ISOAbbreviation></Journal><ArticleTitle>The effectiveness of venous thromboembolism prophylaxis interventions in trauma patients: A systematic review and network meta-analysis.</ArticleTitle><Pagination><StartPage>111078</StartPage><MedlinePgn>111078</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.injury.2023.111078</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0020-1383(23)00782-9</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Venous thromboembolism (VTE) is a major complication of trauma. Currently, there are few studies summarising the evidence for prophylaxis in trauma settings. This review provides evidence for the use of VTE prophylactic interventions in trauma patients to produce evidence-based guidelines.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">A PRISMA-compliant review was conducted from Sep 2021 to June 2023, using Embase, Medline and Google Scholar. The inclusion criteria were: randomized-controlled trials (RCTs) in English published after 2000 of adult trauma patients comparing VTE prophylaxis interventions, with a sample size higher than 20. The network analysis was conducted using RStudio. The results of the pairwise comparisons were presented in the form of a league table. The quality of evidence and heterogeneity sensitivity were assessed. The primary outcome focused on venous thromboembolism (VTE), and examined deep vein thrombosis (DVT) and pulmonary embolism (PE) as separate entities. The secondary outcomes included assessments of bleeding and mortality. PROSPERO registration: CRD42021266393.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Of the 7,948 search results, 23 studies with a total of 21,312 participants fulfilled screening criteria, which included orthopaedic, spine, solid organ, brain, spinal cord, and multi-region trauma. Of the eight papers comparing chemical prophylaxis medications in patients with hip or lower limb injuries, fondaparinux and enoxaparin were found to be significantly superior to placebo in respect of prevention of DVT, with no increased risk of bleeding. Regarding mechanical prophylaxis, meta-analysis of two studies of inferior vena cava filters failed to provide significant benefits to major trauma patients.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Enoxaparin and fondaparinux are safe and effective options for VTE prevention in trauma patients, with fondaparinux being a cheaper and easier administration option between the two. Inconclusive results were found in mechanical prophylaxis, requiring more larger-scale RCTs.</AbstractText><CopyrightInformation>Copyright &#xa9; 2023 The Author(s). Published by Elsevier Ltd.. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Peng</LastName><ForeName>Serena</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>School of Medicine, Faculty of Medical and Health Sciences, The University of Auckland Te Waipapa Taumata Rau, Auckland, New Zealand. Electronic address: NotSerenaPeng@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Mandy</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>School of Medicine, Faculty of Medical and Health Sciences, The University of Auckland Te Waipapa Taumata Rau, Auckland, New Zealand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jin</LastName><ForeName>James</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>School of Medicine, Faculty of Medical and Health Sciences, The University of Auckland Te Waipapa Taumata Rau, Auckland, New Zealand; Department of Surgery, Te Whatu Ora - Counties Manukau, Auckland, New Zealand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>MacCormick</LastName><ForeName>Andrew D</ForeName><Initials>AD</Initials><AffiliationInfo><Affiliation>School of Medicine, Faculty of Medical and Health Sciences, The University of Auckland Te Waipapa Taumata Rau, Auckland, New Zealand; Department of Surgery, Te Whatu Ora - Counties Manukau, Auckland, New Zealand.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D000078182">Systematic Review</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D000099094">Network Meta-Analysis</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>10</Month><Day>05</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Injury</MedlineTA><NlmUniqueID>0226040</NlmUniqueID><ISSNLinking>0020-1383</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D017984">Enoxaparin</NameOfSubstance></Chemical><Chemical><RegistryNumber>J177FOW5JL</RegistryNumber><NameOfSubstance UI="D000077425">Fondaparinux</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000925">Anticoagulants</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D054556" MajorTopicYN="Y">Venous Thromboembolism</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017984" MajorTopicYN="N">Enoxaparin</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000077425" MajorTopicYN="N">Fondaparinux</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000925" MajorTopicYN="N">Anticoagulants</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011655" MajorTopicYN="Y">Pulmonary Embolism</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006470" MajorTopicYN="N">Hemorrhage</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009104" MajorTopicYN="Y">Multiple Trauma</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Meta-analysis</Keyword><Keyword MajorTopicYN="N">Network, analysis</Keyword><Keyword MajorTopicYN="N">Prophylaxis</Keyword><Keyword MajorTopicYN="N">Surgery</Keyword><Keyword MajorTopicYN="N">Systematic review</Keyword><Keyword MajorTopicYN="N">Trauma</Keyword><Keyword MajorTopicYN="N">Venous thromboembolism</Keyword></KeywordList><CoiStatement>Declaration of Competing Interest The author of this article/document hereby declares that they have no relevant financial ties, affiliations, or interests, personal or professional, that could be perceived as a potential conflict of interest in relation to the subject matter discussed. All data, statements, and opinions presented are solely those of the author and are not influenced by any third-party organizations or individuals.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>8</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>9</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>9</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>12</Month><Day>5</Day><Hour>12</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>10</Month><Day>22</Day><Hour>0</Hour><Minute>41</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>10</Month><Day>21</Day><Hour>18</Hour><Minute>6</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37865011</ArticleId><ArticleId IdType="doi">10.1016/j.injury.2023.111078</ArticleId><ArticleId IdType="pii">S0020-1383(23)00782-9</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">24619042</PMID><DateCompleted><Year>2014</Year><Month>12</Month><Day>04</Day></DateCompleted><DateRevised><Year>2022</Year><Month>03</Month><Day>11</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1435-1269</ISSN><JournalIssue CitedMedium="Internet"><Volume>47</Volume><Issue>2</Issue><PubDate><Year>2014</Year><Month>Feb</Month></PubDate></JournalIssue><Title>Zeitschrift fur Gerontologie und Geriatrie</Title><ISOAbbreviation>Z Gerontol Geriatr</ISOAbbreviation></Journal><ArticleTitle>Mode of anesthesia, mortality and outcome in geriatric patients.</ArticleTitle><Pagination><StartPage>110</StartPage><EndPage>124</EndPage><MedlinePgn>110-24</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s00391-014-0611-3</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">In older non-cardiac surgery patients, the influence of the mode of anesthesia on late-term outcome (rehabilitation, mobility, independence) is a controversial issue in the medical literature. In light of an aging society, this review assessed the association between regional (RA), local (LA) and general anesthesia (GA) and mortality and morbidity.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">A literature search within the PubMed and Cochrane databases yielded 47 clinical trials and 35 reviews/meta-analyses published between 1965 and 2013. Potential outcome-influencing factors such as mortality, risk factors, early complications (e.g. postoperative confusion, aspiration, vomiting), adverse events (e.g. deep vein thrombosis, pulmonary embolism), discharge, rehabilitation and mobilization were evaluated in relation to the mode of anesthesia (RA, LA or GA).</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">The current literature contains 82 references covering 74,476 non-cardiac surgery patients. Analysis shows that the particular mode of anesthesia influences mortality and morbidity. RA is associated with reduced early mortality and morbidity, e.g. fewer incidents of deep vein thrombosis and less acute postoperative confusion, as well as a tendency toward fewer myocardial infarctions and fatal pulmonary embolisms. GA has the advantages of a lower incidence of hypotension and reduced surgery time.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Strictly speaking, true anesthesia-related complications appear to be rare and many adverse outcomes may be multifactorial. Postoperative complications are largely related to the perioperative procedure and not to the anesthesia itself. GA and RA are both useful for older non-cardiac patients, but for some procedures, e.g. hip fracture surgery, RA seems to be the technique of choice. The mode of anesthesia may only play a secondary role in mobility, rehabilitation and discharge destination. In general, due to the many different possible outcomes--which are often very difficult or impossible to compare--no other specific recommendations can be made with regard to the type of anesthesia to be preferred for older non-cardiac patients.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Luger</LastName><ForeName>T J</ForeName><Initials>TJ</Initials><AffiliationInfo><Affiliation>Department of Anaesthesiology and Critical Care Medicine, Innsbruck Medical University, Anichstr. 25, 6020, Innsbruck, Austria, thomas.luger@i-med.ac.at.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kammerlander</LastName><ForeName>C</ForeName><Initials>C</Initials></Author><Author ValidYN="Y"><LastName>Luger</LastName><ForeName>M F</ForeName><Initials>MF</Initials></Author><Author ValidYN="Y"><LastName>Kammerlander-Knauer</LastName><ForeName>U</ForeName><Initials>U</Initials></Author><Author ValidYN="Y"><LastName>Gosch</LastName><ForeName>M</ForeName><Initials>M</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>Z Gerontol Geriatr</MedlineTA><NlmUniqueID>9506215</NlmUniqueID><ISSNLinking>0948-6704</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000765" MajorTopicYN="N">Anesthesia, Conduction</DescriptorName><QualifierName UI="Q000401" MajorTopicYN="Y">mortality</QualifierName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000768" MajorTopicYN="N">Anesthesia, General</DescriptorName><QualifierName UI="Q000401" MajorTopicYN="Y">mortality</QualifierName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007902" MajorTopicYN="N">Length of Stay</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="Y">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051346" MajorTopicYN="N">Mobility Limitation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000401" MajorTopicYN="Y">mortality</QualifierName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName><QualifierName UI="Q000534" MajorTopicYN="N">rehabilitation</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015995" MajorTopicYN="N">Prevalence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011788" MajorTopicYN="N">Quality of Life</DescriptorName><QualifierName UI="Q000523" MajorTopicYN="Y">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015996" MajorTopicYN="N">Survival Rate</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2014</Year><Month>3</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2014</Year><Month>3</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2014</Year><Month>12</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">24619042</ArticleId><ArticleId IdType="doi">10.1007/s00391-014-0611-3</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>J Bone Joint Surg Am. 2008 Jan;90(1):34-42</Citation><ArticleIdList><ArticleId IdType="pubmed">18171955</ArticleId></ArticleIdList></Reference><Reference><Citation>Age Ageing. 2006 Mar;35(2):154-60</Citation><ArticleIdList><ArticleId IdType="pubmed">16414964</ArticleId></ArticleIdList></Reference><Reference><Citation>Chirurg. 2000 May;71(5):564-7</Citation><ArticleIdList><ArticleId IdType="pubmed">10875015</ArticleId></ArticleIdList></Reference><Reference><Citation>Minerva Anestesiol. 2011 Apr;77(4):394-400</Citation><ArticleIdList><ArticleId IdType="pubmed">21483383</ArticleId></ArticleIdList></Reference><Reference><Citation>Yonsei Med J. 2011 Jan;52(1):145-50</Citation><ArticleIdList><ArticleId IdType="pubmed">21155047</ArticleId></ArticleIdList></Reference><Reference><Citation>Can J Anaesth. 2006 Jul;53(7):669-77</Citation><ArticleIdList><ArticleId IdType="pubmed">16803914</ArticleId></ArticleIdList></Reference><Reference><Citation>J Med Assoc Thai. 2009 Feb;92(2):198-207</Citation><ArticleIdList><ArticleId IdType="pubmed">19253795</ArticleId></ArticleIdList></Reference><Reference><Citation>Cochrane Database Syst Rev. 2008 Oct 08;(4):CD000126</Citation><ArticleIdList><ArticleId IdType="pubmed">18843606</ArticleId></ArticleIdList></Reference><Reference><Citation>Pain Med. 2012 Jul;13(7):948-56</Citation><ArticleIdList><ArticleId IdType="pubmed">22758782</ArticleId></ArticleIdList></Reference><Reference><Citation>Med Sci Law. 2012 Apr;52(2):112-5</Citation><ArticleIdList><ArticleId IdType="pubmed">22422787</ArticleId></ArticleIdList></Reference><Reference><Citation>Acta Orthop. 2010 Jun;81(3):296-302</Citation><ArticleIdList><ArticleId IdType="pubmed">20450426</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Obstet Gynecol. 2003 Dec;189(6):1584-7; discussion 1587-9</Citation><ArticleIdList><ArticleId IdType="pubmed">14710073</ArticleId></ArticleIdList></Reference><Reference><Citation>Anesthesiology. 2007 Mar;106(3):572-90</Citation><ArticleIdList><ArticleId IdType="pubmed">17325517</ArticleId></ArticleIdList></Reference><Reference><Citation>Z Gerontol Geriatr. 2011 Jun;44(3):187-91</Citation><ArticleIdList><ArticleId IdType="pubmed">21607796</ArticleId></ArticleIdList></Reference><Reference><Citation>Control Clin Trials. 1996 Feb;17(1):1-12</Citation><ArticleIdList><ArticleId IdType="pubmed">8721797</ArticleId></ArticleIdList></Reference><Reference><Citation>Arch Orthop Trauma Surg. 2011 Oct;131(10):1435-44</Citation><ArticleIdList><ArticleId IdType="pubmed">21523326</ArticleId></ArticleIdList></Reference><Reference><Citation>AANA J. 2007 Aug;75(4):267-75</Citation><ArticleIdList><ArticleId IdType="pubmed">17711157</ArticleId></ArticleIdList></Reference><Reference><Citation>J Bone Joint Surg Am. 2013 Apr 17;95(8):729-35</Citation><ArticleIdList><ArticleId IdType="pubmed">23595072</ArticleId></ArticleIdList></Reference><Reference><Citation>J Am Geriatr Soc. 2000 Apr;48(4):405-12</Citation><ArticleIdList><ArticleId IdType="pubmed">10798467</ArticleId></ArticleIdList></Reference><Reference><Citation>Foot Ankle Spec. 2010 Aug;3(4):205-9</Citation><ArticleIdList><ArticleId IdType="pubmed">20664009</ArticleId></ArticleIdList></Reference><Reference><Citation>Br J Anaesth. 2005 Jul;95(1):95-109</Citation><ArticleIdList><ArticleId IdType="pubmed">15908453</ArticleId></ArticleIdList></Reference><Reference><Citation>J Am Geriatr Soc. 1992 Jan;40(1):8-11</Citation><ArticleIdList><ArticleId IdType="pubmed">1727853</ArticleId></ArticleIdList></Reference><Reference><Citation>J Am Geriatr Soc. 2001 Aug;49(8):1080-5</Citation><ArticleIdList><ArticleId IdType="pubmed">11555070</ArticleId></ArticleIdList></Reference><Reference><Citation>Acta Biomed. 2005;76 Suppl 1:64-8</Citation><ArticleIdList><ArticleId IdType="pubmed">16450515</ArticleId></ArticleIdList></Reference><Reference><Citation>Transfusion. 2009 Feb;49(2):227-34</Citation><ArticleIdList><ArticleId IdType="pubmed">19389209</ArticleId></ArticleIdList></Reference><Reference><Citation>Dent Traumatol. 2010 Dec;26(6):459-65</Citation><ArticleIdList><ArticleId IdType="pubmed">21078071</ArticleId></ArticleIdList></Reference><Reference><Citation>Arch Gerontol Geriatr. 2013 May-Jun;56(3):507-12</Citation><ArticleIdList><ArticleId IdType="pubmed">23246499</ArticleId></ArticleIdList></Reference><Reference><Citation>Anesthesiology. 2010 Nov;113(5):1144-62</Citation><ArticleIdList><ArticleId IdType="pubmed">20966667</ArticleId></ArticleIdList></Reference><Reference><Citation>Br J Anaesth. 2009 Sep;103(3):335-45</Citation><ArticleIdList><ArticleId IdType="pubmed">19628483</ArticleId></ArticleIdList></Reference><Reference><Citation>Anesth Analg. 2003 Feb;96(2):590-4, table of contents</Citation><ArticleIdList><ArticleId IdType="pubmed">12538217</ArticleId></ArticleIdList></Reference><Reference><Citation>J Orthop Surg Res. 2011 Feb 07;6:7</Citation><ArticleIdList><ArticleId IdType="pubmed">21294923</ArticleId></ArticleIdList></Reference><Reference><Citation>Z Gerontol Geriatr. 2011 Dec;44(6):363-7</Citation><ArticleIdList><ArticleId IdType="pubmed">22159829</ArticleId></ArticleIdList></Reference><Reference><Citation>Dis Colon Rectum. 2009 Jan;52(1):59-63</Citation><ArticleIdList><ArticleId IdType="pubmed">19273957</ArticleId></ArticleIdList></Reference><Reference><Citation>Cochrane Database Syst Rev. 2007 Apr 18;(2):CD005563</Citation><ArticleIdList><ArticleId IdType="pubmed">17443600</ArticleId></ArticleIdList></Reference><Reference><Citation>J Vasc Surg. 2009 Sep;50(3):518-25</Citation><ArticleIdList><ArticleId IdType="pubmed">19576719</ArticleId></ArticleIdList></Reference><Reference><Citation>Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1999 Mar;87(3):272-80</Citation><ArticleIdList><ArticleId IdType="pubmed">10102585</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet. 2008 Dec 20;372(9656):2132-42</Citation><ArticleIdList><ArticleId IdType="pubmed">19041130</ArticleId></ArticleIdList></Reference><Reference><Citation>Cochrane Database Syst Rev. 2002;(1):CD001159</Citation><ArticleIdList><ArticleId IdType="pubmed">11869594</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Orthop Relat Res. 2012 Jul;470(7):1958-65</Citation><ArticleIdList><ArticleId IdType="pubmed">22270468</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Surg. 2001 May;233(5):612-6</Citation><ArticleIdList><ArticleId IdType="pubmed">11360891</ArticleId></ArticleIdList></Reference><Reference><Citation>BMC Surg. 2012;12 Suppl 1:S12</Citation><ArticleIdList><ArticleId IdType="pubmed">23173755</ArticleId></ArticleIdList></Reference><Reference><Citation>Surg Endosc. 2008 Jan;22(1):61-7</Citation><ArticleIdList><ArticleId IdType="pubmed">17943385</ArticleId></ArticleIdList></Reference><Reference><Citation>Indian J Med Sci. 2002 Aug;56(8):385-90</Citation><ArticleIdList><ArticleId IdType="pubmed">12645164</ArticleId></ArticleIdList></Reference><Reference><Citation>Cochrane Database Syst Rev. 2004 Oct 18;(4):CD000521</Citation><ArticleIdList><ArticleId IdType="pubmed">15494999</ArticleId></ArticleIdList></Reference><Reference><Citation>Geriatr Orthop Surg Rehabil. 2012 Sep;3(3):121-8</Citation><ArticleIdList><ArticleId IdType="pubmed">23569705</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Orthop Relat Res. 2011 May;469(5):1391-400</Citation><ArticleIdList><ArticleId IdType="pubmed">21347818</ArticleId></ArticleIdList></Reference><Reference><Citation>Anesthesiology. 2013 Mar;118(3):729-42</Citation><ArticleIdList><ArticleId IdType="pubmed">23291626</ArticleId></ArticleIdList></Reference><Reference><Citation>N Engl J Med. 1996 Jun 6;334(23):1519-25</Citation><ArticleIdList><ArticleId IdType="pubmed">8618608</ArticleId></ArticleIdList></Reference><Reference><Citation>J Am Geriatr Soc. 2011 Jul;59(7):1313-9</Citation><ArticleIdList><ArticleId IdType="pubmed">21718258</ArticleId></ArticleIdList></Reference><Reference><Citation>BMJ. 2000 Dec 16;321(7275):1493</Citation><ArticleIdList><ArticleId IdType="pubmed">11118174</ArticleId></ArticleIdList></Reference><Reference><Citation>Anesth Analg. 2003 Feb;96(2):583-9, table of contents</Citation><ArticleIdList><ArticleId IdType="pubmed">12538216</ArticleId></ArticleIdList></Reference><Reference><Citation>J Am Geriatr Soc. 2010 Oct;58(10):1843-9</Citation><ArticleIdList><ArticleId IdType="pubmed">20831727</ArticleId></ArticleIdList></Reference><Reference><Citation>Acta Chir Orthop Traumatol Cech. 2009 Feb;76(1):41-6</Citation><ArticleIdList><ArticleId IdType="pubmed">19268048</ArticleId></ArticleIdList></Reference><Reference><Citation>Age Ageing. 2008 Mar;37(2):173-8</Citation><ArticleIdList><ArticleId IdType="pubmed">18349013</ArticleId></ArticleIdList></Reference><Reference><Citation>Can J Anaesth. 1989 May;36(3 Pt 1):311-9</Citation><ArticleIdList><ArticleId IdType="pubmed">2655951</ArticleId></ArticleIdList></Reference><Reference><Citation>Br J Anaesth. 2000 Apr;84(4):450-5</Citation><ArticleIdList><ArticleId IdType="pubmed">10823094</ArticleId></ArticleIdList></Reference><Reference><Citation>Z Gerontol Geriatr. 2008 Dec;41(6):447-52</Citation><ArticleIdList><ArticleId IdType="pubmed">19190867</ArticleId></ArticleIdList></Reference><Reference><Citation>Anesthesiology. 2002 Dec;97(6):1609-17</Citation><ArticleIdList><ArticleId IdType="pubmed">12459692</ArticleId></ArticleIdList></Reference><Reference><Citation>Age Ageing. 1999 Mar;28(2):135-9</Citation><ArticleIdList><ArticleId IdType="pubmed">10350409</ArticleId></ArticleIdList></Reference><Reference><Citation>Acta Orthop Belg. 2001 Dec;67(5):468-74</Citation><ArticleIdList><ArticleId IdType="pubmed">11822077</ArticleId></ArticleIdList></Reference><Reference><Citation>Anesth Analg. 1995 Jun;80(6):1223-32</Citation><ArticleIdList><ArticleId IdType="pubmed">7762856</ArticleId></ArticleIdList></Reference><Reference><Citation>Anaesthesia. 2001 Dec;56(12):1141-53</Citation><ArticleIdList><ArticleId IdType="pubmed">11736769</ArticleId></ArticleIdList></Reference><Reference><Citation>Osteoporos Int. 2010 Dec;21(Suppl 4):S555-72</Citation><ArticleIdList><ArticleId IdType="pubmed">21057995</ArticleId></ArticleIdList></Reference><Reference><Citation>Anesth Analg. 2013 Aug;117(2):471-8</Citation><ArticleIdList><ArticleId IdType="pubmed">23757476</ArticleId></ArticleIdList></Reference><Reference><Citation>BMC Surg. 2012;12 Suppl 1:S2</Citation><ArticleIdList><ArticleId IdType="pubmed">23174028</ArticleId></ArticleIdList></Reference><Reference><Citation>Anesth Analg. 2001 Aug;93(2):301-8, 2nd contents page</Citation><ArticleIdList><ArticleId IdType="pubmed">11473849</ArticleId></ArticleIdList></Reference><Reference><Citation>Anaesthesiol Intensive Ther. 2012 Aug 08;44(2):104-11</Citation><ArticleIdList><ArticleId IdType="pubmed">22992971</ArticleId></ArticleIdList></Reference><Reference><Citation>Br J Anaesth. 2009 Jan;102(1):111-6</Citation><ArticleIdList><ArticleId IdType="pubmed">19059921</ArticleId></ArticleIdList></Reference><Reference><Citation>Cochrane Database Syst Rev. 2008 Jul 16;(3):CD000337</Citation><ArticleIdList><ArticleId IdType="pubmed">18646065</ArticleId></ArticleIdList></Reference><Reference><Citation>Arch Phys Med Rehabil. 2007 Jul;88(7):916-21</Citation><ArticleIdList><ArticleId IdType="pubmed">17601474</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">22626760</PMID><DateCompleted><Year>2012</Year><Month>09</Month><Day>04</Day></DateCompleted><DateRevised><Year>2025</Year><Month>06</Month><Day>26</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1552-6259</ISSN><JournalIssue CitedMedium="Internet"><Volume>94</Volume><Issue>1</Issue><PubDate><Year>2012</Year><Month>Jul</Month></PubDate></JournalIssue><Title>The Annals of thoracic surgery</Title><ISOAbbreviation>Ann Thorac Surg</ISOAbbreviation></Journal><ArticleTitle>A systematic review of pulmonary embolism in patients with lung cancer.</ArticleTitle><Pagination><StartPage>311</StartPage><EndPage>316</EndPage><MedlinePgn>311-6</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.athoracsur.2012.03.025</ELocationID><Abstract><AbstractText>Pulmonary embolism (PE) is increasingly recognized as causing significant morbidity and mortality in modern societies; however, little is known about PE in patients with lung cancer. We systematically reviewed Medline, Web of Science, and the Cochrane Library databases and selected 26 studies, including 2 randomized controlled trials, and 4 prospective, 18 retrospective cohort, and 2 case-control studies. Overall incidence of PE was 3.6%. Pulmonary embolism abbreviated survival in 2 studies when the diagnosis was synchronous with lung cancer. Venous thromboembolism prophylaxis, treatment, and surveillance are inconsistently reported. Clinical outcome data pertaining to this topic are limited and of overall poor methodologic quality.</AbstractText><CopyrightInformation>Copyright &#xa9; 2012 The Society of Thoracic Surgeons. Published by Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Malgor</LastName><ForeName>Rafael D</ForeName><Initials>RD</Initials><AffiliationInfo><Affiliation>Division of Vascular Surgery, Department of Surgery, Stony Brook University Medical Center, Stony Brook, New York 11794-8191, USA. rafael.malgor@sbumed.org</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bilfinger</LastName><ForeName>Thomas V</ForeName><Initials>TV</Initials></Author><Author ValidYN="Y"><LastName>Labropoulos</LastName><ForeName>Nicos</ForeName><Initials>N</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2012</Year><Month>05</Month><Day>23</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Ann Thorac Surg</MedlineTA><NlmUniqueID>15030100R</NlmUniqueID><ISSNLinking>0003-4975</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008175" MajorTopicYN="N">Lung Neoplasms</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011655" MajorTopicYN="N">Pulmonary Embolism</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D054556" MajorTopicYN="N">Venous Thromboembolism</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2011</Year><Month>12</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2012</Year><Month>3</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2012</Year><Month>3</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2012</Year><Month>5</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2012</Year><Month>5</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2012</Year><Month>9</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">22626760</ArticleId><ArticleId IdType="doi">10.1016/j.athoracsur.2012.03.025</ArticleId><ArticleId IdType="pii">S0003-4975(12)00639-X</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">31145362</PMID><DateCompleted><Year>2019</Year><Month>06</Month><Day>07</Day></DateCompleted><DateRevised><Year>2024</Year><Month>07</Month><Day>19</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1536-5964</ISSN><JournalIssue CitedMedium="Internet"><Volume>98</Volume><Issue>22</Issue><PubDate><Year>2019</Year><Month>May</Month></PubDate></JournalIssue><Title>Medicine</Title><ISOAbbreviation>Medicine (Baltimore)</ISOAbbreviation></Journal><ArticleTitle>Bilateral total knee arthroplasty: Simultaneous or staged? A systematic review and meta-analysis.</ArticleTitle><Pagination><StartPage>e15931</StartPage><MedlinePgn>e15931</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e15931</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1097/MD.0000000000015931</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Total knee arthroplasty (TKA) is one of the most successful orthopedic surgeries performed in recent decades. However, controversies still exist between conducting simultaneous or staged bilateral TKA. The objective of this study is to conduct a systematic review assessing the clinical outcome associated with simultaneous bilateral and staged bilateral total knee arthroplasty (BTKA).</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">A search was applied to CNKI, Embase, Medline, and Cochrane central database (January 2000-July 2018). All studies that compared simultaneous bilateral TKA (simBTKA) with staged bilateral TKA (staBTKA) without language restriction were reviewed, and qualities of included studies were assessed using the Newcastle-Ottawa Scale. Data were pooled and a meta-analysis completed.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">The 18 studies were identified to be eligible. The 18 comparative studies published from 2001 to 2018, covered 73617 participants in the simBTKA group and 61838 in the staBTKA group, respectively. Results of meta-analyses indicated that simBTKA showed a lower risk of deep infection and respiratory complications, but increased mortality, pulmonary embolism (PE), and deep-vein thrombosis (DVT) compared with staBTKA. There were no significant differences in revision, superficial infection, arthrofibrosis, cardiac complications, neurological complications and urinary complications between procedures.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Since there are risks and benefits to both procedures, these potential complications must be interpreted in light of each individual patient's needs and concerns. Further research must be conducted, in the form of a randomized clinical trial, to evaluate the outcomes mentioned in this review.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Limin</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Orthopaedic Surgery, The North China Petroleum Administration Bureau General Hospital, Renqiu.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Hongtian</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Tuberculosis prevention and control center, Shijiazhuang Center for Disease Control and Prevention, Shijiazhuang, Hebei, P.R. China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Hui</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Orthopaedic Surgery, The North China Petroleum Administration Bureau General Hospital, Renqiu.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Song</LastName><ForeName>Jingtao</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Orthopaedic Surgery, The North China Petroleum Administration Bureau General Hospital, Renqiu.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Ling</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Orthopaedic Surgery, The North China Petroleum Administration Bureau General Hospital, Renqiu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D003160">Comparative Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Medicine (Baltimore)</MedlineTA><NlmUniqueID>2985248R</NlmUniqueID><ISSNLinking>0025-7974</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019645" MajorTopicYN="N">Arthroplasty, Replacement, Knee</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName><QualifierName UI="Q000401" MajorTopicYN="Y">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName><QualifierName UI="Q000401" MajorTopicYN="Y">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011655" MajorTopicYN="N">Pulmonary Embolism</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020246" MajorTopicYN="N">Venous Thrombosis</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading></MeshHeadingList><CoiStatement>The authors have no conflicts of interest to disclose.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>5</Month><Day>31</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>5</Month><Day>31</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>6</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2019</Year><Month>5</Month><Day>31</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31145362</ArticleId><ArticleId IdType="pmc">PMC6708906</ArticleId><ArticleId IdType="doi">10.1097/MD.0000000000015931</ArticleId><ArticleId IdType="pii">00005792-201905310-00092</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Ferket BS, Feldman Z, Zhou J, et al. Impact of total knee replacement practice: cost effectiveness analysis of data from the osteoarthritis initiative. BMJ 2017;356:j1131.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6284324</ArticleId><ArticleId IdType="pubmed">28351833</ArticleId></ArticleIdList></Reference><Reference><Citation>Rodriguez JA, Bhende H, Ranawat CS. Total condylar knee replacement: a 20-year followup study. Clin Orthop Relat Res 2001;388:10&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">11451106</ArticleId></ArticleIdList></Reference><Reference><Citation>Memtsoudis SG, Ma Y, Chiu YL, et al. Bilateral total knee arthroplasty: risk factors for major morbidity and mortality. Anesth Analg 2011;113:784&#x2013;90.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3183335</ArticleId><ArticleId IdType="pubmed">21752942</ArticleId></ArticleIdList></Reference><Reference><Citation>Leonard L, Williamson DM, Ivory JP, et al. An evaluation of the safety and efficacy of simultaneous bilateral total knee arthroplasty. J Arthrop 2003;18:972&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">14658100</ArticleId></ArticleIdList></Reference><Reference><Citation>Sheth DS, Cafri G, Paxton EW, et al. Bilateral simultaneous vs staged total knee arthroplasty: a comparison of complications and mortality. J Arthrop 2016;31:212&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">27430183</ArticleId></ArticleIdList></Reference><Reference><Citation>Sobh AH, Siljander MP, Mells AJ, et al. Cost analysis, complications, and discharge disposition associated with simultaneous vs staged bilateral total knee arthroplasty. J Arthrop 2018;33:320&#x2013;3.</Citation><ArticleIdList><ArticleId IdType="pubmed">28988612</ArticleId></ArticleIdList></Reference><Reference><Citation>Dong F, Li G, Kai C, et al. Comparison of clinical outcome between simultaneous-bilateral and staged-bilateral total knee arthroplasty: a systematic review of retrospective studies. J Arthrop 2013;28:1141&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">23518424</ArticleId></ArticleIdList></Reference><Reference><Citation>Memtsoudis S, Gaber L, Sculco T. In-hospital complications and mortality of unilateral, bilateral, and revision TKA: Based on an estimate of 4,159,661 discharges. Clin Orthop Relat Res 2008;466:2617&#x2013;27.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2565056</ArticleId><ArticleId IdType="pubmed">18704616</ArticleId></ArticleIdList></Reference><Reference><Citation>Stanley D, Stockley I, Getty CJ. Simultaneous or staged bilateral total knee replacements in rheumatoid arthritis. Prospect Study J Bone Joint Surg Br Vol 1990;72:772&#x2013;4.</Citation><ArticleIdList><ArticleId IdType="pubmed">2211753</ArticleId></ArticleIdList></Reference><Reference><Citation>Adili A, Bhandari M, Petruccelli D, et al. Sequential bilateral total knee arthroplasty under 1 anesthetic in patients &#x2265;75 years old &#x2217; &#x2217;&#x2217;: complications and functional outcomes. J Arthroplasty 2001;16:271&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">11307122</ArticleId></ArticleIdList></Reference><Reference><Citation>Ritter MA, Meding JB. Bilateral simultaneous total knee arthroplasty. J Arthroplasty 1987;2:185&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">3668546</ArticleId></ArticleIdList></Reference><Reference><Citation>Reuben JD, Meyers SJ, Cox DD, et al. Cost comparison between bilateral simultaneous, staged, and unilateral total joint arthroplasty. J Arthroplasty 1998;13:172&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">9526210</ArticleId></ArticleIdList></Reference><Reference><Citation>Binjie Zhu ZC, Feng Liu, Weimin Fan The safety and efficacy of simultaneous or staged bilateral total knee arthroplasty in treatment of both knee osteoarthritis. Chin J Orthop 2014;34:619&#x2013;23.</Citation></Reference><Reference><Citation>Chua HS, Whitehouse SL, Lorimer M, et al. Mortality and implant survival with simultaneous and staged bilateral total knee arthroplasty experience from the australian orthopaedic association national joint replacement registry. J Arthroplasty 2018;33:3167&#x2013;73.</Citation><ArticleIdList><ArticleId IdType="pubmed">29908796</ArticleId></ArticleIdList></Reference><Reference><Citation>Lindberg-Larsen M, J&#xf8;rgensen CC, Husted H, et al. Early morbidity after simultaneous and staged bilateral total knee arthroplasty. Knee Surg Sports Traumatol Arthrosc Off J Esska 2015;23:831&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">24503963</ArticleId></ArticleIdList></Reference><Reference><Citation>Bini SA, Khatod M, Inacio MC, et al. Same-day versus staged bilateral total knee arthroplasty poses no increase in complications in 6672 primary procedures. J Arthroplasty 2014;29:694&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">24360340</ArticleId></ArticleIdList></Reference><Reference><Citation>Moher D, Liberati A, Tetzlaff J, et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med 2009;6:e1000097.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2707599</ArticleId><ArticleId IdType="pubmed">19621072</ArticleId></ArticleIdList></Reference><Reference><Citation>Stang A. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol 2011;25:603&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="pubmed">20652370</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang KV, Chen JD, Wu WT, et al. Is sarcopenia associated with hepatic encephalopathy in liver cirrhosis? A systematic review and meta-analysis. J Formos Med Assoc 2019;118:833&#x2013;42.</Citation><ArticleIdList><ArticleId IdType="pubmed">30279030</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang KV, Chen JD, Wu WT, et al. Association between loss of skeletal muscle mass and mortality and tumor recurrence in hepatocellular carcinoma: a systematic review and meta-analysis. Liver Cancer 2018;7:90&#x2013;103.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5892377</ArticleId><ArticleId IdType="pubmed">29662836</ArticleId></ArticleIdList></Reference><Reference><Citation>Lau J, Ioannidis JP, Schmid CH. Quantitative synthesis in systematic reviews. Ann Internal Med 1997;127:820&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">9382404</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen IJ, Chang KV, Wu WT, et al. Ultrasound parameters other than the direct measurement of ulnar nerve size for diagnosing cubital tunnel syndrome: a systemic review and meta-analysis. Arch Phys Med Rehabil 2018;25:</Citation><ArticleIdList><ArticleId IdType="pubmed">30055161</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang KV, Wu WT, Han DS, et al. Ulnar nerve cross-sectional area for the diagnosis of cubital tunnel syndrome: a meta-analysis of ultrasonographic measurements. Arch Phys Med Rehabil 2018;99:743&#x2013;57.</Citation><ArticleIdList><ArticleId IdType="pubmed">28888384</ArticleId></ArticleIdList></Reference><Reference><Citation>Courtney PM, Melnic CM, Alosh H, et al. Is bilateral total knee arthroplasty staged at a one-week interval safe? A matched case control study. J Arthroplasty 2014;29:1946&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">24953946</ArticleId></ArticleIdList></Reference><Reference><Citation>Memtsoudis SG, Ma Y, Gonz&#xe1;lez DVA, et al. Perioperative outcomes after unilateral and bilateral total knee arthroplasty. Anesthesiology 2009;111:1206&#x2013;16.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2803038</ArticleId><ArticleId IdType="pubmed">19934863</ArticleId></ArticleIdList></Reference><Reference><Citation>Bolognesi MP, Tyler Steven W, Attarian DE, et al. Simultaneous vs staged bilateral total knee arthroplasty among Medicare beneficiaries, 2000-2009. J Arthroplasty 2013;28:87&#x2013;91.</Citation><ArticleIdList><ArticleId IdType="pubmed">23932073</ArticleId></ArticleIdList></Reference><Reference><Citation>Hutchinson JR, Parish EN, Cross MJ. A comparison of bilateral uncemented total knee arthroplasty: simultaneous or staged. J Bone Joint Surg Br Vol 2006;88:40&#x2013;3.</Citation><ArticleIdList><ArticleId IdType="pubmed">16365118</ArticleId></ArticleIdList></Reference><Reference><Citation>Niki Y, Katsuyama E, Takeda Y, et al. Comparison of postoperative morbidity between simultaneous bilateral and staged bilateral total knee arthroplasties: serological perspective and clinical consequences. J Arthroplasty 2014;29:504&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">23988436</ArticleId></ArticleIdList></Reference><Reference><Citation>Yoon H-S, Han C-D, Yang I-H. Comparison of simultaneous bilateral and staged bilateral total knee arthroplasty in terms of perioperative complications. J Arthroplasty 2010;25:179&#x2013;85.</Citation><ArticleIdList><ArticleId IdType="pubmed">19195827</ArticleId></ArticleIdList></Reference><Reference><Citation>Meehan JP, Danielsen B, Tancredi DJ, et al. A population-based comparison of the incidence of adverse outcomes after simultaneous-bilateral and staged-bilateral total knee arthroplasty. J Bone Joint Surg Am Vol 2011;93:2203&#x2013;13.</Citation><ArticleIdList><ArticleId IdType="pubmed">22159856</ArticleId></ArticleIdList></Reference><Reference><Citation>Stubbs G, Pryke SE, Tewari S, et al. Safety and cost benefits of bilateral total knee replacement in an acute hospital. ANZ J Surg 2005;75:739&#x2013;46.</Citation><ArticleIdList><ArticleId IdType="pubmed">16173984</ArticleId></ArticleIdList></Reference><Reference><Citation>Ritter MA, Harty LD, Davis KE, et al. Simultaneous bilateral, staged bilateral, and unilateral total knee arthroplasty. A survival analysis. J Bone Joint Surg Am Vol 2003;85:1532&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">12925634</ArticleId></ArticleIdList></Reference><Reference><Citation>Mangaleshkar SR, Prasad PSV, Chugh S, et al. Staged bilateral total knee replacement&#x2014;a safer approach in older patients. Knee 2001;8:207&#x2013;11.</Citation><ArticleIdList><ArticleId IdType="pubmed">11706728</ArticleId></ArticleIdList></Reference><Reference><Citation>Forster MC, Bauze AJ, Bailie AG, et al. A retrospective comparative study of bilateral total knee replacement staged at a one-week interval. J Bone Joint Surg Br Vol 2006;88:1006&#x2013;10.</Citation><ArticleIdList><ArticleId IdType="pubmed">16877597</ArticleId></ArticleIdList></Reference><Reference><Citation>Walmsley P, Murray A, Brenkel IJ. The practice of bilateral, simultaneous total knee replacement in Scotland over the last decade. Data from the Scottish Arthroplasty Project. Knee 2006;13:102&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="pubmed">16481171</ArticleId></ArticleIdList></Reference><Reference><Citation>Agents AI, Effects NSA. Recommendations for the medical management of osteoarthritis of the hip and knee: 2000 update. American College of Rheumatology Subcommittee on Osteoarthritis Guidelines. Arthritis Rheum 2000;43:1905&#x2013;15.</Citation><ArticleIdList><ArticleId IdType="pubmed">11014340</ArticleId></ArticleIdList></Reference><Reference><Citation>Picavet HSJ, Hazes JMW. Prevalence of self reported musculoskeletal diseases is high. Ann Rheum Dis 2003;62:644&#x2013;50.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1754612</ArticleId><ArticleId IdType="pubmed">12810427</ArticleId></ArticleIdList></Reference><Reference><Citation>Brooks PM. Impact of osteoarthritis on individuals and society: how much disability? Social consequences and health economic implications. Curr Opin Rheumatol 2002;14:573&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">12192258</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun BH, Wu CW, Kalunian KC. New Developments in Osteoarthritis. Rheum Dis Clin North Am 2007;33:135&#x2013;48.</Citation><ArticleIdList><ArticleId IdType="pubmed">17367697</ArticleId></ArticleIdList></Reference><Reference><Citation>Carr AJ, Robertsson O, Graves S, et al. Knee replacement. Lancet 2012;379:1331&#x2013;40.</Citation><ArticleIdList><ArticleId IdType="pubmed">22398175</ArticleId></ArticleIdList></Reference><Reference><Citation>Sculco TP. Establishing a universal protocol for deep vein thrombosis following orthopedic surgery: total knee arthroplasty. Orthopedics 1996;19:6&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">24826713</ArticleId></ArticleIdList></Reference><Reference><Citation>Mckenna R, Bachmann F, Kaushal SP, et al. Thromboembolic disease in patients undergoing total knee replacement. J Bone Joint Surg Am Vol 1976;58:928&#x2013;32.</Citation><ArticleIdList><ArticleId IdType="pubmed">977623</ArticleId></ArticleIdList></Reference><Reference><Citation>Larson CM, Macmillan DP, Lachiewicz PF. Thromboembolism after total knee arthroplasty: intermittent pneumatic compression and aspirin prophylaxis. J South Orthop Assoc 2001;10:155&#x2013;63.</Citation><ArticleIdList><ArticleId IdType="pubmed">12132827</ArticleId></ArticleIdList></Reference><Reference><Citation>Eikelboom J, Karthikeyan GN, Hirsh J. American association of orthopedic surgeons and american college of chest physicians guidelines for venous thromboembolism prevention in hip and knee arthroplasty differ: what are the implications for clinicians and patients. Chest 2009;135:513&#x2013;20.</Citation><ArticleIdList><ArticleId IdType="pubmed">19201714</ArticleId></ArticleIdList></Reference><Reference><Citation>Levy YD, Hardwick ME, Copp SN, et al. Thrombosis incidence in unilateral vs. simultaneous bilateral total knee arthroplasty with compression device prophylaxis. J Arthroplasty 2013;28:474&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">23142435</ArticleId></ArticleIdList></Reference><Reference><Citation>Poultsides LA, Memtsoudis SG, Vasilakakos T, et al. Infection following simultaneous bilateral total knee arthroplasty. J Arthroplasty 2013;28:92&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="pubmed">23937920</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu Y, Zhang F, Chen W, et al. Risk factors for periprosthetic joint infection after total joint arthroplasty: a systematic review and meta-analysis. J Hospital Infect 2015;89:82&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">25575769</ArticleId></ArticleIdList></Reference><Reference><Citation>Bullock DP, Sporer SM, Jr, S.T Comparison of simultaneous bilateral with unilateral total knee arthroplasty in terms of perioperative complications. J Bone Joint Surg Am Vol 2003;85:1981&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">14563808</ArticleId></ArticleIdList></Reference><Reference><Citation>Pavone V, Johnson T, Saulog PS, et al. Perioperative morbidity in bilateral one-stage total knee replacements. Clin Orthop Relat Res 2004;421:155&#x2013;61.</Citation><ArticleIdList><ArticleId IdType="pubmed">15123941</ArticleId></ArticleIdList></Reference><Reference><Citation>Ries MD, Rauscher LA, Hoskins S, et al. Intramedullary pressure and pulmonary function during total knee arthroplasty. Clin Orthop Relat Res 1998;356:154&#x2013;60.</Citation><ArticleIdList><ArticleId IdType="pubmed">9917680</ArticleId></ArticleIdList></Reference><Reference><Citation>Dorr LD, Merkel C, Mellman MF, et al. Fat emboli in bilateral total knee arthroplasty. Predictive factors for neurologic manifestations. Clinorthoprelatres 1989;248:112&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">2805467</ArticleId></ArticleIdList></Reference><Reference><Citation>Lane GJ, Hozack WJ, Shah S, et al. Simultaneous bilateral versus unilateral total knee arthroplasty. Outcomes analysis. Clin Orthop Relat Res 1997;345:106&#x2013;12.</Citation><ArticleIdList><ArticleId IdType="pubmed">9418627</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">34508872</PMID><DateCompleted><Year>2022</Year><Month>04</Month><Day>19</Day></DateCompleted><DateRevised><Year>2025</Year><Month>06</Month><Day>23</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2213-3348</ISSN><JournalIssue CitedMedium="Internet"><Volume>10</Volume><Issue>3</Issue><PubDate><Year>2022</Year><Month>May</Month></PubDate></JournalIssue><Title>Journal of vascular surgery. Venous and lymphatic disorders</Title><ISOAbbreviation>J Vasc Surg Venous Lymphat Disord</ISOAbbreviation></Journal><ArticleTitle>Meta-analysis and systematic review of randomized controlled trials assessing the role of thromboprophylaxis after vascular surgery.</ArticleTitle><Pagination><StartPage>767</StartPage><EndPage>777.e3</EndPage><MedlinePgn>767-777.e3</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jvsv.2021.08.019</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S2213-333X(21)00429-7</ELocationID><Abstract><AbstractText Label="BACKGROUND">Venous thromboembolism (VTE) is a well-known complication associated with surgical procedures. The implementation of thromboprophylaxis in this population has become a vital aspect of perioperative care to decrease VTE-associated morbidity and mortality risk. However, data assessing the role of thromboprophylaxis for patients undergoing vascular surgery are sparse. Assessing the role of thromboprophylaxis by low-molecular-weight heparin or unfractionated heparin in vascular surgery.</AbstractText><AbstractText Label="METHODS">We searched MEDLINE, Embase, and the Cochrane Collaboration Central Register of Controlled Trials from inception until December 2020, for randomized controlled trials assessing the role of thromboprophylaxis in vascular surgery.</AbstractText><AbstractText Label="RESULTS">Eight randomized controlled trials met inclusion criteria, including 3130 patients, with a mean age of 55.35&#xa0;years and 45% were females. Compared with placebo, anticoagulant use was associated with a decrease in deep venous thrombosis (DVT) (risk ratio [RR], 0.34; 95% confidence interval [CI], 0.11-1.05; P&#xa0;= .06; I<sup>2</sup>&#xa0;= 68%) and pulmonary embolism (PE) (RR, 0.17; 95% CI, 0.02-1.22; P&#xa0;= .08; I<sup>2</sup>&#xa0;= 41%), but this trend did not attain statistical significance. There was no difference for bleeding outcomes between anticoagulants and placebo (RR, 0.90; 95% CI, 0.05-15.01; P&#xa0;= .94; I<sup>2</sup>&#xa0;= 76%). There was no significant difference in outcomes when low-molecular-weight heparin was compared directly with unfractionated heparin. In a sensitivity analysis, anticoagulant use was associated with a significant decrease in DVT or PE in patients undergoing venous surgeries, but was not associated with a significant decrease in DVT or PE in patients undergoing arterial surgeries, although this analysis was limited by the small number of studies in each group.</AbstractText><AbstractText Label="CONCLUSIONS">Among patients undergoing vascular surgery, thromboprophylaxis with anticoagulants showed a trend toward a lesser incidence of VTE when compared with placebo, although this difference was not statistically significant. Bleeding outcomes were comparable between both treatment groups.</AbstractText><CopyrightInformation>Copyright &#xa9; 2021 Society for Vascular Surgery. Published by Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Haykal</LastName><ForeName>Tarek</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Division of Hematology, Department of Medicine, Duke University, Durham, NC. Electronic address: tarek.haykal@duke.edu.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zayed</LastName><ForeName>Yazan</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Pulmonary, Critical Care, and Sleep Medicine, University of Florida, Gainesville, Fla.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kerbage</LastName><ForeName>Josiane</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Lebanese University, Beirut, Lebanon.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Deliwala</LastName><ForeName>Smit</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, Hurley Medical Center, Flint, Mich; College of Human Medicine, Michigan State University, East Lansing, Mich.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Long</LastName><ForeName>Chandler A</ForeName><Initials>CA</Initials><AffiliationInfo><Affiliation>Division of Vascular and Endovascular Surgery, Department of Surgery, Duke University, Durham, NC.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ortel</LastName><ForeName>Thomas L</ForeName><Initials>TL</Initials><AffiliationInfo><Affiliation>Division of Hematology, Department of Medicine, Duke University, Durham, NC; Department of Pathology, Duke University, Durham, NC.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>09</Month><Day>08</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Vasc Surg Venous Lymphat Disord</MedlineTA><NlmUniqueID>101607771</NlmUniqueID><ISSNLinking>2213-333X</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000925">Anticoagulants</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D006495">Heparin, Low-Molecular-Weight</NameOfSubstance></Chemical><Chemical><RegistryNumber>9005-49-6</RegistryNumber><NameOfSubstance UI="D006493">Heparin</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000925" MajorTopicYN="N">Anticoagulants</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006470" MajorTopicYN="N">Hemorrhage</DescriptorName><QualifierName UI="Q000139" MajorTopicYN="N">chemically induced</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006493" MajorTopicYN="N">Heparin</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006495" MajorTopicYN="N">Heparin, Low-Molecular-Weight</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011655" MajorTopicYN="N">Pulmonary Embolism</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016032" MajorTopicYN="N">Randomized Controlled Trials as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014656" MajorTopicYN="Y">Vascular Surgical Procedures</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D054556" MajorTopicYN="Y">Venous Thromboembolism</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>2</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>8</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>9</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>4</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>9</Month><Day>11</Day><Hour>20</Hour><Minute>11</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34508872</ArticleId><ArticleId IdType="doi">10.1016/j.jvsv.2021.08.019</ArticleId><ArticleId IdType="pii">S2213-333X(21)00429-7</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">39111699</PMID><DateCompleted><Year>2024</Year><Month>10</Month><Day>17</Day></DateCompleted><DateRevised><Year>2025</Year><Month>01</Month><Day>30</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2213-3348</ISSN><JournalIssue CitedMedium="Internet"><Volume>12</Volume><Issue>6</Issue><PubDate><Year>2024</Year><Month>Nov</Month></PubDate></JournalIssue><Title>Journal of vascular surgery. Venous and lymphatic disorders</Title><ISOAbbreviation>J Vasc Surg Venous Lymphat Disord</ISOAbbreviation></Journal><ArticleTitle>Perioperative and intermediate outcomes of patients with pulmonary embolism undergoing catheter-directed thrombolysis vs percutaneous mechanical thrombectomy.</ArticleTitle><Pagination><StartPage>101958</StartPage><MedlinePgn>101958</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">101958</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jvsv.2024.101958</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S2213-333X(24)00353-6</ELocationID><Abstract><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">Thrombolytic therapy has been a mainstay of treatment for massive or submassive pulmonary embolism (PE), a common and highly morbid pathology. New percutaneous mechanical thrombectomy (PMT) devices have recently become widely available and have been used increasingly for the treatment of acute PE, but evidence demonstrating its efficacy over standard catheter-directed lytic protocol remains limited.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Using TriNetX Data Network, a global federated database of &gt;250 million patients, we conducted a retrospective cohort study of patients from January 2017 to August 2023 with a diagnosis of PE, treated with either PMT or catheter-directed thrombolysis (CDT). Eligible patients were 1:1 propensity score-matched for preoperative covariates including demographics and comorbidities. We calculated and compared the 30-day outcomes of all-cause mortality, bleeding complications (blood transfusion, gastrointestinal bleed, and intracranial hemorrhage), diagnosis of acute respiratory failure (RF), myocardial infarction (MI), and pulmonary hypertension (PH) using odds ratios (OR) with 95% confidence intervals (CIs). Also, the 5-year outcomes of all-cause mortality, a composite outcome of chronic PH (chronic PE, chronic cor pulmonale, chronic thromboembolic PH), right heart failure (RHF), RF, and emergency department visits, were compared using hazard ratios (HRs) with 95% CIs.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">We identified 2978 patients treated with PMT and 1137 patients treated with CDT. After matching, we compared 1102 patients in each cohort. For 30-day outcomes, all-cause mortality, acute RF, and blood transfusion were similar between the two groups. However, compared with CDT, PMT was associated with a better safety profile, including lower bleeding risk for both ICH (OR, 0.46; 95% CI, 0.24-0.890) and gastrointestinal bleed (OR, 0.42; 95% CI, 0.28-0.63). PMT also demonstrated better immediate functional outcomes, with less PH (OR, 0.53; 95% CI, 0.41-0.68) and MI (OR, 0.54; 95% CI, 0.41-0.76). At 5&#xa0;years, the all-cause mortality and RF for both procedures were similar, but PMT was associated with lower rates of chronic PH (HR, 0.70; 95% CI, 0.55-0.90), RHF (HR 0.49; 95% CI, 0.37-0.65), and emergency department visits (348 for PMT vs 426 for CDT; P&#xa0;&lt; .01).</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">In patients undergoing catheter-based therapy for PE, PMT has an improved procedural safety profile vs CDT and results in significantly fewer 30-day postoperative complications, with fewer bleeding events, and is also associated with fewer periprocedural MIs and less acute PH. Perhaps, more important, PMT also demonstrated improved long-term outcomes with significantly fewer chronic PH and RHF diagnoses with fewer emergency department visits.</AbstractText><CopyrightInformation>Copyright &#xa9; 2024 The Author(s). Published by Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Tsukagoshi</LastName><ForeName>Junji</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Surgery, University of Texas Medical Branch, Galveston, TX.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wick</LastName><ForeName>Benjamin</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>John Sealy School of Medicine, University of Texas Medical Branch, Galveston, TX.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Karim</LastName><ForeName>Abbas</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>John Sealy School of Medicine, University of Texas Medical Branch, Galveston, TX.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Khanipov</LastName><ForeName>Kamil</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Pharmacology and Toxicology, University of Texas Medical Branch, Galveston, TX.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cox</LastName><ForeName>Mitchell W</ForeName><Initials>MW</Initials><AffiliationInfo><Affiliation>Division of Vascular Surgery, Department of Surgery, University of Texas Medical Branch, Galveston, TX. Electronic address: mwcox@utmb.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D003160">Comparative Study</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>08</Month><Day>05</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Vasc Surg Venous Lymphat Disord</MedlineTA><NlmUniqueID>101607771</NlmUniqueID><ISSNLinking>2213-333X</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D005343">Fibrinolytic Agents</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011655" MajorTopicYN="Y">Pulmonary Embolism</DescriptorName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015912" MajorTopicYN="Y">Thrombolytic Therapy</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013997" MajorTopicYN="N">Time Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017131" MajorTopicYN="N">Thrombectomy</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016208" MajorTopicYN="N">Databases, Factual</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018570" MajorTopicYN="N">Risk Assessment</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005343" MajorTopicYN="N">Fibrinolytic Agents</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Catheter-directed thrombolysis</Keyword><Keyword MajorTopicYN="N">Percutaneous mechanical thrombectomy</Keyword><Keyword MajorTopicYN="N">Pulmonary embolism</Keyword><Keyword MajorTopicYN="N">Pulmonary hypertension</Keyword></KeywordList><CoiStatement>Disclosures None.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>4</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>7</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>7</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>18</Day><Hour>0</Hour><Minute>30</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>8</Month><Day>8</Day><Hour>0</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>8</Month><Day>7</Day><Hour>19</Hour><Minute>22</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>8</Month><Day>5</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39111699</ArticleId><ArticleId IdType="pmc">PMC11774124</ArticleId><ArticleId IdType="doi">10.1016/j.jvsv.2024.101958</ArticleId><ArticleId IdType="pii">S2213-333X(24)00353-6</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Freund Y., Cohen-Aubart F., Bloom B. Acute pulmonary embolism: a Review. JAMA. 2022;328:1336&#x2013;1345.</Citation><ArticleIdList><ArticleId IdType="pubmed">36194215</ArticleId></ArticleIdList></Reference><Reference><Citation>Kerrigan J., Morse M., Haddad E., Willers E., Ramaiah C. Advances in percutaneous management of pulmonary embolism. Int J Angiol Off Publ Int Coll Angiol Inc. 2022;31:203&#x2013;212.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9507563</ArticleId><ArticleId IdType="pubmed">36157096</ArticleId></ArticleIdList></Reference><Reference><Citation>Stein P.D., Matta F. Thrombolytic therapy in unstable patients with acute pulmonary embolism: saves lives but underused. Am J Med. 2012;125:465&#x2013;470.</Citation><ArticleIdList><ArticleId IdType="pubmed">22325236</ArticleId></ArticleIdList></Reference><Reference><Citation>Carroll B.J., Larnard E.A., Pinto D.S., Giri J., Secemsky E.A. Percutaneous management of high-risk pulmonary embolism. Circ Cardiovasc Interv. 2023;16</Citation><ArticleIdList><ArticleId IdType="pubmed">36744463</ArticleId></ArticleIdList></Reference><Reference><Citation>Inci E.K., Khandhar S., Toma C., et al. Mechanical thrombectomy versus catheter directed thrombolysis in patients with pulmonary embolism: a multicenter experience. Catheter Cardiovasc Interv. 2023;101:140&#x2013;146.</Citation><ArticleIdList><ArticleId IdType="pubmed">36448401</ArticleId></ArticleIdList></Reference><Reference><Citation>Graif A., Patel K.D., Wimmer N.J., et al. Large-bore aspiration thrombectomy versus catheter-directed thrombolysis for acute pulmonary embolism: a propensity score-matched comparison. J&#xa0;Vasc Interv Radiol JVIR. 2020;31:2052&#x2013;2059.</Citation><ArticleIdList><ArticleId IdType="pubmed">33183975</ArticleId></ArticleIdList></Reference><Reference><Citation>Toma C. Impact of a blood return system on mechanical thrombectomy-associated blood loss and hemodynamic outcomes in a pulmonary embolism registry. Eur Heart J. 2022;43(Supplement_2)</Citation></Reference><Reference><Citation>Chung R., Weller A., Morgan R., Belli A.M., Ratnam L. Are complication rates lower with 4-Fr versus 6-Fr transfemoral arterial access &#x2013; prospective audit at a single interventional radiology centre. CVIR Endovasc. 2018;1:15.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6319516</ArticleId><ArticleId IdType="pubmed">30652147</ArticleId></ArticleIdList></Reference><Reference><Citation>Lauder L., P&#xe9;rez Navarro P., G&#xf6;tzinger F., et al. Mechanical thrombectomy in intermediate- and high-risk acute pulmonary embolism: hemodynamic outcomes at three months. Respir Res. 2023;24:257.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10601326</ArticleId><ArticleId IdType="pubmed">37880651</ArticleId></ArticleIdList></Reference><Reference><Citation>Delcroix M., Torbicki A., Gopalan D., et al. ERS statement on chronic thromboembolic pulmonary hypertension. Eur Respir J. 2021;57</Citation><ArticleIdList><ArticleId IdType="pubmed">33334946</ArticleId></ArticleIdList></Reference><Reference><Citation>Desai K.R. Mechanical thrombectomy in pulmonary embolism. JACC Cardiovasc Interv. 2021;14:330&#x2013;332.</Citation><ArticleIdList><ArticleId IdType="pubmed">33454292</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">35716205</PMID><DateCompleted><Year>2022</Year><Month>09</Month><Day>16</Day></DateCompleted><DateRevised><Year>2025</Year><Month>06</Month><Day>23</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1436-3771</ISSN><JournalIssue CitedMedium="Internet"><Volume>26</Volume><Issue>9</Issue><PubDate><Year>2022</Year><Month>Sep</Month></PubDate></JournalIssue><Title>Clinical oral investigations</Title><ISOAbbreviation>Clin Oral Investig</ISOAbbreviation></Journal><ArticleTitle>Association between components of metabolic syndrome and periodontitis: a systematic review and meta-analysis.</ArticleTitle><Pagination><StartPage>5557</StartPage><EndPage>5574</EndPage><MedlinePgn>5557-5574</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s00784-022-04583-x</ELocationID><Abstract><AbstractText Label="OBJECTIVES" NlmCategory="OBJECTIVE">To evaluate the role of metabolic syndrome (MetS) components in the association with periodontitis (PE) (#CRD42020218310).</AbstractText><AbstractText Label="MATERIALS AND METHODS" NlmCategory="METHODS">A systematic electronic search was performed in PUBMED, Scielo and Lilacs databases up to April 2022. Cross-sectional, case-control, and cohort studies presenting data on the association between MetS and PE in the adult and elderly populations were included. A random effect meta-analysis was performed to determine association effect estimates. Results interpretation followed the assessment of methodological quality (Joana Briggs Institute tool) together with the certainty of evidence (GRADE approach).</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">This review included 52 studies, totalling 140,434 participants, and 38 studies were meta-analyzed. Association between PE and MetS was observed (OR<sub>adj</sub> from 1.27 to 1.90; PR<sub>ajd</sub>&#x2009;=&#x2009;1.19; RR<sub>adj</sub> from 1.10 to 1.37) (low and very low certainty of evidence). Hyperglycaemia (OR&#x2009;=&#x2009;1.18), HDL (OR&#x2009;=&#x2009;1.16), obesity (OR&#x2009;=&#x2009;1.08), and hypertension (OR&#x2009;=&#x2009;1.11) were associated with PE, except triglycerides (low and very low certainty of evidence). There was a dose-response gradient between the number of MetS components and PE, with a gradual increase in the effect magnitude for 1 (OR&#x2009;=&#x2009;1.14), 2 (OR&#x2009;=&#x2009;1.52), 3 or more (OR&#x2009;=&#x2009;1.79), and 4 or 5 components (OR&#x2009;=&#x2009;2.02) (low to high certainty of evidence).</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">MetS was associated with PE, with a dose-response gradient between the number of MetS components and the occurrence of PE, with an increasing effect magnitude according to an increasing number of components.</AbstractText><AbstractText Label="CLINICAL RELEVANCE" NlmCategory="CONCLUSIONS">Periodontal examination should be part of a comprehensive propaedeutic approach of MetS patients, particularly those presenting a great number of components.</AbstractText><CopyrightInformation>&#xa9; 2022. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Campos</LastName><ForeName>Julya Ribeiro</ForeName><Initials>JR</Initials><Identifier Source="ORCID">0000-0002-1406-4166</Identifier><AffiliationInfo><Affiliation>Department of Dental Clinics, Oral Pathology, and Oral Surgery, School of Dentistry, Federal University of Minas Gerais, Ant&#xf4;nio Carlos Avenue 6627, Pampulha. PO Box 359, Belo Horizonte, Minas Gerais, 31270-901, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Martins</LastName><ForeName>Carolina Castro</ForeName><Initials>CC</Initials><Identifier Source="ORCID">0000-0001-9072-3226</Identifier><AffiliationInfo><Affiliation>Department of Pediatric Dentistry, School of Dentistry, Federal University of Minas Gerais, Belo Horizonte, Minas Gerais, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Faria</LastName><ForeName>Sandro Felipe Santos</ForeName><Initials>SFS</Initials><Identifier Source="ORCID">0000-0002-1602-0079</Identifier><AffiliationInfo><Affiliation>Department of Dental Clinics, Oral Pathology, and Oral Surgery, School of Dentistry, Federal University of Minas Gerais, Ant&#xf4;nio Carlos Avenue 6627, Pampulha. PO Box 359, Belo Horizonte, Minas Gerais, 31270-901, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Carvalho</LastName><ForeName>Ana Paula</ForeName><Initials>AP</Initials><AffiliationInfo><Affiliation>Department of Dental Clinics, Oral Pathology, and Oral Surgery, School of Dentistry, Federal University of Minas Gerais, Ant&#xf4;nio Carlos Avenue 6627, Pampulha. PO Box 359, Belo Horizonte, Minas Gerais, 31270-901, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pereira</LastName><ForeName>Alexandre Godinho</ForeName><Initials>AG</Initials><AffiliationInfo><Affiliation>Department of Dental Clinics, Oral Pathology, and Oral Surgery, School of Dentistry, Federal University of Minas Gerais, Ant&#xf4;nio Carlos Avenue 6627, Pampulha. PO Box 359, Belo Horizonte, Minas Gerais, 31270-901, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Costa</LastName><ForeName>Fernando Oliveira</ForeName><Initials>FO</Initials><Identifier Source="ORCID">0000-0002-7687-1238</Identifier><AffiliationInfo><Affiliation>Department of Dental Clinics, Oral Pathology, and Oral Surgery, School of Dentistry, Federal University of Minas Gerais, Ant&#xf4;nio Carlos Avenue 6627, Pampulha. PO Box 359, Belo Horizonte, Minas Gerais, 31270-901, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cota</LastName><ForeName>Lu&#xed;s Ot&#xe1;vio Miranda</ForeName><Initials>LOM</Initials><Identifier Source="ORCID">0000-0003-1517-5842</Identifier><AffiliationInfo><Affiliation>Department of Dental Clinics, Oral Pathology, and Oral Surgery, School of Dentistry, Federal University of Minas Gerais, Ant&#xf4;nio Carlos Avenue 6627, Pampulha. PO Box 359, Belo Horizonte, Minas Gerais, 31270-901, Brazil. luiscota@ufmg.br.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>#302251/2019-7</GrantID><Agency>Conselho Nacional de Desenvolvimento Cient&#xed;fico e Tecnol&#xf3;gico</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>06</Month><Day>18</Day></ArticleDate></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>Clin Oral Investig</MedlineTA><NlmUniqueID>9707115</NlmUniqueID><ISSNLinking>1432-6981</ISSNLinking></MedlineJournalInfo><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016022" MajorTopicYN="N">Case-Control Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003430" MajorTopicYN="N">Cross-Sectional Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006973" MajorTopicYN="Y">Hypertension</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D024821" MajorTopicYN="Y">Metabolic Syndrome</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010518" MajorTopicYN="Y">Periodontitis</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Hyperglycemia</Keyword><Keyword MajorTopicYN="N">Hypertension</Keyword><Keyword MajorTopicYN="N">Metabolic syndrome</Keyword><Keyword MajorTopicYN="N">Obesity</Keyword><Keyword MajorTopicYN="N">Periodontal diseases</Keyword><Keyword MajorTopicYN="N">Periodontitis</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>2</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>6</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>6</Month><Day>19</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>9</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>6</Month><Day>18</Day><Hour>11</Hour><Minute>14</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35716205</ArticleId><ArticleId IdType="doi">10.1007/s00784-022-04583-x</ArticleId><ArticleId IdType="pii">10.1007/s00784-022-04583-x</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Papapanou PN, Sanz M, Buduneli N, Dietrich T, Feres M, Fine DH, Flemmig TF, Garcia R, Giannobile WV, Graziani F, Greenwell H, Herrera D, Kao RT, Kebschull M, Kinane DF, Kirkwood KL, Kocher T, KennethKorman SKS, Kumar PS, Loos BG, Machtei E, Meng H, Mombelli A, Needleman I, Offenbacher S, Seymour GJ, Teles R, Tonetti MS (2018) Periodontitis: consensus report of workgroup 2 of the 2017 World Workshop on the Classification of Periodontal and Peri-Implant Diseases and Conditions. J Clin Periodontol 45:162&#x2013;170. https://doi.org/10.1111/jcpe.12946</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jcpe.12946</ArticleId></ArticleIdList></Reference><Reference><Citation>Kapila YL (2000) (2021) Oral health&#x2019;s inextricable connection to systemic health: special populations bring to bear multimodal relationships and factors connecting periodontal disease to systemic diseases and conditions. Periodontol 87:11&#x2013;16. https://doi.org/10.1111/prd.12398</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/prd.12398</ArticleId></ArticleIdList></Reference><Reference><Citation>Pirih FQ, Monajemzadeh S, Singh N, Sinacola RS, Shin JM, Chen T, Fenno JC, Kamarajan P, Rickard AH, Travan S, Paster BJ (2000) Kapila Y (2021) Association between metabolic syndrome and periodontitis: the role of lipids, inflammatory cytokines, altered host response, and the microbiome. Periodontol 87:50&#x2013;75. https://doi.org/10.1111/prd.12379</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/prd.12379</ArticleId></ArticleIdList></Reference><Reference><Citation>Li P, He L, Sha YQ, Luan QX (2009) Relationship of metabolic syndrome to chronic periodontitis. J Periodontol 80:541&#x2013;549. https://doi.org/10.1902/jop.2009.080387</Citation><ArticleIdList><ArticleId IdType="doi">10.1902/jop.2009.080387</ArticleId><ArticleId IdType="pubmed">19335073</ArticleId></ArticleIdList></Reference><Reference><Citation>Nesbitt MJ, Reynolds MA, Shiau H, Choe K, Simonsick EM, Ferrucci L (2010) Association of periodontitis and metabolic syndrome in the Baltimore longitudinal study of aging. Aging Clin Exp Res 22:238&#x2013;242. https://doi.org/10.1007/BF03324802</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/BF03324802</ArticleId><ArticleId IdType="pubmed">20634647</ArticleId><ArticleId IdType="pmc">2929594</ArticleId></ArticleIdList></Reference><Reference><Citation>Alhabashneh R, Khader Y, Herra Z, Asa&#x2019;ad F, Assad F (2015) The association between periodontal disease and metabolic syndrome among outpatients with diabetes in Jordan. J Diabetes Metab Disord 16:67. https://doi.org/10.1186/s40200-015-0192-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40200-015-0192-8</ArticleId></ArticleIdList></Reference><Reference><Citation>Gomes-Filho IS, das Merces MC, de Santana Passos-Soares J, Seixas da Cruz S, Teixeira Ladeia AM, Trindade SC, Cerqueira EMM, Coelho JMF, Monteiro FMM, Barreto ML, Vianna MIP, Costa MCN, Gregory John Seymour GJ, Scannapieco FA (2016) Severity of periodontitis and metabolic syndrome: is there an association? J Periodontol 87:357&#x2013;366. https://doi.org/10.1902/jop.2015.150367</Citation><ArticleIdList><ArticleId IdType="doi">10.1902/jop.2015.150367</ArticleId><ArticleId IdType="pubmed">26654349</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaye EK, Chen N, Cabral HJ, Vokonas P, Garcia RI (2016) Metabolic syndrome and periodontal disease progression in men. J Dent Res 95:822&#x2013;828. https://doi.org/10.1177/0022034516641053</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0022034516641053</ArticleId><ArticleId IdType="pubmed">27025874</ArticleId><ArticleId IdType="pmc">4914866</ArticleId></ArticleIdList></Reference><Reference><Citation>Jaramillo A, Contreras A, Lafaurie GI, Duque A, Ardila CM, Duarte S, Osorio L (2017) Association of metabolic syndrome and chronic periodontitis in Colombians. Clin Oral Investig 21:1537&#x2013;1544. https://doi.org/10.1007/s00784-016-1942-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00784-016-1942-9</ArticleId><ArticleId IdType="pubmed">27535794</ArticleId></ArticleIdList></Reference><Reference><Citation>Musskopf ML, Daudt LD, Weidlich P, Gerchman F, Gross JL, Oppermann RV (2017) Metabolic syndrome as a risk indicator for periodontal disease and tooth loss. Clin Oral Investig 21:675&#x2013;683. https://doi.org/10.1007/s00784-016-1935-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00784-016-1935-8</ArticleId><ArticleId IdType="pubmed">27604232</ArticleId></ArticleIdList></Reference><Reference><Citation>Koo HS, Hong SM (2018) Prevalence and risk factors for periodontitis among patients with metabolic syndrome. Metab Syndr Relat Disord 16:375&#x2013;381. https://doi.org/10.1089/met.2018.0003</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/met.2018.0003</ArticleId><ArticleId IdType="pubmed">29893616</ArticleId></ArticleIdList></Reference><Reference><Citation>Pham T (2018) The association between periodontal disease severity and metabolic syndrome in Vietnamese patients. Int J Dent Hyg 16:484&#x2013;491. https://doi.org/10.1111/idh.12350</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/idh.12350</ArticleId><ArticleId IdType="pubmed">29900658</ArticleId></ArticleIdList></Reference><Reference><Citation>Abdalla-Aslan R, Findler M, Levin L, Zini A, Shay B, Twig G, Almoznino G (2019) Where periodontitis meets metabolic syndrome-the role of common health-related risk factors. J Oral Rehab 46:647&#x2013;656. https://doi.org/10.1111/joor.12798</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/joor.12798</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim JS, Kim SY, Byon MJ, Lee JH, Jeong SH, Kim JB (2019) Association between periodontitis and metabolic syndrome in a Korean nationally representative sample of adults aged 35&#x2013;79 years. Int J Environ Res Public Health 15:16. https://doi.org/10.3390/ijerph16162930</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph16162930</ArticleId></ArticleIdList></Reference><Reference><Citation>Sakurai SI, Yamada SI, Karasawa I, Sakurai A, Kurita H (2019) A longitudinal study on the relationship between dental health and metabolic syndrome in Japan. J Periodontol 90:728&#x2013;746. https://doi.org/10.1002/JPER.18-0523</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/JPER.18-0523</ArticleId><ArticleId IdType="pubmed">30720212</ArticleId></ArticleIdList></Reference><Reference><Citation>Campos JR, Costa FO, Cota LOM (2020) Association between periodontitis and metabolic syndrome: a case-control study. J Periodontol 91:784&#x2013;791. https://doi.org/10.1002/JPER.19-0298</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/JPER.19-0298</ArticleId><ArticleId IdType="pubmed">31691971</ArticleId></ArticleIdList></Reference><Reference><Citation>Alberti K, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA, Fruchart JC, James WPT, Loria CM, Smith SC Jr (2009) Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 120:1640&#x2013;1645. https://doi.org/10.1161/CIRCULATIONAHA.109.192644</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.109.192644</ArticleId><ArticleId IdType="pubmed">19805654</ArticleId></ArticleIdList></Reference><Reference><Citation>Albandar JM, Susin C, Hughes FJ (2018) Manifestations of systemic diseases and conditions that affect the periodontal attachment apparatus: case definitions and diagnostic considerations. J Periodontol 89:S183&#x2013;S203. https://doi.org/10.1002/JPER.16-0480</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/JPER.16-0480</ArticleId><ArticleId IdType="pubmed">29926941</ArticleId></ArticleIdList></Reference><Reference><Citation>Teles F, Wang Y, Hajishengallis G, Hasturk H (2000) Marchesan JT (2021) Impact of systemic factors in shaping the periodontal microbiome. Periodontol 85:126&#x2013;160. https://doi.org/10.1111/prd.12356</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/prd.12356</ArticleId></ArticleIdList></Reference><Reference><Citation>D&#x2019;Aiuto F, Sabbah W, Netuveli G, Donos N, Hingorani AD, Deanfield J, Tsakos G (2008) Association of the metabolic syndrome with severe periodontitis in a large U.S. population-based survey. J Clin Endocrinol Metab 93:3989&#x2013;3994. https://doi.org/10.1210/jc.2007-2522</Citation><ArticleIdList><ArticleId IdType="doi">10.1210/jc.2007-2522</ArticleId><ArticleId IdType="pubmed">18682518</ArticleId></ArticleIdList></Reference><Reference><Citation>Morita T, Ogawa Y, Takada K, Nishinoue N, Sasaki Y, Motohashi M, Maeno M (2009) Association between periodontal disease and metabolic syndrome. J Public Health Dent 69:248&#x2013;253. https://doi.org/10.1111/j.1752-7325.2009.00130.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1752-7325.2009.00130.x</ArticleId><ArticleId IdType="pubmed">19453864</ArticleId></ArticleIdList></Reference><Reference><Citation>Kushiyama M, Shimazaki Y, Yamashita Y (2009) Relationship between metabolic syndrome and periodontal disease in Japanese adults. J Periodontol 80:1610&#x2013;1615. https://doi.org/10.1902/jop.2009.090218</Citation><ArticleIdList><ArticleId IdType="doi">10.1902/jop.2009.090218</ArticleId><ArticleId IdType="pubmed">19792850</ArticleId></ArticleIdList></Reference><Reference><Citation>Adriankaja OM, Sreenivasa S, Dunford R, DeNardin E (2010) Association between metabolic syndrome and periodontal disease. Aust Dent J 55:252&#x2013;259</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1834-7819.2010.01231.x</ArticleId></ArticleIdList></Reference><Reference><Citation>Kwon YE, Ha JE, Paik DI, Jin BH, Bae KH (2011) The relationship between periodontitis and metabolic syndrome among a Korean nationally representative sample of adults. J Clin Periodontol 38:781&#x2013;786. https://doi.org/10.1111/j.1600-051X.2011.01756.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1600-051X.2011.01756.x</ArticleId><ArticleId IdType="pubmed">21722155</ArticleId></ArticleIdList></Reference><Reference><Citation>Han DH, Lim SY, Sun BC, Paek D, Kim HD (2010) The association of metabolic syndrome with periodontal disease is confounded by age and smoking in a Korean population: the Shiwha-Banwol Environmental Health Study. J Clin Periodontol 37:609&#x2013;616. https://doi.org/10.1111/j.1600-051X.2010.01580.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1600-051X.2010.01580.x</ArticleId><ArticleId IdType="pubmed">20492075</ArticleId></ArticleIdList></Reference><Reference><Citation>Tu YK, D&#x2019;Aiuto F, Lin HJ, Chen YW, Chien KL (2013) Relationship between metabolic syndrome and diagnoses of periodontal diseases among participants in a large Taiwanese cohort. J Clin Periodontol 40:994&#x2013;1000. https://doi.org/10.1111/jcpe.12157</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jcpe.12157</ArticleId><ArticleId IdType="pubmed">24007401</ArticleId></ArticleIdList></Reference><Reference><Citation>Thanakun S, Watanabe H, Thaweboon S, Izumi Y (2014) Association of untreated metabolic syndrome with moderate to severe periodontitis in Thai population. J Periodontol 85:1502&#x2013;1514. https://doi.org/10.1902/jop.2014.140105</Citation><ArticleIdList><ArticleId IdType="doi">10.1902/jop.2014.140105</ArticleId><ArticleId IdType="pubmed">24835416</ArticleId></ArticleIdList></Reference><Reference><Citation>Iwasaki M, Sato M, Minagawa K, Manz MC, Yoshihara A, Miyazaki H (2015) Longitudinal relationship between metabolic syndrome and periodontal disease among Japanese adults aged &#x2265;70 years: the Niigata Study. J Periodontol 86:491&#x2013;498. https://doi.org/10.1902/jop.2015.140398</Citation><ArticleIdList><ArticleId IdType="doi">10.1902/jop.2015.140398</ArticleId><ArticleId IdType="pubmed">25579498</ArticleId></ArticleIdList></Reference><Reference><Citation>Minagawa K, Iwasaki M, Ogawa H, Yoshihara A, Miyazaki H (2015) Relationship between metabolic syndrome and periodontitis in 80-year-old Japanese subjects. J Periodontal Res 50:173&#x2013;179. https://doi.org/10.1111/jre.12190</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jre.12190</ArticleId><ArticleId IdType="pubmed">24815529</ArticleId></ArticleIdList></Reference><Reference><Citation>Kumar N, Bhardwaj A, Negi PC, Jhingta PK, Sharma D, Bhardwaj VK (2016) Association of chronic periodontitis with metabolic syndrome: a cross-sectional study. J Indian Soc Periodontol 20:324&#x2013;329. https://doi.org/10.4103/0972-124X.183096</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/0972-124X.183096</ArticleId><ArticleId IdType="pubmed">27563208</ArticleId><ArticleId IdType="pmc">4976555</ArticleId></ArticleIdList></Reference><Reference><Citation>Kikui M, Kokubo Y, Ono T, Kida M, Kosaka T, Yamamoto M, Watanabe M, Maeda Y, Miyamoto Y (2017) Relationship between metabolic syndrome components and periodontal disease in a Japanese general population: the Suita study. J Atheroscler Thromb 24:495&#x2013;507. https://doi.org/10.5551/jat.33761</Citation><ArticleIdList><ArticleId IdType="doi">10.5551/jat.33761</ArticleId><ArticleId IdType="pubmed">27725400</ArticleId><ArticleId IdType="pmc">5429165</ArticleId></ArticleIdList></Reference><Reference><Citation>Zuk A, Qui&#xf1;onez C, Lebenbaum M, Rosella LC (2017) The association between undiagnosed glycaemic abnormalities and cardiometabolic risk factors with periodontitis: results from 2007&#x2013;2009 Canadian Health Measures Survey. J Clin Periodontol 44:132&#x2013;141. https://doi.org/10.1111/jcpe.12684</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jcpe.12684</ArticleId><ArticleId IdType="pubmed">28028834</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim OS, Shin MH, Kweon SS, Lee YH, Kim OJ, Kim YJ, Chung HJ (2018) The severity of periodontitis and metabolic syndrome in Korean population: the Dong-gu study. J Periodontal Res 53:362&#x2013;368. https://doi.org/10.1111/jre.12521</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jre.12521</ArticleId><ArticleId IdType="pubmed">29226321</ArticleId></ArticleIdList></Reference><Reference><Citation>Gobin R, Tian D, Liu Q, Wang J (2020) Periodontal disease and the risk of metabolic syndrome: an updated systematic review and metaanalysis. Front Endocrinol 9:336. https://doi.org/10.3389/fendo.2020.00336</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fendo.2020.00336</ArticleId></ArticleIdList></Reference><Reference><Citation>Lamster IB, Pagan M (2017) Periodontal disease and the metabolic syndrome. Int Dent J 67:67&#x2013;77. https://doi.org/10.1111/idj.12264</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/idj.12264</ArticleId><ArticleId IdType="pubmed">27861820</ArticleId></ArticleIdList></Reference><Reference><Citation>Nibali L, Tatarakis N, Needleman I, Tu YK, D&#x2019;Aiuto F, Rizzo M, Donos N (2013) Clinical review: association between metabolic syndrome and periodontitis: a systematic review and meta-analysis. J Clin Endocrinol Metab 98:913&#x2013;920. https://doi.org/10.1210/jc.2012-3552</Citation><ArticleIdList><ArticleId IdType="doi">10.1210/jc.2012-3552</ArticleId><ArticleId IdType="pubmed">23386648</ArticleId></ArticleIdList></Reference><Reference><Citation>Daudt LD, Musskopf ML, Mendez M, Remonti LLR, Leit&#xe3;o CB, Gross JL, Weidlich P, Oppermann RV (2018) Association between metabolic syndrome and periodontitis: a systematic review and meta-analysis. Braz Oral Res 24:e35. https://doi.org/10.1590/1807-3107bor-2018.vol32.0035</Citation><ArticleIdList><ArticleId IdType="doi">10.1590/1807-3107bor-2018.vol32.0035</ArticleId></ArticleIdList></Reference><Reference><Citation>Watanabe K, Cho YD (2014) Periodontal disease and metabolic syndrome: a qualitative critical review of their association. Arch Oral Biol 59:855&#x2013;870. https://doi.org/10.1016/j.archoralbio.2014.05.003</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.archoralbio.2014.05.003</ArticleId><ArticleId IdType="pubmed">24880501</ArticleId><ArticleId IdType="pmc">4399819</ArticleId></ArticleIdList></Reference><Reference><Citation>Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD et al (2021) The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ 372:n71. https://doi.org/10.1136/bmj.n71</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.n71</ArticleId><ArticleId IdType="pubmed">33782057</ArticleId><ArticleId IdType="pmc">8005924</ArticleId></ArticleIdList></Reference><Reference><Citation>Joanna Briggs Institute. Critical appraisal tools for use in JBI systematic reviews. [Internet]. [cited Apr 08 2021]. Available from: https://jbi.global/critical-appraisal-tools</Citation></Reference><Reference><Citation>Deeks JJ, Higgins JPT, Altan DG, on behalf of the Cochrane Statistical Methods Group (2019) Analysing data and undertaking meta-analyses. https://doi.org/10.1002/9781119536604.ch10</Citation></Reference><Reference><Citation>Egger M, Smith GD, Schneider M, Minder C (1997) Bias in meta-analysis detected by a simple, graphical test. BMJ 315:629&#x2013;634</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.315.7109.629</ArticleId></ArticleIdList></Reference><Reference><Citation>Guyatt GH, Oxman AD, Vist GE, Kunz R, Falck-Ytter Y, Alonso-Coelho P, Schunemann HJ, GRADE Working Group (2008) GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ 336:924&#x2013;926. https://doi.org/10.1136/bmj.39489.470347.AD</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.39489.470347.AD</ArticleId><ArticleId IdType="pubmed">18436948</ArticleId><ArticleId IdType="pmc">2335261</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Y, Akl EA, Schunemann HJ (2018) Using systematic reviews in guideline development: the GRADE approach. Res Synth Methods 14. https://doi.org/10.1002/jrsm.1313</Citation></Reference><Reference><Citation>Shimazaki Y, Saito T, Yonemoto K, Kiyohara Y, Iida M, Yamashita Y (2007) Relationship of metabolic syndrome to periodontal disease in Japanese women: the Hisayama study. J Dent R 86:271&#x2013;275. https://doi.org/10.1177/154405910708600314</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/154405910708600314</ArticleId></ArticleIdList></Reference><Reference><Citation>Patel SP, Kalra N, Pradeep AR, Martande SS, Naik SB, Raju AP, Singh P (2014) Association of metabolic syndrome and periodontal disease in an Indian population. J Inter Acad Periodontol 16:98&#x2013;102</Citation></Reference><Reference><Citation>Morita T, Yamazaki Y, Fujiharu C, Ishii T, Seto M, Nishinoue N, Sasaki Y, Nakai K, Tanaka H, Kawato T (2016) Maeno M (2016) Association between the duration of periodontitis and increased cardiometabolic risk factors: a 9-year cohort study. Metab Syndr Relat Disord 14(10):475&#x2013;482. https://doi.org/10.1089/met.2016.0018</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/met.2016.0018</ArticleId><ArticleId IdType="pubmed">27740886</ArticleId></ArticleIdList></Reference><Reference><Citation>Bandiwadekar AS, Shanbhag N, Madhuniranjanswamy MS, Khanagar SB, Naik S, Siddeeqh S (2020) Association of periodontitis with metabolic syndrome: a case-control study. J Int Soc Prev Community Dent 10:458&#x2013;465. https://doi.org/10.4103/jispcd.JISPCD_91_20</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/jispcd.JISPCD_91_20</ArticleId><ArticleId IdType="pubmed">33042888</ArticleId><ArticleId IdType="pmc">7523929</ArticleId></ArticleIdList></Reference><Reference><Citation>Montero E, Molina A, Carasol M, Fern&#xe1;ndez-Meseguer A, Calvo-Bonacho E, Garc&#xed;a-Margallo MT, Sanz M, Herrera D (2021) The association between metabolic syndrome and periodontitis in Spain: results from the WORALTH (Workers&#x2019; ORAL healTH) Study. J Clin Periodontol 48:37&#x2013;49. https://doi.org/10.1111/jcpe.13391</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jcpe.13391</ArticleId><ArticleId IdType="pubmed">33067816</ArticleId></ArticleIdList></Reference><Reference><Citation>Borges PK, Gimeno SG, Tomita NE, Ferreira SR (2007) Prevalence and characteristics associated with metabolic syndrome in Japanese-Brazilians with and without periodontal disease. Cad Saude Publica 23:657&#x2013;668. https://doi.org/10.1590/s0102-311x2007000300024</Citation><ArticleIdList><ArticleId IdType="doi">10.1590/s0102-311x2007000300024</ArticleId><ArticleId IdType="pubmed">17334579</ArticleId></ArticleIdList></Reference><Reference><Citation>Han DH, Lim S, Paek D, Kim HD (2012) Periodontitis could be related factors on metabolic syndrome among Koreans: a case-control study. J Clin Periodontol 39:30&#x2013;37. https://doi.org/10.1111/j.1600-051X.2011.01806.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1600-051X.2011.01806.x</ArticleId><ArticleId IdType="pubmed">22092822</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen X, Xie L, Liu Y, Chen D, Yu Q, Gan X, Yu H (2016) Metabolic syndrome and periodontal disease among civilian pilots. Aerosp Med Hum Perform 87:1016&#x2013;1020. https://doi.org/10.3357/AMHP.4654.2016</Citation><ArticleIdList><ArticleId IdType="doi">10.3357/AMHP.4654.2016</ArticleId><ArticleId IdType="pubmed">28323587</ArticleId></ArticleIdList></Reference><Reference><Citation>Adachi N, Kobayashi Y (2020) One-year follow-up study on associations between dental caries, periodontitis, and metabolic syndrome. J Oral Sci 62:52&#x2013;56. https://doi.org/10.2334/josnusd.18-0251</Citation><ArticleIdList><ArticleId IdType="doi">10.2334/josnusd.18-0251</ArticleId><ArticleId IdType="pubmed">31996523</ArticleId></ArticleIdList></Reference><Reference><Citation>Khader Y, Khassawneh B, Obeidat B, Hammad M, El-Salem K, Bawadi H, Al-akour N (2008) Periodontal status of patients with metabolic syndrome compared to those without metabolic syndrome. J Periodontol 79:2048&#x2013;2053. https://doi.org/10.1902/jop.2008.080022</Citation><ArticleIdList><ArticleId IdType="doi">10.1902/jop.2008.080022</ArticleId><ArticleId IdType="pubmed">18980512</ArticleId></ArticleIdList></Reference><Reference><Citation>Benguigui C, Bongard V, Ruidavets JB, Chamontin B, Sixou M, Ferri&#xe8;res J, Amar J (2010) Metabolic syndrome, insulin resistance, and periodontitis: a cross-sectional study in a middle-aged French population. J Clin Periodontol 37:601&#x2013;608. https://doi.org/10.1111/j.1600-051X.2010.01571.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1600-051X.2010.01571.x</ArticleId><ArticleId IdType="pubmed">20492076</ArticleId></ArticleIdList></Reference><Reference><Citation>Timonen P, Niskanen M, Suominen-Taipale L, Jula A, Knuuttila M, Yl&#xf6;stalo P (2010) Metabolic syndrome, periodontal infection, and dental caries. J Dent Res 89:1068&#x2013;1073. https://doi.org/10.1177/0022034510376542</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0022034510376542</ArticleId><ArticleId IdType="pubmed">20647498</ArticleId></ArticleIdList></Reference><Reference><Citation>Fukui N, Shimazaki Y, Shinagawa T, Yamashita Y (2012) Periodontal status and metabolic syndrome in middle-aged Japanese. J Periodontol 83:1363&#x2013;1371. https://doi.org/10.1902/jop.2012.110605</Citation><ArticleIdList><ArticleId IdType="doi">10.1902/jop.2012.110605</ArticleId><ArticleId IdType="pubmed">22248226</ArticleId></ArticleIdList></Reference><Reference><Citation>Furuta M, Shimazaki Y, Takeshita T, Shibata Y, Akifusa S, Eshima N, Kiyohara Y, Ninomiya Y, Hirakawa Y, Mukai N, Nagata M, Yamashita Y (2013) Gender differences in the association between metabolic syndrome and periodontal disease: the Hisayama study. J Clin Periodontol 40:743&#x2013;752. https://doi.org/10.1111/jcpe.12119</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jcpe.12119</ArticleId><ArticleId IdType="pubmed">23829196</ArticleId><ArticleId IdType="pmc">3807558</ArticleId></ArticleIdList></Reference><Reference><Citation>Goulart AC, Armani F, Arap AM, Nejm T, Andrade JB, Bufarah HB, Dezen DHS (2017) Relationship between periodontal disease and cardiovascular risk factors among young and middle-aged Brazilians. Cross-sectional study Sao Paulo Med J 135:226&#x2013;233. https://doi.org/10.1590/1516-3180.2016.0357300117</Citation><ArticleIdList><ArticleId IdType="doi">10.1590/1516-3180.2016.0357300117</ArticleId><ArticleId IdType="pubmed">28746658</ArticleId></ArticleIdList></Reference><Reference><Citation>Nascimento GG, Leite FRM, Peres KG, Demarco FF, Corr&#xea;a MB, Peres MA (2019) Metabolic syndrome and periodontitis: a structural equation modeling approach. J Periodontol 90:655&#x2013;662. https://doi.org/10.1002/JPER.18-0483</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/JPER.18-0483</ArticleId><ArticleId IdType="pubmed">30447085</ArticleId></ArticleIdList></Reference><Reference><Citation>Tegelberg P, Tervonen T, Knuuttila M, Jokelainen J, Kein&#xe4;nen-Kiukaanniemi S, Auvinen J, Yl&#xf6;stalo P (2019) Long-term metabolic syndrome is associated with periodontal pockets and alveolar bone loss. J Clin Periodontol 46:799&#x2013;808. https://doi.org/10.1111/jcpe.13154</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jcpe.13154</ArticleId><ArticleId IdType="pubmed">31141197</ArticleId></ArticleIdList></Reference><Reference><Citation>Nibali L, D&#x2019;Aiuto F, Griffiths G, Patel K, Suvan J, Tonetti MS (2007) Severe periodontitis is associated with systemic inflammation and a dysmetabolic status: a case-control study. J Clin Periodontol 34:931&#x2013;937. https://doi.org/10.1111/j.1600-051X.2007.01133.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1600-051X.2007.01133.x</ArticleId><ArticleId IdType="pubmed">17877746</ArticleId></ArticleIdList></Reference><Reference><Citation>Hlushchenko TA, Batig VM, Borysenko AV, Tokar OM, Batih IV, Vynogradova OM, Boychuk-Tovsta OG (2020) Prevalence and intensity of periodontal disease in individuals with metabolic syndrome. J Med Life 13:289&#x2013;292. https://doi.org/10.25122/jml-2020-0073</Citation></Reference><Reference><Citation>Teixeira FCF, Marin-Leon L, Gomes EP, Pedr&#xe3;o AMN, Pereira AC, Francisco PMSB (2020) Relationship between periodontitis and subclinical risk indicators for chronic non-communicable diseases. Braz Oral Res 34:e058. https://doi.org/10.1590/1807-3107bor-2020.vol34.0058.eCollection2020</Citation><ArticleIdList><ArticleId IdType="doi">10.1590/1807-3107bor-2020.vol34.0058.eCollection2020</ArticleId><ArticleId IdType="pubmed">32578801</ArticleId></ArticleIdList></Reference><Reference><Citation>Gomes-Filho IS, Balinha ISCE, da Cruz SS, Trindade SC, Cerqueira EMM, Passos-Soares JS, Coelho JMF, Ladeia AMT, Vianna MIP, Hintz AM, Santana TC, Santos PP, Figueiredo ANMG, Silva ICO, Scannapieco FA, Barreto ML, Loomer PM (2021) Moderate and severe periodontitis are positively associated with metabolic syndrome. Clin Oral Investig 25:3719&#x2013;3727. https://doi.org/10.1007/s00784-020-03699-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00784-020-03699-2</ArticleId><ArticleId IdType="pubmed">33226499</ArticleId></ArticleIdList></Reference><Reference><Citation>Kotin J, Walther C, Wenzel U, Zyriax BC, Borof K, Schnabel RB, Seedorf U, Jagodzinski A, Heydecke G, Lamprecht R, Smeets R, Beikler T, Aarabi G (2021) Association between periodontitis and metabolic syndrome in the Hamburg city health study. J Periodontol. Online ahead of print. https://doi.org/10.1002/JPER.21-0464</Citation></Reference><Reference><Citation>Manzon L, Mandolesi S, Guerra F, Poli O, Niglio T (2021) Associations between bone retraction, lost teeth, and metabolic syndrome. A cross-sectional study in dentistry patients aged over 60 years. Clin Ter 172:442&#x2013;447. https://doi.org/10.7417/CT.2021.2356</Citation><ArticleIdList><ArticleId IdType="doi">10.7417/CT.2021.2356</ArticleId><ArticleId IdType="pubmed">34625777</ArticleId></ArticleIdList></Reference><Reference><Citation>Ngoude JXE, Moor VJA, Nadia-Flore TT, Agoons BB, Marcelle GGC, MacBrain EE, Tcheutchoua DN, Nkeck JR (2021) Relationship between periodontal diseases and newly-diagnosed metabolic syndrome components in a sub-Saharan population: a cross sectional study. BMC Oral Health 21:326. https://doi.org/10.1186/s12903-021-01661-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12903-021-01661-6</ArticleId><ArticleId IdType="pubmed">34187434</ArticleId><ArticleId IdType="pmc">8244141</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsai KG, Su FY, Cheng WC, Ruang RY, Lin YP, Lin GM (2021) Associations between metabolic biomarkers and localized stage II/III periodontitis in young adults: The CHIEF Oral Health study. J Clin Periodontol 48:1549&#x2013;1558. https://doi.org/10.1111/jcpe.13555</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jcpe.13555</ArticleId><ArticleId IdType="pubmed">34605054</ArticleId></ArticleIdList></Reference><Reference><Citation>Suwanprasit W, Lertpimonchai A, Thienpramuk L, Vathesatogkit P, Sritara P, Tamsailom S (2021) Metabolic syndrome and severe periodontitis were associated in Thai adults: a cross-sectional study. J Periodontol 92:1420&#x2013;1429. https://doi.org/10.1002/JPER.20-0651</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/JPER.20-0651</ArticleId><ArticleId IdType="pubmed">33590483</ArticleId></ArticleIdList></Reference><Reference><Citation>Bensley L, VanEenwyk J, Ossiander EM (2011) Associations of self-reported periodontal disease with metabolic syndrome and number of self-reported chronic conditions. Prev Chronic Di 8:A50</Citation></Reference><Reference><Citation>Jepsen S, Suvan J (2000) Deschner J (2020) The association of periodontal diseases with metabolic syndrome and obesity. Periodontol 83:125&#x2013;153. https://doi.org/10.1111/prd.12326</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/prd.12326</ArticleId></ArticleIdList></Reference><Reference><Citation>Wong LB, Yap AU, Allen PF (2020) Periodontal disease and quality of life: umbrella review of systematic reviews. J Periodontal Res 56:1&#x2013;17. https://doi.org/10.1111/jre.12805</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jre.12805</ArticleId><ArticleId IdType="pubmed">32965050</ArticleId></ArticleIdList></Reference><Reference><Citation>Bartold PM, Mariotti A (2017) The future of periodontal-systemic associations: raising the standards. Curr Oral Health Rep 4:258&#x2013;262. https://doi.org/10.1007/s40496-017-0150-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40496-017-0150-2</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">18005235</PMID><DateCompleted><Year>2008</Year><Month>05</Month><Day>01</Day></DateCompleted><DateRevised><Year>2025</Year><Month>06</Month><Day>23</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1538-7836</ISSN><JournalIssue CitedMedium="Internet"><Volume>6</Volume><Issue>2</Issue><PubDate><Year>2008</Year><Month>Feb</Month></PubDate></JournalIssue><Title>Journal of thrombosis and haemostasis : JTH</Title><ISOAbbreviation>J Thromb Haemost</ISOAbbreviation></Journal><ArticleTitle>Intraoperative pulmonary embolism and intracardiac thrombosis complicating liver transplantation: a systematic review.</ArticleTitle><Pagination><StartPage>297</StartPage><EndPage>302</EndPage><MedlinePgn>297-302</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1111/j.1538-7836.2008.02831.x</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S1538-7836(22)12939-9</ELocationID><Abstract><AbstractText Label="BACKGROUND">Pulmonary embolism (PE) and intracardiac thrombosis (ICT) are rare but potentially lethal complications during orthotopic liver transplantation (OLT).</AbstractText><AbstractText Label="METHODS">We aimed to review clinical and pathological correlates of PE and ICT in patients undergoing OLT. A systematic review of the literature was conducted using MEDLINE and ISI Web of Science.</AbstractText><AbstractText Label="RESULTS">Seventy-four cases of intraoperative PE and/or ICT were identified; PE alone in 32 patients (43%) and a combination of PE and ICT in 42 patients (57%). Most frequent clinical symptoms included systemic hypotension and concomitant rising pulmonary artery pressure, often leading to complete circulatory collapse. PE and ICT occurred in every stage of the operation and were reported equally in patients with or without the use of venovenous bypass or antifibrinolytics. A large variety of putative risk factors have been suggested in the literature, including the use of pulmonary artery catheters or certain blood products. Nineteen patients underwent urgent thrombectomy or thrombolysis. Overall mortality was 68% (50/74) and 41 patients (82%) died intraoperatively.</AbstractText><AbstractText Label="CONCLUSION">Mortality was significantly higher in patients with an isolated PE, compared to patients with a combination of PE and ICT (91% and 50%, respectively; P &lt; 0.001). Intraoperative PE and ICT during OLT appear to have multiple etiologies and may occur unexpectedly at any time during the procedure.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Warnaar</LastName><ForeName>N</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Section Hepatobiliary Surgery and Liver Transplantation, Department of Surgery, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Molenaar</LastName><ForeName>I Q</ForeName><Initials>IQ</Initials></Author><Author ValidYN="Y"><LastName>Colquhoun</LastName><ForeName>S D</ForeName><Initials>SD</Initials></Author><Author ValidYN="Y"><LastName>Slooff</LastName><ForeName>M J H</ForeName><Initials>MJ</Initials></Author><Author ValidYN="Y"><LastName>Sherwani</LastName><ForeName>S</ForeName><Initials>S</Initials></Author><Author ValidYN="Y"><LastName>de Wolf</LastName><ForeName>A M</ForeName><Initials>AM</Initials></Author><Author ValidYN="Y"><LastName>Porte</LastName><ForeName>R J</ForeName><Initials>RJ</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2007</Year><Month>11</Month><Day>14</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>J Thromb Haemost</MedlineTA><NlmUniqueID>101170508</NlmUniqueID><ISSNLinking>1538-7836</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Liver Transpl. 2008 Apr;14(4):575.</RefSource><PMID Version="1">18396486</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002675" MajorTopicYN="N">Child, Preschool</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003131" MajorTopicYN="N">Combined Modality Therapy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006331" MajorTopicYN="N">Heart Diseases</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017052" MajorTopicYN="N">Hospital Mortality</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006976" MajorTopicYN="N">Hypertension, Pulmonary</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007022" MajorTopicYN="N">Hypotension</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007223" MajorTopicYN="N">Infant</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007231" MajorTopicYN="N">Infant, Newborn</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007431" MajorTopicYN="N">Intraoperative Complications</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016031" MajorTopicYN="Y">Liver Transplantation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011655" MajorTopicYN="N">Pulmonary Embolism</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012769" MajorTopicYN="N">Shock</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013916" MajorTopicYN="N">Thrombelastography</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013927" MajorTopicYN="N">Thrombosis</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading></MeshHeadingList><NumberOfReferences>58</NumberOfReferences></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2007</Year><Month>11</Month><Day>17</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2008</Year><Month>5</Month><Day>2</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2007</Year><Month>11</Month><Day>17</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">18005235</ArticleId><ArticleId IdType="doi">10.1111/j.1538-7836.2008.02831.x</ArticleId><ArticleId IdType="pii">S1538-7836(22)12939-9</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">40204694</PMID><DateCompleted><Year>2025</Year><Month>04</Month><Day>09</Day></DateCompleted><DateRevised><Year>2025</Year><Month>04</Month><Day>14</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2041-1723</ISSN><JournalIssue CitedMedium="Internet"><Volume>16</Volume><Issue>1</Issue><PubDate><Year>2025</Year><Month>Apr</Month><Day>09</Day></PubDate></JournalIssue><Title>Nature communications</Title><ISOAbbreviation>Nat Commun</ISOAbbreviation></Journal><ArticleTitle>Impact of perioperative organ injury on morbidity and mortality in 28 million surgical patients.</ArticleTitle><Pagination><StartPage>3366</StartPage><MedlinePgn>3366</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">3366</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41467-025-58161-2</ELocationID><Abstract><AbstractText>Perioperative organ injury contributes to morbidity and mortality of surgical patients. This cohort study included all elective and emergent surgeries in Germany over 4 years to address the impact of perioperative organ injuries on outcomes. We analyzed 28,350,953 cases. In-hospital mortality was 1.4% (n&#x2009;=&#x2009;393,157), and 4.4% of cases (n&#x2009;=&#x2009;1,245,898) experienced perioperative organ injury. Perioperative organ injury was associated with 9-fold higher odds of death and prolonged hospital stay by 11.2 days. Acute kidney injury had the highest incidence (2.0%) and was associated with 25.0% mortality. While delirium had the second highest incidence (1.5%), it was associated with the lowest mortality (10.8%). This was followed by acute myocardial infarction (incidence 0.6%, mortality 15.6%), stroke (incidence 0.6%, mortality 13.1%), pulmonary embolism (incidence 0.3%, mortality 20.0%), liver injury (incidence 0.1%, mortality 68.7%), and acute respiratory distress syndrome (incidence 0.1%, mortality 44.7%). These findings help prioritize interventions for preventing or treating individual types of perioperative organ injury.</AbstractText><CopyrightInformation>&#xa9; 2025. This is a U.S. Government work and not under copyright protection in the US; foreign copyright protection may apply.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Kork</LastName><ForeName>Felix</ForeName><Initials>F</Initials><Identifier Source="ORCID">0000-0002-4703-2478</Identifier><AffiliationInfo><Affiliation>Department of Anesthesiology, Medical Faculty, RWTH Aachen University, Aachen, Germany. fkork@ukaachen.de.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Liang</LastName><ForeName>Yafen</ForeName><Initials>Y</Initials><Identifier Source="ORCID">0000-0001-7902-7836</Identifier><AffiliationInfo><Affiliation>Department of Anesthesiology, Critical Care and Pain Medicine, McGovern Medical School, the University of Texas Health Science Center at Houston, Houston, TX, USA. yafen.liang@uth.tmc.edu.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for OUTCOMES RESEARCH and Department of Anesthesiology, UTHealth, Houston, TX, USA. yafen.liang@uth.tmc.edu.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ginde</LastName><ForeName>Adit A</ForeName><Initials>AA</Initials><AffiliationInfo><Affiliation>Department of Emergency Medicine, University of Colorado School of Medicine, Aurora, CO, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yuan</LastName><ForeName>Xiaoyi</ForeName><Initials>X</Initials><Identifier Source="ORCID">0000-0002-2898-6495</Identifier><AffiliationInfo><Affiliation>Department of Anesthesiology, Critical Care and Pain Medicine, McGovern Medical School, the University of Texas Health Science Center at Houston, Houston, TX, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rossaint</LastName><ForeName>Rolf</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Medical Faculty, RWTH Aachen University, Aachen, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Hongfang</ForeName><Initials>H</Initials><Identifier Source="ORCID">0000-0003-2570-3741</Identifier><AffiliationInfo><Affiliation>Department of Health Data Science and Artificial Intelligence, McWilliams School of Biomedical Informatics, the University of Texas Health Science Center at Houston, Houston, TX, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Evers</LastName><ForeName>Alex S</ForeName><Initials>AS</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Washington University, School of Medicine in St. Louis, St. Louis, MO, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Eltzschig</LastName><ForeName>Holger K</ForeName><Initials>HK</Initials><Identifier Source="ORCID">0000-0002-5676-6473</Identifier><AffiliationInfo><Affiliation>Department of Anesthesiology, Critical Care and Pain Medicine, McGovern Medical School, the University of Texas Health Science Center at Houston, Houston, TX, USA. holger.eltzschig@uth.tmc.edu.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for OUTCOMES RESEARCH and Department of Anesthesiology, UTHealth, Houston, TX, USA. holger.eltzschig@uth.tmc.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01 DK122796</GrantID><Acronym>DK</Acronym><Agency>NIDDK NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>T32 GM135118</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 HL169519</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R35 HL177402</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 HL165748</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 HL155950</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 HL154720</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>04</Month><Day>09</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Nat Commun</MedlineTA><NlmUniqueID>101528555</NlmUniqueID><ISSNLinking>2041-1723</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005858" MajorTopicYN="N" Type="Geographic">Germany</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017052" MajorTopicYN="N">Hospital Mortality</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058186" MajorTopicYN="N">Acute Kidney Injury</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015994" MajorTopicYN="N">Incidence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011655" MajorTopicYN="N">Pulmonary Embolism</DescriptorName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007902" MajorTopicYN="N">Length of Stay</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="Y">Postoperative Complications</DescriptorName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009203" MajorTopicYN="N">Myocardial Infarction</DescriptorName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D059035" MajorTopicYN="N">Perioperative Period</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012128" MajorTopicYN="N">Respiratory Distress Syndrome</DescriptorName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020521" MajorTopicYN="N">Stroke</DescriptorName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013514" MajorTopicYN="Y">Surgical Procedures, Operative</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading></MeshHeadingList><CoiStatement>Competing interests: Drs. Holger Eltzschig, Xiaoyi Yuan, and Yafen Liang received research funding through a contract between Akebia Therapeutics and UTHealth to support a clinical trial on the effect of vadadustat in hospitalized COVID-19 patients (NCT04478071). Akebia Therapeutics is not involved in conceptualization, design, data collection, analysis, the decision to publish, or the preparation of the manuscript. The remaining authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>5</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2025</Year><Month>3</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>4</Month><Day>10</Day><Hour>0</Hour><Minute>21</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>4</Month><Day>10</Day><Hour>0</Hour><Minute>20</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>4</Month><Day>9</Day><Hour>23</Hour><Minute>13</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2025</Year><Month>4</Month><Day>9</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">40204694</ArticleId><ArticleId IdType="pmc">PMC11982547</ArticleId><ArticleId IdType="doi">10.1038/s41467-025-58161-2</ArticleId><ArticleId IdType="pii">10.1038/s41467-025-58161-2</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Bartels, K., Karhausen, J., Clambey, E. T., Grenz, A. &amp; Eltzschig, H. K. Perioperative organ injury. Anesthesiology119, 1474&#x2013;1489 (2013).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3929362</ArticleId><ArticleId IdType="pubmed">24126264</ArticleId></ArticleIdList></Reference><Reference><Citation>Evers, A. S. &amp; Miller, R. D. Can we get there if we don&#x2019;t know where we&#x2019;re going? Anesthesiology106, 651&#x2013;652 (2007).</Citation><ArticleIdList><ArticleId IdType="pubmed">17413898</ArticleId></ArticleIdList></Reference><Reference><Citation>Lobo, S. M. et al. Early determinants of death due to multiple organ failure after noncardiac surgery in high-risk patients. Anesth. Analg.112, 877&#x2013;883 (2011).</Citation><ArticleIdList><ArticleId IdType="pubmed">20530615</ArticleId></ArticleIdList></Reference><Reference><Citation>Weiser, T. G. et al. An estimation of the global volume of surgery: a modelling strategy based on available data. Lancet372, 139&#x2013;144 (2008).</Citation><ArticleIdList><ArticleId IdType="pubmed">18582931</ArticleId></ArticleIdList></Reference><Reference><Citation>Dobson, G. P. Addressing the global burden of trauma in major surgery. Front. Surg.2, 43 (2015).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4558465</ArticleId><ArticleId IdType="pubmed">26389122</ArticleId></ArticleIdList></Reference><Reference><Citation>Leape, L. L. Hospital readmissions following surgery: turning complications into &#x201c;treasures&#x201d;. JAMA313, 467&#x2013;468 (2015).</Citation><ArticleIdList><ArticleId IdType="pubmed">25647201</ArticleId></ArticleIdList></Reference><Reference><Citation>Dimick, J. B. &amp; Ghaferi, A. A. Hospital readmission as a quality measure in surgery. JAMA313, 512&#x2013;513 (2015).</Citation><ArticleIdList><ArticleId IdType="pubmed">25647207</ArticleId></ArticleIdList></Reference><Reference><Citation>Pearse, R. M. et al. Mortality after surgery in Europe: a 7 day cohort study. Lancet380, 1059&#x2013;1065 (2012).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3493988</ArticleId><ArticleId IdType="pubmed">22998715</ArticleId></ArticleIdList></Reference><Reference><Citation>Farmer, P. E. &amp; Kim, J. Y. Surgery and global health: a view from beyond the OR. World J. Surg.32, 533&#x2013;536 (2008).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2267857</ArticleId><ArticleId IdType="pubmed">18311574</ArticleId></ArticleIdList></Reference><Reference><Citation>Rose, J., Chang, D. C., Weiser, T. G., Kassebaum, N. J. &amp; Bickler, S. W. The role of surgery in global health: analysis of United States inpatient procedure frequency by condition using the Global Burden of Disease 2010 framework. PLoS One9, e89693 (2014).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3935922</ArticleId><ArticleId IdType="pubmed">24586967</ArticleId></ArticleIdList></Reference><Reference><Citation>Conrad, C. &amp; Eltzschig, H. K. Disease mechanisms of perioperative organ injury. Anesth. Analg.131, 1730&#x2013;1750 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7673233</ArticleId><ArticleId IdType="pubmed">33186161</ArticleId></ArticleIdList></Reference><Reference><Citation>Shah, N. J., Mentz, G. &amp; Kheterpal, S. The incidence of intraoperative hypotension in moderate to high risk patients undergoing non-cardiac surgery: A retrospective multicenter observational analysis. J. Clin. Anesth.66, 109961 (2020).</Citation><ArticleIdList><ArticleId IdType="pubmed">32663738</ArticleId></ArticleIdList></Reference><Reference><Citation>Deitch, E. A. Multiple organ failure. Pathophysiology and potential future therapy. Ann. Surg.216, 117&#x2013;134 (1992).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1242583</ArticleId><ArticleId IdType="pubmed">1503516</ArticleId></ArticleIdList></Reference><Reference><Citation>Baue, A. E. Multiple, progressive, or sequential systems failure. A syndrome of the 1970s. Arch. Surg.110, 779&#x2013;781 (1975).</Citation><ArticleIdList><ArticleId IdType="pubmed">1079720</ArticleId></ArticleIdList></Reference><Reference><Citation>Yuan, X. et al. Targeting hypoxia signaling for perioperative organ injury. Anesth. Analg.126, 308&#x2013;321 (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5735013</ArticleId><ArticleId IdType="pubmed">28759485</ArticleId></ArticleIdList></Reference><Reference><Citation>Schwinn, D. A. &amp; Podgoreanu, M. Pharmacogenomics and end-organ susceptibility to injury in the perioperative period. Best. Pract. Res. Clin. Anaesthesiol.22, 23&#x2013;37 (2008).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2603024</ArticleId><ArticleId IdType="pubmed">18494387</ArticleId></ArticleIdList></Reference><Reference><Citation>Landesberg, G., Beattie, W. S., Mosseri, M., Jaffe, A. S. &amp; Alpert, J. S. Perioperative myocardial infarction. Circulation119, 2936&#x2013;2944 (2009).</Citation><ArticleIdList><ArticleId IdType="pubmed">19506125</ArticleId></ArticleIdList></Reference><Reference><Citation>Subramaniyan, S. &amp; Terrando, N. Neuroinflammation and perioperative neurocognitive disorders. Anesth. Analg.128, 781&#x2013;788 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6437083</ArticleId><ArticleId IdType="pubmed">30883423</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Hader, R. et al. The incidence of perioperative stroke: estimate using state and national databases and systematic review. J. Stroke21, 290&#x2013;301 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6780011</ArticleId><ArticleId IdType="pubmed">31590473</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaku, S. et al. Acute respiratory distress syndrome: etiology, pathogenesis, and summary on management. J. Intensive Care Med. 35, 723&#x2013;737 (2019).</Citation><ArticleIdList><ArticleId IdType="pubmed">31208266</ArticleId></ArticleIdList></Reference><Reference><Citation>Gumbert, S. D. et al. Perioperative Acute Kidney Injury. Anesthesiology132, 180&#x2013;204 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10924686</ArticleId><ArticleId IdType="pubmed">31687986</ArticleId></ArticleIdList></Reference><Reference><Citation>Taylor, R. M. et al. Short and long-term outcomes in patients with acute liver failure due to ischemic hepatitis. Dig. Dis. Sci.57, 777&#x2013;785 (2012).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5154383</ArticleId><ArticleId IdType="pubmed">21948394</ArticleId></ArticleIdList></Reference><Reference><Citation>Cecconi, M., Evans, L., Levy, M. &amp; Rhodes, A. Sepsis and septic shock. Lancet392, 75&#x2013;87 (2018).</Citation><ArticleIdList><ArticleId IdType="pubmed">29937192</ArticleId></ArticleIdList></Reference><Reference><Citation>Eltzschig, H. K. Targeting purinergic signaling for perioperative organ protection. Anesthesiology118, 1001&#x2013;1004 (2013).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3915407</ArticleId><ArticleId IdType="pubmed">23360900</ArticleId></ArticleIdList></Reference><Reference><Citation>McIlroy, D. R. et al. Oxygen administration during surgery and postoperative organ injury: observational cohort study. BMJ379, e070941 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9710248</ArticleId><ArticleId IdType="pubmed">36450405</ArticleId></ArticleIdList></Reference><Reference><Citation>Lehmann, M., Zarbock, A. &amp; Rossaint, J. [New aspects of perioperative organ protection]. Anaesthesiologie71, 741&#x2013;749 (2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">36064976</ArticleId></ArticleIdList></Reference><Reference><Citation>Nepogodiev, D., Martin, J., Biccard, B., Makupe, A. &amp; Bhangu, A. Global burden of postoperative death. Lancet393, 401 (2019).</Citation><ArticleIdList><ArticleId IdType="pubmed">30722955</ArticleId></ArticleIdList></Reference><Reference><Citation>Coronavirus Resource Center, J.H.U. COVID-19 data in motion: thursday, october 15, Vol. 2020 (2020).</Citation></Reference><Reference><Citation>Prowle, J. R. et al. Postoperative acute kidney injury in adult non-cardiac surgery: joint consensus report of the Acute Disease Quality Initiative and PeriOperative Quality Initiative. Nat. Rev. Nephrol.17, 605&#x2013;618 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8367817</ArticleId><ArticleId IdType="pubmed">33976395</ArticleId></ArticleIdList></Reference><Reference><Citation>Billings, F. T., Lopez, M. G. &amp; Shaw, A. D. The incidence, risk, presentation, pathophysiology, treatment, and effects of perioperative acute kidney injury. Can. J. Anaesth.68, 409&#x2013;422 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8088760</ArticleId><ArticleId IdType="pubmed">33403555</ArticleId></ArticleIdList></Reference><Reference><Citation>STARSurg Collaborative. Impact of postoperative acute kidney injury in patients undergoing major gastrointestinal surgery on 1-year survival and renal outcomes: a national multicentre cohort study. BJS Open5, zrab134 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8759520</ArticleId><ArticleId IdType="pubmed">35029656</ArticleId></ArticleIdList></Reference><Reference><Citation>Kork, F. et al. Minor postoperative increases of creatinine are associated with higher mortality and longer hospital length of stay in surgical patients. Anesthesiology123, 1301&#x2013;1311 (2015).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4679549</ArticleId><ArticleId IdType="pubmed">26492475</ArticleId></ArticleIdList></Reference><Reference><Citation>Beck, C., Schwartges, I. &amp; Picker, O. Perioperative liver protection. Curr. Opin. Crit. Care16, 142&#x2013;147 (2010).</Citation><ArticleIdList><ArticleId IdType="pubmed">20134321</ArticleId></ArticleIdList></Reference><Reference><Citation>Friedman, L. S. Surgery in the patient with liver disease. Trans. Am. Clin. Climatol. Assoc.121, 192&#x2013;204 (2010).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2917124</ArticleId><ArticleId IdType="pubmed">20697561</ArticleId></ArticleIdList></Reference><Reference><Citation>Bellani, G. et al. Epidemiology, patterns of care, and mortality for patients with acute respiratory distress syndrome in intensive care units in 50 countries. JAMA315, 788&#x2013;800 (2016).</Citation><ArticleIdList><ArticleId IdType="pubmed">26903337</ArticleId></ArticleIdList></Reference><Reference><Citation>Milot, J. et al. Incidence and predictors of ARDS after cardiac surgery. Chest119, 884&#x2013;888 (2001).</Citation><ArticleIdList><ArticleId IdType="pubmed">11243972</ArticleId></ArticleIdList></Reference><Reference><Citation>Kassis, E. B., Beitler, J. R. &amp; Talmor, D. Lung-protective sedation: moving toward a new paradigm of precision sedation. Intensive Care Med.49, 91&#x2013;94 (2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">36239747</ArticleId></ArticleIdList></Reference><Reference><Citation>Eltzschig, H. K., Sitkovsky, M. V. &amp; Robson, S. C. Purinergic signaling during inflammation. N. Engl. J. Med.368, 1260 (2013).</Citation><ArticleIdList><ArticleId IdType="pubmed">23534573</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee, T. J. et al. Strategies to modulate MicroRNA functions for the treatment of cancer or organ injury. Pharm. Rev.72, 639&#x2013;667 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7300323</ArticleId><ArticleId IdType="pubmed">32554488</ArticleId></ArticleIdList></Reference><Reference><Citation>Matthay, M. A. et al. Treatment with allogeneic mesenchymal stromal cells for moderate to severe acute respiratory distress syndrome (START study): a randomised phase 2a safety trial. Lancet Respir. Med.7, 154&#x2013;162 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7597675</ArticleId><ArticleId IdType="pubmed">30455077</ArticleId></ArticleIdList></Reference><Reference><Citation>Soriano, S. G., Vutskits, L., Jevtovic-Todorovic, V. &amp; Hemmings, H. C. Thinking, fast and slow: highlights from the 2016 BJA seminar on anaesthetic neurotoxicity and neuroplasticity. Br. J. Anaesth.119, 443&#x2013;447 (2017).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6172966</ArticleId><ArticleId IdType="pubmed">28969326</ArticleId></ArticleIdList></Reference><Reference><Citation>Khuri, S. F. et al. Determinants of long-term survival after major surgery and the adverse effect of postoperative complications. Ann. Surg.242, 326&#x2013;341 (2005).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1357741</ArticleId><ArticleId IdType="pubmed">16135919</ArticleId></ArticleIdList></Reference><Reference><Citation>Devereaux, P. J. et al. Association of postoperative high-sensitivity troponin levels with myocardial injury and 30-day mortality among patients undergoing noncardiac surgery. JAMA317, 1642&#x2013;1651 (2017).</Citation><ArticleIdList><ArticleId IdType="pubmed">28444280</ArticleId></ArticleIdList></Reference><Reference><Citation>Devereaux, P. J. et al. Association between postoperative troponin levels and 30-day mortality among patients undergoing noncardiac surgery. JAMA307, 2295&#x2013;2304 (2012).</Citation><ArticleIdList><ArticleId IdType="pubmed">22706835</ArticleId></ArticleIdList></Reference><Reference><Citation>Ackland, G. L., Abbott, T. E. F., Jones, T. F., Leuwer, M. &amp; Pearse, R. M. Early elevation in plasma high-sensitivity troponin T and morbidity after elective noncardiac surgery: prospective multicentre observational cohort study. Br. J. Anaesth.124, 535&#x2013;543 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7222220</ArticleId><ArticleId IdType="pubmed">32147104</ArticleId></ArticleIdList></Reference><Reference><Citation>Ruetzler, K., Khanna, A. K. &amp; Sessler, D. I. Myocardial injury after noncardiac surgery: preoperative, intraoperative, and postoperative aspects, implications, and directions. Anesth. Analg.131, 173&#x2013;186 (2020).</Citation><ArticleIdList><ArticleId IdType="pubmed">31880630</ArticleId></ArticleIdList></Reference><Reference><Citation>Turan, A. et al. Association between postoperative haemoglobin and myocardial injury after noncardiac surgery: a retrospective cohort analysis. Br. J. Anaesth.126, 94&#x2013;101 (2021).</Citation><ArticleIdList><ArticleId IdType="pubmed">33039122</ArticleId></ArticleIdList></Reference><Reference><Citation>Semel, M. E. et al. Rates and patterns of death after surgery in the United States, 1996 and 2006. Surgery151, 171&#x2013;182 (2012).</Citation><ArticleIdList><ArticleId IdType="pubmed">21975292</ArticleId></ArticleIdList></Reference><Reference><Citation>Biccard, B. M. et al. Perioperative patient outcomes in the African surgical outcomes study: a 7-day prospective observational cohort study. Lancet391, 1589&#x2013;1598 (2018).</Citation><ArticleIdList><ArticleId IdType="pubmed">29306587</ArticleId></ArticleIdList></Reference><Reference><Citation>Ludbrook, G. et al. Outcomes of postoperative overnight high-acuity care in medium-risk patients undergoing elective and unplanned noncardiac surgery. JAMA Surg.158, 701&#x2013;708 (2023).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10157507</ArticleId><ArticleId IdType="pubmed">37133876</ArticleId></ArticleIdList></Reference><Reference><Citation>Krebs, J. R. et al. Presentation and outcomes of elective and nonelective complex endovascular repair for thoracoabdominal and juxtarenal aortic aneurysms. Ann. Vasc. Surg.97, 248&#x2013;256 (2023).</Citation><ArticleIdList><ArticleId IdType="pubmed">37714262</ArticleId></ArticleIdList></Reference><Reference><Citation>Dony, P., Pirson, M. &amp; Boogaerts, J. G. In- and out-hospital mortality rate in surgical patients. Acta Chir. Belg.118, 21&#x2013;26 (2018).</Citation><ArticleIdList><ArticleId IdType="pubmed">28728520</ArticleId></ArticleIdList></Reference><Reference><Citation>Maximus, S. et al. Defining operative mortality: impact on outcome reporting. J. Thorac. Cardiovasc. Surg.151, 1101&#x2013;1107 (2016).</Citation><ArticleIdList><ArticleId IdType="pubmed">26876420</ArticleId></ArticleIdList></Reference><Reference><Citation>Moonesinghe, S. R. et al. Survival after postoperative morbidity: a longitudinal observational cohort study. Br. J. Anaesth.113, 977&#x2013;984 (2014).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4235571</ArticleId><ArticleId IdType="pubmed">25012586</ArticleId></ArticleIdList></Reference><Reference><Citation>Born, S. et al. Epidemiology of sepsis among children and neonates in Germany: results from an observational study based on nationwide diagnosis-related groups data between 2010 and 2016. Crit. Care Med.49, 1049&#x2013;1057 (2021).</Citation><ArticleIdList><ArticleId IdType="pubmed">33729720</ArticleId></ArticleIdList></Reference><Reference><Citation>Reutersberg, B. et al. Hospital incidence and in-hospital mortality of surgically and interventionally treated aortic dissections: secondary data analysis of the nationwide German diagnosis-related group statistics from 2006 to 2014. J. Am. Heart Assoc.8, e011402 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6507201</ArticleId><ArticleId IdType="pubmed">30975011</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">29909859</PMID><DateCompleted><Year>2018</Year><Month>11</Month><Day>05</Day></DateCompleted><DateRevised><Year>2025</Year><Month>06</Month><Day>23</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">2213-3348</ISSN><JournalIssue CitedMedium="Internet"><Volume>6</Volume><Issue>4</Issue><PubDate><Year>2018</Year><Month>Jul</Month></PubDate></JournalIssue><Title>Journal of vascular surgery. Venous and lymphatic disorders</Title><ISOAbbreviation>J Vasc Surg Venous Lymphat Disord</ISOAbbreviation></Journal><ArticleTitle>A meta-analysis of outcomes of catheter-directed thrombolysis for high- and intermediate-risk pulmonary embolism.</ArticleTitle><Pagination><StartPage>530</StartPage><EndPage>540</EndPage><MedlinePgn>530-540</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jvsv.2018.03.010</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S2213-333X(18)30141-0</ELocationID><Abstract><AbstractText Label="OBJECTIVE">During the past few years, there has been a surge in the use of catheter-directed thrombolysis (CDT) for acute pulmonary embolism (PE), in the form of either standard CDT or ultrasound-assisted CDT (usCDT). This is a systematic review and meta-analysis of all published series on contemporary CDT for acute PE seeking to determine their clinical efficacy, stratifying by PE severity and CDT modality.</AbstractText><AbstractText Label="METHODS">A comprehensive MEDLINE and Embase search was performed to identify studies that reported outcomes of CDT for acute PE published from 2009 to July 2017. Outcomes included clinical success (in-hospital survival with stabilization of hemodynamics, without decompensation or any major complication), in-hospital mortality, major bleeding, right ventricular/left ventricular ratio, and Miller score changes after CDT. Meta-analyses assumed random effects.</AbstractText><AbstractText Label="RESULTS">Twenty studies with 1168 patients were included in the meta-analysis. Available for subgroup analysis were 210&#xa0;patients with high-risk PE and 945 patients with intermediate-risk PE; 181 patients received CDT using a standard multiside hole catheter, and 850 received usCDT. The pooled average right ventricular/left ventricular improvement and Miller score drop after CDT were 0.30 (95% confidence interval [CI], 0.22-0.39) and 8.8 (95% CI, 7.1-10.5). For high-risk PE, the pooled estimate for clinical success was 81.3% (95% CI, 72.5%-89.1%), the 30-day mortality estimate was 8.0% (95% CI, 3.2%-14.0%), and major bleeding was 6.7% (95% CI, 1.0%-15.3%). For intermediate-risk PE, the pooled estimate for clinical success was 97.5% (95% CI, 95.3%-99.1%), the 30-day mortality was 0% (95% CI, 0%-0.5%), and major bleeding was 1.4% (95% CI, 0.3%-2.8%). In high-risk PE, clinical success for CDT and usCDT was 70.8% (95% CI, 53.4%-85.8%) and 83.1% (95%&#xa0;CI, 68.5%-94.5%), respectively. In intermediate-risk PE, clinical success for CDT and usCDT was 95.0% (95% CI, 88.5%-99.2%) and 97.5% (95% CI, 95.0%-99.4%), respectively.</AbstractText><AbstractText Label="CONCLUSIONS">Catheter thrombolysis has high clinical success rates in both high- and intermediate-risk PE, but higher mortality and bleeding rates should be anticipated in high-risk PE. Ultrasound-assisted thrombolysis may be more effective than standard CDT in the higher risk population.</AbstractText><CopyrightInformation>Copyright &#xa9; 2018 Society for Vascular Surgery. Published by Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Avgerinos</LastName><ForeName>Efthymios D</ForeName><Initials>ED</Initials><AffiliationInfo><Affiliation>Division of Vascular Surgery, University of Pittsburgh Medical Center, Pittsburgh, Pa.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Saadeddin</LastName><ForeName>Zein</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Division of Vascular Surgery, University of Pittsburgh Medical Center, Pittsburgh, Pa.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Abou Ali</LastName><ForeName>Adham N</ForeName><Initials>AN</Initials><AffiliationInfo><Affiliation>Division of Vascular Surgery, University of Pittsburgh Medical Center, Pittsburgh, Pa.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fish</LastName><ForeName>Larry</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Division of Vascular Surgery, University of Pittsburgh Medical Center, Pittsburgh, Pa.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Toma</LastName><ForeName>Catalin</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Heart and Vascular Institute, University of Pittsburgh Medical Center, Pittsburgh, Pa.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chaer</LastName><ForeName>Maria</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Division of Vascular Surgery, University of Pittsburgh Medical Center, Pittsburgh, Pa.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rivera-Lebron</LastName><ForeName>Belinda N</ForeName><Initials>BN</Initials><AffiliationInfo><Affiliation>Department of Medicine, University of Pittsburgh Medical Center, Pittsburgh, Pa.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chaer</LastName><ForeName>Rabih A</ForeName><Initials>RA</Initials><AffiliationInfo><Affiliation>Division of Vascular Surgery, University of Pittsburgh Medical Center, Pittsburgh, Pa. Electronic address: chaerra@upmc.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Vasc Surg Venous Lymphat Disord</MedlineTA><NlmUniqueID>101607771</NlmUniqueID><ISSNLinking>2213-333X</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D005343">Fibrinolytic Agents</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002406" MajorTopicYN="Y">Catheterization, Peripheral</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005343" MajorTopicYN="N">Fibrinolytic Agents</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="Y">administration &amp; dosage</QualifierName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006470" MajorTopicYN="N">Hemorrhage</DescriptorName><QualifierName UI="Q000139" MajorTopicYN="N">chemically induced</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011655" MajorTopicYN="N">Pulmonary Embolism</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName><QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015912" MajorTopicYN="N">Thrombolytic Therapy</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013997" MajorTopicYN="N">Time Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018084" MajorTopicYN="N">Ultrasonography, Interventional</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Acute pulmonary embolism</Keyword><Keyword MajorTopicYN="N">Catheter-directed thrombolysis</Keyword><Keyword MajorTopicYN="N">Ultrasound-assisted thrombolysis</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>10</Month><Day>31</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>3</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>6</Month><Day>19</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>6</Month><Day>19</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>11</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29909859</ArticleId><ArticleId IdType="doi">10.1016/j.jvsv.2018.03.010</ArticleId><ArticleId IdType="pii">S2213-333X(18)30141-0</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">35761099</PMID><DateCompleted><Year>2022</Year><Month>08</Month><Day>15</Day></DateCompleted><DateRevised><Year>2025</Year><Month>07</Month><Day>28</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1432-5195</ISSN><JournalIssue CitedMedium="Internet"><Volume>46</Volume><Issue>9</Issue><PubDate><Year>2022</Year><Month>Sep</Month></PubDate></JournalIssue><Title>International orthopaedics</Title><ISOAbbreviation>Int Orthop</ISOAbbreviation></Journal><ArticleTitle>Incidence, characteristics, and risk factors of venous thromboembolism in shoulder arthroplasty-a systematic review.</ArticleTitle><Pagination><StartPage>2081</StartPage><EndPage>2088</EndPage><MedlinePgn>2081-2088</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s00264-022-05496-w</ELocationID><Abstract><AbstractText Label="PURPOSE">The purpose of this study was to investigate the incidence, characteristics, and risk factors for venous thromboembolism (VTE) in patients who underwent shoulder arthroplasty (SA) through systematic review.</AbstractText><AbstractText Label="METHODS">A search of studies was conducted using the databases for PubMed, EMBASE, Scopus, Ovid, MEDLINE, and Cochrane Library according to the guidelines for PRISMA (Preferred Reporting Items for Systematic Meta-Analyses). Quality assessment was performed using the Methodological Index for Nonrandomized Studies (MINORS).</AbstractText><AbstractText Label="RESULTS">Nine studies (12,566 shoulders) were finally eligible and the mean MINORS score was 13.2 (ranges, 9-18). The overall incidence of VTE was 0.81% (78/9681) including 0.54% (52/9681) for deep vein thrombosis (DVT) and 0.33% (42/12,566) for pulmonary embolism (PE). There were no significant differences in the incidences according to the type of arthroplasty. DVT was detected at an average of 18.8&#xa0;days after index surgery, and PE was detected at an average of 12.7&#xa0;days after index surgery. The risk factors for VTE included age older than 70&#xa0;years, higher BMI, raised Charlson Comorbidity Index, history of DVT, asthma, cardiac arrhythmia, diabetes, lower haemoglobin level, use of general endotracheal anaesthesia without interscalene nerve block, traumatic indication, longer operative time, and revision SA. The mortality rate was 4.1% (2/49) for VTE and 8.3% (2/24) for PE.</AbstractText><AbstractText Label="CONCLUSION">Despite the fact that the overall incidence of VTE following SA was as low as 0.81%, shoulder surgeons should consider the potential for this serious complication in high-risk patients. Further well-designed large-scale studies are necessary to clarify the consensus for VTE after SA including risk factors, treatment, and prophylaxis.</AbstractText><CopyrightInformation>&#xa9; 2022. The Author(s) under exclusive licence to SICOT aisbl.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Na</LastName><ForeName>Sang-Soo</ForeName><Initials>SS</Initials><AffiliationInfo><Affiliation>Department of Orthopedic Surgery, Keimyung University Dongsan Hospital, Keimyung University School of Medicine, 1035 Dalgubeol-daero, Dalseo-gu, Daegu, 42601, South Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Du-Han</ForeName><Initials>DH</Initials><AffiliationInfo><Affiliation>Department of Orthopedic Surgery, Keimyung University Dongsan Hospital, Keimyung University School of Medicine, 1035 Dalgubeol-daero, Dalseo-gu, Daegu, 42601, South Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Choi</LastName><ForeName>Byung-Chan</ForeName><Initials>BC</Initials><AffiliationInfo><Affiliation>Department of Orthopedic Surgery, Keimyung University Dongsan Hospital, Keimyung University School of Medicine, 1035 Dalgubeol-daero, Dalseo-gu, Daegu, 42601, South Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cho</LastName><ForeName>Chul-Hyun</ForeName><Initials>CH</Initials><Identifier Source="ORCID">0000-0003-0252-8741</Identifier><AffiliationInfo><Affiliation>Department of Orthopedic Surgery, Keimyung University Dongsan Hospital, Keimyung University School of Medicine, 1035 Dalgubeol-daero, Dalseo-gu, Daegu, 42601, South Korea. oscho5362@dsmc.or.kr.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>2021R1F1A1047546</GrantID><Agency>the National Research Foundation of Korea</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>06</Month><Day>28</Day></ArticleDate></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>Int Orthop</MedlineTA><NlmUniqueID>7705431</NlmUniqueID><ISSNLinking>0341-2695</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000925">Anticoagulants</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000925" MajorTopicYN="N">Anticoagulants</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001178" MajorTopicYN="N">Arthroplasty</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000072228" MajorTopicYN="Y">Arthroplasty, Replacement, Shoulder</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015994" MajorTopicYN="N">Incidence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011655" MajorTopicYN="Y">Pulmonary Embolism</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D054556" MajorTopicYN="Y">Venous Thromboembolism</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020246" MajorTopicYN="Y">Venous Thrombosis</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Arthroplasty</Keyword><Keyword MajorTopicYN="N">Deep vein thrombosis</Keyword><Keyword MajorTopicYN="N">Pulmonary embolism</Keyword><Keyword MajorTopicYN="N">Shoulder</Keyword><Keyword MajorTopicYN="N">Systematic review</Keyword><Keyword MajorTopicYN="N">Venous thromboembolism</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>5</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>6</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>6</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>8</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>6</Month><Day>27</Day><Hour>23</Hour><Minute>32</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35761099</ArticleId><ArticleId IdType="doi">10.1007/s00264-022-05496-w</ArticleId><ArticleId IdType="pii">10.1007/s00264-022-05496-w</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Navarro RP, Barr JE, Faubus K, Sabharwal AD, Stern E, Unger K (2011) Improving outcomes in patients at risk for venous thromboembolism following total knee and total hip replacement: implications for managed care. Am J Manag Care 17(Suppl 9):S251-258</Citation><ArticleIdList><ArticleId IdType="pubmed">21819165</ArticleId></ArticleIdList></Reference><Reference><Citation>Baser O (2011) Prevalence and economic burden of venous thromboembolism after total hip arthroplasty or total knee arthroplasty. Am J Manag Care 17:S6-8</Citation><ArticleIdList><ArticleId IdType="pubmed">21517654</ArticleId></ArticleIdList></Reference><Reference><Citation>Kunutsor SK, Barrett MC, Whitehouse MR, Blom AW (2020) Venous thromboembolism following 672,495 primary total shoulder and elbow replacements: meta-analyses of incidence, temporal trends and potential risk factors. Thromb Res 189:13&#x2013;23. https://doi.org/10.1016/j.thromres.2020.02.018</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.thromres.2020.02.018</ArticleId><ArticleId IdType="pubmed">32135385</ArticleId></ArticleIdList></Reference><Reference><Citation>Rapp CM, Shields EJ, Wiater BP, Wiater JM (2019) Venous thromboembolism after shoulder arthoplasty and arthroscopy. J Am Acad Orthop Surg 27:265&#x2013;274. https://doi.org/10.5435/jaaos-d-17-00763</Citation><ArticleIdList><ArticleId IdType="doi">10.5435/jaaos-d-17-00763</ArticleId><ArticleId IdType="pubmed">30480588</ArticleId></ArticleIdList></Reference><Reference><Citation>Anakwe RE, Middleton SD, Beresford-Cleary N, McEachan JE, Talwalkar SC (2013) Preventing venous thromboembolism in elective upper limb surgery. J Shoulder Elbow Surg 22:432&#x2013;438. https://doi.org/10.1016/j.jse.2012.10.033</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jse.2012.10.033</ArticleId><ArticleId IdType="pubmed">23333169</ArticleId></ArticleIdList></Reference><Reference><Citation>Day JS, Ramsey ML, Lau E, Williams GR (2015) Risk of venous thromboembolism after shoulder arthroplasty in the Medicare population. J Shoulder Elbow Surg 24:98&#x2013;105. https://doi.org/10.1016/j.jse.2014.09.025</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jse.2014.09.025</ArticleId><ArticleId IdType="pubmed">25467306</ArticleId></ArticleIdList></Reference><Reference><Citation>Lyman S, Sherman S, Carter TI, Bach PB, Mandl LA, Marx RG (2006) Prevalence and risk factors for symptomatic thromboembolic events after shoulder arthroplasty. Clin Orthop Relat Res 448:152&#x2013;156. https://doi.org/10.1097/01.blo.0000194679.87258.6e</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.blo.0000194679.87258.6e</ArticleId><ArticleId IdType="pubmed">16826110</ArticleId></ArticleIdList></Reference><Reference><Citation>Cho SH, Jeong J (2020) Radiologic results of three-dimensional templating for total shoulder arthroplasty. Clin Orthop Surg 12:232&#x2013;237. https://doi.org/10.4055/cios19100</Citation><ArticleIdList><ArticleId IdType="doi">10.4055/cios19100</ArticleId><ArticleId IdType="pubmed">32489546</ArticleId><ArticleId IdType="pmc">7237245</ArticleId></ArticleIdList></Reference><Reference><Citation>Collotte P, Bercik M, Vieira TD, Walch G (2021) Long-term reverse total shoulder arthroplasty outcomes: the effect of the inferior shifting of glenoid component fixation. Clin Orthop Surg 13:505&#x2013;512. https://doi.org/10.4055/cios20245</Citation><ArticleIdList><ArticleId IdType="doi">10.4055/cios20245</ArticleId><ArticleId IdType="pubmed">34868500</ArticleId><ArticleId IdType="pmc">8609210</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim SH, Wise BL, Zhang Y, Szabo RM (2011) Increasing incidence of shoulder arthroplasty in the United States. J Bone Joint Surg Am 93:2249&#x2013;2254. https://doi.org/10.2106/jbjs.J.01994</Citation><ArticleIdList><ArticleId IdType="doi">10.2106/jbjs.J.01994</ArticleId><ArticleId IdType="pubmed">22258770</ArticleId></ArticleIdList></Reference><Reference><Citation>Saleh HE, Pennings AL, ElMaraghy AW (2013) Venous thromboembolism after shoulder arthroplasty: a systematic review. J Shoulder Elbow Surg 22:1440&#x2013;1448. https://doi.org/10.1016/j.jse.2013.05.013</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jse.2013.05.013</ArticleId><ArticleId IdType="pubmed">23973166</ArticleId></ArticleIdList></Reference><Reference><Citation>Aibinder WR, Sanchez-Sotelo J (2018) Venous thromboembolism prophylaxis in shoulder surgery. Orthop Clin North Am 49:257&#x2013;263. https://doi.org/10.1016/j.ocl.2017.11.012</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ocl.2017.11.012</ArticleId><ArticleId IdType="pubmed">29499826</ArticleId></ArticleIdList></Reference><Reference><Citation>Dattani R, Smith CD, Patel VR (2013) The venous thromboembolic complications of shoulder and elbow surgery a systematic review. Bone Joint J 95-b:70&#x2013;74. https://doi.org/10.1302/0301-620x.95b1.29854</Citation><ArticleIdList><ArticleId IdType="doi">10.1302/0301-620x.95b1.29854</ArticleId><ArticleId IdType="pubmed">23307676</ArticleId></ArticleIdList></Reference><Reference><Citation>Ojike NI, Bhadra AK, Giannoudis PV, Roberts CS (2011) Venous thromboembolism in shoulder surgery: a systematic review. Acta Orthop Belg 77:281&#x2013;289</Citation><ArticleIdList><ArticleId IdType="pubmed">21845993</ArticleId></ArticleIdList></Reference><Reference><Citation>Kolz JM, Aibinder WR, Adams RA, Cofield RH, Sperling JW (2019) Symptomatic thromboembolic complications after shoulder arthroplasty: an update. J Bone Joint Surg Am 101:1845&#x2013;1851. https://doi.org/10.2106/jbjs.18.01200</Citation><ArticleIdList><ArticleId IdType="doi">10.2106/jbjs.18.01200</ArticleId><ArticleId IdType="pubmed">31626009</ArticleId></ArticleIdList></Reference><Reference><Citation>Willis AA, Warren RF, Craig EV, Adler RS, Cordasco FA, Lyman S, Fealy S (2009) Deep vein thrombosis after reconstructive shoulder arthroplasty: a prospective observational study. J Shoulder Elbow Surg 18:100&#x2013;106. https://doi.org/10.1016/j.jse.2008.07.011</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jse.2008.07.011</ArticleId><ArticleId IdType="pubmed">19095183</ArticleId></ArticleIdList></Reference><Reference><Citation>Lung BE, Kanjiya S, Bisogno M, Komatsu DE, Wang ED (2019) Risk factors for venous thromboembolism in total shoulder arthroplasty. JSES Open Access 3:183&#x2013;188. https://doi.org/10.1016/j.jses.2019.07.003</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jses.2019.07.003</ArticleId><ArticleId IdType="pubmed">31709360</ArticleId><ArticleId IdType="pmc">6834973</ArticleId></ArticleIdList></Reference><Reference><Citation>Cho CH, Jang HG, Park UJ, Kim HT (2017) The incidence of venous thromboembolism following shoulder surgery: a pilot study. Clin Shoulder Elbow 20:18&#x2013;23. https://doi.org/10.5397/cise.2017.20.1.18</Citation><ArticleIdList><ArticleId IdType="doi">10.5397/cise.2017.20.1.18</ArticleId></ArticleIdList></Reference><Reference><Citation>Heyer JH, Parker RL, Lynch T, Parry T, Neviaser AS (2021) Rate of venous thromboembolism after surgical treatment of proximal humerus fractures. Arch Orthop Trauma Surg 141:403&#x2013;409. https://doi.org/10.1007/s00402-020-03505-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00402-020-03505-4</ArticleId><ArticleId IdType="pubmed">32504179</ArticleId></ArticleIdList></Reference><Reference><Citation>Imberti D, Ivaldo N, Murena L, Paladini P, Castagna A, Barillari G, Guerra E, Fama G, Castoldi F, Marelli B, Pierfranceschi MG, Camporese G, Dentali F, Porcellini G (2014) Venous thromboembolism in patients undergoing shoulder surgery: findings from the RECOS registry. Thromb Res 134:273&#x2013;277. https://doi.org/10.1016/j.thromres.2014.05.014</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.thromres.2014.05.014</ArticleId><ArticleId IdType="pubmed">24916548</ArticleId></ArticleIdList></Reference><Reference><Citation>Kirsch JM, Gutman M, Patel M, Rondon A, Ramsey ML, Abboud JA, Williams GR, Namdari S (2021) Low-dose aspirin and the rate of symptomatic venous thromboembolic complications following primary shoulder arthroplasty. J Shoulder Elbow Surg 30:1613&#x2013;1618. https://doi.org/10.1016/j.jse.2020.09.030</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jse.2020.09.030</ArticleId><ArticleId IdType="pubmed">33536125</ArticleId></ArticleIdList></Reference><Reference><Citation>Sperling JW, Cofield RH (2002) Pulmonary embolism following shoulder arthroplasty. J Bone Joint Surg Am 84:1939&#x2013;1941. https://doi.org/10.2106/00004623-200211000-00005</Citation><ArticleIdList><ArticleId IdType="doi">10.2106/00004623-200211000-00005</ArticleId><ArticleId IdType="pubmed">12429752</ArticleId></ArticleIdList></Reference><Reference><Citation>Tashjian RZ, Lilly DT, Isaacson AM, Georgopoulos CE, Bettwieser SP, Burks RT, Greis PE, Presson AP, Granger EK, Zhang Y (2016) Incidence of and risk factors for symptomatic venous thromboembolism after shoulder arthroplasty. Am J Orthop (Belle Mead NJ) 45:E379-e385</Citation></Reference><Reference><Citation>Wronka KS, Pritchard M, Sinha A (2014) Incidence of symptomatic venous thrombo-embolism following shoulder surgery. Int Orthop 38:1415&#x2013;1418. https://doi.org/10.1007/s00264-014-2329-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00264-014-2329-7</ArticleId><ArticleId IdType="pubmed">24691988</ArticleId><ArticleId IdType="pmc">4071505</ArticleId></ArticleIdList></Reference><Reference><Citation>Navarro RA, Inacio MC, Burke MF, Costouros JG, Yian EH (2013) Risk of thromboembolism in shoulder arthroplasty: effect of implant type and traumatic indication. Clin Orthop Relat Res 471:1576&#x2013;1581. https://doi.org/10.1007/s11999-013-2829-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11999-013-2829-6</ArticleId><ArticleId IdType="pubmed">23392993</ArticleId><ArticleId IdType="pmc">3613522</ArticleId></ArticleIdList></Reference><Reference><Citation>Young BL, Menendez ME, Baker DK, Ponce BA (2015) Factors associated with in-hospital pulmonary embolism after shoulder arthroplasty. J Shoulder Elbow Surg 24:e271-278. https://doi.org/10.1016/j.jse.2015.04.002</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jse.2015.04.002</ArticleId><ArticleId IdType="pubmed">25976989</ArticleId><ArticleId IdType="pmc">4575830</ArticleId></ArticleIdList></Reference><Reference><Citation>Jameson SS, James P, Howcroft DW, Serrano-Pedraza I, Rangan A, Reed MR, Candal-Couto J (2011) Venous thromboembolic events are rare after shoulder surgery: analysis of a national database. J Shoulder Elbow Surg 20:764&#x2013;770. https://doi.org/10.1016/j.jse.2010.11.034</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jse.2010.11.034</ArticleId><ArticleId IdType="pubmed">21420324</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">31039477</PMID><DateCompleted><Year>2020</Year><Month>03</Month><Day>02</Day></DateCompleted><DateRevised><Year>2020</Year><Month>03</Month><Day>02</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1879-2472</ISSN><JournalIssue CitedMedium="Internet"><Volume>178</Volume><PubDate><Year>2019</Year><Month>Jun</Month></PubDate></JournalIssue><Title>Thrombosis research</Title><ISOAbbreviation>Thromb Res</ISOAbbreviation></Journal><ArticleTitle>Sex-specific differences in pulmonary embolism.</ArticleTitle><Pagination><StartPage>173</StartPage><EndPage>181</EndPage><MedlinePgn>173-181</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.thromres.2019.04.020</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0049-3848(19)30213-0</ELocationID><Abstract><AbstractText Label="INTRODUCTION" NlmCategory="BACKGROUND">Sex-specific differences regarding risk factors, symptoms and prognosis have been reported for several cardiovascular diseases. For patients with pulmonary embolism (PE), sex-specific data are limited and inconsistent. We aimed to investigate sex-specific differences in PE.</AbstractText><AbstractText Label="MATERIALS AND METHODS" NlmCategory="METHODS">Over a 10-year period (01/2003-09/2013), patients with confirmed PE were enrolled in a prospective single-centre cohort study.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">We prospectively examined 569 PE patients (55.9% women). Men more often had cancer (20.7% vs. 13.5%, p&#x202f;=&#x202f;0.024) and unprovoked PE (61.0% vs. 47.5%, p&#x202f;=&#x202f;0.001) while women more frequently presented with risk factors for venous thromboembolism such as older age (median, 71 [IQR, 55-79] vs. 67 [53-75] years, p&#x202f;=&#x202f;0.008), surgery/trauma/immobilisation (38.4% vs. 29.5%, p&#x202f;=&#x202f;0.026) and sex-hormone therapy (14.8% vs. 0.8%, p&#x202f;&lt;&#x202f;0.001). Overall, 84 patients (14.8%) had an adverse 30-day outcome and 43 (7.6%) died within 30&#x202f;days; outcomes did not differ between males and females and were not influenced by the patients' sex. Risk stratification markers and models such as right ventricular dysfunction on TTE/CT, cardiac troponin, sPESI, Bova score and 2014 ESC guidelines algorithm predicted adverse outcome in normotensive female patients only, while tachycardia, hypoxia, NT-proBNP and modified FAST score were able to predict an adverse outcome in both sexes. Using sex-specific biomarker cut-off values, the 2014 ESC guidelines algorithm was able to predict adverse outcome in both sexes.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">The 30-day adverse outcomes did not differ between male and female PE patients and were not influenced by the patients' sex despite sex-specific differences in the prognostic performance of risk stratification markers/models.</AbstractText><CopyrightInformation>Copyright &#xa9; 2019 The Authors. Published by Elsevier Ltd.. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Keller</LastName><ForeName>Karsten</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Center for Thrombosis and Hemostasis (CTH), University Medical Center of the Johannes Gutenberg-University Mainz, Mainz, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rappold</LastName><ForeName>Lisa</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Clinic for Internal Medicine, Siloah St. Trudpert Clinic, Pforzheim, Germany; Clinic for Cardiology and Pulmonology, Heart Center, University Medical Center G&#xf6;ttingen, G&#xf6;ttingen, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gerhold-Ay</LastName><ForeName>Aslihan</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Center for Thrombosis and Hemostasis (CTH), University Medical Center of the Johannes Gutenberg-University Mainz, Mainz, Germany; Institute of Medical Biostatistics, Epidemiology and Informatics (IMBEI), Mainz, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hobohm</LastName><ForeName>Lukas</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Center for Thrombosis and Hemostasis (CTH), University Medical Center of the Johannes Gutenberg-University Mainz, Mainz, Germany; Department of Cardiology, Cardiology I, University Medical Center of the Johannes Gutenberg-University Mainz, Mainz, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hasenfu&#xdf;</LastName><ForeName>Gerd</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Clinic for Cardiology and Pulmonology, Heart Center, University Medical Center G&#xf6;ttingen, G&#xf6;ttingen, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Konstantinides</LastName><ForeName>Stavros V</ForeName><Initials>SV</Initials><AffiliationInfo><Affiliation>Center for Thrombosis and Hemostasis (CTH), University Medical Center of the Johannes Gutenberg-University Mainz, Mainz, Germany; Department of Cardiology, Democritus University Thrace, Alexandroupolis, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dellas</LastName><ForeName>Claudia</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Paediatric Cardiology and Intensive Care, GUCH Center, University Medical Center G&#xf6;ttingen, G&#xf6;ttingen, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lankeit</LastName><ForeName>Mareike</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Center for Thrombosis and Hemostasis (CTH), University Medical Center of the Johannes Gutenberg-University Mainz, Mainz, Germany; Clinic for Cardiology and Pulmonology, Heart Center, University Medical Center G&#xf6;ttingen, G&#xf6;ttingen, Germany; Department of Internal Medicine and Cardiology, Campus Virchow Klinikum (CVK), Charit&#xe9; - University Medicine Berlin, Berlin, Germany. Electronic address: mareike.lankeit@charite.de.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2019</Year><Month>04</Month><Day>23</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Thromb Res</MedlineTA><NlmUniqueID>0326377</NlmUniqueID><ISSNLinking>0049-3848</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011655" MajorTopicYN="N">Pulmonary Embolism</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012727" MajorTopicYN="Y">Sex Characteristics</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Gender</Keyword><Keyword MajorTopicYN="N">Mortality</Keyword><Keyword MajorTopicYN="N">Prognosis</Keyword><Keyword MajorTopicYN="N">Pulmonary embolism</Keyword><Keyword MajorTopicYN="N">Risk stratification</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2019</Year><Month>1</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2019</Year><Month>4</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2019</Year><Month>4</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>5</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>3</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>5</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31039477</ArticleId><ArticleId IdType="doi">10.1016/j.thromres.2019.04.020</ArticleId><ArticleId IdType="pii">S0049-3848(19)30213-0</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">21777063</PMID><DateCompleted><Year>2012</Year><Month>01</Month><Day>25</Day></DateCompleted><DateRevised><Year>2025</Year><Month>06</Month><Day>26</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1557-9034</ISSN><JournalIssue CitedMedium="Internet"><Volume>21</Volume><Issue>8</Issue><PubDate><Year>2011</Year><Month>Oct</Month></PubDate></JournalIssue><Title>Journal of laparoendoscopic &amp; advanced surgical techniques. Part A</Title><ISOAbbreviation>J Laparoendosc Adv Surg Tech A</ISOAbbreviation></Journal><ArticleTitle>Systematic review of 23-hour (outpatient) stay laparoscopic gastric bypass surgery.</ArticleTitle><Pagination><StartPage>677</StartPage><EndPage>681</EndPage><MedlinePgn>677-81</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1089/lap.2011.0042</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">The laparoscopic Roux-en-Y gastric bypass (LRYGB) is generally considered the gold-standard bariatric procedure. It has a usual inpatient stay of 3 days. There have been few reports of gastric bypass patients being discharged within 23 hours of surgery, but its safety and feasibility has not been reviewed before. The aim of this study was to review the published literature on 23-hour stay post-LRYGB.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Systematic search was performed in Medline, Embase, and Cochrane library using the medical subject heading terms "ambulatory surgical procedures" and "bariatric surgery" with further free text search and cross references. All articles on 23-hour LRYGB that described patient selection criteria, 23-hour discharge, complications, and readmissions were reviewed. Data were extracted by two independent reviewers.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">There were no randomized controlled trials. Four cohort studies were included in this review. The patients age ranged from 14 to 70 years, mean body mass index ranged from 41.2 to 49.25, and the mean operative time ranged from 112.8 to 169 minutes. 1852/2201(84.14%) patients could be discharged within 23 hours. Forty-eight patients (2.18%) developed complications and 40 patients (1.82%) were readmitted. The commonest 30-day complications were anastomotic strictures (16), gastrointestinal bleeding (9), and internal hernias (9). Five patients developed anastomotic leak and 2 patients developed pulmonary embolism. Two patients died but neither was discharged after their bypass surgery.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">There is a paucity of data regarding 23-hour discharge after LRYGB. The evidence suggests that it is feasible in selected patients. However, further studies are necessary to assess its safety and acceptability.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Thomas</LastName><ForeName>Harun</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>The Academic Unit of Medical and Surgical Gastroenterology, Homerton University Hospital NHS Trust, Homerton Row, London, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Agrawal</LastName><ForeName>Sanjay</ForeName><Initials>S</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2011</Year><Month>07</Month><Day>21</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Laparoendosc Adv Surg Tech A</MedlineTA><NlmUniqueID>9706293</NlmUniqueID><ISSNLinking>1092-6429</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000556" MajorTopicYN="Y">Ambulatory Surgical Procedures</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015992" MajorTopicYN="N">Body Mass Index</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015390" MajorTopicYN="Y">Gastric Bypass</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010535" MajorTopicYN="Y">Laparoscopy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007902" MajorTopicYN="Y">Length of Stay</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009767" MajorTopicYN="N">Obesity, Morbid</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010359" MajorTopicYN="N">Patient Readmission</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2011</Year><Month>7</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2011</Year><Month>7</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2012</Year><Month>1</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">21777063</ArticleId><ArticleId IdType="doi">10.1089/lap.2011.0042</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">33747268</PMID><DateRevised><Year>2022</Year><Month>04</Month><Day>21</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">1734-1922</ISSN><JournalIssue CitedMedium="Print"><Volume>17</Volume><Issue>2</Issue><PubDate><Year>2021</Year></PubDate></JournalIssue><Title>Archives of medical science : AMS</Title><ISOAbbreviation>Arch Med Sci</ISOAbbreviation></Journal><ArticleTitle>Unprovoked pulmonary embolism in older adults: incidence and prognosis.</ArticleTitle><Pagination><StartPage>337</StartPage><EndPage>342</EndPage><MedlinePgn>337-342</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.5114/aoms/90673</ELocationID><Abstract><AbstractText Label="INTRODUCTION" NlmCategory="BACKGROUND">Unprovoked pulmonary embolism (UPE) is not rare and it is associated with an unfavorable prognosis in adults. However, the incidence and the prognosis of UPE in older adults have never been studied.</AbstractText><AbstractText Label="MATERIAL AND METHODS" NlmCategory="METHODS">This was a historical prospective study. We reviewed all the medical charts of all older adults (aged 70 years or more) with UPE, provoked pulmonary embolism (PPE), and malignancy-associated PE (MAPE), admitted to a tertiary medical center between 2010 and 2012. The all-cause 3-year mortality rates and cumulative survival following admission were compared between the groups.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">The final cohort included 249 patients with PE: 161 (64.7%) were women; the mean age was 79.8 &#xb1;5.7 years. Overall, 36 (14.5%) patients had UPE, 81 (32.5%) patients had MAPE, and 132 (53.0%) patients had PPE. Overall, 39 (15.7%) patients died within 30 days, 76 (30.5%) patients died within 6 months, 101 (40.6%) patients died within 1 year, and 136 (54.6%) patients died within 3 years of admission. Relative to PPE and MAPE patients, the cumulative survival was significantly higher in UPE patients at each time point within 1 year of admission (<i>p</i> &lt; 0.05 and <i>p</i> &lt; 0.001, respectively). However, 3 years after admission, the cumulative survival was comparable between PPE patients and UPE patients, and was significantly lower in MAPE patients (<i>p</i> &lt; 0.001).</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">UPE is not rare in older adults with PE, and it is associated with a favorable prognosis within 1 year of admission in this population.</AbstractText><CopyrightInformation>Copyright: &#xa9; 2021 Termedia &amp; Banach.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Aharoni</LastName><ForeName>Mor</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Sackler School of Medicine, Tel-Aviv University, Israel.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Surgery Department, Sheba Medical Center, Tel-Hashomer, Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Horesh</LastName><ForeName>Nir</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Sackler School of Medicine, Tel-Aviv University, Israel.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Surgery Department, Sheba Medical Center, Tel-Hashomer, Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rogowski</LastName><ForeName>Ori</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>Sackler School of Medicine, Tel-Aviv University, Israel.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Internal Medicine C, Sourasky Medical Center, Tel-Aviv, Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kremer</LastName><ForeName>Anjelika</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Geriatrics Division, Sheba Medical Center, Tel-Hashomer, Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mayan</LastName><ForeName>Haim</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Sackler School of Medicine, Tel-Aviv University, Israel.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Internal Medicine E, Sheba Medical Center, Tel-Hashomer, Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Justo</LastName><ForeName>Dan</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Sackler School of Medicine, Tel-Aviv University, Israel.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Geriatrics Division, Sheba Medical Center, Tel-Hashomer, Israel.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>02</Month><Day>26</Day></ArticleDate></Article><MedlineJournalInfo><Country>Poland</Country><MedlineTA>Arch Med Sci</MedlineTA><NlmUniqueID>101258257</NlmUniqueID><ISSNLinking>1734-1922</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">incidence</Keyword><Keyword MajorTopicYN="N">mortality</Keyword><Keyword MajorTopicYN="N">older adults</Keyword><Keyword MajorTopicYN="N">survival</Keyword><Keyword MajorTopicYN="N">unprovoked pulmonary embolism</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>10</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>4</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>3</Month><Day>22</Day><Hour>8</Hour><Minute>12</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>3</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>3</Month><Day>23</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2021</Year><Month>2</Month><Day>26</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33747268</ArticleId><ArticleId IdType="pmc">PMC7959013</ArticleId><ArticleId IdType="doi">10.5114/aoms/90673</ArticleId><ArticleId IdType="pii">90673</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Agnelli G, Becattini C. Acute pulmonary embolism. N Engl J Med. 2010;363:266&#x2013;74.</Citation><ArticleIdList><ArticleId IdType="pubmed">20592294</ArticleId></ArticleIdList></Reference><Reference><Citation>Heit JA, Spencer FA, White RH. The epidemiology of venous thromboembolism. J Thromb Thrombolysis. 2016;41:3&#x2013;14.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4715842</ArticleId><ArticleId IdType="pubmed">26780736</ArticleId></ArticleIdList></Reference><Reference><Citation>Spencer FA, Gore JM, Lessard D, et al. Venous thromboembolism in the elderly. A community-based perspective. Thromb Haemost. 2008;100:780&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2658648</ArticleId><ArticleId IdType="pubmed">18989521</ArticleId></ArticleIdList></Reference><Reference><Citation>Spencer FA, Gurwitz JH, Schulman S, et al. Venous thromboembolism in older adults: a community-based study. Am J Med. 2014;127:530&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">24561112</ArticleId></ArticleIdList></Reference><Reference><Citation>Goldhaber SZ, Bounameaux H. Pulmonary embolism and deep vein thrombosis. Lancet. 2012;379:1835&#x2013;46.</Citation><ArticleIdList><ArticleId IdType="pubmed">22494827</ArticleId></ArticleIdList></Reference><Reference><Citation>White RH, Zhou H, Murin S. Death due to recurrent thromboembolism among younger healthier individuals hospitalized for idiopathic pulmonary embolism. Thromb Haemost. 2008;99:683&#x2013;90.</Citation><ArticleIdList><ArticleId IdType="pubmed">18392326</ArticleId></ArticleIdList></Reference><Reference><Citation>Lehmann R, Luxembourg B, Miesbach W, et al. Idiopathic (unexplained) pulmonary embolism is associated with an impaired prognosis compared to other entities of pulmonary embolism. Blood Coagul Fibrinolysis. 2010;21:70&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">19823078</ArticleId></ArticleIdList></Reference><Reference><Citation>Charlson ME, Cushman M. Epidemiology and risk factors for venous thrombosis. Semin Hematol. 2007;44:62&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2020806</ArticleId><ArticleId IdType="pubmed">17433897</ArticleId></ArticleIdList></Reference><Reference><Citation>Siguret V, Emmerich J, Belleville T, et al. Prevalence of hereditary thrombophilia in patients older than 75 years with venous thromboembolism referred for thrombophilia screening. J Gerontol A Biol Sci Med Sci. 2015;70:977&#x2013;81.</Citation><ArticleIdList><ArticleId IdType="pubmed">25665832</ArticleId></ArticleIdList></Reference><Reference><Citation>Carpintero P, Caeiro JR, Carpintero R, Morales A, Silva S, Mesa M. Complications of hip fractures: a review. World J Orthop. 2014;5:402&#x2013;11.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4133447</ArticleId><ArticleId IdType="pubmed">25232517</ArticleId></ArticleIdList></Reference><Reference><Citation>Weingarz L, Schwonberg J, Schindewolf M, et al. Prevalence of thrombophilia according to age at the first manifestation of venous thromboembolism: results from the MAISTHRO registry. Br J Haematol. 2013;163:655&#x2013;65.</Citation><ArticleIdList><ArticleId IdType="pubmed">24219332</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">30348482</PMID><DateCompleted><Year>2019</Year><Month>05</Month><Day>30</Day></DateCompleted><DateRevised><Year>2019</Year><Month>05</Month><Day>30</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1532-2165</ISSN><JournalIssue CitedMedium="Internet"><Volume>57</Volume><Issue>2</Issue><PubDate><Year>2019</Year><Month>Feb</Month></PubDate></JournalIssue><Title>European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery</Title><ISOAbbreviation>Eur J Vasc Endovasc Surg</ISOAbbreviation></Journal><ArticleTitle>Pulmonary Embolism After Endovascular Aortic Repair, a Retrospective Cohort Study.</ArticleTitle><Pagination><StartPage>304</StartPage><EndPage>310</EndPage><MedlinePgn>304-310</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.ejvs.2018.08.054</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S1078-5884(18)30669-5</ELocationID><Abstract><AbstractText Label="OBJECTIVES">Endovascular aortic repair (EVAR) is associated with an increased risk of pulmonary embolism, which is often clinically silent and therefore difficult to recognise. The aim was to investigate the incidence of pulmonary embolism after EVAR using routinely performed pre- and post-operative aortic computed tomography angiography (CTA), and the association between pulmonary embolism and mortality.</AbstractText><AbstractText Label="METHODS">This single centre retrospective cohort study included adult patients who underwent EVAR in the University Medical Centre Utrecht between January 2010 and July 2015 and who had a total aortic, thoracic aortic, or pulmonary CTA within one month post-operatively. Baseline and mortality data were obtained by reviewing hospital and general practitioner records. The primary outcome was pulmonary embolism within one month after surgery. Secondary outcomes were 30 day and six month mortality.</AbstractText><AbstractText Label="RESULTS">During the study period, 526 EVARs were performed. Seventy-four of these procedures were included in the analysis of which there were 40 thoracic and 34 abdominal EVARs. In nine patients (12%, 95% CI 7-22) pulmonary embolism was observed of which one was central, two were segmental, and six were subsegmental. Seven were clinically silent and two were present on the pre-operative CTA. Thirty day mortality was significantly higher in patients with pulmonary embolism (relative risk 14.4, 95% CI 1.4-143, p&#xa0;=&#xa0;.037) though none of the deaths seemed directly attributable to it.</AbstractText><AbstractText Label="CONCLUSIONS">This study, although preliminary, suggests that silent pulmonary embolism after EVAR occurs in approximately one in 10 patients, despite routine thrombo-embolism prophylaxis. Pulmonary embolism was associated with a higher 30 day mortality risk yet it was not the cause of death in any of these patients.</AbstractText><CopyrightInformation>Copyright &#xa9; 2018 European Society for Vascular Surgery. Published by Elsevier B.V. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Grobben</LastName><ForeName>Remco B</ForeName><Initials>RB</Initials><AffiliationInfo><Affiliation>Department of Cardiology, University Medical Centre Utrecht, the Netherlands; Department of Anaesthesiology, University Medical Centre Utrecht, the Netherlands. Electronic address: r.b.grobben@umcutrecht.nl.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Frima</LastName><ForeName>Cynthia</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Anaesthesiology, University Medical Centre Utrecht, the Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nathoe</LastName><ForeName>Hendrik M</ForeName><Initials>HM</Initials><AffiliationInfo><Affiliation>Department of Cardiology, University Medical Centre Utrecht, the Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Leiner</LastName><ForeName>Tim</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Radiology, University Medical Centre Utrecht, the Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kwakkel-van Erp</LastName><ForeName>Johanna M</ForeName><Initials>JM</Initials><AffiliationInfo><Affiliation>Department of Pulmonology, University Medical Centre Utrecht, the Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>van Klei</LastName><ForeName>Wilton A</ForeName><Initials>WA</Initials><AffiliationInfo><Affiliation>Department of Anaesthesiology, University Medical Centre Utrecht, the Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Peelen</LastName><ForeName>Linda M</ForeName><Initials>LM</Initials><AffiliationInfo><Affiliation>Department of Anaesthesiology, University Medical Centre Utrecht, the Netherlands; Department of Epidemiology, Julius Centre, the Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>van Herwaarden</LastName><ForeName>Joost A</ForeName><Initials>JA</Initials><AffiliationInfo><Affiliation>Department of Vascular Surgery, University Medical Centre Utrecht, the Netherlands.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>10</Month><Day>20</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Eur J Vasc Endovasc Surg</MedlineTA><NlmUniqueID>9512728</NlmUniqueID><ISSNLinking>1078-5884</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Eur J Vasc Endovasc Surg. 2020 Jan;59(1):155. doi: 10.1016/j.ejvs.2019.09.509.</RefSource><PMID Version="1">31668554</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017544" MajorTopicYN="N">Aortic Aneurysm, Abdominal</DescriptorName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017545" MajorTopicYN="N">Aortic Aneurysm, Thoracic</DescriptorName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002423" MajorTopicYN="N">Cause of Death</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000072226" MajorTopicYN="N">Computed Tomography Angiography</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057510" MajorTopicYN="N">Endovascular Procedures</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005500" MajorTopicYN="N">Follow-Up Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011655" MajorTopicYN="N">Pulmonary Embolism</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName><QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Aorta</Keyword><Keyword MajorTopicYN="N">Endovascular</Keyword><Keyword MajorTopicYN="N">Pulmonary embolism</Keyword><Keyword MajorTopicYN="N">Surgery</Keyword><Keyword MajorTopicYN="N">Thrombo-embolism</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2018</Year><Month>1</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>8</Month><Day>31</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>10</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>5</Month><Day>31</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>10</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">30348482</ArticleId><ArticleId IdType="doi">10.1016/j.ejvs.2018.08.054</ArticleId><ArticleId IdType="pii">S1078-5884(18)30669-5</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">38847680</PMID><DateCompleted><Year>2024</Year><Month>06</Month><Day>07</Day></DateCompleted><DateRevised><Year>2025</Year><Month>05</Month><Day>03</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1536-5964</ISSN><JournalIssue CitedMedium="Internet"><Volume>103</Volume><Issue>23</Issue><PubDate><Year>2024</Year><Month>Jun</Month><Day>07</Day></PubDate></JournalIssue><Title>Medicine</Title><ISOAbbreviation>Medicine (Baltimore)</ISOAbbreviation></Journal><ArticleTitle>Effect of different anesthetic modalities on postoperative delirium in elderly hip fractures: A meta-analysis.</ArticleTitle><Pagination><StartPage>e38418</StartPage><MedlinePgn>e38418</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e38418</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1097/MD.0000000000038418</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Previous findings on the effect of general versus spinal anesthesia on postoperative delirium in elderly people with hip fractures are somewhat controversial. This article included the latest randomized controlled study for meta-analysis to evaluate the effect of general anesthesia (GA) and spinal anesthesia (SA) on delirium after hip fracture surgery in the elderly, so as to guide the clinical.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Cochrane Library, PubMed, Web Of Science, and Embase were searched from inception up to January 16, 2024. Randomized controlled trial (RCT) was included to evaluate the postoperative results of GA and SA in elderly patients (&#x2265;50 years old) undergoing hip fracture surgery. Two researchers independently screened for inclusion in the study and extracted data. Heterogeneity was assessed by the I&#xb2;and Chi-square tests, and P&#x2005;&lt;&#x2005;.1 or I&#xb2; &#x2265; 50% indicated marked heterogeneity among studies. The Mantel-Haenszel method was used to estimate the combined relative risk ratio (RR) and the corresponding 95% confidence interval (CI) for the binary variables.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Nine randomized controlled trials were included. There was no significant difference (RR&#x2005;=&#x2005;0.93, 95% CI&#x2005;=&#x2005;0.774-1.111, P&#x2005;&gt;&#x2005;.05) in the incidence of postoperative delirium between the GA group and the SA group. In intraoperative blood transfusion (RR&#x2005;=&#x2005;1.0, 95% CI&#x2005;=&#x2005;0.77-1.28, Z&#x2005;=&#x2005;0.04, P&#x2005;=&#x2005;.971), pulmonary embolism (RR&#x2005;=&#x2005;0.795, 95% CI&#x2005;=&#x2005;0.332-1.904, Z&#x2005;=&#x2005;0.59, P&#x2005;=&#x2005;.606), pneumonia (RR&#x2005;=&#x2005;1.47, 95% CI&#x2005;=&#x2005;0.75-2.87, P&#x2005;=&#x2005;.675), myocardial infarction (RR&#x2005;=&#x2005;0.97, 95% CI&#x2005;=&#x2005;0.24-3.86, Z&#x2005;=&#x2005;0.05, P&#x2005;=&#x2005;.961), heart failure (RR&#x2005;=&#x2005;0.80, 95% CI&#x2005;=&#x2005;0.26-2.42, Z&#x2005;=&#x2005;0.40, P&#x2005;=&#x2005;.961), urinary retention (RR&#x2005;=&#x2005;1.42, 95% CI&#x2005;=&#x2005;0.77-2.61, Z&#x2005;=&#x2005;1.11, P&#x2005;=&#x2005;.267) were similar between the 2 anesthetic techniques.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">There is no significant difference in the effect of GA and SA on postoperative delirium in elderly patients with hip fracture, and their effects on postoperative complications are similar.</AbstractText><CopyrightInformation>Copyright &#xa9; 2024 the Author(s). Published by Wolters Kluwer Health, Inc.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Fan</LastName><ForeName>Guangya</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Orthopedics,The Second Affiliated Hospital of Zhejiang Chinese Medical University, Hangzhou, People's Republic of China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>The Second Clinical Medical College of Zhejiang Chinese Medical University, Hangzhou, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhong</LastName><ForeName>Musen</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Orthopedics,The Second Affiliated Hospital of Zhejiang Chinese Medical University, Hangzhou, People's Republic of China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>The Second Clinical Medical College of Zhejiang Chinese Medical University, Hangzhou, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Su</LastName><ForeName>Wenshuo</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Department of Orthopedics,The Second Affiliated Hospital of Zhejiang Chinese Medical University, Hangzhou, People's Republic of China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>The Second Clinical Medical College of Zhejiang Chinese Medical University, Hangzhou, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>An</LastName><ForeName>Zhongcheng</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Department of Orthopedics,The Second Affiliated Hospital of Zhejiang Chinese Medical University, Hangzhou, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhu</LastName><ForeName>Yuchen</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Orthopedics,The Second Affiliated Hospital of Zhejiang Chinese Medical University, Hangzhou, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Chen</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Orthopedics,The Second Affiliated Hospital of Zhejiang Chinese Medical University, Hangzhou, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dong</LastName><ForeName>Liqiang</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Orthopedics,The Second Affiliated Hospital of Zhejiang Chinese Medical University, Hangzhou, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wu</LastName><ForeName>Lianguo</ForeName><Initials>L</Initials><Identifier Source="ORCID">0009-0008-0382-2065</Identifier><AffiliationInfo><Affiliation>Department of Orthopedics,The Second Affiliated Hospital of Zhejiang Chinese Medical University, Hangzhou, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Xiaoping</ForeName><Initials>X</Initials><Identifier Source="ORCID">0000-0002-4842-8060</Identifier><AffiliationInfo><Affiliation>Department of Geriatrics, The Second Affiliated Hospital of Zhejiang Chinese Medical University, Hangzhou, People's Republic of China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Medicine (Baltimore)</MedlineTA><NlmUniqueID>2985248R</NlmUniqueID><ISSNLinking>0025-7974</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000768" MajorTopicYN="Y">Anesthesia, General</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000775" MajorTopicYN="Y">Anesthesia, Spinal</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003693" MajorTopicYN="Y">Delirium</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000071257" MajorTopicYN="N">Emergence Delirium</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006620" MajorTopicYN="Y">Hip Fractures</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="Y">Postoperative Complications</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016032" MajorTopicYN="Y">Randomized Controlled Trials as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>The authors have no conflicts of interest to disclose.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>6</Month><Day>7</Day><Hour>12</Hour><Minute>57</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>6</Month><Day>7</Day><Hour>12</Hour><Minute>56</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>6</Month><Day>7</Day><Hour>10</Hour><Minute>13</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>6</Month><Day>7</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38847680</ArticleId><ArticleId IdType="pmc">PMC11155603</ArticleId><ArticleId IdType="doi">10.1097/MD.0000000000038418</ArticleId><ArticleId IdType="pii">00005792-202406070-00024</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Curtis EM, van der Velde R, Moon RJ, et al. . Epidemiology of fractures in the United Kingdom 1988-2012: variation with age, sex, geography, ethnicity and socioeconomic status. Bone. 2016;87:19&#x2013;26.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4890652</ArticleId><ArticleId IdType="pubmed">26968752</ArticleId></ArticleIdList></Reference><Reference><Citation>Loggers SAI, Van Lieshout EMM, Joosse P, Verhofstad MHJ, Willems HC. Prognosis of nonoperative treatment in elderly patients with a hip fracture: a systematic review and meta-analysis. Injury. 2020;51:2407&#x2013;13.</Citation><ArticleIdList><ArticleId IdType="pubmed">32907702</ArticleId></ArticleIdList></Reference><Reference><Citation>Jay RH, Hipps D. Hip fracture-great steps forward but we still need better evidence. A commentary on NICE CG124 and QS16 on fractured neck of femur. Age Ageing. 2018;47:630&#x2013;2.</Citation><ArticleIdList><ArticleId IdType="pubmed">29982272</ArticleId></ArticleIdList></Reference><Reference><Citation>Veronese N, Maggi S. Epidemiology and social costs of hip fracture. Injury. 2018;49:1458&#x2013;60.</Citation><ArticleIdList><ArticleId IdType="pubmed">29699731</ArticleId></ArticleIdList></Reference><Reference><Citation>Str&#xf8;m C, Rasmussen LS, Sieber FE. Should general anaesthesia be avoided in the elderly? Anaesthesia. 2014;69(Suppl 1):35&#x2013;44.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5207212</ArticleId><ArticleId IdType="pubmed">24303859</ArticleId></ArticleIdList></Reference><Reference><Citation>Griffiths R, Alper J, Beckingsale A, et al. . Membership of the Working Party. Management of proximal femoral fractures 2011: association of anaesthetists of Great Britain and Ireland. Anaesthesia. 2012;67:85&#x2013;98.</Citation><ArticleIdList><ArticleId IdType="pubmed">22150501</ArticleId></ArticleIdList></Reference><Reference><Citation>Neuman MD, Feng R, Carson JL, et al. . REGAIN Investigators. Spinal anesthesia or general anesthesia for hip surgery in older adults. N Engl J Med. 2021;385:2025&#x2013;35.</Citation><ArticleIdList><ArticleId IdType="pubmed">34623788</ArticleId></ArticleIdList></Reference><Reference><Citation>Zheng X, Tan Y, Gao Y, Liu Z. Comparative efficacy of neuraxial and general anesthesia for hip fracture surgery: a meta-analysis of randomized clinical trials. BMC Anesthesiol. 2020;20:162.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7325684</ArticleId><ArticleId IdType="pubmed">32605591</ArticleId></ArticleIdList></Reference><Reference><Citation>Li T, Li J, Yuan L, et al. . RAGA Study Investigators. Effect of regional vs general anesthesia on incidence of postoperative delirium in older patients undergoing hip fracture surgery: the RAGA randomized trial. JAMA. 2022;327:50&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8689436</ArticleId><ArticleId IdType="pubmed">34928310</ArticleId></ArticleIdList></Reference><Reference><Citation>Higgins JPT, Altman DG, G&#xf8;tzsche PC, et al. . Cochrane Statistical Methods Group. The Cochrane Collaboration&#x2019;s tool for assessing risk of bias in randomised trials. BMJ. 2011;343:d5928&#x2013;d5928.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3196245</ArticleId><ArticleId IdType="pubmed">22008217</ArticleId></ArticleIdList></Reference><Reference><Citation>Heidari SM, Soltani H, Hashemi SJ, Talakoub R, Soleimani B. Comparative study of two anesthesia methods according to postoperative complications and one month mortality rate in the candidates of hip surgery. J Res Med Sci. 2011;16:323&#x2013;30.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3214341</ArticleId><ArticleId IdType="pubmed">22091252</ArticleId></ArticleIdList></Reference><Reference><Citation>Hole A, Terjesen T, Breivik H. Epidural versus general anaesthesia for total hip arthroplasty in elderly patients. Acta Anaesthesiol Scand. 1980;24:279&#x2013;87.</Citation><ArticleIdList><ArticleId IdType="pubmed">7468115</ArticleId></ArticleIdList></Reference><Reference><Citation>Berggren D, Gustafson Y, Eriksson B, et al. . Postoperative confusion after anesthesia in elderly patients with femoral neck fractures. Anesth Analg. 1987;66:497&#x2013;504.</Citation><ArticleIdList><ArticleId IdType="pubmed">3578861</ArticleId></ArticleIdList></Reference><Reference><Citation>Parker MJ, Griffiths R. General versus regional anaesthesia for hip fractures. A pilot randomised controlled trial of 322 patients. Injury. 2015;46:1562&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">26049662</ArticleId></ArticleIdList></Reference><Reference><Citation>Tzimas P, Samara E, Petrou A, Korompilias A, Chalkias A, Papadopoulos G. The influence of anesthetic techniques on postoperative cognitive function in elderly patients undergoing hip fracture surgery: general vs spinal anesthesia. Injury. 2018;49:2221&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">30526923</ArticleId></ArticleIdList></Reference><Reference><Citation>Casati A, Aldegheri G, Vinciguerra E, Marsan A, Fraschini G, Torri G. Randomized comparison between sevoflurane anaesthesia and unilateral spinal anaesthesia in elderly patients undergoing orthopaedic surgery. Eur J Anaesthesiol. 2003;20:640&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">12932066</ArticleId></ArticleIdList></Reference><Reference><Citation>Meuret P, Bouvet L, Villet B, Hafez M, Allaouchiche B, Boselli E. Hypobaric unilateral spinal anaesthesia versus general anaesthesia in elderly patients undergoing hip fracture surgical repair: a prospective randomised open trial. Turk J Anaesthesiol Reanim. 2018;46:121&#x2013;30.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5937458</ArticleId><ArticleId IdType="pubmed">29744247</ArticleId></ArticleIdList></Reference><Reference><Citation>Saied NN, Helwani MA, Weavind LM, Shi Y, Shotwell MS, Pandharipande PP. Effect of anaesthesia type on postoperative mortality and morbidities: a matched analysis of the NSQIP database. Br J Anaesth. 2017;118:105&#x2013;11.</Citation><ArticleIdList><ArticleId IdType="pubmed">28039248</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu J, Yin Y, Jin M, Li B. The risk factors for postoperative delirium in adult patients after hip fracture surgery: a systematic review and meta-analysis. Int J Geriatr Psychiatry. 2021;36:3&#x2013;14.</Citation><ArticleIdList><ArticleId IdType="pubmed">32833302</ArticleId></ArticleIdList></Reference><Reference><Citation>Tanaka P, Goodman S, Sommer BR, Maloney W, Huddleston J, Lemmens HJ. The effect of desflurane versus propofol anesthesia on postoperative delirium in elderly obese patients undergoing total knee replacement: a randomized, controlled, double-blinded clinical trial. J Clin Anesth. 2017;39:17&#x2013;22.</Citation><ArticleIdList><ArticleId IdType="pubmed">28494898</ArticleId></ArticleIdList></Reference><Reference><Citation>Evered LA, Chan MTV, Han R, et al. . Anaesthetic depth and delirium after major surgery: a randomised clinical trial. Br J Anaesth. 2021;127:704&#x2013;12.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8579421</ArticleId><ArticleId IdType="pubmed">34465469</ArticleId></ArticleIdList></Reference><Reference><Citation>Short TG, Campbell D, Frampton C, et al. . Australian and New Zealand College of Anaesthetists Clinical Trials Network. Anaesthetic depth and complications after major surgery: an international, randomised controlled trial. Lancet. 2019;394:1907&#x2013;14.</Citation><ArticleIdList><ArticleId IdType="pubmed">31645286</ArticleId></ArticleIdList></Reference><Reference><Citation>Bedford PD. Adverse cerebral effects of anaesthesia on old people. Lancet. 1955;269:259&#x2013;63.</Citation><ArticleIdList><ArticleId IdType="pubmed">13243706</ArticleId></ArticleIdList></Reference><Reference><Citation>Vutskits L, Xie Z. Lasting impact of general anaesthesia on the brain: mechanisms and relevance. Nat Rev Neurosci. 2016;17:705&#x2013;17.</Citation><ArticleIdList><ArticleId IdType="pubmed">27752068</ArticleId></ArticleIdList></Reference><Reference><Citation>Maxwell BG, Spitz W, Porter J. Association of increasing use of spinal anesthesia in hip fracture repair with treating an aging patient population. JAMA Surg. 2020;155:167&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6902104</ArticleId><ArticleId IdType="pubmed">31746959</ArticleId></ArticleIdList></Reference><Reference><Citation>Urwin SC, Parker MJ, Griffiths R. General versus regional anaesthesia for hip fracture surgery: a meta-analysis of randomized trials. Br J Anaesth. 2000;84:450&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="pubmed">10823094</ArticleId></ArticleIdList></Reference><Reference><Citation>Anwer HMF, Swelem SE, el-Sheshai A, et al. . Postoperative cognitive dysfunction in adult and elderly patients&#x2014;general anesthesia vs subarachnoid or epidural analgesia. Middle East J Anaesthesiol. 2006;18:1123&#x2013;38.</Citation><ArticleIdList><ArticleId IdType="pubmed">17263267</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie Z, Swain CA, Ward SAP, et al. . Preoperative cerebrospinal fluid &#x3b2;-Amyloid/Tau ratio and postoperative delirium. Ann Clin Transl Neurol. 2014;1:319&#x2013;28.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4029597</ArticleId><ArticleId IdType="pubmed">24860840</ArticleId></ArticleIdList></Reference><Reference><Citation>Magnussen RA, Tressler MA, Obremskey WT, Kregor PJ. Predicting blood loss in isolated pelvic and acetabular high-energy trauma. J Orthop Trauma. 2007;21:603&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">17921834</ArticleId></ArticleIdList></Reference><Reference><Citation>Scannell BP, Loeffler BJ, Bosse MJ, Kellam JF, Sims SH. Efficacy of intraoperative red blood cell salvage and autotransfusion in the treatment of acetabular fractures. J Orthop Trauma. 2009;23:340&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="pubmed">19390361</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Y, Chen F, Zhao W, et al. . Pulmonary artery pressure and variations in arterial blood pressure during the induction period of general anesthesia in elderly patients. J Coll Physicians Surg Pak. 2021;31:8&#x2013;13.</Citation><ArticleIdList><ArticleId IdType="pubmed">33546526</ArticleId></ArticleIdList></Reference><Reference><Citation>Pan Y-X, Wang J-C, Lu X-Y, et al. . Intention to control low central venous pressure reduced blood loss during laparoscopic hepatectomy: a double-blind randomized clinical trial. Surgery. 2020;167:933&#x2013;41.</Citation><ArticleIdList><ArticleId IdType="pubmed">32216964</ArticleId></ArticleIdList></Reference><Reference><Citation>Chou M-Y, Wang Y-C, Peng L-N, et al. . Intraoperative blood transfusion predicts postoperative delirium among older patients undergoing elective orthopedic surgery: a prospective cohort study. Int J Geriatr Psychiatry. 2019;34:881&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">30761615</ArticleId></ArticleIdList></Reference><Reference><Citation>van Munster BC, Korevaar JC, Zwinderman AH, Levi M, Wiersinga WJ, De Rooij SE. Time-course of cytokines during delirium in elderly patients with hip fractures. J Am Geriatr Soc. 2008;56:1704&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">18691278</ArticleId></ArticleIdList></Reference><Reference><Citation>Hensler T, Heinemann B, Sauerland S, et al. . Immunologic alterations associated with high blood transfusion volume after multiple injury: effects on plasmatic cytokine and cytokine receptor concentrations. Shock. 2003;20:497&#x2013;502.</Citation><ArticleIdList><ArticleId IdType="pubmed">14625472</ArticleId></ArticleIdList></Reference><Reference><Citation>Fodale V, Tripodi VF, Penna O, et al. . An update on anesthetics and impact on the brain. Expert Opin Drug Saf. 2017;16:997&#x2013;1008.</Citation><ArticleIdList><ArticleId IdType="pubmed">28697315</ArticleId></ArticleIdList></Reference><Reference><Citation>Mei X, Zheng H-L, Li C, et al. . The effects of propofol and sevoflurane on postoperative delirium in older patients: a randomized clinical trial study. J Alzheimers Dis. 2020;76:1627&#x2013;36.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7844419</ArticleId><ArticleId IdType="pubmed">32651322</ArticleId></ArticleIdList></Reference><Reference><Citation>Aldecoa C, Bettelli G, Bilotta F, et al. . European Society of Anaesthesiology evidence-based and consensus-based guideline on postoperative delirium. Eur J Anaesthesiol. 2017;34:192&#x2013;214.</Citation><ArticleIdList><ArticleId IdType="pubmed">28187050</ArticleId></ArticleIdList></Reference><Reference><Citation>Shi M, Miao S, Gu T, Wang D, Zhang H, Liu J. Dexmedetomidine for the prevention of emergence delirium and postoperative behavioral changes in pediatric patients with sevoflurane anesthesia: a double-blind, randomized trial. Drug Des Devel Ther. 2019;13:897&#x2013;905.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6421876</ArticleId><ArticleId IdType="pubmed">30936683</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang H-Y, Chen T-Y, Li D-J, et al. . Association of pharmacological prophylaxis with the risk of pediatric emergence delirium after sevoflurane anesthesia: an updated network meta-analysis. J Clin Anesth. 2021;75:110488.</Citation><ArticleIdList><ArticleId IdType="pubmed">34481361</ArticleId></ArticleIdList></Reference><Reference><Citation>Momeni M, Khalifa C, Lemaire G, et al. . Propofol plus low-dose dexmedetomidine infusion and postoperative delirium in older patients undergoing cardiac surgery. Br J Anaesth. 2021;126:665&#x2013;73.</Citation><ArticleIdList><ArticleId IdType="pubmed">33358336</ArticleId></ArticleIdList></Reference><Reference><Citation>Zarour S, Weiss Y, Kiselevich Y, et al. . The association between midazolam premedication and postoperative delirium&#x2014;a retrospective cohort study. J Clin Anesth. 2024;92:111113.</Citation><ArticleIdList><ArticleId IdType="pubmed">37280146</ArticleId></ArticleIdList></Reference><Reference><Citation>Greengrass RA. Midazolam and delirium: can you have it both ways? Reg Anesth Pain Med. 2022;47:449&#x2013;50.</Citation><ArticleIdList><ArticleId IdType="pubmed">35296540</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37053508</PMID><DateCompleted><Year>2023</Year><Month>08</Month><Day>21</Day></DateCompleted><DateRevised><Year>2024</Year><Month>02</Month><Day>21</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1526-7598</ISSN><JournalIssue CitedMedium="Internet"><Volume>137</Volume><Issue>3</Issue><PubDate><Year>2023</Year><Month>Sep</Month><Day>01</Day></PubDate></JournalIssue><Title>Anesthesia and analgesia</Title><ISOAbbreviation>Anesth Analg</ISOAbbreviation></Journal><ArticleTitle>Complications of Factor V Leiden in Adults Undergoing Noncardiac Surgical Procedures: A Systematic Review.</ArticleTitle><Pagination><StartPage>601</StartPage><EndPage>617</EndPage><MedlinePgn>601-617</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1213/ANE.0000000000006483</ELocationID><Abstract><AbstractText>Factor V Leiden is the commonest hereditary prothrombotic allele, affecting 1% to 5% of the world's population. The objective of this study was to characterize the perioperative and postoperative outcomes of patients with Factor V Leiden compared to patients without a diagnosis of hereditary thrombophilia. This was a focused systematic review of studies including adult (&gt;18 years) patients with Factor V Leiden (heterozygous or homozygous) undergoing noncardiac surgery. Included studies were either randomized controlled trials or observational. The primary clinical outcomes of interest were thromboembolic events occurring from the perioperative period up to 1 year postoperatively, defined as deep venous thrombosis, pulmonary embolism, or other clinically significant thrombosis occurring during or after a surgical procedure. Secondary outcomes included cerebrovascular events, cardiac events, death, transplant-related outcomes, and surgery-specific morbidity. Pediatric and obstetrical patients were excluded, as were case reports and case series. Databases searched included MEDLINE and EMBASE from inception until August 2021. Study bias was assessed through the CLARITY (Collaboration of McMaster University researchers) Risk of Bias tools, and heterogeneity through analysis of study design and end points, as well as the I 2 statistic with its confidence interval and the Q statistic. A total of 5275 potentially relevant studies were identified, with 115 having full text assessed for eligibility and 32 included in the systematic review. On the whole, the literature suggests that patients with Factor V Leiden have an increased risk of perioperative and postoperative thromboembolic events compared to patients without the diagnosis. Increased risk was also seen in relation to surgery-specific morbidity and transplant-related outcomes, particularly arterial thrombotic events. The literature did not support an increased risk for mortality, cerebrovascular, or cardiac complications. Limitations of the data include predisposition toward bias due in many study designs and small sample sizes across the majority of published studies. Variable outcome definitions and durations of patient follow-up across different surgical procedures resulted in high study heterogeneity precluding the effective use of meta-analysis. Factor V Leiden status may confer additional risk for surgery-related adverse outcomes. Large, adequately powered studies are required to accurately estimate the degree of this risk by zygosity.</AbstractText><CopyrightInformation>Copyright &#xa9; 2023 International Anesthesia Research Society.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Au</LastName><ForeName>Emily</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>From the Department of Medicine, Michael G. DeGroote School of Medicine, McMaster University, Hamilton, Ontario, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shao</LastName><ForeName>Ian</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>From the Department of Medicine, Michael G. DeGroote School of Medicine, McMaster University, Hamilton, Ontario, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Elias</LastName><ForeName>Zeyad</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Department of Medicine, Temerty Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Koivu</LastName><ForeName>Annabel</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Edinburgh Medical School, University of Edinburgh, Edinburgh, Scotland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zabida</LastName><ForeName>Amir</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Anaesthesia and Pain Management, Sinai Health System, Women's College Hospital, University Health Network, Toronto, Ontario, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shih</LastName><ForeName>Andrew W</ForeName><Initials>AW</Initials><AffiliationInfo><Affiliation>Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centre for Blood Research, Department of Medicine, University of British Columbia, Vancouver, British Columbia, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cserti-Gazdewich</LastName><ForeName>Christine</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>van Klei</LastName><ForeName>Wilton A</ForeName><Initials>WA</Initials><AffiliationInfo><Affiliation>Department of Anaesthesia and Pain Management, Sinai Health System, Women's College Hospital, University Health Network, Toronto, Ontario, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Medical Science, University of Toronto, Toronto, Ontario, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Anaesthesiology and Pain Medicine, University of Toronto, Toronto, Ontario, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Peter Munk Cardiac Centre, University Health Network, Toronto, Ontario, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bartoszko</LastName><ForeName>Justyna</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Anaesthesia and Pain Management, Sinai Health System, Women's College Hospital, University Health Network, Toronto, Ontario, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Medical Science, University of Toronto, Toronto, Ontario, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Anaesthesiology and Pain Medicine, University of Toronto, Toronto, Ontario, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Peter Munk Cardiac Centre, University Health Network, Toronto, Ontario, Canada.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D000078182">Systematic Review</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>08</Month><Day>17</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Anesth Analg</MedlineTA><NlmUniqueID>1310650</NlmUniqueID><ISSNLinking>0003-2999</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C095381">factor V Leiden</NameOfSubstance></Chemical><Chemical><RegistryNumber>9001-24-5</RegistryNumber><NameOfSubstance UI="D005165">Factor V</NameOfSubstance></Chemical></ChemicalList><SupplMeshList><SupplMeshName Type="Disease" UI="C540694">Thrombophilia, hereditary</SupplMeshName></SupplMeshList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005165" MajorTopicYN="N">Factor V</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019851" MajorTopicYN="Y">Thrombophilia</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006331" MajorTopicYN="Y">Heart Diseases</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>Conflicts of Interest: See Disclosures at the end of the article. Conflicts of Interest: J. Bartoszko supported by a merit award from the Department of Anesthesiology and Pain Medicine, University of Toronto. J. Bartoszko has received honoraria from Octapharma.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>8</Month><Day>21</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>4</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>4</Month><Day>13</Day><Hour>15</Hour><Minute>42</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37053508</ArticleId><ArticleId IdType="doi">10.1213/ANE.0000000000006483</ArticleId><ArticleId IdType="pii">00000539-202309000-00018</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Mullen MG, Michaels AD, Mehaffey JH, et al. Risk associated with complications and mortality after urgent surgery vs elective and emergency surgery: implications for defining &#x201c;quality&#x201d; and reporting outcomes for urgent surgery. JAMA Surg. 2017;152:768&#x2013;774.</Citation></Reference><Reference><Citation>Smilowitz NR, Gupta N, Guo Y, et al. Trends in perioperative venous thromboembolism associated with major noncardiac surgery. TH Open. 2017;1:e82&#x2013;e91.</Citation></Reference><Reference><Citation>Smilowitz NR, Gupta N, Guo Y, Beckman JA, Bangalore S, Berger JS. Trends in cardiovascular risk factor and disease prevalence in patients undergoing non-cardiac surgery. Heart. 2018;104:1180&#x2013;1186.</Citation></Reference><Reference><Citation>Wolters U, Wolf T, St&#xfc;tzer H, Schr&#xf6;der T. ASA classification and perioperative variables as predictors of postoperative outcome. Br J Anaesth. 1996;77:217&#x2013;222.</Citation></Reference><Reference><Citation>Partridge JS, Harari D, Dhesi JK. Frailty in the older surgical patient: a review. Age Ageing. 2012;41:142&#x2013;147.</Citation></Reference><Reference><Citation>Kujovich JL. Factor V Leiden thrombophilia. Genet Med. 2011;13:1&#x2013;16.</Citation></Reference><Reference><Citation>De Stefano V, Chiusolo P, Paciaroni K, Leone G. Epidemiology of factor V Leiden: clinical implications. Semin Thromb Hemost. 1998;24:367&#x2013;379.</Citation></Reference><Reference><Citation>Donahue BS. Factor V Leiden and perioperative risk. Anesth Analg. 2004;98:1623&#x2013;1634.</Citation></Reference><Reference><Citation>Cushman M. Epidemiology and risk factors for venous thrombosis. Semin Hematol. 2007;44:62&#x2013;69.</Citation></Reference><Reference><Citation>Page MJ, McKenzie JE, Bossuyt PM, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71.</Citation></Reference><Reference><Citation>Benford D, Halldorsson T, Jeger MJ, et al.; EFSA Scientific Committee. The principles and methods behind EFSA&#x2019;s guidance on uncertainty analysis in scientific assessment. EFSA J. 2018;16:e05122.</Citation></Reference><Reference><Citation>Foley PW, Irvine CD, Standen GR, et al. Activated protein C resistance, factor V Leiden and peripheral vascular disease. Cardiovasc Surg. 1997;5:157&#x2013;160.</Citation></Reference><Reference><Citation>Kreienberg PB, Chang BB, Darling RC III, et al. Long-term results in patients treated with thrombolysis, thoracic inlet decompression, and subclavian vein stenting for Paget-Schroetter syndrome. J Vasc Surg. 2001;33(2 suppl):S100&#x2013;S105.</Citation></Reference><Reference><Citation>Fijnheer R, Paijmans B, Verdonck LF, Nieuwenhuis HK, Roest M, Dekker AW. Factor V Leiden in central venous catheter-associated thrombosis. Br J Haematol. 2002;118:267&#x2013;270.</Citation></Reference><Reference><Citation>van Adrichem RA, Nelissen RG, Schipper IB, Rosendaal FR, Cannegieter SC. Risk of venous thrombosis after arthroscopy of the knee: results from a large population-based case-control study. J Thromb Haemost. 2015;13:1441&#x2013;1448.</Citation></Reference><Reference><Citation>Nemeth B, Lijfering WM, Nelissen R, et al. Risk and risk factors associated with recurrent venous thromboembolism following surgery in patients with history of venous thromboembolism. JAMA Netw Open. 2019;2:e193690.</Citation></Reference><Reference><Citation>Zambelli R, Nemeth B, Touw CE, Rosendaal FR, Rezende SM, Cannegieter SC. High risk of venous thromboembolism after orthopedic surgery in patients with thrombophilia. J Thromb Haemost. 2021;19:444&#x2013;451.</Citation></Reference><Reference><Citation>Ryan DH, Crowther MA, Ginsberg JS, Francis CW. Relation of factor V Leiden genotype to risk for acute deep venous thrombosis after joint replacement surgery. Ann Intern Med. 1998;128:270&#x2013;276.</Citation></Reference><Reference><Citation>Kibbe MR, Hassett AL, McSherry F, et al. Can screening for genetic markers improve peripheral artery bypass patency? J Vasc Surg. 2002;36:1198&#x2013;1206.</Citation></Reference><Reference><Citation>W&#xe5;hlander K, Larson G, Lindahl TL, et al. Factor V Leiden (G1691A) and prothrombin gene G20210A mutations as potential risk factors for venous thromboembolism after total hip or total knee replacement surgery. Thromb Haemost. 2002;87:580&#x2013;585.</Citation></Reference><Reference><Citation>Douville NJ, Kheterpal S, Engoren M, et al. Genetic mutations associated with susceptibility to perioperative complications in a longitudinal biorepository with integrated genomic and electronic health records. Br J Anaesth. 2020;125:986&#x2013;994.</Citation></Reference><Reference><Citation>Ulrych J, Kvasni&#x10d;ka T, Fr&#xfd;ba V, et al. The impact of hereditary thrombophilia on the incidence of postoperative venous thromboembolism in colorectal cancer patients: a prospective cohort study. Eur Surg. 2018;51:5&#x2013;12.</Citation></Reference><Reference><Citation>Hirshfield G, Collier JD, Brown K, et al. Donor factor V Leiden mutation and vascular thrombosis following liver transplantation. Liver Transpl Surg. 1998;4:58&#x2013;61.</Citation></Reference><Reference><Citation>Ekberg H, Svensson PJ, Simanaitis M, Dahlb&#xe4;ck B. Factor V R506Q mutation (activated protein C resistance) is an additional risk factor for early renal graft loss associated with acute vascular rejection. Transplantation. 2000;69:1577&#x2013;1581.</Citation></Reference><Reference><Citation>Fan J, Nishida S, Selvaggi G, et al. Factor V Leiden mutation is a risk factor for hepatic artery thrombosis in liver transplantation. Transplant Proc. 2013;45:1990&#x2013;1993.</Citation></Reference><Reference><Citation>Loew A, Jacob D, Neuhaus P, Riess H. Resistance to activated protein C caused by factor V Leiden mutation and orthotopic liver transplantation. Transplantation. 2005;79:1422&#x2013;1427.</Citation></Reference><Reference><Citation>Sampram ES, Lindblad B. The impact of factor V mutation on the risk for occlusion in patients undergoing peripheral vascular reconstructions. Eur J Vasc Endovasc Surg. 2001;22:134&#x2013;138.</Citation></Reference><Reference><Citation>Adrogu&#xe9; HE, Matas AJ, McGlennon RC, et al. Do inherited hypercoagulable states play a role in thrombotic events affecting kidney/pancreas transplant recipients? Clin Transplant. 2007;21:32&#x2013;37.</Citation></Reference><Reference><Citation>Heidenreich S, Dercken C, August C, Koch HG, Nowak-G&#xf6;ttl U. High rate of acute rejections in renal allograft recipients with thrombophilic risk factors. J Am Soc Nephrol. 1998;9:1309&#x2013;1313.</Citation></Reference><Reference><Citation>Irish AB, Green FR, Gray DW, Morris PJ. The factor V Leiden (R506Q) mutation and risk of thrombosis in renal transplant recipients. Transplantation. 1997;64:604&#x2013;607.</Citation></Reference><Reference><Citation>Meyer M, Laux G, Scherer S, Tran TH, Opelz G, Mytilineos J. No association of factor V Leiden, prothrombin G20210A, and MTHFR C677T gene polymorphisms with kidney allograft survival: a multicenter study. Transplantation. 2007;83:1055&#x2013;1058.</Citation></Reference><Reference><Citation>Pereboom IT, Adelmeijer J, van der Steege G, van den Berg AP, Lisman T, Porte RJ. Prothrombotic gene polymorphisms: possible contributors to hepatic artery thrombosis after orthotopic liver transplantation. Transplantation. 2011;92:587&#x2013;593.</Citation></Reference><Reference><Citation>Blaszyk H, Bj&#xf6;rnsson J. Factor V Leiden and morbid obesity in fatal postoperative pulmonary embolism. Arch Surg. 2000;135:1410&#x2013;1413.</Citation></Reference><Reference><Citation>Sampram ES, Lindblad B, Dahlb&#xe4;ck B. Activated protein C resistance in patients with peripheral vascular disease. J Vasc Surg. 1998;28:624&#x2013;629.</Citation></Reference><Reference><Citation>W&#xfc;thrich RP, Cicvara-Muzar S, Booy C, Maly FE. Heterozygosity for the factor V Leiden (G1691A) mutation predisposes renal transplant recipients to thrombotic complications and graft loss. Transplantation. 2001;72:549&#x2013;550.</Citation></Reference><Reference><Citation>Baba-Ahmed M, Le Gal G, Couturaud F, Lacut K, Oger E, Leroyer C. High frequency of factor V Leiden in surgical patients with symptomatic venous thromboembolism despite prophylaxis. Thromb Haemost. 2007;97:171&#x2013;175.</Citation></Reference><Reference><Citation>Painter TW, McIlroy D, Myles PS, Leslie K. A survey of anaesthetists&#x2019; use of tranexamic acid in noncardiac surgery. Anaesth Intensive Care. 2019;47:76&#x2013;84.</Citation></Reference><Reference><Citation>Levent A, Kose O, Linke P, Gehrke T, Citak M. Tranexamic acid is safe and effective in patients with heterozygous factor V Leiden mutation during total joint arthroplasty. Arch Orthop Trauma Surg. 2023;143:613&#x2013;620.</Citation></Reference><Reference><Citation>Bowler DJ, Bale E, O'Byrne J. Factor V Leiden: prevalence and thromboembolic complications after total hip replacement in Ireland. Ir J Med Sci. 2007;176(4):273&#x2013;277. doi:10.1007/s11845-007-0095-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11845-007-0095-x</ArticleId></ArticleIdList></Reference><Reference><Citation>Charen DA, Qian ET, Hutzler LH, Bosco JA. Risk factors for postoperative venous thromboembolism in orthopaedic spine surgery, hip arthroplasty, and knee arthroplasty patients. Bull Hosp Jt Dis (2013). 2015;73(3):198&#x2013;203.</Citation></Reference><Reference><Citation>Della Valle CJ, Issack PS, Baitner A, Steiger DJ, Fang C, Di Cesare PE. The relationship of the factor V Leiden mutation or the deletion-deletion polymorphism of the angiotensin converting enzyme to postoperative thromboembolic events following total joint arthroplasty. BMC Musculoskelet Disord. 2001;2:1. doi:10.1186/1471-2474-2-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2474-2-1</ArticleId></ArticleIdList></Reference><Reference><Citation>Donaldson MC, Belkin M, Whittemore AD, Mannick JA, Longtine JA, Dorfman DM. Impact of activated protein C resistance on general vascular surgical patients. J Vasc Surg. 1997;25(6):1054&#x2013;1060. doi:10.1016/s0741-5214(97)70129-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0741-5214(97)70129-0</ArticleId></ArticleIdList></Reference><Reference><Citation>Lowe GD, Haverkate F, Thompson SG, et al. Prediction of deep vein thrombosis after elective hip replacement surgery by preoperative clinical and haemostatic variables: the ECAT DVT Study. European Concerted Action on Thrombosis. Thromb Haemost. 1999;81(6):879&#x2013;886.</Citation></Reference><Reference><Citation>Joseph JE, Low J, Courtenay B, Neil MJ, McGrath M, Ma D. A single-centre prospective study of clinical and haemostatic risk factors for venous thromboembolism following lower limb arthroplasty. Br J Haematol. 2005;129(1):87&#x2013;92. doi:10.1111/j.1365-2141.2005.05419.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1365-2141.2005.05419.x</ArticleId></ArticleIdList></Reference><Reference><Citation>Ringwald J, Berger A, Adler W, Kraus C, Pitto RP. Genetic polymorphisms in venous thrombosis and pulmonary embolism after total hip arthroplasty: a pilot study. Clin Orthop Relat Res. 2009;467(6):1507&#x2013;1515. doi:10.1007/s11999-008-0498-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11999-008-0498-7</ArticleId></ArticleIdList></Reference><Reference><Citation>Sartori M, Conti E, Favaretto E, Frascaro M, Legnani C, Palareti G. Thrombotic risk factors and cardiovascular events after endovascular intervention for peripheral arterial disease. Eur J Vasc Endovasc Surg. 2011;42(6):817&#x2013;823. doi:10.1016/j.ejvs.2011.08.016</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejvs.2011.08.016</ArticleId></ArticleIdList></Reference><Reference><Citation>Sz&#xfc;cs G, Ajzner E, Muszbek L, Simon T, Szepesi K, F&#xfc;lesdi B. Assessment of thrombotic risk factors predisposing to thromboembolic complications in prosthetic orthopedic surgery. J Orthop Sci. 2009;14(5):484&#x2013;490. doi:10.1007/s00776-009-1368-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00776-009-1368-1</ArticleId></ArticleIdList></Reference><Reference><Citation>Woolson ST, Zehnder JL, Maloney WJ. Factor V Leiden and the risk of proximal venous thrombosis after total hip arthroplasty. J Arthroplasty. 1998;13(2):207&#x2013;210.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">31476570</PMID><DateCompleted><Year>2020</Year><Month>08</Month><Day>25</Day></DateCompleted><DateRevised><Year>2020</Year><Month>08</Month><Day>25</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1532-3064</ISSN><JournalIssue CitedMedium="Internet"><Volume>157</Volume><PubDate><Year>2019</Year><Month>Oct</Month></PubDate></JournalIssue><Title>Respiratory medicine</Title><ISOAbbreviation>Respir Med</ISOAbbreviation></Journal><ArticleTitle>Elevated serum cardiac troponin and mortality in acute pulmonary embolism: Systematic review and meta-analysis.</ArticleTitle><Pagination><StartPage>26</StartPage><EndPage>35</EndPage><MedlinePgn>26-35</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.rmed.2019.08.011</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0954-6111(19)30268-9</ELocationID><Abstract><AbstractText Label="OBJECTIVES">To evaluate whether elevated levels of cardiac troponin increases the risk of mortality in patients with acute PE.</AbstractText><AbstractText Label="METHODS">We conducted a systematic review and meta-analysis with rigorous statistical evaluation using publications (2000-2018) from Cochrane Library, MEDLINE, PubMed, Scopus, Cochrane Central Register of Controlled Trials (CENTRAL), WHO International Clinical Trials Registry Platform, and Google Scholar databases. We searched for retrospective, prospective, and randomized controlled trials (RCT) or quasi-RCT studies that assessed the effect of elevated troponin versus normal levels on the outcomes of PE. The main outcome of interest was all-cause mortality. Extracted data included authors, the origin of studies, source population, study settings and duration, inclusion/exclusion criteria, data sources and measurement, sample size, and mortality. Data heterogeneity was assessed using the Cochrane Q homogeneity test with a significance set at p&#x202f;&lt;&#x202f;0.10. If the studies were statistically homogeneous, a fixed effect model was selected.</AbstractText><AbstractText Label="RESULTS">Out of 1825 references, 46 analytical studies were included with a total of 10842 patients with PE. The effect of elevated troponin on mortality had a pooled odd ratio (OR) of 4.33 for all studies, 3.7for HsTnT, 14.81 for HsTnI, 7.85 for cTnT, 2.81 for cTnI, 9.02 for low-risk PE and 4.80 for 90-day mortality. The pooled negative likelihood ratios for all-cause mortality using HsTnI, cTnI and cTnT assay were 0.21, 0.33 and 0.65, respectively.</AbstractText><AbstractText Label="CONCLUSION">Regardless of the troponin assay, pooled analysis indicates that elevated troponin is significantly associated with higher mortality in patients with PE.</AbstractText><CopyrightInformation>Copyright &#xa9; 2019 Elsevier Ltd. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>El-Menyar</LastName><ForeName>Ayman</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Surgery, Clinical Research, Trauma &amp; Vascular Surgery, Hamad Medical Corporation (HMC), Doha, Qatar; Clinical Medicine, Weill Cornell Medical College, Doha, Qatar. Electronic address: aelmenyar@hamad.qa.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sathian</LastName><ForeName>Brijesh</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Surgery, Clinical Research, Trauma &amp; Vascular Surgery, Hamad Medical Corporation (HMC), Doha, Qatar.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Al-Thani</LastName><ForeName>Hassan</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Surgery, Trauma &amp; Vascular Surgery, HMC, Doha, Qatar.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2019</Year><Month>08</Month><Day>23</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Respir Med</MedlineTA><NlmUniqueID>8908438</NlmUniqueID><ISSNLinking>0954-6111</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D014336">Troponin</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D019210">Troponin I</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D020107">Troponin T</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000208" MajorTopicYN="N">Acute Disease</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017063" MajorTopicYN="N">Outcome Assessment, Health Care</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011237" MajorTopicYN="N">Predictive Value of Tests</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011379" MajorTopicYN="N">Prognosis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011655" MajorTopicYN="N">Pulmonary Embolism</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000401" MajorTopicYN="Y">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016032" MajorTopicYN="N">Randomized Controlled Trials as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012306" MajorTopicYN="N">Risk</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012680" MajorTopicYN="N">Sensitivity and Specificity</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014336" MajorTopicYN="N">Troponin</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019210" MajorTopicYN="N">Troponin I</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020107" MajorTopicYN="N">Troponin T</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">All-cause mortality</Keyword><Keyword MajorTopicYN="N">Conventional assay</Keyword><Keyword MajorTopicYN="N">High-sensitive</Keyword><Keyword MajorTopicYN="N">Pulmonary embolism</Keyword><Keyword MajorTopicYN="N">Serum cardiac troponin</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2019</Year><Month>5</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2019</Year><Month>8</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2019</Year><Month>8</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>9</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>8</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>9</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31476570</ArticleId><ArticleId IdType="doi">10.1016/j.rmed.2019.08.011</ArticleId><ArticleId IdType="pii">S0954-6111(19)30268-9</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">40090502</PMID><DateCompleted><Year>2025</Year><Month>08</Month><Day>25</Day></DateCompleted><DateRevised><Year>2025</Year><Month>08</Month><Day>27</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1532-8406</ISSN><JournalIssue CitedMedium="Internet"><Volume>40</Volume><Issue>9</Issue><PubDate><Year>2025</Year><Month>Sep</Month></PubDate></JournalIssue><Title>The Journal of arthroplasty</Title><ISOAbbreviation>J Arthroplasty</ISOAbbreviation></Journal><ArticleTitle>One-Stage Versus Two-Stage Bilateral Total Knee Arthroplasty: A Systematic Review and Meta-Analysis.</ArticleTitle><Pagination><StartPage>2467</StartPage><EndPage>2477</EndPage><MedlinePgn>2467-2477</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.arth.2025.03.026</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0883-5403(25)00238-4</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Bilateral total knee arthroplasty (B-TKA) represents an increasingly used option to address advanced bilateral knee osteoarthritis (OA). The aim of this study was to quantify and compare one-stage and two-stage B-TKA results in terms of clinical outcomes, perioperative parameters, complications, revisions, and mortality rates.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">The literature search was conducted using three databases (PubMed, Cochrane, and Web of Science) in February 2024 according to the guidelines for Preferred Reporting Items for Systematic Reviews and Meta-Analysis. The inclusion criteria were as follows: comparative studies, English language, with no time filter on the comparison of one-stage and two-stage B-TKA for bilateral knee osteoarthritis treatment. The quality of each article was assessed using the Cochrane risk of bias in nonrandomized studies of interventions tool.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Among the 2,130 articles retrieved, 69 studies (366,722 patients) were included. One-stage B-TKA showed lower rates of TKA-related complications (P = 0.043), deep infections (P &lt; 0.001), and wound complications (P = 0.033), as well as lower operative time (P = 0.028), shorter length of hospital stay (P &lt; 0.001), and higher improvements of Western Ontario and McMaster Universities Osteoarthritis Index score (P = 0.013) and Oxford Knee Score (P = 0.004), but higher mortality rates at the 1-month (P &lt; 0.001), 3-month (P &lt; 0.001), and 1-year (P = 0.001) follow-ups, as well as higher rates of neurological (P = 0.013) and gastrointestinal (P &lt; 0.001) complications, deep vein thrombosis (P = 0.016), and pulmonary embolism (P &lt; 0.001). The risk of bias was "low" in 26 studies, "moderate" in 36 studies, "serious" in six studies, and "critical" in one study.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">One-stage B-TKA was associated with a higher mortality rate and thromboembolic risk while presenting lower TKA-related and infective complications compared to two-stage B-TKA. One-stage B-TKA also reduced hospital stay and total surgical time but provided only marginal improvement in clinical outcomes compared to two-stage B-TKA while showing a higher risk of neurologic and gastrointestinal complications. These results offer important information for both patients and surgeons in evaluating the most appropriate surgical approach, thereby contributing to optimize the management of patients undergoing B-TKA.</AbstractText><AbstractText Label="LEVEL OF EVIDENCE" NlmCategory="METHODS">Level I.</AbstractText><CopyrightInformation>Copyright &#xa9; 2025 The Author(s). Published by Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Bensa</LastName><ForeName>Alessandro</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Service of Orthopaedics and Traumatology, Department of Surgery, EOC, Lugano, Switzerland; Universit&#xe0; della Svizzera Italiana, Faculty of Biomedical Sciences, Lugano, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Delcogliano</LastName><ForeName>Marco</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Service of Orthopaedics and Traumatology, Department of Surgery, EOC, Lugano, Switzerland; Universit&#xe0; della Svizzera Italiana, Faculty of Biomedical Sciences, Lugano, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Moraca</LastName><ForeName>Giacomo</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Service of Orthopaedics and Traumatology, Department of Surgery, EOC, Lugano, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bianco Prevot</LastName><ForeName>Luca</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Residency Program in Orthopedics and Traumatology, University of Milan, Milan, Italy; IRCCS Ospedale Galeazzi - S. Ambrogio, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fattini Fellini</LastName><ForeName>Gae</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Service of Orthopaedics and Traumatology, Department of Surgery, EOC, Lugano, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Filardo</LastName><ForeName>Giuseppe</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Service of Orthopaedics and Traumatology, Department of Surgery, EOC, Lugano, Switzerland; Universit&#xe0; della Svizzera Italiana, Faculty of Biomedical Sciences, Lugano, Switzerland.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D003160">Comparative Study</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>03</Month><Day>14</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Arthroplasty</MedlineTA><NlmUniqueID>8703515</NlmUniqueID><ISSNLinking>0883-5403</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019645" MajorTopicYN="Y">Arthroplasty, Replacement, Knee</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020370" MajorTopicYN="Y">Osteoarthritis, Knee</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007902" MajorTopicYN="N">Length of Stay</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D061646" MajorTopicYN="N">Operative Time</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">TKA</Keyword><Keyword MajorTopicYN="N">bilateral</Keyword><Keyword MajorTopicYN="N">knee</Keyword><Keyword MajorTopicYN="N">one-stage</Keyword><Keyword MajorTopicYN="N">total arthroplasty</Keyword><Keyword MajorTopicYN="N">two-stage</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>10</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2025</Year><Month>3</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2025</Year><Month>3</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>9</Month><Day>8</Day><Hour>7</Hour><Minute>51</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>3</Month><Day>17</Day><Hour>0</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>3</Month><Day>16</Day><Hour>20</Hour><Minute>36</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">40090502</ArticleId><ArticleId IdType="doi">10.1016/j.arth.2025.03.026</ArticleId><ArticleId IdType="pii">S0883-5403(25)00238-4</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">39018138</PMID><DateCompleted><Year>2025</Year><Month>03</Month><Day>19</Day></DateCompleted><DateRevised><Year>2025</Year><Month>03</Month><Day>19</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0030-9982</ISSN><JournalIssue CitedMedium="Internet"><Volume>74</Volume><Issue>6 (Supple-6)</Issue><PubDate><Year>2024</Year><Month>Jun</Month></PubDate></JournalIssue><Title>JPMA. The Journal of the Pakistan Medical Association</Title><ISOAbbreviation>J Pak Med Assoc</ISOAbbreviation></Journal><ArticleTitle>Identifying pulmonary embolism - high risk patients after total knee replacement: systematic review.</ArticleTitle><Pagination><StartPage>S41</StartPage><EndPage>S50</EndPage><MedlinePgn>S41-S50</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.47391/JPMA.S6-ACSA-08</ELocationID><Abstract><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">To determine the incidence, onset, risk factors and mortality of pulmonary embolism in total knee replacement patients.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">The systematic review was conducted in September 2022, and comprised search on PubMed, ScienceDirect, Scopus and Crossref databases for studies published from 1977 till September 7, 2022, in the English language related to the incidence of pulmonary embolism after primary total knee replacement. Cochrane Handbook for Systematic Reviews of Interventions was used to assess risk of bias, and the Newcastle-Ottawa Scale was used to assess the quality of evidence.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Of the 3,910 studies initially identified, 66(1.68%) were analysed in detail, which together had 13,258,455 total knee replacement patients. Pulmonary embolism was reported in 76,515(0.58%) cases. The onset of pulmonary embolism ranged 2-150 days post-surgery. Patients with older age, diabetes mellitus, higher body mass index, atrial fibrillation, previous venous thromboembolism, high Charlson Comorbidity Index score, hypertension, arrhythmia and chronic heart failure were at significantly higher risk (p&lt;0.05). The overall mortality rate of pulmonary embolism in such cases ranged 10.53-100%.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Pulmonary embolism is a rare complication after orthopaedic surgery, but it has a very high mortality rate. By recognising the risk factors, attending physicians can optimise the use of chemoprophylaxis, thus preventing pulmonary embolism.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Arnindita</LastName><ForeName>Jannatin Nisa</ForeName><Initials>JN</Initials><AffiliationInfo><Affiliation>Department of Cardiology and Vascular Medicine, Faculty of Medicine, Universitas Airlangga - Dr Soetomo General Academic Hospital, Surabaya, Indonesia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mahyuddin</LastName><ForeName>Muhammad Hanun</ForeName><Initials>MH</Initials><AffiliationInfo><Affiliation>Department of Orthopaedic and Traumatology, Faculty of Medicine, Universitas Airlangga - Dr Soetomo General Academic Hospital, Surabaya, Indonesia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tri Saputra</LastName><ForeName>Pandit Bagus</ForeName><Initials>PB</Initials><AffiliationInfo><Affiliation>Department of Cardiology and Vascular Medicine, Faculty of Medicine, Universitas Airlangga - Dr Soetomo General Academic Hospital, Surabaya, Indonesia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Putra</LastName><ForeName>Rendra Mahardhika</ForeName><Initials>RM</Initials><AffiliationInfo><Affiliation>Department of Cardiology and Vascular Medicine, Faculty of Medicine, Universitas Airlangga - Dr Soetomo General Academic Hospital, Surabaya, Indonesia.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><MedlineTA>J Pak Med Assoc</MedlineTA><NlmUniqueID>7501162</NlmUniqueID><ISSNLinking>0030-9982</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000367" MajorTopicYN="N">Age Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001145" MajorTopicYN="N">Arrhythmias, Cardiac</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019645" MajorTopicYN="Y">Arthroplasty, Replacement, Knee</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001281" MajorTopicYN="N">Atrial Fibrillation</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D048909" MajorTopicYN="N">Diabetes Complications</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006333" MajorTopicYN="N">Heart Failure</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006973" MajorTopicYN="N">Hypertension</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011655" MajorTopicYN="Y">Pulmonary Embolism</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018570" MajorTopicYN="N">Risk Assessment</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D054556" MajorTopicYN="N">Venous Thromboembolism</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015992" MajorTopicYN="N">Body Mass Index</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Venous thromboembolism, Orthopaedic, Pulmonary, Arrhythmias, Cardiac, Bibliometrics, Comorbidity.</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>7</Month><Day>17</Day><Hour>18</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>7</Month><Day>17</Day><Hour>18</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>7</Month><Day>17</Day><Hour>12</Hour><Minute>3</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39018138</ArticleId><ArticleId IdType="doi">10.47391/JPMA.S6-ACSA-08</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">34148191</PMID><DateCompleted><Year>2022</Year><Month>05</Month><Day>30</Day></DateCompleted><DateRevised><Year>2022</Year><Month>05</Month><Day>30</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1863-2491</ISSN><JournalIssue CitedMedium="Internet"><Volume>16</Volume><Issue>3</Issue><PubDate><Year>2022</Year><Month>Jun</Month></PubDate></JournalIssue><Title>Journal of robotic surgery</Title><ISOAbbreviation>J Robot Surg</ISOAbbreviation></Journal><ArticleTitle>Robotic-assisted hiatal hernia repair and pulmonary embolism: an institution-based retrospective cohort study.</ArticleTitle><Pagination><StartPage>501</StartPage><EndPage>505</EndPage><MedlinePgn>501-505</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s11701-021-01264-x</ELocationID><Abstract><AbstractText>Hiatal hernia (HH) is an abnormal protrusion of components of the abdominal viscera through the esophageal hiatus. The laparoscopic approach is the gold standard for repair with the robotic technique now gaining wide acceptance. Pulmonary embolism (PE) is a well-known post-operative complication but its incidence following robotically assisted HH repairs is not well known. This study provides a descriptive analysis of three patients who developed PE after robotic repairs of their HHs. The incidence of PE in the studied cohort was 2.7% (3 of 112) with a male preponderance (66.7%). The mean age of the patients was 55.3&#xa0;years with a mean BMI of 32.2&#xa0;kg/m<sup>2</sup>. The average duration of surgery was 4.2&#xa0;h with sizes of the diaphragmatic defects ranging from 3 to 6&#xa0;cm. Confirmatory PE diagnosis was made with a chest CT angiogram and the mean length of hospital stay was 4&#xa0;days. PE although rare, is a preventable cause of in-patient mortality and morbidity with implications on healthcare costs and hospital resource use. The Caprini model provides a guide to pre-operative patient risk stratification and PE prevention, and the patients in this study were in the moderate to high-risk groups. Risk factors common to all patients were: age&#x2009;&gt;&#x2009;40&#xa0;years, BMI&#x2009;&gt;&#x2009;30&#xa0;kg/m<sup>2</sup> and duration of surgery&#x2009;&gt;&#x2009;2&#xa0;h with one of the patients having a previous history of PE. There are no established PE chemoprophylaxis guidelines for robotic HH repairs and in this cohort, heparin was commenced 6-8&#xa0;h post-operatively. Thus, there is a need for a consensus chemoprophylaxis guideline in this subset of surgical patients. PE following robotic HH repair is associated with prolonged hospital stay and increased healthcare costs. Guidelines for effective pre-operative chemoprophylaxis for these repairs are needed to optimize patient outcomes.</AbstractText><CopyrightInformation>&#xa9; 2021. The Author(s), under exclusive licence to Springer-Verlag London Ltd., part of Springer Nature.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Obisesan</LastName><ForeName>Aanuoluwapo</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0001-5864-1407</Identifier><AffiliationInfo><Affiliation>Department of Surgery, St. Luke's University Health Network, Bethlehem, PA, USA. aanuoluwapo.obisesan@sluhn.org.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Singhal</LastName><ForeName>Vinay</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Department of Surgery, St. Luke's University Health Network, Bethlehem, PA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Satoskar</LastName><ForeName>Savni</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Surgery, St. Luke's University Health Network, Bethlehem, PA, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>06</Month><Day>19</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>J Robot Surg</MedlineTA><NlmUniqueID>101300401</NlmUniqueID><ISSNLinking>1863-2483</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006551" MajorTopicYN="Y">Hernia, Hiatal</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D059685" MajorTopicYN="N">Herniorrhaphy</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010535" MajorTopicYN="Y">Laparoscopy</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011655" MajorTopicYN="Y">Pulmonary Embolism</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D065287" MajorTopicYN="Y">Robotic Surgical Procedures</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Elective hiatal hernia repair</Keyword><Keyword MajorTopicYN="N">Hiatal hernia</Keyword><Keyword MajorTopicYN="N">Pulmonary embolism</Keyword><Keyword MajorTopicYN="N">Robotic-assisted hiatal hernia repair</Keyword><Keyword MajorTopicYN="N">VTE chemoprophylaxis</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>11</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>6</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>6</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>5</Month><Day>31</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>6</Month><Day>20</Day><Hour>21</Hour><Minute>2</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34148191</ArticleId><ArticleId IdType="doi">10.1007/s11701-021-01264-x</ArticleId><ArticleId IdType="pii">10.1007/s11701-021-01264-x</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Cameron AM (2017) Current surgical therapy. Ann Surg. https://doi.org/10.1097/sla.0000000000002518</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/sla.0000000000002518</ArticleId><ArticleId IdType="pubmed">28657938</ArticleId></ArticleIdList></Reference><Reference><Citation>Klinginsmith M, Jolley J, Lomelin D, Krause C, Heiden J, Oleynikov D (2016) Paraesophageal hernia repair in the emergency setting: is laparoscopy with the addition of a fundoplication the new gold standard? Surg Endosc. https://doi.org/10.1007/s00464-015-4447-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00464-015-4447-8</ArticleId><ArticleId IdType="pubmed">26194263</ArticleId></ArticleIdList></Reference><Reference><Citation>Sarkaria IS, Latif MJ, Bianco VJ et al (2017) Early operative outcomes and learning curve of robotic-assisted giant paraesophageal hernia repair. Int J Med Robot Comput Assist Surg. https://doi.org/10.1002/rcs.1730</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/rcs.1730</ArticleId></ArticleIdList></Reference><Reference><Citation>Tian W, Fei Y (2018) Application of Da Vinci robotic surgery to hernia repair. Zhonghua Wei Chang Wai Ke Za Zhi 21:740&#x2013;743</Citation><ArticleIdList><ArticleId IdType="pubmed">30051439</ArticleId></ArticleIdList></Reference><Reference><Citation>Seetharamaiah R, Romero RJ, Kosanovic R et al (2013) Robotic repair of giant paraesophageal hernias. J Soc Laparoendosc Surg. https://doi.org/10.4293/108680813X13654754534594</Citation><ArticleIdList><ArticleId IdType="doi">10.4293/108680813X13654754534594</ArticleId></ArticleIdList></Reference><Reference><Citation>Luca M, Simone G, Maria DM et al (2015) Robotic giant hiatal hernia repair: 3 year prospective evaluation and review of the literature. Int J Med Robot Comput Assist Surg. https://doi.org/10.1002/rcs.1595</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/rcs.1595</ArticleId></ArticleIdList></Reference><Reference><Citation>Tolboom RC, Broeders IAMJ, Draaisma WA (2015) Robot-assisted laparoscopic hiatal hernia and antireflux surgery. J Surg Oncol. https://doi.org/10.1002/jso.23912</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jso.23912</ArticleId><ArticleId IdType="pubmed">25997926</ArticleId></ArticleIdList></Reference><Reference><Citation>Tolboom RC, Draaisma WA, Broeders IAMJ (2016) Evaluation of conventional laparoscopic versus robot-assisted laparoscopic redo hiatal hernia and antireflux surgery: a cohort study. J Robot Surg. https://doi.org/10.1007/s11701-016-0558-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11701-016-0558-z</ArticleId><ArticleId IdType="pubmed">26809755</ArticleId><ArticleId IdType="pmc">4766202</ArticleId></ArticleIdList></Reference><Reference><Citation>Kohn GP, Price RR, Demeester SR et al (2013) Guidelines for the management of hiatal hernia. Surg Endosc. https://doi.org/10.1007/s00464-013-3173-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00464-013-3173-3</ArticleId><ArticleId IdType="pubmed">24018762</ArticleId></ArticleIdList></Reference><Reference><Citation>Heit JA, Spencer FA, White RH (2016) The epidemiology of venous thromboembolism. J Thromb Thrombolysis. https://doi.org/10.1007/s11239-015-1311-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11239-015-1311-6</ArticleId><ArticleId IdType="pubmed">26780736</ArticleId><ArticleId IdType="pmc">4715842</ArticleId></ArticleIdList></Reference><Reference><Citation>Charles M, Alexander CS (2010) Venous thromboembolism prevention: a systematic review of methods to improve prophylaxis and decrease events in the hospitalized patient. Hosp Pract (1995) 38:97&#x2013;108</Citation><ArticleIdList><ArticleId IdType="doi">10.3810/hp.2010.02.284</ArticleId></ArticleIdList></Reference><Reference><Citation>LaMori JC, Shoheiber O, Mody SH, Bookhart BK (2015) Inpatient resource use and cost burden of deep vein thrombosis and pulmonary embolism in the United States. Clin Ther. https://doi.org/10.1016/j.clinthera.2014.10.024</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clinthera.2014.10.024</ArticleId><ArticleId IdType="pubmed">25524389</ArticleId></ArticleIdList></Reference><Reference><Citation>Fernandez MM, Hogue S, Preblick R, Kwong WJ (2015) Review of the cost of venous thromboembolism. Clin Outcomes Res. https://doi.org/10.2147/CEOR.S85635</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/CEOR.S85635</ArticleId></ArticleIdList></Reference><Reference><Citation>Esmon CT (2009) Basic mechanisms and pathogenesis of venous thrombosis. Blood Rev. https://doi.org/10.1016/j.blre.2009.07.002</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.blre.2009.07.002</ArticleId><ArticleId IdType="pubmed">19683659</ArticleId><ArticleId IdType="pmc">2762278</ArticleId></ArticleIdList></Reference><Reference><Citation>Gould MK, Garcia DA, Wren SM et al (2012) Prevention of VTE in nonorthopedic surgical patients. Antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest. https://doi.org/10.1378/chest.11-2297</Citation><ArticleIdList><ArticleId IdType="doi">10.1378/chest.11-2297</ArticleId><ArticleId IdType="pubmed">22315268</ArticleId><ArticleId IdType="pmc">3590883</ArticleId></ArticleIdList></Reference><Reference><Citation>Inderbitzin DT, Opitz I, Giger U, Kocher T, Kr&#xe4;henb&#xfc;hl L (2007) Incidence of clinical pulmonary embolism after laparoscopic surgery. Br J Surg. https://doi.org/10.1002/bjs.5666</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/bjs.5666</ArticleId><ArticleId IdType="pubmed">17330858</ArticleId></ArticleIdList></Reference><Reference><Citation>Anderson DR, Morgano GP, Bennett C et al (2019) American Society of Hematology 2019 guidelines for management of venous thromboembolism: prevention of venous thromboembolism in surgical hospitalized patients. Blood Adv. https://doi.org/10.1182/bloodadvances.2019000975</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/bloodadvances.2019000975</ArticleId><ArticleId IdType="pubmed">31794602</ArticleId><ArticleId IdType="pmc">6963238</ArticleId></ArticleIdList></Reference><Reference><Citation>Kearon C, Akl EA, Comerota AJ et al (2012) Antithrombotic therapy for VTE disease: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest. https://doi.org/10.1378/chest.11-2301</Citation><ArticleIdList><ArticleId IdType="doi">10.1378/chest.11-2301</ArticleId><ArticleId IdType="pubmed">22315268</ArticleId><ArticleId IdType="pmc">3278049</ArticleId></ArticleIdList></Reference><Reference><Citation>Felder S, Rasmussen MS, King R et al (2019) Prolonged thromboprophylaxis with low molecular weight heparin for abdominal or pelvic surgery. Cochrane Database Syst Rev. https://doi.org/10.1002/14651858.CD004318.pub4</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/14651858.CD004318.pub4</ArticleId><ArticleId IdType="pubmed">31449321</ArticleId><ArticleId IdType="pmc">6709764</ArticleId></ArticleIdList></Reference><Reference><Citation>Tang SJ, Tran T, Memmesheimer C et al (2002) Paraesophageal hernia repair and deep vein thrombosis [1]. J Clin Gastroenterol. https://doi.org/10.1097/00004836-200202000-00017</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00004836-200202000-00017</ArticleId><ArticleId IdType="pubmed">11782617</ArticleId><ArticleId IdType="pmc">6736583</ArticleId></ArticleIdList></Reference><Reference><Citation>Davila DG, Stetler JL, Lin E, Davis SS, Yheulon CG (2019) Laparoscopic paraesophageal hernia repair and pulmonary embolism. Surg Laparosc Endosc Percutaneous Tech. https://doi.org/10.1097/SLE.0000000000000708</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/SLE.0000000000000708</ArticleId></ArticleIdList></Reference><Reference><Citation>Bahl V, Hu HM, Henke PK, Wakefield TW, Campbell DA, Caprini JA (2010) A validation study of a retrospective venous thromboembolism risk scoring method. Ann Surg. https://doi.org/10.1097/SLA.0b013e3181b7fca6</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/SLA.0b013e3181b7fca6</ArticleId><ArticleId IdType="pubmed">19779324</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">39994429</PMID><DateCompleted><Year>2025</Year><Month>05</Month><Day>09</Day></DateCompleted><DateRevised><Year>2025</Year><Month>05</Month><Day>09</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2045-2322</ISSN><JournalIssue CitedMedium="Internet"><Volume>15</Volume><Issue>1</Issue><PubDate><Year>2025</Year><Month>Feb</Month><Day>24</Day></PubDate></JournalIssue><Title>Scientific reports</Title><ISOAbbreviation>Sci Rep</ISOAbbreviation></Journal><ArticleTitle>Association of pan-immune inflammation value with mortality in patients with pulmonary embolism: a cohort study.</ArticleTitle><Pagination><StartPage>6571</StartPage><MedlinePgn>6571</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">6571</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41598-025-90951-y</ELocationID><Abstract><AbstractText>Pan-immune inflammation value (PIV) is associated with prognosis in immune and inflammatory diseases, and inflammation is a hallmark of pulmonary embolism (PE). Nonetheless, the link between PIV and prognosis in PE remains unclear. However, few studies have specifically focused on critically ill patients with PE in ICUs. This study retrospectively analyzed electronic health data of patients with PE from the Medical Information Mart for Intensive Care (MIMIC-IV) database. The primary outcome was 28-day ACM; secondary outcomes were 90-day, 1-year, ICU, and in-hospital mortality. The study population included 213 patients with PE. Multivariate Cox proportional hazards regression showed that elevated PIV was significantly associated with ACM at 28 days (adjusted hazard ratio [aHR]: 1.93; 95% confidence interval [CI]: 1.02-3.63) and 90 days (aHR: 1.96; 95% CI: 1.10-3.47). Further, multivariate logistic regression analysis showed that PIV was significantly and positively associated with the risk of ACM. Kaplan-Meier survival curves showed that PIV was positively associated with ACM. Subgroup and interaction analyses corroborated this correlation. PIV was significantly correlated with ACM in critically ill ICU patients with PE. This correlation highlights the potential utility of PIV for stratifying patients with PE according to their risk of death.</AbstractText><CopyrightInformation>&#xa9; 2025. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Zhao</LastName><ForeName>Weihong</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Department of Emergency and Critical Care Centre, Sichuan Science City Hospital, Mianyang, Sichuan Province, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liao</LastName><ForeName>Qunfen</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>Department of Emergency and Critical Care Centre, Sichuan Science City Hospital, Mianyang, Sichuan Province, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Feng</LastName><ForeName>Yanxiu</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Emergency and Critical Care Centre, Sichuan Science City Hospital, Mianyang, Sichuan Province, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Du</LastName><ForeName>Fuhua</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Emergency and Critical Care Centre, Sichuan Science City Hospital, Mianyang, Sichuan Province, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liang</LastName><ForeName>Zhengkai</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Department of Emergency and Critical Care Centre, Sichuan Science City Hospital, Mianyang, Sichuan Province, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Xi</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Emergency and Critical Care Centre, Sichuan Science City Hospital, Mianyang, Sichuan Province, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liao</LastName><ForeName>Xiufen</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Emergency and Critical Care Centre, Sichuan Science City Hospital, Mianyang, Sichuan Province, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gu</LastName><ForeName>Yang</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Emergency and Critical Care Centre, Sichuan Science City Hospital, Mianyang, Sichuan Province, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Ma</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Emergency and Critical Care Centre, Sichuan Science City Hospital, Mianyang, Sichuan Province, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Yingdong</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Emergency and Critical Care Centre, Sichuan Science City Hospital, Mianyang, Sichuan Province, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Xin</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Emergency and Critical Care Centre, Sichuan Science City Hospital, Mianyang, Sichuan Province, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xu</LastName><ForeName>Feng</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Emergency Surgery, The First Affiliated Hospital of Soochow University, Suzhou, Jiangsu Province, China. best_zwh@163.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>02</Month><Day>24</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Sci Rep</MedlineTA><NlmUniqueID>101563288</NlmUniqueID><ISSNLinking>2045-2322</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011655" MajorTopicYN="Y">Pulmonary Embolism</DescriptorName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007249" MajorTopicYN="Y">Inflammation</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011379" MajorTopicYN="N">Prognosis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017052" MajorTopicYN="N">Hospital Mortality</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007362" MajorTopicYN="N">Intensive Care Units</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016638" MajorTopicYN="N">Critical Illness</DescriptorName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D053208" MajorTopicYN="N">Kaplan-Meier Estimate</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016016" MajorTopicYN="N">Proportional Hazards Models</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Cohort studies</Keyword><Keyword MajorTopicYN="N">Mortality</Keyword><Keyword MajorTopicYN="N">Pan-immune inflammation value</Keyword><Keyword MajorTopicYN="N">Pulmonary embolism</Keyword></KeywordList><CoiStatement>Declarations. Competing interests: The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>7</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2025</Year><Month>2</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>2</Month><Day>25</Day><Hour>0</Hour><Minute>23</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>2</Month><Day>25</Day><Hour>0</Hour><Minute>22</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>2</Month><Day>24</Day><Hour>23</Hour><Minute>35</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2025</Year><Month>2</Month><Day>24</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39994429</ArticleId><ArticleId IdType="pmc">PMC11850865</ArticleId><ArticleId IdType="doi">10.1038/s41598-025-90951-y</ArticleId><ArticleId IdType="pii">10.1038/s41598-025-90951-y</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Freund, Y., Cohen-Aubart, F. &amp; Bloom, B. Acute pulmonary embolism: A review. JAMA328, 1336. 10.1001/jama.2022.16815 (2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">36194215</ArticleId></ArticleIdList></Reference><Reference><Citation>Fleitas Sosa, D. et al. Impact of pulmonary embolism response teams on acute pulmonary embolism: A systematic review and meta-analysis. Eur. Respir Rev.31, 220023. 10.1183/16000617.0023-2022 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9724819</ArticleId><ArticleId IdType="pubmed">35831010</ArticleId></ArticleIdList></Reference><Reference><Citation>Konstantinides, S. V. et al. 2019 ESC guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European respiratory society (ERS). Eur. Heart J.41, 543&#x2013;603. 10.1093/eurheartj/ehz405 (2020).</Citation><ArticleIdList><ArticleId IdType="pubmed">31504429</ArticleId></ArticleIdList></Reference><Reference><Citation>Lehnert, P. et al. Acute pulmonary embolism in a National Danish cohort: increasing incidence and decreasing mortality. Thromb. Haemost. 118, 539&#x2013;546. 10.1160/TH17-08-0531 (2018).</Citation><ArticleIdList><ArticleId IdType="pubmed">29536465</ArticleId></ArticleIdList></Reference><Reference><Citation>G&#xf6;tzinger, F. et al. Interventional therapies for pulmonary embolism. Nat. Rev. Cardiol.20, 670&#x2013;684. 10.1038/s41569-023-00876-0 (2023).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10180624</ArticleId><ArticleId IdType="pubmed">37173409</ArticleId></ArticleIdList></Reference><Reference><Citation>Smulders, Y. Pathophysiology and treatment of haemodynamic instability in acute pulmonary embolism: the pivotal role of pulmonary vasoconstriction. Cardiovasc. Res.48, 23&#x2013;33. 10.1016/S0008-6363(00)00168-1 (2000).</Citation><ArticleIdList><ArticleId IdType="pubmed">11033105</ArticleId></ArticleIdList></Reference><Reference><Citation>Sharp, A. &amp; Mahfoud, F. Contemporary outcomes in patients hospitalized with pulmonary embolism: what can we learn from observational data? Eur. Heart J.45, 1999&#x2013;2001. 10.1093/eurheartj/ehae263 (2024).</Citation><ArticleIdList><ArticleId IdType="pubmed">38805685</ArticleId></ArticleIdList></Reference><Reference><Citation>Jim&#xe9;nez, D. et al. Revised paradigm for acute pulmonary embolism prognostication and treatment. Am. J. Respir Crit. Care Med.208, 524&#x2013;527. 10.1164/rccm.202212-2234VP (2023).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10492237</ArticleId><ArticleId IdType="pubmed">37450886</ArticleId></ArticleIdList></Reference><Reference><Citation>Berge, K. H. et al. Resource utilization and outcome in gravely ill intensive care unit patients with predicted in-hospital mortality rates of 95% or higher by APACHE III scores: the relationship with physician and family expectations. Mayo Clin. Proc.80, 166&#x2013;173. 10.4065/80.2.166 (2005).</Citation><ArticleIdList><ArticleId IdType="pubmed">15704770</ArticleId></ArticleIdList></Reference><Reference><Citation>Siddiqui, F. et al. The prognostic value of blood cellular indices in pulmonary embolism. Am. J. Hematol.134 ajh.27379 (2024).</Citation><ArticleIdList><ArticleId IdType="pubmed">38816957</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu, B. et al. The relationship between the pan-immune-inflammation value and long-term prognoses in patients with hypertension: National health and nutrition examination study, 1999&#x2013;2018. Front. Cardiovasc. Med.10, 1099427. 10.3389/fcvm.2023.1099427 (2023).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10017977</ArticleId><ArticleId IdType="pubmed">36937901</ArticleId></ArticleIdList></Reference><Reference><Citation>Li, F. et al. Association of immune inflammatory biomarkers with pathological complete response and clinical prognosis in young breast cancer patients undergoing neoadjuvant chemotherapy. Front. Oncol.14, 1349021. 10.3389/fonc.2024.1349021 (2024).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10877026</ArticleId><ArticleId IdType="pubmed">38380360</ArticleId></ArticleIdList></Reference><Reference><Citation>Ayaz, &#xc7;. M. et al. Can the pan-immune-inflammation value predict gram negative bloodstream infection-related 30-day mortality in solid organ transplant patients? BMC Infect. Dis.24, 526. 10.1186/s12879-024-09413-x (2024).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11127423</ArticleId><ArticleId IdType="pubmed">38789916</ArticleId></ArticleIdList></Reference><Reference><Citation>Su, Z. et al. Pan&#x2013;immune&#x2013;inflammation value as a novel prognostic biomarker in nasopharyngeal carcinoma. Oncol. Lett.27, 252. 10.3892/ol.2024.14385 (2024).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11027095</ArticleId><ArticleId IdType="pubmed">38646495</ArticleId></ArticleIdList></Reference><Reference><Citation>Bayramo&#x11f;lu, A. &amp; Hidayet, &#x15e;. Association between pan-immune-inflammation value and no-reflow in patients with ST elevation myocardial infarction undergoing percutaneous coronary intervention. Scand. J. Clin. Lab. Invest.83, 384&#x2013;389. 10.1080/00365513.2023.2241131 (2023).</Citation><ArticleIdList><ArticleId IdType="pubmed">37498164</ArticleId></ArticleIdList></Reference><Reference><Citation>&#xd3;i&#xe7;ek, V. et al. Evaluation of pan-immuno-inflammation value for in-hospital mortality in acute pulmonary embolism patients. Rev. Investig Clinica. 76, 13487. (2024).</Citation><ArticleIdList><ArticleId IdType="pubmed">38359843</ArticleId></ArticleIdList></Reference><Reference><Citation>Bilgin, M., Akkaya, E. &amp; Dokuyucu, R. Inflammatory and metabolic predictors of mortality in pulmonary thromboembolism: A focus on the triglyceride-glucose index and pan-immune inflammation value. J. Clin. Med.13, 6008. 10.3390/jcm13196008 (2024).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11477710</ArticleId><ArticleId IdType="pubmed">39408068</ArticleId></ArticleIdList></Reference><Reference><Citation>Johnson, A. E. W. et al. MIMIC-IV, a freely accessible electronic health record dataset. Sci. Data. 10, 1. 10.1038/s41597-022-01899-x (2023).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9810617</ArticleId><ArticleId IdType="pubmed">36596836</ArticleId></ArticleIdList></Reference><Reference><Citation>Roy, P-M. et al. Triaging acute pulmonary embolism for home treatment by Hestia or simplified PESI criteria: the HOME-PE randomized trial. Eur. Heart J.42, 3146&#x2013;3157. 10.1093/eurheartj/ehab373 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8408662</ArticleId><ArticleId IdType="pubmed">34363386</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen, Y. et al. Pan-immune-inflammation and its dynamics: predictors of survival and immune-related adverse events in patients with advanced NSCLC receiving immunotherapy. BMC Cancer. 23, 944. 10.1186/s12885-023-11366-4 (2023).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10557237</ArticleId><ArticleId IdType="pubmed">37803437</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiao, J. et al. Association between red cell distribution width and all-cause mortality in patients with breast cancer: A retrospective analysis using MIMIC-IV 2.0. PLoS One. 19, e0302414. 10.1371/journal.pone.0302414 (2024).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11095716</ArticleId><ArticleId IdType="pubmed">38748743</ArticleId></ArticleIdList></Reference><Reference><Citation>Jaddoe, V. W. V. et al. First trimester fetal growth restriction and cardiovascular risk factors in school age children: population based cohort study. BMJ348, g14. 10.1136/bmj.g14 (2014).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3901421</ArticleId><ArticleId IdType="pubmed">24458585</ArticleId></ArticleIdList></Reference><Reference><Citation>Sasmita, B. R., Wang, C. &amp; Xie, S. Vasopressors and Inotropes in cardiogenic shock patients: an analysis of the MIMIC-IV database. Front. Cardiovasc. Med.10, 1300839. 10.3389/fcvm.2023.1300839 (2023).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10716269</ArticleId><ArticleId IdType="pubmed">38094120</ArticleId></ArticleIdList></Reference><Reference><Citation>Kernan, W. N. et al. Phenylpropanolamine and the risk of hemorrhagic stroke. N Engl. J. Med.343, 1826&#x2013;1832. 10.1056/NEJM200012213432501 (2000).</Citation><ArticleIdList><ArticleId IdType="pubmed">11117973</ArticleId></ArticleIdList></Reference><Reference><Citation>Agoritsas, T. et al. Adjusted analyses in studies addressing therapy and harm: users&#x2019; guides to the medical literature. JAMA317, 748&#x2013;759. 10.1001/jama.2016.20029 (2017).</Citation><ArticleIdList><ArticleId IdType="pubmed">28241362</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuang, T. et al. Pan-immune inflammation value as a prognostic biomarker for cancer patients treated with immune checkpoint inhibitors. Front. Immunol.15, 1326083. 10.3389/fimmu.2024.1326083 (2024).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10895004</ArticleId><ArticleId IdType="pubmed">38410508</ArticleId></ArticleIdList></Reference><Reference><Citation>Fuc&#xe0;, G. et al. The pan-immune-inflammation value is a new prognostic biomarker in metastatic colorectal cancer: results from a pooled-analysis of the Valentino and TRIBE first-line trials. Br. J. Cancer. 123, 403&#x2013;409. 10.1038/s41416-020-0894-7 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7403416</ArticleId><ArticleId IdType="pubmed">32424148</ArticleId></ArticleIdList></Reference><Reference><Citation>Jin, C. et al. Associations between pan-immune-inflammation value and abdominal aortic calcification: A cross-sectional study. Front. Immunol.15, 1370516. 10.3389/fimmu.2024.1370516 (2024).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11007162</ArticleId><ArticleId IdType="pubmed">38605946</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang, Y-W. et al. Association between a four-parameter inflammatory index and all-cause mortality in critical ill patients with non-traumatic subarachnoid hemorrhage: A retrospective analysis of the MIMIC-IV database (2012&#x2013;2019). Front. Immunol.14, 1235266. 10.3389/fimmu.2023.1235266 (2023).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10626529</ArticleId><ArticleId IdType="pubmed">37936706</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">21057995</PMID><DateCompleted><Year>2011</Year><Month>07</Month><Day>01</Day></DateCompleted><DateRevised><Year>2022</Year><Month>03</Month><Day>21</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1433-2965</ISSN><JournalIssue CitedMedium="Internet"><Volume>21</Volume><Issue>Suppl 4</Issue><PubDate><Year>2010</Year><Month>Dec</Month></PubDate></JournalIssue><Title>Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA</Title><ISOAbbreviation>Osteoporos Int</ISOAbbreviation></Journal><ArticleTitle>Neuroaxial versus general anaesthesia in geriatric patients for hip fracture surgery: does it matter?</ArticleTitle><Pagination><StartPage>S555</StartPage><EndPage>S572</EndPage><MedlinePgn>S555-72</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s00198-010-1399-7</ELocationID><Abstract><AbstractText>The influence of the mode of anaesthesia on outcome of geriatric patients with hip fractures is a controversial issue in the medical literature. In the light of an ageing society, a conclusive answer to this question is of growing importance. The purpose of this review was to assess the effect of neuroaxial and general anaesthesia on mortality and morbidity in geriatric patients sustaining a hip fracture. Following a current literature search within the Pubmed and Cochrane database (1967-2010), 34 randomised controlled trials, 14 observational studies and eight reviews/meta-analysis publications were included. Potentially outcome-influencing factors such as mortality, deep vein thrombosis, pulmonary embolism, postoperative confusion and other anaesthesia-related outcomes were evaluated. After analysing the current literature with 56 references, covering 18,715 patients with hip fracture, it can be concluded that spinal anaesthesia is associated with significantly reduced early mortality, fewer incidents of deep vein thrombosis, less acute postoperative confusion, a tendency to fewer myocardial infarctions, fewer cases of pneumonia, fatal pulmonary embolism and postoperative hypoxia. General anaesthesia has the advantages of having a lower incidence of hypotension and a tendency towards fewer cerebrovascular accidents compared to neuroaxial anaesthesia. Otherwise, general anaesthesia and respiratory diseases were significant predictors of morbidity in hip fracture patients. These data suggest that regional anaesthesia is the preferred technique, but the limited evidence available does not permit a definitive conclusion to be drawn for mortality or other outcomes. For hip fracture surgery, the choice of anaesthesia (general or neuroaxial) is made by the anaesthesiologist and is based on the patient's preference, comorbidities, potential general postoperative complications and the clinical experience of the anaesthesiologist. The overall therapeutic approach in hip fracture care should be determined jointly by the orthopaedic surgeon, the geriatrician and the anaesthesiologist (multidisciplinary approach).</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Luger</LastName><ForeName>T J</ForeName><Initials>TJ</Initials><AffiliationInfo><Affiliation>Department of Anaesthesiology and Critical Care Medicine, Innsbruck Medical University, Innsbruck, Austria. thomas.luger@i-med.ac.at</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kammerlander</LastName><ForeName>C</ForeName><Initials>C</Initials></Author><Author ValidYN="Y"><LastName>Gosch</LastName><ForeName>M</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Luger</LastName><ForeName>M F</ForeName><Initials>MF</Initials></Author><Author ValidYN="Y"><LastName>Kammerlander-Knauer</LastName><ForeName>U</ForeName><Initials>U</Initials></Author><Author ValidYN="Y"><LastName>Roth</LastName><ForeName>T</ForeName><Initials>T</Initials></Author><Author ValidYN="Y"><LastName>Kreutziger</LastName><ForeName>J</ForeName><Initials>J</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D003160">Comparative Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2010</Year><Month>11</Month><Day>06</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Osteoporos Int</MedlineTA><NlmUniqueID>9100105</NlmUniqueID><ISSNLinking>0937-941X</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000765" MajorTopicYN="N">Anesthesia, Conduction</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000768" MajorTopicYN="N">Anesthesia, General</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005592" MajorTopicYN="N">Fracture Fixation</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006620" MajorTopicYN="N">Hip Fractures</DescriptorName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058866" MajorTopicYN="N">Osteoporotic Fractures</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2010</Year><Month>8</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2010</Year><Month>8</Month><Day>31</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2010</Year><Month>11</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2010</Year><Month>11</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2011</Year><Month>7</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">21057995</ArticleId><ArticleId IdType="doi">10.1007/s00198-010-1399-7</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Reg Anesth Pain Med. 2010 Jan-Feb;35(1):64-101</Citation><ArticleIdList><ArticleId IdType="pubmed">20052816</ArticleId></ArticleIdList></Reference><Reference><Citation>Orthopedics. 1997 Feb;20(2):109-15</Citation><ArticleIdList><ArticleId IdType="pubmed">9048387</ArticleId></ArticleIdList></Reference><Reference><Citation>J Am Geriatr Soc. 1988 Jun;36(6):525-30</Citation><ArticleIdList><ArticleId IdType="pubmed">2897391</ArticleId></ArticleIdList></Reference><Reference><Citation>Anaesthesia. 1980 Nov;35(11):1107-10</Citation><ArticleIdList><ArticleId IdType="pubmed">7446914</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Anesth. 2005 Sep;17(6):431-8</Citation><ArticleIdList><ArticleId IdType="pubmed">16171663</ArticleId></ArticleIdList></Reference><Reference><Citation>Anesth Analg. 2006 May;102(5):1559-63</Citation><ArticleIdList><ArticleId IdType="pubmed">16632842</ArticleId></ArticleIdList></Reference><Reference><Citation>Anesth Analg. 1999 Apr;88(4):822-6</Citation><ArticleIdList><ArticleId IdType="pubmed">10195531</ArticleId></ArticleIdList></Reference><Reference><Citation>Anaesthesia. 2010 Mar;65(3):243-8</Citation><ArticleIdList><ArticleId IdType="pubmed">20039864</ArticleId></ArticleIdList></Reference><Reference><Citation>Acta Anaesthesiol Scand. 1991 Aug;35(6):548-52</Citation><ArticleIdList><ArticleId IdType="pubmed">1897353</ArticleId></ArticleIdList></Reference><Reference><Citation>Masui. 1995 Nov;44(11):1489-97</Citation><ArticleIdList><ArticleId IdType="pubmed">8544286</ArticleId></ArticleIdList></Reference><Reference><Citation>J Am Geriatr Soc. 2005 Oct;53(10):1658-66</Citation><ArticleIdList><ArticleId IdType="pubmed">16181163</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Orthop Relat Res. 1998 Mar;(348):37-41</Citation><ArticleIdList><ArticleId IdType="pubmed">9553531</ArticleId></ArticleIdList></Reference><Reference><Citation>Br J Anaesth. 1985 Sep;57(9):853-7</Citation><ArticleIdList><ArticleId IdType="pubmed">4027101</ArticleId></ArticleIdList></Reference><Reference><Citation>Anaesthesia. 1985 Jul;40(7):672-6</Citation><ArticleIdList><ArticleId IdType="pubmed">4025772</ArticleId></ArticleIdList></Reference><Reference><Citation>Anaesth Intensive Care. 1994 Apr;22(2):150-4</Citation><ArticleIdList><ArticleId IdType="pubmed">8210017</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Anesth. 2006 Mar;18(2):124-8</Citation><ArticleIdList><ArticleId IdType="pubmed">16563330</ArticleId></ArticleIdList></Reference><Reference><Citation>JAMA. 2004 Apr 14;291(14):1738-43</Citation><ArticleIdList><ArticleId IdType="pubmed">15082701</ArticleId></ArticleIdList></Reference><Reference><Citation>Reg Anesth Pain Med. 2005 Sep-Oct;30(5):452-7</Citation><ArticleIdList><ArticleId IdType="pubmed">16135349</ArticleId></ArticleIdList></Reference><Reference><Citation>Anasth Intensivther Notfallmed. 1990 Aug;25(4):263-70</Citation><ArticleIdList><ArticleId IdType="pubmed">2171375</ArticleId></ArticleIdList></Reference><Reference><Citation>Can J Anaesth. 2008 Mar;55(3):146-54</Citation><ArticleIdList><ArticleId IdType="pubmed">18310624</ArticleId></ArticleIdList></Reference><Reference><Citation>Rev Esp Anestesiol Reanim. 2001 Mar;48(3):113-6</Citation><ArticleIdList><ArticleId IdType="pubmed">11333794</ArticleId></ArticleIdList></Reference><Reference><Citation>Scott Med J. 1999 Oct;44(5):152-4</Citation><ArticleIdList><ArticleId IdType="pubmed">10629913</ArticleId></ArticleIdList></Reference><Reference><Citation>Orthopade. 1994 Feb;23(1):16-20</Citation><ArticleIdList><ArticleId IdType="pubmed">8134092</ArticleId></ArticleIdList></Reference><Reference><Citation>Masui. 2003 Sep;52(9):972-5</Citation><ArticleIdList><ArticleId IdType="pubmed">14531256</ArticleId></ArticleIdList></Reference><Reference><Citation>Anaesthesist. 1990 Feb;39(2):83-7</Citation><ArticleIdList><ArticleId IdType="pubmed">2310007</ArticleId></ArticleIdList></Reference><Reference><Citation>Anesthesiology. 2000 Apr;92(4):947-57</Citation><ArticleIdList><ArticleId IdType="pubmed">10754613</ArticleId></ArticleIdList></Reference><Reference><Citation>Control Clin Trials. 1996 Feb;17(1):1-12</Citation><ArticleIdList><ArticleId IdType="pubmed">8721797</ArticleId></ArticleIdList></Reference><Reference><Citation>N Engl J Med. 1999 Mar 4;340(9):669-76</Citation><ArticleIdList><ArticleId IdType="pubmed">10053175</ArticleId></ArticleIdList></Reference><Reference><Citation>J Orthop Trauma. 2009 Jul;23(6):386-94</Citation><ArticleIdList><ArticleId IdType="pubmed">19550223</ArticleId></ArticleIdList></Reference><Reference><Citation>Minerva Anestesiol. 1998 Jan-Feb;64(1-2):13-9</Citation><ArticleIdList><ArticleId IdType="pubmed">9658786</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Orthop (Belle Mead NJ). 2000 Jan;29(1):25-35</Citation><ArticleIdList><ArticleId IdType="pubmed">10647516</ArticleId></ArticleIdList></Reference><Reference><Citation>Br J Anaesth. 1987 Sep;59(9):1080-8</Citation><ArticleIdList><ArticleId IdType="pubmed">3311100</ArticleId></ArticleIdList></Reference><Reference><Citation>Anesth Analg. 1999 Jul;89(1):111-6</Citation><ArticleIdList><ArticleId IdType="pubmed">10389787</ArticleId></ArticleIdList></Reference><Reference><Citation>J Am Geriatr Soc. 1992 Jan;40(1):8-11</Citation><ArticleIdList><ArticleId IdType="pubmed">1727853</ArticleId></ArticleIdList></Reference><Reference><Citation>Anaesth Intensive Care. 1981 Nov;9(4):352-8</Citation><ArticleIdList><ArticleId IdType="pubmed">6797318</ArticleId></ArticleIdList></Reference><Reference><Citation>Anesth Analg. 2002 Jan;94(1):215-20, table of contents</Citation><ArticleIdList><ArticleId IdType="pubmed">11772832</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Fr Anesth Reanim. 1986;5(1):24-30</Citation><ArticleIdList><ArticleId IdType="pubmed">3706840</ArticleId></ArticleIdList></Reference><Reference><Citation>BMJ. 2006 Jul 1;333(7557):27-30</Citation><ArticleIdList><ArticleId IdType="pubmed">16809710</ArticleId></ArticleIdList></Reference><Reference><Citation>CMAJ. 2002 Oct 1;167(7):753-9</Citation><ArticleIdList><ArticleId IdType="pubmed">12389836</ArticleId></ArticleIdList></Reference><Reference><Citation>Anesthesiology. 1992 Dec;77(6):1095-104</Citation><ArticleIdList><ArticleId IdType="pubmed">1466461</ArticleId></ArticleIdList></Reference><Reference><Citation>Br J Anaesth. 2009 Sep;103(3):335-45</Citation><ArticleIdList><ArticleId IdType="pubmed">19628483</ArticleId></ArticleIdList></Reference><Reference><Citation>Acta Anaesthesiol Scand. 1986 Apr;30(3):247-52</Citation><ArticleIdList><ArticleId IdType="pubmed">3739582</ArticleId></ArticleIdList></Reference><Reference><Citation>J Bone Joint Surg Br. 2006 Aug;88(8):1060-4</Citation><ArticleIdList><ArticleId IdType="pubmed">16877606</ArticleId></ArticleIdList></Reference><Reference><Citation>J Am Geriatr Soc. 2008 Jul;56(7):1349-56</Citation><ArticleIdList><ArticleId IdType="pubmed">18503520</ArticleId></ArticleIdList></Reference><Reference><Citation>Anaesthesist. 1999 Jun;48(6):379-86</Citation><ArticleIdList><ArticleId IdType="pubmed">10421921</ArticleId></ArticleIdList></Reference><Reference><Citation>Cochrane Database Syst Rev. 2004 Oct 18;(4):CD000521</Citation><ArticleIdList><ArticleId IdType="pubmed">15494999</ArticleId></ArticleIdList></Reference><Reference><Citation>J Med Assoc Thai. 2002 Sep;85 Suppl 3:S875-83</Citation><ArticleIdList><ArticleId IdType="pubmed">12452224</ArticleId></ArticleIdList></Reference><Reference><Citation>Anesthesiology. 1990 Dec;73(6):1103-9</Citation><ArticleIdList><ArticleId IdType="pubmed">2248389</ArticleId></ArticleIdList></Reference><Reference><Citation>Anaesthesist. 2003 Jul;52(7):596-605</Citation><ArticleIdList><ArticleId IdType="pubmed">12898044</ArticleId></ArticleIdList></Reference><Reference><Citation>Eur J Anaesthesiol. 1998 Nov;15(6):656-63</Citation><ArticleIdList><ArticleId IdType="pubmed">9884850</ArticleId></ArticleIdList></Reference><Reference><Citation>BMJ. 1990 Jun 30;300(6741):1683-7</Citation><ArticleIdList><ArticleId IdType="pubmed">2390547</ArticleId></ArticleIdList></Reference><Reference><Citation>N Engl J Med. 1996 Jun 6;334(23):1519-25</Citation><ArticleIdList><ArticleId IdType="pubmed">8618608</ArticleId></ArticleIdList></Reference><Reference><Citation>BMJ. 2000 Dec 16;321(7275):1493</Citation><ArticleIdList><ArticleId IdType="pubmed">11118174</ArticleId></ArticleIdList></Reference><Reference><Citation>Br Med J. 1980 Dec 6;281(6254):1528-9</Citation><ArticleIdList><ArticleId IdType="pubmed">7437865</ArticleId></ArticleIdList></Reference><Reference><Citation>Anaesthesia. 2001 Dec;56(12):1189-93</Citation><ArticleIdList><ArticleId IdType="pubmed">11736778</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Fr Anesth Reanim. 1988;7(4):305-8</Citation><ArticleIdList><ArticleId IdType="pubmed">3202339</ArticleId></ArticleIdList></Reference><Reference><Citation>Can J Anaesth. 2006 Jul;53(7):669-77</Citation><ArticleIdList><ArticleId IdType="pubmed">16803914</ArticleId></ArticleIdList></Reference><Reference><Citation>Br J Anaesth. 1980 Jan;52(1):49-54</Citation><ArticleIdList><ArticleId IdType="pubmed">6769450</ArticleId></ArticleIdList></Reference><Reference><Citation>Unfallchirurgie. 1981;7(3):138-41</Citation><ArticleIdList><ArticleId IdType="pubmed">7256979</ArticleId></ArticleIdList></Reference><Reference><Citation>Acta Anaesthesiol Scand. 2003 Mar;47(3):260-6</Citation><ArticleIdList><ArticleId IdType="pubmed">12648190</ArticleId></ArticleIdList></Reference><Reference><Citation>Br J Anaesth. 1984 Jun;56(6):581-5</Citation><ArticleIdList><ArticleId IdType="pubmed">6721969</ArticleId></ArticleIdList></Reference><Reference><Citation>Anesth Analg (Paris). 1977 Sep-Oct;34(5):987-97</Citation><ArticleIdList><ArticleId IdType="pubmed">613869</ArticleId></ArticleIdList></Reference><Reference><Citation>Int Anesthesiol Clin. 2002 Winter;40(1):61-71</Citation><ArticleIdList><ArticleId IdType="pubmed">11910250</ArticleId></ArticleIdList></Reference><Reference><Citation>Curr Opin Anaesthesiol. 2008 Dec;21(6):729-35</Citation><ArticleIdList><ArticleId IdType="pubmed">19009689</ArticleId></ArticleIdList></Reference><Reference><Citation>Can J Anaesth. 1989 May;36(3 Pt 1):311-9</Citation><ArticleIdList><ArticleId IdType="pubmed">2655951</ArticleId></ArticleIdList></Reference><Reference><Citation>Br J Anaesth. 2005 Jan;94(1):24-9</Citation><ArticleIdList><ArticleId IdType="pubmed">15516350</ArticleId></ArticleIdList></Reference><Reference><Citation>Anesth Analg. 2004 Jun;98(6):1798-1802</Citation><ArticleIdList><ArticleId IdType="pubmed">15155351</ArticleId></ArticleIdList></Reference><Reference><Citation>Br J Anaesth. 2000 Apr;84(4):450-5</Citation><ArticleIdList><ArticleId IdType="pubmed">10823094</ArticleId></ArticleIdList></Reference><Reference><Citation>Anesth Analg. 1987 Jun;66(6):497-504</Citation><ArticleIdList><ArticleId IdType="pubmed">3578861</ArticleId></ArticleIdList></Reference><Reference><Citation>Eur J Anaesthesiol. 2008 May;25(5):418-23</Citation><ArticleIdList><ArticleId IdType="pubmed">18028577</ArticleId></ArticleIdList></Reference><Reference><Citation>Anaesthesia. 1994 Mar;49(3):237-40</Citation><ArticleIdList><ArticleId IdType="pubmed">8147519</ArticleId></ArticleIdList></Reference><Reference><Citation>Acta Anaesthesiol Scand. 1980 Aug;24(4):279-87</Citation><ArticleIdList><ArticleId IdType="pubmed">7468115</ArticleId></ArticleIdList></Reference><Reference><Citation>Br J Anaesth. 2002 Jul;89(1):3-16</Citation><ArticleIdList><ArticleId IdType="pubmed">12173238</ArticleId></ArticleIdList></Reference><Reference><Citation>Best Pract Res Clin Anaesthesiol. 2006 Jun;20(2):249-63</Citation><ArticleIdList><ArticleId IdType="pubmed">16850776</ArticleId></ArticleIdList></Reference><Reference><Citation>Anaesthesia. 1978 Jan;33(1):10-14</Citation><ArticleIdList><ArticleId IdType="pubmed">626331</ArticleId></ArticleIdList></Reference><Reference><Citation>Age Ageing. 1999 Mar;28(2):135-9</Citation><ArticleIdList><ArticleId IdType="pubmed">10350409</ArticleId></ArticleIdList></Reference><Reference><Citation>Orthop Clin North Am. 1974 Jul;5(3):493-508</Citation><ArticleIdList><ArticleId IdType="pubmed">4600223</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Anesth. 2003 Sep;15(6):433-40</Citation><ArticleIdList><ArticleId IdType="pubmed">14652120</ArticleId></ArticleIdList></Reference><Reference><Citation>Eur J Anaesthesiol. 2005 Jul;22(7):492-9</Citation><ArticleIdList><ArticleId IdType="pubmed">16045136</ArticleId></ArticleIdList></Reference><Reference><Citation>Br J Anaesth. 1986 Mar;58(3):284-91</Citation><ArticleIdList><ArticleId IdType="pubmed">3947489</ArticleId></ArticleIdList></Reference><Reference><Citation>Orthopedics. 2009 Apr;32(4):</Citation><ArticleIdList><ArticleId IdType="pubmed">19388614</ArticleId></ArticleIdList></Reference><Reference><Citation>BMJ. 2007 Dec 15;335(7632):1251-4</Citation><ArticleIdList><ArticleId IdType="pubmed">18056740</ArticleId></ArticleIdList></Reference><Reference><Citation>Anesth Analg. 1994 Apr;78(4):706-9</Citation><ArticleIdList><ArticleId IdType="pubmed">8135390</ArticleId></ArticleIdList></Reference><Reference><Citation>Chest. 2008 Jun;133(6 Suppl):381S-453S</Citation><ArticleIdList><ArticleId IdType="pubmed">18574271</ArticleId></ArticleIdList></Reference><Reference><Citation>Curr Opin Anaesthesiol. 2000 Oct;13(5):539-43</Citation><ArticleIdList><ArticleId IdType="pubmed">17016354</ArticleId></ArticleIdList></Reference><Reference><Citation>J Bone Joint Surg Am. 2008 Sep;90(9):1899-905</Citation><ArticleIdList><ArticleId IdType="pubmed">18762650</ArticleId></ArticleIdList></Reference><Reference><Citation>Eur J Anaesthesiol. 2003 Aug;20(8):640-6</Citation><ArticleIdList><ArticleId IdType="pubmed">12932066</ArticleId></ArticleIdList></Reference><Reference><Citation>Orthopedics. 1999 Jan;22(1):31-4</Citation><ArticleIdList><ArticleId IdType="pubmed">9925195</ArticleId></ArticleIdList></Reference><Reference><Citation>Injury. 2005 Nov;36(11):1355-60</Citation><ArticleIdList><ArticleId IdType="pubmed">16214478</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">24559222</PMID><DateCompleted><Year>2014</Year><Month>09</Month><Day>29</Day></DateCompleted><DateRevised><Year>2025</Year><Month>07</Month><Day>28</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1933-0693</ISSN><JournalIssue CitedMedium="Internet"><Volume>120</Volume><Issue>6</Issue><PubDate><Year>2014</Year><Month>Jun</Month></PubDate></JournalIssue><Title>Journal of neurosurgery</Title><ISOAbbreviation>J Neurosurg</ISOAbbreviation></Journal><ArticleTitle>Evolution of cranial epilepsy surgery complication rates: a 32-year systematic review and meta-analysis.</ArticleTitle><Pagination><StartPage>1415</StartPage><EndPage>1427</EndPage><MedlinePgn>1415-27</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.3171/2014.1.JNS131694</ELocationID><Abstract><AbstractText Label="OBJECT" NlmCategory="OBJECTIVE">Surgical interventions for medically refractory epilepsy are effective in selected patients, but they are underutilized. There remains a lack of pooled data on complication rates and their changes over a period of multiple decades. The authors performed a systematic review and meta-analysis of reported complications from intracranial epilepsy surgery from 1980 to 2012.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">A literature search was performed to find articles published between 1980 and 2012 that contained at least 2 patients. Patients were divided into 3 groups depending on the procedure they underwent: A) temporal lobectomy with or without amygdalohippocampectomy, B) extratemporal lobar or multilobar resections, or C) invasive electrode placement. Articles were divided into 2 time periods, 1980-1995 and 1996-2012.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Sixty-one articles with a total of 5623 patients met the study's eligibility criteria. Based on the 2 time periods, neurological deficits decreased dramatically from 41.8% to 5.2% in Group A and from 30.2% to 19.5% in Group B. Persistent neurological deficits in these 2 groups decreased from 9.7% to 0.8% and from 9.0% to 3.2%, respectively. Wound infections/meningitis decreased from 2.5% to 1.1% in Group A and from 5.3% to 1.9% in Group B. Persistent neurological deficits were uncommon in Group C, although wound infections/meningitis and hemorrhage/hematoma increased over time from 2.3% to 4.3% and from 1.9% to 4.2%, respectively. These complication rates are additive in patients undergoing implantation followed by resection.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Complication rates have decreased dramatically over the last 30 years, particularly for temporal lobectomy, but they remain an unavoidable consequence of epilepsy surgery. Permanent neurological deficits are rare following epilepsy surgery compared with the long-term risks of intractable epilepsy.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Tebo</LastName><ForeName>Collin C</ForeName><Initials>CC</Initials><AffiliationInfo><Affiliation>Department of Neurological Surgery, Weill Cornell Medical College, Cornell University, NewYork-Presbyterian Hospital; and.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Evins</LastName><ForeName>Alexander I</ForeName><Initials>AI</Initials></Author><Author ValidYN="Y"><LastName>Christos</LastName><ForeName>Paul J</ForeName><Initials>PJ</Initials></Author><Author ValidYN="Y"><LastName>Kwon</LastName><ForeName>Jennifer</ForeName><Initials>J</Initials></Author><Author ValidYN="Y"><LastName>Schwartz</LastName><ForeName>Theodore H</ForeName><Initials>TH</Initials></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>2UL1TR000457-06</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2014</Year><Month>02</Month><Day>21</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Neurosurg</MedlineTA><NlmUniqueID>0253357</NlmUniqueID><ISSNLinking>0022-3085</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>J Neurosurg. 2015 Feb;122(2):475-7. doi: 10.3171/2014.7.JNS141680.</RefSource><PMID Version="1">25526269</PMID></CommentsCorrections><CommentsCorrections RefType="CommentIn"><RefSource>J Neurosurg. 2015 Feb;122(2):477-8.</RefSource><PMID Version="1">25763433</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D038481" MajorTopicYN="N">Anterior Temporal Lobectomy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003399" MajorTopicYN="Y">Craniotomy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004567" MajorTopicYN="N">Electrodes, Implanted</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004827" MajorTopicYN="N">Epilepsy</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006624" MajorTopicYN="N">Hippocampus</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019635" MajorTopicYN="Y">Neurosurgical Procedures</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015995" MajorTopicYN="N">Prevalence</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">AED = antiepileptic drug</Keyword><Keyword MajorTopicYN="N">CVA = cerebral vascular accident</Keyword><Keyword MajorTopicYN="N">DVT = deep vein thrombosis</Keyword><Keyword MajorTopicYN="N">PE = pulmonary embolism</Keyword><Keyword MajorTopicYN="N">complication</Keyword><Keyword MajorTopicYN="N">epilepsy surgery</Keyword><Keyword MajorTopicYN="N">meta-analysis</Keyword><Keyword MajorTopicYN="N">morbidity</Keyword><Keyword MajorTopicYN="N">neurological deficits</Keyword><Keyword MajorTopicYN="N">review</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2014</Year><Month>2</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2014</Year><Month>2</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2014</Year><Month>9</Month><Day>30</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">24559222</ArticleId><ArticleId IdType="doi">10.3171/2014.1.JNS131694</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">28807470</PMID><DateCompleted><Year>2018</Year><Month>06</Month><Day>12</Day></DateCompleted><DateRevised><Year>2018</Year><Month>07</Month><Day>02</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1532-8406</ISSN><JournalIssue CitedMedium="Internet"><Volume>32</Volume><Issue>12</Issue><PubDate><Year>2017</Year><Month>Dec</Month></PubDate></JournalIssue><Title>The Journal of arthroplasty</Title><ISOAbbreviation>J Arthroplasty</ISOAbbreviation></Journal><ArticleTitle>Persistent Pulmonary Embolism Rates Following Total Knee Arthroplasty Even With Prophylactic Anticoagulants.</ArticleTitle><Pagination><StartPage>3833</StartPage><EndPage>3839</EndPage><MedlinePgn>3833-3839</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.arth.2017.06.041</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0883-5403(17)30570-3</ELocationID><Abstract><AbstractText Label="BACKGROUND">Symptomatic pulmonary embolism (PE), a significant and life-threatening complication following total knee arthroplasty (TKA), has been described as a "never event." Despite a number of advancements in care, PE continues to occur following TKA. This study evaluates symptomatic PE rates over time in TKA patients enrolled in multicenter randomized clinical trials assessing the efficacy of venous thromboembolism prophylaxis regimens.</AbstractText><AbstractText Label="METHODS">The MEDLINE and Cochrane Central Register of Controlled Trials were searched to identify clinical trials assessing prophylactic anticoagulation in patients undergoing TKA between January 1995 and December 2016. A random effect model was used to combine PE rates across studies. The pooled proportion of symptomatic PEs was calculated and heterogeneity was quantified with the I<sup>2</sup> statistic. A 95% prediction interval was constructed to examine what the expected range in the proportion of symptomatic PEs would be in future studies. Meta-regression was used to explore the effect of time on the rate of symptomatic PEs.</AbstractText><AbstractText Label="RESULTS">A total of 18 studies representing 27,073 patients were included in the meta-analysis. The symptomatic PE rate was 0.37% (95% confidence interval, 0.24%-0.52%). There was significant heterogeneity across studies, I<sup>2</sup>&#xa0;= 66%. Between 1996 and 2010, the proportion of PEs did not change in the regression analysis. The 95% prediction interval was 0.0002 to 0.0106, indicating that in similar future studies, the true proportion of symptomatic PEs would range from 0.02% to 1.06%.</AbstractText><AbstractText Label="CONCLUSION">Over a 14-year period, the symptomatic PE rate after TKA was relatively constant even when patients received potent anticoagulation. These results suggest that some patients may have a genetic predisposition to develop a PE and more effective risk stratification protocols need to be developed to make sure patients receive appropriate anticoagulation.</AbstractText><CopyrightInformation>Copyright &#xa9; 2017 Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Cote</LastName><ForeName>Mark P</ForeName><Initials>MP</Initials><AffiliationInfo><Affiliation>Department of Orthopaedic Surgery, Orthopaedic Surgery, UConn Health, Farmington, Connecticut.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Anthony</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Orthopaedic Surgery, Keck School of Medicine of USC, Los Angeles, California.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jiang</LastName><ForeName>Yue</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Orthopaedic Surgery, Keck School of Medicine of USC, Los Angeles, California.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cheng</LastName><ForeName>Vincent</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Department of Orthopaedic Surgery, Keck School of Medicine of USC, Los Angeles, California.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lieberman</LastName><ForeName>Jay R</ForeName><Initials>JR</Initials><AffiliationInfo><Affiliation>Department of Orthopaedic Surgery, Keck School of Medicine of USC, Los Angeles, California.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2017</Year><Month>07</Month><Day>05</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Arthroplasty</MedlineTA><NlmUniqueID>8703515</NlmUniqueID><ISSNLinking>0883-5403</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000925">Anticoagulants</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D006454">Hemoglobins</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000925" MajorTopicYN="N">Anticoagulants</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019645" MajorTopicYN="N">Arthroplasty, Replacement, Knee</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001803" MajorTopicYN="N">Blood Transfusion</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006454" MajorTopicYN="N">Hemoglobins</DescriptorName><QualifierName UI="Q000032" MajorTopicYN="N">analysis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009985" MajorTopicYN="N">Orthopedics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011655" MajorTopicYN="N">Pulmonary Embolism</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016032" MajorTopicYN="N">Randomized Controlled Trials as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014481" MajorTopicYN="N">United States</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D054556" MajorTopicYN="N">Venous Thromboembolism</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020246" MajorTopicYN="N">Venous Thrombosis</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">anticoagulation</Keyword><Keyword MajorTopicYN="N">meta-analysis</Keyword><Keyword MajorTopicYN="N">pulmonary embolism</Keyword><Keyword MajorTopicYN="N">randomized trials</Keyword><Keyword MajorTopicYN="N">total knee arthroplasty</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>5</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2017</Year><Month>6</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2017</Year><Month>6</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2017</Year><Month>8</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>6</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2017</Year><Month>8</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">28807470</ArticleId><ArticleId IdType="doi">10.1016/j.arth.2017.06.041</ArticleId><ArticleId IdType="pii">S0883-5403(17)30570-3</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">33529719</PMID><DateCompleted><Year>2021</Year><Month>08</Month><Day>26</Day></DateCompleted><DateRevised><Year>2023</Year><Month>11</Month><Day>10</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2213-3348</ISSN><JournalIssue CitedMedium="Internet"><Volume>9</Volume><Issue>5</Issue><PubDate><Year>2021</Year><Month>Sep</Month></PubDate></JournalIssue><Title>Journal of vascular surgery. Venous and lymphatic disorders</Title><ISOAbbreviation>J Vasc Surg Venous Lymphat Disord</ISOAbbreviation></Journal><ArticleTitle>A systematic review and meta-analysis of incidence, prognosis, and laboratory indicators of venous thromboembolism in hospitalized patients with coronavirus disease 2019.</ArticleTitle><Pagination><StartPage>1099</StartPage><EndPage>1111.e6</EndPage><MedlinePgn>1099-1111.e6</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jvsv.2021.01.012</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S2213-333X(21)00072-X</ELocationID><Abstract><AbstractText Label="OBJECTIVE">We have summarized the incidence, anticoagulation panels, laboratory characteristics, and mortality of venous thromboembolism (VTE) in hospitalized patients with coronavirus disease 2019 (COVID-19).</AbstractText><AbstractText Label="METHODS">After systematically searching PubMed, Embase, the Cochrane Library, MedRxiv, and BioRxiv, a systematic review and meta-analysis of 18 retrospective, 6 prospective observational, and 2 cross-sectional studies was performed according to the guidelines of the PRISMA (preferred reporting items for systematic reviews and meta-analyses) statement.</AbstractText><AbstractText Label="RESULTS">Overall, 4382 hospitalized patients with COVID-19 were included. Men accounted for significantly more patients than did women (odds ratio [OR], 1.59; 95% confidence interval [CI], 1.25-2.02; P&#xa0;&lt; .001). The total incidence of VTE among the patients with COVID-19 was 28.3% (95% CI, 21.6%-35.4%), with an incidence of 38.0% (95% CI, 29.1%-47.4%) and 17.2% (95% CI, 11.4%-23.8%) among those with severe and general COVID-19, respectively. The total incidence of deep vein&#xa0;thrombosis (DVT) of the lower extremities was 18.3% (95% CI, 10.8%-27.2%). The incidence of DVT was 22.1% (95% CI, 11.0%-35.5%) and 12.8% (95% CI, 5.0%-23.3%) in those with severe and general COVID-19, respectively. The total incidence of pulmonary embolism was 17.6% (95% CI, 12.3%-23.5%), with a rate of 21.7% (95% CI, 14.8%-29.3%) in severe cases and 12.5% (95% CI, 6.1%-23.5%) in general cases. When COVID-19 severity was unclassified, the mortality for the patients with VTE was not significantly greater (25.2%; 95% CI, 12.2%-40.5%) than that for those without VTE (10.2%; 95% CI, 3.4%-19.5%; OR, 1.88; 95% CI, 0.46-7.64; P&#xa0;= .377). However, among the patients with severe COVID-19, those who had developed VTE had significantly greater mortality compared with those without VTE (OR, 2.02; 95% CI, 1.15-3.53; P&#xa0;= .014). The patients with COVID-19 and VTE had significantly higher D-dimer levels than did similar patients without VTE in multiple studies.</AbstractText><AbstractText Label="CONCLUSIONS">The occurrence of VTE, DVT, and pulmonary embolism has been substantial among hospitalized patients with COVID-19, especially among those with severe COVID-19. Patients with severe COVID-19 and VTE had significantly greater mortality compared with similar patients without VTE. An increased D-dimer level might be an indicator of the occurrence of VTE in patients with COVID-19.</AbstractText><CopyrightInformation>Copyright &#xa9; 2021 Society for Vascular Surgery. Published by Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Yandong</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Vascular and Endovascular Surgery, Changzheng Hospital, Naval Medical University, Shanghai, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cai</LastName><ForeName>Jiawei</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Vascular and Endovascular Surgery, Changzheng Hospital, Naval Medical University, Shanghai, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Chao</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Vascular and Endovascular Surgery, Changzheng Hospital, Naval Medical University, Shanghai, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jin</LastName><ForeName>Jie</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Vascular and Endovascular Surgery, Changzheng Hospital, Naval Medical University, Shanghai, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Qu</LastName><ForeName>Lefeng</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Vascular and Endovascular Surgery, Changzheng Hospital, Naval Medical University, Shanghai, China. Electronic address: qulefeng@smmu.edu.cn.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>01</Month><Day>30</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Vasc Surg Venous Lymphat Disord</MedlineTA><NlmUniqueID>101607771</NlmUniqueID><ISSNLinking>2213-333X</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015415">Biomarkers</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D005338">Fibrin Fibrinogen Degradation Products</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C036309">fibrin fragment D</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015415" MajorTopicYN="N">Biomarkers</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001777" MajorTopicYN="Y">Blood Coagulation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001780" MajorTopicYN="Y">Blood Coagulation Tests</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="N">COVID-19</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005338" MajorTopicYN="N">Fibrin Fibrinogen Degradation Products</DescriptorName><QualifierName UI="Q000032" MajorTopicYN="N">analysis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006760" MajorTopicYN="Y">Hospitalization</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015994" MajorTopicYN="N">Incidence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011237" MajorTopicYN="N">Predictive Value of Tests</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011379" MajorTopicYN="N">Prognosis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011655" MajorTopicYN="N">Pulmonary Embolism</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018570" MajorTopicYN="N">Risk Assessment</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012720" MajorTopicYN="N">Severity of Illness Index</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D054556" MajorTopicYN="N">Venous Thromboembolism</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020246" MajorTopicYN="N">Venous Thrombosis</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">D-dimer</Keyword><Keyword MajorTopicYN="N">Deep vein thrombosis</Keyword><Keyword MajorTopicYN="N">Pulmonary embolism</Keyword><Keyword MajorTopicYN="N">Venous thromboembolism</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>7</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>1</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>2</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>8</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>2</Month><Day>2</Day><Hour>20</Hour><Minute>9</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2021</Year><Month>1</Month><Day>30</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33529719</ArticleId><ArticleId IdType="pmc">PMC7847192</ArticleId><ArticleId IdType="doi">10.1016/j.jvsv.2021.01.012</ArticleId><ArticleId IdType="pii">S2213-333X(21)00072-X</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Richardson S., Hirsch J.S., Narasimhan M., Crawford J.M., McGinn T., Davidson K.W. Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York City area. JAMA. 2020;323:2052&#x2013;2059.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7177629</ArticleId><ArticleId IdType="pubmed">32320003</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou F., Yu T., Du R., Fan G., Liu Y., Liu Z. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395:1054&#x2013;1062.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7270627</ArticleId><ArticleId IdType="pubmed">32171076</ArticleId></ArticleIdList></Reference><Reference><Citation>Du Y., Tu L., Zhu P., Mu M., Wang R., Yang P. Clinical features of 85 fatal cases of COVID-19 from Wuhan: a retrospective observational study. Am J Respir Crit Care Med. 2020;201:1372&#x2013;1379.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7258652</ArticleId><ArticleId IdType="pubmed">32242738</ArticleId></ArticleIdList></Reference><Reference><Citation>Devaux C.A., Rolain J.M., Raoult D. ACE2 receptor polymorphism: susceptibility to SARS-CoV-2, hypertension, multi-organ failure, and COVID-19 disease outcome. J&#xa0;Microbiol Immunol Infect. 2020;53:425&#x2013;435.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7201239</ArticleId><ArticleId IdType="pubmed">32414646</ArticleId></ArticleIdList></Reference><Reference><Citation>Varga Z., Flammer A.J., Steiger P., Haberecker M., Andermatt R., Zinkernagel A.S. Endothelial cell infection and endotheliitis in COVID-19. Lancet. 2020;395:1417&#x2013;1418.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7172722</ArticleId><ArticleId IdType="pubmed">32325026</ArticleId></ArticleIdList></Reference><Reference><Citation>Panigada M., Bottino N., Tagliabue P., Grasselli G., Novembrino C., Chantarangkul V. Hypercoagulability of COVID-19 patients in intensive care unit: a report of thromboelastography findings and other parameters of hemostasis. J&#xa0;Thromb Haemost. 2020;18:1738&#x2013;1742.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9906150</ArticleId><ArticleId IdType="pubmed">32302438</ArticleId></ArticleIdList></Reference><Reference><Citation>Ranucci M., Ballotta A., Di Dedda U., Bayshnikova E., Dei Poli M., Resta M. The procoagulant pattern of patients with COVID-19 acute respiratory distress syndrome. J&#xa0;Thromb Haemost. 2020;18:1747&#x2013;1751.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9906332</ArticleId><ArticleId IdType="pubmed">32302448</ArticleId></ArticleIdList></Reference><Reference><Citation>Tal S., Spectre G., Kornowski R., Perl L. Venous thromboembolism complicated with COVID-19: what do we know so far? Acta Haematol. 2020;143:417&#x2013;420.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7270063</ArticleId><ArticleId IdType="pubmed">32396903</ArticleId></ArticleIdList></Reference><Reference><Citation>Klok F.A., Kruip M., van der Meer N.J.M., Arbous M.S., Gommers D., Kant K.M. Incidence of thrombotic complications in critically ill ICU patients with COVID-19. Thromb Res. 2020;191:145&#x2013;147.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7146714</ArticleId><ArticleId IdType="pubmed">32291094</ArticleId></ArticleIdList></Reference><Reference><Citation>Cui S., Chen S., Li X., Liu S., Wang F. Prevalence of venous thromboembolism in patients with severe novel coronavirus pneumonia. J&#xa0;Thromb Haemost. 2020;18:1421&#x2013;1424.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7262324</ArticleId><ArticleId IdType="pubmed">32271988</ArticleId></ArticleIdList></Reference><Reference><Citation>Wichmann D., Sperhake J.P., Lutgehetmann M., Steurer S., Edler C., Heinemann A. Autopsy findings and venous thromboembolism in patients with COVID-19: a prospective cohort study. Ann Intern Med. 2020;173:268&#x2013;277.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7240772</ArticleId><ArticleId IdType="pubmed">32374815</ArticleId></ArticleIdList></Reference><Reference><Citation>Moher D., Liberati A., Tetzlaff J., Altman D.G., PRISMA Group Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ. 2009;339:b2535.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2714657</ArticleId><ArticleId IdType="pubmed">19622551</ArticleId></ArticleIdList></Reference><Reference><Citation>Feng Y., Ling Y., Bai T., Xie Y., Huang J., Li J. COVID-19 with different severity: a multi-center study of clinical features. Am J Respir Crit Care Med. 2020;20:1380&#x2013;1388.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7258639</ArticleId><ArticleId IdType="pubmed">32275452</ArticleId></ArticleIdList></Reference><Reference><Citation>Kearon C. Natural history of venous thromboembolism. Circulation. 2003;107:I22&#x2013;30.</Citation><ArticleIdList><ArticleId IdType="pubmed">12814982</ArticleId></ArticleIdList></Reference><Reference><Citation>Alonso Martinez J.L., Anniccherico Sanchez F.J., Urbieta Echezarreta M.A., Garcia I.V., Alvaro J.R. Central versus peripheral pulmonary embolism: analysis of the impact on the physiological parameters and long-term survival. N&#xa0;Am J Med Sci. 2016;8:134&#x2013;142.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4821092</ArticleId><ArticleId IdType="pubmed">27114970</ArticleId></ArticleIdList></Reference><Reference><Citation>Lo C.K., Mertz D., Loeb M. Newcastle-Ottawa scale: comparing reviewers' to authors' assessments. BMC Med Res Methodol. 2014;14:45.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4021422</ArticleId><ArticleId IdType="pubmed">24690082</ArticleId></ArticleIdList></Reference><Reference><Citation>Chou R., Baker W.L., Banez L.L., Iyer S., Myers E.R., Newberry S. Agency for Healthcare Research and Quality Evidence-based Practice Center methods provide guidance on prioritization and selection of harms in systematic reviews. J&#xa0;Clin Epidemiol. 2018;98:98&#x2013;104.</Citation><ArticleIdList><ArticleId IdType="pubmed">29409913</ArticleId></ArticleIdList></Reference><Reference><Citation>Higgins J.P., Thompson S.G., Deeks J.J., Altman D.G. Measuring inconsistency in meta-analyses. BMJ. 2003;327:557&#x2013;560.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC192859</ArticleId><ArticleId IdType="pubmed">12958120</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Samkari H., Karp Leaf R.S., Dzik W.H., Carlson J.C.T., Fogerty A.E., Waheed A. COVID-19 and coagulation: bleeding and thrombotic manifestations of SARS-CoV-2 infection. Blood. 2020;136:489&#x2013;500.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7378457</ArticleId><ArticleId IdType="pubmed">32492712</ArticleId></ArticleIdList></Reference><Reference><Citation>Artifoni M., Danic G., Gautier G., Gicquel P., Boutoille D., Raffi F. Systematic assessment of venous thromboembolism in COVID-19 patients receiving thromboprophylaxis: incidence and role of D-dimer as predictive factors. J&#xa0;Thromb Thrombolysis. 2020;50:211&#x2013;216.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7246965</ArticleId><ArticleId IdType="pubmed">32451823</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen S., Zhang D., Zheng T., Yu Y., Jiang J. DVT incidence and risk factors in critically ill patients with COVID-19. J&#xa0;Thromb Thrombolysis. 2020;51:33&#x2013;39.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7324310</ArticleId><ArticleId IdType="pubmed">32607652</ArticleId></ArticleIdList></Reference><Reference><Citation>Contou D., Pajot O., Cally R., Logre E., Fraisse M., Mentec H. Pulmonary embolism or thrombosis in ARDS COVID-19 patients: a French monocenter retrospective study. PLoS One. 2020;15</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7451560</ArticleId><ArticleId IdType="pubmed">32853267</ArticleId></ArticleIdList></Reference><Reference><Citation>Dujardin R.W.G., Hilderink B.N., Haksteen W.E., Middeldorp S., Vlaar A.P.J., Thachil J. Biomarkers for the prediction of venous thromboembolism in critically ill COVID-19 patients. Thromb Res. 2020;196:308&#x2013;312.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7491463</ArticleId><ArticleId IdType="pubmed">32977128</ArticleId></ArticleIdList></Reference><Reference><Citation>Fauvel C., Weizman O., Trimaille A., Mika D., Pommier T., Pace N. Critical COVID-19 France Investigators. Pulmonary embolism in COVID-19 patients: a French multicentre cohort study. Eur Heart J. 2020;41:3058&#x2013;3068.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7528952</ArticleId><ArticleId IdType="pubmed">32656565</ArticleId></ArticleIdList></Reference><Reference><Citation>Le Jeune S., Suhl J., Benainous R., Minvielle F., Purser C., Foudi F. High prevalence of early asymptomatic venous thromboembolism in anticoagulated COVID-19 patients hospitalized in general wards. J&#xa0;Thromb Thrombolysis. 2020:1&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7433772</ArticleId><ArticleId IdType="pubmed">32812199</ArticleId></ArticleIdList></Reference><Reference><Citation>Lodigiani C., Iapichino G., Carenzo L., Cecconi M., Ferrazzi P., Sebastian T. Venous and arterial thromboembolic complications in COVID-19 patients admitted to an academic hospital in Milan, Italy. Thromb Res. 2020;191:9&#x2013;14.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7177070</ArticleId><ArticleId IdType="pubmed">32353746</ArticleId></ArticleIdList></Reference><Reference><Citation>Longchamp A., Longchamp J., Manzocchi-Besson S., Whiting L., Haller C., Jeanneret S. Venous thromboembolism in critically ill patients with COVID-19: results of a screening study for deep vein thrombosis. Res Pract Thromb Haemost. 2020;4:842&#x2013;847.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7272794</ArticleId><ArticleId IdType="pubmed">32685893</ArticleId></ArticleIdList></Reference><Reference><Citation>Maatman T.K., Jalali F., Feizpour C., Douglas A., II, McGuire S.P., Kinnaman G. Routine venous thromboembolism prophylaxis may be inadequate in the hypercoagulable state of severe coronavirus disease 2019. Crit Care Med. 2020;48:e783&#x2013;e790.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7302085</ArticleId><ArticleId IdType="pubmed">32459672</ArticleId></ArticleIdList></Reference><Reference><Citation>Mestre-Gomez B., Lorente-Ramos R.M., Rogado J., Franco-Moreno A., Obispo B., Salazar-Chiriboga D. Incidence of pulmonary embolism in non-critically ill COVID-19 patients: predicting factors for a challenging diagnosis. J&#xa0;Thromb Thrombolysis. 2021;51:40&#x2013;46.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7327193</ArticleId><ArticleId IdType="pubmed">32613385</ArticleId></ArticleIdList></Reference><Reference><Citation>Middeldorp S., Coppens M., van Haaps T.F., Foppen M., Vlaar A.P., Muller M.C.A. Incidence of venous thromboembolism in hospitalized patients with COVID-19. J&#xa0;Thromb Haemost. 2020;18:1995&#x2013;2002.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7497052</ArticleId><ArticleId IdType="pubmed">32369666</ArticleId></ArticleIdList></Reference><Reference><Citation>Mouhat B., Besutti M., Bouiller K., Grillet F., Monnin C., Ecarnot F. Elevated D-dimers and lack of anticoagulation predict PE in severe COVID-19 patients. Eur Respir J. 2020;56:2001811.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7487272</ArticleId><ArticleId IdType="pubmed">32907890</ArticleId></ArticleIdList></Reference><Reference><Citation>Shah A., Donovan K., McHugh A., Pandey M., Aaron L., Bradbury C.A. Thrombotic and haemorrhagic complications in critically ill patients with COVID-19: a multicentre observational study. Crit Care. 2020;24:561.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7499016</ArticleId><ArticleId IdType="pubmed">32948243</ArticleId></ArticleIdList></Reference><Reference><Citation>Taccone F.S., Gevenois P.A., Peluso L., Pletchette Z., Lheureux O., Brasseur A. Higher intensity thromboprophylaxis regimens and pulmonary embolism in critically ill coronavirus disease 2019 patients. Crit Care Med. 2020;48:e1087&#x2013;e1090.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7437413</ArticleId><ArticleId IdType="pubmed">32769623</ArticleId></ArticleIdList></Reference><Reference><Citation>Trigonis R.A., Holt D.B., Yuan R., Siddiqui A.A., Craft M.K., Khan B.A. Incidence of venous thromboembolism in critically ill coronavirus disease 2019 patients receiving prophylactic anticoagulation. Crit Care Med. 2020;48:e805&#x2013;e808.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7314344</ArticleId><ArticleId IdType="pubmed">32618699</ArticleId></ArticleIdList></Reference><Reference><Citation>Whyte M.B., Kelly P.A., Gonzalez E., Arya R., Roberts L.N. Pulmonary embolism in hospitalised patients with COVID-19. Thromb Res. 2020;195:95&#x2013;99.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7351054</ArticleId><ArticleId IdType="pubmed">32682004</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang L., Feng X., Zhang D., Jiang C., Mei H., Wang J. Deep vein thrombosis in hospitalized patients with coronavirus disease 2019 (COVID-19) in Wuhan, China: prevalence, risk factors, and outcome. Circulation. 2020;142:114&#x2013;128.</Citation><ArticleIdList><ArticleId IdType="pubmed">32421381</ArticleId></ArticleIdList></Reference><Reference><Citation>Aleva F.E., van Mourik L., Broeders M., Paling A.J., de Jager C.P.C. COVID-19 in critically ill patients in North Brabant, the Netherlands: patient characteristics and outcomes. J&#xa0;Crit Care. 2020;60:111&#x2013;115.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7414357</ArticleId><ArticleId IdType="pubmed">32799179</ArticleId></ArticleIdList></Reference><Reference><Citation>Alonso-Fernandez A., Toledo-Pons N., Cosio B.G., Millan A., Calvo N., Ramon L. Prevalence of pulmonary embolism in patients with COVID-19 pneumonia and high D-dimer values: a prospective study. PLoS One. 2020;15:e0238216.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7447036</ArticleId><ArticleId IdType="pubmed">32841275</ArticleId></ArticleIdList></Reference><Reference><Citation>Avruscio G., Camporese G., Campello E., Bernardi E., Persona P., Passarella C. COVID-19 and venous thromboembolism in intensive care or medical ward. Clin Transl Sci. 2020;13:1108&#x2013;1114.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7567296</ArticleId><ArticleId IdType="pubmed">32989908</ArticleId></ArticleIdList></Reference><Reference><Citation>Demelo-Rodriguez P., Cervilla-Munoz E., Ordieres-Ortega L., Parra-Virto A., Toledano-Macias M., Toledo-Samaniego N. Incidence of asymptomatic deep vein thrombosis in patients with COVID-19 pneumonia and elevated D-dimer levels. Thromb Res. 2020;192:23&#x2013;26.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7219400</ArticleId><ArticleId IdType="pubmed">32405101</ArticleId></ArticleIdList></Reference><Reference><Citation>Helms J., Tacquard C., Severac F., Leonard-Lorant I., Ohana M., Delabranche X. High risk of thrombosis in patients with severe SARS-CoV-2 infection: a multicenter prospective cohort study. Intensive Care Med. 2020;46:1089&#x2013;1098.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7197634</ArticleId><ArticleId IdType="pubmed">32367170</ArticleId></ArticleIdList></Reference><Reference><Citation>Jimenez-Guiu X., Huici-Sanchez M., Romera-Villegas A., Izquierdo-Miranda A., Sancho-Cerro A., Vila-Coll R. Deep vein thrombosis in non-critically ill patients with coronavirus disease 2019 pneumonia: deep vein thrombosis in non-intensive care unit patients. J&#xa0;Vasc Surg Venous Lymphat Disord. 2020 Sep 7 [E-pub ahead of print]</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7476444</ArticleId><ArticleId IdType="pubmed">32911110</ArticleId></ArticleIdList></Reference><Reference><Citation>Longhitano Y., Racca F., Zanza C., Muncinelli M., Guagliano A., Peretti E. Venous thrombo-embolism in hospitalized SARS-CoV-2 patients treated with three different anticoagulation protocols: prospective observational study. Biology (Basal) 2020;9:310.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7600769</ArticleId><ArticleId IdType="pubmed">32987902</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang H., Rockman C.B., Jacobowitz G.R., Speranza G., Johnson W.S., Horowitz J.M. Deep venous thrombosis in hospitalized patients with coronavirus disease 2019. J&#xa0;Vasc Surg Venous Lymphat Disord. 2020 Oct 8 [E-pub ahead of print]</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7543928</ArticleId><ArticleId IdType="pubmed">33039545</ArticleId></ArticleIdList></Reference><Reference><Citation>McCredie R.J., McCrohon J.A., Turner L., Griffiths K.A., Handelsman D.J., Celermajer D.S. Vascular reactivity is impaired in genetic females taking high-dose androgens. J&#xa0;Am Coll Cardiol. 1998;32:1331&#x2013;1335.</Citation><ArticleIdList><ArticleId IdType="pubmed">9809944</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu Y.F., Pan L.Y., Zhang W.W., Cheng F., Hu S.S., Zhang X. A&#xa0;meta-analysis of the incidence of venous thromboembolic events and impact of anticoagulation on mortality in patients with COVID-19. Int J Infect Dis. 2020;100:34&#x2013;41.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7425668</ArticleId><ArticleId IdType="pubmed">32798659</ArticleId></ArticleIdList></Reference><Reference><Citation>Hasan S.S., Radford S., Kow C.S., Zaidi S.T.R. Venous thromboembolism in critically ill COVID-19 patients receiving prophylactic or therapeutic anticoagulation: a systematic review and meta-analysis. J&#xa0;Thromb Thrombolysis. 2020;50:814&#x2013;821.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7396456</ArticleId><ArticleId IdType="pubmed">32748122</ArticleId></ArticleIdList></Reference><Reference><Citation>Li M., Guo Q., Hu W. Incidence, risk factors, and outcomes of venous thromboembolism after oncologic surgery: a systematic review and meta-analysis. Thromb Res. 2019;173:48&#x2013;56.</Citation><ArticleIdList><ArticleId IdType="pubmed">30471508</ArticleId></ArticleIdList></Reference><Reference><Citation>Hayes J.W., Ryan E.J., Boland P.A., Creavin B., Kelly M.E., Beddy D. The prevalence of venous thromboembolism in rectal surgery: a systematic review and meta-analysis. Int J Colorectal Dis. 2019;34:849&#x2013;860.</Citation><ArticleIdList><ArticleId IdType="pubmed">30824975</ArticleId></ArticleIdList></Reference><Reference><Citation>Tikkinen K.A.O., Craigie S., Agarwal A., Violette P.D., Novara G., Cartwright R. Procedure-specific risks of thrombosis and bleeding in urological cancer surgery: systematic review and meta-analysis. Eur Urol. 2018;73:242&#x2013;251.</Citation><ArticleIdList><ArticleId IdType="pubmed">28342641</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang D., Hu B., Hu C., Zhu F., Liu X., Zhang J. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA. 2020;323:1061&#x2013;1069.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7042881</ArticleId><ArticleId IdType="pubmed">32031570</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">38307782</PMID><DateCompleted><Year>2025</Year><Month>04</Month><Day>21</Day></DateCompleted><DateRevised><Year>2025</Year><Month>05</Month><Day>13</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2531-0437</ISSN><JournalIssue CitedMedium="Internet"><Volume>31</Volume><Issue>1</Issue><PubDate><Year>2025</Year><Month>Dec</Month><Day>31</Day></PubDate></JournalIssue><Title>Pulmonology</Title><ISOAbbreviation>Pulmonology</ISOAbbreviation></Journal><ArticleTitle>In-hospital mortality of high-risk pulmonary embolism: a nationwide population-based cohort study in Portugal from 2010 to 2018.</ArticleTitle><Pagination><StartPage>2416830</StartPage><MedlinePgn>2416830</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.pulmoe.2023.11.002</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="UNASSIGNED">The mortality associated with high-risk pulmonary embolism (PE) is remarkably high, and reperfusion to unload right ventricle should be a priority. However, several registries report reperfusion underuse. In Portugal, epidemiological data about the incidence, rate of reperfusion and mortality of high-risk PE are not known.</AbstractText><AbstractText Label="METHODS" NlmCategory="UNASSIGNED">Nationwide population-based temporal trend study in the incidence and outcome of high-risk PE, who were admitted to hospitals of the National Health Service in Portugal between 2010 and 2018. High-risk PE was defined as patients with PE who developed cardiogenic shock or cardiac arrest. International Classification of Diseases (ICD), 9th and 10th revision, Clinical Modification codes, were used for data from the period between 2010 and 2016 (ICD-9-CM) and 2017-2018 (ICD-10-CM), respectively. The assessment focused on trends in the use of reperfusion treatment, which was defined by application of thrombolysis or pulmonary embolectomy. A comparison was made between the use or non-use of reperfusion therapy in order to examine trends in in-hospital mortality among high-risk PE cases.</AbstractText><AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">From 2010 and 2018, there were 40.311 hospitalization episodes for PE in adult patients at hospitals of the National Health Service in mainland Portugal. There was a significant increase in the annual incidence of PE (41/100.000 inhabitants in 2010 to 46/100.000 in 2018; R<sup>2</sup>=0.582, <i>p</i> = 0.010). The average annual incidence was 45/100.000 inhabitants/year, with 2,7% of the PE episodes (1104) categorized as high-risk. The mortality rate associated with high-risk PE was high, although it has decreased over the years (74.2% in 2010 to 63.6% in 2018; R<sup>2</sup>=0.484; <i>p</i> = 0.022). Thrombolytic therapy was underused in high-risk PE, and its usage has not increased in recent years (17.3% in 2010 to 21.1% in 2018, R<sup>2</sup>=-0.127; <i>p</i> = 0.763). Surgical pulmonary embolectomy was used in 0.27% of cases, and there was no registry of catheter-directed thrombolysis. Patients with high-risk PE undergoing reperfusion therapy had lower in-hospital mortality compared to non-reperfused patients (OR=0.52; IC95% 0.38-0.70).</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="UNASSIGNED">In Portugal, between 2010 and 2018, very few patients with PE developed high-risk forms of the disease, but the mortality rate among those patients was high. The low reperfusion rate could be associated with high in-hospital mortality and highlights the need to implement advanced therapies, as an alternative to systemic thrombolysis.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Cal&#xe9;</LastName><ForeName>R</ForeName><Initials>R</Initials><Identifier Source="ORCID">0000-0002-6719-2065</Identifier><AffiliationInfo><Affiliation>Cardiology Department, Hospital Garcia de Orta, Almada, Portugal.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ascen&#xe7;&#xe3;o</LastName><ForeName>R</ForeName><Initials>R</Initials><Identifier Source="ORCID">0000-0002-9086-0973</Identifier><AffiliationInfo><Affiliation>Centro Cardiovascular da Universidade de Lisboa-CCUL (CCUL@RISE), CAML, Faculdade de Medicina, Universidade de Lisboa, Portugal.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Laboratory of Clinical Pharmacology and Therapeutics, Faculdade de Medicina, Universidade de Lisboa, Portugal.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bulhosa</LastName><ForeName>C</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0002-6636-5657</Identifier><AffiliationInfo><Affiliation>Evigrade, an IQVIA company, Lisboa, Portugal.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pereira</LastName><ForeName>H</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Cardiology Department, Hospital Garcia de Orta, Almada, Portugal.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centro Cardiovascular da Universidade de Lisboa-CCUL (CCUL@RISE), CAML, Faculdade de Medicina, Universidade de Lisboa, Portugal.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Borges</LastName><ForeName>M</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Laboratory of Clinical Pharmacology and Therapeutics, Faculdade de Medicina, Universidade de Lisboa, Portugal.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Evigrade, an IQVIA company, Lisboa, Portugal.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Costa</LastName><ForeName>J</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Evigrade, an IQVIA company, Lisboa, Portugal.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Caldeira</LastName><ForeName>D</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Centro Cardiovascular da Universidade de Lisboa-CCUL (CCUL@RISE), CAML, Faculdade de Medicina, Universidade de Lisboa, Portugal.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Evigrade, an IQVIA company, Lisboa, Portugal.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Instituto de Medicina Molecular, Faculdade de Medicina, Universidade de Lisboa, Lisboa, Portugal.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Servi&#xe7;o de Cardiologia, Departamento do Cora&#xe7;&#xe3;o e Vasos, Hospital Universit&#xe1;rio de Santa Maria-CHULN, Lisboa, Portugal.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centro de Estudos de Medicina Baseada na Evid&#xea;ncia (CEMBE), Faculdade de Medicina, Universidade de Lisboa, Portugal.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>10</Month><Day>24</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Pulmonology</MedlineTA><NlmUniqueID>101723786</NlmUniqueID><ISSNLinking>2531-0429</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011655" MajorTopicYN="Y">Pulmonary Embolism</DescriptorName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011174" MajorTopicYN="N" Type="Geographic">Portugal</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017052" MajorTopicYN="Y">Hospital Mortality</DescriptorName><QualifierName UI="Q000639" MajorTopicYN="N">trends</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015994" MajorTopicYN="N">Incidence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015912" MajorTopicYN="N">Thrombolytic Therapy</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015424" MajorTopicYN="N">Reperfusion</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006760" MajorTopicYN="N">Hospitalization</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012042" MajorTopicYN="N">Registries</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017128" MajorTopicYN="N">Embolectomy</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">High-risk pulmonary embolism</Keyword><Keyword MajorTopicYN="N">Reperfusion</Keyword><Keyword MajorTopicYN="N">Systemic thrombolysis</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>1</Month><Day>30</Day><Hour>18</Hour><Minute>21</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>2</Month><Day>3</Day><Hour>0</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>2</Month><Day>2</Day><Hour>22</Hour><Minute>1</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38307782</ArticleId><ArticleId IdType="doi">10.1016/j.pulmoe.2023.11.002</ArticleId><ArticleId IdType="pii">S2531-0437(23)00200-3</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36960630</PMID><DateCompleted><Year>2023</Year><Month>06</Month><Day>01</Day></DateCompleted><DateRevised><Year>2023</Year><Month>12</Month><Day>06</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1305-3612</ISSN><JournalIssue CitedMedium="Internet"><Volume>29</Volume><Issue>3</Issue><PubDate><Year>2023</Year><Month>May</Month><Day>31</Day></PubDate></JournalIssue><Title>Diagnostic and interventional radiology (Ankara, Turkey)</Title><ISOAbbreviation>Diagn Interv Radiol</ISOAbbreviation></Journal><ArticleTitle>Inferior vena cava filter retrievals using advanced techniques: a systematic review.</ArticleTitle><Pagination><StartPage>500</StartPage><EndPage>508</EndPage><MedlinePgn>500-508</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.4274/dir.2022.22908</ELocationID><Abstract><AbstractText>This study aimed to assess the safety of complex inferior vena cava (IVC) filter retrieval techniques through a systematic review of published literature. Using PubMed, a systematic review was conducted in line with the 2020 Preferred Reporting Items for Systematic Review and Meta-Analysis guidelines to identify articles published through April 2020 that reported on complex IVC filter retrieval techniques in &gt;5 patients. Case reports, review papers, and studies that did not report on primary outcomes or variables of interest were excluded. Risk of bias was assessed using a modified Newcastle-Ottawa Quality Assessment scale. Pooled success and complication rates were calculated for the overall number of complex retrieval attempts as well as for each filter type and each complex retrieval method. Sixteen fair-quality and three good-quality studies met the inclusion criteria, with 758 patients (428 female) who had undergone 770 advanced retrieval attempts. The mean age of the patients was 46.5 &#xb1; 7.1 years (range: 14.1-90), and the mean dwell time was 602.5 &#xb1; 388.6 days (range: 5-7336). Regarding filters, 92.6% (702/758) were retrievable and 7.4% (56/758) were permanent. Indications for complex retrieval included the failure of standard retrieval (89.2%; 676/758) and tilting or embedding in the caval wall (53.8%; 408/758); 92.6% (713/770) of the advanced retrieval attempts were successful. The pooled success rate was 92.0% (602/654) for retrievable filters and 96.4% (53/55) for permanent filters (<i>P</i> = 0.422). Only 2.8% (21/758) of patients experienced major complications, and the major complication rate was not significantly associated with filter type (<i>P</i> = 0.183). Advanced techniques for IVC filter retrieval appear safe for the retrieval of retrievable filters and certain permanent filters, with a low short-term major complication rate. Further studies on complex retrieval techniques used to remove permanent filters should be conducted to clarify their safety with respect to filter type.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Kethidi</LastName><ForeName>Nikhit</ForeName><Initials>N</Initials><Identifier Source="ORCID">0000-0002-1417-201X</Identifier><AffiliationInfo><Affiliation>Department of Radiology, Division of Vascular and Interventional Radiology, Rutgers New Jersey Medical School, Newark, NJ, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Barsoum</LastName><ForeName>Kyrollos</ForeName><Initials>K</Initials><Identifier Source="ORCID">0000-0003-0338-1307</Identifier><AffiliationInfo><Affiliation>Department of Radiology, Division of Vascular and Interventional Radiology, Rutgers New Jersey Medical School, Newark, NJ, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shukla</LastName><ForeName>Pratik A</ForeName><Initials>PA</Initials><Identifier Source="ORCID">0000-0003-3926-1868</Identifier><AffiliationInfo><Affiliation>Department of Radiology, Division of Vascular and Interventional Radiology, Rutgers New Jersey Medical School, Newark, NJ, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kumar</LastName><ForeName>Abhishek</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0003-0134-2857</Identifier><AffiliationInfo><Affiliation>Department of Radiology, Division of Vascular and Interventional Radiology, Rutgers New Jersey Medical School, Newark, NJ, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D000078182">Systematic Review</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>02</Month><Day>27</Day></ArticleDate></Article><MedlineJournalInfo><Country>Turkey</Country><MedlineTA>Diagn Interv Radiol</MedlineTA><NlmUniqueID>101241152</NlmUniqueID><ISSNLinking>1305-3825</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016306" MajorTopicYN="Y">Vena Cava Filters</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020878" MajorTopicYN="N">Device Removal</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014682" MajorTopicYN="N">Vena Cava, Inferior</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013997" MajorTopicYN="N">Time Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011655" MajorTopicYN="Y">Pulmonary Embolism</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Advanced filter retrieval</Keyword><Keyword MajorTopicYN="N">complex filter retrieval</Keyword><Keyword MajorTopicYN="N">pulmonary embolism</Keyword><Keyword MajorTopicYN="N">thromboembolism</Keyword><Keyword MajorTopicYN="N">venous thromboembolism</Keyword></KeywordList><CoiStatement>
<b>Conflict of interest disclosure</b>
. The authors declared no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>6</Month><Day>1</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>3</Month><Day>24</Day><Hour>3</Hour><Minute>49</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>3</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>5</Month><Day>31</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36960630</ArticleId><ArticleId IdType="pmc">PMC10679615</ArticleId><ArticleId IdType="doi">10.4274/dir.2022.22908</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Decousus H, Leizorovicz A, Parent F, et al Pr&#xe9;vention du Risque d&#x2019;Embolie Pulmonaire par Interruption Cave Study Group. A clinical trial of vena caval filters in the prevention of pulmonary embolism in patients with proximal deep-vein thrombosis. N Engl J Med. 1998;338(7):409&#x2013;416.</Citation><ArticleIdList><ArticleId IdType="pubmed">9459643</ArticleId></ArticleIdList></Reference><Reference><Citation>Reddy S, Lakhter V, Zack CJ, Zhao H, Chatterjee S, Bashir R. Association between contemporary trends in inferior vena cava filter placement and the 2010 US Food and Drug Administration Advisory. JAMA Int Med. 2017;177(9):1373&#x2013;1374.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5818830</ArticleId><ArticleId IdType="pubmed">28692712</ArticleId></ArticleIdList></Reference><Reference><Citation>Endovascular Today. (2014, May 7). FDA Updates Safety Communication on IVC Filter Retrieval. [Internet]</Citation></Reference><Reference><Citation>Brown JD, Raissi D, Han Q, Adams VR, Talbert JC. Vena cava filter retrieval rates and factors associated with retrieval in a large US cohort. J Am Heart Assoc. 2017;6(9):e006708.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5634307</ArticleId><ArticleId IdType="pubmed">28871041</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahmed O, Wadhwa V, Patel K, Patel MV, Turba UC, Arslan B. Rising retrieval rates of inferior vena cava filters in the United States: insights from the 2012 to 2016 Summary Medicare Claims Data. J Am Coll Rad. 2018;15(11):1553&#x2013;1557.</Citation><ArticleIdList><ArticleId IdType="pubmed">29606636</ArticleId></ArticleIdList></Reference><Reference><Citation>Ray CE Jr, Mitchell E, Zipser S, Kao EY, Brown CF, Moneta GL. Outcomes with retrievable inferior vena cava filters: a multicenter study. J Vasc Interv Radiol. 2006;17(10):1595&#x2013;1604.</Citation><ArticleIdList><ArticleId IdType="pubmed">17057000</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosenthal D, Wellons ED, Levitt AB, Shuler FW, O&#x2019;Conner RE, Henderson VJ. Role of Prophylactic Temporary Inferior Vena Cava Filters Placed at the ICU bedside under intravascular ultrasound guidance in patients with multiple trauma. J Vasc Surg. 2004;40(5):958&#x2013;964.</Citation><ArticleIdList><ArticleId IdType="pubmed">15557911</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuo WT, Cupp JS, Louie JD, et al. Complex Retrieval of Embedded IVC filters: alternative techniques and histologic tissue analysis. Cardiovasc Interv Radiol. 2012;35(3):588&#x2013;597.</Citation><ArticleIdList><ArticleId IdType="pubmed">21562933</ArticleId></ArticleIdList></Reference><Reference><Citation>Ouzzani M, Hammady H, Fedorowicz Z, Elmagarmid A. Rayyan - a Web and Mobile app for systematic reviews. Syst Rev. 2016;5(1):210.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5139140</ArticleId><ArticleId IdType="pubmed">27919275</ArticleId></ArticleIdList></Reference><Reference><Citation>Dowell JD, Wagner D, Elliott E, Yildiz VO, Pan X. Factors associated with advanced inferior vena cava filter removals: a single-center retrospective study of 203 patients over 7 years. Cardiovasc Intervent Radiol. 2016;39(2):218&#x2013;226.</Citation><ArticleIdList><ArticleId IdType="pubmed">26662292</ArticleId></ArticleIdList></Reference><Reference><Citation>Posham R, Fischman AM, Nowakowski FS, et al. Transfemoral filter eversion technique following unsuccessful retrieval of option inferior vena cava filters: a single center experience. J Vasc Interv Radiol. 2017;28(6):889&#x2013;894.</Citation><ArticleIdList><ArticleId IdType="pubmed">28532748</ArticleId></ArticleIdList></Reference><Reference><Citation>Stavropoulos SW, Ge BH, Mondschein JI, et al. Retrieval of tip-embedded inferior vena cava filters by using the endobronchial forceps technique: experience at a single institution. Radiology. 2015;275(3):900&#x2013;907.</Citation><ArticleIdList><ArticleId IdType="pubmed">25581368</ArticleId></ArticleIdList></Reference><Reference><Citation>Sacks D, McClenny TE, Cardella JF, Lewis CA. Society of Interventional Radiology Clinical Practice guidelines. J Vasc Interv Radiol. 2003;14(9 Pt 2):199&#x2013;202.</Citation><ArticleIdList><ArticleId IdType="pubmed">14514818</ArticleId></ArticleIdList></Reference><Reference><Citation>Tam MD, Spain J, Lieber M, Geisinger M, Sands MJ, Wang W. Fracture and distant migration of the bard recovery filter: a retrospective review of 363 implantations for potentially life-threatening complications. J Vasc Interv Radiol. 2012;23(2):199&#x2013;205.</Citation><ArticleIdList><ArticleId IdType="pubmed">22188776</ArticleId></ArticleIdList></Reference><Reference><Citation>Trerotola SO, Stavropoulos SW. Management of fractured inferior vena cava filters: outcomes by fragment location. Radiology. 2017;284(3):887&#x2013;896.</Citation><ArticleIdList><ArticleId IdType="pubmed">28421970</ArticleId></ArticleIdList></Reference><Reference><Citation>Tavri S, Patel IJ, Kavali P, Irani Z, Ganguli S, Walker TG. Endobronchial forceps-assisted complex retrieval of inferior vena cava filters. J Vasc Surg Venous Lymphat Disord. 2019;7(3):413&#x2013;419.</Citation><ArticleIdList><ArticleId IdType="pubmed">30477980</ArticleId></ArticleIdList></Reference><Reference><Citation>Brahmandam A, Skrip L, Mojibian H, et al. Costs and complications of endovascular inferior vena cava filter retrieval. J Vasc Surg Venous Lymphat Disord. 2019;7(5):653&#x2013;659.</Citation><ArticleIdList><ArticleId IdType="pubmed">31307952</ArticleId></ArticleIdList></Reference><Reference><Citation>Chick JF, Stavropoulos SW, Shin BJ, et al. A 16-F sheath with endobronchial forceps improves reported retrieval success of long-dwelling &#x201c;closed cell&#x201d; inferior vena cava filter designs. J Vasc Interv Radiol. 2016;27(7):1027&#x2013;1033.</Citation><ArticleIdList><ArticleId IdType="pubmed">27241396</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuo WT, Odegaard JI, Louie JD, et al. Photothermal ablation with the excimer laser sheath technique for embedded inferior vena cava filter removal: initial results from a prospective study. J Vasc Interv Radiol. 2011;22(6):813&#x2013;823.</Citation><ArticleIdList><ArticleId IdType="pubmed">21530309</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuo WT, Odegaard JI, Rosenberg JK, Hofmann LV. Excimer laser-assisted removal of embedded inferior vena cava filters: a single-center prospective study. Circ Cardiovasc Interv. 2013;6(5):560&#x2013;566.</Citation><ArticleIdList><ArticleId IdType="pubmed">24065445</ArticleId></ArticleIdList></Reference><Reference><Citation>Mintz JD, Stavropoulos SW, Trerotola SO. Is a venacavogram necessary after inferior vena cava filter retrieval? J Vasc Interv Radiol. 2016;27(12):1857&#x2013;1864.</Citation><ArticleIdList><ArticleId IdType="pubmed">26460235</ArticleId></ArticleIdList></Reference><Reference><Citation>Stavropoulos SW, Dixon RG, Burke CT, et al. Embedded inferior vena cava filter removal: use of endobronchial forceps. J Vasc Interv Radiol. 2008;19(9):1297&#x2013;1301.</Citation><ArticleIdList><ArticleId IdType="pubmed">18725092</ArticleId></ArticleIdList></Reference><Reference><Citation>Moriarty HK, Marshall E, Clements W. A 7-year retrospective review of the technical success of the &#x201c;low-profile&#x201d; hangman technique for complicated inferior vena cava (IVC) filter retrievals. Diagn Interv Radiol. 2020;26(2):118&#x2013;123.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7051261</ArticleId><ArticleId IdType="pubmed">32071027</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Hakim R, McWilliams JP, Derry W, Kee ST. The hangman technique: a modified loop snare technique for the retrieval of inferior vena cava filters with embedded hooks. J Vasc Interv Radiol. 2015;26(1):107&#x2013;110.</Citation><ArticleIdList><ArticleId IdType="pubmed">25541448</ArticleId></ArticleIdList></Reference><Reference><Citation>Avery A, Stephens M, Redmond K, Harper J. Initial experience using the rigid forceps technique to remove wall-embedded IVC filters. J Med Imaging Radiat Oncol. 2015;59(3):306&#x2013;311.</Citation><ArticleIdList><ArticleId IdType="pubmed">25754369</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuo WT, Tong RT, Hwang GL, et al. High-risk retrieval of adherent and chronically implanted IVC filters: techniques for removal and management of thrombotic complications. J Vasc Interv Radiol. 2009;20(12):1548&#x2013;1556.</Citation><ArticleIdList><ArticleId IdType="pubmed">19864160</ArticleId></ArticleIdList></Reference><Reference><Citation>Lynch FC. Balloon-assisted removal of tilted inferior vena cava filters with embedded Tips. J Vasc Interv Radiol. 2009;20(9):1210&#x2013;1214.</Citation><ArticleIdList><ArticleId IdType="pubmed">19729132</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuo WT, Odegaard JI, Rosenberg JK, Hofmann LV. Laser-assisted removal of embedded vena cava filters: a 5-year first-in-human study. Chest. 2017;151(2):417&#x2013;424.</Citation><ArticleIdList><ArticleId IdType="pubmed">27729265</ArticleId></ArticleIdList></Reference><Reference><Citation>Tamrazi A, Wadhwa V, Holly B, et al. Percutaneous retrieval of permanent inferior vena cava filters. Cardiovasc Intervent Radiol. 2016;39(4):538&#x2013;546.</Citation><ArticleIdList><ArticleId IdType="pubmed">26486152</ArticleId></ArticleIdList></Reference><Reference><Citation>Doody O, No&#xeb; G, Given MF, Foley PT, Lyon SM. Assessment of snared-loop technique when standard retrieval of inferior vena cava filters fails. Cardiovasc Intervent Radiol. 2009;32(1):145&#x2013;149.</Citation><ArticleIdList><ArticleId IdType="pubmed">18839244</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahmed O, Kim YJ, Patel MV, et al. A Single-institutional comparative analysis of advanced versus standard snare removal of inferior vena cava filters. J Vasc Interv Radiol. 2020;31(1):53&#x2013;60.</Citation><ArticleIdList><ArticleId IdType="pubmed">31734075</ArticleId></ArticleIdList></Reference><Reference><Citation>Su Q, Ding X, Dong Z, Liu Y, Li G, Jiang J. A modified loop snare technique for difficult retrievals of inferior vena cava filter and migrated coil. Int Heart J. 2019;60(1):93&#x2013;99.</Citation><ArticleIdList><ArticleId IdType="pubmed">30518716</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuo WT, Bostaph AS, Loh CT, Frisoli JK, Kee ST. Retrieval of trapped G&#xfc;nther Tulip inferior vena cava filters: snare-over-guide wire loop technique. J Vasc Interv Radiol. 2006;17(11 Pt 1):1845&#x2013;1849.</Citation><ArticleIdList><ArticleId IdType="pubmed">17142717</ArticleId></ArticleIdList></Reference><Reference><Citation>Cho E, Lim KJ, Jo JH, Jung GS, Park BH. Failed inferior vena cava filter retrieval by conventional method: analysis of its causes and retrieval of it by modified double-loop technique. Phlebology. 2015;30(8):549&#x2013;556.</Citation><ArticleIdList><ArticleId IdType="pubmed">25096757</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuo WT, Cupp JS. The excimer laser sheath technique for embedded inferior vena cava filter removal. J Vasc Interv Radiol. 2010;21(12):1896&#x2013;1899.</Citation><ArticleIdList><ArticleId IdType="pubmed">21050774</ArticleId></ArticleIdList></Reference><Reference><Citation>Du X, Li C, Qian A, et al. Bidirectional pull-back technique for retrieval of strut-embedded cylinder-shaped filters in inferior vena cava. Med Sci Monit. 2017;23:2796&#x2013;2804.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5473375</ArticleId><ArticleId IdType="pubmed">28596513</ArticleId></ArticleIdList></Reference><Reference><Citation>Stang A. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in metaanalyses. Eur J Epidemiol. 2010;25(9):603&#x2013;605.</Citation><ArticleIdList><ArticleId IdType="pubmed">20652370</ArticleId></ArticleIdList></Reference><Reference><Citation>Hartling L, Milne A, Hamm MP, et al. Testing the Newcastle Ottawa scale showed low reliability between individual reviewers. J Clin Epidemiol. 2013;66(9):982&#x2013;993.</Citation><ArticleIdList><ArticleId IdType="pubmed">23683848</ArticleId></ArticleIdList></Reference><Reference><Citation>Brahmandam A, Skrip L, Sumpio B, et al. A survey of vascular specialists&#x2019; practice patterns of inferior vena cava filter placement and retrieval. Vascular. 2019;27(3):291&#x2013;298.</Citation><ArticleIdList><ArticleId IdType="pubmed">30501583</ArticleId></ArticleIdList></Reference><Reference><Citation>Minocha J, Idakoji I, Riaz A, et al. Improving inferior vena cava filter retrieval rates: impact of a dedicated inferior vena cava filter clinic. J Vasc Interv Radiol. 2010;21(12):1847&#x2013;1851.</Citation><ArticleIdList><ArticleId IdType="pubmed">21035356</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuo WT, Robertson SW, Odegaard JI, Hofmann LV. Complex retrieval of fractured, embedded, and penetrating inferior vena cava filters: a prospective study with histologic and electron microscopic analysis. J Vasc Interv Radiol. 2013;24(5):622&#x2013;630.</Citation><ArticleIdList><ArticleId IdType="pubmed">23523157</ArticleId></ArticleIdList></Reference><Reference><Citation>Lian W, Tian F, Li S, Gu X, Jia Z. Forceps-assisted removal of difficult-to-retrieve filters: preliminary results. Ann Vasc Surg. 2019;61:371&#x2013;376.</Citation><ArticleIdList><ArticleId IdType="pubmed">31394218</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">27975103</PMID><DateCompleted><Year>2018</Year><Month>02</Month><Day>26</Day></DateCompleted><DateRevised><Year>2024</Year><Month>03</Month><Day>27</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2567-689X</ISSN><JournalIssue CitedMedium="Internet"><Volume>117</Volume><Issue>2</Issue><PubDate><Year>2017</Year><Month>Jan</Month><Day>26</Day></PubDate></JournalIssue><Title>Thrombosis and haemostasis</Title><ISOAbbreviation>Thromb Haemost</ISOAbbreviation></Journal><ArticleTitle>Reasons for the persistent incidence of venous thromboembolism.</ArticleTitle><Pagination><StartPage>390</StartPage><EndPage>400</EndPage><MedlinePgn>390-400</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1160/TH16-07-0509</ELocationID><Abstract><AbstractText>Reasons for trends in venous thromboembolism (VTE) incidence are uncertain. It was our objective to determine VTE incidence trends and risk factor prevalence, and estimate population-attributable risk (PAR) trends for each risk factor. In a population-based cohort study of all residents of Olmsted County, Minnesota from 1981-2010, annual incidence rates were calculated using incident VTE cases as the numerator and age- and sex-specific Olmsted County population estimates as the denominator. Poisson regression models were used to assess the relationship of crude incidence rates to year of diagnosis, age at diagnosis, and sex. Trends in annual prevalence of major VTE risk factors were estimated using linear regression. Poisson regression with time-dependent risk factors (person-years approach) was used to model the entire population of Olmsted County and derive the PAR. The age- and sex-adjusted annual VTE incidence, 1981-2010, did not change significantly. Over the time period, 1988-2010, the prevalence of obesity, surgery, active cancer and leg paresis increased. Patient age, hospitalisation, surgery, cancer, trauma, leg paresis and nursing home confinement jointly accounted for 79&#x2009;% of incident VTE; obesity accounted for 33&#x2009;% of incident idiopathic VTE. The increasing prevalence of obesity, cancer and surgery accounted in part for the persistent VTE incidence. The PAR of active cancer and surgery, 1981-2010, significantly increased. In conclusion, almost 80&#x2009;% of incident VTE events are attributable to known major VTE risk factors and one-third of incident idiopathic VTE events are attributable to obesity. Increasing surgery PAR suggests that concurrent efforts to prevent VTE may have been insufficient.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Heit</LastName><ForeName>John A</ForeName><Initials>JA</Initials><AffiliationInfo><Affiliation>John A. Heit, MD, Stabile 6-Hematology Research, Mayo Clinic, 200 First Street, SW, Rochester, MN 55905, USA, Tel.: +1 507 284 4634, Fax: +1 507 266 9302, E-mail: heit.john@mayo.edu.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ashrani</LastName><ForeName>Aneel</ForeName><Initials>A</Initials></Author><Author ValidYN="Y"><LastName>Crusan</LastName><ForeName>Daniel J</ForeName><Initials>DJ</Initials></Author><Author ValidYN="Y"><LastName>McBane</LastName><ForeName>Robert D</ForeName><Initials>RD</Initials></Author><Author ValidYN="Y"><LastName>Petterson</LastName><ForeName>Tanya M</ForeName><Initials>TM</Initials></Author><Author ValidYN="Y"><LastName>Bailey</LastName><ForeName>Kent R</ForeName><Initials>KR</Initials></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01 AG034676</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 HL066216</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2016</Year><Month>12</Month><Day>15</Day></ArticleDate></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>Thromb Haemost</MedlineTA><NlmUniqueID>7608063</NlmUniqueID><ISSNLinking>0340-6245</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="ErratumIn"><RefSource>Thromb Haemost. 2017 Feb 28;117(3):643. doi: 10.1160/TH1703002.</RefSource><PMID Version="1">28245032</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017677" MajorTopicYN="N">Age Distribution</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002675" MajorTopicYN="N">Child, Preschool</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015994" MajorTopicYN="N">Incidence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007223" MajorTopicYN="N">Infant</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007231" MajorTopicYN="N">Infant, Newborn</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016014" MajorTopicYN="N">Linear Models</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008910" MajorTopicYN="N">Minnesota</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009765" MajorTopicYN="N">Obesity</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015995" MajorTopicYN="N">Prevalence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011655" MajorTopicYN="N">Pulmonary Embolism</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017678" MajorTopicYN="N">Sex Distribution</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013514" MajorTopicYN="N">Surgical Procedures, Operative</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013997" MajorTopicYN="N">Time Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D054556" MajorTopicYN="N">Venous Thromboembolism</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020246" MajorTopicYN="N">Venous Thrombosis</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Venous thrombosis</Keyword><Keyword MajorTopicYN="N">epidemiology</Keyword><Keyword MajorTopicYN="N">phlebitis</Keyword><Keyword MajorTopicYN="N">pulmonary embolism</Keyword><Keyword MajorTopicYN="N">thrombophlebitis</Keyword></KeywordList><CoiStatement><b>Disclosures</b>. Dr. Heit declares no conflict of interest. Dr. Ashrani declares no conflict of interest. Mr. Crusan declares no conflict of interest. Ms. Petterson declares no conflict of interest. Dr. Bailey declares no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2016</Year><Month>7</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2016</Year><Month>10</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2016</Year><Month>12</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>2</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2016</Year><Month>12</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2018</Year><Month>1</Month><Day>26</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">27975103</ArticleId><ArticleId IdType="mid">NIHMS903702</ArticleId><ArticleId IdType="pmc">PMC5597250</ArticleId><ArticleId IdType="doi">10.1160/TH16-07-0509</ArticleId><ArticleId IdType="pii">16-07-0509</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>The Surgeon General&#x2019;s Call to Action to Prevent Deep Vein Thrombosis and Pulmonary Embolism. U.S. Public Health Service 2008. U.S. Department of Health and Human Services. 2008</Citation></Reference><Reference><Citation>Shojania K, Duncan B, McDonald K-SU, Wachter R. Making Health Care Safer: A Critical Analysis of Patient Safety
Practices: UCSF-Stanford Evidence-Based Practice Center. Agency for Healthcare Research and Quality. 2001 Jul 20; Publication no. 01-E058, Evidence report no. 43.  www.ahrq.gov/clinic/ptsafety/summary/htm; 2001.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4781305</ArticleId><ArticleId IdType="pubmed">11510252</ArticleId></ArticleIdList></Reference><Reference><Citation>Kahn SR, Lim W, Dunn AS, Cushman M, Dentali F, Akl EA, Cook DJ, Balekian AA, Klein RC, Le H, Schulman S, Murad MH. Prevention of VTE in nonsurgical patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2012;141:e195S&#x2013;226S.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3278052</ArticleId><ArticleId IdType="pubmed">22315261</ArticleId></ArticleIdList></Reference><Reference><Citation>Gould MK, Garcia DA, Wren SM, Karanicolas PJ, Arcelus JI, Heit JA, Samama CM. Prevention of VTE in nonorthopedic surgical patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2012;141:e227S&#x2013;277S.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3278061</ArticleId><ArticleId IdType="pubmed">22315263</ArticleId></ArticleIdList></Reference><Reference><Citation>Falck-Ytter Y, Francis CW, Johanson NA, Curley C, Dahl OE, Schulman S, Ortel TL, Pauker SG, Colwell CW., Jr Prevention of VTE in orthopedic surgery patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2012;141:e278S&#x2013;325S.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3278063</ArticleId><ArticleId IdType="pubmed">22315265</ArticleId></ArticleIdList></Reference><Reference><Citation>Naess IA, Christiansen SC, Romundstad P, Cannegieter SC, Rosendaal FR, Hammerstrom J. Incidence and mortality of venous thrombosis: A population-based study. J Thromb Haemost. 2007;5:692&#x2013;699.</Citation><ArticleIdList><ArticleId IdType="pubmed">17367492</ArticleId></ArticleIdList></Reference><Reference><Citation>DeMonaco NA, Dang Q, Kapoor WN, Ragni MV. Pulmonary embolism incidence is increasing with use of spiral computed tomography. Am J Med. 2008;121:611&#x2013;617.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2711635</ArticleId><ArticleId IdType="pubmed">18589057</ArticleId></ArticleIdList></Reference><Reference><Citation>Wiener RS, Schwartz LM, Woloshin S. Time trends in pulmonary embolism in the United States: Evidence of overdiagnosis. Archives of Internal Medicine. 2011;171:831&#x2013;837.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3140219</ArticleId><ArticleId IdType="pubmed">21555660</ArticleId></ArticleIdList></Reference><Reference><Citation>Tagalakis V, Wharin C, Kahn SR. Comprehensive update on the prevention and treatment of venous thromboembolism in cancer patients. Seminars in Thrombosis and Hemostasis. 2013;39:127&#x2013;140.</Citation><ArticleIdList><ArticleId IdType="pubmed">23386467</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang W, Goldberg RJ, Anderson FA, Kiefe CI, Spencer FA. Secular trends in occurrence of acute venous thromboembolism: The Worcester VTE Study (1985&#x2013;2009) Am J Med. 2014;127:829&#x2013;839. e825.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4161646</ArticleId><ArticleId IdType="pubmed">24813864</ArticleId></ArticleIdList></Reference><Reference><Citation>Melton L. History of the Rochester Epidemiology Project. Mayo Clinic Proceedings. 1996;71:266&#x2013;274.</Citation><ArticleIdList><ArticleId IdType="pubmed">8594285</ArticleId></ArticleIdList></Reference><Reference><Citation>St Sauver JL, Grossardt BR, Yawn BP, Melton LJ, 3rd, Rocca WA. Use of a medical records linkage system to enumerate a dynamic population over time: The Rochester Epidemiology Project. American Journal of Epidemiology. 2011;173:1059&#x2013;1068.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3105274</ArticleId><ArticleId IdType="pubmed">21430193</ArticleId></ArticleIdList></Reference><Reference><Citation>St Sauver JL, Grossardt BR, Leibson CL, Yawn BP, Melton LJ, 3rd, Rocca WA. Generalizability of epidemiological findings and public health decisions: An illustration from the Rochester Epidemiology Project. Mayo Clinic Proceedings. 2012;87:151&#x2013;160.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3538404</ArticleId><ArticleId IdType="pubmed">22305027</ArticleId></ArticleIdList></Reference><Reference><Citation>Silverstein MD, Heit JA, Mohr DN, Petterson TM, O'Fallon WM, Melton LJ., 3rd Trends in the incidence of deep vein thrombosis and pulmonary embolism: A 25-year population-based study. Archives of Internal Medicine. 1998;158:585&#x2013;593.</Citation><ArticleIdList><ArticleId IdType="pubmed">9521222</ArticleId></ArticleIdList></Reference><Reference><Citation>Heit JA, Melton LJ, 3rd, Lohse CM, Petterson TM, Silverstein MD, Mohr DN, O'Fallon WM. Incidence of venous thromboembolism in hospitalized patients vs community residents. Mayo Clinic Proceedings. 2001;76:1102&#x2013;1110.</Citation><ArticleIdList><ArticleId IdType="pubmed">11702898</ArticleId></ArticleIdList></Reference><Reference><Citation>Heit JA. Venous thromboembolism: Disease burden, outcomes and risk factors. J Thromb Haemost. 2005;3:1611&#x2013;1617.</Citation><ArticleIdList><ArticleId IdType="pubmed">16102026</ArticleId></ArticleIdList></Reference><Reference><Citation>Kurland LT, Molgaard CA. The patient record in epidemiology. Scientific American. 1981;245:54&#x2013;63.</Citation><ArticleIdList><ArticleId IdType="pubmed">7027437</ArticleId></ArticleIdList></Reference><Reference><Citation>Ashrani AA, Gullerud RE, Petterson TM, Marks RS, Bailey KR, Heit JA. Risk factors for venous thromboembolism among active cancer patients: a population-based case-control study. Thromb Res. 2016;139:29&#x2013;37.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4769375</ArticleId><ArticleId IdType="pubmed">26916293</ArticleId></ArticleIdList></Reference><Reference><Citation>Heit JA, Silverstein MD, Mohr DN, Petterson TM, O'Fallon WM, Melton LJ., 3rd Risk factors for deep vein thrombosis and pulmonary embolism: A population-based case-control study. Archives of Internal Medicine. 2000;160:809&#x2013;815.</Citation><ArticleIdList><ArticleId IdType="pubmed">10737280</ArticleId></ArticleIdList></Reference><Reference><Citation>Cram&#xe9;r H. Mathematical methods of statistics. Princeton, NJ: Princeton University Press; 1946. p. 353.</Citation></Reference><Reference><Citation>Heit JA, Leibson CL, Ashrani AA, Petterson TM, Bailey KR, Melton LJ., 3rd Is diabetes mellitus an independent risk factor for venous thromboembolism?: A population-based case-control study. Arteriosclerosis, Thrombosis, and Vascular Biology. 2009;29:1399&#x2013;1405.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2735343</ArticleId><ArticleId IdType="pubmed">19542020</ArticleId></ArticleIdList></Reference><Reference><Citation>Spencer FA, Gore JM, Reed G, Lessard D, Pacifico L, Emery C, Crowther MA, Goldberg RJ. Venous thromboembolism and bleeding in a community setting. The Worcester Venous Thromboembolism Study. Thrombosis and Haemostasis. 2009;101:878&#x2013;885.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2827872</ArticleId><ArticleId IdType="pubmed">19404541</ArticleId></ArticleIdList></Reference><Reference><Citation>Cushman M, Tsai AW, White RH, Heckbert SR, Rosamond WD, Enright P, Folsom AR. Deep vein thrombosis and pulmonary embolism in two cohorts: The Longitudinal Investigation of Thromboembolism Etiology. Am J Med. 2004;117:19&#x2013;25.</Citation><ArticleIdList><ArticleId IdType="pubmed">15210384</ArticleId></ArticleIdList></Reference><Reference><Citation>Palareti G. How I treat isolated distal deep vein thrombosis (IDDVT) Blood. 2014;123(12):1802&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">24472834</ArticleId></ArticleIdList></Reference><Reference><Citation>Heit JA, Silverstein MD, Mohr DN, Petterson TM, O'Fallon WM, Melton LJ., 3rd Predictors of survival after deep vein thrombosis and pulmonary embolism: A population-based, cohort study. Archives of Internal Medicine. 1999;159:445&#x2013;453.</Citation><ArticleIdList><ArticleId IdType="pubmed">10074952</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahronheim JC, Bernholc AS, Clark WD. Age trends in autopsy rates. Striking decline in late life. JAMA. 1983;250:1182&#x2013;1186.</Citation><ArticleIdList><ArticleId IdType="pubmed">6876357</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoyert DL. The changing profile of autopsied deaths in the United States, 1972&#x2013;2007. NCHS Data Brief. 2011:1&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">22142988</ArticleId></ArticleIdList></Reference><Reference><Citation>Stein PD, Matta F, Dalen JE. Is the campaign to prevent VTE in hospitalized patients working? Chest. 2011;139:1317&#x2013;1321.</Citation><ArticleIdList><ArticleId IdType="pubmed">20884726</ArticleId></ArticleIdList></Reference><Reference><Citation>Burge AJ, Freeman KD, Klapper PJ, Haramati LB. Increased diagnosis of pulmonary embolism without a corresponding decline in mortality during the CT era. Clin Radiol. 2008;63:381&#x2013;386.</Citation><ArticleIdList><ArticleId IdType="pubmed">18325357</ArticleId></ArticleIdList></Reference><Reference><Citation>Leibson CL, Needleman J, Buerhaus P, Heit JA, Melton LJ, 3rd, Naessens JM, Bailey KR, Petterson TM, Ransom JE, Harris MR. Identifying in-hospital venous thromboembolism (VTE): A comparison of claims-based approaches with the Rochester Epidemiology Project VTE cohort. Medical Care. 2008;46:127&#x2013;132.</Citation><ArticleIdList><ArticleId IdType="pubmed">18219240</ArticleId></ArticleIdList></Reference><Reference><Citation>Sarrazin MS, Rosenthal GE. Finding pure and simple truths with administrative data. JAMA. 2012;307:1433&#x2013;1435.</Citation><ArticleIdList><ArticleId IdType="pubmed">22474208</ArticleId></ArticleIdList></Reference><Reference><Citation>Haut ER, Pronovost PJ, Schneider EB. Limitations of administrative databases. JAMA. 2012;307:2589. author reply 2589&#x2013;2590.</Citation><ArticleIdList><ArticleId IdType="pubmed">22735421</ArticleId></ArticleIdList></Reference><Reference><Citation>Ashrani AA, Heit JA. Caution on interpreting the time trends in pulmonary embolism as "overdiagnosis". Archives of Internal Medicine. 2011;171:1962. author reply 1962&#x2013;1963.</Citation><ArticleIdList><ArticleId IdType="pubmed">22123814</ArticleId></ArticleIdList></Reference><Reference><Citation>Delluc A, Mottier D, Le Gal G, Oger E, Lacut K. Underweight is associated with a reduced risk of venous thromboembolism. Results from the EDITH case-control study. J Thromb Haemost. 2009;7:728&#x2013;729.</Citation><ArticleIdList><ArticleId IdType="pubmed">19192117</ArticleId></ArticleIdList></Reference><Reference><Citation>Kahn SR, Lim W, Dunn AS, Cushman M, Dentali F, Akl EA, Cook DJ, Balekian AA, Klein RC, Le H, Schulman S, Hassan Murad M. Prevention of VTE in nonsurgical patients. Chest. 2012;141(2 suppl):e195S&#x2013;e226S.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3278052</ArticleId><ArticleId IdType="pubmed">22315261</ArticleId></ArticleIdList></Reference><Reference><Citation>Gould MK, Garcia DA, Wren SM, Karanicolas PJ, Arcelus JI, Heit JA, Samama CM. Prevention of VTE in nonorthopedic surgical patients. Chest. 2012;141(2 suppl):e227S&#x2013;e277S.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3278061</ArticleId><ArticleId IdType="pubmed">22315263</ArticleId></ArticleIdList></Reference><Reference><Citation>Falck-Ytter Y, Francis CW, Johanson NA, Curley C, Dahl OE, Schulman S, Ortel TL, Pauker SG, Colwell CW., Jr Prevention of VTE in orthopedic surgery patients. Chest. 2012;141(2 suppl):e278S&#x2013;e325S.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3278063</ArticleId><ArticleId IdType="pubmed">22315265</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">25010753</PMID><DateCompleted><Year>2015</Year><Month>03</Month><Day>30</Day></DateCompleted><DateRevised><Year>2022</Year><Month>03</Month><Day>18</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1541-2563</ISSN><JournalIssue CitedMedium="Internet"><Volume>11</Volume><Issue>4</Issue><PubDate><Year>2014</Year><Month>Aug</Month></PubDate></JournalIssue><Title>COPD</Title><ISOAbbreviation>COPD</ISOAbbreviation></Journal><ArticleTitle>Pulmonary embolism in chronic obstructive pulmonary disease: a population-based cohort study.</ArticleTitle><Pagination><StartPage>438</StartPage><EndPage>443</EndPage><MedlinePgn>438-43</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.3109/15412555.2013.813927</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">To evaluate the incidence of pulmonary embolism (PE) in patients with chronic obstructive pulmonary disease (COPD) in Taiwan.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">This was a retrospective population-based cohort study using data retrieved from Taiwan's National Health Insurance Research Database (2000 to 2008), which contains 99% of Taiwanese healthcare data. The evaluations included 355,878 COPD patients and 355,878 non-COPD patients for comparison.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">The incidence of PE in the COPD cohort was 12.31 per 10,000 person-years (1.37/10,000 persons/y), which was approximately 4-times higher than in the comparison cohort (0.35/10,000 persons/y). In the COPD cohort, risk of PE was higher in the young age group (20-59 y, HR 4.64, 95% CI 3.06-7.03) than in other age groups. Risk of PE was higher in patients with COPD combined with hypertension, coronary artery disease, and cancer, or those with previous operation (HR 4.16, 4.75, 4.56, and 4.50 respectively) than in those with COPD and no comorbidity.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">The overall incidence of PE is lower in Taiwan than in western countries. However, the prevalence of PE in COPD patients is higher than in non-COPD patients and increases with age. It is crucial to incorporate PE into the differential diagnosis of COPD exacerbation for clinical physicians.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Wei-Ji</ForeName><Initials>WJ</Initials><AffiliationInfo><Affiliation>1From the Chest Division, Department of Internal Medicine, Mackay Memorial Hospital , Taipei , Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lin</LastName><ForeName>Che-Chen</ForeName><Initials>CC</Initials></Author><Author ValidYN="Y"><LastName>Lin</LastName><ForeName>Chang-Yi</ForeName><Initials>CY</Initials></Author><Author ValidYN="Y"><LastName>Chang</LastName><ForeName>Yen-Jung</ForeName><Initials>YJ</Initials></Author><Author ValidYN="Y"><LastName>Sung</LastName><ForeName>Fung-Chang</ForeName><Initials>FC</Initials></Author><Author ValidYN="Y"><LastName>Kao</LastName><ForeName>Chia-Hung</ForeName><Initials>CH</Initials></Author><Author ValidYN="Y"><LastName>Yeh</LastName><ForeName>Jun-Jun</ForeName><Initials>JJ</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>COPD</MedlineTA><NlmUniqueID>101211769</NlmUniqueID><ISSNLinking>1541-2563</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000367" MajorTopicYN="N">Age Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015897" MajorTopicYN="N">Comorbidity</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003324" MajorTopicYN="N">Coronary Artery Disease</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006973" MajorTopicYN="N">Hypertension</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015994" MajorTopicYN="N">Incidence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009369" MajorTopicYN="N">Neoplasms</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D029424" MajorTopicYN="N">Pulmonary Disease, Chronic Obstructive</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011655" MajorTopicYN="N">Pulmonary Embolism</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013514" MajorTopicYN="N">Surgical Procedures, Operative</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013624" MajorTopicYN="N" Type="Geographic">Taiwan</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">chronic obstructive pulmonary disease</Keyword><Keyword MajorTopicYN="N">cohort study</Keyword><Keyword MajorTopicYN="N">pulmonary embolism</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2014</Year><Month>7</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2014</Year><Month>7</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2015</Year><Month>3</Month><Day>31</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">25010753</ArticleId><ArticleId IdType="doi">10.3109/15412555.2013.813927</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">26864215</PMID><DateCompleted><Year>2016</Year><Month>08</Month><Day>18</Day></DateCompleted><DateRevised><Year>2025</Year><Month>06</Month><Day>26</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1471-2318</ISSN><JournalIssue CitedMedium="Internet"><Volume>16</Volume><PubDate><Year>2016</Year><Month>Feb</Month><Day>10</Day></PubDate></JournalIssue><Title>BMC geriatrics</Title><ISOAbbreviation>BMC Geriatr</ISOAbbreviation></Journal><ArticleTitle>The effects of advanced age on primary total knee arthroplasty: a meta-analysis and systematic review.</ArticleTitle><Pagination><StartPage>41</StartPage><MedlinePgn>41</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">41</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s12877-016-0215-4</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Total knee arthroplasty is an effective treatment when nonsurgical treatments fail, but it is associated with risk of complications which may be increased in advanced age. The purpose of this study was to quantify age-related differences in perioperative morbidity and mortality after total knee arthroplasty through systematic review of existing literature.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">PubMed, the Cochrane database of systematic reviews, Scopus, and clinicaltrials.gov, were queried for relevant studies that compared primary total knee arthroplasty outcomes of mortality, myocardial infarction (MI), deep vein thrombosis (DVT), pulmonary embolism (PE) and functional status, of geriatric patients (&gt;75&#xa0;years old) with a younger control group (&lt;65&#xa0;years old). Pertinent journals and reference lists were hand searched. Eligibility criteria included all articles except case reports, meta-analyses, and systematic reviews. Two authors independently extracted data from each paper. Article quality was assessed using the Newcastle-Ottawa Scale.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Twenty-two studies were included. Geriatric patients had higher rates of mortality, MI, DVT, and length of stay in older compared to younger patients, however the absolute magnitude of these increases were small. The increase in mortality may have reflected decreased life expectancy in the geriatric populations as opposed to mortality specifically due perioperative risk. There were no differences in PE incidence and improvement in pain and functional status was equal in older and younger patients. Existing studies were limited by non-randomized patient selection, as well as variation in definitions and methodology.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Existing data supports offering primary total knee arthroplasty to select geriatric patients, although the risk of complications may be increased. Much of the data was of poor quality. Future prospective studies are needed to better identify risks and benefits of total knee arthroplasty so that patients and surgeons can make informed decisions.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Kuperman</LastName><ForeName>Ethan F</ForeName><Initials>EF</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, University of Iowa, Carver College of Medicine, SE 622 GH 200 Hawkins Drive, Iowa City, IA, 52242, USA. ethan-kuperman@uiowa.edu.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schweizer</LastName><ForeName>Marin</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, University of Iowa, Carver College of Medicine, SE 622 GH 200 Hawkins Drive, Iowa City, IA, 52242, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Comprehensive Access and Delivery Research and Evaluation, Iowa City VA Health System, Iowa City, IA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Epidemiology, College of Public Health, University of Iowa, Iowa City, IA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Joy</LastName><ForeName>Parijat</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, University of Iowa, Carver College of Medicine, SE 622 GH 200 Hawkins Drive, Iowa City, IA, 52242, USA. Parijat-joy@uiowa.edu.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gu</LastName><ForeName>Xiaomei</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Health Sciences Clinical Education Librarian, Hardin Library of the Health Sciences, University of Iowa, Iowa City, IA, USA. Xiaomei-gu@uiowa.edu.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fang</LastName><ForeName>Michele M</ForeName><Initials>MM</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, University of Iowa, Carver College of Medicine, SE 622 GH 200 Hawkins Drive, Iowa City, IA, 52242, USA. Michele-fang@uiowa.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2016</Year><Month>02</Month><Day>10</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>BMC Geriatr</MedlineTA><NlmUniqueID>100968548</NlmUniqueID><ISSNLinking>1471-2318</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000367" MajorTopicYN="N">Age Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019645" MajorTopicYN="N">Arthroplasty, Replacement, Knee</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName><QualifierName UI="Q000639" MajorTopicYN="Y">trends</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009203" MajorTopicYN="N">Myocardial Infarction</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011655" MajorTopicYN="N">Pulmonary Embolism</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020246" MajorTopicYN="N">Venous Thrombosis</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2015</Year><Month>10</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2016</Year><Month>2</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2016</Year><Month>2</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2016</Year><Month>2</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2016</Year><Month>8</Month><Day>19</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2016</Year><Month>2</Month><Day>10</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">26864215</ArticleId><ArticleId IdType="pmc">PMC4750247</ArticleId><ArticleId IdType="doi">10.1186/s12877-016-0215-4</ArticleId><ArticleId IdType="pii">10.1186/s12877-016-0215-4</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Katz BPFD, Heck DA, Dittus RS, Paul JE, Wright J, Coyte P, et al. Demographic variation in the rate of knee replacement: a multi-year analysis. Health Serv Res. 1996;31(2):125&#x2013;40.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1070109</ArticleId><ArticleId IdType="pubmed">8675435</ArticleId></ArticleIdList></Reference><Reference><Citation>Cram P, Lu X, Kates SL, Singh JA, Li Y, Wolf BR. Total knee arthroplasty volume, utilization, and outcomes among Medicare beneficiaries, 1991&#x2013;2010. JAMA. 2012;308(12):1227&#x2013;36. doi: 10.1001/2012.jama.11153.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/2012.jama.11153</ArticleId><ArticleId IdType="pmc">PMC4169369</ArticleId><ArticleId IdType="pubmed">23011713</ArticleId></ArticleIdList></Reference><Reference><Citation>Kane RL, Saleh KJ, Wilt TJ, Bershadsky B. The functional outcomes of total knee arthroplasty. J Bone Joint Surg Am. 2005;87(8):1719&#x2013;24. doi: 10.2106/JBJS.D.02714.</Citation><ArticleIdList><ArticleId IdType="doi">10.2106/JBJS.D.02714</ArticleId><ArticleId IdType="pubmed">16085610</ArticleId></ArticleIdList></Reference><Reference><Citation>Skou ST, Roos EM, Laursen MB, Rathleff MS, Arendt-Nielsen L, Simonsen O, et al. A randomized, controlled trial of total knee replacement. N Engl J Med. 2015;373(17):1597&#x2013;606. doi: 10.1056/NEJMoa1505467.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1505467</ArticleId><ArticleId IdType="pubmed">26488691</ArticleId></ArticleIdList></Reference><Reference><Citation>Baker PN, van der Meulen JH, Lewsey J, Gregg PJ, National Joint Registry for England and Wales The role of pain and function in determining patient satisfaction after total knee replacement. Data from the National Joint Registry for England and Wales. J Bone Joint Surg (Br) 2007;89(7):893&#x2013;900. doi: 10.1302/0301-620X.89B7.19091.</Citation><ArticleIdList><ArticleId IdType="doi">10.1302/0301-620X.89B7.19091</ArticleId><ArticleId IdType="pubmed">17673581</ArticleId></ArticleIdList></Reference><Reference><Citation>Hamel MB, Toth M, Legedza A, Rosen MP. Joint replacement surgery in elderly patients with severe osteoarthritis of the hip or knee: decision making, postoperative recovery, and clinical outcomes. Arch Intern Med. 2008;168(13):1430&#x2013;40. doi: 10.1001/archinte.168.13.1430.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archinte.168.13.1430</ArticleId><ArticleId IdType="pubmed">18625924</ArticleId></ArticleIdList></Reference><Reference><Citation>Wilson M, Baig MK, Ashraf H. Quality of life in octagenarians after coronary artery bypass grafting. Am J Cardiol. 2005;95(6):761&#x2013;4. doi: 10.1016/j.amjcard.2004.11.031.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amjcard.2004.11.031</ArticleId><ArticleId IdType="pubmed">15757606</ArticleId></ArticleIdList></Reference><Reference><Citation>Finlayson EFZ, Birkmeyer JD. Outcomes in Octogenarians undergoing high-risk caner operation: a national study. J Am Coll Surg. 2007;205(6):729&#x2013;34. doi: 10.1016/j.jamcollsurg.2007.06.307.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jamcollsurg.2007.06.307</ArticleId><ArticleId IdType="pubmed">18035254</ArticleId></ArticleIdList></Reference><Reference><Citation>Alibakhshi A, Aminian A, Mirsharifi R, Jahangriri Y, Dashti H, Karimian F. The effect of age on the outcome of esophageal cancer surgery. Ann Thorac Med. 2009;4(2):71&#x2013;4. doi: 10.4103/1817-1737.49415.</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/1817-1737.49415</ArticleId><ArticleId IdType="pmc">PMC2700490</ArticleId><ArticleId IdType="pubmed">19561928</ArticleId></ArticleIdList></Reference><Reference><Citation>Oghalai J, Buxbaum JL, Pitts LH, Jackler RK. The effect of age on acoustic neuroma surgery outcomes. Otol Neurotol. 2003;24(3):473&#x2013;7. doi: 10.1097/00129492-200305000-00020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00129492-200305000-00020</ArticleId><ArticleId IdType="pubmed">12806302</ArticleId></ArticleIdList></Reference><Reference><Citation>Yoshida GKT, Ishikawa Y, Matsumoto A, Ito Z, Tauchi R, Muramoto A, et al. The effects of surgery on locomotion in elderly patients with cervical spondylotic myelopathy. Eur Spine J. 2013;22(11):2545&#x2013;51. doi: 10.1007/s00586-013-2961-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00586-013-2961-8</ArticleId><ArticleId IdType="pmc">PMC3886528</ArticleId><ArticleId IdType="pubmed">23955371</ArticleId></ArticleIdList></Reference><Reference><Citation>Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med. 2009;151(4):264&#x2013;9. doi: 10.7326/0003-4819-151-4-200908180-00135.</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/0003-4819-151-4-200908180-00135</ArticleId><ArticleId IdType="pubmed">19622511</ArticleId></ArticleIdList></Reference><Reference><Citation>Odum SM, Springer BD. In-hospital complication rates and associated factors after simultaneous bilateral versus unilateral total knee arthroplasty. J Bone Joint Surg Am. 2014;96(13):1058&#x2013;65. doi: 10.2106/JBJS.M.00065.</Citation><ArticleIdList><ArticleId IdType="doi">10.2106/JBJS.M.00065</ArticleId><ArticleId IdType="pubmed">24990970</ArticleId></ArticleIdList></Reference><Reference><Citation>The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses [http://www.ohri.ca/programs/clinical_epidemiology/oxford_web.ppt].</Citation></Reference><Reference><Citation>Review Manager (RevMan) VeTNCC, The Cochrane Collaboration, Copenhagen. 2014.</Citation></Reference><Reference><Citation>Zicat B, Rorabeck C, Bourne R, Devane P, Nott L. Total knee arthroplasty in the octogenarian. J Arthroplasty. 1993;8(4):395&#x2013;400. doi: 10.1016/S0883-5403(06)80038-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0883-5403(06)80038-0</ArticleId><ArticleId IdType="pubmed">8409991</ArticleId></ArticleIdList></Reference><Reference><Citation>Adam R, Noble J. Primary total knee arthroplasty in the elderly. J Arthroplasty. 1994;9(5):495&#x2013;7. doi: 10.1016/0883-5403(94)90095-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0883-5403(94)90095-7</ArticleId><ArticleId IdType="pubmed">7807106</ArticleId></ArticleIdList></Reference><Reference><Citation>Ohzawa S, Takahara Y, Furumatsu T, Inoue H. Patient survival after total knee arthroplasty. Acta Med Okayama. 2001;55(5):295&#x2013;300.</Citation><ArticleIdList><ArticleId IdType="pubmed">11688953</ArticleId></ArticleIdList></Reference><Reference><Citation>Parvizi J, Sullivan TA, Trousdale RT, Lewallen DG. Thirty-day mortality after total knee arthroplasty. J Bone Joint Surg Am. 2001;83(8):1157&#x2013;61.</Citation><ArticleIdList><ArticleId IdType="pubmed">11507123</ArticleId></ArticleIdList></Reference><Reference><Citation>Gill GS, Mills D, Joshi AB. Mortality following primary total knee arthroplasty. J Bone Joint Surg Am. 2003;85(3):432&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="pubmed">12637427</ArticleId></ArticleIdList></Reference><Reference><Citation>Hilton AI, Back DL, Espag MP, Briggs TW, Cannon SR. The octogenarian total knee arthroplasty. Orthopedics. 2004;27(1):37&#x2013;40.</Citation><ArticleIdList><ArticleId IdType="pubmed">14763527</ArticleId></ArticleIdList></Reference><Reference><Citation>Hamel MB, Henderson WG, Khuri SF, Daley J. Surgical outcomes for patients aged 80 and older: morbidity and mortality from major noncardiac surgery. J Am Geriatr Soc. 2005;53(3):424&#x2013;9. doi: 10.1111/j.1532-5415.2005.53159.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1532-5415.2005.53159.x</ArticleId><ArticleId IdType="pubmed">15743284</ArticleId></ArticleIdList></Reference><Reference><Citation>Biau D, Mullins M, Judet T, Piriou P. Is anyone too old for a total knee replacement? Clin Orthop Relat Res. 2006;448:180&#x2013;4.</Citation><ArticleIdList><ArticleId IdType="pubmed">16826114</ArticleId></ArticleIdList></Reference><Reference><Citation>Clement N, MacDonald D, Howie C, Biant L. The outcome of primary total hip and knee arthroplasty in patients aged 80 years or more. J Bone Joint Surg Br. 2011;93(9):1265&#x2013;70. doi: 10.1302/0301-620X.93B9.25962.</Citation><ArticleIdList><ArticleId IdType="doi">10.1302/0301-620X.93B9.25962</ArticleId><ArticleId IdType="pubmed">21911540</ArticleId></ArticleIdList></Reference><Reference><Citation>Clement N, Jenkins P, Brenkel I, Walmsley P. Predictors of mortality after total knee replacement A ten-year survivorship analysis. J Bone Joint Surg Br. 2012;94(2):200&#x2013;4. doi: 10.1302/0301-620X.94B2.28114.</Citation><ArticleIdList><ArticleId IdType="doi">10.1302/0301-620X.94B2.28114</ArticleId><ArticleId IdType="pubmed">22323686</ArticleId></ArticleIdList></Reference><Reference><Citation>Chikuda H, Yasunaga H, Horiguchi H, Takeshita K, Sugita S, Taketomi S, et al. Impact of age and comorbidity burden on mortality and major complications in older adults undergoing orthopaedic surgery: an analysis using the Japanese diagnosis procedure combination database. BMC Musculoskelet Disord. 2013;14(1):173. doi: 10.1186/1471-2474-14-173.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2474-14-173</ArticleId><ArticleId IdType="pmc">PMC3669039</ArticleId><ArticleId IdType="pubmed">23711221</ArticleId></ArticleIdList></Reference><Reference><Citation>Maempel JF, Riddoch F, Calleja N, Brenkel IJ. Longer hospital stay, more complications, and increased mortality but substantially improved function after knee replacement in older patients: A study of 3,144 primary unilateral total knee replacements. Acta Orthop. 2015;86(5):1&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4513600</ArticleId><ArticleId IdType="pubmed">25885004</ArticleId></ArticleIdList></Reference><Reference><Citation>Kennedy JW, Johnston L, Cochrane L, Boscainos PJ. Total knee arthroplasty in the elderly: does age affect pain, function or complications? Clin Orthop Relat Res. 2013;471(6):1964&#x2013;9. doi: 10.1007/s11999-013-2803-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11999-013-2803-3</ArticleId><ArticleId IdType="pmc">PMC3706666</ArticleId><ArticleId IdType="pubmed">23354464</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuo F-C, Hsu C-H, Chen W-S, Wang J-W. Total knee arthroplasty in carefully selected patients aged 80 years or older. J Orthop Surg Res. 2014;9:61&#x2013;6. doi: 10.1186/s13018-014-0061-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13018-014-0061-z</ArticleId><ArticleId IdType="pmc">PMC4131159</ArticleId><ArticleId IdType="pubmed">25017667</ArticleId></ArticleIdList></Reference><Reference><Citation>Jones CA, Voaklander DC, Johnston DWC, Suarez-Almazor ME. The effect of age on pain, function, and quality of life after total hip and knee arthroplasty. Arch Intern Med. 2001;161(3):454&#x2013;60. doi: 10.1001/archinte.161.3.454.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archinte.161.3.454</ArticleId><ArticleId IdType="pubmed">11176772</ArticleId></ArticleIdList></Reference><Reference><Citation>Wood M, Mantilla CB, Horlocker TT, Schroeder DR, Berry DJ, Brown DL. Frequency of myocardial infarction, pulmonary embolism, deep venous thrombosis, and death following primary hip or knee arthroplasty. Anesthesiology. 2002;96(5):1140&#x2013;6. doi: 10.1097/00000542-200205000-00017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00000542-200205000-00017</ArticleId><ArticleId IdType="pubmed">11981154</ArticleId></ArticleIdList></Reference><Reference><Citation>Baser O, Supina D, Sengupta N, Wang L, Kwong L. Impact of postoperative venous thromboembolism on Medicare recipients undergoing total hip replacement or total knee replacement surgery. Am J Health Syst Pharm. 2010;67(17):1438&#x2013;45. doi: 10.2146/ajhp090572.</Citation><ArticleIdList><ArticleId IdType="doi">10.2146/ajhp090572</ArticleId><ArticleId IdType="pubmed">20720243</ArticleId></ArticleIdList></Reference><Reference><Citation>Vincent KR, Vincent HK, Lee LW, Alfano AP. Outcomes in total knee arthroplasty patients after inpatient rehabilitation: influence of age and gender. Am J Phys Med Rehabil. 2006;85(6):482&#x2013;9. doi: 10.1097/01.phm.0000219151.18749.50.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.phm.0000219151.18749.50</ArticleId><ArticleId IdType="pubmed">16715017</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith I, Elton R, Ballantyne J, Brenkel I. Pre-operative predictors of the length of hospital stay in total knee replacement. J Bone Joint Surg Br. 2008;90(11):1435&#x2013;40. doi: 10.1302/0301-620X.90B11.20687.</Citation><ArticleIdList><ArticleId IdType="doi">10.1302/0301-620X.90B11.20687</ArticleId><ArticleId IdType="pubmed">18978261</ArticleId></ArticleIdList></Reference><Reference><Citation>Laskin RS. Total knee replacement in patients older than 85 years. Clin Orthop Relat Res. 1999;367:43&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">10546597</ArticleId></ArticleIdList></Reference><Reference><Citation>Hern&#xe1;ndez-Vaquero D, Fern&#xe1;ndez-Carreira JM, P&#xe9;rez-Hern&#xe1;ndez D, Fern&#xe1;ndez-Lombard&#xed;a J, Garc&#xed;a-Sandoval MA. Total knee arthroplasty in the elderly. Is there an age limit? J Arthroplasty. 2006;21(3):358&#x2013;61. doi: 10.1016/j.arth.2005.05.030.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.arth.2005.05.030</ArticleId><ArticleId IdType="pubmed">16627143</ArticleId></ArticleIdList></Reference><Reference><Citation>Williams D, Price A, Beard D, Hadfield S, Arden N, Murray D, et al. The effects of age on patient-reported outcome measures in total knee replacements. Bone Joint J. 2013;95(1):38&#x2013;44. doi: 10.1302/0301-620X.95B1.28061.</Citation><ArticleIdList><ArticleId IdType="doi">10.1302/0301-620X.95B1.28061</ArticleId><ArticleId IdType="pubmed">23307671</ArticleId></ArticleIdList></Reference><Reference><Citation>Sharrock NE, Cazan MG, Hargett MJL, Williams-Russo P, Wilson PD. Changes in mortality after total hip and knee arthroplasty over a ten-year period. Anesth Analg. 1995;80(2):242&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">7818108</ArticleId></ArticleIdList></Reference><Reference><Citation>Mahomed NN, Barrett J, Katz JN, Baron JA, Wright J, Losina E. Epidemiology of total knee replacement in the United States Medicare population. J Bone Joint Surg Am. 2005;87(6):1222&#x2013;8. doi: 10.2106/JBJS.D.02546.</Citation><ArticleIdList><ArticleId IdType="doi">10.2106/JBJS.D.02546</ArticleId><ArticleId IdType="pubmed">15930530</ArticleId></ArticleIdList></Reference><Reference><Citation>Lie SA, Pratt N, Ryan P, Enges&#xe6;ter LB, Havelin LI, Furnes O, et al. Duration of the increase in early postoperative mortality after elective hip and knee replacement. J Bone Joint Surg Am. 2010;92(1):58&#x2013;63. doi: 10.2106/JBJS.H.01882.</Citation><ArticleIdList><ArticleId IdType="doi">10.2106/JBJS.H.01882</ArticleId><ArticleId IdType="pubmed">20048096</ArticleId></ArticleIdList></Reference><Reference><Citation>Murphy SL, Xu J, Kochanek KD. Deaths: final data for 2010. Natl Vital Stat Rep. 2013;61(4):1&#x2013;118.</Citation><ArticleIdList><ArticleId IdType="pubmed">24979972</ArticleId></ArticleIdList></Reference><Reference><Citation>Lalmohamed A, Vestergaard P, Klop C, Grove EL, de Boer A, Leufkens HG, et al. Timing of acute myocardial infarction in patients undergoing total hip or knee replacement: a nationwide cohort study. Arch Intern Med. 2012;172(16):1229&#x2013;35. doi: 10.1001/archinternmed.2012.2713.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archinternmed.2012.2713</ArticleId><ArticleId IdType="pubmed">22826107</ArticleId></ArticleIdList></Reference><Reference><Citation>Piazza G, Seddighzadeh A, Goldhaber SZ. Deep-vein thrombosis in the elderly. Clin Appl Thromb Hemost. 2008.</Citation><ArticleIdList><ArticleId IdType="pubmed">18593747</ArticleId></ArticleIdList></Reference><Reference><Citation>March LM, Cross MJ, Lapsley H, Brnabic A, Tribe KL, Bachmeier C, et al. Outcomes after hip or knee replacement surgery for osteoarthritis. A prospective cohort study comparing patients' quality of life before and after surgery with age-related population norms. Med J Aust. 1999;171(5):235&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">10495753</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">28662956</PMID><DateCompleted><Year>2018</Year><Month>05</Month><Day>29</Day></DateCompleted><DateRevised><Year>2018</Year><Month>12</Month><Day>02</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1532-8406</ISSN><JournalIssue CitedMedium="Internet"><Volume>32</Volume><Issue>11</Issue><PubDate><Year>2017</Year><Month>Nov</Month></PubDate></JournalIssue><Title>The Journal of arthroplasty</Title><ISOAbbreviation>J Arthroplasty</ISOAbbreviation></Journal><ArticleTitle>Tranexamic Acid in Knee Surgery Study-A Multicentered, Randomized, Controlled Trial.</ArticleTitle><Pagination><StartPage>3379</StartPage><EndPage>3384</EndPage><MedlinePgn>3379-3384</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.arth.2017.05.058</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0883-5403(17)30498-9</ELocationID><Abstract><AbstractText Label="BACKGROUND">Postoperative anemia following elective arthroplasty can lead to prolonged hospital stay and delays in rehabilitation and is often poorly tolerated in patients with cardiovascular disease. Tranexamic acid (TXA) has been shown to reduce perioperative blood loss in total knee arthroplasty (TKA). However, questions over its optimal route of administration remain.</AbstractText><AbstractText Label="METHODS">A double-blinded, placebo, multicentered, randomized, controlled trial investigating the efficacy of topical and systemic routes of a single intraoperative dose (1.5 g) of TXA was conducted. Patients undergoing primary, unilateral TKA were screened for eligibility. Eligible patients were consecutively enrolled from 5 New Zealand centers between July 2014 and November 2015. Three prospective groups running in parallel (topical TXA [tTXA], systemic TXA [sTXA], and placebo) were investigated for a primary outcome of estimated perioperative blood loss. An intention-to-treat analysis was used to compare outcomes between the study groups (P value &lt;.05).</AbstractText><AbstractText Label="RESULTS">One hundred and thirty-four patients across the 5 hospitals were recruited into the study. Estimated blood loss was equivalent in the 2 treatment groups, sTXA (749 mL [95% confidence interval, 637-860]) and tTXA (723 mL [620-826]). Compared to the placebo group (1090 mL [923-1257]), blood loss was significantly lower in both treatment groups (P&#xa0;= .001 and P&#xa0;= .0003, respectively). There were no significant differences in secondary outcomes, including rates of symptomatic deep vein thrombosis and pulmonary embolism (P&#xa0;= .759).</AbstractText><AbstractText Label="CONCLUSION">In the setting of elective TKA, a single 1.5-g dose of tTXA given intraoperatively either systemically or topically effectively reduces blood loss without an increase in complications.</AbstractText><CopyrightInformation>Copyright &#xa9; 2017 Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Stowers</LastName><ForeName>Marinus D J</ForeName><Initials>MDJ</Initials><AffiliationInfo><Affiliation>Department of Orthopaedics, Middlemore Hospital, Counties Manukau District Health Board (DHB), Auckland, New Zealand; Ko Awatea, Middlemore Hospital, Auckland, New Zealand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Aoina</LastName><ForeName>James</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Orthopaedics, Tauranga Hospital, Bay of Plenty DHB, Tauranga, New Zealand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vane</LastName><ForeName>Andrew</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Orthopaedics, Tauranga Hospital, Bay of Plenty DHB, Tauranga, New Zealand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Poutawera</LastName><ForeName>Vaughan</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Department of Orthopaedics, Tauranga Hospital, Bay of Plenty DHB, Tauranga, New Zealand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hill</LastName><ForeName>Andrew G</ForeName><Initials>AG</Initials><AffiliationInfo><Affiliation>South Auckland Clinical Campus, University of Auckland, Middlemore Hospital, Auckland, New Zealand; Department of Surgery, Middlemore Hospital, Counties Manukau DHB, Auckland, New Zealand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Munro</LastName><ForeName>Jacob T</ForeName><Initials>JT</Initials><AffiliationInfo><Affiliation>Department of Surgery, School of Medicine, University of Auckland, Auckland Clinical School, Auckland, New Zealand; Department of Orthopaedics, Auckland City Hospital, Auckland DHB, Auckland, New Zealand.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><DataBankList CompleteYN="Y"><DataBank><DataBankName>ClinicalTrials.gov</DataBankName><AccessionNumberList><AccessionNumber>NCT02278263</AccessionNumber></AccessionNumberList></DataBank></DataBankList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016448">Multicenter Study</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2017</Year><Month>06</Month><Day>09</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Arthroplasty</MedlineTA><NlmUniqueID>8703515</NlmUniqueID><ISSNLinking>0883-5403</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000777">Anesthetics</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000933">Antifibrinolytic Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>6T84R30KC1</RegistryNumber><NameOfSubstance UI="D014148">Tranexamic Acid</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000777" MajorTopicYN="N">Anesthetics</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000933" MajorTopicYN="N">Antifibrinolytic Agents</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="Y">administration &amp; dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019645" MajorTopicYN="Y">Arthroplasty, Replacement, Knee</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016063" MajorTopicYN="N">Blood Loss, Surgical</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002318" MajorTopicYN="N">Cardiovascular Diseases</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004311" MajorTopicYN="N">Double-Blind Method</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057194" MajorTopicYN="N">Intention to Treat Analysis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007432" MajorTopicYN="N">Intraoperative Period</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007717" MajorTopicYN="N">Knee</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007902" MajorTopicYN="N">Length of Stay</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009520" MajorTopicYN="N">New Zealand</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D059035" MajorTopicYN="N">Perioperative Period</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011184" MajorTopicYN="N">Postoperative Period</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014148" MajorTopicYN="N">Tranexamic Acid</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="Y">administration &amp; dosage</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">TRACKS</Keyword><Keyword MajorTopicYN="N">blood transfusion</Keyword><Keyword MajorTopicYN="N">estimated blood loss</Keyword><Keyword MajorTopicYN="N">perioperative care</Keyword><Keyword MajorTopicYN="N">total knee arthroplasty</Keyword><Keyword MajorTopicYN="N">tranexamic acid</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2016</Year><Month>11</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2017</Year><Month>5</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2017</Year><Month>5</Month><Day>31</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2017</Year><Month>7</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>5</Month><Day>31</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2017</Year><Month>7</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">28662956</ArticleId><ArticleId IdType="doi">10.1016/j.arth.2017.05.058</ArticleId><ArticleId IdType="pii">S0883-5403(17)30498-9</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">39496064</PMID><DateCompleted><Year>2024</Year><Month>11</Month><Day>04</Day></DateCompleted><DateRevised><Year>2025</Year><Month>05</Month><Day>03</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1536-5964</ISSN><JournalIssue CitedMedium="Internet"><Volume>103</Volume><Issue>44</Issue><PubDate><Year>2024</Year><Month>Nov</Month><Day>01</Day></PubDate></JournalIssue><Title>Medicine</Title><ISOAbbreviation>Medicine (Baltimore)</ISOAbbreviation></Journal><ArticleTitle>Application of dexmedetomidine combined with propofol-etomidate mixture in radical gastrectomy under general anesthesia.</ArticleTitle><Pagination><StartPage>e39669</StartPage><MedlinePgn>e39669</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e39669</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1097/MD.0000000000039669</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Gastric cancer is the third most common malignant tumor with the second highest mortality rate in the world, and radical gastrectomy is the main treatment method, but the operation needs a long period of time to carry out and has strong surgical trauma stimulation, which is likely to cause sympathetic nerve excitement and stress reaction in the body. Therefore, the selection of appropriate anesthetic medication regimen and anesthesia method has an important impact on the intraoperative management and postoperative recovery of patients. This study aims to compare the clinical effects of dexmedetomidine alone in combination with propofol, etomidate and propofol-etomidate mixture in the treatment of radical gastrectomy for gastric cancer.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">A total of 90 patients undergoing elective radical gastrectomy were randomly divided into the propofol group (group P), the etomidate group (group E), and the etomidate-propofol mixture group (group PE). Anesthesia induction was performed under the monitoring of bispectral index anesthesia depth. The same pumping drugs were used in 3 groups: 0.1 to 0.3 &#x3bc;g/kg&#xb7;min remifentanil, 0.5 &#x3bc;g/kg&#xb7;h dexmedetomidine, and 5 to 10 &#x3bc;g/kg&#xb7;min rocuronium. The primary outcome indicator was the hemodynamic conditions. The secondary outcome indicators included awakening time and time to accurately answer questions after operation, the prevalence of postoperative respiratory depression and adverse events, the incidence of postoperative cognitive dysfunction, and preoperative and postoperative Montreal Cognitive Assessment and Mini-Mental State Examination scores.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Among the 3 groups of patients, the use rate of vasoactive drugs in group P was higher (P&#x2005;&lt;&#x2005;.05); the systolic blood pressure, diastolic blood pressure, and heart rate of group P at T1 to T4 were significantly lower than those of groups E and PE (P&#x2005;&lt;&#x2005;.05); the systolic blood pressure, diastolic blood pressure, and heart rate of group E in T2, T4, and T6 were significantly higher than those of groups P and PE (P&#x2005;&lt;&#x2005;.05). The wake-up time after operation and the time to accurately answer the questions were longer in group E than in groups P and PE (P&#x2005;&lt;&#x2005;.05). The incidence of postoperative respiratory depression in group P was higher than that in groups E and PE (P&#x2005;&lt;&#x2005;.05). The Montreal Cognitive Assessment score of group P was lower than that of groups E and PE 7 days after operation (P&#x2005;&lt;&#x2005;.05).</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Dexmedetomidine combined with propofol-etomidate mixture is a better anesthesia drug combination.</AbstractText><CopyrightInformation>Copyright &#xa9; 2024 the Author(s). Published by Wolters Kluwer Health, Inc.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Ji</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Yongchuan Hospital Affiliated to Chongqing Medical University, Chongqing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>Jinqiu</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Chongqing University Three Gorges Hospital, Chongqing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>Xiyang</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Zhongshan Hospital, Fudan University, Shanghai, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yin</LastName><ForeName>Guangfen</ForeName><Initials>G</Initials><Identifier Source="ORCID">0000-0002-4852-0158</Identifier><AffiliationInfo><Affiliation>Department of Anesthesiology, The First Affiliated Hospital of Dali University, Dali, Yunnan, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Tao</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, No.1 People's Hospital of Dali City, Dali, Yunnan, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Ruoyu</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>School of Clinical Medicine, Dali University, Dali, Yunnan, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Ai</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>School of Clinical Medicine, Dali University, Dali, Yunnan, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Medicine (Baltimore)</MedlineTA><NlmUniqueID>2985248R</NlmUniqueID><ISSNLinking>0025-7974</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>67VB76HONO</RegistryNumber><NameOfSubstance UI="D020927">Dexmedetomidine</NameOfSubstance></Chemical><Chemical><RegistryNumber>YI7VU623SF</RegistryNumber><NameOfSubstance UI="D015742">Propofol</NameOfSubstance></Chemical><Chemical><RegistryNumber>Z22628B598</RegistryNumber><NameOfSubstance UI="D005045">Etomidate</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D018686">Anesthetics, Intravenous</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D006993">Hypnotics and Sedatives</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020927" MajorTopicYN="Y">Dexmedetomidine</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015742" MajorTopicYN="Y">Propofol</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005743" MajorTopicYN="Y">Gastrectomy</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005045" MajorTopicYN="Y">Etomidate</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000768" MajorTopicYN="Y">Anesthesia, General</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013274" MajorTopicYN="Y">Stomach Neoplasms</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018686" MajorTopicYN="N">Anesthetics, Intravenous</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006993" MajorTopicYN="N">Hypnotics and Sedatives</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>The authors have no conflicts of interest to disclose.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>11</Month><Day>4</Day><Hour>22</Hour><Minute>25</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>11</Month><Day>4</Day><Hour>22</Hour><Minute>24</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>11</Month><Day>4</Day><Hour>15</Hour><Minute>34</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>11</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39496064</ArticleId><ArticleId IdType="pmc">PMC11537582</ArticleId><ArticleId IdType="doi">10.1097/MD.0000000000039669</ArticleId><ArticleId IdType="pii">00005792-202411010-00097</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Siegel RL, Miller KD, Jemal A. Cancer statistics, 2015. CA Cancer J Clin. 2015;65:5&#x2013;29.</Citation><ArticleIdList><ArticleId IdType="pubmed">25559415</ArticleId></ArticleIdList></Reference><Reference><Citation>Akira Y, Tai O, Tetsuji Y. Changing trends in cancer incidence of upper aerodigestive tract and stomach in Japanese alcohol-dependent men (1993&#x2013;2018). Cancer Med. 2020;9:837&#x2013;46.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6970038</ArticleId><ArticleId IdType="pubmed">31957322</ArticleId></ArticleIdList></Reference><Reference><Citation>Bai HX. Advances in the incidence and mortality of gastric cancer in China. Electronic J Clin Med Literature. 2019;6:192.</Citation></Reference><Reference><Citation>Han C, Wu Q, Ni Z, et al. . Correlation analysis between incidence of gastric cancer and statistical yearbook indicators in China from 1989 to 2014. J Canc Control Treat. 2019;32:434&#x2013;40.</Citation></Reference><Reference><Citation>Sahinovic MM, Struys MMRF, Absalom AR. Clinical pharmacokinetics and pharmacodynamics of propofol. Clin Pharmacokinet. 2018;57:1539&#x2013;58.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6267518</ArticleId><ArticleId IdType="pubmed">30019172</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang J, Duan J, Xie C, Yu Y, Lu Y. Comparison between intravenous nalbuphine and lidocaine in reducing propofol-induced injection pain during gastroscopy: a randomized controlled trial. Pain Ther. 2020;9:563&#x2013;71.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7648831</ArticleId><ArticleId IdType="pubmed">32748184</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiao-Chun S, Xing A, Yan C, et al. . Etomidate-remifentanil is more suitable for monitored anesthesia care during gastroscopy in older patients than propofol-remifentanil. Med Sci Monitor. 2015;21:1&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4288392</ArticleId><ArticleId IdType="pubmed">25553506</ArticleId></ArticleIdList></Reference><Reference><Citation>Liao Y, et al. ., &#x201c;The Component Analysis of Propofol and Etomidate Mixture and Its Clinical Efficacy,&#x201d; 2015 Seventh International Conference on Measuring Technology and Mechatronics Automation, Nanchang, 2015:1152&#x2013;1155.</Citation></Reference><Reference><Citation>Zhou X, Li B-X, Chen L-M, et al. . Etomidate plus propofol versus propofol alone for sedation during gastroscopy: a randomized prospective clinical trial. Surg Endosc. 2016;30:5108&#x2013;16.</Citation><ArticleIdList><ArticleId IdType="pubmed">27005294</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu YE, Tong CC, Zhang YB, Jin H-X, Gao Y, Hou M-X. Effect of dexmedetomidine on rats with renal ischemia-reperfusion injury and the expression of tight junction protein in kidney. Int J Clin Exp Med. 2015;8:18751&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4694391</ArticleId><ArticleId IdType="pubmed">26770491</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Z, Wang Y, Wang Y, et al. . Dexmedetomidine attenuates inflammatory reaction in the lung tissues of septic mice by activating cholinergic anti-inflammatory pathway. Int Immunopharmacol. 2016;35:210&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">27074053</ArticleId></ArticleIdList></Reference><Reference><Citation>McMorrow SP, Abramo TJ. Dexmedetomidine sedation: uses in pediatric procedural sedation outside the operating room. Pediatr Emerg Care. 2012;28:292&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">22391930</ArticleId></ArticleIdList></Reference><Reference><Citation>Mostafa RH, Ibrahim IM, Ayoub AH. Effect of perioperative dexmedetomidine infusion on blood glucose levels in non-diabetic morbid obese patients undergoing laparoscopic bariatric surgery. Egyptian J Anaesth. 2018;34:75&#x2013;81.</Citation></Reference><Reference><Citation>Kim SH, Kim DH, Shin S, Kim SJ, Kim TL, Choi YS. Effects of dexmedetomidine on inflammatory mediators after tourniquet-induced ischemia-reperfusion injury: a randomized, double-blinded, controlled study. Minerva Anestesiol. 2018;85:279&#x2013;87.</Citation><ArticleIdList><ArticleId IdType="pubmed">30207136</ArticleId></ArticleIdList></Reference><Reference><Citation>Lewis SR, Nicholson A, Smith AF, et al. . Alpha-2 adrenergic agonists for the prevention of shivering following general anaesthesia. Cochrane Database Syst Rev. 2015;8:68&#x2013;73.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9221859</ArticleId><ArticleId IdType="pubmed">26256531</ArticleId></ArticleIdList></Reference><Reference><Citation>Funai Y, Pickering AE, Uta D, et al. . Systemic dexmedetomidine augments inhibitory synaptic transmission in the superficial dorsal horn through activation of descending noradrenergic control: an in vivo patch-clamp analysis of analgesic mechanisms. Pain. 2014;155:617&#x2013;28.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4237836</ArticleId><ArticleId IdType="pubmed">24355412</ArticleId></ArticleIdList></Reference><Reference><Citation>Guneli E, Yavasoglu NUK, Apaydin S, et al. . Analysis of the antinociceptive effect of systemic administration of tramadol and dexmedetomidine combination on rat models of acute and neuropathic pain. Pharmacol Biochem Behav. 2007;88:9&#x2013;17.</Citation><ArticleIdList><ArticleId IdType="pubmed">17651791</ArticleId></ArticleIdList></Reference><Reference><Citation>Li WB, Cai YL, Li AX, Zhu H. Application of dexmedetomidine combined with etomidate in interventional anesthesia for stroke. Modern Diagnosis Treat. 2016;27:1040&#x2013;1.</Citation></Reference><Reference><Citation>Liu Y, Huang Y, Wang R, Zhai Y, Huang K, Ren Z. Sedation with a 1:1 mixture of etomidate and propofol for gastroscopy in hypertensive elderly patients. J Clin Hypertens (Greenwich). 2023;25:778&#x2013;83.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10423762</ArticleId><ArticleId IdType="pubmed">37436589</ArticleId></ArticleIdList></Reference><Reference><Citation>Du J, Bie X, Zhu D. Application of etomidate and propofol mixture in hematoma removal in patients with intracranial epidural hematoma. Am J Transl Res. 2021;13:8403&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8340204</ArticleId><ArticleId IdType="pubmed">34377335</ArticleId></ArticleIdList></Reference><Reference><Citation>Bansal V, Sisodia RS, Tiwari D, et al. . A comparative study of effect of propofol, etomidate lipuro and propofol&#x2013;etomidate lipuro admixture on haemodyanamic response and on BIS values at induction of general anaesthesia&#x2014;A RCT. Int J Health Clin Res. 2020;3:61&#x2013;7.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">39840850</PMID><DateCompleted><Year>2025</Year><Month>05</Month><Day>02</Day></DateCompleted><DateRevised><Year>2025</Year><Month>05</Month><Day>23</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1096-8652</ISSN><JournalIssue CitedMedium="Internet"><Volume>100</Volume><Issue>4</Issue><PubDate><Year>2025</Year><Month>Apr</Month></PubDate></JournalIssue><Title>American journal of hematology</Title><ISOAbbreviation>Am J Hematol</ISOAbbreviation></Journal><ArticleTitle>Combination of Biological Aging and Genetic Susceptibility Helps Identifying At-Risk Population of Venous Thromboembolism: A Prospective Cohort Study of 394&#x2009;041 Participants.</ArticleTitle><Pagination><StartPage>575</StartPage><EndPage>583</EndPage><MedlinePgn>575-583</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1002/ajh.27605</ELocationID><Abstract><AbstractText>Phenotypic age acceleration (PhenoAgeAccel) is a novel clinical aging indicator. This study was carried out to investigate the relationship between PhenoAgeAccel and the incidence of VTE, as well as to integrate PhenoAgeAccel with genetic susceptibility to improve risk stratification of VTE. The study included 394&#x2009;041 individuals from the UK Biobank. Phenotypic age was calculated based on actual age and clinical biomarkers. PhenoAgeAccel presents the residual obtained from a linear regression of phenotypic age against actual age, reflecting the rate of aging. Significant associations were observed between PhenoAgeAccel and higher risk of VTE (Hazard ratio [HR] 1.37, 95% CI: 1.32-1.42), deep vein thrombosis (DVT, HR 1.35, 95% CI: 1.29-1.42), and PE (pulmonary embolism, HR 1.41, 95% CI: 1.34-1.48) in the findings. PhenoAgeAccel exhibited a significant additive interaction with genetic susceptibility. Biologically older participants with high genetic risk have a 3.83 (95% CI: 3.51-4.18) folds risk of VTE, a 3.59 (95% CI: 3.21-4.03) folds risk of DVT, and 4.39 (95% CI: 3.88-4.98) folds risk of PE, in comparison to biologically younger participants with low genetic risk. Mediation analyses indicated that PhenoAgeAccel mediated approximately 6% of the association between cancer and VTE, and about 20% of the association between obesity and VTE. Our study indicated that PhenoAgeAccel is significantly associated with higher risk of VTE, and can be combined with genetic risk to improve VTE risk stratification. Additionally, PhenoAgeAccel holds promise as a clinical biomarker for guiding targeted prevention and treatment strategies for VTE.</AbstractText><CopyrightInformation>&#xa9; 2025 Wiley Periodicals LLC.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Hu</LastName><ForeName>Zhensheng</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Zhongshan School of Medicine, Sun Yat-Sen University, Guangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xu</LastName><ForeName>Jiatang</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Zhongshan School of Medicine, Sun Yat-Sen University, Guangzhou, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Cardiovascular Surgery, the First Affiliated Hospital of Sun Yat-Sen University, Sun Yat-Sen University, Guangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shen</LastName><ForeName>Runnan</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Zhongshan School of Medicine, Sun Yat-Sen University, Guangzhou, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Urology Surgery, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lin</LastName><ForeName>Liling</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Su</LastName><ForeName>Yangfan</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Cardiovascular Surgery, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xie</LastName><ForeName>Chaoyu</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Zhongshan School of Medicine, Sun Yat-Sen University, Guangzhou, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Cardiovascular Surgery, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>You</LastName><ForeName>Guochang</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Zhongshan School of Medicine, Sun Yat-Sen University, Guangzhou, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Vascular Surgery, the First Affiliated Hospital of Sun Yat-Sen University, Sun Yat-Sen University, Guangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhou</LastName><ForeName>Yi</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Zhongshan School of Medicine, Sun Yat-Sen University, Guangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Huang</LastName><ForeName>Kai</ForeName><Initials>K</Initials><Identifier Source="ORCID">0000-0001-8797-7671</Identifier><AffiliationInfo><Affiliation>Zhongshan School of Medicine, Sun Yat-Sen University, Guangzhou, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Cardiovascular Surgery, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>81800420</GrantID><Agency>National Natural Science Foundation of China</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>01</Month><Day>22</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Am J Hematol</MedlineTA><NlmUniqueID>7610369</NlmUniqueID><ISSNLinking>0361-8609</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D054556" MajorTopicYN="Y">Venous Thromboembolism</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020022" MajorTopicYN="Y">Genetic Predisposition to Disease</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000375" MajorTopicYN="Y">Aging</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015994" MajorTopicYN="N">Incidence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010641" MajorTopicYN="N">Phenotype</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006113" MajorTopicYN="N" Type="Geographic">United Kingdom</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020246" MajorTopicYN="N">Venous Thrombosis</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">biological aging</Keyword><Keyword MajorTopicYN="N">phenotypic age</Keyword><Keyword MajorTopicYN="N">polygenic risk score</Keyword><Keyword MajorTopicYN="N">risk stratification</Keyword><Keyword MajorTopicYN="N">venous thromboembolism</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>12</Month><Day>31</Day></PubMedPubDate><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>10</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2025</Year><Month>1</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>3</Month><Day>7</Day><Hour>6</Hour><Minute>21</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>1</Month><Day>22</Day><Hour>12</Hour><Minute>29</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>1</Month><Day>22</Day><Hour>8</Hour><Minute>3</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39840850</ArticleId><ArticleId IdType="doi">10.1002/ajh.27605</ArticleId></ArticleIdList><ReferenceList><Title>References</Title><Reference><Citation>S. S. Martin, A. W. Aday, Z. I. Almarzooq, et&#xa0;al., &#x201c;2024 Heart Disease and Stroke Statistics: A Report of US and Global Data From the American Heart Association,&#x201d; Circulation 149, no. 8 (2024): e347&#x2013;e913.</Citation></Reference><Reference><Citation>F. A. Anderson, Jr. and F. A. Spencer, &#x201c;Risk Factors for Venous Thromboembolism,&#x201d; Circulation 107, no. 23 Suppl 1 (2003): I9&#x2013;I16.</Citation></Reference><Reference><Citation>G. E. Raskob, P. Angchaisuksiri, A. N. Blanco, et&#xa0;al., &#x201c;Thrombosis: A Major Contributor to Global Disease Burden,&#x201d; Arteriosclerosis, Thrombosis, and Vascular Biology 34, no. 11 (2014): 2363&#x2013;2371.</Citation></Reference><Reference><Citation>E. Grilz, F. Posch, S. Nopp, et&#xa0;al., &#x201c;Relative Risk of Arterial and Venous Thromboembolism in Persons With Cancer vs. Persons Without Cancer&#x2010;A Nationwide Analysis,&#x201d; European Heart Journal 42, no. 23 (2021): 2299&#x2013;2307.</Citation></Reference><Reference><Citation>M. L. Elliott, A. Caspi, R. M. Houts, et&#xa0;al., &#x201c;Disparities in the Pace of Biological Aging Among Midlife Adults of the Same Chronological Age Have Implications for Future Frailty Risk and Policy,&#x201d; Nature Aging 1, no. 3 (2021): 295&#x2013;308.</Citation></Reference><Reference><Citation>L. Ferrucci, M. Gonzalez&#x2010;Freire, E. Fabbri, et&#xa0;al., &#x201c;Measuring Biological Aging in Humans: A Quest,&#x201d; Aging Cell 19, no. 2 (2020): e13080.</Citation></Reference><Reference><Citation>C. L&#xf3;pez&#x2010;Ot&#xed;n, M. A. Blasco, L. Partridge, M. Serrano, and G. Kroemer, &#x201c;Hallmarks of Aging: An Expanding Universe,&#x201d; Cell 186, no. 2 (2023): 243&#x2013;278.</Citation></Reference><Reference><Citation>Z. Liu, P. L. Kuo, S. Horvath, E. Crimmins, L. Ferrucci, and M. Levine, &#x201c;A New Aging Measure Captures Morbidity and Mortality Risk Across Diverse Subpopulations From NHANES IV: A Cohort Study,&#x201d; PLoS Medicine 15, no. 12 (2018): e1002718.</Citation></Reference><Reference><Citation>T. Wang, W. Duan, X. Jia, et&#xa0;al., &#x201c;Associations of Combined Phenotypic Ageing and Genetic Risk With Incidence of Chronic Respiratory Diseases in the UK Biobank: A Prospective Cohort Study,&#x201d; European Respiratory Journal 63, no. 2 (2024): 2301720.</Citation></Reference><Reference><Citation>X. Gao, T. Geng, M. Jiang, et&#xa0;al., &#x201c;Accelerated Biological Aging and Risk of Depression and Anxiety: Evidence From 424,299 UK Biobank Participants,&#x201d; Nature Communications 14, no. 1 (2023): 2277.</Citation></Reference><Reference><Citation>C. L. Kuo, L. C. Pilling, J. L. Atkins, et&#xa0;al., &#x201c;Biological Aging Predicts Vulnerability to COVID&#x2010;19 Severity in UK Biobank Participants,&#x201d; Journals of Gerontology. Series A, Biological Sciences and Medical Sciences 76, no. 8 (2021): e133&#x2013;e141.</Citation></Reference><Reference><Citation>C. L. Kuo, L. C. Pilling, Z. Liu, J. L. Atkins, and M. E. Levine, &#x201c;Genetic Associations for Two Biological Age Measures Point to Distinct Aging Phenotypes,&#x201d; Aging Cell 20, no. 6 (2021): e13376.</Citation></Reference><Reference><Citation>T. B. Larsen, H. T. S&#xf8;rensen, A. Skytthe, S. P. Johnsen, J. W. Vaupel, and K. Christensen, &#x201c;Major Genetic Susceptibility for Venous Thromboembolism in Men: A Study of Danish Twins,&#x201d; Epidemiology 14, no. 3 (2003): 328&#x2013;332.</Citation></Reference><Reference><Citation>J. A. Heit, M. A. Phelps, S. A. Ward, J. P. Slusser, T. M. Petterson, and M. De Andrade, &#x201c;Familial Segregation of Venous Thromboembolism,&#x201d; Journal of Thrombosis and Haemostasis 2, no. 5 (2004): 731&#x2013;736.</Citation></Reference><Reference><Citation>J. Ghouse, V. Tragante, G. Ahlberg, et&#xa0;al., &#x201c;Genome&#x2010;Wide Meta&#x2010;Analysis Identifies 93 Risk Loci and Enables Risk Prediction Equivalent to Monogenic Forms of Venous Thromboembolism,&#x201d; Nature Genetics 55, no. 3 (2023): 399&#x2013;409.</Citation></Reference><Reference><Citation>D. Klarin, E. Busenkell, R. Judy, et&#xa0;al., &#x201c;Genome&#x2010;Wide Association Analysis of Venous Thromboembolism Identifies New Risk Loci and Genetic Overlap With Arterial Vascular Disease,&#x201d; Nature Genetics 51, no. 11 (2019): 1574&#x2013;1579.</Citation></Reference><Reference><Citation>F. Cui, Y. Sun, J. Xie, et&#xa0;al., &#x201c;Air Pollutants, Genetic Susceptibility and Risk of Incident Idiopathic Pulmonary Fibrosis,&#x201d; European Respiratory Journal 61, no. 2 (2023): 2200777.</Citation></Reference><Reference><Citation>L. Zeng, Z. Wu, J. Yang, Y. Zhou, and R. Chen, &#x201c;Association of Genetic Risk and Lifestyle With Pancreatic Cancer and Their Age Dependency: A Large Prospective Cohort Study in the UK Biobank,&#x201d; BMC Medicine 21, no. 1 (2023): 489.</Citation></Reference><Reference><Citation>C. Sudlow, J. Gallacher, N. Allen, et&#xa0;al., &#x201c;UK Biobank: An Open Access Resource for Identifying the Causes of a Wide Range of Complex Diseases of Middle and Old Age,&#x201d; PLoS Medicine 12, no. 3 (2015): e1001779.</Citation></Reference><Reference><Citation>C. Bycroft, C. Freeman, D. Petkova, et&#xa0;al., &#x201c;The UK Biobank Resource With Deep Phenotyping and Genomic Data,&#x201d; Nature 562, no. 7726 (2018): 203&#x2013;209.</Citation></Reference><Reference><Citation>S. Yuan, Y. Sun, J. Chen, X. Li, and S. C. Larsson, &#x201c;Long&#x2010;Term Risk of Venous Thromboembolism Among Patients With Gastrointestinal Non&#x2010;Neoplastic and Neoplastic Diseases: A Prospective Cohort Study of 484&#x2009;211 Individuals,&#x201d; American Journal of Hematology 99, no. 2 (2024): 172&#x2013;181.</Citation></Reference><Reference><Citation>H. Xiang, M. Liu, C. Zhou, et&#xa0;al., &#x201c;Tea Consumption, Milk or Sweeteners Addition, Genetic Variation in Caffeine Metabolism, and Incident Venous Thromboembolism,&#x201d; Thrombosis and Haemostasis 124, no. 12 (2024): 1143&#x2013;1151.</Citation></Reference><Reference><Citation>R. M. Baron and D. A. Kenny, &#x201c;The Moderator&#x2010;Mediator Variable Distinction in Social Psychological Research: Conceptual, Strategic, and Statistical Considerations,&#x201d; Journal of Personality and Social Psychology 51, no. 6 (1999): 1173.</Citation></Reference><Reference><Citation>C. Becattini and G. Agnelli, &#x201c;Acute Treatment of Venous Thromboembolism,&#x201d; Blood 135, no. 5 (2020): 305&#x2013;316.</Citation></Reference><Reference><Citation>A. Rabinovich and S. R. Kahn, &#x201c;How I Treat the Postthrombotic Syndrome,&#x201d; Blood 131, no. 20 (2018): 2215&#x2013;2222.</Citation></Reference><Reference><Citation>H. K. Nick, M. D. A. Andrea, D. Marion, et&#xa0;al., &#x201c;Chronic Thromboembolic Pulmonary Disease,&#x201d; European Respiratory Journal 64 (2024): 2401294.</Citation></Reference><Reference><Citation>K. A. Martin, R. Molsberry, M. J. Cuttica, K. R. Desai, D. R. Schimmel, and S. S. Khan, &#x201c;Time Trends in Pulmonary Embolism Mortality Rates in the United States, 1999 to 2018,&#x201d; Journal of the American Heart Association 9, no. 17 (2020): e016784.</Citation></Reference><Reference><Citation>Y. Shargall, W. Wiercioch, A. Brunelli, et&#xa0;al., &#x201c;Joint 2022 European Society of Thoracic Surgeons and the American Association for Thoracic Surgery Guidelines for the Prevention of Cancer&#x2010;Associated Venous Thromboembolism in Thoracic Surgery,&#x201d; European Journal of Cardio&#x2010;Thoracic Surgery 63, no. 1 (2022): ezac488.</Citation></Reference><Reference><Citation>C. U. Rank, L. S. Lynggaard, B. Als&#x2010;Nielsen, et&#xa0;al., &#x201c;Prophylaxis of Thromboembolism During Therapy With Asparaginase in Adults With Acute Lymphoblastic Leukaemia,&#x201d; Cochrane Database of Systematic Reviews 10, no. 10 (2020): Cd013399.</Citation></Reference><Reference><Citation>A. J. Darzi, A. B. Repp, F. A. Spencer, et&#xa0;al., &#x201c;Risk&#x2010;Assessment Models for VTE and Bleeding in Hospitalized Medical Patients: An Overview of Systematic Reviews,&#x201d; Blood Advances 4, no. 19 (2020): 4929&#x2013;4944.</Citation></Reference><Reference><Citation>A. J. Darzi, S. G. Karam, F. A. Spencer, et&#xa0;al., &#x201c;Risk Models for VTE and Bleeding in Medical Inpatients: Systematic Identification and Expert Assessment,&#x201d; Blood Advances 4, no. 12 (2020): 2557&#x2013;2566.</Citation></Reference><Reference><Citation>S. Barbar, F. Noventa, V. Rossetto, et&#xa0;al., &#x201c;A Risk Assessment Model for the Identification of Hospitalized Medical Patients at Risk for Venous Thromboembolism: The Padua Prediction Score,&#x201d; Journal of Thrombosis and Haemostasis 8, no. 11 (2010): 2450&#x2013;2457.</Citation></Reference><Reference><Citation>P. Klemera and S. Doubal, &#x201c;A New Approach to the Concept and Computation of Biological Age,&#x201d; Mechanisms of Ageing and Development 127, no. 3 (2006): 240&#x2013;248.</Citation></Reference><Reference><Citation>K. Faizan, T. Tobias, R. K. Susan, and A. R. Marc, &#x201c;Venous Thromboembolism,&#x201d; Lancet 398 (2021): 10294.</Citation></Reference><Reference><Citation>V. Rafaela, H. Philipp, N. Stephan, et&#xa0;al., &#x201c;Association of Telomere Length and Mitochondrial DNA Copy Number, Two Biomarkers of Biological Aging, With the Risk of Venous Thromboembolism,&#x201d; Thrombosis Research 223 (2023): 168&#x2013;173.</Citation></Reference><Reference><Citation>K. D. Salpea and S. E. Humphries, &#x201c;Telomere Length in Atherosclerosis and Diabetes,&#x201d; Atherosclerosis 209, no. 1 (2010): 35&#x2013;38.</Citation></Reference><Reference><Citation>S. Ades, Y. Resnick, J. Barker, et&#xa0;al., &#x201c;Venous Thromboembolism Prevention Program Implementation in a Community Oncology Practice: A Cohort Study,&#x201d; Lancet Regional Health&#x2013;Americas 38 (2024): 100866.</Citation></Reference><Reference><Citation>T. F. Wang, H. H. Billett, J. M. Connors, and G. A. Soff, &#x201c;Approach to Cancer&#x2010;Associated Thrombosis: Challenging Situations and Knowledge Gaps,&#x201d; Oncologist 26, no. 1 (2021): e17&#x2013;e23.</Citation></Reference><Reference><Citation>M. Hua, F. Xiong, S. Chong, et&#xa0;al., &#x201c;Abemaciclib Increases the Risk of Venous Thromboembolism in Breast Cancer: Integrate Meta&#x2010;Analysis, Pharmacovigilance Database Analysis, and In&#xa0;Vitro Validation,&#x201d; Cancer Treatment Reviews 130 (2024): 102827.</Citation></Reference><Reference><Citation>M. B. Streiff, B. Holmstrom, D. Angelini, et&#xa0;al., &#x201c;Cancer&#x2010;Associated Venous Thromboembolic Disease, Version 2.2024, NCCN Clinical Practice Guidelines in Oncology,&#x201d; Journal of the National Comprehensive Cancer Network 22, no. 7 (2024): 483&#x2013;506.</Citation></Reference><Reference><Citation>J. Gregson, S. Kaptoge, T. Bolton, et&#xa0;al., &#x201c;Cardiovascular Risk Factors Associated With Venous Thromboembolism,&#x201d; JAMA Cardiology 4, no. 2 (2019): 163&#x2013;173.</Citation></Reference><Reference><Citation>J. I. Weitz, A. E. Farjat, W. Ageno, et&#xa0;al., &#x201c;Influence of Body Mass Index on Clinical Outcomes in Venous Thromboembolism: Insights From GARFIELD&#x2010;VTE,&#x201d; Journal of Thrombosis and Haemostasis 19, no. 12 (2021): 3031&#x2013;3043.</Citation></Reference><Reference><Citation>Z. Liu, X. Chen, T. M. Gill, C. Ma, E. M. Crimmins, and M. E. Levine, &#x201c;Associations of Genetics, Behaviors, and Life Course Circumstances With a Novel Aging and Healthspan Mure: Evidence From the Health and Retirement Study,&#x201d; PLoS Medicine 16, no. 6 (2019): e1002827.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">34120808</PMID><DateCompleted><Year>2021</Year><Month>12</Month><Day>06</Day></DateCompleted><DateRevised><Year>2022</Year><Month>12</Month><Day>07</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1532-2157</ISSN><JournalIssue CitedMedium="Internet"><Volume>47</Volume><Issue>8</Issue><PubDate><Year>2021</Year><Month>Aug</Month></PubDate></JournalIssue><Title>European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology</Title><ISOAbbreviation>Eur J Surg Oncol</ISOAbbreviation></Journal><ArticleTitle>Major head and neck surgeries in the elderly population, a match-control study.</ArticleTitle><Pagination><StartPage>1947</StartPage><EndPage>1952</EndPage><MedlinePgn>1947-1952</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.ejso.2021.06.009</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0748-7983(21)00571-0</ELocationID><Abstract><AbstractText Label="BACKGROUND AND OBJECTIVES">To investigate complication rates in elderly cancer patients undergoing major head and neck surgeries.</AbstractText><AbstractText Label="METHODS">A retrospective, matched-control, analysis. For each elderly (&#x2265;70 years) patient, a younger, (&lt;70 years) patients were matched based on sex, tumor location, disease stage, and operation time. Post-operative complication and survival analyses were performed.</AbstractText><AbstractText Label="RESULTS">Of 225 patients, 75 (33.3%) were elderly (mean age 76.2 (70-88) years) and compared with a match control group (53.2 (23-69) years). A higher rate of cardio-vascular comorbidity was noted in the elderly group (70.6% vs. 34%, respectively, P&#xa0;&lt;&#xa0;0.001). The majority (62.7%) of elderly patients required reconstruction with 24% receiving vascularized flap reconstruction. Total postoperative complication rate was 49.9% in the study versus 42.3% in the control group, with a major complication rate of 22.5% in the elderly versus 11.9% in the control group (P&#xa0;=&#xa0;0.154). Mean follow-up was 41 (0-144) months. Five-year disease-specific (67.1% vs. 80.7%, P&#xa0;&lt;&#xa0;0.001) and overall survival rates (48.6% vs. 75.4%, P&#xa0;&lt;&#xa0;0.001) were significantly lower among elderly patients.</AbstractText><AbstractText Label="CONCLUSIONS">Major head and neck surgery in the elderly population does not entail higher complication rate, compared with younger patients, and should be allowed when curative intent is feasible and patient's general condition allows.</AbstractText><CopyrightInformation>Copyright &#xa9; 2021 Elsevier Ltd, BASO ~ The Association for Cancer Surgery, and the European Society of Surgical Oncology. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Tzelnick</LastName><ForeName>Sharon</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Otolaryngology, Head and Neck Surgery, Rabin Medical Center - Beilinson Hospital, Petach Tikva, Israel; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel. Electronic address: tzelnicksharon@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mizrachi</LastName><ForeName>Aviram</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Otolaryngology, Head and Neck Surgery, Rabin Medical Center - Beilinson Hospital, Petach Tikva, Israel; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shavit</LastName><ForeName>Sagit Stern</ForeName><Initials>SS</Initials><AffiliationInfo><Affiliation>Department of Otolaryngology, Head and Neck Surgery, Rabin Medical Center - Beilinson Hospital, Petach Tikva, Israel; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ben-Ner</LastName><ForeName>Daniel</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Otolaryngology, Head and Neck Surgery, Rabin Medical Center - Beilinson Hospital, Petach Tikva, Israel; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Reuven</LastName><ForeName>Yonathan</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Otolaryngology, Head and Neck Surgery, Rabin Medical Center - Beilinson Hospital, Petach Tikva, Israel; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Elias</LastName><ForeName>Bshara</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Otolaryngology, Head and Neck Surgery, Rabin Medical Center - Beilinson Hospital, Petach Tikva, Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shpitzer</LastName><ForeName>Thomas</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Otolaryngology, Head and Neck Surgery, Rabin Medical Center - Beilinson Hospital, Petach Tikva, Israel; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bachar</LastName><ForeName>Gideon</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Otolaryngology, Head and Neck Surgery, Rabin Medical Center - Beilinson Hospital, Petach Tikva, Israel; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>06</Month><Day>08</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Eur J Surg Oncol</MedlineTA><NlmUniqueID>8504356</NlmUniqueID><ISSNLinking>0748-7983</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000367" MajorTopicYN="N">Age Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001145" MajorTopicYN="N">Arrhythmias, Cardiac</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016022" MajorTopicYN="N">Case-Control Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015897" MajorTopicYN="N">Comorbidity</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017577" MajorTopicYN="N">Cutaneous Fistula</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018572" MajorTopicYN="N">Disease-Free Survival</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006258" MajorTopicYN="N">Head and Neck Neoplasms</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007511" MajorTopicYN="N">Ischemia</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007822" MajorTopicYN="N">Laryngeal Neoplasms</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007825" MajorTopicYN="N">Laryngectomy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009026" MajorTopicYN="Y">Mortality</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009062" MajorTopicYN="N">Mouth Neoplasms</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D037981" MajorTopicYN="Y">Neck Dissection</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013517" MajorTopicYN="Y">Otorhinolaryngologic Surgical Procedures</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010608" MajorTopicYN="N">Pharyngeal Diseases</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010996" MajorTopicYN="N">Pleural Effusion</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011014" MajorTopicYN="N">Pneumonia</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011655" MajorTopicYN="N">Pulmonary Embolism</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019651" MajorTopicYN="Y">Plastic Surgery Procedures</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016879" MajorTopicYN="N">Salvage Therapy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018805" MajorTopicYN="N">Sepsis</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013524" MajorTopicYN="Y">Surgical Flaps</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013530" MajorTopicYN="N">Surgical Wound Infection</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020246" MajorTopicYN="N">Venous Thrombosis</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Complications</Keyword><Keyword MajorTopicYN="N">Elderly</Keyword><Keyword MajorTopicYN="N">Head and neck surgery</Keyword><Keyword MajorTopicYN="N">Survival</Keyword></KeywordList><CoiStatement>Declaration of competing interest The authors declare that they have no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>2</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2021</Year><Month>4</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>6</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>6</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>12</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>6</Month><Day>14</Day><Hour>6</Hour><Minute>16</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34120808</ArticleId><ArticleId IdType="doi">10.1016/j.ejso.2021.06.009</ArticleId><ArticleId IdType="pii">S0748-7983(21)00571-0</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">21674473</PMID><DateCompleted><Year>2011</Year><Month>10</Month><Day>24</Day></DateCompleted><DateRevised><Year>2025</Year><Month>06</Month><Day>26</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1365-2168</ISSN><JournalIssue CitedMedium="Internet"><Volume>98</Volume><Issue>10</Issue><PubDate><Year>2011</Year><Month>Oct</Month></PubDate></JournalIssue><Title>The British journal of surgery</Title><ISOAbbreviation>Br J Surg</ISOAbbreviation></Journal><ArticleTitle>Systematic review and meta-analysis on the rate of postoperative venous thromboembolism in orthopaedic surgery in Asian patients without thromboprophylaxis.</ArticleTitle><Pagination><StartPage>1356</StartPage><EndPage>1364</EndPage><MedlinePgn>1356-64</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1002/bjs.7589</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Postoperative venous thromboembolism (VTE) is a common life-threatening complication after surgery. This review analysed the rate and mortality of VTE after orthopaedic surgery in Asia.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Inclusion criteria were: prospective study; deep vein thrombosis (DVT) diagnosed by venography or ultrasonography; hip fracture surgery (HFS), total hip arthroplasty (THA) or total knee arthroplasty (TKA); and no thromboprophylaxis. The pooled proportion was back-calculated by Freeman-Tukey variant transformation, using a random-effects model.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Twenty-two studies (total population 2454) published from 1979 to 2009 were included. Using venography, the pooled rates of all-site, proximal, distal and isolated distal DVT were 31&#xb7;7, 8&#xb7;9, 22&#xb7;5 and 18&#xb7;8 per cent respectively. With duplex ultrasonography, the respective rates were 9&#xb7;4, 5&#xb7;9, 5&#xb7;9 and 5&#xb7;8 per cent. After THA or HFS, using venography, the pooled rates of all-site and proximal DVT were 25&#xb7;8 and 9&#xb7;6 per cent; with ultrasonography, the respective rates were 10&#xb7;8 and 7&#xb7;2 per cent. In TKA groups, using venography, the pooled rates of all-site and proximal DVT were 42&#xb7;5 and 8&#xb7;7 per cent; with ultrasonography, the respective rates were 9&#xb7;5 and 5&#xb7;2 per cent. The overall pooled rates of symptomatic DVT and symptomatic pulmonary embolism (PE) were 4&#xb7;5 and 0&#xb7;6 per cent. No patient died from PE (pooled rate 0&#xb7;2 per cent).</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">None of these Asian patients undergoing orthopaedic surgery died from VTE. Pooled rates of proximal and symptomatic DVT were lower than in Western reports.</AbstractText><CopyrightInformation>Copyright &#xa9; 2011 British Journal of Surgery Society Ltd. Published by John Wiley &amp; Sons, Ltd.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Kanchanabat</LastName><ForeName>B</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Vascular Unit, Department of Surgery, Faculty of Medicine, Vajira Hospital, University of Bangkok Metropolitan, Bangkok, Thailand. burapa@vajira.ac.th</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Stapanavatr</LastName><ForeName>W</ForeName><Initials>W</Initials></Author><Author ValidYN="Y"><LastName>Meknavin</LastName><ForeName>S</ForeName><Initials>S</Initials></Author><Author ValidYN="Y"><LastName>Soorapanth</LastName><ForeName>C</ForeName><Initials>C</Initials></Author><Author ValidYN="Y"><LastName>Sumanasrethakul</LastName><ForeName>C</ForeName><Initials>C</Initials></Author><Author ValidYN="Y"><LastName>Kanchanasuttirak</LastName><ForeName>P</ForeName><Initials>P</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2011</Year><Month>06</Month><Day>14</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Br J Surg</MedlineTA><NlmUniqueID>0372553</NlmUniqueID><ISSNLinking>0007-1323</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D019644" MajorTopicYN="N">Arthroplasty, Replacement, Hip</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019645" MajorTopicYN="N">Arthroplasty, Replacement, Knee</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001208" MajorTopicYN="N">Asia</DescriptorName><QualifierName UI="Q000208" MajorTopicYN="N">ethnology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010690" MajorTopicYN="N">Phlebography</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011655" MajorTopicYN="N">Pulmonary Embolism</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName><QualifierName UI="Q000208" MajorTopicYN="Y">ethnology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013997" MajorTopicYN="N">Time Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014463" MajorTopicYN="N">Ultrasonography</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020246" MajorTopicYN="N">Venous Thrombosis</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName><QualifierName UI="Q000208" MajorTopicYN="Y">ethnology</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="accepted"><Year>2011</Year><Month>4</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2011</Year><Month>6</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2011</Year><Month>6</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2011</Year><Month>10</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">21674473</ArticleId><ArticleId IdType="doi">10.1002/bjs.7589</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">19628483</PMID><DateCompleted><Year>2009</Year><Month>09</Month><Day>03</Day></DateCompleted><DateRevised><Year>2025</Year><Month>06</Month><Day>23</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1471-6771</ISSN><JournalIssue CitedMedium="Internet"><Volume>103</Volume><Issue>3</Issue><PubDate><Year>2009</Year><Month>Sep</Month></PubDate></JournalIssue><Title>British journal of anaesthesia</Title><ISOAbbreviation>Br J Anaesth</ISOAbbreviation></Journal><ArticleTitle>Does regional anaesthesia improve outcome after total hip arthroplasty? A systematic review.</ArticleTitle><Pagination><StartPage>335</StartPage><EndPage>345</EndPage><MedlinePgn>335-45</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1093/bja/aep208</ELocationID><Abstract><AbstractText>Total hip arthroplasty (THA) is amenable to a variety of regional anaesthesia (RA) techniques that may improve patient outcome. We sought to answer whether RA decreased mortality, cardiovascular morbidity, deep venous thrombosis (DVT) and pulmonary embolism (PE), blood loss, duration of surgery, pain, opioid-related adverse effects, cognitive defects, and length of stay. We also questioned whether RA improved rehabilitation. To do so, we performed a systematic review of the contemporary literature to compare general anaesthesia (GA) and RA and also systemic and regional analgesia for THA. To reflect contemporary surgical and anaesthetic practice, only randomized controlled trials (RCTs) from 1990 onward were included. We identified 18 studies involving 1239 patients. Only two of the 18 trials were of Level I quality. There is insufficient evidence from RCTs alone to conclude if anaesthetic technique influenced mortality, cardiovascular morbidity, or the incidence of DVT and PE when using thromboprophylaxis. Blood loss may be reduced in patients receiving RA rather than GA for THA. Our review suggests that there is no difference in duration of surgery in patients who receive GA or RA. Compared with systemic analgesia, regional analgesia can reduce postoperative pain, morphine consumption, and nausea and vomiting. Length of stay is not reduced and rehabilitation does not appear to be facilitated by RA or analgesia for THA.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Macfarlane</LastName><ForeName>A J R</ForeName><Initials>AJ</Initials><AffiliationInfo><Affiliation>Department of Anaesthesia and Pain Management, Toronto Western Hospital, University Health Network, 399 Bathurst Street, Toronto, ON M5T 2S8, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Prasad</LastName><ForeName>G A</ForeName><Initials>GA</Initials></Author><Author ValidYN="Y"><LastName>Chan</LastName><ForeName>V W S</ForeName><Initials>VW</Initials></Author><Author ValidYN="Y"><LastName>Brull</LastName><ForeName>R</ForeName><Initials>R</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2009</Year><Month>07</Month><Day>23</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Br J Anaesth</MedlineTA><NlmUniqueID>0372541</NlmUniqueID><ISSNLinking>0007-0912</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000698" MajorTopicYN="N">Analgesia</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000765" MajorTopicYN="Y">Anesthesia, Conduction</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019644" MajorTopicYN="N">Arthroplasty, Replacement, Hip</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName><QualifierName UI="Q000534" MajorTopicYN="N">rehabilitation</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002318" MajorTopicYN="N">Cardiovascular Diseases</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007902" MajorTopicYN="N">Length of Stay</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010149" MajorTopicYN="N">Pain, Postoperative</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016032" MajorTopicYN="N">Randomized Controlled Trials as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList><NumberOfReferences>78</NumberOfReferences></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2009</Year><Month>7</Month><Day>25</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2009</Year><Month>7</Month><Day>25</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2009</Year><Month>9</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">19628483</ArticleId><ArticleId IdType="doi">10.1093/bja/aep208</ArticleId><ArticleId IdType="pii">S0007-0912(17)33968-5</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">28796427</PMID><DateCompleted><Year>2018</Year><Month>07</Month><Day>17</Day></DateCompleted><DateRevised><Year>2023</Year><Month>10</Month><Day>31</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1538-7836</ISSN><JournalIssue CitedMedium="Internet"><Volume>15</Volume><Issue>9</Issue><PubDate><Year>2017</Year><Month>Sep</Month></PubDate></JournalIssue><Title>Journal of thrombosis and haemostasis : JTH</Title><ISOAbbreviation>J Thromb Haemost</ISOAbbreviation></Journal><ArticleTitle>Epidemiology of venous thromboembolism in Africa: a systematic review.</ArticleTitle><Pagination><StartPage>1770</StartPage><EndPage>1781</EndPage><MedlinePgn>1770-1781</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1111/jth.13769</ELocationID><Abstract><AbstractText Label="UNLABELLED">Essentials Venous thromboembolism (VTE) is among the three main causes of cardiovascular disease worldwide. This review is the first to summarize the epidemiology of VTE in African populations. The prevalence of VTE in Africa is high following surgery, in pregnancy and post-partum. At least one quarter of patients at risk of VTE in Africa are not receiving prophylaxis.</AbstractText><AbstractText Label="SUMMARY">Background Venous thromboembolism (VTE) is among the three leading causes of cardiovascular disease worldwide. Despite its high burden, there has been no previous study summarizing the epidemiology of VTE in African populations. Hence, we conducted this systematic review to determine the prevalence, incidence and mortality associated with VTE, and to evaluate the use of VTE prophylaxis in Africa. Methods We searched PubMed, Scopus and African Journals Online to identify articles published on VTE in Africa from inception to November 19, 2016, without language restriction. The reference list of eligible articles were further scrutinized to identify potential additional studies. Results Overall, we included 21 studies. The great majority of the studies yielded a moderate risk of bias. The prevalence of deep vein thrombosis (DVT) varied between 2.4% and 9.6% in postoperative patients, and between 380 and 448 per 100 000 births per year in pregnant and postpartum women. The prevalence of pulmonary embolism (PE) in medical patients varied between 0.14% and 61.5%, with a mortality rate of PE between 40% and 69.5%. The case-fatality rate after surgery was 60%. Overall, 31.7-75% of the patients were at risk of VTE, and between 34.2% and 96.5% of these received VTE prophylaxis. Conclusion The prevalence of VTE and associated mortality are high following surgery, and in pregnant and postpartum women in Africa. At least one-quarter of patients who are at risk for VTE in Africa are not receiving prophylaxis. These results are generated from studies with small sample size, highlighting an urgent need for well-designed studies with larger sample size to evaluate the true burden of VTE in Africa.</AbstractText><CopyrightInformation>&#xa9; 2017 International Society on Thrombosis and Haemostasis.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Danwang</LastName><ForeName>C</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Surgery and Specialties, Faculty of Medicine and Biomedical Sciences, University of Yaound&#xe9; I, Yaound&#xe9;, Cameroon.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Temgoua</LastName><ForeName>M N</ForeName><Initials>MN</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine and Specialties, Faculty of Medicine and Biomedical Sciences, University of Yaound&#xe9; I, Yaound&#xe9;, Cameroon.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Agbor</LastName><ForeName>V N</ForeName><Initials>VN</Initials><AffiliationInfo><Affiliation>Ibal Sub-divisional Hospital, Oku, North-west Region, Cameroon.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tankeu</LastName><ForeName>A T</ForeName><Initials>AT</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine and Specialties, Faculty of Medicine and Biomedical Sciences, University of Yaound&#xe9; I, Yaound&#xe9;, Cameroon.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Noubiap</LastName><ForeName>J J</ForeName><Initials>JJ</Initials><AffiliationInfo><Affiliation>Department of Medicine, Groote Schuur Hospital and University of Cape Town, Cape Town, South Africa.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2017</Year><Month>08</Month><Day>10</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>J Thromb Haemost</MedlineTA><NlmUniqueID>101170508</NlmUniqueID><ISSNLinking>1538-7836</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000925">Anticoagulants</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D005343">Fibrinolytic Agents</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000349" MajorTopicYN="N">Africa</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000925" MajorTopicYN="N">Anticoagulants</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002423" MajorTopicYN="N">Cause of Death</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005343" MajorTopicYN="N">Fibrinolytic Agents</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015994" MajorTopicYN="N">Incidence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008428" MajorTopicYN="N">Maternal Mortality</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011247" MajorTopicYN="N">Pregnancy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011249" MajorTopicYN="N">Pregnancy Complications, Cardiovascular</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015995" MajorTopicYN="N">Prevalence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011655" MajorTopicYN="N">Pulmonary Embolism</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D054556" MajorTopicYN="N">Venous Thromboembolism</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020246" MajorTopicYN="N">Venous Thrombosis</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Africa</Keyword><Keyword MajorTopicYN="N">deep vein thrombosis</Keyword><Keyword MajorTopicYN="N">pulmonary embolism</Keyword><Keyword MajorTopicYN="N">venous thrombosis</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>5</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2017</Year><Month>8</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>7</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2017</Year><Month>8</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">28796427</ArticleId><ArticleId IdType="doi">10.1111/jth.13769</ArticleId><ArticleId IdType="pii">S1538-7836(22)00861-3</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">31718992</PMID><DateCompleted><Year>2020</Year><Month>06</Month><Day>22</Day></DateCompleted><DateRevised><Year>2020</Year><Month>06</Month><Day>22</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1878-0539</ISSN><JournalIssue CitedMedium="Internet"><Volume>73</Volume><Issue>1</Issue><PubDate><Year>2020</Year><Month>Jan</Month></PubDate></JournalIssue><Title>Journal of plastic, reconstructive &amp; aesthetic surgery : JPRAS</Title><ISOAbbreviation>J Plast Reconstr Aesthet Surg</ISOAbbreviation></Journal><ArticleTitle>Pre-, intra-, and/or postoperative arterial and venous thromboembolism prophylaxis for breast surgery: Systematic review and meta-analysis.</ArticleTitle><Pagination><StartPage>1</StartPage><EndPage>18</EndPage><MedlinePgn>1-18</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.bjps.2019.09.038</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S1748-6815(19)30441-3</ELocationID><Abstract><AbstractText>Both thromboembolism and excessive bleeding following breast surgery could result in multiple surgical procedures, breast reconstruction failure, or even mortality. This systematic review and meta-analysis of 5617 female breast surgery patients compared pharmacological prophylaxis to nonpharmacological prophylaxis interventions during the pre-, intra-, and/or postoperative time points and evaluated associated outcomes and complications. The PubMed, EMBASE, Cochrane Library, Web of Science, and Google Scholar databases were systematically and independently searched. Patient and clinical characteristics, surgical and medical interventions, outcomes, and complications were recorded. Eleven of the 344 studies queried were eligible for systematic review and meta-analysis, with results from 26 of the possible 117 outcomes and complications using strict PRISMA and Cochrane guidelines. Patients receiving intraoperative pharmacological prophylaxis for breast surgery were found to have more reoperations and more occurrences of any bleeding, while patients receiving postoperative pharmacological prophylaxis were found to have more occurrences of any bleeding than patients receiving nonpharmacological prophylaxis. Patients were more likely to receive preoperative pharmacological prophylaxis if they had diabetes mellitus and postoperative chemoprophylaxis if they had higher BMIs. Patients administered pharmacological prophylaxis during the pre-, intra-, and/or postoperative time periods did not show a significant decrease in deep vein thrombosis and/or pulmonary embolism or increase in hematomas compared to those administered nonpharmacological prophylaxis.</AbstractText><CopyrightInformation>Copyright &#xa9; 2019 Elsevier Ltd. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Klifto</LastName><ForeName>Kevin M</ForeName><Initials>KM</Initials><AffiliationInfo><Affiliation>Department of Plastic and Reconstructive Surgery, The Johns Hopkins University School of Medicine, Baltimore, MD 21287, United States of America. Electronic address: kklifto@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gurno</LastName><ForeName>Caresse F</ForeName><Initials>CF</Initials><AffiliationInfo><Affiliation>The Johns Hopkins University School of Nursing, Baltimore, MD, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Major</LastName><ForeName>Melissa</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Plastic and Reconstructive Surgery, The Johns Hopkins University School of Medicine, Baltimore, MD 21287, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Seal</LastName><ForeName>Stella M</ForeName><Initials>SM</Initials><AffiliationInfo><Affiliation>Welch Medical Library, The Johns Hopkins University School of Medicine, Baltimore, MD, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sacks</LastName><ForeName>Justin M</ForeName><Initials>JM</Initials><AffiliationInfo><Affiliation>Department of Plastic and Reconstructive Surgery, The Johns Hopkins University School of Medicine, Baltimore, MD 21287, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rosson</LastName><ForeName>Gedge D</ForeName><Initials>GD</Initials><AffiliationInfo><Affiliation>Department of Plastic and Reconstructive Surgery, The Johns Hopkins University School of Medicine, Baltimore, MD 21287, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Manahan</LastName><ForeName>Michele A</ForeName><Initials>MA</Initials><AffiliationInfo><Affiliation>Department of Plastic and Reconstructive Surgery, The Johns Hopkins University School of Medicine, Baltimore, MD 21287, United States of America. Electronic address: mmanahan@jhmi.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2019</Year><Month>10</Month><Day>02</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>J Plast Reconstr Aesthet Surg</MedlineTA><NlmUniqueID>101264239</NlmUniqueID><ISSNLinking>1748-6815</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D005343">Fibrinolytic Agents</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016063" MajorTopicYN="N">Blood Loss, Surgical</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001803" MajorTopicYN="N">Blood Transfusion</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001940" MajorTopicYN="N">Breast</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001943" MajorTopicYN="N">Breast Neoplasms</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005343" MajorTopicYN="N">Fibrinolytic Agents</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016462" MajorTopicYN="N">Mammaplasty</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008408" MajorTopicYN="N">Mastectomy</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019990" MajorTopicYN="N">Perioperative Care</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019106" MajorTopicYN="N">Postoperative Hemorrhage</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012086" MajorTopicYN="N">Reoperation</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018570" MajorTopicYN="N">Risk Assessment</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013923" MajorTopicYN="N">Thromboembolism</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D054556" MajorTopicYN="N">Venous Thromboembolism</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Breast</Keyword><Keyword MajorTopicYN="N">Chemoprevention</Keyword><Keyword MajorTopicYN="N">Hematoma</Keyword><Keyword MajorTopicYN="N">Pulmonary embolism</Keyword><Keyword MajorTopicYN="N">Surgery</Keyword><Keyword MajorTopicYN="N">Thromboembolism</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2019</Year><Month>4</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2019</Year><Month>8</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2019</Year><Month>9</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>11</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>6</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>11</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31718992</ArticleId><ArticleId IdType="doi">10.1016/j.bjps.2019.09.038</ArticleId><ArticleId IdType="pii">S1748-6815(19)30441-3</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">39588393</PMID><DateCompleted><Year>2024</Year><Month>11</Month><Day>26</Day></DateCompleted><DateRevised><Year>2025</Year><Month>04</Month><Day>28</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1177-8881</ISSN><JournalIssue CitedMedium="Internet"><Volume>18</Volume><PubDate><Year>2024</Year></PubDate></JournalIssue><Title>Drug design, development and therapy</Title><ISOAbbreviation>Drug Des Devel Ther</ISOAbbreviation></Journal><ArticleTitle>Comparative Analysis of Hemodynamic Effects of Remimazolam and Propofol Combined with Esketamine in Colonoscopic Procedures in the Elderly.</ArticleTitle><Pagination><StartPage>5269</StartPage><EndPage>5280</EndPage><MedlinePgn>5269-5280</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.2147/DDDT.S490179</ELocationID><Abstract><AbstractText Label="PURPOSE" NlmCategory="UNASSIGNED">The debate continues over the differential impact of remimazolam vs propofol on hemodynamic stability. This study aims to elucidate the effects of a combination of remimazolam and esketamine vs propofol and esketamine on hemodynamic parameters in elderly patients undergoing painless colonoscopies.</AbstractText><AbstractText Label="PATIENTS AND METHODS" NlmCategory="UNASSIGNED">We conducted a randomized controlled trial involving 754 patients, divided equally between two treatment groups. The remimazolam-esketamine group (RE group) received 0.15 mg/kg of remimazolam and 0.3 mg/kg of esketamine. Conversely, the propofol-esketamine group (PE group) was administered 1.5 mg/kg of propofol with 0.3 mg/kg of esketamine. Primary outcomes focused on the incidence of hypotension. Secondary outcomes assessed were other hemodynamic adverse events, intraoperative blood pressure and heart rate fluctuations, usage of vasoactive agents, sedation efficacy, and additional adverse reactions.</AbstractText><AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">Hypotension occurred significantly less frequently in the RE group (9.78%, 95% confidence interval[CI]: 6.67-12.87%) compared to the PE group (23.57%, 95% CI: 21.22-30.52%), <i>P</i>&lt;0.001. The RE group also showed lower incidences of sinus tachycardia, sinus bradycardia, and required less support from vasoactive agents (<i>P</i>&lt;0.001). Additionally, the RE group experienced smaller fluctuations in blood pressure and heart rate (<i>P</i>&lt;0.05). Both groups achieved a 100% sedation success rate. Notably, the RE group had a longer induction period but a quicker recovery time (<i>P</i>&lt;0.001), and lower rates of respiratory depression (<i>P</i>=0.006) and injection pain (<i>P</i>&lt;0.001).</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="UNASSIGNED">Remimazolam combined with esketamine offers superior hemodynamic stability and significantly reduces adverse event rates compared to propofol plus esketamine in elderly patients undergoing painless colonoscopies, while maintaining effective sedation.</AbstractText><CopyrightInformation>&#xa9; 2024 Deng et al.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Deng</LastName><ForeName>Bo-Ran</ForeName><Initials>BR</Initials><Identifier Source="ORCID">0009-0002-6361-917X</Identifier><AffiliationInfo><Affiliation>Surgical Anesthesia Center, Zigong Hospital of TCM, Zigong, 643000, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Zhang</LastName><ForeName>Yang</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Anesthesia, Da'an District Maternal and Child Health Hospital, Zigong, 643000, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Xie</LastName><ForeName>Zi-Feng</ForeName><Initials>ZF</Initials><AffiliationInfo><Affiliation>Department of Anesthesia, The First Affiliated Hospital of Jinzhou Medical University, Jinzhou, 121000, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Wang</LastName><ForeName>Ding-Ding</ForeName><Initials>DD</Initials><AffiliationInfo><Affiliation>Department of Anesthesia, EYE &amp; ENT Hospital of Fudan University, Shanghai, 200031, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zeng</LastName><ForeName>Tao</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Surgical Anesthesia Center, Zigong Hospital of TCM, Zigong, 643000, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Dong-Bo</ForeName><Initials>DB</Initials><AffiliationInfo><Affiliation>Department of Anesthesia, The First Affiliated Hospital of Jinzhou Medical University, Jinzhou, 121000, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Huang</LastName><ForeName>Li</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Surgical Anesthesia Center, Zigong Hospital of TCM, Zigong, 643000, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Qi-Yan</ForeName><Initials>QY</Initials><AffiliationInfo><Affiliation>Surgical Anesthesia Center, Zigong Hospital of TCM, Zigong, 643000, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shen</LastName><ForeName>Tu</ForeName><Initials>T</Initials><Identifier Source="ORCID">0009-0001-6003-2966</Identifier><AffiliationInfo><Affiliation>Department of Anesthesia, The First Affiliated Hospital of Jinzhou Medical University, Jinzhou, 121000, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wu</LastName><ForeName>Qiao-Ling</ForeName><Initials>QL</Initials><AffiliationInfo><Affiliation>Department of Anesthesia, The First Affiliated Hospital of Jinzhou Medical University, Jinzhou, 121000, People's Republic of China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType><PublicationType UI="D003160">Comparative Study</PublicationType><PublicationType UI="D002363">Case Reports</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>11</Month><Day>19</Day></ArticleDate></Article><MedlineJournalInfo><Country>New Zealand</Country><MedlineTA>Drug Des Devel Ther</MedlineTA><NlmUniqueID>101475745</NlmUniqueID><ISSNLinking>1177-8881</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>YI7VU623SF</RegistryNumber><NameOfSubstance UI="D015742">Propofol</NameOfSubstance></Chemical><Chemical><RegistryNumber>690G0D6V8H</RegistryNumber><NameOfSubstance UI="D007649">Ketamine</NameOfSubstance></Chemical><Chemical><RegistryNumber>7V4A8U16MB</RegistryNumber><NameOfSubstance UI="C522201">remimazolam</NameOfSubstance></Chemical><Chemical><RegistryNumber>50LFG02TXD</RegistryNumber><NameOfSubstance UI="C000629870">Esketamine</NameOfSubstance></Chemical><Chemical><RegistryNumber>12794-10-4</RegistryNumber><NameOfSubstance UI="D001569">Benzodiazepines</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D006993">Hypnotics and Sedatives</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015742" MajorTopicYN="Y">Propofol</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007649" MajorTopicYN="Y">Ketamine</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003113" MajorTopicYN="Y">Colonoscopy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006439" MajorTopicYN="Y">Hemodynamics</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001569" MajorTopicYN="N">Benzodiazepines</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006993" MajorTopicYN="N">Hypnotics and Sedatives</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">colonoscopy</Keyword><Keyword MajorTopicYN="N">elderly patients</Keyword><Keyword MajorTopicYN="N">esketamine</Keyword><Keyword MajorTopicYN="N">hemodynamic effects</Keyword><Keyword MajorTopicYN="N">remimazolam</Keyword></KeywordList><CoiStatement>The authors report no conflicts of interest in this work.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>9</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>11</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>11</Month><Day>26</Day><Hour>11</Hour><Minute>28</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>11</Month><Day>26</Day><Hour>11</Hour><Minute>27</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>11</Month><Day>26</Day><Hour>4</Hour><Minute>23</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>11</Month><Day>19</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39588393</ArticleId><ArticleId IdType="pmc">PMC11586265</ArticleId><ArticleId IdType="doi">10.2147/DDDT.S490179</ArticleId><ArticleId IdType="pii">490179</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Isoldi S, Cucchiara S, Repici A, et al. Gastrointestinal endoscopy in children and adults: how do they differ? Dig Liver Dis. 2021;53(6):697&#x2013;705. doi:10.1016/j.dld.2021.02.016</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.dld.2021.02.016</ArticleId><ArticleId IdType="pubmed">33692010</ArticleId></ArticleIdList></Reference><Reference><Citation>Tang L, Ye C, Wang N, et al. The median effective doses of propofol combined with two different doses of nalbuphine for adult patients during painless gastroscopy. Front Pharmacol. 2022;13:1014486. doi:10.3389/fphar.2022.1014486</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphar.2022.1014486</ArticleId><ArticleId IdType="pmc">PMC9531776</ArticleId><ArticleId IdType="pubmed">36204238</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen X, Giles J, Yao Y, et al. The path to healthy ageing in China: a Peking University-Lancet Commission. Lancet. 2022;400(10367):1967&#x2013;2006. doi:10.1016/S0140-6736(22)01546-X</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(22)01546-X</ArticleId><ArticleId IdType="pmc">PMC9801271</ArticleId><ArticleId IdType="pubmed">36423650</ArticleId></ArticleIdList></Reference><Reference><Citation>Sneyd JR, Absalom AR, Barends CRM, et al. Hypotension during propofol sedation for colonoscopy: a retrospective exploratory analysis and meta-analysis. Br J Anaesth. 2022;128(4):610&#x2013;622. doi:10.1016/j.bja.2021.10.044</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bja.2021.10.044</ArticleId><ArticleId IdType="pmc">PMC9008870</ArticleId><ArticleId IdType="pubmed">34916051</ArticleId></ArticleIdList></Reference><Reference><Citation>Hao L, Hu X, Zhu B, et al. Clinical observation of the combined use of propofol and etomidate in painless gastroscopy. Medicine. 2020;99(45):e23061. doi:10.1097/MD.0000000000023061</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MD.0000000000023061</ArticleId><ArticleId IdType="pmc">PMC7647540</ArticleId><ArticleId IdType="pubmed">33157963</ArticleId></ArticleIdList></Reference><Reference><Citation>Jelen LA, Young AH, Stone JM. Ketamine: a tale of two enantiomers. J Psychopharmacol. 2021;35(2):109&#x2013;123. doi:10.1177/0269881120959644</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0269881120959644</ArticleId><ArticleId IdType="pmc">PMC7859674</ArticleId><ArticleId IdType="pubmed">33155503</ArticleId></ArticleIdList></Reference><Reference><Citation>Lian X, Lin Y, Luo T, et al. Efficacy and safety of esketamine for sedation among patients undergoing gastrointestinal endoscopy: a systematic review and meta-analysis. BMC Anesthesiol. 2023;23(1):204. doi:10.1186/s12871-023-02167-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12871-023-02167-0</ArticleId><ArticleId IdType="pmc">PMC10262466</ArticleId><ArticleId IdType="pubmed">37312027</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang H, Zhao Q, Chen HY, et al. The median effective concentration of propofol with different doses of esketamine during gastrointestinal endoscopy in elderly patients: a randomized controlled trial. Br J Clin Pharmacol. 2022;88(3):1279&#x2013;1287. doi:10.1111/bcp.15072</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/bcp.15072</ArticleId><ArticleId IdType="pubmed">34496448</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu Q, Liu X, Wen C, et al. Remimazolam: an updated review of a new sedative and anaesthetic. Drug Des Devel Ther. 2022;16:3957&#x2013;3974. doi:10.2147/DDDT.S384155</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/DDDT.S384155</ArticleId><ArticleId IdType="pmc">PMC9675580</ArticleId><ArticleId IdType="pubmed">36411859</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu B, Jiang K, Shi W, et al. Effect of remimazolam tosilate on respiratory depression in elderly patients undergoing gastroscopy: a multicentered, prospective, and randomized study. Drug Des Devel Ther. 2022;16:4151&#x2013;4159. doi:10.2147/DDDT.S391147</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/DDDT.S391147</ArticleId><ArticleId IdType="pmc">PMC9733689</ArticleId><ArticleId IdType="pubmed">36506792</ArticleId></ArticleIdList></Reference><Reference><Citation>Li W, Zhao J, Hao R, et al. The efficacy and safety of remimazolam besylate combined with esketamine for outpatient colonoscopy: a prospective, randomized, controlled clinical trial. Drug Des Devel Ther. 2023;17:2875&#x2013;2887. doi:10.2147/DDDT.S425860</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/DDDT.S425860</ArticleId><ArticleId IdType="pmc">PMC10516197</ArticleId><ArticleId IdType="pubmed">37746114</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu C, Ren J, Guo X, et al. Effects of remimazolam combined with esketamine anesthesia on circulatory and respiratory function during painless gastroenteroscopy. Contrast Media Mol Imaging. 2022;2022:1079099. doi:10.1155/2022/1079099</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2022/1079099</ArticleId><ArticleId IdType="pmc">PMC9581615</ArticleId><ArticleId IdType="pubmed">36304777</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo J, Qian Y, Zhang X, et al. Remimazolam tosilate compared with propofol for gastrointestinal endoscopy in elderly patients: a prospective, randomized and controlled study. BMC Anesthesiol. 2022;22(1):180. doi:10.1186/s12871-022-01713-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12871-022-01713-6</ArticleId><ArticleId IdType="pmc">PMC9185932</ArticleId><ArticleId IdType="pubmed">35689208</ArticleId></ArticleIdList></Reference><Reference><Citation>Zheng Y, Xu Y, Huang B, et al. Effective dose of propofol combined with a low-dose esketamine for gastroscopy in elderly patients: a dose finding study using dixon&#x2019;s up-and-down method. Front Pharmacol. 2022;13:956392. doi:10.3389/fphar.2022.956392</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphar.2022.956392</ArticleId><ArticleId IdType="pmc">PMC9530901</ArticleId><ArticleId IdType="pubmed">36204220</ArticleId></ArticleIdList></Reference><Reference><Citation>Xin Y, Chu T, Wang J, et al. Sedative effect of remimazolam combined with alfentanil in colonoscopic polypectomy: a prospective, randomized, controlled clinical trial. BMC Anesthesiol. 2022;22(1):262. doi:10.1186/s12871-022-01805-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12871-022-01805-3</ArticleId><ArticleId IdType="pmc">PMC9380378</ArticleId><ArticleId IdType="pubmed">35974309</ArticleId></ArticleIdList></Reference><Reference><Citation>Yue L, Ma X, Li N, et al. Remimazolam versus propofol in combination with esketamine for surgical abortion: a double-blind randomized controlled trial. Clin Transl Sci. 2023;16(9):1606&#x2013;1616. doi:10.1111/cts.13572</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/cts.13572</ArticleId><ArticleId IdType="pmc">PMC10499404</ArticleId><ArticleId IdType="pubmed">37337399</ArticleId></ArticleIdList></Reference><Reference><Citation>Hasegawa G, Hirata N, Yoshikawa Y, et al. Differential effects of remimazolam and propofol on heart rate variability during anesthesia induction. J Anesth. 2022;36(2):239&#x2013;245. doi:10.1007/s00540-022-03037-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00540-022-03037-8</ArticleId><ArticleId IdType="pubmed">35028756</ArticleId></ArticleIdList></Reference><Reference><Citation>Hristova TS, Keating SC, McCoy AM, et al. Heart rate, arterial pressure and propofol-sparing effects of guaifenesin in dogs. Vet Anaesth Analg. 2023;50(1):50&#x2013;56. doi:10.1016/j.vaa.2022.10.001</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaa.2022.10.001</ArticleId><ArticleId IdType="pubmed">36344374</ArticleId></ArticleIdList></Reference><Reference><Citation>Tan Y, Ouyang W, Tang Y, et al. Effect of remimazolam tosilate on early cognitive function in elderly patients undergoing upper gastrointestinal endoscopy. J Gastroenterol Hepatol. 2022;37(3):576&#x2013;583. doi:10.1111/jgh.15761</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jgh.15761</ArticleId><ArticleId IdType="pmc">PMC9303590</ArticleId><ArticleId IdType="pubmed">34907594</ArticleId></ArticleIdList></Reference><Reference><Citation>Wei A, Ma S, Dou Y, et al. The safety and efficacy of remimazolam tosylate combined with propofol in upper gastrointestinal endoscopy: a multicenter, randomized clinical trial. PLoS One. 2023;18(8):e0282930. doi:10.1371/journal.pone.0282930</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0282930</ArticleId><ArticleId IdType="pmc">PMC10399878</ArticleId><ArticleId IdType="pubmed">37535618</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang J, Zhang Y, Fang X, et al. Comparison of remimazolam and propofol for drug-induced sleep endoscopy: a randomized clinical trial. Otolaryngol Head Neck Surg. 2023;169(5):1356&#x2013;1365. doi:10.1002/ohn.387</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ohn.387</ArticleId><ArticleId IdType="pubmed">37264980</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu X, Xiao Q, Zhuang S. Comparison of propofol-esketamine versus propofol for anesthesia in gastroscopy: a double-blind, randomized controlled clinical trial. Front Med. 2023;10:1184709. doi:10.3389/fmed.2023.1184709</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2023.1184709</ArticleId><ArticleId IdType="pmc">PMC10442552</ArticleId><ArticleId IdType="pubmed">37614948</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">32790536</PMID><DateCompleted><Year>2021</Year><Month>03</Month><Day>04</Day></DateCompleted><DateRevised><Year>2021</Year><Month>03</Month><Day>04</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1477-0377</ISSN><JournalIssue CitedMedium="Internet"><Volume>25</Volume><Issue>5</Issue><PubDate><Year>2020</Year><Month>Oct</Month></PubDate></JournalIssue><Title>Vascular medicine (London, England)</Title><ISOAbbreviation>Vasc Med</ISOAbbreviation></Journal><ArticleTitle>Efficacy and safety of extracorporeal membrane oxygenation for high-risk pulmonary embolism: A systematic review and meta-analysis.</ArticleTitle><Pagination><StartPage>460</StartPage><EndPage>467</EndPage><MedlinePgn>460-467</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1177/1358863X20944469</ELocationID><Abstract><AbstractText>High-risk pulmonary embolism (PE) requires hemodynamic and respiratory support along with reperfusion strategies. Recently updated European guidelines assign a low class of recommendation to extracorporeal membrane oxygenation (ECMO) for high-risk PE. This systematic review assessed clinical outcomes after ECMO in high-risk PE. We searched electronic databases including PubMed, Embase and Web of Science from January 2000 to April 2020. Efficacy outcomes included in-hospital survival with good neurological outcome and survival at follow-up. Safety outcomes included lower limb ischemia and hemorrhagic and ischemic stroke. Where possible (absence of high heterogeneity), meta-analyses of outcomes were undertaken using a random-effects model. We included 16 uncontrolled case-series (533 participants). In-hospital survival with good neurological outcome ranged between 50% and 95% while overall survival at follow-up ranged from 35% to 95%, both with a major degree of heterogeneity (I<sup>2</sup> &gt; 70%). The prevalence of lower limb ischemia was 8% (95% CI 3% to 15%). The prevalence of stroke (either hemorrhagic or ischemic) was 11% (95% CI 3% to 23%), with notable heterogeneity (I&#xb2; = 63.35%). Based on currently available literature, it is not possible to draw definite conclusions on the usefulness of ECMO for high-risk PE. Prospective, multicenter, large-scale studies or nationwide registries are needed to best define the role of ECMO for high-risk PE. <b>PROSPERO registration ID: CRD42019136282</b>.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Pozzi</LastName><ForeName>Matteo</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0001-6550-0872</Identifier><AffiliationInfo><Affiliation>Department of Cardiac Surgery, "Louis Pradel" Cardiologic Hospital, Lyon, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Metge</LastName><ForeName>Augustin</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Cardiac Surgery, "Louis Pradel" Cardiologic Hospital, Lyon, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Martelin</LastName><ForeName>Anthony</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Medical Devices Unit - Pharmacy Department, "Edouard Herriot" Hospital, - Lyon University Hospitals, Lyon, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Giroudon</LastName><ForeName>Caroline</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0001-7947-9437</Identifier><AffiliationInfo><Affiliation>Central Documentation Department, Hospices Civils de Lyon, Lyon, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lanier Demma</LastName><ForeName>Justine</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Cardiac Surgery, "Louis Pradel" Cardiologic Hospital, Lyon, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Koffel</LastName><ForeName>Catherine</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Anesthesia and ICU, "Louis Pradel" Cardiologic Hospital, Lyon, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fornier</LastName><ForeName>William</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Department of Anesthesia and ICU, "Louis Pradel" Cardiologic Hospital, Lyon, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chiari</LastName><ForeName>Pascal</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Anesthesia and ICU, "Louis Pradel" Cardiologic Hospital, Lyon, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fellahi</LastName><ForeName>Jean Luc</ForeName><Initials>JL</Initials><AffiliationInfo><Affiliation>Department of Anesthesia and ICU, "Louis Pradel" Cardiologic Hospital, Lyon, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Obadia</LastName><ForeName>Jean Francois</ForeName><Initials>JF</Initials><AffiliationInfo><Affiliation>Department of Cardiac Surgery, "Louis Pradel" Cardiologic Hospital, Lyon, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Armoiry</LastName><ForeName>Xavier</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>University of Lyon, School of Pharmacy - Pharmacy Department (ISPB)/UMR CNRS 5510 MATEIS/"Edouard Herriot" Hospital - Lyon University Hospitals, Lyon, France.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>08</Month><Day>13</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Vasc Med</MedlineTA><NlmUniqueID>9610930</NlmUniqueID><ISSNLinking>1358-863X</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015199" MajorTopicYN="Y">Extracorporeal Membrane Oxygenation</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011655" MajorTopicYN="N">Pulmonary Embolism</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018570" MajorTopicYN="N">Risk Assessment</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013997" MajorTopicYN="N">Time Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">cardiac arrest</Keyword><Keyword MajorTopicYN="N">cardiogenic shock</Keyword><Keyword MajorTopicYN="N">cardiovascular disease</Keyword><Keyword MajorTopicYN="N">extracorporeal membrane oxygenation (ECMO)</Keyword><Keyword MajorTopicYN="N">meta-analysis</Keyword><Keyword MajorTopicYN="N">pulmonary embolism (PE)</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>8</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>3</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>8</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32790536</ArticleId><ArticleId IdType="doi">10.1177/1358863X20944469</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36939472</PMID><DateCompleted><Year>2023</Year><Month>04</Month><Day>19</Day></DateCompleted><DateRevised><Year>2025</Year><Month>06</Month><Day>26</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1525-1489</ISSN><JournalIssue CitedMedium="Internet"><Volume>38</Volume><Issue>6</Issue><PubDate><Year>2023</Year><Month>Jun</Month></PubDate></JournalIssue><Title>Journal of intensive care medicine</Title><ISOAbbreviation>J Intensive Care Med</ISOAbbreviation></Journal><ArticleTitle>Prophylactic Inferior Vena Cava Filters for Venous Thromboembolism in Adults With Trauma: An Updated Systematic Review and Meta-Analysis.</ArticleTitle><Pagination><StartPage>491</StartPage><EndPage>510</EndPage><MedlinePgn>491-510</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1177/08850666231163141</ELocationID><Abstract><AbstractText><b>Background:</b> Trauma is an independent risk factor for venous thromboembolism (VTE). Due to contraindications or delay in starting pharmacological prophylaxis among trauma patients with a high risk of bleeding, the inferior vena cava (IVC) filter has been utilized as alternative prevention for pulmonary embolism (PE). Albeit, its clinical efficacy has remained uncertain. Therefore, we performed an updated systematic review and meta-analysis on the effectiveness and safety of prophylactic IVC filters in severely injured patients. <b>Methods:</b> Three databases (MEDLINE, EMBASE, and Cochrane) were searched from August 1, 2012, to October 27, 2021. Independent reviewers performed data extraction and quality assessment. Relative risk (RR) at 95% confidence interval (CI) pooled in a randomized meta-analysis. A parallel clinical practice guideline committee assessed the certainty of evidence using the GRADE approach. The outcomes of interest included VTE, PE, deep venous thrombosis, mortality, and IVC filter complications. <b>Results:</b> We included 10 controlled studies (47&#x2005;140 patients), of which 3 studies (310 patients) were randomized controlled trials (RCTs) and 7 were observational studies (46&#x2005;830 patients). IVC filters demonstrated no significant reduction in PE and fatal PE (RR, 0.27; 95% CI, 0.06-1.28 and RR, 0.32; 95% CI, 0.01-7.84, respectively) by pooling RCTs with low certainty. However, it demonstrated a significant reduction in the risk of PE and fatal PE (RR, 0.25; 95% CI, 0.12-0.55 and RR, 0.09; 95% CI, 0.011-0.81, respectively) by pooling observational studies with very low certainty. IVC filter did not improve mortality in both RCTs and observational studies (RR, 1.44; 95% CI, 0.86-2.43 and RR, 0.63; 95% CI, 0.3-1.31, respectively). <b>Conclusion:</b> In trauma patients, moderate risk reduction of PE and fatal PE was demonstrated among observational data but not RCTs. The desirable effect is not robust to outweigh the undesirable effects associated with IVC filter complications. Current evidence suggests against routinely using prophylactic IVC filters.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Alshaqaq</LastName><ForeName>Hassan M</ForeName><Initials>HM</Initials><AffiliationInfo><Affiliation>Emergency Medicine Department, King Saud Medical City, Riyadh, Saudi Arabia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Al-Sharydah</LastName><ForeName>Abdulaziz M</ForeName><Initials>AM</Initials><Identifier Source="ORCID">0000-0002-6590-5850</Identifier><AffiliationInfo><Affiliation>Diagnostic and Interventional Radiology Department, King Fahd Hospital of the University, Imam Abdulrahman Bin Faisal University, Dammam, Saudi Arabia.</Affiliation><Identifier Source="RINGGOLD">48023</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alshahrani</LastName><ForeName>Mohammed S</ForeName><Initials>MS</Initials><AffiliationInfo><Affiliation>Department of Emergency and Critical Care, King Fahd Hospital of the University, Imam Abdulrahman Bin Faisal University, Dammam, Saudi Arabia.</Affiliation><Identifier Source="RINGGOLD">48023</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alqahtani</LastName><ForeName>Saad M</ForeName><Initials>SM</Initials><AffiliationInfo><Affiliation>Department of Orthopedics surgery, King Fahd Hospital of the University, Imam Abdulrahman Bin Faisal University, Dammam, Saudi Arabia.</Affiliation><Identifier Source="RINGGOLD">48102</Identifier><Identifier Source="RINGGOLD">48023</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Amer</LastName><ForeName>Marwa</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-9497-1451</Identifier><AffiliationInfo><Affiliation>Medical/Critical Pharmacy Division, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia.</Affiliation><Identifier Source="RINGGOLD">37852</Identifier></AffiliationInfo><AffiliationInfo><Affiliation>College of Medicine, Alfaisal University, Riyadh, Saudi Arabia.</Affiliation><Identifier Source="RINGGOLD">101686</Identifier></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>03</Month><Day>20</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Intensive Care Med</MedlineTA><NlmUniqueID>8610344</NlmUniqueID><ISSNLinking>0885-0666</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D054556" MajorTopicYN="Y">Venous Thromboembolism</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020246" MajorTopicYN="Y">Venous Thrombosis</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016306" MajorTopicYN="Y">Vena Cava Filters</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011655" MajorTopicYN="Y">Pulmonary Embolism</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016032" MajorTopicYN="N">Randomized Controlled Trials as Topic</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">deep venous thrombosis</Keyword><Keyword MajorTopicYN="N">inferior vena cava filters</Keyword><Keyword MajorTopicYN="N">prophylaxis</Keyword><Keyword MajorTopicYN="N">pulmonary embolism</Keyword><Keyword MajorTopicYN="N">trauma</Keyword><Keyword MajorTopicYN="N">venous thromboembolism</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>4</Month><Day>19</Day><Hour>6</Hour><Minute>41</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>3</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>3</Month><Day>20</Day><Hour>10</Hour><Minute>32</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36939472</ArticleId><ArticleId IdType="doi">10.1177/08850666231163141</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">35691358</PMID><DateCompleted><Year>2023</Year><Month>08</Month><Day>30</Day></DateCompleted><DateRevised><Year>2023</Year><Month>08</Month><Day>30</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1879-1026</ISSN><JournalIssue CitedMedium="Internet"><Volume>838</Volume><Issue>Pt 4</Issue><PubDate><Year>2022</Year><Month>Sep</Month><Day>10</Day></PubDate></JournalIssue><Title>The Science of the total environment</Title><ISOAbbreviation>Sci Total Environ</ISOAbbreviation></Journal><ArticleTitle>Impact of high altitude on the incidence of postoperative venous thromboembolism and its genetic susceptibility: A meta-analysis and systematic review.</ArticleTitle><Pagination><StartPage>156632</StartPage><MedlinePgn>156632</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.scitotenv.2022.156632</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0048-9697(22)03729-9</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">The effect of high-altitude (HA) on venous thromboembolism (VTE) and its mechanism remains ambiguous. To clarify this, we aimed to conduct a meta-analysis and systematic review to evaluate the incidence of VTE at HA and comparatively low altitude (LA) and figure out the intrinsic risk factors such as susceptibility genes of patients with VTE at HA.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">We selected studies that explored the risk factors for HA and VTE by searching PubMed, Embase, and Web of Science to analyze the impact of HA on VTE. All relevant studies before August 2021 were screened using the terms ([high altitude] OR [plateau] OR [mountain]) AND ([venous thromboembolism] OR [deep vein thrombosis] OR [pulmonary embolism]). Latest studies on the gene of HA-VTE patients were also summarized and analyzed.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Fifteen studies were eventually assessed, and the overall numbers of subjects with and without VTE were 1475 and 286,926 respectively. The overall incidence of VTE, deep vein thrombosis (DVT) and pulmonary embolism (PE) in the HA group was significantly higher than that in the LA group (P &lt; 0.01). The overall incidence of VTE, DVT and PE in the HA group was significantly higher than that in the LA group at 30 days post operation (P &lt; 0.05, P &lt; 0.05 and P &lt; 0.01, respectively). At 90 days post operation, incidence of VTE and PE in the HA group was higher than that in the LA group (P &lt; 0.01and P &lt; 0.01, respectively), but there was no difference in the incidence of DVT (P = 0.07). Regarding endogenous factors, the analysis of genes in patients with HA-VTE revealed numerous targeted genes such as ANG, ACE, lncRNA-LINC00 659/UXT-AS1 and GP4.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">We observed a significant association between HA and the overall incidence of VTE and that at 30/90 days post operation, indicating that HA may be a risk factor for VTE.</AbstractText><CopyrightInformation>Copyright &#xa9; 2022 Elsevier B.V. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>Haihong</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, The General Hospital of Western Theater Command, Chengdu 610083, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>Guan</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Pain, The General Hospital of Western Theater Command, Chengdu 610083, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xu</LastName><ForeName>Meiling</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Geriatrics, The General Hospital of Western Theater Command, Chengdu 610083, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhao</LastName><ForeName>Yuanyuan</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>The General Hospital of Western Theater Command, Chengdu 610083, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>He</LastName><ForeName>Shengdong</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>The General Hospital of Western Theater Command, Chengdu 610083, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Qiwu</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>The General Hospital of Western Theater Command, Chengdu 610083, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wen</LastName><ForeName>Yi</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>The General Hospital of Western Theater Command, Chengdu 610083, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Huang</LastName><ForeName>Chen</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>The General Hospital of Western Theater Command, Chengdu 610083, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wu</LastName><ForeName>Jianping</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Neurosurgery, The General Hospital of Western Theater Command, Chengdu 610083, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ren</LastName><ForeName>Chao</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>The General Hospital of Western Theater Command, Chengdu 610083, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>Yongxiang</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Neurosurgery, The General Hospital of Western Theater Command, Chengdu 610083, China. Electronic address: yangyongxiang2014@163.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>He</LastName><ForeName>Siyi</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Cardiovascular Surgery, The General Hospital of Western Theater Command, Chengdu 610083, China. Electronic address: hesiyi@vip.163.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>06</Month><Day>09</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Sci Total Environ</MedlineTA><NlmUniqueID>0330500</NlmUniqueID><ISSNLinking>0048-9697</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D018797">Cell Cycle Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D018832">Molecular Chaperones</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C118920">UXT protein, human</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000531" MajorTopicYN="N">Altitude</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018797" MajorTopicYN="N">Cell Cycle Proteins</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020022" MajorTopicYN="N">Genetic Predisposition to Disease</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015994" MajorTopicYN="N">Incidence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018832" MajorTopicYN="N">Molecular Chaperones</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011655" MajorTopicYN="Y">Pulmonary Embolism</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D054556" MajorTopicYN="Y">Venous Thromboembolism</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020246" MajorTopicYN="Y">Venous Thrombosis</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">High altitude</Keyword><Keyword MajorTopicYN="N">Incidence</Keyword><Keyword MajorTopicYN="N">Low altitude</Keyword><Keyword MajorTopicYN="N">Venous thromboembolism</Keyword></KeywordList><CoiStatement>Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>9</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>6</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>6</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>6</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>6</Month><Day>29</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>6</Month><Day>12</Day><Hour>19</Hour><Minute>23</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35691358</ArticleId><ArticleId IdType="doi">10.1016/j.scitotenv.2022.156632</ArticleId><ArticleId IdType="pii">S0048-9697(22)03729-9</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">38582200</PMID><DateCompleted><Year>2024</Year><Month>06</Month><Day>20</Day></DateCompleted><DateRevised><Year>2025</Year><Month>01</Month><Day>14</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1615-5947</ISSN><JournalIssue CitedMedium="Internet"><Volume>105</Volume><PubDate><Year>2024</Year><Month>Aug</Month></PubDate></JournalIssue><Title>Annals of vascular surgery</Title><ISOAbbreviation>Ann Vasc Surg</ISOAbbreviation></Journal><ArticleTitle>Prognostic Value of Neutrophil/Lymphocyte Ratio for Pulmonary Embolism: A Meta-Analysis and External Validation.</ArticleTitle><Pagination><StartPage>48</StartPage><EndPage>59</EndPage><MedlinePgn>48-59</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.avsg.2024.01.019</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0890-5096(24)00134-1</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Prognostic value of neutrophil/lymphocyte ratio (NLR) for pulmonary embolism (PE) has been reported in several retrospective studies. The purpose of this investigation was to perform a pooled analysis and external validation of predictive value of NLR.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">PubMed, Embase, and Cochrane databases were searched from inception to November 5, 2022. A random effects model was used. Grade was used to evaluate the certainty of evidence. External validation was conducted in clinical cohorts before and after a propensity scoring matching (PSM). Covariates include basic clinical characteristics, such as age, gender, etc. The value of NLR in prediction model was also evaluated.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">A total of 15 studies comprising 5,874 patients were included. Pooled risk ratio of NLR was 2.33 (95% confidence interval [CI]: 1.97-2.75), with an area under the curve of 0.78 (95% CI: 0.74-0.81), a sensitivity of 0.75 (95% CI: 0.71-0.79), a specificity of 0.67 (95% CI: 0.61-0.73), and a median cut-off value of 5.7. Grade of Recommendations Assessment Development and Evaluation (GRADE) certainty analysis showed the quality of the evidence was moderate. Before (n&#xa0;=&#xa0;336) and after (n&#xa0;=&#xa0;152) propensity scoring matching, risk ratio of NLR was 2.69 (95% CI: 1.04-6.97) and 6.58 (95% CI: 1.99-17.75). A prediction model consisting of NLR, age, D-dimer, and simplified PE severity index had an area under the curve of 0.809 (95% CI: 0.738-0.88), a sensitivity of 0.638 (95% CI: 0.511-0.745), and a specificity of 0.851 (95% CI: 0.709-0.917). Net reclassification index (12%, P&#xa0;=&#xa0;0.035) and integrated discrimination improvement (17%, P&#xa0;=&#xa0;0.022) indicated an improvement caused by NLR.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Prognostic value of NLR for PE was confirmed by meta-analysis and validated in an independent cohort, deserving further clinical application.</AbstractText><CopyrightInformation>Copyright &#xa9; 2024 Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Ruihua</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of General Surgery, Vascular Surgery, Qilu Hospital of Shandong University, Jinan, Shandong, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shen</LastName><ForeName>Shuohao</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of General Surgery, Vascular Surgery, Qilu Hospital of Shandong University, Jinan, Shandong, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jiang</LastName><ForeName>Jianjun</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of General Surgery, Vascular Surgery, Qilu Hospital of Shandong University, Jinan, Shandong, China. Electronic address: jiangjianjun1995@163.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Yang</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of General Surgery, Vascular Surgery, Qilu Hospital of Shandong University, Jinan, Shandong, China. Electronic address: liuyang_sdu@126.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType><PublicationType UI="D023361">Validation Study</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>04</Month><Day>04</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Ann Vasc Surg</MedlineTA><NlmUniqueID>8703941</NlmUniqueID><ISSNLinking>0890-5096</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009504" MajorTopicYN="Y">Neutrophils</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011655" MajorTopicYN="Y">Pulmonary Embolism</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008214" MajorTopicYN="Y">Lymphocytes</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018655" MajorTopicYN="N">Lymphocyte Count</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011237" MajorTopicYN="Y">Predictive Value of Tests</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011379" MajorTopicYN="N">Prognosis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015203" MajorTopicYN="N">Reproducibility of Results</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018570" MajorTopicYN="N">Risk Assessment</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>11</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>12</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>1</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>6</Month><Day>21</Day><Hour>0</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>4</Month><Day>7</Day><Hour>3</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>4</Month><Day>6</Day><Hour>19</Hour><Minute>14</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38582200</ArticleId><ArticleId IdType="doi">10.1016/j.avsg.2024.01.019</ArticleId><ArticleId IdType="pii">S0890-5096(24)00134-1</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">25189450</PMID><DateCompleted><Year>2015</Year><Month>07</Month><Day>20</Day></DateCompleted><DateRevised><Year>2025</Year><Month>07</Month><Day>11</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1432-2323</ISSN><JournalIssue CitedMedium="Internet"><Volume>39</Volume><Issue>1</Issue><PubDate><Year>2015</Year><Month>Jan</Month></PubDate></JournalIssue><Title>World journal of surgery</Title><ISOAbbreviation>World J Surg</ISOAbbreviation></Journal><ArticleTitle>Incidence of venous thromboembolism and its pharmacological prophylaxis in Asian general surgery patients: a systematic review.</ArticleTitle><Pagination><StartPage>150</StartPage><EndPage>157</EndPage><MedlinePgn>150-7</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s00268-014-2763-0</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Venous thromboembolism (VTE) is a condition that has always been perceived to be rare in Asia. The aim of this systematic review was to gather the current available evidence on the incidence of VTE in this population. A secondary aim was to assess the efficacy of pharmacological prophylaxis, and hence determine its role, in the Asian population.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">A comprehensive literature search was performed using MEDLINE, Embase, and the Cochrane Database of Systematic Reviews in June 2014. Articles found using search terms related to venous thromboembolism (VTE), Asian countries and general surgery procedures and pathologies were screened using the following inclusion criteria: (1) either the population studied was primarily Asian or the study was conducted in an Asian country, (2) the subjects studied underwent a major gastrointestinal or other general surgery procedure, (3) the primary outcome was the incidence of deep vein thrombosis (DVT) or pulmonary embolus (PE), and (4) secondary outcomes assessed included mortality and complications due to the VTE or prophylaxis against VTE.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Fourteen publications with a total of 11,218 patients were analyzed. Nine of the fourteen were observational studies, with half being prospective in nature. There were five interventional studies of which two were randomized controlled trials. Among the observational studies, the median (range) incidence of above-knee DVT was 0.08 % (0-2.9 %), while the median (range) incidence of PE was 0.18 % (0-0.58 %). The rates of DVT in the control groups were reported to be between 0 and 7.4 %, while the incidence of PE in the control groups ranged from 0 to 1.9 %. Analysis of the comparative studies revealed that the incidence of bleeding-related complications varied from 0 to 18.1 % in the low-molecular-weight heparin (LMWH) group compared to 0-7.5 % in the control group. The difference in minor bleeding complications between the LMWH group and the control group was found to be statistically significant.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Data from this systematic review suggest that the risk of VTE in Asian general surgery patients is low, even in the context of risk factors typically regarded as high risk.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Yeo</LastName><ForeName>Danson X W</ForeName><Initials>DX</Initials><AffiliationInfo><Affiliation>Hepatic, Pancreatic and Biliary (HPB) Surgery Unit, Department of General Surgery, Tan Tock Seng Hospital, 11 Jalan Tan Tock Seng, Singapore, 308433, Singapore, dansonis@yahoo.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Junnarkar</LastName><ForeName>Sameer</ForeName><Initials>S</Initials></Author><Author ValidYN="Y"><LastName>Balasubramaniam</LastName><ForeName>Sunder</ForeName><Initials>S</Initials></Author><Author ValidYN="Y"><LastName>Tan</LastName><ForeName>Yen Pin</ForeName><Initials>YP</Initials></Author><Author ValidYN="Y"><LastName>Low</LastName><ForeName>Jee Keem</ForeName><Initials>JK</Initials></Author><Author ValidYN="Y"><LastName>Woon</LastName><ForeName>Winston</ForeName><Initials>W</Initials></Author><Author ValidYN="Y"><LastName>Pang</LastName><ForeName>Tony Chun Yeung</ForeName><Initials>TC</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>World J Surg</MedlineTA><NlmUniqueID>7704052</NlmUniqueID><ISSNLinking>0364-2313</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000925">Anticoagulants</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D006495">Heparin, Low-Molecular-Weight</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>World J Surg. 2016 Jul;40(7):1788-9. doi: 10.1007/s00268-015-3273-4.</RefSource><PMID Version="1">26464151</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000925" MajorTopicYN="N">Anticoagulants</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001208" MajorTopicYN="N" Type="Geographic">Asia</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D044466" MajorTopicYN="N">Asian People</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006495" MajorTopicYN="N">Heparin, Low-Molecular-Weight</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015994" MajorTopicYN="N">Incidence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011655" MajorTopicYN="N">Pulmonary Embolism</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013514" MajorTopicYN="N">Surgical Procedures, Operative</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020246" MajorTopicYN="N">Venous Thrombosis</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2014</Year><Month>9</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2014</Year><Month>9</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2015</Year><Month>7</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">25189450</ArticleId><ArticleId IdType="doi">10.1007/s00268-014-2763-0</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Ann Surg Treat Res. 2014 Jan;86(1):22-7</Citation><ArticleIdList><ArticleId IdType="pubmed">24761403</ArticleId></ArticleIdList></Reference><Reference><Citation>Chest. 2001 Jan;119(1 Suppl):132S-175S</Citation><ArticleIdList><ArticleId IdType="pubmed">11157647</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Surg. 2010 Feb;251(2):344-50</Citation><ArticleIdList><ArticleId IdType="pubmed">19779324</ArticleId></ArticleIdList></Reference><Reference><Citation>Dis Colon Rectum. 1999 Feb;42(2):196-202; discussion 202-3</Citation><ArticleIdList><ArticleId IdType="pubmed">10211496</ArticleId></ArticleIdList></Reference><Reference><Citation>ANZ J Surg. 2001 Nov;71(11):637-40</Citation><ArticleIdList><ArticleId IdType="pubmed">11736821</ArticleId></ArticleIdList></Reference><Reference><Citation>Int Angiol. 2012 Dec;31(6):501-16</Citation><ArticleIdList><ArticleId IdType="pubmed">23222928</ArticleId></ArticleIdList></Reference><Reference><Citation>Singapore Med J. 1968 Dec;9(4):276-9</Citation><ArticleIdList><ArticleId IdType="pubmed">5728867</ArticleId></ArticleIdList></Reference><Reference><Citation>J Thromb Haemost. 2010 Mar;8(3):540-7</Citation><ArticleIdList><ArticleId IdType="pubmed">20040044</ArticleId></ArticleIdList></Reference><Reference><Citation>Int Angiol. 2001 Mar;20(1):1-37</Citation><ArticleIdList><ArticleId IdType="pubmed">11342993</ArticleId></ArticleIdList></Reference><Reference><Citation>J Thromb Haemost. 2005 Jan;3(1):28-34</Citation><ArticleIdList><ArticleId IdType="pubmed">15634263</ArticleId></ArticleIdList></Reference><Reference><Citation>Indian J Crit Care Med. 2012 Apr;16(2):71-4</Citation><ArticleIdList><ArticleId IdType="pubmed">22988360</ArticleId></ArticleIdList></Reference><Reference><Citation>BMJ. 2009 Jul 21;339:b2535</Citation><ArticleIdList><ArticleId IdType="pubmed">19622551</ArticleId></ArticleIdList></Reference><Reference><Citation>Indian J Gastroenterol. 2008 Mar-Apr;27(2):71-3</Citation><ArticleIdList><ArticleId IdType="pubmed">18695308</ArticleId></ArticleIdList></Reference><Reference><Citation>World J Surg. 2011 Apr;35(4):881-7</Citation><ArticleIdList><ArticleId IdType="pubmed">21264469</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS One. 2013 Apr 17;8(4):e61968</Citation><ArticleIdList><ArticleId IdType="pubmed">23613988</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Surg Oncol. 2010 Sep;17(9):2363-9</Citation><ArticleIdList><ArticleId IdType="pubmed">20358302</ArticleId></ArticleIdList></Reference><Reference><Citation>Int Angiol. 2012 Dec;31(6):526-33</Citation><ArticleIdList><ArticleId IdType="pubmed">23222930</ArticleId></ArticleIdList></Reference><Reference><Citation>Chest. 2012 Feb;141(2 Suppl):e227S-e277S</Citation><ArticleIdList><ArticleId IdType="pubmed">22315263</ArticleId></ArticleIdList></Reference><Reference><Citation>Malays J Med Sci. 2004 Jan;11(1):75-80</Citation><ArticleIdList><ArticleId IdType="pubmed">22977363</ArticleId></ArticleIdList></Reference><Reference><Citation>Semin Thromb Hemost. 1991;17 Suppl 3:304-12</Citation><ArticleIdList><ArticleId IdType="pubmed">1754886</ArticleId></ArticleIdList></Reference><Reference><Citation>Asian J Surg. 2008 Apr;31(2):63-8</Citation><ArticleIdList><ArticleId IdType="pubmed">18490217</ArticleId></ArticleIdList></Reference><Reference><Citation>Surg Today. 2004;34(10):805-10</Citation><ArticleIdList><ArticleId IdType="pubmed">15449147</ArticleId></ArticleIdList></Reference><Reference><Citation>Br J Surg. 2001 Jul;88(7):913-30</Citation><ArticleIdList><ArticleId IdType="pubmed">11442521</ArticleId></ArticleIdList></Reference><Reference><Citation>J Thromb Haemost. 2006 Mar;4(3):581-6</Citation><ArticleIdList><ArticleId IdType="pubmed">16460440</ArticleId></ArticleIdList></Reference><Reference><Citation>Chin Med J (Engl). 2010 Aug 5;123(15):1973-5</Citation><ArticleIdList><ArticleId IdType="pubmed">20819527</ArticleId></ArticleIdList></Reference><Reference><Citation>Thromb Haemost. 2011 Dec;106(6):1084-94</Citation><ArticleIdList><ArticleId IdType="pubmed">22072215</ArticleId></ArticleIdList></Reference><Reference><Citation>Eur Heart J. 2003 Jan;24(2):151-60</Citation><ArticleIdList><ArticleId IdType="pubmed">12573272</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">38204918</PMID><DateRevised><Year>2024</Year><Month>01</Month><Day>12</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">2666-5484</ISSN><JournalIssue CitedMedium="Internet"><Volume>17</Volume><PubDate><Year>2024</Year><Month>Mar</Month></PubDate></JournalIssue><Title>North American Spine Society journal</Title><ISOAbbreviation>N Am Spine Soc J</ISOAbbreviation></Journal><ArticleTitle>Chemical prophylaxis and venous thromboembolism following elective spinal surgery: A systematic review and meta-analysis.</ArticleTitle><Pagination><StartPage>100295</StartPage><MedlinePgn>100295</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">100295</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.xnsj.2023.100295</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="UNASSIGNED">Venous thromboembolism (VTE), including deep vein thrombosis (DVT) and pulmonary embolism (PE), is a potentially devastating complication after surgery. Spine surgery is associated with an increased risk of postoperative bleeding, such as spinal epidural hematomas (SEH), which complicates the use of anticoagulation. Despite this dilemma, there is a lack of consensus around perioperative VTE prophylaxis. This systematic review investigates the relationship between chemoprophylaxis and the incidence rates of VTE and SEH in the elective spine surgical population.</AbstractText><AbstractText Label="METHODS" NlmCategory="UNASSIGNED">A comprehensive literature search was performed using PubMed, Embase, and Cochrane databases to identify studies published after 2,000 that compared VTE chemoprophylaxis use in elective spine surgery. Studies involving patients aged &lt; 18 years or with known trauma, cancer, or spinal cord injuries were excluded. Pooled incidence rates of VTE and SEH were calculated for all eligible studies, and meta-analyses were performed to assess the relationship between chemoprophylaxis and the incidences of VTE and SEH.</AbstractText><AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">Nineteen studies met our eligibility criteria, comprising a total of 220,932 patients. The overall pooled incidence of VTE was 3.2%, including 3.3% for DVT and 0.4% for PE. A comparison of VTE incidence between patients that did and did not receive chemoprophylaxis was not statistically significant (OR 0.97, p=.95, 95% CI 0.43-2.19). The overall pooled incidence of SEH was 0.4%, and there was also no significant difference between patients that did and did not receive chemoprophylaxis (OR 1.57, p=.06, 95% CI 0.99-2.50).</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="UNASSIGNED">The use of perioperative chemoprophylaxis may not significantly alter rates of VTE or SEH in the elective spine surgery population. This review highlights the need for additional randomized controlled trials to better define the risks and benefits of specific chemoprophylactic protocols in various subpopulations of elective spine surgery.</AbstractText><CopyrightInformation>&#xa9; 2023 The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Rahmani</LastName><ForeName>Roman</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Mercy Health St. Vincent Medical Center, Department of Orthopedics, 2409 Cherry St, Suite #10, Toledo, OH 43608, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Eaddy</LastName><ForeName>Samuel</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Mercy Health St. Vincent Medical Center, Department of Orthopedics, 2409 Cherry St, Suite #10, Toledo, OH 43608, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Stegelmann</LastName><ForeName>Samuel D</ForeName><Initials>SD</Initials><AffiliationInfo><Affiliation>HCA Medical City Healthcare UNT-TCU GME (Denton), 3535 S Interstate 35, Denton, TX 76210, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Skrobot</LastName><ForeName>Gabriel</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Mercy Health St. Vincent Medical Center, Department of Orthopedics, 2409 Cherry St, Suite #10, Toledo, OH 43608, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Andreshak</LastName><ForeName>Thomas</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Mercy Health St. Vincent Medical Center, Department of Orthopedics, 2409 Cherry St, Suite #10, Toledo, OH 43608, United States.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>11</Month><Day>23</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>N Am Spine Soc J</MedlineTA><NlmUniqueID>9918335076906676</NlmUniqueID><ISSNLinking>2666-5484</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Anticoagulation</Keyword><Keyword MajorTopicYN="N">Chemoprophylaxis</Keyword><Keyword MajorTopicYN="N">Deep vein thrombosis</Keyword><Keyword MajorTopicYN="N">Elective</Keyword><Keyword MajorTopicYN="N">Pulmonary embolism</Keyword><Keyword MajorTopicYN="N">Spinal epidural hematoma</Keyword><Keyword MajorTopicYN="N">Spine surgery</Keyword><Keyword MajorTopicYN="N">Thromboprophylaxis</Keyword><Keyword MajorTopicYN="N">Thrombosis</Keyword><Keyword MajorTopicYN="N">Venous thromboembolism</Keyword></KeywordList><CoiStatement>The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>8</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>11</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>11</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>1</Month><Day>11</Day><Hour>7</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>1</Month><Day>11</Day><Hour>7</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>1</Month><Day>11</Day><Hour>4</Hour><Minute>11</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>11</Month><Day>23</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38204918</ArticleId><ArticleId IdType="pmc">PMC10777073</ArticleId><ArticleId IdType="doi">10.1016/j.xnsj.2023.100295</ArticleId><ArticleId IdType="pii">S2666-5484(23)00097-5</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Mosenthal WP, Landy DC, Boyajian HH, et al. Thromboprophylaxis in spinal surgery. Spine (Phila Pa 1976) 2018;43(8):E474&#x2013;E481. doi: 10.1097/BRS.0000000000002379.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/BRS.0000000000002379</ArticleId><ArticleId IdType="pubmed">28820759</ArticleId></ArticleIdList></Reference><Reference><Citation>Senders ZJ, Zussman BM, Maltenfort MG, Sharan AD, Ratliff JK, Harrop JS. The incidence of pulmonary embolism (PE) after spinal fusions. Clin Neurol Neurosurg. 2012;114(7):897&#x2013;901. doi: 10.1016/j.clineuro.2012.01.044.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clineuro.2012.01.044</ArticleId><ArticleId IdType="pubmed">22386262</ArticleId></ArticleIdList></Reference><Reference><Citation>Glotzbecker MP, Bono CM, Wood KB, Harris MB. Thromboembolic disease in spinal surgery: a systematic review. Spine (Phila Pa 1976) 2009;34(3):291&#x2013;303. doi: 10.1097/BRS.0b013e318195601d.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/BRS.0b013e318195601d</ArticleId><ArticleId IdType="pubmed">19179925</ArticleId></ArticleIdList></Reference><Reference><Citation>Leon L, Rodriguez H, Tawk RG, Ondra SL, Labropoulos N, Morasch MD. The prophylactic use of inferior vena cava filters in patients undergoing high-risk spinal surgery. Ann Vasc Surg. 2005;19(3):442&#x2013;447. doi: 10.1007/s10016-005-0025-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10016-005-0025-1</ArticleId><ArticleId IdType="pubmed">15864473</ArticleId></ArticleIdList></Reference><Reference><Citation>Sansone JM, del Rio AM, Anderson PA. The prevalence of and specific risk factors for venous thromboembolic disease following elective spine surgery. J Bone Joint Surg Am. 2010;92(2):304&#x2013;313. doi: 10.2106/JBJS.H.01815.</Citation><ArticleIdList><ArticleId IdType="doi">10.2106/JBJS.H.01815</ArticleId><ArticleId IdType="pubmed">20124056</ArticleId></ArticleIdList></Reference><Reference><Citation>Gould MK, Garcia DA, Wren SM, et al. Prevention of VTE in nonorthopedic surgical patients: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2012;141(2 Suppl):e227S&#x2013;e277S. doi: 10.1378/chest.11-2297.</Citation><ArticleIdList><ArticleId IdType="doi">10.1378/chest.11-2297</ArticleId><ArticleId IdType="pmc">PMC3278061</ArticleId><ArticleId IdType="pubmed">22315263</ArticleId></ArticleIdList></Reference><Reference><Citation>Ellenbogen Y, Power RG, Martyniuk A, Engels PT, Sharma SV, Kasper EM. Pharmacoprophylaxis for venous thromboembolism in spinal surgery: a systematic review and meta-analysis. World Neurosurg. 2021;150:e144&#x2013;e154. doi: 10.1016/j.wneu.2021.02.120.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.wneu.2021.02.120</ArticleId><ArticleId IdType="pubmed">33684581</ArticleId></ArticleIdList></Reference><Reference><Citation>Glotzbecker MP, Bono CM, Wood KB, Harris MB. Postoperative spinal epidural hematoma: a systematic review. Spine (Phila Pa 1976) 2010;35(10):E413&#x2013;E420. doi: 10.1097/BRS.0b013e3181d9bb77.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/BRS.0b013e3181d9bb77</ArticleId><ArticleId IdType="pubmed">20431474</ArticleId></ArticleIdList></Reference><Reference><Citation>Chimenti P, Molinari R. Postoperative spinal epidural hematoma causing American Spinal Injury Association B spinal cord injury in patients with suction wound drains. J Spinal Cord Med. 2013;36(3):213&#x2013;219. doi: 10.1179/2045772312Y.0000000070.</Citation><ArticleIdList><ArticleId IdType="doi">10.1179/2045772312Y.0000000070</ArticleId><ArticleId IdType="pmc">PMC3654447</ArticleId><ArticleId IdType="pubmed">23809591</ArticleId></ArticleIdList></Reference><Reference><Citation>Adeeb N, Hattab T, Savardekar A, et al. Venous thromboembolism prophylaxis in elective neurosurgery: a survey of board-certified neurosurgeons in the United States and updated literature review. World Neurosurg. 2021;150:e631&#x2013;e638. doi: 10.1016/j.wneu.2021.03.072.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.wneu.2021.03.072</ArticleId><ArticleId IdType="pubmed">33757886</ArticleId></ArticleIdList></Reference><Reference><Citation>Bono CM, Watters WC, 3rd, Heggeness MH, et al. An evidence-based clinical guideline for the use of antithrombotic therapies in spine surgery. Spine J. 2009;9(12):1046&#x2013;1051. doi: 10.1016/j.spinee.2009.09.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.spinee.2009.09.005</ArticleId><ArticleId IdType="pubmed">19931184</ArticleId></ArticleIdList></Reference><Reference><Citation>Colomina MJ, Bago J, Perez-Bracchiglione J, et al. Thromboprophylaxis in elective spinal surgery: a protocol for systematic review. Medicine (Baltimore) 2020;99(21):e20127. doi: 10.1097/MD.0000000000020127.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MD.0000000000020127</ArticleId><ArticleId IdType="pmc">PMC7249943</ArticleId><ArticleId IdType="pubmed">32481281</ArticleId></ArticleIdList></Reference><Reference><Citation>Du W, Zhao C, Wang J, Liu J, Shen B, Zheng Y. Comparison of rivaroxaban and parnaparin for preventing venous thromboembolism after lumbar spine surgery. J Orthop Surg Res. 2015;10:78. doi: 10.1186/s13018-015-0223-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13018-015-0223-7</ArticleId><ArticleId IdType="pmc">PMC4455337</ArticleId><ArticleId IdType="pubmed">25998624</ArticleId></ArticleIdList></Reference><Reference><Citation>McLynn RP, Diaz-Collado PJ, Ottesen TD, et al. Risk factors and pharmacologic prophylaxis for venous thromboembolism in elective spine surgery. Spine J. 2018;18(6):970&#x2013;978. doi: 10.1016/j.spinee.2017.10.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.spinee.2017.10.013</ArticleId><ArticleId IdType="pubmed">29056565</ArticleId></ArticleIdList></Reference><Reference><Citation>Cox JB, Weaver KJ, Neal DW, Jacob RP, Hoh DJ. Decreased incidence of venous thromboembolism after spine surgery with early multimodal prophylaxis: clinical article. J Neurosurg Spine. 2014;21(4):677&#x2013;684. doi: 10.3171/2014.6.SPINE13447.</Citation><ArticleIdList><ArticleId IdType="doi">10.3171/2014.6.SPINE13447</ArticleId><ArticleId IdType="pubmed">25105337</ArticleId></ArticleIdList></Reference><Reference><Citation>Pateder DB, Gonzales RA, Kebaish KM, et al. Pulmonary embolism after adult spinal deformity surgery. Spine (Phila Pa 1976) 2008;33(3):301&#x2013;305. doi: 10.1097/BRS.0b013e31816245e1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/BRS.0b013e31816245e1</ArticleId><ArticleId IdType="pubmed">18303463</ArticleId></ArticleIdList></Reference><Reference><Citation>Karande GY, Hedgire SS, Sanchez Y, et al. Advanced imaging in acute and chronic deep vein thrombosis. Cardiovasc Diagn Ther. 2016;6(6):493&#x2013;507. doi: 10.21037/cdt.2016.12.06.</Citation><ArticleIdList><ArticleId IdType="doi">10.21037/cdt.2016.12.06</ArticleId><ArticleId IdType="pmc">PMC5220209</ArticleId><ArticleId IdType="pubmed">28123971</ArticleId></ArticleIdList></Reference><Reference><Citation>Cushman M, Tsai AW, White RH, et al. Deep vein thrombosis and pulmonary embolism in two cohorts: the longitudinal investigation of thromboembolism etiology. Am J Med. 2004;117(1):19&#x2013;25. doi: 10.1016/j.amjmed.2004.01.018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amjmed.2004.01.018</ArticleId><ArticleId IdType="pubmed">15210384</ArticleId></ArticleIdList></Reference><Reference><Citation>Page MJ, McKenzie JE, Bossuyt PM, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71. doi: 10.1136/bmj.n71.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.n71</ArticleId><ArticleId IdType="pmc">PMC8005924</ArticleId><ArticleId IdType="pubmed">33782057</ArticleId></ArticleIdList></Reference><Reference><Citation>Wells GA, Shea B, O'Connell D, et&#xa0;al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. Accessed February 15, 2023, https://www.ohri.ca/programs/clinical_epidemiology/oxford.asp.</Citation></Reference><Reference><Citation>Sterne JAC, Savovi&#x107; J, Page MJ, et al. RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ. 2019;366:l4898. doi: 10.1136/bmj.l4898.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.l4898</ArticleId><ArticleId IdType="pubmed">31462531</ArticleId></ArticleIdList></Reference><Reference><Citation>Haddaway NR, Page MJ, Pritchard CC, McGuinness LA. PRISMA2020: An R package and Shiny app for producing PRISMA 2020-compliant flow diagrams, with interactivity for optimised digital transparency and open synthesis. Campbell Syst Rev. 2022;18(2):e1230. doi: 10.1002/cl2.1230.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/cl2.1230</ArticleId><ArticleId IdType="pmc">PMC8958186</ArticleId><ArticleId IdType="pubmed">36911350</ArticleId></ArticleIdList></Reference><Reference><Citation>Nicol M, Sun Y, Craig N, Wardlaw D. Incidence of thromboembolic complications in lumbar spinal surgery in 1,111 patients. Eur Spine J. 2009;18(10):1548&#x2013;1552. doi: 10.1007/s00586-009-1035-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00586-009-1035-4</ArticleId><ArticleId IdType="pmc">PMC2899370</ArticleId><ArticleId IdType="pubmed">19484271</ArticleId></ArticleIdList></Reference><Reference><Citation>Cunningham JE, Swamy G, Thomas KC. Does preoperative DVT chemoprophylaxis in spinal surgery affect the incidence of thromboembolic complications and spinal epidural hematomas? J Spinal Disord Tech. 2011;24(4):E31&#x2013;E34. doi: 10.1097/BSD.0b013e3181f605ea.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/BSD.0b013e3181f605ea</ArticleId><ArticleId IdType="pubmed">20975599</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang SD, Liu H, Sun YP, et al. Prevalence and risk factors of deep vein thrombosis in patients after spine surgery: a retrospective case-cohort study. Sci Rep. 2015;5:11834. doi: 10.1038/srep11834.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep11834</ArticleId><ArticleId IdType="pmc">PMC4488742</ArticleId><ArticleId IdType="pubmed">26135271</ArticleId></ArticleIdList></Reference><Reference><Citation>Hamidi S, Riazi M. Incidence of venous thromboembolic complications in instrumental spinal surgeries with preoperative chemoprophylaxis. J Korean Neurosurg Soc. 2015;57(2):114&#x2013;118. doi: 10.3340/jkns.2015.57.2.114.</Citation><ArticleIdList><ArticleId IdType="doi">10.3340/jkns.2015.57.2.114</ArticleId><ArticleId IdType="pmc">PMC4345188</ArticleId><ArticleId IdType="pubmed">25733992</ArticleId></ArticleIdList></Reference><Reference><Citation>Weber B, Seal A, McGirr J, Fielding K. Case series of elective instrumented posterior lumbar spinal fusions demonstrating a low incidence of venous thromboembolism. ANZ J Surg. 2016;86(10):796&#x2013;800. doi: 10.1111/ans.12702.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ans.12702</ArticleId><ArticleId IdType="pubmed">24897952</ArticleId></ArticleIdList></Reference><Reference><Citation>Fawi HMT, Saba K, Cunningham A, et al. Venous thromboembolism in adult elective spinal surgery: a tertiary centre review of 2181 patients. Bone Joint J. 2017;99-B(9):1204&#x2013;1209. doi: 10.1302/0301-620X.99B9.BJJ-2016-1193.R2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1302/0301-620X.99B9.BJJ-2016-1193.R2</ArticleId><ArticleId IdType="pubmed">28860401</ArticleId></ArticleIdList></Reference><Reference><Citation>Shapiro JA, Stillwagon MR, Padovano AG, Moll S, Lim MR. An evidence-based algorithm for determining venous thromboembolism prophylaxis after degenerative spinal surgery. Int J Spine Surg. 2020;14(4):599&#x2013;606. doi: 10.14444/7080.</Citation><ArticleIdList><ArticleId IdType="doi">10.14444/7080</ArticleId><ArticleId IdType="pmc">PMC7478019</ArticleId><ArticleId IdType="pubmed">32986584</ArticleId></ArticleIdList></Reference><Reference><Citation>Kiguchi MM, Schobel H, TenEyck E, et al. The risks and benefits of early venous thromboembolism prophylaxis after elective spinal surgery: a single-centre experience. J Perioper Pract. 2022;32(11):286&#x2013;294. doi: 10.1177/17504589211002070.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/17504589211002070</ArticleId><ArticleId IdType="pubmed">34301162</ArticleId></ArticleIdList></Reference><Reference><Citation>Thota DR, Bagley CA, Tamimi MA, Nakonezny PA, Van Hal M. Anticoagulation in elective spine cases: rates of hematomas versus thromboembolic disease. Spine (Phila Pa 1976) 2021;46(13):901&#x2013;906. doi: 10.1097/BRS.0000000000003935.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/BRS.0000000000003935</ArticleId><ArticleId IdType="pubmed">34100843</ArticleId></ArticleIdList></Reference><Reference><Citation>Li X, Jiao G, Li J, et al. Combined use of tranexamic acid and rivaroxaban in posterior/transforaminal lumbar interbody fusion surgeries safely reduces blood loss and incidence of thrombosis: evidence from a prospective, randomized, double-blind, placebo-controlled study. Global Spine J. 2023;13(5):1229&#x2013;1237. doi: 10.1177/21925682211024556.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/21925682211024556</ArticleId><ArticleId IdType="pmc">PMC10416579</ArticleId><ArticleId IdType="pubmed">34569334</ArticleId></ArticleIdList></Reference><Reference><Citation>Macki M, Haddad Y, Suryadevara R, et al. Prophylactic low-molecular-weight heparin versus unfractionated heparin in spine surgery (PLUSS): a pilot matched cohort study. Neurosurgery. 2021;89(6):1097&#x2013;1103. doi: 10.1093/neuros/nyab363.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/neuros/nyab363</ArticleId><ArticleId IdType="pubmed">34634115</ArticleId></ArticleIdList></Reference><Reference><Citation>Nikouei F, Chehrassan M, Shakeri M, et al. Effect of aspirin in preventing deep vein thrombosis (DVT) after lumbar canal spinal stenosis surgeries: a double-blind parallel randomized clinical trial. Curr Orthop Pract. 2022;33(6):543&#x2013;547. doi: 10.1097/BCO.0000000000001169.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/BCO.0000000000001169</ArticleId></ArticleIdList></Reference><Reference><Citation>Cloney MB, Hopkins B, Dhillon E, El Tecle N, Koski TR, Dahdaleh NS. Chemoprophylactic anticoagulation following lumbar surgery significantly reduces thromboembolic events after instrumented fusions, not decompressions. Spine (Phila Pa 1976) 2023;48(3):172&#x2013;179. doi: 10.1097/BRS.0000000000004489.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/BRS.0000000000004489</ArticleId><ArticleId IdType="pubmed">36191060</ArticleId></ArticleIdList></Reference><Reference><Citation>Fiasconaro M, Poeran J, Liu J, Wilson LA, Memtsoudis SG. Venous thromboembolism and prophylaxis therapy after elective spine surgery: a population-based study. Can J Anaesth. 2021;68(3):345&#x2013;357. doi: 10.1007/s12630-020-01859-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12630-020-01859-2</ArticleId><ArticleId IdType="pubmed">33210220</ArticleId></ArticleIdList></Reference><Reference><Citation>Pirkle S, Cook DJ, Kaskovich S, et al. Comparing Bleeding and thrombotic rates in spine surgery: an analysis of 119,888 patients. Global Spine J. 2021;11(2):161&#x2013;166. doi: 10.1177/2192568219896295.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/2192568219896295</ArticleId><ArticleId IdType="pmc">PMC7882830</ArticleId><ArticleId IdType="pubmed">32875853</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang L, Li Y, Liu D, et al. Combined use of tranexamic acid and rivaroxaban in posterior lumbar interbody fusion safely reduces blood loss and transfusion rates without increasing the risk of thrombosis-a prospective, stratified, randomized, controlled trial. Int Orthop. 2020;44(10):2079&#x2013;2087. doi: 10.1007/s00264-020-04699-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00264-020-04699-3</ArticleId><ArticleId IdType="pubmed">32676780</ArticleId></ArticleIdList></Reference><Reference><Citation>Fourman MS, Shaw JD, Nwasike CO, et al. Use of fondaparinux following elective lumbar spine surgery is associated with a reduction in symptomatic venous thromboembolism. Global Spine J. 2020;10(7):844&#x2013;850. doi: 10.1177/2192568219878418.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/2192568219878418</ArticleId><ArticleId IdType="pmc">PMC7485070</ArticleId><ArticleId IdType="pubmed">32905722</ArticleId></ArticleIdList></Reference><Reference><Citation>Zervos TM, Bazydlo M, Tundo K, Macki M, Rock J. Risk factors associated with symptomatic deep vein thrombosis following elective spine surgery: a case-control study. World Neurosurg. 2020;144:e460&#x2013;e465. doi: 10.1016/j.wneu.2020.08.182.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.wneu.2020.08.182</ArticleId><ArticleId IdType="pubmed">32889183</ArticleId></ArticleIdList></Reference><Reference><Citation>Glotzbecker MP, Bono CM, Harris MB, Brick G, Heary RF, Wood KB. Surgeon practices regarding postoperative thromboembolic prophylaxis after high-risk spinal surgery. Spine (Phila Pa 1976) 2008;33(26):2915&#x2013;2921. doi: 10.1097/BRS.0b013e318190702a.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/BRS.0b013e318190702a</ArticleId><ArticleId IdType="pubmed">19092624</ArticleId></ArticleIdList></Reference><Reference><Citation>Louie P, Harada G, Harrop J, et al. Perioperative anticoagulation management in spine surgery: initial findings from the AO spine anticoagulation global survey. Global Spine J. 2020;10(5):512&#x2013;527. doi: 10.1177/2192568219897598.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/2192568219897598</ArticleId><ArticleId IdType="pmc">PMC7359688</ArticleId><ArticleId IdType="pubmed">32677576</ArticleId></ArticleIdList></Reference><Reference><Citation>Schuster JM, Fischer D, Dettori JR. Is chemical antithrombotic prophylaxis effective in elective thoracolumbar spine surgery? results of a systematic review. Evid Based Spine Care J. 2010;1(2):40&#x2013;45. doi: 10.1055/s-0028-1100913.</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/s-0028-1100913</ArticleId><ArticleId IdType="pmc">PMC3623098</ArticleId><ArticleId IdType="pubmed">23637666</ArticleId></ArticleIdList></Reference><Reference><Citation>Moayer A, Mohebali N, Razmkon A. Incidence of deep vein thrombosis in patients undergoing degenerative spine surgery on prophylactic dalteparin; a single center report. Bull Emerg Trauma. 2016;4(1):38&#x2013;42.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4779468</ArticleId><ArticleId IdType="pubmed">27162925</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">22907738</PMID><DateCompleted><Year>2013</Year><Month>09</Month><Day>25</Day></DateCompleted><DateRevised><Year>2025</Year><Month>06</Month><Day>26</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1433-2965</ISSN><JournalIssue CitedMedium="Internet"><Volume>24</Volume><Issue>4</Issue><PubDate><Year>2013</Year><Month>Apr</Month></PubDate></JournalIssue><Title>Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA</Title><ISOAbbreviation>Osteoporos Int</ISOAbbreviation></Journal><ArticleTitle>Prognostic value of cardiac troponins in elderly patients with hip fracture--a systematic review.</ArticleTitle><Pagination><StartPage>1145</StartPage><EndPage>1149</EndPage><MedlinePgn>1145-9</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s00198-012-2116-5</ELocationID><Abstract><AbstractText>Cardiac troponins can be elevated in cardiac ischemic conditions or other diseases such as pulmonary embolism or renal failure, where they may predict outcome. We hypothesized that cardiac troponins offer useful prognostic information regarding morbidity and mortality in elderly hip fracture patients undergoing surgical therapy. A literature review was conducted using PubMed and CINAHL plus with full text (EBSCOhost). Articles with original data relating troponins to prognosis in elderly hip fracture patients were reviewed. Studies with patients not undergoing surgery or undergoing elective or nonhip fracture surgery were excluded. Six papers met inclusion criteria. Troponin elevation was seen in 26.7-39% of patients, while myocardial infarction, cardiac complications, and cardiac death occurred in &#x2264;35% troponin-positive patients in four of six studies. Several noncardiac factors were associated with elevated troponin including higher American Society of Anaesthesiologists score, current smoking, reduced mobility/activity level, lower hemoglobin, and living in residential care. Patients with elevated troponin had longer lengths of stay, increased risk for discharge to long-term care facilities, and higher mortality. Increased age, male sex, and higher American Society of Anaesthesiologists score were also associated with mortality. Elevated troponin can be used as a marker of increased morbidity/mortality in elderly hip fracture patients undergoing surgery, as hypothesized, even in the absence of cardiac complications. Perioperative troponin evaluation may be useful for risk stratification, but further studies are needed to clarify risks and benefits of such testing.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Sandhu</LastName><ForeName>A</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Division of Rheumatology, University of Mississippi School of Medicine, 2500 North State Street, Jackson, MS 39216, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sanders</LastName><ForeName>S</ForeName><Initials>S</Initials></Author><Author ValidYN="Y"><LastName>Geraci</LastName><ForeName>S A</ForeName><Initials>SA</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2012</Year><Month>08</Month><Day>21</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Osteoporos Int</MedlineTA><NlmUniqueID>9100105</NlmUniqueID><ISSNLinking>0937-941X</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015415">Biomarkers</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D014336">Troponin</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015415" MajorTopicYN="N">Biomarkers</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006620" MajorTopicYN="N">Hip Fractures</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058866" MajorTopicYN="N">Osteoporotic Fractures</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011379" MajorTopicYN="N">Prognosis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014336" MajorTopicYN="N">Troponin</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2012</Year><Month>3</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2012</Year><Month>6</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2012</Year><Month>8</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2012</Year><Month>8</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2013</Year><Month>9</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">22907738</ArticleId><ArticleId IdType="doi">10.1007/s00198-012-2116-5</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>J Interv Cardiol. 2008 Apr;21(2):129-39</Citation><ArticleIdList><ArticleId IdType="pubmed">18248355</ArticleId></ArticleIdList></Reference><Reference><Citation>Injury. 2008 Jul;39(7):775-80</Citation><ArticleIdList><ArticleId IdType="pubmed">18407276</ArticleId></ArticleIdList></Reference><Reference><Citation>Anesthesiology. 2010 Sep;113(3):529-40</Citation><ArticleIdList><ArticleId IdType="pubmed">20733383</ArticleId></ArticleIdList></Reference><Reference><Citation>CMAJ. 2010 Oct 19;182(15):1609-16</Citation><ArticleIdList><ArticleId IdType="pubmed">20837683</ArticleId></ArticleIdList></Reference><Reference><Citation>J Bone Joint Surg Am. 2002 Apr;84(4):562-72</Citation><ArticleIdList><ArticleId IdType="pubmed">11940616</ArticleId></ArticleIdList></Reference><Reference><Citation>N Z Med J. 1994 Aug 10;107(983):308-9</Citation><ArticleIdList><ArticleId IdType="pubmed">8052465</ArticleId></ArticleIdList></Reference><Reference><Citation>Hip Int. 2011 Nov-Dec;21(6):757-61</Citation><ArticleIdList><ArticleId IdType="pubmed">22117257</ArticleId></ArticleIdList></Reference><Reference><Citation>Osteoporos Int. 2004 Nov;15(11):897-902</Citation><ArticleIdList><ArticleId IdType="pubmed">15490120</ArticleId></ArticleIdList></Reference><Reference><Citation>Intensive Care Med. 2001 Jun;27(6):965-9</Citation><ArticleIdList><ArticleId IdType="pubmed">11497154</ArticleId></ArticleIdList></Reference><Reference><Citation>Age Ageing. 2009 Jul;38(4):473-6</Citation><ArticleIdList><ArticleId IdType="pubmed">19383771</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Med. 2012 Jun;125(6):527-8</Citation><ArticleIdList><ArticleId IdType="pubmed">22325234</ArticleId></ArticleIdList></Reference><Reference><Citation>Int Orthop. 2011 Jun;35(6):903-7</Citation><ArticleIdList><ArticleId IdType="pubmed">21079953</ArticleId></ArticleIdList></Reference><Reference><Citation>Arch Orthop Trauma Surg. 2008 Oct;128(10):1073-9</Citation><ArticleIdList><ArticleId IdType="pubmed">18193436</ArticleId></ArticleIdList></Reference><Reference><Citation>BMJ. 2004 May 1;328(7447):1028-9</Citation><ArticleIdList><ArticleId IdType="pubmed">15117768</ArticleId></ArticleIdList></Reference><Reference><Citation>Can J Anaesth. 2008 Mar;55(3):146-54</Citation><ArticleIdList><ArticleId IdType="pubmed">18310624</ArticleId></ArticleIdList></Reference><Reference><Citation>Osteoporos Int. 1997;7(5):407-13</Citation><ArticleIdList><ArticleId IdType="pubmed">9425497</ArticleId></ArticleIdList></Reference><Reference><Citation>J Gerontol A Biol Sci Med Sci. 2012 Nov;67(11):1272-7</Citation><ArticleIdList><ArticleId IdType="pubmed">22454376</ArticleId></ArticleIdList></Reference><Reference><Citation>BMJ. 2002 Oct 19;325(7369):868-9</Citation><ArticleIdList><ArticleId IdType="pubmed">12386038</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">22209606</PMID><DateCompleted><Year>2012</Year><Month>05</Month><Day>01</Day></DateCompleted><DateRevised><Year>2025</Year><Month>06</Month><Day>26</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1097-6809</ISSN><JournalIssue CitedMedium="Internet"><Volume>55</Volume><Issue>3</Issue><PubDate><Year>2012</Year><Month>Mar</Month></PubDate></JournalIssue><Title>Journal of vascular surgery</Title><ISOAbbreviation>J Vasc Surg</ISOAbbreviation></Journal><ArticleTitle>A systematic review of symptomatic duodenal perforation by inferior vena cava filters.</ArticleTitle><Pagination><StartPage>856</StartPage><EndPage>861.e3</EndPage><MedlinePgn>856-861.e3</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jvs.2011.09.082</ELocationID><Abstract><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">A systematic review of the literature on symptomatic duodenal perforation caused by inferior vena cava (IVC) filters.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Three databases, PubMed MEDLINE, Web of Sciences, and Literatura Latino-Americana e do Caribe em Ci&#xea;ncias da Sa&#xfa;de (LILACS), reference lists of review articles and conference proceedings were searched. All articles containing data on clinical presentation, diagnostic strategy, and available treatment of symptomatic duodenal perforation caused by an IVC filter were included regardless of design, language, size, or length of follow-up.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Seventy-two articles were selected for full-text screening, being 21 case reports were selected. The median age was 46 years old (range, 21-83 years old). Abdominal pain was reported in 11 patients and gastrointestinal bleed in 5 patients. The indications for IVC filter placement in this cohort of patients were contraindication of anticoagulation and recurrent pulmonary embolism (PE) despite therapeutic levels in 8 and 5 patients, respectively. Three different imaging modalities were obtained in 9 patients (43%) before confirming the diagnosis. All but 1 patient underwent open approach through laparotomy with or without removal of the filter. No PEs or deaths were reported and only 1 patient had a severe clinical complication of IVC and bilateral iliac vein thrombosis with massive lower extremities edema.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Duodenal perforation caused by IVC filters is a rare complication that frequently requires extensive workup. Excellent outcomes with low complication rate have been reported in cases where an open procedure was performed with either extraction of the filter or removal of the offending struts.</AbstractText><CopyrightInformation>Copyright &#xa9; 2012 Society for Vascular Surgery. Published by Mosby, Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Malgor</LastName><ForeName>Rafael D</ForeName><Initials>RD</Initials><AffiliationInfo><Affiliation>Division of Vascular Surgery, Stony Brook Medical Center, Stony Brook, NY 11794-8191, USA. rafael.malgor@stonybrook.edu</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Labropoulos</LastName><ForeName>Nicos</ForeName><Initials>N</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2011</Year><Month>12</Month><Day>30</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Vasc Surg</MedlineTA><NlmUniqueID>8407742</NlmUniqueID><ISSNLinking>0741-5214</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D015746" MajorTopicYN="N">Abdominal Pain</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020878" MajorTopicYN="N">Device Removal</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004386" MajorTopicYN="N">Duodenum</DescriptorName><QualifierName UI="Q000293" MajorTopicYN="Y">injuries</QualifierName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006471" MajorTopicYN="N">Gastrointestinal Hemorrhage</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007416" MajorTopicYN="N">Intestinal Perforation</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011474" MajorTopicYN="N">Prosthesis Design</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016306" MajorTopicYN="N">Vena Cava Filters</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2011</Year><Month>7</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2011</Year><Month>9</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2011</Year><Month>9</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2012</Year><Month>1</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2012</Year><Month>1</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2012</Year><Month>5</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">22209606</ArticleId><ArticleId IdType="doi">10.1016/j.jvs.2011.09.082</ArticleId><ArticleId IdType="pii">S0741-5214(11)02298-1</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">19373223</PMID><DateCompleted><Year>2010</Year><Month>01</Month><Day>29</Day></DateCompleted><DateRevised><Year>2022</Year><Month>03</Month><Day>11</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Print">1930-7381</ISSN><JournalIssue CitedMedium="Print"><Volume>17</Volume><Issue>11</Issue><PubDate><Year>2009</Year><Month>Nov</Month></PubDate></JournalIssue><Title>Obesity (Silver Spring, Md.)</Title><ISOAbbreviation>Obesity (Silver Spring)</ISOAbbreviation></Journal><ArticleTitle>Prospective study of BMI and the risk of pulmonary embolism in women.</ArticleTitle><Pagination><StartPage>2040</StartPage><EndPage>2046</EndPage><MedlinePgn>2040-6</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1038/oby.2009.92</ELocationID><Abstract><AbstractText>Pulmonary embolism (PE) is common and associated with significant morbidity and mortality. An association between obesity and PE has been suggested, but the nature of the association has not been well defined. We performed a prospective cohort study of 87,226 women in the Nurses' Health Study (1984-2002) to define the association between BMI and the risk of incident PE. Primary exposure was BMI (&lt;22.5, 22.5-24.9, 25.0-27.4, 27.5-29.9, 30.0-34.9, and &gt;or=35.0 kg/m(2)). Primary outcome was idiopathic PE (medical record confirmed cases of PE not associated with prior surgery, trauma, or malignancy). Secondary analysis of nonidiopathic PE was also performed. Multivariable Cox proportional hazards models were controlled for age, physical activity, caloric intake, smoking, pack-years, race, spouse's educational attainment, parity, menopause, nonaspirin nonsteroidal anti-inflammatory drugs, warfarin, multivitamin supplements, hypertension, coronary heart disease, and rheumatological disease. There were 157 incident idiopathic PE and 338 nonidiopathic PE. There was a strong positive association between BMI, the risk of idiopathic PE (relative risk (RR) = 1.08 (95% confidence interval (CI), 1.06-1.10) per 1 kg/m(2) increase in BMI, P &lt; 0.001) and nonidiopathic PE (RR = 1.08 (95% CI, 1.07-1.10), P &lt; 0.001). The association was linear, and apparent even with modest increases in BMI (22.5-25 kg/m(2)). The risk increased nearly sixfold among subjects with BMI &gt;or=35 kg/m(2), and was present in multiple subgroups. Increasing BMI has a strong, linear association with the development of PE in women. Clinicians should consider BMI when assessing the risk of PE in their patients.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Kabrhel</LastName><ForeName>Christopher</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Emergency Medicine, Harvard Medical School, Massachusetts General Hospital, Boston, Massachusetts, USA. ckabrhel@partners.org</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Varraso</LastName><ForeName>Rapha&#xeb;lle</ForeName><Initials>R</Initials></Author><Author ValidYN="Y"><LastName>Goldhaber</LastName><ForeName>Samuel Z</ForeName><Initials>SZ</Initials></Author><Author ValidYN="Y"><LastName>Rimm</LastName><ForeName>Eric B</ForeName><Initials>EB</Initials></Author><Author ValidYN="Y"><LastName>Camargo</LastName><ForeName>Carlos A</ForeName><Initials>CA</Initials></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R21 AG031079</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R21AG031079</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2009</Year><Month>04</Month><Day>16</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Obesity (Silver Spring)</MedlineTA><NlmUniqueID>101264860</NlmUniqueID><ISSNLinking>1930-7381</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000375" MajorTopicYN="N">Aging</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015992" MajorTopicYN="Y">Body Mass Index</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009043" MajorTopicYN="N">Motor Activity</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011655" MajorTopicYN="N">Pulmonary Embolism</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012306" MajorTopicYN="N">Risk</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013223" MajorTopicYN="N">Statistics as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011795" MajorTopicYN="N">Surveys and Questionnaires</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014481" MajorTopicYN="N" Type="Geographic">United States</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2009</Year><Month>4</Month><Day>18</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2009</Year><Month>4</Month><Day>18</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2010</Year><Month>1</Month><Day>30</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2013</Year><Month>9</Month><Day>11</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">19373223</ArticleId><ArticleId IdType="mid">NIHMS515365</ArticleId><ArticleId IdType="pmc">PMC3769947</ArticleId><ArticleId IdType="doi">10.1038/oby.2009.92</ArticleId><ArticleId IdType="pii">oby200992</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Silverstein MD, Heit JA, Mohr DN, et al. Trends in the incidence of deep vein thrombosis and pulmonary embolism: a 25-year population-based study. Arch Intern Med. 1998;158:585&#x2013;593.</Citation><ArticleIdList><ArticleId IdType="pubmed">9521222</ArticleId></ArticleIdList></Reference><Reference><Citation>Goldhaber SZ, Visani L, De Rosa M. Acute pulmonary embolism: clinical outcomes in the International Cooperative Pulmonary Embolism Registry (ICOPER) Lancet. 1999;353:1386&#x2013;1389.</Citation><ArticleIdList><ArticleId IdType="pubmed">10227218</ArticleId></ArticleIdList></Reference><Reference><Citation>Kurkciyan I, Meron G, Sterz F, et al. Pulmonary embolism as a cause of cardiac arrest: presentation and outcome. Arch Intern Med. 2000;160:1529&#x2013;1535.</Citation><ArticleIdList><ArticleId IdType="pubmed">10826469</ArticleId></ArticleIdList></Reference><Reference><Citation>Becattini C, Agnelli G, Pesavento R, et al. Incidence of chronic thromboembolic pulmonary hypertension after a first episode of pulmonary embolism. Chest. 2006;130:172&#x2013;175.</Citation><ArticleIdList><ArticleId IdType="pubmed">16840398</ArticleId></ArticleIdList></Reference><Reference><Citation>Pengo V, Lensing AW, Prins MH, et al. Incidence of chronic thromboembolic pulmonary hypertension after pulmonary embolism. N Engl J Med. 2004;350:2257&#x2013;2264.</Citation><ArticleIdList><ArticleId IdType="pubmed">15163775</ArticleId></ArticleIdList></Reference><Reference><Citation>Tapson VF, Humbert M. Incidence and prevalence of chronic thromboembolic pulmonary hypertension: from acute to chronic pulmonary embolism. Proc Am Thorac Soc. 2006;3:564&#x2013;567.</Citation><ArticleIdList><ArticleId IdType="pubmed">16963534</ArticleId></ArticleIdList></Reference><Reference><Citation>Acting Surgeon General Issues &#x2018;Call to Action to Prevent Deep Vein Thrombosis and Pulmonary Embolism&#x2019;. Office of the Surgeon General, U.S. Department of Health and Human Sciences;  &lt; http://www.surgeongeneral.gov/news/pressreleases/pr20080915.html&gt;.</Citation><ArticleIdList><ArticleId IdType="pubmed">20669525</ArticleId></ArticleIdList></Reference><Reference><Citation>Heit JA. Venous thromboembolism epidemiology: implications for prevention and management. Semin Thromb Hemost. 2002;28(Suppl 2):3&#x2013;13.</Citation><ArticleIdList><ArticleId IdType="pubmed">12073175</ArticleId></ArticleIdList></Reference><Reference><Citation>Heit JA, Silverstein MD, Mohr DN, et al. The epidemiology of venous thromboembolism in the community. Thromb Haemost. 2001;86:452&#x2013;463.</Citation><ArticleIdList><ArticleId IdType="pubmed">11487036</ArticleId></ArticleIdList></Reference><Reference><Citation>Stein PD, Beemath A, Olson RE. Obesity as a risk factor in venous thromboembolism. Am J Med. 2005;118:978&#x2013;980.</Citation><ArticleIdList><ArticleId IdType="pubmed">16164883</ArticleId></ArticleIdList></Reference><Reference><Citation>Kucher N, Tapson VF, Goldhaber SZ. Risk factors associated with symptomatic pulmonary embolism in a large cohort of deep vein thrombosis patients. Thromb Haemost. 2005;93:494&#x2013;498.</Citation><ArticleIdList><ArticleId IdType="pubmed">15735800</ArticleId></ArticleIdList></Reference><Reference><Citation>Linnemann B, Zgouras D, Schindewolf M, et al. Impact of sex and traditional cardiovascular risk factors on the risk of recurrent venous thromboembolism: results from the German MAISTHRO Registry. Blood Coagul Fibrinolysis. 2008;19:159&#x2013;165.</Citation><ArticleIdList><ArticleId IdType="pubmed">18277138</ArticleId></ArticleIdList></Reference><Reference><Citation>Goldhaber SZ, Grodstein F, Stampfer MJ, et al. A prospective study of risk factors for pulmonary embolism in women. JAMA. 1997;277:642&#x2013;645.</Citation><ArticleIdList><ArticleId IdType="pubmed">9039882</ArticleId></ArticleIdList></Reference><Reference><Citation>Goldhaber SZ, Savage DD, Garrison RJ, et al. Risk factors for pulmonary embolism. The Framingham Study. Am J Med. 1983;74:1023&#x2013;1028.</Citation><ArticleIdList><ArticleId IdType="pubmed">6859053</ArticleId></ArticleIdList></Reference><Reference><Citation>Rimm EB, Stampfer MJ, Colditz GA, et al. Validity of self-reported waist and hip circumferences in men and women. Epidemiology. 1990;1:466&#x2013;473.</Citation><ArticleIdList><ArticleId IdType="pubmed">2090285</ArticleId></ArticleIdList></Reference><Reference><Citation>Willett W, Stampfer MJ, Bain C, et al. Cigarette smoking, relative weight, and menopause. Am J Epidemiol. 1983;117:651&#x2013;658.</Citation><ArticleIdList><ArticleId IdType="pubmed">6859020</ArticleId></ArticleIdList></Reference><Reference><Citation>Troy LM, Hunter DJ, Manson JE, et al. The validity of recalled weight among younger women. Int J Obes Relat Metab Disord. 1995;19:570&#x2013;572.</Citation><ArticleIdList><ArticleId IdType="pubmed">7489028</ArticleId></ArticleIdList></Reference><Reference><Citation>Simon T, Beau Yon de Jonage-Canonico M, Oger E, et al. Indicators of lifetime endogenous estrogen exposure and risk of venous thromboembolism. J Thromb Haemost. 2006;4:71&#x2013;76.</Citation><ArticleIdList><ArticleId IdType="pubmed">16409454</ArticleId></ArticleIdList></Reference><Reference><Citation>Canonico M, Oger E, Conard J, et al. Obesity and risk of venous thromboembolism among postmenopausal women: differential impact of hormone therapy by route of estrogen administration. The ESTHER Study. J Thromb Haemost. 2006;4:1259&#x2013;1265.</Citation><ArticleIdList><ArticleId IdType="pubmed">16706969</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsai AW, Cushman M, Rosamond WD, et al. Cardiovascular risk factors and venous thromboembolism incidence: the longitudinal investigation of thromboembolism etiology. Arch Intern Med. 2002;162:1182&#x2013;1189.</Citation><ArticleIdList><ArticleId IdType="pubmed">12020191</ArticleId></ArticleIdList></Reference><Reference><Citation>Hansson PO, Eriksson H, Welin L, Svardsudd K, Wilhelmsen L. Smoking and abdominal obesity: risk factors for venous thromboembolism among middle-aged men: &#x201c;the study of men born in 1913. Arch Intern Med. 1999;159:1886&#x2013;1890.</Citation><ArticleIdList><ArticleId IdType="pubmed">10493318</ArticleId></ArticleIdList></Reference><Reference><Citation>Glynn RJ, Rosner B. Comparison of risk factors for the competing risks of coronary heart disease, stroke, and venous thromboembolism. Am J Epidemiol. 2005;162:975&#x2013;982.</Citation><ArticleIdList><ArticleId IdType="pubmed">16207808</ArticleId></ArticleIdList></Reference><Reference><Citation>Konstantinides S, Schafer K, Neels JG, Dellas C, Loskutoff DJ. Inhibition of endogenous leptin protects mice from arterial and venous thrombosis. Arterioscler Thromb Vasc Biol. 2004;24:2196&#x2013;2201.</Citation><ArticleIdList><ArticleId IdType="pubmed">15458978</ArticleId></ArticleIdList></Reference><Reference><Citation>Napoleone E, ADIS, Amore C, et al. Leptin induces tissue factor expression in human peripheral blood mononuclear cells: a possible link between obesity and cardiovascular risk? J Thromb Haemost. 2007;5:1462&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">17425664</ArticleId></ArticleIdList></Reference><Reference><Citation>Cushman M, Kuller LH, Prentice R, et al. Estrogen plus progestin and risk of venous thrombosis. JAMA. 2004;292:1573&#x2013;1580.</Citation><ArticleIdList><ArticleId IdType="pubmed">15467059</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuczmarski RJ, Flegal KM, Campbell SM, Johnson CL. Increasing prevalence of overweight among US adults. The National Health and Nutrition Examination Surveys, 1960 to 1991. JAMA. 1994;272:205&#x2013;211.</Citation><ArticleIdList><ArticleId IdType="pubmed">8022039</ArticleId></ArticleIdList></Reference><Reference><Citation>Ogden CL, Carroll MD, McDowell MA, Flegal KM. NCHS data brief no 1. Hyattsville, MD: National Center for Health Statistics; 2007. Obesity among adults in the United States&#x2014;no statistically significant change since 2003&#x2013;2004.</Citation><ArticleIdList><ArticleId IdType="pubmed">19389313</ArticleId></ArticleIdList></Reference><Reference><Citation>Di Minno G, Mannucci PM, Tufano A, et al. The first ambulatory screening on thromboembolism: a multicentre, cross-sectional, observational study on risk factors for venous thromboembolism. J Thromb Haemost. 2005;3:1459&#x2013;1466.</Citation><ArticleIdList><ArticleId IdType="pubmed">15978103</ArticleId></ArticleIdList></Reference><Reference><Citation>Arterburn DE, Crane PK, Sullivan SD. The coming epidemic of obesity in elderly Americans. J Am Geriatr Soc. 2004;52:1907&#x2013;1912.</Citation><ArticleIdList><ArticleId IdType="pubmed">15507070</ArticleId></ArticleIdList></Reference><Reference><Citation>Villareal DT, Apovian CM, Kushner RF, Klein S. Obesity in older adults: technical review and position statement of the American Society for Nutrition and NAASO, The Obesity Society. Obes Res. 2005;13:1849&#x2013;1863.</Citation><ArticleIdList><ArticleId IdType="pubmed">16339115</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaplan MS, Huguet N, Newsom JT, McFarland BH, Lindsay J. Prevalence and correlates of overweight and obesity among older adults: findings from the Canadian National Population Health Survey. J Gerontol A Biol Sci Med Sci. 2003;58:1018&#x2013;1030.</Citation><ArticleIdList><ArticleId IdType="pubmed">14630884</ArticleId></ArticleIdList></Reference><Reference><Citation>Gostic CL. The crucial role of exercise and physical activity in weight management and functional improvement for seniors. Clin Geriatr Med. 2005;21:747&#x2013;756. vii.</Citation><ArticleIdList><ArticleId IdType="pubmed">16182087</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37904393</PMID><DateCompleted><Year>2023</Year><Month>11</Month><Day>02</Day></DateCompleted><DateRevised><Year>2024</Year><Month>02</Month><Day>08</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1536-5964</ISSN><JournalIssue CitedMedium="Internet"><Volume>102</Volume><Issue>43</Issue><PubDate><Year>2023</Year><Month>Oct</Month><Day>27</Day></PubDate></JournalIssue><Title>Medicine</Title><ISOAbbreviation>Medicine (Baltimore)</ISOAbbreviation></Journal><ArticleTitle>Ultrasound surveillance for deep venous thrombosis and subsequent venous thromboembolism in adults with trauma: A systematic review and meta-analysis.</ArticleTitle><Pagination><StartPage>e35625</StartPage><MedlinePgn>e35625</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e35625</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1097/MD.0000000000035625</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Studies have shown routine ultrasound surveillance (RUSS) will facilitate deep vein thrombosis (DVT) detection in patients with trauma and reduce the subsequent incidence of pulmonary embolism (PE); however, the findings were inconsistent. In adults with trauma at a high risk of venous thromboembolism, this systematic review and meta-analysis compared RUSS outcomes with those of "no RUSS."</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Three databases were screened for relevant articles from inception to October 18, 2021. Randomized controlled trials (RCTs) and observational studies comparing RUSS with no RUSS were included. We used relative risks (RRs), odds ratios (ORs), and mean differences to pool effect estimates for dichotomous and continuous outcomes. The cochrane risk of bias or the risk of bias in non-randomized studies of interventions were used to assess bias risk. The grading of recommendations, assessment, development, and evaluation framework assessed the certainty of the evidence.</AbstractText><AbstractText Label="FINDINGS" NlmCategory="RESULTS">Out of 1685 articles, 5 met the inclusion criteria (RCT: 1; observational studies: 4). Observational studies suggested RUSS is associated with higher odds of DVT detection (OR, 4.87; 95% confidence interval [CI], 3.13-7.57; very low certainty). Whereas higher risks of DVT were associated with RUSS in the RCT (distal DVT: RR, 15.48; 95% CI, 7.62-31.48; low certainty, and proximal DVT: RR, 2.37; 95% CI, 1.04-5.39; very low certainty). Reduced odds of PE risk were observed with the RUSS (OR, 0.47; 95% CI, 0.24-0.91; very low certainty). Observational studies indicated that RUSS had an uncertain effect on mortality (OR, 0.46; 95% CI, 0.06-3.49). In the RCT, times to proximal and distal DVT diagnoses were shorter with RUSS (proximal DVT, mean difference 2.25 days shorter [95% CI, 5.74-1.24]; distal DVT, mean differences 1.56 days shorter [95% CI, 4.22-1.12]; very low certainty for both). Increasing bleeding risk was not linked to the RUSS group (RR, 1.24; 95% CI, 0.31-4.92).</AbstractText><AbstractText Label="INTERPRETATION" NlmCategory="CONCLUSIONS">The RUSS efficacy in adults with trauma at high risk for venous thromboembolism showed that it increases DVT detection, decreases PE incidence, and shortens the time to DVT diagnosis, with an uncertain impact on mortality. The evidence is low or very low in certainty because of bias, inconsistency, imprecision, and indirectness.</AbstractText><CopyrightInformation>Copyright &#xa9; 2023 the Author(s). Published by Wolters Kluwer Health, Inc.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Al-Sharydah</LastName><ForeName>Abdulaziz M</ForeName><Initials>AM</Initials><Identifier Source="ORCID">0000-0002-6590-5850</Identifier><AffiliationInfo><Affiliation>Diagnostic and Interventional Radiology Department, King Fahd Hospital of the University, Imam Abdulrahman Bin Faisal University, Dammam, Saudi Arabia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alshahrani</LastName><ForeName>Mohammed S</ForeName><Initials>MS</Initials><AffiliationInfo><Affiliation>Department of Emergency and Critical Care, King Fahd Hospital of the University, Imam Abdulrahman Bin Faisal University, Dammam, Saudi Arabia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Maghrabi</LastName><ForeName>Khalid</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Critical Care Medicine, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tashkandi</LastName><ForeName>Wail</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Department of Surgery, King Abdulaziz University, Jeddah, Saudi Arabia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Critical Care, Fakeeh Care Group, Jeddah, Saudi Arabia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Amer</LastName><ForeName>Marwa</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Medical/Critical Pharmacy Division, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>College of Medicine and Pharmacy, Alfaisal University, Riyadh, Saudi Arabia.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Medicine (Baltimore)</MedlineTA><NlmUniqueID>2985248R</NlmUniqueID><ISSNLinking>0025-7974</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000925">Anticoagulants</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D054556" MajorTopicYN="Y">Venous Thromboembolism</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000925" MajorTopicYN="N">Anticoagulants</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011655" MajorTopicYN="Y">Pulmonary Embolism</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020246" MajorTopicYN="Y">Venous Thrombosis</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading></MeshHeadingList><CoiStatement>The authors have no funding and conflicts of interest to disclose.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>11</Month><Day>2</Day><Hour>12</Hour><Minute>46</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>10</Month><Day>31</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>10</Month><Day>31</Day><Hour>1</Hour><Minute>40</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>10</Month><Day>27</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37904393</ArticleId><ArticleId IdType="pmc">PMC10615543</ArticleId><ArticleId IdType="doi">10.1097/MD.0000000000035625</ArticleId><ArticleId IdType="pii">00005792-202310270-00049</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Haut ER, Schneider EB, Patel A, et al. . Duplex ultrasound screening for deep vein thrombosis in asymptomatic trauma patients: a survey of individual trauma surgeon opinions and current trauma center practices. J Trauma. 2011;70:27&#x2013;33; discussion 33.</Citation><ArticleIdList><ArticleId IdType="pubmed">21217477</ArticleId></ArticleIdList></Reference><Reference><Citation>Cipolle MD, Wojcik R, Seislove E, et al. . The role of surveillance duplex scanning in preventing venous thromboembolism in trauma patients. J Trauma. 2002;52:453&#x2013;62.</Citation><ArticleIdList><ArticleId IdType="pubmed">11901319</ArticleId></ArticleIdList></Reference><Reference><Citation>Allen CJ, Murray CR, Meizoso JP, et al. . Surveillance and early management of deep vein thrombosis decreases rate of pulmonary embolism in high-risk trauma patients. J Am Coll Surg. 2016;222:65&#x2013;72.</Citation><ArticleIdList><ArticleId IdType="pubmed">26616034</ArticleId></ArticleIdList></Reference><Reference><Citation>Haut ER, Noll K, Efron DT, et al. . Can increased incidence of deep vein thrombosis (DVT) be used as a marker of quality of care in the absence of standardized screening? The potential effect of surveillance bias on reported DVT rates after trauma. J Trauma. 2007;63:1132&#x2013;5; discussion 1135.</Citation><ArticleIdList><ArticleId IdType="pubmed">17993962</ArticleId></ArticleIdList></Reference><Reference><Citation>Shackford SR, Cipolle MD, Badiee J, et al. . Determining the magnitude of surveillance bias in the assessment of lower extremity deep venous thrombosis: a prospective observational study of two centers. J Trauma Acute Care Surg. 2016;80:734&#x2013;9; discussion 740.</Citation><ArticleIdList><ArticleId IdType="pubmed">26891155</ArticleId></ArticleIdList></Reference><Reference><Citation>Samuel S, Patel N, McGuire MF, et al. . Analysis of venous thromboembolism in neurosurgical patients undergoing standard versus routine ultrasonography. J Thromb Thrombolysis. 2019;47:209&#x2013;15.</Citation><ArticleIdList><ArticleId IdType="pubmed">30392138</ArticleId></ArticleIdList></Reference><Reference><Citation>Satiani B, Falcone R, Shook L, et al. . Screening for major deep vein thrombosis in seriously injured patients: a prospective study. Ann Vasc Surg. 1997;11:626&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">9363309</ArticleId></ArticleIdList></Reference><Reference><Citation>Spain DA, Richardson JD, Polk HC, Jr, et al. . Venous thromboembolism in the high-risk trauma patient: do risks justify aggressive screening and prophylaxis? J Trauma. 1997;42:463&#x2013;7; discussion 467.</Citation><ArticleIdList><ArticleId IdType="pubmed">9095114</ArticleId></ArticleIdList></Reference><Reference><Citation>Napolitano LM, Garlapati VS, Heard SO, et al. . Asymptomatic deep venous thrombosis in the trauma patient: is an aggressive screening protocol justified? J Trauma. 1995;39:651&#x2013;7; discussion 657.</Citation><ArticleIdList><ArticleId IdType="pubmed">7473949</ArticleId></ArticleIdList></Reference><Reference><Citation>Piotrowski JJ, Alexander JJ, Brandt CP, et al. . Is deep vein thrombosis surveillance warranted in high-risk trauma patients? Am J Surg. 1996;172:210&#x2013;3.</Citation><ArticleIdList><ArticleId IdType="pubmed">8795534</ArticleId></ArticleIdList></Reference><Reference><Citation>Schwarcz TH, Quick RC, Minion DJ, et al. . Enoxaparin treatment in high-risk trauma patients limits the utility of surveillance venous duplex scanning. J Vasc Surg. 2001;34:447&#x2013;52.</Citation><ArticleIdList><ArticleId IdType="pubmed">11533596</ArticleId></ArticleIdList></Reference><Reference><Citation>Bandle J, Shackford SR, Kahl JE, et al. . The value of lower-extremity duplex surveillance to detect deep vein thrombosis in trauma patients. J Trauma Acute Care Surg. 2013;74:575&#x2013;80.</Citation><ArticleIdList><ArticleId IdType="pubmed">23354253</ArticleId></ArticleIdList></Reference><Reference><Citation>De Martino RR, Beck AW, Edwards MS, et al. . Impact of screening versus symptomatic measurement of deep vein thrombosis in a national quality improvement registry. J Vasc Surg. 2012;56:1045&#x2013;51.e1.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3767393</ArticleId><ArticleId IdType="pubmed">22832263</ArticleId></ArticleIdList></Reference><Reference><Citation>Velmahos GC, Nigro J, Tatevossian R, et al. . Inability of an aggressive policy of thromboprophylaxis to prevent deep venous thrombosis (DVT) in critically injured patients: are current methods of DVT prophylaxis insufficient? J Am Coll Surg. 1998;187:529&#x2013;33.</Citation><ArticleIdList><ArticleId IdType="pubmed">9809571</ArticleId></ArticleIdList></Reference><Reference><Citation>Dietch ZC, Edwards BL, Thames M, et al. . Rate of lower-extremity ultrasonography in trauma patients is associated with rate of deep venous thrombosis but not pulmonary embolism. Surgery. 2015;158:379&#x2013;85.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4492879</ArticleId><ArticleId IdType="pubmed">26032827</ArticleId></ArticleIdList></Reference><Reference><Citation>Dietch ZC, Petroze RT, Thames M, et al. . The &#x201c;high-risk&#x201d; deep venous thrombosis screening protocol for trauma patients: is it practical? J Trauma Acute Care Surg. 2015;79:970&#x2013;5; discussion 975.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4684967</ArticleId><ArticleId IdType="pubmed">26488317</ArticleId></ArticleIdList></Reference><Reference><Citation>Baker JE, Niziolek GM, Elson NC, et al. . Optimizing lower extremity duplex ultrasound screening after traumatic injury. J Surg Res. 2019;243:143&#x2013;50.</Citation><ArticleIdList><ArticleId IdType="pubmed">31176284</ArticleId></ArticleIdList></Reference><Reference><Citation>Martin GE, Pugh A, Williams SG, et al. . Lower extremity duplex ultrasound screening protocol for moderate- and high-risk trauma patients. J Surg Res. 2019;235:280&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">30691807</ArticleId></ArticleIdList></Reference><Reference><Citation>Azarbal A, Rowell S, Lewis J, et al. . Duplex ultrasound screening detects high rates of deep vein thromboses in critically ill trauma patients. J Vasc Surg. 2011;54:743&#x2013;7; discussion 747.</Citation><ArticleIdList><ArticleId IdType="pubmed">21620614</ArticleId></ArticleIdList></Reference><Reference><Citation>Amer M, Alshahrani MS, Arabi YM, et al. . Saudi Critical Care Society clinical practice guidelines on the prevention of venous thromboembolism in adults with trauma: reviewed for evidence-based integrity and endorsed by the Scandinavian Society of Anaesthesiology and Intensive Care Medicine. Ann Intensive Care. 2023;13:1&#x2013;27.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10172441</ArticleId><ArticleId IdType="pubmed">37165105</ArticleId></ArticleIdList></Reference><Reference><Citation>Sigur&#xf0;sson MI, Chew M, Olkkola KT, et al. . Saudi critical care society clinical practice guidelines on the prevention of venous thromboembolism in adults with trauma: endorsement by the Scandinavian Society of Anaesthesiology and Intensive Care Medicine. Acta Anaesthesiol Scand. 2023;67:1288&#x2013;90.</Citation><ArticleIdList><ArticleId IdType="pubmed">37280639</ArticleId></ArticleIdList></Reference><Reference><Citation>Stroup DF, Berlin JA, Morton SC, et al. . Meta-analysis of observational studies in epidemiology: a proposal for reporting Meta-analysis of observational studies in epidemiology (MOOSE) group. JAMA. 2000;283:2008&#x2013;12.</Citation><ArticleIdList><ArticleId IdType="pubmed">10789670</ArticleId></ArticleIdList></Reference><Reference><Citation>Liberati A, Altman DG, Tetzlaff J, et al. . The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. J Clin Epidemiol. 2009;62:e1&#x2013;34.</Citation><ArticleIdList><ArticleId IdType="pubmed">19631507</ArticleId></ArticleIdList></Reference><Reference><Citation>Veritas Health Innovation Melbourne, Australia. Covidence. Covidence systematic review software.
Available at: http://www.covidence.org [access date September 16, 2022].</Citation></Reference><Reference><Citation>Guyatt G, Busse J. Methods commentary: risk of bias in randomized trials 1. 2019.</Citation></Reference><Reference><Citation>J&#xfc;ni P, Loke Y, Pigott T, et al. . Risk of bias in non-randomized studies of interventions (ROBINS-I): detailed guidance. Br Med J. 2016.</Citation></Reference><Reference><Citation>Sch&#xfc;nemann HJ, Vist GE, Higgins JP, et al. . Interpreting results and drawing conclusions. In: Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA, Cochrane Handbook for Systematic Reviews of Interventions Version 6.1. Cochrane; 2020: Available at: https://training.cochrane.org/handbook/current/chapter-15 [access date September 16, 2022].</Citation></Reference><Reference><Citation>DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7:177&#x2013;88.</Citation><ArticleIdList><ArticleId IdType="pubmed">3802833</ArticleId></ArticleIdList></Reference><Reference><Citation>Cumpston M, Li T, Page MJ, et al. . Updated guidance for trusted systematic reviews: a new edition of the Cochrane handbook for systematic reviews of interventions. Cochrane Database Syst Rev. 2019;10:ED000142.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10284251</ArticleId><ArticleId IdType="pubmed">31643080</ArticleId></ArticleIdList></Reference><Reference><Citation>Li G, Zeng J, Tian J, et al. . Multiple uses of forest plots in presenting analysis results in health research. J Clin Epidemiol. 2020;117:89&#x2013;98.</Citation><ArticleIdList><ArticleId IdType="pubmed">31589955</ArticleId></ArticleIdList></Reference><Reference><Citation>Wan X, Wang W, Liu J, et al. . Estimating the sample mean and standard deviation from the sample size, median, range and/or interquartile range. BMC Med Res Methodol. 2014;14:135.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4383202</ArticleId><ArticleId IdType="pubmed">25524443</ArticleId></ArticleIdList></Reference><Reference><Citation>Arabi YM, Burns KEA, Alsolamy SJ, et al. . Surveillance or no surveillance ultrasonography for deep vein thrombosis and outcomes of critically ill patients: a pre-planned sub-study of the PREVENT trial. Intensive Care Med. 2020;46:737&#x2013;46.</Citation><ArticleIdList><ArticleId IdType="pubmed">32095845</ArticleId></ArticleIdList></Reference><Reference><Citation>Kay AB, Morris DS, Woller SC, et al. . Trauma patients at risk for venous thromboembolism who undergo routine duplex ultrasound screening experience fewer pulmonary emboli: a prospective randomized trial. J Trauma Acute Care Surg. 2021;90:787&#x2013;96.</Citation><ArticleIdList><ArticleId IdType="pubmed">33560104</ArticleId></ArticleIdList></Reference><Reference><Citation>Gruen GS, McClain EJ, Gruen RJ. The diagnosis of deep vein thrombosis in the multiply injured patient with pelvic ring or acetabular fractures. Orthopedics. 1995;18:253&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">7761315</ArticleId></ArticleIdList></Reference><Reference><Citation>White RH, Goulet JA, Bray TJ, et al. . Deep-vein thrombosis after fracture of the pelvis: assessment with serial duplex-ultrasound screening. J Bone Joint Surg Am. 1990;72:495&#x2013;500.</Citation><ArticleIdList><ArticleId IdType="pubmed">2182638</ArticleId></ArticleIdList></Reference><Reference><Citation>Adams RC, Hamrick M, Berenguer C, et al. . Four years of an aggressive prophylaxis and screening protocol for venous thromboembolism in a large trauma population. J Trauma. 2008;65:300&#x2013;6; discussion 306.</Citation><ArticleIdList><ArticleId IdType="pubmed">18695464</ArticleId></ArticleIdList></Reference><Reference><Citation>Kadyan V, Clinchot DM, Colachis SC. Cost-effectiveness of duplex ultrasound surveillance in spinal cord injury. Am J Phys Med Rehabil. 2004;83:191&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">15043353</ArticleId></ArticleIdList></Reference><Reference><Citation>Pierce CA, Haut ER, Kardooni S, et al. . Surveillance bias and deep vein thrombosis in the national trauma data bank: the more we look, the more we find. J Trauma. 2008;64:932&#x2013;6; discussion 936.</Citation><ArticleIdList><ArticleId IdType="pubmed">18404058</ArticleId></ArticleIdList></Reference><Reference><Citation>Yorkgitis BK, Berndtson AE, Cross A, et al. . American association for the surgery of trauma/American college of surgeons-committee on trauma clinical protocol for inpatient venous thromboembolism prophylaxis after trauma. J Trauma Acute Care Surg. 2022;92:597&#x2013;604.</Citation><ArticleIdList><ArticleId IdType="pubmed">34797813</ArticleId></ArticleIdList></Reference><Reference><Citation>Ley EJ, Brown CVR, Moore EE, et al. . Updated guidelines to reduce venous thromboembolism in trauma patients: a Western trauma association critical decisions algorithm. J Trauma Acute Care Surg. 2020;89:971&#x2013;81.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7587238</ArticleId><ArticleId IdType="pubmed">32590563</ArticleId></ArticleIdList></Reference><Reference><Citation>Meizoso JP, Karcutskie CA, 4th, Ray JJ, et al. . A simplified stratification system for venous thromboembolism risk in severely injured trauma patients. J Surg Res. 2017;207:138&#x2013;44.</Citation><ArticleIdList><ArticleId IdType="pubmed">27979470</ArticleId></ArticleIdList></Reference><Reference><Citation>Gould MK, Garcia DA, Wren SM, et al. . Prevention of VTE in nonorthopedic surgical patients: antithrombotic therapy and prevention of thrombosis, 9th ed: American college of chest physicians evidence-based clinical practice guidelines. Chest. 2012;141(2 Suppl):e227S&#x2013;77S.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3278061</ArticleId><ArticleId IdType="pubmed">22315263</ArticleId></ArticleIdList></Reference><Reference><Citation>Chiasson TC, Manns BJ, Stelfox HT. An economic evaluation of venous thromboembolism prophylaxis strategies in critically ill trauma patients at risk of bleeding. PLoS Med. 2009;6:e1000098.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2695771</ArticleId><ArticleId IdType="pubmed">19554085</ArticleId></ArticleIdList></Reference><Reference><Citation>Fraser JD, Anderson DR. Deep venous thrombosis: recent advances and optimal investigation with US. Radiology. 1999;211:9&#x2013;24.</Citation><ArticleIdList><ArticleId IdType="pubmed">10189448</ArticleId></ArticleIdList></Reference><Reference><Citation>Guyatt GH, Oxman AD, Kunz R, et al. . GRADE Working Group GRADE guidelines: 8 Rating the quality of evidence--indirectness. J Clin Epidemiol. 2011;64:1303&#x2013;10.</Citation><ArticleIdList><ArticleId IdType="pubmed">21802903</ArticleId></ArticleIdList></Reference><Reference><Citation>Granholm A, Alhazzani W, Derde LPG, et al. . Randomised clinical trials in critical care: past, present and future. Intensive Care Med. 2022;48:164&#x2013;78.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8636283</ArticleId><ArticleId IdType="pubmed">34853905</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">23887247</PMID><DateCompleted><Year>2013</Year><Month>11</Month><Day>25</Day></DateCompleted><DateRevised><Year>2018</Year><Month>01</Month><Day>26</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1471-6771</ISSN><JournalIssue CitedMedium="Internet"><Volume>111</Volume><Issue>5</Issue><PubDate><Year>2013</Year><Month>Nov</Month></PubDate></JournalIssue><Title>British journal of anaesthesia</Title><ISOAbbreviation>Br J Anaesth</ISOAbbreviation></Journal><ArticleTitle>Hypercapnia and surgical site infection: a randomized trial.</ArticleTitle><Pagination><StartPage>759</StartPage><EndPage>767</EndPage><MedlinePgn>759-67</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1093/bja/aet233</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Tissue oxygenation is a strong predictor of surgical site infection (SSI). Mild intraoperative hypercapnia increases peripheral, gastrointestinal, and splanchnic tissue oxygenation and perfusion. Hypercapnia also has anti-inflammatory effects. However, it is unknown whether hypercapnia reduces SSI risk. We tested the hypothesis that mild intraoperative hypercapnia reduces the risk of SSI in patients having colon resection surgery.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">With institutional review board approval and subject consent, patients having elective colon resection (e.g. hemicolectomy and low-anterior resection) expected to last &gt;2 h were randomly assigned to intraoperative normocapnia (PE'CO2 &#x2248; 35 mm Hg; n=623) or hypercapnia ( PE'CO2 &#x2248; 50 mm Hg; n=592). Investigators blinded to group assignment evaluated perioperative SSI (Center for Disease Control criteria) for 30 postoperative days. SSI rates were compared.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Patient and surgical characteristics were comparable among the groups. The SSI rate for normocapnia was 13.3%, and for hypercapnia, it was 11.2% (P=0.29). The Executive Committee stopped the trial after the first a priori determined statistical assessment point because of much smaller actual effect compared with the projected. However, because the actual difference found in the SSI rates (15-16%) were within the 95% confidence intervals (CIs) of the projected relative difference of 33% (95% CI -43 to +24%), our results cannot be considered as 'no difference', and cannot exclude a Type II error. Time to first bowel movement was half-a-day shorter in the hypercapnia group.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Mild hypercapnia appears to have little or-possibly-no ability to prevent SSI after colon resection. Other strategies for reducing SSI risk should thus take priority.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ak&#xe7;a</LastName><ForeName>O</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>Department of Anaesthesiology and Perioperative Medicine, Neuroscience ICU, University of Louisville, Louisville, KY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kurz</LastName><ForeName>A</ForeName><Initials>A</Initials></Author><Author ValidYN="Y"><LastName>Fleischmann</LastName><ForeName>E</ForeName><Initials>E</Initials></Author><Author ValidYN="Y"><LastName>Buggy</LastName><ForeName>D</ForeName><Initials>D</Initials></Author><Author ValidYN="Y"><LastName>Herbst</LastName><ForeName>F</ForeName><Initials>F</Initials></Author><Author ValidYN="Y"><LastName>Stocchi</LastName><ForeName>L</ForeName><Initials>L</Initials></Author><Author ValidYN="Y"><LastName>Galandiuk</LastName><ForeName>S</ForeName><Initials>S</Initials></Author><Author ValidYN="Y"><LastName>Iscoe</LastName><ForeName>S</ForeName><Initials>S</Initials></Author><Author ValidYN="Y"><LastName>Fisher</LastName><ForeName>J</ForeName><Initials>J</Initials></Author><Author ValidYN="Y"><LastName>Apfel</LastName><ForeName>C C</ForeName><Initials>CC</Initials></Author><Author ValidYN="Y"><LastName>Sessler</LastName><ForeName>D I</ForeName><Initials>DI</Initials></Author><Author ValidYN="Y"><CollectiveName>Hypercapnia Trial Investigators</CollectiveName></Author></AuthorList><Language>eng</Language><DataBankList CompleteYN="Y"><DataBank><DataBankName>ClinicalTrials.gov</DataBankName><AccessionNumberList><AccessionNumber>NCT00273377</AccessionNumber></AccessionNumberList></DataBank></DataBankList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016448">Multicenter Study</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2013</Year><Month>07</Month><Day>24</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Br J Anaesth</MedlineTA><NlmUniqueID>0372541</NlmUniqueID><ISSNLinking>0007-0912</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>142M471B3J</RegistryNumber><NameOfSubstance UI="D002245">Carbon Dioxide</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000768" MajorTopicYN="N">Anesthesia, General</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001784" MajorTopicYN="N">Blood Gas Analysis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015992" MajorTopicYN="N">Body Mass Index</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002245" MajorTopicYN="N">Carbon Dioxide</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003106" MajorTopicYN="N">Colon</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003672" MajorTopicYN="N">Defecation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013505" MajorTopicYN="N">Digestive System Surgical Procedures</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006935" MajorTopicYN="N">Hypercapnia</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013530" MajorTopicYN="N">Surgical Wound Infection</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">carbon dioxide, hypercapnia</Keyword><Keyword MajorTopicYN="N">complications, infections</Keyword><Keyword MajorTopicYN="N">infection</Keyword><Keyword MajorTopicYN="N">surgery, abdominal</Keyword><Keyword MajorTopicYN="N">surgery, gastrointestinal</Keyword></KeywordList><InvestigatorList><Investigator ValidYN="Y"><LastName>Erdik</LastName><ForeName>Klaus</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>Eredics</LastName><ForeName>Erol</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kabon</LastName><ForeName>Barbara</ForeName><Initials>B</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kazerounian</LastName><ForeName>Sara</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kimberger</LastName><ForeName>Oliver</ForeName><Initials>O</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kugener</LastName><ForeName>Andre</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Marschalek</LastName><ForeName>Corinna</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Mikocki</LastName><ForeName>Pia</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Niedermayer</LastName><ForeName>Monika</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Obewegeser</LastName><ForeName>Eva</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ratzenbock</LastName><ForeName>Ina</ForeName><Initials>I</Initials></Investigator><Investigator ValidYN="Y"><LastName>Rozum</LastName><ForeName>Romana</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Sindhuber</LastName><ForeName>Sonja</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Schlemitz</LastName><ForeName>Katja</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>Schebesta</LastName><ForeName>Karl</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>Stift</LastName><ForeName>Anton</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Alvarez</LastName><ForeName>Adrian</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bala</LastName><ForeName>Endrit</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Chen</LastName><ForeName>Samuel T</ForeName><Initials>ST</Initials></Investigator><Investigator ValidYN="Y"><LastName>Devarajan</LastName><ForeName>Jagan</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Maheshwari</LastName><ForeName>Ankit</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Mahboobi</LastName><ForeName>Ramatia</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Mascha</LastName><ForeName>Edward</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Nagem</LastName><ForeName>Hassan</ForeName><Initials>H</Initials></Investigator><Investigator ValidYN="Y"><LastName>Rajogopalan</LastName><ForeName>Suman</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Reynolds</LastName><ForeName>Luke</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Zirzow</LastName><ForeName>Erich</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Hager</LastName><ForeName>Helmut</ForeName><Initials>H</Initials></Investigator><Investigator ValidYN="Y"><LastName>Taguchi</LastName><ForeName>Akiko</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Fleshman</LastName><ForeName>James W</ForeName><Initials>JW</Initials></Investigator><Investigator ValidYN="Y"><LastName>Read</LastName><ForeName>Thomas E</ForeName><Initials>TE</Initials></Investigator><Investigator ValidYN="Y"><LastName>DeLong</LastName><ForeName>Diane</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Doufas</LastName><ForeName>Anthony G</ForeName><Initials>AG</Initials></Investigator><Investigator ValidYN="Y"><LastName>Govinda</LastName><ForeName>Raghavendra</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kasuya</LastName><ForeName>Yusuke</ForeName><Initials>Y</Initials></Investigator><Investigator ValidYN="Y"><LastName>Komatsu</LastName><ForeName>Ryu</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Lenhardt</LastName><ForeName>Rainer</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Orhan-Sungur</LastName><ForeName>Mukadder</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Sengupta</LastName><ForeName>Papiya</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Wadhwa</LastName><ForeName>Anupama</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Arain</LastName><ForeName>Mujeeb</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Burke</LastName><ForeName>Siun</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>McGuire</LastName><ForeName>Barry</ForeName><Initials>B</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ragheb</LastName><ForeName>Jackie</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Podranski</LastName><ForeName>Tobias</ForeName><Initials>T</Initials></Investigator><Investigator ValidYN="Y"><LastName>Taguchi</LastName><ForeName>Akikio</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kimberger</LastName><ForeName>Oliver</ForeName><Initials>O</Initials></Investigator></InvestigatorList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2013</Year><Month>7</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2013</Year><Month>7</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2013</Year><Month>12</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">23887247</ArticleId><ArticleId IdType="doi">10.1093/bja/aet233</ArticleId><ArticleId IdType="pii">S0007-0912(17)32019-6</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">28366298</PMID><DateCompleted><Year>2018</Year><Month>06</Month><Day>05</Day></DateCompleted><DateRevised><Year>2018</Year><Month>06</Month><Day>05</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1579-2129</ISSN><JournalIssue CitedMedium="Internet"><Volume>53</Volume><Issue>9</Issue><PubDate><Year>2017</Year><Month>Sep</Month></PubDate></JournalIssue><Title>Archivos de bronconeumologia</Title><ISOAbbreviation>Arch Bronconeumol</ISOAbbreviation></Journal><ArticleTitle>Clinical Characteristics and Prognosis of Pulmonary Embolism Caused by Economy Class Syndrome.</ArticleTitle><Pagination><StartPage>495</StartPage><EndPage>500</EndPage><MedlinePgn>495-500</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.arbres.2017.02.011</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0300-2896(17)30055-8</ELocationID><Abstract><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">Clinical presentation and short-term prognosis of patients with travel-associated acute pulmonary embolism (PE) (i.e., economy class syndrome [ECS]) is not well understood.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">In this retrospective cohort study of patients with acute PE identified from a single center registry, we assessed the clinical presentation and the association between ECS and the outcomes of all-cause mortality, PE-related mortality, nonfatal venous thromboembolism and nonfatal major bleeding rates through 30days after initiation of PE treatment.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Of the 2,333 patients with acute symptomatic PE, 124 (5.3%; 95% confidence interval, 4.4-6.3%) had ECS. Patients with ECS were younger and had fewer comorbid diseases (recent bleeding, chronic obstructive pulmonary disease, congestive heart failure), but they presented with more signs of clinical severity (syncope [48% vs. 14%; P&lt;.001], tachycardia [37% vs. 21%; P&lt;.001], right ventricular dysfunction [31% vs. 19%; P&lt;.01] and myocardial injury [57% vs. 28%; P&lt;.001]) compared to those without ECS. Regression analyses showed a significantly lower risk of all-cause mortality for patients with ECS compared to patients without ECS (1.6% vs. 9.6%; P&lt;.01). We did not detect a difference in PE-related mortality at 30days between those with and those without ECS (0.8% vs. 3.1%; P=.18).</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">PE patients with ECS are younger and have fewer comorbid diseases compared to those without ECS. Though they present with more signs of clinical severity, their short-term prognosis is excellent.</AbstractText><CopyrightInformation>Copyright &#xa9; 2017 SEPAR. Publicado por Elsevier Espa&#xf1;a, S.L.U. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Abell&#xe1;s</LastName><ForeName>Mar&#xed;a</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Servicio de Cardiolog&#xed;a, Hospital Ram&#xf3;n y Cajal, IRYCIS, Madrid, Espa&#xf1;a.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Men&#xe9;ndez</LastName><ForeName>Ana</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Medicina Familiar y Comunitaria, Hospital Ram&#xf3;n y Cajal, IRYCIS, Madrid, Espa&#xf1;a.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Morillo</LastName><ForeName>Raquel</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Servicio de Neumolog&#xed;a, Hospital Ram&#xf3;n y Cajal, Universidad de Alcal&#xe1;, IRYCIS, Madrid, Espa&#xf1;a.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jara-Palomares</LastName><ForeName>Luis</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Unidad M&#xe9;dico-Quir&#xfa;rgica de Enfermedades Respiratorias, Servicio de Neumolog&#xed;a, Hospital Universitario Virgen del Roc&#xed;o, CIBERES, Sevilla, Espa&#xf1;a.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Barrios</LastName><ForeName>Deisy</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Servicio de Neumolog&#xed;a, Hospital Ram&#xf3;n y Cajal, Universidad de Alcal&#xe1;, IRYCIS, Madrid, Espa&#xf1;a.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nieto</LastName><ForeName>Rosa</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Servicio de Neumolog&#xed;a, Hospital Ram&#xf3;n y Cajal, Universidad de Alcal&#xe1;, IRYCIS, Madrid, Espa&#xf1;a.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Barbero</LastName><ForeName>Esther</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Servicio de Neumolog&#xed;a, Hospital Ram&#xf3;n y Cajal, Universidad de Alcal&#xe1;, IRYCIS, Madrid, Espa&#xf1;a.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Corres</LastName><ForeName>Jes&#xfa;s</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Servicio de Urgencias, Hospital Ram&#xf3;n y Cajal, IRYCIS, Madrid, Espa&#xf1;a.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ruiz-Artacho</LastName><ForeName>Pedro</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Servicio de Urgencias, Hospital Cl&#xed;nico San Carlos, IdISSC, Madrid, Espa&#xf1;a.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jim&#xe9;nez</LastName><ForeName>David</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Servicio de Neumolog&#xed;a, Hospital Ram&#xf3;n y Cajal, Universidad de Alcal&#xe1;, IRYCIS, Madrid, Espa&#xf1;a. Electronic address: djimenez.hrc@gmail.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><Language>spa</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D064888">Observational Study</PublicationType></PublicationTypeList><VernacularTitle>Caracter&#xed;sticas cl&#xed;nicas y pron&#xf3;stico de la tromboembolia pulmonar secundaria al s&#xed;ndrome de clase turista.</VernacularTitle><ArticleDate DateType="Electronic"><Year>2017</Year><Month>03</Month><Day>31</Day></ArticleDate></Article><MedlineJournalInfo><Country>Spain</Country><MedlineTA>Arch Bronconeumol</MedlineTA><NlmUniqueID>0354720</NlmUniqueID><ISSNLinking>0300-2896</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D006495">Heparin, Low-Molecular-Weight</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000367" MajorTopicYN="N">Age Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000401" MajorTopicYN="Y">Aircraft</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015897" MajorTopicYN="N">Comorbidity</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006331" MajorTopicYN="N">Heart Diseases</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006470" MajorTopicYN="N">Hemorrhage</DescriptorName><QualifierName UI="Q000139" MajorTopicYN="N">chemically induced</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006495" MajorTopicYN="N">Heparin, Low-Molecular-Weight</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011379" MajorTopicYN="N">Prognosis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D029424" MajorTopicYN="N">Pulmonary Disease, Chronic Obstructive</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011655" MajorTopicYN="N">Pulmonary Embolism</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012008" MajorTopicYN="N">Recurrence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012042" MajorTopicYN="N">Registries</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016019" MajorTopicYN="N">Survival Analysis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015912" MajorTopicYN="N">Thrombolytic Therapy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014195" MajorTopicYN="Y">Travel</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014682" MajorTopicYN="N">Vena Cava, Inferior</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Economy-class syndrome</Keyword><Keyword MajorTopicYN="N">Prognosis</Keyword><Keyword MajorTopicYN="N">Pron&#xf3;stico</Keyword><Keyword MajorTopicYN="N">Pulmonary embolism</Keyword><Keyword MajorTopicYN="N">S&#xed;ndrome de clase turista</Keyword><Keyword MajorTopicYN="N">Tromboembolia de pulm&#xf3;n</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2016</Year><Month>12</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2017</Year><Month>2</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2017</Year><Month>2</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2017</Year><Month>4</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>6</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2017</Year><Month>4</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">28366298</ArticleId><ArticleId IdType="doi">10.1016/j.arbres.2017.02.011</ArticleId><ArticleId IdType="pii">S0300-2896(17)30055-8</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">31844608</PMID><DateRevised><Year>2023</Year><Month>10</Month><Day>20</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">2214-031X</ISSN><JournalIssue CitedMedium="Print"><Volume>19</Volume><PubDate><Year>2019</Year><Month>Oct</Month></PubDate></JournalIssue><Title>Journal of orthopaedic translation</Title><ISOAbbreviation>J Orthop Translat</ISOAbbreviation></Journal><ArticleTitle>The efficacy and safety of intravenous tranexamic acid in hip fracture surgery: A systematic review and meta-analysis.</ArticleTitle><Pagination><StartPage>1</StartPage><EndPage>11</EndPage><MedlinePgn>1-11</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jot.2019.03.007</ELocationID><Abstract><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">The present meta-analysis was conducted to compare the efficacy and safety of intravenous application of tranexamic acid (TXA) with placebo in patients with hip fracture undergoing hip surgeries.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">PubMed, EMBASE&#xa0;and Cochrane Library were searched from inception until March 2018. A combined searching strategy of subject words and random words was adopted. Only randomized clinical trials were included. The comparisons regarding transfusion rate, total blood loss, intraoperative blood loss, postoperative blood loss, postoperative haemoglobin&#xa0;and postoperative thromboembolic complications were conducted. The meta-analysis was performed using Review Manager 5.3, and the bias evaluation was based on the Cochrane Handbook 5.1.0.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Ten randomized controlled trials published from 2007 to 2018 were included in the meta-analysis. The results showed that there were significant differences in the two groups concerning transfusion rate of allogeneic blood [risk ratio (RR)&#xa0;=&#xa0;0.66, 95% confidence interval (CI): 0.56 to 0.78, P&#xa0;=&#xa0;0.003], total blood loss [mean difference (MD)&#xa0;=&#xa0;-273.00, 95% CI: -353.15 to -192.84, P&#xa0;&lt;&#xa0;0.00001], intraoperative blood loss (MD&#xa0;=&#xa0;-76.63, 95% CI: -139.55 to -13.71, P&#xa0;=&#xa0;0.02), postoperative blood loss (MD&#xa0;=&#xa0;-125.29, 95% CI: -221.96 to -28.62, P&#xa0;=&#xa0;0.01) and postoperative haemoglobin (MD&#xa0;=&#xa0;0.80, 95% CI: 0.38 to 1.22, P&#xa0;=&#xa0;0.0002). Nonsignificant differences were found in the incidence of thromboembolic events (RR&#xa0;=&#xa0;1.38, 95% CI: 0.74 to 2.55, P&#xa0;=&#xa0;0.31).</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">This meta-analysis of the available evidence implies that the intravenous route of TXA shows an ability to reduce transfusion requirements and total blood loss, not increasing the incidence of thromboembolic events in patients undergoing hip surgeries.</AbstractText><AbstractText Label="THE TRANSLATIONAL POTENTIAL OF THIS ARTICLE" NlmCategory="UNASSIGNED">The result of this meta-analysis shows that the utilization of intravenous TXA in patients with hip fracture undergoing hip surgeries possesses great potential in reducing blood loss and allogeneic blood transfusion safely.</AbstractText><CopyrightInformation>&#xa9; 2019 The Authors.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Qi</LastName><ForeName>Yi-Ming</ForeName><Initials>YM</Initials><AffiliationInfo><Affiliation>Department of Orthopaedics, Zhongda Hospital, School of Medicine, Southeast University, NO. 87 Ding Jia Qiao, Nanjing, Jiangsu 210009, PR China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Orthopaedic Trauma Institute of Southeast University, Nanjing, Jiangsu 210009, PR China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Multidisciplinary Team (MDT) for Geriatric Hip Fracture Comprehensive Management, Zhongda Hospital, School of Medicine, Southeast University, NO. 87 Ding Jia Qiao, Nanjing, Jiangsu 210009, PR China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Medicine, Southeast University, NO. 87 Ding Jia Qiao, Nanjing, Jiangsu 210009, PR China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Hai-Peng</ForeName><Initials>HP</Initials><AffiliationInfo><Affiliation>The Department of Orthopedics, Jing' An District Centre Hospital of Shanghai (Huashan Hospital Fudan University Jing' An Branch), 20040, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Ying-Juan</ForeName><Initials>YJ</Initials><AffiliationInfo><Affiliation>Multidisciplinary Team (MDT) for Geriatric Hip Fracture Comprehensive Management, Zhongda Hospital, School of Medicine, Southeast University, NO. 87 Ding Jia Qiao, Nanjing, Jiangsu 210009, PR China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Geriatrics, Zhongda Hospital, School of Medicine, Southeast University, NO. 87 Ding Jia Qiao, Nanjing, Jiangsu 210009, PR China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ma</LastName><ForeName>Bin-Bin</ForeName><Initials>BB</Initials><AffiliationInfo><Affiliation>Department of Orthopaedics, Zhongda Hospital, School of Medicine, Southeast University, NO. 87 Ding Jia Qiao, Nanjing, Jiangsu 210009, PR China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Orthopaedic Trauma Institute of Southeast University, Nanjing, Jiangsu 210009, PR China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Multidisciplinary Team (MDT) for Geriatric Hip Fracture Comprehensive Management, Zhongda Hospital, School of Medicine, Southeast University, NO. 87 Ding Jia Qiao, Nanjing, Jiangsu 210009, PR China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xie</LastName><ForeName>Tian</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Orthopaedics, Zhongda Hospital, School of Medicine, Southeast University, NO. 87 Ding Jia Qiao, Nanjing, Jiangsu 210009, PR China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Orthopaedic Trauma Institute of Southeast University, Nanjing, Jiangsu 210009, PR China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Multidisciplinary Team (MDT) for Geriatric Hip Fracture Comprehensive Management, Zhongda Hospital, School of Medicine, Southeast University, NO. 87 Ding Jia Qiao, Nanjing, Jiangsu 210009, PR China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Medicine, Southeast University, NO. 87 Ding Jia Qiao, Nanjing, Jiangsu 210009, PR China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Chen</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Orthopaedics, Zhongda Hospital, School of Medicine, Southeast University, NO. 87 Ding Jia Qiao, Nanjing, Jiangsu 210009, PR China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Orthopaedic Trauma Institute of Southeast University, Nanjing, Jiangsu 210009, PR China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Multidisciplinary Team (MDT) for Geriatric Hip Fracture Comprehensive Management, Zhongda Hospital, School of Medicine, Southeast University, NO. 87 Ding Jia Qiao, Nanjing, Jiangsu 210009, PR China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Medicine, Southeast University, NO. 87 Ding Jia Qiao, Nanjing, Jiangsu 210009, PR China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Hui</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Orthopaedics, Zhongda Hospital, School of Medicine, Southeast University, NO. 87 Ding Jia Qiao, Nanjing, Jiangsu 210009, PR China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Orthopaedic Trauma Institute of Southeast University, Nanjing, Jiangsu 210009, PR China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Multidisciplinary Team (MDT) for Geriatric Hip Fracture Comprehensive Management, Zhongda Hospital, School of Medicine, Southeast University, NO. 87 Ding Jia Qiao, Nanjing, Jiangsu 210009, PR China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Medicine, Southeast University, NO. 87 Ding Jia Qiao, Nanjing, Jiangsu 210009, PR China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rui</LastName><ForeName>Yun-Feng</ForeName><Initials>YF</Initials><AffiliationInfo><Affiliation>Department of Orthopaedics, Zhongda Hospital, School of Medicine, Southeast University, NO. 87 Ding Jia Qiao, Nanjing, Jiangsu 210009, PR China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Orthopaedic Trauma Institute of Southeast University, Nanjing, Jiangsu 210009, PR China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Multidisciplinary Team (MDT) for Geriatric Hip Fracture Comprehensive Management, Zhongda Hospital, School of Medicine, Southeast University, NO. 87 Ding Jia Qiao, Nanjing, Jiangsu 210009, PR China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Medicine, Southeast University, NO. 87 Ding Jia Qiao, Nanjing, Jiangsu 210009, PR China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2019</Year><Month>04</Month><Day>19</Day></ArticleDate></Article><MedlineJournalInfo><Country>Singapore</Country><MedlineTA>J Orthop Translat</MedlineTA><NlmUniqueID>101625127</NlmUniqueID><ISSNLinking>2214-031X</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Allogeneic blood transfusion</Keyword><Keyword MajorTopicYN="N">Blood loss</Keyword><Keyword MajorTopicYN="N">Hip fracture</Keyword><Keyword MajorTopicYN="N">Meta-analysis</Keyword><Keyword MajorTopicYN="N">Randomized controlled trial, RCT</Keyword><Keyword MajorTopicYN="N">Thromboembolic events</Keyword><Keyword MajorTopicYN="N">Tranexamic acid</Keyword><Keyword MajorTopicYN="N">Tranexamic acid, TXA</Keyword><Keyword MajorTopicYN="N">cerebrovascular accident, CVA</Keyword><Keyword MajorTopicYN="N">confidence interval, CI</Keyword><Keyword MajorTopicYN="N">deep vein thrombolism, DVT</Keyword><Keyword MajorTopicYN="N">haemoglobin, Hb</Keyword><Keyword MajorTopicYN="N">mean difference, MD</Keyword><Keyword MajorTopicYN="N">pulmonary embolism, PE</Keyword><Keyword MajorTopicYN="N">risk ratio, RR</Keyword><Keyword MajorTopicYN="N">standard deviation, SD</Keyword><Keyword MajorTopicYN="N">total hip arthroplasty, THA</Keyword><Keyword MajorTopicYN="N">total knee arthroplasty, TKA</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2018</Year><Month>9</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2019</Year><Month>3</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2019</Year><Month>3</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>12</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>12</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>12</Month><Day>18</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2019</Year><Month>4</Month><Day>19</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31844608</ArticleId><ArticleId IdType="pmc">PMC6896672</ArticleId><ArticleId IdType="doi">10.1016/j.jot.2019.03.007</ArticleId><ArticleId IdType="pii">S2214-031X(18)30165-7</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>LeBlanc K.E., Muncie H.J., LeBlanc L.L. Hip fracture: diagnosis, treatment, and secondary prevention. Am Fam Physician. 2014;89(12):945&#x2013;951.</Citation><ArticleIdList><ArticleId IdType="pubmed">25162161</ArticleId></ArticleIdList></Reference><Reference><Citation>Gullberg B., Johnell O., Kanis J.A. World-wide projections for hip fracture. Osteoporos Int. 1997;7:407.</Citation><ArticleIdList><ArticleId IdType="pubmed">9425497</ArticleId></ArticleIdList></Reference><Reference><Citation>Foss N.B., Kehlet H. Hidden blood loss after surgery for hip fracture. J Bone Joint Surg Br. 2006;88:1053.</Citation><ArticleIdList><ArticleId IdType="pubmed">16877605</ArticleId></ArticleIdList></Reference><Reference><Citation>Khan A.M., Mushtaq N., Giannakas K., Sochart D.H., Andrews J.G. Cross-match protocols for femoral neck fractures--finding one that can work. Ann R Coll Surg Engl. 2004;86:11.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1964008</ArticleId><ArticleId IdType="pubmed">15005938</ArticleId></ArticleIdList></Reference><Reference><Citation>Lawrence V.A., Silverstein J.H., Cornell J.E., Pederson T., Noveck H., Carson J.L. Higher Hb level is associated with better early functional recovery after hip fracture repair. Transfusion. 2003;43:1717.</Citation><ArticleIdList><ArticleId IdType="pubmed">14641869</ArticleId></ArticleIdList></Reference><Reference><Citation>Halm E.A., Wang J.J., Boockvar K., Penrod J., Silberzweig S.B., Magaziner J. The effect of perioperative anemia on clinical and functional outcomes in patients with hip fracture. J Orthop Trauma. 2004;18:369.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1454739</ArticleId><ArticleId IdType="pubmed">15213502</ArticleId></ArticleIdList></Reference><Reference><Citation>Maraldi C., Ble A., Zuliani G., Guralnik J.M., Mussi C., Fellin R. Association between anemia and physical disability in older patients: role of comorbidity. Aging Clin Exp Res. 2006;18:485.</Citation><ArticleIdList><ArticleId IdType="pubmed">17255637</ArticleId></ArticleIdList></Reference><Reference><Citation>Foss N.B., Kristensen M.T., Kehlet H. Anaemia impedes functional mobility after hip fracture surgery. Age Ageing. 2008;37:173.</Citation><ArticleIdList><ArticleId IdType="pubmed">18349013</ArticleId></ArticleIdList></Reference><Reference><Citation>Friedman B.A. An analysis of surgical blood use in United States hospitals with application to the maximum surgical blood order schedule. Transfusion. 1979;19:268.</Citation><ArticleIdList><ArticleId IdType="pubmed">452067</ArticleId></ArticleIdList></Reference><Reference><Citation>Conteduca F., Massai F., Iorio R., Zanzotto E., Luzon D., Ferretti A. Blood loss in computer-assisted mobile bearing total knee arthroplasty. A comparison of computer-assisted surgery with a conventional technique. Int Orthop. 2009;33:1609.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2899193</ArticleId><ArticleId IdType="pubmed">18762940</ArticleId></ArticleIdList></Reference><Reference><Citation>Tengberg P.T., Foss N.B., Palm H., Kallemose T., Troelsen A. Tranexamic acid reduces blood loss in patients with extracapsular fractures of the hip: results of a randomised controlled trial. Bone Joint Lett J. 2016;98-B:747.</Citation><ArticleIdList><ArticleId IdType="pubmed">27235515</ArticleId></ArticleIdList></Reference><Reference><Citation>Chiarugi M., Buccianti P., Disarli M., Galatioto C., Cavina E. Effect of blood transfusions on disease-free interval after rectal cancer surgery. Hepato-Gastroenterology. 2000;47:1002.</Citation><ArticleIdList><ArticleId IdType="pubmed">11020864</ArticleId></ArticleIdList></Reference><Reference><Citation>Marik P.E., Corwin H.L. Efficacy of red blood cell transfusion in the critically ill: a systematic review of the literature. Crit Care Med. 2008;36:2667.</Citation><ArticleIdList><ArticleId IdType="pubmed">18679112</ArticleId></ArticleIdList></Reference><Reference><Citation>Izuel R.M., Garcia E.J., Gomez-Barrera M., Cuenca E.J., Abad S.R., Rabanaque H.M. [Relationship between allogeneic blood transfusion, iron deficiency and nosocomial infection in patients with hip fracture] Med Clin. 2008;131:647.</Citation><ArticleIdList><ArticleId IdType="pubmed">19087790</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang H., Chen J., Chen F., Que W. The effect of tranexamic acid on blood loss and use of blood products in total knee arthroplasty: a meta-analysis. Knee Surg Sports Traumatol Arthrosc. 2012;20:1742.</Citation><ArticleIdList><ArticleId IdType="pubmed">22065294</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang F., Wu D., Ma G., Yin Z., Wang Q. The use of tranexamic acid to reduce blood loss and transfusion in major orthopedic surgery: a meta-analysis. J Surg Res. 2014;186:318.</Citation><ArticleIdList><ArticleId IdType="pubmed">24075404</ArticleId></ArticleIdList></Reference><Reference><Citation>Bilgili M.G., Ercin E., Peker G., Kural C., Basaran S.H., Duramaz A. Efficiency and cost analysis of cell saver auto transfusion system in total knee arthroplasty. Balkan Med J. 2014;31:149.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4115923</ArticleId><ArticleId IdType="pubmed">25207187</ArticleId></ArticleIdList></Reference><Reference><Citation>Appassakij H., Promwong C., Rujirojindakul P., Wutthanarungsan R., Silpapojakul K. The risk of blood transfusion-associated Chikungunya fever during the 2009 epidemic in Songkhla Province, Thailand. Transfusion. 2014;54:1945.</Citation><ArticleIdList><ArticleId IdType="pubmed">24527811</ArticleId></ArticleIdList></Reference><Reference><Citation>Dan M., Liu D., Martos S.M., Beller E. Intra-operative blood salvage in total hip and knee arthroplasty. J Orthop Surg (Hong Kong) 2016;24:204.</Citation><ArticleIdList><ArticleId IdType="pubmed">27574264</ArticleId></ArticleIdList></Reference><Reference><Citation>Aguilera-Roig X., Jordan-Sales M., Natera-Cisneros L., Monllau-Garcia J.C., Martinez-Zapata M.J. [Tranexamic acid in orthopedic surgery] Rev Espa&#xf1;ola Cirug&#xed;a Ortop&#xe9;dica Traumatol. 2014;58:52.</Citation><ArticleIdList><ArticleId IdType="pubmed">24126146</ArticleId></ArticleIdList></Reference><Reference><Citation>Carson J.L., Stanworth S.J., Roubinian N., Fergusson D.A., Triulzi D., Doree C. Transfusion thresholds and other strategies for guiding allogeneic red blood cell transfusion. Cochrane Database Syst Rev. 2016;10:D2042.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6457993</ArticleId><ArticleId IdType="pubmed">27731885</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee Q.J., Chang W.Y., Wong Y.C. Blood-sparing efficacy of oral tranexamic acid in primary total hip arthroplasty. J Arthroplast. 2017;32:139.</Citation><ArticleIdList><ArticleId IdType="pubmed">27498390</ArticleId></ArticleIdList></Reference><Reference><Citation>Wind T.C., Barfield W.R., Moskal J.T. The effect of tranexamic acid on transfusion rate in primary total hip arthroplasty. J Arthroplast. 2014;29:387.</Citation><ArticleIdList><ArticleId IdType="pubmed">23790499</ArticleId></ArticleIdList></Reference><Reference><Citation>Rajesparan K., Biant L.C., Ahmad M., Field R.E. The effect of an intravenous bolus of tranexamic acid on blood loss in total hip replacement. J Bone Joint Surg Br. 2009;91:776.</Citation><ArticleIdList><ArticleId IdType="pubmed">19483232</ArticleId></ArticleIdList></Reference><Reference><Citation>Li G., Sun T.W., Luo G., Zhang C. Efficacy of antifibrinolytic agents on surgical bleeding and transfusion requirements in spine surgery: a meta-analysis. Eur Spine J. 2017;26:140.</Citation><ArticleIdList><ArticleId IdType="pubmed">27671279</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun X., Dong Q., Zhang Y.G. Intravenous versus topical tranexamic acid in primary total hip replacement: a systemic review and meta-analysis. Int J Surg. 2016;32:10.</Citation><ArticleIdList><ArticleId IdType="pubmed">27262881</ArticleId></ArticleIdList></Reference><Reference><Citation>Abbasi H., Behdad S., Ayatollahi V., Nazemian N., Mirshamsi P. Comparison of two doses of tranexamic acid on bleeding and surgery site quality during sinus endoscopy surgery. Adv Clin Exp Med. 2012;21:773.</Citation><ArticleIdList><ArticleId IdType="pubmed">23457130</ArticleId></ArticleIdList></Reference><Reference><Citation>Dunn C.J., Goa K.L. Tranexamic acid: a review of its use in surgery and other indications. Drugs. 1999;57:1005.</Citation><ArticleIdList><ArticleId IdType="pubmed">10400410</ArticleId></ArticleIdList></Reference><Reference><Citation>Kazemi S.M., Mosaffa F., Eajazi A., Kaffashi M., Daftari B.L., Bigdeli M.R. The effect of tranexamic acid on reducing blood loss in cementless total hip arthroplasty under epidural anesthesia. Orthopedics. 2010;33:17.</Citation><ArticleIdList><ArticleId IdType="pubmed">20055345</ArticleId></ArticleIdList></Reference><Reference><Citation>Watts C.D., Houdek M.T., Sems S.A., Cross W.W., Pagnano M.W. Tranexamic acid safely reduced blood loss in hemi- and total hip arthroplasty for acute femoral neck fracture: a randomized clinical trial. J Orthop Trauma. 2017;31:345.</Citation><ArticleIdList><ArticleId IdType="pubmed">28633147</ArticleId></ArticleIdList></Reference><Reference><Citation>Mohib Y., Rashid R.H., Ali M., Zubairi A.J., Umer M. Does tranexamic acid reduce blood transfusion following surgery for inter-trochanteric fracture? A randomized control trial. J Pak Med Assoc. 2015;65:S17.</Citation><ArticleIdList><ArticleId IdType="pubmed">26878513</ArticleId></ArticleIdList></Reference><Reference><Citation>Zufferey P.J., Miquet M., Quenet S., Martin P., Adam P., Albaladejo P. Tranexamic acid in hip fracture surgery: a randomized controlled trial. Br J Anaesth. 2010;104:23.</Citation><ArticleIdList><ArticleId IdType="pubmed">19926634</ArticleId></ArticleIdList></Reference><Reference><Citation>Tian S., Shen Z., Liu Y., Zhang Y., Peng A. The effect of tranexamic acid on hidden bleeding in older intertrochanteric fracture patients treated with PFNA. Injury. 2018;49:680.</Citation><ArticleIdList><ArticleId IdType="pubmed">29426608</ArticleId></ArticleIdList></Reference><Reference><Citation>Vijay B.S., Bedi V., Mitra S., Das B. Role of tranexamic acid in reducing postoperative blood loss and transfusion requirement in patients undergoing hip and femoral surgeries. Saudi J Anaesth. 2013;7:29.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3657919</ArticleId><ArticleId IdType="pubmed">23717228</ArticleId></ArticleIdList></Reference><Reference><Citation>Sadeghi . 2007. Does a single bolus dose of tranexamic acid reduce blood loss and transfusion requirements during hip fracture surgery? A prospective randomized double blind study in 67 patients.</Citation></Reference><Reference><Citation>Emara W.M., Moez K.K., Elkhouly A.H. Topical versus intravenous tranexamic acid as a blood conservation intervention for reduction of post-operative bleeding in hemiarthroplasty. Anesth Essays Res. 2014;8:48.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4173581</ArticleId><ArticleId IdType="pubmed">25886103</ArticleId></ArticleIdList></Reference><Reference><Citation>Lei J., Zhang B., Cong Y., Zhuang Y., Wei X., Fu Y. Tranexamic acid reduces hidden blood loss in the treatment of intertrochanteric fractures with PFNA: a single-center randomized controlled trial. J Orthop Surg Res. 2017;12:124.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5558747</ArticleId><ArticleId IdType="pubmed">28810918</ArticleId></ArticleIdList></Reference><Reference><Citation>Baruah R.K., Borah P.J., Haque R. Use of tranexamic acid in dynamic hip screw plate fixation for trochanteric fractures. J Orthop Surg (Hong Kong) 2016;24:379.</Citation><ArticleIdList><ArticleId IdType="pubmed">28031511</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organization (WHO) WHO model list of essential medicines. 2017.  Available at:  http://www.who.int/medicines/publications/essentialmedicines/en/</Citation><ArticleIdList><ArticleId IdType="pubmed">29221540</ArticleId></ArticleIdList></Reference><Reference><Citation>Drakos A., Raoulis V., Karatzios K., Doxariotis N., Kontogeorgakos V., Malizos K. Efficacy of local administration of tranexamic acid for blood salvage in patients undergoing intertrochanteric fracture surgery. J Orthop Trauma. 2016;30:409.</Citation><ArticleIdList><ArticleId IdType="pubmed">26978136</ArticleId></ArticleIdList></Reference><Reference><Citation>Virani S.R., Dahapute A.A., Panda I., Bava S.S. Role of local infiltration of tranexamic acid in reducing blood loss in peritrochanteric fracture surgery in the elderly population. Malays Orthop J. 2016;10:26.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5333680</ArticleId><ArticleId IdType="pubmed">28553444</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang P., He J., Fang Y., Chen P., Liang Y., Wang J. Efficacy and safety of intravenous tranexamic acid administration in patients undergoing hip fracture surgery for hemostasis: a meta-analysis. Medicine (Baltim) 2017;96:e6940.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5457864</ArticleId><ArticleId IdType="pubmed">28538384</ArticleId></ArticleIdList></Reference><Reference><Citation>Wei Z., Liu M. The effectiveness and safety of tranexamic acid in total hip or knee arthroplasty: a meta-analysis of 2720 cases. Transfus Med. 2015;25:151.</Citation><ArticleIdList><ArticleId IdType="pubmed">26033447</ArticleId></ArticleIdList></Reference><Reference><Citation>Goobie S.M., Meier P.M., Sethna N.F., Soriano S.G., Zurakowski D., Samant S. Population pharmacokinetics of tranexamic acid in paediatric patients undergoing craniosynostosis surgery. Clin Pharmacokinet. 2013;52:267.</Citation><ArticleIdList><ArticleId IdType="pubmed">23371895</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang P., Liang Y., Chen P., Fang Y., He J., Wang J. Intravenous versus topical tranexamic acid in primary total hip replacement: a meta-analysis. Medicine (Baltim) 2016;95:e5573.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5268036</ArticleId><ArticleId IdType="pubmed">27977590</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee Q.J., Chang W.Y., Wong Y.C. Blood-sparing efficacy of oral tranexamic acid in primary total hip arthroplasty. J Arthroplast. 2017;32:139.</Citation><ArticleIdList><ArticleId IdType="pubmed">27498390</ArticleId></ArticleIdList></Reference><Reference><Citation>Gandhi R., Evans H.M., Mahomed S.R., Mahomed N.N. Tranexamic acid and the reduction of blood loss in total knee and hip arthroplasty: a meta-analysis. BMC Res Notes. 2013;6:184.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3655041</ArticleId><ArticleId IdType="pubmed">23651507</ArticleId></ArticleIdList></Reference><Reference><Citation>Benoni G., Lethagen S., Fredin H. The effect of tranexamic acid on local and plasma fibrinolysis during total knee arthroplasty. Thromb Res. 1997;85:195.</Citation><ArticleIdList><ArticleId IdType="pubmed">9058494</ArticleId></ArticleIdList></Reference><Reference><Citation>Sabbag O.D., Abdel M.P., Amundson A.W., Larson D.R., Pagnano M.W. Tranexamic acid was safe in arthroplasty patients with a history of venous thromboembolism: a matched outcome study. J Arthroplasty. 2017;32:S246.</Citation><ArticleIdList><ArticleId IdType="pubmed">28262452</ArticleId></ArticleIdList></Reference><Reference><Citation>Evangelista P.J., Aversano M.W., Koli E., Hutzler L., Inneh I., Bosco J. Effect of tranexamic acid on transfusion rates following total joint arthroplasty: a cost and comparative effectiveness analysis. Orthop Clin N Am. 2017;48:109.</Citation><ArticleIdList><ArticleId IdType="pubmed">28336035</ArticleId></ArticleIdList></Reference><Reference><Citation>Demos H.A., Lin Z.X., Barfield W.R., Wilson S.H., Robertson D.C., Pellegrini V.J. Process improvement Project using tranexamic acid is cost-effective in reducing blood loss and transfusions after total hip and total knee arthroplasty. J Arthroplasty. 2017;32:2375.</Citation><ArticleIdList><ArticleId IdType="pubmed">28343823</ArticleId></ArticleIdList></Reference><Reference><Citation>DiBlasi J.F., Smith R.P., Garavaglia J., Quedado J., Frye B.M., Dietz M.J. Comparing cost, efficacy, and safety of intravenous and topical tranexamic acid in total hip and knee arthroplasty. Am J Orthop (Belle Mead NJ) 2016;45:E439.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5817988</ArticleId><ArticleId IdType="pubmed">28005108</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">38905251</PMID><DateCompleted><Year>2024</Year><Month>06</Month><Day>21</Day></DateCompleted><DateRevised><Year>2024</Year><Month>06</Month><Day>27</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1932-6203</ISSN><JournalIssue CitedMedium="Internet"><Volume>19</Volume><Issue>6</Issue><PubDate><Year>2024</Year></PubDate></JournalIssue><Title>PloS one</Title><ISOAbbreviation>PLoS One</ISOAbbreviation></Journal><ArticleTitle>Association of frailty with adverse outcomes in surgically treated geriatric patients with hip fracture: A meta-analysis and trial sequential analysis.</ArticleTitle><Pagination><StartPage>e0305706</StartPage><MedlinePgn>e0305706</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e0305706</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1371/journal.pone.0305706</ELocationID><Abstract><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">Some studies have associated frailty and prognostic outcomes in geriatric hip fracture patients, but whether frailty can predict postoperative outcomes remains controversial. This review aims to assess the relationship between frailty and adverse postoperative outcomes in geriatric patients with hip fracture.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Based on electronic databases, including PubMed, Embase, Web of Science, Cumulative Index to Nursing and Allied Health Literature, the Cochrane Library, Chinese National Knowledge Infrastructure, and WanFang Data, we systematically searched for studies that investigated the association between frailty and adverse outcomes among patients aged 60 or over after hip fracture surgery. Stata 17.0 and Trial Sequential Analysis viewer software were used to obtain pooled estimates and verify whether the sample size was sufficient and the evidence robust.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Twenty-one studies involving 49,196 patients were included for quantitative analysis. Compared with nonfrail patients, frail patients had a higher risk of inpatient mortality (risk ratio [RR] = 1.93, 95% confidence interval [CI]: 1.66-2.23), 30-day mortality (RR = 2.13, 95% CI: 1.23-3.70), and 1-year mortality (RR = 2.44, 95% CI: 1.47-4.04). Frailty can significantly predict postoperative complications (RR = 1.76, 95% CI: 1.38-2.23), including delirium, pneumonia, cardiac complications, urinary tract infection, and surgical site infection; the association between frailty and deep venous thrombosis/pulmonary embolism and acute kidney injury needs further analysis. Trial sequential analysis showed that the findings regarding mortality were reliable and robust.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">This meta-analysis provides detailed information indicating that frailty is a substantial predictor of mortality and selected postoperative complications.</AbstractText><CopyrightInformation>Copyright: &#xa9; 2024 Dong et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Dong</LastName><ForeName>Xiaomeng</ForeName><Initials>X</Initials><Identifier Source="ORCID">0000-0002-4415-9182</Identifier><AffiliationInfo><Affiliation>Department of 2nd Operating Room, Hebei Medical University Third Hospital, Shijiazhuang, Hebei, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Xiuguo</ForeName><Initials>X</Initials><Identifier Source="ORCID">0000-0003-2727-2711</Identifier><AffiliationInfo><Affiliation>Department of Nursing, Hebei Medical University Third Hospital, Shijiazhuang, Hebei, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hu</LastName><ForeName>Fang</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of 2nd Operating Room, Hebei Medical University Third Hospital, Shijiazhuang, Hebei, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>Shuhong</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of 2nd Operating Room, Hebei Medical University Third Hospital, Shijiazhuang, Hebei, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hong</LastName><ForeName>Zengchao</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Department of 2nd Operating Room, Hebei Medical University Third Hospital, Shijiazhuang, Hebei, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Geng</LastName><ForeName>Qian</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>Department of Nursing, Hebei Medical University Third Hospital, Shijiazhuang, Hebei, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>06</Month><Day>21</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>PLoS One</MedlineTA><NlmUniqueID>101285081</NlmUniqueID><ISSNLinking>1932-6203</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006620" MajorTopicYN="Y">Hip Fractures</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="Y">Postoperative Complications</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000073496" MajorTopicYN="Y">Frailty</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016330" MajorTopicYN="N">Frail Elderly</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011379" MajorTopicYN="N">Prognosis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>The authors declare no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>1</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>6</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>6</Month><Day>21</Day><Hour>18</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>6</Month><Day>21</Day><Hour>18</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>6</Month><Day>21</Day><Hour>13</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>6</Month><Day>21</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38905251</ArticleId><ArticleId IdType="pmc">PMC11192356</ArticleId><ArticleId IdType="doi">10.1371/journal.pone.0305706</ArticleId><ArticleId IdType="pii">PONE-D-24-03320</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Yan B, Sun W, Wang W, Wu J, Wang G, Dou Q. Prognostic significance of frailty in older patients with hip fracture: a systematic review and meta-analysis. Int Orthop. 2022;46(12):2939&#x2013;2952. doi: 10.1007/s00264-022-05605-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00264-022-05605-9</ArticleId><ArticleId IdType="pubmed">36227383</ArticleId></ArticleIdList></Reference><Reference><Citation>Sing CW, Lin TC, Bartholomew S, Bell JS, Bennett C, Beyene K, et al.. Global Epidemiology of Hip Fractures: Secular Trends in Incidence Rate, Post-Fracture Treatment, and All-Cause Mortality. J Bone Miner Res. 2023;38(8):1064&#x2013;1075. doi: 10.1002/jbmr.4821</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jbmr.4821</ArticleId><ArticleId IdType="pubmed">37118993</ArticleId></ArticleIdList></Reference><Reference><Citation>Johansen A, Golding D, Brent L, Close J, Gjertsen JE, Holt G, et al.. Using national hip fracture registries and audit databases to develop an international perspective. Injury. 2017;48(10):2174&#x2013;2179. doi: 10.1016/j.injury.2017.08.001</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.injury.2017.08.001</ArticleId><ArticleId IdType="pubmed">28803651</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen DX, Yang L, Ding L, Li SY, Qi YN, Li Q. Perioperative outcomes in geriatric patients undergoing hip fracture surgery with different anesthesia techniques: A systematic review and meta-analysis. Medicine (Baltimore). 2019;98(49):e18220. doi: 10.1097/MD.0000000000018220</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MD.0000000000018220</ArticleId><ArticleId IdType="pmc">PMC6919429</ArticleId><ArticleId IdType="pubmed">31804347</ArticleId></ArticleIdList></Reference><Reference><Citation>Lian Z, Zhu C, Yuan H, Wang J. Association between changes in depressive symptoms and hip fracture among middle-aged and older Chinese individuals: a prospective cohort study. BMC Geriatr. 2022;22(1):844. doi: 10.1186/s12877-022-03484-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12877-022-03484-8</ArticleId><ArticleId IdType="pmc">PMC9644634</ArticleId><ArticleId IdType="pubmed">36348273</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin X, Xiong D, Peng YQ, Sheng ZF, Wu XY, Wu XP, et al.. Epidemiology and management of osteoporosis in the People&#x2019;s Republic of China: current perspectives. Clin Interv Aging. 2015;10:1017&#x2013;1033. doi: 10.2147/CIA.S54613</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/CIA.S54613</ArticleId><ArticleId IdType="pmc">PMC4485798</ArticleId><ArticleId IdType="pubmed">26150706</ArticleId></ArticleIdList></Reference><Reference><Citation>National Bureau of Statistics of China [Internet]. China: China Statistical Yearbook 2021 [cited 2024 Jan 24]. Available from: https://ghdx.healthdata.org/record/china-statistical-yearbook-2021.</Citation></Reference><Reference><Citation>Partridge JS, Harari D, Dhesi JK. Frailty in the older surgical patient: a review. Age Ageing. 2012;41(2):142&#x2013;147. doi: 10.1093/ageing/afr182</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ageing/afr182</ArticleId><ArticleId IdType="pubmed">22345294</ArticleId></ArticleIdList></Reference><Reference><Citation>Jin HY, Liu X, Xue QL, Chen S, Wu C. The Association between Frailty and Healthcare Expenditure among Chinese Older Adults. J Am Med Dir Assoc. 2020;21(6):780&#x2013;785. doi: 10.1016/j.jamda.2020.03.008</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jamda.2020.03.008</ArticleId><ArticleId IdType="pubmed">32331768</ArticleId></ArticleIdList></Reference><Reference><Citation>Tracy BM, Adams MA, Schenker ML, Gelbard RB. The 5 and 11 Factor Modified Frailty Indices are Equally Effective at Outcome Prediction Using TQIP. J Surg Res. 2020;255:456&#x2013;462. doi: 10.1016/j.jss.2020.05.090</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jss.2020.05.090</ArticleId><ArticleId IdType="pubmed">32619861</ArticleId></ArticleIdList></Reference><Reference><Citation>Pioli G, Bendini C, Pignedoli P, Giusti A, Marsh D. Orthogeriatric co-management&#x2014;managing frailty as well as fragility. Injury. 2018;49(8):1398&#x2013;1402. doi: 10.1016/j.injury.2018.04.014</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.injury.2018.04.014</ArticleId><ArticleId IdType="pubmed">29921533</ArticleId></ArticleIdList></Reference><Reference><Citation>Michael A, Lago A, Swingewood N, Rahman M, Siau K. Frailty in hip fracture patients and its impact on the length of stay. World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO 2020): Poster Abstracts. Osteoporos Int. 2020;31(Suppl 1):S171.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7925810</ArticleId><ArticleId IdType="pubmed">33656611</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao H, Wei PY, Feng Y. Association Between Frailty and Clinical Outcomes and Quality of Life in Older Adults Following Hip Fracture Surgery: A Retrospective Cohort Study. Anesth Analg. 2022;134(5):1035&#x2013;1042. doi: 10.1213/ANE.0000000000005841</Citation><ArticleIdList><ArticleId IdType="doi">10.1213/ANE.0000000000005841</ArticleId><ArticleId IdType="pubmed">34958310</ArticleId></ArticleIdList></Reference><Reference><Citation>Shen Y, Hao Q, Zhou J, Dong B. The impact of frailty and sarcopenia on postoperative outcomes in older patients undergoing gastrectomy surgery: a systematic review and meta-analysis. BMC Geriatr. 2017;17(1):188. doi: 10.1186/s12877-017-0569-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12877-017-0569-2</ArticleId><ArticleId IdType="pmc">PMC5563908</ArticleId><ArticleId IdType="pubmed">28826406</ArticleId></ArticleIdList></Reference><Reference><Citation>Fried LP, Tangen CM, Walston J, Newman AB, Hirsch C, Gottdiener J, et al.. Frailty in older adults: evidence for a phenotype. J Gerontol A Biol Sci Med Sci. 2001;56(3):M146&#x2013;156. doi: 10.1093/gerona/56.3.m146</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/gerona/56.3.m146</ArticleId><ArticleId IdType="pubmed">11253156</ArticleId></ArticleIdList></Reference><Reference><Citation>Sang WA, Durrani H, Liu H, Clark JM, Ferber L, Hagan J, et al.. Frailty Score as a Predictor of Outcomes in Geriatric Patients with Isolated Hip Fractures. Am Surg. 2023;89(5):1479&#x2013;1484. doi: 10.1177/00031348211058629</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/00031348211058629</ArticleId><ArticleId IdType="pubmed">34905976</ArticleId></ArticleIdList></Reference><Reference><Citation>Song Y, Wu Z, Huo H, Zhao P. The Impact of Frailty on Adverse Outcomes in Geriatric Hip Fracture Patients: A Systematic Review and Meta-Analysis. Front Public Health. 2022;10:890652. doi: 10.3389/fpubh.2022.890652</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fpubh.2022.890652</ArticleId><ArticleId IdType="pmc">PMC9280195</ArticleId><ArticleId IdType="pubmed">35844855</ArticleId></ArticleIdList></Reference><Reference><Citation>Ma Y, Wang A, Lou Y, Peng D, Jiang Z, Xia T. Effects of Frailty on Outcomes Following Surgery Among Patients With Hip Fractures: A Systematic Review and Meta-Analysis. Front Med (Lausanne). 2022;9:829762. doi: 10.3389/fmed.2022.829762</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2022.829762</ArticleId><ArticleId IdType="pmc">PMC8984086</ArticleId><ArticleId IdType="pubmed">35402430</ArticleId></ArticleIdList></Reference><Reference><Citation>Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al.. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71. doi: 10.1136/bmj.n71</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.n71</ArticleId><ArticleId IdType="pmc">PMC8005924</ArticleId><ArticleId IdType="pubmed">33782057</ArticleId></ArticleIdList></Reference><Reference><Citation>Lo CK, Mertz D, Loeb M. Newcastle-Ottawa Scale: comparing reviewers&#x2019; to authors&#x2019; assessments. BMC Med Res Methodol. 2014;14:45. doi: 10.1186/1471-2288-14-45</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2288-14-45</ArticleId><ArticleId IdType="pmc">PMC4021422</ArticleId><ArticleId IdType="pubmed">24690082</ArticleId></ArticleIdList></Reference><Reference><Citation>Stang A. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol. 2010;25(9):603&#x2013;605. doi: 10.1007/s10654-010-9491-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10654-010-9491-z</ArticleId><ArticleId IdType="pubmed">20652370</ArticleId></ArticleIdList></Reference><Reference><Citation>Liperoti R, Vetrano DL, Palmer K, Targowski T, Cipriani MC, Lo Monaco MR, et al.. Association between frailty and ischemic heart disease: a systematic review and meta-analysis. BMC Geriatr. 2021;21(1):357. doi: 10.1186/s12877-021-02304-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12877-021-02304-9</ArticleId><ArticleId IdType="pmc">PMC8193864</ArticleId><ArticleId IdType="pubmed">34112104</ArticleId></ArticleIdList></Reference><Reference><Citation>Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med. 2002;21(11):1539&#x2013;58. doi: 10.1002/sim.1186</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/sim.1186</ArticleId><ArticleId IdType="pubmed">12111919</ArticleId></ArticleIdList></Reference><Reference><Citation>Kucukseymen S, Iannaccone M, Grantham JA, Sapontis J, Juricic S, Ciardetti N, et al.. Association of Successful Percutaneous Revascularization of Chronic Total Occlusions With Quality of Life: A Systematic Review and Meta-Analysis. JAMA Netw Open. 2023;6(7):e2324522. doi: 10.1001/jamanetworkopen.2023.24522</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2023.24522</ArticleId><ArticleId IdType="pmc">PMC10359963</ArticleId><ArticleId IdType="pubmed">37471086</ArticleId></ArticleIdList></Reference><Reference><Citation>Dou Q, Wang W, Wang H, Ma Y, Hai S, Lin X, et al.. Prognostic value of frailty in elderly patients with acute coronary syndrome: a systematic review and meta-analysis. BMC Geriatr. 2019;19(1):222. doi: 10.1186/s12877-019-1242-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12877-019-1242-8</ArticleId><ArticleId IdType="pmc">PMC6694517</ArticleId><ArticleId IdType="pubmed">31416442</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang KL, Detroyer E, Van Grootven B, Tuand K, Zhao DN, Rex S, et al.. Association between preoperative anxiety and postoperative delirium in older patients: a systematic review and meta-analysis. BMC Geriatr. 2023;23(1):198. doi: 10.1186/s12877-023-03923-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12877-023-03923-0</ArticleId><ArticleId IdType="pmc">PMC10064748</ArticleId><ArticleId IdType="pubmed">36997928</ArticleId></ArticleIdList></Reference><Reference><Citation>Brok J, Thorlund K, Gluud C, Wetterslev J. Trial sequential analysis reveals insufficient information size and potentially false positive results in many meta-analyses. J Clin Epidemiol. 2008;61(8):763&#x2013;769. doi: 10.1016/j.jclinepi.2007.10.007</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jclinepi.2007.10.007</ArticleId><ArticleId IdType="pubmed">18411040</ArticleId></ArticleIdList></Reference><Reference><Citation>Wetterslev J, Jakobsen JC, Gluud C. Trial Sequential Analysis in systematic reviews with meta-analysis. BMC Med Res Methodol. 2017;17(1):39. doi: 10.1186/s12874-017-0315-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12874-017-0315-7</ArticleId><ArticleId IdType="pmc">PMC5397700</ArticleId><ArticleId IdType="pubmed">28264661</ArticleId></ArticleIdList></Reference><Reference><Citation>Fang T, Gong Y, Wang Y. Prognostic values of myosteatosis for overall survival in patients with gastric cancers: A meta-analysis with trial sequential analysis. Nutrition. 2023;105:111866. doi: 10.1016/j.nut.2022.111866</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nut.2022.111866</ArticleId><ArticleId IdType="pubmed">36368263</ArticleId></ArticleIdList></Reference><Reference><Citation>Patel KV, Brennan KL, Brennan ML, Jupiter DC, Shar A, Davis ML. Association of a modified frailty index with mortality after femoral neck fracture in patients aged 60 years and older. Clin Orthop Relat Res. 2014;472(3):1010&#x2013;1017. doi: 10.1007/s11999-013-3334-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11999-013-3334-7</ArticleId><ArticleId IdType="pmc">PMC3916591</ArticleId><ArticleId IdType="pubmed">24166073</ArticleId></ArticleIdList></Reference><Reference><Citation>Kistler EA, Nicholas JA, Kates SL, Friedman SM. Frailty and Short-Term Outcomes in Patients With Hip Fracture. Geriatr Orthop Surg Rehabil. 2015;6(3):209&#x2013;214. doi: 10.1177/2151458515591170</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/2151458515591170</ArticleId><ArticleId IdType="pmc">PMC4536514</ArticleId><ArticleId IdType="pubmed">26328238</ArticleId></ArticleIdList></Reference><Reference><Citation>Kua J, Ramason R, Rajamoney G, Chong M, Chong MS. Which frailty measure is a good predictor of early post-operative complications in elderly hip fracture patients? Arch Orthop Trauma Surg. 2016;136(5):639&#x2013;647. doi: 10.1007/s00402-016-2435-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00402-016-2435-7</ArticleId><ArticleId IdType="pubmed">26980097</ArticleId></ArticleIdList></Reference><Reference><Citation>Choi J-Y, Cho K-J, Kim S-W, Yoon S-J, Kang M-G, Kim K-I, et al.. Prediction of Mortality and Postoperative Complications using the Hip-Multidimensional Frailty Score in Elderly Patients with Hip Fracture. Sci Rep. 2017;7:42966. doi: 10.1038/srep42966</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep42966</ArticleId><ArticleId IdType="pmc">PMC5324046</ArticleId><ArticleId IdType="pubmed">28233870</ArticleId></ArticleIdList></Reference><Reference><Citation>Gleason LJ, Benton EA, Alvarez-Nebreda ML, Weaver MJ, Harris MB, Javedan H. FRAIL Questionnaire Screening Tool and Short-Term Outcomes in Geriatric Fracture Patients. J Am Med Dir Assoc. 2017;18(12):1082&#x2013;1086. doi: 10.1016/j.jamda.2017.07.005</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jamda.2017.07.005</ArticleId><ArticleId IdType="pmc">PMC6611671</ArticleId><ArticleId IdType="pubmed">28866353</ArticleId></ArticleIdList></Reference><Reference><Citation>Winters AM, Hartog LC, Roijen HIF, Brohet RM, Kamper AM. Relationship between clinical outcomes and Dutch frailty score among elderly patients who underwent surgery for hip fracture. Clin Interv Aging. 2018;13:2481&#x2013;2486. doi: 10.2147/CIA.S181497</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/CIA.S181497</ArticleId><ArticleId IdType="pmc">PMC6287424</ArticleId><ArticleId IdType="pubmed">30584288</ArticleId></ArticleIdList></Reference><Reference><Citation>Jorissen RN, Lang C, Visvanathan R, Crotty M, Inacio MC. The effect of frailty on outcomes of surgically treated hip fractures in older people. Bone. 2020;136. doi: 10.1016/j.bone.2020.115327</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bone.2020.115327</ArticleId><ArticleId IdType="pubmed">32209422</ArticleId></ArticleIdList></Reference><Reference><Citation>Narula S, Lawless A, D&#x2019;Alessandro P, Jones CW, Yates P, Seymour H. Clinical Frailty Scale is a good predictor of mortality after proximal femur fracture: A cohort study of 30-day and one-year mortality. Bone Jt Open. 2020;1(8):443&#x2013;449. doi: 10.1302/2633-1462.18.BJO-2020-0089.R1</Citation><ArticleIdList><ArticleId IdType="doi">10.1302/2633-1462.18.BJO-2020-0089.R1</ArticleId><ArticleId IdType="pmc">PMC7667224</ArticleId><ArticleId IdType="pubmed">33215137</ArticleId></ArticleIdList></Reference><Reference><Citation>Gandossi CM, Zambon A, Oliveri G, Codognola M, Szabo H, Cazzulani I, et al.. Frailty, post-operative delirium and functional status at discharge in patients with hip fracture. Int J Geriatr Psychiatry. 2021;36(10):1524&#x2013;1530. doi: 10.1002/gps.5561</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/gps.5561</ArticleId><ArticleId IdType="pmc">PMC8518900</ArticleId><ArticleId IdType="pubmed">33908103</ArticleId></ArticleIdList></Reference><Reference><Citation>Pizzonia M, Giannotti C, Carmisciano L, Signori A, Rosa G, Santolini F, et al.. Frailty assessment, hip fracture and long-term clinical outcomes in older adults. Eur J Clin Invest. 2021;51(4). doi: 10.1111/eci.13445</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/eci.13445</ArticleId><ArticleId IdType="pubmed">33131066</ArticleId></ArticleIdList></Reference><Reference><Citation>Shen YJ, Hao QK, Wang YT, Chen XY, Jiang JJ, Dong BR, et al.. The association between preoperative modified frailty index and postoperative complications in Chinese elderly patients with hip fractures. BMC Geriatrics. 2021;21(1). doi: 10.1186/s12877-021-02330-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12877-021-02330-7</ArticleId><ArticleId IdType="pmc">PMC8207648</ArticleId><ArticleId IdType="pubmed">34134662</ArticleId></ArticleIdList></Reference><Reference><Citation>Thorne G, Hodgson L. Performance of the Nottingham Hip Fracture Score and Clinical Frailty Scale as predictors of short and long-term outcomes: a dual-centre 3-year observational study of hip fracture patients. J Bone Miner Metab. 2021;39(3):494&#x2013;500. doi: 10.1007/s00774-020-01187-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00774-020-01187-x</ArticleId><ArticleId IdType="pubmed">33387062</ArticleId></ArticleIdList></Reference><Reference><Citation>Shimizu A, Maeda K, Fujishima I, Kayashita J, Mori N, Okada K, et al.. Hospital Frailty Risk Score predicts adverse events in older patients with hip fractures after surgery: Analysis of a nationwide inpatient database in Japan. Arch Gerontol Geriatr. 2022;98.</Citation><ArticleIdList><ArticleId IdType="pubmed">34653923</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou YL, Wang L, Cao AY, Luo WJ, Xu ZP, Sheng ZR, et al.. Modified Frailty Index Combined with a Prognostic Nutritional Index for Predicting Postoperative Complications of Hip Fracture Surgery in Elderly. J Invest Surg. 2022;35(10):1739&#x2013;1746. doi: 10.1080/08941939.2022.2101166</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/08941939.2022.2101166</ArticleId><ArticleId IdType="pubmed">35906737</ArticleId></ArticleIdList></Reference><Reference><Citation>Mathew A, Lukachan GA, Varughese D, Raju N, Mathai AS, Johnson AS. Impact of frailty and comorbidity index on postoperative complications and functional outcomes among elderly patients undergoing hip fracture surgeries under regional anesthesia techniques. Anesthesia, Pain &amp; Intensive Care. 2023;27(2):161&#x2013;169.</Citation></Reference><Reference><Citation>Wong BLL, Chan YH, O&#x2019;Neill GK, Murphy D, Merchant RA. Frailty, length of stay and cost in hip fracture patients. Osteoporos Int. 2023;34(1):59&#x2013;68. doi: 10.1007/s00198-022-06553-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00198-022-06553-1</ArticleId><ArticleId IdType="pubmed">36197493</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu Z, Deng X, He B, Deng J, Hong Q. Association between properative laboratory frailty index scores and complications after hip fracture surgery in the elders. J Guangdong Med. 2023;44(3):340&#x2013;344.</Citation></Reference><Reference><Citation>You L. Effect of frailty on perioperative risk and prognosis in elderly patients with hip fracture. M.Sc. Thesis, Nanchang University. 2020.</Citation></Reference><Reference><Citation>Zhu S, Xing Y, Zhang L, Chen L, Liu X, Gu E. Predictive value of Frail Scale and CHS index on postoperative outcomes in elderly patients with hip fracture. J Cli Anes. 2020;36(10):962&#x2013;965.</Citation></Reference><Reference><Citation>Roopsawang I, Zaslavsky O, Thompson H, Aree-Ue S, Kwan RYC, Belza B. Frailty measurements in hospitalised orthopaedic populations age 65 and older: A scoping review. J Clin Nurs. 2022;31(9&#x2013;10):1149&#x2013;1163. doi: 10.1111/jocn.16035</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jocn.16035</ArticleId><ArticleId IdType="pmc">PMC9293223</ArticleId><ArticleId IdType="pubmed">34622525</ArticleId></ArticleIdList></Reference><Reference><Citation>Kehler DS, Ferguson T, Stammers AN, Bohm C, Arora RC, Duhamel TA, et al.. Prevalence of frailty in Canadians 18&#x2013;79 years old in the Canadian Health Measures Survey. BMC Geriatr. 2017;17(1):28. doi: 10.1186/s12877-017-0423-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12877-017-0423-6</ArticleId><ArticleId IdType="pmc">PMC5251297</ArticleId><ArticleId IdType="pubmed">28107813</ArticleId></ArticleIdList></Reference><Reference><Citation>Badosa-Collell G, Latorre-Vallbona N, Martori JC, et al.. Capacidad predictiva de mortalidad del &#xed;ndice Fr&#xe1;gil-VIG (IF-VIG) en pacientes ancianos con fractura de f&#xe9;mur. Rev Esp Geriatr Gerontol 2022; 57: 220&#x2013;223.</Citation><ArticleIdList><ArticleId IdType="pubmed">35660262</ArticleId></ArticleIdList></Reference><Reference><Citation>Egglestone A, Dietz-Collin G, Eardley W, Baker P. Chin-on-Chest in Neck of Femur Fracture (COCNOF) sign: A simple radiographic predictor of frailty and mortality in hip fracture patients. Injury. 2021;52(6):1494&#x2013;1499. doi: 10.1016/j.injury.2020.10.098</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.injury.2020.10.098</ArticleId><ArticleId IdType="pubmed">33143868</ArticleId></ArticleIdList></Reference><Reference><Citation>Ma Y, Wang A, Lou Y, Peng D, Jiang Z, Xia T. Effects of Frailty on Outcomes Following Surgery Among Patients With Hip Fractures: A Systematic Review and Meta-Analysis. Front Med (Lausanne). 2022;9. doi: 10.3389/fmed.2022.829762</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2022.829762</ArticleId><ArticleId IdType="pmc">PMC8984086</ArticleId><ArticleId IdType="pubmed">35402430</ArticleId></ArticleIdList></Reference><Reference><Citation>Mitnitski A, Song X, Rockwood K. Trajectories of changes over twelve years in the health status of Canadians from late middle age. Exp Gerontol. 2012;47(12):893&#x2013;899. doi: 10.1016/j.exger.2012.06.015</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.exger.2012.06.015</ArticleId><ArticleId IdType="pubmed">22790020</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee JH, Park YS, Kim MJ, Shin HJ, Roh YH, Kim JH, et al.. Clinical Frailty Scale as a predictor of short-term mortality: A systematic review and meta-analysis of studies on diagnostic test accuracy. Acad Emerg Med. 2022;29(11):1347&#x2013;1356. doi: 10.1111/acem.14493</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/acem.14493</ArticleId><ArticleId IdType="pubmed">35349205</ArticleId></ArticleIdList></Reference><Reference><Citation>Albanese AM, Ramazani N, Greene N, Bruse L. Review of Postoperative Delirium in Geriatric Patients After Hip Fracture Treatment. Geriatr Orthop Surg Rehabil. 2022;13:21514593211058947. doi: 10.1177/21514593211058947</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/21514593211058947</ArticleId><ArticleId IdType="pmc">PMC8915233</ArticleId><ArticleId IdType="pubmed">35282299</ArticleId></ArticleIdList></Reference><Reference><Citation>Gandossi CM, Zambon A, Oliveri G, Codognola M, Szabo H, Cazzulani I, et al.. Frailty, post-operative delirium and functional status at discharge in patients with hip fracture. Int J Geriatr Psychiatry. 2021;36(10):1524&#x2013;1530. doi: 10.1002/gps.5561</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/gps.5561</ArticleId><ArticleId IdType="pmc">PMC8518900</ArticleId><ArticleId IdType="pubmed">33908103</ArticleId></ArticleIdList></Reference><Reference><Citation>Inouye SK, Westendorp RG, Saczynski JS. Delirium in elderly people. Lancet. 2014;383(9920):911&#x2013;922. doi: 10.1016/S0140-6736(13)60688-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(13)60688-1</ArticleId><ArticleId IdType="pmc">PMC4120864</ArticleId><ArticleId IdType="pubmed">23992774</ArticleId></ArticleIdList></Reference><Reference><Citation>Gao YC, Zhang YW, Shi L, Gao W, Li YJ, Chen H, et al.. What are Risk Factors of Postoperative Pneumonia in Geriatric Individuals after Hip Fracture Surgery: A Systematic Review and Meta-Analysis. Orthop Surg. 2023;15(1):38&#x2013;52. doi: 10.1111/os.13631</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/os.13631</ArticleId><ArticleId IdType="pmc">PMC9837248</ArticleId><ArticleId IdType="pubmed">36519396</ArticleId></ArticleIdList></Reference><Reference><Citation>Park CM, Kim W, Lee ES, Rhim HC, Cho KH, Kim JH, et al.. Comparison of Frailty Index to Pneumonia Severity Measures in Older Patients With Pneumonia. J Am Med Dir Assoc. 2022;23(1):165&#x2013;169. doi: 10.1016/j.jamda.2021.08.044</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jamda.2021.08.044</ArticleId><ArticleId IdType="pubmed">34624243</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang ZC, Jiang W, Chen X, Yang L, Wang H, Liu YH. Systemic immune-inflammation index independently predicts poor survival of older adults with hip fracture: a prospective cohort study. BMC Geriatr. 2021;21(1):155. doi: 10.1186/s12877-021-02102-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12877-021-02102-3</ArticleId><ArticleId IdType="pmc">PMC7934427</ArticleId><ArticleId IdType="pubmed">33663402</ArticleId></ArticleIdList></Reference><Reference><Citation>Lackner I, Weber B, Pressmar J, Odwarka A, Lam C, Haffner-Luntzer M, et al.. Cardiac alterations following experimental hip fracture&#x2014;inflammaging as independent risk factor. Front Immunol. 2022;13:895888. doi: 10.3389/fimmu.2022.895888</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2022.895888</ArticleId><ArticleId IdType="pmc">PMC9484325</ArticleId><ArticleId IdType="pubmed">36131923</ArticleId></ArticleIdList></Reference><Reference><Citation>Bugaevsky Y, Levy Y, Hershkovitz A, Ocheretny I, Nissenholtz A, Cooper L, et al.. Characteristics and Outcomes of Hip Fracture Patients Hospitalized in an Orthogeriatric Unit Versus an Orthopedic Department: A Retrospective Cohort Study. Geriatr Orthop Surg Rehabil. 2021;12.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7804357</ArticleId><ArticleId IdType="pubmed">33489431</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang T, Guo J, Long Y, Yin Y, Hou Z. Risk factors for preoperative deep venous thrombosis in hip fracture patients: a meta-analysis. J Orthop Traumatol. 2022;23(1):19. doi: 10.1186/s10195-022-00639-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s10195-022-00639-6</ArticleId><ArticleId IdType="pmc">PMC8991371</ArticleId><ArticleId IdType="pubmed">35391566</ArticleId></ArticleIdList></Reference><Reference><Citation>Nederpelt CJ, Bijman Q, Krijnen P, Schipper IB. Equivalence of DOACS and LMWH for thromboprophylaxis after hip fracture surgery: Systematic review and meta-analysis. Injury. 2022;53(3):1169&#x2013;1176. doi: 10.1016/j.injury.2021.11.052</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.injury.2021.11.052</ArticleId><ArticleId IdType="pubmed">34916036</ArticleId></ArticleIdList></Reference><Reference><Citation>Werneburg GT. Catheter-Associated Urinary Tract Infections: Current Challenges and Future Prospects. Res Rep Urol. 2022;14:109&#x2013;133. doi: 10.2147/RRU.S273663</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/RRU.S273663</ArticleId><ArticleId IdType="pmc">PMC8992741</ArticleId><ArticleId IdType="pubmed">35402319</ArticleId></ArticleIdList></Reference><Reference><Citation>Suen KFK, Low JXY, Charalambous CP. Urinary tract infection is associated with 2.4-fold increased risk of surgical site infection in hip fracture surgery: systematic review and meta-analysis. J Hosp Infect. 2023;139:56&#x2013;66. doi: 10.1016/j.jhin.2023.06.016</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jhin.2023.06.016</ArticleId><ArticleId IdType="pubmed">37343771</ArticleId></ArticleIdList></Reference><Reference><Citation>Bohl DD, Iantorno SE, Saltzman BM, Tetreault MW, Darrith B, Della Valle CJ. Sepsis Within 30 Days of Geriatric Hip Fracture Surgery. J Arthroplasty. 2017;32(10):3114&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">28634098</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">31096433</PMID><DateCompleted><Year>2019</Year><Month>05</Month><Day>28</Day></DateCompleted><DateRevised><Year>2022</Year><Month>10</Month><Day>05</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1536-5964</ISSN><JournalIssue CitedMedium="Internet"><Volume>98</Volume><Issue>20</Issue><PubDate><Year>2019</Year><Month>May</Month></PubDate></JournalIssue><Title>Medicine</Title><ISOAbbreviation>Medicine (Baltimore)</ISOAbbreviation></Journal><ArticleTitle>Oral vs intravenous tranexamic acid in total-knee arthroplasty and total hip arthroplasty: A systematic review and meta-analysis.</ArticleTitle><Pagination><StartPage>e15248</StartPage><MedlinePgn>e15248</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e15248</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1097/MD.0000000000015248</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">This study aimed to compare the efficacy and safety of oral tranexamic acid (TXA) with intravenous (IV) TXA in reducing perioperative blood loss in total-knee arthroplasty (TKA) and total-hip arthroplasty (THA).</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">PubMed, Web of Science, Embase, and Cochrane Library were fully searched for relevant studies. Studies comparing the efficacy and safety of oral TXA with IV TXA in TKA and THA were included in this research. Odds ratio (OR) or risk difference (RD) was applied to compare dichotomous variables, while mean difference (MD) was used to compare continues variables.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">A total of 7 studies (5 randomized controlled trials and 2 retrospective studies) were included into this study. As for patients undergoing TKA or THA, there were no obvious differences between oral TXA group and IV TXA group in hemoglobin (Hb) drop (MD&#x200a;=&#x200a;0.06, 95% confidence interval [CI]&#x200a;=&#x200a;-0.01 to 0.13, P&#x200a;=&#x200a;.09), transfusion rate (OR&#x200a;=&#x200a;0.78, 95% CI&#x200a;=&#x200a;0.54-1.13, P&#x200a;=&#x200a;.19), total blood loss (MD&#x200a;=&#x200a;16.31, 95% CI&#x200a;=&#x200a;-69.85 to 102.46, P&#x200a;=&#x200a;.71), total Hb loss (MD&#x200a;=&#x200a;5.18, 95% CI&#x200a;=&#x200a;-12.65 to 23.02, P&#x200a;=&#x200a;.57), length of hospital stay (MD&#x200a;=&#x200a;-0.06, 95% CI&#x200a;=&#x200a;-0.30 to 0.18, P&#x200a;=&#x200a;.63), drain out (MD&#x200a;=&#x200a;21.04, 95% CI&#x200a;=&#x200a;-15.81 to 57.88, P&#x200a;=&#x200a;.26), incidence of deep vein deep vein thrombosis (RD&#x200a;=&#x200a;0.00, 95% CI&#x200a;=&#x200a;-0.01 to 0.01, P&#x200a;=&#x200a;.82) or pulmonary embolism (RD&#x200a;=&#x200a;0.00, 95% CI&#x200a;=&#x200a;-0.01 to 0.01, P&#x200a;=&#x200a;.91). The sample size of this study was small and several included studies were with relatively low quality.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Oral TXA is equivalent to IV TXA in reducing perioperative blood loss and should be recommended in TKA and THA. More high-quality studies are needed to elucidate this issue.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Xuanhuang</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Orthopedics, The Affiliated Hospital of Putian University, Putian, Fujian, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zheng</LastName><ForeName>Feng</ForeName><Initials>F</Initials></Author><Author ValidYN="Y"><LastName>Zheng</LastName><ForeName>Zugao</ForeName><Initials>Z</Initials></Author><Author ValidYN="Y"><LastName>Wu</LastName><ForeName>Xianwei</ForeName><Initials>X</Initials></Author><Author ValidYN="Y"><LastName>Wu</LastName><ForeName>Changfu</ForeName><Initials>C</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D003160">Comparative Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Medicine (Baltimore)</MedlineTA><NlmUniqueID>2985248R</NlmUniqueID><ISSNLinking>0025-7974</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000933">Antifibrinolytic Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>6T84R30KC1</RegistryNumber><NameOfSubstance UI="D014148">Tranexamic Acid</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D061605" MajorTopicYN="N">Administration, Intravenous</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000284" MajorTopicYN="N">Administration, Oral</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000933" MajorTopicYN="N">Antifibrinolytic Agents</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019644" MajorTopicYN="N">Arthroplasty, Replacement, Hip</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019645" MajorTopicYN="N">Arthroplasty, Replacement, Knee</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016063" MajorTopicYN="N">Blood Loss, Surgical</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007902" MajorTopicYN="N">Length of Stay</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D059035" MajorTopicYN="N">Perioperative Period</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011655" MajorTopicYN="N">Pulmonary Embolism</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016032" MajorTopicYN="N">Randomized Controlled Trials as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014148" MajorTopicYN="N">Tranexamic Acid</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="Y">administration &amp; dosage</QualifierName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020246" MajorTopicYN="N">Venous Thrombosis</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>5</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>5</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>5</Month><Day>29</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2019</Year><Month>5</Month><Day>17</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31096433</ArticleId><ArticleId IdType="pmc">PMC6531257</ArticleId><ArticleId IdType="doi">10.1097/MD.0000000000015248</ArticleId><ArticleId IdType="pii">00005792-201905170-00004</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Courpied JP, Caton JH. Total Hip Arthroplasty, state of the art for the 21st century. Int Orthop 2011;35:149&#x2013;50.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3032113</ArticleId><ArticleId IdType="pubmed">21243356</ArticleId></ArticleIdList></Reference><Reference><Citation>Franceschini R, et al. Joint replacement in osteoarthritis: state of the art. Semin Arthritis Rheum 2005;34Suppl 2:73&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">16206963</ArticleId></ArticleIdList></Reference><Reference><Citation>Yan D, Yang J, Pei F. Total knee arthroplasty treatment of rheumatoid arthritis with severe versus moderate flexion contracture. J Orthop Surg Res 2013;8:41.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3829704</ArticleId><ArticleId IdType="pubmed">24229435</ArticleId></ArticleIdList></Reference><Reference><Citation>Oladeji LO, Dreger TK, Pratte EL, et al. Total knee arthroplasty versus osteochondral allograft: prevalence and risk factors following tibial plateau fractures. J Knee Surg 2019;32:380&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">29669383</ArticleId></ArticleIdList></Reference><Reference><Citation>Cherubino P. Total hip arthroplasty. Orthopedics 2012;35:1039&#x2013;41.</Citation><ArticleIdList><ArticleId IdType="pubmed">23218617</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee YK, Kim KC, Ha YC, et al. Combined anterior and posterior approach in total hip arthroplasty for Crowe IV dysplasia or ankylosed hips. J Arthroplasty 2015;30:797&#x2013;802.</Citation><ArticleIdList><ArticleId IdType="pubmed">25682205</ArticleId></ArticleIdList></Reference><Reference><Citation>Albinarrate A, L&#xf3;pez-Picado A, Oiartzabal I, et al. Assessment of the introduction of a blood management program in orthopaedic surgery. Rev Esp Anestesiol Reanim 2015;62:443&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">25315985</ArticleId></ArticleIdList></Reference><Reference><Citation>Jans &#xd8;, Bandholm T, Kurbegovic S, et al. Postoperative anemia and early functional outcomes after fast-track hip arthroplasty: a prospective cohort study. Transfusion 2016;56:917&#x2013;25.</Citation><ArticleIdList><ArticleId IdType="pubmed">26945552</ArticleId></ArticleIdList></Reference><Reference><Citation>Gonzalez-Porras JR, Colado E, Conde MP, et al. An individualized pre-operative blood saving protocol can increase pre-operative haemoglobin levels and reduce the need for transfusion in elective total hip or knee arthroplasty. Transfus Med 2009;19:35&#x2013;42.</Citation><ArticleIdList><ArticleId IdType="pubmed">19302453</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie J, Hu Q, Huang Q, et al. Comparison of intravenous versus topical tranexamic acid in primary total hip and knee arthroplasty: an updated meta-analysis. Thromb Res 2017;153:28&#x2013;36.</Citation><ArticleIdList><ArticleId IdType="pubmed">28319822</ArticleId></ArticleIdList></Reference><Reference><Citation>Yoshihara H, Yoneoka D. Predictors of allogeneic blood transfusion in total hip and knee arthroplasty in the United States, 2000&#x2013;2009. J Arthroplasty 2014;29:1736&#x2013;40.</Citation><ArticleIdList><ArticleId IdType="pubmed">24891002</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin PC, Hsu CH, Chen WS, et al. Does tranexamic acid save blood in minimally invasive total knee arthroplasty? Clin Orthop Relat Res 2011;469:1995&#x2013;2002.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3111781</ArticleId><ArticleId IdType="pubmed">21286886</ArticleId></ArticleIdList></Reference><Reference><Citation>MacGillivray RG, Tarabichi SB, Hawari MF, et al. Tranexamic acid to reduce blood loss after bilateral total knee arthroplasty: a prospective, randomized double blind study. J Arthroplasty 2011;26:24&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">20171048</ArticleId></ArticleIdList></Reference><Reference><Citation>Wind TC, Barfield WR, Moskal JT. The effect of tranexamic acid on transfusion rate in primary total hip arthroplasty. J Arthroplasty 2014;29:387&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">23790499</ArticleId></ArticleIdList></Reference><Reference><Citation>Perreault RE, Fournier CA, Mattingly DA, et al. Oral tranexamic acid reduces transfusions in total knee arthroplasty. J Arthroplasty 2017;32:2990&#x2013;4.</Citation><ArticleIdList><ArticleId IdType="pubmed">28757131</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang LK, Ma JX, Kuang MJ, et al. The efficacy of tranexamic acid using oral administration in total knee arthroplasty: a systematic review and meta-analysis. J Orthop Surg Res 2017;12:159.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5658985</ArticleId><ArticleId IdType="pubmed">29078788</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Z, Shen X. The efficacy of combined intra-articular and intravenous tranexamic acid for blood loss in primary total knee arthroplasty: a meta-analysis. Medicine (Baltimore) 2017;96:e8123.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5662361</ArticleId><ArticleId IdType="pubmed">29049195</ArticleId></ArticleIdList></Reference><Reference><Citation>Georgiev GP, Tanchev PP, Zheleva Z, et al. Comparison of topical and intravenous administration of tranexamic acid for blood loss control during total joint replacement: Review of literature. J Orthop Translat 2018;13:7&#x2013;12.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5892384</ArticleId><ArticleId IdType="pubmed">29662786</ArticleId></ArticleIdList></Reference><Reference><Citation>Fillingham YA, Kayupov E, Plummer DR, et al. The James A. Rand Young Investigator's Award: a randomized controlled trial of oral and intravenous tranexamic acid in total knee arthroplasty: the same efficacy at lower cost? J Arthroplasty 2016;31Suppl:26&#x2013;30.</Citation><ArticleIdList><ArticleId IdType="pubmed">27113948</ArticleId></ArticleIdList></Reference><Reference><Citation>Kayupov E, Fillingham YA, Okroj K, et al. Oral and intravenous tranexamic acid are equivalent at reducing blood loss following total hip arthroplasty: a randomized controlled trial. J Bone Joint Surg Am 2017;99:373&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">28244907</ArticleId></ArticleIdList></Reference><Reference><Citation>Irwin A, Khan SK, Jameson SS, et al. Oral versus intravenous tranexamic acid in enhanced-recovery primary total hip and knee replacement: results of 3000 procedures. Bone Joint J 2013;95-b:1556&#x2013;61.</Citation><ArticleIdList><ArticleId IdType="pubmed">24151279</ArticleId></ArticleIdList></Reference><Reference><Citation>Yuan X, Li B, Wang Q, et al. Comparison of 3 routes of administration of tranexamic acid on primary unilateral total knee arthroplasty: a prospective, randomized, controlled study. J Arthroplasty 2017;32:2738&#x2013;43.</Citation><ArticleIdList><ArticleId IdType="pubmed">28455182</ArticleId></ArticleIdList></Reference><Reference><Citation>Zohar E, Ellis M, Ifrach N, et al. The postoperative blood-sparing efficacy of oral versus intravenous tranexamic acid after total knee replacement. Anesth Analg 2004;99:1679&#x2013;83.</Citation><ArticleIdList><ArticleId IdType="pubmed">15562053</ArticleId></ArticleIdList></Reference><Reference><Citation>Gortemoller MA, Allen B, Forsyth R, et al. Comparison of oral and intravenous tranexamic acid for prevention of perioperative blood loss in total knee and total hip arthroplasty. Ann Pharmacother 2018;52:246&#x2013;50.</Citation><ArticleIdList><ArticleId IdType="pubmed">28980475</ArticleId></ArticleIdList></Reference><Reference><Citation>Luo ZY, Wang HY, Wang D, et al. Oral vs intravenous vs topical tranexamic acid in primary hip arthroplasty: a prospective, randomized, double-blind, controlled study. J Arthroplasty 2018;33:786&#x2013;93.</Citation><ArticleIdList><ArticleId IdType="pubmed">29107495</ArticleId></ArticleIdList></Reference><Reference><Citation>Moher D, et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ 2009;339:b2535.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2714657</ArticleId><ArticleId IdType="pubmed">19622551</ArticleId></ArticleIdList></Reference><Reference><Citation>Higgins J, GS Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.0 [updated February 2008]. The Cochrane Collaboration, 2008</Citation></Reference><Reference><Citation>Stang A. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol 2010;25:603&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="pubmed">20652370</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee QJ, Chang WY, Wong YC. Blood-sparing efficacy of oral tranexamic acid in primary total hip arthroplasty. J Arthroplasty 2017;32:139&#x2013;42.</Citation><ArticleIdList><ArticleId IdType="pubmed">27498390</ArticleId></ArticleIdList></Reference><Reference><Citation>Hao LQ, Wang QW, Chen WQ, et al. Comparison of oral and intravenous tranexamic acid in total knee and hip arthroplasty: a systematic review and meta-analysis. Int J Surg 2017;47:52&#x2013;3.</Citation><ArticleIdList><ArticleId IdType="pubmed">28919096</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang LK, Ma JX, Kuang MJ, et al. Comparison of oral versus intravenous application of tranexamic acid in total knee and hip arthroplasty: a systematic review and meta-analysis. Int J Surg 2017;45:77&#x2013;84.</Citation><ArticleIdList><ArticleId IdType="pubmed">28755884</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">30335177</PMID><DateCompleted><Year>2019</Year><Month>02</Month><Day>13</Day></DateCompleted><DateRevised><Year>2022</Year><Month>03</Month><Day>31</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1460-2393</ISSN><JournalIssue CitedMedium="Internet"><Volume>112</Volume><Issue>2</Issue><PubDate><Year>2019</Year><Month>Feb</Month><Day>01</Day></PubDate></JournalIssue><Title>QJM : monthly journal of the Association of Physicians</Title><ISOAbbreviation>QJM</ISOAbbreviation></Journal><ArticleTitle>Defining risk of general surgery in patients with chronic obstructive pulmonary diseases.</ArticleTitle><Pagination><StartPage>107</StartPage><EndPage>113</EndPage><MedlinePgn>107-113</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1093/qjmed/hcy240</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">The relationship between chronic obstructive pulmonary disease (COPD) and perioperative outcomes remains incompletely understood. Our purpose is to evaluate the features of postoperative adverse outcomes for geriatric surgical patients with COPD receiving non-thoracic surgeries.</AbstractText><AbstractText Label="AIM" NlmCategory="OBJECTIVE">To evaluate the potential impact of COPD history on the outcome after general surgery.</AbstractText><AbstractText Label="DESIGN" NlmCategory="METHODS">A retrospective cohort study with matching procedure by propensity score.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">We conducted a nationwide study of 15 359 COPD patients aged 65 years and older who received major non-thoracic surgeries in 2008-2013 from the Taiwan National Health Insurance Research Database. Comprehensive matching procedure with propensity score were used to select 15 359 surgical patients without COPD for comparison. Major postoperative complications and 30-day in-hospital mortality were evaluated among patients with and without COPD by calculating adjusted odds ratios (ORs) and 95% CIs.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Patients with COPD had significantly increased risk for postoperative complications, including pneumonia (OR = 90.3; 95% CI: 60.3-135), septicemia (OR = 3.11; 95% CI: 2.82-3.43), acute renal failure (OR = 2.53; 95% CI: 2.11-3.02), pulmonary embolism (OR = 2.74; 95% CI: 1.52-4.96), and 30-day postoperative mortality (adjusted OR = 2.09; 95% CI: 1.76-2.50), compared with surgical patients without COPD. Longer length of hospital stay and higher medical expenditures were also noted in COPD patients than those without COPD.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Geriatric patients with COPD showed significantly higher postoperative adverse outcome rates with risk of 30-day mortality nearly twofold when compared with patients without COPD. Our findings remind surgical care team pay more attention to this specific population.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Lin</LastName><ForeName>Chao-Shun</ForeName><Initials>CS</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Taipei Medical University Hospital, Taipei, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Anesthesiology and Health Policy Research Center, Taipei Medical University Hospital, Taipei, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Anesthesiology, School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Chien-Yu</ForeName><Initials>CY</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Taipei Medical University Hospital, Taipei, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Anesthesiology and Health Policy Research Center, Taipei Medical University Hospital, Taipei, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Anesthesiology, School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yeh</LastName><ForeName>Chun-Chieh</ForeName><Initials>CC</Initials><AffiliationInfo><Affiliation>Department of Surgery, China Medical University Hospital, Taichung, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Surgery, University of Illinois, Chicago, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chung</LastName><ForeName>Chi-Li</ForeName><Initials>CL</Initials><AffiliationInfo><Affiliation>Division of Pulmonary Medicine, Department of Internal Medicine, Taipei Medical University Hospital, Taipei, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Ta-Liang</ForeName><Initials>TL</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Taipei Medical University Hospital, Taipei, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Anesthesiology and Health Policy Research Center, Taipei Medical University Hospital, Taipei, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Anesthesiology, School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liao</LastName><ForeName>Chien-Chang</ForeName><Initials>CC</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Taipei Medical University Hospital, Taipei, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Anesthesiology and Health Policy Research Center, Taipei Medical University Hospital, Taipei, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Anesthesiology, School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Chinese Medicine, College of Chinese Medicine, China Medical University, Taichung, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Anesthesiology, Shuan Ho Hospital, Taipei Medical University, New Taipei City, Taiwan.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>QJM</MedlineTA><NlmUniqueID>9438285</NlmUniqueID><ISSNLinking>1460-2393</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>QJM. 2019 Feb 1;112(2):157. doi: 10.1093/qjmed/hcy256.</RefSource><PMID Version="1">30380123</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D058186" MajorTopicYN="N">Acute Kidney Injury</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016208" MajorTopicYN="N">Databases, Factual</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005102" MajorTopicYN="N">Health Expenditures</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017052" MajorTopicYN="Y">Hospital Mortality</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007902" MajorTopicYN="N">Length of Stay</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016015" MajorTopicYN="N">Logistic Models</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015999" MajorTopicYN="N">Multivariate Analysis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011014" MajorTopicYN="N">Pneumonia</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D057216" MajorTopicYN="N">Propensity Score</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D029424" MajorTopicYN="N">Pulmonary Disease, Chronic Obstructive</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName><QualifierName UI="Q000191" MajorTopicYN="N">economics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018805" MajorTopicYN="N">Sepsis</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013514" MajorTopicYN="N">Surgical Procedures, Operative</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013624" MajorTopicYN="N" Type="Geographic">Taiwan</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2018</Year><Month>7</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>10</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>2</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>10</Month><Day>19</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">30335177</ArticleId><ArticleId IdType="doi">10.1093/qjmed/hcy240</ArticleId><ArticleId IdType="pii">5136375</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">32958029</PMID><DateCompleted><Year>2021</Year><Month>05</Month><Day>26</Day></DateCompleted><DateRevised><Year>2021</Year><Month>05</Month><Day>26</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1749-799X</ISSN><JournalIssue CitedMedium="Internet"><Volume>15</Volume><Issue>1</Issue><PubDate><Year>2020</Year><Month>Sep</Month><Day>21</Day></PubDate></JournalIssue><Title>Journal of orthopaedic surgery and research</Title><ISOAbbreviation>J Orthop Surg Res</ISOAbbreviation></Journal><ArticleTitle>The choice of screw internal fixation and hemiarthroplasty in the treatment of femoral neck fractures in the elderly: a meta-analysis.</ArticleTitle><Pagination><StartPage>433</StartPage><MedlinePgn>433</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">433</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s13018-020-01958-2</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Femoral neck fractures are common fractures in the elderly. Common treatment options include internal fixation (IF) and hemiarthroplasty (HA). However, the clinical application of these two options is always controversial due to the potential clinical trauma, postoperative function, early complications, and other factors.</AbstractText><AbstractText Label="MATERIALS AND METHODS" NlmCategory="METHODS">Randomized controlled trials and cohort studies comparing screw fixation and hemiarthroplasty in elderly patients with displaced femoral neck fractures were extracted from databases such as PubMed, Web of Science, EMBASE, and Cochrane. The revised Jadad scale or NOS treatment evaluation form was used to evaluate the quality of the included studies. After extracting the data, the standard deviation of continuous data and the relative risk of binary data were used. The operation time, blood loss during operation, EQ-5D (EuroQol-5 Dimension) score, mortality rate, reoperation rate, and postoperative common complications were reviewed using Review Manager software (RevMan 5.3) were compared.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">There were 7 randomized controlled trials and 5 cohort studies. The results showed that the operation time, intraoperative blood loss, and short-term EQ-5D score of the internal fixation group were lower than those of the hemi-hip replacement group, but the reoperation rate was higher. There was no statistically significant difference in mortality and common complications such as deep vein thrombosis, pulmonary embolism, infection, and pressure sores during short-term follow-up.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">In the treatment of elderly femoral neck fractures, the screw internal fixation group has shorter operation time and less intraoperative bleeding, and the perioperative advantage is more obvious. However, the hemi-hip replacement group had more advantages in postoperative functional scoring and reoperation.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Cui</LastName><ForeName>Shuai</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>School of Mathematics, Jilin University, Changchun, Jilin Province, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Dehui</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>School of Mathematics, Jilin University, Changchun, Jilin Province, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Xuejie</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Hand Surgery, The Second Hospital of Jilin University, Changchun, Jilin Province, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Zehui</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Department of Hand Surgery, The Second Hospital of Jilin University, Changchun, Jilin Province, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Guo</LastName><ForeName>Wenlai</ForeName><Initials>W</Initials><Identifier Source="ORCID">0000-0002-3494-9076</Identifier><AffiliationInfo><Affiliation>Department of Hand Surgery, The Second Hospital of Jilin University, Changchun, Jilin Province, China. 1031557032@qq.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>09</Month><Day>21</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>J Orthop Surg Res</MedlineTA><NlmUniqueID>101265112</NlmUniqueID><ISSNLinking>1749-799X</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000367" MajorTopicYN="N">Age Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016063" MajorTopicYN="N">Blood Loss, Surgical</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001863" MajorTopicYN="Y">Bone Screws</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005265" MajorTopicYN="N">Femoral Neck Fractures</DescriptorName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005593" MajorTopicYN="N">Fracture Fixation, Internal</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D062785" MajorTopicYN="N">Hemiarthroplasty</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D061646" MajorTopicYN="N">Operative Time</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011655" MajorTopicYN="N">Pulmonary Embolism</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012086" MajorTopicYN="N">Reoperation</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020246" MajorTopicYN="N">Venous Thrombosis</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Femoral neck fractures</Keyword><Keyword MajorTopicYN="N">Hemiarthroplasty</Keyword><Keyword MajorTopicYN="N">Internal fixation</Keyword><Keyword MajorTopicYN="N">Meta-analysis</Keyword><Keyword MajorTopicYN="N">The elderly</Keyword></KeywordList><CoiStatement>The authors of this manuscript have no conflict of interests to declare.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>7</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>9</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>9</Month><Day>22</Day><Hour>5</Hour><Minute>31</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>9</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>5</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2020</Year><Month>9</Month><Day>21</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32958029</ArticleId><ArticleId IdType="pmc">PMC7507610</ArticleId><ArticleId IdType="doi">10.1186/s13018-020-01958-2</ArticleId><ArticleId IdType="pii">10.1186/s13018-020-01958-2</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Sterling RS. Gender and race/ethnicity differences in hip fracture incidence, morbidity, mortality, and function[J] Clin Orthop Relat Res. 2011;469(7):1913&#x2013;1918. doi: 10.1007/s11999-010-1736-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11999-010-1736-3</ArticleId><ArticleId IdType="pmc">PMC3111795</ArticleId><ArticleId IdType="pubmed">21161737</ArticleId></ArticleIdList></Reference><Reference><Citation>Frihagen F, Nordsletten, et al. Hemiarthroplasty or internal fixation for intracapsular displaced femoral neck fractures: randomised controlled trial[J]. BMJ. 2007;335(7632):1251&#x2013;4.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2137068</ArticleId><ArticleId IdType="pubmed">18056740</ArticleId></ArticleIdList></Reference><Reference><Citation>Damany DS, Parker MJ, Chojnowski A. Complications after intracapsular hip fractures in young adults. A meta-analysis of 18 published studies involving 564 fractures. Injury. 2005;36:131&#x2013;141.</Citation><ArticleIdList><ArticleId IdType="pubmed">15589931</ArticleId></ArticleIdList></Reference><Reference><Citation>Swiontkowski MF. Comparison of internal fixation with total hip replacement for displaced femoral neck fractures: randomized, controlled trial performed at four years[J] Yearbook Orthopedics. 2006;2006:80&#x2013;81. doi: 10.1016/S0276-1092(08)70381-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0276-1092(08)70381-X</ArticleId><ArticleId IdType="pubmed">16085605</ArticleId></ArticleIdList></Reference><Reference><Citation>van Balen R, Steyerberg EW, Polder JJ, Ribbers TL, Habbema JD, Cools HJ. Hip fracture in elderly patients: outcomes for function, quality of life, and type of residence. Clin Orthop Relat Res. 2001;390:232&#x2013;243. doi: 10.1097/00003086-200109000-00027.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00003086-200109000-00027</ArticleId><ArticleId IdType="pubmed">11550871</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu Yao GL, Keller RB, Littenberg B, Wennberg JE. Outcomes after displaced fractures of the femoral neck. A meta-analysis of one hundred and six published reports. J Bone Joint Surg Am. 1994;76:15&#x2013;25. doi: 10.2106/00004623-199401000-00003.</Citation><ArticleIdList><ArticleId IdType="doi">10.2106/00004623-199401000-00003</ArticleId><ArticleId IdType="pubmed">8288658</ArticleId></ArticleIdList></Reference><Reference><Citation>Johansson T, Jacobsson SA, Ivarsson I, Knutsson A, Wahlstr&#xf6;m O. Internal fixation versus total hip arthroplasty in the treatment of displaced femoral neck fractures: A prospective randomized study of 100 hips. Acta Orthop Scand. 2000;71:597&#x2013;602. doi: 10.1080/000164700317362235.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/000164700317362235</ArticleId><ArticleId IdType="pubmed">11145387</ArticleId></ArticleIdList></Reference><Reference><Citation>Bhandari M, Devereaux PJ, Swiontkowski MF, Tornetta P, 3rd, Obremskey W, Koval KJ, et al. Internal fixation compared with arthroplasty for displaced fractures of the femoral neck. A meta-analysis. J Bone Joint Surg Am. 2003;85-A:1673&#x2013;1681. doi: 10.2106/00004623-200309000-00004.</Citation><ArticleIdList><ArticleId IdType="doi">10.2106/00004623-200309000-00004</ArticleId><ArticleId IdType="pubmed">12954824</ArticleId></ArticleIdList></Reference><Reference><Citation>Moher D, Liberati A, Tetzlaff J, et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. J Clin Epidemiol. 2009;10:1006&#x2013;1012. doi: 10.1016/j.jclinepi.2009.06.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jclinepi.2009.06.005</ArticleId><ArticleId IdType="pubmed">19631508</ArticleId></ArticleIdList></Reference><Reference><Citation>Jadad AR, Moore RA, Carroll D, et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials. 1996;17:1. doi: 10.1016/0197-2456(95)00134-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0197-2456(95)00134-4</ArticleId><ArticleId IdType="pubmed">8721797</ArticleId></ArticleIdList></Reference><Reference><Citation>Shuyu MA, Qing HAN. Choose Model for Meta.[J] J Nanhua Univ (Science &amp; Engineering Edition) 2002;016(002):6&#x2013;13.</Citation></Reference><Reference><Citation>Higgins JPT. Green Se. Cochrane Handbook for Systematic Reviews of Interventions, version 5.1.0. (updated March 2011).</Citation></Reference><Reference><Citation>Puolakka TJ, Laine HJ, Tarvainen T, Aho H. Thompson hemiarthroplasty is superior to Ullevaal screws in treating displaced femoral neck fractures in patient over 75&#x2009;years: a prospective randomized study with two-year follow-up. Ann Chir Gynaecol. 2001;90:225&#x2013;228.</Citation><ArticleIdList><ArticleId IdType="pubmed">11695801</ArticleId></ArticleIdList></Reference><Reference><Citation>Parker MJ, Khan RJK, Crawford J, et al. Hemiarthroplasty versus internal fixation for displaced intracapsular hip fractures in the elderly[J] J Bone Joint Surg Br Vol. 2002;84(8):1150&#x2013;1155. doi: 10.1302/0301-620X.84B8.0841150.</Citation><ArticleIdList><ArticleId IdType="doi">10.1302/0301-620X.84B8.0841150</ArticleId><ArticleId IdType="pubmed">12463661</ArticleId></ArticleIdList></Reference><Reference><Citation>Frihagen F, Nordsletten L, Madsen JE. Hemiarthroplasty or internal fixation for intracapsular displaced femoral neck fractures: randomised controlled trial. BMJ. 2007;335:1251&#x2013;1254. doi: 10.1136/bmj.39399.456551.25.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.39399.456551.25</ArticleId><ArticleId IdType="pmc">PMC2137068</ArticleId><ArticleId IdType="pubmed">18056740</ArticleId></ArticleIdList></Reference><Reference><Citation>Hedbeck CJ, Inngul C, Blomfeldt R, Ponzer S, T&#xf6;rnkvist H, Enocson A. Internal fixation versus cemented hemiarthroplasty for displaced femoral neck fractures in patients with severe cognitive dysfunction: a randomized controlled trial. J Orthop Trauma. 2013;27:690&#x2013;695. doi: 10.1097/BOT.0b013e318291f544.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/BOT.0b013e318291f544</ArticleId><ArticleId IdType="pubmed">23515127</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu H, He L, Zhang G, et al. Comparison of total costs between internal fixation and hemiarthroplasty for displaced femoral neck fractures[J]. J Orthop Sci Official J Japanese Orthop Assoc. 2016;22(1):75&#x2013;80.</Citation><ArticleIdList><ArticleId IdType="pubmed">27693203</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu Q, Tang G, Zhao X, et al. Hemiarthroplasty versus internal fixation in super-aged patients with undisplaced femoral neck fractures: a 5-year follow-up of randomized controlled trial[J]. Arch Orthop Trauma Surg. 2017;137:27&#x2013;35.</Citation><ArticleIdList><ArticleId IdType="pubmed">27837321</ArticleId></ArticleIdList></Reference><Reference><Citation>Dolatowski FC, Frihagen F, Bartels S, et al. Screw fixation versus hemiarthroplasty for nondisplaced femoral neck fractures in elderly patients: a multicenter randomized controlled trial [J] J Bone Joint Surg Am. 2019;101:136&#x2013;144. doi: 10.2106/JBJS.18.00316.</Citation><ArticleIdList><ArticleId IdType="doi">10.2106/JBJS.18.00316</ArticleId><ArticleId IdType="pubmed">30653043</ArticleId></ArticleIdList></Reference><Reference><Citation>Partanen J, Jalovaara P. Functional comparison between uncemented Austin-Moore hemiarthroplasty and osteosynthesis with three screws in displaced femoral neck fractures&#x2014;a matched-pair study of 168 patients[J] Int Orthop. 2004;28(1):28&#x2013;31. doi: 10.1007/s00264-003-0517-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00264-003-0517-y</ArticleId><ArticleId IdType="pmc">PMC3466578</ArticleId><ArticleId IdType="pubmed">14586571</ArticleId></ArticleIdList></Reference><Reference><Citation>Sikand M, Wenn R, Moran CG. Mortality following surgery for undisplaced intracapsular hip fractures. Injury. 2004;35:1015&#x2013;1019. doi: 10.1016/j.injury.2004.01.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.injury.2004.01.004</ArticleId><ArticleId IdType="pubmed">15351669</ArticleId></ArticleIdList></Reference><Reference><Citation>Bj&#xf8;rgul K, Reiker&#xe5;s O. Hemiarthroplasty in worst cases is better than internal fixation in best cases of displaced femoral neck fractures: a prospective study of 683 patients treated with hemiarthroplasty or internal fixation [J] Acta Orthopaedica. 2006;77(3):368&#x2013;374. doi: 10.1080/17453670610046271.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/17453670610046271</ArticleId><ArticleId IdType="pubmed">16819673</ArticleId></ArticleIdList></Reference><Reference><Citation>Gjertsen JE, Vinje T, Enges&#xe6;ter LB, et al. Internal screw fixation compared with bipolar hemiarthroplasty for treatment of displaced femoral neck fractures in elderly patients [J] J Bone Joint Surg Am Vol. 2010;92(3):619&#x2013;628. doi: 10.2106/JBJS.H.01750.</Citation><ArticleIdList><ArticleId IdType="doi">10.2106/JBJS.H.01750</ArticleId><ArticleId IdType="pubmed">20194320</ArticleId></ArticleIdList></Reference><Reference><Citation>Bartels S, Gjertsen J-E, Frihagen F, et al. High failure rate after internal fixation and beneficial outcome after arthroplasty in treatment of displaced femoral neck fractures in patients between 55 and 70&#x2009;years[J]. Acta Orthopaedica. 2018;89:53&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5810833</ArticleId><ArticleId IdType="pubmed">28914130</ArticleId></ArticleIdList></Reference><Reference><Citation>Hedlund R, Lindgren U, Ahlbom A. Age- and sex-specific incidence of femoral neck and trochanteric fractures. An analysis based on 20,538 fractures in Stockholm County, Sweden, 1972- 1981. Clin Orthop Relat Res. 1987;222:132&#x2013;139.</Citation><ArticleIdList><ArticleId IdType="pubmed">3621713</ArticleId></ArticleIdList></Reference><Reference><Citation>Lofthus CM, Osnes EK, Falch JA, Kaastad TS, Kristiansen IS, Nordsletten L, Stensvold I. Meyer HE Epidemiology of hip fractures in Oslo. Norway Bone. 2001;29:413&#x2013;418. doi: 10.1016/S8756-3282(01)00603-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S8756-3282(01)00603-2</ArticleId><ArticleId IdType="pubmed">11704490</ArticleId></ArticleIdList></Reference><Reference><Citation>Parker MJ, Gurusamy K. Internal fixation versus arthroplasty for intracapsular proximal femoral fractures in adults. Cochrane Database Syst Rev. 2006;4:CD001708.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8407320</ArticleId><ArticleId IdType="pubmed">17054139</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang J, Jiang B, Marshall RJ, Zhang P. Arthroplasty or internal fixation for displaced femoral neck fractures: which is the optimal alternative for elderly patients? A meta-analysis. Int Orthop. 2009;33:1179&#x2013;1187. doi: 10.1007/s00264-009-0763-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00264-009-0763-8</ArticleId><ArticleId IdType="pmc">PMC2899139</ArticleId><ArticleId IdType="pubmed">19343344</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang J, Yang CH, Lin Q, et al. Does arthroplasty provide better outcomes than internal fixation at mid- and long-term followup? A meta-analysis[J] Clin Orthop Relat Res? 2015;473(8):2672&#x2013;2679. doi: 10.1007/s11999-015-4345-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11999-015-4345-3</ArticleId><ArticleId IdType="pmc">PMC4488202</ArticleId><ArticleId IdType="pubmed">25981713</ArticleId></ArticleIdList></Reference><Reference><Citation>Gao H, Liu Z, Xing D, Gong M. Which is the best alternative for displaced femoral neck fractures in the elderly?: a meta-analysis. Clin Orthop Relat Res. 2012;470:1782&#x2013;1791. doi: 10.1007/s11999-012-2250-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11999-012-2250-6</ArticleId><ArticleId IdType="pmc">PMC3348330</ArticleId><ArticleId IdType="pubmed">22278852</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen-Yi Y, An L, Ming-Yuan X, et al. Arthroplasty versus internal fixation for displaced intracapsular femoral neck fracture in the elderly: systematic review and meta-analysis of short- and long-term effectiveness[J] Chin Med J. 2016;129(21):2630&#x2013;2638. doi: 10.4103/0366-6999.192788.</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/0366-6999.192788</ArticleId><ArticleId IdType="pmc">PMC5125344</ArticleId><ArticleId IdType="pubmed">27779172</ArticleId></ArticleIdList></Reference><Reference><Citation>Tseng FJ, Chia WT, Pan RY, et al. Comparison of arthroplasty vs. osteosynthesis for displaced femoral neck fractures: a meta-analysis[J] J Orthop Surg Res. 2017;12(1):131. doi: 10.1186/s13018-017-0629-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13018-017-0629-5</ArticleId><ArticleId IdType="pmc">PMC5602948</ArticleId><ArticleId IdType="pubmed">28915928</ArticleId></ArticleIdList></Reference><Reference><Citation>Fisher MA, Matthei JD, Obirieze A, Ortega G, Tran DD, Carnegie DA, et al. Open reduction internal fixation versus hemiarthroplasty versus total hip arthroplasty in the elderly: a review of the National Surgical Quality Improvement Program database. J Surg Res. 2013;181:193&#x2013;198. doi: 10.1016/j.jss.2012.07.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jss.2012.07.004</ArticleId><ArticleId IdType="pubmed">23122668</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">31804347</PMID><DateCompleted><Year>2019</Year><Month>12</Month><Day>26</Day></DateCompleted><DateRevised><Year>2020</Year><Month>01</Month><Day>24</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1536-5964</ISSN><JournalIssue CitedMedium="Internet"><Volume>98</Volume><Issue>49</Issue><PubDate><Year>2019</Year><Month>Dec</Month></PubDate></JournalIssue><Title>Medicine</Title><ISOAbbreviation>Medicine (Baltimore)</ISOAbbreviation></Journal><ArticleTitle>Perioperative outcomes in geriatric patients undergoing hip fracture surgery with different anesthesia techniques: A systematic review and meta-analysis.</ArticleTitle><Pagination><StartPage>e18220</StartPage><MedlinePgn>e18220</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e18220</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1097/MD.0000000000018220</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Previous meta-analyses assessing anesthetic techniques in adult patients undergoing hip fractures surgery are available. However, whether the anesthetic technique is associated with risk of mortality and complications in geriatric patients with hip fractures remains unclear. This study was conducted to assess postoperative outcomes of anesthesia technique in geriatric patients undergoing hip fracture surgery.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Cochrane Library, PubMed, EMBASE, MEDLINE, CNKI, and CBM were searched from inception up to May 25, 2018. Observational studies and randomized controlled trials (RCTs) that assessed the perioperative outcomes of technique of anesthesia (general or regional [epidural/spinal/neuraxial]) in geriatric patients (&#x2265;60 years old) undergoing hip fracture surgery were included. Two investigators independently screened studies for inclusion and performed data extraction. Heterogeneity was assessed by the I and Chi-square tests. The odds ratio (OR) of the dichotomous data, mean difference (MD) of continuous data, and 95% confidence intervals (CI) were calculated to assess the pooled data.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Eleven retrospective and 2 RCTs were included. There was no difference in 30-day mortality (OR&#x200a;=&#x200a;0.96; 95% CI 0.86-1.08; P&#x200a;=&#x200a;.51) between the general and regional anesthesia groups. In-hospital mortality (OR&#x200a;=&#x200a;1.26; 95% CI 1.17-1.36; P&#x200a;&lt;&#x200a;.001), acute respiratory failure (OR&#x200a;=&#x200a;2.66; 95% CI 2.34-3.02; P&#x200a;&lt;&#x200a;.001), length of hospital stay (MD&#x200a;=&#x200a;0.33; 95% CI 0.24-0.42; P&#x200a;&lt;&#x200a;.001), and readmission (OR&#x200a;=&#x200a;1.09; 95% CI 1.01-1.18; P&#x200a;=&#x200a;.03) were significantly reduced in the regional anesthesia group. Pneumonia (OR&#x200a;=&#x200a;0.99; 95% CI 0.91-1.07; P&#x200a;=&#x200a;.79), heart failure (OR&#x200a;=&#x200a;0.97; 95% CI 0.86-1.09; P&#x200a;=&#x200a;.62), acute myocardial infraction (OR&#x200a;=&#x200a;1.07; 95% CI 0.99-1.16; P&#x200a;=&#x200a;.10), acute renal failure (OR&#x200a;=&#x200a;1.32; 95% CI 0.97-1.79; P&#x200a;=&#x200a;.07), cerebrovascular accident (OR&#x200a;=&#x200a;1.08; 95% CI 0.82-1.42; P&#x200a;=&#x200a;.58), postoperative delirium (OR&#x200a;=&#x200a;1.51; 95% CI 0.16-13.97; P&#x200a;=&#x200a;.72), and deep vein thrombosis/pulmonary embolism (OR&#x200a;=&#x200a;1.42; 95% CI 0.84-2.38; P&#x200a;=&#x200a;.19) were similar between the two anesthetic techniques.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">General anesthesia is associated with increased risk of in-hospital mortality, acute respiratory failure, longer hospital stays, and higher readmission. There is evidence to suggest that regional anesthesia is associated with improved perioperative outcomes. Large RCTs are needed to explore the most optimal anesthetic techniques for geriatric patients with hip fractures before drawing final conclusions.</AbstractText><AbstractText Label="PROSPERO REGISTRATION NUMBER" NlmCategory="UNASSIGNED">CRD42018093582.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Dong Xu</ForeName><Initials>DX</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, West China Hospital, Sichuan University.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>Lei</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, West China Hospital, Sichuan University.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ding</LastName><ForeName>Lin</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, West China Hospital, Sichuan University.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Shi Yue</ForeName><Initials>SY</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, West China Hospital, Sichuan University.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Qi</LastName><ForeName>Ya Na</ForeName><Initials>YN</Initials><AffiliationInfo><Affiliation>Chinese Evidence-based Medicine Center, West China Hospital, Sichuan University, Chengdu, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Qian</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, West China Hospital, Sichuan University.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Medicine (Baltimore)</MedlineTA><NlmUniqueID>2985248R</NlmUniqueID><ISSNLinking>0025-7974</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000758" MajorTopicYN="N">Anesthesia</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006620" MajorTopicYN="N">Hip Fractures</DescriptorName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017052" MajorTopicYN="N">Hospital Mortality</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading></MeshHeadingList><CoiStatement>The authors have no conflicts of interest to disclose.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>12</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>12</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>12</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2019</Year><Month>12</Month><Day>10</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31804347</ArticleId><ArticleId IdType="pmc">PMC6919429</ArticleId><ArticleId IdType="doi">10.1097/MD.0000000000018220</ArticleId><ArticleId IdType="pii">00005792-201912060-00046</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Gullberg B, Johnell O, Kanis JA. World-wide projections for hip fracture. Osteoporos Int 1997;5:407&#x2013;13.</Citation><ArticleIdList><ArticleId IdType="pubmed">9425497</ArticleId></ArticleIdList></Reference><Reference><Citation>Hayes WC, Myers ER, Robinovitch SN, et al. Etiology and prevention of age-related hip fractures. Bone 1996;18:77&#x2013;86.</Citation><ArticleIdList><ArticleId IdType="pubmed">8717551</ArticleId></ArticleIdList></Reference><Reference><Citation>Curtis EM, van der Velde R, Moon RJ, et al. Epidemiology of fractures in the United Kingdom 1988-2012: variation with age, sex, geography, ethnicity and socioeconomic status. Bone 2016;87:19&#x2013;26.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4890652</ArticleId><ArticleId IdType="pubmed">26968752</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Waesberghe J, Stevanovic A, Rossaint R, et al. General vs. neuraxial anaesthesia in hip fracture patients: a systematic review and meta-analysis. BMC Anesthesiol 2017;17:1&#x2013;25.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5490182</ArticleId><ArticleId IdType="pubmed">28659127</ArticleId></ArticleIdList></Reference><Reference><Citation>O&#x2019;Donnell CM, McLoughlin L, Patterson CC, et al. Perioperative outcomes in the context of mode of anaesthesia for patients undergoing hip fracture surgery: systematic review and meta-analysis. Br J Anaesth 2018;120:37&#x2013;50.</Citation><ArticleIdList><ArticleId IdType="pubmed">29397135</ArticleId></ArticleIdList></Reference><Reference><Citation>Griffiths R, Alper J, Beckingsale A, et al. Management of proximal femoral fractures 2011: association of anaesthetists of Great Britain and Ireland. Anaesthesia 2012;67:85&#x2013;98.</Citation><ArticleIdList><ArticleId IdType="pubmed">22150501</ArticleId></ArticleIdList></Reference><Reference><Citation>Johansen A, Boulton C, Hertz K, et al. The National Hip Fracture Database (NHFD) &#x2013; using a national clinical audit to raise standards of nursing care. Int J Orthop Trauma Nurs 2017;26:3&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">28237620</ArticleId></ArticleIdList></Reference><Reference><Citation>Brauer CA, Coca-Perraillon M, Cutler DM, et al. Incidence and mortality of hip fractures in the United States. JAMA 2009;302:1573&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4410861</ArticleId><ArticleId IdType="pubmed">19826027</ArticleId></ArticleIdList></Reference><Reference><Citation>Seitz DP, Gill SS, Bell CM, et al. Postoperative medical complications associated with anesthesia in older adults with dementia. J Am Geriatr Soc 2014;62:2102&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">25370019</ArticleId></ArticleIdList></Reference><Reference><Citation>Desai V, Chan PH, Prentice HA, et al. Is anesthesia technique associated with a higher risk of mortality or complications within 90 days of surgery for geriatric patients with hip fractures? Clin Orthop Relat Res 2018;476:1178&#x2013;88.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6263607</ArticleId><ArticleId IdType="pubmed">29601378</ArticleId></ArticleIdList></Reference><Reference><Citation>Calvani R, Martone AM, Marzetti E, et al. Pre-hospital dietary intake correlates with muscle mass at the time of fracture in older hip fractured patients. Front Aging Neurosci 2014;6:1&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4236534</ArticleId><ArticleId IdType="pubmed">25477815</ArticleId></ArticleIdList></Reference><Reference><Citation>Neuman MD, Rosenbaum PR, Ludwig JM, et al. Anesthesia technique, mortality, and length of stay after hip fracture surgery. JAMA 2014;24:2508&#x2013;17.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4344128</ArticleId><ArticleId IdType="pubmed">25058085</ArticleId></ArticleIdList></Reference><Reference><Citation>Parker MJ, Griffiths R. General versus regional anaesthesia for hip fractures. A pilot randomised controlled trial of 322 patients. Injury 2015;46:1562&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">26049662</ArticleId></ArticleIdList></Reference><Reference><Citation>Luger TJ, Kammerlander C, Gosch M, et al. Neuroaxial versus general anaesthesia in geriatric patients for hip fracture surgery: does it matter? Osteoporos Int 2010;21:555&#x2013;72.</Citation><ArticleIdList><ArticleId IdType="pubmed">21057995</ArticleId></ArticleIdList></Reference><Reference><Citation>O&#x2019;Hara DA, Duff A, Berlin JA, et al. The effect of anesthetic technique on postoperative outcomes in hip fracture repair. Anesthesiology 2000;92:947&#x2013;57.</Citation><ArticleIdList><ArticleId IdType="pubmed">10754613</ArticleId></ArticleIdList></Reference><Reference><Citation>Johnson RL, Kopp SL, Burkle CM, et al. Neuraxial vs general anaesthesia for total hip and total knee arthroplasty: a systematic review of comparative-effectiveness research. Br J Anaesth 2016;116:163&#x2013;76.</Citation><ArticleIdList><ArticleId IdType="pubmed">26787787</ArticleId></ArticleIdList></Reference><Reference><Citation>White SM, Moppett IK, Griffiths R. Outcome by mode of anaesthesia for hip fracture surgery. An observational audit of 65 535 patients in a national dataset. Anaesthesia 2014;69:224&#x2013;30.</Citation><ArticleIdList><ArticleId IdType="pubmed">24428375</ArticleId></ArticleIdList></Reference><Reference><Citation>White SM, Altermatt F, Barry J, et al. International fragility fracture network delphi consensus statement on the principles of anaesthesia for patients with hip fracture. Anaesthesia 2018;73:863&#x2013;74.</Citation><ArticleIdList><ArticleId IdType="pubmed">29508382</ArticleId></ArticleIdList></Reference><Reference><Citation>Moher D, Shamseer L, Clarke M, et al. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement. Syst Rev 2015;4:1&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4320440</ArticleId><ArticleId IdType="pubmed">25554246</ArticleId></ArticleIdList></Reference><Reference><Citation>Liberati A, Altman DG, Tetzlaff J, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. BMJ 2009;339:b2700.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2714672</ArticleId><ArticleId IdType="pubmed">19622552</ArticleId></ArticleIdList></Reference><Reference><Citation> Wells GA, Shea B, O&#x2019;Connell D, et al. The Newcastle&#x2013;Ottawa Scale (NOS) for Assessing the Quality of Nonrandomised Studies in Meta-analyses. Available at:  http://wwwohrica/programs/clinicalepidemiology/oxfordasp. [Accessed May 5, 2012]</Citation></Reference><Reference><Citation>Higgins JP, Altman DG, G&#xf8;tzsche PC, et al. The Cochrane Collaboration's tool for assessing risk of bias in randomised trials. BMJ 2011;343:d5928.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3196245</ArticleId><ArticleId IdType="pubmed">22008217</ArticleId></ArticleIdList></Reference><Reference><Citation>Hekimo&#x11f;lu &#x15e;S, Heybeli N, &#xc7;olak A, et al. Comparison of different anesthetic techniques on postoperative outcomes in elderly patients with hip fracture. Turkiye Klin J Med Sci 2012;32:623&#x2013;9.</Citation></Reference><Reference><Citation>Biboulet P, Jourdan A, Van Haevre V, et al. Hemodynamic profile of target-controlled spinal anesthesia compared with 2 target-controlled general anesthesia techniques in elderly patients with cardiac comorbidities. Reg Anesth Pain Med 2012;37:433&#x2013;40.</Citation><ArticleIdList><ArticleId IdType="pubmed">22609644</ArticleId></ArticleIdList></Reference><Reference><Citation>Le-Wendling L, Bihorac A, Baslanti TO, et al. Regional anesthesia as compared with general anesthesia for surgery in geriatric patients with hip fracture: does it decrease morbidity, mortality, and health care costs? Results of a single-centered study. Pain Med 2012;13:948&#x2013;56.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3730262</ArticleId><ArticleId IdType="pubmed">22758782</ArticleId></ArticleIdList></Reference><Reference><Citation>Basques BA, Bohl DD, Golinvaux NS, et al. General versus spinal anaesthesia for patients aged 70 years and older with a fracture of the hip. Bone Jt J 2015;97-B:689&#x2013;95.</Citation><ArticleIdList><ArticleId IdType="pubmed">25922465</ArticleId></ArticleIdList></Reference><Reference><Citation>Chu CC, Weng SF, Chen KT, et al. Propensity score &#x2013; matched comparison of postoperative adverse outcomes between geriatric patients given a general or a neuraxial anesthetic for hip surgery: a population-based study. Anesthesiology 2015;123:136&#x2013;47.</Citation><ArticleIdList><ArticleId IdType="pubmed">25955981</ArticleId></ArticleIdList></Reference><Reference><Citation>Qiu C, Chan PH, Zohman GL, et al. Impact of anesthesia on hospital mortality and morbidities in geriatric patients following emergency hip fracture surgery. J Orthop Trauma 2018;32:116&#x2013;23.</Citation><ArticleIdList><ArticleId IdType="pubmed">29461445</ArticleId></ArticleIdList></Reference><Reference><Citation>Casati A, Aldegheri G, Vinciguerra E, et al. Randomized comparison between sevoflurane anaesthesia and unilateral spinal anaesthesia in elderly patients undergoing orthopaedic surgery. Eur J Anaesthesiol 2003;20:640&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">12932066</ArticleId></ArticleIdList></Reference><Reference><Citation>Fukuda T, Imai S, Nakadera M, et al. Postoperative daily living activities of geriatric patients administered general or spinal anesthesia for hip fracture surgery: a retrospective cohort study. J Orthop Surg (Hong Kong) 2018;26:1&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">29366390</ArticleId></ArticleIdList></Reference><Reference><Citation>Radcliff TA, Henderson WG, Stoner TJ, et al. Patient risk factors, operative care, and outcomes among older community-dwelling male veterans with hip fracture. J Bone Joint Surg Am 2008;90:34&#x2013;42.</Citation><ArticleIdList><ArticleId IdType="pubmed">18171955</ArticleId></ArticleIdList></Reference><Reference><Citation>Shih YJ, Hsieh CH, Kang TW, et al. General versus spinal anesthesia: which is a risk factor for octogenarian hip fracture repair patients? Int J Gerontol 2010;4:37&#x2013;42.</Citation></Reference><Reference><Citation>Guay J, Parker MJ, Gajendragadkar PR, et al. Anaesthesia for hip fracture surgery in adults. Cochrane Database Syst Rev 2016;2:CD000521.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6464323</ArticleId><ArticleId IdType="pubmed">26899415</ArticleId></ArticleIdList></Reference><Reference><Citation>Neuman MD, Silber JH, Elkassabany NM, et al. Comparative effectiveness of regional versus general anesthesia for hip fracture surgery in adults. Anesthesiology 2012;117:72&#x2013;92.</Citation><ArticleIdList><ArticleId IdType="pubmed">22713634</ArticleId></ArticleIdList></Reference><Reference><Citation>Sieber FE, Gottshalk A, Zakriya KJ, et al. General anesthesia occurs frequently in elderly patients during propofol-based sedation and spinal anesthesia. J Clin Anesth 2010;22:179&#x2013;83.</Citation><ArticleIdList><ArticleId IdType="pubmed">20400003</ArticleId></ArticleIdList></Reference><Reference><Citation>Memtsoudis SG, Poeran J, Zubizarreta N, et al. Do hospitals performing frequent neuraxial anesthesia for hip and knee replacements have better outcomes? Anesthesiology 2018;129:428&#x2013;39.</Citation><ArticleIdList><ArticleId IdType="pubmed">29878899</ArticleId></ArticleIdList></Reference><Reference><Citation>Mak JC, Cameron ID, March LM. Evidence-based guidelines for the management of hip fractures in older persons: an update. Med J Aust 2010;192:37&#x2013;41.</Citation><ArticleIdList><ArticleId IdType="pubmed">20047547</ArticleId></ArticleIdList></Reference><Reference><Citation>Kowark A, Adam C, Ahrens J, et al. Improve hip fracture outcome in the elderly patient (iHOPE): a study protocol for a pragmatic, multicentre randomised controlled trial to test the efficacy of spinal versus general anaesthesia. BMJ Open 2018;8:e023609.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6196806</ArticleId><ArticleId IdType="pubmed">30341135</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">33658055</PMID><DateCompleted><Year>2021</Year><Month>09</Month><Day>07</Day></DateCompleted><DateRevised><Year>2021</Year><Month>09</Month><Day>07</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1749-799X</ISSN><JournalIssue CitedMedium="Internet"><Volume>16</Volume><Issue>1</Issue><PubDate><Year>2021</Year><Month>Mar</Month><Day>03</Day></PubDate></JournalIssue><Title>Journal of orthopaedic surgery and research</Title><ISOAbbreviation>J Orthop Surg Res</ISOAbbreviation></Journal><ArticleTitle>Hemiarthroplasty compared to total hip arthroplasty for the treatment of femoral neck fractures: a systematic review and meta-analysis.</ArticleTitle><Pagination><StartPage>172</StartPage><MedlinePgn>172</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">172</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s13018-020-02186-4</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Hip replacement is divided into total hip arthroplasty (THA) and hemiarthroplasty (HA); it is still controversial whether to choose THA or HA for femoral neck fractures (FNF). The goal of this study was to review relevant studies in order to determine the HA compared to THA for the treatment of FNF.</AbstractText><AbstractText Label="PATIENTS AND METHODS" NlmCategory="METHODS">Using appropriate keywords, we identified relevant studies using PubMed, Cochrane, and Embase. Key pertinent sources in the literature were also reviewed, and all articles published through August 2019 were considered for inclusion. For each study, we assessed odds ratios (ORs), mean difference (MD), and 95% confidence interval (95% CI) to assess and synthesize outcomes.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">We included 19 studies with a total of 413,140 patients in the HA group and 44973 in the THA group. The blood loss, surgery time, and dislocation were all significantly decreased in the HA group than the THA group. The length of hospital, pneumonia, and renal failure were significant increased in the HA group than THA group. There has no significant difference of complication, mortality, reoperation, infection, pulmonary embolism, and myocardial infarct between the two groups.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">HA has favor in decrease blood loss and surgery time. THA has favor in decrease the length of hospital, the incidence of pneumonia and renal failure. For the selection of surgical methods for femoral neck fracture in the elderly, we should consider several aspects, such as the age of the patient, whether there is osteoporosis, the type of femoral neck fracture, the preoperative reduction situation, and the needs of the patient and his family for the postoperative situation.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Xinbo</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Trauma Orthopedics Ward 1, Ningbo No. 6 Hospital, No. 1059, Zhongshan East Road, Dongliu Street, Yinzhou District, Ningbo City, 315040, Zhejiang Province, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Luo</LastName><ForeName>Jianning</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0002-0549-1158</Identifier><AffiliationInfo><Affiliation>Trauma Orthopedics Ward 2, Ningbo No. 6 Hospital, No. 1059, Zhongshan East Road, Dongliu Street, Yinzhou District, Ningbo City, 315040, Zhejiang Province, China. yyljn20201001@163.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D003160">Comparative Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>03</Month><Day>03</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>J Orthop Surg Res</MedlineTA><NlmUniqueID>101265112</NlmUniqueID><ISSNLinking>1749-799X</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>J Orthop Surg Res. 2021 May 20;16(1):328. doi: 10.1186/s13018-021-02490-7.</RefSource><PMID Version="1">34016151</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000367" MajorTopicYN="N">Age Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019644" MajorTopicYN="Y">Arthroplasty, Replacement, Hip</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016063" MajorTopicYN="N">Blood Loss, Surgical</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005265" MajorTopicYN="N">Femoral Neck Fractures</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D062785" MajorTopicYN="Y">Hemiarthroplasty</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007902" MajorTopicYN="N">Length of Stay</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D061646" MajorTopicYN="N">Operative Time</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010024" MajorTopicYN="N">Osteoporosis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011014" MajorTopicYN="N">Pneumonia</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D051437" MajorTopicYN="N">Renal Insufficiency</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Femoral neck fractures</Keyword><Keyword MajorTopicYN="N">Hemiarthroplasty</Keyword><Keyword MajorTopicYN="N">Meta-analysis</Keyword><Keyword MajorTopicYN="N">Total hip arthroplasty</Keyword></KeywordList><CoiStatement>The authors declare that they have no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>10</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>12</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>3</Month><Day>4</Day><Hour>5</Hour><Minute>34</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>3</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>9</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2021</Year><Month>3</Month><Day>3</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33658055</ArticleId><ArticleId IdType="pmc">PMC7931515</ArticleId><ArticleId IdType="doi">10.1186/s13018-020-02186-4</ArticleId><ArticleId IdType="pii">10.1186/s13018-020-02186-4</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Guyen O. Hemiarthroplasty or total hip arthroplasty in recent femoral neck fractures? Orthop Traumatol Surg Res. 2019;105(1):95&#x2013;101. doi: 10.1016/j.otsr.2018.04.034.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.otsr.2018.04.034</ArticleId><ArticleId IdType="pubmed">30449680</ArticleId></ArticleIdList></Reference><Reference><Citation>Florschutz AV, Langford JR, Haidukewych GJ, Koval KJ. Femoral neck fractures: current management. J Orthop Trauma. 2015;29(3):121&#x2013;129. doi: 10.1097/BOT.0000000000000291.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/BOT.0000000000000291</ArticleId><ArticleId IdType="pubmed">25635363</ArticleId></ArticleIdList></Reference><Reference><Citation>Miller BJ, Callaghan JJ, Cram P, Karam M, Marsh JL, Noiseux NO. Changing trends in the treatment of femoral neck fractures: a review of the American Board of Orthopaedic surgery database. J Bone Joint Surg Am. 2014;96(17):e149. doi: 10.2106/JBJS.M.01122.</Citation><ArticleIdList><ArticleId IdType="doi">10.2106/JBJS.M.01122</ArticleId><ArticleId IdType="pubmed">25187593</ArticleId></ArticleIdList></Reference><Reference><Citation>Riggs BL, Melton LJ., 3rd The worldwide problem of osteoporosis: insights afforded by epidemiology. Bone. 1995;17(5):505&#x2013;511. doi: 10.1016/8756-3282(95)00258-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/8756-3282(95)00258-4</ArticleId><ArticleId IdType="pubmed">8573428</ArticleId></ArticleIdList></Reference><Reference><Citation>Kannan A, Kancherla R, McMahon S, Hawdon G, Soral A, Malhotra R. Arthroplasty options in femoral-neck fracture: answers from the national registries. Int Orthop. 2012;36(1):1&#x2013;8. doi: 10.1007/s00264-011-1354-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00264-011-1354-z</ArticleId><ArticleId IdType="pmc">PMC3251685</ArticleId><ArticleId IdType="pubmed">21931966</ArticleId></ArticleIdList></Reference><Reference><Citation>Mukka S, Sj&#xf6;holm P, Chammout G, Kelly-Pettersson P, Sayed-Noor AS, Sk&#xf6;ldenberg O. External validity of the HOPE-trial: hemiarthroplasty compared with total hip arthroplasty for displaced femoral neck fractures in octogenarians. JB JS Open Access. 2019;4(2):e0061. doi: 10.2106/JBJS.OA.18.00061.</Citation><ArticleIdList><ArticleId IdType="doi">10.2106/JBJS.OA.18.00061</ArticleId><ArticleId IdType="pmc">PMC6613851</ArticleId><ArticleId IdType="pubmed">31334467</ArticleId></ArticleIdList></Reference><Reference><Citation>Chammout G, Kelly-Pettersson P, Hedbeck CJ, Stark A, Mukka S, Sk&#xf6;ldenberg O. HOPE-Trial: hemiarthroplasty compared with total hip arthroplasty for displaced femoral neck fractures in octogenarians: a randomized controlled trial. JB JS Open Access. 2019;4(2):e0059. doi: 10.2106/JBJS.OA.18.00059.</Citation><ArticleIdList><ArticleId IdType="doi">10.2106/JBJS.OA.18.00059</ArticleId><ArticleId IdType="pmc">PMC6613852</ArticleId><ArticleId IdType="pubmed">31334466</ArticleId></ArticleIdList></Reference><Reference><Citation>Ukaj S, Zhuri O, Ukaj F, Podvorica V, Grezda K, Caton J, et al. Dual mobility acetabular cup versus hemiarthroplasty in treatment of displaced femoral neck fractures in elderly patients: comparative study and results at minimum 3-year follow-up. Geriatr Orthop Surg Rehabil. 2019;10:2151459319848610. doi: 10.1177/2151459319848610.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/2151459319848610</ArticleId><ArticleId IdType="pmc">PMC6540477</ArticleId><ArticleId IdType="pubmed">31192026</ArticleId></ArticleIdList></Reference><Reference><Citation>Ravi B, Pincus D, Khan H, Wasserstein D, Jenkinson R, Kreder HJ. Comparing complications and costs of total hip arthroplasty and hemiarthroplasty for femoral neck fractures: a propensity score-matched, population-based study. J Bone Joint Surg Am. 2019;101(7):572&#x2013;579. doi: 10.2106/JBJS.18.00539.</Citation><ArticleIdList><ArticleId IdType="doi">10.2106/JBJS.18.00539</ArticleId><ArticleId IdType="pubmed">30946190</ArticleId></ArticleIdList></Reference><Reference><Citation>Eskildsen SM, Kamath GV, Del Gaizo DJ. Age matters when comparing hemiarthroplasty and total hip arthroplasty for femoral neck fractures in Medicare patients. Hip Int. 2019;29(6):674&#x2013;679. doi: 10.1177/1120700018816924.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1120700018816924</ArticleId><ArticleId IdType="pubmed">30526123</ArticleId></ArticleIdList></Reference><Reference><Citation>Johnson JP, Kleiner J, Goodman AD, Gil JA, Daniels AH, Hayda RA. Treatment of femoral neck fractures in patients 45-64&#x2009;years of age. Injury. 2019;50(3):708&#x2013;712. doi: 10.1016/j.injury.2018.11.020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.injury.2018.11.020</ArticleId><ArticleId IdType="pubmed">30471942</ArticleId></ArticleIdList></Reference><Reference><Citation>Bar&#x131;&#x15f;han FC, Akesen B, At&#x131;c&#x131; T, Durak K, Bilgen MS. Comparison of hemiarthroplasty and total hip arthroplasty in elderly patients with displaced femoral neck fractures. J Int Med Res. 2018;46(7):2717&#x2013;2730. doi: 10.1177/0300060518770354.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0300060518770354</ArticleId><ArticleId IdType="pmc">PMC6124276</ArticleId><ArticleId IdType="pubmed">29708038</ArticleId></ArticleIdList></Reference><Reference><Citation>Boukebous B, Boutroux P, Zahi R, Azmy C, Guillon P. Comparison of dual mobility total hip arthroplasty and bipolar arthroplasty for femoral neck fractures: a retrospective case-control study of 199 hips. Orthop Traumatol Surg Res. 2018;104(3):369&#x2013;375. doi: 10.1016/j.otsr.2018.01.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.otsr.2018.01.006</ArticleId><ArticleId IdType="pubmed">29454973</ArticleId></ArticleIdList></Reference><Reference><Citation>Fuchs M, Sass FA, Dietze S, Kr&#xe4;mer M, Perka C, M&#xfc;ller M. Cemented hemiarthroplasties are associated with a higher mortality rate after femoral neck fractures in elderly patients. Cementovan&#xe9; hemiartroplastiky u zlomenin kr&#x10d;ku femuru star&#x161;&#xed;ch pacient&#x16f; jsou spojeny s vy&#x161;&#x161;&#xed; &#xfa;mrtnost&#xed;. Acta Chir Orthop Traumatol Cech. 2017;84(5):341&#x2013;346.</Citation><ArticleIdList><ArticleId IdType="pubmed">29351534</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim YT, Yoo JH, Kim MK, Kim S, Hwang J. Dual mobility hip arthroplasty provides better outcomes compared to hemiarthroplasty for displaced femoral neck fractures: a retrospective comparative clinical study. Int Orthop. 2018;42(6):1241&#x2013;1246. doi: 10.1007/s00264-018-3767-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00264-018-3767-4</ArticleId><ArticleId IdType="pubmed">29344700</ArticleId></ArticleIdList></Reference><Reference><Citation>Bartels S, Gjertsen JE, Frihagen F, Rogmark C, Utv&#xe5;g SE. High failure rate after internal fixation and beneficial outcome after arthroplasty in treatment of displaced femoral neck fractures in patients between 55 and 70&#x2009;years. Acta Orthop. 2018;89(1):53&#x2013;58. doi: 10.1080/17453674.2017.1376514.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/17453674.2017.1376514</ArticleId><ArticleId IdType="pmc">PMC5810833</ArticleId><ArticleId IdType="pubmed">28914130</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Z, Bhattacharyya T. Outcomes of hemiarthroplasty and total hip arthroplasty for femoral neck fracture: a Medicare Cohort Study. J Orthop Trauma. 2017;31(5):260&#x2013;263. doi: 10.1097/BOT.0000000000000814.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/BOT.0000000000000814</ArticleId><ArticleId IdType="pmc">PMC5407395</ArticleId><ArticleId IdType="pubmed">28431409</ArticleId></ArticleIdList></Reference><Reference><Citation>Liodakis E, Antoniou J, Zukor DJ, Huk OL, Epure LM, Bergeron SG. Major complications and transfusion rates after hemiarthroplasty and total hip arthroplasty for femoral neck fractures. J Arthroplasty. 2016;31(9):2008&#x2013;2012. doi: 10.1016/j.arth.2016.02.019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.arth.2016.02.019</ArticleId><ArticleId IdType="pubmed">26975602</ArticleId></ArticleIdList></Reference><Reference><Citation>Miller CP, Buerba RA, Leslie MP. Preoperative factors and early complications associated with hemiarthroplasty and total hip arthroplasty for displaced femoral neck fractures. Geriatr Orthop Surg Rehabil. 2014;5(2):73&#x2013;81. doi: 10.1177/2151458514528951.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/2151458514528951</ArticleId><ArticleId IdType="pmc">PMC4212369</ArticleId><ArticleId IdType="pubmed">25360335</ArticleId></ArticleIdList></Reference><Reference><Citation>Park KS, Oh CS, Yoon TR. Comparison of minimally invasive total hip arthroplasty versus conventional hemiarthroplasty for displaced femoral neck fractures in active elderly patients. Chonnam Med J. 2013;49(2):81&#x2013;86. doi: 10.4068/cmj.2013.49.2.81.</Citation><ArticleIdList><ArticleId IdType="doi">10.4068/cmj.2013.49.2.81</ArticleId><ArticleId IdType="pmc">PMC3759687</ArticleId><ArticleId IdType="pubmed">24010071</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu YJ, Xu B, Li ZY, Zhang Q, Zhang YZ. Quantitative score system for the surgical decision on adult femoral neck fractures. Orthopedics. 2012;35(2):e137&#x2013;e143.</Citation><ArticleIdList><ArticleId IdType="pubmed">22310396</ArticleId></ArticleIdList></Reference><Reference><Citation>Hedbeck CJ, Enocson A, Lapidus G, Blomfeldt R, T&#xf6;rnkvist H, Ponzer S, et al. Comparison of bipolar hemiarthroplasty with total hip arthroplasty for displaced femoral neck fractures: a concise four-year follow-up of a randomized trial. J Bone Joint Surg Am. 2011;93(5):445&#x2013;450. doi: 10.2106/JBJS.J.00474.</Citation><ArticleIdList><ArticleId IdType="doi">10.2106/JBJS.J.00474</ArticleId><ArticleId IdType="pubmed">21368076</ArticleId></ArticleIdList></Reference><Reference><Citation>Macaulay W, Nellans KW, Iorio R, Garvin KL, Healy WL, Rosenwasser MP, et al. Total hip arthroplasty is less painful at 12 months compared with hemiarthroplasty in treatment of displaced femoral neck fracture. HSS J. 2008;4(1):48&#x2013;54. doi: 10.1007/s11420-007-9061-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11420-007-9061-4</ArticleId><ArticleId IdType="pmc">PMC2504272</ArticleId><ArticleId IdType="pubmed">18751862</ArticleId></ArticleIdList></Reference><Reference><Citation>Gebhard JS, Amstutz HC, Zinar DM, Dorey FJ. A comparison of total hip arthroplasty and hemiarthroplasty for treatment of acute fracture of the femoral neck. Clin Orthop Relat Res. 1992;282:123-131.</Citation><ArticleIdList><ArticleId IdType="pubmed">1516303</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">34049258</PMID><DateCompleted><Year>2021</Year><Month>10</Month><Day>18</Day></DateCompleted><DateRevised><Year>2022</Year><Month>03</Month><Day>02</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1557-8615</ISSN><JournalIssue CitedMedium="Internet"><Volume>64</Volume><PubDate><Year>2021</Year><Month>Aug</Month></PubDate></JournalIssue><Title>Journal of critical care</Title><ISOAbbreviation>J Crit Care</ISOAbbreviation></Journal><ArticleTitle>Survival of patients with acute pulmonary embolism treated with venoarterial extracorporeal membrane oxygenation: A systematic review and meta-analysis.</ArticleTitle><Pagination><StartPage>245</StartPage><EndPage>254</EndPage><MedlinePgn>245-254</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jcrc.2021.03.006</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0883-9441(21)00053-8</ELocationID><Abstract><AbstractText Label="BACKGROUND">To examine whether venoarterial extracorporeal membrane oxygenation (VA-ECMO) improves survival of patients with acute pulmonary embolism (PE).</AbstractText><AbstractText Label="METHODS">Following the PRISMA guidelines, a systematic search was conducted up to August 2019 of the databases: PubMed/MEDLINE, EMBASE and Cochrane. All studies reporting the survival of adult patients with acute PE treated with VA-ECMO and including four patients or more were included. Exclusion criteria were: correspondences, reviews and studies in absence of a full text, written in other languages than English or Dutch, or dating before 1980. Short-term (hospital or 30-day) survival data were pooled and presented with relative risks (RR) and 95% confidence intervals (95% CI). Also, the following pre-defined factors were evaluated for their association with survival in VA-ECMO treated patients: age &gt; 60 years, male sex, pre-ECMO cardiac arrest, surgical embolectomy, catheter directed therapy, systemic thrombolysis, and VA-ECMO as single therapy.</AbstractText><AbstractText Label="RESULTS">A total of 29 observational studies were included (N = 1947 patients: VA-ECMO N = 1138 and control N = 809). There was no difference in short-term survival between VA-ECMO treated patients and control patients (RR 0.91, 95% CI 0.71-1.16). In acute PE patients undergoing VA-ECMO, age &gt; 60 years was associated with lower survival (RR 0.72, 95% CI 0.52-0.99), surgical embolectomy was associated with higher survival (RR 1.96, 95% CI 1.39-2.76) and pre-ECMO cardiac arrest showed a trend toward lower survival (RR 0.88, 95% CI 0.77-1.01). The other evaluated factors were not associated with a difference in survival.</AbstractText><AbstractText Label="CONCLUSIONS">At present, there is insufficient evidence that VA-ECMO treatment improves short-term survival of acute PE patients. Low quality evidence suggest that VA-ECMO patients aged &#x2264;60 years or who received SE have higher survival rates. Considering the limited evidence derived from the present data, this study emphasizes the need for prospective studies.</AbstractText><AbstractText Label="PROTOCOL REGISTRATION">PROSPERO CRD42019120370.</AbstractText><CopyrightInformation>Copyright &#xa9; 2021 The Authors. Published by Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Karami</LastName><ForeName>Mina</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Heart Center; Department of Cardiology, Amsterdam Cardiovascular Sciences, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mandigers</LastName><ForeName>Loes</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Intensive Care Medicine, Erasmus University Medical Center, Rotterdam, the Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Miranda</LastName><ForeName>Dinis Dos Reis</ForeName><Initials>DDR</Initials><AffiliationInfo><Affiliation>Department of Intensive Care Medicine, Erasmus University Medical Center, Rotterdam, the Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rietdijk</LastName><ForeName>Wim J R</ForeName><Initials>WJR</Initials><AffiliationInfo><Affiliation>Department of Intensive Care Medicine, Erasmus University Medical Center, Rotterdam, the Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Binnekade</LastName><ForeName>Jan M</ForeName><Initials>JM</Initials><AffiliationInfo><Affiliation>Department of Intensive Care Medicine, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Knijn</LastName><ForeName>Dani&#xeb;lle C M</ForeName><Initials>DCM</Initials><AffiliationInfo><Affiliation>Department of Intensive Care Medicine, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lagrand</LastName><ForeName>Wim K</ForeName><Initials>WK</Initials><AffiliationInfo><Affiliation>Department of Intensive Care Medicine, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>den Uil</LastName><ForeName>Corstiaan A</ForeName><Initials>CA</Initials><AffiliationInfo><Affiliation>Department of Intensive Care Medicine, Erasmus University Medical Center, Rotterdam, the Netherlands; Department of Cardiology, Erasmus University Medical Center, Rotterdam, the Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Henriques</LastName><ForeName>Jos&#xe9; P S</ForeName><Initials>JPS</Initials><AffiliationInfo><Affiliation>Heart Center; Department of Cardiology, Amsterdam Cardiovascular Sciences, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vlaar</LastName><ForeName>Alexander P J</ForeName><Initials>APJ</Initials><AffiliationInfo><Affiliation>Department of Intensive Care Medicine, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands. Electronic address: a.p.vlaar@amsterdamumc.nl.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><CollectiveName>DUTCH ECLS Study Group</CollectiveName></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>03</Month><Day>24</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Crit Care</MedlineTA><NlmUniqueID>8610642</NlmUniqueID><ISSNLinking>0883-9441</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>J Crit Care. 2022 Feb;67:223-224. doi: 10.1016/j.jcrc.2021.11.002.</RefSource><PMID Version="1">34782186</PMID></CommentsCorrections><CommentsCorrections RefType="CommentIn"><RefSource>J Crit Care. 2022 Feb;67:225-226. doi: 10.1016/j.jcrc.2021.11.003.</RefSource><PMID Version="1">34794835</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000208" MajorTopicYN="N">Acute Disease</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015199" MajorTopicYN="Y">Extracorporeal Membrane Oxygenation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006323" MajorTopicYN="Y">Heart Arrest</DescriptorName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011655" MajorTopicYN="Y">Pulmonary Embolism</DescriptorName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Cardiac arrest</Keyword><Keyword MajorTopicYN="N">ECPR</Keyword><Keyword MajorTopicYN="N">Extracorporeal life support</Keyword><Keyword MajorTopicYN="N">Extracorporeal membrane oxygenation</Keyword><Keyword MajorTopicYN="N">Hemodynamic instability</Keyword><Keyword MajorTopicYN="N">Pulmonary embolism</Keyword></KeywordList><CoiStatement>Declaration of Competing Interest The authors declare that they have no competing interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>6</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2020</Year><Month>12</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>3</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>5</Month><Day>29</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>10</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>5</Month><Day>28</Day><Hour>20</Hour><Minute>29</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34049258</ArticleId><ArticleId IdType="doi">10.1016/j.jcrc.2021.03.006</ArticleId><ArticleId IdType="pii">S0883-9441(21)00053-8</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">39423670</PMID><DateCompleted><Year>2024</Year><Month>11</Month><Day>30</Day></DateCompleted><DateRevised><Year>2024</Year><Month>11</Month><Day>30</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1879-0267</ISSN><JournalIssue CitedMedium="Internet"><Volume>55</Volume><Issue>12</Issue><PubDate><Year>2024</Year><Month>Dec</Month></PubDate></JournalIssue><Title>Injury</Title><ISOAbbreviation>Injury</ISOAbbreviation></Journal><ArticleTitle>Incidence of deep vein thrombosis and pulmonary embolism in closed foot and ankle fractures treated with conservative versus surgical management: A nationwide analysis.</ArticleTitle><Pagination><StartPage>111859</StartPage><MedlinePgn>111859</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.injury.2024.111859</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0020-1383(24)00588-6</ELocationID><Abstract><AbstractText Label="OBJECTIVES" NlmCategory="OBJECTIVE">Though there is extensive research on recovery and outcomes of proximal joint fractures, such as hip and knee, there is a paucity of such research in foot and ankle fractures and a lack of uniform data on the incidence of venous thromboembolism (VTE). This is a retrospective cohort study that seeks to investigate the incidence of VTE following surgically versus conservatively treated foot and ankle fractures METHODS: This study included all adult-patient hospitalizations with International Classification of Disease 10th Revision diagnosis codes related to closed foot and ankle fractures as a primary diagnosis in the National Inpatient Sample, an administrative database part of the Healthcare Cost and Utilization Project, for a total of 209,595 cases. Multivariate binary logistic regression was performed to determine the effect of age, gender, past medical history of venous thromboembolism (PMHVTE), Charlson Comorbidity Index, race, surgery, and transfusion of red cell products on the incidence of deep venous thrombosis (DVT) and pulmonary embolism (PE).</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Our study found an overall incidence of DVT and PE to be 0.4 % and 0.3 %, respectively, following foot or ankle fracture. Conservative management was found to have an increased relative risk of DVT and PE of 2.02 and 1.15, respectively. This difference persisted on performing inverse probability treatment weighting (IPTW) analysis to account for confounders. PMHVTE and requirement of blood transfusion was associated with an increased odds ratio (OR) of 3.41 and 3.217, respectively. Cases identified as Black and Asian/Pacific Islander also had an increased OR of DVT.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">The results of this study demonstrate that surgical management of foot and ankle fractures is associated with a lower relative risk of VTE compared to medical management. PMHVTE and transfusion of red cell products increase the odds of VTE following either form of intervention.</AbstractText><CopyrightInformation>Copyright &#xa9; 2024 Elsevier Ltd. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Kohli</LastName><ForeName>Meera</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Thomas Jefferson University Hospital - Philadelphia, PA, USA. Electronic address: mxk430@jefferson.edu.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Atodaria</LastName><ForeName>Kuldeepsinh P</ForeName><Initials>KP</Initials><AffiliationInfo><Affiliation>Internal Medicine, Jefferson Health - Abington, PA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Patel</LastName><ForeName>Rajeshkumar</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Pulmonology, Jefferson Health - Abington, PA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Brahmabhatt</LastName><ForeName>Shyam</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Rothman Orthopaedics - Willow Grove, PA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Goyal</LastName><ForeName>Aakash R</ForeName><Initials>AR</Initials><AffiliationInfo><Affiliation>Internal Medicine, Crozer Medical Center - Chester, PA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Raval</LastName><ForeName>Neha</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Vanita Vishram Women's University - Gujurat, India.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D003160">Comparative Study</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>09</Month><Day>14</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Injury</MedlineTA><NlmUniqueID>0226040</NlmUniqueID><ISSNLinking>0020-1383</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011655" MajorTopicYN="Y">Pulmonary Embolism</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015994" MajorTopicYN="N">Incidence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D064386" MajorTopicYN="Y">Ankle Fractures</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020246" MajorTopicYN="Y">Venous Thrombosis</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000072700" MajorTopicYN="Y">Conservative Treatment</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014481" MajorTopicYN="N" Type="Geographic">United States</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005596" MajorTopicYN="N">Fractures, Closed</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018409" MajorTopicYN="N">Foot Injuries</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Deep venous thrombosis</Keyword><Keyword MajorTopicYN="N">Foot and ankle fracture</Keyword><Keyword MajorTopicYN="N">Orthopaedics</Keyword><Keyword MajorTopicYN="N">Pulmonary embolism</Keyword><Keyword MajorTopicYN="N">Trauma</Keyword><Keyword MajorTopicYN="N">Venous thromboembolism</Keyword></KeywordList><CoiStatement>Declaration of competing interest None.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>8</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>8</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>9</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>12</Month><Day>1</Day><Hour>15</Hour><Minute>22</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>19</Day><Hour>16</Hour><Minute>23</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>18</Day><Hour>18</Hour><Minute>6</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39423670</ArticleId><ArticleId IdType="doi">10.1016/j.injury.2024.111859</ArticleId><ArticleId IdType="pii">S0020-1383(24)00588-6</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">29198992</PMID><DateCompleted><Year>2018</Year><Month>08</Month><Day>17</Day></DateCompleted><DateRevised><Year>2018</Year><Month>08</Month><Day>17</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1873-3492</ISSN><JournalIssue CitedMedium="Internet"><Volume>477</Volume><PubDate><Year>2018</Year><Month>Feb</Month></PubDate></JournalIssue><Title>Clinica chimica acta; international journal of clinical chemistry</Title><ISOAbbreviation>Clin Chim Acta</ISOAbbreviation></Journal><ArticleTitle>Cardiac troponin and adverse outcomes in atrial fibrillation: A meta-analysis.</ArticleTitle><Pagination><StartPage>48</StartPage><EndPage>52</EndPage><MedlinePgn>48-52</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.cca.2017.11.040</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0009-8981(17)30483-7</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">The prognostic value of cardiac troponin elevation in atrial fibrillation (AF) is unclear.</AbstractText><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">To investigate the association of cardiac troponin elevation with adverse outcomes in AF by conducting a meta-analysis.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">We systematically searched the PubMed and Embase databases until April 2017 for studies assessing the association of cardiac troponin-T (cTnT) or troponin-I (cTnI) elevation with adverse outcomes in AF. The outcome measures were all-cause mortality and major adverse cardiac events (MACEs: death, stroke, myocardial infarction, pulmonary embolism, major bleeding, or revascularization).</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Six studies involving 22,697 AF patients were identified. Meta-analysis showed that AF with elevated cardiac troponin was independently associated with increased risk of all-cause mortality (HR 2.04; 95% CI 1.56-2.67) and MACEs (HR 1.93; 95% CI 1.61-2.30). Furthermore, the prognostic value of cardiac troponin elevation was consistently found irrespective of method determination, type of troponin measured, sample size, and study quality subgroup.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">AF with cardiac troponin elevation was independently associated with increased risk of all-cause mortality and MACEs. Therefore, determination of troponin should be considered for risk stratification in AF.</AbstractText><CopyrightInformation>Copyright &#xa9; 2017 Elsevier B.V. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Fan</LastName><ForeName>Yichuan</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Vascular and Thyroid Surgery, The First Affiliated Hospital, China Medical University, Shenyang 110001, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhao</LastName><ForeName>Xingzhi</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Vascular and Thyroid Surgery, The First Affiliated Hospital, China Medical University, Shenyang 110001, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Xiaodong</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Vascular and Thyroid Surgery, The First Affiliated Hospital, China Medical University, Shenyang 110001, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Nan</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Vascular and Thyroid Surgery, The First Affiliated Hospital, China Medical University, Shenyang 110001, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hu</LastName><ForeName>Xinhua</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Vascular and Thyroid Surgery, The First Affiliated Hospital, China Medical University, Shenyang 110001, China. Electronic address: xinhuahu@126.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2017</Year><Month>12</Month><Day>02</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Clin Chim Acta</MedlineTA><NlmUniqueID>1302422</NlmUniqueID><ISSNLinking>0009-8981</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015415">Biomarkers</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D019210">Troponin I</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D020107">Troponin T</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001281" MajorTopicYN="N">Atrial Fibrillation</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015415" MajorTopicYN="N">Biomarkers</DescriptorName><QualifierName UI="Q000032" MajorTopicYN="N">analysis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019210" MajorTopicYN="N">Troponin I</DescriptorName><QualifierName UI="Q000032" MajorTopicYN="Y">analysis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020107" MajorTopicYN="N">Troponin T</DescriptorName><QualifierName UI="Q000032" MajorTopicYN="Y">analysis</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Atrial fibrillation</Keyword><Keyword MajorTopicYN="N">Cardiac troponin</Keyword><Keyword MajorTopicYN="N">Major adverse cardiac events</Keyword><Keyword MajorTopicYN="N">Meta-analysis</Keyword><Keyword MajorTopicYN="N">all-cause mortality</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>8</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2017</Year><Month>11</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2017</Year><Month>11</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2017</Year><Month>12</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>8</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2017</Year><Month>12</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29198992</ArticleId><ArticleId IdType="doi">10.1016/j.cca.2017.11.040</ArticleId><ArticleId IdType="pii">S0009-8981(17)30483-7</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">39621062</PMID><DateCompleted><Year>2024</Year><Month>12</Month><Day>02</Day></DateCompleted><DateRevised><Year>2024</Year><Month>12</Month><Day>02</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1434-3916</ISSN><JournalIssue CitedMedium="Internet"><Volume>145</Volume><Issue>1</Issue><PubDate><Year>2024</Year><Month>Dec</Month><Day>02</Day></PubDate></JournalIssue><Title>Archives of orthopaedic and trauma surgery</Title><ISOAbbreviation>Arch Orthop Trauma Surg</ISOAbbreviation></Journal><ArticleTitle>Thrombotic events in patients underwent simultaneous bilateral total knee arthroplasty with modern perioperative blood management strategy.</ArticleTitle><Pagination><StartPage>2</StartPage><MedlinePgn>2</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s00402-024-05624-8</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Thrombotic events, the leading cause of death after total knee arthroplasty (TKA), occurred more frequently in simultaneous bilateral TKA than unilateral TKA under conventional perioperative management. The aim of the study was to determine whether the simultaneous bilateral TKA using contemporary blood management strategies would be associated with higher risk of thrombotic events than unilateral TKA.</AbstractText><AbstractText Label="METHOD" NlmCategory="METHODS">This propensity score-matched cohort study included 1,069 patients, with 324 undergoing simultaneous bilateral TKA and 745 undergoing unilateral TKA. All TKAs were performed without use of a tourniquet and with use of intravenous tranexamic acid administration. For patients receiving chronic antithrombotic therapy, the antithrombotic medications were continued during the perioperative period, including on the day of the operation. The primary outcome was the thrombotic events up to 1 year after TKA.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">The propensity score-matched cohort consisted of 324 matched pairs of patients. There was no significant difference between simultaneous bilateral and unilateral TKA groups in the occurrence of the thrombotic events (25 of 324 [7.7%] versus 19 of 324 [5.9%] patients, p&#x2009;=&#x2009;0.44). Additionally, no significant differences were found in the occurrence of the bleeding events (1 of 324 [0.3%] versus 1 of 324 [0.3%] patients, p&#x2009;&gt;&#x2009;0.99) and death within the postoperative 1 year (1 of 324 [0.3%] versus 3 of 324 [0.9%] patients, p&#x2009;=&#x2009;0.62).</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">The rate of thrombotic events after simultaneous bilateral TKA with contemporary perioperative blood management strategies did not significantly differ from that after unilateral TKA.</AbstractText><CopyrightInformation>&#xa9; 2024. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Tsukada</LastName><ForeName>Sachiyuki</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0002-1186-5232</Identifier><AffiliationInfo><Affiliation>Department of Orthopaedic Surgery, Hokusuikai Kinen Hospital, 3-2-1 Higashihara, Mito, 310-0035, Ibaraki, Japan. s8058@nms.ac.jp.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Saito</LastName><ForeName>Masayoshi</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Orthopaedic Surgery, Hokusuikai Kinen Hospital, 3-2-1 Higashihara, Mito, 310-0035, Ibaraki, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ogawa</LastName><ForeName>Hiroyuki</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Orthopaedic Surgery, Hokusuikai Kinen Hospital, 3-2-1 Higashihara, Mito, 310-0035, Ibaraki, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nishino</LastName><ForeName>Masahiro</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Orthopaedic Surgery, Hokusuikai Kinen Hospital, 3-2-1 Higashihara, Mito, 310-0035, Ibaraki, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hirasawa</LastName><ForeName>Naoyuki</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Orthopaedic Surgery, Hokusuikai Kinen Hospital, 3-2-1 Higashihara, Mito, 310-0035, Ibaraki, Japan.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>12</Month><Day>02</Day></ArticleDate></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>Arch Orthop Trauma Surg</MedlineTA><NlmUniqueID>9011043</NlmUniqueID><ISSNLinking>0936-8051</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>6T84R30KC1</RegistryNumber><NameOfSubstance UI="D014148">Tranexamic Acid</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000933">Antifibrinolytic Agents</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019645" MajorTopicYN="Y">Arthroplasty, Replacement, Knee</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013927" MajorTopicYN="Y">Thrombosis</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057216" MajorTopicYN="Y">Propensity Score</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014148" MajorTopicYN="N">Tranexamic Acid</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019990" MajorTopicYN="N">Perioperative Care</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000933" MajorTopicYN="N">Antifibrinolytic Agents</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016063" MajorTopicYN="N">Blood Loss, Surgical</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Bilateral total knee arthroplasty</Keyword><Keyword MajorTopicYN="N">Complication</Keyword><Keyword MajorTopicYN="N">Deep vein thrombosis</Keyword><Keyword MajorTopicYN="N">Knee</Keyword><Keyword MajorTopicYN="N">Primary arthroplasty</Keyword><Keyword MajorTopicYN="N">Pulmonary embolism</Keyword></KeywordList><CoiStatement>Declarations. Ethical approval: The study was initiated after receiving approval from the institutional review board. Informed consent: Informed consent was obtained both for participation and publication in the form of opt-out on the web-site, and those who rejected were excluded. Conflict of interest: One of the authors (S.T.) certifies receipt of personal payments during the study period, in an amount of less than USD 10,000 from Stryker Japan and Zimmer-Biomet Japan.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>8</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>11</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>12</Month><Day>2</Day><Hour>12</Hour><Minute>33</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>12</Month><Day>2</Day><Hour>12</Hour><Minute>32</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>12</Month><Day>2</Day><Hour>11</Hour><Minute>14</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39621062</ArticleId><ArticleId IdType="doi">10.1007/s00402-024-05624-8</ArticleId><ArticleId IdType="pii">10.1007/s00402-024-05624-8</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Rondon AJ, Shohat N, Tan TL, Goswami K, Huang RC, Parvizi J (2019) The use of aspirin for prophylaxis against venous thromboembolism decreases mortality following primary total joint arthroplasty. J Bone Joint Surg Am 101:504&#x2013;513</Citation><ArticleIdList><ArticleId IdType="doi">10.2106/JBJS.18.00143</ArticleId><ArticleId IdType="pubmed">30893231</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang KY, LaVelle MJ, Gazgalis A, Bender JM, Geller JA, Neuwirth AL, Cooper HJ, Shah RP (2023) Bilateral total knee arthroplasty: current concepts review. JBJS Rev 11:e2200194</Citation><ArticleIdList><ArticleId IdType="doi">10.2106/JBJS.RVW.22.00194</ArticleId></ArticleIdList></Reference><Reference><Citation>Richardson MK, Liu KC, Mayfield CK, Kistler NM, Christ AB, Heckmann ND (2023) Complications and safety of simultaneous bilateral total knee arthroplasty: a patient characteristic and comorbidity-matched analysis. J Bone Joint Surg Am 105:1072&#x2013;1079</Citation><ArticleIdList><ArticleId IdType="doi">10.2106/JBJS.23.00112</ArticleId><ArticleId IdType="pubmed">37418542</ArticleId></ArticleIdList></Reference><Reference><Citation>Warren JA, Siddiqi A, Krebs VE, Molloy R, Higuera CA, Piuzzi NS (2021) Bilateral simultaneous total knee arthroplasty may not be safe even in the healthiest patients. J Bone Joint Surg Am 103:303&#x2013;311</Citation><ArticleIdList><ArticleId IdType="doi">10.2106/JBJS.20.01046</ArticleId><ArticleId IdType="pubmed">33369981</ArticleId></ArticleIdList></Reference><Reference><Citation>Masrouha KZ, Hoballah JJ, Tamim HM, Sagherian BH (2018) Comparing the 30-day risk of venous thromboembolism and bleeding in simultaneous bilateral vs unilateral total knee arthroplasty. J Arthroplasty 33:3273&#x2013; 3280e1</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.arth.2018.06.002</ArticleId><ArticleId IdType="pubmed">29970325</ArticleId></ArticleIdList></Reference><Reference><Citation>Hummel A, Matsumoto M, Shimoda B, Au DLMT, Andrews SN, Nakasone CK (2024) Complications following single-stage bilateral total knee arthroplasty and unilateral procedures: experience of a high-volume community hospital. Arch Orthop Trauma Surg 144:315&#x2013;322</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00402-023-05026-2</ArticleId><ArticleId IdType="pubmed">37632532</ArticleId></ArticleIdList></Reference><Reference><Citation>Raffaelli A, L&#xe9;vy Y, Boileau P, Trojani C (2022) Same-day bilateral total knee replacement versus unilateral total knee replacement: a comparative study. Orthop Traumatol Surg Res 108:103301</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.otsr.2022.103301</ArticleId><ArticleId IdType="pubmed">35508293</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsukada S, Kurosaka K, Nishino M, Maeda T, Hirasawa N, Matsue Y (2020) Intraoperative intravenous and intra-articular plus postoperative intravenous tranexamic acid in total knee arthroplasty: a placebo-controlled randomized controlled trial. J Bone Joint Surg Am 102:687&#x2013;692</Citation><ArticleIdList><ArticleId IdType="doi">10.2106/JBJS.19.01083</ArticleId><ArticleId IdType="pubmed">32053522</ArticleId></ArticleIdList></Reference><Reference><Citation>Mori N, Kimura S, Onodera T, Iwasaki N, Nakagawa I, Masuda T (2016) Use of a pneumatic tourniquet in total knee arthroplasty increases the risk of distal deep vein thrombosis: a prospective, randomized study. Knee 23:887&#x2013;889</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.knee.2016.02.007</ArticleId><ArticleId IdType="pubmed">27372555</ArticleId></ArticleIdList></Reference><Reference><Citation>Watanabe T, Muneta T, Yagishita K, Hara K, Koga H, Sekiya I (2016) Closed suction drainage is not necessary for total knee arthroplasty: a prospective study on simultaneous bilateral surgeries of a mean follow-up of 5.5 years. J Arthroplasty 31:641&#x2013;645</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.arth.2015.10.005</ArticleId><ArticleId IdType="pubmed">26631284</ArticleId></ArticleIdList></Reference><Reference><Citation>Nishitani K, Kuriyama S, Nakamura S, Ito H, Matsuda S (2019) A multivariate analysis on the effect of no closed suction drain on the length of hospital stay in total knee arthroplasty. Knee Surg Relat Res 31:25&#x2013;30</Citation><ArticleIdList><ArticleId IdType="doi">10.5792/ksrr.18.013</ArticleId><ArticleId IdType="pubmed">30871289</ArticleId><ArticleId IdType="pmc">6425893</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsukada S, Wakui M (2017) Combined intravenous and intra-articular tranexamic acid in simultaneous bilateral total knee arthroplasty without tourniquet use. JBJS Open Access 2:e0002</Citation><ArticleIdList><ArticleId IdType="doi">10.2106/JBJS.OA.17.00002</ArticleId><ArticleId IdType="pubmed">30229212</ArticleId><ArticleId IdType="pmc">6132473</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsukada S, Wakui M, Hoshino A (2015) Pain control after simultaneous bilateral total knee arthroplasty: a randomized controlled trial comparing periarticular injection and epidural analgesia. J Bone Joint Surg Am 97:367&#x2013;373</Citation><ArticleIdList><ArticleId IdType="doi">10.2106/JBJS.N.00373</ArticleId><ArticleId IdType="pubmed">25740026</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsukada S, Wakui M, Hoshino A (2014) Postoperative epidural analgesia compared with intraoperative periarticular injection for pain control following total knee arthroplasty under spinal anesthesia: a randomized controlled trial. J Bone Joint Surg Am 96:1433&#x2013;1438</Citation><ArticleIdList><ArticleId IdType="doi">10.2106/JBJS.M.01098</ArticleId><ArticleId IdType="pubmed">25187581</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsukada S, Kurosaka K, Nishino M, Maeda T, Hirasawa N (2019) A strategy of continued antiplatelet agents, vitamin K antagonists, and direct oral anticoagulants throughout the perioperative period of total knee arthroplasty in patients receiving chronic antithrombotic therapy. JBJS Open Access 4:e0057</Citation><ArticleIdList><ArticleId IdType="doi">10.2106/JBJS.OA.18.00057</ArticleId><ArticleId IdType="pmc">6766380</ArticleId></ArticleIdList></Reference><Reference><Citation>Wells PS, Anderson DR, Rodger M, Forgie M, Kearon C, Dreyer J, Kovacs G, Mitchell M, Lewandowski B, Kovacs MJ (2003) Evaluation of D-dimer in the diagnosis of suspected deep-vein thrombosis. N Engl J Med 349:1227&#x2013;1235</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa023153</ArticleId><ArticleId IdType="pubmed">14507948</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsukada S, Wakui M (2018) Continuing versus discontinuing antiplatelet drugs, vasodilators, and/or cerebral ameliorators on perioperative total blood loss in total knee arthroplasty without pneumatic tourniquet. Arthroplast Today 4:89&#x2013;93</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.artd.2017.07.002</ArticleId><ArticleId IdType="pubmed">29560402</ArticleId><ArticleId IdType="pmc">5859674</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsukada S, Kurosaka K, Nishino M, Maeda T, Yonekawa Y, Hirasawa N (2019) Intra-articular tranexamic acid as an adjunct to intravenous tranexamic acid for simultaneous bilateral total knee arthroplasty: a randomized double-blind, placebo-controlled trial. BMC Musculoskelet Disord 20:464</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12891-019-2890-8</ArticleId><ArticleId IdType="pubmed">31638960</ArticleId><ArticleId IdType="pmc">6805302</ArticleId></ArticleIdList></Reference><Reference><Citation>Baron TH, Kamath PS, McBane RD (2013) Management of antithrombotic therapy in patients undergoing invasive procedures. N Engl J Med 368:2113&#x2013;2124</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMra1206531</ArticleId><ArticleId IdType="pubmed">23718166</ArticleId></ArticleIdList></Reference><Reference><Citation>Douketis JD, Spyropoulos AC, Kaatz S, Becker RC, Caprini JA, Dunn AS, Garcia DA, Jacobson A, Jaffer AK, Kong DF, Schulman S, Turpie AG, Hasselblad V, Ortel TL, BRIDGE Investigators (2015) Perioperative bridging anticoagulation in patients with atrial fibrillation. N Engl J Med 373:823&#x2013;833</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1501035</ArticleId><ArticleId IdType="pubmed">26095867</ArticleId><ArticleId IdType="pmc">4931686</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">30056128</PMID><DateCompleted><Year>2018</Year><Month>11</Month><Day>20</Day></DateCompleted><DateRevised><Year>2018</Year><Month>11</Month><Day>20</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1743-9159</ISSN><JournalIssue CitedMedium="Internet"><Volume>57</Volume><PubDate><Year>2018</Year><Month>Sep</Month></PubDate></JournalIssue><Title>International journal of surgery (London, England)</Title><ISOAbbreviation>Int J Surg</ISOAbbreviation></Journal><ArticleTitle>Comparison of mini-subvastus approach versus medial parapatellar approach in primary total knee arthroplasty.</ArticleTitle><Pagination><StartPage>15</StartPage><EndPage>21</EndPage><MedlinePgn>15-21</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.ijsu.2018.07.007</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S1743-9191(18)31543-7</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Minimally invasive knee arthroplasty is rapidly gaining recognition with the aim of reducing the damage to the extensional mechanism of traditional medial parapatellar approach and achieving faster recovery of patients after surgery. The purpose of this meta-analysis was to compare the efficacy and safety of mini-subvastus (MSV) and medial parapatellar (MMP) approach in primary total knee arthroplasty (TKA).</AbstractText><AbstractText Label="MATERIAL AND METHODS" NlmCategory="METHODS">PubMed, EMBASE, the Cochrane Library, Web of Science and China National Knowledge Infrastructure and Google Search Engine were systematically searched for randomized controlled trials (RCTs) comparing mini-subvastus and medial parapatellar approach in primary TKA. Primary outcomes were total knee society score (KSS), functional KSS, straight leg-raising days. Secondary outcomes were hospital stays, blood loss, operation time, wound-related complications, deep venous thrombosis (DVT) and/or pulmonary embolism (PE). Subgroup analyzes were performed on the range of motion (ROM) at different follow-up times.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">A total of 14 RCTs involving 1172 patients were included in the meta-analysis. No significant difference between the two groups was found in functional KSS (P&#x202f;=&#x202f;0.31), hospital stays (P&#x202f;=&#x202f;0.07), wound-related complications (P&#x202f;=&#x202f;0.77), DVT (P&#x202f;=&#x202f;0.59) and/or PE (P&#x202f;=&#x202f;0.33). The MSV approach provides higher total KSS (P&#x202f;=&#x202f;0.007), lower straight leg raising days (P&#x202f;=&#x202f;0.003) and less blood loss (P&#x202f;=&#x202f;0.004) compared with the MMP approach. Additionally, patients in the MSV group had also better ROM at 4-6 weeks (P&#x202f;=&#x202f;0.04), 3 months (P&#x202f;=&#x202f;0.007), 6 months (P&#x202f;=&#x202f;0.02) after surgery compared with the patients in the MMP group.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">The available evidence indicates that using the MSV approach could be a reasonable alternative to the MMP approach that may potentially ensure the integrity of the quadriceps muscles and enhance the early rapid recovery in primary TKA.</AbstractText><AbstractText Label="LEVEL OF EVIDENCE" NlmCategory="METHODS">Level II, therapeutic study.</AbstractText><CopyrightInformation>Copyright &#xa9; 2018. Published by Elsevier Ltd.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Wu</LastName><ForeName>Yuangang</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Orthopaedic Surgery, West China Hospital, West China Medical School, Sichuan University, Chengdu, Sichuan Province, 610041, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zeng</LastName><ForeName>Yi</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Orthopaedic Surgery, West China Hospital, West China Medical School, Sichuan University, Chengdu, Sichuan Province, 610041, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bao</LastName><ForeName>Xianchao</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Orthopaedic Surgery, West China Hospital, West China Medical School, Sichuan University, Chengdu, Sichuan Province, 610041, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xiong</LastName><ForeName>Huazhang</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Orthopaedic Surgery, West China Hospital, West China Medical School, Sichuan University, Chengdu, Sichuan Province, 610041, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hu</LastName><ForeName>Qinsheng</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>Department of Orthopaedic Surgery, West China Hospital, West China Medical School, Sichuan University, Chengdu, Sichuan Province, 610041, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Mingyang</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Orthopaedic Surgery, West China Hospital, West China Medical School, Sichuan University, Chengdu, Sichuan Province, 610041, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shen</LastName><ForeName>Bin</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Orthopaedic Surgery, West China Hospital, West China Medical School, Sichuan University, Chengdu, Sichuan Province, 610041, China. Electronic address: shenbin_1971@163.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D003160">Comparative Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>07</Month><Day>26</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Int J Surg</MedlineTA><NlmUniqueID>101228232</NlmUniqueID><ISSNLinking>1743-9159</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019645" MajorTopicYN="N">Arthroplasty, Replacement, Knee</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007719" MajorTopicYN="N">Knee Joint</DescriptorName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007902" MajorTopicYN="N">Length of Stay</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010329" MajorTopicYN="N">Patella</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011184" MajorTopicYN="N">Postoperative Period</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D052097" MajorTopicYN="N">Quadriceps Muscle</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016032" MajorTopicYN="N">Randomized Controlled Trials as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016059" MajorTopicYN="N">Range of Motion, Articular</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020127" MajorTopicYN="N">Recovery of Function</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Medial parapatellar</Keyword><Keyword MajorTopicYN="N">Mini-subvastus</Keyword><Keyword MajorTopicYN="N">Randomized controlled trials</Keyword><Keyword MajorTopicYN="N">Total knee arthroplasty</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2018</Year><Month>4</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2018</Year><Month>7</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>7</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>7</Month><Day>30</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>11</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>7</Month><Day>30</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">30056128</ArticleId><ArticleId IdType="doi">10.1016/j.ijsu.2018.07.007</ArticleId><ArticleId IdType="pii">S1743-9191(18)31543-7</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37000238</PMID><DateCompleted><Year>2023</Year><Month>09</Month><Day>18</Day></DateCompleted><DateRevised><Year>2025</Year><Month>06</Month><Day>26</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1432-1068</ISSN><JournalIssue CitedMedium="Internet"><Volume>33</Volume><Issue>7</Issue><PubDate><Year>2023</Year><Month>Oct</Month></PubDate></JournalIssue><Title>European journal of orthopaedic surgery &amp; traumatology : orthopedie traumatologie</Title><ISOAbbreviation>Eur J Orthop Surg Traumatol</ISOAbbreviation></Journal><ArticleTitle>The use of pre-operative Inferior Vena Cava filters for thromboprophylaxis in ultra-high-risk patients undergoing total hip and knee arthroplasty: a systematic review and narrative analysis.</ArticleTitle><Pagination><StartPage>2749</StartPage><EndPage>2764</EndPage><MedlinePgn>2749-2764</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s00590-023-03531-z</ELocationID><Abstract><AbstractText Label="PURPOSE" NlmCategory="OBJECTIVE">Patients undergoing total hip (THA) or knee (TKA) arthroplasty are at high risk of venous thromboembolism (VTE). As the number performed annually increases, the population at risk of fatal pulmonary embolism (PE) also grows. Ultra-high-risk arthroplasty patients (UHRAPs) include those with additional comorbidities, or a history of VTE, for many of whom routine prophylaxis will previously have failed. Pre-operative insertion of Inferior Vena Cava filters (IVCFs) has been recommended for thromboprophylaxis in UHRAPs, and this review was performed to establish their results.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">A systematic search of MEDLINE and Embase databases was performed for studies reporting the use of Inferior Vena Cava filters in hip and knee arthroplasty patients.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Ten studies met the inclusion criteria, containing 718 IVCFs in Orthopaedic patients, 343 of which were permanent (47.8%), 369 potentially retrievable (51.4%), 5 absorbable (0.6%) and one of unknown design (0.1%). Patient age averaged 64.7yrs (17-95) and 56% were female. Pre-operatively, 415 prophylactic IVCFs were inserted in 409 UHRAPs, undergoing a total of 438 total joint arthroplasties (TJA). There were 11 cases of PE in the entire series (1.5%) only one of which was fatal (0.01%), with four non-fatal PE in the UHRAP group (0.96%). Removal was attempted for 283 of the retrievable filters (76.7%) and was successful in 280 (98.9%).</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">The use of IVCFs eliminated fatal PE in UHRAPs, but larger, high-quality studies, with standardised reporting, are still required to determine their absolute indications for use, complication profile, efficacy and optimum design.</AbstractText><CopyrightInformation>&#xa9; 2023. The Author(s), under exclusive licence to Springer-Verlag France SAS, part of Springer Nature.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Sochart</LastName><ForeName>Sarita</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Hyperacute Stroke Unit, Frimley Park Hospital, Portsmouth Rd, Frimley, Camberley, GU16 7UJ, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Baryeh</LastName><ForeName>Kwaku</ForeName><Initials>K</Initials><Identifier Source="ORCID">0000-0002-2807-1965</Identifier><AffiliationInfo><Affiliation>Postgraduate Medical Education Department, West Middlesex University Hospital, Twickenham Road, Middlesex, TW7 6AF, UK. Kwaku.baryeh1@nhs.net.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sochart</LastName><ForeName>David H</ForeName><Initials>DH</Initials><AffiliationInfo><Affiliation>The Academic Surgical Unit, South West London Elective Orthopaedic Centre (SWLEOC), Dorking Road, Epsom, Surrey, KT18 7EG, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>The School of Health and Society, The University of Salford, Salford, UK.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D000078182">Systematic Review</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>03</Month><Day>31</Day></ArticleDate></Article><MedlineJournalInfo><Country>France</Country><MedlineTA>Eur J Orthop Surg Traumatol</MedlineTA><NlmUniqueID>9518037</NlmUniqueID><ISSNLinking>1633-8065</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000925">Anticoagulants</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016306" MajorTopicYN="Y">Vena Cava Filters</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D054556" MajorTopicYN="Y">Venous Thromboembolism</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019645" MajorTopicYN="Y">Arthroplasty, Replacement, Knee</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000925" MajorTopicYN="N">Anticoagulants</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011655" MajorTopicYN="Y">Pulmonary Embolism</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Deep vein thrombosis</Keyword><Keyword MajorTopicYN="N">Hip and knee arthroplasty</Keyword><Keyword MajorTopicYN="N">Inferior Vena Cava filter</Keyword><Keyword MajorTopicYN="N">Pulmonary embolism</Keyword><Keyword MajorTopicYN="N">Thromboprophylaxis</Keyword></KeywordList><CoiStatement>The authors declare no conflicts of interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>11</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>3</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>9</Month><Day>18</Day><Hour>12</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>4</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>3</Month><Day>31</Day><Hour>11</Hour><Minute>14</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>3</Month><Day>31</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37000238</ArticleId><ArticleId IdType="pmc">PMC10063930</ArticleId><ArticleId IdType="doi">10.1007/s00590-023-03531-z</ArticleId><ArticleId IdType="pii">10.1007/s00590-023-03531-z</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>N&#xe6;ss IA, Christiansen SC, Romundstad P, et al. Incidence and mortality of venous thrombosis: a population-based study. J Thromb Haemost. 2007;5:692&#x2013;699. doi: 10.1111/j.1538-7836.2007.02450.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1538-7836.2007.02450.x</ArticleId><ArticleId IdType="pubmed">17367492</ArticleId></ArticleIdList></Reference><Reference><Citation>Ks V, Stefano B, Mareike L, Guy M. Management of pulmonary embolism. J Am Coll Cardiol. 2016;67:976&#x2013;990. doi: 10.1016/j.jacc.2015.11.061.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2015.11.061</ArticleId><ArticleId IdType="pubmed">26916489</ArticleId></ArticleIdList></Reference><Reference><Citation>Prandoni P, Lensing AWA, Cogo A, et al. The long-term clinical course of acute deep venous thrombosis. Ann Intern Med. 1996;125:1&#x2013;7. doi: 10.7326/0003-4819-125-1-199607010-00001.</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/0003-4819-125-1-199607010-00001</ArticleId><ArticleId IdType="pubmed">8644983</ArticleId></ArticleIdList></Reference><Reference><Citation>Schiff RL, Kahn SR, Shrier I, et al. Identifying orthopedic patients at high risk for venous thromboembolism despite thromboprophylaxis. Chest. 2005;128:3364&#x2013;3371. doi: 10.1378/chest.128.5.3364.</Citation><ArticleIdList><ArticleId IdType="doi">10.1378/chest.128.5.3364</ArticleId><ArticleId IdType="pubmed">16304285</ArticleId></ArticleIdList></Reference><Reference><Citation>White RH, Gettner S, Newman JM, et al. Predictors of rehospitalization for symptomatic venous thromboembolism after total hip arthroplasty. N Engl J Med. 2000;343:1758&#x2013;1764. doi: 10.1056/NEJM200012143432403.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJM200012143432403</ArticleId><ArticleId IdType="pubmed">11114314</ArticleId></ArticleIdList></Reference><Reference><Citation>Poultsides LA, Gonzalez Della Valle A, Memtsoudis SG, et al. Meta-analysis of cause of death following total joint replacement using different thromboprophylaxis regimens. J Bone Joint Surg Br. 2012;94-B:113&#x2013;121. doi: 10.1302/0301-620X.94B1.27301.</Citation><ArticleIdList><ArticleId IdType="doi">10.1302/0301-620X.94B1.27301</ArticleId><ArticleId IdType="pubmed">22219258</ArticleId></ArticleIdList></Reference><Reference><Citation>Hunt LP, Ben-Shlomo Y, Clark EM, et al. 90-day mortality after 409&#x2008;096 total hip replacements for osteoarthritis, from the national joint registry for England and Wales: a retrospective analysis. Lancet. 2013;382:1097&#x2013;1104. doi: 10.1016/S0140-6736(13)61749-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(13)61749-3</ArticleId><ArticleId IdType="pubmed">24075049</ArticleId></ArticleIdList></Reference><Reference><Citation>Hunt LP, Ben-Shlomo Y, Clark EM, et al. 45-day mortality after 467&#x2008;779 knee replacements for osteoarthritis from the national joint registry for England and Wales: an observational study. Lancet. 2014;384:1429&#x2013;1436. doi: 10.1016/S0140-6736(14)60540-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(14)60540-7</ArticleId><ArticleId IdType="pubmed">25012118</ArticleId></ArticleIdList></Reference><Reference><Citation>Bayley E, Brown S, Bhamber NS, Howard PW. Fatal pulmonary embolism following elective total hip arthroplasty. Bone Joint J. 2016;98-B:585&#x2013;588. doi: 10.1302/0301-620X.98B5.34996.</Citation><ArticleIdList><ArticleId IdType="doi">10.1302/0301-620X.98B5.34996</ArticleId><ArticleId IdType="pubmed">27143726</ArticleId></ArticleIdList></Reference><Reference><Citation>Quah C, Bayley E, Bhamber N, Howard P. Fatal pulmonary embolism following elective total knee replacement using aspirin in multi-modal prophylaxis &amp; #x2014; A 12&#x2005;year study. Knee. 2017;24:1187&#x2013;1190. doi: 10.1016/j.knee.2017.05.021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.knee.2017.05.021</ArticleId><ArticleId IdType="pubmed">28622843</ArticleId></ArticleIdList></Reference><Reference><Citation>Januel J-M, Chen G, Ruffieux C, et al. Symptomatic in-hospital deep vein thrombosis and pulmonary embolism following hip and knee arthroplasty among patients receiving recommended prophylaxis: a systematic review. JAMA. 2012;307:294&#x2013;303. doi: 10.1001/jama.2011.2029.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2011.2029</ArticleId><ArticleId IdType="pubmed">22253396</ArticleId></ArticleIdList></Reference><Reference><Citation>Nam D, Nunley RM, Johnson SR, et al. The effectiveness of a risk stratification protocol for thromboembolism prophylaxis after hip and knee arthroplasty. J Arthroplast. 2016;31:1299&#x2013;1306. doi: 10.1016/j.arth.2015.12.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.arth.2015.12.007</ArticleId><ArticleId IdType="pubmed">26777547</ArticleId></ArticleIdList></Reference><Reference><Citation>Nemeth B, Nelissen R, Arya R, Cannegieter S. Preventing VTE following total hip and knee arthroplasty: is prediction the future? J Thromb Haemost. 2021;19:41&#x2013;45. doi: 10.1111/jth.15132.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jth.15132</ArticleId><ArticleId IdType="pmc">PMC7839761</ArticleId><ArticleId IdType="pubmed">33043553</ArticleId></ArticleIdList></Reference><Reference><Citation>Parvizi J, Huang R, Rezapoor M, et al. Individualized risk model for venous thromboembolism after total joint arthroplasty. J Arthroplast. 2016;31:180&#x2013;186. doi: 10.1016/j.arth.2016.02.077.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.arth.2016.02.077</ArticleId><ArticleId IdType="pubmed">27094244</ArticleId></ArticleIdList></Reference><Reference><Citation>Warren JA, Sundaram K, Kamath AF, et al. Venous thromboembolism rates did not decrease in lower extremity revision total joint arthroplasty from 2008 to 2016. J Arthroplast. 2019;34:2774&#x2013;2779. doi: 10.1016/j.arth.2019.05.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.arth.2019.05.012</ArticleId><ArticleId IdType="pubmed">31153709</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang J, Chen Z, Zheng J, et al. Risk factors for venous thromboembolism after total hip and total knee arthroplasty: a meta-analysis. Arch Orthop Trauma Surg. 2015;135:759&#x2013;772. doi: 10.1007/s00402-015-2208-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00402-015-2208-8</ArticleId><ArticleId IdType="pubmed">25854654</ArticleId></ArticleIdList></Reference><Reference><Citation>Registry NJ (2020) National Joint Registry-17th Annual Report 2020. Natl Jt Regist</Citation><ArticleIdList><ArticleId IdType="pubmed">33439585</ArticleId></ArticleIdList></Reference><Reference><Citation>Matharu GS, Culliford DJ, Blom AW, Judge A. Projections for primary hip and knee replacement surgery up to the year 2060: an analysis based on data from the national joint registry for England, Wales, Northern Ireland and the Isle of Man. Ann R Coll Surg Engl. 2022;104:443&#x2013;448. doi: 10.1308/rcsann.2021.0206.</Citation><ArticleIdList><ArticleId IdType="doi">10.1308/rcsann.2021.0206</ArticleId><ArticleId IdType="pmc">PMC9157920</ArticleId><ArticleId IdType="pubmed">34939832</ArticleId></ArticleIdList></Reference><Reference><Citation>Penfold CM, Judge A, Sayers A, et al. Temporal trends in comorbidity in adult elective hip and knee arthroplasty patients in England. Bone Joint J. 2022;104-B:1052&#x2013;1059. doi: 10.1302/0301-620X.104B9.BJJ-2022-0013.R1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1302/0301-620X.104B9.BJJ-2022-0013.R1</ArticleId><ArticleId IdType="pubmed">36047019</ArticleId></ArticleIdList></Reference><Reference><Citation>Menendez ME, Neuhaus V, van Dijk NC, Ring D. The elixhauser comorbidity method outperforms the charlson index in predicting inpatient death after orthopaedic surgery. Clin Orthop Relat Res. 2014;472(2878):2886.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4117875</ArticleId><ArticleId IdType="pubmed">24867450</ArticleId></ArticleIdList></Reference><Reference><Citation>Garland A, B&#xfc;low E, Lenguerrand E, et al. Prediction of 90-day mortality after total hip arthroplasty. Bone Joint J. 2021;103-B:469&#x2013;478. doi: 10.1302/0301-620X.103B3.BJJ-2020-1249.R1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1302/0301-620X.103B3.BJJ-2020-1249.R1</ArticleId><ArticleId IdType="pubmed">33641419</ArticleId></ArticleIdList></Reference><Reference><Citation>Sloan M, Premkumar A, Sheth NP. Projected volume of primary total joint arthroplasty in the U.S., 2014 to 2030. JBJS. 2018;100:1455&#x2013;1460. doi: 10.2106/JBJS.17.01617.</Citation><ArticleIdList><ArticleId IdType="doi">10.2106/JBJS.17.01617</ArticleId><ArticleId IdType="pubmed">30180053</ArticleId></ArticleIdList></Reference><Reference><Citation>Kurtz S, Ong K, Lau E, et al. Projections of primary and revision hip and knee arthroplasty in the United States from 2005 to 2030. JBJS. 2007;89:780&#x2013;785. doi: 10.2106/00004623-200704000-00012.</Citation><ArticleIdList><ArticleId IdType="doi">10.2106/00004623-200704000-00012</ArticleId><ArticleId IdType="pubmed">17403800</ArticleId></ArticleIdList></Reference><Reference><Citation>Ackerman IN, Bohensky MA, Zomer E, et al. The projected burden of primary total knee and hip replacement for osteoarthritis in Australia to the year 2030. BMC Musculoskelet Disord. 2019;20:90. doi: 10.1186/s12891-019-2411-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12891-019-2411-9</ArticleId><ArticleId IdType="pmc">PMC6387488</ArticleId><ArticleId IdType="pubmed">30797228</ArticleId></ArticleIdList></Reference><Reference><Citation>Klug A, Gramlich Y, Rudert M, et al. The projected volume of primary and revision total knee arthroplasty will place an immense burden on future health care systems over the next 30 years. Knee Surg Sport Traumatol Arthrosc. 2021;29:3287&#x2013;3298. doi: 10.1007/s00167-020-06154-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00167-020-06154-7</ArticleId><ArticleId IdType="pmc">PMC7362328</ArticleId><ArticleId IdType="pubmed">32671435</ArticleId></ArticleIdList></Reference><Reference><Citation>Mesko DR, Nikkole Haines MD, Sadauskas A, Sporer SM. Inferior vena cava filter use and risk of DVT/PE post arthroplasty. Orthop Rheumatol Open Access J. 2018;12:45&#x2013;49. doi: 10.19080/OROAJ.2018.12.555836.</Citation><ArticleIdList><ArticleId IdType="doi">10.19080/OROAJ.2018.12.555836</ArticleId></ArticleIdList></Reference><Reference><Citation>Greenfield LJ. Evolution of venous interruption for pulmonary thromboembolism. Arch Surg. 1992;127:622&#x2013;626. doi: 10.1001/archsurg.1992.01420050150020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archsurg.1992.01420050150020</ArticleId><ArticleId IdType="pubmed">1575633</ArticleId></ArticleIdList></Reference><Reference><Citation>Moser KM, Harsany PG, Harvey-Smith W, et al. Reversible interruption of inferior vena cava by means of a balloon catheter: preliminary report. J Thorac Cardiovasc Surg. 1971;62:205&#x2013;212. doi: 10.1016/S0022-5223(19)42072-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0022-5223(19)42072-2</ArticleId><ArticleId IdType="pubmed">5560502</ArticleId></ArticleIdList></Reference><Reference><Citation>Hunter JA, Sessions R, Buenger R. Experimental balloon obstruction of the inferior vena cava. Ann Surg. 1970;171:315. doi: 10.1097/00000658-197002000-00023.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00000658-197002000-00023</ArticleId><ArticleId IdType="pmc">PMC1396660</ArticleId><ArticleId IdType="pubmed">5413467</ArticleId></ArticleIdList></Reference><Reference><Citation>Mobin-Uddin K, Callard GM, Bolooki H, et al. Transvenous caval interruption with umbrella filter. N Engl J Med. 1972;286:55&#x2013;58. doi: 10.1056/NEJM197201132860202.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJM197201132860202</ArticleId><ArticleId IdType="pubmed">5006878</ArticleId></ArticleIdList></Reference><Reference><Citation>Dripps RD. New classification of physical status. Anesthesiology. 1963;24:111.</Citation></Reference><Reference><Citation>Muscatelli SR, Charters MA, Hallstrom BR. Time for an update? A look at current guidelines for venous thromboembolism prophylaxis after hip and knee arthroplasty and hip fracture. Arthroplast Today. 2021;10:105&#x2013;107. doi: 10.1016/j.artd.2021.06.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.artd.2021.06.015</ArticleId><ArticleId IdType="pmc">PMC8318891</ArticleId><ArticleId IdType="pubmed">34337116</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuy S, Dua A, Lee CJ, et al. National trends in utilization of inferior vena cava filters in the United States, 2000&#x2013;2009. J Vasc Surg Venous Lymphat Disord. 2014;2:15&#x2013;20. doi: 10.1016/j.jvsv.2013.08.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jvsv.2013.08.007</ArticleId><ArticleId IdType="pubmed">26992963</ArticleId></ArticleIdList></Reference><Reference><Citation>Kidane B, Madani AM, Vogt K, et al. The use of prophylactic inferior vena cava filters in trauma patients: a systematic review. Injury. 2012;43:542&#x2013;547. doi: 10.1016/j.injury.2012.01.020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.injury.2012.01.020</ArticleId><ArticleId IdType="pubmed">22386925</ArticleId></ArticleIdList></Reference><Reference><Citation>Rowland SP, Dharmarajah B, Moore HM, et al. Inferior vena cava filters for prevention of venous thromboembolism in obese patients undergoing bariatric surgery: a systematic review. Ann Surg. 2015;261:35&#x2013;45. doi: 10.1097/SLA.0000000000000621.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/SLA.0000000000000621</ArticleId><ArticleId IdType="pubmed">25599325</ArticleId></ArticleIdList></Reference><Reference><Citation>Page MJ, McKenzie JE, Bossuyt PM, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71. doi: 10.1136/bmj.n71.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.n71</ArticleId><ArticleId IdType="pmc">PMC8005924</ArticleId><ArticleId IdType="pubmed">33782057</ArticleId></ArticleIdList></Reference><Reference><Citation>Slim K, Nini E, Forestier D, et al. Methodological index for non-randomized studies (MINORS): development and validation of a new instrument. ANZ J Surg. 2003;73:712&#x2013;716. doi: 10.1046/j.1445-2197.2003.02748.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1046/j.1445-2197.2003.02748.x</ArticleId><ArticleId IdType="pubmed">12956787</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahmed O, Kim YJ, Patel MV, et al. Efficacy and safety of mechanical IVC filtration for preventing pulmonary embolism in high-risk orthopedic patients undergoing total hip or knee arthroplasty. J Arthroplast. 2021;36:2586&#x2013;2590. doi: 10.1016/j.arth.2021.02.042.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.arth.2021.02.042</ArticleId><ArticleId IdType="pubmed">33741245</ArticleId></ArticleIdList></Reference><Reference><Citation>Austin MS, Parvizi J, Grossman S, et al. The inferior vena cava filter is effective in preventing fatal pulmonary embolus after hip and knee arthroplasties. J Arthroplast. 2007;22:343&#x2013;348. doi: 10.1016/j.arth.2006.10.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.arth.2006.10.008</ArticleId><ArticleId IdType="pubmed">17400088</ArticleId></ArticleIdList></Reference><Reference><Citation>Bass AR, Mattern CJ, Voos JE, et al. Inferior vena cava filter placement in orthopedic surgery. Am J Orthop. 2010;39:435.</Citation><ArticleIdList><ArticleId IdType="pubmed">21290021</ArticleId></ArticleIdList></Reference><Reference><Citation>Dhand S, David Stulberg S, Puri L, et al. The role of potentially retrievable inferior vena cava filters in high-risk patients undergoing joint arthroplasty. J Clin Diagn Res. 2015;9:TC01&#x2013;TC03. doi: 10.7860/JCDR/2015/11397.6890.</Citation><ArticleIdList><ArticleId IdType="doi">10.7860/JCDR/2015/11397.6890</ArticleId><ArticleId IdType="pmc">PMC4717762</ArticleId><ArticleId IdType="pubmed">26816965</ArticleId></ArticleIdList></Reference><Reference><Citation>Elizondo G, Eggers M, Falcon M, et al. First-in-human study with eight patients using an absorbable vena cava filter for the prevention of pulmonary embolism. J Vasc Interv Radiol. 2020;31:1817&#x2013;1824. doi: 10.1016/j.jvir.2020.07.021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jvir.2020.07.021</ArticleId><ArticleId IdType="pubmed">33008719</ArticleId></ArticleIdList></Reference><Reference><Citation>Emerson RH, Cross R, Head WC. Prophylactic and early therapeutic use of the greenfield filter in hip and knee joint arthroplasty. J Arthroplast. 1991;6:129&#x2013;135. doi: 10.1016/S0883-5403(11)80007-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0883-5403(11)80007-0</ArticleId><ArticleId IdType="pubmed">1875203</ArticleId></ArticleIdList></Reference><Reference><Citation>Golueke PJ, Garrett WV, Thompson JE, et al. Interruption of the vena cava by means of the Greenfield filter: expanding the indications. Surgery. 1988;103:111&#x2013;117.</Citation><ArticleIdList><ArticleId IdType="pubmed">3336860</ArticleId></ArticleIdList></Reference><Reference><Citation>Strauss EJ, Egol KA, Alaia M, et al. The use of retrievable inferior vena cava filters in orthopaedic patients. J Bone Jt Surg Ser B. 2008;90:662&#x2013;667. doi: 10.1302/0301-620X.90B5.19743.</Citation><ArticleIdList><ArticleId IdType="doi">10.1302/0301-620X.90B5.19743</ArticleId><ArticleId IdType="pubmed">18450637</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaughn BK, Knezevich S, Lombardi AV, Jr, Mallory TH. Use of the greenfield filter to prevent fatal pulmonary embolism associated with total hip and knee arthroplasty. J Bone Joint Surg Am. 1989;71:1542&#x2013;1548. doi: 10.2106/00004623-198971100-00013.</Citation><ArticleIdList><ArticleId IdType="doi">10.2106/00004623-198971100-00013</ArticleId><ArticleId IdType="pubmed">2592395</ArticleId></ArticleIdList></Reference><Reference><Citation>Angel LF, Tapson V, Galgon RE, et al. Systematic review of the use of retrievable inferior vena cava filters. J Vasc Interv Radiol. 2011 doi: 10.1016/j.jvir.2011.08.024.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jvir.2011.08.024</ArticleId><ArticleId IdType="pubmed">22024114</ArticleId></ArticleIdList></Reference><Reference><Citation>Li X, Haddadin I, McLennan G, et al. Inferior vena cava filter &#x2013; comprehensive overview of current indications, techniques, complications and retrieval rates. Vasa. 2020;49:449&#x2013;462. doi: 10.1024/0301-1526/a000887.</Citation><ArticleIdList><ArticleId IdType="doi">10.1024/0301-1526/a000887</ArticleId><ArticleId IdType="pubmed">32660360</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaufman JA, Kinney TB, Streiff MB, et al. Special communications-guidelines for the use of retrievable and convertible vena cava filters: report from the society of interventional radiology multidisciplinary consensus conference. J Vasc Interv Radiol. 2006;17:449&#x2013;459. doi: 10.1097/01.RVI.0000203418-39769.0D.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.RVI.0000203418-39769.0D</ArticleId><ArticleId IdType="pubmed">16567669</ArticleId></ArticleIdList></Reference><Reference><Citation>Morales JP, Li X, Irony TZ, et al. Decision analysis of retrievable inferior vena cava filters in patients without pulmonary embolism. J Vasc Surg Venous Lymphat Disord. 2013;1:376&#x2013;384. doi: 10.1016/j.jvsv.2013.04.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jvsv.2013.04.005</ArticleId><ArticleId IdType="pubmed">26992759</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahmed O, Wadhwa V, Patel K, et al. Rising retrieval rates of inferior vena cava filters in the united states: insights from the 2012 to 2016 summary medicare claims data. J Am Coll Radiol. 2018;15:1553&#x2013;1557. doi: 10.1016/j.jacr.2018.01.037.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacr.2018.01.037</ArticleId><ArticleId IdType="pubmed">29606636</ArticleId></ArticleIdList></Reference><Reference><Citation>Jacobs JJ, Mont MA, Bozic KJ, et al. American academy of orthopaedic surgeons clinical practice guideline on: preventing venous thromboembolic disease in patients undergoing elective hip and knee arthroplasty. JBJS. 2012;94:746. doi: 10.2106/JBJS.9408.ebo746.</Citation><ArticleIdList><ArticleId IdType="doi">10.2106/JBJS.9408.ebo746</ArticleId><ArticleId IdType="pmc">PMC3326685</ArticleId><ArticleId IdType="pubmed">22517391</ArticleId></ArticleIdList></Reference><Reference><Citation>Group BC for S in HW. Baglin TP, Brush J, Streiff M. Guidelines on use of vena cava filters. Br J Haematol. 2006;134:590&#x2013;595. doi: 10.1111/j.1365-2141.2006.06226.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1365-2141.2006.06226.x</ArticleId><ArticleId IdType="pubmed">16869824</ArticleId></ArticleIdList></Reference><Reference><Citation>Young T, Sriram KB. Vena caval filters for the prevention of pulmonary embolism. Cochrane Database Syst Rev. 2020 doi: 10.1002/14651858.CD006212.pub5/full.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/14651858.CD006212.pub5/full</ArticleId><ArticleId IdType="pmc">PMC8971091</ArticleId><ArticleId IdType="pubmed">33027844</ArticleId></ArticleIdList></Reference><Reference><Citation>Decousus H, Leizorovicz A, Parent F, et al. A clinical trial of vena caval filters in the prevention of pulmonary embolism in patients with proximal deep-vein thrombosis. N Engl J Med. 1998;338:409&#x2013;416. doi: 10.1056/nejm199802123380701.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/nejm199802123380701</ArticleId><ArticleId IdType="pubmed">9459643</ArticleId></ArticleIdList></Reference><Reference><Citation>Fullen WD, Miller EH, Steele WF, McDonough JJ. Prophylactic vena caval interruption in hip fractures. J Trauma Acute Care Surg. 1973;13:403&#x2013;410. doi: 10.1097/00005373-197305000-00001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00005373-197305000-00001</ArticleId><ArticleId IdType="pubmed">4540786</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">28248851</PMID><DateCompleted><Year>2017</Year><Month>03</Month><Day>24</Day></DateCompleted><DateRevised><Year>2021</Year><Month>01</Month><Day>09</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1536-5964</ISSN><JournalIssue CitedMedium="Internet"><Volume>96</Volume><Issue>9</Issue><PubDate><Year>2017</Year><Month>Mar</Month></PubDate></JournalIssue><Title>Medicine</Title><ISOAbbreviation>Medicine (Baltimore)</ISOAbbreviation></Journal><ArticleTitle>Acute kidney injury in patients with pulmonary embolism: A population-based cohort study.</ArticleTitle><Pagination><StartPage>e5822</StartPage><MedlinePgn>e5822</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e5822</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1097/MD.0000000000005822</ELocationID><Abstract><AbstractText>Acute kidney injury (AKI) is overlooked in patients with pulmonary embolism (PE). Risk factors for and long-term outcomes of this complication remain unknown. This study evaluated the predictors and prognosis of AKI in patients with PE.This retrospective cohort study used Taiwan's National Health Insurance Research Database. We enrolled a total of 7588 patients who were admitted to a hospital for PE from January1997 to December 2011 and administered anticoagulation or thrombolytic agents. All demographic data, risk factors, and outcomes were analyzed.AKI was diagnosed in 372 (4.9%) patients. Multivariate logistic regression analysis revealed pre-existing chronic kidney disease, hypertension, diabetes mellitus, massive PE, anemia, and sepsis as independent risk factors for AKI. In the long-term follow-up, the survival rate was similar in the AKI and non-AKI groups.Careful risk factor screening and intensive intervention in patients with AKI might yield outcomes similar to those in patients without AKI.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Chang</LastName><ForeName>Chih-Hsiang</ForeName><Initials>CH</Initials><AffiliationInfo><Affiliation>Department of Nephrology, Kidney Research Center, Chang Gung Memorial Hospital, Linkou Medical Center Department of Nephrology, Chang Gung Memorial Hospital, Kaohsiung Medical Center Division of Thoracic and Cardiovascular Surgery, Department of Surgery, Chang Gung Memorial Hospital, Linkou Medical Center, Chang Gung University, Taoyuan City Department of Cardiology, Chang Gung Memorial Hospital, Linkou Medical Center Clinical Informatics and Medical Statistics Research Center, Chang Gung University, Taoyuan City Department of Cardiology, Chang Gung Memorial Hospital, Keelung Branch Division of Allergy, Asthma, and Rheumatology, Department of Pediatrics, Chang Gung Memorial Hospital, Taoyuan, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fu</LastName><ForeName>Chung-Ming</ForeName><Initials>CM</Initials></Author><Author ValidYN="Y"><LastName>Fan</LastName><ForeName>Pei-Chun</ForeName><Initials>PC</Initials></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Shao-Wei</ForeName><Initials>SW</Initials></Author><Author ValidYN="Y"><LastName>Chang</LastName><ForeName>Su-Wei</ForeName><Initials>SW</Initials></Author><Author ValidYN="Y"><LastName>Mao</LastName><ForeName>Chun-Tai</ForeName><Initials>CT</Initials></Author><Author ValidYN="Y"><LastName>Tian</LastName><ForeName>Ya-Chung</ForeName><Initials>YC</Initials></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Yung-Chang</ForeName><Initials>YC</Initials></Author><Author ValidYN="Y"><LastName>Chu</LastName><ForeName>Pao-Hsien</ForeName><Initials>PH</Initials></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Tien-Hsing</ForeName><Initials>TH</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D064888">Observational Study</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Medicine (Baltimore)</MedlineTA><NlmUniqueID>2985248R</NlmUniqueID><ISSNLinking>0025-7974</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D058186" MajorTopicYN="N">Acute Kidney Injury</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008137" MajorTopicYN="N">Longitudinal Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011655" MajorTopicYN="N">Pulmonary Embolism</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013624" MajorTopicYN="N">Taiwan</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading></MeshHeadingList><CoiStatement>The authors have no conflicts of interest to disclose.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2017</Year><Month>3</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2017</Year><Month>3</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2017</Year><Month>3</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2017</Year><Month>3</Month><Day>3</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">28248851</ArticleId><ArticleId IdType="pmc">PMC5340424</ArticleId><ArticleId IdType="doi">10.1097/MD.0000000000005822</ArticleId><ArticleId IdType="pii">00005792-201703030-00002</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Chertow GM, Burdick E, Honour M, et al. Acute kidney injury, mortality, length of stay, and costs in hospitalized patients. J Am Soc Nephrol 2005;16:3365&#x2013;70.</Citation><ArticleIdList><ArticleId IdType="pubmed">16177006</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen YC, Tsai FC, Chang CH, et al. Prognosis of patients on extracorporeal membrane oxygenation: the impact of acute kidney injury on mortality. Ann Thorac Surg 2011;91:137&#x2013;42.</Citation><ArticleIdList><ArticleId IdType="pubmed">21172502</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang CH, Chang CH, Chen TH, et al. Combination of urinary biomarkers improves early detection of acute kidney injury in ppatients With heart failure. Circ J 2016;80:1017&#x2013;23.</Citation><ArticleIdList><ArticleId IdType="pubmed">26888148</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen TH, Chang CH, Lin CY, et al. Acute kidney injury biomarkers for patients in a coronary care unit: a prospective cohort study. PloS One 2012;7:e32328.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3285210</ArticleId><ArticleId IdType="pubmed">22384218</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang CH, Lee CC, Chen SW, et al. Predicting acute kidney injury following mitral valve repair. Int J Med Sci 2016;13:19&#x2013;24.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4716816</ArticleId><ArticleId IdType="pubmed">26816491</ArticleId></ArticleIdList></Reference><Reference><Citation>Kostrubiec M, Pruszczyk P, Bochowicz A, et al. Biomarker-based risk assessment model in acute pulmonary embolism. Eur Heart J 2005;26:2166&#x2013;72.</Citation><ArticleIdList><ArticleId IdType="pubmed">15911566</ArticleId></ArticleIdList></Reference><Reference><Citation>Goldhaber SZ, Visani L, De Rosa M. Acute pulmonary embolism: clinical outcomes in the International Cooperative Pulmonary Embolism Registry (ICOPER). Lancet 1999;353:1386&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">10227218</ArticleId></ArticleIdList></Reference><Reference><Citation>Kostrubiec M, Labyk A, Pedowska-Wloszek J, et al. Neutrophil gelatinase-associated lipocalin, cystatin C and eGFR indicate acute kidney injury and predict prognosis of patients with acute pulmonary embolism. Heart 2012;98:1221&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">22705926</ArticleId></ArticleIdList></Reference><Reference><Citation>Hsing AW, Ioannidis JP. Nationwide population science: lessons from the Taiwan National Health Insurance Research Database. JAMA Int Med 2015;175:1527&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">26192815</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen DY, Mao CT, Tsai ML, et al. Clinical outcomes of drug-eluting stents versus bare-metal stents in patients with cardiogenic shock complicating acute myocardial infarction. Int J Cardiol 2016;215:98&#x2013;104.</Citation><ArticleIdList><ArticleId IdType="pubmed">27111168</ArticleId></ArticleIdList></Reference><Reference><Citation>Wiener RS, Schwartz LM, Woloshin S. Time trends in pulmonary embolism in the United States: evidence of overdiagnosis. Arch Int Med 2011;171:831&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3140219</ArticleId><ArticleId IdType="pubmed">21555660</ArticleId></ArticleIdList></Reference><Reference><Citation>Tagalakis V, Patenaude V, Kahn SR, et al. Incidence of and mortality from venous thromboembolism in a real-world population: the Q-VTE Study Cohort. Am J Med 2013;126: 832.e813-821.</Citation><ArticleIdList><ArticleId IdType="pubmed">23830539</ArticleId></ArticleIdList></Reference><Reference><Citation>Schrier RW, Bansal S. Pulmonary hypertension, right ventricular failure, and kidney: different from left ventricular failure? Clin J Am Soc Nephrol 2008;3:1232&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4571151</ArticleId><ArticleId IdType="pubmed">18614776</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Dorzi HM, Al-Heijan A, Tamim HM, et al. Renal failure as a risk factor for venous thromboembolism in critically Ill patients: a cohort study. Thrombosis Res 2013;132:671&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="pubmed">24144445</ArticleId></ArticleIdList></Reference><Reference><Citation>Coca SG, Singanamala S, Parikh CR. Chronic kidney disease after acute kidney injury: a systematic review and meta-analysis. Kidney Int 2012;81:442&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3788581</ArticleId><ArticleId IdType="pubmed">22113526</ArticleId></ArticleIdList></Reference><Reference><Citation>James MT, Ghali WA, Tonelli M, et al. Acute kidney injury following coronary angiography is associated with a long-term decline in kidney function. Kidney Int 2010;78:803&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">20686453</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">25047161</PMID><DateCompleted><Year>2014</Year><Month>12</Month><Day>16</Day></DateCompleted><DateRevised><Year>2022</Year><Month>04</Month><Day>09</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1434-3916</ISSN><JournalIssue CitedMedium="Internet"><Volume>134</Volume><Issue>11</Issue><PubDate><Year>2014</Year><Month>Nov</Month></PubDate></JournalIssue><Title>Archives of orthopaedic and trauma surgery</Title><ISOAbbreviation>Arch Orthop Trauma Surg</ISOAbbreviation></Journal><ArticleTitle>Complications after arthroscopic knee surgery.</ArticleTitle><Pagination><StartPage>1561</StartPage><EndPage>1564</EndPage><MedlinePgn>1561-4</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s00402-014-2054-0</ELocationID><Abstract><AbstractText Label="PURPOSE" NlmCategory="OBJECTIVE">To examine the complications of arthroscopic knee surgeries conducted in the Sports Medicine and Knee Center of our hospital.</AbstractText><AbstractText Label="SUBJECTS AND METHODS" NlmCategory="METHODS">In this prospective study, a total of 2,623 patients (1,396 men and 1,227 women) who underwent arthroscopic knee surgeries in our center between January 2006 and March 2013 (7&#xa0;years and 3&#xa0;months) were studied. The ages at surgery ranged 7-96&#xa0;years (mean 33.5&#xa0;years). Arthroscopy was conducted because of sports injuries in 1,653 patients (63.0&#xa0;%). The main diagnoses included meniscal injury in 920 patients, discoid meniscus in 64 patients, anterior cruciate ligament injury in 580 knees, posterior cruciate ligament injury in 30 knees, loose body in 61 knees, and intraarticular fracture in 33 knees. Arthroscopic procedures included meniscectomy in 987 knees, meniscal suture repair in 262 knees, and anterior cruciate ligament reconstruction in 508 knees. Intraoperative and postoperative complications in these cases were investigated.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">The rate of complication was 7 in 2,623 cases (0.27&#xa0;%). Intraoperative complications comprised three cases of intraarticular instrument breakage and one case of meniscal injury. Postoperative complications consisted of two cases of septic arthritis and one case of superficial infection, and reoperation was necessary in the two cases of septic arthritis. There were no neural, vascular and ligament injuries during surgery, and no complex regional pain syndrome, symptomatic deep vein thrombosis, and pulmonary embolism were observed.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Arthroscopic knee surgeries are considered to be minimally invasive, and are conducted relatively safe with low complication rates. In this series, however, seven cases of complications occurred, including two cases (0.08&#xa0;%) of septic arthritis. Furthermore, symptomatic thromboembolism has been reported to occur also in arthroscopic surgery. The risk of severe complications has to be acknowledged.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Hagino</LastName><ForeName>Tetsuo</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>The Sports Medicine and Knee Center, Kofu National Hospital, 11-35 Tenjin-cho, Kofu, Yamanashi, 400-8533, Japan, tmhagino@amber.plala.or.jp.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ochiai</LastName><ForeName>Satoshi</ForeName><Initials>S</Initials></Author><Author ValidYN="Y"><LastName>Watanabe</LastName><ForeName>Yoshiyuki</ForeName><Initials>Y</Initials></Author><Author ValidYN="Y"><LastName>Senga</LastName><ForeName>Shinya</ForeName><Initials>S</Initials></Author><Author ValidYN="Y"><LastName>Wako</LastName><ForeName>Masanori</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Ando</LastName><ForeName>Takashi</ForeName><Initials>T</Initials></Author><Author ValidYN="Y"><LastName>Sato</LastName><ForeName>Eiichi</ForeName><Initials>E</Initials></Author><Author ValidYN="Y"><LastName>Haro</LastName><ForeName>Hirotaka</ForeName><Initials>H</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2014</Year><Month>07</Month><Day>22</Day></ArticleDate></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>Arch Orthop Trauma Surg</MedlineTA><NlmUniqueID>9011043</NlmUniqueID><ISSNLinking>0936-8051</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001182" MajorTopicYN="N">Arthroscopy</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007431" MajorTopicYN="N">Intraoperative Complications</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007718" MajorTopicYN="N">Knee Injuries</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007719" MajorTopicYN="N">Knee Joint</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016119" MajorTopicYN="N">Posterior Cruciate Ligament</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012086" MajorTopicYN="N">Reoperation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017695" MajorTopicYN="N">Soft Tissue Injuries</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2014</Year><Month>2</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2014</Year><Month>7</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2014</Year><Month>7</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2014</Year><Month>12</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">25047161</ArticleId><ArticleId IdType="doi">10.1007/s00402-014-2054-0</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">29723672</PMID><DateCompleted><Year>2018</Year><Month>09</Month><Day>28</Day></DateCompleted><DateRevised><Year>2025</Year><Month>06</Month><Day>23</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1743-9159</ISSN><JournalIssue CitedMedium="Internet"><Volume>54</Volume><Issue>Pt A</Issue><PubDate><Year>2018</Year><Month>Jun</Month></PubDate></JournalIssue><Title>International journal of surgery (London, England)</Title><ISOAbbreviation>Int J Surg</ISOAbbreviation></Journal><ArticleTitle>Tranexamic acid versus aminocaproic acid for blood management after total knee and total hip arthroplasty: A systematic review and meta-analysis.</ArticleTitle><Pagination><StartPage>105</StartPage><EndPage>112</EndPage><MedlinePgn>105-112</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.ijsu.2018.04.042</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S1743-9191(18)30729-5</ELocationID><Abstract><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">To compare the efficacy and safety of tranexamic acid and aminocaproic acid for reducing blood loss and transfusion requirements after total knee and total hip arthroplasty.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">We conduct electronic searches of Medline (1966-2017.11), PubMed (1966-2017.11), Embase (1980-2017.11), ScienceDirect (1985-2017.11) and the Cochrane Library (1900-2017.11). The primary outcomes, including total blood loss, hemoglobin decline and transfusion requirements. Secondary outcomes include length of hospital stay and postoperative complications such as the incidence of deep vein thrombosis and pulmonary embolism. Each outcome is combined and calculated using the statistical software STATA 12.0. Fixed/random effect model is adopted based on the heterogeneity tested by I<sup>2</sup> statistic.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">A total of 1714 patients are analyzed across three randomized controlled trials (RCTs) and one non-RCT. The present meta-analysis reveals that TXA is associated with a significantly reduction of total blood loss and postoperative hemoglobin drop compared with EACA. No significant differences are identified in terms of transfusion rates, length of hospital stay, and the incidence of postoperative complications.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Although total blood loss and postoperative hemoglobin drop are significant greater in EACA groups, there is no significant difference between TXA and EACA groups in terms of transfusion rates. Based on the current evidence available, higher quality RCTs are still required for further research.</AbstractText><CopyrightInformation>Copyright &#xa9; 2018 IJS Publishing Group Ltd. Published by Elsevier Ltd. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Qiuliang</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>Department of Pediatric Surgery, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, 450052, Henan, China. Electronic address: liuqiuliang1919@sina.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Geng</LastName><ForeName>Peishuo</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Pediatric Surgery, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, 450052, Henan, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shi</LastName><ForeName>Longyan</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Pediatric Surgery, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, 450052, Henan, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Qi</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>Department of Pediatric Surgery, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, 450052, Henan, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Pengliang</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Pediatric Surgery, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, 450052, Henan, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D003160">Comparative Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>05</Month><Day>01</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Int J Surg</MedlineTA><NlmUniqueID>101228232</NlmUniqueID><ISSNLinking>1743-9159</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000933">Antifibrinolytic Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D006454">Hemoglobins</NameOfSubstance></Chemical><Chemical><RegistryNumber>6T84R30KC1</RegistryNumber><NameOfSubstance UI="D014148">Tranexamic Acid</NameOfSubstance></Chemical><Chemical><RegistryNumber>U6F3787206</RegistryNumber><NameOfSubstance UI="D015119">Aminocaproic Acid</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015119" MajorTopicYN="N">Aminocaproic Acid</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000933" MajorTopicYN="N">Antifibrinolytic Agents</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019644" MajorTopicYN="N">Arthroplasty, Replacement, Hip</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019645" MajorTopicYN="N">Arthroplasty, Replacement, Knee</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016063" MajorTopicYN="N">Blood Loss, Surgical</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001803" MajorTopicYN="N">Blood Transfusion</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006454" MajorTopicYN="N">Hemoglobins</DescriptorName><QualifierName UI="Q000032" MajorTopicYN="N">analysis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007902" MajorTopicYN="N">Length of Stay</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017713" MajorTopicYN="N">Platelet Transfusion</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011184" MajorTopicYN="N">Postoperative Period</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011655" MajorTopicYN="N">Pulmonary Embolism</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014148" MajorTopicYN="N">Tranexamic Acid</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020246" MajorTopicYN="N">Venous Thrombosis</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Aminocaproic acid</Keyword><Keyword MajorTopicYN="N">Blood loss</Keyword><Keyword MajorTopicYN="N">Meta-analysis</Keyword><Keyword MajorTopicYN="N">Total hip arthroplasty</Keyword><Keyword MajorTopicYN="N">Total knee arthroplasty</Keyword><Keyword MajorTopicYN="N">Tranexamic acid</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>11</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2018</Year><Month>4</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>4</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>5</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>10</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>5</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29723672</ArticleId><ArticleId IdType="doi">10.1016/j.ijsu.2018.04.042</ArticleId><ArticleId IdType="pii">S1743-9191(18)30729-5</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">40128110</PMID><DateCompleted><Year>2025</Year><Month>05</Month><Day>14</Day></DateCompleted><DateRevised><Year>2025</Year><Month>05</Month><Day>14</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1535-3907</ISSN><JournalIssue CitedMedium="Internet"><Volume>24</Volume><Issue>4</Issue><PubDate><Year>2025</Year><Month>Apr</Month><Day>04</Day></PubDate></JournalIssue><Title>Journal of proteome research</Title><ISOAbbreviation>J Proteome Res</ISOAbbreviation></Journal><ArticleTitle>Identification of Serum Metabolites to Improve Diagnostic Efficacy in Pulmonary Embolism.</ArticleTitle><Pagination><StartPage>1885</StartPage><EndPage>1894</EndPage><MedlinePgn>1885-1894</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1021/acs.jproteome.4c00863</ELocationID><Abstract><AbstractText>Pulmonary embolism (PE) is a life-threatening disease. Our aim was to search for potential biomarkers by using modern high-throughput metabolomics methods to improve diagnostic efficacy. The discovery cohort included 60 participants, including 30 PE patients and 30 healthy individuals. The validation cohort included 40 participants, including 20 PE patients and 20 healthy individuals. Gas chromatography-mass spectrometry (GC-MS) was combined with multivariate data analysis to determine serum metabolic profiles in patients with PE and healthy controls. The distribution of metabolic profiles in the two cohorts was assessed by unsupervised principal component analysis (PCA) and supervised partial least-squares discriminant analysis (PLS-DA). Sixteen metabolites were initially selected from the ranked variable of predictive importance (VIP) scores and applied to the correlation analysis of PE-related clinical indicators. Four metabolites that were correlated with D-dimer levels were selected, including l-tryptophan, <i>N</i>-alpha-acetyl-l-lysine, dopamine, and <i>N</i><sup>2</sup>-acetylornithine. Finally, the AUC values were calculated to be 0.958 (95% CI: 0.9072-1) for the combined biomarker panel, including the 4 specific metabolites in the discovery cohort, and 0.963 (95% CI: 0.9122-1) in the validation cohort. The results suggest that these four specific metabolites can be used as diagnostic biomarkers to improve diagnostic efficacy in pulmonary embolism.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Shili</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Shanghai Key Laboratory of Biliary Tract Disease Research, Department of General Surgery, Xinhua Hospital Affiliated to Shanghai Jiaotong University School of Medicine, Shanghai 200092, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xu</LastName><ForeName>Xue</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Respiratory Medicine, Xinhua Hospital Affiliated to Shanghai Jiaotong University School of Medicine, Shanghai 200092, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Xiaoming</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Respiratory Medicine, Xinhua Hospital Affiliated to Shanghai Jiaotong University School of Medicine, Shanghai 200092, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Qin</LastName><ForeName>Qiangqiang</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>Department of Respiratory Medicine, Xinhua Hospital Affiliated to Shanghai Jiaotong University School of Medicine, Shanghai 200092, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhu</LastName><ForeName>Guiyin</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Respiratory Medicine, Xinhua Hospital Affiliated to Shanghai Jiaotong University School of Medicine, Shanghai 200092, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yu</LastName><ForeName>Haiyang</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Respiratory Medicine, Xinhua Hospital Affiliated to Shanghai Jiaotong University School of Medicine, Shanghai 200092, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Du</LastName><ForeName>Kun</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Clinical Laboratory, Xinhua Hospital Affiliated to Shanghai Jiaotong University School of Medicine, Shanghai 200092, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Xueting</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Respiratory Medicine, Xinhua Hospital Affiliated to Shanghai Jiaotong University School of Medicine, Shanghai 200092, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ye</LastName><ForeName>Wenjing</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Department of Respiratory Medicine, Xinhua Hospital Affiliated to Shanghai Jiaotong University School of Medicine, Shanghai 200092, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gu</LastName><ForeName>Wen</ForeName><Initials>W</Initials><Identifier Source="ORCID">0000-0003-1414-0605</Identifier><AffiliationInfo><Affiliation>Department of Respiratory Medicine, Xinhua Hospital Affiliated to Shanghai Jiaotong University School of Medicine, Shanghai 200092, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>03</Month><Day>24</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Proteome Res</MedlineTA><NlmUniqueID>101128775</NlmUniqueID><ISSNLinking>1535-3893</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015415">Biomarkers</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D005338">Fibrin Fibrinogen Degradation Products</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C036309">fibrin fragment D</NameOfSubstance></Chemical><Chemical><RegistryNumber>8DUH1N11BX</RegistryNumber><NameOfSubstance UI="D014364">Tryptophan</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011655" MajorTopicYN="Y">Pulmonary Embolism</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015415" MajorTopicYN="N">Biomarkers</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008401" MajorTopicYN="N">Gas Chromatography-Mass Spectrometry</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055432" MajorTopicYN="Y">Metabolomics</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D025341" MajorTopicYN="N">Principal Component Analysis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005338" MajorTopicYN="N">Fibrin Fibrinogen Degradation Products</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000032" MajorTopicYN="N">analysis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D055442" MajorTopicYN="Y">Metabolome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016022" MajorTopicYN="N">Case-Control Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014364" MajorTopicYN="N">Tryptophan</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016002" MajorTopicYN="N">Discriminant Analysis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">diagnostic biomarker</Keyword><Keyword MajorTopicYN="N">mass spectrometry</Keyword><Keyword MajorTopicYN="N">metabolomics</Keyword><Keyword MajorTopicYN="N">pulmonary embolism</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>4</Month><Day>4</Day><Hour>6</Hour><Minute>25</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>3</Month><Day>25</Day><Hour>0</Hour><Minute>38</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>3</Month><Day>24</Day><Hour>23</Hour><Minute>3</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">40128110</ArticleId><ArticleId IdType="doi">10.1021/acs.jproteome.4c00863</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">30989803</PMID><DateCompleted><Year>2020</Year><Month>09</Month><Day>22</Day></DateCompleted><DateRevised><Year>2025</Year><Month>07</Month><Day>11</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1445-2197</ISSN><JournalIssue CitedMedium="Internet"><Volume>89</Volume><Issue>10</Issue><PubDate><Year>2019</Year><Month>Oct</Month></PubDate></JournalIssue><Title>ANZ journal of surgery</Title><ISOAbbreviation>ANZ J Surg</ISOAbbreviation></Journal><ArticleTitle>Safety and effectiveness of aspirin and enoxaparin for venous thromboembolism prophylaxis after total hip and knee arthroplasty: a systematic review.</ArticleTitle><Pagination><StartPage>1204</StartPage><EndPage>1210</EndPage><MedlinePgn>1204-1210</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1111/ans.15122</ELocationID><Abstract><AbstractText Label="BACKGROUND">Patients undergoing total hip arthroplasty (THA) or total knee arthroplasty (TKA) are at risk of venous thromboembolism (VTE). Australian orthopaedic guidelines recommend aspirin and low-molecular-weight heparin (e.g. enoxaparin) for VTE prophylaxis; however, there is debate in the international literature around the use of aspirin as VTE prophylaxis. This review assesses the risks and benefits of aspirin compared to enoxaparin as VTE prophylaxis for patients undergoing THA or TKA.</AbstractText><AbstractText Label="METHODS">A systematic review was conducted to identify relevant randomized controlled trials. Studies comparing enoxaparin, aspirin and/or placebo for VTE prophylaxis in THA or TKA patients were included. Network meta-analysis (NMA) was performed to calculate risk ratios (RRs) and confidence intervals (CIs). Quality appraisal was conducted by assessing risk of bias and the strength of the evidence.</AbstractText><AbstractText Label="RESULTS">Nine randomized controlled trials were eligible for inclusion. The NMA found no statistically significant differences for the investigated outcomes: total DVT rates (RR&#x2009;=&#x2009;1.21, 95% CI 0.86, 1.72), symptomatic pulmonary embolism (PE) rates (RR&#x2009;=&#x2009;1.02, 95% CI 0.02, 50.86), major haemorrhage (RR&#x2009;=&#x2009;0.97, 95% CI 0.02, 50.99) and wound complication (RR&#x2009;=&#x2009;0.73, 95% CI 0.17, 3.20). The occurrence of PE was rare. Due to limited data, sub-group analysis was not possible. The overall quality of evidence in the NMA is considered to be very low.</AbstractText><AbstractText Label="CONCLUSION">This review did not find statistically significant differences between aspirin and enoxaparin. Future studies should identify more evidence, particularly for rare outcomes such as PE, as this might help decision-makers to get consensus on the use of aspirin as VTE prophylaxis.</AbstractText><CopyrightInformation>&#xa9; 2019 Royal Australasian College of Surgeons.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Nadi</LastName><ForeName>Sinan</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0001-7882-9079</Identifier><AffiliationInfo><Affiliation>Research and Evaluation, Incorporating ASERNIP-S, Royal Australasian College of Surgeons, Adelaide, South Australia, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Epidemiology, Biostatistics and HTA, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vreugdenburg</LastName><ForeName>Thomas D</ForeName><Initials>TD</Initials><Identifier Source="ORCID">0000-0003-3265-3551</Identifier><AffiliationInfo><Affiliation>Research and Evaluation, Incorporating ASERNIP-S, Royal Australasian College of Surgeons, Adelaide, South Australia, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Atukorale</LastName><ForeName>Yasoba</ForeName><Initials>Y</Initials><Identifier Source="ORCID">0000-0003-3848-9289</Identifier><AffiliationInfo><Affiliation>Research and Evaluation, Incorporating ASERNIP-S, Royal Australasian College of Surgeons, Adelaide, South Australia, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ma</LastName><ForeName>Ning</ForeName><Initials>N</Initials><Identifier Source="ORCID">0000-0002-3191-8688</Identifier><AffiliationInfo><Affiliation>Research and Evaluation, Incorporating ASERNIP-S, Royal Australasian College of Surgeons, Adelaide, South Australia, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Maddern</LastName><ForeName>Guy</ForeName><Initials>G</Initials><Identifier Source="ORCID">0000-0003-2064-181X</Identifier><AffiliationInfo><Affiliation>Research and Evaluation, Incorporating ASERNIP-S, Royal Australasian College of Surgeons, Adelaide, South Australia, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Discipline of Surgery, The University of Adelaide and The Queen Elizabeth Hospital, Adelaide, South Australia, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rovers</LastName><ForeName>Maroeska</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-3095-170X</Identifier><AffiliationInfo><Affiliation>Department of Epidemiology, Biostatistics and HTA, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><Agency>Royal Australasian College of Surgeons</Agency><Country>International</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D000099094">Network Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2019</Year><Month>04</Month><Day>15</Day></ArticleDate></Article><MedlineJournalInfo><Country>Australia</Country><MedlineTA>ANZ J Surg</MedlineTA><NlmUniqueID>101086634</NlmUniqueID><ISSNLinking>1445-1433</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>R16CO5Y76E</RegistryNumber><NameOfSubstance UI="D001241">Aspirin</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D017984">Enoxaparin</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D005343">Fibrinolytic Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D006495">Heparin, Low-Molecular-Weight</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D010919">Placebos</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>ANZ J Surg. 2019 Oct;89(10):1184-1185. doi: 10.1111/ans.15420.</RefSource><PMID Version="1">31621169</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019644" MajorTopicYN="Y">Arthroplasty, Replacement, Hip</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019645" MajorTopicYN="Y">Arthroplasty, Replacement, Knee</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001241" MajorTopicYN="Y">Aspirin</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001315" MajorTopicYN="N" Type="Geographic">Australia</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016022" MajorTopicYN="N">Case-Control Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004359" MajorTopicYN="N">Drug Therapy, Combination</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017984" MajorTopicYN="Y">Enoxaparin</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005343" MajorTopicYN="Y">Fibrinolytic Agents</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006495" MajorTopicYN="N">Heparin, Low-Molecular-Weight</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009985" MajorTopicYN="N">Orthopedics</DescriptorName><QualifierName UI="Q000458" MajorTopicYN="N">organization &amp; administration</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010919" MajorTopicYN="N">Placebos</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017410" MajorTopicYN="N">Practice Guidelines as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016032" MajorTopicYN="N">Randomized Controlled Trials as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012449" MajorTopicYN="N">Safety</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D054556" MajorTopicYN="Y">Venous Thromboembolism</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">arthroplasty</Keyword><Keyword MajorTopicYN="N">aspirin</Keyword><Keyword MajorTopicYN="N">deep vein</Keyword><Keyword MajorTopicYN="N">enoxaparin</Keyword><Keyword MajorTopicYN="N">thromboembolism</Keyword><Keyword MajorTopicYN="N">thrombosis</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2018</Year><Month>11</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2019</Year><Month>1</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2019</Year><Month>1</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>4</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>9</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>4</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">30989803</ArticleId><ArticleId IdType="doi">10.1111/ans.15122</ArticleId></ArticleIdList><ReferenceList><Title>References</Title><Reference><Citation>White RH, Henderson MC. Risk factors for venous thromboembolism after total hip and knee replacement surgery. Curr. Opin. Pulm. Med. 2002; 8: 365-71.</Citation></Reference><Reference><Citation>Arthroplasty Society of Australia. Arthroplasty Society of Australia Guidelines for VTE Prophylaxis for Hip and Knee Arthroplasty. 2017. [Cited 20 Jan 2018.] Available from URL: https://www.aoa.org.au/</Citation></Reference><Reference><Citation>Ricket AL, Stewart DW, Wood RC et al. Comparison of postoperative bleeding in total hip and knee arthroplasty patients receiving rivaroxaban or enoxaparin. Ann. Pharmacother. 2016; 50: 270-5.</Citation></Reference><Reference><Citation>Guijarro R, Montes J, San Roman C et al. Venous thromboembolism and bleeding after total knee and hip arthroplasty. Findings from the Spanish National Discharge Database. Thromb. Haemost. 2011; 105: 610-5.</Citation></Reference><Reference><Citation>National Institute of Clinical Excellence. Venous Thromboembolism: Reducing the Risk for Patients in Hospital. 2015. [Cited 22 Jan 2018.] Available from URL: https://www.nice.org.uk/Guidance/CG92</Citation></Reference><Reference><Citation>Cooke A, Smith D, Booth A. Beyond PICO: the SPIDER tool for qualitative evidence synthesis. Qual. Health Res. 2012; 22: 1435-43.</Citation></Reference><Reference><Citation>Sterne J, Becker B, Egger M. The funnel plot. In: Publication Bias in Meta-Analysis: Prevention, Assessment and Adjustments. Chichester, UK: John Wiley &amp; Sons, 2005.</Citation></Reference><Reference><Citation>Higgins J, Sterne J, Savovi&#x107; J et al. A revised tool for assessing risk of bias in randomized trials. Cochrane Database Syst. Rev. 2016; 10(Suppl 1): 29-31.</Citation></Reference><Reference><Citation>Balshem H, Helfand M, Schunemann HJ et al. GRADE guidelines: 3. Rating the quality of evidence. J. Clin. Epidemiol. 2011; 64: 401-6.</Citation></Reference><Reference><Citation>GRADEpro GDT: GRADEpro Guideline Development Tool [Software]. McMaster University, 2015 (developed by Evidence Prime, Inc.). Available from gradepro.org</Citation></Reference><Reference><Citation>Zou Y, Tian S, Wang Y, Sun K. Administering aspirin, rivaroxaban and low-molecular-weight heparin to prevent deep venous thrombosis after total knee arthroplasty. Blood Coagul. Fibrinolysis 2014; 25: 660-4.</Citation></Reference><Reference><Citation>Westrich GH, Bottner F, Windsor RE, Laskin RS, Haas SB, Sculco TP. VenaFlow plus Lovenox vs VenaFlow plus aspirin for thromboembolic disease prophylaxis in total knee arthroplasty. J. Arthroplasty 2006; 21: 139-43.</Citation></Reference><Reference><Citation>Chin PL, Amin MS, Yang KY, Yeo SJ, Lo NN. Thromboembolic prophylaxis for total knee arthroplasty in Asian patients: a randomised controlled trial. J. Orthop. Surg. (Hong Kong) 2009; 17: 1-5.</Citation></Reference><Reference><Citation>Fuji T, Ochi T, Niwa S, Fujita S. Prevention of postoperative venous thromboembolism in Japanese patients undergoing total hip or knee arthroplasty: two randomized, double-blind, placebo-controlled studies with three dosage regimens of enoxaparin. J. Orthop. Sci. 2008; 13: 442-51.</Citation></Reference><Reference><Citation>Intiyanaravut T, Thongpulsawasdi N, Sinthuvanich N, Teavirat S, Kunopart M. Enoxaparin versus no anticoagulation prophylaxis after total knee arthroplasty in Thai patients: a randomized controlled trial. J. Med. Assoc. Thai. 2017; 100: 42-9.</Citation></Reference><Reference><Citation>Jain V, Dhal AK, Dhaon BK, Pradhan G. Deep vein thrombosis after total hip arthroplasty in Indian patients with and without enoxaparin. J. Orthop. Surg. (Hong Kong) 2004; 12: 173-7.</Citation></Reference><Reference><Citation>Kim SM, Moon YW, Lim SJ, Kim DW, Park YS. Effect of oral factor Xa inhibitor and low-molecular-weight heparin on surgical complications following total hip arthroplasty. Thromb. Haemost. 2016; 115: 600-7.</Citation></Reference><Reference><Citation>Kim YH, Choi IY, Park MR, Park TS, Cho JL. Prophylaxis for deep vein thrombosis with aspirin or low molecular weight dextran in Korean patients undergoing total hip replacement. A randomized controlled trial. Int. Orthop. 1998; 22: 6-10.</Citation></Reference><Reference><Citation>Rodgers A, MacMahon S, Collins R, Prentice C. Prevention of pulmonary embolism and deep vein thrombosis with low dose aspirin: pulmonary embolism prevention (PEP) trial. Lancet 2000; 355: 1295-302.</Citation></Reference><Reference><Citation>Kapoor A, Ellis A, Shaffer N et al. Comparative effectiveness of venous thromboembolism prophylaxis options for the patient undergoing total hip and knee replacement: a network meta-analysis. J. Thromb. Haemost. 2017; 15: 284-94.</Citation></Reference><Reference><Citation>Quinlan DJ, Eikelboom JW, Dahl OE, Eriksson BI, Sidhu PS, Hirsh J. Association between asymptomatic deep vein thrombosis detected by venography and symptomatic venous thromboembolism in patients undergoing elective hip or knee surgery. J. Thromb. Haemost. 2007; 5: 1438-43.</Citation></Reference><Reference><Citation>Struijk-Mulder MC, Ettema HB, Verheyen CC, Buller HR. Comparing consensus guidelines on thromboprophylaxis in orthopedic surgery. J. Thromb. Haemost. 2010; 8: 678-83.</Citation></Reference><Reference><Citation>Katz JN, Losina E, Barrett J et al. Association between hospital and surgeon procedure volume and outcomes of total hip replacement in the United States medicare population. J. Bone Joint Surg. Am. 2001; 83-a: 1622-9.</Citation></Reference><Reference><Citation>SooHoo NF, Lieberman JR, Ko CY, Zingmond DS. Factors predicting complication rates following total knee replacement. J. Bone Joint Surg. Am. 2006; 88: 480-5.</Citation></Reference><Reference><Citation>American Academy of Orthopedic Surgeons Clinical Guideline on Prevention of Symptomatic Pulmonary Embolism in Patients Undergoing Total Hip or Knee Arthroplasty. 2007. [Cited 22 Jan 2018.] Available from URL: http://www.aaos.org/Research/guidelines/PE_guideline.pdf</Citation></Reference><Reference><Citation>James MJ, Foreman RK, Burnett JR, Cleland LG. Inhibition of human endothelial prostacyclin synthesis by different aspirin formulations. Aust. N. Z. J. Surg. 1991; 61: 849-52.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">32080078</PMID><DateCompleted><Year>2020</Year><Month>03</Month><Day>09</Day></DateCompleted><DateRevised><Year>2022</Year><Month>10</Month><Day>05</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1536-5964</ISSN><JournalIssue CitedMedium="Internet"><Volume>99</Volume><Issue>8</Issue><PubDate><Year>2020</Year><Month>Feb</Month></PubDate></JournalIssue><Title>Medicine</Title><ISOAbbreviation>Medicine (Baltimore)</ISOAbbreviation></Journal><ArticleTitle>Cemented versus uncemented hemi-arthroplasty for femoral neck fractures in elderly patients: A systematic review and meta-analysis of randomized controlled trials.</ArticleTitle><Pagination><StartPage>e19039</StartPage><MedlinePgn>e19039</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e19039</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1097/MD.0000000000019039</ELocationID><Abstract><AbstractText Label="AIM" NlmCategory="OBJECTIVE">To compare the efficacy and safety of cemented and uncemented hemiarthroplasty in elderly patients with femoral neck fracture.</AbstractText><AbstractText Label="MATERIALS AND METHODS" NlmCategory="METHODS">We searched PubMed, EMBASE, and Cochrane Library databases for published randomized clinical trials comparing cemented hemiarthroplasty with uncemented hemiarthroplasty in elderly patients with a femoral neck fracture. The search was not limited to language, time, or other factors. The quality of each study was assessed using the revised Jadad scale. Two researchers independently extracted data from all selected studies, including the following base line data: study period, fracture stage, number of patients, male female ratio, average age, and per-protocol (PP) or intent-to-treat (ITT), and the interest outcomes: the mortality at 12 months, operative time, hospital stay, common complications, prosthetic-related complications, blood loss and Harris Hip Score (HHS). Fixed-effects or random-effects models with mean differences and odds ratios were used to pool the continuous and dichotomous variables to determine heterogeneity of the included studies.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">A total of 8 studies involving 1577 hips (782 uncemented and 795 cemented) were included in this meta-analysis. The meta-analysis is indicated that the operation time of cemented hemiarthroplasty was longer than uncemented hemiarthroplasty and there was statistical significance between two groups (OR&#x200a;=&#x200a;-7.30, 95%CI, -13.13, -1.46; P&#x200a;=&#x200a;.01). However, there was no significant difference between the two methods of fixation in mortality at 12 months (OR&#x200a;=&#x200a;1.22, 95%CI, 0.94-1.59; P&#x200a;=&#x200a;.14), hospital stay (OR&#x200a;=&#x200a;0.26, 95%CI, -0.41, 0.93; P&#x200a;=&#x200a;.44), blood loss (OR&#x200a;=&#x200a;-17.94, 95%CI, -65.83, 29.95; P&#x200a;=&#x200a;.46), and HHS score. There were significant differences in the common complications of pulmonary embolism between the two groups, but there were no differences in the other five common complications. The results showed that uncemented hemiarthroplasty could reduce the incidence of pulmonary embolism after operation. Moreover, the outcomes of prosthetic-related complications showed that there were significant differences between the two groups in periprosthetic fracture (OR&#x200a;=&#x200a;8.32, 95%CI, 3.85-17.98; P&#x200a;&lt;&#x200a;.00001) and prosthetic subsidence and loosening (OR&#x200a;=&#x200a;5.33, 95%CI, 2.18-13.00; P&#x200a;=&#x200a;.0002).</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Our study shows that uncemented prosthesis can shorten the operation time and reduce the incidence of pulmonary embolism, but it does not reduce mortality, blood loss, and hospital stay. Most importantly, the incidence of prosthetic-related complications was higher in uncemented patients.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Na</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Orthopedics, The Second Hospital of Jilin University.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Applied Statistical Research and College of Mathematics, Jilin University.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhong</LastName><ForeName>Lei</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Orthopedics, The Second Hospital of Jilin University.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Chang</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Center for Applied Statistical Research and College of Mathematics, Jilin University.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xu</LastName><ForeName>Meng</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Orthopedics, The Second Hospital of Jilin University.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Wei</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, The First Hospital of Jilin University, Changchun, Jilin, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D003160">Comparative Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Medicine (Baltimore)</MedlineTA><NlmUniqueID>2985248R</NlmUniqueID><ISSNLinking>0025-7974</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D001843">Bone Cements</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016063" MajorTopicYN="N">Blood Loss, Surgical</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001843" MajorTopicYN="N">Bone Cements</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005265" MajorTopicYN="N">Femoral Neck Fractures</DescriptorName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D062785" MajorTopicYN="N">Hemiarthroplasty</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000639" MajorTopicYN="Y">trends</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006622" MajorTopicYN="N">Hip Prosthesis</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015994" MajorTopicYN="N">Incidence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007902" MajorTopicYN="N">Length of Stay</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D061646" MajorTopicYN="N">Operative Time</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011655" MajorTopicYN="N">Pulmonary Embolism</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016032" MajorTopicYN="N">Randomized Controlled Trials as Topic</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>The authors have no conflicts of interest to disclose.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>2</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>2</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>3</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2020</Year><Month>2</Month><Day>21</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32080078</ArticleId><ArticleId IdType="pmc">PMC7034642</ArticleId><ArticleId IdType="doi">10.1097/MD.0000000000019039</ArticleId><ArticleId IdType="pii">00005792-202002210-00008</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Burge R, Dawson-Hughes B, Solomon DH, et al. Incidence and economic burden of osteoporosis-related fractures in the United States, 2005&#x2013;2025. J Bone Miner Res 2007;22:465&#x2013;75.</Citation><ArticleIdList><ArticleId IdType="pubmed">17144789</ArticleId></ArticleIdList></Reference><Reference><Citation>Bhandari M, Devereaux PJ, Tornetta IIIP, et al. Operative management of displaced femoral neck fractures in elderly patients. An international survey. J Bone Joint Surg Am 2005;87:2122&#x2013;30.</Citation><ArticleIdList><ArticleId IdType="pubmed">16140828</ArticleId></ArticleIdList></Reference><Reference><Citation>Crossman PT, Khan RJ, MacDowell A, et al. A survey of the treatment of displaced intracapsular femoral neck fractures in the UK. Injury 2002;33:383&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">12095715</ArticleId></ArticleIdList></Reference><Reference><Citation>Li T, Zhuang Q, Weng X, et al. Cemented versus uncemented hemiarthroplasty for femoral neck fractures in elderly patients: a meta-analysis. PLoS One 2013;8:68903.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3720851</ArticleId><ArticleId IdType="pubmed">23935902</ArticleId></ArticleIdList></Reference><Reference><Citation>Luo X, He S, Li Z, et al. Systematic review of cemented versus uncemented hemiarthroplasty for displaced femoral neck fractures in older patients. Arch Orthop Trauma Surg 2012;132:455&#x2013;63.</Citation><ArticleIdList><ArticleId IdType="pubmed">22160512</ArticleId></ArticleIdList></Reference><Reference><Citation>Ning GZ, Li YL, Wu Q, et al. Cemented versus uncemented hemiarthroplasty for displaced femoral neck fractures: an updated meta-analysis. Eur J Orthop Surg Traumatol 2014;24:7&#x2013;14.</Citation><ArticleIdList><ArticleId IdType="pubmed">23412274</ArticleId></ArticleIdList></Reference><Reference><Citation>Parker MJ, Gurusamy KS, Azegami S. Arthroplasties (with and without bone cement) for proximal femoral fractures in adults. Cochrane Database Syst Rev 2010;6:CD001706.</Citation><ArticleIdList><ArticleId IdType="pubmed">20556753</ArticleId></ArticleIdList></Reference><Reference><Citation>Skyrme AD, Jeer PJ, Berry J, et al. Intravenous polymethyl methacrylate after cemented hemiarthroplasty of the hip. J Arthroplasty 2001;16:521&#x2013;3.</Citation><ArticleIdList><ArticleId IdType="pubmed">11402421</ArticleId></ArticleIdList></Reference><Reference><Citation>Fallon KM, Fuller JG, Morley-Forster P. Fat embolization and fatal cardiac arrest during hip arthroplasty with methylmethacrylate. Can J Anaesth 2001;48:626&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">11495867</ArticleId></ArticleIdList></Reference><Reference><Citation>Hansen SK, Brix M, Birkelund L, et al. Can introduction of an uncemented, hydroxyapatite coated hemiarthroplasty for displaced femoral neck fractures be recommended. Hip Int 2010;20:109&#x2013;14.</Citation><ArticleIdList><ArticleId IdType="pubmed">20235070</ArticleId></ArticleIdList></Reference><Reference><Citation>Figved W, Opland V, Frihagen F, et al. Cemented versus uncemented hemiarthroplasty for displaced femoral neck fractures. Clin Orthop Relat Res 2009;467:2426&#x2013;35.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2866935</ArticleId><ArticleId IdType="pubmed">19130162</ArticleId></ArticleIdList></Reference><Reference><Citation>Deangelis JP, Ademi A, Staff I, et al. Cemented versus uncemented hemiarthroplasty for displaced femoral neck fractures: a prospective randomized trial with early follow-up. J Orthop Trauma 2012;26:135&#x2013;40.</Citation><ArticleIdList><ArticleId IdType="pubmed">22198652</ArticleId></ArticleIdList></Reference><Reference><Citation>Moerman S, Mathijssen NMC, Niesten DD, et al. More complications in uncemented compared to cemented hemiarthroplasty for displaced femoral neck fractures: a randomized controlled trial of 201 patients, with one year follow-up. BMC Musculoskelet Disord 2017;18:169.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5399836</ArticleId><ArticleId IdType="pubmed">28431543</ArticleId></ArticleIdList></Reference><Reference><Citation>Moher D, Liberati A, Tetzlaff J, et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med 2009;6:e1000097.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2707599</ArticleId><ArticleId IdType="pubmed">19621072</ArticleId></ArticleIdList></Reference><Reference><Citation>Vidovic D, Matejcic A, Punda M, et al. Periprosthetic bone loss following hemiarthroplasty: a comparison between cemented and cementless hip prosthesis. Injury 2013;44: Suppl 3: S62&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">24060022</ArticleId></ArticleIdList></Reference><Reference><Citation>Langslet E, Frihagen F, Opland V, et al. Cemented versus uncemented hemiarthroplasty for displaced femoral neck fractures: 5-year followup of a randomized trial. Clin Orthop Relat Res 2014;472:1291&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3940758</ArticleId><ArticleId IdType="pubmed">24081667</ArticleId></ArticleIdList></Reference><Reference><Citation>Emery RJ, Broughton NS, Desai K, et al. Bipolar hemiarthroplasty for subcapital fracture of the femoral neck: a prospective randomised trial of cemented Thompson and uncemented Moore stems. J Bone Joint Surg Br 1991;73:322&#x2013;4.</Citation><ArticleIdList><ArticleId IdType="pubmed">2005165</ArticleId></ArticleIdList></Reference><Reference><Citation>Taylor F, Wright M, Zhu M. Hemiarthroplasty of the hip with and without cement: a randomized clinical trial. J Bone Joint Surg [Am] 2012;94-A:577&#x2013;83.</Citation><ArticleIdList><ArticleId IdType="pubmed">22488613</ArticleId></ArticleIdList></Reference><Reference><Citation>DeAngelis JP, Ademi A, Staff I, et al. Cemented versus uncemented hemiarthroplasty for displaced femoral neck fractures: a prospective randomized trial with early follow-up. J Orthop Trauma 2012;26:135&#x2013;40.</Citation><ArticleIdList><ArticleId IdType="pubmed">22198652</ArticleId></ArticleIdList></Reference><Reference><Citation>Parker MI, Pryor G, Gurusamy K. Cemented versus uncemented hemiarthroplasty for intracapsular hip fractures: a randomised controlled trial in 400 patients. J Bone Joint Surg Br 2010;92:116&#x2013;22.</Citation><ArticleIdList><ArticleId IdType="pubmed">20044689</ArticleId></ArticleIdList></Reference><Reference><Citation>Talsnes O, Hjelmstedt F, Pripp AH. No difference in mortality between cemented and uncemented hemiprosthesis for elderly patients with cervical hip fracture. A prospective randomized study on 334 patients over 75 years. Arch Orthop Trauma Surg 2013;133:805&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">23532371</ArticleId></ArticleIdList></Reference><Reference><Citation>Jadad AR, Moore RA, Carroll D, et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials 1996;17:1&#x2013;2.</Citation><ArticleIdList><ArticleId IdType="pubmed">8721797</ArticleId></ArticleIdList></Reference><Reference><Citation>Khan RJK, MacDowell A, Crossman P, et al. Cemented or uncemented hemiarthroplasty for displaced intracapsular fractures of the hip&#x2014;a systematic review. Injury 2002;33:13&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">11879826</ArticleId></ArticleIdList></Reference><Reference><Citation>Azegami S, Gurusamy KS, Parker MJ. Cemented versus uncemented hemiarthroplasty for hip fractures: a systematic review of randomised controlled trials. Hip Int 2011;21:509&#x2013;17.</Citation><ArticleIdList><ArticleId IdType="pubmed">21948035</ArticleId></ArticleIdList></Reference><Reference><Citation>Lo WH, Chen WM, Huang CK, et al. Bateman bipolar hemiarthroplasty for displaced interacapsular femoral neck fracture: uncemented versus cemented. Clin Orthop Relat Res 1994;302:75&#x2013;82.</Citation><ArticleIdList><ArticleId IdType="pubmed">8168326</ArticleId></ArticleIdList></Reference><Reference><Citation>Faraj AA, Branfoot T. Cemented versus uncemented Thompson prostheses: a functional outcome study. Injury 1999;30:671&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="pubmed">10707241</ArticleId></ArticleIdList></Reference><Reference><Citation>Santini S, Rebeccato A, Bolgan I, et al. Hip fractures in elderly patients treated with bipolar hemiarthroplasty: comparison between cemented and cementless implants. J Orthopaed Traumatol 2005;6:80&#x2013;7.</Citation></Reference><Reference><Citation>Harper WMGP. The treatment of intracapsular proximal femoral fractures: a randomized prospective trial. J Bone Joint Surg Br 1992;74-B:282.</Citation></Reference><Reference><Citation>Jameson SS, Jensen CD, Elson DW, et al. Cemented versus cementless hemiarthroplasty for intracapsular neck of femur fracture&#x2014;a comparison of 60848 matched patients using national data. Injury 2012;44:730&#x2013;4.</Citation><ArticleIdList><ArticleId IdType="pubmed">23206920</ArticleId></ArticleIdList></Reference><Reference><Citation>Tao Li, Qianyu Z, Xisheng W. Cemented versus uncemented hemiarthroplasty for femoral neck fractures in elderly patients: a meta-analysis. PLoS One 2014;8:e68903.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3720851</ArticleId><ArticleId IdType="pubmed">23935902</ArticleId></ArticleIdList></Reference><Reference><Citation>Talsnes O, Vinje T, Gjertsen JE, et al. Perioperative mortality in hip fracture patients treated with cemented and uncemented hemiprosthesis: a register study of 11,210 patients. Int Orthop 2013;37:1135&#x2013;40.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3664168</ArticleId><ArticleId IdType="pubmed">23508867</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh U, Singh K, Waikhom S, et al. A comparative study between cemented and uncemented bipolar hemiarthroplasty in the treatment of fresh fracture of femoral neck in the elderly patients. JMS 2011;1:19&#x2013;23.</Citation></Reference><Reference><Citation>Veldman HD, Heyligers IC, Grimm B. Cemented versus cementless hemiarthroplasty for a displaced fracture of the femoral neck. A systematic review and meta-analysis of current generation hip stems. Bone Joint J 2017;99-B:421&#x2013;31.</Citation><ArticleIdList><ArticleId IdType="pubmed">28385929</ArticleId></ArticleIdList></Reference><Reference><Citation>Clark DI, Ahmed AB, Baxendale BR, et al. Cardiac output during hemiarthroplasty of the hip&#x2014;a prospective, controlled trial of cemented and uncemented prostheses. J Bone Joint Surg Br 2001;83:414&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">11341430</ArticleId></ArticleIdList></Reference><Reference><Citation>Christie J, Burnett R, Potts HR, et al. Echocardiography of transatrial embolism during cemented and uncemented hemiarthroplasty of the hip. J Bone Joint Surg Br 1994;76:409&#x2013;12.</Citation><ArticleIdList><ArticleId IdType="pubmed">8175843</ArticleId></ArticleIdList></Reference><Reference><Citation>Parker MJ, Gurusamy K. Arthroplasties (with and without bone cement) for proximal femoral fractures in adults. Cochrane Database Syst Rev 2006;CD001706.</Citation><ArticleIdList><ArticleId IdType="pubmed">16855974</ArticleId></ArticleIdList></Reference><Reference><Citation>Parvizi J, Holiday AD, Ereth MH, et al. Sudden death during primary hip arthroplasty. Clin Orthop Relat Res 1999;369:39&#x2013;48.</Citation><ArticleIdList><ArticleId IdType="pubmed">10611859</ArticleId></ArticleIdList></Reference><Reference><Citation>Holt EM, Evans RA, Hindley CJ, et al. 1000 femoral neck fractures: the effect of pre-injury mobility and surgical experience on outcome. Injury 1994;25:91&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="pubmed">8138305</ArticleId></ArticleIdList></Reference><Reference><Citation>Donaldson AJ, Thomson HE, Harper NJ, et al. Bone cement implantation syndrome. Br J Anaesth 2009;102:12&#x2013;22.</Citation><ArticleIdList><ArticleId IdType="pubmed">19059919</ArticleId></ArticleIdList></Reference><Reference><Citation>Garellick G, Malchau H, Herberts P. The Charnley versus the Spectron hip prosthesis: clinical evaluation of a randomized, prospective study of 2 different hip implants. J Arthroplasty 1999;14:407&#x2013;13.</Citation><ArticleIdList><ArticleId IdType="pubmed">10428220</ArticleId></ArticleIdList></Reference><Reference><Citation>Grammatopoulos G, Wilson HA, Kendrick BJ, et al. Hemiarthroplasty using cemented or uncemented stems of proven design: a comparative study. Bone Joint J 2015;97-B:94&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">25568420</ArticleId></ArticleIdList></Reference><Reference><Citation>Morris K, Davies H, Wronka K. Implant-related complications following hip hemiarthroplasty: a comparison of modern cemented and uncemented prostheses. Eur J Orthop Surg 2015;25:1161&#x2013;4.</Citation><ArticleIdList><ArticleId IdType="pubmed">26174416</ArticleId></ArticleIdList></Reference><Reference><Citation>Yli-Kyyny T, Ojanper&#xe4; J, Venesmaa P, et al. Perioperative complications after cemented or uncemented hemiarthroplasty in hip fracture patients. Scand J Surg 2013;102:124&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">23820689</ArticleId></ArticleIdList></Reference><Reference><Citation>Gjertsen JE, Lie SA, Vinje T, et al. More re-operations after uncemented than cemented hemiarthroplasty used in the treatment of displaced fractures of the femoral neck: an observational study of 11,116 hemiarthroplasties from a national register. J Bone Joint Surg Br 2012;94:1113&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">22844055</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">38810699</PMID><DateCompleted><Year>2024</Year><Month>08</Month><Day>22</Day></DateCompleted><DateRevised><Year>2025</Year><Month>01</Month><Day>22</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1538-7836</ISSN><JournalIssue CitedMedium="Internet"><Volume>22</Volume><Issue>9</Issue><PubDate><Year>2024</Year><Month>Sep</Month></PubDate></JournalIssue><Title>Journal of thrombosis and haemostasis : JTH</Title><ISOAbbreviation>J Thromb Haemost</ISOAbbreviation></Journal><ArticleTitle>Identification of hemodynamically stable patients with acute pulmonary embolism at high risk for death: external validation of different models.</ArticleTitle><Pagination><StartPage>2502</StartPage><EndPage>2513</EndPage><MedlinePgn>2502-2513</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jtha.2024.04.025</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S1538-7836(24)00302-7</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">The optimal strategy for identification of hemodynamically stable patients with acute pulmonary embolism (PE) at risk for death and clinical deterioration remains undefined.</AbstractText><AbstractText Label="OBJECTIVES" NlmCategory="OBJECTIVE">We aimed to assess the performances of currently available models/scores for identifying hemodynamically stable patients with acute, symptomatic PE at risk of death and clinical deterioration.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">This was a prospective multicenter cohort study including patients with acute PE (NCT03631810). Primary study outcome was in-hospital death within 30 days or clinical deterioration. Other outcomes were in-hospital death, death, and PE-related death, all at 30 days. We calculated positive and negative predictive values, c-statistics of European Society of Cardiology (ESC)-2014, ESC-2019, Pulmonary Embolism Thrombolysis (PEITHO), Bova, Thrombo-embolism lactate outcome study (TELOS), fatty acid binding protein, syncope and tachicardia (FAST), and National Early Warning Scale 2 (NEWS2) for the study outcomes.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">In 5036 hemodynamically stable patients with acute PE, positive predictive values for the evaluated models/scores were all below 10%, except for TELOS and NEWS2; negative predictive values were above 98% for all the models/scores, except for FAST and NEWS2. ESC-2014 and TELOS had good performances for in-hospital death or clinical deterioration (c-statistic of 0.700 and 0.722, respectively), in-hospital death (c-statistic of 0.713 and 0.723, respectively), and PE-related death (c-statistic of 0.712 and 0.777, respectively); PEITHO, Bova, and NEWS2 also had good performances for PE-related death (c-statistic of 0.738, 0.741, and 0.742, respectively).</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">In hemodynamically stable patients with acute PE, the accuracy for identification of hemodynamically stable patients at risk for death and clinical deterioration varies across the available models/scores; TELOS seems to have the best performance. These data can inform management studies and clinical practice.</AbstractText><CopyrightInformation>Copyright &#xa9; 2024 The Author(s). Published by Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Becattini</LastName><ForeName>Cecilia</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Internal, Vascular and Emergency Medicine - Stroke Unit, Department of Medicine and Surgery, University of Perugia, Perugia, Italy. Electronic address: cecilia.becattini@unipg.it.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vedovati</LastName><ForeName>Maria Cristina</ForeName><Initials>MC</Initials><AffiliationInfo><Affiliation>Internal, Vascular and Emergency Medicine - Stroke Unit, Department of Medicine and Surgery, University of Perugia, Perugia, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Colombo</LastName><ForeName>Silvia</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Emergency Department, Niguarda Hospital, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vanni</LastName><ForeName>Simone</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Emergency Department, Saint Joseph Hospital, Empoli, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Abrignani</LastName><ForeName>Maurizio Giuseppe</ForeName><Initials>MG</Initials><AffiliationInfo><Affiliation>Division of Cardiology, Borsellino Hospital, Marsala, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Scardovi</LastName><ForeName>Angela Beatrice</ForeName><Initials>AB</Initials><AffiliationInfo><Affiliation>Division of Cardiology, Saint Spirit Hospital, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Marrazzo</LastName><ForeName>Alessandra</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>General Medicine, Pavullo nel Frignano Hospital, Pavullo nel Frignano, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Borselli</LastName><ForeName>Matteo</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Emergency Department, Misericordia Hospital, Grosseto, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Barchetti</LastName><ForeName>Marco</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Emergency Medicine, Sassuolo Hospital, Sassuolo, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fabbri</LastName><ForeName>Andrea</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Emergency Department, Romagna Hospital, Forl&#xec;, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dentali</LastName><ForeName>Francesco</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Medicine and Surgery, University of Insubria, Varese, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Maggioni</LastName><ForeName>Aldo Pietro</ForeName><Initials>AP</Initials><AffiliationInfo><Affiliation>ANMCO (Associazione Nazionale Medici Cardiologi Ospedalieri) Research Center, Heart Cre Foundation, Florence, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Agnelli</LastName><ForeName>Giancarlo</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Internal, Vascular and Emergency Medicine - Stroke Unit, Department of Medicine and Surgery, University of Perugia, Perugia, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gulizia</LastName><ForeName>Michele M</ForeName><Initials>MM</Initials><AffiliationInfo><Affiliation>Division of Cardiology, Garibaldi-Nesima Hospital, Catania, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><CollectiveName>COntemporary management of Pulmonary Embolism (COPE) Investigators</CollectiveName></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016448">Multicenter Study</PublicationType><PublicationType UI="D023361">Validation Study</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>05</Month><Day>27</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>J Thromb Haemost</MedlineTA><NlmUniqueID>101170508</NlmUniqueID><ISSNLinking>1538-7836</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000208" MajorTopicYN="N">Acute Disease</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003661" MajorTopicYN="N">Decision Support Techniques</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017052" MajorTopicYN="Y">Hospital Mortality</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011237" MajorTopicYN="N">Predictive Value of Tests</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011379" MajorTopicYN="N">Prognosis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011655" MajorTopicYN="Y">Pulmonary Embolism</DescriptorName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015203" MajorTopicYN="N">Reproducibility of Results</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018570" MajorTopicYN="N">Risk Assessment</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013997" MajorTopicYN="N">Time Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008962" MajorTopicYN="Y">Models, Theoretical</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">mortality</Keyword><Keyword MajorTopicYN="N">pulmonary embolism</Keyword><Keyword MajorTopicYN="N">right ventricle</Keyword><Keyword MajorTopicYN="N">risk stratification</Keyword></KeywordList><CoiStatement>Declaration of competing interests None of the authors have conflicts of interest related to this manuscript.</CoiStatement><InvestigatorList><Investigator ValidYN="Y"><LastName>Becattini</LastName><ForeName>Cecilia</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Gulizia</LastName><ForeName>Michele M</ForeName><Initials>MM</Initials></Investigator><Investigator ValidYN="Y"><LastName>Agnelli</LastName><ForeName>Giancarlo</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>Dentali</LastName><ForeName>Francesco</ForeName><Initials>F</Initials></Investigator><Investigator ValidYN="Y"><LastName>Di Lenarda</LastName><ForeName>Andrea</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Enea</LastName><ForeName>Iolanda</ForeName><Initials>I</Initials></Investigator><Investigator ValidYN="Y"><LastName>Fabbri</LastName><ForeName>Andrea</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Maggioni</LastName><ForeName>Aldo P</ForeName><Initials>AP</Initials></Investigator><Investigator ValidYN="Y"><LastName>Pomero</LastName><ForeName>Fulvio</ForeName><Initials>F</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ruggeri</LastName><ForeName>Maria Pia</ForeName><Initials>MP</Initials></Investigator><Investigator ValidYN="Y"><LastName>Becattini</LastName><ForeName>Cecilia</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Lucci</LastName><ForeName>Donata</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Maggioni</LastName><ForeName>Aldo P</ForeName><Initials>AP</Initials></Investigator><Investigator ValidYN="Y"><LastName>Vedovati</LastName><ForeName>Maria Cristina</ForeName><Initials>MC</Initials></Investigator><Investigator ValidYN="Y"><LastName>Duranti</LastName><ForeName>Michele</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Guercini</LastName><ForeName>Francesco</ForeName><Initials>F</Initials></Investigator><Investigator ValidYN="Y"><LastName>Groff</LastName><ForeName>Paolo</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Verso</LastName><ForeName>Melina</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Fabbri</LastName><ForeName>Gianna</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>Savoia</LastName><ForeName>Martina</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Lucci</LastName><ForeName>Donata</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Baldini</LastName><ForeName>Ester</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Mecatti</LastName><ForeName>Barbara Bartolomei</ForeName><Initials>BB</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bianchini</LastName><ForeName>Francesca</ForeName><Initials>F</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ceseri</LastName><ForeName>Martina</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Fabbri</LastName><ForeName>Gianna</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>Gonzini</LastName><ForeName>Lucio</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Gorini</LastName><ForeName>Marco</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Lorimer</LastName><ForeName>Andrea</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Orsini</LastName><ForeName>Giampietro</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>Tricoli</LastName><ForeName>Martina</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Cimini</LastName><ForeName>L A</ForeName><Initials>LA</Initials></Investigator><Investigator ValidYN="Y"><LastName>Becattini</LastName><ForeName>C</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Agnelli</LastName><ForeName>G</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>Cesarini</LastName><ForeName>V</ForeName><Initials>V</Initials></Investigator><Investigator ValidYN="Y"><LastName>Sanna</LastName><ForeName>M</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Pepe</LastName><ForeName>G</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>Marchetti</LastName><ForeName>C</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Roldan</LastName><ForeName>M Olivan</ForeName><Initials>MO</Initials></Investigator><Investigator ValidYN="Y"><LastName>Lenzi</LastName><ForeName>L</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Cozzio</LastName><ForeName>S</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Tomio</LastName><ForeName>P</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Diamanti</LastName><ForeName>M</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Beltrame</LastName><ForeName>A</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Glinski</LastName><ForeName>L</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Treleani</LastName><ForeName>M</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Coppa</LastName><ForeName>A</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Vanni</LastName><ForeName>S</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bartalucci</LastName><ForeName>P</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Taccone</LastName><ForeName>A</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Costacurta</LastName><ForeName>C</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bortolotti</LastName><ForeName>P</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bortolussi</LastName><ForeName>M</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>De Vecchi</LastName><ForeName>M</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Zanardi</LastName><ForeName>F</ForeName><Initials>F</Initials></Investigator><Investigator ValidYN="Y"><LastName>Greco</LastName><ForeName>I</ForeName><Initials>I</Initials></Investigator><Investigator ValidYN="Y"><LastName>Cosentini</LastName><ForeName>R</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Gerloni</LastName><ForeName>R</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Artusi</LastName><ForeName>N</ForeName><Initials>N</Initials></Investigator><Investigator ValidYN="Y"><LastName>Cominotto</LastName><ForeName>F</ForeName><Initials>F</Initials></Investigator><Investigator ValidYN="Y"><LastName>Sisto</LastName><ForeName>U G</ForeName><Initials>UG</Initials></Investigator><Investigator ValidYN="Y"><LastName>Picariello</LastName><ForeName>C</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Roncon</LastName><ForeName>L</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Maddalozzo</LastName><ForeName>A</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Nitti</LastName><ForeName>C</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Riccomi</LastName><ForeName>F</ForeName><Initials>F</Initials></Investigator><Investigator ValidYN="Y"><LastName>Buzzo</LastName><ForeName>M</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bassanelli</LastName><ForeName>G</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>Savonitto</LastName><ForeName>S</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bianchi</LastName><ForeName>A</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bilato</LastName><ForeName>C</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Lobascio</LastName><ForeName>I</ForeName><Initials>I</Initials></Investigator><Investigator ValidYN="Y"><LastName>Dalla Valle</LastName><ForeName>C</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Pomata</LastName><ForeName>D P</ForeName><Initials>DP</Initials></Investigator><Investigator ValidYN="Y"><LastName>Giostra</LastName><ForeName>F</ForeName><Initials>F</Initials></Investigator><Investigator ValidYN="Y"><LastName>Tinuper</LastName><ForeName>A L</ForeName><Initials>AL</Initials></Investigator><Investigator ValidYN="Y"><LastName>Zalunardo</LastName><ForeName>B</ForeName><Initials>B</Initials></Investigator><Investigator ValidYN="Y"><LastName>Vison&#xe0;</LastName><ForeName>A</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Panzavolta</LastName><ForeName>C</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Novelli</LastName><ForeName>A</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bertini</LastName><ForeName>A</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Granai</LastName><ForeName>C</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Colombo</LastName><ForeName>S</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Periti</LastName><ForeName>E</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bonacchini</LastName><ForeName>L</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Abrignani</LastName><ForeName>M G</ForeName><Initials>MG</Initials></Investigator><Investigator ValidYN="Y"><LastName>Casciolo</LastName><ForeName>M F</ForeName><Initials>MF</Initials></Investigator><Investigator ValidYN="Y"><LastName>D'Amato</LastName><ForeName>A</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Scardovi</LastName><ForeName>A B</ForeName><Initials>AB</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ricci</LastName><ForeName>R</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Iosi</LastName><ForeName>S</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Fontana</LastName><ForeName>M C</ForeName><Initials>MC</Initials></Investigator><Investigator ValidYN="Y"><LastName>Marrazzo</LastName><ForeName>A</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Borselli</LastName><ForeName>M</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Di Fusco</LastName><ForeName>S A</ForeName><Initials>SA</Initials></Investigator><Investigator ValidYN="Y"><LastName>Colivicchi</LastName><ForeName>F</ForeName><Initials>F</Initials></Investigator><Investigator ValidYN="Y"><LastName>Enea</LastName><ForeName>I</ForeName><Initials>I</Initials></Investigator><Investigator ValidYN="Y"><LastName>Triggiani</LastName><ForeName>M</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Papa</LastName><ForeName>I</ForeName><Initials>I</Initials></Investigator><Investigator ValidYN="Y"><LastName>Pasini</LastName><ForeName>G F</ForeName><Initials>GF</Initials></Investigator><Investigator ValidYN="Y"><LastName>Fioravanti</LastName><ForeName>C</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Panarello</LastName><ForeName>S</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Raggi</LastName><ForeName>F</ForeName><Initials>F</Initials></Investigator><Investigator ValidYN="Y"><LastName>Marzolo</LastName><ForeName>M</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Cuppini</LastName><ForeName>S</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Milan</LastName><ForeName>M</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Barchetti</LastName><ForeName>M</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>De Laura</LastName><ForeName>D</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Caldarola</LastName><ForeName>P</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Fiorini</LastName><ForeName>R</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Rastelli</LastName><ForeName>G</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ameri</LastName><ForeName>P</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>La Malfa</LastName><ForeName>G</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>Cinelli</LastName><ForeName>F</ForeName><Initials>F</Initials></Investigator><Investigator ValidYN="Y"><LastName>Sganzerla</LastName><ForeName>P C</ForeName><Initials>PC</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ubaldi</LastName><ForeName>S</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Sanchez</LastName><ForeName>F A</ForeName><Initials>FA</Initials></Investigator><Investigator ValidYN="Y"><LastName>Forgione</LastName><ForeName>C</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Cuccia</LastName><ForeName>C</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Predieri</LastName><ForeName>S</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Fusco</LastName><ForeName>S</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Mumoli</LastName><ForeName>N</ForeName><Initials>N</Initials></Investigator><Investigator ValidYN="Y"><LastName>Porta</LastName><ForeName>C</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Romei</LastName><ForeName>M</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Lucidi</LastName><ForeName>M</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Romaniello</LastName><ForeName>A</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Volpe</LastName><ForeName>M</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Mogni</LastName><ForeName>P</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Pizzolato</LastName><ForeName>E</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Martino</LastName><ForeName>G P</ForeName><Initials>GP</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bitti</LastName><ForeName>G</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>Righini</LastName><ForeName>G</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bandiera</LastName><ForeName>G</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>Pennacchio</LastName><ForeName>E</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Limauro</LastName><ForeName>S</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Dachille</LastName><ForeName>A</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ignone</LastName><ForeName>G</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>Fuscaldo</LastName><ForeName>G F</ForeName><Initials>GF</Initials></Investigator><Investigator ValidYN="Y"><LastName>De Rosa</LastName><ForeName>F M</ForeName><Initials>FM</Initials></Investigator><Investigator ValidYN="Y"><LastName>Vazzana</LastName><ForeName>N</ForeName><Initials>N</Initials></Investigator><Investigator ValidYN="Y"><LastName>Chesi</LastName><ForeName>G</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>Di Filippo</LastName><ForeName>F</ForeName><Initials>F</Initials></Investigator><Investigator ValidYN="Y"><LastName>Pierpaoli</LastName><ForeName>L</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Corapi</LastName><ForeName>A</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Vatrano</LastName><ForeName>M</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Angotti</LastName><ForeName>C</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Baccetti</LastName><ForeName>F</ForeName><Initials>F</Initials></Investigator><Investigator ValidYN="Y"><LastName>Harari</LastName><ForeName>S A</ForeName><Initials>SA</Initials></Investigator><Investigator ValidYN="Y"><LastName>Luisi</LastName><ForeName>F</ForeName><Initials>F</Initials></Investigator><Investigator ValidYN="Y"><LastName>Daghini</LastName><ForeName>E</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>De Curtis</LastName><ForeName>E</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Luc&#xe0;</LastName><ForeName>F</ForeName><Initials>F</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ciancia</LastName><ForeName>F</ForeName><Initials>F</Initials></Investigator><Investigator ValidYN="Y"><LastName>Blandizzi</LastName><ForeName>S</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Lettica</LastName><ForeName>G V</ForeName><Initials>GV</Initials></Investigator><Investigator ValidYN="Y"><LastName>D'Orazio</LastName><ForeName>S</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Cosmi</LastName><ForeName>F</ForeName><Initials>F</Initials></Investigator><Investigator ValidYN="Y"><LastName>Zaccaroni</LastName><ForeName>S</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Silingardi</LastName><ForeName>M</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Valeriano</LastName><ForeName>V</ForeName><Initials>V</Initials></Investigator><Investigator ValidYN="Y"><LastName>Pugliese</LastName><ForeName>F R</ForeName><Initials>FR</Initials></Investigator><Investigator ValidYN="Y"><LastName>Murgia</LastName><ForeName>A P</ForeName><Initials>AP</Initials></Investigator><Investigator ValidYN="Y"><LastName>Parpaglia</LastName><ForeName>P Pinna</ForeName><Initials>PP</Initials></Investigator><Investigator ValidYN="Y"><LastName>Martinelli</LastName><ForeName>L</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Caponi</LastName><ForeName>C</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Clemente</LastName><ForeName>M A</ForeName><Initials>MA</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ciccarone</LastName><ForeName>A</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bongarzoni</LastName><ForeName>A</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Garagiola</LastName><ForeName>M</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Leone</LastName><ForeName>M C</ForeName><Initials>MC</Initials></Investigator><Investigator ValidYN="Y"><LastName>Veropalumbo</LastName><ForeName>M R</ForeName><Initials>MR</Initials></Investigator><Investigator ValidYN="Y"><LastName>Sacco</LastName><ForeName>M</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Morella</LastName><ForeName>P</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Dorigoni</LastName><ForeName>S</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Peterlana</LastName><ForeName>D</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Di Paola</LastName><ForeName>R</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Felis</LastName><ForeName>S</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Correale</LastName><ForeName>M</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Brunetti</LastName><ForeName>N D</ForeName><Initials>ND</Initials></Investigator><Investigator ValidYN="Y"><LastName>Petrelli</LastName><ForeName>G</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>Feliziani</LastName><ForeName>F T</ForeName><Initials>FT</Initials></Investigator><Investigator ValidYN="Y"><LastName>Mastroiacovo</LastName><ForeName>D</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Romualdi</LastName><ForeName>R</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Pasin</LastName><ForeName>F</ForeName><Initials>F</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bonardi</LastName><ForeName>S</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Delfino</LastName><ForeName>P</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Scifo</LastName><ForeName>C</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Savioli</LastName><ForeName>G</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ceresa</LastName><ForeName>I F</ForeName><Initials>IF</Initials></Investigator><Investigator ValidYN="Y"><LastName>Galeotalanza</LastName><ForeName>M</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Benazzi</LastName><ForeName>B</ForeName><Initials>B</Initials></Investigator><Investigator ValidYN="Y"><LastName>Porzio</LastName><ForeName>M</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Rosini</LastName><ForeName>F</ForeName><Initials>F</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ancona</LastName><ForeName>C</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Verrelli</LastName><ForeName>C</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Pasini</LastName><ForeName>A Fratta</ForeName><Initials>AF</Initials></Investigator><Investigator ValidYN="Y"><LastName>Dalle Carbonare</LastName><ForeName>L</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bozza</LastName><ForeName>N</ForeName><Initials>N</Initials></Investigator><Investigator ValidYN="Y"><LastName>Nacci</LastName><ForeName>F</ForeName><Initials>F</Initials></Investigator><Investigator ValidYN="Y"><LastName>Scarabelli</LastName><ForeName>M A</ForeName><Initials>MA</Initials></Investigator><Investigator ValidYN="Y"><LastName>Amico</LastName><ForeName>F</ForeName><Initials>F</Initials></Investigator><Investigator ValidYN="Y"><LastName>Marchesi</LastName><ForeName>C</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Mazzone</LastName><ForeName>A</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Di Tommaso</LastName><ForeName>R</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Cocco</LastName><ForeName>F</ForeName><Initials>F</Initials></Investigator><Investigator ValidYN="Y"><LastName>Pezzuto</LastName><ForeName>G</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>Luciani</LastName><ForeName>A</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Zamboni</LastName><ForeName>P</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Muriago</LastName><ForeName>M</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Del Pesce</LastName><ForeName>L</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Lucarini</LastName><ForeName>A R</ForeName><Initials>AR</Initials></Investigator><Investigator ValidYN="Y"><LastName>Guglielmelli</LastName><ForeName>E</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Vannucchi</LastName><ForeName>V</ForeName><Initials>V</Initials></Investigator><Investigator ValidYN="Y"><LastName>Moroni</LastName><ForeName>F</ForeName><Initials>F</Initials></Investigator><Investigator ValidYN="Y"><LastName>Fichera</LastName><ForeName>D</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Malatino</LastName><ForeName>L</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Sgroi</LastName><ForeName>C</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Morana</LastName><ForeName>I M</ForeName><Initials>IM</Initials></Investigator><Investigator ValidYN="Y"><LastName>Cicero</LastName><ForeName>S</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>La Rosa</LastName><ForeName>D</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Mete</LastName><ForeName>F</ForeName><Initials>F</Initials></Investigator><Investigator ValidYN="Y"><LastName>Gino</LastName><ForeName>M</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>De Palma</LastName><ForeName>A</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Alessandri</LastName><ForeName>M</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Maestripieri</LastName><ForeName>V</ForeName><Initials>V</Initials></Investigator><Investigator ValidYN="Y"><LastName>Battocchio</LastName><ForeName>M</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>De Santis</LastName><ForeName>M T</ForeName><Initials>MT</Initials></Investigator><Investigator ValidYN="Y"><LastName>Saladini</LastName><ForeName>F</ForeName><Initials>F</Initials></Investigator><Investigator ValidYN="Y"><LastName>Corsi</LastName><ForeName>D C</ForeName><Initials>DC</Initials></Investigator><Investigator ValidYN="Y"><LastName>Macarone Palmieri</LastName><ForeName>N</ForeName><Initials>N</Initials></Investigator><Investigator ValidYN="Y"><LastName>Pierfranceschi</LastName><ForeName>M Giorgi</ForeName><Initials>MG</Initials></Investigator><Investigator ValidYN="Y"><LastName>Palmonari</LastName><ForeName>V</ForeName><Initials>V</Initials></Investigator><Investigator ValidYN="Y"><LastName>Fontanella</LastName><ForeName>L</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Airoldi</LastName><ForeName>L</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bonocore</LastName><ForeName>M</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Paliani</LastName><ForeName>U</ForeName><Initials>U</Initials></Investigator><Investigator ValidYN="Y"><LastName>Prat</LastName><ForeName>L Iogna</ForeName><Initials>LI</Initials></Investigator><Investigator ValidYN="Y"><LastName>Chiecchi</LastName><ForeName>L</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Cuonzo</LastName><ForeName>M</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Paludo</LastName><ForeName>A</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Padula</LastName><ForeName>D</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Antonelli</LastName><ForeName>A</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bicchi</LastName><ForeName>M</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Tota</LastName><ForeName>G</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ariello</LastName><ForeName>M</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Sai</LastName><ForeName>R</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Civita</LastName><ForeName>M</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Tucci</LastName><ForeName>M</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Barbati</LastName><ForeName>G</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>Conti</LastName><ForeName>M</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Cettina</LastName><ForeName>R</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Magnani</LastName><ForeName>O</ForeName><Initials>O</Initials></Investigator><Investigator ValidYN="Y"><LastName>Levato</LastName><ForeName>M</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Gessi</LastName><ForeName>V</ForeName><Initials>V</Initials></Investigator><Investigator ValidYN="Y"><LastName>De Rui</LastName><ForeName>M</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bellizzi</LastName><ForeName>A</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Farneti</LastName><ForeName>L</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Salomone</LastName><ForeName>P</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Mannarini</LastName><ForeName>A</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Grifoni</LastName><ForeName>E</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Del Ghianda</LastName><ForeName>S</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Campodonico</LastName><ForeName>J</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>De Cesare</LastName><ForeName>N</ForeName><Initials>N</Initials></Investigator><Investigator ValidYN="Y"><LastName>Mutone</LastName><ForeName>D</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Pasoli</LastName><ForeName>P</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Meloni</LastName><ForeName>S</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Frenda</LastName><ForeName>A</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Viola</LastName><ForeName>G</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>Torromeo</LastName><ForeName>C</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Campana</LastName><ForeName>C</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Pistone</LastName><ForeName>M C</ForeName><Initials>MC</Initials></Investigator><Investigator ValidYN="Y"><LastName>Caravita</LastName><ForeName>S</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>La Creta</LastName><ForeName>C P</ForeName><Initials>CP</Initials></Investigator><Investigator ValidYN="Y"><LastName>Miscio</LastName><ForeName>F</ForeName><Initials>F</Initials></Investigator><Investigator ValidYN="Y"><LastName>Loreno</LastName><ForeName>M</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Fenu</LastName><ForeName>P</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Mazzetti</LastName><ForeName>M</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Rossini</LastName><ForeName>D</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Brunacci</LastName><ForeName>M</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Capuano</LastName><ForeName>A</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Tagliamonte</LastName><ForeName>G</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>Pinelli</LastName><ForeName>M</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ballocca</LastName><ForeName>F</ForeName><Initials>F</Initials></Investigator><Investigator ValidYN="Y"><LastName>Parca</LastName><ForeName>G</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>Pasini</LastName><ForeName>S M</ForeName><Initials>SM</Initials></Investigator><Investigator ValidYN="Y"><LastName>Maragno</LastName><ForeName>M G</ForeName><Initials>MG</Initials></Investigator><Investigator ValidYN="Y"><LastName>Vecchi</LastName><ForeName>F</ForeName><Initials>F</Initials></Investigator><Investigator ValidYN="Y"><LastName>Mancinelli</LastName><ForeName>L</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Cavalli</LastName><ForeName>A</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Di Mare</LastName><ForeName>F</ForeName><Initials>F</Initials></Investigator><Investigator ValidYN="Y"><LastName>Conficoni</LastName><ForeName>E</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Miceli</LastName><ForeName>R</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Pecoraro</LastName><ForeName>R</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Fonti</LastName><ForeName>C</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Pegoraro</LastName><ForeName>S</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Piccinni</LastName><ForeName>G C</ForeName><Initials>GC</Initials></Investigator><Investigator ValidYN="Y"><LastName>Caruso</LastName><ForeName>G</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>Boriani</LastName><ForeName>G</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>Lanzillotta</LastName><ForeName>P</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Piccolo</LastName><ForeName>P</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Cal&#xf2;</LastName><ForeName>L</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Stolfo</LastName><ForeName>D</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Mangiacapra</LastName><ForeName>S</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Marziali</LastName><ForeName>A</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Volponi</LastName><ForeName>M C</ForeName><Initials>MC</Initials></Investigator><Investigator ValidYN="Y"><LastName>Querci</LastName><ForeName>G</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>Terribile</LastName><ForeName>R</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Menabue</LastName><ForeName>M</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Fiorentini</LastName><ForeName>A</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Musci</LastName><ForeName>R L</ForeName><Initials>RL</Initials></Investigator><Investigator ValidYN="Y"><LastName>Uras</LastName><ForeName>S</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Cicini</LastName><ForeName>M P</ForeName><Initials>MP</Initials></Investigator><Investigator ValidYN="Y"><LastName>Pegoraro</LastName><ForeName>S</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Manetti</LastName><ForeName>S</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Francese</LastName><ForeName>G M</ForeName><Initials>GM</Initials></Investigator><Investigator ValidYN="Y"><LastName>Melchio</LastName><ForeName>R</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Scorpiglione</LastName><ForeName>N</ForeName><Initials>N</Initials></Investigator><Investigator ValidYN="Y"><LastName>Carrara</LastName><ForeName>D</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Pani</LastName><ForeName>A</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Morisco</LastName><ForeName>C</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Rodolico</LastName><ForeName>M</ForeName><Initials>M</Initials></Investigator></InvestigatorList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>12</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>4</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>4</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>8</Month><Day>23</Day><Hour>0</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>5</Month><Day>30</Day><Hour>5</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>5</Month><Day>29</Day><Hour>19</Hour><Minute>12</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38810699</ArticleId><ArticleId IdType="doi">10.1016/j.jtha.2024.04.025</ArticleId><ArticleId IdType="pii">S1538-7836(24)00302-7</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">39581655</PMID><DateCompleted><Year>2024</Year><Month>11</Month><Day>24</Day></DateCompleted><DateRevised><Year>2024</Year><Month>11</Month><Day>24</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1879-0267</ISSN><JournalIssue CitedMedium="Internet"><Volume>55 Suppl 5</Volume><PubDate><Year>2024</Year><Month>Oct</Month></PubDate></JournalIssue><Title>Injury</Title><ISOAbbreviation>Injury</ISOAbbreviation></Journal><ArticleTitle>Retrospective paired cohort study comparing internal fixation for undisplaced versus hemiarthroplasty for displaced femoral neck fracture in the elderly.</ArticleTitle><Pagination><StartPage>111674</StartPage><MedlinePgn>111674</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.injury.2024.111674</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0020-1383(24)00380-2</ELocationID><Abstract><AbstractText Label="INTRODUCTION" NlmCategory="BACKGROUND">The debate continues regarding the best treatment for elderly patients with non-displaced femoral neck fractures (FNFs): internal fixation (IF) vs hemiarthroplasty (HA). The Aim of the present study is to compare surgical insult, mortality, complications, and walking recovery after one year in patients older than 65 treated with cannulated screws or HA for FNFs.</AbstractText><AbstractText Label="PATIENTS AND METHODS" NlmCategory="METHODS">Match-paired comparison of retrospective cohorts: 220 non-displaced FNFs treated with cannulated screws vs 220 displaced FNFs treated with bipolar HA from 2013 to 2021. No differences were observed in age (82.1 &#xb1; 7.5 IF vs 83&#xb1;6.8 HA) (p = 0.172), sex (74.6 % IF females vs 74.6 % HA females) (p = 0.912), year of intervention (p = 0.638) and ASA scale (III in 55.5 % IF vs 55.9 % HA) (IV in 21.8 % IF vs 18.2 % HA) (p = 0.726). Medical complications analyzed included respiratory and urinary infections, heart failure, myocardial infarction, stroke, pulmonary embolism, deep vein thrombosis, acute digestive bleeding.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Lower surgical aggression in IF: surgical time (p &lt; 0.001), hemoglobin and hematocrit decrease (p &lt; 0.001), need for transfusion (p &lt; 0.001), hospital stay (p &lt; 0.001).</AbstractText><AbstractText Label="MORTALITY" NlmCategory="RESULTS">higher in-hospital for hemiarthroplasties: 12 deaths (5.5 %) vs 1 (0.5 %) (p = 0.004) (RR=12, 1.5-91.5). No differences after 1 month (13 (6 %) in HA vs 9 (4.1 %) in cannulated screws) and 1 year (33 (15 %) in HA vs 35 (16 %) in IF). Medical complications showed no significant differences (p = 0.055).</AbstractText><AbstractText Label="SURGICAL COMPLICATIONS" NlmCategory="UNASSIGNED">No differences in surgical infections (5 HA (2.3 %) vs 2 IF (0.9 %);p = 0,253) or neurovascular injuries (3 HA (1,4 %) vs 2 IF (0.9 %); p = 1). HA: 10 dislocations (4.5 %), 11 periprosthetic fractures (5 %). Cannulated screws: 10 fixation failures (4.6 %), 9 non-unions (4.1 %), 16 ischemic necrosis of femoral head (7.3 %). Reoperation rate: 15/220 IF (6.8 %) and 8/220 HA (3.6 %) (p = 0.134).</AbstractText><AbstractText Label="FUNCTIONAL RESULTS" NlmCategory="RESULTS">No differences were detected (p = 0.285): 111 osteosynthesis patients (50.45 %) and 99 HA (45 %) returned to their pre-fracture walking ability (p = 0.322). There were also no differences between groups in those patients with worsening of walking status: 108 (49 %) osteosynthesis and 118 (53,6 %) prosthesis (p = 0.412).</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Cannulated screws in patients over 65 with non-displaced femoral neck fractures results in less surgical insult, lower in-hospital mortality, comparable medical and surgical complications, a similar re-operation rate, and functional outcomes equivalent to hemiarthroplasty.</AbstractText><AbstractText Label="LEVEL OF EVIDENCE" NlmCategory="METHODS">Level III (retrospective comparison of matched cohorts).</AbstractText><CopyrightInformation>Copyright &#xa9; 2024 Elsevier Ltd. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Cordero-Ampuero</LastName><ForeName>Jos&#xe9;</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>University Hospital La Princesa, c/ Diego de Le&#xf3;n 62 28006 Madrid, Spain; Medicine School, Universidad Aut&#xf3;noma de Madrid, c/ Arzobispo Morcillo s/n, Madrid, Spain. Electronic address: jcordera@telefonica.net.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Descalzo</LastName><ForeName>Ignacio</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>University Hospital La Princesa, c/ Diego de Le&#xf3;n 62 28006 Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fern&#xe1;ndez-Villaca&#xf1;as</LastName><ForeName>Pablo</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>University Hospital La Princesa, c/ Diego de Le&#xf3;n 62 28006 Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Berdullas</LastName><ForeName>Jos&#xe9; Manuel</ForeName><Initials>JM</Initials><AffiliationInfo><Affiliation>University Hospital La Princesa, c/ Diego de Le&#xf3;n 62 28006 Madrid, Spain; Medicine School, Universidad Aut&#xf3;noma de Madrid, c/ Arzobispo Morcillo s/n, Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hern&#xe1;ndez-Rodr&#xed;guez</LastName><ForeName>Ainhoa</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>University Hospital La Princesa, c/ Diego de Le&#xf3;n 62 28006 Madrid, Spain; Medicine School, Universidad Aut&#xf3;noma de Madrid, c/ Arzobispo Morcillo s/n, Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>de Quadros</LastName><ForeName>Javier</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>University Hospital La Princesa, c/ Diego de Le&#xf3;n 62 28006 Madrid, Spain; Medicine School, Universidad Aut&#xf3;noma de Madrid, c/ Arzobispo Morcillo s/n, Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Marcos-Aguilar</LastName><ForeName>Sergio</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>University Hospital La Princesa, c/ Diego de Le&#xf3;n 62 28006 Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Peix</LastName><ForeName>Claudio</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>University Hospital La Princesa, c/ Diego de Le&#xf3;n 62 28006 Madrid, Spain.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D003160">Comparative Study</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Injury</MedlineTA><NlmUniqueID>0226040</NlmUniqueID><ISSNLinking>0020-1383</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005265" MajorTopicYN="Y">Femoral Neck Fractures</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005593" MajorTopicYN="Y">Fracture Fixation, Internal</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D062785" MajorTopicYN="Y">Hemiarthroplasty</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="Y">Postoperative Complications</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001863" MajorTopicYN="Y">Bone Screws</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020127" MajorTopicYN="N">Recovery of Function</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Cannulated screws</Keyword><Keyword MajorTopicYN="N">Complications</Keyword><Keyword MajorTopicYN="N">Femoral neck fracture</Keyword><Keyword MajorTopicYN="N">Functional results</Keyword><Keyword MajorTopicYN="N">Hemiarthroplasty</Keyword><Keyword MajorTopicYN="N">Mortality</Keyword><Keyword MajorTopicYN="N">Surgical aggression</Keyword></KeywordList><CoiStatement>Declaration of competing interest Jos&#xe9; Cordero-Ampuero has received fundings for attending Congresses / Scientific Meetings from Exactech, Stryker, MBA and Waldemar-Link. The other authors have no interest / nothing to declare.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>4</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>5</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>6</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>11</Month><Day>25</Day><Hour>1</Hour><Minute>27</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>11</Month><Day>25</Day><Hour>1</Hour><Minute>26</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>11</Month><Day>24</Day><Hour>20</Hour><Minute>58</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39581655</ArticleId><ArticleId IdType="doi">10.1016/j.injury.2024.111674</ArticleId><ArticleId IdType="pii">S0020-1383(24)00380-2</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">31855876</PMID><DateCompleted><Year>2021</Year><Month>12</Month><Day>06</Day></DateCompleted><DateRevised><Year>2021</Year><Month>12</Month><Day>14</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1528-1140</ISSN><JournalIssue CitedMedium="Internet"><Volume>274</Volume><Issue>6</Issue><PubDate><Year>2021</Year><Month>Dec</Month><Day>01</Day></PubDate></JournalIssue><Title>Annals of surgery</Title><ISOAbbreviation>Ann Surg</ISOAbbreviation></Journal><ArticleTitle>Long-term Impact of Bariatric Surgery on Venous Thromboembolic Risk: A Matched Cohort Study.</ArticleTitle><Pagination><StartPage>1017</StartPage><EndPage>1024</EndPage><MedlinePgn>1017-1024</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1097/SLA.0000000000003750</ELocationID><Abstract><AbstractText Label="OBJECTIVE">The aim of this study is to evaluate the effect of bariatric surgery on long-term risk of VTEs in a large cohort of patients with obesity.</AbstractText><AbstractText Label="BACKGROUND">Obesity is a well-established risk factor for VTEs, such as pulmonary embolism and deep vein thrombosis. The rising prevalence of obesity and its associated co-morbidities, including VTE, represent a growing public health issue.</AbstractText><AbstractText Label="METHODS">A nested, retrospective matched cohort study was designed and conducted on prospectively collected national electronic healthcare records data from the Clinical Practice Research Datalink. Eight thousand, one hundred twelve patients were included in the study: the 4056 patients on the database who had undergone bariatric surgery, and equal numbers of age, sex, and body mass index matched controls. The primary endpoint was the occurrence of VTEs; secondary endpoints were the occurrence of deep vein thrombosis alone, pulmonary embolism alone.</AbstractText><AbstractText Label="RESULTS">Patients were followed up for a median of 10.7 years. The bariatric surgery cohort had a significantly lower occurrence of the primary outcome [hazard ratio (HR) 0.601; 95% confidence interval (CI) 0.430-0.841, P = 0.003]; mainly driven by a reduction in deep vein thrombosis (HR 0.523; 95% CI 0.349-0.783, P = 0&#xb7;002) and not in pulmonary embolism (HR 0.882; 95% CI 0.511-1.521, P = 0.651).</AbstractText><AbstractText Label="CONCLUSIONS">The results of this nation-wide study set out to characterize the impact of bariatric surgery on long-term risk of thromboembolic events outline a significant reduction in thromboembolic events, driven by a reduction in deep vein thrombosis.</AbstractText><CopyrightInformation>Copyright &#xa9; 2019 Wolters Kluwer Health, Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Moussa</LastName><ForeName>Osama</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>St Mary's Academic Unit, Imperial College London, London W2 1NY, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ardissino</LastName><ForeName>Maddalena</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Imperial College London, London SW7 2AZ, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Magill Department of Anaesthesia, Intensive Care and Pain Management, Chelsea and Westminster Hospital, London SW10 9NH, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tang</LastName><ForeName>Alice</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Imperial College London, London SW7 2AZ, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lazzari</LastName><ForeName>Laura</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Imperial College London, London SW7 2AZ, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Millar</LastName><ForeName>Ophelia</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>Imperial College London, London SW7 2AZ, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ziprin</LastName><ForeName>Paul</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>St Mary's Academic Unit, Imperial College London, London W2 1NY, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Darzi</LastName><ForeName>Ara</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>St Mary's Academic Unit, Imperial College London, London W2 1NY, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Khan</LastName><ForeName>Omar</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>Department of Upper GI and Bariatric Surgery, St George's University of London, London SW17 0RE, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Collins</LastName><ForeName>Peter</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Royal Brompton Hospital and National Heart and Lung Institute, Imperial College London, London SW3 6NP, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Purkayastha</LastName><ForeName>Sanjay</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>St Mary's Academic Unit, Imperial College London, London W2 1NY, UK.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Ann Surg</MedlineTA><NlmUniqueID>0372354</NlmUniqueID><ISSNLinking>0003-4932</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D050110" MajorTopicYN="Y">Bariatric Surgery</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005500" MajorTopicYN="N">Follow-Up Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018570" MajorTopicYN="N">Risk Assessment</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006113" MajorTopicYN="N" Type="Geographic">United Kingdom</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D054556" MajorTopicYN="N">Venous Thromboembolism</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName></MeshHeading></MeshHeadingList><CoiStatement>The authors report no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>12</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>12</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>12</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31855876</ArticleId><ArticleId IdType="doi">10.1097/SLA.0000000000003750</ArticleId><ArticleId IdType="pii">00000658-202112000-00021</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Cohen AT, Agnelli G, Anderson FA, et al. Venous thromboembolism (VTE) in Europe. The number of VTE events and associated morbidity and mortality. Thromb Haemost 2007; 98:756&#x2013;764.</Citation></Reference><Reference><Citation>Zhu T, Martinez I, Emmerich J. Venous thromboembolism: risk factors for recurrence. Arterioscler Thromb Vasc Biol 2009; 29:298&#x2013;310.</Citation></Reference><Reference><Citation>White RH. The epidemiology of venous thromboembolism. Circulation 2003; 107:4&#x2013;8.</Citation></Reference><Reference><Citation>Heit JA, Silverstein MD, Mohr DN, et al. Risk factors for deep vein thrombosis and pulmonary embolism. Arch Intern Med 2003; 160:809&#x2013;815.</Citation></Reference><Reference><Citation>Martinelli I, De Stefano V, Mannucci PM. Inherited risk factors for venous thromboembolism. Nat Rev Cardiol 2014; 11:140&#x2013;156.</Citation></Reference><Reference><Citation>Stein PD, Beemath A, Olson RE. Obesity as a risk factor in venous thromboembolism. Am J Med 2005; 118:978&#x2013;980.</Citation></Reference><Reference><Citation>WHO. Obesity and overweight. World Heal Organ Media Cent Fact Sheet No 311. 2011:1-2. Available at: 10.3233/978-1-61499-438-1-372</Citation></Reference><Reference><Citation>Douglas IJ, Bhaskaran K, Batterham RL, et al. Bariatric surgery in the united kingdom: a cohort study of weight loss and clinical outcomes in routine clinical care. PLoS Med 2015; 12:1&#x2013;18.</Citation></Reference><Reference><Citation>Pareek M, Schauer PR, Kaplan LM, et al. Metabolic surgery: weight loss, diabetes, and beyond. J Am Coll Cardiol 2018; 71:670&#x2013;687.</Citation></Reference><Reference><Citation>Chang SH, Stoll CRT, Song J, et al. The effectiveness and risks of bariatric surgery an updated systematic review and meta-analysis. JAMA Surg 2014; 149:275&#x2013;287.</Citation></Reference><Reference><Citation>Sj&#xf6;str&#xf6;m L, Peltonen M, Jacobson P, et al. Association of bariatric surgery with long-term remission of type 2 diabetes and with microvascular and macrovascular complications. JAMA 2014; 311:2297&#x2013;2304.</Citation></Reference><Reference><Citation>Sj&#xf6;str&#xf6;m L, Peltonen M, Jacobson P, et al. Bariatric surgery and long-term cardiovascular events. JAMA 2012; 307:56&#x2013;65.</Citation></Reference><Reference><Citation>Mistry P, Currie V, Super P, et al. Changes in glycaemic control, blood pressure and lipids 5 years following laparoscopic adjustable gastric banding combined with medical care in patients with type 2 diabetes: a longitudinal analysis. Clin Obes 2018; 8:151&#x2013;158.</Citation></Reference><Reference><Citation>Adams TD, Arterburn DE, Nathan DM, et al. Clinical outcomes of metabolic surgery: microvascular and macrovascular complications. Diabetes Care 2016; 39:912&#x2013;923.</Citation></Reference><Reference><Citation>Fisher DP, Johnson E, Haneuse S, et al. Association between bariatric surgery and macrovascular disease outcomes in patients with type 2 diabetes and severe obesity. JAMA 2018; 320:1570&#x2013;1582.</Citation></Reference><Reference><Citation>Hamad GG, Bergqvist D. Venous thromboembolism in bariatric surgery patients: an update of risk and prevention. Surg Obes Relat Dis 2007; 3:97&#x2013;102.</Citation></Reference><Reference><Citation>Steele KE, Schweitzer MA, Prokopowicz G, et al. The long-term risk of venous thromboembolism following bariatric surgery. Obes Surg 2011; 21:1371&#x2013;1376.</Citation></Reference><Reference><Citation>Jamal MH, Corcelles R, Shimizu H, et al. Thromboembolic events in bariatric surgery: a large multi-institutional referral center experience. Surg Endosc 2015; 29:376&#x2013;380.</Citation></Reference><Reference><Citation>Herrett E, Gallagher AM, Bhaskaran K, et al. Data resource profile: clinical practice research datalink (CPRD). Int J Epidemiol 2015; 44:827&#x2013;836.</Citation></Reference><Reference><Citation>Clinical Practice Research Datalink. CPRD Governance. Clinical Practice Research Datalink website. Published 2016. Available at: https://www.cprd.com/governance/ Accessed 18 September, 2019</Citation></Reference><Reference><Citation>Dafni U. Primer on statistical interpretation and methods landmark analysis at the 25-year landmark point background. Circ Cardiovasc Qual Outcomes 2011; 4:363&#x2013;371.</Citation></Reference><Reference><Citation>Buchwald H, Avidor Y, Braunwald E, et al. Bariatric surgery: a systematic review and meta-analysis. J Am Med Assoc 2004; 292:1724&#x2013;1737.</Citation></Reference><Reference><Citation>Vest AR, Heneghan HM, Agarwal S, et al. Bariatric surgery and cardiovascular outcomes: a systematic review. Heart 2012; 98:1763&#x2013;1777.</Citation></Reference><Reference><Citation>Sj&#xf6;str&#xf6;m L. Review of the key results from the Swedish Obese Subjects (SOS) trial &#x2013; a prospective controlled intervention study of bariatric surgery. J Intern Med 2013; 273:219&#x2013;234.</Citation></Reference><Reference><Citation>Booth H, Khan O, Prevost AT, et al. Impact of bariatric surgery on clinical depression. Interrupted time series study with matched controls. J Affect Disord 2015; 174:644&#x2013;649.</Citation></Reference><Reference><Citation>Christou NV, Sampalis JS, Liberman M, et al. Surgery decreases long-term mortality, morbidity, and health care use in morbidly obese patients. Ann Surg 2004; 240:416&#x2013;424.</Citation></Reference><Reference><Citation>Stein PD, Matta F. Pulmonary embolism and deep venous thrombosis following bariatric surgery. Obes Surg 2013; 23:663&#x2013;668.</Citation></Reference><Reference><Citation>Hutter MM, Randall S, Khuri SF, et al. Laparoscopic versus open gastric bypass for morbid obesity: a multicenter, prospective, risk-adjusted analysis from the National Surgical Quality Improvement Program. Ann Surg 2006; 243:657&#x2013;662.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">29151453</PMID><DateCompleted><Year>2019</Year><Month>06</Month><Day>03</Day></DateCompleted><DateRevised><Year>2024</Year><Month>12</Month><Day>16</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1347-4820</ISSN><JournalIssue CitedMedium="Internet"><Volume>82</Volume><Issue>3</Issue><PubDate><Year>2018</Year><Month>Feb</Month><Day>23</Day></PubDate></JournalIssue><Title>Circulation journal : official journal of the Japanese Circulation Society</Title><ISOAbbreviation>Circ J</ISOAbbreviation></Journal><ArticleTitle>Diastolic Dysfunction Is a Risk of Perioperative Myocardial Injury Assessed by High-Sensitivity Cardiac Troponin T in Elderly Patients Undergoing Non-Cardiac Surgery.</ArticleTitle><Pagination><StartPage>775</StartPage><EndPage>782</EndPage><MedlinePgn>775-782</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1253/circj.CJ-17-0747</ELocationID><Abstract><AbstractText Label="BACKGROUND">High-sensitivity cardiac troponin T (hs-cTnT) is useful for detecting myocardial injury and is expected to become a prognostic marker in patients undergoing non-cardiac surgery. The aim of this pilot study evaluating the efficacy of &#x3b2;-blocker therapy in a perioperative setting (MAMACARI study) was to assess perioperative myocardial injury (PMI) in elderly patients with preserved ejection fraction (EF) undergoing non-cardiac surgery.</AbstractText><AbstractText Label="METHODS&#x2004;AND&#x2004;RESULTS">In this prospective observational cohort study of 151 consecutive patients with preserved EF and aged &gt;60 years who underwent non-cardiac surgery, serum levels of hs-cTnT were measured before and on postoperative days 1 and 3 after surgery. PMI was defined as postoperative hs-cTnT &gt;0.014 ng/mL and relative hs-cTnT change &#x2265;20%. A total of 36 (23.8%) of the patients were diagnosed as having PMI. The incidence of a composite of cardiovascular events within 30 days after surgery, including myocardial infarction, stroke, worsening heart failure, atrial fibrillation and pulmonary embolism, was significantly higher in patients with PMI than in patients without PMI (odds ratio (OR) 9.25, P&lt;0.001, 95% confidence interval (CI) 2.65-32.3). Multivariate analysis revealed that left ventricular diastolic dysfunction defined by echocardiography was independently associated with PMI (OR: 3.029, 95% CI: 1.341-6.84, P=0.008).</AbstractText><AbstractText Label="CONCLUSIONS">PMI is frequently observed in elderly patients undergoing non-cardiac surgery. Diastolic dysfunction is an independent predictor of PMI.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Toda</LastName><ForeName>Hironobu</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Cardiovascular Medicine, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nakamura</LastName><ForeName>Kazufumi</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Cardiovascular Medicine, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nakagawa</LastName><ForeName>Koji</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Cardiovascular Medicine, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Watanabe</LastName><ForeName>Atsuyuki</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Cardiovascular Medicine, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Miyoshi</LastName><ForeName>Toru</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Cardiovascular Medicine, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nishii</LastName><ForeName>Nobuhiro</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Cardiovascular Medicine, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shimizu</LastName><ForeName>Kazuyoshi</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hayashi</LastName><ForeName>Masao</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Morita</LastName><ForeName>Hiroshi</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Cardiovascular Medicine, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Cardiovascular Therapeutics, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Morimatsu</LastName><ForeName>Hiroshi</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ito</LastName><ForeName>Hiroshi</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Cardiovascular Medicine, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D064888">Observational Study</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2017</Year><Month>11</Month><Day>18</Day></ArticleDate></Article><MedlineJournalInfo><Country>Japan</Country><MedlineTA>Circ J</MedlineTA><NlmUniqueID>101137683</NlmUniqueID><ISSNLinking>1346-9843</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D020107">Troponin T</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002318" MajorTopicYN="N">Cardiovascular Diseases</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004452" MajorTopicYN="N">Echocardiography</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017202" MajorTopicYN="N">Myocardial Ischemia</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D059035" MajorTopicYN="Y">Perioperative Period</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010865" MajorTopicYN="N">Pilot Projects</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013318" MajorTopicYN="N">Stroke Volume</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013514" MajorTopicYN="N">Surgical Procedures, Operative</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020107" MajorTopicYN="N">Troponin T</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018487" MajorTopicYN="N">Ventricular Dysfunction, Left</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000000981" MajorTopicYN="Y">diagnostic imaging</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Diastolic dysfunction</Keyword><Keyword MajorTopicYN="N">High-sensitivity cardiac troponin T</Keyword><Keyword MajorTopicYN="N">Perioperative myocardial injury</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2017</Year><Month>11</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>6</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2017</Year><Month>11</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29151453</ArticleId><ArticleId IdType="doi">10.1253/circj.CJ-17-0747</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">28747317</PMID><DateCompleted><Year>2018</Year><Month>09</Month><Day>10</Day></DateCompleted><DateRevised><Year>2025</Year><Month>06</Month><Day>23</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1708-8267</ISSN><JournalIssue CitedMedium="Internet"><Volume>65</Volume><Issue>8</Issue><PubDate><Year>2017</Year><Month>Dec</Month></PubDate></JournalIssue><Title>Journal of investigative medicine : the official publication of the American Federation for Clinical Research</Title><ISOAbbreviation>J Investig Med</ISOAbbreviation></Journal><ArticleTitle>The risk of postoperative hemorrhage and efficacy of heparin for preventing deep vein thrombosis and pulmonary embolism in adult patients undergoing neurosurgery: a systematic review and meta-analysis.</ArticleTitle><Pagination><StartPage>1136</StartPage><EndPage>1146</EndPage><MedlinePgn>1136-1146</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1136/jim-2016-000235</ELocationID><Abstract><AbstractText>The aim of this meta-analysis was to examine the risk of postoperative bleeding and efficacy of heparin for preventing deep vein thrombosis (DVT) and pulmonary embolism (PE) in adult patients undergoing neurosurgery. MEDLINE, Cochrane, and EMBASE databases were searched until October 31, 2016, for randomized controlled trials (RCTs) and non-randomized comparative studies that assessed the rates of postoperative hemorrhage, DVT, PE, and mortality in adult patients undergoing neurosurgery. Nine eligible studies (five RCTs, four retrospective studies) including 874 patients treated with either unfractionated heparin (UFH) or low-molecular-weight heparin (LMWH) and 1033 patients in control group (placebo with or without compression device) were analyzed. The overall analysis revealed that there was an increase in the risk of postoperative hemorrhage in patients who received heparin (pooled OR 1.66, 95%&#x2009;CI 1.01 to 2.72, p=0.046) compared with no treatment group. The risk of postoperative hemorrhage was more significant if only RCTs were included in analysis. Heparin prophylaxis was associated with a decrease in the risk of DVT (pooled OR 0.48, 95%&#x2009;CI 0.36 to 0.65, p&lt;0.001) and PE (pooled OR 0.25, 95%&#x2009;CI 0.09 to 0.73, p=0.011) but it did not affect the rate of mortality. In conclusion, heparin increased the rate of postoperative bleeding, decreased the risk of DVT, PE and venous thromboembolic event (VTE) but it did not affect the mortality of patients undergoing neurosurgery. For the heparin prophylaxis, the trade-off between the risk of postoperative bleeding and benefit of prophylaxis against VTEs requires further investigation.</AbstractText><CopyrightInformation>&#xa9; American Federation for Medical Research (unless otherwise stated in the text of the article) 2017. All rights reserved. No commercial use is permitted unless otherwise expressly granted.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Xuan</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Neurosurgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhou</LastName><ForeName>Ying-Chun</ForeName><Initials>YC</Initials><AffiliationInfo><Affiliation>Department of Neurosurgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhu</LastName><ForeName>Wen-De</ForeName><Initials>WD</Initials><AffiliationInfo><Affiliation>Department of Neurosurgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sun</LastName><ForeName>Yun</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Neurosurgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fu</LastName><ForeName>Peng</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Neurosurgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lei</LastName><ForeName>De-Qiang</ForeName><Initials>DQ</Initials><AffiliationInfo><Affiliation>Department of Neurosurgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhao</LastName><ForeName>Hong-Yang</ForeName><Initials>HY</Initials><AffiliationInfo><Affiliation>Department of Neurosurgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2017</Year><Month>07</Month><Day>26</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>J Investig Med</MedlineTA><NlmUniqueID>9501229</NlmUniqueID><ISSNLinking>1081-5589</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>9005-49-6</RegistryNumber><NameOfSubstance UI="D006493">Heparin</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006493" MajorTopicYN="N">Heparin</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009493" MajorTopicYN="Y">Neurosurgery</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019106" MajorTopicYN="N">Postoperative Hemorrhage</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017594" MajorTopicYN="N">Publication Bias</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011655" MajorTopicYN="N">Pulmonary Embolism</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016032" MajorTopicYN="N">Randomized Controlled Trials as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020246" MajorTopicYN="N">Venous Thrombosis</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">anticoagulation</Keyword><Keyword MajorTopicYN="N">deep vein thrombosis</Keyword><Keyword MajorTopicYN="N">heparin</Keyword><Keyword MajorTopicYN="N">intracranial surgery</Keyword><Keyword MajorTopicYN="N">postoperative bleeding</Keyword><Keyword MajorTopicYN="N">pulmonary embolism</Keyword></KeywordList><CoiStatement>Competing interests: None declared.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="accepted"><Year>2017</Year><Month>6</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2017</Year><Month>7</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>9</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2017</Year><Month>7</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">28747317</ArticleId><ArticleId IdType="doi">10.1136/jim-2016-000235</ArticleId><ArticleId IdType="pii">jim-2016-000235</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">30193575</PMID><DateCompleted><Year>2018</Year><Month>12</Month><Day>17</Day></DateCompleted><DateRevised><Year>2018</Year><Month>12</Month><Day>17</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1471-2474</ISSN><JournalIssue CitedMedium="Internet"><Volume>19</Volume><Issue>1</Issue><PubDate><Year>2018</Year><Month>Sep</Month><Day>08</Day></PubDate></JournalIssue><Title>BMC musculoskeletal disorders</Title><ISOAbbreviation>BMC Musculoskelet Disord</ISOAbbreviation></Journal><ArticleTitle>Low molecular weight heparin versus other anti-thrombotic agents for prevention of venous thromboembolic events after total hip or total knee replacement surgery: a systematic review and meta-analysis.</ArticleTitle><Pagination><StartPage>322</StartPage><MedlinePgn>322</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">322</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s12891-018-2215-3</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Venous thromboembolism (VTE) is an important complication following total hip replacement (THR) and total knee replacement (TKR) surgeries. Aim of this study was to comprehensively compare the clinical outcomes of low-molecular-weight heparin (LMWH) with other anticoagulants in patients who underwent TKR or THR surgery.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Medline, Cochrane, EMBASE, and Google Scholar databases were searched for eligible randomized controlled studies (RCTs) published before June 30, 2017. Meta-analyses of odds ratios were performed along with subgroup and sensitivity analyses.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Twenty-one RCTs were included. In comparison with placebo, LMWH treatment was associated with a lower risk of VTE and deep vein thrombosis (DVT) (P values &lt;&#x2009;0.001) but similar risk of pulmonary embolism (PE) (P&#x2009;=&#x2009;0.227) in THR subjects. Compared to factor Xa inhibitors, LMWH treatment was associated with higher risk of VTE in TKR subjects (P&#x2009;&lt;&#x2009;0.001), and higher DVT risk (P&#x2009;&lt;&#x2009;0.001) but similar risk of PE and major bleeding in both THR and TKR. The risk of either VTE, DVT, PE, or major bleeding was similar between LMWH and direct thrombin inhibitors in both THR and TKR, but major bleeding was lower with LMWH in patients who underwent THR (P&#x2009;=&#x2009;0.048).</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">In comparison with factor Xa inhibitors, LMWH may have higher risk of VTE and DVT, whereas compared to direct thrombin inhibitors, LMWH may have lower risk of major bleeding after THR or TKR.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Lu</LastName><ForeName>Xin</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Orthopaedics, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lin</LastName><ForeName>Jin</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0001-7646-6411</Identifier><AffiliationInfo><Affiliation>Department of Orthopaedics, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China. captainlx@163.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>09</Month><Day>08</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>BMC Musculoskelet Disord</MedlineTA><NlmUniqueID>100968565</NlmUniqueID><ISSNLinking>1471-2474</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000925">Anticoagulants</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000991">Antithrombins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D065427">Factor Xa Inhibitors</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D005343">Fibrinolytic Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D006495">Heparin, Low-Molecular-Weight</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000925" MajorTopicYN="N">Anticoagulants</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000991" MajorTopicYN="N">Antithrombins</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019644" MajorTopicYN="N">Arthroplasty, Replacement, Hip</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019645" MajorTopicYN="N">Arthroplasty, Replacement, Knee</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D065427" MajorTopicYN="N">Factor Xa Inhibitors</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005343" MajorTopicYN="N">Fibrinolytic Agents</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006470" MajorTopicYN="N">Hemorrhage</DescriptorName><QualifierName UI="Q000139" MajorTopicYN="N">chemically induced</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006495" MajorTopicYN="N">Heparin, Low-Molecular-Weight</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011655" MajorTopicYN="N">Pulmonary Embolism</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D054556" MajorTopicYN="N">Venous Thromboembolism</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020246" MajorTopicYN="N">Venous Thrombosis</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Bleeding</Keyword><Keyword MajorTopicYN="N">Low molecular weight heparin</Keyword><Keyword MajorTopicYN="N">Thrombosis</Keyword><Keyword MajorTopicYN="N">Total hip replacement</Keyword><Keyword MajorTopicYN="N">Total knee replacement</Keyword></KeywordList><CoiStatement>ETHICS APPROVAL AND CONSENT TO PARTICIPATE: Not applicable. CONSENT FOR PUBLICATION: Not applicable. COMPETING INTERESTS: The authors declare that they have no competing interests, and all authors should confirm its accuracy. PUBLISHER&#x2019;S NOTE: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2018</Year><Month>5</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>8</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>9</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>9</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>12</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2018</Year><Month>9</Month><Day>8</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">30193575</ArticleId><ArticleId IdType="pmc">PMC6129001</ArticleId><ArticleId IdType="doi">10.1186/s12891-018-2215-3</ArticleId><ArticleId IdType="pii">10.1186/s12891-018-2215-3</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Chapelle C, Rosencher N, Jacques Zufferey P, Mismetti P, Cucherat M, Laporte S. Prevention of venous thromboembolic events with low-molecular-weight heparin in the non-major orthopaedic setting: meta-analysis of randomized controlled trials. Arthroscopy. 2014;30:987&#x2013;996. doi: 10.1016/j.arthro.2014.03.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.arthro.2014.03.009</ArticleId><ArticleId IdType="pubmed">24813323</ArticleId></ArticleIdList></Reference><Reference><Citation>Falck-Ytter Y, Francis CW, Johanson NA, Curley C, Dahl OE, Schulman S, et al. Prevention of VTE in orthopedic surgery patients: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2012;141:e278S&#x2013;e325S. doi: 10.1378/chest.11-2404.</Citation><ArticleIdList><ArticleId IdType="doi">10.1378/chest.11-2404</ArticleId><ArticleId IdType="pmc">PMC3278063</ArticleId><ArticleId IdType="pubmed">22315265</ArticleId></ArticleIdList></Reference><Reference><Citation>Thorlund JB, Juhl CB, Roos EM, Lohmander LS. Arthroscopic surgery for degenerative knee: systematic review and meta-analysis of benefits and harms. BMJ. 2015;350:h2747. doi: 10.1136/bmj.h2747.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.h2747</ArticleId><ArticleId IdType="pmc">PMC4469973</ArticleId><ArticleId IdType="pubmed">26080045</ArticleId></ArticleIdList></Reference><Reference><Citation>Yeo KS, Lim WS, Lee YH. Deep vein thrombosis in arthroscopic surgery and chemoprophylaxis recommendation in an Asian population. Singap Med J. 2016;57:452&#x2013;455. doi: 10.11622/smedj.2016136.</Citation><ArticleIdList><ArticleId IdType="doi">10.11622/smedj.2016136</ArticleId><ArticleId IdType="pmc">PMC4993970</ArticleId><ArticleId IdType="pubmed">27549352</ArticleId></ArticleIdList></Reference><Reference><Citation>Sobieraj DM, Coleman CI, Tongbram V, Lee S, Colby J, Chen WT, et al. Venous thromboembolism in orthopedic surgery. Comparative effectiveness review no. 49. AHRQ publication no. 12-EHC020-EF. Rockville: Agency for Healthcare Research and Quality; 2012. www.effectivehealthcare.ahrq.gov/reports/final.cfm. Accessed 19 Sept 2017.</Citation></Reference><Reference><Citation>Eikelboom JW, Quinlan DJ, O&#x2019;Donnell M. Major bleeding, mortality, and effi cacy of fondaparinux in venous thromboembolism prevention trials. Circulation. 2009;120:2006&#x2013;2011. doi: 10.1161/CIRCULATIONAHA.109.872630.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.109.872630</ArticleId><ArticleId IdType="pubmed">19884469</ArticleId></ArticleIdList></Reference><Reference><Citation>Adam SS, McDuffie JR, Lachiewicz PF, Ortel TL, Williams JW., Jr Comparative effectiveness of new oral anticoagulants and standard thromboprophylaxis in patients having total hip or knee replacement: a systematic review. Ann Intern Med. 2013;159:275&#x2013;284. doi: 10.7326/0003-4819-159-4-201308200-00008.</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/0003-4819-159-4-201308200-00008</ArticleId><ArticleId IdType="pubmed">24026260</ArticleId></ArticleIdList></Reference><Reference><Citation>Kwong LM. Therapeutic potential of rivaroxaban in the prevention of venous thromboembolism following hip and knee replacement surgery: a review of clinical trial data. Vasc Health Risk Manag. 2011;7:461&#x2013;466. doi: 10.2147/VHRM.S4441.</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/VHRM.S4441</ArticleId><ArticleId IdType="pmc">PMC3148419</ArticleId><ArticleId IdType="pubmed">21822393</ArticleId></ArticleIdList></Reference><Reference><Citation>Hirsh J, Levine MN. Low molecular weight heparin: laboratory properties and clinical evaluation. A review Eur J Surg Suppl. 1994:9&#x2013;22.</Citation><ArticleIdList><ArticleId IdType="pubmed">7519092</ArticleId></ArticleIdList></Reference><Reference><Citation>Heit JA, Colwell CW, Francis CW, Ginsberg JS, Berkowitz SD, Whipple J, et al. Comparison of the oral direct thrombin inhibitor ximelagatran with enoxaparin as prophylaxis against venous thromboembolism after total knee replacement: a phase 2 dose-finding study. Arch Intern Med. 2001;161:2215&#x2013;2221. doi: 10.1001/archinte.161.18.2215.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archinte.161.18.2215</ArticleId><ArticleId IdType="pubmed">11575978</ArticleId></ArticleIdList></Reference><Reference><Citation>Wilke T, Muller S. Nonadherence in outpatient thromboprophylaxis after major orthopedic surgery: a systematic review. Expert Rev Pharmacoecon Outcomes Res. 2010;10:691&#x2013;700. doi: 10.1586/erp.10.77.</Citation><ArticleIdList><ArticleId IdType="doi">10.1586/erp.10.77</ArticleId><ArticleId IdType="pubmed">21155702</ArticleId></ArticleIdList></Reference><Reference><Citation>Weitz JI. Low-molecular-weight heparins. N Engl J Med. 1997;337:688&#x2013;698. doi: 10.1056/NEJM199709043371007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJM199709043371007</ArticleId><ArticleId IdType="pubmed">9278467</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun Y, Chen D, Xu Z, Shi D, Dai J, Qin J, et al. Deep venous thrombosis after knee arthroscopy: a systematic review and meta-analysis. Arthroscopy. 2014;30:406&#x2013;412. doi: 10.1016/j.arthro.2013.12.021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.arthro.2013.12.021</ArticleId><ArticleId IdType="pubmed">24581264</ArticleId></ArticleIdList></Reference><Reference><Citation>Huisman MV, Quinlan DJ, Dahl OE, Schulman S. Enoxaparin versus dabigatran or rivaroxaban for thromboprophylaxis after hip or knee arthroplasty: results of separate pooled analyses of phase III multicenter randomized trials. Circ Cardiovasc Qual Outcomes. 2010;3:652&#x2013;660. doi: 10.1161/CIRCOUTCOMES.110.957712.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCOUTCOMES.110.957712</ArticleId><ArticleId IdType="pubmed">20923996</ArticleId></ArticleIdList></Reference><Reference><Citation>Hayden JA, van der Windt DA, Cartwright JL, Cote P, Bombardier C. Assessing bias in studies of prognostic factors. Ann Intern Med. 2013;158:280&#x2013;286. doi: 10.7326/0003-4819-158-4-201302190-00009.</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/0003-4819-158-4-201302190-00009</ArticleId><ArticleId IdType="pubmed">23420236</ArticleId></ArticleIdList></Reference><Reference><Citation>Higgins JP, Altman DG, Gotzsche PC, Juni P, Moher D, Oxman AD, et al. The Cochrane Collaboration's tool for assessing risk of bias in randomised trials. BMJ. 2011;343:d5928. doi: 10.1136/bmj.d5928.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.d5928</ArticleId><ArticleId IdType="pmc">PMC3196245</ArticleId><ArticleId IdType="pubmed">22008217</ArticleId></ArticleIdList></Reference><Reference><Citation>Hardy RJ, Thompson SG. Detecting and describing heterogeneity in meta-analysis. Stat Med. 1998;17:841&#x2013;856. doi: 10.1002/(SICI)1097-0258(19980430)17:8&lt;841::AID-SIM781&gt;3.0.CO;2-D.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/(SICI)1097-0258(19980430)17:8&lt;841::AID-SIM781&gt;3.0.CO;2-D</ArticleId><ArticleId IdType="pubmed">9595615</ArticleId></ArticleIdList></Reference><Reference><Citation>Takkouche B, Cadarso-Suarez C, Spiegelman D. Evaluation of old and new tests of heterogeneity in epidemiologic meta-analysis. Am J Epidemiol. 1999;150:206&#x2013;215. doi: 10.1093/oxfordjournals.aje.a009981.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/oxfordjournals.aje.a009981</ArticleId><ArticleId IdType="pubmed">10412966</ArticleId></ArticleIdList></Reference><Reference><Citation>Sterne JA, Sutton AJ, Ioannidis JP, Terrin N, Jones DR, Lau J, et al. Recommendations for examining and interpreting funnel plot asymmetry in meta-analyses of randomised controlled trials. BMJ. 2011;343:d4002. doi: 10.1136/bmj.d4002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.d4002</ArticleId><ArticleId IdType="pubmed">21784880</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim SM, Moon YW, Lim SJ, Kim DW, Park YS. Effect of oral factor Xa inhibitor and low-molecular-weight heparin on surgical complications following total hip arthroplasty. Thromb Haemost. 2016;115:600&#x2013;607. doi: 10.1160/th15-07-0527.</Citation><ArticleIdList><ArticleId IdType="doi">10.1160/th15-07-0527</ArticleId><ArticleId IdType="pubmed">26790579</ArticleId></ArticleIdList></Reference><Reference><Citation>Eriksson BI, Agnelli G, Gallus AS, Lassen MR, Prins MH, Renfurm RW, et al. Darexaban (YM150) versus enoxaparin for the prevention of venous thromboembolism after total hip arthroplasty: a randomised phase IIb dose confirmation study (ONYX-3) Thromb Haemost. 2014;111:213&#x2013;225. doi: 10.1160/TH13-04-0296.</Citation><ArticleIdList><ArticleId IdType="doi">10.1160/TH13-04-0296</ArticleId><ArticleId IdType="pubmed">24136153</ArticleId></ArticleIdList></Reference><Reference><Citation>Zou Y, Tian S, Wang Y, Sun K. Administering aspirin, rivaroxaban and low-molecular-weight heparin to prevent deep venous thrombosis after total knee arthroplasty. Blood Coagul Fibrinolysis. 2014;25:660&#x2013;664. doi: 10.1097/MBC.0000000000000121.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MBC.0000000000000121</ArticleId><ArticleId IdType="pubmed">24695091</ArticleId></ArticleIdList></Reference><Reference><Citation>Eriksson BI, Dahl OE, Huo MH, Kurth AA, Hantel S, Hermansson K, et al. Oral dabigatran versus enoxaparin for thromboprophylaxis after primary total hip arthroplasty (RE-NOVATE II*). A randomised, double-blind, non-inferiority trial. Thromb Haemost. 2011;105:721&#x2013;729. doi: 10.1160/TH10-10-0679.</Citation><ArticleIdList><ArticleId IdType="doi">10.1160/TH10-10-0679</ArticleId><ArticleId IdType="pubmed">21225098</ArticleId></ArticleIdList></Reference><Reference><Citation>Lassen MR, Raskob GE, Gallus A, Pineo G, Chen D, Hornick P. Apixaban versus enoxaparin for thromboprophylaxis after knee replacement (ADVANCE-2): a randomised double-blind trial. Lancet. 2010;375:807&#x2013;815. doi: 10.1016/S0140-6736(09)62125-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(09)62125-5</ArticleId><ArticleId IdType="pubmed">20206776</ArticleId></ArticleIdList></Reference><Reference><Citation>Lassen MR, Gallus A, Raskob GE, Pineo G, Chen D, Ramirez LM. Apixaban versus enoxaparin for thromboprophylaxis after hip replacement. N Engl J Med. 2010;363:2487&#x2013;2498. doi: 10.1056/NEJMoa1006885.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1006885</ArticleId><ArticleId IdType="pubmed">21175312</ArticleId></ArticleIdList></Reference><Reference><Citation>Ginsberg JS, Davidson BL, Comp PC, Francis CW, Friedman RJ, Huo MH, et al. Oral thrombin inhibitor dabigatran etexilate vs north American enoxaparin regimen for prevention of venous thromboembolism after knee arthroplasty surgery. J Arthroplast. 2009;24:1&#x2013;9. doi: 10.1016/S0883-5403(09)00345-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0883-5403(09)00345-3</ArticleId><ArticleId IdType="pubmed">18534438</ArticleId></ArticleIdList></Reference><Reference><Citation>Turpie AG, Lassen MR, Davidson BL, Bauer KA, Gent M, Kwong LM, et al. Rivaroxaban versus enoxaparin for thromboprophylaxis after total knee arthroplasty (RECORD4): a randomised trial. Lancet. 2009;373:1673&#x2013;1680. doi: 10.1016/S0140-6736(09)60734-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(09)60734-0</ArticleId><ArticleId IdType="pubmed">19411100</ArticleId></ArticleIdList></Reference><Reference><Citation>Lassen MR, Raskob GE, Gallus A, Pineo G, Chen D, Portman RJ. Apixaban or enoxaparin for thromboprophylaxis after knee replacement. N Engl J Med. 2009;361:594&#x2013;604. doi: 10.1056/NEJMoa0810773.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa0810773</ArticleId><ArticleId IdType="pubmed">19657123</ArticleId></ArticleIdList></Reference><Reference><Citation>Fuji T, Ochi T, Niwa S, Fujita S. Prevention of postoperative venous thromboembolism in Japanese patients undergoing total hip or knee arthroplasty: two randomized, double-blind, placebo-controlled studies with three dosage regimens of enoxaparin. J Orthop Sci. 2008;13:442&#x2013;451. doi: 10.1007/s00776-008-1264-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00776-008-1264-0</ArticleId><ArticleId IdType="pubmed">18843459</ArticleId></ArticleIdList></Reference><Reference><Citation>Kakkar AK, Brenner B, Dahl OE, Eriksson BI, Mouret P, Muntz J, et al. Extended duration rivaroxaban versus short-term enoxaparin for the prevention of venous thromboembolism after total hip arthroplasty: a double-blind, randomised controlled trial. Lancet. 2008;372:31&#x2013;39. doi: 10.1016/S0140-6736(08)60880-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(08)60880-6</ArticleId><ArticleId IdType="pubmed">18582928</ArticleId></ArticleIdList></Reference><Reference><Citation>Eriksson BI, Borris LC, Friedman RJ, Haas S, Huisman MV, Kakkar AK, et al. Rivaroxaban versus enoxaparin for thromboprophylaxis after hip arthroplasty. N Engl J Med. 2008;358:2765&#x2013;2775. doi: 10.1056/NEJMoa0800374.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa0800374</ArticleId><ArticleId IdType="pubmed">18579811</ArticleId></ArticleIdList></Reference><Reference><Citation>Lassen MR, Ageno W, Borris LC, Lieberman JR, Rosencher N, Bandel TJ, et al. Rivaroxaban versus enoxaparin for thromboprophylaxis after total knee arthroplasty. N Engl J Med. 2008;358:2776&#x2013;2786. doi: 10.1056/NEJMoa076016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa076016</ArticleId><ArticleId IdType="pubmed">18579812</ArticleId></ArticleIdList></Reference><Reference><Citation>Eriksson BI, Dahl OE, Rosencher N, Kurth AA, van Dijk CN, Frostick SP, et al. Oral dabigatran etexilate vs. subcutaneous enoxaparin for the prevention of venous thromboembolism after total knee replacement: the RE-MODEL randomized trial. J Thromb Haemost. 2007;5:2178&#x2013;2185. doi: 10.1111/j.1538-7836.2007.02748.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1538-7836.2007.02748.x</ArticleId><ArticleId IdType="pubmed">17764540</ArticleId></ArticleIdList></Reference><Reference><Citation>Eriksson BI, Dahl OE, Rosencher N, Kurth AA, van Dijk CN, Frostick SP, et al. Dabigatran etexilate versus enoxaparin for prevention of venous thromboembolism after total hip replacement: a randomised, double-blind, non-inferiority trial. Lancet. 2007;370:949&#x2013;956. doi: 10.1016/S0140-6736(07)61445-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(07)61445-7</ArticleId><ArticleId IdType="pubmed">17869635</ArticleId></ArticleIdList></Reference><Reference><Citation>Eriksson BI, Agnelli G, Cohen AT, Dahl OE, Lassen MR, Mouret P, et al. The direct thrombin inhibitor melagatran followed by oral ximelagatran compared with enoxaparin for the prevention of venous thromboembolism after total hip or knee replacement: the EXPRESS study. J Thromb Haemost. 2003;1:2490&#x2013;2496. doi: 10.1111/j.1538-7836.2003.00494.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1538-7836.2003.00494.x</ArticleId><ArticleId IdType="pubmed">14675083</ArticleId></ArticleIdList></Reference><Reference><Citation>Colwell CW, Jr, Berkowitz SD, Davidson BL, Lotke PA, Ginsberg JS, Lieberman JR, et al. Comparison of ximelagatran, an oral direct thrombin inhibitor, with enoxaparin for the prevention of venous thromboembolism following total hip replacement. A randomized, double-blind study. J Thromb Haemost. 2003;1:2119&#x2013;2130. doi: 10.1046/j.1538-7836.2003.00368.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1046/j.1538-7836.2003.00368.x</ArticleId><ArticleId IdType="pubmed">14521593</ArticleId></ArticleIdList></Reference><Reference><Citation>Eriksson BI, Agnelli G, Cohen AT, Dahl OE, Mouret P, Rosencher N, et al. Direct thrombin inhibitor melagatran followed by oral ximelagatran in comparison with enoxaparin for prevention of venous thromboembolism after total hip or knee replacement. Thromb Haemost. 2003;89:288&#x2013;296. doi: 10.1055/s-0037-1613445.</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/s-0037-1613445</ArticleId><ArticleId IdType="pubmed">12574809</ArticleId></ArticleIdList></Reference><Reference><Citation>Bergqvist D, Benoni G, Bjorgell O, Fredin H, Hedlundh U, Nicolas S, et al. Low-molecular-weight heparin (enoxaparin) as prophylaxis against venous thromboembolism after total hip replacement. N Engl J Med. 1996;335:696&#x2013;700. doi: 10.1056/NEJM199609053351002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJM199609053351002</ArticleId><ArticleId IdType="pubmed">8703168</ArticleId></ArticleIdList></Reference><Reference><Citation>Planes A, Vochelle N, Darmon JY, Fagola M, Bellaud M, Huet Y. Risk of deep-venous thrombosis after hospital discharge in patients having undergone total hip replacement: double-blind randomised comparison of enoxaparin versus placebo. Lancet. 1996;348:224&#x2013;228. doi: 10.1016/S0140-6736(96)01453-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(96)01453-5</ArticleId><ArticleId IdType="pubmed">8684199</ArticleId></ArticleIdList></Reference><Reference><Citation>Hull RD, Pineo GF, Stein PD, Mah AF, MacIsaac SM, Dahl OE, et al. Extended out-of-hospital low-molecular-weight heparin prophylaxis against deep venous thrombosis in patients after elective hip arthroplasty: a systematic review. Ann Intern Med. 2001;135:858&#x2013;869. doi: 10.7326/0003-4819-135-10-200111200-00006.</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/0003-4819-135-10-200111200-00006</ArticleId><ArticleId IdType="pubmed">11712876</ArticleId></ArticleIdList></Reference><Reference><Citation>Tasker A, Harbord R, Bannister GC. Meta-analysis of low molecular weight heparin versus placebo in patients undergoing total hip replacement and post-operative morbidity and mortality since their introduction. Hip Int. 2010;20:64&#x2013;74. doi: 10.1177/112070001002000110.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/112070001002000110</ArticleId><ArticleId IdType="pubmed">20383852</ArticleId></ArticleIdList></Reference><Reference><Citation>Ning GZ, Kan SL, Chen LX, Shangguan L, Feng SQ, Zhou Y. Rivaroxaban for thromboprophylaxis after total hip or knee arthroplasty: a meta-analysis with trial sequential analysis of randomized controlled trials. Sci Rep. 2016;6:23726. doi: 10.1038/srep23726.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep23726</ArticleId><ArticleId IdType="pmc">PMC4810418</ArticleId><ArticleId IdType="pubmed">27020475</ArticleId></ArticleIdList></Reference><Reference><Citation>Feng W, Wu K, Liu Z, Kong G, Deng Z, Chen S, et al. Oral direct factor Xa inhibitor versus enoxaparin for thromboprophylaxis after hip or knee arthroplasty: systemic review, traditional meta-analysis, dose-response meta-analysis and network meta-analysis. Thromb Res. 2015;136:1133&#x2013;1144. doi: 10.1016/j.thromres.2015.10.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.thromres.2015.10.009</ArticleId><ArticleId IdType="pubmed">26498222</ArticleId></ArticleIdList></Reference><Reference><Citation>G&#xf3;mez-Outes A, Terleira-Fern&#xe1;ndez AI, Su&#xe1;rez-Gea ML, Vargas-Castrill&#xf3;n E. Dabigatran, rivaroxaban, or apixaban versus enoxaparin for thromboprophylaxis after total hip or knee replacement: systematic review, meta-analysis, and indirect treatment comparisons. BMJ. 2012;344</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3375207</ArticleId><ArticleId IdType="pubmed">22700784</ArticleId></ArticleIdList></Reference><Reference><Citation>Wolowacz SE, Roskell NS, Plumb JM, Caprini JA, Eriksson BI. Efficacy and safety of dabigatran etexilate for the prevention of venous thromboembolism following total hip or knee arthroplasty. A meta-analysis Thromb Haemost. 2009;101:77&#x2013;85. doi: 10.1160/TH08-07-0493.</Citation><ArticleIdList><ArticleId IdType="doi">10.1160/TH08-07-0493</ArticleId><ArticleId IdType="pubmed">19132192</ArticleId></ArticleIdList></Reference><Reference><Citation>Cohen AT, Hirst C, Sherrill B, Holmes P, Fidan D. Meta-analysis of trials comparing ximelagatran with low molecular weight heparin for prevention of venous thromboembolism after major orthopaedic surgery. Br J Surg. 2005;92:1335&#x2013;1344. doi: 10.1002/bjs.5180.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/bjs.5180</ArticleId><ArticleId IdType="pubmed">16237737</ArticleId></ArticleIdList></Reference><Reference><Citation>Ma G, Zhang R, Wu X, Wang D, Ying K. Direct factor Xa inhibitors (rivaroxaban and apixaban) versus enoxaparin for the prevention of venous thromboembolism after total knee replacement: A meta-analysis of 6 randomized clinical trials. Thromb Res. 2015;135:816&#x2013;822. doi: 10.1016/j.thromres.2015.02.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.thromres.2015.02.008</ArticleId><ArticleId IdType="pubmed">25728496</ArticleId></ArticleIdList></Reference><Reference><Citation>Neumann I, Rada G, Claro JC, Carrasco-Labra A, Thorlund K, Akl EA, et al. Oral direct Factor Xa inhibitors versus low-molecular-weight heparin to prevent venous thromboembolism in patients undergoing total hip or knee replacement: a systematic review and meta-analysis. Ann Intern Med. 2012;156:710&#x2013;719. doi: 10.7326/0003-4819-156-10-201205150-00421.</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/0003-4819-156-10-201205150-00421</ArticleId><ArticleId IdType="pubmed">22412038</ArticleId></ArticleIdList></Reference><Reference><Citation>Nieto JA, Espada NG, Merino RG, Gonz&#xe1;lez TC. Dabigatran, rivaroxaban and apixaban versus enoxaparin for thomboprophylaxis after total knee or hip arthroplasty: pool-analysis of phase III randomized clinical trials. Thromb Res. 2012;130:183&#x2013;191. doi: 10.1016/j.thromres.2012.02.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.thromres.2012.02.011</ArticleId><ArticleId IdType="pubmed">22425218</ArticleId></ArticleIdList></Reference><Reference><Citation>Li XM, Sun SG, Zhang WD. Apixaban versus enoxaparin for thromboprophylaxis after total hip or knee arthroplasty: a meta-analysis of randomized controlled trials. Chin Med J. 2012;125:2339&#x2013;2345.</Citation><ArticleIdList><ArticleId IdType="pubmed">22882859</ArticleId></ArticleIdList></Reference><Reference><Citation>Raskob GE, Gallus AS, Pineo GF, Chen D, Ramirez LM, Wright RT, et al. Apixaban versus enoxaparin for thromboprophylaxis after hip or knee replacement: pooled analysis of major venous thromboembolism and bleeding in 8464 patients from the ADVANCE-2 and ADVANCE-3 trials. J Bone Joint Surg Br. 2012;94:257&#x2013;264. doi: 10.1302/0301-620X.94B2.27850.</Citation><ArticleIdList><ArticleId IdType="doi">10.1302/0301-620X.94B2.27850</ArticleId><ArticleId IdType="pubmed">22323697</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang J, Cao Y, Liao C, Wu L, Gao F. Apixaban versus enoxaparin in patients with total knee arthroplasty. A meta-analysis of randomised trials. Thromb Haemost. 2011;105:245&#x2013;253. doi: 10.1160/TH10-08-0552.</Citation><ArticleIdList><ArticleId IdType="doi">10.1160/TH10-08-0552</ArticleId><ArticleId IdType="pubmed">20941455</ArticleId></ArticleIdList></Reference><Reference><Citation>Cao YB, Zhang JD, Shen H, Jiang YY. Rivaroxaban versus enoxaparin for thromboprophylaxis after total hip or knee arthroplasty: a meta-analysis of randomized controlled trials. Eur J Clin Pharmacol. 2010;66:1099&#x2013;1108. doi: 10.1007/s00228-010-0889-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00228-010-0889-z</ArticleId><ArticleId IdType="pubmed">20812009</ArticleId></ArticleIdList></Reference><Reference><Citation>Melillo SN, Scanlon JV, Exter BP, Steinberg M, Jarvis CI. Rivaroxaban for thromboprophylaxis in patients undergoing major orthopedic surgery. Ann Pharmacother. 2010;44:1061&#x2013;1071. doi: 10.1345/aph.1M681.</Citation><ArticleIdList><ArticleId IdType="doi">10.1345/aph.1M681</ArticleId><ArticleId IdType="pubmed">20424181</ArticleId></ArticleIdList></Reference><Reference><Citation>Eriksson BI, Dahl OE, Rosencher N, Clemens A, Hantel S, Feuring M, et al. Oral dabigatran etexilate versus enoxaparin for venous thromboembolism prevention after total hip arthroplasty: pooled analysis of two phase 3 randomized trials. Thromb J. 2015;13:36. doi: 10.1186/s12959-015-0067-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12959-015-0067-8</ArticleId><ArticleId IdType="pmc">PMC4647514</ArticleId><ArticleId IdType="pubmed">26578849</ArticleId></ArticleIdList></Reference><Reference><Citation>Friedman RJ, Dahl OE, Rosencher N, Caprini JA, Kurth AA, Francis CW, et al. Dabigatran versus enoxaparin for prevention of venous thromboembolism after hip or knee arthroplasty: a pooled analysis of three trials. Thromb Res. 2010;126:175&#x2013;182. doi: 10.1016/j.thromres.2010.03.021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.thromres.2010.03.021</ArticleId><ArticleId IdType="pubmed">20434759</ArticleId></ArticleIdList></Reference><Reference><Citation>Kwok CS, Pradhan S, Yeong JK, Loke YK. Relative effects of two different enoxaparin regimens as comparators against newer oral anticoagulants: meta-analysis and adjusted indirect comparison. Chest. 2013;144:593&#x2013;600. doi: 10.1378/chest.12-2634.</Citation><ArticleIdList><ArticleId IdType="doi">10.1378/chest.12-2634</ArticleId><ArticleId IdType="pubmed">23519234</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">31430799</PMID><DateCompleted><Year>2020</Year><Month>03</Month><Day>24</Day></DateCompleted><DateRevised><Year>2020</Year><Month>06</Month><Day>30</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2567-689X</ISSN><JournalIssue CitedMedium="Internet"><Volume>119</Volume><Issue>10</Issue><PubDate><Year>2019</Year><Month>Oct</Month></PubDate></JournalIssue><Title>Thrombosis and haemostasis</Title><ISOAbbreviation>Thromb Haemost</ISOAbbreviation></Journal><ArticleTitle>Use of Prophylaxis for Prevention of Venous Thromboembolism in Patients with Isolated Foot or Ankle Surgery: A Systematic Review and Meta-Analysis.</ArticleTitle><Pagination><StartPage>1686</StartPage><EndPage>1694</EndPage><MedlinePgn>1686-1694</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1055/s-0039-1693464</ELocationID><Abstract><AbstractText>Although prophylaxis for venous thromboembolism (VTE) is recommended after many surgeries, evidence base for use of VTE prophylaxis after foot or ankle surgery has been elusive, leading into varying guidelines recommendations and notable practice variations. We conducted a systematic review of the literature to determine if use of VTE prophylaxis decreased the frequency of subsequent VTE, including deep vein thrombosis (DVT) or pulmonary embolism (PE), compared with control. We searched PubMed, the Cochrane Central Register of Controlled Trials, and ClinicalTrials.gov through May 2018, for randomized controlled trials (RCTs) or prospective controlled observational studies of VTE prophylaxis in patients undergoing foot and ankle surgery. Our search retrieved 263 studies, of which 6 were finally included comprising 1,600 patients. Patients receiving VTE prophylaxis had lower risk for subsequent DVT (risk ratio [RR]: 0.72; 95% confidence interval [CI]: 0.55-0.94) and subsequent VTE (RR: 0.72; 95% CI: 0.55-0.94). There was only one case of nonfatal PE, no cases of fatal PE, and no change in all-cause mortality (RR: 3.51; 95% CI: 0.14-84.84). There was no significant difference in the risk for bleeding (RR: 2.12; 95% CI: 0.53-8.56). Very few RCTs exist regarding the efficacy and safety of VTE prophylaxis in foot and ankle surgery. Prophylaxis appears to reduce the risk of subsequent VTE, but the event rates are low and symptomatic events are rare. Future studies should determine the subgroups of patients undergoing foot or ankle surgery in whom prophylaxis may be most useful.</AbstractText><CopyrightInformation>Georg Thieme Verlag KG Stuttgart &#xb7; New York.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Bikdeli</LastName><ForeName>Bavand</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Aged &amp; Extended Care Services, The Queen Elizabeth Hospital, Adelaide, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Adelaide Geriatrics Training and Research with Aged Care (GTRAC) Centre, School of Medicine, Faculty of Health and Medical Science, University of Adelaide, Adelaide, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Medical Sub-specialties, Lyell McEwin Hospital, Adelaide, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Visvanathan</LastName><ForeName>Renuka</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Aged &amp; Extended Care Services, The Queen Elizabeth Hospital, Adelaide, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Adelaide Geriatrics Training and Research with Aged Care (GTRAC) Centre, School of Medicine, Faculty of Health and Medical Science, University of Adelaide, Adelaide, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jimenez</LastName><ForeName>David</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Respiratory and Medicine Department, Hospital Ram&#xf3;n y Cajal, Universidad de Alcal&#xe1; (IRYCIS), Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Monreal</LastName><ForeName>Manuel</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, Hospital Universitari Germans Trias i Pujol, Badalona, Barcelona.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Universidad Cat&#xf3;lica de Murcia, Murcia, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Goldhaber</LastName><ForeName>Samuel Z</ForeName><Initials>SZ</Initials><AffiliationInfo><Affiliation>Cardiovascular Division, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bikdeli</LastName><ForeName>Behnood</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, Hospital Universitari Germans Trias i Pujol, Badalona, Barcelona.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Cardiology, Department of Medicine, Columbia University Medical Center/NewYork-Presbyterian Hospital, New York, New York, United States.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Outcomes Research &amp; Evaluation, Yale New Haven Hospital, New Haven, Connecticut, United States.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2019</Year><Month>08</Month><Day>20</Day></ArticleDate></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>Thromb Haemost</MedlineTA><NlmUniqueID>7608063</NlmUniqueID><ISSNLinking>0340-6245</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000925">Anticoagulants</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D006495">Heparin, Low-Molecular-Weight</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="ErratumIn"><RefSource>Thromb Haemost. 2019 Oct;119(10):e1. doi: 10.1055/s-0040-1702204.</RefSource><PMID Version="1">32422665</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000842" MajorTopicYN="N">Ankle</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000925" MajorTopicYN="N">Anticoagulants</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005528" MajorTopicYN="N">Foot</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006495" MajorTopicYN="N">Heparin, Low-Molecular-Weight</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D064887" MajorTopicYN="N">Observational Studies as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011655" MajorTopicYN="N">Pulmonary Embolism</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016032" MajorTopicYN="N">Randomized Controlled Trials as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012306" MajorTopicYN="N">Risk</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D054556" MajorTopicYN="N">Venous Thromboembolism</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020246" MajorTopicYN="N">Venous Thrombosis</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading></MeshHeadingList><CoiStatement>Behnood Bikdeli is supported by the National Heart, Lung, and Blood Institute, National Institutes of Health (NIH), through grant number T32 HL007854. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH. Behnood Bikdeli reports that he serves as an expert (on behalf of the plaintiff) for litigation related to inferior vena caval filters. The content of the current manuscript is not directly related to that litigation. None of the other authors report any conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>8</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>3</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>8</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31430799</ArticleId><ArticleId IdType="doi">10.1055/s-0039-1693464</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">26845754</PMID><DateCompleted><Year>2018</Year><Month>01</Month><Day>02</Day></DateCompleted><DateRevised><Year>2025</Year><Month>06</Month><Day>26</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1538-7836</ISSN><JournalIssue CitedMedium="Internet"><Volume>14</Volume><Issue>5</Issue><PubDate><Year>2016</Year><Month>May</Month></PubDate></JournalIssue><Title>Journal of thrombosis and haemostasis : JTH</Title><ISOAbbreviation>J Thromb Haemost</ISOAbbreviation></Journal><ArticleTitle>Prevalence of deep vein thrombosis and pulmonary embolism in patients with superficial vein thrombosis: a systematic review and meta-analysis.</ArticleTitle><Pagination><StartPage>964</StartPage><EndPage>972</EndPage><MedlinePgn>964-72</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1111/jth.13279</ELocationID><Abstract><AbstractText Label="UNLABELLED">Essentials The association of superficial vein thrombosis (SVT) with venous thromboembolism (VTE) is variable. We performed a meta-analysis to assess the prevalence of concomitant VTE in patients with SVT. Deep vein thrombosis was found in 18.1%, and pulmonary embolism in 6.9%, of SVT patients. Screening for VTE may be worthy in some SVT patients to plan adequate anticoagulant treatment.</AbstractText><AbstractText Label="SUMMARY">Background Some studies have suggested that patients with superficial vein thrombosis (SVT) have a non-negligible risk of concomitant deep vein thrombosis (DVT) or pulmonary embolism (PE) at the time of SVT diagnosis. Unfortunately, the available data on this association are widely variable. Objectives To perform a systematic review and meta-analysis of the literature in order to evaluate the prevalence of concomitant DVT/PE in patients with SVT of the lower limbs. Methods Studies reporting on the presence of DVT/PE in SVT patients were systematically searched for in the PubMed, Web of Science, Scopus and EMBASE databases. The weighted mean prevalence (WMP) of DVT and PE was calculated by use of the random effect model. Results Twenty-one studies (4358 patients) evaluated the prevalence of DVT and 11 studies (2484 patients) evaluated the prevalence of PE in patients with SVT. The WMP of DVT at SVT diagnosis was 18.1% (95%CI: 13.9%, 23.3%) and the WMP of PE was 6.9% (95%CI: 3.9%, 11.8%). Heterogeneity among the studies was substantial. Selection of studies including outpatients only gave similar results (WMP of DVT, 18.2%, 95%&#xa0;CI&#xa0;12.2-26.3%; and WMP of PE, 8.2%, 95%&#xa0;CI&#xa0;3.3-18.9%). Younger age, female gender, recent trauma and pregnancy were inversely associated with the presence of DVT/PE in SVT patients. Conclusions The results of our large meta-analysis suggest that the prevalence of DVT and PE in patients presenting with SVT is not negligible. Screening for a major thromboembolic event may be worthwhile in some SVT patients, in order to allow adequate anticoagulant treatment to be planned. Other high-quality studies are warranted to confirm our findings.</AbstractText><CopyrightInformation>&#xa9; 2016 International Society on Thrombosis and Haemostasis.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Di Minno</LastName><ForeName>M N D</ForeName><Initials>MN</Initials><AffiliationInfo><Affiliation>Division of Cardiology - Department of Advanced Biomedical Sciences, Federico II University, Naples, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Unit of Cell and Molecular Biology in Cardiovascular Diseases, Centro Cardiologico Monzino, IRCCS, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ambrosino</LastName><ForeName>P</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Clinical Medicine and Surgery, Federico II University, Naples, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ambrosini</LastName><ForeName>F</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Clinical and Experimental Medicine, University of Insubria, Varese, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tremoli</LastName><ForeName>E</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Unit of Cell and Molecular Biology in Cardiovascular Diseases, Centro Cardiologico Monzino, IRCCS, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Di Minno</LastName><ForeName>G</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Clinical Medicine and Surgery, Federico II University, Naples, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dentali</LastName><ForeName>F</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Clinical and Experimental Medicine, University of Insubria, Varese, Italy.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2016</Year><Month>03</Month><Day>15</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>J Thromb Haemost</MedlineTA><NlmUniqueID>101170508</NlmUniqueID><ISSNLinking>1538-7836</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000925">Anticoagulants</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000925" MajorTopicYN="N">Anticoagulants</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003625" MajorTopicYN="N">Data Collection</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D035002" MajorTopicYN="N">Lower Extremity</DescriptorName><QualifierName UI="Q000098" MajorTopicYN="Y">blood supply</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010045" MajorTopicYN="N">Outpatients</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011247" MajorTopicYN="N">Pregnancy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011249" MajorTopicYN="N">Pregnancy Complications, Cardiovascular</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015995" MajorTopicYN="N">Prevalence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011655" MajorTopicYN="N">Pulmonary Embolism</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012044" MajorTopicYN="N">Regression Analysis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D054556" MajorTopicYN="N">Venous Thromboembolism</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020246" MajorTopicYN="N">Venous Thrombosis</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">deep vein thrombosis</Keyword><Keyword MajorTopicYN="N">phlebothrombosis</Keyword><Keyword MajorTopicYN="N">pulmonary embolism</Keyword><Keyword MajorTopicYN="N">superficial vein thrombosis</Keyword><Keyword MajorTopicYN="N">thrombophlebitis</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2015</Year><Month>9</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2016</Year><Month>1</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2016</Year><Month>2</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2016</Year><Month>2</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>1</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">26845754</ArticleId><ArticleId IdType="doi">10.1111/jth.13279</ArticleId><ArticleId IdType="pii">S1538-7836(22)03495-X</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">25275670</PMID><DateCompleted><Year>2015</Year><Month>03</Month><Day>16</Day></DateCompleted><DateRevised><Year>2022</Year><Month>03</Month><Day>31</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">2168-619X</ISSN><JournalIssue CitedMedium="Internet"><Volume>140</Volume><Issue>12</Issue><PubDate><Year>2014</Year><Month>Dec</Month></PubDate></JournalIssue><Title>JAMA otolaryngology-- head &amp; neck surgery</Title><ISOAbbreviation>JAMA Otolaryngol Head Neck Surg</ISOAbbreviation></Journal><ArticleTitle>Transoral robotic surgery for obstructive sleep apnea: perioperative management and postoperative complications.</ArticleTitle><Pagination><StartPage>1207</StartPage><EndPage>1212</EndPage><MedlinePgn>1207-12</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1001/jamaoto.2014.2299</ELocationID><Abstract><AbstractText Label="IMPORTANCE" NlmCategory="OBJECTIVE">Patients who undergo surgery for obstructive sleep apnea (OSA) have acceptable perioperative morbidity that is similar to that seen in other sleep-related surgical procedures.</AbstractText><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">To perform the first large-scale evaluation of perioperative management and postoperative complications in patients who undergo transoral robotic surgery (TORS) for OSA.</AbstractText><AbstractText Label="DESIGN, SETTING, AND PARTICIPANTS" NlmCategory="METHODS">Retrospective cohort study from 2010 to 2013 of 166 adult patients with moderate to severe OSA (defined as apnea-hypopnea index, &gt;20) who had experienced failure of conventional therapy with positive airway pressure and underwent TORS at an academic practice with follow-up greater than 3 months.</AbstractText><AbstractText Label="INTERVENTIONS" NlmCategory="METHODS">Transoral robotic surgery with or without additional multilevel airway procedures.</AbstractText><AbstractText Label="MAIN OUTCOMES AND MEASURES" NlmCategory="METHODS">Major and minor complication rates.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">There were 122 men and 44 women with a mean (SD) age of 54.6 (12.3) years. The mean (SD) American Society of Anesthesiologists (ASA) score was 2.3 (0.5). There were 11 major complications, including secondary bleeding requiring intervention (7 patients), pulmonary embolism requiring anticoagulation therapy (2 patients), aspiration requiring prolonged hospitalization (1 patient), and dysphagia resulting in gastrostomy tube dependence (1 patient). There were 32 minor complications, including dehydration and/or uncontrolled pain (16 patients), globus sensation (8 patients), bleeding (5 patients), lip burn (2 patients), and pharyngeal laceration during intubation (1 patient); the majority resolved without sequelae. Preoperative ASA score (P&#x2009;=&#x2009;.003) and number of procedures performed (P&#x2009;=&#x2009;.004) predicted a postoperative complication. Age (P&#x2009;=&#x2009;.29), body mass index (P&#x2009;=&#x2009;.55), apnea-hypopnea index (P&#x2009;=&#x2009;.67), lowest arterial oxygen saturation (P&#x2009;=&#x2009;.63), number of comorbidities (P&#x2009;=&#x2009;.46), and individual comorbidities did not predict a complication.</AbstractText><AbstractText Label="CONCLUSIONS AND RELEVANCE" NlmCategory="CONCLUSIONS">Transoral robotic surgery can be safely performed in patients with OSA with an acceptable complication rate. Complications are similar to those seen with other surgical treatments of OSA and were only predicted by ASA score and number of procedures performed.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Glazer</LastName><ForeName>Tiffany A</ForeName><Initials>TA</Initials><AffiliationInfo><Affiliation>Department of Otolaryngology-Head and Neck Surgery, University of Michigan Health System, Ann Arbor, Michigan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hoff</LastName><ForeName>Paul T</ForeName><Initials>PT</Initials><AffiliationInfo><Affiliation>Department of Otolaryngology-Head and Neck Surgery, St Joseph Mercy Health System, Ann Arbor, Michigan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Spector</LastName><ForeName>Matthew E</ForeName><Initials>ME</Initials><AffiliationInfo><Affiliation>Department of Otolaryngology-Head and Neck Surgery, University of Michigan Health System, Ann Arbor, Michigan.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>JAMA Otolaryngol Head Neck Surg</MedlineTA><NlmUniqueID>101589542</NlmUniqueID><ISSNLinking>2168-6181</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007902" MajorTopicYN="N">Length of Stay</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009055" MajorTopicYN="N">Mouth</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019990" MajorTopicYN="Y">Perioperative Care</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D065287" MajorTopicYN="N">Robotic Surgical Procedures</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020181" MajorTopicYN="N">Sleep Apnea, Obstructive</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2014</Year><Month>10</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2014</Year><Month>10</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2015</Year><Month>3</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">25275670</ArticleId><ArticleId IdType="doi">10.1001/jamaoto.2014.2299</ArticleId><ArticleId IdType="pii">1913579</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">39228215</PMID><DateCompleted><Year>2025</Year><Month>04</Month><Day>25</Day></DateCompleted><DateRevised><Year>2025</Year><Month>07</Month><Day>11</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1433-7347</ISSN><JournalIssue CitedMedium="Internet"><Volume>33</Volume><Issue>5</Issue><PubDate><Year>2025</Year><Month>May</Month></PubDate></JournalIssue><Title>Knee surgery, sports traumatology, arthroscopy : official journal of the ESSKA</Title><ISOAbbreviation>Knee Surg Sports Traumatol Arthrosc</ISOAbbreviation></Journal><ArticleTitle>The efficacy of aspirin versus low-molecular-weight heparin for venous thromboembolism prophylaxis after knee and hip arthroplasty: A systematic review and meta-analysis of randomized controlled trials.</ArticleTitle><Pagination><StartPage>1605</StartPage><EndPage>1616</EndPage><MedlinePgn>1605-1616</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1002/ksa.12456</ELocationID><Abstract><AbstractText Label="PURPOSE" NlmCategory="OBJECTIVE">The purpose of this study was to assess the efficacy of aspirin versus low-molecular-weight heparin (LMWH) in preventing venous thromboembolism (VTE) following hip and knee arthroplasty.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">PubMed/Medline, Embase, Cochrane Library and Google Scholar databases were searched from inception till June 2024 for original trials investigating the outcomes of aspirin versus LMWH in hip and knee arthroplasty. The primary outcome was VTE. Secondary outcomes included minor and major bleeding events, and postoperative mortality within 90 days. This review was conducted per the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">A total of 7 randomized controlled trials with 12,134 participants were included. The mean ages for the aspirin and LMWH cohorts were 66.6 (57.6-69.0) years and 66.8 (57.9-68.9) years, respectively. There was no statistically significant difference in the overall risk of VTE between the aspirin and the LMWH cohorts (odds ratio [OR]: 0.95; 95% confidence interval [CI]: 0.48-1.89; p: 0.877). A subanalysis based on the specific VTE entity (pulmonary embolism [PE] or deep venous thrombosis) showed a significantly higher PE risk for patients receiving aspirin than the LMWH cohort (OR: 1.79; 95% CI: 1.11-2.89; p: 0.017). There was no difference in minor (OR: 0.64; 95% CI: 0.40-1.04; p: 0.072) and major bleeding (OR: 0.77; 95% CI: 0.40-1.47; p: 0.424) episodes across both groups. Furthermore, subanalysis among the total knee arthroplasty group showed that the aspirin cohort was significantly more likely to suffer VTEs than their LMWH counterparts (OR: 1.55; 95% CI: 1.21-1.98; p&#x2009;&lt;&#x2009;0.001).</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">This study demonstrated a significantly higher risk of PE among patients receiving aspirin compared to LMWH following hip or knee arthroplasty for osteoarthritis. Aspirin was associated with a significantly higher overall VTE risk among patients undergoing knee arthroplasty, in particular. This might suggest the inferiority of aspirin compared to LMWH in preventing VTE following such procedures.</AbstractText><AbstractText Label="LEVEL OF EVIDENCE" NlmCategory="METHODS">Level I.</AbstractText><CopyrightInformation>&#xa9; 2024 The Author(s). Knee Surgery, Sports Traumatology, Arthroscopy published by John Wiley &amp; Sons Ltd on behalf of European Society of Sports Traumatology, Knee Surgery and Arthroscopy.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Salman</LastName><ForeName>Loay A</ForeName><Initials>LA</Initials><Identifier Source="ORCID">0000-0001-8414-2660</Identifier><AffiliationInfo><Affiliation>Department of Orthopaedic Surgery, Surgical Specialty Center, Hamad General Hospital, Hamad Medical Corporation, Doha, Qatar.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Altahtamouni</LastName><ForeName>Seif B</ForeName><Initials>SB</Initials><AffiliationInfo><Affiliation>Department of Orthopaedic Surgery, Surgical Specialty Center, Hamad General Hospital, Hamad Medical Corporation, Doha, Qatar.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Khatkar</LastName><ForeName>Harman</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Royal London Hospital, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Al-Ani</LastName><ForeName>Abdallah</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Office of Scientific Affairs and Research, King Hussein Cancer Center, Amman, Jordan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hameed</LastName><ForeName>Shamsi</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Orthopaedic Surgery, Surgical Specialty Center, Hamad General Hospital, Hamad Medical Corporation, Doha, Qatar.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alvand</LastName><ForeName>Abtin</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Nuffield Orthopaedic Centre, University of Oxford, Oxford, UK.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D003160">Comparative Study</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>09</Month><Day>03</Day></ArticleDate></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>Knee Surg Sports Traumatol Arthrosc</MedlineTA><NlmUniqueID>9314730</NlmUniqueID><ISSNLinking>0942-2056</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D006495">Heparin, Low-Molecular-Weight</NameOfSubstance></Chemical><Chemical><RegistryNumber>R16CO5Y76E</RegistryNumber><NameOfSubstance UI="D001241">Aspirin</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000925">Anticoagulants</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006495" MajorTopicYN="Y">Heparin, Low-Molecular-Weight</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D054556" MajorTopicYN="Y">Venous Thromboembolism</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019645" MajorTopicYN="Y">Arthroplasty, Replacement, Knee</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001241" MajorTopicYN="Y">Aspirin</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019644" MajorTopicYN="Y">Arthroplasty, Replacement, Hip</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016032" MajorTopicYN="N">Randomized Controlled Trials as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000925" MajorTopicYN="Y">Anticoagulants</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="Y">Postoperative Complications</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">DVT</Keyword><Keyword MajorTopicYN="N">PE</Keyword><Keyword MajorTopicYN="N">arthroplasty</Keyword><Keyword MajorTopicYN="N">hip</Keyword><Keyword MajorTopicYN="N">knee</Keyword><Keyword MajorTopicYN="N">venous thromboembolism</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>8</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>7</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>8</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>4</Month><Day>25</Day><Hour>13</Hour><Minute>47</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>9</Month><Day>4</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>9</Month><Day>4</Day><Hour>3</Hour><Minute>3</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2025</Year><Month>4</Month><Day>25</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39228215</ArticleId><ArticleId IdType="pmc">PMC12022833</ArticleId><ArticleId IdType="doi">10.1002/ksa.12456</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Abdel, M.P. , Meneghini, R.M. &amp; Berry, D.J. (2021) Current practice trends in primary hip and knee arthroplasties among members of the American Association of Hip and Knee Surgeons: an update during the COVID&#x2010;19 pandemic. The Journal of Arthroplasty, 36, S40&#x2013;S44.e3. Available from: 10.1016/j.arth.2021.01.080</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.arth.2021.01.080</ArticleId><ArticleId IdType="pubmed">33640185</ArticleId></ArticleIdList></Reference><Reference><Citation>

Aggarwal, V.K.
, 
Suh, Y.M.
, 
Hutzler, L.
, 
Moscona, L.
 &amp; 
Casta&#xf1;eda, P.
 (2019) Total hip arthroplasty for secondary causes of arthritis an increase in time and money. Bulletin of the Hospital for Joint Disease (2013), 77, 233&#x2013;237. Available from: https://pubmed.ncbi.nlm.nih.gov/31785135/

</Citation><ArticleIdList><ArticleId IdType="pubmed">31785135</ArticleId></ArticleIdList></Reference><Reference><Citation>An, V.V.G. , Phan, K. , Levy, Y.D. &amp; Bruce, W.J.M. (2016) Aspirin as thromboprophylaxis in hip and knee arthroplasty: a systematic review and meta&#x2010;analysis. The Journal of Arthroplasty, 31, 2608&#x2013;2616. Available from: 10.1016/j.arth.2016.04.004</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.arth.2016.04.004</ArticleId><ArticleId IdType="pubmed">27178011</ArticleId></ArticleIdList></Reference><Reference><Citation>Anderson, D.R. , Dunbar, M. , Murnaghan, J. , Kahn, S.R. , Gross, P. , Forsythe, M. et al. (2018) Aspirin or rivaroxaban for VTE prophylaxis after hip or knee arthroplasty. New England Journal of Medicine, 378, 699&#x2013;707. Available from: 10.1056/NEJMoa1712746</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1712746</ArticleId><ArticleId IdType="pubmed">29466159</ArticleId></ArticleIdList></Reference><Reference><Citation>Anderson, D.R. , Dunbar, M.J. , Bohm, E.R. , Belzile, E. , Kahn, S.R. , Zukor, D. et al. (2013) Aspirin versus low&#x2010;molecular&#x2010;weight heparin for extended venous thromboembolism prophylaxis after total hip arthroplasty: a randomized trial. Annals of Internal Medicine, 158, 800&#x2013;806. Available from: 10.7326/0003-4819-158-11-201306040-00004</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/0003-4819-158-11-201306040-00004</ArticleId><ArticleId IdType="pubmed">23732713</ArticleId></ArticleIdList></Reference><Reference><Citation>Bohl, D.D. , Maltenfort, M.G. , Huang, R. , Parvizi, J. , Lieberman, J.R. &amp; Della Valle, C.J. (2016) Development and validation of a risk stratification system for pulmonary embolism after elective primary total joint arthroplasty. The Journal of Arthroplasty, 31, 187&#x2013;191. Available from: 10.1016/j.arth.2016.02.080</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.arth.2016.02.080</ArticleId><ArticleId IdType="pubmed">27067463</ArticleId></ArticleIdList></Reference><Reference><Citation>Bozic, K.J. , Vail, T.P. , Pekow, P.S. , Maselli, J.H. , Lindenauer, P.K. &amp; Auerbach, A.D. (2010) Does aspirin have a role in venous thromboembolism prophylaxis in total knee arthroplasty patients? The Journal of Arthroplasty, 25, 1053&#x2013;1060. Available from: 10.1016/j.arth.2009.06.021</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.arth.2009.06.021</ArticleId><ArticleId IdType="pmc">PMC4142798</ArticleId><ArticleId IdType="pubmed">19679434</ArticleId></ArticleIdList></Reference><Reference><Citation>Chan, N.C. &amp; Weitz, J.I. (2020) Recent advances in understanding, diagnosing and treating venous thrombosis. F1000Research, 9, 1206. Available from: 10.12688/f1000research.27115.1</Citation><ArticleIdList><ArticleId IdType="doi">10.12688/f1000research.27115.1</ArticleId><ArticleId IdType="pmc">PMC7539078</ArticleId><ArticleId IdType="pubmed">33082930</ArticleId></ArticleIdList></Reference><Reference><Citation>Chandler, J. , Cumpston, M. , Li, T. , Page, M.J. &amp; Welch, V. (2019) Cochrane handbook for systematic reviews of interventions. Hoboken: Wiley.</Citation></Reference><Reference><Citation>Falck&#x2010;Ytter, Y. , Francis, C.W. , Johanson, N.A. , Curley, C. , Dahl, O.E. &amp; Schulman, S. et al. (2012) Prevention of VTE in orthopedic surgery patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence&#x2010;Based Clinical Practice Guidelines. Chest, 141, e278S&#x2013;e325S. Available from: 10.1378/chest.11-2404</Citation><ArticleIdList><ArticleId IdType="doi">10.1378/chest.11-2404</ArticleId><ArticleId IdType="pmc">PMC3278063</ArticleId><ArticleId IdType="pubmed">22315265</ArticleId></ArticleIdList></Reference><Reference><Citation>Farey, J.E. , An, V.V.G. , Sidhu, V. , Karunaratne, S. &amp; Harris, I.A. (2021) Aspirin versus enoxaparin for the initial prevention of venous thromboembolism following elective arthroplasty of the hip or knee: a systematic review and meta&#x2010;analysis. Orthopaedics &amp; Traumatology: Surgery &amp; Research, 107, 102606. Available from: 10.1016/j.otsr.2020.04.002</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.otsr.2020.04.002</ArticleId><ArticleId IdType="pubmed">32631716</ArticleId></ArticleIdList></Reference><Reference><Citation>Gelfer, Y. , Tavor, H. , Oron, A. , Peer, A. , Halperin, N. &amp; Robinson, D. (2006) Deep vein thrombosis prevention in joint arthroplasties. The Journal of Arthroplasty, 21, 206&#x2013;214. Available from: 10.1016/j.arth.2005.04.031</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.arth.2005.04.031</ArticleId><ArticleId IdType="pubmed">16520208</ArticleId></ArticleIdList></Reference><Reference><Citation>Guijarro, R. , Montes, J. , Roman, C.S. , Arcelus, J.I. , Barillari, G. , Granero, X. et al. (2011) Venous thromboembolism and bleeding after total knee and hip arthroplasty. Findings from the Spanish National Discharge Database. Thrombosis and Haemostasis, 105, 610&#x2013;615. Available from: 10.1160/TH10-10-0645</Citation><ArticleIdList><ArticleId IdType="doi">10.1160/TH10-10-0645</ArticleId><ArticleId IdType="pubmed">21174008</ArticleId></ArticleIdList></Reference><Reference><Citation>Guyatt, G.H. , Oxman, A.D. , Vist, G.E. , Kunz, R. , Falck&#x2010;Ytter, Y. , Alonso&#x2010;Coello, P. et al. (2008) GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ, 336(7650), 924&#x2013;926. Available from: 10.1136/bmj.39489.470347.AD</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.39489.470347.AD</ArticleId><ArticleId IdType="pmc">PMC2335261</ArticleId><ArticleId IdType="pubmed">18436948</ArticleId></ArticleIdList></Reference><Reference><Citation>Herring, B. , Lowen, D. , Ho, P. &amp; Hodgson, R. (2023) A systematic review of venous thromboembolism mechanical prophylaxis devices during surgery. Langenbeck's Archives of Surgery, 408, 410. Available from: 10.1007/s00423-023-03142-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00423-023-03142-6</ArticleId><ArticleId IdType="pmc">PMC10584699</ArticleId><ArticleId IdType="pubmed">37851108</ArticleId></ArticleIdList></Reference><Reference><Citation>Jadad, A.R. , Moore, R.A. , Carroll, D. , Jenkinson, C. , Reynolds, D.J.M. , Gavaghan, D.J. et al. (1996) Assessing the quality of reports of randomized clinical trials: is blinding necessary? Controlled Clinical Trials, 17, 1&#x2013;12. Available from: 10.1016/0197-2456(95)00134-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0197-2456(95)00134-4</ArticleId><ArticleId IdType="pubmed">8721797</ArticleId></ArticleIdList></Reference><Reference><Citation>Jameson, S.S. , Charman, S.C. , Gregg, P.J. , Reed, M.R. &amp; van der Meulen, J.H. (2011) The effect of aspirin and low&#x2010;molecular&#x2010;weight heparin on venous thromboembolism after hip replacement: a non&#x2010;randomised comparison from information in the National Joint Registry. The Journal of Bone and Joint Surgery. British Volume, 93, 1465&#x2013;1470. Available from: 10.1302/0301-620X.93B11.27622</Citation><ArticleIdList><ArticleId IdType="doi">10.1302/0301-620X.93B11.27622</ArticleId><ArticleId IdType="pubmed">22058295</ArticleId></ArticleIdList></Reference><Reference><Citation>Jenny, J.Y. , Pabinger, I. &amp; Samama, C.M. (2018) European guidelines on perioperative venous thromboembolism prophylaxis: aspirin. European Journal of Anaesthesiology, 35, 123&#x2013;129. Available from: 10.1097/EJA.0000000000000728</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/EJA.0000000000000728</ArticleId><ArticleId IdType="pubmed">29112548</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang, Y. , Du, H. , Liu, J. &amp; Zhou, Y. (2014) Aspirin combined with mechanical measures to prevent venous thromboembolism after total knee arthroplasty: a randomized controlled trial. Chinese Medical Journal, 127, 2201&#x2013;2205. Available from: 10.3760/cma.j.issn.0366-6999.20132175</Citation><ArticleIdList><ArticleId IdType="doi">10.3760/cma.j.issn.0366-6999.20132175</ArticleId><ArticleId IdType="pubmed">24931228</ArticleId></ArticleIdList></Reference><Reference><Citation>Johnson, S.A. , Jones, A.E. , Young, E. , Jennings, C. , Simon, K. , Fleming, R.P. et al. (2021) A risk&#x2010;stratified approach to venous thromboembolism prophylaxis with aspirin or warfarin following total hip and knee arthroplasty: a cohort study. Thrombosis Research, 206, 120&#x2013;127. Available from: 10.1016/j.thromres.2021.08.009</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.thromres.2021.08.009</ArticleId><ArticleId IdType="pmc">PMC10510472</ArticleId><ArticleId IdType="pubmed">34455129</ArticleId></ArticleIdList></Reference><Reference><Citation>Kulshrestha, V. &amp; Kumar, S. (2013) DVT prophylaxis after TKA: routine anticoagulation vs risk screening approach &#x2013; a randomized study. The Journal of Arthroplasty, 28, 1868&#x2013;1873. Available from: 10.1016/j.arth.2013.05.025</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.arth.2013.05.025</ArticleId><ArticleId IdType="pubmed">23796558</ArticleId></ArticleIdList></Reference><Reference><Citation>Lavu, M.S. , Porto, J.R. , Hecht, C.J. , Acu&#xf1;a, A.J. , Kaelber, D.C. , Parvizi, J. et al. (2024) Low&#x2010;dose aspirin is the safest prophylaxis for prevention of venous thromboembolism after total knee arthroplasty across all patient risk profiles. Journal of Bone and Joint Surgery, 106, 1256&#x2013;1267. Available from: 10.2106/jbjs.23.01158</Citation><ArticleIdList><ArticleId IdType="doi">10.2106/jbjs.23.01158</ArticleId><ArticleId IdType="pmc">PMC11254562</ArticleId><ArticleId IdType="pubmed">38753809</ArticleId></ArticleIdList></Reference><Reference><Citation>Lieberman, J.R. &amp; Heckmann, N. (2017) Venous thromboembolism prophylaxis in total hip arthroplasty and total knee arthroplasty patients: from guidelines to practice. Journal of the American Academy of Orthopaedic Surgeons, 25, 789&#x2013;798. Available from: 10.5435/JAAOS-D-15-00760</Citation><ArticleIdList><ArticleId IdType="doi">10.5435/JAAOS-D-15-00760</ArticleId><ArticleId IdType="pubmed">29176502</ArticleId></ArticleIdList></Reference><Reference><Citation>Memtsoudis, S.G. , Besculides, M.C. , Gaber, L. , Liu, S. &amp; Gonz&#xe1;lez Della Valle, A. (2009) Risk factors for pulmonary embolism after hip and knee arthroplasty: a population&#x2010;based study. International Orthopaedics, 33, 1739&#x2013;1745. Available from: 10.1007/s00264-008-0659-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00264-008-0659-z</ArticleId><ArticleId IdType="pmc">PMC2899166</ArticleId><ArticleId IdType="pubmed">18925395</ArticleId></ArticleIdList></Reference><Reference><Citation>Mirkazemi, C. , Bereznicki, L.R. &amp; Peterson, G.M. (2019) Comparing Australian orthopaedic surgeons' reported use of thromboprophylaxis following arthroplasty in 2012 and 2017. BMC Musculoskeletal Disorders, 20, 57. Available from: 10.1186/s12891-019-2409-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12891-019-2409-3</ArticleId><ArticleId IdType="pmc">PMC6368726</ArticleId><ArticleId IdType="pubmed">30736774</ArticleId></ArticleIdList></Reference><Reference><Citation>Moher, D. , Liberati, A. , Tetzlaff, J. &amp; Altman, D.G. (2009) Preferred reporting items for systematic reviews and meta&#x2010;analyses: the PRISMA statement. Journal of Clinical Epidemiology, 62, 1006&#x2013;1012. Available from: 10.1016/j.jclinepi.2009.06.005</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jclinepi.2009.06.005</ArticleId><ArticleId IdType="pubmed">19631508</ArticleId></ArticleIdList></Reference><Reference><Citation>Mont, M.A. &amp; Jacobs, J.J. (2011) AAOS clinical practice guideline: preventing venous thromboembolic disease in patients undergoing elective hip and knee arthroplasty. American Academy of Orthopaedic Surgeon, 19, 777&#x2013;778. Available from: 10.5435/00124635-201112000-00008</Citation><ArticleIdList><ArticleId IdType="doi">10.5435/00124635-201112000-00008</ArticleId><ArticleId IdType="pubmed">22134210</ArticleId></ArticleIdList></Reference><Reference><Citation>Neeman, E. , Liu, V. , Mishra, P. , Thai, K.K. , Xu, J. , Clancy, H.A. et al. (2022) Trends and risk factors for venous thromboembolism among hospitalized medical patients. JAMA Network Open, 5, e2240373. Available from: 10.1001/jamanetworkopen.2022.40373</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2022.40373</ArticleId><ArticleId IdType="pmc">PMC9679881</ArticleId><ArticleId IdType="pubmed">36409498</ArticleId></ArticleIdList></Reference><Reference><Citation>Nemeth, B. , Nelissen, R. , Arya, R. &amp; Cannegieter, S. (2021) Preventing VTE following total hip and knee arthroplasty: is prediction the future? Journal of Thrombosis and Haemostasis, 19, 41&#x2013;45. Available from: 10.1111/jth.15132</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jth.15132</ArticleId><ArticleId IdType="pmc">PMC7839761</ArticleId><ArticleId IdType="pubmed">33043553</ArticleId></ArticleIdList></Reference><Reference><Citation>
OCEBM Levels of Evidence Working Group
(2011) The Oxford levels of evidence 2. https://www.cebm.net/index.aspx?o=5653 [Accessed 10 July 2024].</Citation></Reference><Reference><Citation>Ouzzani, M. , Hammady, H. , Fedorowicz, Z. &amp; Elmagarmid, A. (2016) Rayyan&#x2014;a web and mobile app for systematic reviews. Systematic Reviews, 5, 210. Available from: 10.1186/s13643-016-0384-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13643-016-0384-4</ArticleId><ArticleId IdType="pmc">PMC5139140</ArticleId><ArticleId IdType="pubmed">27919275</ArticleId></ArticleIdList></Reference><Reference><Citation>Patel, H. , Sun, H. , Hussain, A.N. &amp; Vakde, T. (2020) Advances in the diagnosis of venous thromboembolism: a literature review. Diagnostics, 10, 365. Available from: 10.3390/diagnostics10060365</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/diagnostics10060365</ArticleId><ArticleId IdType="pmc">PMC7345080</ArticleId><ArticleId IdType="pubmed">32498355</ArticleId></ArticleIdList></Reference><Reference><Citation>Pellegrini Jr., V.D. , Eikelboom, J.W. , Evarts, C.M. , Franklin, P.D. , Garvin, K.L. , Goldhaber, S.Z. et al. (2022) Randomised comparative effectiveness trial of Pulmonary Embolism Prevention after hiP and kneE Replacement (PEPPER): the PEPPER trial protocol. BMJ Open, 12, e060000. Available from: 10.1136/bmjopen-2021-060000</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjopen-2021-060000</ArticleId><ArticleId IdType="pmc">PMC8905949</ArticleId><ArticleId IdType="pubmed">35260464</ArticleId></ArticleIdList></Reference><Reference><Citation>Phillips, C.B. , Barrett, J.A. , Losina, E. , Mahomed, N.N. , Lingard, E.A. , Guadagnoli, E. et al. (2003) Incidence rates of dislocation, pulmonary embolism, and deep infection during the first six months after elective total hip replacement. The Journal of Bone and Joint Surgery &#x2013; American Volume, 85, 20&#x2013;26. Available from: 10.2106/00004623-200301000-00004</Citation><ArticleIdList><ArticleId IdType="doi">10.2106/00004623-200301000-00004</ArticleId><ArticleId IdType="pubmed">12533567</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosemont IAAoOSA (2021) American Joint Replacement Registry (AJRR). 2021. Annual report.</Citation></Reference><Reference><Citation>Salman, L.A. , Hantouly, A.T. , Khatkar, H. , Al&#x2010;Ani, A. , Abudalou, A. , Al&#x2010;Juboori, M. et al. (2023) The outcomes of total hip replacement in osteonecrosis versus osteoarthritis: a systematic review and meta&#x2010;analysis. International Orthopaedics, 47, 3043&#x2013;3052. Available from: 10.1007/s00264-023-05761-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00264-023-05761-6</ArticleId><ArticleId IdType="pmc">PMC10673986</ArticleId><ArticleId IdType="pubmed">36905418</ArticleId></ArticleIdList></Reference><Reference><Citation>Salvi, A. , Nitti, C. , Fabbri, A. , Groff, P. , Ruggiero, E.G. &amp; Agnelli, G. (2020) Diagnosis and treatment of deep vein thrombosis in the emergency department: results of an Italian Nominal Group technique study. Clinical and Applied Thrombosis/Hemostasis, 26, 1076029620959720. Available from: 10.1177/1076029620959720</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1076029620959720</ArticleId><ArticleId IdType="pmc">PMC7791439</ArticleId><ArticleId IdType="pubmed">33112649</ArticleId></ArticleIdList></Reference><Reference><Citation>Sidhu, V.S. , Kelly, T.L. , Pratt, N. , Graves, S.E. , Buchbinder, R. , Adie, S. et al. (2022) Effect of aspirin vs enoxaparin on symptomatic venous thromboembolism in patients undergoing hip or knee arthroplasty: the CRISTAL randomized trial. Journal of the American Medical Association, 328, 719&#x2013;727. Available from: 10.1001/jama.2022.13416</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2022.13416</ArticleId><ArticleId IdType="pmc">PMC9399863</ArticleId><ArticleId IdType="pubmed">35997730</ArticleId></ArticleIdList></Reference><Reference><Citation>Simon, S.J. , Patell, R. , Zwicker, J.I. , Kazi, D.S. &amp; Hollenbeck, B.L. (2023) Venous thromboembolism in total hip and total knee arthroplasty. JAMA Network Open, 6, e2345883. Available from: 10.1001/jamanetworkopen.2023.45883</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2023.45883</ArticleId><ArticleId IdType="pmc">PMC10692868</ArticleId><ArticleId IdType="pubmed">38039005</ArticleId></ArticleIdList></Reference><Reference><Citation>Sloan, M. , Premkumar, A. &amp; Sheth, N.P. (2018) Projected volume of primary total joint arthroplasty in the U.S., 2014 to 2030. Journal of Bone and Joint Surgery, 100, 1455&#x2013;1460. Available from: 10.2106/JBJS.17.01617</Citation><ArticleIdList><ArticleId IdType="doi">10.2106/JBJS.17.01617</ArticleId><ArticleId IdType="pubmed">30180053</ArticleId></ArticleIdList></Reference><Reference><Citation>Westrich, G.H. , Bottner, F. , Windsor, R.E. , Laskin, R.S. , Haas, S.B. &amp; Sculco, T.P. (2006) VenaFlow plus Lovenox vs VenaFlow plus aspirin for thromboembolic disease prophylaxis in total knee arthroplasty. The Journal of Arthroplasty, 21, 139&#x2013;143. Available from: 10.1016/j.arth.2006.05.017</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.arth.2006.05.017</ArticleId><ArticleId IdType="pubmed">16950076</ArticleId></ArticleIdList></Reference><Reference><Citation>Za, P. , Papalia, G.F. , Franceschetti, E. , Rizzello, G. , Adravanti, P. &amp; Papalia, R. (2023) Aspirin is a safe and effective thromboembolic prophylaxis after total knee arthroplasty: a systematic review and meta&#x2010;analysis. Knee Surgery, Sports Traumatology, Arthroscopy, 31, 4407&#x2013;4421. Available from: 10.1007/s00167-023-07500-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00167-023-07500-1</ArticleId><ArticleId IdType="pubmed">37449989</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou, L.B. , Wang, C.C. , Zhang, L.T. , Wu, T. &amp; Zhang, G.Q. (2023) Effectiveness of different antithrombotic agents in combination with tranexamic acid for venous thromboembolism prophylaxis and blood management after total knee replacement: a prospective randomized study. BMC Musculoskeletal Disorders, 24, 5. Available from: 10.1186/s12891-022-06117-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12891-022-06117-8</ArticleId><ArticleId IdType="pmc">PMC9811690</ArticleId><ArticleId IdType="pubmed">36600227</ArticleId></ArticleIdList></Reference><Reference><Citation>Zou, Y. , Tian, S. , Wang, Y. &amp; Sun, K. (2014) Administering aspirin, rivaroxaban and low&#x2010;molecular&#x2010;weight heparin to prevent deep venous thrombosis after total knee arthroplasty. Blood Coagulation &amp; Fibrinolysis, 25, 660&#x2013;664. Available from: 10.1097/MBC.0000000000000121</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MBC.0000000000000121</ArticleId><ArticleId IdType="pubmed">24695091</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">39451152</PMID><DateCompleted><Year>2025</Year><Month>06</Month><Day>05</Day></DateCompleted><DateRevised><Year>2025</Year><Month>06</Month><Day>05</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1528-1159</ISSN><JournalIssue CitedMedium="Internet"><Volume>50</Volume><Issue>7</Issue><PubDate><Year>2025</Year><Month>Apr</Month><Day>01</Day></PubDate></JournalIssue><Title>Spine</Title><ISOAbbreviation>Spine (Phila Pa 1976)</ISOAbbreviation></Journal><ArticleTitle>Surgical Outcomes After Preoperative Embolization in Hypervascular Spinal Metastases: A Propensity Scored Study of 191 Patients.</ArticleTitle><Pagination><StartPage>437</StartPage><EndPage>446</EndPage><MedlinePgn>437-446</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1097/BRS.0000000000005182</ELocationID><Abstract><AbstractText Label="STUDY DESIGN" NlmCategory="METHODS">Retrospective propensity-score matched, case-control study at 2 academic tertiary care centers.</AbstractText><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">To assess the effect of preoperative embolization (PE) on (1) intraoperative blood loss, defined as conventional estimates of blood loss (EBL) and hemoglobin mass loss; and (2) secondary outcomes in patients with spinal metastases from hypervascular histologies.</AbstractText><AbstractText Label="BACKGROUND CONTEXT" NlmCategory="BACKGROUND">PE intends to reduce blood loss during surgery for spinal metastases of hypervascular tumors such as renal cell carcinoma. However, studies investigating the effect of PE in hypervascular tumors often consist of small cohorts, do not correct for confounding factors, and have conflicting results.</AbstractText><AbstractText Label="MATERIALS AND METHODS" NlmCategory="METHODS">After propensity score matching, 46 PE patients were matched to 46 non-PE patients without baseline differences. The constraints of propensity score matching did not allow analysis of patients with tumor volumes &gt;9&#xa0;cm 3 . Multiple linear regression models were fitted for EBL and hemoglobin mass loss. Poisson regression models were fitted for both intraoperative and postoperative transfusions.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">There was no difference in EBL [948&#xa0;mL (IQR: 500-1750) vs. 1100&#xa0;mL (IQR: 388-1925), P =0.68] and hemoglobin mass loss [201&#xa0;g (IQR: 119-307) vs. 232&#xa0;g (IQR: 173-373), P =0.18] between PE and non-PE patients. Other than higher 1-year survival rates (65% vs. 43%, P =0.05) in PE patients, there were no differences in secondary outcomes. In multiple regression analyses, PE was not associated with decreased intraoperative blood loss, hemoglobin mass loss, or perioperative blood transfusions.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Our study demonstrated that, for tumors &lt;9&#xa0;cm 3 , PE did not reduce EBL, hemoglobin mass loss, or perioperative blood transfusions in patients undergoing spine surgery for metastases from hypervascular histologies. These findings suggest that urgent spine surgeries indicated for hypervascular histologies should not be delayed based on the availability of PE and accurate detection of preoperative hypervascularity, beyond histology, will likely be an important determination of future PE utilization for spinal metastases.</AbstractText><AbstractText Label="LEVEL OF EVIDENCE" NlmCategory="METHODS">Level III-treatment benefits.</AbstractText><CopyrightInformation>Copyright &#xa9; 2024 Wolters Kluwer Health, Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Pierik</LastName><ForeName>Robertus J B</ForeName><Initials>RJB</Initials><Identifier Source="ORCID">0000-0003-0885-1750</Identifier><AffiliationInfo><Affiliation>Department of Orthopedic Surgery, Massachusetts General Hospital-Harvard Medical School, Boston, MA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Orthopedic Surgery, University Medical Center Utrecht, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Amelink</LastName><ForeName>Jantijn J G J</ForeName><Initials>JJGJ</Initials><AffiliationInfo><Affiliation>Department of Orthopedic Surgery, Massachusetts General Hospital-Harvard Medical School, Boston, MA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Orthopedic Surgery, University Medical Center Utrecht, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Groot</LastName><ForeName>Olivier Q</ForeName><Initials>OQ</Initials><AffiliationInfo><Affiliation>Department of Orthopedic Surgery, University Medical Center Utrecht, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Som</LastName><ForeName>Avik</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Radiology, Massachusetts General Hospital-Harvard Medical School, Boston, MA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>van Munster</LastName><ForeName>Bram T</ForeName><Initials>BT</Initials><AffiliationInfo><Affiliation>Department of Orthopedic Surgery, Massachusetts General Hospital-Harvard Medical School, Boston, MA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Orthopedic Surgery, University Medical Center Utrecht, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>de Reus</LastName><ForeName>Dani&#xeb;l C</ForeName><Initials>DC</Initials><AffiliationInfo><Affiliation>Department of Orthopedic Surgery, Massachusetts General Hospital-Harvard Medical School, Boston, MA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Orthopedic Surgery, University Medical Center Utrecht, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chua</LastName><ForeName>Theresa L</ForeName><Initials>TL</Initials><AffiliationInfo><Affiliation>Department of Orthopedic Surgery, Massachusetts General Hospital-Harvard Medical School, Boston, MA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zijlstra</LastName><ForeName>Hester</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Orthopedic Surgery, University Medical Center Utrecht, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Verlaan</LastName><ForeName>Jorrit-Jan</ForeName><Initials>JJ</Initials><AffiliationInfo><Affiliation>Department of Orthopedic Surgery, University Medical Center Utrecht, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shin</LastName><ForeName>John H</ForeName><Initials>JH</Initials><AffiliationInfo><Affiliation>Department of Neurosurgery, Massachusetts General Hospital-Harvard Medical School, Boston, MA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rabinov</LastName><ForeName>James D</ForeName><Initials>JD</Initials><AffiliationInfo><Affiliation>Department of Radiology, Massachusetts General Hospital-Harvard Medical School, Boston, MA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tobert</LastName><ForeName>Daniel G</ForeName><Initials>DG</Initials><AffiliationInfo><Affiliation>Department of Orthopedic Surgery, Massachusetts General Hospital-Harvard Medical School, Boston, MA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016448">Multicenter Study</PublicationType><PublicationType UI="D064888">Observational Study</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>10</Month><Day>14</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Spine (Phila Pa 1976)</MedlineTA><NlmUniqueID>7610646</NlmUniqueID><ISSNLinking>0362-2436</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D057216" MajorTopicYN="N">Propensity Score</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016063" MajorTopicYN="Y">Blood Loss, Surgical</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011300" MajorTopicYN="Y">Preoperative Care</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016022" MajorTopicYN="N">Case-Control Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002292" MajorTopicYN="N">Carcinoma, Renal Cell</DescriptorName><QualifierName UI="Q000098" MajorTopicYN="N">blood supply</QualifierName><QualifierName UI="Q000556" MajorTopicYN="N">secondary</QualifierName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007680" MajorTopicYN="N">Kidney Neoplasms</DescriptorName><QualifierName UI="Q000098" MajorTopicYN="N">blood supply</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013125" MajorTopicYN="Y">Spinal Neoplasms</DescriptorName><QualifierName UI="Q000098" MajorTopicYN="N">blood supply</QualifierName><QualifierName UI="Q000556" MajorTopicYN="N">secondary</QualifierName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009369" MajorTopicYN="Y">Neoplasms</DescriptorName><QualifierName UI="Q000098" MajorTopicYN="N">blood supply</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016014" MajorTopicYN="N">Linear Models</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016012" MajorTopicYN="N">Poisson Distribution</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001803" MajorTopicYN="N">Blood Transfusion</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004621" MajorTopicYN="Y">Embolization, Therapeutic</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009389" MajorTopicYN="N">Neovascularization, Pathologic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>The authors report no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>7</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>9</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>3</Month><Day>7</Day><Hour>18</Hour><Minute>21</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>25</Day><Hour>12</Hour><Minute>23</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>25</Day><Hour>9</Hour><Minute>44</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39451152</ArticleId><ArticleId IdType="doi">10.1097/BRS.0000000000005182</ArticleId><ArticleId IdType="pii">00007632-990000000-00813</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Prince EA, Ahn SH. Interventional management of vertebral body metastases. Semin Intervent Radiol. 2013;30:278&#x2013;281.</Citation></Reference><Reference><Citation>Wewel JT, O&#x2019;Toole JE. Epidemiology of spinal cord and column tumors. Neurooncol Pract. 2020;7(suppl 1):i5&#x2013;i9.</Citation></Reference><Reference><Citation>Albiges L, Salem M, Rini B, Escudier B. Vascular endothelial growth factor targeted therapies in advanced renal cell carcinoma. Hematol Oncol Clin North Am. 2011;25:813&#x2013;833.</Citation></Reference><Reference><Citation>Ibrahim A, Crockard A, Antonietti P, Boriani S, Bunger C, Gasbarrini A, et al. Does spinal surgery improve the quality of life for those with extradural (spinal) osseous metastases? An international multicenter prospective observational study of 223 patients. J Neurosurg Spine. 2008;8:271&#x2013;278.</Citation></Reference><Reference><Citation>Fehlings MG, Nater A, Tetreault L, et al. Survival and clinical outcomes in surgically treated patients with metastatic epidural spinal cord compression: results of the Prospective Multicenter AOSpine Study. J Clin Oncol. 2016;34:268&#x2013;276.</Citation></Reference><Reference><Citation>Hu SS. Blood loss in adult spinal surgery. Eur Spine J. 2004;13(suppl 1):S3&#x2013;S5.</Citation></Reference><Reference><Citation>Paulino Pereira NR, Langerhuizen DW, Janssen SJ, et al. Are perioperative allogeneic blood transfusions associated with 90-days infection after operative treatment for bone metastases? J Surg Oncol. 2016;114:997&#x2013;1003.</Citation></Reference><Reference><Citation>Paulino Pereira NR, Beks RB, Janssen SJ, et al. Are allogeneic blood transfusions associated with decreased survival after surgical treatment for spinal metastases? Spine J. 2016;16:951&#x2013;961.</Citation></Reference><Reference><Citation>Cata JP, Gottumukkala V. Blood loss and massive transfusion in patients undergoing major oncological surgery: what do we know? ISRN Anesthesiol. 2012;2012:1&#x2013;11.</Citation></Reference><Reference><Citation>Bernard AC, Davenport DL, Chang PK, Vaughan TB, Zwischenberger JB. Intraoperative transfusion of 1 U to 2 U packed red blood cells is associated with increased 30-day mortality, surgical-site infection, pneumonia, and sepsis in general surgery patients. J Am Coll Surg. 2009;208:931&#x2013;937.e2.</Citation></Reference><Reference><Citation>Guzman R, Dubach-Schwizer S, Heini P, et al. Preoperative transarterial embolization of vertebral metastases. Eur Spine J. 2005;14:263&#x2013;268.</Citation></Reference><Reference><Citation>Ozkan E, Gupta S. Embolization of spinal tumors: vascular anatomy, indications, and technique. Tech Vasc Interv Radiol. 2011;14:129&#x2013;140.</Citation></Reference><Reference><Citation>Wahood W, Alexander AY, Yolcu YU, et al. Trends in utilization of preoperative embolization for spinal metastases: a study of the National Inpatient Sample 2005-2017. Neurointervention. 2021;16:52&#x2013;58.</Citation></Reference><Reference><Citation>Luksanapruksa P, Buchowski JM, Tongsai S, Singhatanadgige W, Jennings JW. Systematic review and meta-analysis of effectiveness of preoperative embolization in surgery for metastatic spine disease. J Neurointerv Surg. 2018;10:596&#x2013;601.</Citation></Reference><Reference><Citation>Gao ZY, Zhang T, Zhang H, Pang CG, Xia Q. Effectiveness of preoperative embolization in patients with spinal metastases: a systematic review and meta-analysis. World Neurosurg. 2021;152:e745&#x2013;e757.</Citation></Reference><Reference><Citation>Qiao R, Ma R, Zhang X, Lun D, Li R, Hu Y. Comparison of intraoperative blood loss and perioperative complications between preoperative embolization and nonembolization combined with spinal tumor surgeries: a systematic review and meta-analysis. Eur Spine J. 2023;32:4272&#x2013;4296.</Citation></Reference><Reference><Citation>Reitz M, Mende KC, Cramer C, et al. Surgical treatment of spinal metastases from renal cell carcinoma-effects of preoperative embolization on intraoperative blood loss. Neurosurg Rev. 2018;41:861&#x2013;867.</Citation></Reference><Reference><Citation>Thirunavu VM, Roumeliotis A, Shlobin NA, et al. The role of preoperative embolization in the treatment of spinal metastases from renal cell carcinoma. Clin Neurol Neurosurg. 2022;215:107181.</Citation></Reference><Reference><Citation>Motov S, Stengel F, Ringel F, Bozinov O, Stienen MN. Current state of preoperative embolization for spinal metastasis&#x2014;a survey by the EANS spine section. Brain Spine. 2023;3:102712.</Citation></Reference><Reference><Citation>Jaramillo S, Montane-Muntane M, Gambus PL, Capitan D, Navarro-Ripoll R, Blasi A. Perioperative blood loss: estimation of blood volume loss or haemoglobin mass loss? Blood Transfus. 2020;18:20&#x2013;29.</Citation></Reference><Reference><Citation>STROBE&#x2014;Strengthening the reporting of observational studies in epidemiology. Accessed August 8, 2023. https://www.strobe-statement.org/</Citation></Reference><Reference><Citation>Huang YC, Tsuang FY, Lee CW, Lin YH. Efficacy of preoperative embolization for metastatic spinal tumor surgery using angiographic vascularity assessment. Eur Radiol. 2023;33:2638&#x2013;2646.</Citation></Reference><Reference><Citation>Roberts TT, Leonard GR, Cepela DJ. Classifications in Brief: American Spinal Injury Association (ASIA) Impairment Scale. Clin Orthop Relat Res. 2017;475:1499&#x2013;1504.</Citation></Reference><Reference><Citation>Groot OQ, van Steijn NJ, Ogink PT, et al. Preoperative embolization in surgical treatment of spinal metastases originating from non-hypervascular primary tumors: a propensity score matched study using 495 patients. Spine J. 2022;22:1334&#x2013;1344.</Citation></Reference><Reference><Citation>Austin PC. Balance diagnostics for comparing the distribution of baseline covariates between treatment groups in propensity-score matched samples. Stat Med. 2009;28:3083&#x2013;3107.</Citation></Reference><Reference><Citation>Funk MJ, Westreich D, Wiesen C, St&#xfc;rmer T, Brookhart MA, Davidian M. Doubly robust estimation of causal effects. Am J Epidemiol. 2011;173:761&#x2013;767.</Citation></Reference><Reference><Citation>Ho DE, Imai K, King G, Stuart EA. Matching as nonparametric preprocessing for reducing model dependence in parametric causal inference. Political Analysis. 2007;15:199&#x2013;236.</Citation></Reference><Reference><Citation>Marcoulides KM, Raykov T. Evaluation of variance inflation factors in regression models using latent variable modeling methods. Educ Psychol Meas. 2019;79:874&#x2013;882.</Citation></Reference><Reference><Citation>Gong Y, Wang C, Liu H, Liu X, Jiang L. Only tumors angiographically identified as hypervascular exhibit lower intraoperative blood loss upon selective preoperative embolization of spinal metastases: systematic review and meta-analysis. Front Oncol. 2021;10:597476.</Citation></Reference><Reference><Citation>Acu&#xf1;a AJ, Vijayakumar G, Buac NP, Colman MW, Gitelis S, Blank AT. The effect of timing between preoperative embolization and surgery: a retrospective analysis of hypervascular bone metastases. J Surg Oncol. 2023;129:416&#x2013;423.</Citation></Reference><Reference><Citation>Tan BWL, Zaw AS, Rajendran PC, Ruiz JN, Kumar N, Anil G. Preoperative embolization in spinal tumour surgery: enhancing its effectiveness. J Clin Neurosci. 2017;43:108&#x2013;114.</Citation></Reference><Reference><Citation>Clausen C, Dahl B, Christiansen Frevert S, Forman JL, Nielsen MB, L&#xf6;nn L. Inter- and intra-rater agreement in the assessment of the vascularity of spinal metastases using digital subtraction angiography tumor blush. Acta Radiol. 2017;58:734&#x2013;739.</Citation></Reference><Reference><Citation>Tafelmeier S, Kesseler E, Iancu AM, Nikoubashman O, Wiesmann M. Spectrum of complications and complication rates after diagnostic catheter angiography in neuroradiology. Clin Neuroradiol. 2023;33:763&#x2013;768.</Citation></Reference><Reference><Citation>Meng XX, Zhang YQ, Liao HQ, et al. Dynamic contrast-enhanced MRI for the assessment of spinal tumor vascularity: correlation with angiography. Eur Spine J. 2016;25:3952&#x2013;3961.</Citation></Reference><Reference><Citation>Westbroek EM, Ahmed AK, Pennington Z, et al. Hypervascular metastatic spine tumor angiographic relationships with the artery of adamkiewicz and other radiculomedullary arteries. World Neurosurg. 2019;126:e480&#x2013;e485.</Citation></Reference><Reference><Citation>Papalexis N, Peta G, Gasbarrini A, Miceli M, Spinnato P, Facchini G. Unraveling the enigma of Adamkiewicz: exploring the prevalence, anatomical variability, and clinical impact in spinal embolization procedures for bone metastases. Acta Radiol. 2023;64:2908&#x2013;2914.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">31400621</PMID><DateCompleted><Year>2020</Year><Month>02</Month><Day>13</Day></DateCompleted><DateRevised><Year>2020</Year><Month>02</Month><Day>13</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1879-2472</ISSN><JournalIssue CitedMedium="Internet"><Volume>181</Volume><PubDate><Year>2019</Year><Month>Sep</Month></PubDate></JournalIssue><Title>Thrombosis research</Title><ISOAbbreviation>Thromb Res</ISOAbbreviation></Journal><ArticleTitle>Venous thromboembolism in epithelial ovarian cancer. A prospective cohort study.</ArticleTitle><Pagination><StartPage>112</StartPage><EndPage>119</EndPage><MedlinePgn>112-119</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.thromres.2019.07.027</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0049-3848(19)30320-2</ELocationID><Abstract><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">To determine the incidence of symptomatic and incidental venous thromboembolism (VTE) at time of diagnosis and throughout the first year, in patients with suspected epithelial ovarian cancer (EOC).</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Patients were recruited consecutively in the gynecological outpatient clinic at Aalborg University Hospital, Denmark from December 2014 to May 2017. All patients underwent a whole leg compression ultrasound scan (CUS), Computed Tomography (CT) of the thorax in arterial phase at time of inclusion, to be able to diagnose deep vein thrombosis (DVT) and pulmonary embolism (PE), respectively. Patients were followed and systematically screened for VTE throughout 12&#x202f;months.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Ninety-seven patients with suspected EOC were enrolled in the study and followed up. Within the group of EOC patients (N&#x202f;=&#x202f;53) eleven were diagnosed with VTE during the first year from EOC diagnosis, the incidence of VTE at time of diagnosis was low (2/53-3.8%). No patients with borderline or benign ovarian neoplasms were diagnosed with VTE. One EOC patient had a VTE during the postoperative period and further eight EOC patients were diagnosed with VTE within the first year, during periods undergoing non-surgical cancer treatment. Median time to VTE was 87&#x202f;days.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">The one year cumulative incidence of VTE in EOC patients was 20.8% with a low incidence at time of diagnosis. A substantial number of VTE cases (73%) appeared during periods of non-surgical oncologic treatment. Future research should focus on risk factors and timing of VTE in EOC patients, as this could have important implications for future prophylaxis guidelines.</AbstractText><CopyrightInformation>Copyright &#xa9; 2019 Elsevier Ltd. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Kahr</LastName><ForeName>Henriette Str&#xf8;m</ForeName><Initials>HS</Initials><AffiliationInfo><Affiliation>Department of Gynecology and Obstetrics, Aalborg University Hospital, Denmark; Department of Surgical Gastroenterology, Aalborg University Hospital, Denmark; Department of Clinical Medicine, Aalborg University, Aalborg, Denmark; Clinical Cancer Research Center, Aalborg University Hospital, Denmark. Electronic address: hestje@rn.dk.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Christiansen</LastName><ForeName>Ole Bjarne</ForeName><Initials>OB</Initials><AffiliationInfo><Affiliation>Department of Gynecology and Obstetrics, Aalborg University Hospital, Denmark; Department of Clinical Medicine, Aalborg University, Aalborg, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Grove</LastName><ForeName>Anni</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Institute of Pathology, Aalborg University Hospital, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Iyer</LastName><ForeName>Victor</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Department of Nuclear Medicine, Aalborg University Hospital, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Torp-Pedersen</LastName><ForeName>Christian</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Aalborg University Hospital, Denmark; Department of Cardiology and Clinical Investigation, Nordsjaellands Hospital, Hilleroed, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Knudsen</LastName><ForeName>Aage</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Gynecology and Obstetrics, Aalborg University Hospital, Denmark; Department of Clinical Medicine, Aalborg University, Aalborg, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Thorlacius-Ussing</LastName><ForeName>Ole</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>Department of Surgical Gastroenterology, Aalborg University Hospital, Denmark; Department of Clinical Medicine, Aalborg University, Aalborg, Denmark; Clinical Cancer Research Center, Aalborg University Hospital, Denmark.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2019</Year><Month>08</Month><Day>02</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Thromb Res</MedlineTA><NlmUniqueID>0326377</NlmUniqueID><ISSNLinking>0049-3848</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000077216" MajorTopicYN="N">Carcinoma, Ovarian Epithelial</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D054556" MajorTopicYN="N">Venous Thromboembolism</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Deep venous thrombosis</Keyword><Keyword MajorTopicYN="N">Epithelial ovarian cancer</Keyword><Keyword MajorTopicYN="N">Pulmonary embolism</Keyword><Keyword MajorTopicYN="N">Venous thromboembolism</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2019</Year><Month>6</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2019</Year><Month>7</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2019</Year><Month>7</Month><Day>31</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>8</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>2</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>8</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31400621</ArticleId><ArticleId IdType="doi">10.1016/j.thromres.2019.07.027</ArticleId><ArticleId IdType="pii">S0049-3848(19)30320-2</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">31453837</PMID><DateCompleted><Year>2021</Year><Month>07</Month><Day>08</Day></DateCompleted><DateRevised><Year>2021</Year><Month>07</Month><Day>08</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">2380-0194</ISSN><JournalIssue CitedMedium="Internet"><Volume>33</Volume><Issue>2</Issue><PubDate><Year>2020</Year><Month>Mar</Month></PubDate></JournalIssue><Title>Clinical spine surgery</Title><ISOAbbreviation>Clin Spine Surg</ISOAbbreviation></Journal><ArticleTitle>Postoperative Complications Associated With Metabolic Syndrome Following Adult Spinal Deformity Surgery.</ArticleTitle><Pagination><StartPage>E87</StartPage><EndPage>E91</EndPage><MedlinePgn>E87-E91</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1097/BSD.0000000000000859</ELocationID><Abstract><AbstractText Label="STUDY DESIGN">A retrospective cohort study.</AbstractText><AbstractText Label="OBJECTIVE">The objective of this study was to examine the effect of metabolic syndrome on 30-day postoperative complications following corrective surgery for the adult spinal deformity (ASD).</AbstractText><AbstractText Label="SUMMARY OF BACKGROUND DATA">Metabolic syndrome has been shown to increase the risk of cardiovascular morbidity and mortality. Few studies have examined the effect of metabolic syndrome on patients with ASD undergoing surgery.</AbstractText><AbstractText Label="MATERIALS AND METHODS">We performed a retrospective cohort study of patients who underwent spinal fusion for ASD. Patients were divided into 2 groups based on the presence or absence of metabolic syndrome, which was defined as a combination of hypertension, diabetes mellitus, and obesity. Baseline patient characteristics and operative variables were compared between the 2 groups. We also compared the incidence of 30-day postoperative complications between the 2 groups. A multivariable regression analysis was then performed to identify 30-day postoperative complications that were independently associated with metabolic syndrome.</AbstractText><AbstractText Label="RESULTS">A total of 6696 patients were included with 8.3% (n=553) having metabolic syndrome. Patients with metabolic syndrome were more likely to have renal comorbidity (P=0.042), bleeding disorder (P=0.011), American Society of Anesthesiology classification &#x2265;3 (P&lt;0.001), and undergo a long fusion (P=0.009). Patients with metabolic syndrome had higher rates of 30-day mortality (P=0.042), superficial surgical site infection (P=0.006), sepsis (P=0.003), cardiac complications (P&lt;0.001), pulmonary complications (P=0.003), pulmonary embolism (P=0.050), prolonged hospitalization (P=0.010), nonhome discharge (P=0.007), and reoperation (P=0.003). Metabolic syndrome was an independent risk factor for cardiac complications [odds ratio (OR)=4.2; 95% confidence interval (CI): 1.7-10.2; P=0.001], superficial surgical site infection (OR=2.8; 95% CI: 1.4-5.7; P=0.004), sepsis (OR=2.2, 95% CI: 1.2-3.9; P=0.009), reoperation (OR=1.7; 95% CI: 1.2-2.5; P=0.006), pulmonary complications (OR=1.7; 95% CI: 1.1-2.5; P=0.017), and prolonged hospitalization (OR=1.4; 95% CI: 1.0-1.9; P=0.039).</AbstractText><AbstractText Label="CONCLUSIONS">Recognition and awareness of the relationship between metabolic syndrome and postoperative complications following ASD surgery is important for preoperative optimization and perioperative care.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ye</LastName><ForeName>Ivan B</ForeName><Initials>IB</Initials><AffiliationInfo><Affiliation>Department of Orthopaedic Surgery, Icahn School of Medicine at Mount Sinai, New York, NY.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tang</LastName><ForeName>Ray</ForeName><Initials>R</Initials></Author><Author ValidYN="Y"><LastName>Schwartz</LastName><ForeName>John T</ForeName><Initials>JT</Initials></Author><Author ValidYN="Y"><LastName>Cheung</LastName><ForeName>Zoe B</ForeName><Initials>ZB</Initials></Author><Author ValidYN="Y"><LastName>Cho</LastName><ForeName>Samuel K</ForeName><Initials>SK</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Clin Spine Surg</MedlineTA><NlmUniqueID>101675083</NlmUniqueID><ISSNLinking>2380-0186</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D024821" MajorTopicYN="N">Metabolic Syndrome</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015999" MajorTopicYN="N">Multivariate Analysis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013131" MajorTopicYN="N">Spine</DescriptorName><QualifierName UI="Q000002" MajorTopicYN="Y">abnormalities</QualifierName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>8</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>7</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>8</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31453837</ArticleId><ArticleId IdType="doi">10.1097/BSD.0000000000000859</ArticleId><ArticleId IdType="pii">01933606-202003000-00015</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Kaur J. A comprehensive review on metabolic syndrome. Cardiol Res Pract. 2014;2014:943162.</Citation></Reference><Reference><Citation>Aguilar M, Bhuket T, Torres S, et al. Prevalence of the metabolic syndrome in the United States, 2003&#x2013;2012. JAMA. 2015;313:1973&#x2013;1974.</Citation></Reference><Reference><Citation>Alberti G, Zimmet P, Shaw J, et al. The IDF consensus worldwide definition of the metabolic syndrome [International Diabetes Federation]; 2006. Available at: www.idf.org/e-library/consensus-statements/60-idfconsensus-worldwide-definitionof-the-metabolic-syndrome.html. Accessed January 1, 2019.</Citation></Reference><Reference><Citation>Pollex RL, Hegele RA. Genetic determinants of the metabolic syndrome. Nat Clin Pract Cardiovasc Med. 2006;3:482&#x2013;489.</Citation></Reference><Reference><Citation>Isomaa B, Almgren P, Tuomi T, et al. Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care. 2001;24:683&#x2013;689.</Citation></Reference><Reference><Citation>Lakka HM, Laaksonen DE, Lakka TA, et al. The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. JAMA. 2002;288:2709&#x2013;2716.</Citation></Reference><Reference><Citation>Memtsoudis SG, Kirksey M, Ma Y, et al. Metabolic syndrome and lumbar spine fusion surgery: epidemiology and perioperative outcomes. Spine. 2012;37:989&#x2013;995.</Citation></Reference><Reference><Citation>Bagry HS, Raghavendran S, Carli F. Metabolic syndrome and insulin resistance: perioperative considerations. Anesthesiology. 2008;108:506&#x2013;523.</Citation></Reference><Reference><Citation>Tzimas P, Petrou A, Laou E, et al. Impact of metabolic syndrome in surgical patients: should we bother? Br J Anaesth. 2015;115:194&#x2013;202.</Citation></Reference><Reference><Citation>Youssef JA, Orndorff DO, Patty CA, et al. Current status of adult spinal deformity. Global Spine J. 2013;3:51&#x2013;62.</Citation></Reference><Reference><Citation>Cowman JA Jr, Dimick JB, Wainess R, et al. Changes in the utilization of spinal fusion in the United States. Neurosurgery. 2006;59:15&#x2013;20.</Citation></Reference><Reference><Citation>Memtsoudis SG, Hughes A, Ma Y, et al. Increased in-hospital complications after primary posterior versus primary anterior cervical fusion. Clin Orthop Relat Res. 2011;469:649&#x2013;657.</Citation></Reference><Reference><Citation>Chung AS, Campbell D, Waldrop R, et al. Metabolic syndrome and 30-day outcomes in elective lumbar spinal fusion. Spine. 2018;43:661&#x2013;666.</Citation></Reference><Reference><Citation>Di Capua J, Somani S, Kim JS, et al. Hospital-acquired conditions in adult spinal deformity surgery: predictors for hospital-acquired conditions and other 30-day postoperative outcomes. Spine. 2017;42:595&#x2013;602.</Citation></Reference><Reference><Citation>Gierach M, Gierach J, Ewertowska M, et al. Correlation between body mass index and waist circumference in patients with metabolic syndrome. ISRN Endocrinol. 2014;2014:514589.</Citation></Reference><Reference><Citation>Galassi A, Reynolds K, He J. Metabolic syndrome and risk of cardiovascular disease: a meta-analysis. Am J Med. 2006;119:812&#x2013;819.</Citation></Reference><Reference><Citation>Ford ES, Li C. Metabolic syndrome and health-related quality of life among U.S. adults. Ann Epidemiol. 2008;18:165&#x2013;171.</Citation></Reference><Reference><Citation>Stepanova M, Rafiq N, Younossi ZM. Components of metabolic syndrome are independent predictors of mortality in patients with chronic liver disease: a population-based study. Gut. 2010;59:1410&#x2013;1415.</Citation></Reference><Reference><Citation>Yilmaz H, Ozcan KS, Sayar N, et al. Metabolic syndrome is associated with atrial electrical and mechanical dysfunction. Med Princ Pract. 2015;24:147&#x2013;152.</Citation></Reference><Reference><Citation>Glance LG, Wissler R, Mukamel DB, et al. Perioperative outcomes among patients with modified metabolic syndrome who are undergoing noncardiac surgery. Anesthesiology. 2010;113:859&#x2013;872.</Citation></Reference><Reference><Citation>Murphy AB, Menendez ME, Watson SL, et al. Metabolic syndrome and shoulder arthroplasty: epidemiology and perioperative outcomes. Int Orthop. 2016;40:1927&#x2013;1933.</Citation></Reference><Reference><Citation>Bhayani NH, Hyder O, Frederick W, et al. Effect of metabolic syndrome on perioperative outcomes after liver surgery: a National Surgical Quality Improvement Program (NSQIP) analysis. Surgery. 2012;152:218&#x2013;226.</Citation></Reference><Reference><Citation>Cichos KH, Churchill JL, Phillips SG, et al. Metabolic syndrome and hip fracture: epidemiology and perioperative outcomes. Injury. 2018;49:2036&#x2013;2041.</Citation></Reference><Reference><Citation>Ljungqvist O, Soop M, Hedstrom M. Why metabolism matters in elective orthopedic surgery: a review. Acta Orthop. 2007;78:610&#x2013;615.</Citation></Reference><Reference><Citation>Hedstrom M, Ljungqvist O, Cederholm T. Metabolism and catabolism in hip fracture patients: nutritional and anabolic intervention&#x2013;a review. Acta Orthop. 2006;77:741&#x2013;747.</Citation></Reference><Reference><Citation>Jacobsson G, Dashti S, Wahlberg T, et al. The epidemiology of and risk factors for invasive Staphylococcus aureus infections in western Sweden. Scand J Infect Dis. 2007;39:6&#x2013;13.</Citation></Reference><Reference><Citation>Engemann JJ, Carmeli Y, Cosgrove SE, et al. Adverse clinical and economic outcomes attributable to methicillin resistance among patients with Staphylococcus aureus surgical site infection. Clin Infect Dis. 2003;36:592&#x2013;598.</Citation></Reference><Reference><Citation>Befus M, Low FD, Miko BA, et al. Obesity as a determinant of Staphylococcus aureus colonization among inmates in maximum-security prisons in New York state. Am J Epidemiol. 2015;182:494&#x2013;502.</Citation></Reference><Reference><Citation>Scully IL, McNeil LK, Pathirana S, et al. Neutrophil killing of Staphylococcus aurues in diabetes, obesity, and metabolic syndrome: a prospective cellular surveillance study. Diabetol Metab Syndr. 2017;9:76.</Citation></Reference><Reference><Citation>Angus DC, van der Poll T. Severe sepsis and septic shock. N Engl J Med. 2013;369:840&#x2013;851.</Citation></Reference><Reference><Citation>Abbasi J. In treating sepsis, questions about timing and mandates. JAMA. 2017;318:506&#x2013;508.</Citation></Reference><Reference><Citation>Shahreyar M, Fahhoum R, Akinseye O, et al. Severe sepsis and cardiac arrhythmias. Ann Transl Med. 2018;6:6.</Citation></Reference><Reference><Citation>Meydan C, Bekenstein U, Soreq H. Molecular regulatory pathways link sepsis with metabolic syndrome: non-coding RNA elements underlying the sepsis/metabolic cross-talk. Front Mol Neurosci. 2018;11:189.</Citation></Reference><Reference><Citation>Bluth T, Pelosi P, de Abreu MG. The obese patient undergoing nonbariatric surgery. Curr Opin Anaesthesiol. 2016;29:421&#x2013;429.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">33019422</PMID><DateCompleted><Year>2020</Year><Month>10</Month><Day>19</Day></DateCompleted><DateRevised><Year>2022</Year><Month>10</Month><Day>05</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1536-5964</ISSN><JournalIssue CitedMedium="Internet"><Volume>99</Volume><Issue>40</Issue><PubDate><Year>2020</Year><Month>Oct</Month><Day>02</Day></PubDate></JournalIssue><Title>Medicine</Title><ISOAbbreviation>Medicine (Baltimore)</ISOAbbreviation></Journal><ArticleTitle>Procedural and post-operative complications associated with laparoscopic versus open abdominal surgery for right-sided colonic cancer resection: A systematic review and meta-analysis.</ArticleTitle><Pagination><StartPage>e22431</StartPage><MedlinePgn>e22431</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e22431</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1097/MD.0000000000022431</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">In this analysis, we aimed to systematically compare the procedural and post-operative complications (POC) associated with laparoscopic versus open abdominal surgery for right-sided colonic cancer resection.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">We searched MEDLINE, http://www.ClinicalTrials.gov, EMBASE, Web of Science, Cochrane Central, and Google scholar for English studies comparing the POC in patients who underwent laparoscopic versus open surgery (OS) for right colonic cancer. Data were assessed by the Cochrane-based RevMan 5.4 software (The Cochrane Community, London, UK). Mean difference (MD) with 95% confidence intervals (CIs) were used to represent the results for continuous variables, whereas risk ratios (RR) with 95% CIs were used for dichotomous data.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Twenty-six studies involving a total number of 3410 participants with right colonic carcinoma were included in this analysis. One thousand five hundred and fifteen participants were assigned to undergo invasive laparoscopic surgery whereas 1895 participants were assigned to the open abdominal surgery. Our results showed that the open resection was associated with a shorter length of surgery (MD: 48.63, 95% CI: 30.15-67.12; P&#x200a;=&#x200a;.00001) whereas laparoscopic intervention was associated with a shorter hospital stay [MD (-3.09), 95% CI [-5.82 to (-0.37)]; P&#x200a;=&#x200a;.03]. In addition, POC such as anastomotic leak (RR: 0.96, 95% CI: 0.60-1.55; P&#x200a;=&#x200a;.88), abdominal abscess (RR: 1.13, 95% CI: 0.52-2.49; P&#x200a;=&#x200a;.75), pulmonary embolism (RR: 0.40, 95% CI: 0.09-1.69; P&#x200a;=&#x200a;.21) and deep vein thrombosis (RR: 0.94, 95% CI: 0.39-2.28; P&#x200a;=&#x200a;.89) were not significantly different. Paralytic ileus (RR: 0.87, 95% CI: 0.67-1.11; P&#x200a;=&#x200a;.26), intra-abdominal infection (RR: 0.82, 95% CI: 0.15-4.48; P&#x200a;=&#x200a;.82), pulmonary complications (RR: 0.83, 95% CI: 0.57-1.20; P&#x200a;=&#x200a;.32), cardiac complications (RR: 0.73, 95% CI: 0.42-1.27; P&#x200a;=&#x200a;.27) and urological complications (RR: 0.83, 95% CI: 0.52-1.33; P&#x200a;=&#x200a;.44) were also similarly manifested. Our analysis also showed 30-day re-admission and re-operation, and mortality to be similar between laparoscopic versus OS for right colonic carcinoma resection. However, surgical wound infection (RR: 0.65, 95% CI: 0.50-0.86; P&#x200a;=&#x200a;.002) was significantly higher with the OS.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">In conclusion, laparoscopic surgery was almost comparable to OS in terms of post-operative outcomes for right-sided colonic cancer resection and was not associated with higher unwanted outcomes. Therefore, laparoscopic intervention should be considered as safe as the open abdominal surgery for right-sided colonic cancer resection, with a decreased hospital stay.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Yong Sheng</ForeName><Initials>YS</Initials><AffiliationInfo><Affiliation>Department of Colorectal surgery.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Meng</LastName><ForeName>Fan Chun</ForeName><Initials>FC</Initials><AffiliationInfo><Affiliation>Department of Colorectal surgery.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lin</LastName><ForeName>Jun Kai</ForeName><Initials>JK</Initials><Identifier Source="ORCID">0000-0002-1416-1265</Identifier><AffiliationInfo><Affiliation>Department of Gastroenterology, Dongying Shengli Oilfield Central Hospital, Dongying, Shandong, P.R. China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Medicine (Baltimore)</MedlineTA><NlmUniqueID>2985248R</NlmUniqueID><ISSNLinking>0025-7974</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003082" MajorTopicYN="N">Colectomy</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003110" MajorTopicYN="N">Colonic Neoplasms</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010535" MajorTopicYN="N">Laparoscopy</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007902" MajorTopicYN="N">Length of Stay</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D061646" MajorTopicYN="N">Operative Time</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName></MeshHeading></MeshHeadingList><CoiStatement>The authors have no funding and conflicts of interest to disclose.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>10</Month><Day>6</Day><Hour>1</Hour><Minute>7</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>10</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>10</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2020</Year><Month>10</Month><Day>2</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33019422</ArticleId><ArticleId IdType="pmc">PMC7535660</ArticleId><ArticleId IdType="doi">10.1097/MD.0000000000022431</ArticleId><ArticleId IdType="pii">00005792-202010020-00044</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Ries LAG HD, Krapcho M, Mariotto A, et al, eds. SEER cancer statistics review. Bethesda, MD: National Cancer Institute, 1975&#x2013;2003.</Citation></Reference><Reference><Citation>Jacobs M, Verdeja JC, Goldstein HS. Minimally invasive colon resection (laparoscopic colectomy). Surg Laparosc Endosc 1991;1:144&#x2013;50.</Citation><ArticleIdList><ArticleId IdType="pubmed">1688289</ArticleId></ArticleIdList></Reference><Reference><Citation>Bailey MB, Davenport DL, Vargas HD, et al. Longer operative time: deterioration of clinical outcomes of laparoscopic colectomy versus open colectomy. Dis Colon Rectum 2014;57:616&#x2013;22.</Citation><ArticleIdList><ArticleId IdType="pubmed">24819102</ArticleId></ArticleIdList></Reference><Reference><Citation>Facy O, De Magistris L, Poulain V, et al. Right colectomy: value of the totally laparoscopic approach. J Visc Surg 2013;150:207&#x2013;12.</Citation><ArticleIdList><ArticleId IdType="pubmed">23747084</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim SJ, Choi BJ, Lee SC. Overview of single-port laparoscopic surgery for colorectal cancers: past, present, and the future. World J Gastroenterol 2014;20:997&#x2013;1004.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3921551</ArticleId><ArticleId IdType="pubmed">24574772</ArticleId></ArticleIdList></Reference><Reference><Citation>Marchesi F, Pinna F, Percalli L, et al. Totally laparoscopic right colectomy: theoretical and practical advantages over the laparo-assisted approach. J Laparoendosc Adv Surg Tech A 2013;23:418&#x2013;24.</Citation><ArticleIdList><ArticleId IdType="pubmed">23414125</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim H. Hand-assisted laparoscopic right colectomy: is it useful? Ann Coloproctol 2014;30:1.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3953161</ArticleId><ArticleId IdType="pubmed">24639959</ArticleId></ArticleIdList></Reference><Reference><Citation>Baek MJ. Laparoscopic right hemicolectomy for colon cancer: technically feasible and safe to perform in terms of oncologic outcomes. J Korean Soc Coloproctol 2012;28:5.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3296943</ArticleId><ArticleId IdType="pubmed">22413074</ArticleId></ArticleIdList></Reference><Reference><Citation>Stang A. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol 2010;25:603&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="pubmed">20652370</ArticleId></ArticleIdList></Reference><Reference><Citation>Higgins JP, Altman DG, G&#xf8;tzsche PC, et al. Cochrane Bias Methods Group; Cochrane Statistical Methods Group. The Cochrane Collaboration's tool for assessing risk of bias in randomised trials. BMJ 2011;343:d5928.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3196245</ArticleId><ArticleId IdType="pubmed">22008217</ArticleId></ArticleIdList></Reference><Reference><Citation>Liberati A, Altman DG, Tetzlaff J, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ 2009;339:b2700.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2714672</ArticleId><ArticleId IdType="pubmed">19622552</ArticleId></ArticleIdList></Reference><Reference><Citation>Abdel-Halim MR, Moore HM, Cohen P, et al. Impact of laparoscopic right hemicolectomy for colon cancer. Ann R Coll Surg Engl 2010;92:211&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3080061</ArticleId><ArticleId IdType="pubmed">20412672</ArticleId></ArticleIdList></Reference><Reference><Citation>Guida F, Clemente M, Valvano L, et al. Laparoscopic or open hemicolectomy for elderly patients with right colon cancer? A retrospective analysis. G Chir 2015;36:205&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4711975</ArticleId><ArticleId IdType="pubmed">26712256</ArticleId></ArticleIdList></Reference><Reference><Citation>Habib K, Daniels S, Lee M, et al. Cost implications and oncological outcomes for laparoscopic versus open surgery for right hemicolectomy. Ann R Coll Surg Engl 2016;98:212&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5226162</ArticleId><ArticleId IdType="pubmed">26890838</ArticleId></ArticleIdList></Reference><Reference><Citation>Khan JS, Hemandas AK, Flashman KG, et al. Clinical outcome of laparoscopic and open colectomy for right colonic carcinoma. Ann R Coll Surg Engl 2011;93:603&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3566685</ArticleId><ArticleId IdType="pubmed">22041236</ArticleId></ArticleIdList></Reference><Reference><Citation>Li JC, Leung KL, Ng SS, et al. Laparoscopic-assisted versus open resection of right-sided colonic cancer--a prospective randomized controlled trial. Int J Colorectal Dis 2012;27:95&#x2013;102.</Citation><ArticleIdList><ArticleId IdType="pubmed">21861071</ArticleId></ArticleIdList></Reference><Reference><Citation>Quyn AJ, Moussa O, Millar F, et al. Open versus laparoscopic right hemicolectomy in the elderly population. World J Gastrointest Surg 2013;5:187&#x2013;91.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3692954</ArticleId><ArticleId IdType="pubmed">23805362</ArticleId></ArticleIdList></Reference><Reference><Citation>Tong DK, Law WL. Laparoscopic versus open right hemicolectomy for carcinoma of the colon. JSLS 2007;11:76&#x2013;80.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3015791</ArticleId><ArticleId IdType="pubmed">17651561</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang H, Wang Y, Xing H, et al. Laparoscopic surgery within an enhanced recovery after surgery (ERAS) protocol reduced postoperative ileus by increasing postoperative Treg levels in patients with right-side colon carcinoma. Med Sci Monit 2018;24:7231&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6192453</ArticleId><ArticleId IdType="pubmed">30303179</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao LY, Chi P, Ding WX, et al. Laparoscopic vs open extended right hemicolectomy for colon cancer. World J Gastroenterol 2014;20:7926&#x2013;32.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4069319</ArticleId><ArticleId IdType="pubmed">24976728</ArticleId></ArticleIdList></Reference><Reference><Citation>Zheng MH, Feng B, Lu AG, et al. Laparoscopic versus open right hemicolectomy with curative intent for colon carcinoma. World J Gastroenterol 2005;11:323&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4205329</ArticleId><ArticleId IdType="pubmed">15637736</ArticleId></ArticleIdList></Reference><Reference><Citation>Arman K, Tarik S, Kamran Z-S, et al. Recovery after open and laparoscopic right hemicolectomy: a comparison. J Surg Res 2010;162:11&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">20452623</ArticleId></ArticleIdList></Reference><Reference><Citation>Richard P, Baker, Liviu V, et al. A case-control study of laparoscopic right hemicolectomy vs. open right hemicolectomy. Dis Colon Rectum 2004;47:1675&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">15540298</ArticleId></ArticleIdList></Reference><Reference><Citation>Leung KL, Meng WC, Lee JF, et al. Laparoscopic-assisted resection of right-sided colonic carcinoma: a case-control study. J Surg Oncol 1999;71:97&#x2013;100.</Citation><ArticleIdList><ArticleId IdType="pubmed">10389865</ArticleId></ArticleIdList></Reference><Reference><Citation>Takatoshi N, Wataru O, Hiroyuki M, et al. Retrospective, matched case-control study comparing the oncologic outcomes between laparoscopic surgery and open surgery in patients with right-sided colon cancer. Surg Today 2009;39:1040&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="pubmed">19997798</ArticleId></ArticleIdList></Reference><Reference><Citation>Manfred O, Danilo M, Najaf S, et al. Short- and long-term outcomes after laparoscopic versus open emergency resection for colon cancer: an observational propensity score-matched study. World J Surg 2013;37:2458&#x2013;67.</Citation><ArticleIdList><ArticleId IdType="pubmed">23846176</ArticleId></ArticleIdList></Reference><Reference><Citation>Nawar A, Alkhamesi, Janet Martin, et al. Cost-efficiency of laparoscopic versus open colon surgery in a tertiary care center. Surg Endosc 2011;25:3597&#x2013;604.</Citation><ArticleIdList><ArticleId IdType="pubmed">21656072</ArticleId></ArticleIdList></Reference><Reference><Citation>Jonah J, Stulberg, Brad J, et al. Emergency laparoscopic colectomy: does it measure up to open? Am J Surg 2009;197:296&#x2013;301.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2681486</ArticleId><ArticleId IdType="pubmed">19245904</ArticleId></ArticleIdList></Reference><Reference><Citation>Frederick H, Koh, Ker-Kan T, et al. Laparoscopic versus an open colectomy in an emergency setting: a case-controlled study. Ann Coloproctol 2013;29:12&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3624978</ArticleId><ArticleId IdType="pubmed">23586009</ArticleId></ArticleIdList></Reference><Reference><Citation>Han DP, Lu AG, Feng H, et al. Long-term outcome of laparoscopic-assisted right-hemicolectomy with D3 lymphadenectomy versus open surgery for colon carcinoma. Surg Today 2014;44:868&#x2013;74.</Citation><ArticleIdList><ArticleId IdType="pubmed">23989942</ArticleId></ArticleIdList></Reference><Reference><Citation>Tanis E, van Geloven AAW, Bemelman WA, et al. A comparison of short-term outcome after laparoscopic, transverse, and midline right-sided colectomy. Int J Colorectal Dis 2012;27:797&#x2013;802.</Citation><ArticleIdList><ArticleId IdType="pubmed">22249439</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhengrong Li, Daojiang Li, Zhigang Jie, et al. Comparative study on therapeutic efficacy between hand-assisted laparoscopic surgery and conventional laparotomy for acute obstructive right-sided colon cancer. J Laparoendosc Adv Surg Tech A 2015;25:548&#x2013;54.</Citation><ArticleIdList><ArticleId IdType="pubmed">26134068</ArticleId></ArticleIdList></Reference><Reference><Citation>Simon SM, Ng, Janet FY, et al. Emergency laparoscopic-assisted versus open right hemicolectomy for obstructing right-sided colonic carcinoma: a comparative study of short-term clinical outcomes. World J Surg 2008;32:454&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">18196317</ArticleId></ArticleIdList></Reference><Reference><Citation>Lezoche E, Feliciotti F, Paganini AM, et al. Laparoscopic vs open hemicolectomy for colon cancer. Surg Endosc 2002;16:596&#x2013;602.</Citation><ArticleIdList><ArticleId IdType="pubmed">11972196</ArticleId></ArticleIdList></Reference><Reference><Citation>Bokey EL, Moore JW, Chapuis PH, et al. Morbidity and mortality following laparoscopic-assisted right hemicolectomy for cancer. Dis Colon Rectum 1996;39: Suppl 10: S24&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">8831543</ArticleId></ArticleIdList></Reference><Reference><Citation>Wah-Siew Tan, Min-Hoe Chew, Boon-Swee Ooi, et al. Laparoscopic versus open right hemicolectomy: a comparison of short-term outcomes. Int J Colorectal Dis 2009;24:1333&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">19488767</ArticleId></ArticleIdList></Reference><Reference><Citation>Inderbitzin DT, Opitz I, Giger U, et al. Incidence of clinical pulmonary embolism after laparoscopic surgery. Br J Surg 2007;94:599&#x2013;603.</Citation><ArticleIdList><ArticleId IdType="pubmed">17330858</ArticleId></ArticleIdList></Reference><Reference><Citation>Ena Alsina, Jaime Ruiz-Tovar, Maria Remedios Alpera, et al. Incidence of deep vein thrombosis and thrombosis of the portal-mesenteric axis after laparoscopic sleeve gastrectomy. J Laparoendosc Adv Surg Tech A 2014;24:601&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="pubmed">25072524</ArticleId></ArticleIdList></Reference><Reference><Citation>Yoshinori Kagawa, Daisaku Yamada, Makoto Yamasaki, et al. The association between the increased performance of laparoscopic colon surgery and a reduced risk of surgical site infection. Surg Today 2019;49:474&#x2013;81.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6526142</ArticleId><ArticleId IdType="pubmed">30684051</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun JL, Xing SY. Short-term outcome of laparoscopic surgery versus open surgery on colon carcinoma: a meta-analysis. Math Biosci Eng 2019;16:4645&#x2013;59.</Citation><ArticleIdList><ArticleId IdType="pubmed">31499682</ArticleId></ArticleIdList></Reference><Reference><Citation>Feinberg AE, Chesney TR, Acuna SA, et al. Oncologic outcomes following laparoscopic versus open resection of pT4 colon cancer: a systematic review and meta-analysis. Dis Colon Rectum 2017;60:116&#x2013;25.</Citation><ArticleIdList><ArticleId IdType="pubmed">27926565</ArticleId></ArticleIdList></Reference><Reference><Citation>Vela N, Bubis LD, Davis LE, et al. Comparison of patient-reported outcomes in laparoscopic and open right hemicolectomy: a retrospective cohort study. Dis Colon Rectum 2019;62:1439&#x2013;47.</Citation><ArticleIdList><ArticleId IdType="pubmed">31567922</ArticleId></ArticleIdList></Reference><Reference><Citation>Arezzo A, Passera R, Ferri V, et al. Laparoscopic right colectomy reduces short-term mortality and morbidity. Results of a systematic review and meta-analysis. Int J Colorectal Dis 2015;30:1457&#x2013;72.</Citation><ArticleIdList><ArticleId IdType="pubmed">26137968</ArticleId></ArticleIdList></Reference><Reference><Citation>Cirocchi R, Cesare Campanile F, Di Saverio S, et al. Laparoscopic versus open colectomy for obstructing right colon cancer: A systematic review and meta-analysis. J Visc Surg 2017;154:387&#x2013;99.</Citation><ArticleIdList><ArticleId IdType="pubmed">29113714</ArticleId></ArticleIdList></Reference><Reference><Citation>Rausa E, Kelly ME, Asti E, et al. Bonavina L.Right hemicolectomy: a network meta-analysis comparing open, laparoscopic-assisted, total laparoscopic, and robotic approach. Surg Endosc 2018;33:1020&#x2013;32.</Citation><ArticleIdList><ArticleId IdType="pubmed">30456506</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhobin Moghadamyeghaneh, Mark H, Hanna, et al. Comparison of open, laparoscopic, and robotic approaches for total abdominal colectomy. Surg Endosc 2016;30:2792&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">26487196</ArticleId></ArticleIdList></Reference><Reference><Citation>Fuertes-Guir&#xf2; F, Girabent-Farr&#xe9;s M. Higher cost of single incision laparoscopic cholecystectomy due to longer operating time. A study of opportunity cost based on meta-analysis. G Chir Jan-Feb 2018;39:24&#x2013;34.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5902141</ArticleId><ArticleId IdType="pubmed">29549678</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhamak Khorgami, Wei T, Li, et al. The cost of robotics: an analysis of the added costs of robotic-assisted versus laparoscopic surgery using the National Inpatient Sample. Surg Endosc 2019;33:2217&#x2013;21.</Citation><ArticleIdList><ArticleId IdType="pubmed">30327915</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">30193586</PMID><DateCompleted><Year>2018</Year><Month>12</Month><Day>17</Day></DateCompleted><DateRevised><Year>2018</Year><Month>12</Month><Day>17</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1471-2474</ISSN><JournalIssue CitedMedium="Internet"><Volume>19</Volume><Issue>1</Issue><PubDate><Year>2018</Year><Month>Sep</Month><Day>07</Day></PubDate></JournalIssue><Title>BMC musculoskeletal disorders</Title><ISOAbbreviation>BMC Musculoskelet Disord</ISOAbbreviation></Journal><ArticleTitle>The efficacy and safety of combined administration of intravenous and topical tranexamic acid in primary total knee arthroplasty: a meta-analysis of randomized controlled trials.</ArticleTitle><Pagination><StartPage>321</StartPage><MedlinePgn>321</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">321</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s12891-018-2181-9</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">The combined administration of intravenous (IV) and topical tranexamic acid (TXA) in primary total knee (TKA) knee remains controversial. The purpose of this meta-analysis was to assess the efficacy and safety of combined administration of IV and topical TXA in primary TKA.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">PubMed, EMBASE, Cochrane Central Register of Controlled Trials, Web of Science, Google Search Engine and China National Knowledge Infrastructure databases were searched for randomized controlled trials (RCTs) were comparing the combined administration of IV and topical TXA following primary TKA. The primary outcomes were total blood loss, maximum hemoglobin drop, and deep venous thrombosis (DVT) and/or pulmonary embolism (PE). The second outcomes were drainage volume and transfusion requirements. Data were analyzed using RevMan 5.3.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">A total of 6 RCTs involving 701 patients were included in the meta-analysis. The combined group provided lower total blood loss (MD -&#x2009;156.34&#xa0;mL, 95% CI, -&#x2009;241.51 to -&#x2009;71.18; P&#x2009;=&#x2009;0.0003), drainage volume (MD -&#x2009;43.54&#xa0;mL, 95% CI, -&#x2009;67.59 to -&#x2009;19.48; P&#x2009;=&#x2009;0.0004), maximum hemoglobin drop (MD -&#x2009;0.56&#xa0;g/dl, 95% CI, -&#x2009;0.93 to -&#x2009;0.19; P&#x2009;=&#x2009;0.003) than IV TXA alone. No significant difference were found in terms of transfusion requirements (RR 0.48, 95% CI, 0.16 to 1.44; P&#x2009;=&#x2009;0.19), DVT (RR 1.01, 95% CI, 0.14 to 7.12; P&#x2009;=&#x2009;0.99) and PE (RR 0.33, 95% CI, 0.01 to 7.91; P&#x2009;=&#x2009;0.49) between the two group. Subgroup analyses shows that the combined group was less total blood loss in non-tourniquet (P&#x2009;=&#x2009;0.0008), topical TXA dose &gt;&#x2009;1.5&#xa0;g (P&#x2009;&lt;&#x2009;&#xa0;0.00001) and number of IV TXA&#x2009;&#x2265;&#x2009;2 doses (P&#x2009;=&#x2009;0.005) of TXA compared with the IV group alone.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">The available evidence indicates combined group were associated with lower total blood loss, drainage volume, and maximum hemoglobin drop. A similar transfusion requirement was found in both groups. Subgroup analyses demonstrates that total blood loss was less in patients with non-tourniquet, topical TXA dose &gt;&#x2009;1.5&#xa0;g and number of IV TXA&#x2009;&#x2265;&#x2009;2 doses of TXA. There was no increase the rates of DVT and PE.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Xiong</LastName><ForeName>Huazhang</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Orthopaedic Surgery, West China Hospital, West China Medical School, Sichuan University, Chengdu, Sichuan Province, 610041, People's Republic of China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Orthopedic Surgery, The First Affiliated Hospital of Zunyi Medical College, Zunyi, 563003, Guizhou Province, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Yi</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Orthopedic Surgery, The First Affiliated Hospital of Zunyi Medical College, Zunyi, 563003, Guizhou Province, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zeng</LastName><ForeName>Yi</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Orthopaedic Surgery, West China Hospital, West China Medical School, Sichuan University, Chengdu, Sichuan Province, 610041, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wu</LastName><ForeName>Yuangang</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Orthopaedic Surgery, West China Hospital, West China Medical School, Sichuan University, Chengdu, Sichuan Province, 610041, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shen</LastName><ForeName>Bin</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Orthopaedic Surgery, West China Hospital, West China Medical School, Sichuan University, Chengdu, Sichuan Province, 610041, People's Republic of China. shenbin71@hotmail.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>09</Month><Day>07</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>BMC Musculoskelet Disord</MedlineTA><NlmUniqueID>100968565</NlmUniqueID><ISSNLinking>1471-2474</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000933">Antifibrinolytic Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015415">Biomarkers</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D006454">Hemoglobins</NameOfSubstance></Chemical><Chemical><RegistryNumber>6T84R30KC1</RegistryNumber><NameOfSubstance UI="D014148">Tranexamic Acid</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D061605" MajorTopicYN="N">Administration, Intravenous</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000287" MajorTopicYN="N">Administration, Topical</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000933" MajorTopicYN="N">Antifibrinolytic Agents</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="Y">administration &amp; dosage</QualifierName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019645" MajorTopicYN="Y">Arthroplasty, Replacement, Knee</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015415" MajorTopicYN="N">Biomarkers</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016063" MajorTopicYN="N">Blood Loss, Surgical</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001803" MajorTopicYN="N">Blood Transfusion</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004322" MajorTopicYN="N">Drainage</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006454" MajorTopicYN="N">Hemoglobins</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011655" MajorTopicYN="N">Pulmonary Embolism</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016032" MajorTopicYN="N">Randomized Controlled Trials as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014111" MajorTopicYN="N">Tourniquets</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014148" MajorTopicYN="N">Tranexamic Acid</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="Y">administration &amp; dosage</QualifierName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020246" MajorTopicYN="N">Venous Thrombosis</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Blood loss</Keyword><Keyword MajorTopicYN="N">Intravenous</Keyword><Keyword MajorTopicYN="N">Topical</Keyword><Keyword MajorTopicYN="N">Total knee arthroplasty</Keyword><Keyword MajorTopicYN="N">Tranexamic acid</Keyword></KeywordList><CoiStatement>ETHICS APPROVAL AND CONSENT TO PARTICIPATE: Ethical approval is not necessary because it is a comment on previously published articles and does not involve the handling of any personal patient data. CONSENT FOR PUBLICATION: All authors agree to publish. COMPETING INTERESTS: The authors declare that they have no competing interests. PUBLISHER&#x2019;S NOTE: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2018</Year><Month>2</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>7</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>9</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>9</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>12</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2018</Year><Month>9</Month><Day>7</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">30193586</ArticleId><ArticleId IdType="pmc">PMC6129000</ArticleId><ArticleId IdType="doi">10.1186/s12891-018-2181-9</ArticleId><ArticleId IdType="pii">10.1186/s12891-018-2181-9</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Zeni JA, Jr, Axe MJ, Snyder-Mackler L. Clinical predictors of elective total joint replacement in persons with end-stage knee osteoarthritis. BMC Musculoskelet Disord. 2010;11:86. doi: 10.1186/1471-2474-11-86.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2474-11-86</ArticleId><ArticleId IdType="pmc">PMC2877653</ArticleId><ArticleId IdType="pubmed">20459622</ArticleId></ArticleIdList></Reference><Reference><Citation>Levine BR, Haughom B, Strong B, Hellman M, Frank RM. Blood management strategies for total knee arthroplasty. J Am Acad Orthop Surg. 2014;22:361&#x2013;371. doi: 10.5435/JAAOS-22-06-361.</Citation><ArticleIdList><ArticleId IdType="doi">10.5435/JAAOS-22-06-361</ArticleId><ArticleId IdType="pubmed">24860132</ArticleId></ArticleIdList></Reference><Reference><Citation>Edelstein AI, Kwasny MJ, Suleiman LI, Khakhkhar RH, Moore MA, Beal MD, et al. Can the American College of Surgeons risk calculator predict 30-day complications after knee and hip arthroplasty? J Arthroplast 2015;30:5&#x2013;10.</Citation><ArticleIdList><ArticleId IdType="pubmed">26165953</ArticleId></ArticleIdList></Reference><Reference><Citation>Wong J, Abrishami A, El Beheiry H, Mahomed NN, Roderick Davey J, Gandhi R, et al. Topical application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty: a randomized, controlled trial.J Bone Joint Surg Am 2010 ;92:2503&#x2013;2513.</Citation><ArticleIdList><ArticleId IdType="pubmed">21048170</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen JY, Chin PL, Moo IH, Pang HN, Tay DK, Chia SL, et al. Intravenous versus intra-articular tranexamic acid in total knee arthroplasty: a double-blinded randomised controlled noninferiority trial. Knee. 2016;23:152&#x2013;156. doi: 10.1016/j.knee.2015.09.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.knee.2015.09.004</ArticleId><ArticleId IdType="pubmed">26746044</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu Y, Yang T, Zeng Y, Li C, Shen B, Pei F. Clamping drainage is unnecessary after minimally invasive total knee arthroplasty in patients with tranexamic acid: a randomized, controlled trial. Medicine. 2017;96:e5804. doi: 10.1097/MD.0000000000005804.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MD.0000000000005804</ArticleId><ArticleId IdType="pmc">PMC5319492</ArticleId><ArticleId IdType="pubmed">28207503</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie J, Ma J, Kang P, Zhou Z, Shen B, Yang J, et al. Does tranexamic acid alter the risk of thromboembolism following primary total knee arthroplasty with sequential earlier anticoagulation? A large, single center, prospective cohort study of consecutive cases. Thromb Res. 2015;136:234&#x2013;238. doi: 10.1016/j.thromres.2015.05.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.thromres.2015.05.014</ArticleId><ArticleId IdType="pubmed">26026635</ArticleId></ArticleIdList></Reference><Reference><Citation>May JH, Rieser GR, Williams CG, Markert RJ, Bauman RD, Lawless MW. The assessment of blood loss during Total knee arthroplasty when comparing intravenous vs Intracapsular Administration of Tranexamic Acid. J Arthroplast. 2016;31:2452&#x2013;2457. doi: 10.1016/j.arth.2016.04.018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.arth.2016.04.018</ArticleId><ArticleId IdType="pubmed">27259391</ArticleId></ArticleIdList></Reference><Reference><Citation>Georgiadis AG, Muh SJ, Silverton CD, Weir RM, Laker MW. A prospective double-blind placebo controlled trial of topical tranexamic acid in total knee arthroplasty. J Arthroplast. 2013;28:78&#x2013;82. doi: 10.1016/j.arth.2013.03.038.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.arth.2013.03.038</ArticleId><ArticleId IdType="pubmed">23906869</ArticleId></ArticleIdList></Reference><Reference><Citation>MacGillivray RG, Tarabichi SB, Hawari MF, Raoof NT. Tranexamic acid to reduce blood loss after bilateral total knee arthroplasty: a prospective, randomized double blind study. J. Arthroplasty. 2011;26:24&#x2013;28. doi: 10.1016/j.arth.2009.11.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.arth.2009.11.013</ArticleId><ArticleId IdType="pubmed">20171048</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang H, Shen B, Zeng Y. Comparison of topical versus intravenous tranexamic acid in primary total knee arthroplasty: a meta-analysis of randomized controlled and prospective cohort trials. Knee. 2014;21:987&#x2013;993. doi: 10.1016/j.knee.2014.09.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.knee.2014.09.010</ArticleId><ArticleId IdType="pubmed">25450009</ArticleId></ArticleIdList></Reference><Reference><Citation>Wei Z, Liu M. The effectiveness and safety of tranexamic acid in total hip or knee arthroplasty: a meta-analysis of 2720 cases. Transfusion medicine (Oxford, England) 2015;25:151&#x2013;162. doi: 10.1111/tme.12212.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/tme.12212</ArticleId><ArticleId IdType="pubmed">26033447</ArticleId></ArticleIdList></Reference><Reference><Citation>Charoencholvanich K, Siriwattanasakul P. Tranexamic acid reduces blood loss and blood transfusion after TKA: a prospective randomized controlled trial. Clin Orthop Relat Res. 2011;469:2874&#x2013;2880. doi: 10.1007/s11999-011-1874-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11999-011-1874-2</ArticleId><ArticleId IdType="pmc">PMC3171556</ArticleId><ArticleId IdType="pubmed">21512813</ArticleId></ArticleIdList></Reference><Reference><Citation>Tzatzairis TK, Drosos GI, Kotsios SE, Ververidis AN, Vogiatzaki TD, Kazakos KI. Intravenous vs topical tranexamic acid in Total knee arthroplasty without tourniquet application: a randomized controlled study. J Arthroplast. 2016;31:2465&#x2013;2470. doi: 10.1016/j.arth.2016.04.036.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.arth.2016.04.036</ArticleId><ArticleId IdType="pubmed">27267228</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee QJ, Ching WY, Wong YC. Blood sparing efficacy of oral tranexamic acid in primary Total knee arthroplasty: a randomized controlled trial. Knee surgery &amp; related research. 2017;29:57&#x2013;62. doi: 10.5792/ksrr.16.074.</Citation><ArticleIdList><ArticleId IdType="doi">10.5792/ksrr.16.074</ArticleId><ArticleId IdType="pmc">PMC5336374</ArticleId><ArticleId IdType="pubmed">28231650</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang Z, Ma J, Shen B, Pei F. Combination of intravenous and topical application of tranexamic acid in primary total knee arthroplasty: a prospective randomized controlled trial. J Arthroplast. 2014;29:2342&#x2013;2346. doi: 10.1016/j.arth.2014.05.026.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.arth.2014.05.026</ArticleId><ArticleId IdType="pubmed">25007725</ArticleId></ArticleIdList></Reference><Reference><Citation>Jain NP, Nisthane PP, Shah NA. Combined Administration of Systemic and Topical Tranexamic Acid for Total knee arthroplasty: can it be a better regimen and yet safe? A randomized controlled trial. J Arthroplast. 2016;31:542&#x2013;547. doi: 10.1016/j.arth.2015.09.029.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.arth.2015.09.029</ArticleId><ArticleId IdType="pubmed">26507526</ArticleId></ArticleIdList></Reference><Reference><Citation>Seo JG, Moon YW, Park SH, Kim SM, Ko KR. The comparative efficacies of intra-articular and IV tranexamic acid for reducing blood loss during total knee arthroplasty. Knee Surg Sports Traumatol Arthrosc. 2013;21(8):1869&#x2013;1874. doi: 10.1007/s00167-012-2079-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00167-012-2079-2</ArticleId><ArticleId IdType="pubmed">22729012</ArticleId></ArticleIdList></Reference><Reference><Citation>Shang J, Wang H, Zheng B, Rui M, Wang Y. Combined intravenous and topical tranexamic acid versus intravenous use alone in primary total knee and hip arthroplasty: a meta-analysis of randomized controlled trials. Int J Surg. 2016;36:324&#x2013;329. doi: 10.1016/j.ijsu.2016.11.033.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijsu.2016.11.033</ArticleId><ArticleId IdType="pubmed">27856355</ArticleId></ArticleIdList></Reference><Reference><Citation>Li JF, Li H, Zhao H, Wang J, Liu S, Song Y, Wu HF. Combined use of intravenous and topical versus intravenous tranexamic acid in primary total knee and hip arthroplasty: a meta-analysis of randomised controlled trials. J Orthop Surg Res. 2017;12(1):22. doi: 10.1186/s13018-017-0520-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13018-017-0520-4</ArticleId><ArticleId IdType="pmc">PMC5290625</ArticleId><ArticleId IdType="pubmed">28153031</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Z, Shen X. The efficacy of combined intra-articular and intravenous tranexamic acid for blood loss in primary total knee arthroplasty: a meta-analysis. Medicine. 2017;96(42)</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5662361</ArticleId><ArticleId IdType="pubmed">29049195</ArticleId></ArticleIdList></Reference><Reference><Citation>Nielsen CS, Jans O, Orsnes T, Foss NB, Troelsen A, Husted H. Combined intra-articular and intravenous tranexamic acid reduces blood loss in Total knee arthroplasty: a randomized, double-blind, placebo-controlled trial. J Bone Joint Surg Am. 2016;98:835&#x2013;841. doi: 10.2106/JBJS.15.00810.</Citation><ArticleIdList><ArticleId IdType="doi">10.2106/JBJS.15.00810</ArticleId><ArticleId IdType="pubmed">27194493</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee SY, Chong S, Balasubramanian D, Na YG, Kim TK. What is the Ideal Route of Administration of Tranexamic Acid in TKA? A Randomized Controlled Trial. Clin Orthop Relat Res. 2017;475:1987-96.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5498377</ArticleId><ArticleId IdType="pubmed">28283902</ArticleId></ArticleIdList></Reference><Reference><Citation>Song EK, Seon JK, Prakash J, Seol YJ, Park YJ, Jin C. Combined administration of IV and topical tranexamic acid is not superior to either individually in primary navigated TKA. J Arthroplast. 2017;32:37&#x2013;42. doi: 10.1016/j.arth.2016.06.052.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.arth.2016.06.052</ArticleId><ArticleId IdType="pubmed">27633946</ArticleId></ArticleIdList></Reference><Reference><Citation>Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Open medicine : a peer-reviewed, independent, open-access journal. 2009;3:e123&#x2013;e130.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3090117</ArticleId><ArticleId IdType="pubmed">21603045</ArticleId></ArticleIdList></Reference><Reference><Citation>Higgins JP, Altman DG, Gotzsche PC, Juni P, Moher D, Oxman AD, et al. The Cochrane Collaboration's tool for assessing risk of bias in randomised trials. BMJ (Clinical research ed) 2011;343:d5928. doi: 10.1136/bmj.d5928.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.d5928</ArticleId><ArticleId IdType="pmc">PMC3196245</ArticleId><ArticleId IdType="pubmed">22008217</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang Z, Ma J, Pei F, Yang J, Zhou Z, Kang P, et al. Meta-analysis of temporary versus no clamping in TKA. Orthopedics. 2013;36:543&#x2013;550. doi: 10.3928/01477447-20130624-11.</Citation><ArticleIdList><ArticleId IdType="doi">10.3928/01477447-20130624-11</ArticleId><ArticleId IdType="pubmed">23823038</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu L, Yang Z, Yao J, Xu P. Effect of local injection combined intravenous drip tranexamic acid on blood loss in total knee arthroplasty. J N Sichuan Med Coll. 2015;30:611&#x2013;614.</Citation></Reference><Reference><Citation>Gomez-Barrena E, Ortega-Andreu M, Padilla-Eguiluz NG, Perez-Chrzanowska H, Figueredo-Zalve R. Topical intra-articular compared with intravenous tranexamic acid to reduce blood loss in primary total knee replacement: a double-blind, randomized, controlled, noninferiority clinical trial. J Bone Joint Surg Am. 2014;96:1937&#x2013;1944. doi: 10.2106/JBJS.N.00060.</Citation><ArticleIdList><ArticleId IdType="doi">10.2106/JBJS.N.00060</ArticleId><ArticleId IdType="pubmed">25471907</ArticleId></ArticleIdList></Reference><Reference><Citation>Patel JN, Spanyer JM, Smith LS, Huang J, Yakkanti MR, Malkani AL. Comparison of intravenous versus topical tranexamic acid in total knee arthroplasty: a prospective randomized study. J Arthroplast. 2014;29:1528&#x2013;1531. doi: 10.1016/j.arth.2014.03.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.arth.2014.03.011</ArticleId><ArticleId IdType="pubmed">24768543</ArticleId></ArticleIdList></Reference><Reference><Citation>Alshryda S, Sarda P, Sukeik M, Nargol A, Blenkinsopp J, Mason JM. Tranexamic acid in total knee replacement: a systematic review and meta-analysis. J Bone Joint Surg. 2011;93:1577&#x2013;1585. doi: 10.1302/0301-620X.93B12.26989.</Citation><ArticleIdList><ArticleId IdType="doi">10.1302/0301-620X.93B12.26989</ArticleId><ArticleId IdType="pubmed">22161917</ArticleId></ArticleIdList></Reference><Reference><Citation>Alshryda S, Sukeik M, Sarda P, Blenkinsopp J, Haddad FS, Mason JM. A systematic review and meta-analysis of the topical administration of tranexamic acid in total hip and knee replacement. The bone &amp; joint journal. 2014;96-B:1005&#x2013;1015. doi: 10.1302/0301-620X.96B8.33745.</Citation><ArticleIdList><ArticleId IdType="doi">10.1302/0301-620X.96B8.33745</ArticleId><ArticleId IdType="pubmed">25086114</ArticleId></ArticleIdList></Reference><Reference><Citation>Fillingham YA, Kayupov E, Plummer DR, Moric M, Gerlinger TL, Della Valle CJ. The James a. Rand young Investigator's award: a randomized controlled trial of oral and intravenous tranexamic acid in Total knee arthroplasty: the same efficacy at lower cost? J Arthroplast. 2016;31:26&#x2013;30. doi: 10.1016/j.arth.2016.02.081.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.arth.2016.02.081</ArticleId><ArticleId IdType="pubmed">27113948</ArticleId></ArticleIdList></Reference><Reference><Citation>Akgul T, Buget M, Salduz A, Edipoglu IS, Ekinci M, Kucukay S, et al. Efficacy of preoperative administration of single high dose intravenous tranexamic acid in reducing blood loss in total knee arthroplasty: a prospective clinical study. Acta Orthop Traumatol Turc 2016;50:429&#x2013;431.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6197312</ArticleId><ArticleId IdType="pubmed">27435332</ArticleId></ArticleIdList></Reference><Reference><Citation>Pitta M, Zawadsky M, Verstraete R, Rubinstein A. Intravenous administration of tranexamic acid effectively reduces blood loss in primary total knee arthroplasty in a 610-patient consecutive case series. Transfusion. 2016;56:466&#x2013;471. doi: 10.1111/trf.13354.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/trf.13354</ArticleId><ArticleId IdType="pubmed">26509250</ArticleId></ArticleIdList></Reference><Reference><Citation>Ishida K, Tsumura N, Kitagawa A, Hamamura S, Fukuda K, Dogaki Y, et al. Intra-articular injection of tranexamic acid reduces not only blood loss but also knee joint swelling after total knee arthroplasty. Int Orthop. 2011;35:1639&#x2013;1645. doi: 10.1007/s00264-010-1205-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00264-010-1205-3</ArticleId><ArticleId IdType="pmc">PMC3193960</ArticleId><ArticleId IdType="pubmed">21253725</ArticleId></ArticleIdList></Reference><Reference><Citation>Anderson DR, Dunbar M, Murnaghan J, Kahn SR, Gross P, Forsythe M. Aspirin or rivaroxaban for VTE prophylaxis after hip or knee arthroplasty. N Engl J Med. 2018;378(8):699&#x2013;707. doi: 10.1056/NEJMoa1712746.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1712746</ArticleId><ArticleId IdType="pubmed">29466159</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang XQ, Ni J, Ge WH. Combined use of intravenous and topical versus intravenous tranexamic acid in primary total joint arthroplasty: a meta-analysis of randomized controlled trials. International journal of surgery (London, England) 2017;38:15&#x2013;20. doi: 10.1016/j.ijsu.2016.11.136.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijsu.2016.11.136</ArticleId><ArticleId IdType="pubmed">27913237</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao-Yu C, Yan G, Wei C, Yuejv L, Ying-Ze Z. Reduced blood loss after intra-articular tranexamic acid injection during total knee arthroplasty: a meta-analysis of the literature. Knee surgery, sports traumatology, arthroscopy : official journal of the ESSKA. 2014;22:3181&#x2013;3190. doi: 10.1007/s00167-013-2814-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00167-013-2814-3</ArticleId><ArticleId IdType="pubmed">24352523</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">30817570</PMID><DateCompleted><Year>2019</Year><Month>03</Month><Day>06</Day></DateCompleted><DateRevised><Year>2021</Year><Month>01</Month><Day>09</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1536-5964</ISSN><JournalIssue CitedMedium="Internet"><Volume>98</Volume><Issue>9</Issue><PubDate><Year>2019</Year><Month>Mar</Month></PubDate></JournalIssue><Title>Medicine</Title><ISOAbbreviation>Medicine (Baltimore)</ISOAbbreviation></Journal><ArticleTitle>Effectiveness and safety of rivaroxaban for the prevention of thrombosis following total hip or knee replacement: A systematic review and meta-analysis.</ArticleTitle><Pagination><StartPage>e14539</StartPage><MedlinePgn>e14539</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e14539</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1097/MD.0000000000014539</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Prophylactic anticoagulant therapy is recommended to reduce the risk of venous thromboembolism (VTE) after total hip or knee arthroplasty, and has become the standard of care. Rivaroxaban is a novel oral medication that directly inhibits factor Xa for the prevention and treatment of thromboembolic conditions.</AbstractText><AbstractText Label="METHOD" NlmCategory="METHODS">A meta-analysis of randomized controlled trials (RCTs) was performed to determine the efficacy and safety of rivaroxaban after total hip arthroplasty (THA) and total knee arthroplasty (TKA) surgery. We reviewed several databases including PubMed, the Cochrane Library, Embase and the US trial registry to detect appropriate RCTs for our meta-analysis. The primary efficacy outcome of this meta-analysis was the combination of any deep-vein thrombosis (DVT), non-fatal pulmonary embolism (PE), and death from any cause. The main safety outcome was bleeding events which included significant bleeding events, clinically relevant insignificant bleeding events, or minor events. Other end points were the number of patients who received blood transfusion the volume of transfused whole blood or red blood cells, and the volume of postoperative drainage.</AbstractText><AbstractText Label="RESULT" NlmCategory="RESULTS">Thirteen RCTs were included in this meta-analysis. This meta-analysis showed that the overall rate of VTE events, DVT, PE, and death were 1%, 6%,&#x200a;&lt;&#x200a;1% and &lt;&#x200a;1%, respectively, for patients receiving treatment with rivaroxaban after THA and TKA surgery. The subgroup analysis demonstrated rivaroxaban had more superior effects in THA patients. The pooled analysis of bleeding events showed that the overall rate of major bleeding events, overt bleeding events associated with fall in Hb of &gt;&#x200a;2&#x200a;g/DL, clinically overt bleeding events leading to transfusion of&#x200a;&gt;&#x200a;2 units of blood, clinically overt bleeding events leading to further surgeries, and non-major bleeding events were&#x200a;&lt;&#x200a;1%,&#x200a;&lt;&#x200a;1%,&#x200a;&lt;&#x200a;1%,&#x200a;&lt;&#x200a;1%, and 3%, respectively.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">This is the first systematic review of the literature providing incidence of efficacy and safety outcomes for thromboprophylaxis in THA and TKA patients. Moreover, this meta-analysis showed that rivaroxaban had more superior effect in THA patients.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Jichao</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Orthopedics, Sanerlingyi Hospital, Hanzhong.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhao</LastName><ForeName>Jinlong</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Orthopedics, Sanerlingyi Hospital, Hanzhong.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yan</LastName><ForeName>Yong</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Second Department of Orthopaedics, Shaanxi Traditional Chinese Medicine Hospital, Xian.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Su</LastName><ForeName>Jinping</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Osteoarthropathy, The WenDeng Osteopath Hospital, Weihai, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Medicine (Baltimore)</MedlineTA><NlmUniqueID>2985248R</NlmUniqueID><ISSNLinking>0025-7974</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000925">Anticoagulants</NameOfSubstance></Chemical><Chemical><RegistryNumber>9NDF7JZ4M3</RegistryNumber><NameOfSubstance UI="D000069552">Rivaroxaban</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000925" MajorTopicYN="N">Anticoagulants</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019644" MajorTopicYN="N">Arthroplasty, Replacement, Hip</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019645" MajorTopicYN="N">Arthroplasty, Replacement, Knee</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015994" MajorTopicYN="N">Incidence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011655" MajorTopicYN="N">Pulmonary Embolism</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016032" MajorTopicYN="N">Randomized Controlled Trials as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000069552" MajorTopicYN="N">Rivaroxaban</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D054556" MajorTopicYN="N">Venous Thromboembolism</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020246" MajorTopicYN="N">Venous Thrombosis</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading></MeshHeadingList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>3</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>3</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>3</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2019</Year><Month>3</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">30817570</ArticleId><ArticleId IdType="pmc">PMC6831257</ArticleId><ArticleId IdType="doi">10.1097/MD.0000000000014539</ArticleId><ArticleId IdType="pii">00005792-201903010-00010</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Memtsoudis SG, Pumberger M, Ma Y, et al. Epidemiology and risk factors for perioperative mortality after total hip and knee arthroplasty. J Orthop Res 2012;30:1811&#x2013;21.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3407319</ArticleId><ArticleId IdType="pubmed">22517400</ArticleId></ArticleIdList></Reference><Reference><Citation>Kinov P, Tanchev PP, Ellis M, et al. Antithrombotic prophylaxis in major orthopaedic surgery: an historical overview and update of current recommendations. Int Orthop 2014;38:169&#x2013;75.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3890144</ArticleId><ArticleId IdType="pubmed">24114249</ArticleId></ArticleIdList></Reference><Reference><Citation>Warwick D, Friedman RJ, Agnelli G, et al. Insufficient duration of venous thromboembolism prophylaxis after total hip or knee replacement when compared with the time course of thromboembolic events. Bone Joint J 2007;89:799&#x2013;807.</Citation><ArticleIdList><ArticleId IdType="pubmed">17613508</ArticleId></ArticleIdList></Reference><Reference><Citation>White RH. The epidemiology of venous thromboembolism. Circulation 2003;107Suppl 1:I-4&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">12814979</ArticleId></ArticleIdList></Reference><Reference><Citation>Geerts WH, Heit JA, Clagett GP, et al. Prevention of venous thromboembolism. Chest J 2001;119suppl 1:132S&#x2013;75S.</Citation><ArticleIdList><ArticleId IdType="pubmed">11157647</ArticleId></ArticleIdList></Reference><Reference><Citation>Markovic-Denic L, Zivkovic K, Lesic A, et al. Risk factors and distribution of symptomatic venous thromboembolism in total hip and knee replacements: prospective study. Int Orthop 2012;36:1299&#x2013;305.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3353084</ArticleId><ArticleId IdType="pubmed">22215369</ArticleId></ArticleIdList></Reference><Reference><Citation>Falck-Ytter Y, Francis CW, Johanson NA, et al. Prevention of VTE in orthopedic surgery patients: antithrombotic therapy and prevention of thrombosis: American College of Chest Physicians evidence-based clinical practice guidelines. Chest J 2012;141suppl 2:e278S&#x2013;325S.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3278063</ArticleId><ArticleId IdType="pubmed">22315265</ArticleId></ArticleIdList></Reference><Reference><Citation>Geerts WH, Pineo GF, Heit JA, et al. Prevention of venous thromboembolism: the seventh ACCP conference on antithrombotic and thrombolytic therapy. Chest J 2004;126suppl 3:338S&#x2013;400S.</Citation><ArticleIdList><ArticleId IdType="pubmed">15383478</ArticleId></ArticleIdList></Reference><Reference><Citation>Stein PD, Matta F, Hughes MJ. Home treatment of deep venous thrombosis according to comorbid conditions. Am J Med 2016;129:392&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">26551984</ArticleId></ArticleIdList></Reference><Reference><Citation>Eriksson BI, Borris LC, Dahl OE, et al. Dose-escalation study of rivaroxaban (BAY 59-7939)-an oral, direct Factor Xa inhibitor-for the prevention of venous thromboembolism in patients undergoing total hip replacement. Thromb Res 2007;120:685&#x2013;93.</Citation><ArticleIdList><ArticleId IdType="pubmed">17292948</ArticleId></ArticleIdList></Reference><Reference><Citation>Turpie A, Fisher W, Bauer K, et al. BAY 59-7939: an oral, direct factor Xa inhibitor for the prevention of venous thromboembolism in patients after total knee replacement. A phase II dose-ranging study. J Thromb Haemost 2005;3:2479&#x2013;86.</Citation><ArticleIdList><ArticleId IdType="pubmed">16241946</ArticleId></ArticleIdList></Reference><Reference><Citation>Eriksson BI, Borris L, Dahl O, et al. Oral, direct Factor Xa inhibition with BAY 59-7939 for the prevention of venous thromboembolism after total hip replacement. J Thromb Haemost 2006;4:121&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">16409461</ArticleId></ArticleIdList></Reference><Reference><Citation>Eriksson BI, Borris LC, Dahl OE, et al. A once-daily, oral, direct Factor Xa inhibitor, rivaroxaban (BAY 59-7939), for thromboprophylaxis after total hip replacement. Circulation 2006;114:2374&#x2013;81.</Citation><ArticleIdList><ArticleId IdType="pubmed">17116766</ArticleId></ArticleIdList></Reference><Reference><Citation>Mueck W, Eriksson BI, Bauer KA, et al. Population pharmacokinetics and pharmacodynamics of rivaroxaban-an oral, direct factor Xa inhibitor-in patients undergoing major orthopaedic surgery. Clin Pharmacokin 2008;47:203&#x2013;16.</Citation><ArticleIdList><ArticleId IdType="pubmed">18307374</ArticleId></ArticleIdList></Reference><Reference><Citation>Cao YB, Zhang JD, Shen H, et al. Rivaroxaban versus enoxaparin for thromboprophylaxis after total hip or knee arthroplasty: a meta-analysis of randomized controlled trials. Eur J Clin Pharmacol 2010;66:1099&#x2013;108.</Citation><ArticleIdList><ArticleId IdType="pubmed">20812009</ArticleId></ArticleIdList></Reference><Reference><Citation>Feng W, Wu K, Liu Z, et al. Oral direct factor Xa inhibitor versus enoxaparin for thromboprophylaxis after hip or knee arthroplasty: Systemic review, traditional meta-analysis, dose-response meta-analysis and network meta-analysis. Thromb Res 2015;136:1133&#x2013;44.</Citation><ArticleIdList><ArticleId IdType="pubmed">26498222</ArticleId></ArticleIdList></Reference><Reference><Citation>Yoshida Rde A, Yoshida WB, Maffei FH, et al. Systematic review of randomized controlled trials of new anticoagulants for venous thromboembolism prophylaxis in major orthopedic surgeries, compared with enoxaparin. Ann Vasc Surg 2013;27:355&#x2013;69.</Citation><ArticleIdList><ArticleId IdType="pubmed">23351997</ArticleId></ArticleIdList></Reference><Reference><Citation>Ning GZ, Kan SL, Chen LX, et al. Rivaroxaban for thromboprophylaxis after total hip or knee arthroplasty: a meta-analysis with trial sequential analysis of randomized controlled trials. Sci Rep 2016;6:23726.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4810418</ArticleId><ArticleId IdType="pubmed">27020475</ArticleId></ArticleIdList></Reference><Reference><Citation>Kakkar AK, Brenner B, Dahl OE, et al. Extended duration rivaroxaban versus short-term enoxaparin for the prevention of venous thromboembolism after total hip arthroplasty: a double-blind, randomised controlled trial. Lancet 2008;372:31&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">18582928</ArticleId></ArticleIdList></Reference><Reference><Citation>Eriksson BI, Borris LC, Friedman RJ, et al. Oral rivaroxaban compared with subcutaneous enoxaparin for extended thrombopro-phylaxis after total hip arthroplasty: The RECORD1 Trial. Am Soc Hematol 2007;6&#x2013;16.</Citation></Reference><Reference><Citation>Lassen MR, Ageno W, Borris LC, et al. Rivaroxaban versus enoxaparin for thromboprophylaxis after total knee arthroplasty. N Engl J Med 2008;358:2776&#x2013;86.</Citation><ArticleIdList><ArticleId IdType="pubmed">18579812</ArticleId></ArticleIdList></Reference><Reference><Citation>Turpie AG, Benson A, Misselwitz F. Rivaroxaban versus enoxaparin after total knee arthroplasty-Authors&#x2019; reply. Lancet 2009;374:683&#x2013;1683.</Citation><ArticleIdList><ArticleId IdType="pubmed">0</ArticleId></ArticleIdList></Reference><Reference><Citation>Zou Y, Tian S, Wang Y, et al. Administering aspirin, rivaroxaban and low-molecular-weight heparin to prevent deep venous thrombosis after total knee arthroplasty. Blood Coagul Fibrinolysis 2014;25:660&#x2013;4.</Citation><ArticleIdList><ArticleId IdType="pubmed">24695091</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang Y, Du H, Liu J, et al. Aspirin combined with mechanical measures to prevent venous thromboembolism after total knee arthroplasty: a randomized controlled trial. Chin Med J (Engl) 2014;127:2201&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="pubmed">24931228</ArticleId></ArticleIdList></Reference><Reference><Citation>&#xd6;zler T, Ulu&#xe7;ay &#xc7;, &#xd6;nal A, et al. Comparison of switch-therapy modalities (enoxaparin to rivaroxaban/dabigatran) and enoxaparin monotherapy after hip and knee replacement. Acta Orthop Traumatol Turc 2015;49:255&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">26200403</ArticleId></ArticleIdList></Reference><Reference><Citation>Di Benedetto P, Vetrugno L, De Franceschi D, et al. Patient compliance with new oral anticoagulants after major orthopaedic surgery: rivaroxaban and dabigatran compared with subcutaneous injection of fondaparinux. Joints 2016;4:214&#x2013;1214.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5297345</ArticleId><ArticleId IdType="pubmed">28217657</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu P, Liu J, Chen L, et al. Intermittent pneumatic compression devices combined with anticoagulants for prevention of symptomatic deep vein thrombosis after total knee arthroplasty: a pilot study. Ther Clin Risk Manag 2017;13:179&#x2013;179.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5317322</ArticleId><ArticleId IdType="pubmed">28243107</ArticleId></ArticleIdList></Reference><Reference><Citation>Moher D, Liberati A, Tetzlaff J, et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med 2009;6:e1000097.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2707599</ArticleId><ArticleId IdType="pubmed">19621072</ArticleId></ArticleIdList></Reference><Reference><Citation>Higgins JP, Thompson SG, Deeks JJ, et al. Measuring inconsistency in meta-analyses. BMJ: Br Med J 2003;327:557&#x2013;1557.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC192859</ArticleId><ArticleId IdType="pubmed">12958120</ArticleId></ArticleIdList></Reference><Reference><Citation>Geerts WH, Bergqvist D, Pineo GF, et al. Prevention of venous thromboembolism: American College of Chest Physicians evidence-based clinical practice guidelines. Chest J 2008;133Suppl 6:381S&#x2013;453S.</Citation><ArticleIdList><ArticleId IdType="pubmed">18574271</ArticleId></ArticleIdList></Reference><Reference><Citation>Hill J, Treasure T. Reducing the risk of venous thromboembolism (deep vein thrombosis and pulmonary embolism) in inpatients having surgery: summary of NICE guidance. BMJ: Br Med J 2007;334:1053&#x2013;1053.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1871784</ArticleId><ArticleId IdType="pubmed">17510154</ArticleId></ArticleIdList></Reference><Reference><Citation>Yoshida RdA, Yoshida WB, Rollo HdA. New anticoagulants for the prophylaxis of venous thromboembolism. J Vasc Brasileiro 2011;10:145&#x2013;53.</Citation></Reference><Reference><Citation>Ma G, Zhang R, Wu X, et al. Direct factor Xa inhibitors (rivaroxaban and apixaban) versus enoxaparin for the prevention of venous thromboembolism after total knee replacement: A meta-analysis of 6 randomized clinical trials. Thromb Res 2015;135:816&#x2013;22.</Citation><ArticleIdList><ArticleId IdType="pubmed">25728496</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">26448633</PMID><DateCompleted><Year>2016</Year><Month>11</Month><Day>02</Day></DateCompleted><DateRevised><Year>2023</Year><Month>08</Month><Day>29</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1538-7836</ISSN><JournalIssue CitedMedium="Internet"><Volume>13</Volume><Issue>12</Issue><PubDate><Year>2015</Year><Month>Dec</Month></PubDate></JournalIssue><Title>Journal of thrombosis and haemostasis : JTH</Title><ISOAbbreviation>J Thromb Haemost</ISOAbbreviation></Journal><ArticleTitle>Bemiparin for thromboprophylaxis after benign gynecologic surgery: a randomized clinical trial.</ArticleTitle><Pagination><StartPage>2161</StartPage><EndPage>2167</EndPage><MedlinePgn>2161-7</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1111/jth.13164</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Venous thromboembolism (VTE) is the leading cause of mortality and morbidity in women following gynecologic surgery.</AbstractText><AbstractText Label="OBJECTIVES" NlmCategory="OBJECTIVE">To determine the efficacy of a second-generation low molecular weight heparin (bemiparin) for thromboprophylaxis after benign gynecologic surgery.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">We performed a single-blind randomized controlled trial including women in the moderate-risk, high-risk and highest-risk groups for developing VTE after benign gynecologic surgery. Participants were randomized at a 1&#xa0;:&#xa0;1 ratio into parallel groups to receive either seven daily doses of 3500&#xa0;IU of subcutaneous bemiparin or to a non-intervention group receiving standard rehydration and advice on ambulation. Participants were followed up for 7&#xa0;days and 30&#xa0;days postoperatively for symptomatic VTE, which was confirmed by compression Doppler ultrasound, magnetic resonance imaging, or computed tomographic pulmonary angiography, according to the type of VTE.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">In total, 387 participants were randomized to the bemiparin group and 387 to the non-intervention group. The incidence of symptomatic VTE (deep vein thrombosis and pulmonary embolism) events was lower (0/377) in participants who received bemiparin than in those who received no pharmacologic intervention (12/380, 3.2%; 95% confidence interval [CI]&#xa0;0.002-0.6). Logistic regression analysis showed significant associations between VTE and immobility (odds ratio [OR]&#xa0;7.1; 95%&#xa0;CI&#xa0;1.3-36.2), varicose veins (OR&#xa0;16.8; 95%&#xa0;CI&#xa0;3.1-76.2), and thrombophilia (OR&#xa0;39.3; 95%&#xa0;CI&#xa0;1.5-1006.7). There were no major bleeding events or side effects related to the use of bemiparin.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Bemiparin was an effective thromboprophylactic agent for preventing venous thrombosis after benign gynecologic surgery.</AbstractText><CopyrightInformation>&#xa9; 2015 International Society on Thrombosis and Haemostasis.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Alalaf</LastName><ForeName>S K</ForeName><Initials>SK</Initials><AffiliationInfo><Affiliation>Department of Obstetrics and Gynecology, College of Medicine, Hawler Medical University, Erbil City, Kurdistan Region, Iraq.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jawad</LastName><ForeName>A K</ForeName><Initials>AK</Initials><AffiliationInfo><Affiliation>Department of Obstetrics and Gynecology, College of Medicine, Hawler Medical University, Erbil City, Kurdistan Region, Iraq.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jawad</LastName><ForeName>R K</ForeName><Initials>RK</Initials><AffiliationInfo><Affiliation>Department of Obstetrics and Gynecology, College of Medicine, Hawler Medical University, Erbil City, Kurdistan Region, Iraq.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ali</LastName><ForeName>M S</ForeName><Initials>MS</Initials><AffiliationInfo><Affiliation>Department of Obstetrics and Gynecology, Maternity Teaching Hospital, Hawler Ministry of Health, Erbil City, Kurdistan Region, Iraq.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Al Tawil</LastName><ForeName>N G</ForeName><Initials>NG</Initials><AffiliationInfo><Affiliation>Department of Community Medicine, College of Medicine, Hawler Medical University, Erbil City, Kurdistan Region, Iraq.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2015</Year><Month>10</Month><Day>31</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>J Thromb Haemost</MedlineTA><NlmUniqueID>101170508</NlmUniqueID><ISSNLinking>1538-7836</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000925">Anticoagulants</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D006495">Heparin, Low-Molecular-Weight</NameOfSubstance></Chemical><Chemical><RegistryNumber>PUE0TO3XDR</RegistryNumber><NameOfSubstance UI="C411345">bemiparin</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000925" MajorTopicYN="N">Anticoagulants</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013509" MajorTopicYN="N">Gynecologic Surgical Procedures</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006495" MajorTopicYN="N">Heparin, Low-Molecular-Weight</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015994" MajorTopicYN="N">Incidence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007493" MajorTopicYN="N">Iraq</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016015" MajorTopicYN="N">Logistic Models</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008279" MajorTopicYN="N">Magnetic Resonance Imaging</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016017" MajorTopicYN="N">Odds Ratio</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011655" MajorTopicYN="N">Pulmonary Embolism</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018570" MajorTopicYN="N">Risk Assessment</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016037" MajorTopicYN="N">Single-Blind Method</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013997" MajorTopicYN="N">Time Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014057" MajorTopicYN="N">Tomography, X-Ray Computed</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018608" MajorTopicYN="N">Ultrasonography, Doppler</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D054556" MajorTopicYN="N">Venous Thromboembolism</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020246" MajorTopicYN="N">Venous Thrombosis</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">bemiparin</Keyword><Keyword MajorTopicYN="N">clinical trial</Keyword><Keyword MajorTopicYN="N">gynecologic surgery</Keyword><Keyword MajorTopicYN="N">pulmonary embolism</Keyword><Keyword MajorTopicYN="N">venous thromboembolism</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2015</Year><Month>6</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2015</Year><Month>9</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2015</Year><Month>10</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2015</Year><Month>10</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2016</Year><Month>11</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">26448633</ArticleId><ArticleId IdType="doi">10.1111/jth.13164</ArticleId><ArticleId IdType="pii">S1538-7836(22)08774-8</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">18089542</PMID><DateCompleted><Year>2008</Year><Month>07</Month><Day>17</Day></DateCompleted><DateRevised><Year>2025</Year><Month>06</Month><Day>23</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">1460-2725</ISSN><JournalIssue CitedMedium="Print"><Volume>100</Volume><Issue>12</Issue><PubDate><Year>2007</Year><Month>Dec</Month></PubDate></JournalIssue><Title>QJM : monthly journal of the Association of Physicians</Title><ISOAbbreviation>QJM</ISOAbbreviation></Journal><ArticleTitle>The value of clinical features in the diagnosis of acute pulmonary embolism: systematic review and meta-analysis.</ArticleTitle><Pagination><StartPage>763</StartPage><EndPage>769</EndPage><MedlinePgn>763-9</MedlinePgn></Pagination><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Clinical assessment of patients with suspected pulmonary embolus (PE) is used to estimate the probability of PE and determine what (if any) diagnostic testing is required.</AbstractText><AbstractText Label="AIM" NlmCategory="OBJECTIVE">We aimed to estimate the diagnostic value of individual clinical features used to determine the pre-test probability of acute PE.</AbstractText><AbstractText Label="DESIGN" NlmCategory="METHODS">Systematic review and meta-analysis.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">We searched electronic databases (1966 to May 2007) and the bibliographies of retrieved articles for any article that reported the diagnostic performance of clinical features compared to a reference standard diagnostic test in patients with suspected acute pulmonary embolism. Likelihood ratios were calculated for each feature and pooled using a random effects model, as implemented by MetaDiSc statistical software.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">We identified 18 studies for inclusion with a total of 5997 patients. The most useful features (pooled likelihood ratio) for ruling in PE were syncope (2.38), shock (4.07), thrombophlebitis (2.20), current DVT (2.05), leg swelling (2.11), sudden dyspnoea (1.83), active cancer (1.74), recent surgery (1.63), haemoptysis (1.62) and leg pain (1.60); while the most useful features for ruling out PE were the absence of sudden dyspnoea (0.430), any dyspnoea (0.521) and tachypnea (0.561). All other clinical features had likelihood ratios near to one. Many of the analyses involved pooling results that had significant heterogeneity, so these estimates should be used with caution.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Individual clinical features only slightly raise or lower the probability of PE. In isolation, they have limited diagnostic value and none can be used to rule in or rule out PE without further testing.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>West</LastName><ForeName>J</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Medical Care Research Unit, University of Sheffield, Regent Court, 30 Regent Street, Sheffield, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Goodacre</LastName><ForeName>S</ForeName><Initials>S</Initials></Author><Author ValidYN="Y"><LastName>Sampson</LastName><ForeName>F</ForeName><Initials>F</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>QJM</MedlineTA><NlmUniqueID>9438285</NlmUniqueID><ISSNLinking>1460-2393</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000208" MajorTopicYN="N">Acute Disease</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016013" MajorTopicYN="N">Likelihood Functions</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011237" MajorTopicYN="N">Predictive Value of Tests</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011655" MajorTopicYN="N">Pulmonary Embolism</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading></MeshHeadingList><NumberOfReferences>27</NumberOfReferences></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2007</Year><Month>12</Month><Day>20</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2008</Year><Month>7</Month><Day>18</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2007</Year><Month>12</Month><Day>20</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">18089542</ArticleId><ArticleId IdType="doi">10.1093/qjmed/hcm113</ArticleId><ArticleId IdType="pii">100/12/763</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">31902124</PMID><DateCompleted><Year>2021</Year><Month>06</Month><Day>07</Day></DateCompleted><DateRevised><Year>2021</Year><Month>06</Month><Day>07</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1573-742X</ISSN><JournalIssue CitedMedium="Internet"><Volume>50</Volume><Issue>2</Issue><PubDate><Year>2020</Year><Month>Aug</Month></PubDate></JournalIssue><Title>Journal of thrombosis and thrombolysis</Title><ISOAbbreviation>J Thromb Thrombolysis</ISOAbbreviation></Journal><ArticleTitle>The efficacy and safety of tranexamic acid in the treatment of intertrochanteric fracture: an updated meta-analysis of 11 randomized controlled trials.</ArticleTitle><Pagination><StartPage>243</StartPage><EndPage>257</EndPage><MedlinePgn>243-257</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s11239-019-02034-1</ELocationID><Abstract><AbstractText>This meta-analysis was performed to investigate the efficacy and safety of tranexamic acid (TXA) in the elderly patients undergoing intertrochanteric fracture surgery from the current literatures. The electronic literature database of PubMed, Embase and Cochrane library were searched in October 2019. The intraoperative blood loss, hidden blood loss, postoperative drainage and total blood loss, postoperative hemoglobin, length of stay, transfusion rate, mortality rate, thromboembolic events and wound complications were extracted. Stata 14.0 software was used for our meta-analysis. A total of 11 RCTs (3 new RCTs in 2019) with 1202 patients met our inclusion criteria. This meta-analysis showed that administration of TXA can reduce intraoperative blood loss (P&#x2009;=&#x2009;0.009), hidden blood loss (P&#x2009;=&#x2009;0.000), total blood loss (P&#x2009;=&#x2009;0.000), length of stay (P&#x2009;=&#x2009;0.003), transfusion rate (P&#x2009;=&#x2009;0.000) and the occurrence of wound complications (P&#x2009;=&#x2009;0.006). Furthermore, administration of TXA was associated with an increase in the postoperative Hb level at day 1, 2 and 3 (P&#x2009;=&#x2009;0.000, P&#x2009;=&#x2009;0.000 and P&#x2009;=&#x2009;0.000, respectively) after surgery. However, no significant difference was found between the TXA group and control group regarding the occurrence of thromboembolic events (P&#x2009;=&#x2009;0.978, including deep vein thrombosis, P&#x2009;=&#x2009;0.850; pulmonary embolism, P&#x2009;=&#x2009;0.788; cerebrovascular accident, P&#x2009;=&#x2009;0.549; myocardial infarction, P&#x2009;=&#x2009;0.395) and mortality rate (P&#x2009;=&#x2009;0. 338). Our meta-analysis suggested that administration of TXA is effective in reducing intraoperative blood loss, hidden blood loss, total blood loss, length of stay, transfusion rate, wound complications and enhancing postoperative Hb without increasing the risk of thromboembolic events and mortality rate in intertrochanteric fracture surgery. More large multi-center and high-quality RCTs are required for further research.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Yu</LastName><ForeName>Xianbin</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Orthopaedic Surgery, The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, 109 Xueyuan Xi Road, Wenzhou, 325000, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Jinwu</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Orthopaedic Surgery, The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, 109 Xueyuan Xi Road, Wenzhou, 325000, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Xingyu</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Orthopaedic Surgery, The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, 109 Xueyuan Xi Road, Wenzhou, 325000, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xie</LastName><ForeName>Linzhen</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Orthopaedic Surgery, The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, 109 Xueyuan Xi Road, Wenzhou, 325000, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Chunhui</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Orthopaedic Surgery, The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, 109 Xueyuan Xi Road, Wenzhou, 325000, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zheng</LastName><ForeName>Wenhao</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Department of Orthopaedic Surgery, The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, 109 Xueyuan Xi Road, Wenzhou, 325000, China. zhengwenhao@wmu.edu.cn.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>J Thromb Thrombolysis</MedlineTA><NlmUniqueID>9502018</NlmUniqueID><ISSNLinking>0929-5305</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000933">Antifibrinolytic Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>6T84R30KC1</RegistryNumber><NameOfSubstance UI="D014148">Tranexamic Acid</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000933" MajorTopicYN="N">Antifibrinolytic Agents</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016063" MajorTopicYN="N">Blood Loss, Surgical</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005592" MajorTopicYN="Y">Fracture Fixation</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006620" MajorTopicYN="N">Hip Fractures</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007902" MajorTopicYN="N">Length of Stay</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019106" MajorTopicYN="N">Postoperative Hemorrhage</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016032" MajorTopicYN="N">Randomized Controlled Trials as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018570" MajorTopicYN="N">Risk Assessment</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013997" MajorTopicYN="N">Time Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014148" MajorTopicYN="N">Tranexamic Acid</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Blood loss</Keyword><Keyword MajorTopicYN="N">Intertrochanteric fracture</Keyword><Keyword MajorTopicYN="N">Meta-analysis</Keyword><Keyword MajorTopicYN="N">RCT</Keyword><Keyword MajorTopicYN="N">Tranexamic acid</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>1</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>6</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>1</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31902124</ArticleId><ArticleId IdType="doi">10.1007/s11239-019-02034-1</ArticleId><ArticleId IdType="pii">10.1007/s11239-019-02034-1</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">24745310</PMID><DateCompleted><Year>2014</Year><Month>07</Month><Day>01</Day></DateCompleted><DateRevised><Year>2022</Year><Month>04</Month><Day>10</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1532-6500</ISSN><JournalIssue CitedMedium="Internet"><Volume>23</Volume><Issue>5</Issue><PubDate><Year>2014</Year><Month>May</Month></PubDate></JournalIssue><Title>Journal of shoulder and elbow surgery</Title><ISOAbbreviation>J Shoulder Elbow Surg</ISOAbbreviation></Journal><ArticleTitle>Venous thromboembolism after elective shoulder surgery: a prospective cohort study of 175 patients.</ArticleTitle><Pagination><StartPage>605</StartPage><EndPage>612</EndPage><MedlinePgn>605-12</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jse.2014.01.054</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S1058-2746(14)00121-9</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">The purpose of this study was to investigate the incidence of venous thromboembolism (VTE) after elective arthroscopic shoulder surgery.</AbstractText><AbstractText Label="MATERIALS AND METHODS" NlmCategory="METHODS">One hundred seventy-five consecutive patients who underwent arthroscopic shoulder surgery were enrolled (mean age, 61&#xa0;years). Patients who had VTE preoperatively and underwent trauma surgery or arthroplasty were excluded. All the patients used foot pumps or elastic stockings after surgery for deep venous thrombosis (DVT) prophylaxis. DVT in the 4 limbs was assessed by ultrasound before and after surgery. Pulmonary embolism was diagnosed by computed tomography pulmonary angiography. Risk factors related to DVT were assessed.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">The overall incidence of DVT was 10 of 175 patients (5.7%). Most of the DVT cases were detected at 1 to 2&#xa0;days after surgery. All patients were asymptomatic. There were no patients who had symptomatic pulmonary embolism. However, an asymptomatic pulmonary embolus developed in 1 patient during the 3-month follow-up period. There were no significant differences between the DVT and non-DVT groups regarding the risk factors.</AbstractText><AbstractText Label="DISCUSSION AND CONCLUSION" NlmCategory="CONCLUSIONS">Our data have shown that symptomatic VTE is rare after elective arthroscopic shoulder surgery. However, asymptomatic VTE may occur even with DVT preventive measures. Because most of the DVTs were found in the calf veins, we recommend that surgeons pay attention to the possibility of DVT in the lower extremities even after arthroscopic shoulder surgery. The incidence of asymptomatic VTE after elective arthroscopic shoulder surgery was 5.7%. All patients were asymptomatic, and most of the DVTs occurred 1 or 2&#xa0;days after surgery.</AbstractText><CopyrightInformation>Copyright &#xa9; 2014 Journal of Shoulder and Elbow Surgery Board of Trustees. Published by Mosby, Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Takahashi</LastName><ForeName>Hiroyuki</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Orthopaedic Surgery, Tohoku University School of Medicine, Sendai, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yamamoto</LastName><ForeName>Nobuyuki</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Orthopaedic Surgery, Tohoku University School of Medicine, Sendai, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nagamoto</LastName><ForeName>Hideaki</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Orthopaedic Surgery, Tohoku University School of Medicine, Sendai, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sano</LastName><ForeName>Hirotaka</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Orthopaedic Surgery, Tohoku University School of Medicine, Sendai, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tanaka</LastName><ForeName>Minoru</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Orthopaedic Surgery, Tohoku Rosai Hospital, Sendai, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Itoi</LastName><ForeName>Eiji</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Orthopaedic Surgery, Tohoku University School of Medicine, Sendai, Japan. Electronic address: itoi-eiji@med.tohoku.ac.jp.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Shoulder Elbow Surg</MedlineTA><NlmUniqueID>9206499</NlmUniqueID><ISSNLinking>1058-2746</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001182" MajorTopicYN="N">Arthroscopy</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017558" MajorTopicYN="N">Elective Surgical Procedures</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011655" MajorTopicYN="N">Pulmonary Embolism</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012785" MajorTopicYN="N">Shoulder Joint</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D054556" MajorTopicYN="N">Venous Thromboembolism</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020246" MajorTopicYN="N">Venous Thrombosis</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Venous thromboembolism</Keyword><Keyword MajorTopicYN="N">arthroscopy</Keyword><Keyword MajorTopicYN="N">asymptomatic</Keyword><Keyword MajorTopicYN="N">deep venous thrombosis</Keyword><Keyword MajorTopicYN="N">pulmonary embolism</Keyword><Keyword MajorTopicYN="N">shoulder surgery</Keyword><Keyword MajorTopicYN="N">ultrasonography</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2013</Year><Month>9</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2014</Year><Month>1</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2014</Year><Month>1</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2014</Year><Month>4</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2014</Year><Month>4</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2014</Year><Month>7</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">24745310</ArticleId><ArticleId IdType="doi">10.1016/j.jse.2014.01.054</ArticleId><ArticleId IdType="pii">S1058-2746(14)00121-9</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">39547678</PMID><DateRevised><Year>2025</Year><Month>01</Month><Day>04</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Print">2211-4599</ISSN><JournalIssue CitedMedium="Print"><Volume>18</Volume><Issue>6</Issue><PubDate><Year>2024</Year><Month>Nov</Month><Day>15</Day></PubDate></JournalIssue><Title>International journal of spine surgery</Title><ISOAbbreviation>Int J Spine Surg</ISOAbbreviation></Journal><ArticleTitle>Meta-Analysis Investigating Optimal Timing of Chemoprophylaxis for Venous Thromboembolism in Operatively Managed Blunt Spinal Injuries.</ArticleTitle><Pagination><StartPage>731</StartPage><EndPage>737</EndPage><MedlinePgn>731-7</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">8656</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.14444/8656</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Blunt spinal injuries (BSIs) are associated with substantial morbidity and mortality. Management typically involves stabilization of the spinal column and may include chemoprophylaxis for venous thromboembolism (VTE) prevention. The optimal timing of chemoprophylaxis initiation in operatively managed BSI patients remains debated.</AbstractText><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">Analyze available literature on optimal chemoprophylaxis timing for the prevention of VTE in patients postinjury undergoing operative repair.</AbstractText><AbstractText Label="STUDY DESIGN" NlmCategory="METHODS">Systematic review and meta-analysis.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">A systematic review and meta-analysis were conducted following Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines. PubMed and MEDLINE were searched for studies assessing chemoprophylaxis timing in adult BSI patients. Inclusion criteria focused on operatively managed BSIs and anticoagulant usage assessment.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Three studies involving 4345 patients were included. Early chemoprophylaxis initiation was associated with significantly lower deep vein thrombosis (DVT) and overall VTE incidence compared with late initiation. No significant differences were found in pulmonary embolism (PE) incidence or mortality.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Early anticoagulant administration after spinal fixation for BSI reduces DVT and overall VTE risk without impacting PE incidence or mortality. Further research is recommended to solidify these findings and address existing gaps in the literature.</AbstractText><AbstractText Label="CLINICAL RELEVANCE" NlmCategory="CONCLUSIONS">Early chemoprophylaxis initiation in operatively managed BSI patients reduces DVT and overall VTE risk without affecting PE incidence or mortality LEVEL OF EVIDENCE: 2.</AbstractText><CopyrightInformation>This manuscript is generously published free of charge by ISASS, the International Society for the Advancement of Spine Surgery. Copyright &#xa9; 2024 ISASS. To see more or order reprints or permissions, see http://ijssurgery.com.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>AlGhamdi</LastName><ForeName>Faisal A</ForeName><Initials>FA</Initials><AffiliationInfo><Affiliation>Emergency Department, King Fahad University Hospital, Khobar, Saudi Arabia Faisalgh218@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alzayer</LastName><ForeName>Mohammed O</ForeName><Initials>MO</Initials><AffiliationInfo><Affiliation>Medical Student, College of Medicine, Imam Abdulrahman bin Faisal University, Dammam, Saudi Arabia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>AlKabbani</LastName><ForeName>Mohammed M</ForeName><Initials>MM</Initials><AffiliationInfo><Affiliation>Medical Student, College of Medicine, Imam Abdulrahman bin Faisal University, Dammam, Saudi Arabia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>AlJoaid</LastName><ForeName>Renad M</ForeName><Initials>RM</Initials><AffiliationInfo><Affiliation>Emergency Department, King Fahad University Hospital, Khobar, Saudi Arabia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>AlJoaib</LastName><ForeName>Nasser A</ForeName><Initials>NA</Initials><AffiliationInfo><Affiliation>General Surgery Department, King Fahad University Hospital, Khobar, Saudi Arabia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hadhiah</LastName><ForeName>Kawther M</ForeName><Initials>KM</Initials><AffiliationInfo><Affiliation>Neurosurgery Department, King Fahad University Hospital, Khobar, Saudi Arabia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>AlMaghraby</LastName><ForeName>Nisreen H</ForeName><Initials>NH</Initials><AffiliationInfo><Affiliation>Emergency Department, King Fahad University Hospital, Khobar, Saudi Arabia.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>11</Month><Day>15</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Int J Spine Surg</MedlineTA><NlmUniqueID>101579005</NlmUniqueID><ISSNLinking>2211-4599</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Spinal injury</Keyword><Keyword MajorTopicYN="N">blunt trauma</Keyword><Keyword MajorTopicYN="N">deep venous thrombosis</Keyword><Keyword MajorTopicYN="N">heparin</Keyword><Keyword MajorTopicYN="N">low molecular weight heparin</Keyword><Keyword MajorTopicYN="N">neurosurgery</Keyword><Keyword MajorTopicYN="N">pulmonary embolism</Keyword><Keyword MajorTopicYN="N">thromboembolism</Keyword><Keyword MajorTopicYN="N">trauma</Keyword><Keyword MajorTopicYN="N">venous thromboprophylaxis</Keyword></KeywordList><CoiStatement>Declaration of Conflicting Interests : The authors report no conflicts of interest in this work.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>11</Month><Day>16</Day><Hour>9</Hour><Minute>58</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>11</Month><Day>16</Day><Hour>9</Hour><Minute>58</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>11</Month><Day>15</Day><Hour>20</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>11</Month><Day>8</Day></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39547678</ArticleId><ArticleId IdType="pmc">PMC11687032</ArticleId><ArticleId IdType="doi">10.14444/8656</ArticleId><ArticleId IdType="pii">8656</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Sundgren PC, Flanders AE. Spinal trauma and spinal cord injury (SCI). Hodler J, Kubik-Huch RA, Schulthess GK, eds. Diseases of the Brain, Head and Neck, Spine 2020&#x2013;2023: Diagnostic Imaging. Cham (CH): Springer; 2020.</Citation></Reference><Reference><Citation>Roach MJ, Chen Y, Kelly ML. Comparing blunt and penetrating trauma in spinal cord injury: analysis of long-term functional and neurological outcomes. Top Spinal Cord Inj Rehabil. 2018;24(2):121&#x2013;132. 10.1310/sci2402-121</Citation><ArticleIdList><ArticleId IdType="doi">10.1310/sci2402-121</ArticleId><ArticleId IdType="pmc">PMC5915103</ArticleId><ArticleId IdType="pubmed">29706756</ArticleId></ArticleIdList></Reference><Reference><Citation>Walters BC, Hadley MN, Hurlbert RJ, et al. . Guidelines for the management of acute cervical spine and spinal cord injuries. Neurosurgery. 2013;60(Supplement 1):82&#x2013;91. 10.1227/01.neu.0000430319.32247.7f</Citation><ArticleIdList><ArticleId IdType="doi">10.1227/01.neu.0000430319.32247.7f</ArticleId><ArticleId IdType="pubmed">23839357</ArticleId></ArticleIdList></Reference><Reference><Citation>Lowery A, Patel A, Ames R, Ramsey F, Slattery B, Pazionis T. Prevalence of venous thromboembolism following acute spinal cord injury in an urban inner city hospital. Int J Spine Surg. 2021;15(3):562&#x2013;569. 10.14444/8076</Citation><ArticleIdList><ArticleId IdType="doi">10.14444/8076</ArticleId><ArticleId IdType="pmc">PMC8176826</ArticleId><ArticleId IdType="pubmed">33963036</ArticleId></ArticleIdList></Reference><Reference><Citation>Schellenberg M, Costantini T, Joseph B, Price MA, Bernard AC, Haut ER. Timing of venous thromboembolism prophylaxis initiation after injury: findings from the consensus conference to implement optimal VTE prophylaxis in trauma. J Trauma Acute Care Surg. 2023;94(3):484&#x2013;489. 10.1097/TA.0000000000003847</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/TA.0000000000003847</ArticleId><ArticleId IdType="pmc">PMC9970012</ArticleId><ArticleId IdType="pubmed">36729602</ArticleId></ArticleIdList></Reference><Reference><Citation>Taghlabi K, Carlson BB, Bunch J, Jackson RS, Winfield R, Burton DC. Chemoprophylactic anticoagulation 72 hours after spinal fracture surgical treatment decreases venous thromboembolic events without increasing surgical complications. N Am Spine Soc J. 2022;11. 10.1016/j.xnsj.2022.100141</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.xnsj.2022.100141</ArticleId><ArticleId IdType="pmc">PMC9309228</ArticleId><ArticleId IdType="pubmed">35898944</ArticleId></ArticleIdList></Reference><Reference><Citation>
American College of Surgeons . Best Practice Guidelines: Spine Injury. 2022. https://www.facs.org/media/k45gikqv/spine_injury_guidelines.pdf.  March 3,  March 2024.</Citation></Reference><Reference><Citation>DeVivo MJ, Chen Y. Trends in new injuries, prevalent cases, and aging with spinal cord injury. Arch Phys Med Rehabil. 2011;92(3):332&#x2013;338. 10.1016/j.apmr.2010.08.031</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.apmr.2010.08.031</ArticleId><ArticleId IdType="pubmed">21353817</ArticleId></ArticleIdList></Reference><Reference><Citation>Hamidi M, Asmar S, Bible L, et al. . Early thromboprophylaxis in operative spinal trauma does not increase risk of bleeding complications. J Surg Res. 2021;258:119&#x2013;124. 10.1016/j.jss.2020.08.029</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jss.2020.08.029</ArticleId><ArticleId IdType="pubmed">33010556</ArticleId></ArticleIdList></Reference><Reference><Citation>Zeeshan M, Khan M, O&#x2019;Keeffe T, et al. . Optimal timing of initiation of thromboprophylaxis in spine trauma managed operatively: a nationwide propensity-matched analysis of trauma quality improvement program. J Trauma Acute Care Surg. 2018;85(2):387&#x2013;392. 10.1097/TA.0000000000001916</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/TA.0000000000001916</ArticleId><ArticleId IdType="pubmed">29613956</ArticleId></ArticleIdList></Reference><Reference><Citation>Aito S, Pieri A, D&#x2019;Andrea M, Marcelli F, Cominelli E. Primary prevention of deep venous thrombosis and pulmonary embolism in acute spinal cord injured patients. Spinal Cord. 2002;40(6):300&#x2013;303. 10.1038/sj.sc.3101298</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/sj.sc.3101298</ArticleId><ArticleId IdType="pubmed">12037712</ArticleId></ArticleIdList></Reference><Reference><Citation>Agarwal NK, Mathur N. Deep vein thrombosis in acute spinal cord injury. Spinal Cord. 2009;47(10):769&#x2013;772. 10.1038/sc.2009.37</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/sc.2009.37</ArticleId><ArticleId IdType="pubmed">19365397</ArticleId></ArticleIdList></Reference><Reference><Citation>Weidner N, M&#xfc;ller OJ, Hach-Wunderle V, et al. . Prevention of thromboembolism in spinal cord injury -S1 guideline. Neurol Res Pract. 2020;2. 10.1186/s42466-020-00089-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s42466-020-00089-7</ArticleId><ArticleId IdType="pmc">PMC7727164</ArticleId><ArticleId IdType="pubmed">33324943</ArticleId></ArticleIdList></Reference><Reference><Citation>Geerts WH, Bergqvist D, Pineo GF, et al. . Prevention of venous thromboembolism. Chest. 2008;133(6):381S&#x2013;453S. 10.1378/chest.08-0656</Citation><ArticleIdList><ArticleId IdType="doi">10.1378/chest.08-0656</ArticleId><ArticleId IdType="pubmed">18574271</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang R, Scerbo MH, Schmitt KM, et al. . Early chemoprophylaxis is associated with decreased venous thromboembolism risk without concomitant increase in intraspinal hematoma expansion after traumatic spinal cord injury. J Trauma Acute Care Surg. 2017;83(6):1088&#x2013;1094. 10.1097/TA.0000000000001675</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/TA.0000000000001675</ArticleId><ArticleId IdType="pmc">PMC5709167</ArticleId><ArticleId IdType="pubmed">28863085</ArticleId></ArticleIdList></Reference><Reference><Citation>Godat LN, Haut ER, Moore EE, Knudson MM, Costantini TW. Venous thromboembolism risk after spinal cord injury: a secondary analysis of the CLOTT study. J Trauma Acute Care Surg. 2023;94(1):23&#x2013;29. 10.1097/TA.0000000000003807</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/TA.0000000000003807</ArticleId><ArticleId IdType="pubmed">36203245</ArticleId></ArticleIdList></Reference><Reference><Citation>Rappold JF, Sheppard FR, Carmichael Ii SP, et al. . Venous thromboembolism prophylaxis in the trauma intensive care unit: an American Association for the Surgery of Trauma Critical Care Committee clinical consensus document. Trauma Surg Acute Care Open. 2021;6(1). 10.1136/tsaco-2020-000643</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/tsaco-2020-000643</ArticleId><ArticleId IdType="pmc">PMC7908288</ArticleId><ArticleId IdType="pubmed">33718615</ArticleId></ArticleIdList></Reference><Reference><Citation>Ley EJ, Brown CVR, Moore EE, et al. . Updated guidelines to reduce venous thromboembolism in trauma patients: a Western Trauma Association critical decisions algorithm. J Trauma Acute Care Surg. 2020;89(5):971&#x2013;981. 10.1097/TA.0000000000002830</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/TA.0000000000002830</ArticleId><ArticleId IdType="pmc">PMC7587238</ArticleId><ArticleId IdType="pubmed">32590563</ArticleId></ArticleIdList></Reference><Reference><Citation>Amer M, Alshahrani MS, Arabi YM, et al. . Saudi critical care society clinical practice guidelines on the prevention of venous thromboembolism in adults with trauma: reviewed for evidence-based integrity and endorsed by the Scandinavian Society of Anaesthesiology and Intensive Care Medicine. Ann Intensive Care. 2023;13(1). 10.1186/s13613-023-01135-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13613-023-01135-8</ArticleId><ArticleId IdType="pmc">PMC10172441</ArticleId><ArticleId IdType="pubmed">37165105</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">30770054</PMID><DateCompleted><Year>2019</Year><Month>04</Month><Day>22</Day></DateCompleted><DateRevised><Year>2019</Year><Month>04</Month><Day>22</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1471-6771</ISSN><JournalIssue CitedMedium="Internet"><Volume>122</Volume><Issue>3</Issue><PubDate><Year>2019</Year><Month>Mar</Month></PubDate></JournalIssue><Title>British journal of anaesthesia</Title><ISOAbbreviation>Br J Anaesth</ISOAbbreviation></Journal><ArticleTitle>Association between night-time surgery and occurrence of intraoperative adverse events and postoperative pulmonary complications.</ArticleTitle><Pagination><StartPage>361</StartPage><EndPage>369</EndPage><MedlinePgn>361-369</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.bja.2018.10.063</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0007-0912(18)31333-3</ELocationID><Abstract><AbstractText Label="BACKGROUND">The aim of this post hoc analysis of a large cohort study was to evaluate the association between night-time surgery and the occurrence of intraoperative adverse events (AEs) and postoperative pulmonary complications (PPCs).</AbstractText><AbstractText Label="METHODS">LAS VEGAS (Local Assessment of Ventilatory Management During General Anesthesia for Surgery) was a prospective international 1-week study that enrolled adult patients undergoing surgical procedures with general anaesthesia and mechanical ventilation in 146 hospitals across 29 countries. Surgeries were defined as occurring during 'daytime' when induction of anaesthesia was between 8:00 AM and 7:59 PM, and as 'night-time' when induction was between 8:00 PM and 7:59 AM.</AbstractText><AbstractText Label="RESULTS">Of 9861 included patients, 555 (5.6%) underwent surgery during night-time. The proportion of patients who developed intraoperative AEs was higher during night-time surgery in unmatched (43.6% vs 34.1%; P&lt;0.001) and propensity-matched analyses (43.7% vs 36.8%; P=0.029). PPCs also occurred more often in patients who underwent night-time surgery (14% vs 10%; P=0.004) in an unmatched cohort analysis, although not in a propensity-matched analysis (13.8% vs 11.8%; P=0.39). In a multivariable regression model, including patient characteristics and types of surgery and anaesthesia, night-time surgery was independently associated with a higher incidence of intraoperative AEs (odds ratio: 1.44; 95% confidence interval: 1.09-1.90; P=0.01), but not with a higher incidence of PPCs (odds ratio: 1.32; 95% confidence interval: 0.89-1.90; P=0.15).</AbstractText><AbstractText Label="CONCLUSIONS">Intraoperative adverse events and postoperative pulmonary complications occurred more often in patients undergoing night-time surgery. Imbalances in patients' clinical characteristics, types of surgery, and intraoperative management at night-time partially explained the higher incidence of postoperative pulmonary complications, but not the higher incidence of adverse events.</AbstractText><AbstractText Label="CLINICAL TRIAL REGISTRATION">NCT01601223.</AbstractText><CopyrightInformation>Copyright &#xa9; 2018 British Journal of Anaesthesia. Published by Elsevier Ltd. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Cortegiani</LastName><ForeName>A</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Surgical, Oncological and Oral Science, Section of Anesthesia, Analgesia, Intensive Care and Emergency, Policlinico Paolo Giaccone, University of Palermo, Palermo, Italy. Electronic address: andrea.cortegiani@unipa.it.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gregoretti</LastName><ForeName>C</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Surgical, Oncological and Oral Science, Section of Anesthesia, Analgesia, Intensive Care and Emergency, Policlinico Paolo Giaccone, University of Palermo, Palermo, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Neto</LastName><ForeName>A S</ForeName><Initials>AS</Initials><AffiliationInfo><Affiliation>Department of Intensive Care and Laboratory of Experimental Intensive Care and Anesthesia, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands; Department of Critical Care Medicine, Hospital Israelita Albert Einstein, S&#xe3;o Paulo, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hemmes</LastName><ForeName>S N T</ForeName><Initials>SNT</Initials><AffiliationInfo><Affiliation>Department of Intensive Care and Laboratory of Experimental Intensive Care and Anesthesia, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands; Department of Anaesthesiology, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ball</LastName><ForeName>L</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Dipartimento di Scienze Chirurgiche e Diagnostiche Integrate, Universit&#xe0; degli Studi di Genova, Genova, Italy; IRCCS Ospedale Policlinico San Martino, Genova, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Canet</LastName><ForeName>J</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Postoperative Care, Hospital Universitari Germans Trias i Pujol, Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hiesmayr</LastName><ForeName>M</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Division of Cardiac, Thoracic, Vascular Anesthesia and Intensive Care, Medical University of Vienna, Vienna, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hollmann</LastName><ForeName>M W</ForeName><Initials>MW</Initials><AffiliationInfo><Affiliation>Department of Anaesthesiology, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mills</LastName><ForeName>G H</ForeName><Initials>GH</Initials><AffiliationInfo><Affiliation>Operating Services, Critical Care and Anesthesia, Sheffield Teaching Hospitals, Sheffield and University of Sheffield, Sheffield, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Melo</LastName><ForeName>M F V</ForeName><Initials>MFV</Initials><AffiliationInfo><Affiliation>Department of Anesthesia, Critical Care and Pain Medicine, Massachusetts General Hospital, Boston, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Putensen</LastName><ForeName>C</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Intensive Care Medicine, University Hospital Bonn, Bonn, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schmid</LastName><ForeName>W</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Division of Cardiac, Thoracic, Vascular Anesthesia and Intensive Care, Medical University of Vienna, Vienna, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Severgnini</LastName><ForeName>P</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Biotechnology and Sciences of Life, ASST Sette Laghi Ospedale di Circolo e Fondazione Macchi, University of Insubria, Varese, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wrigge</LastName><ForeName>H</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Intensive Care Medicine, University of Leipzig, Leipzig, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gama de Abreu</LastName><ForeName>M</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Anaesthesiology and Intensive Care Medicine, Pulmonary Engineering Group, University Hospital Carl Gustav Carus, Technische Universit&#xe4;t Dresden, Dresden, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schultz</LastName><ForeName>M J</ForeName><Initials>MJ</Initials><AffiliationInfo><Affiliation>Department of Intensive Care and Laboratory of Experimental Intensive Care and Anesthesia, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands; Mahidol Oxford Tropical Medicine Research Unit, Mahidol University, Bangkok, Thailand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pelosi</LastName><ForeName>P</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Dipartimento di Scienze Chirurgiche e Diagnostiche Integrate, Universit&#xe0; degli Studi di Genova, Genova, Italy; IRCCS Ospedale Policlinico San Martino, Genova, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><CollectiveName>LAS VEGAS Investigators, the PROVE Network, and the Clinical Trial Network of the European Society of Anaesthesiology</CollectiveName></Author></AuthorList><Language>eng</Language><DataBankList CompleteYN="Y"><DataBank><DataBankName>ClinicalTrials.gov</DataBankName><AccessionNumberList><AccessionNumber>NCT01601223</AccessionNumber></AccessionNumberList></DataBank></DataBankList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016448">Multicenter Study</PublicationType><PublicationType UI="D064888">Observational Study</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2019</Year><Month>02</Month><Day>08</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Br J Anaesth</MedlineTA><NlmUniqueID>0372541</NlmUniqueID><ISSNLinking>0007-0912</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D039602" MajorTopicYN="N">After-Hours Care</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="Y">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015994" MajorTopicYN="N">Incidence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D038622" MajorTopicYN="N">Internationality</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007431" MajorTopicYN="N">Intraoperative Complications</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008171" MajorTopicYN="N">Lung Diseases</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013514" MajorTopicYN="Y">Surgical Procedures, Operative</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">general anaesthesia</Keyword><Keyword MajorTopicYN="N">intraoperative complications</Keyword><Keyword MajorTopicYN="N">patient safety</Keyword><Keyword MajorTopicYN="N">postoperative complications</Keyword><Keyword MajorTopicYN="N">pulmonary</Keyword></KeywordList><InvestigatorList><Investigator ValidYN="Y"><LastName>Kroell</LastName><ForeName>W</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>LKH Graz, Graz, Austria.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Metzler</LastName><ForeName>H</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>LKH Graz, Graz, Austria.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Struber</LastName><ForeName>G</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>LKH Graz, Graz, Austria.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Wegscheider</LastName><ForeName>T</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>LKH Graz, Graz, Austria.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Gombotz</LastName><ForeName>H</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>AKH Linz, Linz, Austria.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Hiesmayr</LastName><ForeName>M</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Medical University Vienna, Austria.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Schmid</LastName><ForeName>W</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Medical University Vienna, Austria.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Urbanek</LastName><ForeName>B</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Medical University Vienna, Austria.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Kahn</LastName><ForeName>D</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>UCL - Cliniques Universitaires Saint Luc Brussels, Belgium.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Momeni</LastName><ForeName>M</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>UCL - Cliniques Universitaires Saint Luc Brussels, Belgium.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Pospiech</LastName><ForeName>A</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>UCL - Cliniques Universitaires Saint Luc Brussels, Belgium.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Lois</LastName><ForeName>F</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>UCL - Cliniques Universitaires Saint Luc Brussels, Belgium.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Forget</LastName><ForeName>P</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>UCL - Cliniques Universitaires Saint Luc Brussels, Belgium.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Grosu</LastName><ForeName>I</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>UCL - Cliniques Universitaires Saint Luc Brussels, Belgium.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Poelaert</LastName><ForeName>J</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Universitary Hospital Brussels (UZ Brussel), Belgium.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Mossevelde</LastName><ForeName>V</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Universitary Hospital Brussels (UZ Brussel), Belgium.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>van Malderen</LastName><ForeName>M C</ForeName><Initials>MC</Initials><AffiliationInfo><Affiliation>Universitary Hospital Brussels (UZ Brussel), Belgium.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Dylst</LastName><ForeName>D</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Het Ziekenhuis Oost Limburg (ZOL), Genk, Belgium.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Melkebeek</LastName><ForeName>J V</ForeName><Initials>JV</Initials><AffiliationInfo><Affiliation>Het Ziekenhuis Oost Limburg (ZOL), Genk, Belgium.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Beran</LastName><ForeName>M</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Het Ziekenhuis Oost Limburg (ZOL), Genk, Belgium.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Hert</LastName><ForeName>S D</ForeName><Initials>SD</Initials><AffiliationInfo><Affiliation>Ghent University Hospital, Gent, Belgium.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Baerdemaeker</LastName><ForeName>L D</ForeName><Initials>LD</Initials><AffiliationInfo><Affiliation>Ghent University Hospital, Gent, Belgium.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Heyse</LastName><ForeName>B</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Ghent University Hospital, Gent, Belgium.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Limmen</LastName><ForeName>J V</ForeName><Initials>JV</Initials><AffiliationInfo><Affiliation>Ghent University Hospital, Gent, Belgium.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Wyffels</LastName><ForeName>P</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Ghent University Hospital, Gent, Belgium.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Jacobs</LastName><ForeName>T</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Ghent University Hospital, Gent, Belgium.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Roels</LastName><ForeName>N</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Ghent University Hospital, Gent, Belgium.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Bruyne</LastName><ForeName>A D</ForeName><Initials>AD</Initials><AffiliationInfo><Affiliation>Ghent University Hospital, Gent, Belgium.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Velde</LastName><ForeName>S V D</ForeName><Initials>SVD</Initials><AffiliationInfo><Affiliation>Maria Middelares, Gent, Belgium.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Marina</LastName><ForeName>J Z</ForeName><Initials>JZ</Initials><AffiliationInfo><Affiliation>General Hospital "prim Dr Abdulah Nakas" Sarajevo, Bosnia and Herzegovina.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Dejana</LastName><ForeName>D O</ForeName><Initials>DO</Initials><AffiliationInfo><Affiliation>General Hospital "prim Dr Abdulah Nakas" Sarajevo, Bosnia and Herzegovina.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Pernar</LastName><ForeName>S</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>General Hospital Cakovec, Cakovec, Croatia.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Zunic</LastName><ForeName>J</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>General Hospital Karlovac, Karlovac, Croatia.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Miskovic</LastName><ForeName>P</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>General Hospital Karlovac, Karlovac, Croatia.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Zilic</LastName><ForeName>A</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>General Hospital Karlovac, Karlovac, Croatia.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Kvolik</LastName><ForeName>S</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>University Clinical Hospital Osijek, Osijek, Croatia.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Ivic</LastName><ForeName>D</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>University Clinical Hospital Osijek, Osijek, Croatia.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Darija</LastName><ForeName>A V</ForeName><Initials>AV</Initials><AffiliationInfo><Affiliation>University Clinical Hospital Osijek, Osijek, Croatia.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Skiljic</LastName><ForeName>S</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>University Clinical Hospital Osijek, Osijek, Croatia.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Vinkovic</LastName><ForeName>H</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>University Clinical Hospital Osijek, Osijek, Croatia.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Oputric</LastName><ForeName>I</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>University Clinical Hospital Osijek, Osijek, Croatia.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Juricic</LastName><ForeName>K</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>University Hospital Rijeka, Rijeka, Croatia.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Frkovic</LastName><ForeName>V</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>University Hospital Rijeka, Rijeka, Croatia.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Kopic</LastName><ForeName>J</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>General Hospital Dr J Bencevic, Slavonski Brod, Croatia.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Mirkovic</LastName><ForeName>I</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>General Hospital Dr J Bencevic, Slavonski Brod, Croatia.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Saric</LastName><ForeName>J P</ForeName><Initials>JP</Initials><AffiliationInfo><Affiliation>University Hospital Merkur, Zagreb, Croatia.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Erceg</LastName><ForeName>G</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>University Hospital Merkur, Zagreb, Croatia.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Dvorscak</LastName><ForeName>M B</ForeName><Initials>MB</Initials><AffiliationInfo><Affiliation>University Hospital Merkur, Zagreb, Croatia.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Branka</LastName><ForeName>M S</ForeName><Initials>MS</Initials><AffiliationInfo><Affiliation>University Hospital Sveti Duh, Zagreb, Croatia.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Pavicic</LastName><ForeName>A M</ForeName><Initials>AM</Initials><AffiliationInfo><Affiliation>University Hospital Sveti Duh, Zagreb, Croatia.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Goranovic</LastName><ForeName>T</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>University Hospital Sveti Duh, Zagreb, Croatia.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Maldini</LastName><ForeName>B</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>University Hospital, Medical School, "Sestre milosrdnice" (Sister of Charity), Zagreb, Croatia.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Radocaj</LastName><ForeName>T</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>University Hospital, Medical School, "Sestre milosrdnice" (Sister of Charity), Zagreb, Croatia.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Gavranovic</LastName><ForeName>Z</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>University Hospital, Medical School, "Sestre milosrdnice" (Sister of Charity), Zagreb, Croatia.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Inga</LastName><ForeName>M B</ForeName><Initials>MB</Initials><AffiliationInfo><Affiliation>University Hospital, Medical School, "Sestre milosrdnice" (Sister of Charity), Zagreb, Croatia.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Sehovic</LastName><ForeName>M</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>University Hospital, Medical School, "Sestre milosrdnice" (Sister of Charity), Zagreb, Croatia.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Stourac</LastName><ForeName>P</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>University Hospital Brno, Brno, Czech Republic.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Harazim</LastName><ForeName>H</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>University Hospital Brno, Brno, Czech Republic.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Smekalova</LastName><ForeName>O</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>University Hospital Brno, Brno, Czech Republic.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Kosinova</LastName><ForeName>M</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>University Hospital Brno, Brno, Czech Republic.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Kolacek</LastName><ForeName>T</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>University Hospital Brno, Brno, Czech Republic.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Hudacek</LastName><ForeName>K</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>University Hospital Brno, Brno, Czech Republic.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Drab</LastName><ForeName>M</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>University Hospital Brno, Brno, Czech Republic.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Brujevic</LastName><ForeName>J</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>University Hospital Hradec Kralove, Hradec Kralove, Czech Republic.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Vitkova</LastName><ForeName>K</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>University Hospital Hradec Kralove, Hradec Kralove, Czech Republic.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Jirmanova</LastName><ForeName>K</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>University Hospital Hradec Kralove, Hradec Kralove, Czech Republic.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Volfova</LastName><ForeName>I</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>University Hospital Ostrava, Ostrava, Czech Republic.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Dzurnakova</LastName><ForeName>P</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>University Hospital Ostrava, Ostrava, Czech Republic.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Liskova</LastName><ForeName>K</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>University Hospital Ostrava, Ostrava, Czech Republic.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Dudas</LastName><ForeName>R</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Nemocnice Znojmo, Znojmo, Czech Republic.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Filipsky</LastName><ForeName>R</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Nemocnice Znojmo, Znojmo, Czech Republic.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Kafrawy</LastName><ForeName>S E</ForeName><Initials>SE</Initials><AffiliationInfo><Affiliation>El Sahel Teaching hospital, Cairo, Egypt.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Abdelwahab</LastName><ForeName>H H</ForeName><Initials>HH</Initials><AffiliationInfo><Affiliation>Kasr Al-Ainy Medical School, Cairo University, Egypt.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Metwally</LastName><ForeName>T</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Kasr Al-Ainy Medical School, Cairo University, Egypt.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Ahmed</LastName><ForeName>A R</ForeName><Initials>AR</Initials><AffiliationInfo><Affiliation>Kasr Al-Ainy Medical School, Cairo University, Egypt.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Ahmed Mostafa</LastName><ForeName>E S</ForeName><Initials>ES</Initials><AffiliationInfo><Affiliation>Beni Sueif University Hospital, Giza, Egypt.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Hasan</LastName><ForeName>W F</ForeName><Initials>WF</Initials><AffiliationInfo><Affiliation>Beni Sueif University Hospital, Giza, Egypt.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Ahmed</LastName><ForeName>A G</ForeName><Initials>AG</Initials><AffiliationInfo><Affiliation>Beni Sueif University Hospital, Giza, Egypt.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Yassin</LastName><ForeName>H</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Fayoum University Hospital, Giza, Egypt.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Magdy</LastName><ForeName>M</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Fayoum University Hospital, Giza, Egypt.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Abdelhady</LastName><ForeName>M</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Fayoum University Hospital, Giza, Egypt.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Mahran</LastName><ForeName>M</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Suis medical Insurance Hospital, Suis, Egypt.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Herodes</LastName><ForeName>E</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>North Estonia Medical Center, Tallinn, Estonia.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Kivik</LastName><ForeName>P</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>North Estonia Medical Center, Tallinn, Estonia.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Oganjan</LastName><ForeName>J</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>North Estonia Medical Center, Tallinn, Estonia.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Aun</LastName><ForeName>A</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>North Estonia Medical Center, Tallinn, Estonia.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Sormus</LastName><ForeName>A</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Tartu University Hospital, Tartu, Estonia.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Sarapuu</LastName><ForeName>K</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Tartu University Hospital, Tartu, Estonia.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Mall</LastName><ForeName>M</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Tartu University Hospital, Tartu, Estonia.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Karjagin</LastName><ForeName>J</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Tartu University Hospital, Tartu, Estonia.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Futier</LastName><ForeName>E</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>University Hospital of Clermont-Ferrand, Clermont-Ferrand, France.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Petit</LastName><ForeName>A</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>University Hospital of Clermont-Ferrand, Clermont-Ferrand, France.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Gerard</LastName><ForeName>A</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>University Hospital of Clermont-Ferrand, Clermont-Ferrand, France.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Marret</LastName><ForeName>E</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Institut Hospitalier Franco-Britannique, Levallois-Perret, France.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Solier</LastName><ForeName>M</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Institut Hospitalier Franco-Britannique, Levallois-Perret, France.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Jaber</LastName><ForeName>S</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Saint Eloi University Hospital, Montpellier, France.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Prades</LastName><ForeName>A</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Saint Eloi University Hospital, Montpellier, France.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Krassler</LastName><ForeName>J</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Fachkrankenhaus Coswig, Coswig, Germany.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Merzky</LastName><ForeName>S</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Fachkrankenhaus Coswig, Coswig, Germany.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Abreu</LastName><ForeName>M G D</ForeName><Initials>MGD</Initials><AffiliationInfo><Affiliation>University Hospital Carl Gustav Carus, Dresden, Germany.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Uhlig</LastName><ForeName>C</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>University Hospital Carl Gustav Carus, Dresden, Germany.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Kiss</LastName><ForeName>T</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>University Hospital Carl Gustav Carus, Dresden, Germany.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Bundy</LastName><ForeName>A</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>University Hospital Carl Gustav Carus, Dresden, Germany.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Bluth</LastName><ForeName>T</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>University Hospital Carl Gustav Carus, Dresden, Germany.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Gueldner</LastName><ForeName>A</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>University Hospital Carl Gustav Carus, Dresden, Germany.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Spieth</LastName><ForeName>P</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>University Hospital Carl Gustav Carus, Dresden, Germany.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Scharffenberg</LastName><ForeName>M</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>University Hospital Carl Gustav Carus, Dresden, Germany.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Thiem</LastName><ForeName>D T</ForeName><Initials>DT</Initials><AffiliationInfo><Affiliation>University Hospital Carl Gustav Carus, Dresden, Germany.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Koch</LastName><ForeName>T</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>University Hospital Carl Gustav Carus, Dresden, Germany.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Treschan</LastName><ForeName>T</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Duesseldorf University Hospital, Heinrich-Heine University, Germany.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Schaefer</LastName><ForeName>M</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Duesseldorf University Hospital, Heinrich-Heine University, Germany.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Bastin</LastName><ForeName>B</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Duesseldorf University Hospital, Heinrich-Heine University, Germany.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Geib</LastName><ForeName>J</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Duesseldorf University Hospital, Heinrich-Heine University, Germany.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Weiss</LastName><ForeName>M</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Duesseldorf University Hospital, Heinrich-Heine University, Germany.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Kienbaum</LastName><ForeName>P</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Duesseldorf University Hospital, Heinrich-Heine University, Germany.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Pannen</LastName><ForeName>B</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Duesseldorf University Hospital, Heinrich-Heine University, Germany.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Gottschalk</LastName><ForeName>A</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Diakoniekrankenhaus Friederikenstift, Hannover, Germany.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Konrad</LastName><ForeName>M</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Diakoniekrankenhaus Friederikenstift, Hannover, Germany.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Westerheide</LastName><ForeName>D</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Diakoniekrankenhaus Friederikenstift, Hannover, Germany.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Schwerdtfeger</LastName><ForeName>B</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Diakoniekrankenhaus Friederikenstift, Hannover, Germany.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Wrigge</LastName><ForeName>H</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>University of Leipzig, Leipzig, Germany.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Simon</LastName><ForeName>P</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>University of Leipzig, Leipzig, Germany.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Reske</LastName><ForeName>A</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>University of Leipzig, Leipzig, Germany.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Nestler</LastName><ForeName>C</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>University of Leipzig, Leipzig, Germany.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Valsamidis</LastName><ForeName>D</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Alexandra" General hospital of Athens, Athens, Greece.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Stroumpoulis</LastName><ForeName>K</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Alexandra" General hospital of Athens, Athens, Greece.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Antholopoulos</LastName><ForeName>G</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>General Air Force hospital, Athens, Greece.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Andreou</LastName><ForeName>A</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>General Air Force hospital, Athens, Greece.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Karapanos</LastName><ForeName>D</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>General Air Force hospital, Athens, Greece.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Theodoraki</LastName><ForeName>K</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Aretaieion University Hospital, Athens, Greece.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Gkiokas</LastName><ForeName>G</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Aretaieion University Hospital, Athens, Greece.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Tasoulis</LastName><ForeName>M K</ForeName><Initials>MK</Initials><AffiliationInfo><Affiliation>Aretaieion University Hospital, Athens, Greece.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Sidiropoulou</LastName><ForeName>T</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Attikon University Hospital, Athens, Greece.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Zafeiropoulou</LastName><ForeName>F</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Attikon University Hospital, Athens, Greece.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Florou</LastName><ForeName>P</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Attikon University Hospital, Athens, Greece.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Pandazi</LastName><ForeName>A</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Attikon University Hospital, Athens, Greece.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Tsaousi</LastName><ForeName>G</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Ahepa University Hospital Thessaloniki, Thessaloniki, Greece.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Nouris</LastName><ForeName>C</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Ahepa University Hospital Thessaloniki, Thessaloniki, Greece.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Pourzitaki</LastName><ForeName>C</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Ahepa University Hospital Thessaloniki, Thessaloniki, Greece.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Bystritski</LastName><ForeName>D</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>The Lady Davis Carmel Medical Center, Haifa, Israel.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Pizov</LastName><ForeName>R</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>The Lady Davis Carmel Medical Center, Haifa, Israel.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Eden</LastName><ForeName>A</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>The Lady Davis Carmel Medical Center, Haifa, Israel.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Pesce</LastName><ForeName>C V</ForeName><Initials>CV</Initials><AffiliationInfo><Affiliation>Ospedale San. Paolo Bari, Bari, Italy.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Campanile</LastName><ForeName>A</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Ospedale San. Paolo Bari, Bari, Italy.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Marrella</LastName><ForeName>A</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Ospedale San. Paolo Bari, Bari, Italy.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Grasso</LastName><ForeName>S</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>University of Bari "Aldo Moro", Bari, Italy.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Michele</LastName><ForeName>M D</ForeName><Initials>MD</Initials><AffiliationInfo><Affiliation>University of Bari "Aldo Moro", Bari, Italy.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Bona</LastName><ForeName>F</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Institute for Cancer Research and Treatment, Candiolo, Turin, Italy.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Giacoletto</LastName><ForeName>G</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Institute for Cancer Research and Treatment, Candiolo, Turin, Italy.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Sardo</LastName><ForeName>E</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Institute for Cancer Research and Treatment, Candiolo, Turin, Italy.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Sottosanti</LastName><ForeName>L G V</ForeName><Initials>LGV</Initials><AffiliationInfo><Affiliation>Azienda Ospedaliera per l'emergenza Cannizzaro, Catania, Italy.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Solca</LastName><ForeName>M</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Ospedale Melegnano, Cernuso, Milano, Italy.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Volta</LastName><ForeName>C A</ForeName><Initials>CA</Initials><AffiliationInfo><Affiliation>Azienda Ospedaliera - Universitaria Sant'Anna, Ferrara, Italy.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Spadaro</LastName><ForeName>S</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Azienda Ospedaliera - Universitaria Sant'Anna, Ferrara, Italy.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Verri</LastName><ForeName>M</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Azienda Ospedaliera - Universitaria Sant'Anna, Ferrara, Italy.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Ragazzi</LastName><ForeName>R</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Azienda Ospedaliera - Universitaria Sant'Anna, Ferrara, Italy.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Zoppellari</LastName><ForeName>R</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Azienda Ospedaliera - Universitaria Sant'Anna, Ferrara, Italy.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Cinnella</LastName><ForeName>G</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Ospedali Riuniti Di Foggia - University of Foggia, Foggia, Italy.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Raimondo</LastName><ForeName>P</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Ospedali Riuniti Di Foggia - University of Foggia, Foggia, Italy.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Bella</LastName><ForeName>D L</ForeName><Initials>DL</Initials><AffiliationInfo><Affiliation>Ospedali Riuniti Di Foggia - University of Foggia, Foggia, Italy.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Mirabella</LastName><ForeName>L</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Ospedali Riuniti Di Foggia - University of Foggia, Foggia, Italy.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>D'antini</LastName><ForeName>D</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Ospedali Riuniti Di Foggia - University of Foggia, Foggia, Italy.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Pelosi</LastName><ForeName>P</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>IRCCS AOU San Martino IST Hospital, University of Genoa, Genoa, Italy.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Molin</LastName><ForeName>A</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>IRCCS AOU San Martino IST Hospital, University of Genoa, Genoa, Italy.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Brunetti</LastName><ForeName>I</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>IRCCS AOU San Martino IST Hospital, University of Genoa, Genoa, Italy.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Gratarola</LastName><ForeName>A</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>IRCCS AOU San Martino IST Hospital, University of Genoa, Genoa, Italy.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Pellerano</LastName><ForeName>G</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>IRCCS AOU San Martino IST Hospital, University of Genoa, Genoa, Italy.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Sileo</LastName><ForeName>R</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>IRCCS AOU San Martino IST Hospital, University of Genoa, Genoa, Italy.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Pezzatto</LastName><ForeName>S</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>IRCCS AOU San Martino IST Hospital, University of Genoa, Genoa, Italy.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Montagnani</LastName><ForeName>L</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>IRCCS AOU San Martino IST Hospital, University of Genoa, Genoa, Italy.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Pasin</LastName><ForeName>L</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>IRCCS San Raffaele Scientific Institute, Milano, Italy.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Landoni</LastName><ForeName>G</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>IRCCS San Raffaele Scientific Institute, Milano, Italy.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Zangrillo</LastName><ForeName>A</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>IRCCS San Raffaele Scientific Institute, Milano, Italy.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Beretta</LastName><ForeName>L</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>IRCCS San Raffaele Scientific Institute, Milano, Italy.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Parma</LastName><ForeName>A L D</ForeName><Initials>ALD</Initials><AffiliationInfo><Affiliation>IRCCS San Raffaele Scientific Institute, Milano, Italy.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Tarzia</LastName><ForeName>V</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>IRCCS San Raffaele Scientific Institute, Milano, Italy.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Dossi</LastName><ForeName>R</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>IRCCS San Raffaele Scientific Institute, Milano, Italy.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Sassone</LastName><ForeName>M E</ForeName><Initials>ME</Initials><AffiliationInfo><Affiliation>IRCCS San Raffaele Scientific Institute, Milano, Italy.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Sances</LastName><ForeName>D</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Istituto europeo di oncologia - ieo, Milano, Italy.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Tredici</LastName><ForeName>S</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Istituto europeo di oncologia - ieo, Milano, Italy.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Spano</LastName><ForeName>G</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Istituto europeo di oncologia - ieo, Milano, Italy.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Castellani</LastName><ForeName>G</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Istituto europeo di oncologia - ieo, Milano, Italy.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Delunas</LastName><ForeName>L</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Istituto europeo di oncologia - ieo, Milano, Italy.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Peradze</LastName><ForeName>S</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Istituto europeo di oncologia - ieo, Milano, Italy.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Venturino</LastName><ForeName>M</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Istituto europeo di oncologia - ieo, Milano, Italy.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Arpino</LastName><ForeName>I</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Ospedale Niguarda Ca'Granda Milano, Milano, Italy.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Sher</LastName><ForeName>S</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Ospedale Niguarda Ca'Granda Milano, Milano, Italy.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Tommasino</LastName><ForeName>C</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Ospedale San Paolo - University of Milano, Milano, Italy.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Rapido</LastName><ForeName>F</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Ospedale San Paolo - University of Milano, Milano, Italy.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Morelli</LastName><ForeName>P</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Ospedale San Paolo - University of Milano, Milano, Italy.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Vargas</LastName><ForeName>M</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>University of Naples "Federico II" Naples, Italy.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Servillo</LastName><ForeName>G</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>University of Naples "Federico II" Naples, Italy.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Cortegiani</LastName><ForeName>A</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Policlinico "P. Giaccone", Palermo, Italy.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Raineri</LastName><ForeName>S M</ForeName><Initials>SM</Initials><AffiliationInfo><Affiliation>Policlinico "P. Giaccone", Palermo, Italy.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Montalto</LastName><ForeName>F</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Policlinico "P. Giaccone", Palermo, Italy.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Russotto</LastName><ForeName>V</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Policlinico "P. Giaccone", Palermo, Italy.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Giarratano</LastName><ForeName>A</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Policlinico "P. Giaccone", Palermo, Italy.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Baciarello</LastName><ForeName>M</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Azienda Ospedaliero-Universitaria, Parma, Italy.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Generali</LastName><ForeName>M</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Azienda Ospedaliero-Universitaria, Parma, Italy.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Cerati</LastName><ForeName>G</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Azienda Ospedaliero-Universitaria, Parma, Italy.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Leykin</LastName><ForeName>Y</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Santa Maria degli Angeli, Pordenone, Italy.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Bressan</LastName><ForeName>F</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Ospedale Misericordia e Dolce - Usl4 Prato, Prato, Italy.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Bartolini</LastName><ForeName>V</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Ospedale Misericordia e Dolce - Usl4 Prato, Prato, Italy.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Zamidei</LastName><ForeName>L</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Ospedale Misericordia e Dolce - Usl4 Prato, Prato, Italy.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Brazzi</LastName><ForeName>L</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>University hospital of Sassari, Sassari, Italy.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Liperi</LastName><ForeName>C</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>University hospital of Sassari, Sassari, Italy.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Sales</LastName><ForeName>G</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>University hospital of Sassari, Sassari, Italy.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Pistidda</LastName><ForeName>L</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>University hospital of Sassari, Sassari, Italy.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Severgnini</LastName><ForeName>P</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Insubria University, Varese, Italy.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Brugnoni</LastName><ForeName>E</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Insubria University, Varese, Italy.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Musella</LastName><ForeName>G</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Insubria University, Varese, Italy.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Bacuzzi</LastName><ForeName>A</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Insubria University, Varese, Italy.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Muhardri</LastName><ForeName>D</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Distric hospital Gjakova, Gjakove, Republic of Kosovo.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Agreta</LastName><ForeName>G G</ForeName><Initials>GG</Initials><AffiliationInfo><Affiliation>University Clinical Center of Kosova, Prishtina, Republic of Kosovo.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Sada</LastName><ForeName>F</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>University Clinical Center of Kosova, Prishtina, Republic of Kosovo.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Bytyqi</LastName><ForeName>A</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Regional Hospital "Prim.Dr. Daut Mustafa", Prizren, Republic of Kosovo.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Karbonskiene</LastName><ForeName>A</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Medical University Hospital, Hospital of Lithuanian University of Health Sciences, Kaunas, Lithuania.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Aukstakalniene</LastName><ForeName>R</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Medical University Hospital, Hospital of Lithuanian University of Health Sciences, Kaunas, Lithuania.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Teberaite</LastName><ForeName>Z</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Medical University Hospital, Hospital of Lithuanian University of Health Sciences, Kaunas, Lithuania.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Salciute</LastName><ForeName>E</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Medical University Hospital, Hospital of Lithuanian University of Health Sciences, Kaunas, Lithuania.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Tikuisis</LastName><ForeName>R</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Vilnius University Hospital - Institute of Oncology, Vilnius, Lithuania.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Miliauskas</LastName><ForeName>P</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Vilnius University Hospital - Institute of Oncology, Vilnius, Lithuania.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Jurate</LastName><ForeName>S</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Vilnius University Hospital - Santariskiu Clinics, Vilnius, Lithuania.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Kontrimaviciute</LastName><ForeName>E</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Vilnius University Hospital - Santariskiu Clinics, Vilnius, Lithuania.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Tomkute</LastName><ForeName>G</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Vilnius University Hospital - Santariskiu Clinics, Vilnius, Lithuania.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Xuereb</LastName><ForeName>J</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Mater Dei Hospital, Msida, Malta.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Bezzina</LastName><ForeName>M</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Mater Dei Hospital, Msida, Malta.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Borg</LastName><ForeName>F Joseph</ForeName><Initials>FJ</Initials><AffiliationInfo><Affiliation>Mater Dei Hospital, Msida, Malta.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Hemmes</LastName><ForeName>S</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Academic Medical Centre, University of Amsterdam, Netherlands.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Schultz</LastName><ForeName>M</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Academic Medical Centre, University of Amsterdam, Netherlands.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Hollmann</LastName><ForeName>M</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Academic Medical Centre, University of Amsterdam, Netherlands.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Wiersma</LastName><ForeName>I</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Academic Medical Centre, University of Amsterdam, Netherlands.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Binnekade</LastName><ForeName>J</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Academic Medical Centre, University of Amsterdam, Netherlands.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Bos</LastName><ForeName>L</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Academic Medical Centre, University of Amsterdam, Netherlands.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Boer</LastName><ForeName>C</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>VU University Medical Center, Amsterdam, Netherlands.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Duvekot</LastName><ForeName>A</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>VU University Medical Center, Amsterdam, Netherlands.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Veld</LastName><ForeName>B I 't</ForeName><Initials>BI'</Initials><AffiliationInfo><Affiliation>MC Haaglanden, Den Haag, Netherlands.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Werger</LastName><ForeName>A</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>MC Haaglanden, Den Haag, Netherlands.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Dennesen</LastName><ForeName>P</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>MC Haaglanden, Den Haag, Netherlands.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Severijns</LastName><ForeName>C</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>MC Haaglanden, Den Haag, Netherlands.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Jong</LastName><ForeName>J D</ForeName><Initials>JD</Initials><AffiliationInfo><Affiliation>Westfriesgasthuis, Hoorn, Netherlands.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Hering</LastName><ForeName>J</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Westfriesgasthuis, Hoorn, Netherlands.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Beek</LastName><ForeName>R V</ForeName><Initials>RV</Initials><AffiliationInfo><Affiliation>Westfriesgasthuis, Hoorn, Netherlands.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Ivars</LastName><ForeName>S</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Haukeland University Hospital, Bergen, Norway.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Jammer</LastName><ForeName>I B</ForeName><Initials>IB</Initials><AffiliationInfo><Affiliation>Haukeland University Hospital, Bergen, Norway.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Breidablik</LastName><ForeName>A</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>F&#xf8;rde Central Hospital /F&#xf8;rde Sentral Sykehus, F&#xf8;rde, Norway.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Hodt</LastName><ForeName>K S</ForeName><Initials>KS</Initials><AffiliationInfo><Affiliation>Martina Hansens Hospital, Gjettum, Norway.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Fjellanger</LastName><ForeName>F</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Martina Hansens Hospital, Gjettum, Norway.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Avalos</LastName><ForeName>M V</ForeName><Initials>MV</Initials><AffiliationInfo><Affiliation>Martina Hansens Hospital, Gjettum, Norway.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Jannicke</LastName><ForeName>M O</ForeName><Initials>MO</Initials><AffiliationInfo><Affiliation>B&#xe6;rum Hospital, Vestre Viken, Rud, Norway.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Andersson</LastName><ForeName>E</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>B&#xe6;rum Hospital, Vestre Viken, Rud, Norway.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Amir</LastName><ForeName>S K</ForeName><Initials>SK</Initials><AffiliationInfo><Affiliation>Stavanger University Hospital, Stavanger, Norway.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Molina</LastName><ForeName>R</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Hospital Santo Tom&#xe1;s, Panama, Panama.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Wutai</LastName><ForeName>S</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Hospital Santo Tom&#xe1;s, Panama, Panama.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Morais</LastName><ForeName>E</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Hospital Santo Tom&#xe1;s, Panama, Panama.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Tareco</LastName><ForeName>G</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Hospital do Esp&#xed;rito Santo - &#xc9;vora, E.P.E, &#xc9;vora, Portugal.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Ferreira</LastName><ForeName>D</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Hospital do Esp&#xed;rito Santo - &#xc9;vora, E.P.E, &#xc9;vora, Portugal.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Amaral</LastName><ForeName>J</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Hospital do Esp&#xed;rito Santo - &#xc9;vora, E.P.E, &#xc9;vora, Portugal.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Castro</LastName><ForeName>M D L G</ForeName><Initials>MDLG</Initials><AffiliationInfo><Affiliation>Centro Hospitalar de Lisboa Central, E.P.E, Lisboa, Portugal.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Cadilha</LastName><ForeName>S</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Centro Hospitalar de Lisboa Central, E.P.E, Lisboa, Portugal.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Appleton</LastName><ForeName>S</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Centro Hospitalar de Lisboa Central, E.P.E, Lisboa, Portugal.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Parente</LastName><ForeName>S</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Centro Hospitalar de Lisboa Ocidental, E.P.E. Hospital de S. Francisco Xavier, Lisboa, Portugal.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Correia</LastName><ForeName>M</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Centro Hospitalar de Lisboa Ocidental, E.P.E. Hospital de S. Francisco Xavier, Lisboa, Portugal.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Martins</LastName><ForeName>D</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Centro Hospitalar de Lisboa Ocidental, E.P.E. Hospital de S. Francisco Xavier, Lisboa, Portugal.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Monteirosa</LastName><ForeName>A</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Santarem Hospital, Santarem, Portugal.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Ricardo</LastName><ForeName>A</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Santarem Hospital, Santarem, Portugal.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Rodrigues</LastName><ForeName>S</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Santarem Hospital, Santarem, Portugal.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Horhota</LastName><ForeName>L</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Spital Orasenesc, Bolintin Vale, Romania.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Grintescu</LastName><ForeName>I M</ForeName><Initials>IM</Initials><AffiliationInfo><Affiliation>Clinical Emergency Hospital of Bucharest, Bucharest, Romania.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Mirea</LastName><ForeName>L</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Clinical Emergency Hospital of Bucharest, Bucharest, Romania.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Grintescu</LastName><ForeName>I C</ForeName><Initials>IC</Initials><AffiliationInfo><Affiliation>Clinical Emergency Hospital of Bucharest, Bucharest, Romania.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Corneci</LastName><ForeName>D</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Elias University Emergency Hospital, Bucharest, Romania.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Negoita</LastName><ForeName>S</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Elias University Emergency Hospital, Bucharest, Romania.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Dutu</LastName><ForeName>M</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Elias University Emergency Hospital, Bucharest, Romania.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Popescu Garotescu</LastName><ForeName>I</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Elias University Emergency Hospital, Bucharest, Romania.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Filipescu</LastName><ForeName>D</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Emergency Institute of Cardiovascular Diseases Inst. ''Prof. C. C. Iliescu'', Bucharest, Romania.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Prodan</LastName><ForeName>A B</ForeName><Initials>AB</Initials><AffiliationInfo><Affiliation>Emergency Institute of Cardiovascular Diseases Inst. ''Prof. C. C. Iliescu'', Bucharest, Romania.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Droc</LastName><ForeName>G</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Fundeni Clinical institute - Anaesthesia and Intensive Care, Bucharest, Romania.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Fota</LastName><ForeName>R</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Fundeni Clinical institute - Anaesthesia and Intensive Care, Bucharest, Romania.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Popescu</LastName><ForeName>M</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Fundeni Clinical institute - Anaesthesia and Intensive Care, Bucharest, Romania.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Tomescu</LastName><ForeName>D</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Fundeni Clinical institute - Intensive Care Unit, Bucharest, Romania.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Petcu</LastName><ForeName>A M</ForeName><Initials>AM</Initials><AffiliationInfo><Affiliation>Fundeni Clinical institute - Intensive Care Unit, Bucharest, Romania.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Tudoroiu</LastName><ForeName>M I</ForeName><Initials>MI</Initials><AffiliationInfo><Affiliation>Fundeni Clinical institute - Intensive Care Unit, Bucharest, Romania.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Moise</LastName><ForeName>A</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Hospital Profesor D Gerota, Bucharest, Romania.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Guran</LastName><ForeName>C T</ForeName><Initials>CT</Initials><AffiliationInfo><Affiliation>Hospital Profesor D Gerota, Bucharest, Romania.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Gherghina</LastName><ForeName>I</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Constanta County Emergency Hospital, Constanta, Romania.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Costea</LastName><ForeName>D</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Constanta County Emergency Hospital, Constanta, Romania.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Cindea</LastName><ForeName>I</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Constanta County Emergency Hospital, Constanta, Romania.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Copotoiu</LastName><ForeName>S M</ForeName><Initials>SM</Initials><AffiliationInfo><Affiliation>University Emergency County Hospital Targu Mures, Targu Mures, Romania.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Copotoiu</LastName><ForeName>R</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>University Emergency County Hospital Targu Mures, Targu Mures, Romania.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Barsan</LastName><ForeName>V</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>University Emergency County Hospital Targu Mures, Targu Mures, Romania.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Tolcser</LastName><ForeName>Z</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>University Emergency County Hospital Targu Mures, Targu Mures, Romania.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Riciu</LastName><ForeName>M</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>University Emergency County Hospital Targu Mures, Targu Mures, Romania.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Moldovan</LastName><ForeName>S G</ForeName><Initials>SG</Initials><AffiliationInfo><Affiliation>University Emergency County Hospital Targu Mures, Targu Mures, Romania.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Veres</LastName><ForeName>M</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>University Emergency County Hospital Targu Mures, Targu Mures, Romania.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Gritsan</LastName><ForeName>A</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Krasnoyarsk State Medical University, Krasnoyarsk, Russia.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Kapkan</LastName><ForeName>T</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Krasnoyarsk State Medical University, Krasnoyarsk, Russia.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Gritsan</LastName><ForeName>G</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Krasnoyarsk State Medical University, Krasnoyarsk, Russia.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Korolkov</LastName><ForeName>O</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>Krasnoyarsk State Medical University, Krasnoyarsk, Russia.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Kulikov</LastName><ForeName>A</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Burdenko Neurosurgery Institute, Moscow, Russia.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Lubnin</LastName><ForeName>A</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Burdenko Neurosurgery Institute, Moscow, Russia.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Ovezov</LastName><ForeName>A</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Moscow Regional Research Clinical Institute, Moscow, Russia.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Prokoshev</LastName><ForeName>P</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Moscow Regional Research Clinical Institute, Moscow, Russia.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Lugovoy</LastName><ForeName>A</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Moscow Regional Research Clinical Institute, Moscow, Russia.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Anipchenko</LastName><ForeName>N</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Moscow Regional Research Clinical Institute, Moscow, Russia.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Babayants</LastName><ForeName>A</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Municipal Clinical Hospital 7, Moscow, Russia.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Komissarova</LastName><ForeName>I</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Municipal Clinical Hospital 7, Moscow, Russia.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Zalina</LastName><ForeName>K</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Municipal Clinical Hospital 7, Moscow, Russia.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Likhvantsev</LastName><ForeName>V</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Reanimatology Research Institute n.a. Negovskij RAMS, Moscow, Russia.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Fedorov</LastName><ForeName>S</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Reanimatology Research Institute n.a. Negovskij RAMS, Moscow, Russia.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Lazukic</LastName><ForeName>A</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Clinical Center of Vojvodina, Emergency Center, Novisad, Serbia.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Pejakovic</LastName><ForeName>J</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Clinical Center of Vojvodina, Emergency Center, Novisad, Serbia.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Mihajlovic</LastName><ForeName>D</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Clinical Center of Vojvodina, Emergency Center, Novisad, Serbia.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Kusnierikova</LastName><ForeName>Z</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>National Cancer Institute, Bratislava, Slovakia.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Zelinkova</LastName><ForeName>M</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>National Cancer Institute, Bratislava, Slovakia.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Bruncakova</LastName><ForeName>K</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>F.D. Roosevelt Teaching Hospital, Bansk&#xe1; Bystrica, Slovakia.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Polakovicova</LastName><ForeName>L</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>F.D. Roosevelt Teaching Hospital, Bansk&#xe1; Bystrica, Slovakia.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Sobona</LastName><ForeName>V</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Faculty Hospital Nov&#xe9; Z&#xe1;mky, Nov&#xe9; Z&#xe1;mky, Slovakia.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Barbka</LastName><ForeName>N S</ForeName><Initials>NS</Initials><AffiliationInfo><Affiliation>Institute of Oncology Ljubljana, Ljubljana, Slovenia.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Ana</LastName><ForeName>P G</ForeName><Initials>PG</Initials><AffiliationInfo><Affiliation>Institute of Oncology Ljubljana, Ljubljana, Slovenia.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Jovanov</LastName><ForeName>M</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Institute of Oncology Ljubljana, Ljubljana, Slovenia.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Strazisar</LastName><ForeName>B</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Institute of Oncology Ljubljana, Ljubljana, Slovenia.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Jasmina</LastName><ForeName>M B</ForeName><Initials>MB</Initials><AffiliationInfo><Affiliation>University Medical Centre Ljubljana, Ljubljana, Slovenia.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Vesna</LastName><ForeName>N J</ForeName><Initials>NJ</Initials><AffiliationInfo><Affiliation>University Medical Centre Ljubljana, Ljubljana, Slovenia.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Voje</LastName><ForeName>M</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>University Medical Centre Ljubljana, Ljubljana, Slovenia.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Grynyuk</LastName><ForeName>A</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>University Medical Centre Ljubljana, Ljubljana, Slovenia.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Kostadinov</LastName><ForeName>I</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>University Medical Centre Ljubljana, Ljubljana, Slovenia.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Alenka</LastName><ForeName>S V</ForeName><Initials>SV</Initials><AffiliationInfo><Affiliation>University Medical Centre Ljubljana, Ljubljana, Slovenia.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Moral</LastName><ForeName>V</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Hospital Sant Pau, Barcelona, Spain.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Unzueta</LastName><ForeName>M C</ForeName><Initials>MC</Initials><AffiliationInfo><Affiliation>Hospital Sant Pau, Barcelona, Spain.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Puigbo</LastName><ForeName>C</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Hospital Sant Pau, Barcelona, Spain.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Fava</LastName><ForeName>J</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Hospital Sant Pau, Barcelona, Spain.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Canet</LastName><ForeName>J</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Hospital Universitari Germans Trias I Pujol, Barcelona, Spain.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Moret</LastName><ForeName>E</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Hospital Universitari Germans Trias I Pujol, Barcelona, Spain.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Nunez</LastName><ForeName>M R</ForeName><Initials>MR</Initials><AffiliationInfo><Affiliation>Hospital Universitari Germans Trias I Pujol, Barcelona, Spain.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Sendra</LastName><ForeName>M</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Hospital Universitari Germans Trias I Pujol, Barcelona, Spain.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Brunelli</LastName><ForeName>A</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Hospital Universitari Germans Trias I Pujol, Barcelona, Spain.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Rodenas</LastName><ForeName>F</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Hospital Universitari Germans Trias I Pujol, Barcelona, Spain.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Monedero</LastName><ForeName>P</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>University of Navarra, Pamplona, Spain.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Hidalgo</LastName><ForeName>F</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>University of Navarra, Pamplona, Spain.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Yepes</LastName><ForeName>M J</ForeName><Initials>MJ</Initials><AffiliationInfo><Affiliation>University of Navarra, Pamplona, Spain.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Martinez-Simon</LastName><ForeName>A</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>University of Navarra, Pamplona, Spain.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Abajo</LastName><ForeName>A</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>University of Navarra, Pamplona, Spain.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Lisi</LastName><ForeName>A</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Corporacion Sanitaria Parc Tauli, Sabadell, Spain.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Perez</LastName><ForeName>G</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Corporacion Sanitaria Parc Tauli, Sabadell, Spain.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Martinez</LastName><ForeName>R</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Corporacion Sanitaria Parc Tauli, Sabadell, Spain.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Granell</LastName><ForeName>M</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Consorcio Hospital General Universitario de Valencia, Valencia, Spain.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Vivo</LastName><ForeName>J T</ForeName><Initials>JT</Initials><AffiliationInfo><Affiliation>Consorcio Hospital General Universitario de Valencia, Valencia, Spain.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Ruiz</LastName><ForeName>C S</ForeName><Initials>CS</Initials><AffiliationInfo><Affiliation>Consorcio Hospital General Universitario de Valencia, Valencia, Spain.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Andr&#xe9;s Iba&#xf1;ez</LastName><ForeName>J A D</ForeName><Initials>JAD</Initials><AffiliationInfo><Affiliation>Consorcio Hospital General Universitario de Valencia, Valencia, Spain.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Pastor</LastName><ForeName>E</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Hospital Clinico Valencia, Valencia, Spain.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Soro</LastName><ForeName>M</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Hospital Clinico Valencia, Valencia, Spain.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Ferrando</LastName><ForeName>C</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Hospital Clinico Valencia, Valencia, Spain.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Defez</LastName><ForeName>M</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Hospital Clinico Valencia, Valencia, Spain.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Cesar Aldecoa</LastName><ForeName>A S</ForeName><Initials>AS</Initials><AffiliationInfo><Affiliation>Hospital Universitario Rio Hortega, Valladolid, Spain.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Perez</LastName><ForeName>R</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Hospital Universitario Rio Hortega, Valladolid, Spain.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Rico</LastName><ForeName>J</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Hospital Universitario Rio Hortega, Valladolid, Spain.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Jawad</LastName><ForeName>M</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Central Hospital in Kristianstad, Sweden.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Saeed</LastName><ForeName>Y</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Central Hospital in Kristianstad, Sweden.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Gillberg</LastName><ForeName>L</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Central Hospital in Kristianstad, Sweden.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Bengisun</LastName><ForeName>Z K</ForeName><Initials>ZK</Initials><AffiliationInfo><Affiliation>Ufuk University Hospital Ankara, Ankara, Turkey.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Kazbek</LastName><ForeName>B K</ForeName><Initials>BK</Initials><AffiliationInfo><Affiliation>Ufuk University Hospital Ankara, Ankara, Turkey.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Coskunfirat</LastName><ForeName>N</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Akdeniz University Hospital, Antalya, Turkey.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Boztug</LastName><ForeName>N</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Akdeniz University Hospital, Antalya, Turkey.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Sanli</LastName><ForeName>S</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Akdeniz University Hospital, Antalya, Turkey.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Yilmaz</LastName><ForeName>M</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Akdeniz University Hospital, Antalya, Turkey.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Hadimioglu</LastName><ForeName>N</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Akdeniz University Hospital, Antalya, Turkey.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Senturk</LastName><ForeName>N M</ForeName><Initials>NM</Initials><AffiliationInfo><Affiliation>Istanbul University, Istanbul medical Faculty, Istanbul, Turkey.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Camci</LastName><ForeName>E</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Istanbul University, Istanbul medical Faculty, Istanbul, Turkey.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Kucukgoncu</LastName><ForeName>S</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Istanbul University, Istanbul medical Faculty, Istanbul, Turkey.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Sungur</LastName><ForeName>Z</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Istanbul University, Istanbul medical Faculty, Istanbul, Turkey.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Sivrikoz</LastName><ForeName>N</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Istanbul University, Istanbul medical Faculty, Istanbul, Turkey.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Ozgen</LastName><ForeName>S U</ForeName><Initials>SU</Initials><AffiliationInfo><Affiliation>Acibadem University, Istanbul, Turkey.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Toraman</LastName><ForeName>F</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Acibadem University, Istanbul, Turkey.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Selvi</LastName><ForeName>O</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>Maltepe University, Istanbul, Turkey.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Senturk</LastName><ForeName>O</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>Maltepe University, Istanbul, Turkey.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Yildiz</LastName><ForeName>M</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Maltepe University, Istanbul, Turkey.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Kuvaki</LastName><ForeName>B</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Dokuz Eyl&#xfc;l Universitesi Tip Fak&#xfc;ltesi, Izmir, Turkey.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Gunenc</LastName><ForeName>F</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Dokuz Eyl&#xfc;l Universitesi Tip Fak&#xfc;ltesi, Izmir, Turkey.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Kucukguclu</LastName><ForeName>S</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Dokuz Eyl&#xfc;l Universitesi Tip Fak&#xfc;ltesi, Izmir, Turkey.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Ozbilgin</LastName><ForeName>S</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Dokuz Eyl&#xfc;l Universitesi Tip Fak&#xfc;ltesi, Izmir, Turkey.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Maral</LastName><ForeName>J</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>&#x15e;ifa University Hospital, &#x130;zmir, Turkey.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Canli</LastName><ForeName>S</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>&#x15e;ifa University Hospital, &#x130;zmir, Turkey.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Arun</LastName><ForeName>O</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>&#x15e;ifa University Hospital, &#x130;zmir, Turkey.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Saltali</LastName><ForeName>A</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>&#x15e;ifa University Hospital, &#x130;zmir, Turkey.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Aydogan</LastName><ForeName>E</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>&#x15e;ifa University Hospital, &#x130;zmir, Turkey.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Arun</LastName><ForeName>O</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>Selcuk University Faculty of medicine, Konya, Turkey.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Saltali</LastName><ForeName>A</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Selcuk University Faculty of medicine, Konya, Turkey.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Aydogan</LastName><ForeName>E</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Selcuk University Faculty of medicine, Konya, Turkey.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Akgun</LastName><ForeName>F N</ForeName><Initials>FN</Initials><AffiliationInfo><Affiliation>Fatih Sultan Mehmet E&#x11f;itim Ve Ara&#x15f;tirma Hastanesi, Istanbul, Turkey.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Sanlikarip</LastName><ForeName>C</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Fatih Sultan Mehmet E&#x11f;itim Ve Ara&#x15f;tirma Hastanesi, Istanbul, Turkey.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Karaman</LastName><ForeName>F M</ForeName><Initials>FM</Initials><AffiliationInfo><Affiliation>Fatih Sultan Mehmet E&#x11f;itim Ve Ara&#x15f;tirma Hastanesi, Istanbul, Turkey.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Mazur</LastName><ForeName>A</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Institute Of Surgery and Transplantology, Kiev, Ukraine.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Vorotyntsev</LastName><ForeName>S</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Zaporizhzhia State Medical University, Zaporizhzhia, Ukraine.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Rousseau</LastName><ForeName>G</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Northern Devon Healthcare NHS Trust, Barnstaple, United Kingdom.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Barrett</LastName><ForeName>C</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Northern Devon Healthcare NHS Trust, Barnstaple, United Kingdom.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Stancombe</LastName><ForeName>L</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Northern Devon Healthcare NHS Trust, Barnstaple, United Kingdom.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Shelley</LastName><ForeName>B</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Golden Jubilee National Hospital, Clydebank, Scotland, United Kingdom.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Scholes</LastName><ForeName>H</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Golden Jubilee National Hospital, Clydebank, Scotland, United Kingdom.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Limb</LastName><ForeName>J</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Darlington Memorial Hospital, County Durham and Darlington Foundation NHS Trust, Darlington, United Kingdom.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Rafi</LastName><ForeName>A</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Darlington Memorial Hospital, County Durham and Darlington Foundation NHS Trust, Darlington, United Kingdom.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Wayman</LastName><ForeName>L</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Darlington Memorial Hospital, County Durham and Darlington Foundation NHS Trust, Darlington, United Kingdom.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Deane</LastName><ForeName>J</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Darlington Memorial Hospital, County Durham and Darlington Foundation NHS Trust, Darlington, United Kingdom.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Rogerson</LastName><ForeName>D</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Royal Derby Hospital, Derby, United Kingdom.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Williams</LastName><ForeName>J</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Royal Derby Hospital, Derby, United Kingdom.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Yates</LastName><ForeName>S</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Royal Derby Hospital, Derby, United Kingdom.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Rogers</LastName><ForeName>E</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Royal Derby Hospital, Derby, United Kingdom.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Pulletz</LastName><ForeName>M</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Dorset County Hospital, Dorchester, United Kingdom.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Moreton</LastName><ForeName>S</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Dorset County Hospital, Dorchester, United Kingdom.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Jones</LastName><ForeName>S</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Dorset County Hospital, Dorchester, United Kingdom.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Venkatesh</LastName><ForeName>S</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>The Princess Alexandra NHS Hospital Trust, Essex, United Kingdom.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Burton</LastName><ForeName>M</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>The Princess Alexandra NHS Hospital Trust, Essex, United Kingdom.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Brown</LastName><ForeName>L</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>The Princess Alexandra NHS Hospital Trust, Essex, United Kingdom.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Goodall</LastName><ForeName>C</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>The Princess Alexandra NHS Hospital Trust, Essex, United Kingdom.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Rucklidge</LastName><ForeName>M</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Royal Devon and Exeter NHS Foundation Trust, Exeter, United Kingdom.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Fuller</LastName><ForeName>D</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Royal Devon and Exeter NHS Foundation Trust, Exeter, United Kingdom.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Nadolski</LastName><ForeName>M</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Royal Devon and Exeter NHS Foundation Trust, Exeter, United Kingdom.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Kusre</LastName><ForeName>S</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Royal Devon and Exeter NHS Foundation Trust, Exeter, United Kingdom.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Lundberg</LastName><ForeName>M</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Hospital James Paget University Hospital NHS Foundation Trust, Great Yarmouth, United Kingdom.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Everett</LastName><ForeName>L</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Hospital James Paget University Hospital NHS Foundation Trust, Great Yarmouth, United Kingdom.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Nutt</LastName><ForeName>H</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Hospital James Paget University Hospital NHS Foundation Trust, Great Yarmouth, United Kingdom.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Zuleika</LastName><ForeName>M</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Royal Surrey County Hospital NHS Foundation Trust, Guildford, United Kingdom.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Carvalho</LastName><ForeName>P</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Royal Surrey County Hospital NHS Foundation Trust, Guildford, United Kingdom.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Clements</LastName><ForeName>D</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Royal Surrey County Hospital NHS Foundation Trust, Guildford, United Kingdom.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Ben</LastName><ForeName>C B</ForeName><Initials>CB</Initials><AffiliationInfo><Affiliation>Royal Surrey County Hospital NHS Foundation Trust, Guildford, United Kingdom.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Watt</LastName><ForeName>P</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Kettering General Hospital NHS Foundation Trust, Kettering, United Kingdom.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Raymode</LastName><ForeName>P</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Kettering General Hospital NHS Foundation Trust, Kettering, United Kingdom.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Pearse</LastName><ForeName>R</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Barts Health NHS Trust, Royal London Hospital, London, United Kingdom.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Mohr</LastName><ForeName>O</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>Barts Health NHS Trust, Royal London Hospital, London, United Kingdom.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Raj</LastName><ForeName>A</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Barts Health NHS Trust, Royal London Hospital, London, United Kingdom.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Creary</LastName><ForeName>T</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Barts Health NHS Trust, Royal London Hospital, London, United Kingdom.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Chishti</LastName><ForeName>A</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Newcastle Upon Tyne Hospitals NHS Trust the Freeman Hospital High Heaton, Newcastle upon Tyne, United Kingdom.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Bell</LastName><ForeName>A</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Newcastle Upon Tyne Hospitals NHS Trust the Freeman Hospital High Heaton, Newcastle upon Tyne, United Kingdom.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Higham</LastName><ForeName>C</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Newcastle Upon Tyne Hospitals NHS Trust the Freeman Hospital High Heaton, Newcastle upon Tyne, United Kingdom.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Cain</LastName><ForeName>A</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Newcastle Upon Tyne Hospitals NHS Trust the Freeman Hospital High Heaton, Newcastle upon Tyne, United Kingdom.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Gibb</LastName><ForeName>S</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Newcastle Upon Tyne Hospitals NHS Trust the Freeman Hospital High Heaton, Newcastle upon Tyne, United Kingdom.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Mowat</LastName><ForeName>S</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Newcastle Upon Tyne Hospitals NHS Trust the Freeman Hospital High Heaton, Newcastle upon Tyne, United Kingdom.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Franklin</LastName><ForeName>D</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Derriford Hospital Plymouth Hospitals NHS Trust, Plymouth, United Kingdom.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>West</LastName><ForeName>C</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Derriford Hospital Plymouth Hospitals NHS Trust, Plymouth, United Kingdom.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Minto</LastName><ForeName>G</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Derriford Hospital Plymouth Hospitals NHS Trust, Plymouth, United Kingdom.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Boyd</LastName><ForeName>N</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Derriford Hospital Plymouth Hospitals NHS Trust, Plymouth, United Kingdom.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Mills</LastName><ForeName>G</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Royal Hallamshire Hospital, Sheffield, United Kingdom.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Calton</LastName><ForeName>E</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Royal Hallamshire Hospital, Sheffield, United Kingdom.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Walker</LastName><ForeName>R</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Royal Hallamshire Hospital, Sheffield, United Kingdom.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Mackenzie</LastName><ForeName>F</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Royal Hallamshire Hospital, Sheffield, United Kingdom.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Ellison</LastName><ForeName>B</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Royal Hallamshire Hospital, Sheffield, United Kingdom.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Roberts</LastName><ForeName>H</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Royal Hallamshire Hospital, Sheffield, United Kingdom.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Chikungwa</LastName><ForeName>M</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Mid Staffordshire NHS, Stafford, United Kingdom.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Jackson</LastName><ForeName>C</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Mid Staffordshire NHS, Stafford, United Kingdom.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Donovan</LastName><ForeName>A</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Musgrove Park Hospital, Taunton, United Kingdom.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Foot</LastName><ForeName>J</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Musgrove Park Hospital, Taunton, United Kingdom.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Homan</LastName><ForeName>E</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Musgrove Park Hospital, Taunton, United Kingdom.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Montgomery</LastName><ForeName>J</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>South Devon Healthcare NHS Foundation Trust /Torbay Hospital, Torquay, Torbay, United Kingdom.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Portch</LastName><ForeName>D</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>South Devon Healthcare NHS Foundation Trust /Torbay Hospital, Torquay, Torbay, United Kingdom.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Mercer</LastName><ForeName>P</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>South Devon Healthcare NHS Foundation Trust /Torbay Hospital, Torquay, Torbay, United Kingdom.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Palmer</LastName><ForeName>J</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>South Devon Healthcare NHS Foundation Trust /Torbay Hospital, Torquay, Torbay, United Kingdom.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Paddle</LastName><ForeName>J</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Royal Cornwall Hospital, Truro, United Kingdom.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Fouracres</LastName><ForeName>A</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Royal Cornwall Hospital, Truro, United Kingdom.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Datson</LastName><ForeName>A</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Royal Cornwall Hospital, Truro, United Kingdom.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Andrew</LastName><ForeName>A</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Royal Cornwall Hospital, Truro, United Kingdom.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Welch</LastName><ForeName>L</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Royal Cornwall Hospital, Truro, United Kingdom.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Rose</LastName><ForeName>A</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Mid Yorkshire Hospitals NHS Trust, Pinderfields Hospital, Wakefield, United Kingdom.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Varma</LastName><ForeName>S</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Mid Yorkshire Hospitals NHS Trust, Pinderfields Hospital, Wakefield, United Kingdom.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Simeson</LastName><ForeName>K</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Mid Yorkshire Hospitals NHS Trust, Pinderfields Hospital, Wakefield, United Kingdom.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Rambhatla</LastName><ForeName>M</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Sandwell and West Birmingham NHS Trust, West Bromich, United Kingdom.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Susarla</LastName><ForeName>J</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Sandwell and West Birmingham NHS Trust, West Bromich, United Kingdom.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Marri</LastName><ForeName>S</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Sandwell and West Birmingham NHS Trust, West Bromich, United Kingdom.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Kodaganallur</LastName><ForeName>K</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Sandwell and West Birmingham NHS Trust, West Bromich, United Kingdom.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Das</LastName><ForeName>A</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Sandwell and West Birmingham NHS Trust, West Bromich, United Kingdom.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Algarsamy</LastName><ForeName>S</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Sandwell and West Birmingham NHS Trust, West Bromich, United Kingdom.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Colley</LastName><ForeName>J</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Sandwell and West Birmingham NHS Trust, West Bromich, United Kingdom.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Davies</LastName><ForeName>S</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>York Teaching Hospitals NHS Foundation Trust, York, United Kingdom.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Szewczyk</LastName><ForeName>M</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>York Teaching Hospitals NHS Foundation Trust, York, United Kingdom.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Smith</LastName><ForeName>T</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>York Teaching Hospitals NHS Foundation Trust, York, United Kingdom.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Ana</LastName><ForeName>F B</ForeName><Initials>FB</Initials><AffiliationInfo><Affiliation>University of Colorado School of Medicine/University of Colorado Hospital, Aurora, United States.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Luzier</LastName><ForeName>E</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>University of Colorado School of Medicine/University of Colorado Hospital, Aurora, United States.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Almagro</LastName><ForeName>A</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>University of Colorado School of Medicine/University of Colorado Hospital, Aurora, United States.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Melo</LastName><ForeName>M V</ForeName><Initials>MV</Initials><AffiliationInfo><Affiliation>Massachusetts General Hospital, Boston, United States.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Fernando</LastName><ForeName>L</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Massachusetts General Hospital, Boston, United States.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Sulemanji</LastName><ForeName>D</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Massachusetts General Hospital, Boston, United States.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Sprung</LastName><ForeName>J</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Mayo Clinic, Rochester, United States.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Weingarten</LastName><ForeName>T</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Mayo Clinic, Rochester, United States.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Kor</LastName><ForeName>D</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Mayo Clinic, Rochester, United States.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Scavonetto</LastName><ForeName>F</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Mayo Clinic, Rochester, United States.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Tze</LastName><ForeName>Y</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Mayo Clinic, Rochester, United States.</Affiliation></AffiliationInfo></Investigator></InvestigatorList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2018</Year><Month>8</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2018</Year><Month>10</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>10</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>2</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>2</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>4</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">30770054</ArticleId><ArticleId IdType="doi">10.1016/j.bja.2018.10.063</ArticleId><ArticleId IdType="pii">S0007-0912(18)31333-3</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">29049195</PMID><DateCompleted><Year>2017</Year><Month>10</Month><Day>31</Day></DateCompleted><DateRevised><Year>2022</Year><Month>03</Month><Day>18</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1536-5964</ISSN><JournalIssue CitedMedium="Internet"><Volume>96</Volume><Issue>42</Issue><PubDate><Year>2017</Year><Month>Oct</Month></PubDate></JournalIssue><Title>Medicine</Title><ISOAbbreviation>Medicine (Baltimore)</ISOAbbreviation></Journal><ArticleTitle>The efficacy of combined intra-articular and intravenous tranexamic acid for blood loss in primary total knee arthroplasty: A meta-analysis.</ArticleTitle><Pagination><StartPage>e8123</StartPage><MedlinePgn>e8123</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e8123</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1097/MD.0000000000008123</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">This meta-analysis aimed to illustrate the efficacy and safety of combined topical and intravenous (IV) tranexamic acid (TXA) for blood loss control in primary total knee arthroplasty (TKA) patients.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">In April 2017, a systematic computer-based search was conducted in PubMed, EMBASE, Web of Science, Cochrane Database of Systematic Reviews, and Google database. Data on patients prepared for TKA surgery in studies that compared combined topical and IV TXA versus placebo, topical, or IV TXA alone were retrieved. The primary endpoint was the need for transfusion, total blood loss, hemoglobin drop, and the occurrence of deep venous thrombosis (DVT), pulmonary embolism (PE), and the infection. After testing for publication bias and heterogeneity between studies, data were aggregated for random-effects models when necessary.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Seven clinical studies were ultimately included in the meta-analysis. Compared with IV TXA and control group, combined TXA was associated with less need for transfusion, blood loss, and hemoglobin drop (P&#x200a;&lt;&#x200a;.05). There was no significant difference between the combined TXA and topical TXA in terms of the need for transfusion, total blood loss, and hemoglobin drop (P&#x200a;&gt;&#x200a;.05). There was no significant difference between the complications (DVT, PE, and infection) between the combined TXA, IV TXA, topical TXA, and control group.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Current meta-analysis suggests that the combined IV and topical TXA was superior than IV TXA or control group. There is still need for more studies to identify whether combined TXA was superior than topical TXA alone.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Zhao</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Department of Orthopedics, Jingjiang People's Hospital, Jingjiang Department of Orthopedics, Yancheng City No. 1 People's Hospital, Yancheng City, Jiangsu Province, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shen</LastName><ForeName>Xiaofei</ForeName><Initials>X</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Medicine (Baltimore)</MedlineTA><NlmUniqueID>2985248R</NlmUniqueID><ISSNLinking>0025-7974</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000933">Antifibrinolytic Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>6T84R30KC1</RegistryNumber><NameOfSubstance UI="D014148">Tranexamic Acid</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D061605" MajorTopicYN="N">Administration, Intravenous</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000933" MajorTopicYN="N">Antifibrinolytic Agents</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="Y">administration &amp; dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019645" MajorTopicYN="N">Arthroplasty, Replacement, Knee</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016063" MajorTopicYN="N">Blood Loss, Surgical</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007270" MajorTopicYN="N">Injections, Intra-Articular</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011655" MajorTopicYN="N">Pulmonary Embolism</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014148" MajorTopicYN="N">Tranexamic Acid</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="Y">administration &amp; dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020246" MajorTopicYN="N">Venous Thrombosis</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading></MeshHeadingList><CoiStatement>The authors report no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2017</Year><Month>10</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2017</Year><Month>10</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2017</Year><Month>11</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2017</Year><Month>10</Month><Day>20</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29049195</ArticleId><ArticleId IdType="pmc">PMC5662361</ArticleId><ArticleId IdType="doi">10.1097/MD.0000000000008123</ArticleId><ArticleId IdType="pii">00005792-201710200-00033</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Li J, Deng X, Jiang T. Combined femoral and sciatic nerve block versus femoral and local infiltration anesthesia for pain control after total knee arthroplasty: a meta-analysis of randomized controlled trials. J Orthop Surg Res 2016;11:158.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5142141</ArticleId><ArticleId IdType="pubmed">27923404</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu SQ, Chen X, Yu CC, et al. Comparison of periarticular anesthesia with liposomal bupivacaine with femoral nerve block for pain control after total knee arthroplasty: a PRISMA-compliant meta-analysis. Medicine (Baltimore) 2017;96:e6462.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5380264</ArticleId><ArticleId IdType="pubmed">28353580</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang C, Lou J, Qian W, et al. Impact of flexion versus extension of knee position on outcomes after total knee arthroplasty: a meta-analysis. Arch Orthop Trauma Surg 2017;137:257&#x2013;65.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5250658</ArticleId><ArticleId IdType="pubmed">28028616</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim JL, Park JH, Han SB, et al. Allogeneic blood transfusion is a significant risk factor for surgical-site infection following total hip and knee arthroplasty: a meta-analysis. J Arthroplasty 2017;32:320&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="pubmed">27682006</ArticleId></ArticleIdList></Reference><Reference><Citation>Pawaskar A, Salunke AA, Kekatpure A, et al. Do autologous blood transfusion systems reduce allogeneic blood transfusion in total knee arthroplasty? Knee Surg Sports Traumatol Arthrosc 2016;[Epub ahead of print].</Citation><ArticleIdList><ArticleId IdType="pubmed">27085359</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang P, Liang Y, Chen P, et al. Intravenous versus topical tranexamic acid in primary total hip replacement: a meta-analysis. Medicine (Baltimore) 2016;95:e5573.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5268036</ArticleId><ArticleId IdType="pubmed">27977590</ArticleId></ArticleIdList></Reference><Reference><Citation>Fu Y, Shi Z, Han B, et al. Comparing efficacy and safety of 2 methods of tranexamic acid administration in reducing blood loss following total knee arthroplasty: a meta-analysis. Medicine (Baltimore) 2016;95:e5583.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5268039</ArticleId><ArticleId IdType="pubmed">27977593</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang S, Gao X, An Y. Topical versus intravenous tranexamic acid in total knee arthroplasty: a meta-analysis of randomized controlled trials. Int Orthop 2017;41:739&#x2013;48.</Citation><ArticleIdList><ArticleId IdType="pubmed">27837327</ArticleId></ArticleIdList></Reference><Reference><Citation>Higgins JPT, G. S. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0. 2011. Available at: http://www.cochrane-handbook.org. Accessed date: 2011.</Citation></Reference><Reference><Citation>Liberati A, Altman DG, Tetzlaff J, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ 2009;339:b2700.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2714672</ArticleId><ArticleId IdType="pubmed">19622552</ArticleId></ArticleIdList></Reference><Reference><Citation>Higgins JP, Altman DG, Gotzsche PC, et al. The Cochrane Collaboration's tool for assessing risk of bias in randomised trials. BMJ 2011;343:d5928.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3196245</ArticleId><ArticleId IdType="pubmed">22008217</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang Z, Ma J, Shen B, et al. Combination of intravenous and topical application of tranexamic acid in primary total knee arthroplasty: a prospective randomized controlled trial. J Arthroplasty 2014;29:2342&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">25007725</ArticleId></ArticleIdList></Reference><Reference><Citation>Jain NP, Nisthane PP, Shah NA. Combined administration of systemic and topical tranexamic acid for total knee arthroplasty: can it be a better regimen and yet safe? A randomized controlled trial. J Arthroplasty 2016;31:542&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">26507526</ArticleId></ArticleIdList></Reference><Reference><Citation>Karaaslan F, Karaoglu S, Mermerkaya MU, et al. Reducing blood loss in simultaneous bilateral total knee arthroplasty: combined intravenous-intra-articular tranexamic acid administration. A prospective randomized controlled trial. Knee 2015;22:131&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="pubmed">25659440</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee SY, Chong S, Balasubramanian D, et al. What is the ideal route of administration of tranexamic acid in TKA? A randomized controlled trial. Clin Orthop Relat Res 2017;475:1987&#x2013;96.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5498377</ArticleId><ArticleId IdType="pubmed">28283902</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin SY, Chen CH, Fu YC, et al. The efficacy of combined use of intraarticular and intravenous tranexamic acid on reducing blood loss and transfusion rate in total knee arthroplasty. J Arthroplasty 2015;30:776&#x2013;80.</Citation><ArticleIdList><ArticleId IdType="pubmed">25534864</ArticleId></ArticleIdList></Reference><Reference><Citation>Nielsen CS, Jans O, Orsnes T, et al. Combined intra-articular and intravenous tranexamic acid reduces blood loss in total knee arthroplasty: a randomized, double-blind, placebo-controlled trial. J Bone Joint Surg Am 2016;98:835&#x2013;41.</Citation><ArticleIdList><ArticleId IdType="pubmed">27194493</ArticleId></ArticleIdList></Reference><Reference><Citation>Song EK, Seon JK, Prakash J, et al. Combined administration of IV and topical tranexamic acid is not superior to either individually in primary navigated TKA. J Arthroplasty 2017;32:37&#x2013;42.</Citation><ArticleIdList><ArticleId IdType="pubmed">27633946</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang P, Liang Y, Chen P, et al. Combined application versus topical and intravenous application of tranexamic acid following primary total hip arthroplasty: a meta-analysis. BMC Musculoskelet Disord 2017;18:90.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5320770</ArticleId><ArticleId IdType="pubmed">28222709</ArticleId></ArticleIdList></Reference><Reference><Citation>Li JF, Li H, Zhao H, et al. Combined use of intravenous and topical versus intravenous tranexamic acid in primary total knee and hip arthroplasty: a meta-analysis of randomised controlled trials. J Orthop Surg Res 2017;12:22.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5290625</ArticleId><ArticleId IdType="pubmed">28153031</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin C, Qi Y, Jie L, et al. Is combined topical with intravenous tranexamic acid superior than topical, intravenous tranexamic acid alone and control groups for blood loss controlling after total knee arthroplasty: a meta-analysis. Medicine (Baltimore) 2016;95:e5344.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5181805</ArticleId><ArticleId IdType="pubmed">28002321</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang XQ, Ni J, Ge WH. Combined use of intravenous and topical versus intravenous tranexamic acid in primary total joint arthroplasty: a meta-analysis of randomized controlled trials. Int J Surg 2017;38:15&#x2013;20.</Citation><ArticleIdList><ArticleId IdType="pubmed">27913237</ArticleId></ArticleIdList></Reference><Reference><Citation>Astedt B, Liedholm P, Wingerup L. The effect of tranexamic acid on the fibrinolytic activity of vein walls. Ann Chir Gynaecol 1978;67:203&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="pubmed">742821</ArticleId></ArticleIdList></Reference><Reference><Citation>Moskal JT, Capps SG. Intra-articular tranexamic acid in primary total knee arthroplasty: meta-analysis. J Knee Surg 2017;[Epub ahead of print].</Citation><ArticleIdList><ArticleId IdType="pubmed">28395370</ArticleId></ArticleIdList></Reference><Reference><Citation>Mi B, Liu G, Zhou W, et al. Intra-articular versus intravenous tranexamic acid application in total knee arthroplasty: a meta-analysis of randomized controlled trials. Arch Orthop Trauma Surg 2017;137:997&#x2013;1009.</Citation><ArticleIdList><ArticleId IdType="pubmed">28378211</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie J, Hu Q, Huang Q, et al. Comparison of intravenous versus topical tranexamic acid in primary total hip and knee arthroplasty: an updated meta-analysis. Thromb Res 2017;153:28&#x2013;36.</Citation><ArticleIdList><ArticleId IdType="pubmed">28319822</ArticleId></ArticleIdList></Reference><Reference><Citation>Meena S, Benazzo F, Dwivedi S, et al. Topical versus intravenous tranexamic acid in total knee arthroplasty. J Orthop Surg (Hong Kong) 2017;25:2309499016684300.</Citation><ArticleIdList><ArticleId IdType="pubmed">28176605</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">19249419</PMID><DateCompleted><Year>2009</Year><Month>03</Month><Day>31</Day></DateCompleted><DateRevised><Year>2024</Year><Month>10</Month><Day>17</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1097-6744</ISSN><JournalIssue CitedMedium="Internet"><Volume>157</Volume><Issue>3</Issue><PubDate><Year>2009</Year><Month>Mar</Month></PubDate></JournalIssue><Title>American heart journal</Title><ISOAbbreviation>Am Heart J</ISOAbbreviation></Journal><ArticleTitle>Nitrous oxide and perioperative cardiac morbidity (ENIGMA-II) Trial: rationale and design.</ArticleTitle><Pagination><StartPage>488</StartPage><EndPage>494.e1</EndPage><MedlinePgn>488-494.e1</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.ahj.2008.11.015</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Globally there are &gt;200 million major surgical procedures undertaken annually, and about 20% of these involve patients who have coronary artery disease. Many receive nitrous oxide, which impairs methionine synthase, thus inhibiting folate synthesis and increasing postoperative homocysteine levels. Nitrous oxide anesthesia leads to postoperative endothelial dysfunction, and there is some evidence that it increases myocardial ischemia and, possibly, myocardial infarction. We have initiated the Nitrous oxide and perioperative cardiac morbidity (ENIGMA-II) Trial to test the hypothesis that in inpatients undergoing anesthesia for major noncardiac surgery, avoidance of nitrous oxide will reduce the incidence of death and major cardiovascular events.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">ENIGMA-II is a 7,000-patient, international randomized trial involving patients at risk of coronary artery disease undergoing noncardiac surgery. The patients, health care providers (except for the anesthesiologists), data collectors, and outcome adjudicators are blinded to whether patients receive nitrous oxide-containing or nitrous oxide-free anesthetic. The primary outcome is a composite of death and major nonfatal events (ie, myocardial infarction, cardiac arrest, pulmonary embolism, and stroke) at 30 days after surgery.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">At present, ENIGMA-II has randomized &gt;1,000 patients in 22 hospitals in 5 countries. To date, patients' mean age is 70 years, 66% are men, 38% have a history of coronary artery disease, 19% have a history of cerebrovascular disease, and 84% have a history of hypertension. Most patients have undergone intra-abdominal 28%, vascular 32%, and orthopedic 16% surgery.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">The ENIGMA-II Trial will be the largest study yet conducted to ascertain the benefits and risks of removing nitrous oxide from the gas mixture in anesthesia. The results of this large international trial will guide the clinical care of the hundreds of millions of adults undergoing noncardiac surgery annually.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Myles</LastName><ForeName>Paul S</ForeName><Initials>PS</Initials><AffiliationInfo><Affiliation>Department of Anaesthesia and Perioperative Medicine, Alfred Hospital, Melbourne, Victoria, Australia. p.myles@alfred.org.au</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Leslie</LastName><ForeName>Kate</ForeName><Initials>K</Initials></Author><Author ValidYN="Y"><LastName>Peyton</LastName><ForeName>Philip</ForeName><Initials>P</Initials></Author><Author ValidYN="Y"><LastName>Paech</LastName><ForeName>Michael</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Forbes</LastName><ForeName>Andrew</ForeName><Initials>A</Initials></Author><Author ValidYN="Y"><LastName>Chan</LastName><ForeName>Matthew T V</ForeName><Initials>MT</Initials></Author><Author ValidYN="Y"><LastName>Sessler</LastName><ForeName>Daniel</ForeName><Initials>D</Initials></Author><Author ValidYN="Y"><LastName>Devereaux</LastName><ForeName>Philip J</ForeName><Initials>PJ</Initials></Author><Author ValidYN="Y"><LastName>Silbert</LastName><ForeName>Brendan S</ForeName><Initials>BS</Initials></Author><Author ValidYN="Y"><LastName>Jamrozik</LastName><ForeName>Konrad</ForeName><Initials>K</Initials></Author><Author ValidYN="Y"><LastName>Beattie</LastName><ForeName>Scott</ForeName><Initials>S</Initials></Author><Author ValidYN="Y"><LastName>Badner</LastName><ForeName>Neal</ForeName><Initials>N</Initials></Author><Author ValidYN="Y"><LastName>Tomlinson</LastName><ForeName>James</ForeName><Initials>J</Initials></Author><Author ValidYN="Y"><LastName>Wallace</LastName><ForeName>Sophia</ForeName><Initials>S</Initials></Author><Author ValidYN="Y"><CollectiveName>ANZCA Trials Group</CollectiveName></Author></AuthorList><Language>eng</Language><DataBankList CompleteYN="Y"><DataBank><DataBankName>ClinicalTrials.gov</DataBankName><AccessionNumberList><AccessionNumber>NCT00430989</AccessionNumber></AccessionNumberList></DataBank></DataBankList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016448">Multicenter Study</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Am Heart J</MedlineTA><NlmUniqueID>0370465</NlmUniqueID><ISSNLinking>0002-8703</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D018685">Anesthetics, Inhalation</NameOfSubstance></Chemical><Chemical><RegistryNumber>0LVT1QZ0BA</RegistryNumber><NameOfSubstance UI="D006710">Homocysteine</NameOfSubstance></Chemical><Chemical><RegistryNumber>K50XQU1029</RegistryNumber><NameOfSubstance UI="D009609">Nitrous Oxide</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018685" MajorTopicYN="N">Anesthetics, Inhalation</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002318" MajorTopicYN="N">Cardiovascular Diseases</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006710" MajorTopicYN="N">Homocysteine</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007902" MajorTopicYN="N">Length of Stay</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009609" MajorTopicYN="N">Nitrous Oxide</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011014" MajorTopicYN="N">Pneumonia</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012107" MajorTopicYN="N">Research Design</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018570" MajorTopicYN="N">Risk Assessment</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013514" MajorTopicYN="N">Surgical Procedures, Operative</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013530" MajorTopicYN="N">Surgical Wound Infection</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014839" MajorTopicYN="N">Vomiting</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading></MeshHeadingList><InvestigatorList><Investigator ValidYN="Y"><LastName>Myles</LastName><ForeName>Paul</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Leslie</LastName><ForeName>Kate</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>Peyton</LastName><ForeName>Phil</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Peach</LastName><ForeName>Mike</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Silbert</LastName><ForeName>Brendan</ForeName><Initials>B</Initials></Investigator><Investigator ValidYN="Y"><LastName>Devereaux</LastName><ForeName>Philip J</ForeName><Initials>PJ</Initials></Investigator><Investigator ValidYN="Y"><LastName>Sessler</LastName><ForeName>Dan</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Forbes</LastName><ForeName>Andrew</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Beattie</LastName><ForeName>Scott</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Wallace</LastName><ForeName>Sophia</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Myles</LastName><ForeName>Paul</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Leslie</LastName><ForeName>Kate</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>Peyton</LastName><ForeName>Phil</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Peach</LastName><ForeName>Mike</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Silbert</LastName><ForeName>Brendan</ForeName><Initials>B</Initials></Investigator><Investigator ValidYN="Y"><LastName>Devereaux</LastName><ForeName>Philip J</ForeName><Initials>PJ</Initials></Investigator><Investigator ValidYN="Y"><LastName>Sessler</LastName><ForeName>Dan</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Forbes</LastName><ForeName>Andrew</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Tomlinson</LastName><ForeName>James W</ForeName><Initials>JW</Initials></Investigator><Investigator ValidYN="Y"><LastName>McIlroy</LastName><ForeName>David R</ForeName><Initials>DR</Initials></Investigator><Investigator ValidYN="Y"><LastName>Badner</LastName><ForeName>Neal</ForeName><Initials>N</Initials></Investigator><Investigator ValidYN="Y"><LastName>Krum</LastName><ForeName>Henry</ForeName><Initials>H</Initials></Investigator><Investigator ValidYN="Y"><LastName>Forbes</LastName><ForeName>Andrew</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Jamrozik</LastName><ForeName>Konrad</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>Rigg</LastName><ForeName>John</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Krum</LastName><ForeName>Henry</ForeName><Initials>H</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ryan</LastName><ForeName>Philip</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Wallace</LastName><ForeName>Sophia</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Meehan</LastName><ForeName>Adam</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Meehan</LastName><ForeName>Adam</ForeName><Initials>A</Initials></Investigator></InvestigatorList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2008</Year><Month>9</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2008</Year><Month>11</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2009</Year><Month>3</Month><Day>3</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2009</Year><Month>3</Month><Day>3</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2009</Year><Month>4</Month><Day>1</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">19249419</ArticleId><ArticleId IdType="doi">10.1016/j.ahj.2008.11.015</ArticleId><ArticleId IdType="pii">S0002-8703(08)01038-7</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">28682954</PMID><DateCompleted><Year>2018</Year><Month>12</Month><Day>31</Day></DateCompleted><DateRevised><Year>2018</Year><Month>12</Month><Day>31</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1526-7598</ISSN><JournalIssue CitedMedium="Internet"><Volume>126</Volume><Issue>2</Issue><PubDate><Year>2018</Year><Month>Feb</Month></PubDate></JournalIssue><Title>Anesthesia and analgesia</Title><ISOAbbreviation>Anesth Analg</ISOAbbreviation></Journal><ArticleTitle>Acute Intracardiac Thrombosis and Pulmonary Thromboembolism After Cardiopulmonary Bypass: A Systematic Review of Reported Cas.</ArticleTitle><Pagination><StartPage>425</StartPage><EndPage>434</EndPage><MedlinePgn>425-434</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1213/ANE.0000000000002259</ELocationID><Abstract><AbstractText>Intracardiac thrombosis (ICT) and pulmonary thromboembolism (PE) after cardiopulmonary bypass (CPB) are life-threatening events, but pathological mechanisms are not yet well defined. The aim of this review is to provide an update of case literature of a postbypass hypercoagulable state. Case commonalities among 48 ICT/PE events included congestive heart failure (50%), platelet transfusion (37.5%), CPB duration greater than 3 hours (37.5%), and aortic injury (27.1%). Preexisting thrombophilia was rarely reported, and 16.7% had low activated clotting time, &#x2264;400 seconds during CPB. Mortality rate was very high (85.4%), despite attempted thrombectomy and supportive therapy. Thrombolytic therapy was infrequently used (5 of 48 times), but its efficacy is questionable due to common use of antifibrinolytic therapy (77.1% of cases). Acute ICT/PE events appear to rarely occur, but common features include prolonged CPB, depressed myocardial function, major vascular injury, and hemostatic interventions. Further efforts to elucidate pathomechanisms and optimize anticoagulation during CPB and hemostatic interventions after CPB are warranted.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Williams</LastName><ForeName>Brittney</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>From the Department of Anesthesiology.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wehman</LastName><ForeName>Brody</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Surgery, Division of Cardiac Surgery, University of Maryland School of Medicine, Baltimore, Maryland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mazzeffi</LastName><ForeName>Michael A</ForeName><Initials>MA</Initials><AffiliationInfo><Affiliation>From the Department of Anesthesiology.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Odonkor</LastName><ForeName>Patrick</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>From the Department of Anesthesiology.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Harris</LastName><ForeName>Ryan L</ForeName><Initials>RL</Initials><AffiliationInfo><Affiliation>Health Sciences and Human Services Library, University of Maryland, Baltimore, Maryland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kon</LastName><ForeName>Zachary</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Department of Surgery, Division of Cardiac Surgery, University of Maryland School of Medicine, Baltimore, Maryland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tanaka</LastName><ForeName>Kenichi A</ForeName><Initials>KA</Initials><AffiliationInfo><Affiliation>From the Department of Anesthesiology.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D002363">Case Reports</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Anesth Analg</MedlineTA><NlmUniqueID>1310650</NlmUniqueID><ISSNLinking>0003-2999</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002315" MajorTopicYN="N">Cardiopulmonary Bypass</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName><QualifierName UI="Q000639" MajorTopicYN="N">trends</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006331" MajorTopicYN="N">Heart Diseases</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011655" MajorTopicYN="N">Pulmonary Embolism</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013927" MajorTopicYN="N">Thrombosis</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2017</Year><Month>7</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>1</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2017</Year><Month>7</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">28682954</ArticleId><ArticleId IdType="doi">10.1213/ANE.0000000000002259</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">35439203</PMID><DateCompleted><Year>2022</Year><Month>06</Month><Day>20</Day></DateCompleted><DateRevised><Year>2022</Year><Month>09</Month><Day>27</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1940-5480</ISSN><JournalIssue CitedMedium="Internet"><Volume>30</Volume><Issue>13</Issue><PubDate><Year>2022</Year><Month>Jul</Month><Day>01</Day></PubDate></JournalIssue><Title>The Journal of the American Academy of Orthopaedic Surgeons</Title><ISOAbbreviation>J Am Acad Orthop Surg</ISOAbbreviation></Journal><ArticleTitle>Red Blood Cell Transfusions and Risk of Postoperative Venous Thromboembolism.</ArticleTitle><Pagination><StartPage>e919</StartPage><EndPage>e928</EndPage><MedlinePgn>e919-e928</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.5435/JAAOS-D-22-00043</ELocationID><Abstract><AbstractText Label="INTRODUCTION">Postoperative venous thromboembolism (VTE) is a major risk for orthopaedic surgery and associated with notable morbidity and mortality. Knowing a patient's risk for VTE may help guide the choice of perioperative VTE prophylaxis. Recently, red blood cells (RBCs) have been implicated for their role in pathologic thrombosis. Therefore, we examine the association between perioperative RBC transfusion and postoperative VTE after orthopaedic surgery.</AbstractText><AbstractText Label="METHODS">A retrospective cohort study was done by conducting a secondary analysis of data obtained from the 2016 American College of Surgeons National Surgical Quality Improvement Program database. Our population consisted of 234,608 adults who underwent orthopaedic surgery. The exposure was whether patients received a perioperative RBC transfusion. The primary outcome was postoperative VTE within 30 days of surgery that warranted therapeutic intervention, which was subsequently split into symptomatic deep vein thrombosis (DVT) and pulmonary embolism (PE). Odds ratios (ORs) were estimated using a multivariate logistic regression model.</AbstractText><AbstractText Label="RESULTS">At baseline, 1,952 patients (0.83%) had postoperative VTE (DVT in 1,299 [0.55%], PE in 801 [0.34%], and both DVT and PE in 148 [0.06%]). Seven hundred ninety-five patients (0.3%) received preoperative RBC transfusions only, 11,587 patients (4.9%) received postoperative RBC transfusions only, and 848 patients (0.4%) received both preoperative and postoperative RBC transfusions. Postoperative RBC transfusion was associated with higher odds of VTE (adjusted OR [aOR],&#x2009;1.47; 95% confidence interval [CI], 1.19-1.81), DVT (aOR, 1.40; 95% CI, 1.09-1.79), PE (aOR, 1.59; 95% CI, 1.14-2.22), and 30-day mortality (aOR, 1.21; 95% CI, 1.01-1.45) independent of various presumed risk factors. When creating subgroups within orthopaedics by Current Procedural Terminology codes, postoperative transfusions in spine (aOR, 2.03; 95% CI, 1.13-3.67) and trauma (aOR, 1.40; 95% CI, 1.06-1.86) were associated with higher odds of postoperative VTE.</AbstractText><AbstractText Label="CONCLUSION">Our results suggest that postoperative RBC transfusion may be associated with an increased risk of postoperative VTE, both symptomatic DVT and life-threatening PE, independent of confounders. Additional prospective validation in cohort studies is necessary to confirm these findings. In addition, careful perioperative planning for patients deemed to be at high risk of requiring blood transfusion may reduce these postoperative complications in orthopaedic patients.</AbstractText><AbstractText Label="LEVEL OF EVIDENCE">III.</AbstractText><CopyrightInformation>Copyright &#xa9; 2022 by the American Academy of Orthopaedic Surgeons.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Sheth</LastName><ForeName>Bhavya K</ForeName><Initials>BK</Initials><Identifier Source="ORCID">0000-0001-8189-4947</Identifier><AffiliationInfo><Affiliation>From the Florida International University Herbert Wertheim College of Medicine, Miami, FL (Sheth, Ravipati, Arif, and Castro), the Department of Orthopaedic Surgery and Rehabilitation, Maimonides Medical Center, Brooklyn, NY (Sheth), and the Department of Orthopaedic Surgery, University of Miami, Miami, FL (Yakkanti and Hernandez).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yakkanti</LastName><ForeName>Ramakanth</ForeName><Initials>R</Initials></Author><Author ValidYN="Y"><LastName>Ravipati</LastName><ForeName>Kaushik</ForeName><Initials>K</Initials></Author><Author ValidYN="Y"><LastName>Arif</LastName><ForeName>Bilal</ForeName><Initials>B</Initials></Author><Author ValidYN="Y"><LastName>Castro</LastName><ForeName>Grettel</ForeName><Initials>G</Initials></Author><Author ValidYN="Y"><LastName>Hernandez</LastName><ForeName>Victor</ForeName><Initials>V</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>04</Month><Day>18</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Am Acad Orthop Surg</MedlineTA><NlmUniqueID>9417468</NlmUniqueID><ISSNLinking>1067-151X</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017707" MajorTopicYN="N">Erythrocyte Transfusion</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011655" MajorTopicYN="Y">Pulmonary Embolism</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D054556" MajorTopicYN="Y">Venous Thromboembolism</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>1</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>2</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>4</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>6</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>4</Month><Day>19</Day><Hour>17</Hour><Minute>11</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35439203</ArticleId><ArticleId IdType="doi">10.5435/JAAOS-D-22-00043</ArticleId><ArticleId IdType="pii">00124635-202207010-00012</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Anderson FA Jr, Spencer FA: Risk factors for venous thromboembolism. Circulation 2003;107(23 suppl 1):I9-I16.</Citation></Reference><Reference><Citation>Lau BD, Haut ER: Practices to prevent venous thromboembolism: A brief review. BMJ Qual Saf 2014;23:187-195.</Citation></Reference><Reference><Citation>Zeidan AM, Streiff MB, Lau BD, et al.: Impact of a venous thromboembolism prophylaxis &#x201c;smart order set&#x201d;: Improved compliance, fewer events. Am J Hematol 2013;88:545-549.</Citation></Reference><Reference><Citation>Gangireddy C, Rectenwald JR, Upchurch GR, et al.: Risk factors and clinical impact of postoperative symptomatic venous thromboembolism. J Vasc Surg 2007;45:335-342.</Citation></Reference><Reference><Citation>Flordal PA, Berggvist D, Burmark US, Ljungstr&#xf6;m KG, T&#xf6;rngren S: Risk factors for major thromboembolism and bleeding tendency after elective general surgical operations. The Fragmin Multicentre Study Group. Eur J Surg 1996;162:783-789.</Citation></Reference><Reference><Citation>Geerts WH, Code KI, Jay RM, Chen E, Szalai JP: A prospective study of venous thromboembolism after major trauma. N Engl J Med 1994;331:1601-1606.</Citation></Reference><Reference><Citation>Cook D, Crowther M, Meade M, et al.: Deep venous thrombosis in medical-surgical critically ill patients: Prevalence, incidence, and risk factors. Crit Care Med 2005;33:1565-1571.</Citation></Reference><Reference><Citation>Fleming FJ, Kim MJ, Salloum RM, Young KC, Monson JR: How much do we need to worry about venous thromboembolism after hospital discharge? A study of colorectal surgery patients using the National Surgical Quality Improvement Program database. Dis Colon Rectum 2010;53:1355-1360.</Citation></Reference><Reference><Citation>Rosenfeld BA, Beattie C, Christopherson R, et al.; Perioperative Ischemia Randomized Anesthesia Trial Study Group: The effects of different anesthetic regimens on fibrinolysis and the development of postoperative arterial thrombosis. Anesthesiology 1993;79:435-443.</Citation></Reference><Reference><Citation>Gray DH, Mackie CE: The effect of blood transfusion on the incidence of deep vein thrombosis. Aust N Z J Surg 1983;53:439-443.</Citation></Reference><Reference><Citation>Spahn DR, Casutt M: Eliminating blood transfusions: New aspects and perspectives. Anesthesiology 2000;93:242-255.</Citation></Reference><Reference><Citation>Goodnough LT, Brecher ME, Kanter MH, AuBuchon JP: Transfusion medicine. First of two parts&#x2014;Blood transfusion. N Engl J Med 1999;340:438-447.</Citation></Reference><Reference><Citation>Byrnes JR, Wolberg AS: Red blood cells in thrombosis. Blood 2017;130:1795-1799.</Citation></Reference><Reference><Citation>Litvinov RI, Weisel JW: Role of red blood cells in haemostasis and thrombosis. ISBT Sci Ser 2017;12:176-183.</Citation></Reference><Reference><Citation>Hod EA, Godbey EA: The outsider adverse event in transfusion: Inflammation. Presse Med 2016;45(7-8 pt 2):e325-e329.</Citation></Reference><Reference><Citation>Hod EA: Red blood cell transfusion-induced inflammation: Myth or reality. ISBT Sci Ser 2015;10(suppl 1):188-191.</Citation></Reference><Reference><Citation>Donadee C, Raat NJ, Kanias T, et al.: Nitric oxide scavenging by red blood cell microparticles and cell-free hemoglobin as a mechanism for the red cell storage lesion. Circulation 2011;124:465-476.</Citation></Reference><Reference><Citation>Liu C, Zhao W, Christ GJ, Gladwin MT, Kim-Shapiro DB: Nitric oxide scavenging by red cell microparticles. Free Radic Biol Med 2013;65:1164-1173.</Citation></Reference><Reference><Citation>Blumberg N, Heal JM: Blood transfusion immunomodulation: The silent epidemic. Arch Pathol Lab Med 1998;122:117-119.</Citation></Reference><Reference><Citation>Barr JD, Chauhan AK, Schaeffer GV, Hansen JK, Motto DG: Red blood cells mediate the onset of thrombosis in the ferric chloride murine model. Blood 2013;121:3733-3741.</Citation></Reference><Reference><Citation>Goel R, Patel EU, Cushing MM, et al.: Association of perioperative red blood cell transfusions with venous thromboembolism in a North American Registry. JAMA Surg 2018;153:826-833.</Citation></Reference><Reference><Citation>Xenos ES, Vargas HD, Davenport DL: Association of blood transfusion and venous thromboembolism after colorectal cancer resection. Thromb Res 2012;129:568-572.</Citation></Reference><Reference><Citation>Khorana AA, Francis CW, Blumberg N, Culakova E, Refaai MA, Lyman GH: Blood transfusions, thrombosis, and mortality in hospitalized patients with cancer. Arch Intern Med 2008;168:2377-2381.</Citation></Reference><Reference><Citation>Aoude A, Nooh A, Fortin M, et al.: Incidence, predictors, and postoperative complications of blood transfusion in thoracic and lumbar fusion surgery: An analysis of 13,695 patients from the American College of Surgeons National Surgical Quality Improvement Program Database. Global Spine J 2016;6:756-764.</Citation></Reference><Reference><Citation>Jiang T, Song K, Yao Y, Pan P, Jiang Q: Perioperative allogenic blood transfusion increases the incidence of postoperative deep vein thrombosis in total knee and hip arthroplasty. J Orthop Surg Res 2019;14:235.</Citation></Reference><Reference><Citation>Acu&#xf1;a AJ, Grits D, Samuel LT, Emara AK, Kamath AF: Perioperative blood transfusions are associated with a higher incidence of thromboembolic events after TKA: An analysis of 333,463 TKAs. Clin Orthop Relat Res 2021;479:589-600.</Citation></Reference><Reference><Citation>Liu Y, Cohen ME, Hall BL, Ko CY, Bilimoria KY: Evaluation and enhancement of calibration in the American College of Surgeons NSQIP surgical risk calculator. J Am Coll Surg 2016;223:231-239.</Citation></Reference><Reference><Citation>Mansmann U, Rieger A, Strahwald B, Crispin A: Risk calculators: Methods, development, implementation, and validation. Int J Colorectal Dis 2016;31:1111-1116.</Citation></Reference><Reference><Citation>Kaafarani HM, Mavros MN, Hwabejire J, et al.: Derivation and validation of a novel severity classification for intraoperative adverse events. J Am Coll Surg 2014;218:1120-1128.</Citation></Reference><Reference><Citation>Khuri SF, Daley J, Henderson W, et al.; National VA Surgical Quality Improvement Program: The Department of Veterans Affairs' NSQIP: The first national, validated, outcome-based, risk-adjusted, and peer-controlled program for the measurement and enhancement of the quality of surgical care. Ann Surg 1998;228:491-507.</Citation></Reference><Reference><Citation>Daley J, Khuri SF, Henderson W, et al.: Risk adjustment of the postoperative morbidity rate for the comparative assessment of the quality of surgical care: Results of the National Veterans Affairs Surgical Risk Study. J Am Coll Surg 1997;185:328-340.</Citation></Reference><Reference><Citation>Accreditation Council for Graduate Medical Education Orthopedic Surgery Case Log Guidelines. Available at: https://www.acgme.org/Specialties/Documents-and-Resources/pfcatid/14/Orthopaedic%20Surgery . Accessed May 13, 2021.</Citation></Reference><Reference><Citation>Blajchman MA, Bordin JO, Bardossy L, Heddle NM: The contribution of the haematocrit to thrombocytopenic bleeding in experimental animals. Br J Haematol 1994;86:347-350.</Citation></Reference><Reference><Citation>Valeri CR, Cassidy G, Pivacek LE, et al.: Anemia-induced increase in the bleeding time: Implications for treatment of nonsurgical blood loss. Transfusion 2001;41:977-983.</Citation></Reference><Reference><Citation>Uhl L, Assmann SF, Hamza TH, Harrison RW, Gernsheimer T, Slichter SJ: Laboratory predictors of bleeding and the effect of platelet and RBC transfusions on bleeding outcomes in the PLADO trial. Blood 2017;130:1247-1258.</Citation></Reference><Reference><Citation>Schafer AI: Bleeding and thrombosis in the myeloproliferative disorders. Blood 1984;64:1-12.</Citation></Reference><Reference><Citation>Rossi C, Randi ML, Zerbinati P, Rinaldi V, Girolami A: Acute coronary disease in essential thrombocythemia and polycythemia vera. J Intern Med 1998;244:49-53.</Citation></Reference><Reference><Citation>Stoltz JF, Donner M: New trends in clinical hemorheology: An introduction to the concept of the hemorheological profile. Schweiz Med Wochenschr Suppl 1991;43:41-49.</Citation></Reference><Reference><Citation>Valles J, Santos MT, Aznar J, et al.: Erythrocytes metabolically enhance collagen-induced platelet responsiveness via increased thromboxane production, adenosine diphosphate release, and recruitment. Blood 1991;78:154-162.</Citation></Reference><Reference><Citation>Zimrin AB, Hess JR: Current issues relating to the transfusion of stored red blood cells. Vox Sang 2009;96:93-103.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">19726018</PMID><DateCompleted><Year>2009</Year><Month>12</Month><Day>29</Day></DateCompleted><DateRevised><Year>2025</Year><Month>06</Month><Day>23</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">2046-4924</ISSN><JournalIssue CitedMedium="Internet"><Volume>13</Volume><Issue>41</Issue><PubDate><Year>2009</Year><Month>Sep</Month></PubDate></JournalIssue><Title>Health technology assessment (Winchester, England)</Title><ISOAbbreviation>Health Technol Assess</ISOAbbreviation></Journal><ArticleTitle>The clinical effectiveness and cost-effectiveness of bariatric (weight loss) surgery for obesity: a systematic review and economic evaluation.</ArticleTitle><Pagination><StartPage>1</StartPage><EndPage>iv</EndPage><MedlinePgn>1-190, 215-357, iii-iv</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.3310/hta13410</ELocationID><Abstract><AbstractText Label="OBJECTIVES" NlmCategory="OBJECTIVE">To assess the clinical effectiveness and cost-effectiveness of bariatric surgery for obesity.</AbstractText><AbstractText Label="DATA SOURCES" NlmCategory="METHODS">Seventeen electronic databases were searched [MEDLINE; EMBASE; PreMedline In-Process &amp; Other Non-Indexed Citations; The Cochrane Library including the Cochrane Systematic Reviews Database, Cochrane Controlled Trials Register, DARE, NHS EED and HTA databases; Web of Knowledge Science Citation Index (SCI); Web of Knowledge ISI Proceedings; PsycInfo; CRD databases; BIOSIS; and databases listing ongoing clinical trials] from inception to August 2008. Bibliographies of related papers were assessed and experts were contacted to identify additional published and unpublished references.</AbstractText><AbstractText Label="REVIEW METHODS" NlmCategory="METHODS">Two reviewers independently screened titles and abstracts for eligibility. Inclusion criteria were applied to the full text using a standard form. Interventions investigated were open and laparoscopic bariatric surgical procedures in widespread current use compared with one another and with non-surgical interventions. Population comprised adult patients with body mass index (BMI) &gt; or = 30 and young obese people. Main outcomes were at least one of the following after at least 12 months follow-up: measures of weight change; quality of life (QoL); perioperative and postoperative mortality and morbidity; change in obesity-related comorbidities; cost-effectiveness. Studies eligible for inclusion in the systematic review for comparisons of Surgery versus Surgery were RCTs. For comparisons of Surgery versus Non-surgical procedures eligible studies were RCTs, controlled clinical trials and prospective cohort studies (with a control cohort). Studies eligible for inclusion in the systematic review of cost-effectiveness were full cost-effectiveness analyses, cost-utility analyses, cost-benefit analyses and cost-consequence analyses. One reviewer performed data extraction, which was checked by two reviewers independently. Two reviewers independently applied quality assessment criteria and differences in opinion were resolved at each stage. Studies were synthesised through a narrative review with full tabulation of the results of all included studies. In the economic model the analysis was developed for three patient populations, those with BMI &gt; or = 40; BMI &gt; or = 30 and &lt; 40 with Type 2 diabetes at baseline; and BMI &gt; or = 30 and &lt; 35. Models were applied with assumptions on costs and comorbidity.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">A total of 5386 references were identified of which 26 were included in the clinical effectiveness review: three randomised controlled trials (RCTs) and three cohort studies compared surgery with non-surgical interventions and 20 RCTs compared different surgical procedures. Bariatric surgery was a more effective intervention for weight loss than non-surgical options. In one large cohort study weight loss was still apparent 10 years after surgery, whereas patients receiving conventional treatment had gained weight. Some measures of QoL improved after surgery, but not others. After surgery statistically fewer people had metabolic syndrome and there was higher remission of Type 2 diabetes than in non-surgical groups. In one large cohort study the incidence of three out of six comorbidities assessed 10 years after surgery was significantly reduced compared with conventional therapy. Gastric bypass (GBP) was more effective for weight loss than vertical banded gastroplasty (VBG) and adjustable gastric banding (AGB). Laparoscopic isolated sleeve gastrectomy (LISG) was more effective than AGB in one study. GBP and banded GBP led to similar weight loss and results for GBP versus LISG and VBG versus AGB were equivocal. All comparisons of open versus laparoscopic surgeries found similar weight losses in each group. Comorbidities after surgery improved in all groups, but with no significant differences between different surgical interventions. Adverse event reporting varied; mortality ranged from none to 10%. Adverse events from conventional therapy included intolerance to medication, acute cholecystitis and gastrointestinal problems. Major adverse events following surgery, some necessitating reoperation, included anastomosis leakage, pneumonia, pulmonary embolism, band slippage and band erosion. Bariatric surgery was cost-effective in comparison to non-surgical treatment in the reviewed published estimates of cost-effectiveness. However, these estimates are likely to be unreliable and not generalisable because of methodological shortcomings and the modelling assumptions made. Therefore a new economic model was developed. Surgical management was more costly than non-surgical management in each of the three patient populations analysed, but gave improved outcomes. For morbid obesity, incremental cost-effectiveness ratios (ICERs) (base case) ranged between 2000 pounds and 4000 pounds per QALY gained. They remained within the range regarded as cost-effective from an NHS decision-making perspective when assumptions for deterministic sensitivity analysis were changed. For BMI &gt; or = 30 and 40, ICERs were 18,930 pounds at two years and 1397 pounds at 20 years, and for BMI &gt; or = 30 and &lt; 35, ICERs were 60,754 pounds at two years and 12,763 pounds at 20 years. Deterministic and probabilistic sensitivity analyses produced ICERs which were generally within the range considered cost-effective, particularly at the long twenty year time horizons, although for the BMI 30-35 group some ICERs were above the acceptable range.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Bariatric surgery appears to be a clinically effective and cost-effective intervention for moderately to severely obese people compared with non-surgical interventions. Uncertainties remain and further research is required to provide detailed data on patient QoL; impact of surgeon experience on outcome; late complications leading to reoperation; duration of comorbidity remission; resource use. Good-quality RCTs will provide evidence on bariatric surgery for young people and for adults with class I or class II obesity. New research must report on the resolution and/or development of comorbidities such as Type 2 diabetes and hypertension so that the potential benefits of early intervention can be assessed.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Picot</LastName><ForeName>J</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Southampton Health Technology Assessments Centre, University of Southampton, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jones</LastName><ForeName>J</ForeName><Initials>J</Initials></Author><Author ValidYN="Y"><LastName>Colquitt</LastName><ForeName>J L</ForeName><Initials>JL</Initials></Author><Author ValidYN="Y"><LastName>Gospodarevskaya</LastName><ForeName>E</ForeName><Initials>E</Initials></Author><Author ValidYN="Y"><LastName>Loveman</LastName><ForeName>E</ForeName><Initials>E</Initials></Author><Author ValidYN="Y"><LastName>Baxter</LastName><ForeName>L</ForeName><Initials>L</Initials></Author><Author ValidYN="Y"><LastName>Clegg</LastName><ForeName>A J</ForeName><Initials>AJ</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Health Technol Assess</MedlineTA><NlmUniqueID>9706284</NlmUniqueID><ISSNLinking>1366-5278</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D050110" MajorTopicYN="N">Bariatric Surgery</DescriptorName><QualifierName UI="Q000191" MajorTopicYN="Y">economics</QualifierName><QualifierName UI="Q000592" MajorTopicYN="Y">standards</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003362" MajorTopicYN="N">Cost-Benefit Analysis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009765" MajorTopicYN="N">Obesity</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017063" MajorTopicYN="Y">Outcome Assessment, Health Care</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading></MeshHeadingList><NumberOfReferences>197</NumberOfReferences></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2009</Year><Month>9</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2009</Year><Month>9</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2009</Year><Month>12</Month><Day>30</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">19726018</ArticleId><ArticleId IdType="doi">10.3310/hta13410</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">40465043</PMID><DateCompleted><Year>2025</Year><Month>06</Month><Day>04</Day></DateCompleted><DateRevised><Year>2025</Year><Month>06</Month><Day>05</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1437-2320</ISSN><JournalIssue CitedMedium="Internet"><Volume>48</Volume><Issue>1</Issue><PubDate><Year>2025</Year><Month>Jun</Month><Day>04</Day></PubDate></JournalIssue><Title>Neurosurgical review</Title><ISOAbbreviation>Neurosurg Rev</ISOAbbreviation></Journal><ArticleTitle>Predictors of pulmonary embolism in adult patients following neurosurgery: a Chinese single-center, retrospective study.</ArticleTitle><Pagination><StartPage>481</StartPage><MedlinePgn>481</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s10143-025-03633-8</ELocationID><Abstract><AbstractText>Patients undergoing neurosurgery are at elevated risk for venous thromboembolism (VTE), including deep vein thrombosis (DVT) and pulmonary embolism (PE). The incidence and risk factors for PE in neurosurgical patients remain a subject of debate. This study aimed to identify risk factors for PE in this population. We conducted a retrospective case-control study of post-neurosurgical hospitalized patients with PE from January 2017 to March 2023 at the First Affiliated Hospital of Sun Yat-sen University. A control group, matched for age, sex, and entry time (1:3 ratio), consisted of patients without PE. Clinical and biomarker variables were recorded for analysis. Univariate and multivariable logistic regression (MLR) analyses were performed to identify predictive factors for postoperative PE, and diagnostic performance was assessed using receiver operating characteristic (ROC) curve analysis.47 PE patients confirmed by computed tomography pulmonary angiography (CTPA) and 141 matched controls were included. The average annual incidence of PE was 0.4%. MLR identified longer surgical duration (OR 1.404, P&#x2009;&lt;&#x2009;0.001), higher postoperative D-dimer levels (OR 1.170, P&#x2009;=&#x2009;0.003), and lower platelet count (OR 0.991, P&#x2009;=&#x2009;0.040) as independent risk factors for PE. The logistic regression model demonstrated strong diagnostic performance. Prognosis analysis revealed a lower mortality rate in the PE group (10.64%) compared to the non-PE group (20.57%). The clinical prediction model, incorporating surgery duration, postoperative D-dimer levels, and platelet count, effectively identifies patients at high risk for PE following neurosurgery, aiding in prevention strategies.</AbstractText><CopyrightInformation>&#xa9; 2025. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Gong</LastName><ForeName>Jie</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Neurosurgery ICU, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, 510080, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Xie</LastName><ForeName>Baoshu</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Neurosurgery, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, 510080, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Wang</LastName><ForeName>Yufang</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Neurosurgery ICU, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, 510080, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Yanting</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Neurosurgery ICU, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, 510080, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shi</LastName><ForeName>Lei</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Neurosurgery ICU, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, 510080, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yao</LastName><ForeName>Mingli</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Neurosurgery ICU, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, 510080, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Jingchao</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Neurosurgery ICU, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, 510080, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ouyang</LastName><ForeName>Bin</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Neurosurgery ICU, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, 510080, China. ouyb@mail.sysu.edu.cn.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Lingyan</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Neurosurgery ICU, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, 510080, China. wlingy@mail.sysu.edu.cn.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Yan</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Neurosurgery ICU, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, 510080, China. liyan249@mail.sysu.edu.cn.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>81801249</GrantID><Agency>the National Natural Science Foundation of China</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>06</Month><Day>04</Day></ArticleDate></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>Neurosurg Rev</MedlineTA><NlmUniqueID>7908181</NlmUniqueID><ISSNLinking>0344-5607</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D005338">Fibrin Fibrinogen Degradation Products</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C036309">fibrin fragment D</NameOfSubstance></Chemical></ChemicalList><SupplMeshList><SupplMeshName Type="Population" UI="C000724312">Chinese people</SupplMeshName></SupplMeshList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011655" MajorTopicYN="Y">Pulmonary Embolism</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="Y">Postoperative Complications</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019635" MajorTopicYN="Y">Neurosurgical Procedures</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016022" MajorTopicYN="N">Case-Control Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002681" MajorTopicYN="N" Type="Geographic">China</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015994" MajorTopicYN="N">Incidence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005338" MajorTopicYN="N">Fibrin Fibrinogen Degradation Products</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000095225" MajorTopicYN="N" AutoHM="Y">East Asian People</DescriptorName></MeshHeading></MeshHeadingList><OtherAbstract Type="Publisher" Language="ger"><AbstractText>Not applicable.</AbstractText><CopyrightInformation>&#xa9; 2025. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.</CopyrightInformation></OtherAbstract><CoiStatement>Declarations. Ethics approval and consent to participate: The study was approved by the Ethics Committee of the First Affiliated Hospital of Sun Yat-Sen University. Patients and their families informed and agreed to this study. Competing interests: The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2025</Year><Month>2</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2025</Year><Month>5</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2025</Year><Month>5</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>6</Month><Day>4</Day><Hour>12</Hour><Minute>30</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>6</Month><Day>4</Day><Hour>12</Hour><Minute>29</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>6</Month><Day>4</Day><Hour>11</Hour><Minute>18</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">40465043</ArticleId><ArticleId IdType="doi">10.1007/s10143-025-03633-8</ArticleId><ArticleId IdType="pii">10.1007/s10143-025-03633-8</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Cheuk BL, Cheung GC, Cheng SW (2004) Epidemiology of venous thromboembolism in a Chinese population. Br J Surg 91(4):424&#x2013;428</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/bjs.4454</ArticleId><ArticleId IdType="pubmed">15048741</ArticleId></ArticleIdList></Reference><Reference><Citation>Iorio A, Agnelli G (2000) Low-molecular-weight and unfractionated heparin for prevention of venous thromboembolism in neurosurgery: a meta-analysis. Arch Intern Med 160(15):2327&#x2013;2332</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archinte.160.15.2327</ArticleId><ArticleId IdType="pubmed">10927730</ArticleId></ArticleIdList></Reference><Reference><Citation>Haines ST (2003) Venous thromboembolism: pathophysiology and clinical presentation. Am J Health Syst Pharm 60(22 Suppl 7):S3&#x2013;5</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ajhp/60.suppl_7.S3</ArticleId><ArticleId IdType="pubmed">14650859</ArticleId></ArticleIdList></Reference><Reference><Citation>Taniguchi S et al (2009) Prevalence of venous thromboembolism in neurosurgical patients. Heart Vessels 24(6):425&#x2013;428</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00380-008-1135-9</ArticleId><ArticleId IdType="pubmed">20108074</ArticleId></ArticleIdList></Reference><Reference><Citation>Khaldi A et al (2011) Venous thromboembolism: deep venous thrombosis and pulmonary embolism in a neurosurgical population. J Neurosurg 114(1):40&#x2013;46</Citation><ArticleIdList><ArticleId IdType="doi">10.3171/2010.8.JNS10332</ArticleId><ArticleId IdType="pubmed">20815694</ArticleId></ArticleIdList></Reference><Reference><Citation>Li J et al (2020) Clinical predictive factors of lower extremity deep vein thrombosis in relative High-Risk patients after neurosurgery: A retrospective study. Dis Markers 2020:p5820749</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2020/5820749</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang MT et al (2022) Venous thromboembolism rates and risk factors following endoscopic skull base surgery. Int Forum Allergy Rhinol 12(7):935&#x2013;941</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/alr.22943</ArticleId><ArticleId IdType="pubmed">34894093</ArticleId></ArticleIdList></Reference><Reference><Citation>Rinaldo L et al (2020) Venous thromboembolic events in patients undergoing craniotomy for tumor resection: incidence, predictors, and review of literature. J Neurosurg 132(1):10&#x2013;21</Citation><ArticleIdList><ArticleId IdType="doi">10.3171/2018.7.JNS181175</ArticleId><ArticleId IdType="pubmed">30611138</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu D et al (2023) Development and validation of a clinical prediction model for venous thromboembolism following neurosurgery: A 6-Year, multicenter, retrospective and prospective diagnostic cohort study, Cancers (Basel) 15(22).</Citation></Reference><Reference><Citation>Wang X et al (2017) The risk of postoperative hemorrhage and efficacy of heparin for preventing deep vein thrombosis and pulmonary embolism in adult patients undergoing neurosurgery: a systematic review and meta-analysis. J Investig Med 65(8):1136&#x2013;1146</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jim-2016-000235</ArticleId><ArticleId IdType="pubmed">28747317</ArticleId></ArticleIdList></Reference><Reference><Citation>Ganau M et al (2017) Risk of deep vein thrombosis in neurosurgery: state of the Art on prophylaxis protocols and best clinical practices. J Clin Neurosci 45:60&#x2013;66</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jocn.2017.08.008</ArticleId><ArticleId IdType="pubmed">28890040</ArticleId></ArticleIdList></Reference><Reference><Citation>Shi S et al (2020) Preoperative and intraoperative predictors of deep venous thrombosis in adult patients undergoing craniotomy for brain tumors: A Chinese single-center, retrospective study. Thromb Res 196:245&#x2013;250</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.thromres.2020.09.005</ArticleId><ArticleId IdType="pubmed">32919179</ArticleId></ArticleIdList></Reference><Reference><Citation>Shi S et al (2021) Incidence, and preoperative and intraoperative prognostic factors of deep venous thrombosis in patients with glioma following craniotomy. Clin Neurol Neurosurg 210:106998</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clineuro.2021.106998</ArticleId><ArticleId IdType="pubmed">34739883</ArticleId></ArticleIdList></Reference><Reference><Citation>Brakenridge SC et al (2011) Predictors of early versus late timing of pulmonary embolus after traumatic injury. Am J Surg 201(2):209&#x2013;215</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amjsurg.2009.12.005</ArticleId><ArticleId IdType="pubmed">20385370</ArticleId></ArticleIdList></Reference><Reference><Citation>Velmahos GC et al (2009) Pulmonary embolism and deep venous thrombosis in trauma: are they related? Arch Surg 144(10):928&#x2013;932</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archsurg.2009.97</ArticleId><ArticleId IdType="pubmed">19841360</ArticleId></ArticleIdList></Reference><Reference><Citation>Menaker J, Stein DM, Scalea TM (2007) Incidence of early pulmonary embolism after injury. J Trauma 63(3):620&#x2013;624</Citation><ArticleIdList><ArticleId IdType="pubmed">18073610</ArticleId></ArticleIdList></Reference><Reference><Citation>van Langevelde K et al (2013) Finding the origin of pulmonary emboli with a total-body magnetic resonance direct thrombus imaging technique. Haematologica 98(2):309&#x2013;315</Citation><ArticleIdList><ArticleId IdType="doi">10.3324/haematol.2012.069195</ArticleId><ArticleId IdType="pubmed">22801962</ArticleId><ArticleId IdType="pmc">3561441</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin P et al (2023) Low awareness of venous thromboembolism among neurosurgical hospitalized patients: a cross-sectional study. Thromb J 21(1):30</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12959-023-00466-7</ArticleId><ArticleId IdType="pubmed">36927371</ArticleId><ArticleId IdType="pmc">10018870</ArticleId></ArticleIdList></Reference><Reference><Citation>Jeraq M, Cote DJ, Smith TR (2017) Venous thromboembolism in brain tumor patients. Adv Exp Med Biol 906:215&#x2013;228</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/5584_2016_117</ArticleId><ArticleId IdType="pubmed">27628002</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Q et al (2016) Risk factors for deep venous thrombosis of lower limbs in postoperative neurosurgical patients. Pak J Med Sci 32(5):1107&#x2013;1110</Citation><ArticleIdList><ArticleId IdType="doi">10.12669/pjms.325.10481</ArticleId><ArticleId IdType="pubmed">27882003</ArticleId><ArticleId IdType="pmc">5103115</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang X et al (2021) Comparative efficacy and safety of Pharmacological prophylaxis and intermittent pneumatic compression for prevention of venous thromboembolism in adult undergoing neurosurgery: a systematic review and network meta-analysis. Neurosurg Rev 44(2):721&#x2013;729</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10143-020-01297-0</ArticleId><ArticleId IdType="pubmed">32300889</ArticleId></ArticleIdList></Reference><Reference><Citation>Coleman JJ et al (2015) Factors associated with pulmonary embolism within 72 hours of admission after trauma: a multicenter study. J Am Coll Surg 220(4):731&#x2013;736</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jamcollsurg.2014.12.032</ArticleId><ArticleId IdType="pubmed">25724603</ArticleId></ArticleIdList></Reference><Reference><Citation>Skrifvars MB et al (2017) Venous thromboembolic events in critically ill traumatic brain injury patients. Intensive Care Med 43(3):419&#x2013;428</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-016-4655-2</ArticleId><ArticleId IdType="pubmed">28028552</ArticleId></ArticleIdList></Reference><Reference><Citation>Majoor C et al (2013) Risk of deep vein thrombosis and pulmonary embolism in asthma. Eur Respir J 42(3):655&#x2013;661</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/09031936.00150312</ArticleId><ArticleId IdType="pubmed">23258790</ArticleId></ArticleIdList></Reference><Reference><Citation>Lieber BA et al (2016) Association of steroid use with deep venous thrombosis and pulmonary embolism in neurosurgical patients: A National database analysis. World Neurosurg 89:126&#x2013;132</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.wneu.2016.01.033</ArticleId><ArticleId IdType="pubmed">26805689</ArticleId></ArticleIdList></Reference><Reference><Citation>Linkins LA, Takach Lapner S (2017) Review of D-dimer testing: good, bad, and ugly. Int J Lab Hematol 39(Suppl 1):98&#x2013;103</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ijlh.12665</ArticleId><ArticleId IdType="pubmed">28447414</ArticleId></ArticleIdList></Reference><Reference><Citation>Sartori M et al (2012) The wells rule and D-dimer for the diagnosis of isolated distal deep vein thrombosis. J Thromb Haemost 10(11):2264&#x2013;2269</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1538-7836.2012.04895.x</ArticleId><ArticleId IdType="pubmed">22906051</ArticleId></ArticleIdList></Reference><Reference><Citation>Yan X et al (2022) Construction and verification of a nomogram predicting the risk of preoperative deep vein thrombosis progression after elective spine surgery. Clin Neurol Neurosurg 222:107439</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clineuro.2022.107439</ArticleId><ArticleId IdType="pubmed">36152418</ArticleId></ArticleIdList></Reference><Reference><Citation>De Monye W et al (2002) Embolus location affects the sensitivity of a rapid quantitative D-dimer assay in the diagnosis of pulmonary embolism. Am J Respir Crit Care Med 165(3):345&#x2013;348</Citation><ArticleIdList><ArticleId IdType="doi">10.1164/ajrccm.165.3.2104099</ArticleId><ArticleId IdType="pubmed">11818319</ArticleId></ArticleIdList></Reference><Reference><Citation>Righini M et al (2006) Clinical usefulness of D-dimer testing in cancer patients with suspected pulmonary embolism. Thromb Haemost 95(4):715&#x2013;719</Citation><ArticleIdList><ArticleId IdType="doi">10.1160/TH05-12-0791</ArticleId><ArticleId IdType="pubmed">16601844</ArticleId></ArticleIdList></Reference><Reference><Citation>Moore E et al (2021) Trauma-induced coagulopathy. Nat Rev Dis Primers 7(1):30</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41572-021-00264-3</ArticleId><ArticleId IdType="pubmed">33927200</ArticleId><ArticleId IdType="pmc">9107773</ArticleId></ArticleIdList></Reference><Reference><Citation>Deshpande SP et al (2025) Cancer-Related coagulopathy and perioperative considerations. Anesth Analg 140(4):860&#x2013;872</Citation><ArticleIdList><ArticleId IdType="doi">10.1213/ANE.0000000000007286</ArticleId><ArticleId IdType="pubmed">39630596</ArticleId></ArticleIdList></Reference><Reference><Citation>Koster A et al (2022) Heparin-induced Thrombocytopenia: Perioperative Diagnosis Manage Anesthesiology 136(2):336&#x2013;344</Citation><ArticleIdList><ArticleId IdType="pubmed">34910815</ArticleId></ArticleIdList></Reference><Reference><Citation>Yasser M, Kamal et al (2022) Value of platelet indices in prediction of pulmonary embolism. Menoufia Med J 35:1779&#x2013;1786</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/mmj.mmj_247_22</ArticleId></ArticleIdList></Reference><Reference><Citation>Monreal M et al (1991) Platelet count and venous thromboembolism. A useful test for suspected pulmonary embolism. Chest 100(6):1493&#x2013;1496</Citation><ArticleIdList><ArticleId IdType="doi">10.1378/chest.100.6.1493</ArticleId><ArticleId IdType="pubmed">1959389</ArticleId></ArticleIdList></Reference><Reference><Citation>Groot OQ et al (2019) High risk of symptomatic venous thromboembolism after surgery for spine metastatic bone lesions: A retrospective study. Clin Orthop Relat Res 477(7):1674&#x2013;1686</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CORR.0000000000000733</ArticleId><ArticleId IdType="pubmed">31135550</ArticleId><ArticleId IdType="pmc">6999978</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang HR et al (2021) Nomogram for predicting the postoperative venous thromboembolism in spinal metastasis tumor: A multicenter retrospective study. Front Oncol 11:629823</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fonc.2021.629823</ArticleId><ArticleId IdType="pubmed">34249679</ArticleId><ArticleId IdType="pmc">8264656</ArticleId></ArticleIdList></Reference><Reference><Citation>Furie B, Furie BC (1992) Molecular and cellular biology of blood coagulation. N Engl J Med 326(12):800&#x2013;806</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJM199203193261205</ArticleId><ArticleId IdType="pubmed">1538724</ArticleId></ArticleIdList></Reference><Reference><Citation>von Kanel R, Dimsdale JE (2000) Effects of sympathetic activation by adrenergic infusions on hemostasis in vivo. Eur J Haematol 65(6):357&#x2013;369</Citation><ArticleIdList><ArticleId IdType="doi">10.1034/j.1600-0609.2000.065006357.x</ArticleId></ArticleIdList></Reference><Reference><Citation>Karhade AV et al (2017) Impact of operative length on post-operative complications in meningioma surgery: a NSQIP analysis. J Neurooncol 131(1):59&#x2013;67</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11060-016-2262-2</ArticleId><ArticleId IdType="pubmed">27864707</ArticleId></ArticleIdList></Reference><Reference><Citation>Nunno A et al (2019) Risk factors and associated complications of symptomatic venous thromboembolism in patients with craniotomy for meningioma. World Neurosurg 122:e1505&#x2013;e1510</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.wneu.2018.11.091</ArticleId><ArticleId IdType="pubmed">30468929</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">27876519</PMID><DateCompleted><Year>2017</Year><Month>05</Month><Day>15</Day></DateCompleted><DateRevised><Year>2025</Year><Month>06</Month><Day>23</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1097-6809</ISSN><JournalIssue CitedMedium="Internet"><Volume>65</Volume><Issue>4</Issue><PubDate><Year>2017</Year><Month>Apr</Month></PubDate></JournalIssue><Title>Journal of vascular surgery</Title><ISOAbbreviation>J Vasc Surg</ISOAbbreviation></Journal><ArticleTitle>The effect of body mass index on major outcomes after vascular surgery.</ArticleTitle><Pagination><StartPage>1193</StartPage><EndPage>1207</EndPage><MedlinePgn>1193-1207</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jvs.2016.09.032</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0741-5214(16)31274-5</ELocationID><Abstract><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">Obesity has been associated with an increased risk for cardiovascular morbidity and mortality, although pooled evidence in patients undergoing vascular surgery are lacking. The aim of this systematic review was to evaluate the effect of body mass index (BMI) on major postoperative outcomes in patients undergoing vascular surgery.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">A systematic literature review conforming to established criteria to identify eligible articles published before May 2016 was conducted. Eligible studies evaluated major postoperative outcomes in vascular surgery patients of different BMI groups according to the weight classification of the National Institutes of Health criteria: underweight (UW), BMI &#x2264;18.5&#xa0;kg/m<sup>2</sup>; normal weight (NW), BMI of 18.6 to 24.9&#xa0;kg/m<sup>2</sup>; overweight (OW), BMI of 25 to 29.9&#xa0;kg/m<sup>2</sup>; and obese&#xa0;(OB), BMI &#x2265;30&#xa0;kg/m<sup>2</sup>. Major outcomes included 30-day mortality, cardiac complications, and respiratory complications. Secondary outcomes included wound and cerebrovascular complications, renal complications, deep venous thrombosis/pulmonary embolism, and other complications.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Overall, eight retrospective studies were eligible including a total of 92,525 vascular surgery patients (2223 UW patients, 29,727 NW patients, 34,517 OW patients, and 26,058 OB patients). Pooled data were as follows: mortality rate, 2.5%; cardiac events, 2.1%; respiratory events, 8.6%; wound complications, 6.4%; cerebrovascular events, 6.4%; renal complications, 3.9%; other infections, 5.3%; deep venous thrombosis/pulmonary embolism, 1.2%; and other complications, 3.7%. Meta-analysis showed that OB patients were associated with lower mortality (odds ratio [OR], 0.64; 95% confidence interval [CI], 0.541-0.757; P&#xa0;&lt; .0001), cardiac morbidity (OR, 0.81; 95% CI, 0.708-0.938; P&#xa0;= .004), and respiratory morbidity (OR, 0.87; 95% CI, 0.802-0.941; P&#xa0;= .0006) after vascular surgery compared with NW patients. However, OB patients were associated with a higher wound complication rate (OR, 2.39; 95% CI, 1.777-3.211; P&#xa0;&lt; .0001) compared with NW patients. In contrast, UW patients were associated with a higher mortality (OR, 1.71; 95% CI, 1.177-2.505; P&#xa0;= .005) and respiratory morbidity (OR, 1.84; 95% CI, 1.554-2.166; P&#xa0;&lt; .0001) compared with NW patients.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">The "obesity paradox" does exist in patients undergoing vascular surgery. This paradox refers not only to 30-day overall mortality but also to 30-day cardiac and respiratory complications. However, obesity seems to be associated with more wound complications. Surprisingly, UW patients are associated with higher mortality as well as respiratory events postoperatively.</AbstractText><CopyrightInformation>Copyright &#xa9; 2016 Society for Vascular Surgery. Published by Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Galyfos</LastName><ForeName>George</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>First Department of Propaedeutic Surgery, University of Athens Medical School, Hippocration Hospital, Athens, Greece; Department of Vascular Surgery, "KAT" General Hospital, Athens, Greece. Electronic address: georgegalyfos@hotmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Geropapas</LastName><ForeName>Georgios I</ForeName><Initials>GI</Initials><AffiliationInfo><Affiliation>Department of Vascular Surgery, "KAT" General Hospital, Athens, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kerasidis</LastName><ForeName>Stavros</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Vascular Surgery, "KAT" General Hospital, Athens, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sianou</LastName><ForeName>Argiri</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Microbiology, University of Athens Medical School, Areteion Hospital, Athens, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sigala</LastName><ForeName>Fragiska</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>First Department of Propaedeutic Surgery, University of Athens Medical School, Hippocration Hospital, Athens, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Filis</LastName><ForeName>Konstantinos</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>First Department of Propaedeutic Surgery, University of Athens Medical School, Hippocration Hospital, Athens, Greece.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2016</Year><Month>11</Month><Day>19</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Vasc Surg</MedlineTA><NlmUniqueID>8407742</NlmUniqueID><ISSNLinking>0741-5214</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015992" MajorTopicYN="Y">Body Mass Index</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016009" MajorTopicYN="N">Chi-Square Distribution</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009765" MajorTopicYN="N">Obesity</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016017" MajorTopicYN="N">Odds Ratio</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D065840" MajorTopicYN="N">Protective Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018570" MajorTopicYN="N">Risk Assessment</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013997" MajorTopicYN="N">Time Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014652" MajorTopicYN="N">Vascular Diseases</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014656" MajorTopicYN="N">Vascular Surgical Procedures</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2016</Year><Month>6</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2016</Year><Month>9</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2016</Year><Month>11</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2017</Year><Month>5</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2016</Year><Month>11</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">27876519</ArticleId><ArticleId IdType="doi">10.1016/j.jvs.2016.09.032</ArticleId><ArticleId IdType="pii">S0741-5214(16)31274-5</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">40576035</PMID><DateCompleted><Year>2025</Year><Month>07</Month><Day>01</Day></DateCompleted><DateRevised><Year>2025</Year><Month>07</Month><Day>03</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2047-9980</ISSN><JournalIssue CitedMedium="Internet"><Volume>14</Volume><Issue>13</Issue><PubDate><Year>2025</Year><Month>Jul</Month></PubDate></JournalIssue><Title>Journal of the American Heart Association</Title><ISOAbbreviation>J Am Heart Assoc</ISOAbbreviation></Journal><ArticleTitle>Predicting Deterioration in Patients With Normotensive Acute Pulmonary Embolism Using Clinical-Imaging Features: A&#xa0;Multicenter Prospective Cohort Study.</ArticleTitle><Pagination><StartPage>e038984</StartPage><MedlinePgn>e038984</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1161/JAHA.124.038984</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Prioritization of management strategies in patients with normotensive acute pulmonary embolism is based on the identification of individuals at risk for early deterioration. This study aims to develop and validate a novel score for deterioration prediction using clinical-imaging features.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">This is multicenter, prospective observational cohort study (AOAPECT [Adverse Outcomes in Acute Pulmonary Embolism patients using Computed Tomography pulmonary angiography] cohort, NCT05098769). Registered-enrolled patients with normotensive acute pulmonary embolism were collected consecutively from 5 centers across China. Derivation set was established from 2 centers, while local and nonlocal external validation sets were derived from the remaining 3 centers. The end point was pulmonary embolism-related deterioration within 30&#x2009;days after admission. Deterioration-related candidate predictors consisted of clinical, laboratory and computed tomography pulmonary angiography parameters were screened and then split into dichotomous values. The predictive score was conducted by a multivariable logistics regression and validated. Score performances were quantified using the area under the receiver operating characteristic curve.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Of 3310 enrolled patients including 1 derivation (n=2061) and 2 validation sets (n=969 and 280), 272 patients (8.2%) experienced deterioration. In the derivation set, an increased risk of deterioration was observed with right to left ventricle diameter ratio &#x2265;1.2, appearance of pulmonary vein sign on computed tomography pulmonary angiography, and heart rate &#x2265;110 beats/min. When at least 2 out of 3 items were positive, patients were assigned to the high-risk deterioration group. This PE-RPH&#xa0;score revealed good discrimination to deterioration in derivation and validation sets (area under the receiver operating characteristic curve, 0.82, 0.82, and 0.80).</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">This PE-RPH score incorporating 2 computed tomography pulmonary angiography parameters and heart rate may help predict the deterioration risk in patients with normotensive acute pulmonary embolism. REGISTRATION: https://clinicaltrials.gov; identifier: NCT05098769.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Gao</LastName><ForeName>Yizhuo</ForeName><Initials>Y</Initials><Identifier Source="ORCID">0000-0002-4220-1260</Identifier><AffiliationInfo><Affiliation>Department of Pulmonary and Critical Care Medicine Shengjing Hospital of China Medical University Shenyang China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wei</LastName><ForeName>Shibo</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of General Surgery The Fourth Affiliated Hospital of China Medical University Shenyang China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Yuchen</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Hernia and Abdominal Wall Surgery, Beijing Chaoyang Hospital Capital Medical University Beijing China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yu</LastName><ForeName>Zhenglun</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Department of Thoracic Surgery The First Affiliated Hospital of China Medical University Shenyang China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhan</LastName><ForeName>Shanshan</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Gerontology and Geriatrics The First Affiliated Hospital of China Medical University Shenyang China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>Binze</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of General Surgery The Fourth Affiliated Hospital of China Medical University Shenyang China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Qi</LastName><ForeName>Chuanxin</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Emergency Medicine The Third People's Hospital of Datong Datong China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Emergency Medicine Shengjing Hospital of China Medical University Shenyang China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Qi</LastName><ForeName>Shougang</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Emergency Medicine The Third People's Hospital of Datong Datong China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Minggang</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Hernia and Abdominal Wall Surgery, Beijing Chaoyang Hospital Capital Medical University Beijing China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jia</LastName><ForeName>Dong</ForeName><Initials>D</Initials><Identifier Source="ORCID">0000-0002-2361-0739</Identifier><AffiliationInfo><Affiliation>Department of Emergency Medicine Shengjing Hospital of China Medical University Shenyang China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><DataBankList CompleteYN="Y"><DataBank><DataBankName>ClinicalTrials.gov</DataBankName><AccessionNumberList><AccessionNumber>NCT05098769</AccessionNumber></AccessionNumberList></DataBank></DataBankList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016448">Multicenter Study</PublicationType><PublicationType UI="D064888">Observational Study</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>06</Month><Day>27</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>J Am Heart Assoc</MedlineTA><NlmUniqueID>101580524</NlmUniqueID><ISSNLinking>2047-9980</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011655" MajorTopicYN="Y">Pulmonary Embolism</DescriptorName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000072226" MajorTopicYN="Y">Computed Tomography Angiography</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000208" MajorTopicYN="N">Acute Disease</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011237" MajorTopicYN="N">Predictive Value of Tests</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018570" MajorTopicYN="N">Risk Assessment</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002681" MajorTopicYN="N" Type="Geographic">China</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011379" MajorTopicYN="N">Prognosis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011651" MajorTopicYN="Y">Pulmonary Artery</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000075902" MajorTopicYN="Y">Clinical Deterioration</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">clinical deterioration</Keyword><Keyword MajorTopicYN="N">heart rate</Keyword><Keyword MajorTopicYN="N">heart ventricles</Keyword><Keyword MajorTopicYN="N">pulmonary embolism</Keyword><Keyword MajorTopicYN="N">pulmonary vein</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>7</Month><Day>1</Day><Hour>21</Hour><Minute>17</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>6</Month><Day>27</Day><Hour>12</Hour><Minute>29</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>6</Month><Day>27</Day><Hour>6</Hour><Minute>3</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">40576035</ArticleId><ArticleId IdType="doi">10.1161/JAHA.124.038984</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">22663958</PMID><DateCompleted><Year>2012</Year><Month>10</Month><Day>22</Day></DateCompleted><DateRevised><Year>2025</Year><Month>06</Month><Day>26</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">2212-3911</ISSN><JournalIssue CitedMedium="Internet"><Volume>7</Volume><Issue>1</Issue><PubDate><Year>2012</Year><Month>Feb</Month></PubDate></JournalIssue><Title>Current drug safety</Title><ISOAbbreviation>Curr Drug Saf</ISOAbbreviation></Journal><ArticleTitle>The frequency of thrombotic events among adults given antifibrinolytic drugs for spontaneous bleeding: systematic review and meta-analysis of observational studies and randomized trials.</ArticleTitle><Pagination><StartPage>44</StartPage><EndPage>54</EndPage><MedlinePgn>44-54</MedlinePgn></Pagination><Abstract><AbstractText Label="AIMS" NlmCategory="OBJECTIVE">The antifibrinolytic drug tranexamic acid (TXA) improves survival after trauma. Antifibrinolytic drugs may also improve outcome after spontaneous bleeding, so we conducted a systematic review of the frequency of thrombotic events associated with their use after spontaneous bleeding, to help design future randomized controlled trials.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">We sought trials or observational studies of &#x2265;20 adults involving any antifibrinolytic drug (TXA, epsilonaminocaproic acid (EACA) or aprotinin) for spontaneous (non-traumatic, non-surgical/iatrogenic), non-heamophiliac bleeding. We searched the Cochrane Central Register of Controlled Trials, OVID Medline from 1966, EMBASE from 1980, and the bibliographies of relevant articles in October 2009. We meta-analysed proportions of patients with thrombotic events, using a random effects model.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">We found 57 studies involving 5,049 patients, 3,616 (72%) of whom had spontaneous subarachnoid haemorrhage. 3,414 (68%) patients received TXA-based treatment and 1,635 (32%) received EACA. The frequencies of limb ischaemia and myocardial infarction were &lt;1% for TXA and EACA. The frequency of deep vein thrombosis or pulmonary embolism was 1.9% (95% confidence interval (CI) 1.1 to 2.9) for TXA and 3.0% (95% CI 1.8 to 4.6) for EACA. The occurrence of cerebral infarction was restricted to studies of subarachnoid haemorrhage when compared to other indications, both for TXA (9.7% [95% CI 5.5 to 14.8] versus 0% [95% CI 0 to 0.5]) and for EACA (7.7% [95% CI 1.8 to 17.4] versus 0% [95% CI 0 to 2.1]).</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Thrombotic events have occurred infrequently with antifibrinolytic drugs after spontaneous bleeding apart from subarachnoid haemorrhage, so further exploration of their safety and efficacy after spontaneous bleeding is justified in randomized trials.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ross</LastName><ForeName>Jenny</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Division of Clinical Neurosciences, Centre for Clinical Brain Sciences, University of Edinburgh, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Al-Shahi Salman</LastName><ForeName>Rustam</ForeName><Initials>R</Initials></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>G1002605</GrantID><Acronym>MRC_</Acronym><Agency>Medical Research Council</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>G108/613</GrantID><Acronym>MRC_</Acronym><Agency>Medical Research Council</Agency><Country>United Kingdom</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D003160">Comparative Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United Arab Emirates</Country><MedlineTA>Curr Drug Saf</MedlineTA><NlmUniqueID>101270895</NlmUniqueID><ISSNLinking>1574-8863</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000933">Antifibrinolytic Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>6T84R30KC1</RegistryNumber><NameOfSubstance UI="D014148">Tranexamic Acid</NameOfSubstance></Chemical><Chemical><RegistryNumber>9087-70-1</RegistryNumber><NameOfSubstance UI="D007611">Aprotinin</NameOfSubstance></Chemical><Chemical><RegistryNumber>U6F3787206</RegistryNumber><NameOfSubstance UI="D015119">Aminocaproic Acid</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015119" MajorTopicYN="N">Aminocaproic Acid</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000933" MajorTopicYN="N">Antifibrinolytic Agents</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007611" MajorTopicYN="N">Aprotinin</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006470" MajorTopicYN="N">Hemorrhage</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015233" MajorTopicYN="N">Models, Statistical</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013345" MajorTopicYN="N">Subarachnoid Hemorrhage</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013927" MajorTopicYN="N">Thrombosis</DescriptorName><QualifierName UI="Q000139" MajorTopicYN="Y">chemically induced</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014148" MajorTopicYN="N">Tranexamic Acid</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2011</Year><Month>12</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2012</Year><Month>2</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2012</Year><Month>2</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2012</Year><Month>6</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2012</Year><Month>6</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2012</Year><Month>10</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">22663958</ArticleId><ArticleId IdType="doi">10.2174/157488612800492744</ArticleId><ArticleId IdType="pii">CDS-7-1-44</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">35552827</PMID><DateCompleted><Year>2022</Year><Month>06</Month><Day>23</Day></DateCompleted><DateRevised><Year>2022</Year><Month>07</Month><Day>21</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1433-7339</ISSN><JournalIssue CitedMedium="Internet"><Volume>30</Volume><Issue>8</Issue><PubDate><Year>2022</Year><Month>Aug</Month></PubDate></JournalIssue><Title>Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer</Title><ISOAbbreviation>Support Care Cancer</ISOAbbreviation></Journal><ArticleTitle>Can thromboprophylaxis build a link for cancer patients undergoing surgical and/or chemotherapy treatment? The MeTHOS cohort study.</ArticleTitle><Pagination><StartPage>6973</StartPage><EndPage>6984</EndPage><MedlinePgn>6973-6984</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s00520-022-07096-1</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Patients with active cancer have a 4-sevenfold increased risk for venous thromboembolism (VTE) especially during systematic anticancer treatment. Simultaneously, surgery is an additional risk factor.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">The Metaxas's Hospital THromboprophylaxis program in Oncological &amp; Surgical Patients (MeTHOS) is a prospective, phase IV, observational, non-interventional cohort study, aiming to record the thromboprophylaxis practice patterns in high-risk active cancer patients undergoing surgical and/or chemotherapy treatment.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">We are reporting results from 291 ambulatory patients (median age: 67&#xa0;years, Q1-Q3: 59-73&#xa0;years, 54.6% males) who received anti-neoplastic treatment and administered thromboprophylaxis. 59.8% had cardiovascular disease (mostly hypertension), 76.6% were reported as having at least one comorbidity, while 27.5% and 15.8% accumulated two and three comorbidities, respectively. 94.9% of the patients were receiving highly thrombogenic agents such as platinum-based agents, 5-FU, immunotherapy, antiangiogenics/anti-VEGF, or erythropoietin. 26.5% of the patients were initially surgically treated. In terms of anticoagulation, all patients were treated with tinzaparin (fixed dose, 10,000 Anti-Xa IU, OD). The median anticoagulation duration was 6.2&#xa0;months. Six thrombotic events were observed (2.06%, 95% CI: 0.76-4.43%): 5 were DVT, and one PE. With respect to safety, 7 bleeding events occurred (2.6%, 95% CI: 1.0-5.3%); 6 of them were minor.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Thromboprophylaxis with LMWH in patients with active cancer and high thrombotic burden was safe and effective. Intermediate dose of tinzaparin seems to be an appropriate agent for cancer-associated thromboprophylaxis management.</AbstractText><AbstractText Label="CLINICAL TRIAL REGISTRATION" NlmCategory="BACKGROUND">ClinicalTrials.gov: NCT04248348.</AbstractText><CopyrightInformation>&#xa9; 2022. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Xynogalos</LastName><ForeName>Spyridon</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Medical Oncology, "METAXA" Memorial Piraeus Cancer Hospital, Mpotasi 51, 185 37, Piraeus, Greece. sxyn@otenet.gr.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Simeonidis</LastName><ForeName>David</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Medical Oncology, "METAXA" Memorial Piraeus Cancer Hospital, Mpotasi 51, 185 37, Piraeus, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Papageorgiou</LastName><ForeName>George</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Medical Oncology, "METAXA" Memorial Piraeus Cancer Hospital, Mpotasi 51, 185 37, Piraeus, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pouliakis</LastName><ForeName>Abraham</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>2nd Department of Pathology, National and Kapodistrian University of Athens, University General Hospital "Attikon", Athens, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Charalambakis</LastName><ForeName>Nikolaos</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Medical Oncology, "METAXA" Memorial Piraeus Cancer Hospital, Mpotasi 51, 185 37, Piraeus, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lianos</LastName><ForeName>Evangelos</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Medical Oncology, "METAXA" Memorial Piraeus Cancer Hospital, Mpotasi 51, 185 37, Piraeus, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mazlimoglou</LastName><ForeName>Evridiki</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Medical Oncology, "METAXA" Memorial Piraeus Cancer Hospital, Mpotasi 51, 185 37, Piraeus, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liatsos</LastName><ForeName>Alexandros-Nikolaos</ForeName><Initials>AN</Initials><AffiliationInfo><Affiliation>Department of Medical Oncology, "METAXA" Memorial Piraeus Cancer Hospital, Mpotasi 51, 185 37, Piraeus, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kosmas</LastName><ForeName>Christos</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Medical Oncology, "METAXA" Memorial Piraeus Cancer Hospital, Mpotasi 51, 185 37, Piraeus, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ziras</LastName><ForeName>Nicolaos</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Medical Oncology, "METAXA" Memorial Piraeus Cancer Hospital, Mpotasi 51, 185 37, Piraeus, Greece.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><DataBankList CompleteYN="Y"><DataBank><DataBankName>ClinicalTrials.gov</DataBankName><AccessionNumberList><AccessionNumber>NCT04248348</AccessionNumber></AccessionNumberList></DataBank></DataBankList><PublicationTypeList><PublicationType UI="D017429">Clinical Trial, Phase IV</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D064888">Observational Study</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>05</Month><Day>12</Day></ArticleDate></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>Support Care Cancer</MedlineTA><NlmUniqueID>9302957</NlmUniqueID><ISSNLinking>0941-4355</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000925">Anticoagulants</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D006495">Heparin, Low-Molecular-Weight</NameOfSubstance></Chemical><Chemical><RegistryNumber>7UQ7X4Y489</RegistryNumber><NameOfSubstance UI="D000078222">Tinzaparin</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000925" MajorTopicYN="N">Anticoagulants</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006495" MajorTopicYN="N">Heparin, Low-Molecular-Weight</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009369" MajorTopicYN="Y">Neoplasms</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011655" MajorTopicYN="Y">Pulmonary Embolism</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013927" MajorTopicYN="Y">Thrombosis</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000078222" MajorTopicYN="N">Tinzaparin</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D054556" MajorTopicYN="Y">Venous Thromboembolism</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Bleeding</Keyword><Keyword MajorTopicYN="N">Cancer-associated thrombosis</Keyword><Keyword MajorTopicYN="N">Conformance</Keyword><Keyword MajorTopicYN="N">Heparin</Keyword><Keyword MajorTopicYN="N">LMWH</Keyword><Keyword MajorTopicYN="N">Low molecular weight heparin</Keyword><Keyword MajorTopicYN="N">Pulmonary embolism</Keyword><Keyword MajorTopicYN="N">Thrombosis</Keyword><Keyword MajorTopicYN="N">Tinzaparin</Keyword><Keyword MajorTopicYN="N">Venous thromboembolism</Keyword></KeywordList><CoiStatement>The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>11</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>4</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>5</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>6</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>5</Month><Day>13</Day><Hour>14</Hour><Minute>35</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>5</Month><Day>12</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35552827</ArticleId><ArticleId IdType="pmc">PMC9213358</ArticleId><ArticleId IdType="doi">10.1007/s00520-022-07096-1</ArticleId><ArticleId IdType="pii">10.1007/s00520-022-07096-1</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Heit JA, Spencer FA, White RH. The epidemiology of venous thromboembolism. J Thromb Thrombolysis. 2016;41(1):3&#x2013;14. doi: 10.1007/s11239-015-1311-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11239-015-1311-6</ArticleId><ArticleId IdType="pmc">PMC4715842</ArticleId><ArticleId IdType="pubmed">26780736</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuderer NM, Culakova E, Lyman GH, Francis C, Falanga A, Khorana AA. A validated risk score for venous thromboembolism is predictive of cancer progression and mortality. Oncologist. 2016;21(7):861&#x2013;867. doi: 10.1634/theoncologist.2015-0361.</Citation><ArticleIdList><ArticleId IdType="doi">10.1634/theoncologist.2015-0361</ArticleId><ArticleId IdType="pmc">PMC4943384</ArticleId><ArticleId IdType="pubmed">27125754</ArticleId></ArticleIdList></Reference><Reference><Citation>Khorana AA, Francis CW, Culakova E, Fisher RI, Kuderer NM, Lyman GH. Thromboembolism in hospitalized neutropenic cancer patients. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2006;24(3):484&#x2013;490. doi: 10.1200/JCO.2005.03.8877.</Citation><ArticleIdList><ArticleId IdType="doi">10.1200/JCO.2005.03.8877</ArticleId><ArticleId IdType="pubmed">16421425</ArticleId></ArticleIdList></Reference><Reference><Citation>Mulder FI, Horvath-Puho E, van Es N, van Laarhoven HWM, Pedersen L, Moik F, et al. Venous thromboembolism in cancer patients: a population-based cohort study. Blood. 2021;137(14):1959&#x2013;1969. doi: 10.1182/blood.2020007338.</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/blood.2020007338</ArticleId><ArticleId IdType="pubmed">33171494</ArticleId></ArticleIdList></Reference><Reference><Citation>Ay C, Pabinger I, Cohen AT. Cancer-associated venous thromboembolism: burden, mechanisms, and management. Thromb Haemost. 2017;117(2):219&#x2013;230. doi: 10.1160/TH16-08-0615.</Citation><ArticleIdList><ArticleId IdType="doi">10.1160/TH16-08-0615</ArticleId><ArticleId IdType="pubmed">27882374</ArticleId></ArticleIdList></Reference><Reference><Citation>Haltout J, Awada A, Paesmans M, Moreau M, Klastersky J, Machiels G, et al. Predictive factors for cancer-associated thrombosis in a large retrospective single-center study. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer. 2019;27(4):1163&#x2013;1170. doi: 10.1007/s00520-018-4602-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00520-018-4602-6</ArticleId><ArticleId IdType="pubmed">30610431</ArticleId></ArticleIdList></Reference><Reference><Citation>Frere C, Font C, Esposito F, Crichi B, Girard P, Janus N. Incidence, risk factors, and management of bleeding in patients receiving anticoagulants for the treatment of cancer-associated thrombosis. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer. 2022;30(4):2919&#x2013;2931. doi: 10.1007/s00520-021-06598-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00520-021-06598-8</ArticleId><ArticleId IdType="pubmed">34617159</ArticleId></ArticleIdList></Reference><Reference><Citation>Patel HK, Khorana AA. Anticoagulation in cancer patients: a summary of pitfalls to avoid. Curr Oncol Rep. 2019;21(2):18. doi: 10.1007/s11912-019-0767-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11912-019-0767-5</ArticleId><ArticleId IdType="pubmed">30715628</ArticleId></ArticleIdList></Reference><Reference><Citation>Min JS, Bae SK. Prediction of drug-drug interaction potential using physiologically based pharmacokinetic modeling. Arch Pharmacal Res. 2017;40(12):1356&#x2013;1379. doi: 10.1007/s12272-017-0976-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12272-017-0976-0</ArticleId><ArticleId IdType="pubmed">29079968</ArticleId></ArticleIdList></Reference><Reference><Citation>van Leeuwen RW, Brundel DH, Neef C, van Gelder T, Mathijssen RH, Burger DM, et al. Prevalence of potential drug-drug interactions in cancer patients treated with oral anticancer drugs. Br J Cancer. 2013;108(5):1071&#x2013;1078. doi: 10.1038/bjc.2013.48.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/bjc.2013.48</ArticleId><ArticleId IdType="pmc">PMC3619066</ArticleId><ArticleId IdType="pubmed">23412102</ArticleId></ArticleIdList></Reference><Reference><Citation>Farmakis I, Zafeiropoulos S, Pagiantza A, Boulmpou A, Arvanitaki A, Tampaki A, et al. Low-density lipoprotein cholesterol target value attainment based on 2019 ESC/EAS guidelines and lipid-lowering therapy titration for patients with acute coronary syndrome. Eur J Prev Cardiol. 2020;27(19):2314&#x2013;2317. doi: 10.1177/2047487319891780.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/2047487319891780</ArticleId><ArticleId IdType="pubmed">31818140</ArticleId></ArticleIdList></Reference><Reference><Citation>Estrada YMRM, Oldham SA. CTPA as the gold standard for the diagnosis of pulmonary embolism. Int J Comput Assist Radiol Surg. 2011;6(4):557&#x2013;563. doi: 10.1007/s11548-010-0526-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11548-010-0526-4</ArticleId><ArticleId IdType="pubmed">20689999</ArticleId></ArticleIdList></Reference><Reference><Citation>Zierler BK. Ultrasonography and diagnosis of venous thromboembolism. Circulation. 2004;109(12 Suppl 1):I9&#x2013;14. doi: 10.1161/01.CIR.0000122870.22669.4a.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/01.CIR.0000122870.22669.4a</ArticleId><ArticleId IdType="pubmed">15051663</ArticleId></ArticleIdList></Reference><Reference><Citation>Short NJ, Connors JM. New oral anticoagulants and the cancer patient. Oncologist. 2014;19(1):82&#x2013;93. doi: 10.1634/theoncologist.2013-0239.</Citation><ArticleIdList><ArticleId IdType="doi">10.1634/theoncologist.2013-0239</ArticleId><ArticleId IdType="pmc">PMC3903061</ArticleId><ArticleId IdType="pubmed">24319019</ArticleId></ArticleIdList></Reference><Reference><Citation>Chu G, Versteeg HH, Verschoor AJ, Trines SA, Hemels MEW, Ay C, et al. Atrial fibrillation and cancer - an unexplored field in cardiovascular oncology. Blood Rev. 2019;35:59&#x2013;67. doi: 10.1016/j.blre.2019.03.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.blre.2019.03.005</ArticleId><ArticleId IdType="pubmed">30928168</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang TF, Baumann Kreuziger L, Leader A, Spectre G, Lim MY, Gahagan A, et al. Characteristics and outcomes of patients on concurrent direct oral anticoagulants and targeted anticancer therapies-TacDOAC registry: communication from the ISTH SSC Subcommittee on Hemostasis and Malignancy. J Thromb Haemost. 2021;19(8):2068&#x2013;2081. doi: 10.1111/jth.15367.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jth.15367</ArticleId><ArticleId IdType="pubmed">34327825</ArticleId></ArticleIdList></Reference><Reference><Citation>van Leeuwen RW, van Gelder T, Mathijssen RH, Jansman FG. Drug-drug interactions with tyrosine-kinase inhibitors: a clinical perspective. Lancet Oncol. 2014;15(8):e315&#x2013;e326. doi: 10.1016/s1470-2045(13)70579-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s1470-2045(13)70579-5</ArticleId><ArticleId IdType="pubmed">24988935</ArticleId></ArticleIdList></Reference><Reference><Citation>Hussaarts K, Veerman GDM, Jansman FGA, van Gelder T, Mathijssen RHJ, van Leeuwen RWF. Clinically relevant drug interactions with multikinase inhibitors: a review. Ther Adv Med Oncol. 2019;11:1758835918818347. doi: 10.1177/1758835918818347.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1758835918818347</ArticleId><ArticleId IdType="pmc">PMC6322107</ArticleId><ArticleId IdType="pubmed">30643582</ArticleId></ArticleIdList></Reference><Reference><Citation>Delord JP, Ravaud A, Bennouna J, Fumoleau P, Favrel S, Pinel MC, et al. Phase I and pharmacokinetic study of IV vinflunine in cancer patients with liver dysfunction. Invest New Drugs. 2013;31(3):724&#x2013;733. doi: 10.1007/s10637-012-9878-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10637-012-9878-7</ArticleId><ArticleId IdType="pubmed">22996801</ArticleId></ArticleIdList></Reference><Reference><Citation>Groenland SL, Martinez-Chavez A, van Dongen MGJ, Beijnen JH, Schinkel AH, Huitema ADR, et al. Clinical pharmacokinetics and pharmacodynamics of the cyclin-dependent kinase 4 and 6 inhibitors palbociclib, ribociclib, and abemaciclib. Clin Pharmacokinet. 2020;59(12):1501&#x2013;1520. doi: 10.1007/s40262-020-00930-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40262-020-00930-x</ArticleId><ArticleId IdType="pubmed">33029704</ArticleId></ArticleIdList></Reference><Reference><Citation>Elalamy I, Canon J, Bols A, Lybaert W, Duck L, Jochmans K, et al. Thrombo-embolic events in cancer patients with impaired renal function. Journal of Blood Disorders &amp; Transfusion. 2014;5(4):1000202. doi: 10.4172/2155-9864.1000202.</Citation><ArticleIdList><ArticleId IdType="doi">10.4172/2155-9864.1000202</ArticleId></ArticleIdList></Reference><Reference><Citation>Nightingale G, Hajjar E, Swartz K, Andrel-Sendecki J, Chapman A. Evaluation of a pharmacist-led medication assessment used to identify prevalence of and associations with polypharmacy and potentially inappropriate medication use among ambulatory senior adults with cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2015;33(13):1453&#x2013;1459. doi: 10.1200/JCO.2014.58.7550.</Citation><ArticleIdList><ArticleId IdType="doi">10.1200/JCO.2014.58.7550</ArticleId><ArticleId IdType="pubmed">25800766</ArticleId></ArticleIdList></Reference><Reference><Citation>Martinez BK, Baker WL, Sood NA, Bunz TJ, Meinecke AK, Eriksson D, et al. Influence of polypharmacy on the effectiveness and safety of rivaroxaban versus warfarin in patients with nonvalvular atrial fibrillation. Pharmacotherapy. 2019;39(2):196&#x2013;203. doi: 10.1002/phar.2213.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/phar.2213</ArticleId><ArticleId IdType="pubmed">30597611</ArticleId></ArticleIdList></Reference><Reference><Citation>Scotte F, Elalamy I, Mayeur D, Meyer G. Physicians&#x2019; decision about long-term thromboprophylaxis in cancer outpatients: CAT AXIS, a case vignette study on clinical practice in France. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer. 2018;26(6):2049&#x2013;2056. doi: 10.1007/s00520-017-4034-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00520-017-4034-8</ArticleId><ArticleId IdType="pubmed">29353416</ArticleId></ArticleIdList></Reference><Reference><Citation>Iorga RA, Bratu OG, Marcu RD, Constantin T, Mischianu DLD, Socea B, et al. Venous thromboembolism in cancer patients: still looking for answers. Exp Ther Med. 2019;18(6):5026&#x2013;5032. doi: 10.3892/etm.2019.8019.</Citation><ArticleIdList><ArticleId IdType="doi">10.3892/etm.2019.8019</ArticleId><ArticleId IdType="pmc">PMC6895781</ArticleId><ArticleId IdType="pubmed">31819767</ArticleId></ArticleIdList></Reference><Reference><Citation>Galgani A, Palleria C, Iannone LF, De Sarro G, Giorgi FS, Maschio M, et al. Pharmacokinetic interactions of clinical interest between direct oral anticoagulants and antiepileptic drugs. Front Neurol. 2018;9:1067. doi: 10.3389/fneur.2018.01067.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2018.01067</ArticleId><ArticleId IdType="pmc">PMC6292857</ArticleId><ArticleId IdType="pubmed">30581412</ArticleId></ArticleIdList></Reference><Reference><Citation>Campello E, Ilich A, Simioni P, Key NS. The relationship between pancreatic cancer and hypercoagulability: a comprehensive review on epidemiological and biological issues. Br J Cancer. 2019;121(5):359&#x2013;371. doi: 10.1038/s41416-019-0510-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41416-019-0510-x</ArticleId><ArticleId IdType="pmc">PMC6738049</ArticleId><ArticleId IdType="pubmed">31327867</ArticleId></ArticleIdList></Reference><Reference><Citation>Vazquez SR. Drug-drug interactions in an era of multiple anticoagulants: a focus on clinically relevant drug interactions. Hematology Am Soc Hematol Educ Program. 2018;2018(1):339&#x2013;347. doi: 10.1182/asheducation-2018.1.339.</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/asheducation-2018.1.339</ArticleId><ArticleId IdType="pmc">PMC6246002</ArticleId><ArticleId IdType="pubmed">30504330</ArticleId></ArticleIdList></Reference><Reference><Citation>Siegel RL, Miller KD, Fuchs HE, Jemal A. Cancer statistics, 2021. CA: a cancer journal for clinicians. 2021;71(1):7&#x2013;33. doi: 10.3322/caac.21654.</Citation><ArticleIdList><ArticleId IdType="doi">10.3322/caac.21654</ArticleId><ArticleId IdType="pubmed">33433946</ArticleId></ArticleIdList></Reference><Reference><Citation>Jemal A, Siegel R, Xu J, Ward E. Cancer statistics, 2010. CA: a cancer journal for clinicians. 2010;60(5):277&#x2013;300. doi: 10.3322/caac.20073.</Citation><ArticleIdList><ArticleId IdType="doi">10.3322/caac.20073</ArticleId><ArticleId IdType="pubmed">20610543</ArticleId></ArticleIdList></Reference><Reference><Citation>Tagalakis V, Levi D, Agulnik JS, Cohen V, Kasymjanova G, Small D. High risk of deep vein thrombosis in patients with non-small cell lung cancer: a cohort study of 493 patients. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer. 2007;2(8):729&#x2013;734. doi: 10.1097/JTO.0b013e31811ea275.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/JTO.0b013e31811ea275</ArticleId><ArticleId IdType="pubmed">17762339</ArticleId></ArticleIdList></Reference><Reference><Citation>Walker AJ, Baldwin DR, Card TR, Powell HA, Hubbard RB, Grainge MJ. Risk of venous thromboembolism in people with lung cancer: a cohort study using linked UK healthcare data. Br J Cancer. 2016;115(1):115&#x2013;121. doi: 10.1038/bjc.2016.143.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/bjc.2016.143</ArticleId><ArticleId IdType="pmc">PMC4931366</ArticleId><ArticleId IdType="pubmed">27253177</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Y, Yang Y, Chen W, Guo L, Liang L, Zhai Z, et al. Prevalence and associations of VTE in patients with newly diagnosed lung cancer. Chest. 2014;146(3):650&#x2013;658. doi: 10.1378/chest.13-2379.</Citation><ArticleIdList><ArticleId IdType="doi">10.1378/chest.13-2379</ArticleId><ArticleId IdType="pubmed">24676401</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh R, Sousou T, Mohile S, Khorana AA. High rates of symptomatic and incidental thromboembolic events in gastrointestinal cancer patients. J Thromb Haemost. 2010;8(8):1879&#x2013;1881. doi: 10.1111/j.1538-7836.2010.03929.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1538-7836.2010.03929.x</ArticleId><ArticleId IdType="pmc">PMC2946968</ArticleId><ArticleId IdType="pubmed">20492461</ArticleId></ArticleIdList></Reference><Reference><Citation>Trugilho IA, Renni MJP, Medeiros GC, Thuler LCS, Bergmann A. Incidence and factors associated with venous thromboembolism in women with gynecologic cancer. Thromb Res. 2020;185:49&#x2013;54. doi: 10.1016/j.thromres.2019.11.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.thromres.2019.11.009</ArticleId><ArticleId IdType="pubmed">31759190</ArticleId></ArticleIdList></Reference><Reference><Citation>Gale AJ, Gordon SG. Update on tumor cell procoagulant factors. Acta Haematol. 2001;106(1&#x2013;2):25&#x2013;32. doi: 10.1159/000046586.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000046586</ArticleId><ArticleId IdType="pubmed">11549774</ArticleId></ArticleIdList></Reference><Reference><Citation>Khorana AA, Connolly GC. Assessing risk of venous thromboembolism in the patient with cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2009;27(29):4839&#x2013;4847. doi: 10.1200/JCO.2009.22.3271.</Citation><ArticleIdList><ArticleId IdType="doi">10.1200/JCO.2009.22.3271</ArticleId><ArticleId IdType="pmc">PMC2764392</ArticleId><ArticleId IdType="pubmed">19720906</ArticleId></ArticleIdList></Reference><Reference><Citation>Blom JW, Osanto S, Rosendaal FR. The risk of a venous thrombotic event in lung cancer patients: higher risk for adenocarcinoma than squamous cell carcinoma. J Thromb Haemost. 2004;2(10):1760&#x2013;1765. doi: 10.1111/j.1538-7836.2004.00928.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1538-7836.2004.00928.x</ArticleId><ArticleId IdType="pubmed">15456487</ArticleId></ArticleIdList></Reference><Reference><Citation>Khorana AA, Francis CW, Culakova E, Lyman GH. Risk factors for chemotherapy-associated venous thromboembolism in a prospective observational study. Cancer. 2005;104(12):2822&#x2013;2829. doi: 10.1002/cncr.21496.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/cncr.21496</ArticleId><ArticleId IdType="pubmed">16284987</ArticleId></ArticleIdList></Reference><Reference><Citation>Munoz Martin AJ, Ortega I, Font C, Pachon V, Castellon V, Martinez-Marin V, et al. Multivariable clinical-genetic risk model for predicting venous thromboembolic events in patients with cancer. Br J Cancer. 2018;118(8):1056&#x2013;1061. doi: 10.1038/s41416-018-0027-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41416-018-0027-8</ArticleId><ArticleId IdType="pmc">PMC5931103</ArticleId><ArticleId IdType="pubmed">29588512</ArticleId></ArticleIdList></Reference><Reference><Citation>Gade IL, Braekkan SK, Naess IA, Hansen JB, Cannegieter SC, Overvad K, et al. The impact of initial cancer stage on the incidence of venous thromboembolism: the Scandinavian Thrombosis and Cancer (STAC) cohort. J Thromb Haemost. 2017;15(8):1567&#x2013;1575. doi: 10.1111/jth.13752.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jth.13752</ArticleId><ArticleId IdType="pubmed">28585779</ArticleId></ArticleIdList></Reference><Reference><Citation>Blom JW, Doggen CJ, Osanto S, Rosendaal FR. Malignancies, prothrombotic mutations, and the risk of venous thrombosis. JAMA, J Am Med Assoc. 2005;293(6):715&#x2013;722. doi: 10.1001/jama.293.6.715.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.293.6.715</ArticleId><ArticleId IdType="pubmed">15701913</ArticleId></ArticleIdList></Reference><Reference><Citation>Otten HM, Mathijssen J, ten Cate H, Soesan M, Inghels M, Richel DJ, et al. Symptomatic venous thromboembolism in cancer patients treated with chemotherapy: an underestimated phenomenon. Arch Intern Med. 2004;164(2):190&#x2013;194. doi: 10.1001/archinte.164.2.190.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archinte.164.2.190</ArticleId><ArticleId IdType="pubmed">14744843</ArticleId></ArticleIdList></Reference><Reference><Citation>Grover SP, Hisada YM, Kasthuri RS, Reeves BN, Mackman N. Cancer therapy-associated thrombosis. Arterioscler Thromb Vasc Biol. 2021;41(4):1291&#x2013;1305. doi: 10.1161/ATVBAHA.120.314378.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/ATVBAHA.120.314378</ArticleId><ArticleId IdType="pmc">PMC7990713</ArticleId><ArticleId IdType="pubmed">33567864</ArticleId></ArticleIdList></Reference><Reference><Citation>Oppelt P, Betbadal A, Nayak L. Approach to chemotherapy-associated thrombosis. Vasc Med. 2015;20(2):153&#x2013;161. doi: 10.1177/1358863X14568705.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1358863X14568705</ArticleId><ArticleId IdType="pmc">PMC4655120</ArticleId><ArticleId IdType="pubmed">25832603</ArticleId></ArticleIdList></Reference><Reference><Citation>Roopkumar J, Kim AS, Bicky T, Hobbs BP, Khorana AA. Venous thromboembolism in cancer patients receiving immunotherapy. Blood. 2018;132:2510. doi: 10.1182/blood-2018-99-116439.</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/blood-2018-99-116439</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang H, Xu X, Pu C, Li L. Clinical characteristics and prognosis of cancer patients with venous thromboembolism. J Cancer Res Ther. 2019;15(2):344&#x2013;349. doi: 10.4103/jcrt.JCRT_121_18.</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/jcrt.JCRT_121_18</ArticleId><ArticleId IdType="pubmed">30964109</ArticleId></ArticleIdList></Reference><Reference><Citation>Papakotoulas P, Tsoukalas N, Christopoulou A, Ardavanis A, Koumakis G, Papandreou C, et al. Management of cancer-associated thrombosis (CAT): symptomatic or incidental. Anticancer Res. 2020;40(1):305&#x2013;313. doi: 10.21873/anticanres.13954.</Citation><ArticleIdList><ArticleId IdType="doi">10.21873/anticanres.13954</ArticleId><ArticleId IdType="pubmed">31892581</ArticleId></ArticleIdList></Reference><Reference><Citation>Key NS, Khorana AA, Kuderer NM, Bohlke K, Lee AYY, Arcelus JI, et al. Venous thromboembolism prophylaxis and treatment in patients with cancer: ASCO clinical practice guideline update. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2020;38(5):496&#x2013;520. doi: 10.1200/JCO.19.01461.</Citation><ArticleIdList><ArticleId IdType="doi">10.1200/JCO.19.01461</ArticleId><ArticleId IdType="pubmed">31381464</ArticleId></ArticleIdList></Reference><Reference><Citation>Rojas-Hernandez CM. The role of direct oral anticoagulants in cancer-related venous thromboembolism: a perspective beyond the guidelines. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer. 2018;26(3):711&#x2013;720. doi: 10.1007/s00520-017-3990-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00520-017-3990-3</ArticleId><ArticleId IdType="pubmed">29188376</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang N, Lou W, Ji F, Qiu L, Tsang BK, Di W. Low molecular weight heparin and cancer survival: clinical trials and experimental mechanisms. J Cancer Res Clin Oncol. 2016;142(8):1807&#x2013;1816. doi: 10.1007/s00432-016-2131-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00432-016-2131-6</ArticleId><ArticleId IdType="pmc">PMC11819449</ArticleId><ArticleId IdType="pubmed">26912316</ArticleId></ArticleIdList></Reference><Reference><Citation>Bochenek J, P&#xfc;sk&#xfc;ll&#xfc;o&#x11f;lu M, Krzemieniecki K. The antineoplastic effect of low-molecular-weight heparins - a literature review. Contemp Oncol (Pozn) 2013;17(1):6&#x2013;13. doi: 10.5114/wo.2013.33766.</Citation><ArticleIdList><ArticleId IdType="doi">10.5114/wo.2013.33766</ArticleId><ArticleId IdType="pmc">PMC3685354</ArticleId><ArticleId IdType="pubmed">23788954</ArticleId></ArticleIdList></Reference><Reference><Citation>Fossler MJ, Barrett JS, Hainer JW, Riddle JG, Ostergaard P, van der Elst E, et al. Pharmacodynamics of intravenous and subcutaneous tinzaparin and heparin in healthy volunteers. American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists. 2001;58(17):1614&#x2013;1621. doi: 10.1093/ajhp/58.17.1614.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ajhp/58.17.1614</ArticleId><ArticleId IdType="pubmed">11556655</ArticleId></ArticleIdList></Reference><Reference><Citation>Christopoulou A, Ardavanis A, Papandreou C, Koumakis G, Papatsimpas G, Papakotoulas P, et al. Prophylaxis of cancer-associated venous thromboembolism with low-molecular-weight heparin-tinzaparin: real world evidence. Oncol Lett. 2022;23(4):115. doi: 10.3892/ol.2022.13235.</Citation><ArticleIdList><ArticleId IdType="doi">10.3892/ol.2022.13235</ArticleId><ArticleId IdType="pmc">PMC8850961</ArticleId><ArticleId IdType="pubmed">35251346</ArticleId></ArticleIdList></Reference><Reference><Citation>Dimakakos EP, Vathiotis I, Syrigos K. The role of tinzaparin in oncology. Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis. 2018;24(5):697&#x2013;707. doi: 10.1177/1076029617729215.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1076029617729215</ArticleId><ArticleId IdType="pmc">PMC6714870</ArticleId><ArticleId IdType="pubmed">29088922</ArticleId></ArticleIdList></Reference><Reference><Citation>Scotte F, Rey JB, Launay-Vacher V. Thrombosis, cancer and renal insufficiency: low molecular weight heparin at the crossroads. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer. 2012;20(12):3033&#x2013;3042. doi: 10.1007/s00520-012-1590-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00520-012-1590-9</ArticleId><ArticleId IdType="pubmed">22960941</ArticleId></ArticleIdList></Reference><Reference><Citation>Schlesinger M, Roblek M, Ortmann K, Naggi A, Torri G, Borsig L, et al. The role of VLA-4 binding for experimental melanoma metastasis and its inhibition by heparin. Thromb Res. 2014;133(5):855&#x2013;862. doi: 10.1016/j.thromres.2014.02.020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.thromres.2014.02.020</ArticleId><ArticleId IdType="pubmed">24636486</ArticleId></ArticleIdList></Reference><Reference><Citation>Alyahya R, Sudha T, Racz M, Stain SC, Mousa SA. Anti-metastasis efficacy and safety of non-anticoagulant heparin derivative versus low molecular weight heparin in surgical pancreatic cancer models. Int J Oncol. 2015;46(3):1225&#x2013;1231. doi: 10.3892/ijo.2014.2803.</Citation><ArticleIdList><ArticleId IdType="doi">10.3892/ijo.2014.2803</ArticleId><ArticleId IdType="pubmed">25530018</ArticleId></ArticleIdList></Reference><Reference><Citation>Sarantis P, Bokas A, Papadimitropoulou A, Koustas E, Theocharis S, Papakotoulas P et al. (2021) Combinatorial treatment of tinzaparin and chemotherapy can induce a significant antitumor effect in pancreatic cancer. International journal of molecular sciences. 22(13). 10.3390/ijms22137053</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8268558</ArticleId><ArticleId IdType="pubmed">34208987</ArticleId></ArticleIdList></Reference><Reference><Citation>Karamouzis MV, Athanasiadis I, Samelis G, Vallilas C, Bokas A, Nikolaidi A et al. (2021) The impact of thromboprophylaxis on the survival of patients with advanced pancreatic cancer. The Pancreatic Cancer and Tinzaparin (PaCT) Study. Cancers (Basel). 13(12). 10.3390/cancers13122884</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8228127</ArticleId><ArticleId IdType="pubmed">34207591</ArticleId></ArticleIdList></Reference><Reference><Citation>Agnelli G, George DJ, Kakkar AK, Fisher W, Lassen MR, Mismetti P, et al. Semuloparin for thromboprophylaxis in patients receiving chemotherapy for cancer. N Engl J Med. 2012;366(7):601&#x2013;609. doi: 10.1056/NEJMoa1108898.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1108898</ArticleId><ArticleId IdType="pubmed">22335737</ArticleId></ArticleIdList></Reference><Reference><Citation>Agnelli G, Gussoni G, Bianchini C, Verso M, Mandala M, Cavanna L, et al. Nadroparin for the prevention of thromboembolic events in ambulatory patients with metastatic or locally advanced solid cancer receiving chemotherapy: a randomised, placebo-controlled, double-blind study. Lancet Oncol. 2009;10(10):943&#x2013;949. doi: 10.1016/S1470-2045(09)70232-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1470-2045(09)70232-3</ArticleId><ArticleId IdType="pubmed">19726226</ArticleId></ArticleIdList></Reference><Reference><Citation>Patsopoulos NA. A pragmatic view on pragmatic trials. Dialogues Clin Neurosci. 2011;13(2):217&#x2013;224. doi: 10.31887/DCNS.2011.13.2/npatsopoulos.</Citation><ArticleIdList><ArticleId IdType="doi">10.31887/DCNS.2011.13.2/npatsopoulos</ArticleId><ArticleId IdType="pmc">PMC3181997</ArticleId><ArticleId IdType="pubmed">21842619</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">24513419</PMID><DateCompleted><Year>2014</Year><Month>10</Month><Day>18</Day></DateCompleted><DateRevised><Year>2022</Year><Month>03</Month><Day>11</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">2331-0936</ISSN><JournalIssue CitedMedium="Internet"><Volume>29</Volume><Issue>2</Issue><PubDate><Year>2014</Year><Month>Feb</Month></PubDate></JournalIssue><Title>The Consultant pharmacist : the journal of the American Society of Consultant Pharmacists</Title><ISOAbbreviation>Consult Pharm</ISOAbbreviation></Journal><ArticleTitle>Evaluating warfarin management by pharmacists in a community teaching hospital.</ArticleTitle><Pagination><StartPage>95</StartPage><EndPage>103</EndPage><MedlinePgn>95-103</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.4140/TCP.n.2014.95</ELocationID><Abstract><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">The purpose of this study was to evaluate warfarin management by pharmacists compared with physicians through an inpatient anticoagulation management service (AMS).</AbstractText><AbstractText Label="DESIGN" NlmCategory="METHODS">Retrospective cohort study.</AbstractText><AbstractText Label="SETTING" NlmCategory="METHODS">Community teaching hospital.</AbstractText><AbstractText Label="PATIENTS, PARTICIPANTS" NlmCategory="METHODS">Patients were randomly selected from the Inpatient AMS from January 1, 2009 to January 1, 2011. Patients were included if they were 18 of age years or older and received warfarin for at least three days and excluded for indefinite warfarin discontinuation or an indication following orthopedic surgery. A total of 179 patients were included in each group.</AbstractText><AbstractText Label="INTERVENTIONS" NlmCategory="METHODS">The electronic medical record was reviewed for demographics, warfarin indication and goal range, international normalized ratios (INRs), albumin, drug-drug interactions, bleeding, and thrombotic rates.</AbstractText><AbstractText Label="MAIN OUTCOME MEASURES" NlmCategory="METHODS">Primary endpoints included mean time to therapeutic INR, mean time within goal, frequency of supratherapeutic INRs, bleeding, thrombotic rates, and mean INR on discharge.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">There was no statistically significant difference in the time required to reach a therapeutic INR; 3.17 vs. 2.65 days (95% confidence interval -0.09-1.13; P = 0.093). However, the pharmacist group resulted in a lower frequency of supratherapeutic INRs and significantly more time within goal range.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Similar results were observed for pharmacist-managed and physician-managed patients for INR monitoring and outcome rates. However, the pharmacist-managed patients demonstrated a lower incidence of supratherapeutic INRs and significantly more time within goal.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Chilipko</LastName><ForeName>Allison A</ForeName><Initials>AA</Initials><AffiliationInfo><Affiliation>MedStar Union Memorial Hospital, Baltimore, Maryland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Norwood</LastName><ForeName>Daryn K</ForeName><Initials>DK</Initials><AffiliationInfo><Affiliation>MedStar Union Memorial Hospital, Baltimore, Maryland.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D003160">Comparative Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Consult Pharm</MedlineTA><NlmUniqueID>9013983</NlmUniqueID><ISSNLinking>0888-5109</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000925">Anticoagulants</NameOfSubstance></Chemical><Chemical><RegistryNumber>5Q7ZVV76EI</RegistryNumber><NameOfSubstance UI="D014859">Warfarin</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000925" MajorTopicYN="N">Anticoagulants</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004347" MajorTopicYN="N">Drug Interactions</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016903" MajorTopicYN="N">Drug Monitoring</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006470" MajorTopicYN="N">Hemorrhage</DescriptorName><QualifierName UI="Q000139" MajorTopicYN="N">chemically induced</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006784" MajorTopicYN="N">Hospitals, Teaching</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019934" MajorTopicYN="N">International Normalized Ratio</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010595" MajorTopicYN="N">Pharmacists</DescriptorName><QualifierName UI="Q000458" MajorTopicYN="Y">organization &amp; administration</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010607" MajorTopicYN="N">Pharmacy Service, Hospital</DescriptorName><QualifierName UI="Q000458" MajorTopicYN="N">organization &amp; administration</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010820" MajorTopicYN="N">Physicians</DescriptorName><QualifierName UI="Q000458" MajorTopicYN="N">organization &amp; administration</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013997" MajorTopicYN="N">Time Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014859" MajorTopicYN="N">Warfarin</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">AE = Adverse events</Keyword><Keyword MajorTopicYN="N">AMS = Anticoagulation management service</Keyword><Keyword MajorTopicYN="N">Afib = Atrial fibrillation</Keyword><Keyword MajorTopicYN="N">Anticoagulation</Keyword><Keyword MajorTopicYN="N">CT = Computed tomography</Keyword><Keyword MajorTopicYN="N">DVT = Deep venous thrombosis</Keyword><Keyword MajorTopicYN="N">FDA = Food and Drug Administration</Keyword><Keyword MajorTopicYN="N">FFP = Fresh frozen plasma</Keyword><Keyword MajorTopicYN="N">Hgb = Hemoglobin</Keyword><Keyword MajorTopicYN="N">INR = International normalized ratio</Keyword><Keyword MajorTopicYN="N">International normalized ratio</Keyword><Keyword MajorTopicYN="N">Joint Commission</Keyword><Keyword MajorTopicYN="N">NNT = Number needed to treat</Keyword><Keyword MajorTopicYN="N">NPSG = National Patient Safety Goal</Keyword><Keyword MajorTopicYN="N">PE = Pulmonary embolism</Keyword><Keyword MajorTopicYN="N">PI = Performance improvement</Keyword><Keyword MajorTopicYN="N">PMS = Pharmacokinetics Monitoring Service</Keyword><Keyword MajorTopicYN="N">Pharmacist</Keyword><Keyword MajorTopicYN="N">Pharmacokinetics</Keyword><Keyword MajorTopicYN="N">Scr = Serum creatinine</Keyword><Keyword MajorTopicYN="N">TTR = Time in therapeutic range</Keyword><Keyword MajorTopicYN="N">Warfarin</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2014</Year><Month>2</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2014</Year><Month>2</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2014</Year><Month>10</Month><Day>19</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">24513419</ArticleId><ArticleId IdType="doi">10.4140/TCP.n.2014.95</ArticleId><ArticleId IdType="pii">YL412717R25X6M20</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">28871623</PMID><DateCompleted><Year>2018</Year><Month>07</Month><Day>02</Day></DateCompleted><DateRevised><Year>2023</Year><Month>08</Month><Day>29</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1538-7836</ISSN><JournalIssue CitedMedium="Internet"><Volume>15</Volume><Issue>11</Issue><PubDate><Year>2017</Year><Month>Nov</Month></PubDate></JournalIssue><Title>Journal of thrombosis and haemostasis : JTH</Title><ISOAbbreviation>J Thromb Haemost</ISOAbbreviation></Journal><ArticleTitle>Clinical course of patients with symptomatic isolated superficial vein thrombosis: the ICARO follow-up study.</ArticleTitle><Pagination><StartPage>2176</StartPage><EndPage>2183</EndPage><MedlinePgn>2176-2183</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1111/jth.13840</ELocationID><Abstract><AbstractText Label="UNLABELLED">Essentials Late sequelae of isolated superficial vein thrombosis (iSVT) have rarely been investigated. We studied 411 consecutive outpatients with acute iSVT with a median follow-up of three years. Male sex and cancer are risk factors for future deep vein thrombosis or pulmonary embolism. Patients without cancer appear to be at a negligible risk for death.</AbstractText><AbstractText Label="SUMMARY">Background Studies of long-term thromboembolic complications and death following acute isolated superficial vein thrombosis (iSVT) of the lower extremities are scarce. Objectives To investigate the course of iSVT in the setting of an observational multicenter study. Methods We collected longitudinal data of 411 consecutive outpatients with acute, symptomatic, objectively diagnosed iSVT who were previously included in the cross-sectional ICARO study. Four patients followed for &lt; 30 days and 79 with concomitant deep vein thrombosis (DVT) or pulmonary embolism (PE) were excluded from the present analysis. The primary outcome was symptomatic DVT or PE. The safety outcomes were major bleeding and all-cause death. Results The median follow-up time was 1026 days (interquartile range 610-1796). Symptomatic DVT/PE occurred in 52 (12.9%) patients, giving annualized rates of 1.3% (95% confidence interval [CI] 0.3-3.9%) on anticoagulant treatment and 4.4% (95% CI 3.2-5.8%) off anticoagulant treatment. Male sex (adjusted hazard ratio [HR] 2.03 [95% CI 1.16-3.54]) and active solid cancer (adjusted HR 3.14 [95% CI 1.11-8.93]) were associated with future DVT/PE, whereas prior DVT/PE failed to show significance, most likely because of bias resulting from prolonged anticoagulant treatment. Three major bleeding events occurred on treatment, giving an annualized rate of 1.4% (95 CI 0.3-4.0%). Death was recorded in 16 patients (annualized rate: 1.1% [95% CI 0.6-1.7%]), and was attributable to cancer (n = 8), PE (n = 1), cardiovascular events (n = 3), or other causes (n = 4). Conclusions The long-term risk of DVT/PE after anticoagulant discontinuation for acute iSVT is clinically relevant, especially in males and in the presence of active cancer. The risk of death appears to be negligible in patients without cancer.</AbstractText><CopyrightInformation>&#xa9; 2017 International Society on Thrombosis and Haemostasis.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Barco</LastName><ForeName>S</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0002-2618-347X</Identifier><AffiliationInfo><Affiliation>Center for Thrombosis and Hemostasis, University Medical Hospital of the Johannes Gutenberg University, Mainz, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pomero</LastName><ForeName>F</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Clinical Medicine, ASO S. Croce e Carle, Cuneo, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Di Minno</LastName><ForeName>M N D</ForeName><Initials>MND</Initials><AffiliationInfo><Affiliation>Department of Clinical Medicine and Surgery, Federico II University, Napoli, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Unit of Cell and Molecular Biology in Cardiovascular Diseases, Centro Cardiologico Monzino, IRCCS, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tamborini Permunian</LastName><ForeName>E</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Medicine and Surgery, University of Insubria, Varese, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Malato</LastName><ForeName>A</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Hematology Unit, University of Palermo, Palermo, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pasca</LastName><ForeName>S</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Center for Hemorrhagic and Thrombotic Diseases, University Hospital of Udine, Udine, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Barillari</LastName><ForeName>G</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Center for Hemorrhagic and Thrombotic Diseases, University Hospital of Udine, Udine, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fenoglio</LastName><ForeName>L</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Clinical Medicine, ASO S. Croce e Carle, Cuneo, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Siragusa</LastName><ForeName>S</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Hematology Unit, University of Palermo, Palermo, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Di Minno</LastName><ForeName>G</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Clinical Medicine and Surgery, Federico II University, Napoli, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ageno</LastName><ForeName>W</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Department of Medicine and Surgery, University of Insubria, Varese, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dentali</LastName><ForeName>F</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Medicine and Surgery, University of Insubria, Varese, Italy.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016448">Multicenter Study</PublicationType><PublicationType UI="D064888">Observational Study</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2017</Year><Month>10</Month><Day>19</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>J Thromb Haemost</MedlineTA><NlmUniqueID>101170508</NlmUniqueID><ISSNLinking>1538-7836</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000925">Anticoagulants</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000925" MajorTopicYN="N">Anticoagulants</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="Y">administration &amp; dosage</QualifierName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002423" MajorTopicYN="N">Cause of Death</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006470" MajorTopicYN="N">Hemorrhage</DescriptorName><QualifierName UI="Q000139" MajorTopicYN="N">chemically induced</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015994" MajorTopicYN="N">Incidence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007558" MajorTopicYN="N">Italy</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D053208" MajorTopicYN="N">Kaplan-Meier Estimate</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008137" MajorTopicYN="N">Longitudinal Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D035002" MajorTopicYN="N">Lower Extremity</DescriptorName><QualifierName UI="Q000098" MajorTopicYN="Y">blood supply</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015999" MajorTopicYN="N">Multivariate Analysis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009369" MajorTopicYN="N">Neoplasms</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016017" MajorTopicYN="N">Odds Ratio</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016016" MajorTopicYN="N">Proportional Hazards Models</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011655" MajorTopicYN="N">Pulmonary Embolism</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012008" MajorTopicYN="N">Recurrence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012737" MajorTopicYN="N">Sex Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013997" MajorTopicYN="N">Time Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020246" MajorTopicYN="N">Venous Thrombosis</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName><QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">cohort study</Keyword><Keyword MajorTopicYN="N">death</Keyword><Keyword MajorTopicYN="N">major bleeding</Keyword><Keyword MajorTopicYN="N">superficial vein thrombosis</Keyword><Keyword MajorTopicYN="N">venous thromboembolism</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>5</Month><Day>31</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2017</Year><Month>9</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>7</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2017</Year><Month>9</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">28871623</ArticleId><ArticleId IdType="doi">10.1111/jth.13840</ArticleId><ArticleId IdType="pii">S1538-7836(22)04391-4</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">24076972</PMID><DateCompleted><Year>2014</Year><Month>01</Month><Day>22</Day></DateCompleted><DateRevised><Year>2022</Year><Month>04</Month><Day>08</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">2168-619X</ISSN><JournalIssue CitedMedium="Internet"><Volume>139</Volume><Issue>11</Issue><PubDate><Year>2013</Year><Month>Nov</Month></PubDate></JournalIssue><Title>JAMA otolaryngology-- head &amp; neck surgery</Title><ISOAbbreviation>JAMA Otolaryngol Head Neck Surg</ISOAbbreviation></Journal><ArticleTitle>Prospective study of venous thromboembolism in patients with head and neck cancer after surgery.</ArticleTitle><Pagination><StartPage>1143</StartPage><EndPage>1150</EndPage><MedlinePgn>1143-50</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1001/jamaoto.2013.4911</ELocationID><Abstract><AbstractText Label="IMPORTANCE" NlmCategory="OBJECTIVE">Venous thromboembolism (VTE) is associated with significant morbidity and mortality in surgery patients, but little data exist on the incidence of VTE in head and neck cancer surgical patients.</AbstractText><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">To determine the incidence of VTE in postoperative patients with head and neck cancer.</AbstractText><AbstractText Label="DESIGN, SETTING, AND PARTICIPANTS" NlmCategory="METHODS">A prospective study of 100 consecutive patients hospitalized at a tertiary care academic surgical center who underwent surgery to treat head and neck cancer. Routine chemoprophylaxis was not used. On postoperative day (POD) 2 or 3, participants received clinical examination and duplex ultrasonographic evaluation (US). Participants with negative findings on clinical examination and US were followed up clinically; participants with evidence of deep venous thrombosis (DVT) or pulmonary embolism (PE) were given therapeutic anticoagulation. Participants with superficial VTE underwent repeated US on POD 4, 5, or 6. Participants were monitored for 30 days after surgery.</AbstractText><AbstractText Label="MAIN OUTCOME AND MEASURE" NlmCategory="METHODS">Total number of new cases of VTE (superficial and deep) identified within 30 days of surgery and confirmed on diagnostic imaging.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Of the 111 participants enrolled, 11 withdrew before completing the study; thus, 100 participants were included. The overall incidence of VTE was 13%. Eight participants were identified with clinically significant VTE: 7 DVT and 1 PE. An additional 5 participants had asymptomatic lower extremity superficial VTE detected on US alone. Fourteen percent of patients received some form of postoperative anticoagulation therapy; the rate of bleeding complications in these patients (30.1%) was higher than that in patients without anticoagulation therapy (5.6%) (P = .01).</AbstractText><AbstractText Label="CONCLUSIONS AND RELEVANCE" NlmCategory="CONCLUSIONS">Hospitalized patients with head and neck cancer not routinely receiving anticoagulation therapy after surgery have an increased risk of VTE. Bleeding complications are elevated in patients receiving postoperative anticoagulation.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Clayburgh</LastName><ForeName>Daniel R</ForeName><Initials>DR</Initials><AffiliationInfo><Affiliation>Department of Otolaryngology-Head and Neck Surgery, Oregon Health and Science University, Portland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Stott</LastName><ForeName>Will</ForeName><Initials>W</Initials></Author><Author ValidYN="Y"><LastName>Cordiero</LastName><ForeName>Teresa</ForeName><Initials>T</Initials></Author><Author ValidYN="Y"><LastName>Park</LastName><ForeName>Renee</ForeName><Initials>R</Initials></Author><Author ValidYN="Y"><LastName>Detwiller</LastName><ForeName>Kara</ForeName><Initials>K</Initials></Author><Author ValidYN="Y"><LastName>Buniel</LastName><ForeName>Maria</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Flint</LastName><ForeName>Paul</ForeName><Initials>P</Initials></Author><Author ValidYN="Y"><LastName>Schindler</LastName><ForeName>Joshua</ForeName><Initials>J</Initials></Author><Author ValidYN="Y"><LastName>Andersen</LastName><ForeName>Peter</ForeName><Initials>P</Initials></Author><Author ValidYN="Y"><LastName>Wax</LastName><ForeName>Mark K</ForeName><Initials>MK</Initials></Author><Author ValidYN="Y"><LastName>Gross</LastName><ForeName>Neil</ForeName><Initials>N</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D003160">Comparative Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>JAMA Otolaryngol Head Neck Surg</MedlineTA><NlmUniqueID>101589542</NlmUniqueID><ISSNLinking>2168-6181</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005500" MajorTopicYN="N">Follow-Up Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006258" MajorTopicYN="N">Head and Neck Neoplasms</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015994" MajorTopicYN="N">Incidence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D037981" MajorTopicYN="N">Neck Dissection</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018570" MajorTopicYN="N">Risk Assessment</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018616" MajorTopicYN="N">Ultrasonography, Doppler, Duplex</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014481" MajorTopicYN="N" Type="Geographic">United States</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D054556" MajorTopicYN="N">Venous Thromboembolism</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2013</Year><Month>10</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2013</Year><Month>10</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2014</Year><Month>1</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">24076972</ArticleId><ArticleId IdType="doi">10.1001/jamaoto.2013.4911</ArticleId><ArticleId IdType="pii">1741449</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">24626268</PMID><DateCompleted><Year>2014</Year><Month>10</Month><Day>23</Day></DateCompleted><DateRevised><Year>2022</Year><Month>03</Month><Day>18</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1806-3756</ISSN><JournalIssue CitedMedium="Internet"><Volume>40</Volume><Issue>1</Issue><PubDate><Year>2014</Year><Season>Jan-Feb</Season></PubDate></JournalIssue><Title>Jornal brasileiro de pneumologia : publicacao oficial da Sociedade Brasileira de Pneumologia e Tisilogia</Title><ISOAbbreviation>J Bras Pneumol</ISOAbbreviation></Journal><ArticleTitle>Incidence of pulmonary embolism during COPD exacerbation.</ArticleTitle><Pagination><StartPage>38</StartPage><EndPage>45</EndPage><MedlinePgn>38-45</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1590/S1806-37132014000100006</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S1806-37132014000100038</ELocationID><Abstract><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">Because pulmonary embolism (PE) and COPD exacerbation have similar presentations and symptoms, PE can be overlooked in COPD patients. Our objective was to determine the prevalence of PE during COPD exacerbation and to describe the clinical aspects in COPD patients diagnosed with PE.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">This was a prospective study conducted at a university hospital in the city of Ankara, Turkey. We included all COPD patients who were hospitalized due to acute exacerbation of COPD between May of 2011 and May of 2013. All patients underwent clinical risk assessment, arterial blood gas analysis, chest CT angiography, and Doppler ultrasonography of the lower extremities. In addition, we measured D-dimer levels and N-terminal pro-brain natriuretic peptide (NT-pro-BNP) levels.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">We included 172 patients with COPD. The prevalence of PE was 29.1%. The patients with pleuritic chest pain, lower limb asymmetry, and high NT-pro-BNP levels were more likely to develop PE, as were those who were obese or immobile. Obesity and lower limb asymmetry were independent predictors of PE during COPD exacerbation (OR = 4.97; 95% CI, 1.775-13.931 and OR = 2.329; 95% CI, 1.127-7.105, respectively).</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">The prevalence of PE in patients with COPD exacerbation was higher than expected. The association between PE and COPD exacerbation should be considered, especially in patients who are immobile or obese.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Akpinar</LastName><ForeName>Evrim Eylem</ForeName><Initials>EE</Initials><AffiliationInfo><Affiliation>Ufuk University School of Medicine, Department of Chest Diseases, Ankara, Turkey, MD. Department of Chest Diseases, Ufuk University School of Medicine, Ankara, Turkey.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ho&#x15f;g&#xfc;n</LastName><ForeName>Derya</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Ufuk University, School of Medicine, Department of Chest Diseases, Ankara, Turkey, MD. Department of Chest Diseases, Ufuk University School of Medicine, Ankara, Turkey.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Akpinar</LastName><ForeName>Serdar</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Chest Surgery Training Hospital, Ankara, Turkey, MD. Atat&#xfc;rk Chest Diseases and Chest Surgery Training Hospital, Ankara, Turkey.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ata&#xe7;</LastName><ForeName>G&#xf6;k&#xe7;e Kaan</ForeName><Initials>GK</Initials><AffiliationInfo><Affiliation>Ufuk University, School of Medicine, Department of Radiology, Ankara, Turkey, MD. Department of Radiology, Ufuk University School of Medicine, Ankara, Turkey.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Do&#x11f;anay</LastName><ForeName>Beyza</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Ankara University, School of Medicine, Department of Biostatistics, Ankara, Turkey, PhD. Department of Biostatistics, Ankara University School of Medicine, Ankara, Turkey.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>G&#xfc;lhan</LastName><ForeName>Meral</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Ufuk University, School of Medicine, Department of Chest Diseases, Ankara, Turkey, Chief. Department of Chest Diseases School of Medicine, Ufuk University, Ankara, Turkey.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><Language>por</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>Brazil</Country><MedlineTA>J Bras Pneumol</MedlineTA><NlmUniqueID>101222274</NlmUniqueID><ISSNLinking>1806-3713</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015995" MajorTopicYN="N">Prevalence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D029424" MajorTopicYN="N">Pulmonary Disease, Chronic Obstructive</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011655" MajorTopicYN="N">Pulmonary Embolism</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014057" MajorTopicYN="N">Tomography, X-Ray Computed</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014421" MajorTopicYN="N" Type="Geographic">Turkey</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018615" MajorTopicYN="N">Ultrasonography, Doppler, Color</DescriptorName></MeshHeading></MeshHeadingList><OtherAbstract Type="Publisher" Language="por"><AbstractText Label="OBJETIVO:">Visto que a embolia pulmonar (EP) e a exacerba&#xe7;&#xe3;o da DPOC t&#xea;m apresenta&#xe7;&#xe3;o e sintomas comuns, o diagn&#xf3;stico de EP pode ser negligenciado nesses pacientes. Nosso objetivo foi determinar a preval&#xea;ncia de EP durante a exacerba&#xe7;&#xe3;o da DPOC e descrever os aspectos cl&#xed;nicos em portadores de DPOC diagnosticados com EP.</AbstractText><AbstractText Label="M&#xc9;TODOS:">Estudo prospectivo conduzido em um hospital universit&#xe1;rio na cidade de Ancara, Turquia. Entre maio de 2011 e maio de 2013, todos os pacientes hospitalizados por exacerba&#xe7;&#xe3;o aguda da DPOC foram inclu&#xed;dos no estudo. Todos os pacientes foram submetidos a avalia&#xe7;&#xe3;o de risco cl&#xed;nico, gasometria arterial, angiotomografia de t&#xf3;rax e ultrassonografia Doppler de membros inferiores. Al&#xe9;m disso, foram medidos os n&#xed;veis de d&#xed;mero-D e de <i>N-terminal pro-brain natriuretic peptide</i> (NT-pro-BNP).</AbstractText><AbstractText Label="RESULTADOS:">Foram inclu&#xed;dos 172 pacientes com DPOC. A preval&#xea;ncia de EP foi de 29,1 %. Os pacientes com DPOC e dor tor&#xe1;cica pleur&#xed;tica, assimetria de membros inferiores e altos n&#xed;veis de NT-pro-BNP, assim como aqueles que estavam obesos ou imobilizados, apresentavam maior probabilidade de desenvolver EP. Obesidade e assimetria de membros inferiores foram preditores independentes de EP nos pacientes com exacerba&#xe7;&#xe3;o da DPOC (OR = 4,97; IC95%, 1,775-13,931 e OR = 2,329; IC95% CI, 1,127-7,105, respectivamente).</AbstractText><AbstractText Label="CONCLUS&#xd5;ES:">A preval&#xea;ncia de EP em pacientes com exacerba&#xe7;&#xe3;o da DPOC foi maior que a esperada. A associa&#xe7;&#xe3;o entre EP e exacerba&#xe7;&#xe3;o da DPOC deve ser considerada nesses pacientes, especialmente naqueles imobilizados ou obesos.</AbstractText></OtherAbstract></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2013</Year><Month>9</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2013</Year><Month>12</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2014</Year><Month>3</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2014</Year><Month>3</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2014</Year><Month>10</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2014</Year><Month>1</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">24626268</ArticleId><ArticleId IdType="pmc">PMC4075911</ArticleId><ArticleId IdType="doi">10.1590/S1806-37132014000100006</ArticleId><ArticleId IdType="pii">S1806-37132014000100038</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Sapey E, Stockley RA. COPD exacerbations . 2: Aetiology . Thorax. 2006;61(3):250&#x2013;258. http://dx.doi.org/10.1136/thx.2005.041822</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/thx.2005.041822</ArticleId><ArticleId IdType="pmc">PMC2080749</ArticleId><ArticleId IdType="pubmed">16517585</ArticleId></ArticleIdList></Reference><Reference><Citation>Seneff MG, Wagner DP, Wagner RP, Zimmerman JE, Knaus WA. Hospital and 1-year survival of patients admitted to
intensive care units with acute exacerbation of chronic obstructive pulmonary
disease. JAMA. 1995;274(23):1852&#x2013;1857. http://dx.doi.org/10.1001/jama.1995.03530230038027</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.1995.03530230038027</ArticleId><ArticleId IdType="pubmed">7500534</ArticleId></ArticleIdList></Reference><Reference><Citation>Rizkallah J, Man SF, Sin DD. Prevalence of pulmonary embolism in acute exacerbations
of COPD: A systematic review and metanalysis. Chest. 2009;135(3):786&#x2013;793. http://dx.doi.org/10.1378/chest.08-1516</Citation><ArticleIdList><ArticleId IdType="doi">10.1378/chest.08-1516</ArticleId><ArticleId IdType="pubmed">18812453</ArticleId></ArticleIdList></Reference><Reference><Citation>Gunen H, Gulbas G, In E, Yetkin O, Hacievliyagil SS. Venous thromboemboli and exacerbations of
COPD. Eur Respir J. 2010;35(6):1243&#x2013;1248. http://dx.doi.org/10.1183/09031936.00120909</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/09031936.00120909</ArticleId><ArticleId IdType="pubmed">19926740</ArticleId></ArticleIdList></Reference><Reference><Citation>Baum GL, Fisher FD. The relationship of fatal pulmonary insufficiency with cor pulmonale, rightsided mural thrombi and pulmonary emboli: a preliminary report. Am J Med Sci. 1960;240:609&#x2013;612.</Citation><ArticleIdList><ArticleId IdType="pubmed">13687964</ArticleId></ArticleIdList></Reference><Reference><Citation>Mitchell RS, Silvers GW, Dart GA, Petty TL, Vincent TN, Ryan SF, et al. Clinical and morphologic correlations in chronic airway obstruction. Aspen Emphysema Conf. 1968;9:109&#x2013;123.</Citation><ArticleIdList><ArticleId IdType="pubmed">5722654</ArticleId></ArticleIdList></Reference><Reference><Citation>Poulsen SH, Noer I, M&#xf8;ller JE, Knudsen TE, Frandsen JL. Clinical outcome of patients with suspected pulmonary
embolism. A follow-up study of 588 consecutive patients. J Intern Med. 2001;250(2):137&#x2013;143. http://dx.doi.org/10.1046/j.1365-2796.2001.00866.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1046/j.1365-2796.2001.00866.x</ArticleId><ArticleId IdType="pubmed">11489063</ArticleId></ArticleIdList></Reference><Reference><Citation>Fern&#xe1;ndez C, Jim&#xe9;nez D, De Miguel J, Mart&#xed; D, D&#xed;az G, Sueiro A. Chronic obstructive pulmonary disease in patients with
acute symptomatic pulmonary embolism [Article in Spanish] Arch Bronconeumol. 2009;45(6):286&#x2013;290. http://dx.doi.org/10.1016/j.arbres.2008.10.008</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.arbres.2008.10.008</ArticleId><ArticleId IdType="pubmed">19394747</ArticleId></ArticleIdList></Reference><Reference><Citation>Tillie-Leblond I, Marquette CH, Perez T, Scherpereel A, Zanetti C, Tonnel AB, et al.  Pulmonary embolism in patients with unexplained
exacerbation of chronic obstructive pulmonary disease: prevalence and risk
factors. Ann Intern Med. 2006;144(6):390&#x2013;396. http://dx.doi.org/10.7326/0003-4819-144-6-200603210-00005</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/0003-4819-144-6-200603210-00005</ArticleId><ArticleId IdType="pubmed">16549851</ArticleId></ArticleIdList></Reference><Reference><Citation>Global Initiative for Chronic Obstructive Lung Disease - GOLD  . [homepage on the Internet] Bethesda: Global Initiative for Chronic Obstructive Lung Disease ; Global Strategy for the Diagnosis, Management, and Prevention of COPD
- Revised 2011. [Adobe Acrobat document, 90p.];  [cited 2013
Aug 26]. 2011.  a Available from:  Available from:
http://www.goldcopd.org/</Citation></Reference><Reference><Citation>Klok FA, Mos IC, Nijkeuter M, Righini M, Perrier A, Le Gal G, et al.  Simplification of the revised Geneva score for assessing
clinical probability of pulmonary embolism. Arch Intern Med. 2008;168(19):2131&#x2013;2136. http://dx.doi.org/10.1001/archinte.168.19.2131</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archinte.168.19.2131</ArticleId><ArticleId IdType="pubmed">18955643</ArticleId></ArticleIdList></Reference><Reference><Citation>Wells PS, Owen C, Doucette S, Ferguson D, Tran H. Does this patient have deep vein
thrombosis? JAMA. 2006;295(2):199&#x2013;207. http://dx.doi.org/10.1001/jama.295.2.199</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.295.2.199</ArticleId><ArticleId IdType="pubmed">16403932</ArticleId></ArticleIdList></Reference><Reference><Citation>Miniati M, Prediletto R, Formichi B, Marini C, Di Ricco G, Tonelli L, et al.  Accuracy of clinical assessment in the diagnosis of
pulmonary embolism. Am J Respir Crit Care Med. 1999;159(3):864&#x2013;871. http://dx.doi.org/10.1164/ajrccm.159.3.9806130</Citation><ArticleIdList><ArticleId IdType="doi">10.1164/ajrccm.159.3.9806130</ArticleId><ArticleId IdType="pubmed">10051264</ArticleId></ArticleIdList></Reference><Reference><Citation>Rose BD, TW Post. Clinical physiology of acid-base and electrolyte disorders. New York: McGraw Hill; 1999.</Citation></Reference><Reference><Citation>NHLBI Obesity Education Initiative Expert Panel on the Identification, Evaluation, and Treatment of Obesity in Adults. Clinical Guidelines on the Identification, Evaluation, and Treatment of Overweight and Obesity in Adults: The Evidence Report. Bethesda: National Heart, Lung, and Blood Institute; 1998.</Citation></Reference><Reference><Citation>Schols AM, Broekhuizen R, Weling-Scheepers CA, Wouters EF. Body composition and mortality in chronic obstructive pulmonary disease. Am J Clin Nutr. 2005;82(1):53&#x2013;59.</Citation><ArticleIdList><ArticleId IdType="pubmed">16002800</ArticleId></ArticleIdList></Reference><Reference><Citation>Carretero OA, Oparil S. Essential hypertension. Part I: definition and etiology . Circulation. 2000; 101(3):329&#x2013;335. http://dx.doi.org/10.1161/01.CIR.101.3.329</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/01.CIR.101.3.329</ArticleId><ArticleId IdType="pubmed">10645931</ArticleId></ArticleIdList></Reference><Reference><Citation>American Diabetes Association  Diagnosis and classification of diabetes
mellitus. Diabetes Care. 2010;33 Suppl 1:S62&#x2013;S69. http://dx.doi.org/10.2337/dc10-S062</Citation><ArticleIdList><ArticleId IdType="doi">10.2337/dc10-S062</ArticleId><ArticleId IdType="pmc">PMC2797383</ArticleId><ArticleId IdType="pubmed">20042775</ArticleId></ArticleIdList></Reference><Reference><Citation>White CT, Barrett BJ, Madore F, Moist LM, Klarenbach SW, Foley RN, et al.  Clinical practice guidelines for evaluation of
anemia. Kidney Int Suppl. 2008;(110):S4&#x2013;S6. http://dx.doi.org/10.1038/ki.2008.268</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ki.2008.268</ArticleId><ArticleId IdType="pubmed">18668118</ArticleId></ArticleIdList></Reference><Reference><Citation>Rutschmann OT, Cornuz J, Poletti PA, Bridevaux PO, Hugli OW, Qanadli SD, et al.  Should pulmonary embolism be suspected in exacerbation
of chronic obstructive pulmonary disease? Thorax. 2007;62(2):121&#x2013;125. http://dx.doi.org/10.1136/thx.2006.065557</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/thx.2006.065557</ArticleId><ArticleId IdType="pmc">PMC2111235</ArticleId><ArticleId IdType="pubmed">17101737</ArticleId></ArticleIdList></Reference><Reference><Citation>Choi KJ, Cha SI, Shin KM, Lee J, Hwangbo Y, Yoo SS, et al.  Prevalence and predictors of pulmonary embolism in
Korean patients with exacerbation of chronic obstructive pulmonary
disease. Respiration. 2013;85(3):203&#x2013;209. http://dx.doi.org/10.1159/000335904</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000335904</ArticleId><ArticleId IdType="pubmed">22338649</ArticleId></ArticleIdList></Reference><Reference><Citation>Lippmann M, Fein A. Pulmonary embolism in the patient with chronic
obstructive pulmonary disease A diagnostic dilemma. Chest. 1981;79(1):39&#x2013;42. http://dx.doi.org/10.1378/chest.79.1.39</Citation><ArticleIdList><ArticleId IdType="doi">10.1378/chest.79.1.39</ArticleId><ArticleId IdType="pubmed">6778664</ArticleId></ArticleIdList></Reference><Reference><Citation>Rodger MA, Jones G, Rasuli P, Raymond F, Djunaedi H, Bredeson CN, et al.  Steady-state end-tidal alveolar dead space fraction and
D-dimer: bedside tests to exclude pulmonary embolism. Chest. 2001;120(1):115&#x2013;119. http://dx.doi.org/10.1378/chest.120.1.115</Citation><ArticleIdList><ArticleId IdType="doi">10.1378/chest.120.1.115</ArticleId><ArticleId IdType="pubmed">11451825</ArticleId></ArticleIdList></Reference><Reference><Citation>Klok FA, Mos IC, Huisman MV. Brain-type natriuretic peptide levels in the prediction
of adverse outcome in patients with pulmonary embolism: a systematic review and
meta-analysis. Am J Respir Crit Care Med. 2008;178(4):425&#x2013;430. http://dx.doi.org/10.1164/rccm.200803-459OC</Citation><ArticleIdList><ArticleId IdType="doi">10.1164/rccm.200803-459OC</ArticleId><ArticleId IdType="pubmed">18556626</ArticleId></ArticleIdList></Reference><Reference><Citation>Yetkin &#xd6;, In E, Aksoy Y, Hac&#x131;evliyagil SS, G&#xfc;nen H. Brain natriuretic peptide in acute pulmonary embolism: its association with pulmonary artery pressure and oxygen saturations. Turkish Resp J. 2006;7(3):105&#x2013;108.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">22959496</PMID><DateCompleted><Year>2013</Year><Month>03</Month><Day>08</Day></DateCompleted><DateRevised><Year>2025</Year><Month>06</Month><Day>26</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1879-0267</ISSN><JournalIssue CitedMedium="Internet"><Volume>43</Volume><Issue>11</Issue><PubDate><Year>2012</Year><Month>Nov</Month></PubDate></JournalIssue><Title>Injury</Title><ISOAbbreviation>Injury</ISOAbbreviation></Journal><ArticleTitle>Clinical outcomes after repair of quadriceps tendon rupture: a systematic review.</ArticleTitle><Pagination><StartPage>1931</StartPage><EndPage>1938</EndPage><MedlinePgn>1931-8</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.injury.2012.08.044</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0020-1383(12)00355-5</ELocationID><Abstract><AbstractText>The existing evidence regarding the management of quadriceps tendon rupture remains obscure. The aim of the current review is to investigate the characteristics, the different techniques employed and to analyse the clinical outcomes following surgical repair of quadriceps tendon rupture. An Internet based search of the English literature of the last 25 years was carried out. Case reports and non-clinical studies were excluded. The methodological quality of the included studies was assessed using the Coleman Methodology Score. All data regarding mechanism and site of rupture, type of treatment, time elapsed between diagnosis and repair, patients' satisfaction, clinical outcome, return to pre-injury activities, complications and recurrence rates were extracted and analysed. Out of 474 studies identified, 12 met the inclusion criteria. The average of Coleman Methodology Score was 50.46/100. In total 319 patients were analysed with a mean age of 57 years (16-85). The mean time of follow-up was 47.5 months (3 months to 24 years). The most common mechanism of injury was simple fall (61.5%). Spontaneous ruptures were reported in 3.2% of cases. The most common sites of tear were noted between 1cm and 2 cm of the superior pole of the patella and, in the older people, at the osseotendinous junction. The most frequently used repair technique was patella drill holes (50% of patients). Simple sutures were used in mid-substance ruptures. Several reinforcement techniques were employed in case of poor quality or retraction of the torn ends of tendon. The affected limb was immobilised in a cast for a period of 3-10 weeks. Quadriceps muscular atrophy and muscle strength deficit were present in most of the cases. Worst results were noted in delayed repairs. Reported complications included heterotopic ossifications in 6.9% of patients, deep venous thrombosis or pulmonary embolism in 2.5%, superficial infection in 1.2% and deep infection in 1.1%. It appears that the type of surgical repair does not influence the clinical results. The majority of the studies reported good or excellent ROM and return to the pre-injury activities. The overall rate of re-rupture was 2%.</AbstractText><CopyrightInformation>Copyright &#xa9; 2012 Elsevier Ltd. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ciriello</LastName><ForeName>Vincenzo</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Academic Department of Trauma &amp; Orthopaedic Surgery, Clarendon Wing, Floor A, Great George Street, Leeds General Infirmary, LS1 3EX Leeds, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gudipati</LastName><ForeName>Suribabu</ForeName><Initials>S</Initials></Author><Author ValidYN="Y"><LastName>Tosounidis</LastName><ForeName>Theodoros</ForeName><Initials>T</Initials></Author><Author ValidYN="Y"><LastName>Soucacos</LastName><ForeName>P N</ForeName><Initials>PN</Initials></Author><Author ValidYN="Y"><LastName>Giannoudis</LastName><ForeName>Peter V</ForeName><Initials>PV</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2012</Year><Month>09</Month><Day>07</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Injury</MedlineTA><NlmUniqueID>0226040</NlmUniqueID><ISSNLinking>0020-1383</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017060" MajorTopicYN="N">Patient Satisfaction</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="Y">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D052097" MajorTopicYN="N">Quadriceps Muscle</DescriptorName><QualifierName UI="Q000293" MajorTopicYN="Y">injuries</QualifierName><QualifierName UI="Q000503" MajorTopicYN="Y">physiopathology</QualifierName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012421" MajorTopicYN="N">Rupture</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012422" MajorTopicYN="N">Rupture, Spontaneous</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013708" MajorTopicYN="N">Tendon Injuries</DescriptorName><QualifierName UI="Q000503" MajorTopicYN="Y">physiopathology</QualifierName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013997" MajorTopicYN="N">Time Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2012</Year><Month>9</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2012</Year><Month>9</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2013</Year><Month>3</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">22959496</ArticleId><ArticleId IdType="doi">10.1016/j.injury.2012.08.044</ArticleId><ArticleId IdType="pii">S0020-1383(12)00355-5</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">34489264</PMID><DateCompleted><Year>2021</Year><Month>09</Month><Day>15</Day></DateCompleted><DateRevised><Year>2021</Year><Month>09</Month><Day>23</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2044-6055</ISSN><JournalIssue CitedMedium="Internet"><Volume>11</Volume><Issue>9</Issue><PubDate><Year>2021</Year><Month>Sep</Month><Day>06</Day></PubDate></JournalIssue><Title>BMJ open</Title><ISOAbbreviation>BMJ Open</ISOAbbreviation></Journal><ArticleTitle>Protocol for a prospective, international cohort study on the Management and Outcomes of Perioperative Care among European Diabetic Patients (MOPED).</ArticleTitle><Pagination><StartPage>e044394</StartPage><MedlinePgn>e044394</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e044394</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1136/bmjopen-2020-044394</ELocationID><Abstract><AbstractText Label="INTRODUCTION">Diabetes is common (about 20 million patients in Europe) and patients with diabetes have more surgical interventions than the general population. There are plausible pathophysiological and clinical mechanisms suggesting that patients with diabetes are at an increased risk of postoperative complications. When postoperative complications occur in the general population, they increase major adverse events and subsequently increase 1-year mortality. This is likely to be worse in patients with diabetes. There is variation in practice guidelines in different countries in the perioperative management of patients with diabetes undergoing major surgery and whether this may affect postoperative outcome has not been investigated on a large scale. Neither is it known whether different strata of preoperative glycaemic control affects outcome.</AbstractText><AbstractText Label="METHODS AND ANALYSIS">A prospective, observational, international, multicentre cohort study, recruiting 5000 patients with diabetes undergoing elective or emergency surgery in at least n=50 centres. Inclusion criteria are any patient with diabetes undergoing surgery under any substantive anaesthetic technique. Exclusion criteria are not being a confirmed diabetic patient and patients with diabetes undergoing procedures under monitored sedation or local anaesthetic infiltration only. Follow-up duration is 30 days after surgery. Primary outcome is days at home at 30 days. Secondary outcomes are Comprehensive Complications Index, Quality of Recovery (QoR-15) score on Day 1 postoperatively, 30-day mortality, length of hospital stay and incidence of specific major adverse events (Myocardial Infarction (MI), Myocardial Injury after Non-cardiac Surgery (MINS), Acute Kidney Injury (AKI), Postoperative Pulmonary Complications (PPC), Cerebrovascular Accident (CVA), Pulmonary Embolism (PE), DVT, surgical site infection, postoperative pulmonary infection). Tertiary outcomes include time to resumption of normal diabetes therapy, incidence of diabetic ketoacidosis or hypoglycaemia, incidence and duration of use of intravenous insulin infusion therapy and change in diabetic management at 30 days.</AbstractText><AbstractText Label="ETHICS AND DISSEMINATION">This study will adhere to the principles of the Declaration of Helsinki (amendment 2013) by the World Medical Association and the ICH-Good Clinical Practice (GCP) Guidelines E6(R2). Specific national and local regulatory authority requirements will be followed as applicable. Ethical approval has been granted by the Institutional Review Board of the Mater Misericordiae University Hospital, Dublin, Ireland (Reference: 1/378/2167). As enrolment for this study is ongoing, ethical approval from additional centres is being added continuously. The main results of Management and Outcomes of Perioperative Care among European Diabetic Patients and its substudies will be published in peer-reviewed international medical journals and presented at Euroanaesthesia congress and other international and national meetings.</AbstractText><AbstractText Label="TRIAL REGISTRATION NUMBER">NCT04511312.</AbstractText><CopyrightInformation>&#xa9; Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Buggy</LastName><ForeName>Donal J</ForeName><Initials>DJ</Initials><Identifier Source="ORCID">0000-0003-3922-4397</Identifier><AffiliationInfo><Affiliation>Dept. Anaesthesiology, Mater University Hospital, University College Dublin, Dublin, Ireland donal.buggy@ucd.ie.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Mater University Hospital, University College Dublin, Dublin, Ireland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Outcomes Research, Cleveland Clinic, Cleveland, OH, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nolan</LastName><ForeName>Rachel</ForeName><Initials>R</Initials><Identifier Source="ORCID">0000-0001-9644-8958</Identifier><AffiliationInfo><Affiliation>Dept. Anaesthesiology, Mater University Hospital, University College Dublin, Dublin, Ireland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Coburn</LastName><ForeName>Mark</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>University of Bonn, Bonn, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Columb</LastName><ForeName>Malachy</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Wythenshawe Hospital Acute Intensive Care Unit, Manchester University NHS Foundation Trust, Manchester, Greater Manchester, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hermanides</LastName><ForeName>Jeroen</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Amsterdam University Medical Center, Duivendrecht, Noord-Holland, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hollman</LastName><ForeName>Markus W</ForeName><Initials>MW</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Amsterdam University Medical Center, Duivendrecht, Noord-Holland, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zarbock</LastName><ForeName>Alexander</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-2124-1714</Identifier><AffiliationInfo><Affiliation>Universit&#xe4;t M&#xfc;nster, M&#xfc;nster, UK.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><DataBankList CompleteYN="Y"><DataBank><DataBankName>ClinicalTrials.gov</DataBankName><AccessionNumberList><AccessionNumber>NCT04511312</AccessionNumber></AccessionNumberList></DataBank></DataBankList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>09</Month><Day>06</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>BMJ Open</MedlineTA><NlmUniqueID>101552874</NlmUniqueID><ISSNLinking>2044-6055</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000772" MajorTopicYN="N">Anesthesia, Local</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003920" MajorTopicYN="Y">Diabetes Mellitus</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009049" MajorTopicYN="Y">Motorcycles</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019990" MajorTopicYN="N">Perioperative Care</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">adult anaesthesia</Keyword><Keyword MajorTopicYN="N">diabetes &amp; endocrinology</Keyword><Keyword MajorTopicYN="N">surgery</Keyword></KeywordList><CoiStatement>Competing interests: None declared.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>9</Month><Day>7</Day><Hour>7</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>9</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>9</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2021</Year><Month>9</Month><Day>6</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34489264</ArticleId><ArticleId IdType="pmc">PMC8422310</ArticleId><ArticleId IdType="doi">10.1136/bmjopen-2020-044394</ArticleId><ArticleId IdType="pii">bmjopen-2020-044394</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Cho NH, Kirigia J, Claude J, International diabetes federation . IDF diabetes atlas. 8th ed, 2019. http://www.diabetesatlas.org/resources/2017-atlas.html</Citation></Reference><Reference><Citation>Frisch A, Chandra P, Smiley D, et al. . Prevalence and clinical outcome of hyperglycemia in the perioperative period in noncardiac surgery. Diabetes Care 2010;33:1783&#x2013;8. 10.2337/dc10-0304</Citation><ArticleIdList><ArticleId IdType="doi">10.2337/dc10-0304</ArticleId><ArticleId IdType="pmc">PMC2909062</ArticleId><ArticleId IdType="pubmed">20435798</ArticleId></ArticleIdList></Reference><Reference><Citation>Hulst AH, Hermanides J, Hollmann MW, et al. . Lack of consensus on the peri-operative management of patients with diabetes mellitus. Eur J Anaesthesiol 2019;36:168&#x2013;9. 10.1097/EJA.0000000000000897</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/EJA.0000000000000897</ArticleId><ArticleId IdType="pubmed">30624296</ArticleId></ArticleIdList></Reference><Reference><Citation>Plummer MP, Bellomo R, Cousins CE, et al. . Dysglycaemia in the critically ill and the interaction of chronic and acute glycaemia with mortality. Intensive Care Med 2014;40:973&#x2013;80. 10.1007/s00134-014-3287-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-014-3287-7</ArticleId><ArticleId IdType="pubmed">24760120</ArticleId></ArticleIdList></Reference><Reference><Citation>Umpierrez GE, Smiley D, Jacobs S, et al. . Randomized study of basal-bolus insulin therapy in the inpatient management of patients with type 2 diabetes undergoing general surgery (rabbit 2 surgery). Diabetes Care 2011;34:256&#x2013;61. 10.2337/dc10-1407</Citation><ArticleIdList><ArticleId IdType="doi">10.2337/dc10-1407</ArticleId><ArticleId IdType="pmc">PMC3024330</ArticleId><ArticleId IdType="pubmed">21228246</ArticleId></ArticleIdList></Reference><Reference><Citation>Martin ET, Kaye KS, Knott C, et al. . Diabetes and risk of surgical site infection: a systematic review and meta-analysis. Infect Control Hosp Epidemiol 2016;37:88&#x2013;99. 10.1017/ice.2015.249</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/ice.2015.249</ArticleId><ArticleId IdType="pmc">PMC4914132</ArticleId><ArticleId IdType="pubmed">26503187</ArticleId></ArticleIdList></Reference><Reference><Citation>Vascular Events in Noncardiac Surgery Patients Cohort Evaluation (VISION) Study Investigators, Spence J, LeManach Y, et al. . Association between complications and death within 30 days after noncardiac surgery. CMAJ 2019;191:E830&#x2013;7. 10.1503/cmaj.190221</Citation><ArticleIdList><ArticleId IdType="doi">10.1503/cmaj.190221</ArticleId><ArticleId IdType="pmc">PMC6663503</ArticleId><ArticleId IdType="pubmed">31358597</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuzulugil D, Papeix G, Luu J, et al. . Recent advances in diabetes treatments and their perioperative implications. Curr Opin Anaesthesiol 2019;32:398&#x2013;404. 10.1097/ACO.0000000000000735</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/ACO.0000000000000735</ArticleId><ArticleId IdType="pmc">PMC6522201</ArticleId><ArticleId IdType="pubmed">30958402</ArticleId></ArticleIdList></Reference><Reference><Citation>National Confidential enquiry into patient outcome and death. highs and Lows, London, 2018. Available: https://www.ncepod.org.uk/2018pd/HighsandLows_SummaryReport.pdf [Accessed 22 Jan 2020].</Citation></Reference><Reference><Citation>Garg R, Schuman B, Bader A, et al. . Effect of preoperative diabetes management on glycemic control and clinical outcomes after elective surgery. Ann Surg 2018;267:858&#x2013;62. 10.1097/SLA.0000000000002323</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/SLA.0000000000002323</ArticleId><ArticleId IdType="pubmed">28549013</ArticleId></ArticleIdList></Reference><Reference><Citation>Gatti G, Perrotti A, Reichart D, et al. . Glycated hemoglobin and risk of sternal wound infection after isolated coronary surgery. Circ J 2016;81:36&#x2013;43. 10.1253/circj.CJ-16-0778</Citation><ArticleIdList><ArticleId IdType="doi">10.1253/circj.CJ-16-0778</ArticleId><ArticleId IdType="pubmed">27928145</ArticleId></ArticleIdList></Reference><Reference><Citation>Myles PS, Shulman MA, Heritier S, et al. . Validation of days at home as an outcome measure after surgery: a prospective cohort study in Australia. BMJ Open 2017;7:E015828. 10.1136/bmjopen-2017-015828</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjopen-2017-015828</ArticleId><ArticleId IdType="pmc">PMC5629653</ArticleId><ArticleId IdType="pubmed">28821518</ArticleId></ArticleIdList></Reference><Reference><Citation>Bell M, Eriksson LI, Svensson T, et al. . Days at home after surgery: an integrated and efficient outcome measure for clinical trials and quality assurance. EClinicalMedicine 2019;11:18&#x2013;26. 10.1016/j.eclinm.2019.04.011</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2019.04.011</ArticleId><ArticleId IdType="pmc">PMC6610780</ArticleId><ArticleId IdType="pubmed">31317130</ArticleId></ArticleIdList></Reference><Reference><Citation>Slankamenac K, Nederlof N, Pessaux P, et al. . The comprehensive complication index: a novel and more sensitive endpoint for assessing outcome and reducing sample size in randomized controlled trials. Ann Surg 2014;260:757&#x2013;62. discussion 762-3. 10.1097/SLA.0000000000000948</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/SLA.0000000000000948</ArticleId><ArticleId IdType="pubmed">25379846</ArticleId></ArticleIdList></Reference><Reference><Citation>Clavien P-A, Vetter D, Staiger RD, et al. . The Comprehensive Complication Index (CCI&#xae;): Added Value and Clinical Perspectives 3 Years "Down the Line". Ann Surg 2017;265:1045&#x2013;50. 10.1097/SLA.0000000000002132</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/SLA.0000000000002132</ArticleId><ArticleId IdType="pubmed">28486288</ArticleId></ArticleIdList></Reference><Reference><Citation>Stark PA, Myles PS, Burke JA. Development and psychometric evaluation of a postoperative quality of recovery score: the QoR-15. Anesthesiology 2013;118:1332&#x2013;40. 10.1097/ALN.0b013e318289b84b</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/ALN.0b013e318289b84b</ArticleId><ArticleId IdType="pubmed">23411725</ArticleId></ArticleIdList></Reference><Reference><Citation>Protopapa KL, Simpson JC, Smith NCE, et al. . Development and validation of the surgical outcome risk tool (SORT). Br J Surg 2014;101:1774&#x2013;83. 10.1002/bjs.9638</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/bjs.9638</ArticleId><ArticleId IdType="pmc">PMC4240514</ArticleId><ArticleId IdType="pubmed">25388883</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">25183697</PMID><DateCompleted><Year>2016</Year><Month>06</Month><Day>29</Day></DateCompleted><DateRevised><Year>2015</Year><Month>07</Month><Day>03</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1708-539X</ISSN><JournalIssue CitedMedium="Internet"><Volume>23</Volume><Issue>4</Issue><PubDate><Year>2015</Year><Month>Aug</Month></PubDate></JournalIssue><Title>Vascular</Title><ISOAbbreviation>Vascular</ISOAbbreviation></Journal><ArticleTitle>A single center experience with retrievable IVC filters.</ArticleTitle><Pagination><StartPage>350</StartPage><EndPage>357</EndPage><MedlinePgn>350-7</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1177/1708538114546713</ELocationID><Abstract><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">To evaluate retrievable IVC filters in our institution and assess their retrieval following a well-structured follow up program.</AbstractText><AbstractText Label="DESIGN" NlmCategory="METHODS">Retrospective cohort study.</AbstractText><AbstractText Label="MATERIALS" NlmCategory="METHODS">The medical records of patients implanted with retrievable IVC filters were reviewed.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">All retrievable filter insertions between July 2007 and August 2011 at our institution were reviewed. Data was analyzed for age, gender, indication, complications, retrieval rate, and brand of filter inserted. Statistical analysis was done using SPSS software v19. Chi-square was used to compare discrete data and t-test for continuous data. P&#x2009;&lt;&#x2009;0.05 was significant.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">A total of 484 patients were reviewed of which 258 (53.1%) had a complete medical record. And 96 (37.2%) filters were placed as permanent at the time of insertion. An additional 40 (15.5%) filters were converted to permanent (total permanent filters 136; 52.7%). Death was reported in 26 (10%) patients and 96 (37.2%) out of the remaining 232 patients presented for potential retrieval. Also, 73 (28.2%) had an attempt to retrieve the filters, 69 (94.5%) were successful and 4 (5.4%) failed to retrieve. The remaining 23 (8.9%) patients declined retrieval. Filters studied include Celect (38%), Bard (31.4%), Option (26.2%), Tulip (4.1%), and Recovery (0.2%). Bard was more commonly used as a retrievable filter (80.9%). Retrieval on the first attempt was 90.4% (n&#x2009;=&#x2009;66) successful. Of the remaining seven filters, three were successfully retrieved on a second attempt, and four failed to retrieve due to filter tilt. The success rates of retrieval for Celect and Tulip were significantly lower than for Bard (p&#x2009;=&#x2009;0.04 and 0.023, respectively).</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Our study showed that a variety of IVC filters can be retrieved successfully with minimal complication rates. In more than half of our patients, IVC filters were used as permanent. Failure of retrieval was most frequently due to filter tilting.</AbstractText><CopyrightInformation>&#xa9; The Author(s) 2014.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Renno</LastName><ForeName>Anas</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Division of Vascular and Endovascular Surgery, University of Toledo Medical Center, Toledo, OH, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Khateeb</LastName><ForeName>Faisal</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Division of Vascular and Endovascular Surgery, University of Toledo Medical Center, Toledo, OH, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kazan</LastName><ForeName>Viviane</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Division of Vascular and Endovascular Surgery, University of Toledo Medical Center, Toledo, OH, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Qu</LastName><ForeName>Weikai</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Division of Vascular and Endovascular Surgery, University of Toledo Medical Center, Toledo, OH, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gollapudi</LastName><ForeName>Anurekha</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Division of Vascular and Endovascular Surgery, University of Toledo Medical Center, Toledo, OH, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Aplin</LastName><ForeName>Brett</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Division of Vascular and Endovascular Surgery, University of Toledo Medical Center, Toledo, OH, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Abbas</LastName><ForeName>Jihad</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Division of Vascular and Endovascular Surgery, University of Toledo Medical Center, Toledo, OH, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zelenock</LastName><ForeName>Gerald</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Division of Vascular and Endovascular Surgery, University of Toledo Medical Center, Toledo, OH, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nazzal</LastName><ForeName>Munier</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Division of Vascular and Endovascular Surgery, University of Toledo Medical Center, Toledo, OH, USA Munier.Nazzal@utoledo.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2014</Year><Month>09</Month><Day>02</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Vascular</MedlineTA><NlmUniqueID>101196722</NlmUniqueID><ISSNLinking>1708-5381</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000367" MajorTopicYN="N">Age Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016009" MajorTopicYN="N">Chi-Square Distribution</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020878" MajorTopicYN="N">Device Removal</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009820" MajorTopicYN="N" Type="Geographic">Ohio</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011474" MajorTopicYN="N">Prosthesis Design</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019919" MajorTopicYN="N">Prosthesis Implantation</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000295" MajorTopicYN="Y">instrumentation</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011655" MajorTopicYN="N">Pulmonary Embolism</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012042" MajorTopicYN="N">Registries</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012737" MajorTopicYN="N">Sex Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013997" MajorTopicYN="N">Time Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016306" MajorTopicYN="Y">Vena Cava Filters</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014682" MajorTopicYN="Y">Vena Cava, Inferior</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020246" MajorTopicYN="N">Venous Thrombosis</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">IVC filter prophylaxis</Keyword><Keyword MajorTopicYN="N">Retrievable IVC filters</Keyword><Keyword MajorTopicYN="N">deep vein thrombosis</Keyword><Keyword MajorTopicYN="N">permanent filters</Keyword><Keyword MajorTopicYN="N">retrieval rate</Keyword><Keyword MajorTopicYN="N">trauma</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2014</Year><Month>9</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2014</Year><Month>9</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2016</Year><Month>6</Month><Day>30</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">25183697</ArticleId><ArticleId IdType="doi">10.1177/1708538114546713</ArticleId><ArticleId IdType="pii">1708538114546713</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">34431356</PMID><DateCompleted><Year>2022</Year><Month>01</Month><Day>06</Day></DateCompleted><DateRevised><Year>2022</Year><Month>12</Month><Day>07</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2047-9980</ISSN><JournalIssue CitedMedium="Internet"><Volume>10</Volume><Issue>17</Issue><PubDate><Year>2021</Year><Month>Sep</Month><Day>07</Day></PubDate></JournalIssue><Title>Journal of the American Heart Association</Title><ISOAbbreviation>J Am Heart Assoc</ISOAbbreviation></Journal><ArticleTitle>Association Between Black Race, Clinical Severity, and Management of Acute Pulmonary Embolism: A Retrospective Cohort Study.</ArticleTitle><Pagination><StartPage>e021818</StartPage><MedlinePgn>e021818</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e021818</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1161/JAHA.121.021818</ELocationID><Abstract><AbstractText>Background Existing evidence indicates Black patients have higher incidence of pulmonary embolism (PE) and PE-related mortality compared with other races/ethnicities, yet disparities in presenting severity and treatment remain incompletely understood. Methods and Results We retrospectively queried a multihospital healthcare system for all hospitalizations for acute PE (2012-2019). Of 10&#xa0;329 hospitalizations, 8743 met inclusion criteria. Black patients (14.3%) were significantly younger (54.6&#xb1;17.8 versus 63.1&#xb1;16.6&#xa0;years; <i>P</i>&lt;0.001) and more female (56.1% versus 51.6%; <i>P</i>=0.003) compared with White patients. Using ordinal regression, Black race was significantly associated with higher PE severity after matching 1:3 on age and sex (1210:3264; odds ratio [OR], 1.08; 95% CI, 1.03-1.14), adjusting for clinical (OR, 1.13; 95% CI, 1.01-1.27), and socioeconomic (OR, 1.05; 95% CI, 1.05-1.35) characteristics. Among intermediate and high-severity PE, Black race was associated with a decreased risk of intervention controlling for the competing risk of mortality and censoring on hospital discharge. This effect was modified by PE severity (<i>P</i> value &lt;0.001), with a lower and higher risk of intervention for intermediate and high-severity PE, respectively. Race was not associated with in-hospital mortality (OR, 0.84; 95% CI, 0.69-1.02). Conclusions Black patients hospitalized with PE are younger with a higher severity of disease compared with White patients. Although Black patients are less likely to receive an intervention overall, this differed depending on PE severity with higher risk of intervention only for life-threatening PE. This suggests nuanced racial disparities in management of PE and highlights the complexities of healthcare inequalities.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Phillips</LastName><ForeName>Amanda R</ForeName><Initials>AR</Initials><Identifier Source="ORCID">0000-0002-2422-1524</Identifier><AffiliationInfo><Affiliation>Division of Vascular Surgery University of Pittsburgh Pittsburgh PA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Reitz</LastName><ForeName>Katherine M</ForeName><Initials>KM</Initials><Identifier Source="ORCID">0000-0002-9397-321X</Identifier><AffiliationInfo><Affiliation>Division of Vascular Surgery University of Pittsburgh Pittsburgh PA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Surgery University of Pittsburgh Pittsburgh PA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Myers</LastName><ForeName>Sara</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Surgery University of Pittsburgh Pittsburgh PA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Thoma</LastName><ForeName>Floyd</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Division of Cardiology University of Pittsburgh Pittsburgh PA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Andraska</LastName><ForeName>Elizabeth A</ForeName><Initials>EA</Initials><AffiliationInfo><Affiliation>Division of Vascular Surgery University of Pittsburgh Pittsburgh PA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jano</LastName><ForeName>Antalya</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>School of Medicine University of Pittsburgh Pittsburgh PA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sridharan</LastName><ForeName>Natalie</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Division of Vascular Surgery University of Pittsburgh Pittsburgh PA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Medicine University of Pittsburgh Pittsburgh PA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Smith</LastName><ForeName>Roy E</ForeName><Initials>RE</Initials><AffiliationInfo><Affiliation>School of Medicine University of Pittsburgh Pittsburgh PA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Hematology/Oncology University of Pittsburgh Pittsburgh PA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mulukutla</LastName><ForeName>Suresh R</ForeName><Initials>SR</Initials><Identifier Source="ORCID">0000-0001-5060-429X</Identifier><AffiliationInfo><Affiliation>Division of Cardiology University of Pittsburgh Pittsburgh PA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Medicine University of Pittsburgh Pittsburgh PA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chaer</LastName><ForeName>Rabih</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Division of Vascular Surgery University of Pittsburgh Pittsburgh PA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Medicine University of Pittsburgh Pittsburgh PA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>L30 AG064730</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>T32 HL098036</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>08</Month><Day>25</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>J Am Heart Assoc</MedlineTA><NlmUniqueID>101580524</NlmUniqueID><ISSNLinking>2047-9980</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000208" MajorTopicYN="N">Acute Disease</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D044383" MajorTopicYN="Y">Black People</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D054625" MajorTopicYN="Y">Healthcare Disparities</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011655" MajorTopicYN="Y">Pulmonary Embolism</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000208" MajorTopicYN="N">ethnology</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">healthcare disparities</Keyword><Keyword MajorTopicYN="N">outcomes</Keyword><Keyword MajorTopicYN="N">pulmonary embolism</Keyword><Keyword MajorTopicYN="N">racial disparities</Keyword><Keyword MajorTopicYN="N">venous thromboembolism</Keyword></KeywordList><CoiStatement>None.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>8</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>1</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>8</Month><Day>25</Day><Hour>8</Hour><Minute>40</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2021</Year><Month>9</Month><Day>7</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34431356</ArticleId><ArticleId IdType="pmc">PMC8649302</ArticleId><ArticleId IdType="doi">10.1161/JAHA.121.021818</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>National Center for Health Statistics (US) . Health, United States, 2018. National Center for Health Statistics (US) 2019.</Citation><ArticleIdList><ArticleId IdType="pubmed">31944640</ArticleId></ArticleIdList></Reference><Reference><Citation>Laiteerapong N, Fairchild P, Chou C, Chin M, Huang E. Revisiting disparities in quality of care among US adults with diabetes in the era of individualized care, NHANES 2007&#x2013;2010. Med Care. 2015;53:25&#x2013;31. DOI: 10.1097/MLR.0000000000000255.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MLR.0000000000000255</ArticleId><ArticleId IdType="pmc">PMC4394649</ArticleId><ArticleId IdType="pubmed">25373405</ArticleId></ArticleIdList></Reference><Reference><Citation>Casagrande S, Fradkin J, Saydah S, Rust K, Cowie CC. The prevalence of meeting A1C, blood pressure, and LDL goals among people with diabetes, 1988&#x2013;2010. Am Diabetes Assoc. 2013;36:2271&#x2013;2279. DOI: 10.2337/dc12-2258.</Citation><ArticleIdList><ArticleId IdType="doi">10.2337/dc12-2258</ArticleId><ArticleId IdType="pmc">PMC3714503</ArticleId><ArticleId IdType="pubmed">23418368</ArticleId></ArticleIdList></Reference><Reference><Citation>Fiscella K, Sanders MR. Racial and ethnic disparities in the quality of health care. Annu Rev Public Health. 2016;37:375&#x2013;394. DOI: 10.1146/annurev-publhealth-032315-021439.</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev-publhealth-032315-021439</ArticleId><ArticleId IdType="pubmed">26789384</ArticleId></ArticleIdList></Reference><Reference><Citation>
2018 National Healthcare Quality and Disparities Report. Content last reviewed April 2020. Agency for Healthcare Research and Quality, Rockville, MD. n.d. https://WwwAhrqGov/Research/Findings/Nhqrdr/Nhqdr18/IndexHtml
</Citation><ArticleIdList><ArticleId IdType="pubmed">35476374</ArticleId></ArticleIdList></Reference><Reference><Citation>White RH. The epidemiology of venous thromboembolism. Circulation. 2003;107:I&#x2010;4&#x2013;I&#x2010;8. DOI: 10.1161/01.CIR.0000078468.11849.66.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/01.CIR.0000078468.11849.66</ArticleId><ArticleId IdType="pubmed">12814979</ArticleId></ArticleIdList></Reference><Reference><Citation>Horlander K, Mannino D, Leeper K. Pulmonary embolism mortality in the United States, 1979&#x2013;1998: an analysis using multiple&#x2010;cause mortality data. Arch Intern Med. 2003;163:1711&#x2013;1717. DOI: 10.1001/archinte.163.14.1711.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archinte.163.14.1711</ArticleId><ArticleId IdType="pubmed">12885687</ArticleId></ArticleIdList></Reference><Reference><Citation>Arshad N, Isaksen T, Hansen JB, Br&#xe6;kkan SK. Time trends in incidence rates of venous thromboembolism in a large cohort recruited from the general population. Eur J Epidemiol. 2017;32:299&#x2013;305. DOI: 10.1007/s10654-017-0238-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10654-017-0238-y</ArticleId><ArticleId IdType="pubmed">28314981</ArticleId></ArticleIdList></Reference><Reference><Citation>Virani SS, Alonso A, Benjamin EJ, Bittencourt MS, Callaway CW, Carson AP, Chamberlain A, Chang A, Cheng S, Delling F, et al. Heart disease and stroke statistics&#x2014;2020 update: a report from the American Heart Association. Circulation. 2020;141:e139&#x2013;e596. DOI: 10.1161/CIR.0000000000000757.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIR.0000000000000757</ArticleId><ArticleId IdType="pubmed">31992061</ArticleId></ArticleIdList></Reference><Reference><Citation>Goldhaber SZ, Bounameaux H. Pulmonary embolism and deep vein thrombosis. Lancet. 2012;379:1835&#x2013;1846. DOI: 10.1016/S0140-6736(11)61904-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(11)61904-1</ArticleId><ArticleId IdType="pubmed">22494827</ArticleId></ArticleIdList></Reference><Reference><Citation>Barco S, Valerio L, Ageno W, Cohen AT, Goldhaber SZ, Hunt BJ, Iorio A, Jimenez D, Klok FA, Kucher N, et al. Age&#x2010;sex specific pulmonary embolism&#x2010;related mortality in the USA and Canada, 2000&#x2013;18: an analysis of the WHO Mortality Database and of the CDC Multiple Cause of Death database. Lancet Respir Med. 2021;9:33&#x2013;42. DOI: 10.1016/S2213-2600(20)30417-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(20)30417-3</ArticleId><ArticleId IdType="pmc">PMC7550106</ArticleId><ArticleId IdType="pubmed">33058771</ArticleId></ArticleIdList></Reference><Reference><Citation>Martin KA, McCabe ME, Feinglass J, Khan SS. Racial disparities exist across age groups in Illinois for pulmonary embolism hospitalizations. Arterioscler Thromb Vasc Biol. 2020;40:2338&#x2013;2340. DOI: 10.1161/ATVBAHA.120.314573.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/ATVBAHA.120.314573</ArticleId><ArticleId IdType="pmc">PMC7484333</ArticleId><ArticleId IdType="pubmed">32762456</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu Y, Siegal DM, Anand SS. Ethnoracial variations in venous thrombosis: implications for management, and a call to action. J Thromb Haemost. 2020;19:1&#x2013;11. DOI: 10.1111/jth.15140.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jth.15140</ArticleId><ArticleId IdType="pubmed">33078911</ArticleId></ArticleIdList></Reference><Reference><Citation>
National Institute on Minority Health and Health Disparities
. NIMHD Research Framework. 2017. Available at: https://nimhd.nih.gov/researchFramework. Accessed June 7, 2021.</Citation></Reference><Reference><Citation>Laveist T, Gaskin D, Richard P. Estimating the economic burden of racial health inequalities in the United States. Int J Health Serv. 2011;41:231&#x2013;238. DOI: 10.2190/HS.41.2.c.</Citation><ArticleIdList><ArticleId IdType="doi">10.2190/HS.41.2.c</ArticleId><ArticleId IdType="pubmed">21563622</ArticleId></ArticleIdList></Reference><Reference><Citation>Nanney MS, Myers SL, Xu M, Kent K, Durfee T, Allen ML. The economic benefits of reducing racial disparities in health: the case of Minnesota. Int J Environ Res Public Health. 2019;16:742. DOI: 10.3390/ijerph16050742.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph16050742</ArticleId><ArticleId IdType="pmc">PMC6427451</ArticleId><ArticleId IdType="pubmed">30823675</ArticleId></ArticleIdList></Reference><Reference><Citation>von Elm E, Altman DG, Egger M, Pocock SJ, G&#xf8;tzsche PC, Vandenbroucke JP. The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies. Int J Surg. 2014;12:1495&#x2013;1499. DOI: 10.1016/j.ijsu.2014.07.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijsu.2014.07.013</ArticleId><ArticleId IdType="pubmed">25046131</ArticleId></ArticleIdList></Reference><Reference><Citation>Kind AJH, Buckingham WR. Making neighborhood&#x2010;disadvantage metrics accessible &#x2014; the neighborhood atlas. N Engl J Med. 2018;378:2456&#x2013;2458. DOI: 10.1056/NEJMp1802313.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMp1802313</ArticleId><ArticleId IdType="pmc">PMC6051533</ArticleId><ArticleId IdType="pubmed">29949490</ArticleId></ArticleIdList></Reference><Reference><Citation>Reitz KM, Marroquin OC, Zenati MS, Kennedy J, Korytkowski M, Tzeng E, Koscum S, Newhouse D, Garcia R, Vates J, et al. Association between preoperative metformin exposure and postoperative outcomes in adults with type 2 diabetes. JAMA Surg. 2020;155:e200416. DOI: 10.1001/jamasurg.2020.0416.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamasurg.2020.0416</ArticleId><ArticleId IdType="pmc">PMC7142798</ArticleId><ArticleId IdType="pubmed">32267474</ArticleId></ArticleIdList></Reference><Reference><Citation>
Healthcare Cost and Utilization Project (HCUP) NIS Notes. n.d. Available at: https://www.hcup&#x2010;us.ahrq.gov/db/vars/hosp_bedsize/nisnote.jsp. Accessed January 1, 2021.</Citation></Reference><Reference><Citation>Konstantinides SV, Meyer G, Gali&#xe9; N, Simon R Gibbs J, Aboyans V, Ageno W, Agewall S, Almeida A, Andreotti F, Barbato E, et al. 2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS). Eur Heart J. 2020;41:543&#x2013;603.</Citation><ArticleIdList><ArticleId IdType="pubmed">31504429</ArticleId></ArticleIdList></Reference><Reference><Citation>Wiske CP, Shen C, Amoroso N, Brosnahan SB, Goldenberg R, Horowitz J, Jamin C, Sista A, Smith D, Maldonado T. Evaluating time to treatment and in&#x2010;hospital outcomes of pulmonary embolism response teams. J Vasc Surg. 2020;8:717&#x2013;724. DOI: 10.1016/j.jvsv.2019.12.077.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jvsv.2019.12.077</ArticleId><ArticleId IdType="pubmed">32179041</ArticleId></ArticleIdList></Reference><Reference><Citation>D&#x2019;Auria S, Sezer A, Thoma F, Sharbaugh M, McKibben J, Maholic R, Avgerinos E, Rivera&#x2010;Lebron B, Toma C. Outcomes of catheter&#x2010;directed thrombolysis vs. standard medical therapy in patients with acute submassive pulmonary embolism. Pulm Circ. 2020;10:1&#x2013;8. DOI: 10.1177/2045894019898368.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/2045894019898368</ArticleId><ArticleId IdType="pmc">PMC7144676</ArticleId><ArticleId IdType="pubmed">32292583</ArticleId></ArticleIdList></Reference><Reference><Citation>Smedley BD, Stith AY, Nelson AR. Unequal Treatment: Confronting Racial and Ethnic Disparities in Health Care (with CD). National Academies Press; 2003.</Citation><ArticleIdList><ArticleId IdType="pubmed">25032386</ArticleId></ArticleIdList></Reference><Reference><Citation>VanderWeele TJ, Robinson WR. On the causal interpretation of race in regressions adjusting for confounding and mediating variables. Epidemiology. 2014;25:473&#x2013;484. DOI: 10.1097/EDE.0000000000000105.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/EDE.0000000000000105</ArticleId><ArticleId IdType="pmc">PMC4125322</ArticleId><ArticleId IdType="pubmed">24887159</ArticleId></ArticleIdList></Reference><Reference><Citation>Chaudhury P, Gadre S, Schneider E, Renapurkar R, Gomes M, Haddadin I, Heresi G, Tong M, Bartholomew J. Impact of multidisciplinary pulmonary embolism response team availability on management and outcomes. Am J Cardiol. 2019;124:1465&#x2013;1469. DOI: 10.1016/j.amjcard.2019.07.043.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amjcard.2019.07.043</ArticleId><ArticleId IdType="pubmed">31495443</ArticleId></ArticleIdList></Reference><Reference><Citation>Austin PC, Fine JP. Practical recommendations for reporting Fine&#x2010;Gray model analyses for competing risk data. Stat Med. 2017;36. DOI: 10.1002/sim.7501.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/sim.7501</ArticleId><ArticleId IdType="pmc">PMC5698744</ArticleId><ArticleId IdType="pubmed">28913837</ArticleId></ArticleIdList></Reference><Reference><Citation>Ibrahim SA, Stone RA, Obrosky S, Sartorius J, Fine MJ, Aujesky D. Racial differences in 30&#x2010;day mortality for pulmonary embolism. Am J Public Health. 2006;96:2161&#x2013;2164. DOI: 10.2105/AJPH.2005.078618.</Citation><ArticleIdList><ArticleId IdType="doi">10.2105/AJPH.2005.078618</ArticleId><ArticleId IdType="pmc">PMC1698166</ArticleId><ArticleId IdType="pubmed">17077409</ArticleId></ArticleIdList></Reference><Reference><Citation>Carnethon MR, Pu J, Howard G, Albert MA, Anderson CAM, Bertoni AG, Mujahid MS, Palaniappan L, Taylor HA, Willis M, et al. Cardiovascular health in African Americans: a scientific statement from the American Heart Association. Circulation. 2017;136:e393&#x2013;e423. DOI: 10.1161/CIR.0000000000000534.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIR.0000000000000534</ArticleId><ArticleId IdType="pubmed">29061565</ArticleId></ArticleIdList></Reference><Reference><Citation>Ellis C. Stroke in young adults. Disabil Health J. 2010;3:222&#x2013;224. DOI: 10.1016/j.dhjo.2010.01.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.dhjo.2010.01.001</ArticleId><ArticleId IdType="pubmed">21122787</ArticleId></ArticleIdList></Reference><Reference><Citation>Kujovich JL. Factor v Leiden thrombophilia. Genet Med. 2011;13:1&#x2013;6. DOI: 10.1097/GIM.0b013e3181faa0f2</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/GIM.0b013e3181faa0f2</ArticleId><ArticleId IdType="pubmed">21116184</ArticleId></ArticleIdList></Reference><Reference><Citation>Morange PE, Suchon P, Tr&#xe9;gou&#xeb;t DA. Genetics of venous thrombosis: update in 2015. Thromb Haemost. 2015;114:910&#x2013;919. DOI: 10.1160/TH15-05-0410.</Citation><ArticleIdList><ArticleId IdType="doi">10.1160/TH15-05-0410</ArticleId><ArticleId IdType="pubmed">26354877</ArticleId></ArticleIdList></Reference><Reference><Citation>Lutsey PL, Cushman M, Steffen LM, Green D, Barr RG, Herrington D, Ouyang P, Folsom AR, et al. Plasma hemostatic factors and endothelial markers in four racial/ethnic groups: the MESA study. J Thromb Haemost. 2006;4:2629&#x2013;2635. DOI: 10.1111/j.1538-7836.2006.02237.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1538-7836.2006.02237.x</ArticleId><ArticleId IdType="pubmed">17002663</ArticleId></ArticleIdList></Reference><Reference><Citation>Mielck A, Reitmeir P, Wjst M. Severity of childhood asthma by socioeconomic status. Int J Epidemiol. 1996;25:388&#x2013;393. DOI: 10.1093/ije/25.2.388.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ije/25.2.388</ArticleId><ArticleId IdType="pubmed">9119565</ArticleId></ArticleIdList></Reference><Reference><Citation>Duerson W, Lafer M, Ahmed O, Bandler I, Wang B, Lieberman S, Lebowitz R. Health care disparities in patients undergoing endoscopic sinus surgery for chronic rhinosinusitis: differences in disease presentation and access to care. Ann Otol Rhinol Laryngol. 2019;128:608&#x2013;613. DOI: 10.1177/0003489419834947.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0003489419834947</ArticleId><ArticleId IdType="pubmed">30832483</ArticleId></ArticleIdList></Reference><Reference><Citation>Z&#xf6;ller B, Li X, Sundquist J, Sundquist K. A nationwide family study of pulmonary embolism: identification of high risk families with increased risk of hospitalized and fatal pulmonary embolism. Thromb Res. 2012;130:178&#x2013;182. DOI: 10.1016/j.thromres.2012.02.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.thromres.2012.02.002</ArticleId><ArticleId IdType="pubmed">22386135</ArticleId></ArticleIdList></Reference><Reference><Citation>Tagalakis V, Patenaude V, Kahn SR, Suissa S. Incidence of and mortality from venous thromboembolism in a real&#x2010;world population: the Q&#x2010;VTE study cohort. Am J Med. 2013;126:832.e13&#x2013;832.e21. DOI: 10.1016/j.amjmed.2013.02.024.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amjmed.2013.02.024</ArticleId><ArticleId IdType="pubmed">23830539</ArticleId></ArticleIdList></Reference><Reference><Citation>Schwamm LH, Reeves MJ, Pan W, Smith EE, Frankel MR, Olson D, Zhao X, Peterson E, Fonarow G. Race/ethnicity, quality of care, and outcomes in ischemic stroke. Circulation. 2010;121:1492&#x2013;1501. DOI: 10.1161/CIRCULATIONAHA.109.881490.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.109.881490</ArticleId><ArticleId IdType="pubmed">20308617</ArticleId></ArticleIdList></Reference><Reference><Citation>Dong L, Fakeye OA, Graham G, Gaskin DJ. Racial/ethnic disparities in quality of care for cardiovascular disease in ambulatory settings: a review. Med Care Res Rev. 2018;75:263&#x2013;291. DOI: 10.1177/1077558717725884.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1077558717725884</ArticleId><ArticleId IdType="pubmed">28882087</ArticleId></ArticleIdList></Reference><Reference><Citation>Dovidio JF, Penner LA, Albrecht TL, Norton WE, Gaertner SL, Shelton JN. Disparities and distrust: the implications of psychological processes for understanding racial disparities in health and health care. Soc Sci Med. 2008;67:478&#x2013;486. DOI: 10.1016/j.socscimed.2008.03.019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.socscimed.2008.03.019</ArticleId><ArticleId IdType="pubmed">18508171</ArticleId></ArticleIdList></Reference><Reference><Citation>Giri J, Sista AK, Weinberg I, Kearon C, Kumbhani DJ, Desai ND, Piazza G, Gladwin M, Chatterjee S, Kobayashi T, et al. Interventional therapies for acute pulmonary embolism: current status and principles for the development of novel evidence. Circulation. 2019;140:E774&#x2013;E801.</Citation><ArticleIdList><ArticleId IdType="pubmed">31585051</ArticleId></ArticleIdList></Reference><Reference><Citation>Kearon C, Akl EA, Ornelas J, Blaivas A, Jimenez D, Bounameaux H, Huisman M, King CS, Morris TA, Sood N, et al. Antithrombotic therapy for VTE disease: CHEST guideline and expert panel report. Chest. 2016;149:315&#x2013;352. DOI: 10.1016/j.chest.2015.11.026.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chest.2015.11.026</ArticleId><ArticleId IdType="pubmed">26867832</ArticleId></ArticleIdList></Reference><Reference><Citation>Barnato AE, Anthony DL, Skinner J, Gallagher PM, Fisher ES. Racial and ethnic differences in preferences for end&#x2010;of&#x2010;life treatment. J Gen Intern Med. 2009;24:695&#x2013;701. DOI: 10.1007/s11606-009-0952-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11606-009-0952-6</ArticleId><ArticleId IdType="pmc">PMC2686762</ArticleId><ArticleId IdType="pubmed">19387750</ArticleId></ArticleIdList></Reference><Reference><Citation>de Souza J, Gillett K, Froggatt K, Walshe C. Perspectives of elders and their adult children of Black and minority ethnic heritage on end&#x2010;of&#x2010;life conversations: a meta&#x2010;ethnography. Palliat Med. 2020;34:195&#x2013;208. DOI: 10.1177/0269216319887070.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0269216319887070</ArticleId><ArticleId IdType="pmc">PMC7000852</ArticleId><ArticleId IdType="pubmed">31965907</ArticleId></ArticleIdList></Reference><Reference><Citation>Agarwal S, Menon V, Jaber WA. Residential zip code influences outcomes following hospitalization for acute pulmonary embolism in the United States. Vasc Med. 2015;20:439&#x2013;446. DOI: 10.1177/1358863X15592486.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1358863X15592486</ArticleId><ArticleId IdType="pubmed">26163399</ArticleId></ArticleIdList></Reference><Reference><Citation>Avgerinos ED, Abou Ali AN, Liang NL, Rivera&#x2010;Lebron B, Toma C, Maholic R, Makaroun M, Chaer R. Catheter&#x2010;directed interventions compared with systemic thrombolysis achieve improved ventricular function recovery at a potentially lower complication rate for acute pulmonary embolism. J Vasc Surg. 2018;6:425&#x2013;432. DOI: 10.1016/j.jvsv.2017.12.058.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jvsv.2017.12.058</ArticleId><ArticleId IdType="pmc">PMC7151647</ArticleId><ArticleId IdType="pubmed">29615372</ArticleId></ArticleIdList></Reference><Reference><Citation>Konstantinides SV, Vicaut E, Danays T, Becattini C, Bertoletti L, Beyer&#x2010;Westendorf J, Bouvaist H, Couturaud F, Dellas C, Duerschmied D, et al. Impact of thrombolytic therapy on the long&#x2010;term outcome of intermediate&#x2010;risk pulmonary embolism. J Am Coll Cardiol. 2017;69:1536&#x2013;1544. DOI: 10.1016/j.jacc.2016.12.039.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2016.12.039</ArticleId><ArticleId IdType="pubmed">28335835</ArticleId></ArticleIdList></Reference><Reference><Citation>Avgerinos ED, Saadeddin Z, Abou Ali AN, Fish L, Toma C, Chaer M, Rivera&#x2010;Lebron B, Chaer R. A meta&#x2010;analysis of outcomes of catheter&#x2010;directed thrombolysis for high&#x2010; and intermediate&#x2010;risk pulmonary embolism. J Vasc Surg. 2018;6:530&#x2013;540. DOI: 10.1016/j.jvsv.2018.03.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jvsv.2018.03.010</ArticleId><ArticleId IdType="pubmed">29909859</ArticleId></ArticleIdList></Reference><Reference><Citation>The ARIC investigators . The Atherosclerosis Risk in Communities (ARIC) Study: design and objectives. Am J Epidemiol. 1989;129:687&#x2013;702.</Citation><ArticleIdList><ArticleId IdType="pubmed">2646917</ArticleId></ArticleIdList></Reference><Reference><Citation>Fried LP, Borhani NO, Enright P, Furberg CD, Gardin JM, Kronmal RA, Kuller LH, Manolio TA, Mittelmark MB, Newman A, et al. The cardiovascular health study: design and rationale. Ann Epidemiol. 1991;1:263&#x2013;276. DOI: 10.1016/1047-2797(91)90005-W.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/1047-2797(91)90005-W</ArticleId><ArticleId IdType="pubmed">1669507</ArticleId></ArticleIdList></Reference><Reference><Citation>Agarwal S, Clark D, Sud K, Jaber WA, Cho L, Menon V. Gender disparities in outcomes and resource utilization for acute pulmonary embolism hospitalizations in the United States. Am J Cardiol. 2015;116:1270&#x2013;1276. DOI: 10.1016/j.amjcard.2015.07.048.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amjcard.2015.07.048</ArticleId><ArticleId IdType="pubmed">26341183</ArticleId></ArticleIdList></Reference><Reference><Citation>
2019 US census data. https://WwwCensusGov/Quickfacts/Fact/Table/US/IPE120219. n.d.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">24638843</PMID><DateCompleted><Year>2014</Year><Month>06</Month><Day>24</Day></DateCompleted><DateRevised><Year>2015</Year><Month>01</Month><Day>28</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">2168-6114</ISSN><JournalIssue CitedMedium="Internet"><Volume>174</Volume><Issue>5</Issue><PubDate><Year>2014</Year><Month>May</Month></PubDate></JournalIssue><Title>JAMA internal medicine</Title><ISOAbbreviation>JAMA Intern Med</ISOAbbreviation></Journal><ArticleTitle>Nonleg venous thrombosis in critically ill adults: a nested prospective cohort study.</ArticleTitle><Pagination><StartPage>689</StartPage><EndPage>696</EndPage><MedlinePgn>689-96</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1001/jamainternmed.2014.169</ELocationID><Abstract><AbstractText Label="IMPORTANCE" NlmCategory="OBJECTIVE">Critically ill patients are at risk of venous thrombosis, and therefore guidelines recommend daily thromboprophylaxis. Deep vein thrombosis (DVT) commonly occurs in the lower extremities but can occur in other sites including the head and neck, trunk, and upper extremities. The risk of nonleg deep venous thromboses (NLDVTs), predisposing factors, and the association between NLDVTs and pulmonary embolism (PE) or death are unclear.</AbstractText><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">To describe the frequency, anatomical location, risk factors, management, and consequences of NLDVTs in a large cohort of medical-surgical critically ill adults.</AbstractText><AbstractText Label="DESIGN, SETTING, AND PARTICIPANTS" NlmCategory="METHODS">A nested prospective cohort study in the setting of secondary and tertiary care intensive care units (ICUs). The study population comprised 3746 patients, who were expected to remain in the ICU for at least 3 days and were enrolled in a randomized clinical trial of dalteparin vs standard heparin for thromboprophylaxis.</AbstractText><AbstractText Label="MAIN OUTCOMES AND MEASURES" NlmCategory="METHODS">The proportion of patients who had NLDVTs, the mean number per patient, and the anatomical location. We characterized NLDVTs as prevalent or incident (identified within 72 hours of ICU admission or thereafter) and whether they were catheter related or not. We used multivariable regression models to evaluate risk factors for NLDVT and to examine subsequent anticoagulant therapy, associated PE, and death. RESULTS Of 3746 trial patients, 84 (2.2%) developed 1 or more non-leg vein thromboses (superficial or deep, proximal or distal). Thromboses were more commonly incident (n = 75 [2.0%]) than prevalent (n = 9 [0.2%]) (P &lt;&#x2009;.001) and more often deep (n = 67 [1.8%]) than superficial (n = 31 [0.8%]) (P &lt;&#x2009;.001). Cancer was the only independent predictor of incident NLDVT (hazard ratio [HR], 2.22; 95% CI, 1.06-4.65). After adjusting for Acute Physiology and Chronic Health Evaluation (APACHE) II scores, personal or family history of venous thromboembolism, body mass index, vasopressor use, type of thromboprophylaxis, and presence of leg DVT, NLDVTs were associated with an increased risk of PE (HR, 11.83; 95% CI, 4.80-29.18). Nonleg DVTs were not associated with ICU mortality (HR, 1.09; 95% CI, 0.62-1.92) in a model adjusting for age, APACHE II, vasopressor use, mechanical ventilation, renal replacement therapy, and platelet count below 50 &#xd7; 10(9)/L. CONCLUSIONS AND RELEVANCE Despite universal heparin thromboprophylaxis, nonleg thromboses are found in 2.2% of medical-surgical critically ill patients, primarily in deep veins and proximal veins. Patients who have a malignant condition may have a significantly higher risk of developing NLDVT, and patients with NLDVT, compared with those without, appeared to be at higher risk of PE but not higher risk of death.</AbstractText><AbstractText Label="TRIAL REGISTRATION" NlmCategory="BACKGROUND">clinicaltrials.gov Identifier: NCT00182143.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Lamontagne</LastName><ForeName>Francois</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Centre de recherche Clinique &#xc9;tienne-Le Bel, Universit&#xe9; de Sherbrooke, Sherbrooke, Quebec, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>McIntyre</LastName><ForeName>Lauralyn</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Medicine (Division of Critical Care), The Ottawa Hospital, Ottawa, Ontario, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dodek</LastName><ForeName>Peter</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Center for Health Evaluation and Outcome Sciences and Department of Medicine, St Paul's Hospital and University of British Columbia, Vancouver, British Columbia, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Heels-Ansdell</LastName><ForeName>Diane</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Clinical Epidemiology and Biostatistics, McMaster University, Hamilton, Ontario, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Meade</LastName><ForeName>Maureen</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Clinical Epidemiology and Biostatistics, McMaster University, Hamilton, Ontario, Canada5Department of Medicine, McMaster University, Hamilton, Ontario, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pemberton</LastName><ForeName>Julia</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Surgery, McMaster University, Hamilton, Ontario, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Skrobik</LastName><ForeName>Yoanna</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Medicine, H&#xf4;pital Maisonneuve Rosemont, Montreal, Quebec, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Seppelt</LastName><ForeName>Ian</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Department of Intensive Care Medicine, Nepean Hospital, University of Sydney, Sydney, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vlahakis</LastName><ForeName>Nicholas E</ForeName><Initials>NE</Initials><AffiliationInfo><Affiliation>Department of Pulmonary and Critical Care, Mayo Clinic, Rochester, Minnesota.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Muscedere</LastName><ForeName>John</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Critical Care, Queen's University, Kingston, Ontario, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Reece</LastName><ForeName>Graham</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Intensive Care Medicine, Blacktown Hospital, Sydney, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ostermann</LastName><ForeName>Marlies</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Critical Care, Guys and St Thomas Hospital, London, England.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Padayachee</LastName><ForeName>Soundrie</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Ultrasonic Angiology, Guys and St Thomas Hospital, London, England.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alhashemi</LastName><ForeName>Jamal</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Anesthesia and Critical Care, King Abdulaziz University, Jeddah, Saudi Arabia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Walsh</LastName><ForeName>Michael</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Clinical Epidemiology and Biostatistics, McMaster University, Hamilton, Ontario, Canada5Department of Medicine, McMaster University, Hamilton, Ontario, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lewis</LastName><ForeName>Bradley</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Radiology, Mayo Clinic, Rochester, Minnesota.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schiff</LastName><ForeName>David</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Radiology, McMaster University, Hamilton, Ontario, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Moody</LastName><ForeName>Alan</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Medical Imaging, University of Toronto, Toronto, Ontario, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zytaruk</LastName><ForeName>Nicole</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Clinical Epidemiology and Biostatistics, McMaster University, Hamilton, Ontario, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Leblanc</LastName><ForeName>Martine</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Medicine, H&#xf4;pital Maisonneuve Rosemont, Montreal, Quebec, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cook</LastName><ForeName>Deborah J</ForeName><Initials>DJ</Initials><AffiliationInfo><Affiliation>Department of Clinical Epidemiology and Biostatistics, McMaster University, Hamilton, Ontario, Canada5Department of Medicine, McMaster University, Hamilton, Ontario, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><CollectiveName>Prophylaxis for Thromboembolism in Critical Care Trial Investigators</CollectiveName></Author><Author ValidYN="Y"><CollectiveName>Canadian Critical Care Trials Group</CollectiveName></Author><Author ValidYN="Y"><CollectiveName>Australian and New Zealand Intensive Care Society Clinical Trials Group</CollectiveName></Author></AuthorList><Language>eng</Language><DataBankList CompleteYN="Y"><DataBank><DataBankName>ClinicalTrials.gov</DataBankName><AccessionNumberList><AccessionNumber>NCT00182143</AccessionNumber></AccessionNumberList></DataBank></DataBankList><GrantList CompleteYN="Y"><Grant><Agency>Canadian Institutes of Health Research</Agency><Country>Canada</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016448">Multicenter Study</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>JAMA Intern Med</MedlineTA><NlmUniqueID>101589534</NlmUniqueID><ISSNLinking>2168-6106</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000925">Anticoagulants</NameOfSubstance></Chemical><Chemical><RegistryNumber>9005-49-6</RegistryNumber><NameOfSubstance UI="D006493">Heparin</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>JAMA Intern Med. 2014 May;174(5):696-8. doi: 10.1001/jamainternmed.2013.14014.</RefSource><PMID Version="1">24638129</PMID></CommentsCorrections><CommentsCorrections RefType="CommentIn"><RefSource>JAMA. 2015 Jan 27;313(4):411-2. doi: 10.1001/jama.2014.12496.</RefSource><PMID Version="1">25626038</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D018806" MajorTopicYN="N">APACHE</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000925" MajorTopicYN="N">Anticoagulants</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016638" MajorTopicYN="Y">Critical Illness</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006493" MajorTopicYN="N">Heparin</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015994" MajorTopicYN="N">Incidence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007362" MajorTopicYN="N">Intensive Care Units</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008168" MajorTopicYN="N">Lung</DescriptorName><QualifierName UI="Q000503" MajorTopicYN="Y">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011655" MajorTopicYN="N">Pulmonary Embolism</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D034941" MajorTopicYN="N">Upper Extremity</DescriptorName><QualifierName UI="Q000503" MajorTopicYN="Y">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D054556" MajorTopicYN="N">Venous Thromboembolism</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020246" MajorTopicYN="N">Venous Thrombosis</DescriptorName><QualifierName UI="Q000145" MajorTopicYN="N">classification</QualifierName><QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading></MeshHeadingList><InvestigatorList><Investigator ValidYN="Y"><LastName>Lesur</LastName><ForeName>Olivier</ForeName><Initials>O</Initials></Investigator><Investigator ValidYN="Y"><LastName>Lamontagne</LastName><ForeName>Francois</ForeName><Initials>F</Initials></Investigator><Investigator ValidYN="Y"><LastName>Proulx</LastName><ForeName>Sandra</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Cloutier</LastName><ForeName>Sylvie</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bolduc</LastName><ForeName>Brigitte</ForeName><Initials>B</Initials></Investigator><Investigator ValidYN="Y"><LastName>Rousseau</LastName><ForeName>Marie-Pierre</ForeName><Initials>MP</Initials></Investigator><Investigator ValidYN="Y"><LastName>Leblond</LastName><ForeName>Julie</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Schmutz</LastName><ForeName>G&#xe9;rard</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>McIntyre</LastName><ForeName>Lauralyn</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Hebert</LastName><ForeName>Paul</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Watpool</LastName><ForeName>Irene</ForeName><Initials>I</Initials></Investigator><Investigator ValidYN="Y"><LastName>McArdle</LastName><ForeName>Tracy</ForeName><Initials>T</Initials></Investigator><Investigator ValidYN="Y"><LastName>Gaudert</LastName><ForeName>Claude</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Marchand</LastName><ForeName>Paule</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Davidson</LastName><ForeName>Carson</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Dugal</LastName><ForeName>Anne-Marie</ForeName><Initials>AM</Initials></Investigator><Investigator ValidYN="Y"><LastName>Fetzer</LastName><ForeName>Susan</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Shabana</LastName><ForeName>Wael</ForeName><Initials>W</Initials></Investigator><Investigator ValidYN="Y"><LastName>Castonguay</LastName><ForeName>Marc</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Anwar</LastName><ForeName>Sohail</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kozarenko</LastName><ForeName>Valentina</ForeName><Initials>V</Initials></Investigator><Investigator ValidYN="Y"><LastName>Mohammad</LastName><ForeName>Shahina</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Sikalska</LastName><ForeName>Svitlana</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Gauthier</LastName><ForeName>Suzanne</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Mustafa</LastName><ForeName>Arif</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Dodek</LastName><ForeName>Peter</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ashley</LastName><ForeName>Betty Jean</ForeName><Initials>BJ</Initials></Investigator><Investigator ValidYN="Y"><LastName>Mans</LastName><ForeName>Sheilagh</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Pavan</LastName><ForeName>Mara</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Leipsic</LastName><ForeName>Jonathon</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Meiersdorf</LastName><ForeName>Sam</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Yoong</LastName><ForeName>Adrian</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Flores</LastName><ForeName>Francisco Avila</ForeName><Initials>FA</Initials></Investigator><Investigator ValidYN="Y"><LastName>Mumtaz</LastName><ForeName>Hina</ForeName><Initials>H</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ng</LastName><ForeName>Patrick</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Fix</LastName><ForeName>Cathy</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Meade</LastName><ForeName>Maureen</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Hand</LastName><ForeName>Lori</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Biljan</LastName><ForeName>Maya</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Patlas</LastName><ForeName>Michael</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Broughton</LastName><ForeName>Lianne</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Degrow</LastName><ForeName>Lucy</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Connor</LastName><ForeName>Dianna</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Tuhy</LastName><ForeName>Maggie</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Whyte</LastName><ForeName>Dawn</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Jefferson</LastName><ForeName>Meaghan</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Aarts</LastName><ForeName>Kaitlyn</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>Vooys</LastName><ForeName>Lindsay</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Anzovino</LastName><ForeName>Michael</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Skrobik</LastName><ForeName>Yoanna</ForeName><Initials>Y</Initials></Investigator><Investigator ValidYN="Y"><LastName>Harvey</LastName><ForeName>Johanne</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Chitu</LastName><ForeName>Stefania</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Quach</LastName><ForeName>Marceline</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Pinet</LastName><ForeName>Linda</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Muscedere</LastName><ForeName>John</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Fleury</LastName><ForeName>Susan</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Godfrey</LastName><ForeName>Nicole</ForeName><Initials>N</Initials></Investigator><Investigator ValidYN="Y"><LastName>Hammond</LastName><ForeName>Sharlene</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Mann</LastName><ForeName>Elizabeth</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Myers</LastName><ForeName>Monica</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Robinson</LastName><ForeName>Amber</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Grey</LastName><ForeName>Chris</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Saurbrei</LastName><ForeName>Eric</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Cox</LastName><ForeName>Jennifer</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Nugent</LastName><ForeName>Angela</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kolesar</LastName><ForeName>Julie</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Fisher</LastName><ForeName>Amy</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Northrup-St-Onge</LastName><ForeName>Amy</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Paterson-Skeete</LastName><ForeName>Marshaw</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Schlottke</LastName><ForeName>Wendy</ForeName><Initials>W</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bertrim</LastName><ForeName>Wendy</ForeName><Initials>W</Initials></Investigator><Investigator ValidYN="Y"><LastName>Marshall</LastName><ForeName>Cathy</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Cook</LastName><ForeName>Deborah</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>McDonald</LastName><ForeName>Ellen</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Tkaczyk</LastName><ForeName>Andrea</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Clarke</LastName><ForeName>France</ForeName><Initials>F</Initials></Investigator><Investigator ValidYN="Y"><LastName>Wallace</LastName><ForeName>Christine</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Schiff</LastName><ForeName>David</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>McDonald</LastName><ForeName>Jennifer</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Todd</LastName><ForeName>Sarah</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Harkness</LastName><ForeName>Patty</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Medic</LastName><ForeName>Angela</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Andrews</LastName><ForeName>Joanna</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Sands</LastName><ForeName>Moira</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Hall</LastName><ForeName>Iwona</ForeName><Initials>I</Initials></Investigator><Investigator ValidYN="Y"><LastName>Boniakowski</LastName><ForeName>Tanya</ForeName><Initials>T</Initials></Investigator><Investigator ValidYN="Y"><LastName>Lichty</LastName><ForeName>Kim</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>Seppelt</LastName><ForeName>Ian</ForeName><Initials>I</Initials></Investigator><Investigator ValidYN="Y"><LastName>Weisbrodt</LastName><ForeName>Leonie</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bond</LastName><ForeName>Robyn</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Suen</LastName><ForeName>Stella</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Trinh</LastName><ForeName>Jason</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Hall</LastName><ForeName>Roger</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Huang</LastName><ForeName>Richard</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Chow</LastName><ForeName>Helen</ForeName><Initials>H</Initials></Investigator><Investigator ValidYN="Y"><LastName>Reece</LastName><ForeName>Graham</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>Sara</LastName><ForeName>Treena</ForeName><Initials>T</Initials></Investigator><Investigator ValidYN="Y"><LastName>Nand</LastName><ForeName>Kiran</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ibrahim</LastName><ForeName>Rabsima</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Jarrett</LastName><ForeName>James</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Seehra</LastName><ForeName>Jagdish</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Stringer</LastName><ForeName>Gill</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>Alhashemi</LastName><ForeName>Jamal</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Shalabi</LastName><ForeName>Sanaa</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ainosah</LastName><ForeName>Randa</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Sonbul</LastName><ForeName>Julie Ann</ForeName><Initials>JA</Initials></Investigator><Investigator ValidYN="Y"><LastName>Gloriani</LastName><ForeName>Rustico</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Huertazuela</LastName><ForeName>Rosalinda</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Abbas</LastName><ForeName>Ibrahim</ForeName><Initials>I</Initials></Investigator><Investigator ValidYN="Y"><LastName>Chavez</LastName><ForeName>Judy</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>El Toum</LastName><ForeName>Nahid</ForeName><Initials>N</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ostermann</LastName><ForeName>Marlies</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Treacher</LastName><ForeName>David</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Sherry</LastName><ForeName>Tony</ForeName><Initials>T</Initials></Investigator><Investigator ValidYN="Y"><LastName>Smith</LastName><ForeName>John</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Sanderson</LastName><ForeName>Barnaby</ForeName><Initials>B</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ng</LastName><ForeName>Josephine</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Brooks</LastName><ForeName>John</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Lim</LastName><ForeName>Ling</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Lei</LastName><ForeName>Katie</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>Tunstell</LastName><ForeName>Paul</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>McKenzie</LastName><ForeName>Cathy</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Cicirello</LastName><ForeName>Francesco</ForeName><Initials>F</Initials></Investigator><Investigator ValidYN="Y"><LastName>Padayachee</LastName><ForeName>T S</ForeName><Initials>T</Initials></Investigator><Investigator ValidYN="Y"><LastName>Thomas</LastName><ForeName>Nicholas</ForeName><Initials>N</Initials></Investigator><Investigator ValidYN="Y"><LastName>Arnold</LastName><ForeName>Andrew J</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Vlahakis</LastName><ForeName>Nicholas E</ForeName><Initials>NE</Initials></Investigator><Investigator ValidYN="Y"><LastName>Meade</LastName><ForeName>Laurie</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bauer</LastName><ForeName>Debbie</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Lewis</LastName><ForeName>Bradley</ForeName><Initials>B</Initials></Investigator><Investigator ValidYN="Y"><LastName>Harer</LastName><ForeName>Nora</ForeName><Initials>N</Initials></Investigator></InvestigatorList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2014</Year><Month>3</Month><Day>19</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2014</Year><Month>3</Month><Day>19</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2014</Year><Month>6</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">24638843</ArticleId><ArticleId IdType="doi">10.1001/jamainternmed.2014.169</ArticleId><ArticleId IdType="pii">1835349</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">20488908</PMID><DateCompleted><Year>2011</Year><Month>01</Month><Day>04</Day></DateCompleted><DateRevised><Year>2022</Year><Month>04</Month><Day>10</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1936-959X</ISSN><JournalIssue CitedMedium="Internet"><Volume>31</Volume><Issue>8</Issue><PubDate><Year>2010</Year><Month>Sep</Month></PubDate></JournalIssue><Title>AJNR. American journal of neuroradiology</Title><ISOAbbreviation>AJNR Am J Neuroradiol</ISOAbbreviation></Journal><ArticleTitle>Percutaneous vertebroplasty and pulmonary cement embolism: results from VERTOS II.</ArticleTitle><Pagination><StartPage>1451</StartPage><EndPage>1453</EndPage><MedlinePgn>1451-3</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.3174/ajnr.A2127</ELocationID><Abstract><AbstractText Label="BACKGROUND AND PURPOSE" NlmCategory="OBJECTIVE">The reported incidence of PCE during PV varies, depending on the sensitivity of diagnostic tests used. To assess the true incidence of PCE, we performed native chest CT during follow-up in a large proportion of patients from the VERTOS II trial.</AbstractText><AbstractText Label="MATERIALS AND METHODS" NlmCategory="METHODS">VERTOS II is a prospective multicenter randomized controlled trial comparing PV with conservative therapy in 202 patients. After a mean follow-up of 22 months (median, 21 months; range, 6-42 months), 54 of 78 patients (69%) with 80 vertebrae treated with PV underwent native chest CT to detect possible PCE. The presence, location, number, and size of PCE were recorded. In addition, the presence of pulmonary parenchymal changes adjacent to PCE was noted. Possible risk factors for PCE, such as age, sex, number of treated vertebrae, cement volume per vertebra, and presence and location of perivertebral cement leakage, were evaluated.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">PCE was detected in 14 of 54 patients (26% 95% CI, 16%-39%). All patients were asymptomatic. Cement emboli were small and randomly distributed in peripheral small vessels. There were no reactive pulmonary changes. Cement leakage in the azygos vein was the only risk factor for the occurrence of PCE (OR, 43; 95% CI, 5-396).</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Small and clinically silent PCE occurred in a quarter of patients treated with PV. Cement leakage into the azygos vein was the only risk factor. With time, these small cement emboli remained inert, without inflammatory pulmonary response. Standard postprocedural CT or chest radiographs are not necessary.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Venmans</LastName><ForeName>A</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Radiology, St.Elisabeth Ziekenhuis, Hilvarenbeekseweg 60, 5022 GC Tilburg, the Netherlands. alexandervenmans@hotmail.com</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Klazen</LastName><ForeName>C A H</ForeName><Initials>CA</Initials></Author><Author ValidYN="Y"><LastName>Lohle</LastName><ForeName>P N M</ForeName><Initials>PN</Initials></Author><Author ValidYN="Y"><LastName>van Rooij</LastName><ForeName>W J</ForeName><Initials>WJ</Initials></Author><Author ValidYN="Y"><LastName>Verhaar</LastName><ForeName>H J J</ForeName><Initials>HJ</Initials></Author><Author ValidYN="Y"><LastName>de Vries</LastName><ForeName>J</ForeName><Initials>J</Initials></Author><Author ValidYN="Y"><LastName>Mali</LastName><ForeName>W P Th M</ForeName><Initials>WP</Initials></Author></AuthorList><Language>eng</Language><DataBankList CompleteYN="Y"><DataBank><DataBankName>ClinicalTrials.gov</DataBankName><AccessionNumberList><AccessionNumber>NCT00232466</AccessionNumber></AccessionNumberList></DataBank></DataBankList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016448">Multicenter Study</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2010</Year><Month>05</Month><Day>20</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>AJNR Am J Neuroradiol</MedlineTA><NlmUniqueID>8003708</NlmUniqueID><ISSNLinking>0195-6108</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D001843">Bone Cements</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001401" MajorTopicYN="N">Azygos Vein</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001843" MajorTopicYN="N">Bone Cements</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005500" MajorTopicYN="N">Follow-Up Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D050815" MajorTopicYN="N">Fractures, Compression</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015994" MajorTopicYN="N">Incidence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010024" MajorTopicYN="N">Osteoporosis</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011655" MajorTopicYN="N">Pulmonary Embolism</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016103" MajorTopicYN="N">Spinal Fractures</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D036542" MajorTopicYN="N">Tomography, Spiral Computed</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D054854" MajorTopicYN="Y">Vertebroplasty</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2010</Year><Month>5</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2010</Year><Month>5</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2011</Year><Month>1</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2011</Year><Month>9</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">20488908</ArticleId><ArticleId IdType="pmc">PMC7966118</ArticleId><ArticleId IdType="doi">10.3174/ajnr.A2127</ArticleId><ArticleId IdType="pii">ajnr.A2127</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Krueger A, Bliemel C, Zettl R, et al. . Management of pulmonary cement embolism after percutaneous vertebroplasty and kyphoplasty: a systematic review of the literature. Eur Spine J 2009;18:1257&#x2013;65</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2899525</ArticleId><ArticleId IdType="pubmed">19575243</ArticleId></ArticleIdList></Reference><Reference><Citation>Jensen ME, Evans AJ, Mathis JM, et al. . Percutaneous polymethylmethacrylate vertebroplasty in the treatment of osteoporotic vertebral body compression fractures: technical aspects. AJNR Am J Neuroradiol 1997;18:1897&#x2013;904</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8337380</ArticleId><ArticleId IdType="pubmed">9403451</ArticleId></ArticleIdList></Reference><Reference><Citation>Grados F, Depriester C, Cayrolle G, et al. . Long-term observations of vertebral osteoporotic fractures treated by percutaneous vertebroplasty. Rheumatology (Oxford) 2000;39:1410&#x2013;14</Citation><ArticleIdList><ArticleId IdType="pubmed">11136886</ArticleId></ArticleIdList></Reference><Reference><Citation>Zoarski GH, Snow P, Olan WJ, et al. . Percutaneous vertebroplasty for osteoporotic compression fractures: quantitative prospective evaluation of long-term outcomes. J Vasc Interv Radiol 2002;13(2 pt 1):39&#x2013;148</Citation><ArticleIdList><ArticleId IdType="pubmed">11830619</ArticleId></ArticleIdList></Reference><Reference><Citation>Legroux-Gerot I, Lormeau C, Boutry N, et al. . Long-term follow-up of vertebral osteoporotic fractures treated by percutaneous vertebroplasty. Clin Rheumatol 2004;23:310&#x2013;17</Citation><ArticleIdList><ArticleId IdType="pubmed">15293091</ArticleId></ArticleIdList></Reference><Reference><Citation>Diamond TH, Bryant C, Browne L, et al. . Clinical outcomes after acute osteoporotic vertebral fractures: a 2-year non-randomised trial comparing percutaneous vertebroplasty with conservative therapy. Med J Aust 2006;184:113&#x2013;17</Citation><ArticleIdList><ArticleId IdType="pubmed">16460295</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen HL, Wong CS, Ho ST, et al. . A lethal pulmonary embolism during percutaneous vertebroplasty. Anesth Analg 2002;95:1060&#x2013;62</Citation><ArticleIdList><ArticleId IdType="pubmed">12351294</ArticleId></ArticleIdList></Reference><Reference><Citation>Monticelli F, Meyer HJ, Tutsch-Bauer E. Fatal pulmonary cement embolism following percutaneous vertebroplasty (PVP). Forensic Sci Int 2005;149:35&#x2013;38</Citation><ArticleIdList><ArticleId IdType="pubmed">15734107</ArticleId></ArticleIdList></Reference><Reference><Citation>Venmans A, Lohle PNM, van Rooij WJ, et al. . Frequency and outcome of pulmonary polymethylmethacrylate embolism during percutaneous vertebroplasty. AJNR Am J Neuroradiol 2008;29:1983&#x2013;85</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8118909</ArticleId><ArticleId IdType="pubmed">18719030</ArticleId></ArticleIdList></Reference><Reference><Citation>Duran C, Sirvanci M, Aydooan M, et al. . Pulmonary cement embolism: a complication of percutaneous vertebroplasty. Acta Radiol 2007;48:854&#x2013;59</Citation><ArticleIdList><ArticleId IdType="pubmed">17924216</ArticleId></ArticleIdList></Reference><Reference><Citation>Choe DH, Marom EM, Ahrar K, et al. . Pulmonary embolism of polymethyl methacrylate during percutaneous vertebroplasty and kyphoplasty. AJR Am J Roentgenol 2004;183:1097&#x2013;102</Citation><ArticleIdList><ArticleId IdType="pubmed">15385313</ArticleId></ArticleIdList></Reference><Reference><Citation>Klazen CA, Verhaar HJ, Lampmann LE, et al. . VERTOS II: percutaneous vertebroplasty versus conservative therapy in patients with painful osteoporotic vertebral compression fractures; rationale, objectives and design of a multicenter randomized controlled trial. Trials 2007;8:33.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2169262</ArticleId><ArticleId IdType="pubmed">17973983</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim JY, Lee JW, Park KW, et al. . Pulmonary cement embolism after percutaneous vertebroplasty in osteoporotic vertebral compression fractures: incidence, characteristics, and risk factors. Radiology 2009;251:250&#x2013;59</Citation><ArticleIdList><ArticleId IdType="pubmed">19332856</ArticleId></ArticleIdList></Reference><Reference><Citation>Barrag&#xe1;n-Campos HM, Vall&#xe9;e JN, Lo D, et al. . Percutaneous vertebroplasty for spinal metastases: complications. Radiology 2006;238:354&#x2013;62</Citation><ArticleIdList><ArticleId IdType="pubmed">16373777</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">21462279</PMID><DateCompleted><Year>2011</Year><Month>10</Month><Day>13</Day></DateCompleted><DateRevised><Year>2013</Year><Month>11</Month><Day>21</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1099-1557</ISSN><JournalIssue CitedMedium="Internet"><Volume>20</Volume><Issue>6</Issue><PubDate><Year>2011</Year><Month>Jun</Month></PubDate></JournalIssue><Title>Pharmacoepidemiology and drug safety</Title><ISOAbbreviation>Pharmacoepidemiol Drug Saf</ISOAbbreviation></Journal><ArticleTitle>Non-steroidal anti-inflammatory drugs and risk of pulmonary embolism.</ArticleTitle><Pagination><StartPage>635</StartPage><EndPage>642</EndPage><MedlinePgn>635-42</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1002/pds.2130</ELocationID><Abstract><AbstractText Label="PURPOSE" NlmCategory="OBJECTIVE">Non-steroidal anti-inflammatory drugs (NSAIDs) have been associated with an increased risk of arterial thrombosis, but their effect on venous thrombotic events is less well established. The study aimed to assess the risk of symptomatic pulmonary embolism (PE) in patients using NSAIDs and to evaluate any effect of type, dose, and duration of therapy.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">A case-control study was conducted using the PHARMO Record Linkage System, a Dutch population-based registry. Cases were patients hospitalized with a primary diagnosis of PE and were matched to controls without a history of PE. To exclude confounding by indication, the effect of painkillers without known hemostatic effects was assessed.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">The study population consisted of 4433 cases and 16,802 controls. After adjustment for surgery, trauma, and malignancy, current use of NSAIDs was associated with PE (odds ratio (OR) 2.39, 95% confidence interval (CI) 2.06-2.77). The risk was highest for traditional NSAIDs, and the overall risk for NSAIDs was highest in the first 30 days of exposure (OR 4.77, 95%CI 3.92-5.81), as compared with chronic (&lt;1 year; OR 1.83, 95%CI 1.47-2.28) or long-term use (&gt;1 year; OR 2.14, 95%CI 1.48-3.09). Use of acetaminophen and tramadol also increased the risk of PE (OR 1.74, 95%CI 1.42-2.14 and OR 4.07, 95%CI 2.86-5.75, respectively) with a similar time trend.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Use of NSAIDs is associated with an increased risk of symptomatic PE. This association may be partially explained by underlying medical conditions, as suggested by a similarly increased thrombotic risk in patients receiving acetaminophen and tramadol.</AbstractText><CopyrightInformation>Copyright &#xa9; 2011 John Wiley &amp; Sons, Ltd.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Biere-Rafi</LastName><ForeName>Sara</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Vascular Medicine, Academic Medical Center, Amsterdam, The Netherlands. s.rafi@amc.uva.nl</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Di Nisio</LastName><ForeName>Marcello</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Gerdes</LastName><ForeName>Victor</ForeName><Initials>V</Initials></Author><Author ValidYN="Y"><LastName>Porreca</LastName><ForeName>Ettore</ForeName><Initials>E</Initials></Author><Author ValidYN="Y"><LastName>Souverein</LastName><ForeName>Patrick</ForeName><Initials>P</Initials></Author><Author ValidYN="Y"><LastName>Boer</LastName><ForeName>Anthonius</ForeName><Initials>A</Initials></Author><Author ValidYN="Y"><LastName>B&#xfc;ller</LastName><ForeName>Harry</ForeName><Initials>H</Initials></Author><Author ValidYN="Y"><LastName>Kamphuisen</LastName><ForeName>Pieter</ForeName><Initials>P</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Pharmacoepidemiol Drug Saf</MedlineTA><NlmUniqueID>9208369</NlmUniqueID><ISSNLinking>1053-8569</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D018712">Analgesics, Non-Narcotic</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000701">Analgesics, Opioid</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000894">Anti-Inflammatory Agents, Non-Steroidal</NameOfSubstance></Chemical><Chemical><RegistryNumber>362O9ITL9D</RegistryNumber><NameOfSubstance UI="D000082">Acetaminophen</NameOfSubstance></Chemical><Chemical><RegistryNumber>39J1LGJ30J</RegistryNumber><NameOfSubstance UI="D014147">Tramadol</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000082" MajorTopicYN="N">Acetaminophen</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018712" MajorTopicYN="N">Analgesics, Non-Narcotic</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000701" MajorTopicYN="N">Analgesics, Opioid</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000894" MajorTopicYN="N">Anti-Inflammatory Agents, Non-Steroidal</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016022" MajorTopicYN="N">Case-Control Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016208" MajorTopicYN="N">Databases, Factual</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="Y">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004305" MajorTopicYN="N">Dose-Response Relationship, Drug</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008498" MajorTopicYN="N">Medical Record Linkage</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009426" MajorTopicYN="N" Type="Geographic">Netherlands</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011655" MajorTopicYN="N">Pulmonary Embolism</DescriptorName><QualifierName UI="Q000139" MajorTopicYN="Y">chemically induced</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012042" MajorTopicYN="N">Registries</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013997" MajorTopicYN="N">Time Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014147" MajorTopicYN="N">Tramadol</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2011</Year><Month>4</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2011</Year><Month>4</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2011</Year><Month>10</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">21462279</ArticleId><ArticleId IdType="doi">10.1002/pds.2130</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">31419080</PMID><DateCompleted><Year>2020</Year><Month>02</Month><Day>06</Day></DateCompleted><DateRevised><Year>2020</Year><Month>02</Month><Day>06</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1757-7861</ISSN><JournalIssue CitedMedium="Internet"><Volume>11</Volume><Issue>4</Issue><PubDate><Year>2019</Year><Month>Aug</Month></PubDate></JournalIssue><Title>Orthopaedic surgery</Title><ISOAbbreviation>Orthop Surg</ISOAbbreviation></Journal><ArticleTitle>Efficacy and Safety of Tranexamic Acid in Intertrochanteric Fractures: A Single-Blind Randomized Controlled Trial.</ArticleTitle><Pagination><StartPage>635</StartPage><EndPage>642</EndPage><MedlinePgn>635-642</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1111/os.12511</ELocationID><Abstract><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">To investigate the efficacy and safety of tranexamic acid (TXA) in the reduction of bleeding and the need for transfusion in elderly intertrochanteric fracture patients.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">A total of 100 patients with intertrochanteric fractures undergoing surgery were enrolled and randomly allocated to the TXA group in which patients (75.10&#x2009;&#xb1;&#x2009;8.27&#x2009;years old) were treated with 1 g of TXA, or the control group (77.82&#x2009;&#xb1;&#x2009;6.42&#x2009;years old) treated with a placebo. Surgery was performed by two senior orthopaedic surgeons from two institutions. The proximal femoral nail antirotation (PFNA) was conducted using the standard procedure. Three outcome measures, including blood loss, transfusion, and complications, were recorded. Blood loss and transfusion were investigated to assess TXA's effectiveness, while complications were investigated to assess TXA's safety. Statistical indicators for blood loss included total, intraoperative, postoperative, and hidden blood loss volumes, calculated by hemoglobin levels, hematocrit levels, and drainage volume. The number and amount of blood transfusions were recorded. Complications associated with surgery, including deep vein thrombosis, pulmonary embolism, wound hematoma, wound infection, cardiovascular and cerebrovascular accidents, and respiratory infections, were also recorded.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">All patients were followed up for 1&#x2009;month after surgery. There were no significant differences in demographic and clinical characteristics between the two groups. The TXA group suffered significantly less total blood loss (563.37&#x2009;&#xb1;&#x2009;197.51 vs 819.25&#x2009;&#xb1;&#x2009;273.96 mL, 95% CI: -349.49 to -162.27, P&#x2009;&lt;&#x2009;0.01), intraoperative blood loss (140.3&#x2009;&#xb1;&#x2009;80.64 vs 230.5&#x2009;&#xb1;&#x2009;130.56 mL, 95% CI -132.74 to -47.66, P&#x2009;&lt;&#x2009;0.01), and hidden blood loss (410.42&#x2009;&#xb1;&#x2009;178.23 vs 571.19&#x2009;&#xb1;&#x2009;218.13 mL, 95% CI: -238.85 to -82.69, P&#x2009;&lt;&#x2009;0.01) than the control group. However, postoperative total blood loss was not significantly different (97.5&#x2009;&#xb1;&#x2009;20.93 vs 94.7&#x2009;&#xb1;&#x2009;35.78 mL; P = 0.63). A total of 5&#x2009;patients from the TXA group and 27 from the control group received packed RBC for postoperative transfusion, but the mean number of transfusion units was not significantly different between groups. Complications including deep vein thrombosis, pulmonary embolism, myocardial infarction, ischemic cerebral infarction, hematoma, and infection were observed in both groups, but no significant differences were found.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">In intertrochanteric fracture surgery performed using PFNA, intravenous administration of TXA significantly reduced the risk of intraoperative, total and hidden blood loss, in addition to the need for allogeneic transfusion, without increasing the rate of complications.</AbstractText><CopyrightInformation>&#xa9; 2019 The Authors. Orthopaedic Surgery published by Chinese Orthopaedic Association and John Wiley &amp; Sons Australia, Ltd.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Zhou</LastName><ForeName>Xin-Die</ForeName><Initials>XD</Initials><AffiliationInfo><Affiliation>Department of Orthopaedics, The Affiliated Changzhou No. 2 People's Hospital of Nanjing Medical University, Changzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Yi</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Orthopaedics, The Affiliated Changzhou No. 2 People's Hospital of Nanjing Medical University, Changzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jiang</LastName><ForeName>Li-Feng</ForeName><Initials>LF</Initials><AffiliationInfo><Affiliation>Department of Orthopaedic Surgery, The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Jun-Jie</ForeName><Initials>JJ</Initials><AffiliationInfo><Affiliation>Department of Orthopaedics, The Affiliated Changzhou No. 2 People's Hospital of Nanjing Medical University, Changzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhou</LastName><ForeName>Dong</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Orthopaedics, The Affiliated Changzhou No. 2 People's Hospital of Nanjing Medical University, Changzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wu</LastName><ForeName>Li-Dong</ForeName><Initials>LD</Initials><AffiliationInfo><Affiliation>Department of Orthopaedic Surgery, The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Huang</LastName><ForeName>Yong</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Orthopaedics, The Affiliated Changzhou No. 2 People's Hospital of Nanjing Medical University, Changzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xu</LastName><ForeName>Nan-Wei</ForeName><Initials>NW</Initials><Identifier Source="ORCID">0000-0001-6927-3312</Identifier><AffiliationInfo><Affiliation>Department of Orthopaedics, The Affiliated Changzhou No. 2 People's Hospital of Nanjing Medical University, Changzhou, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>ZD201809</GrantID><Agency>Major scientific and technological project of Changzhou municipal commission of health and family planning</Agency><Country/></Grant><Grant><GrantID>81702179</GrantID><Agency>National Natural Science Foundation of China</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2019</Year><Month>08</Month><Day>16</Day></ArticleDate></Article><MedlineJournalInfo><Country>Australia</Country><MedlineTA>Orthop Surg</MedlineTA><NlmUniqueID>101501666</NlmUniqueID><ISSNLinking>1757-7853</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000933">Antifibrinolytic Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>6T84R30KC1</RegistryNumber><NameOfSubstance UI="D014148">Tranexamic Acid</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D061605" MajorTopicYN="N">Administration, Intravenous</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000933" MajorTopicYN="N">Antifibrinolytic Agents</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016063" MajorTopicYN="N">Blood Loss, Surgical</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001803" MajorTopicYN="N">Blood Transfusion</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005593" MajorTopicYN="N">Fracture Fixation, Internal</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006620" MajorTopicYN="N">Hip Fractures</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019106" MajorTopicYN="N">Postoperative Hemorrhage</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016037" MajorTopicYN="N">Single-Blind Method</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014148" MajorTopicYN="N">Tranexamic Acid</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Blood loss</Keyword><Keyword MajorTopicYN="N">Intertrochanteric fracture</Keyword><Keyword MajorTopicYN="N">Randomized controlled trial</Keyword><Keyword MajorTopicYN="N">Tranexamic acid</Keyword><Keyword MajorTopicYN="N">Transfusion</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2018</Year><Month>11</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2019</Year><Month>7</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2019</Year><Month>7</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>8</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>2</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>8</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2019</Year><Month>8</Month><Day>16</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31419080</ArticleId><ArticleId IdType="pmc">PMC6712408</ArticleId><ArticleId IdType="doi">10.1111/os.12511</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Gullberg B, Johnell O, Kanis JA. World&#x2010;wide projections for hip fracture. Osteoporos Int, 1997, 7: 407&#x2013;413.</Citation><ArticleIdList><ArticleId IdType="pubmed">9425497</ArticleId></ArticleIdList></Reference><Reference><Citation>Miyamoto RG, Kaplan KM, Levine BR, Egol KA, Zuckerman JD. Surgical management of hip fractures: an evidence&#x2010;based review of the literature. I: femoral neck fractures. J Am Acad Orthop Surg, 2008, 16: 596&#x2013;607.</Citation><ArticleIdList><ArticleId IdType="pubmed">18832603</ArticleId></ArticleIdList></Reference><Reference><Citation>Zuckerman JD. Hip fracture. N Engl J Med, 1996, 334: 1519&#x2013;1525.</Citation><ArticleIdList><ArticleId IdType="pubmed">8618608</ArticleId></ArticleIdList></Reference><Reference><Citation>Sheehan SE, Shyu JY, Weaver MJ, Sodickson AD, Khurana B. Proximal femoral fractures: what the Orthopedic surgeon wants to know. Radiographics, 2015, 35: 1563&#x2013;1584.</Citation><ArticleIdList><ArticleId IdType="pubmed">26186669</ArticleId></ArticleIdList></Reference><Reference><Citation>Blomfeldt R, Tornkvist H, Eriksson K, Soderqvist A, Ponzer S, Tidermark J. A randomised controlled trial comparing bipolar hemiarthroplasty with total hip replacement for displaced intracapsular fractures of the femoral neck in elderly patients. J Bone Joint Surg Br, 2007, 89: 160&#x2013;165.</Citation><ArticleIdList><ArticleId IdType="pubmed">17322427</ArticleId></ArticleIdList></Reference><Reference><Citation>Panula J, Pihlajam&#xe4;ki H, Mattila VM, et al Mortality and cause of death in hip fracture patients aged 65 or older: a population&#x2010;based study. BMC Musculoskelet Disord, 2011, 12: 105.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3118151</ArticleId><ArticleId IdType="pubmed">21599967</ArticleId></ArticleIdList></Reference><Reference><Citation>Gregersen M, Borris LC, Damsgaard EM. Postoperative blood transfusion strategy in frail, anemic elderly patients with hip fracture: the TRIFE randomized controlled trial. Acta Orthop, 2015, 86: 363&#x2013;372.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4443456</ArticleId><ArticleId IdType="pubmed">25586270</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang L, Yin P, Lv H, et al Anemia on admission is an independent predictor of Long&#x2010;term mortality in hip fracture population: a prospective study with 2&#x2010;year follow&#x2010;up. Medicine (Baltimore), 2016, 95: e2469.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4748873</ArticleId><ArticleId IdType="pubmed">26844456</ArticleId></ArticleIdList></Reference><Reference><Citation>Tengberg PT, Foss NB, Palm H, Kallemose T, Troelsen A. Tranexamic acid reduces blood loss in patients with extracapsular fractures of the hip: results of a randomised controlled trial. Bone Joint J, 2016, 98: 747&#x2013;753.</Citation><ArticleIdList><ArticleId IdType="pubmed">27235515</ArticleId></ArticleIdList></Reference><Reference><Citation>Hughes NT, Burd RS, Teach SJ. Damage control resuscitation: permissive hypotension and massive transfusion protocols. Pediatr Emerg Care, 2014, 30: 651&#x2013;656.</Citation><ArticleIdList><ArticleId IdType="pubmed">25186511</ArticleId></ArticleIdList></Reference><Reference><Citation>R&#xfc;egger CM, Hagmann CF, B&#xfc;hrer C, et al Erythropoietin for the repair of cerebral injury in very preterm infants (EpoRepair). Neonatology, 2015, 108: 198&#x2013;204.</Citation><ArticleIdList><ArticleId IdType="pubmed">26278911</ArticleId></ArticleIdList></Reference><Reference><Citation>Henry DA, Carless PA, Moxey AJ, et al Anti&#x2010;fibrinolytic use for minimising perioperative allogeneic blood transfusion. Cochrane Database Syst Rev, 2011, 3: CD001886.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4234031</ArticleId><ArticleId IdType="pubmed">21412876</ArticleId></ArticleIdList></Reference><Reference><Citation>Astedt B. Clinical pharmacology of tranexamic acid. Scand J Gastroenterol Suppl, 1987, 137: 22&#x2013;25.</Citation><ArticleIdList><ArticleId IdType="pubmed">3321402</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou XD, Tao LJ, Li J, Wu LD. Do we really need tranexamic acid in total hip arthroplasty? A meta&#x2010;analysis of nineteen randomized controlled trials. Arch Orthop Trauma Surg, 2013, 133: 1017&#x2013;1027.</Citation><ArticleIdList><ArticleId IdType="pubmed">23615973</ArticleId></ArticleIdList></Reference><Reference><Citation>Roberts I, Shakur H, Coats T, et al The CRASH&#x2010;2 trial: a randomised controlled trial and economic evaluation of the effects of tranexamic acid on death, vascular occlusive events and transfusion requirement in bleeding trauma patients. Health Technol Assess, 2013, 17: 1&#x2013;79.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4780956</ArticleId><ArticleId IdType="pubmed">23477634</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen TT, Jiandong L, Wang G, Jiang SL, Li LB, Gao CQ. Combined treatment of ulinastatin and tranexamic acid provides beneficial effects by inhibiting inflammatory and fibrinolytic response in patients undergoing heart valve replacement surgery. Heart Surg Forum, 2013, 16: E38&#x2013;E47.</Citation><ArticleIdList><ArticleId IdType="pubmed">23439357</ArticleId></ArticleIdList></Reference><Reference><Citation>Hasegawa T, Oshima Y, Maruo A, et al Intraoperative tranexamic acid in pediatric bloodless cardiac surgery. Asian Cardiovasc Thorac Ann, 2014, 22: 1039&#x2013;1045.</Citation><ArticleIdList><ArticleId IdType="pubmed">24637029</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang W, Duan K, Ma M, et al Tranexamic acid decreases visible and hidden blood loss without affecting prethrombotic state molecular markers in transforaminal thoracic interbody fusion for treatment of thoracolumbar fracture&#x2010;dislocation. Spine (Phila Pa 1976), 2018, 43: E734&#x2013;E739.</Citation><ArticleIdList><ArticleId IdType="pubmed">29189568</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheriyan T, Maier SP 2nd, Bianco K, et al Efficacy of tranexamic acid on surgical bleeding in spine surgery: a meta&#x2010;analysis. Spine J, 2015, 15: 752&#x2013;761.</Citation><ArticleIdList><ArticleId IdType="pubmed">25617507</ArticleId></ArticleIdList></Reference><Reference><Citation>Raksakietisak M, Sathitkarnmanee B, Srisaen P, et al Two doses of Tranexamic acid reduce blood transfusion in complex spine surgery: a prospective randomized study. Spine (Phila Pa 1976), 2015, 40: E1257&#x2013;E1263.</Citation><ArticleIdList><ArticleId IdType="pubmed">26208230</ArticleId></ArticleIdList></Reference><Reference><Citation>Poeran J, Rasul R, Suzuki S, et al Tranexamic acid use and postoperative outcomes in patients undergoing total hip or knee arthroplasty in the United States: retrospective analysis of effectiveness and safety. BMJ, 2014, 349: g4829.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4130961</ArticleId><ArticleId IdType="pubmed">25116268</ArticleId></ArticleIdList></Reference><Reference><Citation>Tian S, Shen Z, Liu Y, Zhang Y, Peng A. The effect of tranexamic acid on hidden bleeding in older intertrochanteric fracture patients treated with PFNA. Injury, 2018, 49: 680&#x2013;684.</Citation><ArticleIdList><ArticleId IdType="pubmed">29426608</ArticleId></ArticleIdList></Reference><Reference><Citation>Mohib Y, Rashid RH, Ali M, Zubairi AJ, Umer M. Does tranexamic acid reduce blood transfusion following surgery for inter&#x2010;trochanteric fracture? A randomized control trial. J Pak Med Assoc, 2015, 65: S17&#x2013;S20.</Citation><ArticleIdList><ArticleId IdType="pubmed">26878513</ArticleId></ArticleIdList></Reference><Reference><Citation>Baruah RK, Borah PJ, Haque R. Use of tranexamic acid in dynamic hip screw plate fixation for trochanteric fractures. J Orthop Surg (Hong Kong), 2016, 24: 379&#x2013;382.</Citation><ArticleIdList><ArticleId IdType="pubmed">28031511</ArticleId></ArticleIdList></Reference><Reference><Citation>Drakos A, Raoulis V, Karatzios K, et al Efficacy of local administration of tranexamic acid for blood salvage in patients undergoing intertrochanteric fracture surgery. J Orthop Trauma, 2016, 30: 409&#x2013;414.</Citation><ArticleIdList><ArticleId IdType="pubmed">26978136</ArticleId></ArticleIdList></Reference><Reference><Citation>Virani SR, Dahapute AA, Panda I, Bava SS. Role of local infiltration of tranexamic acid in reducing blood loss in peritrochanteric fracture surgery in the elderly population. Malays Orthop J, 2016, 10: 26&#x2013;30.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5333680</ArticleId><ArticleId IdType="pubmed">28553444</ArticleId></ArticleIdList></Reference><Reference><Citation>Lei J, Zhang B, Cong Y, et al Tranexamic acid reduces hidden blood loss in the treatment of intertrochanteric fractures with PFNA: a single&#x2010;center randomized controlled trial. J Orthop Surg Res, 2017, 12: 124.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5558747</ArticleId><ArticleId IdType="pubmed">28810918</ArticleId></ArticleIdList></Reference><Reference><Citation>Levine RJ. Some recent developments in the international guidelines on the ethics of research involving human subjects. Ann N Y Acad Sci, 2000, 918: 170&#x2013;178.</Citation><ArticleIdList><ArticleId IdType="pubmed">11131702</ArticleId></ArticleIdList></Reference><Reference><Citation>Schulz KF, Altman DG, Moher D, Group C. CONSORT . Statement: updated guidelines for reporting parallel group randomized trials. Ann Intern Med, 2010, 2010: 726&#x2013;732.</Citation><ArticleIdList><ArticleId IdType="pubmed">20335313</ArticleId></ArticleIdList></Reference><Reference><Citation>Gross JB. Estimating allowable blood loss: corrected for dilution. Anesthesiology, 1983, 58: 277&#x2013;280.</Citation><ArticleIdList><ArticleId IdType="pubmed">6829965</ArticleId></ArticleIdList></Reference><Reference><Citation>Meunier A, Petersson A, Good L, Berlin G. Validation of a haemoglobin dilution method for estimation of blood loss. Vox Sang, 2008, 95: 120&#x2013;124.</Citation><ArticleIdList><ArticleId IdType="pubmed">18510580</ArticleId></ArticleIdList></Reference><Reference><Citation>Nadler SB, Hidalgo JH, Bloch T. Prediction of blood volume in normal human adults. Surgery, 1962, 51: 224&#x2013;232.</Citation><ArticleIdList><ArticleId IdType="pubmed">21936146</ArticleId></ArticleIdList></Reference><Reference><Citation>Fiechtner BK, Nuttall GA, Johnson ME, et al Plasma tranexamic acid concentrations during cardiopulmonary bypass. Anesth Analg, 2001, 92: 1131&#x2013;1136.</Citation><ArticleIdList><ArticleId IdType="pubmed">11323334</ArticleId></ArticleIdList></Reference><Reference><Citation>Crescenti A, Borghi G, Bignami E, et al Intraoperative use of tranexamic acid to reduce transfusion rate in patients undergoing radical retropubic prostatectomy: double blind, randomised, placebo controlled trial. BMJ, 2011, 343: d5701.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3198510</ArticleId><ArticleId IdType="pubmed">22012809</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou XD, Li J, Fan GM, Huang Y, Xu NW. Efficacy and safety of tranexamic acid in elderly patients with intertrochanteric fracture: an updated meta&#x2010;analysis. World J Clin Cases, 2019, 7: 1302&#x2013;1314.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6580343</ArticleId><ArticleId IdType="pubmed">31236394</ArticleId></ArticleIdList></Reference><Reference><Citation>McCormack PL. Tranexamic acid: a review of its use in the treatment of hyperfibrinolysis. Drugs, 2012, 72: 585&#x2013;617.</Citation><ArticleIdList><ArticleId IdType="pubmed">22397329</ArticleId></ArticleIdList></Reference><Reference><Citation>Williams&#x2010;Johnson JA, McDonald AH, Strachan GG, Williams EW. Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH&#x2010;2) a randomised, placebo&#x2010;controlled trial. West Indian Med J, 2010, 59: 612&#x2013;624.</Citation><ArticleIdList><ArticleId IdType="pubmed">21702233</ArticleId></ArticleIdList></Reference><Reference><Citation>Guerriero C, Cairns J, Perel P, Shakur H, Roberts I. Collaborators Ct. Cost&#x2010;effectiveness analysis of administering tranexamic acid to bleeding trauma patients using evidence from the CRASH&#x2010;2 trial. PLoS One, 2011, 6: e18987.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3086904</ArticleId><ArticleId IdType="pubmed">21559279</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang ZG, Chen WP, Wu LD. Effectiveness and safety of tranexamic acid in reducing blood loss in total knee arthroplasty: a meta&#x2010;analysis. J Bone Joint Surg Am, 2012, 94: 1153&#x2013;1159.</Citation><ArticleIdList><ArticleId IdType="pubmed">22623147</ArticleId></ArticleIdList></Reference><Reference><Citation>Elwatidy S, Jamjoom Z, Elgamal E, Zakaria A, Turkistani A, El&#x2010;Dawlatly A. Efficacy and safety of prophylactic large dose of tranexamic acid in spine surgery: a prospective, randomized, double&#x2010;blind, placebo&#x2010;controlled study. Spine (Phila Pa 1976), 2008, 33: 2577&#x2013;2580.</Citation><ArticleIdList><ArticleId IdType="pubmed">19011538</ArticleId></ArticleIdList></Reference><Reference><Citation>Dennison E, Mohamed MA, Cooper C. Epidemiology of osteoporosis. Rheum Dis Clin North Am, 2006, 32: 617&#x2013;629.</Citation><ArticleIdList><ArticleId IdType="pubmed">17288968</ArticleId></ArticleIdList></Reference><Reference><Citation>Carson JL, Altman DG, Duff A, et al Risk of bacterial infection associated with allogeneic blood transfusion among patients undergoing hip fracture repair. Transfusion, 1999, 39: 694&#x2013;700.</Citation><ArticleIdList><ArticleId IdType="pubmed">10413276</ArticleId></ArticleIdList></Reference><Reference><Citation>Vincent JL, Baron JF, Reinhart K, et al Anemia and blood transfusion in critically ill patients. JAMA, 2002, 288: 1499&#x2013;1507.</Citation><ArticleIdList><ArticleId IdType="pubmed">12243637</ArticleId></ArticleIdList></Reference><Reference><Citation>Zufferey PJ, Miquet M, Quenet S, et al Tranexamic acid in hip fracture surgery: a randomized controlled trial. Br J Anaesth, 2010, 104: 23&#x2013;30.</Citation><ArticleIdList><ArticleId IdType="pubmed">19926634</ArticleId></ArticleIdList></Reference><Reference><Citation>Geerts WH, Code KI, Jay RM, Chen E, Szalai JP. A prospective study of venous thromboembolism after major trauma. N Engl J Med, 1994, 331: 1601&#x2013;1606.</Citation><ArticleIdList><ArticleId IdType="pubmed">7969340</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">26230536</PMID><DateCompleted><Year>2016</Year><Month>08</Month><Day>23</Day></DateCompleted><DateRevised><Year>2022</Year><Month>04</Month><Day>10</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1528-1159</ISSN><JournalIssue CitedMedium="Internet"><Volume>40</Volume><Issue>19</Issue><PubDate><Year>2015</Year><Month>Oct</Month><Day>01</Day></PubDate></JournalIssue><Title>Spine</Title><ISOAbbreviation>Spine (Phila Pa 1976)</ISOAbbreviation></Journal><ArticleTitle>Timing of Complications After Spinal Fusion Surgery.</ArticleTitle><Pagination><StartPage>1527</StartPage><EndPage>1535</EndPage><MedlinePgn>1527-35</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1097/BRS.0000000000001073</ELocationID><Abstract><AbstractText Label="STUDY DESIGN" NlmCategory="METHODS">Retrospective cohort study.</AbstractText><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">To characterize the timing of complications after spinal fusion procedures.</AbstractText><AbstractText Label="SUMMARY OF BACKGROUND DATA" NlmCategory="BACKGROUND">Despite many publications on risk factors for complications after spine surgery, there are few publications on the timing at which such complications occur.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Patients undergoing anterior cervical decompression and fusion (ACDF) or posterior lumbar fusion (PLF; with or without interbody) procedures during 2011-2013 were identified in the American College of Surgeons National Surgical Quality Improvement Program (ACS-NSQIP) database. For each of 8 different complications, the median time from surgery until complication was determined, along with the interquartile range and middle 80%.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">A total of 12,067 patients undergoing ACDF and 11,807 patients undergoing PLF were identified. For ACDF, the median day of diagnosis (and interquartile range; middle 80%) for anemia requiring transfusion was 0 (0-1; 0-2), myocardial infarction 2 (1-5; 0-15), pneumonia 4 (2-9; 1-14), pulmonary embolism 5 (2-9; 1-10), deep vein thrombosis 10.5 (7-16.5; 5-21), sepsis 10.5 (4-18; 1-23), surgical site infection 13 (8-19; 5-25), and urinary tract infection 17 (8-22; 4-26). For PLF, the median day of diagnosis (and interquartile range; middle 80%) for anemia requiring transfusion was 0 (0-1; 0-2), myocardial infarction 2 (1-4; 1-8), pneumonia 4 (2-9; 1-17), pulmonary embolism 5 (3-11; 2-17), urinary tract infection 7 (4-14; 2-23), deep vein thrombosis 8 (5-16; 3-20), sepsis 9 (4-16; 2-22), and surgical site infection 17 (13-22; 9-27).</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">These precisely described postoperative time periods enable heightened clinical awareness among spine surgeons. Spine surgeons should have the lowest threshold for testing for each complication during the time period of greatest risk. Authors, reviewers, and surgeons utilizing research on postoperative complications should carefully consider the impact that the duration of follow-up has on study results.</AbstractText><AbstractText Label="LEVEL OF EVIDENCE" NlmCategory="METHODS">3.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Bohl</LastName><ForeName>Daniel D</ForeName><Initials>DD</Initials><AffiliationInfo><Affiliation>*Department of Orthopaedic Surgery, Rush University Medical Center, Chicago, IL &#x2020;Department of Orthopaedics and Rehabilitation, Yale School of Medicine, New Haven, CT; and &#x2021;Departments of Orthopaedic Surgery and Neurological Surgery, Thomas Jefferson University and The Rothman Institute, Philadelphia, PA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Webb</LastName><ForeName>Matthew L</ForeName><Initials>ML</Initials></Author><Author ValidYN="Y"><LastName>Lukasiewicz</LastName><ForeName>Adam M</ForeName><Initials>AM</Initials></Author><Author ValidYN="Y"><LastName>Samuel</LastName><ForeName>Andre M</ForeName><Initials>AM</Initials></Author><Author ValidYN="Y"><LastName>Basques</LastName><ForeName>Bryce A</ForeName><Initials>BA</Initials></Author><Author ValidYN="Y"><LastName>Ahn</LastName><ForeName>Junyoung</ForeName><Initials>J</Initials></Author><Author ValidYN="Y"><LastName>Singh</LastName><ForeName>Kern</ForeName><Initials>K</Initials></Author><Author ValidYN="Y"><LastName>Vaccaro</LastName><ForeName>Alexander R</ForeName><Initials>AR</Initials></Author><Author ValidYN="Y"><LastName>Grauer</LastName><ForeName>Jonathan N</ForeName><Initials>JN</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Spine (Phila Pa 1976)</MedlineTA><NlmUniqueID>7610646</NlmUniqueID><ISSNLinking>0362-2436</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019299" MajorTopicYN="N">Decompression, Surgical</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008159" MajorTopicYN="N">Lumbar Vertebrae</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011655" MajorTopicYN="N">Pulmonary Embolism</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013123" MajorTopicYN="N">Spinal Fusion</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D066231" MajorTopicYN="Y">Surgeons</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013997" MajorTopicYN="N">Time Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2015</Year><Month>8</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2015</Year><Month>8</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2016</Year><Month>8</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">26230536</ArticleId><ArticleId IdType="doi">10.1097/BRS.0000000000001073</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">24589368</PMID><DateCompleted><Year>2014</Year><Month>08</Month><Day>25</Day></DateCompleted><DateRevised><Year>2021</Year><Month>10</Month><Day>21</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1741-7015</ISSN><JournalIssue CitedMedium="Internet"><Volume>12</Volume><PubDate><Year>2014</Year><Month>Mar</Month><Day>04</Day></PubDate></JournalIssue><Title>BMC medicine</Title><ISOAbbreviation>BMC Med</ISOAbbreviation></Journal><ArticleTitle>A cohort study on the incidence and outcome of pulmonary embolism in trauma and orthopedic patients.</ArticleTitle><Pagination><StartPage>39</StartPage><MedlinePgn>39</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1186/1741-7015-12-39</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">This study aims to determine the incidence of pulmonary embolism (PE) in trauma and orthopedic patients within a regional tertiary referral center and its association with the pattern of injury, type of treatment, co-morbidities, thromboprophylaxis and mortality.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">All patients admitted to our institution between January 2010 and December 2011, for acute trauma or elective orthopedic procedures, were eligible to participate in this study. Our cohort was formed by identifying all patients with clinical features of PE who underwent Computed Tomography-Pulmonary Angiogram (CT-PA) to confirm or exclude the clinical suspicion of PE, within six months after the injury or the surgical procedure.Case notes and electronic databases were reviewed retrospectively to identify each patient's venous thromboembolism (VTE) risk factors, type of treatment, thromboprophylaxis and mortality.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Out of 18,151 patients admitted during the study period only 85 (0.47%) patients developed PE (positive CT-PA) (24 underwent elective surgery and 61 sustained acute trauma). Of these, only 76% of the patients received thromboprophylaxis. Hypertension, obesity and cardiovascular disease were the most commonly identifiable risk factors. In 39% of the cases, PE was diagnosed during the in-hospital stay. The median time of PE diagnosis, from the date of injury or the surgical intervention was 23 days (range 1 to 312). The overall mortality rate was 0.07% (13/18,151), but for those who developed PE it was 15.29% (13/85). Concomitant deep venous thrombosis (DVT) was identified in 33.3% of patients. The presence of two or more co-morbidities was significantly associated with the incidence of mortality (unadjusted odds ratio (OR) = 3.52, 95% confidence interval (CI) (1.34, 18.99), P = 0.034). Although there was also a similar clinical effect size for polytrauma injury on mortality (unadjusted OR = 1.90 (0.38, 9.54), P = 0.218), evidence was not statistically significant for this factor.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">The incidence of VTE was comparable to previously reported rates, whereas the mortality rate was lower. Our local protocols that comply with the National Institute for Health and Clinical Excellence (NICE) guidelines in the UK appear to be effective in preventing VTE and reducing mortality in trauma and orthopedic patients.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Gudipati</LastName><ForeName>Suribabu</ForeName><Initials>S</Initials></Author><Author ValidYN="Y"><LastName>Fragkakis</LastName><ForeName>Evangelos M</ForeName><Initials>EM</Initials></Author><Author ValidYN="Y"><LastName>Ciriello</LastName><ForeName>Vincenzo</ForeName><Initials>V</Initials></Author><Author ValidYN="Y"><LastName>Harrison</LastName><ForeName>Simon J</ForeName><Initials>SJ</Initials></Author><Author ValidYN="Y"><LastName>Stavrou</LastName><ForeName>Petros Z</ForeName><Initials>PZ</Initials></Author><Author ValidYN="Y"><LastName>Kanakaris</LastName><ForeName>Nikolaos K</ForeName><Initials>NK</Initials></Author><Author ValidYN="Y"><LastName>West</LastName><ForeName>Robert M</ForeName><Initials>RM</Initials></Author><Author ValidYN="Y"><LastName>Giannoudis</LastName><ForeName>Peter V</ForeName><Initials>PV</Initials><AffiliationInfo><Affiliation>Academic Department of Trauma and Orthopaedics, School of Medicine, University of Leeds, Leeds General Infirmary, Clarendon Wing Level A, Great George Street, LS1 3EX Leeds, West Yorkshire, UK. pgiannoudi@aol.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2014</Year><Month>03</Month><Day>04</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>BMC Med</MedlineTA><NlmUniqueID>101190723</NlmUniqueID><ISSNLinking>1741-7015</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017558" MajorTopicYN="N">Elective Surgical Procedures</DescriptorName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000639" MajorTopicYN="N">trends</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015994" MajorTopicYN="N">Incidence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009026" MajorTopicYN="N">Mortality</DescriptorName><QualifierName UI="Q000639" MajorTopicYN="N">trends</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019637" MajorTopicYN="N">Orthopedic Procedures</DescriptorName><QualifierName UI="Q000401" MajorTopicYN="Y">mortality</QualifierName><QualifierName UI="Q000639" MajorTopicYN="N">trends</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011655" MajorTopicYN="N">Pulmonary Embolism</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000401" MajorTopicYN="Y">mortality</QualifierName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015912" MajorTopicYN="N">Thrombolytic Therapy</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000639" MajorTopicYN="N">trends</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014947" MajorTopicYN="N">Wounds and Injuries</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000401" MajorTopicYN="Y">mortality</QualifierName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2013</Year><Month>8</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2014</Year><Month>2</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2014</Year><Month>3</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2014</Year><Month>3</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2014</Year><Month>8</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2014</Year><Month>3</Month><Day>4</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">24589368</ArticleId><ArticleId IdType="pmc">PMC3996019</ArticleId><ArticleId IdType="doi">10.1186/1741-7015-12-39</ArticleId><ArticleId IdType="pii">1741-7015-12-39</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Markovic-Denic L, Zivkovic K, Lesic A, Bumbasirevic V, Dubljanin-Raspopovic ER, Bumbasirevic M. Risk factors and distribution of symptomatic venous thromboembolism in total hip and knee replacements: prospective study. Int Orthop. 2012;36:1299&#x2013;1305. doi: 10.1007/s00264-011-1466-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00264-011-1466-5</ArticleId><ArticleId IdType="pmc">PMC3353084</ArticleId><ArticleId IdType="pubmed">22215369</ArticleId></ArticleIdList></Reference><Reference><Citation>Cohen AT, Tapson VF, Bergmann JF, Goldhaber SZ, Kakkar AK, Deslandes B, Huang W, Zayaruzny M, Emery L, Anderson FA Jr. ENDORSE Investigators. Venous thromboembolism risk and prophylaxis in the acute hospital care setting (ENDORSE study): a multinational cross-sectional study. Lancet. 2008;371:387&#x2013;394. doi: 10.1016/S0140-6736(08)60202-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(08)60202-0</ArticleId><ArticleId IdType="pubmed">18242412</ArticleId></ArticleIdList></Reference><Reference><Citation>Geerts WH, Pineo GF, Heit JA, Bergqvist D, Lassen MR, Colwell CW, Ray JG. Prevention of venous thromboembolism: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest. 2004;126:338S&#x2013;400S. doi: 10.1378/chest.126.3_suppl.338S.</Citation><ArticleIdList><ArticleId IdType="doi">10.1378/chest.126.3_suppl.338S</ArticleId><ArticleId IdType="pubmed">15383478</ArticleId></ArticleIdList></Reference><Reference><Citation>Linblad B, Sternby NH, Bergqvist D. Incidence of venous thromboembolism verified by necropsy over 30&#xa0;years. BMJ. 1991;302:709&#x2013;711. doi: 10.1136/bmj.302.6778.709.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.302.6778.709</ArticleId><ArticleId IdType="pmc">PMC1669118</ArticleId><ArticleId IdType="pubmed">2021744</ArticleId></ArticleIdList></Reference><Reference><Citation>Sandler DA, Martin JF. Autopsy proven pulmonary embolism in hospital patients: are we detecting enough deep vein thrombosis? J R Soc Med. 1989;82:203&#x2013;205.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1292084</ArticleId><ArticleId IdType="pubmed">2716016</ArticleId></ArticleIdList></Reference><Reference><Citation>Alikhan R, Peters F, Wilmott R, Cohen AT. Fatal pulmonary embolism in hospitalized patients: a necropsy review. J Clin Pathol. 2004;57:1254&#x2013;1257. doi: 10.1136/jcp.2003.013581.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jcp.2003.013581</ArticleId><ArticleId IdType="pmc">PMC1770519</ArticleId><ArticleId IdType="pubmed">15563663</ArticleId></ArticleIdList></Reference><Reference><Citation>Prandoni P, Villalta S, Bagatella P, Rossi L, Marchiori A, Piccioli A, Bernardi E, Girolami B, Simioni P, Girolami A. The clinical course of deep-vein thrombosis. Prospective long-term follow-up of 528 symptomatic patients. Haematologica. 1997;82:423&#x2013;428.</Citation><ArticleIdList><ArticleId IdType="pubmed">9299855</ArticleId></ArticleIdList></Reference><Reference><Citation>Pengo V, Lensing AW, Prins MH, Marchiori A, Davidson BL, Tiozzo F, Albanese P, Biasiolo A, Pegoraro C, Iliceto S, Prandoni P. Thromboembolic Pulmonary Hypertension Study Group. Incidence of chronic thromboembolic pulmonary hypertension after pulmonary embolism. N Engl J Med. 2004;350:2257&#x2013;2264. doi: 10.1056/NEJMoa032274.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa032274</ArticleId><ArticleId IdType="pubmed">15163775</ArticleId></ArticleIdList></Reference><Reference><Citation>Paffrath T, Wafaisade A, Lefering R, Simanski C, Bouillon B, Spanholtz T, Wutzler S, Maegele M. Trauma Registry of DGU. Venous thromboembolism after severe trauma: incidence, risk factors and outcome. Injury. 2010;41:97&#x2013;101. doi: 10.1016/j.injury.2009.06.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.injury.2009.06.010</ArticleId><ArticleId IdType="pubmed">19608183</ArticleId></ArticleIdList></Reference><Reference><Citation>Ho KM, Burrell M, Rao S, Baker R. Incidence and risk factors for fatal pulmonary embolism after major trauma: a nested cohort study. Br J Anaesth. 2010;105:596&#x2013;602. doi: 10.1093/bja/aeq254.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bja/aeq254</ArticleId><ArticleId IdType="pmc">PMC2955535</ArticleId><ArticleId IdType="pubmed">20861095</ArticleId></ArticleIdList></Reference><Reference><Citation>Poultsides LA, Gonzalez Della Valle A, Memtsoudis SG, Ma Y, Roberts T, Sharrock N, Salvati E. Meta-analysis of cause of death following total joint replacement using different thromboprophylaxis regimens. J Bone Joint Surg Br. 2012;94:113&#x2013;121.</Citation><ArticleIdList><ArticleId IdType="pubmed">22219258</ArticleId></ArticleIdList></Reference><Reference><Citation>Januel JM, Chen G, Ruffieux C, Quan H, Douketis JD, Crowther MA, Colin C, Ghali WA, Burnand B. IMECCHI Group. Symptomatic in-hospital deep vein thrombosis and pulmonary embolism following hip and knee arthroplasty among patients receiving recommended prophylaxis a systematic review. JAMA. 2012;307:294&#x2013;303.</Citation><ArticleIdList><ArticleId IdType="pubmed">22253396</ArticleId></ArticleIdList></Reference><Reference><Citation>Subramaniam RM, Blair D, Gilbert K, Sleigh J, Karalus N. Computed tomography pulmonary angiogram diagnosis of pulmonary embolism. Australas Radiol. 2006;50:193&#x2013;200. doi: 10.1111/j.1440-1673.2006.01561.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1440-1673.2006.01561.x</ArticleId><ArticleId IdType="pubmed">16732813</ArticleId></ArticleIdList></Reference><Reference><Citation>Stein PD, Fowler SE, Goodman LR, Gottschalk A, Hales CA, Hull RD, Leeper KV Jr, Popovich J Jr, Quinn DA, Sos TA, Sostman HD, Tapson VF, Wakefield TW, Weg JG, Woodard PK. PIOPED II Investigators. Multidetector computed tomography for acute pulmonary embolism. N Engl J Med. 2006;354:2317&#x2013;2327. doi: 10.1056/NEJMoa052367.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa052367</ArticleId><ArticleId IdType="pubmed">16738268</ArticleId></ArticleIdList></Reference><Reference><Citation>Pruszczyk P, Torbicki A, Pacho R, Chlebus M, Kuch-Wocial A, Pruszynski B, Gurba H. Noninvasive diagnosis of suspected severe pulmonary embolism: transesophageal echocardiography vs. spiral CT. Chest. 1997;112:722&#x2013;728. doi: 10.1378/chest.112.3.722.</Citation><ArticleIdList><ArticleId IdType="doi">10.1378/chest.112.3.722</ArticleId><ArticleId IdType="pubmed">9315806</ArticleId></ArticleIdList></Reference><Reference><Citation>NICE guidelines.  Venous thromboembolism - reducing the risk (CG92). [http treatment protocol:  http://guidance.nice.org.uk/CG92] Venous thromboembolism (surgical) (CG46) (replaced by CG92) http treatment protocol:  http://guidance.nice.org.uk/CG46.</Citation></Reference><Reference><Citation>Jim&#xe9;nez D, Aujesky D, Moores L, G&#xf3;mez V, Lobo JL, Uresandi F, Otero R, Monreal M, Muriel A, Yusen RD. RIETE Investigators. Simplification of the pulmonary embolism severity index for prognostication in patients with acute symptomatic pulmonary embolism. Arch Intern Med. 2010;170:1383&#x2013;1389. doi: 10.1001/archinternmed.2010.199.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archinternmed.2010.199</ArticleId><ArticleId IdType="pubmed">20696966</ArticleId></ArticleIdList></Reference><Reference><Citation>Cohen AT, Edmondson RA, Phillips MJ, Ward VP, Kakkar VV. The changing pattern of venous thromboembolic disease. Haemostasis. 1996;26:65&#x2013;71.</Citation><ArticleIdList><ArticleId IdType="pubmed">9119284</ArticleId></ArticleIdList></Reference><Reference><Citation>MacDonald D, Hobson S. VTE Prophylaxis for Elective Knee Replacement, eClinical VTE Guidelines Template. Leeds Teaching Hospitals Trust; Publication date: 1 July 2010.</Citation></Reference><Reference><Citation>MacDonald D, Hobson S. VTE Prophylaxis for Elective Hip Replacement, eClinical VTE Guidelines Template. Leeds Teaching Hospitals Trust; Publication date: 1 July 2010.</Citation></Reference><Reference><Citation>Rao A, Monkhouse R, Gummerson N, Hobson S. VTE Prophylaxis for Hip Fracture, eClinical VTE Guidelines Template. Leeds Teaching Hospitals Trust; Publication date: 1 July 2010.</Citation></Reference><Reference><Citation>Rao A, Monkhouse R, Gummerson N, Hobson S. VTE Prophylaxis for Other Orthopedic Surgery, eClinical VTE Guidelines Template. Leeds Teaching Hospitals Trust; Publication date: 1 July 2010.</Citation></Reference><Reference><Citation>Rao A, Monkhouse R, Gummerson N, Hobson S. VTE Prophylaxis for Lower Limb Plaster Casts, eClinical VTE Guidelines Template. Leeds Teaching Hospitals Trust; Publication date: 1 July 2010.</Citation></Reference><Reference><Citation>R Core Team. R: A language and environment for statistical computing.  Vienna, Austria: Foundation for Statistical Computing; 2013. URL  http://www.R-project.org/</Citation></Reference><Reference><Citation>Heit JA. The epidemiology of venous thromboembolism in the community. Arterioscler Thromb Vasc Biol. 2008;28:370&#x2013;372. doi: 10.1161/ATVBAHA.108.162545.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/ATVBAHA.108.162545</ArticleId><ArticleId IdType="pmc">PMC2873781</ArticleId><ArticleId IdType="pubmed">18296591</ArticleId></ArticleIdList></Reference><Reference><Citation>Falck-Ytter Y, Francis CW, Johanson NA, Curley C, Dahl OE, Schulman S, Ortel TL, Pauker SG, Colwell CW Jr. American College of Chest Physicians. Prevention of VTE in orthopedic surgery patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th Ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2012;141(2 suppl):e278S&#x2013;e325S.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3278063</ArticleId><ArticleId IdType="pubmed">22315265</ArticleId></ArticleIdList></Reference><Reference><Citation>Jawa RS, Warren K, Young D, Wagner M, Nelson L, Yetter D, Banks S, Shostrom V, Stothert J. Venous thromboembolic disease in trauma and surveillance ultrasonography. J Surg Res. 2011;167:24&#x2013;31. doi: 10.1016/j.jss.2010.09.046.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jss.2010.09.046</ArticleId><ArticleId IdType="pubmed">21176915</ArticleId></ArticleIdList></Reference><Reference><Citation>Huseynova K, Xiong W, Ray JG, Ahmed N, Nathens AB. Venous thromboembolism as a marker of quality of care in trauma. J Am Coll Surg. 2009;208:547&#x2013;552. doi: 10.1016/j.jamcollsurg.2009.01.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jamcollsurg.2009.01.002</ArticleId><ArticleId IdType="pubmed">19476788</ArticleId></ArticleIdList></Reference><Reference><Citation>Menaker J, Stein DM, Scalea TM. Incidence of early pulmonary embolism after injury. J Trauma. 2007;63:620&#x2013;624. doi: 10.1097/TA.0b013e31812f60aa.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/TA.0b013e31812f60aa</ArticleId><ArticleId IdType="pubmed">18073610</ArticleId></ArticleIdList></Reference><Reference><Citation>McNamara I, Sharma A, Prevost T, Parker M. Symptomatic venous thromboembolism following a hip fracture. Acta Orthop. 2009;80:687&#x2013;692. doi: 10.3109/17453670903448273.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/17453670903448273</ArticleId><ArticleId IdType="pmc">PMC2823318</ArticleId><ArticleId IdType="pubmed">19968601</ArticleId></ArticleIdList></Reference><Reference><Citation>Estrada-Y-Martin RM, Oldham SA. CTPA as the gold standard for the diagnosis of pulmonary embolism. Int J Comput Assist Radiol Surg. 2011;6:557&#x2013;563. doi: 10.1007/s11548-010-0526-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11548-010-0526-4</ArticleId><ArticleId IdType="pubmed">20689999</ArticleId></ArticleIdList></Reference><Reference><Citation>Vedovati MC, Becattini C, Agnelli G, Kamphuisen PW, Masotti L, Pruszczyk P, Casazza F, Salvi A, Grifoni S, Carugati A, Konstantinides S, Schreuder M, Golebiowski M, Duranti M. Multidetector CT for acute pulmonary embolism: embolic burden and clinical outcome. Chest. 2012;142(6):1417&#x2013;1424. doi: 10.1378/chest.11-2739.</Citation><ArticleIdList><ArticleId IdType="doi">10.1378/chest.11-2739</ArticleId><ArticleId IdType="pubmed">22628491</ArticleId></ArticleIdList></Reference><Reference><Citation>Pedersen AB, Sorensen HT, Mehnert F, Overgaard S, Johnsen SP. Risk factors for venous thromboembolism in patients undergoing total hip replacement and receiving routine thromboprophylaxis. J Bone Joint Surg Am. 2010;92:2156&#x2013;2164. doi: 10.2106/JBJS.I.00882.</Citation><ArticleIdList><ArticleId IdType="doi">10.2106/JBJS.I.00882</ArticleId><ArticleId IdType="pubmed">20844157</ArticleId></ArticleIdList></Reference><Reference><Citation>Pedersen AB, Mehnert F, Johnsen SP, Husted S, Sorensen HT. Venous thromboembolism in patients having knee replacement and receiving thromboprophylaxis: a Danish population-based follow-up study. J Bone Joint Surg Am. 2011;93:1281&#x2013;1287.</Citation><ArticleIdList><ArticleId IdType="pubmed">21792493</ArticleId></ArticleIdList></Reference><Reference><Citation>Dy CJ, Wilkinson JD, Tamariz L, Scully SP. Influence of preoperative cardiovascular risk factor clusters on complications of total joint arthroplasty. Am J Orthop (Belle Mead, NJ) 2011;40:560&#x2013;565.</Citation><ArticleIdList><ArticleId IdType="pubmed">22263208</ArticleId></ArticleIdList></Reference><Reference><Citation>Haut ER, Chang DC, Pierce CA, Colantuoni E, Efron DT, Haider AH, Cornwell EE 3rd, Pronovost PJ. Predictors of posttraumatic deep vein thrombosis (DVT): hospital practice versus patient factors - an analysis of the National Trauma Data Bank (NTDB) J Trauma. 2009;66:994&#x2013;1001. doi: 10.1097/TA.0b013e3181991adc.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/TA.0b013e3181991adc</ArticleId><ArticleId IdType="pubmed">19359905</ArticleId></ArticleIdList></Reference><Reference><Citation>Rogers MA, Levine DA, Blumberg N, Flanders SA, Chopra V, Langa KM. Triggers of hospitalization for venous thromboembolism. Circulation. 2012;2012:125.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3342773</ArticleId><ArticleId IdType="pubmed">22474264</ArticleId></ArticleIdList></Reference><Reference><Citation>Shibuya N, Frost CH, Campbell JD, Davis ML, Jupiter DC. Incidence of acute deep vein thrombosis and pulmonary embolism in foot and ankle trauma: analysis of the National Trauma Data Bank. J Foot Ankle Surg. 2012;51:63&#x2013;68. doi: 10.1053/j.jfas.2011.10.017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.jfas.2011.10.017</ArticleId><ArticleId IdType="pubmed">22196459</ArticleId></ArticleIdList></Reference><Reference><Citation>Knudson MM, Ikossi DG, Khaw L, Morabito D, Speetzen LS. Thromboembolism after trauma: an analysis of 1602 episodes from the American College of Surgeons National Trauma Data Bank. Ann Surg. 2004;240:490&#x2013;498. doi: 10.1097/01.sla.0000137138.40116.6c.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.sla.0000137138.40116.6c</ArticleId><ArticleId IdType="pmc">PMC1356439</ArticleId><ArticleId IdType="pubmed">15319720</ArticleId></ArticleIdList></Reference><Reference><Citation>Turkstra F, Kuijer PM, van Beek EJ, Brandjes DP, ten Cate JW, B&#xfc;ller HR. Diagnostic utility of ultrasonography of leg veins in patients suspected of having pulmonary embolism. Ann Intern Med. 1997;126:775&#x2013;781. doi: 10.7326/0003-4819-126-10-199705150-00005.</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/0003-4819-126-10-199705150-00005</ArticleId><ArticleId IdType="pubmed">9148650</ArticleId></ArticleIdList></Reference><Reference><Citation>Cipolle MD, Wojcik R, Seislove E, Wasser TE, Pasquale MD. The role of surveillance duplex scanning in preventing venous thromboembolism in trauma patients. J Trauma. 2002;52:453&#x2013;462. doi: 10.1097/00005373-200203000-00007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00005373-200203000-00007</ArticleId><ArticleId IdType="pubmed">11901319</ArticleId></ArticleIdList></Reference><Reference><Citation>Velmahos GC, Spaniolas K, Tabbara M, Abujudeh HH, de Moya M, Gervasini A, Alam HB. Pulmonary embolism and deep venous thrombosis in trauma: are they related? Arch Surg. 2009;144:928&#x2013;932. doi: 10.1001/archsurg.2009.97.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archsurg.2009.97</ArticleId><ArticleId IdType="pubmed">19841360</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">34584149</PMID><DateCompleted><Year>2021</Year><Month>12</Month><Day>27</Day></DateCompleted><DateRevised><Year>2021</Year><Month>12</Month><Day>27</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2045-2322</ISSN><JournalIssue CitedMedium="Internet"><Volume>11</Volume><Issue>1</Issue><PubDate><Year>2021</Year><Month>Sep</Month><Day>28</Day></PubDate></JournalIssue><Title>Scientific reports</Title><ISOAbbreviation>Sci Rep</ISOAbbreviation></Journal><ArticleTitle>A nested case-control study of risk for pulmonary embolism in the general trauma population using nationwide trauma registry data in Japan.</ArticleTitle><Pagination><StartPage>19192</StartPage><MedlinePgn>19192</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">19192</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41598-021-98692-4</ELocationID><Abstract><AbstractText>Post-trauma patients are at great risk of pulmonary embolism (PE), however, data assessing specific risk factors for post-traumatic PE are scarce. This was a nested case-control study using the Japan Trauma Data Bank between 2004 and 2017. We enrolled patients aged&#x2009;&#x2265;&#x2009;16&#xa0;years, Injury Severity Score&#x2009;&#x2265;&#x2009;9, and length of hospital stay&#x2009;&#x2265;&#x2009;2&#xa0;days, with PE and without PE, using propensity score matching. We conducted logistic regression analyses to examine risk factors for PE. We included 719 patients with PE and 3595 patients without PE. Of these patients, 1864 [43.2%] were male, and their median Interquartile Range (IQR) age was 73 [55-84] years. The major mechanism of injury was blunt (4282 [99.3%]). Median [IQR] Injury Severity Score (ISS) was 10 [9-18]. In the multivariate analysis, the variables spinal injury [odds ratio (OR), 1.40 (1.03-1.89)]; long bone open fracture in upper extremity and lower extremity [OR, 1.51 (1.06-2.15) and OR, 3.69 (2.89-4.71), respectively]; central vein catheter [OR, 2.17 (1.44-3.27)]; and any surgery [OR, 4.48 (3.46-5.81)] were independently associated with PE. Spinal injury, long bone open fracture in extremities, central vein catheter placement, and any surgery were risk factors for post-traumatic PE. Prompt initiation of prophylaxis is needed for patients with such trauma.</AbstractText><CopyrightInformation>&#xa9; 2021. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Iriyama</LastName><ForeName>Hiroki</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of General Medicine, Faculty of Medicine, Juntendo University, 2-1-2 Hongo, Bunkyo-ku, Tokyo, 113-8421, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Komori</LastName><ForeName>Akira</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of General Medicine, Faculty of Medicine, Juntendo University, 2-1-2 Hongo, Bunkyo-ku, Tokyo, 113-8421, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kainoh</LastName><ForeName>Takako</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of General Medicine, Faculty of Medicine, Juntendo University, 2-1-2 Hongo, Bunkyo-ku, Tokyo, 113-8421, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kondo</LastName><ForeName>Yutaka</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Emergency and Critical Care Medicine, Juntendo University Urayasu Hospital, 2-1-1 Tomioka, Urayasu, Chiba, 270-0021, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Naito</LastName><ForeName>Toshio</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of General Medicine, Faculty of Medicine, Juntendo University, 2-1-2 Hongo, Bunkyo-ku, Tokyo, 113-8421, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Abe</LastName><ForeName>Toshikazu</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Health Services Research, Faculty of Medicine, University of Tsukuba, 1-1-1 Tennodai, Tsukuba, Ibaraki, 305-8577, Japan. abetoshi111@gmail.com.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Health Services Research and Development Center, University of Tsukuba, 1-1-1 Tennodai, Tsukuba, Ibaraki, 305-8577, Japan. abetoshi111@gmail.com.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Emergency and Critical Care Medicine, Tsukuba Memorial Hospital, 1187-299 Kaname, Tsukuba, Ibaraki, 300-2622, Japan. abetoshi111@gmail.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>09</Month><Day>28</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Sci Rep</MedlineTA><NlmUniqueID>101563288</NlmUniqueID><ISSNLinking>2045-2322</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016022" MajorTopicYN="N">Case-Control Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002405" MajorTopicYN="N">Catheterization, Central Venous</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007564" MajorTopicYN="N" Type="Geographic">Japan</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007902" MajorTopicYN="N">Length of Stay</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057216" MajorTopicYN="N">Propensity Score</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011655" MajorTopicYN="N">Pulmonary Embolism</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012042" MajorTopicYN="N">Registries</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018570" MajorTopicYN="N">Risk Assessment</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013514" MajorTopicYN="N">Surgical Procedures, Operative</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015599" MajorTopicYN="N">Trauma Severity Indices</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014947" MajorTopicYN="N">Wounds and Injuries</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>4</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>9</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>9</Month><Day>29</Day><Hour>6</Hour><Minute>28</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>9</Month><Day>30</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>12</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2021</Year><Month>9</Month><Day>28</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34584149</ArticleId><ArticleId IdType="pmc">PMC8478977</ArticleId><ArticleId IdType="doi">10.1038/s41598-021-98692-4</ArticleId><ArticleId IdType="pii">10.1038/s41598-021-98692-4</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Knudson MM, Collins JA, Goodman SB, McCrory DW. Thromboembolism following multiple trauma. J. Trauma. 1992;32:2&#x2013;11. doi: 10.1097/00005373-199201000-00002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00005373-199201000-00002</ArticleId><ArticleId IdType="pubmed">1732568</ArticleId></ArticleIdList></Reference><Reference><Citation>Gudipati S, et al. A cohort study on the incidence and outcome of pulmonary embolism in trauma and orthopedic patients. BMC Med. 2014;12:39. doi: 10.1186/1741-7015-12-39.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1741-7015-12-39</ArticleId><ArticleId IdType="pmc">PMC3996019</ArticleId><ArticleId IdType="pubmed">24589368</ArticleId></ArticleIdList></Reference><Reference><Citation>Knudson MM, Ikossi DG, Khaw L, Morabito D, Speetzen LS. Thromboembolism after trauma: An analysis of 1602 episodes from the American College of Surgeons National Trauma Data Bank. Ann. Surg. 2004;240:490&#x2013;498. doi: 10.1097/01.sla.0000137138.40116.6c.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.sla.0000137138.40116.6c</ArticleId><ArticleId IdType="pmc">PMC1356439</ArticleId><ArticleId IdType="pubmed">15319720</ArticleId></ArticleIdList></Reference><Reference><Citation>Schultz DJ, et al. Incidence of asymptomatic pulmonary embolism in moderately to severely injured trauma patients. J. Trauma. 2004;56:727&#x2013;733. doi: 10.1097/01.TA.0000119687.23542.EC.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.TA.0000119687.23542.EC</ArticleId><ArticleId IdType="pubmed">15187734</ArticleId></ArticleIdList></Reference><Reference><Citation>Tuttle-Newhall JE, Rutledge R, Hultman CS, Fakhry SM. Statewide, population-based, time-series analysis of the frequency and outcome of pulmonary embolus in 318,554 trauma patients. J. Trauma. 1997;42:90&#x2013;99. doi: 10.1097/00005373-199701000-00016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00005373-199701000-00016</ArticleId><ArticleId IdType="pubmed">9003264</ArticleId></ArticleIdList></Reference><Reference><Citation>O'Malley KF, Ross SE. Pulmonary embolism in major trauma patients. J. Trauma. 1990;30:748&#x2013;750. doi: 10.1097/00005373-199006000-00018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00005373-199006000-00018</ArticleId><ArticleId IdType="pubmed">2352304</ArticleId></ArticleIdList></Reference><Reference><Citation>Netto FS, et al. Pulmonary emboli after blunt trauma: Timing, clinical characteristics and natural history. Injury. 2012;43:1502&#x2013;1506. doi: 10.1016/j.injury.2010.12.028.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.injury.2010.12.028</ArticleId><ArticleId IdType="pubmed">21722897</ArticleId></ArticleIdList></Reference><Reference><Citation>Rogers FB, et al. Determining venous thromboembolic risk assessment for patients with trauma: The trauma embolic scoring system. J. Trauma Acute Care Surg. 2012;73:511&#x2013;515. doi: 10.1097/TA.0b013e3182588b54.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/TA.0b013e3182588b54</ArticleId><ArticleId IdType="pubmed">23019680</ArticleId></ArticleIdList></Reference><Reference><Citation>Jeremitsky E, Germain NS, Kao AH, Ong AW, Smith RS. Risk of pulmonary embolism in trauma patients: Not all created equal. Surgery. 2013;154:810&#x2013;815. doi: 10.1016/j.surg.2013.04.045.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.surg.2013.04.045</ArticleId><ArticleId IdType="pubmed">24074419</ArticleId></ArticleIdList></Reference><Reference><Citation>Meizoso JP, et al. A simplified stratification system for venous thromboembolism risk in severely injured trauma patients. J. Surg. Res. 2017;207:138&#x2013;144. doi: 10.1016/j.jss.2016.08.072.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jss.2016.08.072</ArticleId><ArticleId IdType="pubmed">27979470</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoyt DB, et al. A risk analysis of pulmonary complications following major trauma. J. Trauma. 1993;35:524&#x2013;531. doi: 10.1097/00005373-199310000-00005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00005373-199310000-00005</ArticleId><ArticleId IdType="pubmed">8411274</ArticleId></ArticleIdList></Reference><Reference><Citation>Azu MC, McCormack JE, Huang EC, Lee TK, Shapiro MJ. Venous thromboembolic events in hospitalized trauma patients. Am. Surg. 2007;73:1228&#x2013;1231. doi: 10.1177/000313480707301206.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/000313480707301206</ArticleId><ArticleId IdType="pubmed">18186377</ArticleId></ArticleIdList></Reference><Reference><Citation>Paffrath T, et al. Venous thromboembolism after severe trauma: Incidence, risk factors and outcome. Injury. 2010;41:97&#x2013;101. doi: 10.1016/j.injury.2009.06.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.injury.2009.06.010</ArticleId><ArticleId IdType="pubmed">19608183</ArticleId></ArticleIdList></Reference><Reference><Citation>Lichte P, et al. Post-traumatic thrombo-embolic complications in polytrauma patients. Int. Orthop. 2015;39:947&#x2013;954. doi: 10.1007/s00264-015-2698-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00264-015-2698-6</ArticleId><ArticleId IdType="pubmed">25690923</ArticleId></ArticleIdList></Reference><Reference><Citation>Brakenridge SC, et al. Comparing clinical predictors of deep venous thrombosis versus pulmonary embolus after severe injury: A new paradigm for posttraumatic venous thromboembolism? J. Trauma Acute Care Surg. 2013;74:1231&#x2013;1238.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3716365</ArticleId><ArticleId IdType="pubmed">23609272</ArticleId></ArticleIdList></Reference><Reference><Citation>Benns M, Reilly P, Kim P. Early pulmonary embolism after injury: A different clinical entity? Injury. 2014;45:241&#x2013;244. doi: 10.1016/j.injury.2013.02.026.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.injury.2013.02.026</ArticleId><ArticleId IdType="pubmed">23518042</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim KS, Brophy GM. Symptomatic venous thromboembolism: Incidence and risk factors in patients with spontaneous or traumatic intracranial hemorrhage. Neurocrit. Care. 2009;11:28&#x2013;33. doi: 10.1007/s12028-009-9201-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12028-009-9201-4</ArticleId><ArticleId IdType="pubmed">19238588</ArticleId></ArticleIdList></Reference><Reference><Citation>Abe T, et al. Trauma complications and in-hospital mortality: Failure-to-rescue. Crit. Care. 2020;24:223. doi: 10.1186/s13054-020-02951-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13054-020-02951-1</ArticleId><ArticleId IdType="pmc">PMC7226721</ArticleId><ArticleId IdType="pubmed">32414401</ArticleId></ArticleIdList></Reference><Reference><Citation>Schultz, D. J. et al. Incidence of asymptomatic pulmonary embolism in moderately to severely injured trauma patients. J. Trauma56, 727&#x2013;731; discussion 731&#x2013;723 (2004).</Citation><ArticleIdList><ArticleId IdType="pubmed">15187734</ArticleId></ArticleIdList></Reference><Reference><Citation>Selby R, et al. Hypercoagulability after trauma: Hemostatic changes and relationship to venous thromboembolism. Thromb. Res. 2009;124:281&#x2013;287. doi: 10.1016/j.thromres.2008.10.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.thromres.2008.10.002</ArticleId><ArticleId IdType="pubmed">19041119</ArticleId></ArticleIdList></Reference><Reference><Citation>Barrera, L. M. et al. Thromboprophylaxis for trauma patients. Cochrane Database Syst. Rev. CD008303 (2013).</Citation><ArticleIdList><ArticleId IdType="pubmed">23543562</ArticleId></ArticleIdList></Reference><Reference><Citation>Knudson MM, Gomez D, Haas B, Cohen MJ, Nathens AB. Three thousand seven hundred thirty-eight posttraumatic pulmonary emboli: A new look at an old disease. Ann. Surg. 2011;254:625&#x2013;632. doi: 10.1097/SLA.0b013e3182300209.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/SLA.0b013e3182300209</ArticleId><ArticleId IdType="pubmed">21869675</ArticleId></ArticleIdList></Reference><Reference><Citation>Geerts WH, Code KI, Jay RM, Chen E, Szalai JP. A prospective study of venous thromboembolism after major trauma. N. Engl. J. Med. 1994;331:1601&#x2013;1606. doi: 10.1056/NEJM199412153312401.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJM199412153312401</ArticleId><ArticleId IdType="pubmed">7969340</ArticleId></ArticleIdList></Reference><Reference><Citation>Vallier HA, Cureton BA, Ekstein C, Oldenburg FP, Wilber JH. Early definitive stabilization of unstable pelvis and acetabulum fractures reduces morbidity. J. Trauma. 2010;69:677&#x2013;684.</Citation><ArticleIdList><ArticleId IdType="pubmed">20838139</ArticleId></ArticleIdList></Reference><Reference><Citation>Haas B, Gomez D, Hemmila MR, Nathens AB. Prevention of complications and successful rescue of patients with serious complications: Characteristics of high-performing trauma centers. J. Trauma. 2011;70:575&#x2013;582.</Citation><ArticleIdList><ArticleId IdType="pubmed">21610345</ArticleId></ArticleIdList></Reference><Reference><Citation>R Core Team. R: A Language and Environment for Statistical Computing. https://www.R-project.org (2019).</Citation></Reference><Reference><Citation>Blann AD. How a damaged blood vessel wall contibutes to thrombosis and hypertension. Pathophysiol. Haemost. Thromb. 2003;33:445&#x2013;448. doi: 10.1159/000083843.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000083843</ArticleId><ArticleId IdType="pubmed">15692258</ArticleId></ArticleIdList></Reference><Reference><Citation>Johansson PI, Stensballe J, Rasmussen LS, Ostrowski SR. A high admission syndecan-1 level, a marker of endothelial glycocalyx degradation, is associated with inflammation, protein C depletion, fibrinolysis, and increased mortality in trauma patients. Ann. Surg. 2011;254:194&#x2013;200. doi: 10.1097/SLA.0b013e318226113d.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/SLA.0b013e318226113d</ArticleId><ArticleId IdType="pubmed">21772125</ArticleId></ArticleIdList></Reference><Reference><Citation>Engelman DT, Gabram SG, Allen L, Ens GE, Jacobs LM. Hypercoagulability following multiple trauma. World J. Surg. 1996;20:5&#x2013;10. doi: 10.1007/s002689900001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s002689900001</ArticleId><ArticleId IdType="pubmed">8588412</ArticleId></ArticleIdList></Reference><Reference><Citation>Lowe GDO. Virchow&#x2019;s triad revisited: Abnormal flow. Pathophysiol. Haemost. Thromb. 2003;33:455&#x2013;457. doi: 10.1159/000083845.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000083845</ArticleId><ArticleId IdType="pubmed">15692260</ArticleId></ArticleIdList></Reference><Reference><Citation>Fujii Y, et al. Thrombosis in spinal cord injury. Thromb. Res. 1992;68:357&#x2013;368. doi: 10.1016/0049-3848(92)90094-Q.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0049-3848(92)90094-Q</ArticleId><ArticleId IdType="pubmed">1290164</ArticleId></ArticleIdList></Reference><Reference><Citation>Aito S, Pieri A, D'Andrea M, Marcelli F, Cominelli E. Primary prevention of deep venous thrombosis and pulmonary embolism in acute spinal cord injured patients. Spinal Cord. 2002;40:300&#x2013;303. doi: 10.1038/sj.sc.3101298.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/sj.sc.3101298</ArticleId><ArticleId IdType="pubmed">12037712</ArticleId></ArticleIdList></Reference><Reference><Citation>Merli GJ, Crabbe S, Paluzzi RG, Fritz D. Etiology, incidence, and prevention of deep vein thrombosis in acute spinal cord injury. Arch. Phys. Med. Rehabil. 1993;74:1199&#x2013;1205.</Citation><ArticleIdList><ArticleId IdType="pubmed">8239962</ArticleId></ArticleIdList></Reference><Reference><Citation>Bahl V, et al. A validation study of a retrospective venous thromboembolism risk scoring method. Ann. Surg. 2010;251:344&#x2013;350. doi: 10.1097/SLA.0b013e3181b7fca6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/SLA.0b013e3181b7fca6</ArticleId><ArticleId IdType="pubmed">19779324</ArticleId></ArticleIdList></Reference><Reference><Citation>Levy MM, Albuquerque F, Pfeifer JD. Low incidence of pulmonary embolism associated with upper-extremity deep venous thrombosis. Ann. Vasc. Surg. 2012;26:964&#x2013;972. doi: 10.1016/j.avsg.2011.12.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.avsg.2011.12.016</ArticleId><ArticleId IdType="pubmed">22749742</ArticleId></ArticleIdList></Reference><Reference><Citation>Brakenridge SC, Toomay SM, Sheng JL, Gentilello LM, Shafi S. Predictors of early versus late timing of pulmonary embolus after traumatic injury. Am. J. Surg. 2011;201:209&#x2013;215. doi: 10.1016/j.amjsurg.2009.12.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amjsurg.2009.12.005</ArticleId><ArticleId IdType="pmc">PMC5575912</ArticleId><ArticleId IdType="pubmed">20385370</ArticleId></ArticleIdList></Reference><Reference><Citation>Coleman JJ, et al. Factors associated with pulmonary embolism within 72 hours of admission after trauma: A multicenter study. J. Am. Coll. Surg. 2015;220:731&#x2013;736. doi: 10.1016/j.jamcollsurg.2014.12.032.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jamcollsurg.2014.12.032</ArticleId><ArticleId IdType="pubmed">25724603</ArticleId></ArticleIdList></Reference><Reference><Citation>Gambhir S, et al. Early versus late pulmonary embolism in trauma patients: Not all pulmonary embolisms are created similarly. J. Surg. Res. 2019;239:174&#x2013;179. doi: 10.1016/j.jss.2019.02.018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jss.2019.02.018</ArticleId><ArticleId IdType="pubmed">30836300</ArticleId></ArticleIdList></Reference><Reference><Citation>Brundage SI, McGhan R, Jurkovich GJ, Mack CD, Maier RV. Timing of femur fracture fixation: Effect on outcome in patients with thoracic and head injuries. J. Trauma. 2002;52:299&#x2013;307.</Citation><ArticleIdList><ArticleId IdType="pubmed">11834992</ArticleId></ArticleIdList></Reference><Reference><Citation>Nahm NJ, Como JJ, Wilber JH, Vallier HA. Early appropriate care: Definitive stabilization of femoral fractures within 24 hours of injury is safe in most patients with multiple injuries. J. Trauma. 2011;71:175&#x2013;185.</Citation><ArticleIdList><ArticleId IdType="pubmed">21336198</ArticleId></ArticleIdList></Reference><Reference><Citation>Harvin JA, et al. Early femur fracture fixation is associated with a reduction in pulmonary complications and hospital charges: A decade of experience with 1,376 diaphyseal femur fractures. J. Trauma Acute Care Surg. 2012;73:1442&#x2013;1449. doi: 10.1097/TA.0b013e3182782696.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/TA.0b013e3182782696</ArticleId><ArticleId IdType="pubmed">23188236</ArticleId></ArticleIdList></Reference><Reference><Citation>Byrne JP, Nathens AB, Gomez D, Pincus D, Jenkinson RJ. Timing of femoral shaft fracture fixation following major trauma: A retrospective cohort study of United States trauma centers. PLoS Med. 2017;14:e1002336. doi: 10.1371/journal.pmed.1002336.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pmed.1002336</ArticleId><ArticleId IdType="pmc">PMC5497944</ArticleId><ArticleId IdType="pubmed">28678793</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuroiwa M, et al. Changes in the incidence, case fatality rate, and characteristics of symptomatic perioperative pulmonary thromboembolism in Japan: Results of the 2002&#x2013;2011 Japanese Society of Anesthesiologists Perioperative Pulmonary Thromboembolism (JSA-PTE) study. J. Anesth. 2015;29:433&#x2013;441. doi: 10.1007/s00540-014-1939-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00540-014-1939-y</ArticleId><ArticleId IdType="pubmed">25412800</ArticleId></ArticleIdList></Reference><Reference><Citation>Gangireddy, C. et al. Risk factors and clinical impact of postoperative symptomatic venous thromboembolism. J. Vasc. Surg.45, 335&#x2013;341; discussion 341&#x2013;332 (2007).</Citation><ArticleIdList><ArticleId IdType="pubmed">17264013</ArticleId></ArticleIdList></Reference><Reference><Citation>Organisation for Economic Co-operation and Development. Computed Tomography (CT) Scanners (Indicator). https://data.oecd.org/healtheqt/computed-tomography-ct-scanners.htm#indicator-chart (2021).</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">35187962</PMID><DateCompleted><Year>2022</Year><Month>03</Month><Day>24</Day></DateCompleted><DateRevised><Year>2022</Year><Month>05</Month><Day>01</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1938-2723</ISSN><JournalIssue CitedMedium="Internet"><Volume>28</Volume><PubDate><Year>2022</Year><Season>Jan-Dec</Season></PubDate></JournalIssue><Title>Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis</Title><ISOAbbreviation>Clin Appl Thromb Hemost</ISOAbbreviation></Journal><ArticleTitle>The Predictor Potential Role of the Glucose to Potassium Ratio in the Diagnostic Differentiation of Massive and Non-Massive Pulmonary Embolism.</ArticleTitle><Pagination><StartPage>10760296221076146</StartPage><MedlinePgn>10760296221076146</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">10760296221076146</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1177/10760296221076146</ELocationID><Abstract><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">Acute pulmonary embolism (PE) is one of the main causes of death and has a course as massive (MPE) or non-massive (NMPE). The study investigates the indicator potential of Glucose to Potassium ratio (GPR) in the differential diagnosis of MPE and NMPE.</AbstractText><AbstractText Label="MATERIALS AND METHODS" NlmCategory="METHODS">The study was designed as a retrospective cross-sectional clinical cohort in patients with PE. A total of 111 participants enrolled in the research separating two groups: MPE (n:54) and NMPE (n:67). The GPR was calculated by dividing serum glucose by potassium levels and its results were compared with D-Dimer, Pulmonary Artery Pressure (PAP), and C-Reactive Protein Test (CRP).</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">D-Dimer was measured as 6.5&#x2009;&#xb1;&#x2009;5.7&#x2005;&#xb5;g/L in the MPE and found higher than the NMPE (3.9&#x2009;&#xb1;&#x2009;5.2&#x2005;&#xb5;g/L) (<i>P</i>&#x2009;=&#x2009;.019). CRP (100&#x2009;&#xb1;&#x2009;83.5 to 30.9&#x2009;&#xb1;&#x2009;42.7&#x2005;mg/L; <i>P</i>&#x2009;=&#x2009;.0001) and PAP (49.5&#x2009;&#xb1;&#x2009;11.9 to 34.8&#x2009;&#xb1;&#x2009;7.3&#x2005;mmHg; <i>P</i>&#x2009;=&#x2009;.0001) were found increased in the MPE. GPR strongly increased in the MPE (30.7&#x2009;&#xb1;&#x2009;7.5 to 24.9&#x2009;&#xb1;&#x2009;4.3; <i>P</i>&#x2009;=&#x2009;.0003) in line with CRP, D-Dimer and PAP. GPR showed a stronger diagnostic value (AUC: 0.733; <i>P</i>&#x2009;=&#x2009;.00001; Sensitivity:72%; Spesifity:70%; Cut-off: 26.5). PAP and GPR showed significant efficiency on occurrence of the MPE according to the binary logistic regression.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">The GPR, as a novel and cheap marker, can be useful for diagnostic differentiation of MPE from NMPE, but weaker than PAP and better than D-dimer.</AbstractText><AbstractText Label="TYPE OF STUDY AND LEVEL OF EVIDENCE" NlmCategory="METHODS">Level-II, Retrospective clinical cohort study.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Boyuk</LastName><ForeName>Ferit</ForeName><Initials>F</Initials><Identifier Source="ORCID">0000-0003-2313-1495</Identifier><AffiliationInfo><Affiliation>147022Department of Cardiology, Yedikule Chest Disease and Thoracic Surgery Training and Research Hospital, Istanbul, Turkey.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Clin Appl Thromb Hemost</MedlineTA><NlmUniqueID>9508125</NlmUniqueID><ISSNLinking>1076-0296</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015415">Biomarkers</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D001786">Blood Glucose</NameOfSubstance></Chemical><Chemical><RegistryNumber>RWP5GA015D</RegistryNumber><NameOfSubstance UI="D011188">Potassium</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015415" MajorTopicYN="N">Biomarkers</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001786" MajorTopicYN="Y">Blood Glucose</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003430" MajorTopicYN="N">Cross-Sectional Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011188" MajorTopicYN="N">Potassium</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011655" MajorTopicYN="N">Pulmonary Embolism</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">D-dimer</Keyword><Keyword MajorTopicYN="N">glucose to potassium ratio</Keyword><Keyword MajorTopicYN="N">massive pulmonary embolism</Keyword><Keyword MajorTopicYN="N">non-massive pulmonary embolism</Keyword></KeywordList><CoiStatement><b>Declaration of Conflicting Interests:</b> The author(s) declared no potential conflicts of interest with respect to the
research, authorship, and/or publication of this article.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>2</Month><Day>21</Day><Hour>8</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>2</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>3</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>2</Month><Day>21</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35187962</ArticleId><ArticleId IdType="pmc">PMC8864281</ArticleId><ArticleId IdType="doi">10.1177/10760296221076146</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Alotaibi GS, Wu C, Senthilselvan A, McMurtry MS. Secular trends in incidence and mortality of acute venous thromboembolism: the AB-VTE population-based study. Am J Med. 2016;129(8):879. e19&#x2010;e25.</Citation><ArticleIdList><ArticleId IdType="pubmed">26925811</ArticleId></ArticleIdList></Reference><Reference><Citation>Beckman MG, Hooper WC, Critchley SE, Ortel TL. Venous thromboembolism: a public health concern. Am J Prev Med. 2010;38(4):S495&#x2010;S501.</Citation><ArticleIdList><ArticleId IdType="pubmed">20331949</ArticleId></ArticleIdList></Reference><Reference><Citation>Heit JA, Silverstein MD, Mohr DN, et al. The epidemiology of venous thromboembolism in the community. Thromb Haemostasis. 2001;86(7):452&#x2010;463.</Citation><ArticleIdList><ArticleId IdType="pubmed">11487036</ArticleId></ArticleIdList></Reference><Reference><Citation>Ageno W, Agnelli G, Imberti D, et al. Risk factors for venous thromboembolism in the elderly: results of the master registry. Blood Coagul Fibrinolysis. 2008;19(7):663&#x2010;667.</Citation><ArticleIdList><ArticleId IdType="pubmed">18832907</ArticleId></ArticleIdList></Reference><Reference><Citation>Farrokhi F, Smiley D, Umpierrez GE. Glycemic control in non-diabetic critically ill patients. Best Pract Res Clin Endocrinol Metab. 2011;25(5):813&#x2010;824.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3718463</ArticleId><ArticleId IdType="pubmed">21925080</ArticleId></ArticleIdList></Reference><Reference><Citation>Marik PE, Bellomo R. Stress hyperglycemia: an essential survival response!. Crit Care. 2013;17(2):1&#x2010;7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3672537</ArticleId><ArticleId IdType="pubmed">23470218</ArticleId></ArticleIdList></Reference><Reference><Citation>Matano F, Fujiki Y, Mizunari T, et al. Serum glucose and potassium ratio as risk factors for cerebral vasospasm after aneurysmal subarachnoid hemorrhage. J Stroke Cerebrovasc Dis. 2019;28(7):1951&#x2010;1957.</Citation><ArticleIdList><ArticleId IdType="pubmed">31060790</ArticleId></ArticleIdList></Reference><Reference><Citation>Omar HR, Mirsaeidi M, Rashad R, et al. Association of serum albumin and severity of pulmonary embolism. Medicina (B Aires). 2020;56(1):26.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7023373</ArticleId><ArticleId IdType="pubmed">31936687</ArticleId></ArticleIdList></Reference><Reference><Citation>Phan T, Brailovsky Y, Fareed J, Hoppensteadt D, Iqbal O, Darki A. Neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios predict all-cause mortality in acute pulmonary embolism. Clin Appl Thromb Hemost. 2020;26(3):1076029619900549.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7098206</ArticleId><ArticleId IdType="pubmed">31960711</ArticleId></ArticleIdList></Reference><Reference><Citation>Altabas V, Pukec L, Mlinari&#x107; S, Pintari&#x107; H, &#x160;iki&#x107; A. Stress hyperglycaemia indicates embolus size and localization in patients with acute pulmonary embolism. Int J Endocrinol. 2020;20(4):3606757.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7366194</ArticleId><ArticleId IdType="pubmed">32724305</ArticleId></ArticleIdList></Reference><Reference><Citation>Konstantinides SV, Meyer G, Becattini C, et al.. 2019 ESC guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European respiratory society (ERS) The task force for the diagnosis and management of acute pulmonary embolism of the European society of cardiology (ESC). Eur Heart J. 2020;41(4):543&#x2010;603.</Citation><ArticleIdList><ArticleId IdType="pubmed">31504429</ArticleId></ArticleIdList></Reference><Reference><Citation>Malmberg K, Ryd&#xe9;n L, Efendic S, et al. Randomized trial of insulin-glucose infusion followed by subcutaneous insulin treatment in diabetic patients with acute myocardial infarction (DIGAMI study): effects on mortality at 1 year. J Am Coll Cardiol. 1995;26(1):57&#x2010;65.</Citation><ArticleIdList><ArticleId IdType="pubmed">7797776</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee JH, Huh JW, Hong S-B, et al. Prognostic value of blood biomarkers in patients with unprovoked acute pulmonary embolism. Ann Thorac Med. 2019;14(4):248.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6784442</ArticleId><ArticleId IdType="pubmed">31620208</ArticleId></ArticleIdList></Reference><Reference><Citation>Melek FE, Baroncini LAV, Repka JCD, Nascimento CS, Pr&#xe9;coma DB. Oxidative stress and inflammatory response increase during coronary artery bypass grafting with extracorporeal circulation. Braz J Cardiovasc Surg. 2012;27(1):61&#x2010;65.</Citation><ArticleIdList><ArticleId IdType="pubmed">22729302</ArticleId></ArticleIdList></Reference><Reference><Citation>Sadiq SMM, Dakhil MA, Dakhil ZA. (ed). Effect of diabetes on laboratory markers in patients with non-ST elevation acute coronary syndromes. J Phys Conf Ser. 2021.</Citation></Reference><Reference><Citation>Wu X-Y, Zhuang Y-K, Cai Y, et al. Serum glucose and potassium ratio as a predictive factor for prognosis of acute intracerebral hemorrhage. J Int Med Res. 2021;49(4):030006052110096.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8108090</ArticleId><ArticleId IdType="pubmed">33906531</ArticleId></ArticleIdList></Reference><Reference><Citation>Fujiki Y, Matano F, Mizunari T, et al. Serum glucose/potassium ratio as a clinical risk factor for aneurysmal subarachnoid hemorrhage. J Neurosurg. 2018;129(4):870&#x2010;875.</Citation><ArticleIdList><ArticleId IdType="pubmed">29148905</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">25456730</PMID><DateCompleted><Year>2015</Year><Month>11</Month><Day>17</Day></DateCompleted><DateRevised><Year>2017</Year><Month>11</Month><Day>16</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1879-2472</ISSN><JournalIssue CitedMedium="Internet"><Volume>135</Volume><Issue>1</Issue><PubDate><Year>2015</Year><Month>Jan</Month></PubDate></JournalIssue><Title>Thrombosis research</Title><ISOAbbreviation>Thromb Res</ISOAbbreviation></Journal><ArticleTitle>Prognostic role of heart-type fatty acid binding protein in pulmonary embolism: a meta-analysis.</ArticleTitle><Pagination><StartPage>20</StartPage><EndPage>25</EndPage><MedlinePgn>20-5</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.thromres.2014.10.007</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0049-3848(14)00531-3</ELocationID><Abstract><AbstractText Label="INTRODUCTION" NlmCategory="BACKGROUND">Pulmonary embolism (PE) has a high morbidity and mortality. Hence it is important to recognize factors associated with higher risk of adverse outcomes in hemodynamically stable patients. Heart-type fatty acid binding protein (H-FABP) is a novel marker evaluated in recent years for prognosis in acute PE. Our aim was to evaluate the available evidence on the accuracy of H-FABP for predicting the prognosis of adverse clinical outcomes (defined as the occurrence of any of the following: death, cardiopulmonary resuscitation, endotracheal intubation, use of vasopressors, thrombolysis, surgical embolectomy, or admission to the intensive care unit) or mortality in patients with acute PE.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Unrestricted searches of PubMed, the Cochrane Library, Web of Science and Science Direct were performed using the terms of "H-FABP" or "heart-type fatty acid binding protein" and ("pulmonary embolism" or "pulmonary thromboembolism"). A random-effect model was used to pool study results; &#x3c7;(2) and I(2) testing was used to test for heterogeneity. Data of six studies were included in this analysis.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">34 of 119(28.57%; 95%CI, 20.42%-36.72%) patients with elevated H-FABP levels had adverse events during follow-up compared with 24 of 475 (5.05%; 95%CI, 3.08%-7.02%) patients with normal levels. High H-FABP levels were associated with a high risk of occurrence of adverse clinical outcome (pooled OR, 10.81; 95%CI, 3.92-29.83).</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">The results of this meta-analysis indicate that H-FABP is a good predictor for adverse outcomes in patients with acute PE.</AbstractText><CopyrightInformation>Copyright &#xa9; 2014 Elsevier Ltd. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Mingjie</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Respiratory Medicine, Shandong Provincial Hospital affiliated to Shandong University, Jinan 250021, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yuan</LastName><ForeName>Xia</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, Yankuang Group General Hospital, Jining 272000, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Qiu</LastName><ForeName>Xianming</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Intensive Care Unit, Zhongda Hospital Southeast University, Nanjing 210000, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shan</LastName><ForeName>Xiaoxi</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Respiratory, Yuhuangding Hospital, Yantai 264000, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lin</LastName><ForeName>Dianjie</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Respiratory Medicine, Shandong Provincial Hospital affiliated to Shandong University, Jinan 250021, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhu</LastName><ForeName>Ling</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Respiratory Medicine, Shandong Provincial Hospital affiliated to Shandong University, Jinan 250021, China. Electronic address: llqysys1114@163.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2014</Year><Month>10</Month><Day>14</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Thromb Res</MedlineTA><NlmUniqueID>0326377</NlmUniqueID><ISSNLinking>0049-3848</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015415">Biomarkers</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C493408">FABP3 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000074026">Fatty Acid Binding Protein 3</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D050556">Fatty Acid-Binding Proteins</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000465" MajorTopicYN="N">Algorithms</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015415" MajorTopicYN="N">Biomarkers</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000074026" MajorTopicYN="N">Fatty Acid Binding Protein 3</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D050556" MajorTopicYN="N">Fatty Acid-Binding Proteins</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006321" MajorTopicYN="N">Heart</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009206" MajorTopicYN="N">Myocardium</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011237" MajorTopicYN="N">Predictive Value of Tests</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011379" MajorTopicYN="N">Prognosis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011655" MajorTopicYN="N">Pulmonary Embolism</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Adverse clinical outcome</Keyword><Keyword MajorTopicYN="N">Heart-type fatty acid binding protein</Keyword><Keyword MajorTopicYN="N">Pulmonary embolism</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2014</Year><Month>7</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2014</Year><Month>9</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2014</Year><Month>10</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2014</Year><Month>12</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2014</Year><Month>12</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2015</Year><Month>11</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">25456730</ArticleId><ArticleId IdType="doi">10.1016/j.thromres.2014.10.007</ArticleId><ArticleId IdType="pii">S0049-3848(14)00531-3</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">31690519</PMID><DateCompleted><Year>2020</Year><Month>06</Month><Day>22</Day></DateCompleted><DateRevised><Year>2020</Year><Month>06</Month><Day>22</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1875-2128</ISSN><JournalIssue CitedMedium="Internet"><Volume>113</Volume><Issue>1</Issue><PubDate><Year>2020</Year><Month>Jan</Month></PubDate></JournalIssue><Title>Archives of cardiovascular diseases</Title><ISOAbbreviation>Arch Cardiovasc Dis</ISOAbbreviation></Journal><ArticleTitle>Clinical patterns and significance of non-compliance with guideline-recommended treatment of acute pulmonary embolism.</ArticleTitle><Pagination><StartPage>31</StartPage><EndPage>39</EndPage><MedlinePgn>31-39</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.acvd.2019.09.009</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S1875-2136(19)30176-7</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Evidence-based clinical practice guidelines define initial management of acute pulmonary embolism (PE) according to risk stratification for early death.</AbstractText><AbstractText Label="AIMS" NlmCategory="OBJECTIVE">The aims of the present study were to investigate patterns of non-compliance with guidelines for the acute PE treatment, and the associated risk of adverse events.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">We performed an observational, multicentre, cohort study of acute PE. Inclusion criteria were all patients with pulmonary embolism admitted to the participating centres between January 2011 and April 2017. The measure of 100% compliance was used to allocate patients in the compliant or non-compliant groups. The primary outcome was all-cause death at 6 months. Secondary outcomes included recurrent venous thromboembolism and major bleeding.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">In total, 1285&#xa0;patients were included. Treatment was not in compliance with the guidelines in 172 patients (13.4%). Four factors were identified to be related to non-compliance with the guidelines: shock or hypotension (relative risk [RR] 5.23, 95% confidence interval [CI] 2.64-10.30; P&lt;0.001), renal insufficiency (RR 1.80, 95% CI 1.41-2.28; P&lt;0.001), active cancer (RR 1.35, 95% CI 1.24-1.48; P&lt;0.001) and right ventricular dysfunction at admission (RR 1.06, 95% CI 1.01-1.11; P=0.01). The primary endpoint of all-cause death at 6&#xa0;months occurred in 62 of 172 patients (36.0%) in the non-compliant group and in 131 of 1113 patients (11.8%) in the compliant group (hazard ratio 2.02, 95% CI 1.45-2.81; P&lt;0.001). The rates of recurrent venous thromboembolism (8.7% vs 1.1%; P&lt;0.001) and major bleeding (13.4% vs 4.9%, P=0.04) from admission to 6-month follow-up were higher in the non-compliant group.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Non-compliance with guidelines was independently associated with worse outcomes, including death, recurrent venous thromboembolism and bleeding.</AbstractText><CopyrightInformation>Copyright &#xa9; 2019 Elsevier Masson SAS. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Cart</LastName><ForeName>Lisbeth</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of cardiology, EA3920, university hospital Besan&#xe7;on, boulevard Fleming, 25030 Besan&#xe7;on, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Serzian</LastName><ForeName>Guillaume</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of cardiology, EA3920, university hospital Besan&#xe7;on, boulevard Fleming, 25030 Besan&#xe7;on, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Humbert</LastName><ForeName>S&#xe9;bastien</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of internal medicine, hospital Besan&#xe7;on, boulevard Fleming, 25030 Besan&#xe7;on, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Falvo</LastName><ForeName>Nicolas</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of internal medicine, university hospital, 2, boulevard du Mar&#xe9;chal-de-Lattre-de-Tassigny, 21000 Dijon, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Morel-Aleton</LastName><ForeName>Mathilde</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of cardiology, general hospital, 2, faubourg Saint-&#xc9;tienne, 25300 Pontarlier, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bonnet</LastName><ForeName>Benjamin</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of cardiology, general hospital of Vesoul, 2, avenue Ren&#xe9;-Heymes, 70000 Vesoul, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Napporn</LastName><ForeName>Gabriel</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of cardiology, hospital center Louis-Pasteur, 73, avenue L&#xe9;on-Jouhaux, 39100 Dole, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kalbacher</LastName><ForeName>Elsa</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Medical oncology unit, university hospital Besan&#xe7;on, boulevard Fleming, 25030 Besan&#xe7;on, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Obert</LastName><ForeName>Laurent</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Orthopedic, trauma, plastic, reconstructive and hand surgery department, university hospital Besan&#xe7;on, boulevard Fleming, 25030 Besan&#xe7;on, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cappelier</LastName><ForeName>Gilles</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Medical intensive care unit, EA3920, university hospital Besan&#xe7;on, boulevard Fleming, 25030 Besan&#xe7;on, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cottin</LastName><ForeName>Yves</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of cardiology, university hospital, 2, boulevard du Mar&#xe9;chal-de-Lattre-de-Tassigny, 21000 Dijon, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schiele</LastName><ForeName>Fran&#xe7;ois</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of cardiology, EA3920, university hospital Besan&#xe7;on, boulevard Fleming, 25030 Besan&#xe7;on, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Meneveau</LastName><ForeName>Nicolas</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of cardiology, EA3920, university hospital Besan&#xe7;on, boulevard Fleming, 25030 Besan&#xe7;on, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chopard</LastName><ForeName>Romain</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of cardiology, EA3920, university hospital Besan&#xe7;on, boulevard Fleming, 25030 Besan&#xe7;on, France. Electronic address: chopardromain@yahoo.fr.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016448">Multicenter Study</PublicationType><PublicationType UI="D064888">Observational Study</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2019</Year><Month>11</Month><Day>02</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Arch Cardiovasc Dis</MedlineTA><NlmUniqueID>101465655</NlmUniqueID><ISSNLinking>1875-2128</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000208" MajorTopicYN="N">Acute Disease</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000066491" MajorTopicYN="N">Clinical Decision-Making</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015897" MajorTopicYN="N">Comorbidity</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005602" MajorTopicYN="N" Type="Geographic">France</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019983" MajorTopicYN="N">Guideline Adherence</DescriptorName><QualifierName UI="Q000639" MajorTopicYN="Y">trends</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017410" MajorTopicYN="Y">Practice Guidelines as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010818" MajorTopicYN="N">Practice Patterns, Physicians'</DescriptorName><QualifierName UI="Q000639" MajorTopicYN="Y">trends</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011655" MajorTopicYN="N">Pulmonary Embolism</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012042" MajorTopicYN="N">Registries</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013997" MajorTopicYN="N">Time Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Compliance</Keyword><Keyword MajorTopicYN="N">Compliance with guidelines</Keyword><Keyword MajorTopicYN="N">Embolie pulmonaire</Keyword><Keyword MajorTopicYN="N">Guidelines</Keyword><Keyword MajorTopicYN="N">Outcomes</Keyword><Keyword MajorTopicYN="N">Pulmonary embolism</Keyword><Keyword MajorTopicYN="N">Recommandations</Keyword><Keyword MajorTopicYN="N">&#xc9;volution clinique</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2019</Year><Month>5</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2019</Year><Month>9</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2019</Year><Month>9</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>11</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>6</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>11</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31690519</ArticleId><ArticleId IdType="doi">10.1016/j.acvd.2019.09.009</ArticleId><ArticleId IdType="pii">S1875-2136(19)30176-7</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">32343741</PMID><DateCompleted><Year>2020</Year><Month>07</Month><Day>27</Day></DateCompleted><DateRevised><Year>2025</Year><Month>03</Month><Day>20</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1932-6203</ISSN><JournalIssue CitedMedium="Internet"><Volume>15</Volume><Issue>4</Issue><PubDate><Year>2020</Year></PubDate></JournalIssue><Title>PloS one</Title><ISOAbbreviation>PLoS One</ISOAbbreviation></Journal><ArticleTitle>Quality of initial anticoagulant treatment and risk of CTEPH after acute pulmonary embolism.</ArticleTitle><Pagination><StartPage>e0232354</StartPage><MedlinePgn>e0232354</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e0232354</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1371/journal.pone.0232354</ELocationID><Abstract><AbstractText Label="BACKGROUND">The pathophysiology of chronic thromboembolic pulmonary hypertension (CTEPH) is not fully understood. Poor-quality anticoagulation may contribute to a higher risk of CTEPH after acute pulmonary embolism (PE), partly explaining the transition from acute PE to CTEPH. We assessed the association between the time in therapeutic range (TTR) of vitamin-K antagonist (VKA) treatment and incidence of CTEPH after a PE diagnosis.</AbstractText><AbstractText Label="METHODS">Case-control study in which the time spent in, under and above therapeutic range was calculated in 44 PE patients who were subsequently diagnosed with CTEPH (cases). Controls comprised 150 consecutive PE patients in whom echocardiograms two years later did not show pulmonary hypertension. All patients were treated with VKA for at least 6 months after the PE diagnosis. Time in (TTR), under and above range were calculated. Mean differences between cases and controls were estimated by linear regression.</AbstractText><AbstractText Label="RESULTS">Mean TTR during the initial 6-month treatment period was 72% in cases versus 78% in controls (mean difference -6%, 95%CI -12 to -0.1), mainly explained by more time above the therapeutic range in the cases. Mean difference of time under range was 0% (95%CI -6 to 7) and 2% (95CI% -3 to 7) during the first 3 and 6 months, respectively. In a multivariable model, adjusted odds ratios (ORs) for CTEPH were around unity considering different thresholds for 'poor anticoagulation', i.e. TTR &lt;50%, &lt;60% and &lt;70%.</AbstractText><AbstractText Label="CONCLUSION">Subtherapeutic initial anticoagulation was not more prevalent among PE patients diagnosed with CTEPH than in those who did not develop CTEPH.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Boon</LastName><ForeName>Gudula J A M</ForeName><Initials>GJAM</Initials><Identifier Source="ORCID">0000-0003-4532-436X</Identifier><AffiliationInfo><Affiliation>Department of Thrombosis and Hemostasis, Leiden University Medical Center, Leiden, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>van Rein</LastName><ForeName>Nienke</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Clinical Pharmacy and Toxicology, Leiden University Medical Center, Leiden, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bogaard</LastName><ForeName>Harm Jan</ForeName><Initials>HJ</Initials><AffiliationInfo><Affiliation>Department of Pulmonary Medicine, Amsterdam University Medical Centers, Amsterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ende-Verhaar</LastName><ForeName>Yvonne M</ForeName><Initials>YM</Initials><AffiliationInfo><Affiliation>Department of Thrombosis and Hemostasis, Leiden University Medical Center, Leiden, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Huisman</LastName><ForeName>Menno V</ForeName><Initials>MV</Initials><AffiliationInfo><Affiliation>Department of Thrombosis and Hemostasis, Leiden University Medical Center, Leiden, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kroft</LastName><ForeName>Lucia J M</ForeName><Initials>LJM</Initials><AffiliationInfo><Affiliation>Department of Radiology, Leiden University Medical Center, Leiden, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>van der Meer</LastName><ForeName>Felix J M</ForeName><Initials>FJM</Initials><AffiliationInfo><Affiliation>Department of Thrombosis and Hemostasis, Leiden University Medical Center, Leiden, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Meijboom</LastName><ForeName>Lilian J</ForeName><Initials>LJ</Initials><AffiliationInfo><Affiliation>Department of Radiology and Nuclear medicine, Amsterdam University Medical Centers, Amsterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Symersky</LastName><ForeName>Petr</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Cardiac Surgery, VU University Medical Center, Amsterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vonk Noordegraaf</LastName><ForeName>Anton</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Pulmonary Medicine, Amsterdam University Medical Centers, Amsterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Klok</LastName><ForeName>Frederikus A</ForeName><Initials>FA</Initials><AffiliationInfo><Affiliation>Department of Thrombosis and Hemostasis, Leiden University Medical Center, Leiden, The Netherlands.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>04</Month><Day>28</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>PLoS One</MedlineTA><NlmUniqueID>101285081</NlmUniqueID><ISSNLinking>1932-6203</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000925">Anticoagulants</NameOfSubstance></Chemical><Chemical><RegistryNumber>12001-79-5</RegistryNumber><NameOfSubstance UI="D014812">Vitamin K</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="ErratumIn"><RefSource>PLoS One. 2020 Jun 2;15(6):e0234298. doi: 10.1371/journal.pone.0234298.</RefSource><PMID Version="1">32484829</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000925" MajorTopicYN="N">Anticoagulants</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016022" MajorTopicYN="N">Case-Control Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006976" MajorTopicYN="N">Hypertension, Pulmonary</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015994" MajorTopicYN="N">Incidence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011655" MajorTopicYN="N">Pulmonary Embolism</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012306" MajorTopicYN="N">Risk</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014812" MajorTopicYN="N">Vitamin K</DescriptorName><QualifierName UI="Q000037" MajorTopicYN="N">antagonists &amp; inhibitors</QualifierName></MeshHeading></MeshHeadingList><CoiStatement>I have read the journal's policy and the authors of this manuscript have the following competing interests: G.J.A.M. Boon and F.A. Klok were supported by the Dutch Heart Foundation (2017T064). F.A. Klok reports research grants from Bayer, Bristol-Myers Squibb, Boehringer-Ingelheim, Daiichi Sankyo, MSD and Actelion, and the Netherlands Thrombosis Foundation. M.V. Huisman reports grants from ZonMW Dutch Healthcare Fund, grants and personal fees from Boehringer Ingelheim, grants and personal fees from Pfizer-BMS, grants and personal fees from Bayer Health Care, grants from Aspen, grants and personal fees from Daiichi-Sankyo, outside the submitted work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2019</Year><Month>11</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>4</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>4</Month><Day>29</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>4</Month><Day>29</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>7</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2020</Year><Month>4</Month><Day>28</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32343741</ArticleId><ArticleId IdType="pmc">PMC7188241</ArticleId><ArticleId IdType="doi">10.1371/journal.pone.0232354</ArticleId><ArticleId IdType="pii">PONE-D-19-31809</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Huisman MV, Barco S, Cannegieter SC, Le Gal G, Konstantinides SV, Reitsma PH, et al. Pulmonary embolism. Nature reviews Disease primers. 2018;4:18028 10.1038/nrdp.2018.28</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrdp.2018.28</ArticleId><ArticleId IdType="pubmed">29770793</ArticleId></ArticleIdList></Reference><Reference><Citation>Simonneau G, Torbicki A, Dorfmuller P, Kim N. The pathophysiology of chronic thromboembolic pulmonary hypertension. European respiratory review: an official journal of the European Respiratory Society. 2017;26(143).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9488693</ArticleId><ArticleId IdType="pubmed">28356405</ArticleId></ArticleIdList></Reference><Reference><Citation>Pepke-Zaba J, Delcroix M, Lang I, Mayer E, Jansa P, Ambroz D, et al. Chronic thromboembolic pulmonary hypertension (CTEPH): results from an international prospective registry. Circulation. 2011;124(18):1973&#x2013;81. 10.1161/CIRCULATIONAHA.110.015008</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.110.015008</ArticleId><ArticleId IdType="pubmed">21969018</ArticleId></ArticleIdList></Reference><Reference><Citation>Egermayer P, Peacock AJ. Is pulmonary embolism a common cause of chronic pulmonary hypertension? Limitations of the embolic hypothesis. The European respiratory journal. 2000;15(3):440&#x2013;8. 10.1034/j.1399-3003.2000.15.03.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1034/j.1399-3003.2000.15.03.x</ArticleId><ArticleId IdType="pubmed">10759434</ArticleId></ArticleIdList></Reference><Reference><Citation>Ende-Verhaar YM, Meijboom LJ, Kroft LJM, Beenen LFM, Boon G, Middeldorp S, et al. Usefulness of standard computed tomography pulmonary angiography performed for acute pulmonary embolism for identification of chronic thromboembolic pulmonary hypertension: results of the InShape III study. The Journal of heart and lung transplantation: the official publication of the International Society for Heart Transplantation. 2019.</Citation><ArticleIdList><ArticleId IdType="pubmed">30962147</ArticleId></ArticleIdList></Reference><Reference><Citation>Guerin L, Couturaud F, Parent F, Revel MP, Gillaizeau F, Planquette B, et al. Prevalence of chronic thromboembolic pulmonary hypertension after acute pulmonary embolism. Prevalence of CTEPH after pulmonary embolism. Thrombosis and haemostasis. 2014;112(3):598&#x2013;605. 10.1160/TH13-07-0538</Citation><ArticleIdList><ArticleId IdType="doi">10.1160/TH13-07-0538</ArticleId><ArticleId IdType="pubmed">24898545</ArticleId></ArticleIdList></Reference><Reference><Citation>Ende-Verhaar YM, Huisman MV, Klok FA. To screen or not to screen for chronic thromboembolic pulmonary hypertension after acute pulmonary embolism. Thromb Res. 2017;151:1&#x2013;7. 10.1016/j.thromres.2016.12.026</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.thromres.2016.12.026</ArticleId><ArticleId IdType="pubmed">28073030</ArticleId></ArticleIdList></Reference><Reference><Citation>Ende-Verhaar YM, van den Hout WB, Bogaard HJ, Meijboom LJ, Huisman MV, Symersky P, et al. Healthcare utilization in chronic thromboembolic pulmonary hypertension after acute pulmonary embolism. Journal of thrombosis and haemostasis: JTH. 2018;16(11):2168&#x2013;74. 10.1111/jth.14266</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jth.14266</ArticleId><ArticleId IdType="pubmed">30099844</ArticleId></ArticleIdList></Reference><Reference><Citation>Galie N, Humbert M, Vachiery JL, Gibbs S, Lang I, Torbicki A, et al. 2015 ESC/ERS Guidelines for the Diagnosis and Treatment of Pulmonary Hypertension. Revista espanola de cardiologia (English ed). 2016;69(2):177.</Citation><ArticleIdList><ArticleId IdType="pubmed">26837729</ArticleId></ArticleIdList></Reference><Reference><Citation>Ende-Verhaar YM, Cannegieter SC, Vonk Noordegraaf A, Delcroix M, Pruszczyk P, Mairuhu AT, et al. Incidence of chronic thromboembolic pulmonary hypertension after acute pulmonary embolism: a contemporary view of the published literature. The European respiratory journal. 2017;49(2).</Citation><ArticleIdList><ArticleId IdType="pubmed">28232411</ArticleId></ArticleIdList></Reference><Reference><Citation>Palareti G, Legnani C, Cosmi B, Guazzaloca G, Cini M, Mattarozzi S. Poor anticoagulation quality in the first 3 months after unprovoked venous thromboembolism is a risk factor for long-term recurrence. Journal of thrombosis and haemostasis: JTH. 2005;3(5):955&#x2013;61. 10.1111/j.1538-7836.2005.01330.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1538-7836.2005.01330.x</ArticleId><ArticleId IdType="pubmed">15869591</ArticleId></ArticleIdList></Reference><Reference><Citation>van Dongen CJ, Prandoni P, Frulla M, Marchiori A, Prins MH, Hutten BA. Relation between quality of anticoagulant treatment and the development of the postthrombotic syndrome. Journal of thrombosis and haemostasis: JTH. 2005;3(5):939&#x2013;42. 10.1111/j.1538-7836.2005.01333.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1538-7836.2005.01333.x</ArticleId><ArticleId IdType="pubmed">15869588</ArticleId></ArticleIdList></Reference><Reference><Citation>Klok FA, van Kralingen KW, van Dijk AP, Heyning FH, Vliegen HW, Huisman MV. Prospective cardiopulmonary screening program to detect chronic thromboembolic pulmonary hypertension in patients after acute pulmonary embolism. Haematologica. 2010;95(6):970&#x2013;5. 10.3324/haematol.2009.018960</Citation><ArticleIdList><ArticleId IdType="doi">10.3324/haematol.2009.018960</ArticleId><ArticleId IdType="pmc">PMC2878796</ArticleId><ArticleId IdType="pubmed">20053871</ArticleId></ArticleIdList></Reference><Reference><Citation>van der Bijl N, Klok FA, Huisman MV, van Rooden JK, Mertens BJA, de Roos A, et al. Measurement of right and left ventricular function by ECG-synchronized CT scanning in patients with acute pulmonary embolism: usefulness for predicting short-term outcome. Chest. 2011;140(4):1008&#x2013;15. 10.1378/chest.10-3174</Citation><ArticleIdList><ArticleId IdType="doi">10.1378/chest.10-3174</ArticleId><ArticleId IdType="pubmed">21474573</ArticleId></ArticleIdList></Reference><Reference><Citation>Klok FA, Van Der Bijl N, Eikenboom HC, Van Rooden CJ, De Roos A, Kroft LJ, et al. Comparison of CT assessed right ventricular size and cardiac biomarkers for predicting short-term clinical outcome in normotensive patients suspected of having acute pulmonary embolism. Journal of thrombosis and haemostasis: JTH. 2010;8(4):853&#x2013;6. 10.1111/j.1538-7836.2010.03780.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1538-7836.2010.03780.x</ArticleId><ArticleId IdType="pubmed">20096002</ArticleId></ArticleIdList></Reference><Reference><Citation>White HD, Gruber M, Feyzi J, Kaatz S, Tse HF, Husted S, et al. Comparison of outcomes among patients randomized to warfarin therapy according to anticoagulant control: results from SPORTIF III and V. Archives of internal medicine. 2007;167(3):239&#x2013;45. 10.1001/archinte.167.3.239</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archinte.167.3.239</ArticleId><ArticleId IdType="pubmed">17296878</ArticleId></ArticleIdList></Reference><Reference><Citation>Caldeira D, Cruz I, Morgado G, Stuart B, Gomes AC, Martins C, et al. Is the time in therapeutic range using the ratio of tests equivalent to the Rosendaal method? Blood coagulation &amp; fibrinolysis: an international journal in haemostasis and thrombosis. 2015;26(8):972&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">26083988</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosendaal FR, Cannegieter SC, van der Meer FJ, Briet E. A method to determine the optimal intensity of oral anticoagulant therapy. Thrombosis and haemostasis. 1993;69(3):236&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">8470047</ArticleId></ArticleIdList></Reference><Reference><Citation>Kearon C, Akl EA, Ornelas J, Blaivas A, Jimenez D, Bounameaux H, et al. Antithrombotic Therapy for VTE Disease: CHEST Guideline and Expert Panel Report. Chest. 2016;149(2):315&#x2013;52. 10.1016/j.chest.2015.11.026</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chest.2015.11.026</ArticleId><ArticleId IdType="pubmed">26867832</ArticleId></ArticleIdList></Reference><Reference><Citation>van Rein N, Lijfering WM, Bos MH, Herruer MH, Vermaas HW, van der Meer FJ, et al. Objectives and Design of BLEEDS: A Cohort Study to Identify New Risk Factors and Predictors for Major Bleeding during Treatment with Vitamin K Antagonists. PloS one. 2016;11(12):e0164485 10.1371/journal.pone.0164485</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0164485</ArticleId><ArticleId IdType="pmc">PMC5147785</ArticleId><ArticleId IdType="pubmed">27935941</ArticleId></ArticleIdList></Reference><Reference><Citation>Cannegieter SC, Rosendaal FR, Wintzen AR, van der Meer FJ, Vandenbroucke JP, Briet E. Optimal oral anticoagulant therapy in patients with mechanical heart valves. The New England journal of medicine. 1995;333(1):11&#x2013;7. 10.1056/NEJM199507063330103</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJM199507063330103</ArticleId><ArticleId IdType="pubmed">7776988</ArticleId></ArticleIdList></Reference><Reference><Citation>NIV. Richtlijn Antitrombotisch beleid: Nederlandse Internisten Vereniging; [updated December 2015. https://internisten.nl/files/Richtlijn%20Antitrombotisch%20beleid_def.pdf.</Citation></Reference><Reference><Citation>Baker WL, Cios DA, Sander SD, Coleman CI. Meta-analysis to assess the quality of warfarin control in atrial fibrillation patients in the United States. Journal of managed care pharmacy: JMCP. 2009;15(3):244&#x2013;52. 10.18553/jmcp.2009.15.3.244</Citation><ArticleIdList><ArticleId IdType="doi">10.18553/jmcp.2009.15.3.244</ArticleId><ArticleId IdType="pmc">PMC10437339</ArticleId><ArticleId IdType="pubmed">19326955</ArticleId></ArticleIdList></Reference><Reference><Citation>Pepke-Zaba J, Jansa P, Kim NH, Naeije R, Simonneau G. Chronic thromboembolic pulmonary hypertension: role of medical therapy. The European respiratory journal. 2013;41(4):985&#x2013;90. 10.1183/09031936.00201612</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/09031936.00201612</ArticleId><ArticleId IdType="pubmed">23397304</ArticleId></ArticleIdList></Reference><Reference><Citation>Dutt TS, Mohan BV, Tousheed SZ, Ramanjenaya R, Shetty DP. Incidence of chronic thrombo-embolic pulmonary hypertension following acute pulmonary thrombo-embolism: an Indian perspective. The Indian journal of chest diseases &amp; allied sciences. 2013;55(4):205&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">24660562</ArticleId></ArticleIdList></Reference><Reference><Citation>van der Hulle T, Kooiman J, den Exter PL, Dekkers OM, Klok FA, Huisman MV. Effectiveness and safety of novel oral anticoagulants as compared with vitamin K antagonists in the treatment of acute symptomatic venous thromboembolism: a systematic review and meta-analysis. Journal of thrombosis and haemostasis: JTH. 2014;12(3):320&#x2013;8. 10.1111/jth.12485</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jth.12485</ArticleId><ArticleId IdType="pubmed">24330006</ArticleId></ArticleIdList></Reference><Reference><Citation>Abdou JK, Auyeung V, Patel JP, Arya R. Adherence to long-term anticoagulation treatment, what is known and what the future might hold. British journal of haematology. 2016;174(1):30&#x2013;42. 10.1111/bjh.14134</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/bjh.14134</ArticleId><ArticleId IdType="pubmed">27173746</ArticleId></ArticleIdList></Reference><Reference><Citation>Dronkers CEA, Lijfering WM, Teichert M, van der Meer FJM, Klok FA, Cannegieter SC, et al. Persistence to direct oral anticoagulants for acute venous thromboembolism. Thrombosis research. 2018;167:135&#x2013;41. 10.1016/j.thromres.2018.05.013</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.thromres.2018.05.013</ArticleId><ArticleId IdType="pubmed">29843087</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">21143084</PMID><DateCompleted><Year>2011</Year><Month>03</Month><Day>24</Day></DateCompleted><DateRevised><Year>2010</Year><Month>12</Month><Day>14</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">1441-2772</ISSN><JournalIssue CitedMedium="Print"><Volume>12</Volume><Issue>4</Issue><PubDate><Year>2010</Year><Month>Dec</Month></PubDate></JournalIssue><Title>Critical care and resuscitation : journal of the Australasian Academy of Critical Care Medicine</Title><ISOAbbreviation>Crit Care Resusc</ISOAbbreviation></Journal><ArticleTitle>Management of massive pulmonary embolism: a retrospective single-centre cohort study.</ArticleTitle><Pagination><StartPage>242</StartPage><EndPage>247</EndPage><MedlinePgn>242-7</MedlinePgn></Pagination><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Massive pulmonary embolism (PE) (PE associated with hypotension or shock) is a condition with a mortality rate in excess of 50%. Although expert opinion favouring thrombolysis exists, this is based predominantly on studies demonstrating physiological benefits rather than a mortality benefit. The optimal treatment for massive PE remains unclear. The majority of studies to date have studied medical therapy, and case series of surgical pulmonary embolectomy have also been reported. No studies directly comparing mortality between medical and surgical therapies have been published. In our institution, both medical and surgical therapies are used in the treatment of massive PE.</AbstractText><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">To identify the characteristics and outcomes of patients who received thrombolysis, surgical embolectomy or heparin anticoagulation for management of massive PE.</AbstractText><AbstractText Label="DESIGN AND SETTING" NlmCategory="METHODS">Retrospective cohort study of patients with massive PE at the Royal North Shore Hospital, Sydney, Australia. The hospital medical records database was searched from 1 January 1996 to 31 December 2006. In addition, both the intensive care and cardiothoracic surgery databases were searched for the diagnosis of PE. Patients were included in our study if there was an ICD-9 diagnosis of PE and a review of notes indicated that the criteria for massive PE were met.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Fifty-one patients with massive PE were identified. Nine received embolectomy, 10 thrombolysis and 14 heparin anticoagulation. There were no statistically significant differences in mortality between these three groups, although resource utilisation was higher in the embolectomy group. Eighteen patients received no definitive treatment because of the poor prognosis of their underlying disease. All patients who received no definitive therapy died.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Massive PE has a high mortality. No significant mortality benefit was associated with any particular therapy. Patients for whom thrombolysis and/or embolectomy are contraindicated may benefit from simple anticoagulation.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Barrett</LastName><ForeName>Nicholas A</ForeName><Initials>NA</Initials><AffiliationInfo><Affiliation>Department of Critical Care, Guy's and St Thomas' NHS Foundation Trust, King's Health Partners, London, UK. nicholas.barrett@gstt.nhs.uk</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Byrne</LastName><ForeName>Anthony</ForeName><Initials>A</Initials></Author><Author ValidYN="Y"><LastName>Delaney</LastName><ForeName>Anthony</ForeName><Initials>A</Initials></Author><Author ValidYN="Y"><LastName>Hibbert</LastName><ForeName>Michael</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Ramakrishnan</LastName><ForeName>Naresh</ForeName><Initials>N</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Crit Care Resusc</MedlineTA><NlmUniqueID>100888170</NlmUniqueID><ISSNLinking>1441-2772</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000925">Anticoagulants</NameOfSubstance></Chemical><Chemical><RegistryNumber>9005-49-6</RegistryNumber><NameOfSubstance UI="D006493">Heparin</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000925" MajorTopicYN="N">Anticoagulants</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017128" MajorTopicYN="Y">Embolectomy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006493" MajorTopicYN="N">Heparin</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017052" MajorTopicYN="N">Hospital Mortality</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011655" MajorTopicYN="N">Pulmonary Embolism</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015996" MajorTopicYN="N">Survival Rate</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015912" MajorTopicYN="Y">Thrombolytic Therapy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2010</Year><Month>12</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2010</Year><Month>12</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2011</Year><Month>3</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">21143084</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">35317982</PMID><DateCompleted><Year>2023</Year><Month>01</Month><Day>31</Day></DateCompleted><DateRevised><Year>2023</Year><Month>02</Month><Day>02</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Print">1479-666X</ISSN><JournalIssue CitedMedium="Internet"><Volume>21</Volume><Issue>1</Issue><PubDate><Year>2023</Year><Month>Feb</Month></PubDate></JournalIssue><Title>The surgeon : journal of the Royal Colleges of Surgeons of Edinburgh and Ireland</Title><ISOAbbreviation>Surgeon</ISOAbbreviation></Journal><ArticleTitle>Incidence, risk factors and potential timing of occurrence of pulmonary embolism in fatal trauma: An autopsy based case-control study on 2705 victims.</ArticleTitle><Pagination><StartPage>8</StartPage><EndPage>15</EndPage><MedlinePgn>8-15</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.surge.2022.03.002</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S1479-666X(22)00051-8</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Pulmonary embolism (PE) following trauma is a potentially preventable but highly lethal complication. We sought to investigate the incidence, risk factors and potential timing of occurrence of post-traumatic PE in a large cohort of trauma fatalities.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">A case-control study on 9266 consecutive trauma fatalities (between 1996 and 2005) from a regional autopsy-based trauma registry. Injuries were classified according to the Abbreviated Injury Scale-1990 edition (AIS-90) and the Injury Severity Score (ISS) was calculated. Hospitalized victims were categorized according to the presence or absence of PE on autopsy. Univariate comparisons and multivariate logistic regression analysis for probabilities of association (odds ratios-OR) were performed.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Out of 2705 subjects who met the inclusion criteria, 116 had autopsy findings of PE and constituted the PE group (incidence of 4,3%), while the remaining victims formed the control group. The survival time of the PE group ranged from 0.66 to 104.73 days. Victims in the PE group were older (median age 69.5 vs 59), had lower ISS values (median 16 vs 26) and longer post-injury survival times (median 13.6 vs 5.7 days). Positively associated risk factors were AIS2-5 pelvic ring injuries (OR:2.23) and secondary deaths following an uneventful hospital discharge (OR:3.97), while AIS2-5 head (OR:0.33) and abdominal injuries (OR:0.23) showed a reverse association.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Trauma fatalities with autopsy findings of PE were associated with less severe trauma indicating that PE was likely detrimental to the fatal outcome. Both the early and delayed occurrence of PE was reaffirmed. Prophylactic measures should be initiated promptly and extended post discharge for high risk patients to prevent secondary deaths.</AbstractText><CopyrightInformation>Copyright &#xa9; 2022 Royal College of Surgeons of Edinburgh (Scottish charity number SC005317) and Royal College of Surgeons in Ireland. Published by Elsevier Ltd. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Roumeliotis</LastName><ForeName>Leonidas</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>4th Department of Surgery, School of Medicine, National and Kapodistrian University of Athens, University General Hospital 'Attikon', Athens, Greece. Electronic address: leonidasroumeliotis@yahoo.gr.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kanakaris</LastName><ForeName>Nikolaos K</ForeName><Initials>NK</Initials><AffiliationInfo><Affiliation>Leeds Major Trauma Centre, Leeds Teaching Hospitals NHS Trust, Leeds, Yorkshire, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Papadopoulos</LastName><ForeName>Iordanis N</ForeName><Initials>IN</Initials><AffiliationInfo><Affiliation>4th Department of Surgery, School of Medicine, National and Kapodistrian University of Athens, University General Hospital 'Attikon', Athens, Greece.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>03</Month><Day>19</Day></ArticleDate></Article><MedlineJournalInfo><Country>Scotland</Country><MedlineTA>Surgeon</MedlineTA><NlmUniqueID>101168329</NlmUniqueID><ISSNLinking>1479-666X</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015994" MajorTopicYN="N">Incidence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016022" MajorTopicYN="N">Case-Control Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001344" MajorTopicYN="N">Autopsy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000359" MajorTopicYN="N">Aftercare</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010351" MajorTopicYN="N">Patient Discharge</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011655" MajorTopicYN="Y">Pulmonary Embolism</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015601" MajorTopicYN="N">Injury Severity Score</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014947" MajorTopicYN="Y">Wounds and Injuries</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Abbreviated injury scale</Keyword><Keyword MajorTopicYN="N">Injury severity score</Keyword><Keyword MajorTopicYN="N">Multiple trauma</Keyword><Keyword MajorTopicYN="N">Pulmonary embolism</Keyword><Keyword MajorTopicYN="N">Registries</Keyword><Keyword MajorTopicYN="N">Risk factors</Keyword></KeywordList><CoiStatement>Declaration of competing interest None.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>10</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>2</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>3</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>3</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>2</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>3</Month><Day>23</Day><Hour>5</Hour><Minute>37</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35317982</ArticleId><ArticleId IdType="doi">10.1016/j.surge.2022.03.002</ArticleId><ArticleId IdType="pii">S1479-666X(22)00051-8</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">30611138</PMID><DateCompleted><Year>2020</Year><Month>04</Month><Day>23</Day></DateCompleted><DateRevised><Year>2024</Year><Month>08</Month><Day>06</Day></DateRevised><Article PubModel="Electronic-Print"><Journal><ISSN IssnType="Electronic">1933-0693</ISSN><JournalIssue CitedMedium="Internet"><Volume>132</Volume><Issue>1</Issue><PubDate><Year>2020</Year><Month>Jan</Month><Day>01</Day></PubDate></JournalIssue><Title>Journal of neurosurgery</Title><ISOAbbreviation>J Neurosurg</ISOAbbreviation></Journal><ArticleTitle>Venous thromboembolic events in patients undergoing craniotomy for tumor resection: incidence, predictors, and review of literature.</ArticleTitle><Pagination><StartPage>10</StartPage><EndPage>21</EndPage><MedlinePgn>10-21</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.3171/2018.7.JNS181175</ELocationID><Abstract><AbstractText Label="OBJECTIVE">The authors sought to investigate the incidence and predictors of venous thromboembolic events (VTEs) after craniotomy for tumor resection, which are not well established, and the efficacy of and risks associated with VTE chemoprophylaxis, which remains controversial.</AbstractText><AbstractText Label="METHODS">The authors investigated the incidence of VTEs in a consecutive series of patients presenting to the authors' institution for resection of an intracranial lesion between 2012 and 2017. Information on patient and tumor characteristics was collected and independent predictors of VTEs were determined using stepwise multivariate logistic regression analysis. Review of the literature was performed by searching MEDLINE using the keywords "venous thromboembolism," "deep venous thrombosis," "pulmonary embolism," "craniotomy," and "brain neoplasms."</AbstractText><AbstractText Label="RESULTS">There were 1622 patients included for analysis. A small majority of patients were female (52.6%) and the mean age of the cohort was 52.9 years (SD 15.8 years). A majority of intracranial lesions were intraaxial (59.3%). The incidence of VTEs was 3.0% and the rates of deep venous thromboses and pulmonary emboli were 2.3% and 0.9%, respectively. On multivariate analysis, increasing patient age (unit OR 1.02, 95% CI 1.00-1.05; p = 0.018), history of VTE (OR 7.26, 95% CI 3.24-16.27; p &lt; 0.001), presence of motor deficit (OR 2.64, 95% CI 1.43-4.88; p = 0.002), postoperative intracranial hemorrhage (OR 4.35, 95% CI 1.51-12.55; p &lt; 0.001), and prolonged intubation or reintubation (OR 3.27, 95% CI 1.28-8.32; p &lt; 0.001) were independently associated with increased odds of a VTE. There were 192 patients who received VTE chemoprophylaxis (11.8%); the mean postoperative day of chemoprophylaxis initiation was 4.6 (SD 3.8). The incidence of VTEs was higher in patients receiving chemoprophylaxis than in patients not receiving chemoprophylaxis (8.3% vs 2.2%; p &lt; 0.001). There were 30 instances of clinically significant postoperative hemorrhage (1.9%), with only 1 hemorrhage occurring after initiation of VTE chemoprophylaxis (0.1%).</AbstractText><AbstractText Label="CONCLUSIONS">The study results show the incidence and predictors of VTEs after craniotomy for tumor resection in this patient population. The incidence of VTE within this cohort appears low and comparable to that observed in other institutional series, despite the lack of routine prophylactic anticoagulation in the postoperative setting.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Rinaldo</LastName><ForeName>Lorenzo</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>1Department of Neurological Surgery, Mayo Clinic.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Brown</LastName><ForeName>Desmond A</ForeName><Initials>DA</Initials><AffiliationInfo><Affiliation>1Department of Neurological Surgery, Mayo Clinic.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bhargav</LastName><ForeName>Adip G</ForeName><Initials>AG</Initials><AffiliationInfo><Affiliation>2Mayo Clinic College of Medicine and Science, Mayo Clinic; and.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rusheen</LastName><ForeName>Aaron E</ForeName><Initials>AE</Initials><AffiliationInfo><Affiliation>3Medical Scientist Training Program, Mayo Clinic College of Medicine and Science, Mayo Clinic, Rochester, Minnesota.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Naylor</LastName><ForeName>Ryan M</ForeName><Initials>RM</Initials><AffiliationInfo><Affiliation>1Department of Neurological Surgery, Mayo Clinic.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gilder</LastName><ForeName>Hannah E</ForeName><Initials>HE</Initials><AffiliationInfo><Affiliation>1Department of Neurological Surgery, Mayo Clinic.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Monie</LastName><ForeName>Dileep D</ForeName><Initials>DD</Initials><AffiliationInfo><Affiliation>3Medical Scientist Training Program, Mayo Clinic College of Medicine and Science, Mayo Clinic, Rochester, Minnesota.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Youssef</LastName><ForeName>Stephanie J</ForeName><Initials>SJ</Initials><AffiliationInfo><Affiliation>2Mayo Clinic College of Medicine and Science, Mayo Clinic; and.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Parney</LastName><ForeName>Ian F</ForeName><Initials>IF</Initials><AffiliationInfo><Affiliation>1Department of Neurological Surgery, Mayo Clinic.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>T32 GM065841</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D003160">Comparative Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2019</Year><Month>01</Month><Day>04</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Neurosurg</MedlineTA><NlmUniqueID>0253357</NlmUniqueID><ISSNLinking>0022-3085</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000925">Anticoagulants</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D010975">Platelet Aggregation Inhibitors</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000367" MajorTopicYN="N">Age Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000925" MajorTopicYN="N">Anticoagulants</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001932" MajorTopicYN="N">Brain Neoplasms</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002543" MajorTopicYN="N">Cerebral Hemorrhage</DescriptorName><QualifierName UI="Q000139" MajorTopicYN="N">chemically induced</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018890" MajorTopicYN="N">Chemoprevention</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003399" MajorTopicYN="Y">Craniotomy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015994" MajorTopicYN="N">Incidence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007442" MajorTopicYN="N">Intubation, Intratracheal</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017567" MajorTopicYN="N">Karnofsky Performance Status</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010975" MajorTopicYN="N">Platelet Aggregation Inhibitors</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000139" MajorTopicYN="N">chemically induced</QualifierName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019106" MajorTopicYN="N">Postoperative Hemorrhage</DescriptorName><QualifierName UI="Q000139" MajorTopicYN="N">chemically induced</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011292" MajorTopicYN="N">Premedication</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011655" MajorTopicYN="N">Pulmonary Embolism</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019851" MajorTopicYN="N">Thrombophilia</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D054556" MajorTopicYN="N">Venous Thromboembolism</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020246" MajorTopicYN="N">Venous Thrombosis</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">DVT = deep venous thrombosis</Keyword><Keyword MajorTopicYN="N">ICH = intracranial hemorrhage</Keyword><Keyword MajorTopicYN="N">KPS = Karnofsky Performance Scale</Keyword><Keyword MajorTopicYN="N">LMWH = low-molecular-weight heparin</Keyword><Keyword MajorTopicYN="N">PE = pulmonary embolism</Keyword><Keyword MajorTopicYN="N">RCT = randomized controlled trial</Keyword><Keyword MajorTopicYN="N">VTE = venous thromboembolic event</Keyword><Keyword MajorTopicYN="N">brain neoplasms</Keyword><Keyword MajorTopicYN="N">chemoprevention</Keyword><Keyword MajorTopicYN="N">deep venous thrombosis</Keyword><Keyword MajorTopicYN="N">neurosurgery</Keyword><Keyword MajorTopicYN="N">pulmonary embolism</Keyword><Keyword MajorTopicYN="N">vascular disorders</Keyword><Keyword MajorTopicYN="N">venous thromboembolism</Keyword></KeywordList><CoiStatement>Disclosures. The authors report no conflict of interest concerning the materials or methods used in this study or the findings specified in this paper.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2018</Year><Month>4</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>7</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>1</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>4</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>1</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2020</Year><Month>7</Month><Day>4</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">30611138</ArticleId><ArticleId IdType="mid">NIHMS1005218</ArticleId><ArticleId IdType="pmc">PMC6609511</ArticleId><ArticleId IdType="doi">10.3171/2018.7.JNS181175</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Agarwal N, Zenonos GA, Agarwal P, Walch FJ, Roach E, Stokes SJ, et al.: Risk-to-benefit ratio of venous thromboembolism prophylaxis for neurosurgical procedures at a quaternary referral center. Neurosurgery [epub ahead of print], 2018</Citation><ArticleIdList><ArticleId IdType="pubmed">29538700</ArticleId></ArticleIdList></Reference><Reference><Citation>Agnelli G, Piovella F, Buoncristiani P, Severi P, Pini M, D&#x2019;Angelo A, et al.: Enoxaparin plus compression stockings compared with compression stockings alone in the prevention of venous thromboembolism after elective neurosurgery. N Engl J Med 339:80&#x2013;85, 1998</Citation><ArticleIdList><ArticleId IdType="pubmed">9654538</ArticleId></ArticleIdList></Reference><Reference><Citation>Algattas H, Damania D, DeAndrea-Lazarus I, Kimmell KT, Marko NF, Walter KA, et al.: Systematic review of safety and cost-effectiveness of venous thromboembolism prophylaxis strategies in patients undergoing craniotomy for brain tumor. Neurosurgery 82:142&#x2013;154, 2018</Citation><ArticleIdList><ArticleId IdType="pubmed">28402497</ArticleId></ArticleIdList></Reference><Reference><Citation>Algattas H, Kimmell KT, Vates GE, Jahromi BS: Analysis of venous thromboembolism risk in patients undergoing craniotomy. World Neurosurg 84:1372&#x2013;1379, 2015</Citation><ArticleIdList><ArticleId IdType="pubmed">26117085</ArticleId></ArticleIdList></Reference><Reference><Citation>Alshehri N, Cote DJ, Hulou MM, Alghamdi A, Alshahrani A, Mekary RA, et al.: Venous thromboembolism prophylaxis in brain tumor patients undergoing craniotomy: a meta-analysis. J Neurooncol 130:561&#x2013;570, 2016</Citation><ArticleIdList><ArticleId IdType="pubmed">27591773</ArticleId></ArticleIdList></Reference><Reference><Citation>Auguste KI, Quinones-Hinojosa A, Gadkary C, Zada G, Lamborn KR, Berger MS: Incidence of venous thromboembolism in patients undergoing craniotomy and motor mapping for glioma without intraoperative mechanical prophylaxis to the contralateral leg. J Neurosurg 99:680&#x2013;684, 2003</Citation><ArticleIdList><ArticleId IdType="pubmed">14567603</ArticleId></ArticleIdList></Reference><Reference><Citation>Bucci MN, Papadopoulos SM, Chen JC, Campbell JA, Hoff JT: Mechanical prophylaxis of venous thrombosis in patients undergoing craniotomy: a randomized trial. Surg Neurol 32:285&#x2013;288, 1989</Citation><ArticleIdList><ArticleId IdType="pubmed">2675364</ArticleId></ArticleIdList></Reference><Reference><Citation>Cage TA, Lamborn KR, Ware ML, Frankfurt A, Chakalian L, Berger MS, et al.: Adjuvant enoxaparin therapy may decrease the incidence of postoperative thrombotic events though does not increase the incidence of postoperative intracranial hemorrhage in patients with meningiomas. J Neurooncol 93:151&#x2013;156, 2009</Citation><ArticleIdList><ArticleId IdType="pubmed">19430892</ArticleId></ArticleIdList></Reference><Reference><Citation>Cerrato D, Ariano C, Fiacchino F: Deep vein thrombosis and low-dose heparin prophylaxis in neurosurgical patients. J Neurosurg 49:378&#x2013;381, 1978</Citation><ArticleIdList><ArticleId IdType="pubmed">681999</ArticleId></ArticleIdList></Reference><Reference><Citation>Chaichana KL, Pendleton C, Jackson C, Martinez-Gutierrez JC, Diaz-Stransky A, Aguayo J, et al.: Deep venous thrombosis and pulmonary embolisms in adult patients undergoing craniotomy for brain tumors. Neurol Res 35:206&#x2013;211, 2013</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3991124</ArticleId><ArticleId IdType="pubmed">23336127</ArticleId></ArticleIdList></Reference><Reference><Citation>Cogo A, Lensing AWA, Prandoni P, Hirsh J: Distribution of thrombosis in patients with symptomatic deep vein thrombosis. Implications for simplifying the diagnostic process with compression ultrasound. Arch Intern Med 153:2777&#x2013;2780, 1993</Citation><ArticleIdList><ArticleId IdType="pubmed">8257253</ArticleId></ArticleIdList></Reference><Reference><Citation>Constantini S, Kanner A, Friedman A, Shoshan Y, Israel Z, Ashkenazi E, et al.: Safety of perioperative minidose heparin in patients undergoing brain tumor surgery: a prospective, randomized, double-blind study. J Neurosurg 94:918&#x2013;921, 2001</Citation><ArticleIdList><ArticleId IdType="pubmed">11409520</ArticleId></ArticleIdList></Reference><Reference><Citation>Cote DJ, Dubois HM, Karhade AV, Smith TR: Venous thromboembolism in patients undergoing craniotomy for brain tumors: a U.S. nationwide analysis. Semin Thromb Hemost 42:870&#x2013;876, 2016</Citation><ArticleIdList><ArticleId IdType="pubmed">27764877</ArticleId></ArticleIdList></Reference><Reference><Citation>Danish SF, Burnett MG, Ong JG, Sonnad SS, Maloney-Wilensky E, Stein SC: Prophylaxis for deep venous thrombosis in craniotomy patients: a decision analysis. Neurosurgery 56:1286&#x2013;1294, 2005</Citation><ArticleIdList><ArticleId IdType="pubmed">15918945</ArticleId></ArticleIdList></Reference><Reference><Citation>Dermody M, Alessi-Chinetti J, Iafrati MD, Estes JM: The utility of screening for deep venous thrombosis in asymptomatic, non-ambulatory neurosurgical patients. J Vasc Surg 53:1309&#x2013;1315, 2011</Citation><ArticleIdList><ArticleId IdType="pubmed">21215569</ArticleId></ArticleIdList></Reference><Reference><Citation>Dickinson LD, Miller LD, Patel CP, Gupta SK: Enoxaparin increases the incidence of postoperative intracranial hemorrhage when initiated preoperatively for deep venous thrombosis prophylaxis in patients with brain tumors. Neurosurgery 43:1074&#x2013;1081, 1998</Citation><ArticleIdList><ArticleId IdType="pubmed">9802851</ArticleId></ArticleIdList></Reference><Reference><Citation>Flinn WR, Sandager GP, Silva MB Jr, Benjamin ME, Cerullo LJ, Taylor M: Prospective surveillance for perioperative venous thrombosis. Experience in 2643 patients. Arch Surg 131:472&#x2013;480, 1996</Citation><ArticleIdList><ArticleId IdType="pubmed">8624191</ArticleId></ArticleIdList></Reference><Reference><Citation>Frim DM, Barker FG II, Poletti CE, Hamilton AJ: Postoperative low-dose heparin decreases thromboembolic complications in neurosurgical patients. Neurosurgery 30:830&#x2013;833, 1992</Citation><ArticleIdList><ArticleId IdType="pubmed">1614582</ArticleId></ArticleIdList></Reference><Reference><Citation>Frisius J, Ebeling M, Karst M, Fahlbusch R, Schedel I, Gerganov V, et al.: Prevention of venous thromboembolic complications with and without intermittent pneumatic compression in neurosurgical cranial procedures using intraoperative magnetic resonance imaging. A retrospective analysis. Clin Neurol Neurosurg 133:46&#x2013;54, 2015</Citation><ArticleIdList><ArticleId IdType="pubmed">25837574</ArticleId></ArticleIdList></Reference><Reference><Citation>Gerber DE, Segal JB, Salhotra A, Olivi A, Grossman SA, Streiff MB: Venous thromboembolism occurs infrequently in meningioma patients receiving combined modality prophylaxis. Cancer 109:300&#x2013;305, 2007</Citation><ArticleIdList><ArticleId IdType="pubmed">17154163</ArticleId></ArticleIdList></Reference><Reference><Citation>Gerlach R, Scheuer T, Beck J, Woszczyk A, Seifert V, Raabe A: Risk of postoperative hemorrhage after intracranial surgery after early nadroparin administration: results of a prospective study. Neurosurgery 53:1028&#x2013;1035, 2003</Citation><ArticleIdList><ArticleId IdType="pubmed">14580268</ArticleId></ArticleIdList></Reference><Reference><Citation>Goldhaber SZ, Dunn K, Gerhard-Herman M, Park JK, Black PM: Low rate of venous thromboembolism after craniotomy for brain tumor using multimodality prophylaxis. Chest 122:1933&#x2013;1937, 2002</Citation><ArticleIdList><ArticleId IdType="pubmed">12475829</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo X, Zhang F, Wu Y, Gao L, Wang Q, Wang Z, et al.: Coagulation alteration and deep vein thrombosis in brain tumor patients during the perioperative period. World Neurosurg 114:e982&#x2013;e991, 2018</Citation><ArticleIdList><ArticleId IdType="pubmed">29588239</ArticleId></ArticleIdList></Reference><Reference><Citation>Hamilton MG, Yee WH, Hull RD, Ghali WA: Venous thromboembolism prophylaxis in patients undergoing cranial neurosurgery: a systematic review and meta-analysis. Neurosurgery 68:571&#x2013;581, 2011</Citation><ArticleIdList><ArticleId IdType="pubmed">21311292</ArticleId></ArticleIdList></Reference><Reference><Citation>Hirmerova J, Seidlerova J, Chudacek Z: The prevalence of concomitant deep vein thrombosis, symptomatic or asymptomatic, proximal or distal, in patients with symptomatic pulmonary embolism. Clin Appl Thromb Hemost 24:1352&#x2013;1357, 2018</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6714772</ArticleId><ArticleId IdType="pubmed">29848045</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoefnagel D, Kwee LE, van Putten EH, Kros JM, Dirven CM, Dammers R: The incidence of postoperative thromboembolic complications following surgical resection of intracranial meningioma. A retrospective study of a large single center patient cohort. Clin Neurol Neurosurg 123:150&#x2013;154, 2014</Citation><ArticleIdList><ArticleId IdType="pubmed">24956544</ArticleId></ArticleIdList></Reference><Reference><Citation>Joffe SN: Incidence of postoperative deep vein thrombosis in neurosurgical patients. J Neurosurg 42:201&#x2013;203, 1975</Citation><ArticleIdList><ArticleId IdType="pubmed">1113155</ArticleId></ArticleIdList></Reference><Reference><Citation>Kearon C: Natural history of venous thromboembolism. Circulation 107 (23 Suppl 1):I22&#x2013;I30, 2003</Citation><ArticleIdList><ArticleId IdType="pubmed">12814982</ArticleId></ArticleIdList></Reference><Reference><Citation>Kimmell KT, Jahromi BS: Clinical factors associated with venous thromboembolism risk in patients undergoing craniotomy. J Neurosurg 122:1004&#x2013;1011, 2015</Citation><ArticleIdList><ArticleId IdType="pubmed">25495743</ArticleId></ArticleIdList></Reference><Reference><Citation>Kumar K, Tang KK, Thomas J, Chumpon C: Is postoperative deep vein thrombosis a problem in neurosurgical patients with brain tumours in Singapore? Singapore Med J 43:345&#x2013;349, 2002</Citation><ArticleIdList><ArticleId IdType="pubmed">12437041</ArticleId></ArticleIdList></Reference><Reference><Citation>Lagerstedt CI, Olsson CG, Fagher BO, Oqvist BW, Albrechtsson U: Need for long-term anticoagulant treatment in symptomatic calf-vein thrombosis. Lancet 2:515&#x2013;518, 1985</Citation><ArticleIdList><ArticleId IdType="pubmed">2863541</ArticleId></ArticleIdList></Reference><Reference><Citation>Macdonald RL, Amidei C, Baron J, Weir B, Brown F, Erickson RK, et al.: Randomized, pilot study of intermittent pneumatic compression devices plus dalteparin versus intermittent pneumatic compression devices plus heparin for prevention of venous thromboembolism in patients undergoing craniotomy. Surg Neurol 59:363&#x2013;374, 2003</Citation><ArticleIdList><ArticleId IdType="pubmed">12765806</ArticleId></ArticleIdList></Reference><Reference><Citation>Macdonald RL, Amidei C, Lin G, Munshi I, Baron J, Weir BK, et al.: Safety of perioperative subcutaneous heparin for prophylaxis of venous thromboembolism in patients undergoing craniotomy. Neurosurgery 45:245&#x2013;252, 1999</Citation><ArticleIdList><ArticleId IdType="pubmed">10449068</ArticleId></ArticleIdList></Reference><Reference><Citation>Melon E, Keravel Y, Gaston A, Huet Y, Combes S, the NEURO-NOX Group: Deep venous thrombosis prophylaxis by low molecular weight heparin in neurosurgical patients. Anesthesiology 75:A214, 1991. (Abstract)</Citation></Reference><Reference><Citation>Nakano F, Matsubara T, Ishigaki T, Hatazaki S, Mouri G, Nakatsuka Y, et al.: Incidence and risk factor of deep venous thrombosis in patients undergoing craniotomy for brain tumors: A Japanese single-center, retrospective study. Thromb Res 165:95&#x2013;100, 2018</Citation><ArticleIdList><ArticleId IdType="pubmed">29605752</ArticleId></ArticleIdList></Reference><Reference><Citation>Natsumeda M, Uzuka T, Watanabe J, Fukuda M, Akaiwa Y, Hanzawa K, et al.: High incidence of deep vein thrombosis in the perioperative period of neurosurgical patients. World Neurosurg 112:e103&#x2013;e112, 2018</Citation><ArticleIdList><ArticleId IdType="pubmed">29294399</ArticleId></ArticleIdList></Reference><Reference><Citation>Nu&#xf1;o M, Carico C, Mukherjee D, Ly D, Ortega A, Black KL, et al.: Association between in-hospital adverse events and mortality for patients with brain tumors. J Neurosurg 123:1247&#x2013;1255, 2015</Citation><ArticleIdList><ArticleId IdType="pubmed">26053457</ArticleId></ArticleIdList></Reference><Reference><Citation>Nurmohamed MT, van Riel AM, Henkens CM, Koopman MM, Que GT, d&#x2019;Azemar P, et al.: Low molecular weight heparin and compression stockings in the prevention of venous thromboembolism in neurosurgery. Thromb Haemost 75:233&#x2013;238, 1996</Citation><ArticleIdList><ArticleId IdType="pubmed">8815566</ArticleId></ArticleIdList></Reference><Reference><Citation>Prell J, Rachinger J, Smaczny R, Taute BM, Rampp S, Illert J, et al.: D-dimer plasma level: a reliable marker for venous thromboembolism after elective craniotomy. J Neurosurg 119:1340&#x2013;1346, 2013</Citation><ArticleIdList><ArticleId IdType="pubmed">23915033</ArticleId></ArticleIdList></Reference><Reference><Citation>Prell J, Schenk G, Taute BM, Scheller C, Marquart C, Strauss C, et al.: Reduced risk of venous thromboembolism with the use of intermittent pneumatic compression after craniotomy: a randomized controlled prospective study. J Neurosurg [epub ahead of print March 30, 2018. DOI: 10.3171/2017.9.JNS17533]</Citation><ArticleIdList><ArticleId IdType="doi">10.3171/2017.9.JNS17533</ArticleId><ArticleId IdType="pubmed">29600912</ArticleId></ArticleIdList></Reference><Reference><Citation>Raabe A, Gerlach R, Zimmermann M, Seifert V: The risk of haemorrhage associated with early postoperative heparin administration after intracranial surgery. Acta Neurochir (Wien) 143:1&#x2013;7, 2001</Citation><ArticleIdList><ArticleId IdType="pubmed">11345711</ArticleId></ArticleIdList></Reference><Reference><Citation>Rolston JD, Han SJ, Bloch O, Parsa AT: What clinical factors predict the incidence of deep venous thrombosis and pulmonary embolism in neurosurgical patients? J Neurosurg 121:908&#x2013;918, 2014</Citation><ArticleIdList><ArticleId IdType="pubmed">25084467</ArticleId></ArticleIdList></Reference><Reference><Citation>Ruff RL, Posner JB: Incidence and treatment of peripheral venous thrombosis in patients with glioma. Ann Neurol 13:334&#x2013;336, 1983</Citation><ArticleIdList><ArticleId IdType="pubmed">6303201</ArticleId></ArticleIdList></Reference><Reference><Citation>Salmaggi A, Simonetti G, Trevisan E, Beecher D, Carapella CM, DiMeco F, et al.: Perioperative thromboprophylaxis in patients with craniotomy for brain tumours: a systematic review. J Neurooncol 113:293&#x2013;303, 2013</Citation><ArticleIdList><ArticleId IdType="pubmed">23543244</ArticleId></ArticleIdList></Reference><Reference><Citation>Scheller C, Rachinger J, Strauss C, Alfieri A, Prell J, Koman G: Therapeutic anticoagulation after craniotomies: is the risk for secondary hemorrhage overestimated? J Neurol Surg A Cent Eur Neurosurg 75:2&#x2013;6, 2014</Citation><ArticleIdList><ArticleId IdType="pubmed">23959615</ArticleId></ArticleIdList></Reference><Reference><Citation>Senders JT, Goldhaber NH, Cote DJ, Muskens IS, Dawood HY, De Vos FYFL, et al.: Venous thromboembolism and intracranial hemorrhage after craniotomy for primary malignant brain tumors: a National Surgical Quality Improvement Program analysis. J Neurooncol 136:135&#x2013;145, 2018</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5754452</ArticleId><ArticleId IdType="pubmed">29039075</ArticleId></ArticleIdList></Reference><Reference><Citation>Sj&#xe5;vik K, Bartek J Jr, Solheim O, Ingebrigtsen T, Gulati S, Sagberg LM, et al.: Venous thromboembolism prophylaxis in meningioma surgery: a population-based comparative effectiveness study of routine mechanical prophylaxis with or without preoperative low-molecular-weight heparin. World Neurosurg 88:320&#x2013;326, 2016</Citation><ArticleIdList><ArticleId IdType="pubmed">26746334</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith TR, Lall RR, Graham RB, Mcclendon J Jr, Lall RR, Nanney AD, et al.: Venous thromboembolism in high grade glioma among surgical patients: results from a single center over a 10 year period. J Neurooncol 120:347&#x2013;352, 2014</Citation><ArticleIdList><ArticleId IdType="pubmed">25062669</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith TR, Nanney AD III, Lall RR, Graham RB, McClendon J Jr, Lall RR, et al.: Development of venous thromboembolism (VTE) in patients undergoing surgery for brain tumors: results from a single center over a 10 year period. J Clin Neurosci 22:519&#x2013;525, 2015</Citation><ArticleIdList><ArticleId IdType="pubmed">25533212</ArticleId></ArticleIdList></Reference><Reference><Citation>Ting AC, Cheng SW, Cheung GC, Wu LL, Hung KN, Fan YW: Perioperative deep vein thrombosis in Chinese patients undergoing craniotomy. Surg Neurol 58:274&#x2013;279, 2002</Citation><ArticleIdList><ArticleId IdType="pubmed">12480241</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">23807721</PMID><DateCompleted><Year>2014</Year><Month>05</Month><Day>29</Day></DateCompleted><DateRevised><Year>2021</Year><Month>10</Month><Day>21</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1432-1750</ISSN><JournalIssue CitedMedium="Internet"><Volume>191</Volume><Issue>5</Issue><PubDate><Year>2013</Year><Month>Oct</Month></PubDate></JournalIssue><Title>Lung</Title><ISOAbbreviation>Lung</ISOAbbreviation></Journal><ArticleTitle>Pulmonary embolism, myocardial infarction, and ischemic stroke in lung cancer patients: results from a longitudinal study.</ArticleTitle><Pagination><StartPage>501</StartPage><EndPage>509</EndPage><MedlinePgn>501-9</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s00408-013-9485-1</ELocationID><Abstract><AbstractText Label="PURPOSE" NlmCategory="OBJECTIVE">In this cohort study, the rates of pulmonary embolism (PE), myocardial infarction (MI), and ischemic stroke (IS) before and after lung cancer (LC) diagnosis were compared to cancer-free controls.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Patients with LC during 2000-2007 were selected from PALGA, the Dutch Pathology Registry, and linked to the PHARMO medical record linkage system, including drug use and hospitalizations of 3 million inhabitants in the Netherlands. Included LC patients were matched 1:10 by age and gender to cancer-free controls. Hospitalizations for PE, MI, and IS were assessed in the 12&#xa0;months before and after LC diagnosis.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">LC patients (N&#xa0;=&#xa0;3,717) were six times more likely than cancer-free controls to have had a PE in the 12&#xa0;months before diagnosis. After LC diagnosis, patients experienced an extremely increased risk of PE in the first 6&#xa0;months (hazard ratio [HR] 16.8; 95&#xa0;% confidence interval [CI] 7.6-36.8) compared with controls), which decreased to a five times increased risk (HR 5.1; 95&#xa0;% CI 2.7-9.4) thereafter. However, there were less than two events per 100 person years during both time periods. LC patients receiving chemotherapy were eight times more likely to develop PE, whereas surgery increased the risk on PE three times. For MI and IS, no significant difference was observed compared with cancer-free controls before or after LC diagnosis.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">LC patients have a higher risk of developing PE compared with cancer-free controls, although the frequency of PE hospitalizations was low. Surgery and chemotherapy were associated with an increased risk of PE.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>van Herk-Sukel</LastName><ForeName>Myrthe P P</ForeName><Initials>MP</Initials><AffiliationInfo><Affiliation>PHARMO Institute for Drug Outcomes Research, P.O. Box 85222, 3508 AE, Utrecht, The Netherlands, myrthe.van.herk@pharmo.nl.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shantakumar</LastName><ForeName>Sumitra</ForeName><Initials>S</Initials></Author><Author ValidYN="Y"><LastName>Penning-van Beest</LastName><ForeName>Fernie J A</ForeName><Initials>FJ</Initials></Author><Author ValidYN="Y"><LastName>Kamphuisen</LastName><ForeName>Pieter W</ForeName><Initials>PW</Initials></Author><Author ValidYN="Y"><LastName>Majoor</LastName><ForeName>Christof J</ForeName><Initials>CJ</Initials></Author><Author ValidYN="Y"><LastName>Overbeek</LastName><ForeName>Lucy I H</ForeName><Initials>LI</Initials></Author><Author ValidYN="Y"><LastName>Herings</LastName><ForeName>Ron M C</ForeName><Initials>RM</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D003160">Comparative Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2013</Year><Month>06</Month><Day>27</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Lung</MedlineTA><NlmUniqueID>7701875</NlmUniqueID><ISSNLinking>0341-2040</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016022" MajorTopicYN="N">Case-Control Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004358" MajorTopicYN="N">Drug Therapy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005500" MajorTopicYN="N">Follow-Up Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015994" MajorTopicYN="N">Incidence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008137" MajorTopicYN="N">Longitudinal Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008175" MajorTopicYN="N">Lung Neoplasms</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009203" MajorTopicYN="N">Myocardial Infarction</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009426" MajorTopicYN="N" Type="Geographic">Netherlands</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011013" MajorTopicYN="N">Pneumonectomy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011655" MajorTopicYN="N">Pulmonary Embolism</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012042" MajorTopicYN="N">Registries</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020521" MajorTopicYN="N">Stroke</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2013</Year><Month>4</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2013</Year><Month>6</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2013</Year><Month>6</Month><Day>29</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2013</Year><Month>6</Month><Day>29</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2014</Year><Month>5</Month><Day>30</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">23807721</ArticleId><ArticleId IdType="doi">10.1007/s00408-013-9485-1</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>J Thorac Oncol. 2007 Aug;2(8):729-34</Citation><ArticleIdList><ArticleId IdType="pubmed">17762339</ArticleId></ArticleIdList></Reference><Reference><Citation>Acta Haematol. 2001;106(1-2):13-7</Citation><ArticleIdList><ArticleId IdType="pubmed">11549772</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Oncol. 2009 Oct 10;27(29):4839-47</Citation><ArticleIdList><ArticleId IdType="pubmed">19720906</ArticleId></ArticleIdList></Reference><Reference><Citation>Melanoma Res. 2009 Oct;19(5):327-32</Citation><ArticleIdList><ArticleId IdType="pubmed">19593232</ArticleId></ArticleIdList></Reference><Reference><Citation>Cancer. 2007 Nov 15;110(10):2339-46</Citation><ArticleIdList><ArticleId IdType="pubmed">17918266</ArticleId></ArticleIdList></Reference><Reference><Citation>Arch Intern Med. 2006 Feb 27;166(4):458-64</Citation><ArticleIdList><ArticleId IdType="pubmed">16505267</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Oncol. 2006 Jan 20;24(3):484-90</Citation><ArticleIdList><ArticleId IdType="pubmed">16421425</ArticleId></ArticleIdList></Reference><Reference><Citation>Thromb Haemost. 2011 Jul;106(1):149-55</Citation><ArticleIdList><ArticleId IdType="pubmed">21614410</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Oncol. 2009 Oct 10;27(29):4902-11</Citation><ArticleIdList><ArticleId IdType="pubmed">19738120</ArticleId></ArticleIdList></Reference><Reference><Citation>BMC Health Serv Res. 2006 Dec 15;6:161</Citation><ArticleIdList><ArticleId IdType="pubmed">17173686</ArticleId></ArticleIdList></Reference><Reference><Citation>J Thromb Haemost. 2004 Oct;2(10):1760-5</Citation><ArticleIdList><ArticleId IdType="pubmed">15456487</ArticleId></ArticleIdList></Reference><Reference><Citation>Arch Intern Med. 2005 Aug 8-22;165(15):1782-7</Citation><ArticleIdList><ArticleId IdType="pubmed">16087828</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet Oncol. 2005 Jun;6(6):401-10</Citation><ArticleIdList><ArticleId IdType="pubmed">15925818</ArticleId></ArticleIdList></Reference><Reference><Citation>IARC Sci Publ. 1987;(82):1-406</Citation><ArticleIdList><ArticleId IdType="pubmed">3329634</ArticleId></ArticleIdList></Reference><Reference><Citation>Br J Cancer. 2010 Sep 28;103(7):947-53</Citation><ArticleIdList><ArticleId IdType="pubmed">20842120</ArticleId></ArticleIdList></Reference><Reference><Citation>Cell Oncol. 2007;29(1):19-24</Citation><ArticleIdList><ArticleId IdType="pubmed">17429138</ArticleId></ArticleIdList></Reference><Reference><Citation>J Thromb Haemost. 2006 Mar;4(3):529-35</Citation><ArticleIdList><ArticleId IdType="pubmed">16460435</ArticleId></ArticleIdList></Reference><Reference><Citation>Haematologica. 2006 Aug;91(8):1052-8</Citation><ArticleIdList><ArticleId IdType="pubmed">16885045</ArticleId></ArticleIdList></Reference><Reference><Citation>J Thromb Haemost. 2007 Jul;5 Suppl 1:246-54</Citation><ArticleIdList><ArticleId IdType="pubmed">17635733</ArticleId></ArticleIdList></Reference><Reference><Citation>Pharmacoepidemiol Drug Saf. 2008 Jan;17(1):20-6</Citation><ArticleIdList><ArticleId IdType="pubmed">17979142</ArticleId></ArticleIdList></Reference><Reference><Citation>Med Care. 1998 Apr;36(4):449-61</Citation><ArticleIdList><ArticleId IdType="pubmed">9544586</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet. 2011 Nov 12;378(9804):1741-55</Citation><ArticleIdList><ArticleId IdType="pubmed">21565397</ArticleId></ArticleIdList></Reference><Reference><Citation>Curr Opin Pulm Med. 2007 Sep;13(5):362-7</Citation><ArticleIdList><ArticleId IdType="pubmed">17940477</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Oncol. 2010 May 10;28(14):2423-9</Citation><ArticleIdList><ArticleId IdType="pubmed">20385997</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Oncol. 2009 Oct 10;27(29):4865-73</Citation><ArticleIdList><ArticleId IdType="pubmed">19704059</ArticleId></ArticleIdList></Reference><Reference><Citation>Arch Intern Med. 2003 Jul 28;163(14):1711-7</Citation><ArticleIdList><ArticleId IdType="pubmed">12885687</ArticleId></ArticleIdList></Reference><Reference><Citation>Thromb Res. 2001 Jun 15;102(6):V187-94</Citation><ArticleIdList><ArticleId IdType="pubmed">11516452</ArticleId></ArticleIdList></Reference><Reference><Citation>J Thromb Haemost. 2008 Apr;6(4):601-8</Citation><ArticleIdList><ArticleId IdType="pubmed">18208538</ArticleId></ArticleIdList></Reference><Reference><Citation>Stroke. 2011 Nov;42(11):3034-9</Citation><ArticleIdList><ArticleId IdType="pubmed">21903961</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Med. 2006 Jan;119(1):60-8</Citation><ArticleIdList><ArticleId IdType="pubmed">16431186</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Oncol. 2009 Oct;20(10):1619-30</Citation><ArticleIdList><ArticleId IdType="pubmed">19561038</ArticleId></ArticleIdList></Reference><Reference><Citation>Arch Intern Med. 1994 Apr 25;154(8):861-6</Citation><ArticleIdList><ArticleId IdType="pubmed">8154949</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">38619204</PMID><DateCompleted><Year>2024</Year><Month>05</Month><Day>27</Day></DateCompleted><DateRevised><Year>2024</Year><Month>05</Month><Day>31</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1827-1839</ISSN><JournalIssue CitedMedium="Internet"><Volume>43</Volume><Issue>2</Issue><PubDate><Year>2024</Year><Month>Apr</Month></PubDate></JournalIssue><Title>International angiology : a journal of the International Union of Angiology</Title><ISOAbbreviation>Int Angiol</ISOAbbreviation></Journal><ArticleTitle>Urological complications caused by inferior vena cava filters: a systematic review.</ArticleTitle><Pagination><StartPage>247</StartPage><EndPage>254</EndPage><MedlinePgn>247-254</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.23736/S0392-9590.24.05041-7</ELocationID><Abstract><AbstractText Label="INTRODUCTION" NlmCategory="BACKGROUND">Inferior vena cava (IVC) filters act in preventing pulmonary embolisms (PE). Various complications have been reported with their use. However, a credible urological complication rate, filter characteristics, and clinical presentation has yet to be summarized. Thus, we reported these complications in the form of a systematic review.</AbstractText><AbstractText Label="EVIDENCE ACQUISITION" NlmCategory="METHODS">A search strategy was designed using PubMed, MEDLINE, and EMBASE on February 10<sup>th</sup>, 2022. The design of this search strategy did not include any language restrictions. The key words (and wildcard terms) used in the search strategy were urolog*, ureter*, bladder, kidney coupled with filter, inferior vena cava, and cava*. Inclusion criteria were: patients older than 18, with previous IVC filter placement, and urologic complication reported. Exclusion criteria were: patients younger than 18, no IVC filter placement, and no urologic complication reported. Other case series and reviews were excluded to avoid patient duplication.</AbstractText><AbstractText Label="EVIDENCE SYNTHESIS" NlmCategory="RESULTS">Thirty-five articles were selected for full-text screening. Thirty-seven patient cases were reviewed, and the median age was 53 (range: 21-92 years old). Abdominal and or flank pain was reported in 16 (43%) patients, hematuria was seen in eight (22%) and two (5%) patients died due to acute renal failure resulting from the urologic complications of the IVC filter. Indications for IVC filter placement were recurrent pulmonary embolism (PE), contraindication to or noncompliance with anticoagulant therapy. The IVC filters were infrarenal in 29 (78.4%) patients, suprarenal in five (13.5%) patients, not reported in two patients, and misplaced into the right ovarian vein in one patient. Three or more imaging modalities were obtained in 19 patients (51%) for planning. IVC filter removal was not performed in 17 (45.9%) patients, endovascular retrieval occurred in nine (24.3%) patients, and open removal was performed in seven (18.9%) patients, and tissue interposition was performed in two (5.4%) patients. One patient did not have the management reported.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Urological complications caused by IVC filters although rare, are likely underreported, require extensive workup, and pose surgical challenges. Due to their complex management, filter retrieval should be planned for as soon as feasible, and plans should be made as early as during the IVC filter implant. For those that do develop complications, clinical judgement must be exercised in management, and open surgical, endovascular or even conservative management strategies can be viable options and should be discussed in a multidisciplinary setting.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Choi</LastName><ForeName>Paul J</ForeName><Initials>PJ</Initials><AffiliationInfo><Affiliation>Division of Vascular Surgery, University of Colorado, Anschutz Medical Campus, Aurora, CO, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kabeil</LastName><ForeName>Mahmood</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Division of Vascular Surgery, University of Colorado, Anschutz Medical Campus, Aurora, CO, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Furtado Neves</LastName><ForeName>Pedro J</ForeName><Initials>PJ</Initials><AffiliationInfo><Affiliation>Division of Vascular Surgery, University of Colorado, Anschutz Medical Campus, Aurora, CO, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Labropoulos</LastName><ForeName>Nicos</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Division of Vascular Surgery, Department of Surgery, Stony Brook University, Stony Brook, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zil-E-Ali</LastName><ForeName>Ahsan</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Surgery, The Pennsylvania State University, College of Medicine, Hershey, PA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Aziz</LastName><ForeName>Faisal</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Surgery, The Pennsylvania State University, College of Medicine, Hershey, PA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Malgor</LastName><ForeName>Emily A</ForeName><Initials>EA</Initials><AffiliationInfo><Affiliation>Division of Vascular Surgery, University of Colorado, Anschutz Medical Campus, Aurora, CO, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Malgor</LastName><ForeName>Rafael D</ForeName><Initials>RD</Initials><AffiliationInfo><Affiliation>Division of Vascular Surgery, University of Colorado, Anschutz Medical Campus, Aurora, CO, USA - rafael.malgor@cuanschutz.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D000078182">Systematic Review</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>04</Month><Day>12</Day></ArticleDate></Article><MedlineJournalInfo><Country>Italy</Country><MedlineTA>Int Angiol</MedlineTA><NlmUniqueID>8402693</NlmUniqueID><ISSNLinking>0392-9590</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D016306" MajorTopicYN="Y">Vena Cava Filters</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011655" MajorTopicYN="Y">Pulmonary Embolism</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006417" MajorTopicYN="N">Hematuria</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020878" MajorTopicYN="N">Device Removal</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014682" MajorTopicYN="N">Vena Cava, Inferior</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014570" MajorTopicYN="N">Urologic Diseases</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>5</Month><Day>27</Day><Hour>12</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>4</Month><Day>15</Day><Hour>12</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>4</Month><Day>15</Day><Hour>8</Hour><Minute>42</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38619204</ArticleId><ArticleId IdType="doi">10.23736/S0392-9590.24.05041-7</ArticleId><ArticleId IdType="pii">S0392-9590.24.05041-7</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">24374549</PMID><DateCompleted><Year>2014</Year><Month>06</Month><Day>27</Day></DateCompleted><DateRevised><Year>2024</Year><Month>12</Month><Day>19</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1528-1140</ISSN><JournalIssue CitedMedium="Internet"><Volume>259</Volume><Issue>6</Issue><PubDate><Year>2014</Year><Month>Jun</Month></PubDate></JournalIssue><Title>Annals of surgery</Title><ISOAbbreviation>Ann Surg</ISOAbbreviation></Journal><ArticleTitle>Preoperative enoxaparin versus postoperative semuloparin thromboprophylaxis in major abdominal surgery: a randomized controlled trial.</ArticleTitle><Pagination><StartPage>1073</StartPage><EndPage>1079</EndPage><MedlinePgn>1073-9</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1097/SLA.0000000000000430</ELocationID><Abstract><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">To compare efficacy and safety of thromboprophylaxis with semuloparin started postoperatively versus enoxaparin started preoperatively in major abdominal surgery.</AbstractText><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Venous thromboembolism is an important complication following major abdominal surgery. Semuloparin is a novel ultra-low-molecular-weight heparin with high antifactor Xa and minimal antifactor IIa activity.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">In this double-blind noninferiority trial, adult patients undergoing major abdominal or pelvic operation under general anesthesia lasting more than 45 minutes were assigned to either daily enoxaparin 40 mg commenced preoperatively or daily semuloparin 20 mg commenced postoperatively, for 7 to 10 days. Patients underwent bilateral leg venography between 7 and 11 days postsurgery. The primary efficacy end point was the composite of any deep vein thrombosis, nonfatal pulmonary embolism, or all-cause death. The primary safety outcome was bleeding. Both were independently adjudicated.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">In total, 4413 patients were randomized; 3030 (1499 in the enoxaparin and 1531 in the semuloparin groups) were evaluable for the primary efficacy end point, which occurred in 97 patients (6.3%) in the semuloparin group and 82 patients (5.5%) in the enoxaparin group [odds ratio (OR) = 1.16, 95% confidence interval (CI): 0.84-1.59]. On the basis of a noninferiority margin of 1.25, postoperative semuloparin did not demonstrate noninferiority to preoperative enoxaparin. Major bleeding occurred in 63 of 2175 patients (2.9%) in the semuloparin group and 98 of 2177 patients (4.5%) in the enoxaparin group (OR = 0.63, 95% CI: 0.46-0.87).</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Semuloparin commenced postoperatively did not demonstrate noninferiority to enoxaparin initiated preoperatively for thromboprophylaxis after major abdominal surgery. Study registered with clinicaltrials.gov: NCT00679588.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Kakkar</LastName><ForeName>Ajay K</ForeName><Initials>AK</Initials><AffiliationInfo><Affiliation>*Thrombosis Research Institute and University College London, London, UK &#x2020;Stroke Unit and Division of Cardiovascular Medicine, Department of Internal Medicine, University of Perugia, Perugia, Italy &#x2021;Department of Orthopaedic Surgery, McGill University Health Centre, Montreal, QC, Canada &#xa7;Duke University Medical Center, Durham, NC &#xb6;Spine Center Copenhagen, Copenhagen University Hospital, Glostrup, Denmark &#x2016;University of Saint-&#xc9;tienne, Saint-&#xc9;tienne, France **Klinikum Frankfurt H&#xf6;echst, Frankfurt, Germany &#x2020;&#x2020;Sanofi, Bridgewater, NJ &#x2021;&#x2021;Hamilton Health Sciences General Hospital, McMaster University, Hamilton, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Agnelli</LastName><ForeName>Giancarlo</ForeName><Initials>G</Initials></Author><Author ValidYN="Y"><LastName>Fisher</LastName><ForeName>William</ForeName><Initials>W</Initials></Author><Author ValidYN="Y"><LastName>George</LastName><ForeName>Daniel</ForeName><Initials>D</Initials></Author><Author ValidYN="Y"><LastName>Lassen</LastName><ForeName>Michael R</ForeName><Initials>MR</Initials></Author><Author ValidYN="Y"><LastName>Mismetti</LastName><ForeName>Patrick</ForeName><Initials>P</Initials></Author><Author ValidYN="Y"><LastName>Mouret</LastName><ForeName>Patrick</ForeName><Initials>P</Initials></Author><Author ValidYN="Y"><LastName>Murphy</LastName><ForeName>Judith</ForeName><Initials>J</Initials></Author><Author ValidYN="Y"><LastName>Lawson</LastName><ForeName>Francesca</ForeName><Initials>F</Initials></Author><Author ValidYN="Y"><LastName>Turpie</LastName><ForeName>Alexander G G</ForeName><Initials>AG</Initials></Author><Author ValidYN="Y"><CollectiveName>SAVE-ABDO Investigators</CollectiveName></Author></AuthorList><Language>eng</Language><DataBankList CompleteYN="Y"><DataBank><DataBankName>ClinicalTrials.gov</DataBankName><AccessionNumberList><AccessionNumber>NCT00679588</AccessionNumber></AccessionNumberList></DataBank></DataBankList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016448">Multicenter Study</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Ann Surg</MedlineTA><NlmUniqueID>0372354</NlmUniqueID><ISSNLinking>0003-4932</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D017984">Enoxaparin</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D005343">Fibrinolytic Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D006495">Heparin, Low-Molecular-Weight</NameOfSubstance></Chemical><Chemical><RegistryNumber>4QW4AN84NQ</RegistryNumber><NameOfSubstance UI="C569346">semuloparin</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000005" MajorTopicYN="N">Abdomen</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004305" MajorTopicYN="N">Dose-Response Relationship, Drug</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004311" MajorTopicYN="N">Double-Blind Method</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017984" MajorTopicYN="N">Enoxaparin</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="Y">administration &amp; dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005343" MajorTopicYN="N">Fibrinolytic Agents</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005500" MajorTopicYN="N">Follow-Up Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006495" MajorTopicYN="N">Heparin, Low-Molecular-Weight</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="Y">administration &amp; dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011184" MajorTopicYN="N">Postoperative Period</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057234" MajorTopicYN="N">Preoperative Period</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013514" MajorTopicYN="N">Surgical Procedures, Operative</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D054556" MajorTopicYN="N">Venous Thromboembolism</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading></MeshHeadingList><InvestigatorList><Investigator ValidYN="Y"><LastName>Turpie</LastName><ForeName>A G G</ForeName><Initials>AG</Initials></Investigator><Investigator ValidYN="Y"><LastName>Agnelli</LastName><ForeName>G</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>George</LastName><ForeName>D</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Fisher</LastName><ForeName>W</ForeName><Initials>W</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kakkar</LastName><ForeName>A K</ForeName><Initials>AK</Initials></Investigator><Investigator ValidYN="Y"><LastName>Lassen</LastName><ForeName>M R</ForeName><Initials>MR</Initials></Investigator><Investigator ValidYN="Y"><LastName>Mismetti</LastName><ForeName>P</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Mouret</LastName><ForeName>P</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Levine</LastName><ForeName>M</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Leizorovicz</LastName><ForeName>A</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Borris</LastName><ForeName>L</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Buyse</LastName><ForeName>M</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Fisher</LastName><ForeName>M R</ForeName><Initials>MR</Initials></Investigator><Investigator ValidYN="Y"><LastName>White</LastName><ForeName>R H</ForeName><Initials>RH</Initials></Investigator><Investigator ValidYN="Y"><LastName>Larrey</LastName><ForeName>D</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bluguerman</LastName><ForeName>J</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Carlevaro</LastName><ForeName>O</ForeName><Initials>O</Initials></Investigator><Investigator ValidYN="Y"><LastName>Damia</LastName><ForeName>O</ForeName><Initials>O</Initials></Investigator><Investigator ValidYN="Y"><LastName>Gaite</LastName><ForeName>L</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Hendler</LastName><ForeName>H</ForeName><Initials>H</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kevorkian</LastName><ForeName>R</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Tatangelo</LastName><ForeName>M</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Facello</LastName><ForeName>A</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Chong</LastName><ForeName>B</ForeName><Initials>B</Initials></Investigator><Investigator ValidYN="Y"><LastName>Coughlin</LastName><ForeName>P</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Salem</LastName><ForeName>H</ForeName><Initials>H</Initials></Investigator><Investigator ValidYN="Y"><LastName>Carroll</LastName><ForeName>P</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Mischinger</LastName><ForeName>H-J</ForeName><Initials>HJ</Initials></Investigator><Investigator ValidYN="Y"><LastName>Schauer</LastName><ForeName>W</ForeName><Initials>W</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ceelen</LastName><ForeName>W</ForeName><Initials>W</Initials></Investigator><Investigator ValidYN="Y"><LastName>Verhelst</LastName><ForeName>H</ForeName><Initials>H</Initials></Investigator><Investigator ValidYN="Y"><LastName>Figueiredo</LastName><ForeName>L</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Freire</LastName><ForeName>A</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Genzini</LastName><ForeName>T</ForeName><Initials>T</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kato</LastName><ForeName>M</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Paula</LastName><ForeName>A</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Pereira</LastName><ForeName>A</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Robles</LastName><ForeName>L</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Souza</LastName><ForeName>H</ForeName><Initials>H</Initials></Investigator><Investigator ValidYN="Y"><LastName>Wainstein</LastName><ForeName>A</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Westphal</LastName><ForeName>G</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>Von Bahten</LastName><ForeName>L</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Brienze</LastName><ForeName>S</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Giovanardi</LastName><ForeName>R</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Scarpelini</LastName><ForeName>S</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Lefterov</LastName><ForeName>G</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ninov</LastName><ForeName>B</ForeName><Initials>B</Initials></Investigator><Investigator ValidYN="Y"><LastName>Petrov</LastName><ForeName>N</ForeName><Initials>N</Initials></Investigator><Investigator ValidYN="Y"><LastName>Platikanov</LastName><ForeName>V</ForeName><Initials>V</Initials></Investigator><Investigator ValidYN="Y"><LastName>Tcherveniakov</LastName><ForeName>A</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Grigorov</LastName><ForeName>G</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>Madjov</LastName><ForeName>R</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Draganov</LastName><ForeName>K</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>Beliakouski</LastName><ForeName>V</ForeName><Initials>V</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bordakov</LastName><ForeName>V</ForeName><Initials>V</Initials></Investigator><Investigator ValidYN="Y"><LastName>Dosta</LastName><ForeName>N</ForeName><Initials>N</Initials></Investigator><Investigator ValidYN="Y"><LastName>Erushevich</LastName><ForeName>A</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kuzmin</LastName><ForeName>Y</ForeName><Initials>Y</Initials></Investigator><Investigator ValidYN="Y"><LastName>Mikhailova</LastName><ForeName>E</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Shchastny</LastName><ForeName>A</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Shmak</LastName><ForeName>A</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Zhu</LastName><ForeName>N</ForeName><Initials>N</Initials></Investigator><Investigator ValidYN="Y"><LastName>Woods</LastName><ForeName>A</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Telang</LastName><ForeName>H</ForeName><Initials>H</Initials></Investigator><Investigator ValidYN="Y"><LastName>McFadyen</LastName><ForeName>C</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Warriner</LastName><ForeName>B</ForeName><Initials>B</Initials></Investigator><Investigator ValidYN="Y"><LastName>Dolan</LastName><ForeName>S</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Stein</LastName><ForeName>B</ForeName><Initials>B</Initials></Investigator><Investigator ValidYN="Y"><LastName>Farries</LastName><ForeName>L</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bellolio</LastName><ForeName>F</ForeName><Initials>F</Initials></Investigator><Investigator ValidYN="Y"><LastName>Guerra Castro</LastName><ForeName>J F</ForeName><Initials>JF</Initials></Investigator><Investigator ValidYN="Y"><LastName>Vigueras</LastName><ForeName>G</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bainan</LastName><ForeName>L</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Zhou</LastName><ForeName>F</ForeName><Initials>F</Initials></Investigator><Investigator ValidYN="Y"><LastName>Lu</LastName><ForeName>J</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Shi</LastName><ForeName>K</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>Wang</LastName><ForeName>L</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Zhou</LastName><ForeName>Y</ForeName><Initials>Y</Initials></Investigator><Investigator ValidYN="Y"><LastName>Huang</LastName><ForeName>F</ForeName><Initials>F</Initials></Investigator><Investigator ValidYN="Y"><LastName>Li</LastName><ForeName>M</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Li</LastName><ForeName>Y</ForeName><Initials>Y</Initials></Investigator><Investigator ValidYN="Y"><LastName>Peng</LastName><ForeName>B</ForeName><Initials>B</Initials></Investigator><Investigator ValidYN="Y"><LastName>Zhao</LastName><ForeName>Y</ForeName><Initials>Y</Initials></Investigator><Investigator ValidYN="Y"><LastName>Gluhacic</LastName><ForeName>B</ForeName><Initials>B</Initials></Investigator><Investigator ValidYN="Y"><LastName>Horzic</LastName><ForeName>M</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Simlesa</LastName><ForeName>D</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Divis</LastName><ForeName>P</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ryska</LastName><ForeName>M</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Mrazek</LastName><ForeName>T</ForeName><Initials>T</Initials></Investigator><Investigator ValidYN="Y"><LastName>Baader</LastName><ForeName>M</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Neumann</LastName><ForeName>J</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Penka</LastName><ForeName>I</ForeName><Initials>I</Initials></Investigator><Investigator ValidYN="Y"><LastName>Visokai</LastName><ForeName>V</ForeName><Initials>V</Initials></Investigator><Investigator ValidYN="Y"><LastName>Lajmar</LastName><ForeName>K</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>Sauer</LastName><ForeName>M</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Meduna</LastName><ForeName>J</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Sakra</LastName><ForeName>L</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Stembera</LastName><ForeName>S</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Hendrych</LastName><ForeName>D</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Buzek</LastName><ForeName>J</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Schnack</LastName><ForeName>M</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ovist</LastName><ForeName>N</ForeName><Initials>N</Initials></Investigator><Investigator ValidYN="Y"><LastName>Soplepmann</LastName><ForeName>J</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Tein</LastName><ForeName>A</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Teras</LastName><ForeName>J</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Birth</LastName><ForeName>M</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>B&#xfc;chler</LastName><ForeName>M</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Schilling</LastName><ForeName>M</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Schellong</LastName><ForeName>S</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Uhl</LastName><ForeName>W</ForeName><Initials>W</Initials></Investigator><Investigator ValidYN="Y"><LastName>Winkler</LastName><ForeName>M</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Schuhmacher</LastName><ForeName>C</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kujath</LastName><ForeName>P</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Boehner</LastName><ForeName>H</ForeName><Initials>H</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ridwelski</LastName><ForeName>K</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>Chalkiadakis</LastName><ForeName>G</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>Sz&#xe1;nt&#xf3;</LastName><ForeName>Z</ForeName><Initials>Z</Initials></Investigator><Investigator ValidYN="Y"><LastName>Altorjay</LastName><ForeName>A</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Damjanovich</LastName><ForeName>L</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Lazar</LastName><ForeName>G</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>Csap&#xf3;</LastName><ForeName>Z</ForeName><Initials>Z</Initials></Investigator><Investigator ValidYN="Y"><LastName>Augustine</LastName><ForeName>A</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Gupta</LastName><ForeName>A</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kapoor</LastName><ForeName>V</ForeName><Initials>V</Initials></Investigator><Investigator ValidYN="Y"><LastName>Behari</LastName><ForeName>A</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kukreja</LastName><ForeName>A</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Mehta</LastName><ForeName>R</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Pitchamuthu</LastName><ForeName>A</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Hariharan</LastName><ForeName>R</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Mayakonda</LastName><ForeName>R</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Sudhir</LastName><ForeName>Rawal</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Venkat</LastName><ForeName>Rao</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Rozario</LastName><ForeName>A</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Sastry</LastName><ForeName>R</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Dhar</LastName><ForeName>P</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Menon</LastName><ForeName>R</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Janaviculam</LastName><ForeName>R</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Chaitanvanand</LastName><ForeName>K</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>Hemanth</LastName><ForeName>R</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Devarajan</LastName><ForeName>T</ForeName><Initials>T</Initials></Investigator><Investigator ValidYN="Y"><LastName>Yuvaraja</LastName><ForeName>S</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Harish</LastName><ForeName>K</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>Annamalai</LastName><ForeName>R</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Mathur</LastName><ForeName>J</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kalambe</LastName><ForeName>B</ForeName><Initials>B</Initials></Investigator><Investigator ValidYN="Y"><LastName>Vora</LastName><ForeName>H</ForeName><Initials>H</Initials></Investigator><Investigator ValidYN="Y"><LastName>Abhijith</LastName><ForeName>C</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Chowdappa</LastName><ForeName>R</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Srinivasalu</LastName><ForeName>M</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Mehta</LastName><ForeName>A</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Samaiya</LastName><ForeName>A</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Virk</LastName><ForeName>S</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Voonna</LastName><ForeName>M</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bertoglio</LastName><ForeName>S</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Terranova</LastName><ForeName>O</ForeName><Initials>O</Initials></Investigator><Investigator ValidYN="Y"><LastName>Silingardi</LastName><ForeName>M</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Di Carlo</LastName><ForeName>V</ForeName><Initials>V</Initials></Investigator><Investigator ValidYN="Y"><LastName>Liguori</LastName><ForeName>G</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>Quintavalla</LastName><ForeName>R</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Belluco</LastName><ForeName>C</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Grossi</LastName><ForeName>P</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Levkin</LastName><ForeName>Y</ForeName><Initials>Y</Initials></Investigator><Investigator ValidYN="Y"><LastName>Baldini</LastName><ForeName>E</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Imberti</LastName><ForeName>D</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Gianetta</LastName><ForeName>E</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Gvu-Seok</LastName><ForeName>C</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Chun</LastName><ForeName>H-K</ForeName><Initials>HK</Initials></Investigator><Investigator ValidYN="Y"><LastName>Han</LastName><ForeName>S-Y</ForeName><Initials>SY</Initials></Investigator><Investigator ValidYN="Y"><LastName>Hyung</LastName><ForeName>W J</ForeName><Initials>WJ</Initials></Investigator><Investigator ValidYN="Y"><LastName>Park</LastName><ForeName>Y J</ForeName><Initials>YJ</Initials></Investigator><Investigator ValidYN="Y"><LastName>In</LastName><ForeName>H K</ForeName><Initials>HK</Initials></Investigator><Investigator ValidYN="Y"><LastName>Yu</LastName><ForeName>C S</ForeName><Initials>CS</Initials></Investigator><Investigator ValidYN="Y"><LastName>Choi</LastName><ForeName>S K</ForeName><Initials>SK</Initials></Investigator><Investigator ValidYN="Y"><LastName>Yang</LastName><ForeName>H-K</ForeName><Initials>HK</Initials></Investigator><Investigator ValidYN="Y"><LastName>Pupelis</LastName><ForeName>G</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>Krievins</LastName><ForeName>D</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Novikovs</LastName><ForeName>N</ForeName><Initials>N</Initials></Investigator><Investigator ValidYN="Y"><LastName>Zelobovskis</LastName><ForeName>J</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Endzinas</LastName><ForeName>Z</ForeName><Initials>Z</Initials></Investigator><Investigator ValidYN="Y"><LastName>Gradauskas</LastName><ForeName>A</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Venskutonis</LastName><ForeName>D</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Chavez-Michel</LastName><ForeName>J</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Javer-Fernandez</LastName><ForeName>E</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Mark</LastName><ForeName>S</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Meffan</LastName><ForeName>P</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Smith</LastName><ForeName>M</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Gronbech</LastName><ForeName>J E</ForeName><Initials>JE</Initials></Investigator><Investigator ValidYN="Y"><LastName>Arias</LastName><ForeName>J</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Flores Mena</LastName><ForeName>M</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Flores Yabar</LastName><ForeName>J</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Colca Ccahuana</LastName><ForeName>M</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Luque Vasquez</LastName><ForeName>C</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Munoz</LastName><ForeName>A</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Santillana</LastName><ForeName>J</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Dabrowiecki</LastName><ForeName>S</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Dziki</LastName><ForeName>A</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Jawien</LastName><ForeName>A</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Krasnodebski</LastName><ForeName>I</ForeName><Initials>I</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kulig</LastName><ForeName>J</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Sledzinski</LastName><ForeName>Z</ForeName><Initials>Z</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bednarz</LastName><ForeName>W</ForeName><Initials>W</Initials></Investigator><Investigator ValidYN="Y"><LastName>Grzebieniak</LastName><ForeName>Z</ForeName><Initials>Z</Initials></Investigator><Investigator ValidYN="Y"><LastName>Modzelewski</LastName><ForeName>B</ForeName><Initials>B</Initials></Investigator><Investigator ValidYN="Y"><LastName>Wallner</LastName><ForeName>G</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>Jackowski</LastName><ForeName>M</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Karczewski</LastName><ForeName>M</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kladny</LastName><ForeName>J</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ciostek</LastName><ForeName>P</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Starzewski</LastName><ForeName>J</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Witkiewicz</LastName><ForeName>W</ForeName><Initials>W</Initials></Investigator><Investigator ValidYN="Y"><LastName>Labza</LastName><ForeName>H</ForeName><Initials>H</Initials></Investigator><Investigator ValidYN="Y"><LastName>Drop</LastName><ForeName>R</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Lesi</LastName><ForeName>C</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Negrau</LastName><ForeName>M</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Sandesc</LastName><ForeName>D</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ciuce</LastName><ForeName>C</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Duse</LastName><ForeName>T</ForeName><Initials>T</Initials></Investigator><Investigator ValidYN="Y"><LastName>Nadim</LastName><ForeName>A H</ForeName><Initials>AH</Initials></Investigator><Investigator ValidYN="Y"><LastName>Muntean</LastName><ForeName>V</ForeName><Initials>V</Initials></Investigator><Investigator ValidYN="Y"><LastName>Rodoman</LastName><ForeName>G</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>Shulutko</LastName><ForeName>A</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ushakov</LastName><ForeName>I</ForeName><Initials>I</Initials></Investigator><Investigator ValidYN="Y"><LastName>Karapetvan</LastName><ForeName>G</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>Isakov</LastName><ForeName>A</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Shevcova</LastName><ForeName>O</ForeName><Initials>O</Initials></Investigator><Investigator ValidYN="Y"><LastName>Parfeev</LastName><ForeName>S</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Shcherbakov</LastName><ForeName>P</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Korolev</LastName><ForeName>M</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Lenskaya</LastName><ForeName>L</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Staroverov</LastName><ForeName>I</ForeName><Initials>I</Initials></Investigator><Investigator ValidYN="Y"><LastName>Agafina</LastName><ForeName>A</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Matevosyan</LastName><ForeName>E</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Oseshnuk</LastName><ForeName>R</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Topuzov</LastName><ForeName>E</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Medvedev</LastName><ForeName>V</ForeName><Initials>V</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bychkova</LastName><ForeName>L</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ruchkin</LastName><ForeName>D</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Severtsev</LastName><ForeName>A</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Vyushkov</LastName><ForeName>D</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Hadzi Djokic</LastName><ForeName>J</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Marusic</LastName><ForeName>G</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ivanovic</LastName><ForeName>N</ForeName><Initials>N</Initials></Investigator><Investigator ValidYN="Y"><LastName>Hutan</LastName><ForeName>M</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Osole</LastName><ForeName>M</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Potrc</LastName><ForeName>S</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Pretorius</LastName><ForeName>C F</ForeName><Initials>CF</Initials></Investigator><Investigator ValidYN="Y"><LastName>Van Zyl</LastName><ForeName>L</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Warren</LastName><ForeName>B</ForeName><Initials>B</Initials></Investigator><Investigator ValidYN="Y"><LastName>Rafecas</LastName><ForeName>A</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Tellado</LastName><ForeName>J M</ForeName><Initials>JM</Initials></Investigator><Investigator ValidYN="Y"><LastName>Andr&#xe9;n-Sandberg</LastName><ForeName>A</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Mardani</LastName><ForeName>J</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Lundgren</LastName><ForeName>A</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Edin</LastName><ForeName>R</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Franz&#xe9;n</LastName><ForeName>T</ForeName><Initials>T</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kurtoglu</LastName><ForeName>M</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Aygun</LastName><ForeName>E</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Karahan</LastName><ForeName>S R</ForeName><Initials>SR</Initials></Investigator><Investigator ValidYN="Y"><LastName>Cokmez</LastName><ForeName>A</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Dubovyi</LastName><ForeName>V</ForeName><Initials>V</Initials></Investigator><Investigator ValidYN="Y"><LastName>Paramonov</LastName><ForeName>V</ForeName><Initials>V</Initials></Investigator><Investigator ValidYN="Y"><LastName>Cheshuk</LastName><ForeName>V</ForeName><Initials>V</Initials></Investigator><Investigator ValidYN="Y"><LastName>Shchepotin</LastName><ForeName>I</ForeName><Initials>I</Initials></Investigator><Investigator ValidYN="Y"><LastName>Sedakov</LastName><ForeName>I</ForeName><Initials>I</Initials></Investigator><Investigator ValidYN="Y"><LastName>Zaychuk</LastName><ForeName>A</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Borota</LastName><ForeName>O</ForeName><Initials>O</Initials></Investigator><Investigator ValidYN="Y"><LastName>Datsenko</LastName><ForeName>O</ForeName><Initials>O</Initials></Investigator><Investigator ValidYN="Y"><LastName>Cohen</LastName><ForeName>A</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Touliatos</LastName><ForeName>J G</ForeName><Initials>JG</Initials></Investigator><Investigator ValidYN="Y"><LastName>Berger</LastName><ForeName>D</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Wilson</LastName><ForeName>M A</ForeName><Initials>MA</Initials></Investigator><Investigator ValidYN="Y"><LastName>Lal</LastName><ForeName>R</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Wittgen</LastName><ForeName>C</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Taylor</LastName><ForeName>W E</ForeName><Initials>WE</Initials></Investigator><Investigator ValidYN="Y"><LastName>Waxman</LastName><ForeName>K</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>De Moya</LastName><ForeName>M A</ForeName><Initials>MA</Initials></Investigator><Investigator ValidYN="Y"><LastName>Velmahos</LastName><ForeName>G C</ForeName><Initials>GC</Initials></Investigator><Investigator ValidYN="Y"><LastName>Mancuso</LastName><ForeName>P</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kerwin</LastName><ForeName>A J</ForeName><Initials>AJ</Initials></Investigator><Investigator ValidYN="Y"><LastName>Luchette</LastName><ForeName>F A</ForeName><Initials>FA</Initials></Investigator><Investigator ValidYN="Y"><LastName>Goodman</LastName><ForeName>E</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Maroni</LastName><ForeName>P D</ForeName><Initials>PD</Initials></Investigator><Investigator ValidYN="Y"><LastName>Minkowitz</LastName><ForeName>H S</ForeName><Initials>HS</Initials></Investigator><Investigator ValidYN="Y"><LastName>Williams</LastName><ForeName>D</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Erickson</LastName><ForeName>K</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>Valenzuela</LastName><ForeName>G</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>Griswold</LastName><ForeName>J</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ward</LastName><ForeName>J A</ForeName><Initials>JA</Initials></Investigator><Investigator ValidYN="Y"><LastName>Hassan</LastName><ForeName>I</ForeName><Initials>I</Initials></Investigator><Investigator ValidYN="Y"><LastName>Koura</LastName><ForeName>F A</ForeName><Initials>FA</Initials></Investigator><Investigator ValidYN="Y"><LastName>Murray</LastName><ForeName>R M</ForeName><Initials>RM</Initials></Investigator><Investigator ValidYN="Y"><LastName>Cassim</LastName><ForeName>R</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Candiotti</LastName><ForeName>K</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>Wood</LastName><ForeName>M T</ForeName><Initials>MT</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bergese</LastName><ForeName>S D</ForeName><Initials>SD</Initials></Investigator></InvestigatorList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2013</Year><Month>12</Month><Day>31</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2014</Year><Month>1</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2014</Year><Month>6</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">24374549</ArticleId><ArticleId IdType="doi">10.1097/SLA.0000000000000430</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">31481323</PMID><DateCompleted><Year>2021</Year><Month>01</Month><Day>06</Day></DateCompleted><DateRevised><Year>2021</Year><Month>01</Month><Day>06</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1460-9584</ISSN><JournalIssue CitedMedium="Internet"><Volume>26</Volume><Issue>6</Issue><PubDate><Year>2020</Year><Month>Aug</Month></PubDate></JournalIssue><Title>Foot and ankle surgery : official journal of the European Society of Foot and Ankle Surgeons</Title><ISOAbbreviation>Foot Ankle Surg</ISOAbbreviation></Journal><ArticleTitle>Risk factors for symptomatic venous thromboembolism following surgery for closed ankle fractures: A case-control study.</ArticleTitle><Pagination><StartPage>681</StartPage><EndPage>686</EndPage><MedlinePgn>681-686</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.fas.2019.08.006</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S1268-7731(19)30138-9</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">We analyzed risk factors for venous thromboembolism (VTE) within 6 months after surgery for closed ankle fractures.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">This was a case-control study based on data from chart review in a cohort of patients having open reduction and internal fixation (ORIF) for closed ankle fractures in two large general hospitals 2009-2011. Cases with symptomatic VTE (pulmonary embolism or deep venous thrombosis) were identified in the cohort, and additional cases of VTE were identified by computerized search of discharge diagnoses in the same hospitals in 2004-2008 and 2012-2016. In total, we identified 60 cases with VTE and compared with 240 randomly selected controls among 998 patients without VTE in the cohort. Risk factors were assessed using logistic regression analysis.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Among cases, 27 (45%) had pulmonary embolism, 33 (55%) deep venous thrombosis. Those with VTE were older, had higher BMI, had more often a family history of VTE, and more often had antibiotic prophylaxis during surgery than controls. In multivariable logistic regression analysis age/10 (OR 25.75, 95%CI 3.52-188.44, p=0.001), (age/10)<sup>2</sup> (OR 0.77, 95%CI 0.65-0.93, p=0.005), BMI (1.15 per kg/m<sup>2</sup>, 95%CI 1.07-1.24, p&lt;0.001) and Charlson comorbidity index &#x2265;2 vs.0 (OR 0.27, 95%CI 0.08-0.92, p=0.036) and 1 vs. 0 (OR 0.27, 95%CI 0.09-0.86, p=0.026) were associated with VTE within 6 months of surgery.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">The odds of symptomatic VTE within 6 months of ORIF increased with increasing age and BMI, but were lower with increasing comorbidity.</AbstractText><CopyrightInformation>Copyright &#xa9; 2019 European Foot and Ankle Society. Published by Elsevier Ltd. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Stavem</LastName><ForeName>Knut</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Institute of Clinical Medicine, University of Oslo, Norway; Health Services Research Unit, Akershus University Hospital, Norway; Department of Pulmonary Medicine, Medical Division, Akershus University Hospital, Norway. Electronic address: knut.stavem@medisin.uio.no.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Skjaker</LastName><ForeName>Stein Arve</ForeName><Initials>SA</Initials><AffiliationInfo><Affiliation>Section for Orthopaedic Emergency, Orthopaedic Department, Oslo University Hospital, Norway.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hoel</LastName><ForeName>Henrik</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Vascular Surgery, Oslo University Hospital, Aker, Norway.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Naumann</LastName><ForeName>Markus Georg</ForeName><Initials>MG</Initials><AffiliationInfo><Affiliation>Department of Orthopaedics, &#xd8;stfold Hospital, Norway.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sigurdsen</LastName><ForeName>Ulf</ForeName><Initials>U</Initials><AffiliationInfo><Affiliation>Department of Orthopaedics, Akershus University Hospital, Norway.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ghanima</LastName><ForeName>Waleed</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Institute of Clinical Medicine, University of Oslo, Norway; Department of Medicine, &#xd8;stfold Hospital, Norway.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Utv&#xe5;g</LastName><ForeName>Stein Erik</ForeName><Initials>SE</Initials><AffiliationInfo><Affiliation>Institute of Clinical Medicine, University of Oslo, Norway; Department of Orthopaedics, Akershus University Hospital, Norway.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2019</Year><Month>08</Month><Day>28</Day></ArticleDate></Article><MedlineJournalInfo><Country>France</Country><MedlineTA>Foot Ankle Surg</MedlineTA><NlmUniqueID>9609647</NlmUniqueID><ISSNLinking>1268-7731</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000367" MajorTopicYN="N">Age Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D064386" MajorTopicYN="N">Ankle Fractures</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015992" MajorTopicYN="N">Body Mass Index</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016022" MajorTopicYN="N">Case-Control Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015897" MajorTopicYN="N">Comorbidity</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005596" MajorTopicYN="N">Fractures, Closed</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009765" MajorTopicYN="N">Obesity</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="Y">Postoperative Complications</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D054556" MajorTopicYN="N">Venous Thromboembolism</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Ankle fracture</Keyword><Keyword MajorTopicYN="N">Case-control</Keyword><Keyword MajorTopicYN="N">Deep venous thrombosis</Keyword><Keyword MajorTopicYN="N">Lung embolism</Keyword><Keyword MajorTopicYN="N">ORIF</Keyword><Keyword MajorTopicYN="N">Risk factors</Keyword><Keyword MajorTopicYN="N">Venous thromboembolism</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2019</Year><Month>6</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2019</Year><Month>7</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2019</Year><Month>8</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>9</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>1</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>9</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31481323</ArticleId><ArticleId IdType="doi">10.1016/j.fas.2019.08.006</ArticleId><ArticleId IdType="pii">S1268-7731(19)30138-9</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">27466030</PMID><DateCompleted><Year>2017</Year><Month>06</Month><Day>09</Day></DateCompleted><DateRevised><Year>2022</Year><Month>04</Month><Day>08</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1528-1175</ISSN><JournalIssue CitedMedium="Internet"><Volume>125</Volume><Issue>4</Issue><PubDate><Year>2016</Year><Month>Oct</Month></PubDate></JournalIssue><Title>Anesthesiology</Title><ISOAbbreviation>Anesthesiology</ISOAbbreviation></Journal><ArticleTitle>Anesthesia Technique and Mortality after Total Hip or Knee Arthroplasty: A Retrospective, Propensity Score-matched Cohort Study.</ArticleTitle><Pagination><StartPage>724</StartPage><EndPage>731</EndPage><MedlinePgn>724-31</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1097/ALN.0000000000001248</ELocationID><Abstract><AbstractText Label="BACKGROUND">This propensity score-matched cohort study evaluates the effect of anesthetic technique on a 30-day mortality after total hip or knee arthroplasty.</AbstractText><AbstractText Label="METHODS">All patients who had hip or knee arthroplasty between January 1, 2003, and December 31, 2014, were evaluated. The principal exposure was spinal versus general anesthesia. The primary outcome was 30-day mortality. Secondary outcomes were (1) perioperative myocardial infarction; (2) a composite of major adverse cardiac events that includes cardiac arrest, myocardial infarction, or newly diagnosed arrhythmia; (3) pulmonary embolism; (4) major blood loss; (5) hospital length of stay; and (6) operating room procedure time. A propensity score-matched-pair analysis was performed using a nonparsimonious logistic regression model of regional anesthetic use.</AbstractText><AbstractText Label="RESULTS">We identified 10,868 patients, of whom 8,553 had spinal anesthesia and 2,315 had general anesthesia. Ninety-two percent (n = 2,135) of the patients who had general anesthesia were matched to similar patients who did not have general anesthesia. In the matched cohort, the 30-day mortality rate was 0.19% (n = 4) in the spinal anesthesia group and 0.8% (n = 17) in the general anesthesia group (risk ratio, 0.42; 95% CI, 0.21 to 0.83; P = 0.0045). Spinal anesthesia was also associated with a shorter hospital length of stay (5.7 vs. 6.6 days; P &lt; 0.001).</AbstractText><AbstractText Label="CONCLUSIONS">The results of this observational, propensity score-matched cohort study suggest a strong association between spinal anesthesia and lower 30-day mortality, as well as a shorter hospital length of stay, after elective joint replacement surgery.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Perlas</LastName><ForeName>Anahi</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>From the Department of Anesthesia, University of Toronto, Toronto Western Hospital, University Health Network, Toronto, Ontario, Canada (A.P., V.W.S.C.); and the Department of Anesthesia, University of Toronto, Toronto General Hospital, University Health Network, Toronto, Ontario, Canada (S.B.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chan</LastName><ForeName>Vincent W S</ForeName><Initials>VW</Initials></Author><Author ValidYN="Y"><LastName>Beattie</LastName><ForeName>Scott</ForeName><Initials>S</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D064888">Observational Study</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Anesthesiology</MedlineTA><NlmUniqueID>1300217</NlmUniqueID><ISSNLinking>0003-3022</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Reg Anesth Pain Med. 2020 Nov;45(11):934-936. doi: 10.1136/rapm-2020-101578.</RefSource><PMID Version="1">32561653</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000768" MajorTopicYN="N">Anesthesia, General</DescriptorName><QualifierName UI="Q000401" MajorTopicYN="Y">mortality</QualifierName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000775" MajorTopicYN="N">Anesthesia, Spinal</DescriptorName><QualifierName UI="Q000401" MajorTopicYN="Y">mortality</QualifierName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019644" MajorTopicYN="N">Arthroplasty, Replacement, Hip</DescriptorName><QualifierName UI="Q000401" MajorTopicYN="Y">mortality</QualifierName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019645" MajorTopicYN="N">Arthroplasty, Replacement, Knee</DescriptorName><QualifierName UI="Q000401" MajorTopicYN="Y">mortality</QualifierName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016063" MajorTopicYN="N">Blood Loss, Surgical</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007902" MajorTopicYN="N">Length of Stay</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016017" MajorTopicYN="N">Odds Ratio</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D061646" MajorTopicYN="N">Operative Time</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057216" MajorTopicYN="Y">Propensity Score</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2016</Year><Month>7</Month><Day>29</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2016</Year><Month>7</Month><Day>29</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2017</Year><Month>6</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">27466030</ArticleId><ArticleId IdType="doi">10.1097/ALN.0000000000001248</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">25424529</PMID><DateCompleted><Year>2016</Year><Month>04</Month><Day>25</Day></DateCompleted><DateRevised><Year>2016</Year><Month>11</Month><Day>25</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1938-2723</ISSN><JournalIssue CitedMedium="Internet"><Volume>21</Volume><Issue>6</Issue><PubDate><Year>2015</Year><Month>Sep</Month></PubDate></JournalIssue><Title>Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis</Title><ISOAbbreviation>Clin Appl Thromb Hemost</ISOAbbreviation></Journal><ArticleTitle>Wells Score and Poor Outcomes Among Adult Patients With Subsegmental Pulmonary Embolism: A Cohort Study.</ArticleTitle><Pagination><StartPage>539</StartPage><EndPage>545</EndPage><MedlinePgn>539-45</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1177/1076029614559772</ELocationID><Abstract><AbstractText Label="INTRODUCTION" NlmCategory="BACKGROUND">Since the introduction of computed tomography pulmonary angiography, isolated subsegmental pulmonary embolism has become a commonly recognized clinical problem, but its clinical relevance remains unclear. The objective of the present study was to evaluate the extent to which the simplified Wells score discriminates between patients with varying levels of risk of complications after presenting with subsegmental pulmonary embolism.</AbstractText><AbstractText Label="MATERIALS AND METHODS" NlmCategory="METHODS">Retrospective cohort study. Patients included had subsegmental pulmonary embolism (1 or multiple emboli limited to subsegmental arteries). Primary explanatory variable was the simplified Wells score, categorized as high (&gt;4) or low (&#x2264;4). The primary outcome was time to death or new venous thromboembolism. Kaplan-Meier techniques and Cox regression analysis were used to compare the survival experience of patients with high versus low Wells score with and without adjustment for active malignancy, age, Charlson score, previous venous thromboembolism, and previous major surgery in the last 30 days.</AbstractText><AbstractText Label="MAIN RESULTS" NlmCategory="RESULTS">Seventy-nine patients with subsegmental pulmonary embolism were included. Patients with a high Wells score had a 4-fold increased risk of the composite outcome (hazard ratio = 4.2, 95% confidence interval [CI] = 2.0-8.9, P &lt; .001). Other covariates significantly associated with increased risk in univariate analyses included active malignancy, a low serum albumin, and an increased Charlson score. In multivariate Cox regression analyses adjusting for these other factors, a high Wells score remained significant (hazard ratio 5.5, 95% CI 2.4-12.6, P &lt; .001).</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">High Wells score is associated with death or new venous thromboembolism during follow-up among patients with subsegmental pulmonary embolism.</AbstractText><AbstractText Label="CLINICAL TRIAL REGISTRATION" NlmCategory="BACKGROUND">ClinicalTrials.gov number, NCT01372514.</AbstractText><CopyrightInformation>&#xa9; The Author(s) 2014.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Angriman</LastName><ForeName>Federico</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Internal Medicine Department, Hospital Italiano de Buenos Aires, Buenos Aires University, Buenos Aires, Argentina federico.angriman@hospitalitaliano.org.ar.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ferreyro</LastName><ForeName>Bruno L</ForeName><Initials>BL</Initials><AffiliationInfo><Affiliation>Internal Medicine Department, Hospital Italiano de Buenos Aires, Buenos Aires University, Buenos Aires, Argentina.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Posadas-Martinez</LastName><ForeName>Mar&#xed;a L</ForeName><Initials>ML</Initials><AffiliationInfo><Affiliation>Internal Medicine Research Unit, Hospital Italiano de Buenos Aires, Buenos Aires, Argentina.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Giunta</LastName><ForeName>Diego</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Internal Medicine Research Unit, Hospital Italiano de Buenos Aires, Buenos Aires, Argentina.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vazquez</LastName><ForeName>Fernando J</ForeName><Initials>FJ</Initials><AffiliationInfo><Affiliation>Internal Medicine Department, Hospital Italiano de Buenos Aires, Buenos Aires, Argentina.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vollmer</LastName><ForeName>William M</ForeName><Initials>WM</Initials><AffiliationInfo><Affiliation>Kaiser Permanente Center for Health Research, Portland, OR, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><DataBankList CompleteYN="Y"><DataBank><DataBankName>ClinicalTrials.gov</DataBankName><AccessionNumberList><AccessionNumber>NCT01372514</AccessionNumber></AccessionNumberList></DataBank></DataBankList><PublicationTypeList><PublicationType UI="D016430">Clinical Trial</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2014</Year><Month>11</Month><Day>25</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Clin Appl Thromb Hemost</MedlineTA><NlmUniqueID>9508125</NlmUniqueID><ISSNLinking>1076-0296</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000792" MajorTopicYN="N">Angiography</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011655" MajorTopicYN="N">Pulmonary Embolism</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="Y">diagnostic imaging</QualifierName><QualifierName UI="Q000401" MajorTopicYN="Y">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012720" MajorTopicYN="N">Severity of Illness Index</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014057" MajorTopicYN="N">Tomography, X-Ray Computed</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">pulmonary embolism</Keyword><Keyword MajorTopicYN="N">risk factors</Keyword><Keyword MajorTopicYN="N">subsegmental</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2014</Year><Month>11</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2014</Year><Month>11</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2016</Year><Month>4</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">25424529</ArticleId><ArticleId IdType="doi">10.1177/1076029614559772</ArticleId><ArticleId IdType="pii">1076029614559772</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">31066352</PMID><DateCompleted><Year>2019</Year><Month>12</Month><Day>09</Day></DateCompleted><DateRevised><Year>2019</Year><Month>12</Month><Day>17</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">2245-1919</ISSN><JournalIssue CitedMedium="Internet"><Volume>66</Volume><Issue>5</Issue><PubDate><Year>2019</Year><Month>May</Month></PubDate></JournalIssue><Title>Danish medical journal</Title><ISOAbbreviation>Dan Med J</ISOAbbreviation></Journal><ArticleTitle>Venous thromboembolic complications following surgical treatment for degenerative spinal disease.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">A5541</ELocationID><Abstract><AbstractText Label="INTRODUCTION" NlmCategory="BACKGROUND">A venous thromboembolism (VTE), i.e. deep vein thrombosis (DVT) or pulmonary embolism (PE), is a potentially lethal complication to surgical procedures. The aim of this study was to evaluate the incidence of symptomatic VTEs in a large consecutive Danish cohort treated surgically for degenerative spinal disease.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">This was a retrospective, consecutive, one-centre cohort study of patients treated surgically for either cervical or lumbar degenerative disease. According to the local treatment protocol, patients with an increased risk of VTE received rivaroxaban as thrombosis prophylaxis. VTE events within six months from the surgical procedure were identified via the Danish National Patient Register and confirmed by patient chart review.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">A total of 6,145 surgical procedures were included - 808 cervical and 5,337 lumbar procedures. Twelve patients (0.2%) were examined on suspicion of symptomatic VTE, ten for DVT and two for PE. VTE was confirmed in eight patients (0.1%), seven DVT and one PE. One patient died within six months, producing a mortality rate of 0.01%.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">VTEs are an uncommon but potentially lethal complication in patients who undergo surgery for a degenerative spinal disease. Incidence and mortality were low in a consecutive cohort where rivaroxaban was used as thrombosis prophylaxis in patients with an increased preoperative risk of VTE.</AbstractText><AbstractText Label="FUNDING" NlmCategory="BACKGROUND">none.</AbstractText><AbstractText Label="TRIAL REGISTRATION" NlmCategory="BACKGROUND">not relevant.</AbstractText><CopyrightInformation>Articles published in the DMJ are &#x201c;open access&#x201d;. This means that the articles are distributed under the terms of the Creative Commons Attribution Non-commercial License, which permits any non-commercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Winther</LastName><ForeName>Casper F</ForeName><Initials>CF</Initials><AffiliationInfo><Affiliation>cwlrsn@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Thomsen</LastName><ForeName>Karsten</ForeName><Initials>K</Initials></Author><Author ValidYN="Y"><LastName>S&#xf8;rensen</LastName><ForeName>Lars P</ForeName><Initials>LP</Initials></Author><Author ValidYN="Y"><LastName>Jenstrup</LastName><ForeName>Morten</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Thomsen</LastName><ForeName>Frederik B</ForeName><Initials>FB</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>Denmark</Country><MedlineTA>Dan Med J</MedlineTA><NlmUniqueID>101576205</NlmUniqueID><ISSNLinking>2245-1919</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000925">Anticoagulants</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000925" MajorTopicYN="N">Anticoagulants</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015994" MajorTopicYN="N">Incidence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011655" MajorTopicYN="N">Pulmonary Embolism</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013122" MajorTopicYN="N">Spinal Diseases</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D054556" MajorTopicYN="N">Venous Thromboembolism</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020246" MajorTopicYN="N">Venous Thrombosis</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>5</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>5</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>12</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31066352</ArticleId><ArticleId IdType="pii">A5541</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36210021</PMID><DateCompleted><Year>2022</Year><Month>12</Month><Day>20</Day></DateCompleted><DateRevised><Year>2023</Year><Month>03</Month><Day>20</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2213-3348</ISSN><JournalIssue CitedMedium="Internet"><Volume>11</Volume><Issue>1</Issue><PubDate><Year>2023</Year><Month>Jan</Month></PubDate></JournalIssue><Title>Journal of vascular surgery. Venous and lymphatic disorders</Title><ISOAbbreviation>J Vasc Surg Venous Lymphat Disord</ISOAbbreviation></Journal><ArticleTitle>Improved long-term outcomes with catheter-directed therapies over medical management in patients with submassive pulmonary embolism-a retrospective matched cohort study.</ArticleTitle><Pagination><StartPage>70</StartPage><EndPage>81</EndPage><MedlinePgn>70-81</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jvsv.2022.09.007</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S2213-333X(22)00420-6</ELocationID><Abstract><AbstractText Label="BACKGROUND">The benefit of catheter-directed therapy (CDT) for submassive pulmonary embolism (sPE) has been the subject of debate. We sought to determine the short- and long-term mortality and outcomes of CDT compared with anticoagulation for patients with sPE.</AbstractText><AbstractText Label="METHODS">We performed a single healthcare network, multihospital, retrospective cohort study of hospitalizations for sPE from 2012 to 2019. sPE was defined as the presence of right heart strain or elevated biomarkers (troponin I or B-type natriuretic peptide). Patients with massive PE and those who had undergone systemic thrombolysis were excluded. The sPE groups included therapeutic anticoagulation alone or anticoagulation plus CDT (ie, thrombolysis or suction thrombectomy). The primary outcome was mortality at 1, 3, and 5&#xa0;years. The other measured outcomes included PE-related death, short term mortality (30&#xa0;days and 3 and 6&#xa0;months), 30-day treatment-related complications (eg,&#xa0;bleeding, transfusion, stroke), chronic thromboembolic pulmonary hypertension, and 6-minute walk test at 1&#xa0;year. After 1:1 nearest-neighbor propensity score matching, Kaplan-Meier survival plots were generated, and the treatment groups were compared using log-rank testing. We used Cox multivariate analysis to evaluate the outcomes after clustering at the hospital level, generating matched hazard ratios (mHRs) with associated 95% confidence intervals (CIs).</AbstractText><AbstractText Label="RESULTS">Of 6746 sPE hospitalizations, the patients who had received CDT were younger (age, 58.9&#xa0;&#xb1; 15.5&#xa0;years vs 61.5&#xa0;&#xb1; 17.4&#xa0;years; P&#xa0;= .004), were more frequently White (92.5% vs 85.7%; P&#xa0;&lt; .001), and had presented with a higher mean heart rate (104.6 bpm vs 94.9 bpm; P&#xa0;&lt; .001), lower median systolic blood pressure (129&#xa0;mm Hg vs 135&#xa0;mm Hg; P&#xa0;&lt; .001), and a greater incidence of right heart strain (79.2% vs 20.3%; P&#xa0;&lt; .001). A total of 470 patients were matched, with 235 in the CDT group and 235 in the anticoagulation-only group. CDT was associated with a lower risk of mortality compared with anticoagulation at 1&#xa0;year (7.6% vs 9.8%; mHR, 0.77; 95% CI, 0.65-0.92; P&#xa0;= .004), 3&#xa0;years (11.1% vs 16.6%; mHR, 0.64; 95% CI, 0.55-0.73; P&#xa0;&lt; .001), and 5&#xa0;years (14.5% vs 19.1%; mHR, 0.71; 95% CI, 0.66-0.77; P&#xa0;&lt; .001). Anticoagulation alone resulted in a greater incidence of PE-related deaths at 1, 3, and 5&#xa0;years. The mortality at 30&#xa0;days and 3&#xa0;months was similar; however, CDT had resulted in better survival at 6&#xa0;months (mHR, 0.81; 95% CI, 0.68-0.97; P&#xa0;= .02). No differences were found between the two groups in the incidence of bleeding complications at 30&#xa0;days, development of chronic thromboembolic pulmonary hypertension, or the mean walking distance at 1&#xa0;year.</AbstractText><AbstractText Label="CONCLUSIONS">CDT plus anticoagulation for sPE was associated with improved long-term survival compared with anticoagulation alone, with a lower incidence of PE-related death and a low complication rate. CDT should be considered for select patients with sPE given its survival benefit.</AbstractText><CopyrightInformation>Copyright &#xa9; 2022 Society for Vascular Surgery. Published by Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Semaan</LastName><ForeName>Dana B</ForeName><Initials>DB</Initials><AffiliationInfo><Affiliation>Division of Vascular Surgery, University of Pittsburgh Medical Center, Pittsburgh, PA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Phillips</LastName><ForeName>Amanda R</ForeName><Initials>AR</Initials><AffiliationInfo><Affiliation>Division of Vascular Surgery, University of Pittsburgh Medical Center, Pittsburgh, PA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Reitz</LastName><ForeName>Katherine</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Surgery, University of Pittsburgh Medical Center, Pittsburgh, PA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sridharan</LastName><ForeName>Natalie</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Division of Vascular Surgery, University of Pittsburgh Medical Center, Pittsburgh, PA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mulukutla</LastName><ForeName>Suresh</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Division of Cardiology, University of Pittsburgh Medical Center, Pittsburgh, PA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Avgerinos</LastName><ForeName>Efthymios</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Division of Vascular Surgery, University of Pittsburgh Medical Center, Pittsburgh, PA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Eslami</LastName><ForeName>Mohammad H</ForeName><Initials>MH</Initials><AffiliationInfo><Affiliation>Division of Vascular Surgery, University of Pittsburgh Medical Center, Pittsburgh, PA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chaer</LastName><ForeName>Rabih</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Division of Vascular Surgery, University of Pittsburgh Medical Center, Pittsburgh, PA. Electronic address: chaerra@upmc.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>L30 AG064730</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>T32 HL098036</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>10</Month><Day>06</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Vasc Surg Venous Lymphat Disord</MedlineTA><NlmUniqueID>101607771</NlmUniqueID><ISSNLinking>2213-333X</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000925">Anticoagulants</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015912" MajorTopicYN="N">Thrombolytic Therapy</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006976" MajorTopicYN="Y">Hypertension, Pulmonary</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011655" MajorTopicYN="Y">Pulmonary Embolism</DescriptorName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D057785" MajorTopicYN="N">Catheters</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000925" MajorTopicYN="N">Anticoagulants</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Anticoagulation</Keyword><Keyword MajorTopicYN="N">CDT</Keyword><Keyword MajorTopicYN="N">Catheter-directed therapy</Keyword><Keyword MajorTopicYN="N">Outcomes</Keyword><Keyword MajorTopicYN="N">Submassive pulmonary embolism</Keyword><Keyword MajorTopicYN="N">sPE</Keyword></KeywordList><CoiStatement>Author conflict of interest: none. The editors and reviewers of this article have no relevant financial relationships to disclose per the Journal polity that requires reviewers to decline review of any manuscript for which they may have a conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>8</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>9</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>10</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>12</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>10</Month><Day>9</Day><Hour>19</Hour><Minute>26</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>3</Month><Day>18</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36210021</ArticleId><ArticleId IdType="mid">NIHMS1879221</ArticleId><ArticleId IdType="pmc">PMC10024252</ArticleId><ArticleId IdType="doi">10.1016/j.jvsv.2022.09.007</ArticleId><ArticleId IdType="pii">S2213-333X(22)00420-6</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Barco S, Valerio L, Ageno W, Cohen AT, Goldhaber SZ, Hunt BJ, et al. Age-sex specific pulmonary embolism-related mortality in the USA and Canada, 2000&#x2013;18: an analysis of the WHO Mortality Database and of the CDC Multiple Cause of Death database. Lancet Respir Med 2021:933&#x2013;42.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7550106</ArticleId><ArticleId IdType="pubmed">33058771</ArticleId></ArticleIdList></Reference><Reference><Citation>Giordano NJ, Jansson PS, Young MN, Hagan KA, Kabrhel C. Epidemiology, pathophysiology, stratification, and natural history of pulmonary embolism. Tech Vase Interv Radiol 2017;20:135&#x2013;40.</Citation><ArticleIdList><ArticleId IdType="pubmed">29029707</ArticleId></ArticleIdList></Reference><Reference><Citation>Konstantinides SV, Meyer C, Becattini C, Bueno H, Geersing G-J, Harjola V-P, et al. 2019. ESC guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS): the task force for the diagnosis and management of acute pulmonary embolism of the European Society of Cardiology (ESC). Eur Respir J 2019:54:1901647.</Citation><ArticleIdList><ArticleId IdType="pubmed">31473594</ArticleId></ArticleIdList></Reference><Reference><Citation>Fasullo S, Scalzo S, Maringhini G, Ganci F, Cannizzaro S, Terrazzino G, et al. Six-month echocardiographic study in patients with submassive pulmonary embolism and right ventricle dysfunction: comparison of thrombolysis with heparin. Am J Med Sci 2011:34133&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">20890176</ArticleId></ArticleIdList></Reference><Reference><Citation>Meyer G, Vicaut E, Danays T, Agnelli G, Becattini C, Beyer-Westendorf 3, et al. Fibrinolysis for patients with intermediate-risk pulmonary embolism. N Engl J Med 2014;370:1402&#x2013;11.</Citation><ArticleIdList><ArticleId IdType="pubmed">24716681</ArticleId></ArticleIdList></Reference><Reference><Citation>Nakamura S, Takano H, Kubota V, Asai K, Shimizu W. Impact of the efficacy of thrombolytic therapy on the mortality of patients with acute submassive pulmonary embolism: a meta-analysis. J Thromb Haemost 2014;12:1086&#x2013;95.</Citation><ArticleIdList><ArticleId IdType="pubmed">24829097</ArticleId></ArticleIdList></Reference><Reference><Citation>Marti C, John G, Konstantinides S, Combescure C, Sanchez O, Lankeit M, et al. Systemic thrombolytic therapy for acute pulmonary embolism: a systematic review and meta-analysis. Eur Heart J 2015;36:605&#x2013;14.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4352209</ArticleId><ArticleId IdType="pubmed">24917641</ArticleId></ArticleIdList></Reference><Reference><Citation>Liang NL, Avgerinos ED, Singh MJ, Makaroun MS, Chaer RA. Systemic thrombolysis increases hemorrhagic stroke risk without survival benefit compared to catheter-directed intervention for the treatment of acute pulmonary embolism. J Vase Surg Venous Lymphat Disord 2017;5:171&#x2013;6.el.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5324829</ArticleId><ArticleId IdType="pubmed">28214483</ArticleId></ArticleIdList></Reference><Reference><Citation>Kucher N, Boekstegers P. M&#xfc;ller OJ, Kupatt C, Beyer-Westendorf J, Heitzer T, et al. ULTIMA randomized, controlled trial of ultrasound-assisted catheter-directed thrombolysis for acute intermediate-risk pulmonary embolism. Circulation 2014;129:479&#x2013;86.</Citation><ArticleIdList><ArticleId IdType="pubmed">24226805</ArticleId></ArticleIdList></Reference><Reference><Citation>D&#x2019;Auria S, Sezer A, Thoma F, Sharbaugh M, McKibben J, Maholic R, et al. Outcomes of catheter-directed thrombolysis vs. standard medical therapy in patients with acute submassive pulmonary embolism. Pulm Circ 2020:10. 2045894019898368.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7144676</ArticleId><ArticleId IdType="pubmed">32292583</ArticleId></ArticleIdList></Reference><Reference><Citation>Avgerinos ED, Liang NL, El-Shazly OM, Toma C, Singh MJ, Makaroun MS, et al. Improved early right ventricular function recovery but increased complications with catheter-directed interventions compared with anticoagulation alone for submassive pulmonary embolism. J Vase Surg Venous Lymphat Disord 2016:4: 268&#x2013;75.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7151648</ArticleId><ArticleId IdType="pubmed">27318043</ArticleId></ArticleIdList></Reference><Reference><Citation>Centers for Disease Control and Prevention. CDC Museum COVID-19 Timeline. Available at, https://www.cdc.gov/museum/timeline/covid19.html.
Accessed
June 9, 2022.</Citation></Reference><Reference><Citation>von Elm E, Altman DC, Egger M, Pocock SJ, G&#xf8;tzsche PC, Vandenbroucke JP. The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies. Int J Surg 2014;12:1495&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">25046131</ArticleId></ArticleIdList></Reference><Reference><Citation>Phillips AR, Reitz KM, Myers S, Thoma F, Andraska EA, Jano A, et al. Association between black race, clinical severity, and management of acute pulmonary embolism: a retrospective cohort study. J Am Heart Assoc 2021;10:e021818.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8649302</ArticleId><ArticleId IdType="pubmed">34431356</ArticleId></ArticleIdList></Reference><Reference><Citation>Agency for Healthcare Research and Quality. Healthcare Cost and Utilization Project: User Support. NIS Description of Data Elements: Hosp. Bedsize &#x2013; Bedsize Hosp, https://www.hcup-us.ahrq.gov/db/vars/hosp_bedsize/nisnote.jsp.
Accessed
March 14, 2022.</Citation></Reference><Reference><Citation>Avgerinos ED, Chaer RA. Catheter-directed interventions for acute pulmonary embolism. J Vase Surg 2015:61559&#x2013;65.</Citation><ArticleIdList><ArticleId IdType="pubmed">25524824</ArticleId></ArticleIdList></Reference><Reference><Citation>Reitz KM, Marroquin OC, Zenati MS, Kennedy J, Korytkowski M, Tzeng E, et al. Association between preoperative metformin exposure and postoperative outcomes in adults with type 2 diabetes. JAMA Surg 2020:155:e200416.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7142798</ArticleId><ArticleId IdType="pubmed">32267474</ArticleId></ArticleIdList></Reference><Reference><Citation>Klok FA, Couturaud F, Delcroix M, Humbert M. Diagnosis of chronic thromboembolic pulmonary hypertension after acute pulmonary embolism. Eur Respir J 2020:55:2000189.</Citation><ArticleIdList><ArticleId IdType="pubmed">32184319</ArticleId></ArticleIdList></Reference><Reference><Citation>ATS Committee on Proficiency Standards for Clinical Pulmonary Function Laboratories. ATS statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med 2002;166:111&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">12091180</ArticleId></ArticleIdList></Reference><Reference><Citation>Austin PC. An introduction to propensity score methods for reducing the effects of confounding in observational studies. Multivar Behav Res 2011;46:399&#x2013;424.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3144483</ArticleId><ArticleId IdType="pubmed">21818162</ArticleId></ArticleIdList></Reference><Reference><Citation>Stein PD, Matta F, Hughes MJ. Catheter-directed thrombolysis in submassive pulmonary embolism and acute cor pulmonale. Am J Cardiol 2020;131:109&#x2013;14.</Citation><ArticleIdList><ArticleId IdType="pubmed">32718549</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin DS, Lin V, Wu C, Lin H, Lee J. Midterm prognosis of patients with pulmonary embolism receiving catheter-directed thrombolysis or systemic thrombolysis: a nationwide population-based study. J Am Heart Assoc 2021;10:e019296.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8174309</ArticleId><ArticleId IdType="pubmed">33787288</ArticleId></ArticleIdList></Reference><Reference><Citation>Weeda ER, Hakamiun KM, Leschorn HX, Tran E. Comorbid cancer and use of thrombolysis in acute pulmonary embolism. J Thromb Thrombolysis 2019;47:324&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">30448999</ArticleId></ArticleIdList></Reference><Reference><Citation>Ende-Verhaar VM, Cannegieter SC, Noordegraaf AV, Delcroix M, Pruszczyk P, Mairuhu ATA et al. Incidence of chronic thromboembolic pulmonary hypertension after acute pulmonary embolism: a contemporary view of the published literature. Eur Respir J 2017:49:1601792.</Citation><ArticleIdList><ArticleId IdType="pubmed">28232411</ArticleId></ArticleIdList></Reference><Reference><Citation>Konstantinides SV, Vicaut E, Danays T, Becattini C, Bertoletti L, Beyer-Westendorf J, et al. Impact of thrombolytic therapy on the long-term outcome of intermediate-risk pulmonary embolism. J Am Coll Cardiol 2017;69:1536&#x2013;44.</Citation><ArticleIdList><ArticleId IdType="pubmed">28335835</ArticleId></ArticleIdList></Reference><Reference><Citation>Konstantinides SV, Rosenfield K. A randomized trial of ultrasound-facilitated, catheter-directed, thrombolysis versus anticoagulation for acute intermediate-high risk pulmonary embolism: the higher-risk pulmonary embolism thrombolysis study, https://dinicaltrials.gov/ct2/show/NCT04790370.
Accessed
March 28, 2022.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">33548221</PMID><DateCompleted><Year>2021</Year><Month>10</Month><Day>19</Day></DateCompleted><DateRevised><Year>2021</Year><Month>10</Month><Day>19</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1931-3543</ISSN><JournalIssue CitedMedium="Internet"><Volume>159</Volume><Issue>6</Issue><PubDate><Year>2021</Year><Month>Jun</Month></PubDate></JournalIssue><Title>Chest</Title><ISOAbbreviation>Chest</ISOAbbreviation></Journal><ArticleTitle>Quality of Life 3 and 12 Months Following Acute Pulmonary Embolism: Analysis From a Prospective Multicenter Cohort Study.</ArticleTitle><Pagination><StartPage>2428</StartPage><EndPage>2438</EndPage><MedlinePgn>2428-2438</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.chest.2021.01.071</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0012-3692(21)00242-7</ELocationID><Abstract><AbstractText Label="BACKGROUND">Few data are available on the long-term course and predictors of quality of life (QoL) following acute pulmonary embolism (PE).</AbstractText><AbstractText Label="RESEARCH QUESTION">What are the kinetics and determinants of disease-specific and generic health-related QoL 3 and 12&#xa0;months following an acute PE?</AbstractText><AbstractText Label="STUDY DESIGN AND METHODS">The Follow-up after Acute Pulmonary Embolism (FOCUS) study prospectively followed up consecutive adult patients with objectively diagnosed PE. Patients were considered for study who completed the Pulmonary Embolism Quality of Life (PEmb-QoL) questionnaire at predefined visits 3 and 12&#xa0;months following PE. The course of disease-specific QoL as assessed using the PEmb-QoL and the impact of baseline characteristics using multivariable mixed effects linear regression were studied; also assessed was the course of generic QoL as evaluated by using the EuroQoL Group 5-Dimension 5-Level utility index and the EuroQoL Visual Analog Scale.</AbstractText><AbstractText Label="RESULTS">In 620 patients (44%&#xa0;women; median age, 62 years), overall disease-specific QoL improved from 3 to 12&#xa0;months, with a decrease in the median PEmb-QoL score from 19.4%&#xa0;to 13.0%&#xa0;and a mean individual change of -4.3%&#xa0;(95%&#xa0;CI, -3.2 to -5.5). Female sex, cardiopulmonary disease, and higher BMI were associated with worse QoL at both 3 and 12&#xa0;months. Over time, the association with BMI became weaker, whereas older age and previous VTE were associated with worsening QoL. Generic QoL also improved: the mean &#xb1; SD EuroQoL Group 5-Dimension 5-Level utility index increased from 0.85 &#xb1; 0.22 to 0.87 &#xb1; 0.20 and the visual analog scale from 72.9 &#xb1; 18.8 to 74.4 &#xb1; 19.1.</AbstractText><AbstractText Label="INTERPRETATION">In a large cohort of survivors of acute PE, the change of QoL was quantified between months 3 and 12 following diagnosis, and factors independently associated with lower QoL and slower recovery of QoL were identified. This information may facilitate the planning and interpretation of clinical trials assessing QoL and help guide patient management.</AbstractText><AbstractText Label="CLINICAL TRIAL REGISTRATION">German Clinical Trials Registry (Deutsches Register Klinischer Studien: www.drks.de); No.: DRKS00005939.</AbstractText><CopyrightInformation>Copyright &#xa9; 2021 The Authors. Published by Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Valerio</LastName><ForeName>Luca</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Center for Thrombosis and Hemostasis, University Medical Center of the Johannes Gutenberg University, Mainz, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Barco</LastName><ForeName>Stefano</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Center for Thrombosis and Hemostasis, University Medical Center of the Johannes Gutenberg University, Mainz, Germany; Clinic of Angiology, University Hospital Zurich, Zurich, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jankowski</LastName><ForeName>Marius</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Center for Thrombosis and Hemostasis, University Medical Center of the Johannes Gutenberg University, Mainz, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rosenkranz</LastName><ForeName>Stephan</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Heart Center at the University Hospital Cologne, and Cologne Cardiovascular Research Center, Cologne, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lankeit</LastName><ForeName>Mareike</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Center for Thrombosis and Hemostasis, University Medical Center of the Johannes Gutenberg University, Mainz, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Held</LastName><ForeName>Matthias</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Abteilung f&#xfc;r Innere Medizin, Missions&#xe4;rztliche Klinik W&#xfc;rzburg, W&#xfc;rzburg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gerhardt</LastName><ForeName>Felix</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Heart Center at the University Hospital Cologne, and Cologne Cardiovascular Research Center, Cologne, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bruch</LastName><ForeName>Leonhard</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Klinik f&#xfc;r Innere Medizin und Kardiologie, Unfallkrankenhaus Berlin, Berlin, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ewert</LastName><ForeName>Ralf</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department for Internal Medicine, Greifswald University Hospital, Greifswald, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Faehling</LastName><ForeName>Martin</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Klinik f&#xfc;r Kardiologie, Angiologie und Pneumologie, Klinikum Esslingen, Esslingen am Neckar, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Freise</LastName><ForeName>Julia</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Klinik f&#xfc;r Pneumologie, Medizinische Hochschule Hannover, Member of the German Center for Lung Research (DZL), Hannover, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ghofrani</LastName><ForeName>Hossein-Ardeschir</ForeName><Initials>HA</Initials><AffiliationInfo><Affiliation>Lung Center at the University of Giessen and Marburg, Member of the German Center for Lung Research (DZL), Marburg, Germany; Department of Medicine, Imperial College London, London, England.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gr&#xfc;nig</LastName><ForeName>Ekkehard</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Center for Pulmonary Hypertension, Thoraxklinik at Heidelberg University Hospital, Heidelberg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Halank</LastName><ForeName>Michael</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Medizinische Klinik und Poliklinik I, Universit&#xe4;tsklinikum an der TU Dresden, Dresden, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hoeper</LastName><ForeName>Marius M</ForeName><Initials>MM</Initials><AffiliationInfo><Affiliation>Klinik f&#xfc;r Pneumologie, Medizinische Hochschule Hannover, Member of the German Center for Lung Research (DZL), Hannover, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Klok</LastName><ForeName>Frederikus A</ForeName><Initials>FA</Initials><AffiliationInfo><Affiliation>Department of Thrombosis and Hemostasis, Leiden University Medical Center, Leiden, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Leuchte</LastName><ForeName>Hanno H</ForeName><Initials>HH</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine II, Neuwittelsbach Academic Hospital, Ludwig Maximilians University, Member of the DZL, Munich, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mayer</LastName><ForeName>Eckhard</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Thoracic Surgery, Kerckhoff Heart and Lung Center, Bad Nauheim, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Meyer</LastName><ForeName>F Joachim</ForeName><Initials>FJ</Initials><AffiliationInfo><Affiliation>Lungenzentrum M&#xfc;nchen, Klinik f&#xfc;r Pneumologie und Pneumologische Onkologie, Klinikum Bogenhausen, Munich, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Neurohr</LastName><ForeName>Claus</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Medizinische Klinik und Poliklinik, LMU Klinikum der Universit&#xe4;t M&#xfc;nchen, Munich, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Opitz</LastName><ForeName>Christian</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Klinik f&#xfc;r Innere Medizin, DRK Kliniken Berlin Westend, Berlin, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schmidt</LastName><ForeName>Kai-Helge</ForeName><Initials>KH</Initials><AffiliationInfo><Affiliation>Center for Cardiology, Cardiology 1, University Medical Center of the Johannes Gutenberg University, Mainz, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Seyfarth</LastName><ForeName>Hans-J&#xfc;rgen</ForeName><Initials>HJ</Initials><AffiliationInfo><Affiliation>Department of Pneumology, Universit&#xe4;tsklinikum Leipzig A&#xf6;R, Leipzig, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Trudzinski</LastName><ForeName>Franziska</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Saarland University Medical Center, Homburg, Germany; Pneumology and Critical Care Medicine at University Hospital Heidelberg, Translational Lung Research Center Heidelberg (TLRC), Member of German Center for Lung Research (DZL), Heidelberg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wachter</LastName><ForeName>Rolf</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Klinik und Poliklinik f&#xfc;r Kardiologie, Universit&#xe4;tsklinikum Leipzig A&#xf6;R, Leipzig, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wilkens</LastName><ForeName>Heinrike</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Saarland University Medical Center, Homburg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wild</LastName><ForeName>Philipp S</ForeName><Initials>PS</Initials><AffiliationInfo><Affiliation>Center for Thrombosis and Hemostasis, University Medical Center of the Johannes Gutenberg University, Mainz, Germany; Preventive Cardiology and Preventive Medicine, Center for Cardiology, University Medical Center of the Johannes Gutenberg University, Mainz, Germany; German Center for Cardiovascular Research (DZHK), Partner Site RheinMain, Mainz, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Konstantinides</LastName><ForeName>Stavros V</ForeName><Initials>SV</Initials><AffiliationInfo><Affiliation>Center for Thrombosis and Hemostasis, University Medical Center of the Johannes Gutenberg University, Mainz, Germany; Department of Cardiology, Democritus University of Thrace, Alexandroupolis, Greece. Electronic address: stavros.konstantinides@unimedizin-mainz.de.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><DataBankList CompleteYN="Y"><DataBank><DataBankName>DRKS</DataBankName><AccessionNumberList><AccessionNumber>DRKS00005939</AccessionNumber></AccessionNumberList></DataBank></DataBankList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016448">Multicenter Study</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>02</Month><Day>03</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Chest</MedlineTA><NlmUniqueID>0231335</NlmUniqueID><ISSNLinking>0012-3692</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Chest. 2021 Jun;159(6):2153-2155. doi: 10.1016/j.chest.2021.02.003.</RefSource><PMID Version="1">34099127</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000208" MajorTopicYN="N">Acute Disease</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005500" MajorTopicYN="N">Follow-Up Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005858" MajorTopicYN="N" Type="Geographic">Germany</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011379" MajorTopicYN="N">Prognosis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011655" MajorTopicYN="N">Pulmonary Embolism</DescriptorName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000523" MajorTopicYN="Y">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011788" MajorTopicYN="Y">Quality of Life</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011795" MajorTopicYN="N">Surveys and Questionnaires</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015996" MajorTopicYN="N">Survival Rate</DescriptorName><QualifierName UI="Q000639" MajorTopicYN="N">trends</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013997" MajorTopicYN="N">Time Factors</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">EQ-5D-5L</Keyword><Keyword MajorTopicYN="N">PeMB-QoL</Keyword><Keyword MajorTopicYN="N">VTE</Keyword><Keyword MajorTopicYN="N">patient-centered outcomes</Keyword><Keyword MajorTopicYN="N">patient-reported outcomes</Keyword><Keyword MajorTopicYN="N">pulmonary embolism</Keyword><Keyword MajorTopicYN="N">quality of life</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>8</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2021</Year><Month>1</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>1</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>2</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>10</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>2</Month><Day>6</Day><Hour>20</Hour><Minute>9</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33548221</ArticleId><ArticleId IdType="doi">10.1016/j.chest.2021.01.071</ArticleId><ArticleId IdType="pii">S0012-3692(21)00242-7</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">26316113</PMID><DateCompleted><Year>2016</Year><Month>08</Month><Day>29</Day></DateCompleted><DateRevised><Year>2022</Year><Month>04</Month><Day>19</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1432-2323</ISSN><JournalIssue CitedMedium="Internet"><Volume>40</Volume><Issue>2</Issue><PubDate><Year>2016</Year><Month>Feb</Month></PubDate></JournalIssue><Title>World journal of surgery</Title><ISOAbbreviation>World J Surg</ISOAbbreviation></Journal><ArticleTitle>Incidence of Venous Thromboembolism Following Laparoscopic Surgery for Gastrointestinal Cancer: A Single-Center, Prospective Cohort Study.</ArticleTitle><Pagination><StartPage>309</StartPage><EndPage>314</EndPage><MedlinePgn>309-14</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s00268-015-3234-y</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">The occurrence of venous thromboembolism (VTE), manifesting as deep vein thrombosis or pulmonary embolism, after gastric and colorectal cancer surgery remains poorly characterized. The purpose of this study was to investigate the incidence of VTE following laparoscopic surgery in Japanese patients with gastric and colorectal cancer and identify the associated risk factors.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">We prospectively analyzed VTE events after laparoscopic surgery for gastric and colorectal cancer from April 2012 to March 2013 in our institute. Deep vein thrombosis was diagnosed with Doppler ultrasound sonography of the lower limb. Thromboprophylaxis, graduated compression stockings, and intermittent pneumatic compression were used in all patients. Fondaparinux sodium was used in several patients. We examined all patients' plasma D-dimer levels throughout the perioperative period.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">In total, 101 patients were enrolled in this study; 71 who underwent laparoscopic surgery for gastrointestinal cancer were finally analyzed. Thirteen patients (18.3 %) developed asymptomatic VTE. There were no relationships between the development of VTE and perioperative factors such as cardiovascular disease, operation time, blood loss, postoperative complications, and fondaparinux administration. Neoadjuvant treatment (chemotherapy or chemoradiotherapy) was significantly associated with VTE (p &lt; 0.05). Plasma D-dimer levels were higher 7 days after surgery in patients with than without VTE, although the levels remained high after surgery in all patients.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">The incidence of VTE among Japanese patients who underwent laparoscopic surgery for gastrointestinal cancer was not low. In particular, clinicians should consider the higher risk of VTE in patients undergoing neoadjuvant therapy.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Kimura</LastName><ForeName>Yasue</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Surgery and Science, Graduate School of Medical Sciences, Kyushu University, 3-1-1 Maidashi Higashi-ku, Fukuoka, 812-8582, Japan. yasuek@surg2.med.kyushu-u.ac.jp.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Gastroenterological Surgery, Clinical Research Institute, National Hospital Organization Kyushu Medical Center, Fukuoka, Japan. yasuek@surg2.med.kyushu-u.ac.jp.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Oki</LastName><ForeName>Eiji</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Surgery and Science, Graduate School of Medical Sciences, Kyushu University, 3-1-1 Maidashi Higashi-ku, Fukuoka, 812-8582, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ando</LastName><ForeName>Koji</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Surgery and Science, Graduate School of Medical Sciences, Kyushu University, 3-1-1 Maidashi Higashi-ku, Fukuoka, 812-8582, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Saeki</LastName><ForeName>Hiroshi</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Surgery and Science, Graduate School of Medical Sciences, Kyushu University, 3-1-1 Maidashi Higashi-ku, Fukuoka, 812-8582, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kusumoto</LastName><ForeName>Tetsuya</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Gastroenterological Surgery, Clinical Research Institute, National Hospital Organization Kyushu Medical Center, Fukuoka, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Maehara</LastName><ForeName>Yoshihiko</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Surgery and Science, Graduate School of Medical Sciences, Kyushu University, 3-1-1 Maidashi Higashi-ku, Fukuoka, 812-8582, Japan.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>World J Surg</MedlineTA><NlmUniqueID>7704052</NlmUniqueID><ISSNLinking>0364-2313</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D005338">Fibrin Fibrinogen Degradation Products</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C036309">fibrin fragment D</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015179" MajorTopicYN="N">Colorectal Neoplasms</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005338" MajorTopicYN="N">Fibrin Fibrinogen Degradation Products</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010535" MajorTopicYN="N">Laparoscopy</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011182" MajorTopicYN="N">Postoperative Care</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011655" MajorTopicYN="N">Pulmonary Embolism</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D053828" MajorTopicYN="N">Stockings, Compression</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013274" MajorTopicYN="N">Stomach Neoplasms</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014463" MajorTopicYN="N">Ultrasonography</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D054556" MajorTopicYN="N">Venous Thromboembolism</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName><QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020246" MajorTopicYN="N">Venous Thrombosis</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2015</Year><Month>8</Month><Day>29</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2015</Year><Month>9</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2016</Year><Month>8</Month><Day>30</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">26316113</ArticleId><ArticleId IdType="doi">10.1007/s00268-015-3234-y</ArticleId><ArticleId IdType="pii">10.1007/s00268-015-3234-y</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Arch Intern Med. 2000 Dec 11-25;160(22):3415-20</Citation><ArticleIdList><ArticleId IdType="pubmed">11112234</ArticleId></ArticleIdList></Reference><Reference><Citation>Arch Surg. 2011 Jun;146(6):739-43</Citation><ArticleIdList><ArticleId IdType="pubmed">21690452</ArticleId></ArticleIdList></Reference><Reference><Citation>Dis Colon Rectum. 2000 Aug;43(8):1037-47</Citation><ArticleIdList><ArticleId IdType="pubmed">10950001</ArticleId></ArticleIdList></Reference><Reference><Citation>Surg Endosc. 2015 Feb;29(2):376-80</Citation><ArticleIdList><ArticleId IdType="pubmed">24986019</ArticleId></ArticleIdList></Reference><Reference><Citation>J Thromb Haemost. 2006 Mar;4(3):581-6</Citation><ArticleIdList><ArticleId IdType="pubmed">16460440</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet. 1986 Jul 19;2(8499):143-6</Citation><ArticleIdList><ArticleId IdType="pubmed">2873407</ArticleId></ArticleIdList></Reference><Reference><Citation>Br J Cancer. 2010 Jan 5;102(1):73-9</Citation><ArticleIdList><ArticleId IdType="pubmed">19953092</ArticleId></ArticleIdList></Reference><Reference><Citation>J Thromb Haemost. 2007 Sep;5(9):1854-61</Citation><ArticleIdList><ArticleId IdType="pubmed">17723125</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Surg. 1997 Jul;174(1):1-5</Citation><ArticleIdList><ArticleId IdType="pubmed">9240942</ArticleId></ArticleIdList></Reference><Reference><Citation>Br J Surg. 2001 Jul;88(7):913-30</Citation><ArticleIdList><ArticleId IdType="pubmed">11442521</ArticleId></ArticleIdList></Reference><Reference><Citation>Chest. 2008 Jun;133(6 Suppl):381S-453S</Citation><ArticleIdList><ArticleId IdType="pubmed">18574271</ArticleId></ArticleIdList></Reference><Reference><Citation>J Thromb Haemost. 2007 Jul;5 Suppl 1:41-50</Citation><ArticleIdList><ArticleId IdType="pubmed">17635707</ArticleId></ArticleIdList></Reference><Reference><Citation>Surg Endosc. 2007 Jun;21(6):1007-9</Citation><ArticleIdList><ArticleId IdType="pubmed">17410400</ArticleId></ArticleIdList></Reference><Reference><Citation>Thromb Res. 2006;118(5):555-68</Citation><ArticleIdList><ArticleId IdType="pubmed">16388837</ArticleId></ArticleIdList></Reference><Reference><Citation>Br J Surg. 2014 Feb;101(3):246-53</Citation><ArticleIdList><ArticleId IdType="pubmed">24446107</ArticleId></ArticleIdList></Reference><Reference><Citation>Colorectal Dis. 2005 Mar;7(2):122-7</Citation><ArticleIdList><ArticleId IdType="pubmed">15720347</ArticleId></ArticleIdList></Reference><Reference><Citation>J Thromb Haemost. 2006 Mar;4(3):529-35</Citation><ArticleIdList><ArticleId IdType="pubmed">16460435</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Clin Pathol. 1989 Jan;91(1):82-5</Citation><ArticleIdList><ArticleId IdType="pubmed">2642640</ArticleId></ArticleIdList></Reference><Reference><Citation>JAMA. 2006 Jan 11;295(2):199-207</Citation><ArticleIdList><ArticleId IdType="pubmed">16403932</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">16828301</PMID><DateCompleted><Year>2006</Year><Month>10</Month><Day>31</Day></DateCompleted><DateRevised><Year>2006</Year><Month>07</Month><Day>24</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Print">1010-7940</ISSN><JournalIssue CitedMedium="Print"><Volume>30</Volume><Issue>2</Issue><PubDate><Year>2006</Year><Month>Aug</Month></PubDate></JournalIssue><Title>European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery</Title><ISOAbbreviation>Eur J Cardiothorac Surg</ISOAbbreviation></Journal><ArticleTitle>Pulmonary endarterectomy for chronic thromboembolic pulmonary hypertension: is deep hypothermia required?</ArticleTitle><Pagination><StartPage>237</StartPage><EndPage>243</EndPage><MedlinePgn>237-41; discussion 241-3</MedlinePgn></Pagination><Abstract><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">To investigate whether deep (&lt;20 degrees C) hypothermia is necessary in patients undergoing pulmonary endarterectomy for chronic thromboembolic pulmonary hypertension.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Between January 2004 and February 2005, 30 patients (New York Heart Association (NYHA) class III or IV) were randomly assigned to increasing (1 degrees C) levels of moderate (28-32 degrees C) hypothermic cardiopulmonary bypass (CPB), each study group including six patients. Primary study endpoint was adverse neurological outcome. Overall preoperative total pulmonary vascular resistance was 1110+/-192 dynes cm(-5).</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Mean CPB and cross-clamp times, and core temperature at the time of circulatory arrests were 129+/-39 min and 92+/-24 min, and 30.1+/-1.5 degrees C, respectively. Circulatory arrest was induced 2+/-0.7 times and its mean total duration was 10.3+/-5.2 min (range, 2-19 min). Postoperatively, three patients (10%) belonging to the 31 degrees C (n=1) and 32 degrees C (n=2) groups suffered from temporary neurological dysfunction. Postoperative mechanical ventilatory support and ICU stay were 26.3+/-18.9 h and 6.6+/-8.5 days, respectively, and uninfluenced by degree of hypothermia. There were no lung reperfusion injuries or any other major complications. All patients had a significant hemodynamic improvement.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Results suggest that pulmonary endarterectomy can be safely performed with moderate hypothermia and short periods of circulatory arrests without the need of profound hypothermia.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Macchiarini</LastName><ForeName>Paolo</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Division of Thoracic and Cardiovascular Surgery, Hannover Medical School, Hannover, Germany. pmacchiarini@clinic.ub.es</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kamiya</LastName><ForeName>Hiroyuki</ForeName><Initials>H</Initials></Author><Author ValidYN="Y"><LastName>Hagl</LastName><ForeName>Christian</ForeName><Initials>C</Initials></Author><Author ValidYN="Y"><LastName>Winterhalter</LastName><ForeName>Michael</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Barbera</LastName><ForeName>Joan</ForeName><Initials>J</Initials></Author><Author ValidYN="Y"><LastName>Karck</LastName><ForeName>Matthias</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Pomar</LastName><ForeName>Jose</ForeName><Initials>J</Initials></Author><Author ValidYN="Y"><LastName>Haverich</LastName><ForeName>Axel</ForeName><Initials>A</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016448">Multicenter Study</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2006</Year><Month>07</Month><Day>07</Day></ArticleDate></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>Eur J Cardiothorac Surg</MedlineTA><NlmUniqueID>8804069</NlmUniqueID><ISSNLinking>1010-7940</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001831" MajorTopicYN="N">Body Temperature</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002908" MajorTopicYN="N">Chronic Disease</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004691" MajorTopicYN="N">Endarterectomy</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006976" MajorTopicYN="N">Hypertension, Pulmonary</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007036" MajorTopicYN="N">Hypothermia, Induced</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007430" MajorTopicYN="N">Intraoperative Care</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011182" MajorTopicYN="N">Postoperative Care</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011651" MajorTopicYN="N">Pulmonary Artery</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011655" MajorTopicYN="N">Pulmonary Embolism</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2005</Year><Month>11</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2005</Year><Month>12</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2006</Year><Month>2</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2006</Year><Month>7</Month><Day>11</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2006</Year><Month>11</Month><Day>1</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2006</Year><Month>7</Month><Day>11</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">16828301</ArticleId><ArticleId IdType="doi">10.1016/j.ejcts.2006.02.071</ArticleId><ArticleId IdType="pii">S1010-7940(06)00493-3</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">16920438</PMID><DateCompleted><Year>2006</Year><Month>09</Month><Day>28</Day></DateCompleted><DateRevised><Year>2016</Year><Month>11</Month><Day>24</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0002-9610</ISSN><JournalIssue CitedMedium="Print"><Volume>192</Volume><Issue>3</Issue><PubDate><Year>2006</Year><Month>Sep</Month></PubDate></JournalIssue><Title>American journal of surgery</Title><ISOAbbreviation>Am J Surg</ISOAbbreviation></Journal><ArticleTitle>Pulmonary embolism after off-pump coronary artery bypass surgery as detected by computed tomography.</ArticleTitle><Pagination><StartPage>396</StartPage><EndPage>398</EndPage><MedlinePgn>396-8</MedlinePgn></Pagination><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">The incidence of pulmonary embolism (PE) after coronary artery bypass surgery is ill defined.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Twenty-four patients undergoing off-pump coronary artery bypass surgery were enrolled in a prospective randomized study evaluating a new proximal aortic anastomotic device. Computed tomography was performed postoperatively about 1 week after surgery.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Computed tomography showed signs of PE in 6 patients (25%), which were bilateral in 2 cases. None of these patients had symptoms or signs of PE or deep venous thrombosis.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">The present findings widen the controversial issue of thromboprophylaxis after cardiac surgery and suggest that low-dose heparin may be indicated after coronary artery bypass surgery.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Lahtinen</LastName><ForeName>Jarmo</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Division of Cardio-thoracic and Vascular Surgery, Department of Surgery, Oulu University Hospital, P.O. Box 21, 90029 Oulu, Finland. faustobiancari@yahoo.it</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ahvenj&#xe4;rvi</LastName><ForeName>Lauri</ForeName><Initials>L</Initials></Author><Author ValidYN="Y"><LastName>Biancari</LastName><ForeName>Fausto</ForeName><Initials>F</Initials></Author><Author ValidYN="Y"><LastName>Ojala</LastName><ForeName>Risto</ForeName><Initials>R</Initials></Author><Author ValidYN="Y"><LastName>Mosorin</LastName><ForeName>Martti</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Cresti</LastName><ForeName>Riccardo</ForeName><Initials>R</Initials></Author><Author ValidYN="Y"><LastName>Lepoj&#xe4;rvi</LastName><ForeName>Martti</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Juvonen</LastName><ForeName>Tatu</ForeName><Initials>T</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Am J Surg</MedlineTA><NlmUniqueID>0370473</NlmUniqueID><ISSNLinking>0002-9610</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000714" MajorTopicYN="N">Anastomosis, Surgical</DescriptorName><QualifierName UI="Q000295" MajorTopicYN="N">instrumentation</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001011" MajorTopicYN="N">Aorta</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D047549" MajorTopicYN="N">Coronary Artery Bypass, Off-Pump</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName><QualifierName UI="Q000295" MajorTopicYN="N">instrumentation</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005500" MajorTopicYN="N">Follow-Up Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015994" MajorTopicYN="N">Incidence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011655" MajorTopicYN="N">Pulmonary Embolism</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="Y">diagnostic imaging</QualifierName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014057" MajorTopicYN="N">Tomography, X-Ray Computed</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2005</Year><Month>1</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2005</Year><Month>8</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2005</Year><Month>8</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2006</Year><Month>8</Month><Day>22</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2006</Year><Month>9</Month><Day>29</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2006</Year><Month>8</Month><Day>22</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">16920438</ArticleId><ArticleId IdType="doi">10.1016/j.amjsurg.2005.08.005</ArticleId><ArticleId IdType="pii">S0002-9610(05)00676-8</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">35943246</PMID><DateCompleted><Year>2022</Year><Month>11</Month><Day>30</Day></DateCompleted><DateRevised><Year>2022</Year><Month>12</Month><Day>15</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1528-1159</ISSN><JournalIssue CitedMedium="Internet"><Volume>47</Volume><Issue>24</Issue><PubDate><Year>2022</Year><Month>Dec</Month><Day>15</Day></PubDate></JournalIssue><Title>Spine</Title><ISOAbbreviation>Spine (Phila Pa 1976)</ISOAbbreviation></Journal><ArticleTitle>Are Octogenarians at Higher Risk of Complications After Elective Lumbar Spinal Fusion Surgery? Analysis of a Cohort of 7880 Patients From the Kaiser Permanente Spine Registry.</ArticleTitle><Pagination><StartPage>1719</StartPage><EndPage>1727</EndPage><MedlinePgn>1719-1727</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1097/BRS.0000000000004451</ELocationID><Abstract><AbstractText Label="STUDY DESIGN" NlmCategory="METHODS">A retrospective cohort study with chart review.</AbstractText><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">To determine if there is a difference in risk of adverse outcomes following elective posterior instrumented lumbar spinal fusions for patients aged 80 years and above compared with patients aged 50 to 79 years.</AbstractText><AbstractText Label="SUMMARY OF BACKGROUND DATA" NlmCategory="BACKGROUND">Patients aged 80 years and above are undergoing elective lumbar spinal fusion surgery in increasing numbers. There are conflicting data on the risks of intraoperative and postoperative complications in these patients.</AbstractText><AbstractText Label="MATERIALS AND METHODS" NlmCategory="METHODS">Patients aged 80 years and above were compared with 50 to 79 years (reference group) using time-dependent multivariable Cox proportional hazards regression with a competing risk of death for longitudinal outcomes and multivariable logistic regression for binary outcomes. Outcome measures used were: (1) intraoperative complications (durotomy), (2) postoperative complications: 30-day outcomes (pneumonia); 90-day outcomes (deep vein thrombosis, pulmonary embolism, emergency room visits, readmission, reoperations, and mortality); and two-year outcomes (reoperations and mortality).</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">The cohort consisted of 7880 patients who underwent primary elective posterior instrumented lumbar spinal fusion (L1-S1) for degenerative disk disease or spondylolisthesis. This was subdivided into 596 patients were aged 80 years and above and 7284 patients aged 50 to 79. After adjustment, patients aged 80 years and above had a higher likelihood of durotomy [odds ratio (OR)=1.43, 95% confidence interval (CI)=1.02-2.02] and 30-day pneumonia (OR=1.81, 95% CI=1.01-3.23). However, there was a lower risk of reoperation within two years of the index procedure (hazard ratio=0.69, 95% CI=0.48-0.99). No differences were observed for mortality, readmissions, emergency room visits, pulmonary embolism, or deep vein thrombosis.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">In a cohort of 7880 elective posterior instrumented lumbar fusion patients for degenerative disk disease or spondylolisthesis, we did not observe any significant risks of adverse events between patients aged 80 years and above and those aged 50 to 79 except for higher durotomies and 30-day pneumonia in the former. We believe octogenarians can safely undergo lumbar fusions, but proper preoperative screening is necessary to reduce the risks of 30-day pneumonia.</AbstractText><CopyrightInformation>Copyright &#xa9; 2022 Wolters Kluwer Health, Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Kuo</LastName><ForeName>Calvin C</ForeName><Initials>CC</Initials><AffiliationInfo><Affiliation>Department of Spine Surgery, Kaiser Permanente Oakland Medical Center, Oakland, CA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Royse</LastName><ForeName>Kathryn E</ForeName><Initials>KE</Initials><AffiliationInfo><Affiliation>Medical Device Surveillance and Assessment, Kaiser Permanente, San Diego, CA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Prentice</LastName><ForeName>Heather A</ForeName><Initials>HA</Initials><AffiliationInfo><Affiliation>Medical Device Surveillance and Assessment, Kaiser Permanente, San Diego, CA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Harris</LastName><ForeName>Jessica E</ForeName><Initials>JE</Initials><AffiliationInfo><Affiliation>Medical Device Surveillance and Assessment, Kaiser Permanente, San Diego, CA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Guppy</LastName><ForeName>Kern H</ForeName><Initials>KH</Initials><AffiliationInfo><Affiliation>Department of Neurosurgery, Kaiser Permanente Sacramento Medical Center, Sacramento, CA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurological Surgery, University of California, San Francisco, CA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>08</Month><Day>09</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Spine (Phila Pa 1976)</MedlineTA><NlmUniqueID>7610646</NlmUniqueID><ISSNLinking>0362-2436</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013123" MajorTopicYN="Y">Spinal Fusion</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013168" MajorTopicYN="Y">Spondylolisthesis</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008159" MajorTopicYN="N">Lumbar Vertebrae</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000087742" MajorTopicYN="N">Octogenarians</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012042" MajorTopicYN="N">Registries</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011014" MajorTopicYN="Y">Pneumonia</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011655" MajorTopicYN="Y">Pulmonary Embolism</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020246" MajorTopicYN="Y">Venous Thrombosis</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading></MeshHeadingList><CoiStatement>The authors report no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>6</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>7</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>8</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>12</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>8</Month><Day>9</Day><Hour>8</Hour><Minute>53</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35943246</ArticleId><ArticleId IdType="doi">10.1097/BRS.0000000000004451</ArticleId><ArticleId IdType="pii">00007632-202212150-00005</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>He W, Goodkind D, Kowal P US Census Bureau. An aging world: 2015. International Population Reports , P95/16-1. Washington, DC: National Institutes of Health; 2016.</Citation></Reference><Reference><Citation>Kha ST, Ilyas H, Tanenbaum JE, et al. Trends in lumbar fusion surgery among octogenarians: a Nationwide Inpatient Sample study from 2004 to 2013. Global Spine J. 2018;8:593&#x2013;599.</Citation></Reference><Reference><Citation>Deyo RA, Mirza SK, Martin BI, et al. Trends, major medical complications, and charges associated with surgery for lumbar spinal stenosis in older adults. JAMA. 2010;303:1259&#x2013;1265.</Citation></Reference><Reference><Citation>Carreon LY, Puno RM, Dimar JR, et al. Perioperative complications of posterior lumbar decompression and arthrodesis in older adults. J Bone Joint Surg Am. 2003;85:2089&#x2013;2092.</Citation></Reference><Reference><Citation>Raffo CS, Lauerman WC. Predicting morbidity and mortality of lumbar spine arthrodesis in patients in their ninth decade. Spine. 2006;31:99&#x2013;103.</Citation></Reference><Reference><Citation>Rodgers WB, Gerber EJ, Rodgers JA. Lumbar fusion in octogenarians: the promise of minimally invasive surgery. Spine. 2010;35(suppl):S355&#x2013;S360.</Citation></Reference><Reference><Citation>Nanjo Y, Nagashima H, Dokai T, et al. Clinical features and surgical outcomes of lumbar spinal stenosis in patients aged 80 years or older: a multi-center retrospective study. Arch Orthop Trauma Surg. 2013;133:1243&#x2013;1248.</Citation></Reference><Reference><Citation>Marbacher S, Mannion AF, Burkhardt JK, et al. Patient-rated outcomes of lumbar fusion in patients with degenerative disease of the lumbar spine: does age matter? Spine. 2016;41:893&#x2013;900.</Citation></Reference><Reference><Citation>Vasilikos I, Fistouris P, Kr&#xfc;ger MT, et al. How safe is minimally invasive transforaminal lumbar interbody fusion for octogenarians?: a perioperative complication analysis. World Neurosurg. 2020;139:e754&#x2013;e760.</Citation></Reference><Reference><Citation>Rihn JA, Hilibrand AS, Zhao W, et al. Effectiveness of surgery for lumbar stenosis and degenerative spondylolisthesis in the octogenarian population: analysis of the Spine Patient Outcomes Research Trial (SPORT) data. J Bone Joint Surg Am. 2015;97:177&#x2013;185.</Citation></Reference><Reference><Citation>Balabaud L, Pitel S, Caux I, et al. Lumbar spine surgery in patients 80 years of age or older: morbidity and mortality. Eur J Orthop Surg Traumatol. 2015;25(suppl 1):S205&#x2013;212.</Citation></Reference><Reference><Citation>Kobayashi K, Imagama S, Ando K, et al. Complications associated with spine surgery in patients aged 80 years or older: Japan Association of Spine Surgeons with Ambition (JASA) Multicenter Study. Global Spine J. 2017;7:636&#x2013;641.</Citation></Reference><Reference><Citation>Saleh A, Thirukumaran C, Mesfin A, et al. Complications and readmission after lumbar spine surgery in elderly patients: an analysis of 2320 patients. Spine J. 2017;17:1106&#x2013;1112.</Citation></Reference><Reference><Citation>Gerhardt J, Bette S, Janssen I, et al. Is eighty the new sixty? Outcomes and complications after lumbar decompression surgery in elderly patients over 80 years of age. World Neurosurg. 2018;112:e555&#x2013;e560.</Citation></Reference><Reference><Citation>Karter AJ, Ferrara A, Liu JY, et al. Ethnic disparities in diabetic complications in an insured population. JAMA. 2002;287:2519&#x2013;2527.</Citation></Reference><Reference><Citation>Koebnick C, Langer-Gould AM, Gould MK, et al. Sociodemographic characteristics of members of a large, integrated health care system: comparison with US Census Bureau data. Perm J. 2012;16:37&#x2013;41.</Citation></Reference><Reference><Citation>Paxton EW, Kiley ML, Love R, et al. Kaiser Permanente implant registries benefit patient safety, quality improvement, cost-effectiveness. Jt Comm J Qual Patient Saf. 2013;39:246&#x2013;252.</Citation></Reference><Reference><Citation>Guppy KH, Harris J, Bernbeck JA, et al. Ratliff J, Albert TJ, Cheng J, Knightly J. Impact of quality assessment on clinical practice, Kaiser Permanente. Quality Spine Care: Healthcare Systems, Quality Reporting, and Risk Adjustment. Cham, Switzerland: Springer International Publishing; 2019:315&#x2013;339.</Citation></Reference><Reference><Citation>Elixhauser A, Steiner C, Harris DR, et al. Comorbidity measures for use with administrative data. Med Care. 1998;36:8&#x2013;27.</Citation></Reference><Reference><Citation>Quan H, Sundararajan V, Halfon P, et al. Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data. Med Care. 2005;43:1130&#x2013;1139.</Citation></Reference><Reference><Citation>Puvanesarajah V, Jain A, Shimer AL, et al. Complications and mortality following 1 to 2 level lumbar fusion surgery in patients above 80 years of age. Spine. 2017;42:437&#x2013;441.</Citation></Reference><Reference><Citation>Aimar E, Iess G, Mezza F, et al. Complications of degenerative lumbar spondylolisthesis and stenosis surgery in patients over 80s: comparative study with over 60s and 70s. Experience with 678 cases. Acta Neurochir (Wien). 2022;164:923&#x2013;931.</Citation></Reference><Reference><Citation>Baker GA, Cizik AM, Bransford RJ, et al. Risk factors for unintended durotomy during spine surgery: a multivariate analysis. Spine J. 2012;12:121&#x2013;126.</Citation></Reference><Reference><Citation>Str&#xf6;mqvist F, J&#xf6;nsson B, Str&#xf6;mqvist B. Dural lesions in decompression for lumbar spinal stenosis: incidence, risk factors and effect on outcome. Eur Spine J. 2012;21:825&#x2013;828.</Citation></Reference><Reference><Citation>Yoshihara H, Yoneoka D. Incidental dural tear in lumbar spinal decompression and discectomy: analysis of a nationwide database. Arch Orthop Trauma Surg. 2013;133:1501&#x2013;1508.</Citation></Reference><Reference><Citation>Du JY, Aichmair A, Kueper J, et al. Incidental durotomy during spinal surgery: a multivariate analysis for risk factors. Spine. 2014;39:E1339&#x2013;E1345.</Citation></Reference><Reference><Citation>Chen Z, Shao P, Sun Q, et al. Risk factors for incidental durotomy during lumbar surgery: a retrospective study by multivariate analysis. Clin Neurol Neurosurg. 2015;130:101&#x2013;104.</Citation></Reference><Reference><Citation>Herren C, Sobottke R, Mannion AF, et al. Incidental durotomy in decompression for lumbar spinal stenosis: incidence, risk factors and effect on outcomes in the Spine Tango registry. Eur Spine J. 2017;26:2483&#x2013;2495.</Citation></Reference><Reference><Citation>Alshameeri ZAF, Jasani V. Risk factors for accidental dural tears in spinal surgery. Int J Spine Surg. 2021;15:536&#x2013;548.</Citation></Reference><Reference><Citation>Buck JS, Yoon ST. The incidence of durotomy and its clinical and economic impact in primary, short-segment lumbar fusion: an analysis of 17,232 cases. Spine. 2015;40:1444&#x2013;1450.</Citation></Reference><Reference><Citation>Jankowitz BT, Atteberry DS, Gerszten PC, et al. Effect of fibrin glue on the prevention of persistent cerebral spinal fluid leakage after incidental durotomy during lumbar spinal surgery. Eur Spine J. 2009;18:1169&#x2013;1174.</Citation></Reference><Reference><Citation>Ahmad W, Fernandez L, Bell J, et al. Assessment of postoperative outcomes of spine fusion patients with history of cardiac disease. J Am Acad Orthop Surg. 2022;30:e683&#x2013;e689.</Citation></Reference><Reference><Citation>Lee LKK, Tsai PNW, Ip KY, et al. Pre-operative cardiac optimisation: a directed review. Anaesthesia. 2019;74(suppl 1):67&#x2013;79.</Citation></Reference><Reference><Citation>Chan SP, Ip KY, Irwin MG. Peri-operative optimisation of elderly and frail patients: a narrative review. Anaesthesia. 2019;74(suppl 1):80&#x2013;89.</Citation></Reference><Reference><Citation>Endler P, Ekman P, Berglund I, et al. Long-term outcome of fusion for degenerative disc disease in the lumbar spine. Bone Joint J. 2019;101-b:1526&#x2013;1533.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">29102272</PMID><DateCompleted><Year>2018</Year><Month>07</Month><Day>09</Day></DateCompleted><DateRevised><Year>2018</Year><Month>07</Month><Day>09</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1535-7732</ISSN><JournalIssue CitedMedium="Internet"><Volume>29</Volume><Issue>1</Issue><PubDate><Year>2018</Year><Month>Jan</Month></PubDate></JournalIssue><Title>Journal of vascular and interventional radiology : JVIR</Title><ISOAbbreviation>J Vasc Interv Radiol</ISOAbbreviation></Journal><ArticleTitle>Aspiration Thrombectomy for Treatment of Acute Massive and Submassive Pulmonary Embolism: Initial Single-Center Prospective Experience.</ArticleTitle><Pagination><StartPage>101</StartPage><EndPage>106</EndPage><MedlinePgn>101-106</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jvir.2017.08.010</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S1051-0443(17)30759-5</ELocationID><Abstract><AbstractText Label="PURPOSE" NlmCategory="OBJECTIVE">To evaluate the feasibility of aspiration thrombectomy in patients with acute massive or submassive pulmonary embolism (PE).</AbstractText><AbstractText Label="MATERIALS AND METHODS" NlmCategory="METHODS">This prospective study analyzed patient demographic data, procedural details, and outcomes in 18 consecutive patients (8 men and 10 women; mean age, 60.1 y; range, 36-80 y), 10 with acute submassive PE and 8 with massive PE, treated with an Indigo Continuous Aspiration Mechanical Thrombectomy Catheter between January 2016 and February 2017. Three patients underwent concomitant systemic fibrinolytic treatment with 100 mg tissue plasminogen activator. Technical success was defined as successful placement of devices and initiation of aspiration thrombectomy. Clinical success was defined as stabilization of hemodynamic parameters; improvement in pulmonary hypertension, right heart strain, or both; and survival to hospital discharge. Complications were also analyzed.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">The procedure was considered a technical success in 17 patients (94.4%) and a clinical success in 15 (83.3%). Echocardiography showed significant improvements in right ventricle size (46.36 mm &#xb1; 2.2 before treatment vs 41.79 mm &#xb1; 7.4 after; P&#xa0;= .041), tricuspid annular plane systolic excursion (16 &#xb1; 3 before treatment vs 18.57 &#xb1; 3.9 after; P&#xa0;= .011), and systolic wave (10 &#xb1; 2.1 before treatment vs 13.1 &#xb1; 3.8 after; P&#xa0;= .020). Two patients died of massive PE, and 1 died of submassive PE.&#xa0;Two patients who received systemic fibrinolytic agents experienced intracranial bleeding, and abdominal bleeding developed in&#xa0;1.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Aspiration thrombectomy is a feasible option for the treatment of acute massive or submassive PE in patients with hemodynamic compromise or right ventricular dysfunction.</AbstractText><CopyrightInformation>Copyright &#xa9; 2017 SIR. Published by Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ciampi-Dopazo</LastName><ForeName>Juan Jos&#xe9;</ForeName><Initials>JJ</Initials><AffiliationInfo><Affiliation>Interventional Radiology Unit, Department of Radiology, Complejo Hospitalario de Toledo, Toledo, Spain. Electronic address: juanciampi@hotmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Romeu-Prieto</LastName><ForeName>Juan Mar&#xed;a</ForeName><Initials>JM</Initials><AffiliationInfo><Affiliation>Department of Critical and Intensive Medicine, Complejo Hospitalario de Toledo, Toledo, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>S&#xe1;nchez-Casado</LastName><ForeName>Marcelino</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Critical and Intensive Medicine, Complejo Hospitalario de Toledo, Toledo, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Romerosa</LastName><ForeName>Beatriz</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Complejo Hospitalario de Toledo, Toledo, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Canabal</LastName><ForeName>Alfonso</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Critical and Intensive Medicine, Complejo Hospitalario de Toledo, Toledo, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rodr&#xed;guez-Blanco</LastName><ForeName>Mar&#xed;a Luisa</ForeName><Initials>ML</Initials><AffiliationInfo><Affiliation>Department of Critical and Intensive Medicine, Complejo Hospitalario de Toledo, Toledo, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lanciego</LastName><ForeName>Carlos</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Interventional Radiology Unit, Department of Radiology, Complejo Hospitalario de Toledo, Toledo, Spain.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2017</Year><Month>11</Month><Day>06</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Vasc Interv Radiol</MedlineTA><NlmUniqueID>9203369</NlmUniqueID><ISSNLinking>1051-0443</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D005343">Fibrinolytic Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.4.21.68</RegistryNumber><NameOfSubstance UI="D010959">Tissue Plasminogen Activator</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000208" MajorTopicYN="N">Acute Disease</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004452" MajorTopicYN="N">Echocardiography</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005343" MajorTopicYN="N">Fibrinolytic Agents</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011655" MajorTopicYN="N">Pulmonary Embolism</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017131" MajorTopicYN="N">Thrombectomy</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010959" MajorTopicYN="N">Tissue Plasminogen Activator</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>4</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2017</Year><Month>8</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2017</Year><Month>8</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2017</Year><Month>11</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>7</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2017</Year><Month>11</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29102272</ArticleId><ArticleId IdType="doi">10.1016/j.jvir.2017.08.010</ArticleId><ArticleId IdType="pii">S1051-0443(17)30759-5</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">29374780</PMID><DateCompleted><Year>2019</Year><Month>03</Month><Day>11</Day></DateCompleted><DateRevised><Year>2019</Year><Month>03</Month><Day>11</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1863-9941</ISSN><JournalIssue CitedMedium="Internet"><Volume>44</Volume><Issue>6</Issue><PubDate><Year>2018</Year><Month>Dec</Month></PubDate></JournalIssue><Title>European journal of trauma and emergency surgery : official publication of the European Trauma Society</Title><ISOAbbreviation>Eur J Trauma Emerg Surg</ISOAbbreviation></Journal><ArticleTitle>Wound complications after ankle surgery. Does compression treatment work? A randomized, controlled trial.</ArticleTitle><Pagination><StartPage>947</StartPage><EndPage>956</EndPage><MedlinePgn>947-956</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s00068-017-0892-5</ELocationID><Abstract><AbstractText Label="PURPOSE" NlmCategory="OBJECTIVE">Infection rates following ankle fractures are as high as 19% in selected material and is the most common complication following this type of surgery, with potential catastrophic consequences. The purpose of this study was to test a regime of intermittent pneumatic compression, a compression bandage and a compression stocking and its effect on the rate of wound complications. The hypothesis was that compression could lower the infection rate from 20 to 5%.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">We performed a randomized, controlled, non-blinded trial, including 153 adult patients with unstable ankle fractures. Patients were randomized to either compression (N&#x2009;=&#x2009;82) or elevation (N&#x2009;=&#x2009;71). Patients with open fracture, DVT, pulmonary embolism, dementia, no pedal pulse, or no Danish address were excluded. Primary endpoint was infection. Secondary endpoints were necrosis and wound dehiscence.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">After 2&#xa0;weeks, 1.4% (0.0;7.6) in the compression group had infection compared to 4.6% (1.0;12.9) in the control group, p&#x2009;=&#x2009;0.35. The rate of necrosis after 2&#xa0;weeks was 7.0% (95% CI 2.3;15.7) in the compression group compared with 26.2% (95% CI 16.0;38.5) in the elevation group, p&#x2009;=&#x2009;0.004. No difference was shown regarding wound dehiscence.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Based on this study, we cannot conclude if compression therapy prevents infection or not. This is mainly due to under-powering of the study. The effect on necrosis was in favor of compression, but the trial was not powered to show a difference regarding this endpoints and the result is thus hypothesis generating. Further research is needed before a thorough recommendation on the use of compression treatment that can be made.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Winge</LastName><ForeName>Rikke</ForeName><Initials>R</Initials><Identifier Source="ORCID">0000-0002-0501-8192</Identifier><AffiliationInfo><Affiliation>Department of Orthopedic Surgery, Nordsj&#xe6;llands Hospital, Dyrehavevej 29, 3400, Hiller&#xf8;d, Denmark. rikkewinge@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ryge</LastName><ForeName>Camilla</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Orthopedic Surgery, Gentofte Hospital, Kildeg&#xe5;rdsvej 28, 2900, Hellerup, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bayer</LastName><ForeName>Lasse</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Orthopedic Surgery, Nordsj&#xe6;llands Hospital, Dyrehavevej 29, 3400, Hiller&#xf8;d, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Klausen</LastName><ForeName>Tobias Wirenfeldt</ForeName><Initials>TW</Initials><AffiliationInfo><Affiliation>Herlev Hospital, Herlev Ringvej 75, 2730, Herlev, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gottlieb</LastName><ForeName>Hans</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Orthopedic Surgery, Herlev Hospital, Herlev Ringvej 75, 2730, Herlev, Denmark.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>NOH-431</GrantID><Agency>Nordsjaellands Hospital</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>01</Month><Day>27</Day></ArticleDate></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>Eur J Trauma Emerg Surg</MedlineTA><NlmUniqueID>101313350</NlmUniqueID><ISSNLinking>1863-9933</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D064386" MajorTopicYN="N">Ankle Fractures</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D058128" MajorTopicYN="N">Compression Bandages</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003718" MajorTopicYN="N" Type="Geographic">Denmark</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005593" MajorTopicYN="N">Fracture Fixation, Internal</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D048228" MajorTopicYN="N">Intermittent Pneumatic Compression Devices</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011187" MajorTopicYN="N">Posture</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011312" MajorTopicYN="N">Pressure</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013530" MajorTopicYN="N">Surgical Wound Infection</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Ankle fracture</Keyword><Keyword MajorTopicYN="N">Compression treatment</Keyword><Keyword MajorTopicYN="N">Necrosis</Keyword><Keyword MajorTopicYN="N">Surgical site infection</Keyword><Keyword MajorTopicYN="N">Trauma</Keyword><Keyword MajorTopicYN="N">Wound complications</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2016</Year><Month>12</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2017</Year><Month>12</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>1</Month><Day>29</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>3</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>1</Month><Day>29</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29374780</ArticleId><ArticleId IdType="doi">10.1007/s00068-017-0892-5</ArticleId><ArticleId IdType="pii">10.1007/s00068-017-0892-5</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Eur J Vasc Endovasc Surg. 2000 Mar;19(3):250-60</Citation><ArticleIdList><ArticleId IdType="pubmed">10753688</ArticleId></ArticleIdList></Reference><Reference><Citation>J Bone Joint Surg Br. 1991 May;73(3):511-3</Citation><ArticleIdList><ArticleId IdType="pubmed">1670461</ArticleId></ArticleIdList></Reference><Reference><Citation>Injury. 2001 Sep;32(7):559-63</Citation><ArticleIdList><ArticleId IdType="pubmed">11524089</ArticleId></ArticleIdList></Reference><Reference><Citation>J Orthop Res. 2007 Sep;25(9):1185-92</Citation><ArticleIdList><ArticleId IdType="pubmed">17469190</ArticleId></ArticleIdList></Reference><Reference><Citation>Injury. 2011 Oct;42(10):1125-9</Citation><ArticleIdList><ArticleId IdType="pubmed">21329921</ArticleId></ArticleIdList></Reference><Reference><Citation>Foot Ankle Int. 2016 Apr;37(4):401-6</Citation><ArticleIdList><ArticleId IdType="pubmed">26830839</ArticleId></ArticleIdList></Reference><Reference><Citation>Hip Int. 2012 Sep-Oct;22(5):527-33</Citation><ArticleIdList><ArticleId IdType="pubmed">23112075</ArticleId></ArticleIdList></Reference><Reference><Citation>J Appl Physiol (1985). 2012 Jun;112(12):2099-109</Citation><ArticleIdList><ArticleId IdType="pubmed">22442025</ArticleId></ArticleIdList></Reference><Reference><Citation>J Bone Joint Surg Am. 2014 Aug 6;96(15):1263-1271</Citation><ArticleIdList><ArticleId IdType="pubmed">25100773</ArticleId></ArticleIdList></Reference><Reference><Citation>J Orthop Surg (Hong Kong). 2015 Apr;23(1):59-61</Citation><ArticleIdList><ArticleId IdType="pubmed">25920646</ArticleId></ArticleIdList></Reference><Reference><Citation>J Appl Physiol (1985). 2002 Feb;92(2):559-66</Citation><ArticleIdList><ArticleId IdType="pubmed">11796664</ArticleId></ArticleIdList></Reference><Reference><Citation>Eur J Vasc Endovasc Surg. 2015 Jun;49(6):678-737</Citation><ArticleIdList><ArticleId IdType="pubmed">25920631</ArticleId></ArticleIdList></Reference><Reference><Citation>Arch Phys Med Rehabil. 1992 May;73(5):482-5</Citation><ArticleIdList><ArticleId IdType="pubmed">1580778</ArticleId></ArticleIdList></Reference><Reference><Citation>Intern Med. 2006;45(2):93-4</Citation><ArticleIdList><ArticleId IdType="pubmed">16484746</ArticleId></ArticleIdList></Reference><Reference><Citation>J Bone Joint Surg Br. 2005 Apr;87(4):489-95</Citation><ArticleIdList><ArticleId IdType="pubmed">15795198</ArticleId></ArticleIdList></Reference><Reference><Citation>Acta Orthop. 2005 Feb;76(1):89-94</Citation><ArticleIdList><ArticleId IdType="pubmed">15788314</ArticleId></ArticleIdList></Reference><Reference><Citation>PM R. 2012 Aug;4(8):580-601</Citation><ArticleIdList><ArticleId IdType="pubmed">22920313</ArticleId></ArticleIdList></Reference><Reference><Citation>Anesthesiology. 2000 Mar;92(3):880-2</Citation><ArticleIdList><ArticleId IdType="pubmed">10719972</ArticleId></ArticleIdList></Reference><Reference><Citation>J Bone Joint Surg Br. 1992 Sep;74(5):775-8</Citation><ArticleIdList><ArticleId IdType="pubmed">1527133</ArticleId></ArticleIdList></Reference><Reference><Citation>Acta Orthop Scand. 1998 Feb;69(1):48-50</Citation><ArticleIdList><ArticleId IdType="pubmed">9524518</ArticleId></ArticleIdList></Reference><Reference><Citation>Asian J Surg. 2008 Jul;31(3):124-9</Citation><ArticleIdList><ArticleId IdType="pubmed">18658010</ArticleId></ArticleIdList></Reference><Reference><Citation>Infect Control Hosp Epidemiol. 1999 Apr;20(4):250-78; quiz 279-80</Citation><ArticleIdList><ArticleId IdType="pubmed">10219875</ArticleId></ArticleIdList></Reference><Reference><Citation>J Bone Joint Surg Am. 2009 May;91(5):1042-9</Citation><ArticleIdList><ArticleId IdType="pubmed">19411451</ArticleId></ArticleIdList></Reference><Reference><Citation>Acta Orthop. 2014 Sep;85(5):525-30</Citation><ArticleIdList><ArticleId IdType="pubmed">24694275</ArticleId></ArticleIdList></Reference><Reference><Citation>Foot Ankle Int. 2002 Nov;23(11):999-1002</Citation><ArticleIdList><ArticleId IdType="pubmed">12449403</ArticleId></ArticleIdList></Reference><Reference><Citation>Foot Ankle Surg. 2014 Mar;20(1):40-3</Citation><ArticleIdList><ArticleId IdType="pubmed">24480498</ArticleId></ArticleIdList></Reference><Reference><Citation>J Bone Joint Surg Am. 2012 Nov 21;94(22):2047-52</Citation><ArticleIdList><ArticleId IdType="pubmed">23172322</ArticleId></ArticleIdList></Reference><Reference><Citation>Foot Ankle Int. 2011 Feb;32(2):120-30</Citation><ArticleIdList><ArticleId IdType="pubmed">21288410</ArticleId></ArticleIdList></Reference><Reference><Citation>Orthopedics. 1998 Jan;21(1):59-61</Citation><ArticleIdList><ArticleId IdType="pubmed">9474633</ArticleId></ArticleIdList></Reference><Reference><Citation>Bone Joint J. 2014 Aug;96-B(8):1062-9</Citation><ArticleIdList><ArticleId IdType="pubmed">25086122</ArticleId></ArticleIdList></Reference><Reference><Citation>Yonsei Med J. 2013 May 1;54(3):801-2</Citation><ArticleIdList><ArticleId IdType="pubmed">23549834</ArticleId></ArticleIdList></Reference><Reference><Citation>Foot Ankle Surg. 2013 Sep;19(3):173-6</Citation><ArticleIdList><ArticleId IdType="pubmed">23830165</ArticleId></ArticleIdList></Reference><Reference><Citation>Anaesthesia. 2005 Feb;60(2):207-8</Citation><ArticleIdList><ArticleId IdType="pubmed">15644032</ArticleId></ArticleIdList></Reference><Reference><Citation>Acta Orthop. 2012 Jun;83(3):276-81</Citation><ArticleIdList><ArticleId IdType="pubmed">22401675</ArticleId></ArticleIdList></Reference><Reference><Citation>Eur J Vasc Endovasc Surg. 2000 Mar;19(3):270-7</Citation><ArticleIdList><ArticleId IdType="pubmed">10753690</ArticleId></ArticleIdList></Reference><Reference><Citation>J Perioper Pract. 2014 Apr;24(4):84-6</Citation><ArticleIdList><ArticleId IdType="pubmed">24855719</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">29560667</PMID><DateCompleted><Year>2018</Year><Month>04</Month><Day>30</Day></DateCompleted><DateRevised><Year>2018</Year><Month>04</Month><Day>30</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">1784-3227</ISSN><JournalIssue CitedMedium="Print"><Volume>80</Volume><Issue>3</Issue><PubDate><Year>2017</Year><Season>Jul-Sep</Season></PubDate></JournalIssue><Title>Acta gastro-enterologica Belgica</Title><ISOAbbreviation>Acta Gastroenterol Belg</ISOAbbreviation></Journal><ArticleTitle>Epidural analgesia is infrequently used in patients with acute pancreatitis : a retrospective cohort study.</ArticleTitle><Pagination><StartPage>381</StartPage><EndPage>384</EndPage><MedlinePgn>381-384</MedlinePgn></Pagination><Abstract><AbstractText Label="BACKGROUNDS AND AIMS" NlmCategory="OBJECTIVE">Epidural analgesia is an option for pain control in patients with acute pancreatitis. The aim of this study is to describe characteristics, morbidity and mortality of patients with acute pancreatitis treated with epidural analgesia.</AbstractText><AbstractText Label="PATIENTS AND METHODS" NlmCategory="METHODS">Data was extracted from a national inpatient database in Japan on patients hospitalized with acute pancreatitis between July 2010 and March 2013. A total of 44,146 patients discharged from acute care hospitals were included in this retrospective cohort study. The patient background, timing and duration of epidural analgesia, complications (epidural hematoma or abscess), surgery (for cholelithiasis / cholecystitis or complications) and mortality were verified.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Epidural analgesia was used in 307 patients (0.70 %). The mean age was 64.0 years (standard deviation, 15.4 years) and 116 (37.8%) of the patients were female. The median duration of epidural analgesia was four days (interquartile range, 3-5 days). No patient underwent surgery for epidural hematoma or abscess. Six (2.0%) patients died during hospitalization. Most likely causes of death were pulmonary embolism, multiple organ failure, sepsis, and methicillin-resistant staphylococcus aureus enterocolitis. The responsible physician for 250 of the patients (81.4%) was a gastroenterological surgeon. Epidural analgesia was started on the day of surgery in 278 (90.6%) patients.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Epidural analgesia is rarely used in patients with acute pancreatitis. None of the patients included in the study required surgery for epidural hematoma or abscess. Further research to evaluate the efficacy and safety of epidural analgesia in patients with acute pancreatitis is warranted.</AbstractText><CopyrightInformation>&#xa9; Acta Gastro-Enterologica Belgica.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Sasabuchi</LastName><ForeName>Y</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Health Services Research, Graduate School of Medicine, The University of Tokyo, Tokyo, 113-0033, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yasunaga</LastName><ForeName>H</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Clinical Epidemiology and Health Economics, School of Public Health, The University of Tokyo, Tokyo, 113-0033, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Matsui</LastName><ForeName>H</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Clinical Epidemiology and Health Economics, School of Public Health, The University of Tokyo, Tokyo, 113-0033, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lefor</LastName><ForeName>A K</ForeName><Initials>AK</Initials><AffiliationInfo><Affiliation>Department of Surgery, Jichi Medical University, Tochigi, 329-0498, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fushimi</LastName><ForeName>K</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Health Policy and Informatics, Tokyo Medical and Dental University Graduate School of Medicine, Tokyo, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sanui</LastName><ForeName>M</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Critical Care Medicine, Jichi Medical University, Saitama Medical Center, Saitama, 330-0834, Japan.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>Belgium</Country><MedlineTA>Acta Gastroenterol Belg</MedlineTA><NlmUniqueID>0414075</NlmUniqueID><ISSNLinking>1784-3227</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000208" MajorTopicYN="N">Acute Disease</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015360" MajorTopicYN="Y">Analgesia, Epidural</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020802" MajorTopicYN="N">Epidural Abscess</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D046748" MajorTopicYN="N">Hematoma, Epidural, Spinal</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006760" MajorTopicYN="N">Hospitalization</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007564" MajorTopicYN="N">Japan</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010146" MajorTopicYN="Y">Pain</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D059408" MajorTopicYN="Y">Pain Management</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010195" MajorTopicYN="Y">Pancreatitis</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">acute pancreatitis</Keyword><Keyword MajorTopicYN="N">administrative data</Keyword><Keyword MajorTopicYN="N">epidural analgesia</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>3</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>3</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>5</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29560667</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">24781568</PMID><DateCompleted><Year>2014</Year><Month>06</Month><Day>12</Day></DateCompleted><DateRevised><Year>2022</Year><Month>03</Month><Day>17</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1526-7598</ISSN><JournalIssue CitedMedium="Internet"><Volume>118</Volume><Issue>5</Issue><PubDate><Year>2014</Year><Month>May</Month></PubDate></JournalIssue><Title>Anesthesia and analgesia</Title><ISOAbbreviation>Anesth Analg</ISOAbbreviation></Journal><ArticleTitle>A pilot study for a prospective, randomized, double-blind trial of the influence of anesthetic depth on long-term outcome.</ArticleTitle><Pagination><StartPage>981</StartPage><EndPage>986</EndPage><MedlinePgn>981-6</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1213/ANE.0000000000000209</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Deep general anesthesia has been associated with increased mortality in 5 observational studies. The association may be causal or an epiphenomenon due to increased anesthetic sensitivity in high-risk patients. We conducted a pilot study to assess the feasibility of performing a definitive randomized controlled trial. The aims of the study were to determine whether anesthetic depth targeting in a high-risk group was feasible and to document anesthetic doses and arterial blood pressures associated with "deep" and "light" general anesthesia.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">ASA physical status III and IV patients, aged &#x2265;60 years, having surgery lasting &#x2265;2 hours, with expected hospital stay &#x2265;2 days, and receiving general anesthesia were randomly allocated to a Bispectral Index (BIS) or spectral entropy (SE) target of 35 ("low" group) or 50 ("high" group). The primary end point was mean BIS or SE. Secondary end points were postanesthesia care unit length of stay and pain scores, quality of recovery score, hospital length of stay, postoperative complications, and death. A composite end point of postoperative complications (pneumonia, myocardial infarction, stroke, pulmonary embolism, heart failure, and death) was determined at 1 year.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">One hundred twenty-five patients were recruited. The mean of the median BIS/SE values for each patient during the maintenance phase of anesthesia in the low and high groups was significantly different: 39 vs 48 (mean difference 8 [95% confidence interval {CI95}, 6 to 10], P &lt; 0.001). There was also a significant difference in mean volatile anesthetic administration (minimum alveolar concentration): 0.98 vs 0.64 (mean difference -0.35 [CI95, -0.44 to -0.26], P &lt; 0.001) and target propofol concentrations: 4.0 vs 3.1 &#x3bc;g/mL (mean difference -0.8 [CI95, -1.2 to -0.3], P = 0.004). Intraoperative mean arterial blood pressures were similar (85 vs 87 mm Hg; mean difference 2 [CI95, -2 to 6], P = 0.86), and there were no differences in short-term recovery characteristics or hospital length of stay. There was a significant difference in the incidence of wound infection at 30 days (13% vs 3%; risk difference -10% [CI95, -21 to -0.1], P = 0.04). At 1 year, the composite rates of complications in the low and high groups were 28% and 17% (risk difference -11 [CI95, -25 to 4], P = 0.15) and mortality rates were 12% and 9%, respectively (risk difference -2 [CI95, -14 to 9], P = 0.70).</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">This pilot study demonstrated that depth of anesthesia targeting with BIS or SE was achievable in a high-risk population with adequate separation of processed electroencephalogram monitor targets. The expected incidence of postoperative complications and mortality occurred. We conclude that a large, multicenter, randomized controlled trial is feasible.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Short</LastName><ForeName>Timothy G</ForeName><Initials>TG</Initials><AffiliationInfo><Affiliation>From the *Department of Anaesthesia, Auckland City Hospital, Auckland, New Zealand; &#x2020;Department of Anaesthesia and Pain Management, Royal Melbourne Hospital, Melbourne, Victoria, Australia; &#x2021;Department of Anaesthesia and Intensive Care, The Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, Hong Kong, China; &#xa7;Department of Anaesthesia and Pain Medicine, Royal Perth Hospital, Perth; &#x2016;School of Medicine and Pharmacology, University of Western Australia; &#xb6;Department of Anaesthesia, Fremantle Hospital, Fremantle, Western Australia, Australia; #Department of Statistics, University of Canterbury, Christchurch, New Zealand; **Department of Anaesthesia and Perioperative Medicine, Alfred Hospital, Melbourne; and &#x2020;&#x2020;Anaesthesia and Perioperative Medicine, Monash University, Melbourne, Victoria, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Leslie</LastName><ForeName>Kate</ForeName><Initials>K</Initials></Author><Author ValidYN="Y"><LastName>Campbell</LastName><ForeName>Douglas</ForeName><Initials>D</Initials></Author><Author ValidYN="Y"><LastName>Chan</LastName><ForeName>Matthew T V</ForeName><Initials>MT</Initials></Author><Author ValidYN="Y"><LastName>Corcoran</LastName><ForeName>Tomas</ForeName><Initials>T</Initials></Author><Author ValidYN="Y"><LastName>O'Loughlin</LastName><ForeName>Edward</ForeName><Initials>E</Initials></Author><Author ValidYN="Y"><LastName>Frampton</LastName><ForeName>Chris</ForeName><Initials>C</Initials></Author><Author ValidYN="Y"><LastName>Myles</LastName><ForeName>Paul</ForeName><Initials>P</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016448">Multicenter Study</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Anesth Analg</MedlineTA><NlmUniqueID>1310650</NlmUniqueID><ISSNLinking>0003-2999</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000777">Anesthetics</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000758" MajorTopicYN="N">Anesthesia</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000762" MajorTopicYN="N">Anesthesia Recovery Period</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000777" MajorTopicYN="N">Anesthetics</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015897" MajorTopicYN="N">Comorbidity</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D056805" MajorTopicYN="N">Consciousness Monitors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003422" MajorTopicYN="N">Critical Care</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004311" MajorTopicYN="N">Double-Blind Method</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004569" MajorTopicYN="N">Electroencephalography</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D023381" MajorTopicYN="N">Endpoint Determination</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019277" MajorTopicYN="N">Entropy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005240" MajorTopicYN="N">Feasibility Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007902" MajorTopicYN="N">Length of Stay</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010865" MajorTopicYN="N">Pilot Projects</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018401" MajorTopicYN="N">Sample Size</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="Y">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2014</Year><Month>5</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2014</Year><Month>5</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2014</Year><Month>6</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">24781568</ArticleId><ArticleId IdType="doi">10.1213/ANE.0000000000000209</ArticleId><ArticleId IdType="pii">00000539-201405000-00018</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">25199629</PMID><DateCompleted><Year>2015</Year><Month>02</Month><Day>20</Day></DateCompleted><DateRevised><Year>2024</Year><Month>03</Month><Day>25</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1756-1833</ISSN><JournalIssue CitedMedium="Internet"><Volume>349</Volume><PubDate><Year>2014</Year><Month>Sep</Month><Day>08</Day></PubDate></JournalIssue><Title>BMJ (Clinical research ed.)</Title><ISOAbbreviation>BMJ</ISOAbbreviation></Journal><ArticleTitle>Impact of sepsis on risk of postoperative arterial and venous thromboses: large prospective cohort study.</ArticleTitle><Pagination><StartPage>g5334</StartPage><MedlinePgn>g5334</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">g5334</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1136/bmj.g5334</ELocationID><Abstract><AbstractText Label="OBJECTIVES" NlmCategory="OBJECTIVE">To evaluate the impact of preoperative sepsis on risk of postoperative arterial and venous thromboses.</AbstractText><AbstractText Label="DESIGN" NlmCategory="METHODS">Prospective cohort study using the National Surgical Quality Improvement Program database of the American College of Surgeons (ACS-NSQIP).</AbstractText><AbstractText Label="SETTING" NlmCategory="METHODS">Inpatient and outpatient procedures in 374 hospitals of all types across the United States, 2005-12.</AbstractText><AbstractText Label="PARTICIPANTS" NlmCategory="METHODS">2,305,380 adults who underwent surgical procedures.</AbstractText><AbstractText Label="MAIN OUTCOME MEASURES" NlmCategory="METHODS">Arterial thrombosis (myocardial infarction or stroke) and venous thrombosis (deep venous thrombosis or pulmonary embolism) in the 30 days after surgery.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Among all surgical procedures, patients with preoperative systemic inflammatory response syndrome or any sepsis had three times the odds of having an arterial or venous postoperative thrombosis (odds ratio 3.1, 95% confidence interval 3.0 to 3.1). The adjusted odds ratios were 2.7 (2.5 to 2.8) for arterial thrombosis and 3.3 (3.2 to 3.4) for venous thrombosis. The adjusted odds ratios for thrombosis were 2.5 (2.4 to 2.6) in patients with systemic inflammatory response syndrome, 3.3 (3.1 to 3.4) in patients with sepsis, and 5.7 (5.4 to 6.1) in patients with severe sepsis, compared with patients without any systemic inflammation. In patients with preoperative sepsis, both emergency and elective surgical procedures had a twofold increased odds of thrombosis.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Preoperative sepsis represents an important independent risk factor for both arterial and venous thromboses. The risk of thrombosis increases with the severity of the inflammatory response and is higher in both emergent and elective surgical procedures. Suspicion of thrombosis should be higher in patients with sepsis who undergo surgery.</AbstractText><CopyrightInformation>&#xa9; Donz&#xe9; et al 2014.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Donz&#xe9;</LastName><ForeName>Jacques D</ForeName><Initials>JD</Initials><AffiliationInfo><Affiliation>Division of General Internal Medicine, Bern University Hospital, 3010 Bern, Switzerland Division of General Internal Medicine and Primary Care, Brigham and Women's Hospital, 02120 Boston, Massachusetts, USA Harvard Medical School, 02115 Boston, Massachusetts, USA donze.author@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ridker</LastName><ForeName>Paul M</ForeName><Initials>PM</Initials><AffiliationInfo><Affiliation>Harvard Medical School, 02115 Boston, Massachusetts, USA Center for Cardiovascular Disease Prevention, Division of Preventive Medicine, Brigham and Women's Hospital, 02215 Boston, MA Division of Cardiovascular Medicine, Brigham and Women's Hospital, 02215 Boston, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Finlayson</LastName><ForeName>Samuel R G</ForeName><Initials>SR</Initials><AffiliationInfo><Affiliation>Department of Surgery, University of Utah, 84132 Salt Lake City, UT, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bates</LastName><ForeName>David W</ForeName><Initials>DW</Initials><AffiliationInfo><Affiliation>Division of General Internal Medicine and Primary Care, Brigham and Women's Hospital, 02120 Boston, Massachusetts, USA Harvard Medical School, 02115 Boston, Massachusetts, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2014</Year><Month>09</Month><Day>08</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>BMJ</MedlineTA><NlmUniqueID>8900488</NlmUniqueID><ISSNLinking>0959-8138</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>BMJ. 2014 Sep 08;349:g5444. doi: 10.1136/bmj.g5444.</RefSource><PMID Version="1">25199797</PMID></CommentsCorrections><CommentsCorrections RefType="CommentIn"><RefSource>BMJ. 2014 Oct 21;349:g6291. doi: 10.1136/bmj.g6291.</RefSource><PMID Version="1">25336047</PMID></CommentsCorrections><CommentsCorrections RefType="CommentIn"><RefSource>BMJ. 2014 Oct 21;349:g6294. doi: 10.1136/bmj.g6294.</RefSource><PMID Version="1">25336428</PMID></CommentsCorrections><CommentsCorrections RefType="CommentIn"><RefSource>BMJ. 2014 Oct 21;349:g6293. doi: 10.1136/bmj.g6293.</RefSource><PMID Version="1">25336445</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009203" MajorTopicYN="N">Myocardial Infarction</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D057234" MajorTopicYN="N">Preoperative Period</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011655" MajorTopicYN="N">Pulmonary Embolism</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018570" MajorTopicYN="N">Risk Assessment</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018805" MajorTopicYN="N">Sepsis</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020521" MajorTopicYN="N">Stroke</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018746" MajorTopicYN="N">Systemic Inflammatory Response Syndrome</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014481" MajorTopicYN="N" Type="Geographic">United States</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020246" MajorTopicYN="N">Venous Thrombosis</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>Competing interests: All authors have completed the ICMJE uniform disclosure at www.icmje.org/coi_disclosure.pdf and declare: no support from any organisation for the submitted work; JD does consultancy for Profility and Homeward Health; PR is listed as a co-inventor on patents held by the Brigham and Women&#x2019;s hospital that relate to the use of inflammatory biomarkers in cardiovascular disease and diabetes that have been licensed to Siemens and AstraZeneca, has received investigator initiated research grants from the National Institutes of Health, Amgen, Novartis, Pfizer, and AstraZeneca, and has served as a consultant to Vascular Biogenics, ISIS, Aegerion, Lilly, and BostonHeart. DB is a board member of SAE Medical, does consultancy for Zynx, and has received grants from Earlysense and received royalties from Medicalis.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2014</Year><Month>9</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2014</Year><Month>9</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2015</Year><Month>2</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2014</Year><Month>9</Month><Day>8</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">25199629</ArticleId><ArticleId IdType="pmc">PMC4157562</ArticleId><ArticleId IdType="doi">10.1136/bmj.g5334</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Ashton CM, Petersen NJ, Wray NP, Kiefe CI, Dunn JK, Wu L, et al. The incidence of perioperative myocardial infarction in men undergoing noncardiac surgery. Ann Intern Med 1993;118:504-10.</Citation><ArticleIdList><ArticleId IdType="pubmed">8442621</ArticleId></ArticleIdList></Reference><Reference><Citation>Gould MK, Garcia DA, Wren SM, Karanicolas PJ, Arcelus JI, Heit JA, et al. Prevention of VTE in nonorthopedic surgical patients: antithrombotic therapy and prevention of thrombosis. 9th ed. American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 2012;141:e227S-77S.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3278061</ArticleId><ArticleId IdType="pubmed">22315263</ArticleId></ArticleIdList></Reference><Reference><Citation>Devereaux PJ, Bradley D, Chan MT, Walsh M, Villar JC, Polanczyk CA, et al. An international prospective cohort study evaluating major vascular complications among patients undergoing noncardiac surgery: the VISION Pilot Study. Open Med 2011;5:e193-200.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3345376</ArticleId><ArticleId IdType="pubmed">22567075</ArticleId></ArticleIdList></Reference><Reference><Citation>Ridker PM, Cushman M, Stampfer MJ, Tracy RP, Hennekens CH. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med 1997;336:973-9.</Citation><ArticleIdList><ArticleId IdType="pubmed">9077376</ArticleId></ArticleIdList></Reference><Reference><Citation>Libby P, Ridker PM, Hansson GK. Progress and challenges in translating the biology of atherosclerosis. Nature 2011;473:317-25.</Citation><ArticleIdList><ArticleId IdType="pubmed">21593864</ArticleId></ArticleIdList></Reference><Reference><Citation>Ross R. Atherosclerosis&#x2014;an inflammatory disease. N Engl J Med 1999;340:115-26.</Citation><ArticleIdList><ArticleId IdType="pubmed">9887164</ArticleId></ArticleIdList></Reference><Reference><Citation>Epstein SE, Zhou YF, Zhu J. Infection and atherosclerosis: emerging mechanistic paradigms. Circulation 1999;100:e20-8.</Citation><ArticleIdList><ArticleId IdType="pubmed">10421626</ArticleId></ArticleIdList></Reference><Reference><Citation>Vallance P, Collier J, Bhagat K. Infection, inflammation, and infarction: does acute endothelial dysfunction provide a link? Lancet 1997;349:1391-2.</Citation><ArticleIdList><ArticleId IdType="pubmed">9149715</ArticleId></ArticleIdList></Reference><Reference><Citation>Danesh J, Collins R, Peto R. Chronic infections and coronary heart disease: is there a link? Lancet 1997;350:430-6.</Citation><ArticleIdList><ArticleId IdType="pubmed">9259669</ArticleId></ArticleIdList></Reference><Reference><Citation>Fong IW. Emerging relations between infectious diseases and coronary artery disease and atherosclerosis. CMAJ 2000;163:49-56.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1232552</ArticleId><ArticleId IdType="pubmed">10920732</ArticleId></ArticleIdList></Reference><Reference><Citation>American College of Surgeons. ACS NSQIP: Program Overview, 2012. http://site.acsnsqip.org/wp-content/uploads/2012/11/NSQIP-Overview-10.12.pdf.</Citation></Reference><Reference><Citation>Von Elm E, Altman DG, Egger M, Pocock SJ, Gotzsche PC, Vandenbroucke JP. Strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies. BMJ 2007;335:806-8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2034723</ArticleId><ArticleId IdType="pubmed">17947786</ArticleId></ArticleIdList></Reference><Reference><Citation>Bone RC, Balk RA, Cerra FB, Dellinger RP, Fein AM, Knaus WA, et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest 1992;101:1644-55.</Citation><ArticleIdList><ArticleId IdType="pubmed">1303622</ArticleId></ArticleIdList></Reference><Reference><Citation>Graham JW, Donaldson SI. Evaluating interventions with differential attrition: the importance of nonresponse mechanisms and use of follow-up data. J Appl Psychol 1993;78:119-28.</Citation><ArticleIdList><ArticleId IdType="pubmed">8449850</ArticleId></ArticleIdList></Reference><Reference><Citation>Levine RL, LeClerc JR, Bailey JE, Monberg MJ, Sarwat S. Venous and arterial thromboembolism in severe sepsis. Thromb Haemost 2008;99:892-8.</Citation><ArticleIdList><ArticleId IdType="pubmed">18449418</ArticleId></ArticleIdList></Reference><Reference><Citation>Andraws R, Berger JS, Brown DL. Effects of antibiotic therapy on outcomes of patients with coronary artery disease: a meta-analysis of randomized controlled trials. JAMA 2005;293:2641-7.</Citation><ArticleIdList><ArticleId IdType="pubmed">15928286</ArticleId></ArticleIdList></Reference><Reference><Citation>Paganini-Hill A, Lozano E, Fischberg G, Perez Barreto M, Rajamani K, Ameriso SF, et al. Infection and risk of ischemic stroke: differences among stroke subtypes. Stroke 2003;34:452-7.</Citation><ArticleIdList><ArticleId IdType="pubmed">12574559</ArticleId></ArticleIdList></Reference><Reference><Citation>Saikku P, Leinonen M, Tenkanen L, Linnanmaki E, Ekman MR, Manninen V, et al. Chronic Chlamydia pneumoniae infection as a risk factor for coronary heart disease in the Helsinki Heart Study. Ann Intern Med 1992;116:273-8.</Citation><ArticleIdList><ArticleId IdType="pubmed">1733381</ArticleId></ArticleIdList></Reference><Reference><Citation>Meier CR, Jick SS, Derby LE, Vasilakis C, Jick H. Acute respiratory-tract infections and risk of first-time acute myocardial infarction. Lancet 1998;351:1467-71.</Citation><ArticleIdList><ArticleId IdType="pubmed">9605802</ArticleId></ArticleIdList></Reference><Reference><Citation>Mattila KJ, Valtonen VV, Nieminen MS, Asikainen S. Role of infection as a risk factor for atherosclerosis, myocardial infarction, and stroke. Clin Infect Dis 1998;26:719-34.</Citation><ArticleIdList><ArticleId IdType="pubmed">9524851</ArticleId></ArticleIdList></Reference><Reference><Citation>Lindsberg PJ, Grau AJ. Inflammation and infections as risk factors for ischemic stroke. Stroke 2003;34:2518-32.</Citation><ArticleIdList><ArticleId IdType="pubmed">14500942</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee TH, Marcantonio ER, Mangione CM, Thomas EJ, Polanczyk CA, Cook EF, et al. Derivation and prospective validation of a simple index for prediction of cardiac risk of major noncardiac surgery. Circulation 1999;100:1043-9.</Citation><ArticleIdList><ArticleId IdType="pubmed">10477528</ArticleId></ArticleIdList></Reference><Reference><Citation>Ridker PM, Danielson E, Fonseca FA, Genest J, Gotto AM Jr, Kastelein JJ, et al. Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. N Engl J Med 2008;359:2195-207.</Citation><ArticleIdList><ArticleId IdType="pubmed">18997196</ArticleId></ArticleIdList></Reference><Reference><Citation>Dellinger RP, Levy MM, Rhodes A, Annane D, Gerlach H, Opal SM, et al. Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2012. Crit Care Med 2013;41:580-637.</Citation><ArticleIdList><ArticleId IdType="pubmed">23353941</ArticleId></ArticleIdList></Reference><Reference><Citation>Cade JF. High risk of the critically ill for venous thromboembolism. Crit Care Med 1982;10:448-50.</Citation><ArticleIdList><ArticleId IdType="pubmed">7044682</ArticleId></ArticleIdList></Reference><Reference><Citation>Pingleton SK, Bone RC, Pingleton WW, Ruth WE. Prevention of pulmonary emboli in a respiratory intensive care unit: efficacy of low-dose heparin. Chest 1981;79:647-50.</Citation><ArticleIdList><ArticleId IdType="pubmed">6971738</ArticleId></ArticleIdList></Reference><Reference><Citation>Hirsch DR, Ingenito EP, Goldhaber SZ. Prevalence of deep venous thrombosis among patients in medical intensive care. JAMA 1995;274:335-7.</Citation><ArticleIdList><ArticleId IdType="pubmed">7609264</ArticleId></ArticleIdList></Reference><Reference><Citation>Rogers SO Jr, Kilaru RK, Hosokawa P, Henderson WG, Zinner MJ, Khuri SF. Multivariable predictors of postoperative venous thromboembolic events after general and vascular surgery: results from the patient safety in surgery study. J Am Coll Surg 2007;204:1211-21.</Citation><ArticleIdList><ArticleId IdType="pubmed">17544079</ArticleId></ArticleIdList></Reference><Reference><Citation>Caprini JA, Arcelus JI, Hasty JH, Tamhane AC, Fabrega F. Clinical assessment of venous thromboembolic risk in surgical patients. Semin Thromb Hemost 1991;17 Suppl 3:304-12.</Citation><ArticleIdList><ArticleId IdType="pubmed">1754886</ArticleId></ArticleIdList></Reference><Reference><Citation>Caprini JA. Thrombosis risk assessment as a guide to quality patient care. Dis Mon 2005;51:70-8.</Citation><ArticleIdList><ArticleId IdType="pubmed">15900257</ArticleId></ArticleIdList></Reference><Reference><Citation>Shorr AF, Williams MD. Venous thromboembolism in critically ill patients. Observations from a randomized trial in sepsis. Thromb Haemost 2009;101:139-44.</Citation><ArticleIdList><ArticleId IdType="pubmed">19132200</ArticleId></ArticleIdList></Reference><Reference><Citation>Gardlund B. Randomised, controlled trial of low-dose heparin for prevention of fatal pulmonary embolism in patients with infectious diseases. The Heparin Prophylaxis Study Group. Lancet 1996;347:1357-61.</Citation><ArticleIdList><ArticleId IdType="pubmed">8637340</ArticleId></ArticleIdList></Reference><Reference><Citation>Glynn RJ, Danielson E, Fonseca FA, Genest J, Gotto AM, Jr., Kastelein JJ, et al. A randomized trial of rosuvastatin in the prevention of venous thromboembolism. N Engl J Med 2009;360:1851-61.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2710995</ArticleId><ArticleId IdType="pubmed">19329822</ArticleId></ArticleIdList></Reference><Reference><Citation>Hansson GK. Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med 2005;352:1685-95.</Citation><ArticleIdList><ArticleId IdType="pubmed">15843671</ArticleId></ArticleIdList></Reference><Reference><Citation>Swirski FK, Nahrendorf M. Leukocyte behavior in atherosclerosis, myocardial infarction, and heart failure. Science 2013;339:161-6.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3891792</ArticleId><ArticleId IdType="pubmed">23307733</ArticleId></ArticleIdList></Reference><Reference><Citation>Ghattas A, Griffiths HR, Devitt A, Lip GY, Shantsila E. Monocytes in coronary artery disease and atherosclerosis: where are we now? J Am Coll Cardiol 2013;62:1541-51.</Citation><ArticleIdList><ArticleId IdType="pubmed">23973684</ArticleId></ArticleIdList></Reference><Reference><Citation>Ridker PM. Targeting inflammatory pathways for the treatment of cardiovascular disease. Eur Heart J 2013.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3954097</ArticleId><ArticleId IdType="pubmed">24204011</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">34014333</PMID><DateCompleted><Year>2022</Year><Month>08</Month><Day>18</Day></DateCompleted><DateRevised><Year>2025</Year><Month>07</Month><Day>28</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1434-3916</ISSN><JournalIssue CitedMedium="Internet"><Volume>142</Volume><Issue>9</Issue><PubDate><Year>2022</Year><Month>Sep</Month></PubDate></JournalIssue><Title>Archives of orthopaedic and trauma surgery</Title><ISOAbbreviation>Arch Orthop Trauma Surg</ISOAbbreviation></Journal><ArticleTitle>Multidisciplinary care model for geriatric patients with hip fracture in Japan: 5-year experience.</ArticleTitle><Pagination><StartPage>2205</StartPage><EndPage>2214</EndPage><MedlinePgn>2205-2214</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s00402-021-03933-w</ELocationID><Abstract><AbstractText Label="INTRODUCTION" NlmCategory="BACKGROUND">Japan is a super-aging society, the geriatric care system establishment for hip fractures is at an urgent task. This report described our concept of multidisciplinary care model for geriatric hip fractures and 5-year outcomes at the Toyama City Hospital, Japan.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">In this retrospective cohort study, a multidisciplinary treatment approach was applied for elderly patients with hip fracture since 2014. These patients (n&#x2009;=&#x2009;678, males: n&#x2009;=&#x2009;143, mean age: 84.6&#x2009;&#xb1;&#x2009;7.5&#xa0;years), were treated per the multidisciplinary care model. Time to surgery, length of hospital stays, complications, osteoporosis treatment, mortality, and medical costs were evaluated.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">The mean time to surgery was 1.7&#xa0;days. Overall, 78.0% patients underwent surgery within 2&#xa0;days. The mean duration of hospital stay was 21.0&#x2009;&#xb1;&#x2009;12.4&#xa0;days. The most frequent complication was deep venous thrombosis (19.0%) followed by dysuria (14.5%). Severe complications were pneumonia 3.4%, heart failure 0.8% and pulmonary embolism 0.4%. The in-hospital mortality rate was 1.2%. The 90-day, 6-month, and 1-year mortality rates were 2.5%, 6.7%, and 12.6%, respectively. The pharmacotherapy rate for osteoporosis at discharge was 90.7%, and the continuation pharmacotherapy rate was 84.7% at 1-year follow-up. The total hospitalization medical cost per person was lower than about 400 other hospitals' average costs every year, totaled 14% less during the 5-year study period.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">We have organized a multidisciplinary team approach for geriatric hip fracture. This approach resulted in a shorter time to surgery and hospital stay than the national average. The incidence of severe complications and mortality was low. The multidisciplinary treatment has maintained a high rate of osteoporosis treatment after discharge and at follow-up. Furthermore, the total medical cost per person was less than the national average. Thus, the multidisciplinary treatment approach for geriatric hip fractures was effective and feasible to conduct in Japan.</AbstractText><CopyrightInformation>&#xa9; 2021. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Shigemoto</LastName><ForeName>Kenji</ForeName><Initials>K</Initials><Identifier Source="ORCID">0000-0002-9815-8003</Identifier><AffiliationInfo><Affiliation>Department of Orthopedic Surgery and Joint Reconstruction Surgery, Toyama City Hospital, 2-1, Imaizumihokubumachi, Toyama, Toyama, 939-8511, Japan. ywwds017@ybb.ne.jp.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sawaguchi</LastName><ForeName>Takeshi</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Traumatology, Trauma and Reconstruction Center, Shinyurigaoka General Hospital, Fukushima Medical University, Fukushima, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Horii</LastName><ForeName>Takeshi</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Orthopedic Surgery and Joint Reconstruction Surgery, Toyama City Hospital, 2-1, Imaizumihokubumachi, Toyama, Toyama, 939-8511, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Goshima</LastName><ForeName>Kenichi</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Orthopedic Surgery and Joint Reconstruction Surgery, Toyama City Hospital, 2-1, Imaizumihokubumachi, Toyama, Toyama, 939-8511, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Iwai</LastName><ForeName>Shintaro</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Orthopedic Surgery and Joint Reconstruction Surgery, Toyama City Hospital, 2-1, Imaizumihokubumachi, Toyama, Toyama, 939-8511, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Higashikawa</LastName><ForeName>Toshihiro</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Geriatric Medicine, Kanazawa Medical University Himi Municipal Hospital, Toyama, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Okuro</LastName><ForeName>Masashi</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Geriatric Medicine, Kanazawa Medical University Himi Municipal Hospital, Toyama, Japan.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>05</Month><Day>20</Day></ArticleDate></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>Arch Orthop Trauma Surg</MedlineTA><NlmUniqueID>9011043</NlmUniqueID><ISSNLinking>0936-8051</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006620" MajorTopicYN="Y">Hip Fractures</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007564" MajorTopicYN="N" Type="Geographic">Japan</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007902" MajorTopicYN="N">Length of Stay</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010024" MajorTopicYN="Y">Osteoporosis</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Geriatric fractures</Keyword><Keyword MajorTopicYN="N">Hip fractures</Keyword><Keyword MajorTopicYN="N">Multidisciplinary care model</Keyword><Keyword MajorTopicYN="N">Orthogeriatric comanagement</Keyword><Keyword MajorTopicYN="N">Osteoporosis treatment</Keyword><Keyword MajorTopicYN="N">Secondary fracture prevention</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>10</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>5</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>5</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>8</Month><Day>19</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>5</Month><Day>20</Day><Hour>12</Hour><Minute>38</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34014333</ArticleId><ArticleId IdType="doi">10.1007/s00402-021-03933-w</ArticleId><ArticleId IdType="pii">10.1007/s00402-021-03933-w</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Ministry of Health, Labor and Welfare of Japan. Life expectancy Report. http://www.mhlw.go.jp/toukei/saikin/hw/life/life16/dl/life16-04.pdf . Accessed 5 May 2020</Citation></Reference><Reference><Citation>Orimo H, Yaegashi Y, Hosoi T, Fukushima Y, Onoda T, Hashimoto T, Sakata K (2016) Hip fracture incidence in Japan: estimates of new patients in 2012 and 25-year trends. Osteoporos Int 27:1777&#x2013;1784</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00198-015-3464-8</ArticleId></ArticleIdList></Reference><Reference><Citation>Hagino H (2012) Fragility fracture prevention: review from a Japanese perspective. Yonago Acta Med 55:21&#x2013;28</Citation><ArticleIdList><ArticleId IdType="pubmed">24031136</ArticleId><ArticleId IdType="pmc">3763792</ArticleId></ArticleIdList></Reference><Reference><Citation>Adunsky A, Lerner-Geva L, Blumstein T, Boyko V, Mizrahi E, Arad M (2011) Improved survival of hip fracture patients treated within a comprehensive geriatric hip fracture unit, compared with standard of care treatment. J Am Med Dir Assoc 12:439&#x2013;444</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jamda.2010.09.003</ArticleId></ArticleIdList></Reference><Reference><Citation>Vidan M, Serra JA, Moreno C, Riquelme G, Ortiz J (2005) Efficacy of a comprehensive geriatric intervention in older patients hospitalized for hip fracture: a randomized, controlled trial. J Am Geriatr Soc 53:1476&#x2013;1482</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1532-5415.2005.53466.x</ArticleId></ArticleIdList></Reference><Reference><Citation>Gonzalez-Montalvo JI, Alarcon T, Mauleon JL, Gil-Garay E, Gotor P, Martin-Vega A (2010) The orthogeriatric unit for acute patients: a new model of care that improves efficiency in the management of patients with hip fracture. Hip Int 20:229&#x2013;235</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/112070001002000214</ArticleId></ArticleIdList></Reference><Reference><Citation>Friedman SM, Mendelson DA, Bingham KW, Kates SL (2009) Impact of a comanaged Geriatric Fracture Center on short-term hip fracture outcomes. Arch Intern Med 169:1712&#x2013;1717</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archinternmed.2009.321</ArticleId></ArticleIdList></Reference><Reference><Citation>Leung AH, Lam TP, Cheung WH, Chan T, Sze PC, Lau T, Leung KS (2011) An orthogeriatric collaborative intervention program for fragility fractures: a retrospective cohort study. J Trauma 71:1390&#x2013;1394</Citation><ArticleIdList><ArticleId IdType="pubmed">22002614</ArticleId></ArticleIdList></Reference><Reference><Citation>Folbert EC, Hegeman JH, Gierveld R, van Netten JJ, Velde DV, Ten Duis HJ, Slaets JP (2017) Complications during hospitalization and risk factors in elderly patients with hip fracture following integrated orthogeriatric treatment. Arch Orthop Trauma Surg 137:507&#x2013;515</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00402-017-2646-6</ArticleId></ArticleIdList></Reference><Reference><Citation>Folbert EC, Hegeman JH, Vermeer M, Regtuijt EM, van der Velde D, Ten Duis HJ, Slaets JP (2017) Improved 1-year mortality in elderly patients with a hip fracture following integrated orthogeriatric treatment. Osteoporos Int 28:269&#x2013;277</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00198-016-3711-7</ArticleId></ArticleIdList></Reference><Reference><Citation>Baroni M, Serra R, Boccardi V, Ercolani S, Zengarini E, Casucci P, Valecchi R, Rinonapoli G, Caraffa A, Mecocci P, Ruggiero C (2019) The orthogeriatric comanagement improves clinical outcomes of hip fracture in older adults. Osteoporos Int 30:907&#x2013;916</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00198-019-04858-2</ArticleId></ArticleIdList></Reference><Reference><Citation>Neuerburg C, F&#xf6;rch S, Gleich J, B&#xf6;cker W, Gosch M, Kammerlander C, Mayr E (2019) Improved outcome in hip fracture patients in the aging population following co-managed care compared to conventional surgical treatment: a retrospective, dual-center cohort study. BMC Geriatr 19:330</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12877-019-1289-6</ArticleId></ArticleIdList></Reference><Reference><Citation>Shigemoto K, Sawaguchi T, Goshima K, Iwai S, Nakanishi A, Ueoka K (2019) The effect of a multidisciplinary approach on geriatric hip fractures in Japan. J Orthop Sci 24:280&#x2013;285</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jos.2018.09.012</ArticleId></ArticleIdList></Reference><Reference><Citation>Grimes JP, Gregory PM, Noveck H, Butler MS, Carson JL (2002) The effects of time-to surgery on mortality and morbidity in patients following hip fracture. Am J Med 112:702&#x2013;709</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0002-9343(02)01119-1</ArticleId></ArticleIdList></Reference><Reference><Citation>Bergeron E, Lavoie A, Moore L, Bamvita JM, Ratte S, Gravel C, Clas D (2006) Is the delay to surgery for isolated hip fracture predictive of outcome in efficient systems? J Trauma 60:753&#x2013;757</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.ta.0000214649.53190.2a</ArticleId></ArticleIdList></Reference><Reference><Citation>Khan SK, Kalra S, Khanna A, Thiruvengada MM, Parker MJ (2009) Timing of surgery for hip fractures: a systematic review of 52 published studies involving 291,413 patients. Injury 40:692&#x2013;697</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.injury.2009.01.010</ArticleId></ArticleIdList></Reference><Reference><Citation>Shiga T, Wajima Z, Ohe Y (2008) Is operative delay associated with increased mortality of hip fracture patients? Systematic review, meta-analysis, and meta-regression. Can J Anaesth 55:146&#x2013;154</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/BF03016088</ArticleId></ArticleIdList></Reference><Reference><Citation>Hagino H, Endo N, Harada A, Iwamoto J, Mashiba T, Mori S, Ohtori S, Sakai A, Takada J, Yamamoto T (2017) Survey of hip fractures in Japan: recent trends in prevalence and treatment. J Orthop Sci 22:909&#x2013;914</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jos.2017.06.003</ArticleId></ArticleIdList></Reference><Reference><Citation>Moja L, Piatti A, Pecoraro V, Ricci C, Virgili G, Salanti G, Germagnoli L, Liberati A, Banfi G (2012) Timing matters in hip fracture surgery: patients operated within 48 hours have better outcomes. A meta-analysis and meta-regression of over 190,000 patients. PLoS ONE 7:e46175</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0046175</ArticleId></ArticleIdList></Reference><Reference><Citation>Falck-Ytter Y, Francis CW, Johanson NA, Curley C, Dahl OE, Schulman S, Ortel TL, Pauker SG, Colwell CW Jr (2012) Prevention of VTE in orthopedic surgery patients: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest 141:e278S-e325S</Citation><ArticleIdList><ArticleId IdType="doi">10.1378/chest.11-2404</ArticleId></ArticleIdList></Reference><Reference><Citation>American Academy of Orthopaedic Surgeons. Preventing venous thromboembolic disease in patients undergoing elective hip and knee arthroplasty. Evidence-based guidelines and evidence report. http://www.aaos.org/research/guidelines/VTE/VTE_full_guideline.pdf . Accessed 5 May 2020</Citation></Reference><Reference><Citation>National Institute for Health and Clinical Excellence. Venous thromboembolism in over 16s: reducing the risk of hospital-acquired deep vein thrombosis or pulmonary embolism. https://www.nice.org.uk/guidance/ng89 . Accessed 5 May 2020</Citation></Reference><Reference><Citation>Scottish Intercollegiate Guidelines Network (SIGN). Management of hip fractures in older people. Edinburgh: SIGN, 2009. http://www.sign.ac.uk/pdf/sign111.pdf . Accessed May 5 2020</Citation></Reference><Reference><Citation>The management of hip fracture in adults. March 2014. guidance.nice.org.uk/cg124. Roberts KC, Brox WT.</Citation></Reference><Reference><Citation>Roberts KC, Brox WT (2015) AAOS clinical practice guideline: management of hip fractures in the elderly. J Am Acad Orthop Surg 23:138&#x2013;140</Citation><ArticleIdList><ArticleId IdType="doi">10.5435/JAAOS-D-14-00433</ArticleId></ArticleIdList></Reference><Reference><Citation>Pulmonary Embolism Prevention (PEP) Trial Collaborative Group (2000) Prevention of pulmonary embolism and deep vein thrombosis with low dose aspirin: pulmonary embolism prevention (PEP) trial. Lancet 355:1295&#x2013;1302</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(00)02110-3</ArticleId></ArticleIdList></Reference><Reference><Citation>Eriksson BI, Bauer KA, Lassen MR, Turpie AGG for the Steering Committee of the Pentasaccharide in Hip&#x2010;Fracture Surgery Study (2001) Fondaparinux compared with enoxaparin for the prevention of venous thromboembolism after hip-fracture surgery. N Engl J Med 345:1298&#x2013;1304</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa011100</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosencher N, Vielpeau C, Emmerich J, Emmerich J, Fagnani F, Samama CM, ESCORTE group (2005) Venous thromboembolism and mortality after hip fracture surgery: the ESCORTE study. J Thromb Haemost 3:2006&#x2013;2014</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1538-7836.2005.01545.x</ArticleId></ArticleIdList></Reference><Reference><Citation>Thaler HW, Roller RE, Greiner N, Sim E, Korninger C (2001) Thromboprophylaxis with 60 mg enoxaparin is safe in hip trauma surgery. J Trauma 51:518&#x2013;521</Citation><ArticleIdList><ArticleId IdType="pubmed">11535902</ArticleId></ArticleIdList></Reference><Reference><Citation>Barrera LM, Perel P, Ker K, Cirocchi R, Farinella E, Morales Uribe CH (2013) Thromboprophylaxis for trauma patients. Cochrane Database Syst Rev (3):CD008303</Citation></Reference><Reference><Citation>Adunsky A, Nenaydenko O, Koren-Morag N, Puritz L, Fleissig Y, Arad M (2015) Perioperative urinary retention, short-term functional outcome and mortality rates of elderly hip fracture patients. Geriatr Gerontol Int 15:65&#x2013;71</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ggi.12229</ArticleId></ArticleIdList></Reference><Reference><Citation>Roche JJW, Wenn RT, Sahota O, Moran CG (2005) Effect of comorbidities and postoperative complications on mortality after hip fracture in elderly people: prospective observational cohort study. Br Med J 331:1374&#x2013;1376</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.38643.663843.55</ArticleId></ArticleIdList></Reference><Reference><Citation>Guzon-Illescas O, Perez Fernandez E, Cresp&#xed; Villarias N, Quir&#xf3;s Donate FJ, Pe&#xf1;a M, Alonso-Blas C, Garc&#xed;a-Vadillo A, Mazzucchelli R (2019) Mortality after osteoporotic hip fracture: incidence, trends, and associated factors. J Orthop Surg Res 14:203</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13018-019-1226-6</ArticleId></ArticleIdList></Reference><Reference><Citation>Hagino H, Sawaguchi T, Endo N, Ito Y, Nakano T, Watanabe Y (2012) The risk of a second hip fracture in patients after their first hip fracture. Calcif Tissue Int 90:14&#x2013;21</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00223-011-9545-6</ArticleId></ArticleIdList></Reference><Reference><Citation>Hagino H, Wada T (2019) Osteoporosis liaison service in Japan. Osteoporos Sarcopenia 5:65&#x2013;68</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.afos.2019.09.003</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">35263662</PMID><DateCompleted><Year>2022</Year><Month>07</Month><Day>19</Day></DateCompleted><DateRevised><Year>2022</Year><Month>09</Month><Day>02</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1878-1632</ISSN><JournalIssue CitedMedium="Internet"><Volume>22</Volume><Issue>8</Issue><PubDate><Year>2022</Year><Month>Aug</Month></PubDate></JournalIssue><Title>The spine journal : official journal of the North American Spine Society</Title><ISOAbbreviation>Spine J</ISOAbbreviation></Journal><ArticleTitle>Preoperative embolization in surgical treatment of spinal metastases originating from non-hypervascular primary tumors: a propensity score matched study using 495 patients.</ArticleTitle><Pagination><StartPage>1334</StartPage><EndPage>1344</EndPage><MedlinePgn>1334-1344</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.spinee.2022.03.001</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S1529-9430(22)00099-7</ELocationID><Abstract><AbstractText Label="BACKGROUND CONTEXT">Preoperative embolization (PE) reduces intraoperative blood loss during surgery for spinal metastases of hypervascular primary tumors such as thyroid and renal cell tumors. However, most spinal metastases originate from primary breast, prostate, and lung tumors and it remains unclear whether these and other spinal metastases benefit from PE.</AbstractText><AbstractText Label="PURPOSE">To assess the (1) efficacy of PE on the amount of intraoperative blood loss and safety in patients with spinal metastases originating from non-hypervascular primary tumors, and (2) secondary outcomes including perioperative allogeneic blood transfusion, anesthesia time, hospitalization, postoperative complication within 30 days, reoperation, 90-day mortality, and 1-year mortality.</AbstractText><AbstractText Label="STUDY DESIGN">Retrospective propensity-score matched, case-control study at 2 academic tertiary medical centers.</AbstractText><AbstractText Label="PATIENT SAMPLE">Patients 18 years of age or older undergoing surgery for spinal metastases originating from primary non-thyroid, non-renal cell, and non-hepatocellular tumors between January 1, 2002 and December 31, 2016 were included.</AbstractText><AbstractText Label="OUTCOME MEASURES">The primary outcomes were estimated amount of intraoperative blood loss and complications attributable to PE, such as neurologic injury, wound infection, thrombosis, or dissection. The secondary outcomes included perioperative allogeneic blood transfusion, anesthesia time, hospitalization, postoperative complication within 30 days, reoperation, 90-day mortality, and 1-year mortality.</AbstractText><AbstractText Label="METHODS">In total, 495 patients were identified, of which 54 (11%) underwent PE. After propensity score matching on 21 variables, including primary tumor, number of spinal levels, and surgical treatment, 53 non-PE patients were matched to 53 PE patients. Matching was adequate measured by comparing the matched variables, testing the standardized mean differences (&lt;0.25), and inspecting Kernel density plots. The degree of embolization was noted to be complete, until stasis, or successful in 43 (80%) patients.</AbstractText><AbstractText Label="RESULTS">Intraoperative blood loss did not differ between both groups with a median blood loss in liters of 0.6 (IQR, 0.4-1.2) for non-PE patients and 0.9 (IQR, 0.6-1.2) for PE patients (p=.32). No complications occurred during embolization or the time between embolization and surgery. No differences were found in terms of the secondary outcomes.</AbstractText><AbstractText Label="CONCLUSIONS">Our data suggest that, although no complications occurred and the embolization procedure can be considered safe, patients with non-hypervascular spinal metastases might not benefit from PE. A larger, prospective study could confirm or refute these study findings and aid in elucidating a subset of spinal metastases that might benefit from PE.</AbstractText><CopyrightInformation>Copyright &#xa9; 2022 Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Groot</LastName><ForeName>Olivier Q</ForeName><Initials>OQ</Initials><AffiliationInfo><Affiliation>Department of Orthopedic Surgery, Orthopedic Oncology Service, Massachusetts General Hospital - Harvard Medical School, 55 Fruit St., Boston, MA 02114, USA; Department of Orthopedic Surgery, University Medical Center Utrecht - Utrecht University, Heidelberglaan 100, 3584 CX, Utrecht, The Netherlands. Electronic address: oqgroot@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>van Steijn</LastName><ForeName>Nicole J</ForeName><Initials>NJ</Initials><AffiliationInfo><Affiliation>Department of Orthopedic Surgery, Orthopedic Oncology Service, Massachusetts General Hospital - Harvard Medical School, 55 Fruit St., Boston, MA 02114, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ogink</LastName><ForeName>Paul T</ForeName><Initials>PT</Initials><AffiliationInfo><Affiliation>Department of Orthopedic Surgery, University Medical Center Utrecht - Utrecht University, Heidelberglaan 100, 3584 CX, Utrecht, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pierik</LastName><ForeName>Robert-Jan</ForeName><Initials>RJ</Initials><AffiliationInfo><Affiliation>Department of Orthopedic Surgery, Orthopedic Oncology Service, Massachusetts General Hospital - Harvard Medical School, 55 Fruit St., Boston, MA 02114, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bongers</LastName><ForeName>Michiel E R</ForeName><Initials>MER</Initials><AffiliationInfo><Affiliation>Department of Orthopedic Surgery, Orthopedic Oncology Service, Massachusetts General Hospital - Harvard Medical School, 55 Fruit St., Boston, MA 02114, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zijlstra</LastName><ForeName>Hester</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Orthopedic Surgery, Orthopedic Oncology Service, Massachusetts General Hospital - Harvard Medical School, 55 Fruit St., Boston, MA 02114, USA; Department of Orthopedic Surgery, University Medical Center Utrecht - Utrecht University, Heidelberglaan 100, 3584 CX, Utrecht, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>de Groot</LastName><ForeName>Tom M</ForeName><Initials>TM</Initials><AffiliationInfo><Affiliation>Department of Orthopedic Surgery, Orthopedic Oncology Service, Massachusetts General Hospital - Harvard Medical School, 55 Fruit St., Boston, MA 02114, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>An</LastName><ForeName>Thomas J</ForeName><Initials>TJ</Initials><AffiliationInfo><Affiliation>Department of Radiology, Radiology Oncology Service, Massachusetts General Hospital - Harvard Medical School, 55 Fruit St. Boston, MA 02114, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rabinov</LastName><ForeName>James D</ForeName><Initials>JD</Initials><AffiliationInfo><Affiliation>Department of Radiology, Radiology Oncology Service, Massachusetts General Hospital - Harvard Medical School, 55 Fruit St. Boston, MA 02114, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Verlaan</LastName><ForeName>Jorrit-Jan</ForeName><Initials>JJ</Initials><AffiliationInfo><Affiliation>Department of Orthopedic Surgery, University Medical Center Utrecht - Utrecht University, Heidelberglaan 100, 3584 CX, Utrecht, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schwab</LastName><ForeName>Joseph H</ForeName><Initials>JH</Initials><AffiliationInfo><Affiliation>Department of Orthopedic Surgery, Orthopedic Oncology Service, Massachusetts General Hospital - Harvard Medical School, 55 Fruit St., Boston, MA 02114, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>03</Month><Day>06</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Spine J</MedlineTA><NlmUniqueID>101130732</NlmUniqueID><ISSNLinking>1529-9430</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016063" MajorTopicYN="N">Blood Loss, Surgical</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016022" MajorTopicYN="N">Case-Control Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004621" MajorTopicYN="Y">Embolization, Therapeutic</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007680" MajorTopicYN="Y">Kidney Neoplasms</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011300" MajorTopicYN="N">Preoperative Care</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D057216" MajorTopicYN="N">Propensity Score</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013125" MajorTopicYN="Y">Spinal Neoplasms</DescriptorName><QualifierName UI="Q000556" MajorTopicYN="N">secondary</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Complications</Keyword><Keyword MajorTopicYN="N">Intraoperative blood loss</Keyword><Keyword MajorTopicYN="N">Non&#x2013;hypervascular tumors</Keyword><Keyword MajorTopicYN="N">Preoperative embolization</Keyword><Keyword MajorTopicYN="N">Spinal metastases</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>12</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>2</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>3</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>3</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>7</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>3</Month><Day>9</Day><Hour>20</Hour><Minute>6</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35263662</ArticleId><ArticleId IdType="doi">10.1016/j.spinee.2022.03.001</ArticleId><ArticleId IdType="pii">S1529-9430(22)00099-7</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">35659160</PMID><DateCompleted><Year>2022</Year><Month>12</Month><Day>26</Day></DateCompleted><DateRevised><Year>2022</Year><Month>12</Month><Day>26</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1542-2224</ISSN><JournalIssue CitedMedium="Internet"><Volume>62</Volume><Issue>1</Issue><PubDate><Year>2023</Year><Season>Jan-Feb</Season></PubDate></JournalIssue><Title>The Journal of foot and ankle surgery : official publication of the American College of Foot and Ankle Surgeons</Title><ISOAbbreviation>J Foot Ankle Surg</ISOAbbreviation></Journal><ArticleTitle>Incidence of Venous Thromboembolism in Patients Receiving Anticoagulation for Foot and Ankle Surgery.</ArticleTitle><Pagination><StartPage>35</StartPage><EndPage>38</EndPage><MedlinePgn>35-38</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1053/j.jfas.2022.03.008</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S1067-2516(22)00104-1</ELocationID><Abstract><AbstractText>Venous thromboembolism (VTE) is a serious medical condition that can be an unfortunate complication arising from foot and ankle surgery. Many factors may predispose a patient to a VTE event including prolonged postoperative immobilization, comorbidities, extended length of tourniquet time, and higher risk surgeries. Unfortunately, there is no clinical consensus for guidelines on VTE prophylaxis following foot and ankle surgery. In this retrospective cohort study, we present our patient population who were prophylactically anticoagulated following foot and ankle surgery along with their incidence of deep vein thrombosis and pulmonary embolism (PE). Included in the study were patients who had undergone elective and traumatic foot and ankle surgery from June 2017 to December 2018. Using retrospective data obtained we compared patient demographics, surgery type, length of tourniquet time, postoperative immobilization, type of VTE prophylaxis, and comorbidities including history of smoking, peripheral vascular disease, bleeding disorders, and patients undergoing dialysis. Five of 425 (1.2%) patients were diagnosed with a deep vein thrombosis and 1 of 425 (0.2%) patients was diagnosed with a pulmonary embolism. Risks factors statistically significant for developing a VTE in our patient population included extended periods of immobilization and an increasing patient age. We were able to conclude that routine prophylaxis for elective and traumatic foot and ankle surgery is both effective and safe for especially in older patients requiring extended immobilization. It's also important to take into consideration comorbidities, smoking history, tourniquet time, and the type of surgery that is being performed.</AbstractText><CopyrightInformation>Copyright &#xa9; 2022 the American College of Foot and Ankle Surgeons. Published by Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Claveau</LastName><ForeName>Tyler</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Podiatric Physician, Shoreline Foot &amp; Ankle Associates, Ludington, MI. Electronic address: tylerclaveau@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hilbert</LastName><ForeName>Damian</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Podiatric Physician, Mile Bluff Medical Center, Mauston, WI.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dhaduk</LastName><ForeName>Romesh</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Podiatric Physician, Foot &amp; Ankle Institute, Indianapolis, IN.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Morrison</LastName><ForeName>Pamela</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Co-director, Podiatric Foot &amp; Ankle Residency, Beaumont Wayne Hospital, Wayne, MI.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fallat</LastName><ForeName>Lawrence</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Director, Podiatric Foot &amp; Ankle Residency, Beaumont Wayne Hospital, Wayne, MI.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jarski</LastName><ForeName>Robert</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Statistician, Oakland University School of Health Sciences, Oakland, MI.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>04</Month><Day>01</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Foot Ankle Surg</MedlineTA><NlmUniqueID>9308427</NlmUniqueID><ISSNLinking>1067-2516</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000925">Anticoagulants</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D054556" MajorTopicYN="Y">Venous Thromboembolism</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000842" MajorTopicYN="N">Ankle</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015994" MajorTopicYN="N">Incidence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011655" MajorTopicYN="Y">Pulmonary Embolism</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020246" MajorTopicYN="Y">Venous Thrombosis</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000925" MajorTopicYN="N">Anticoagulants</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">deep vein thrombosis</Keyword><Keyword MajorTopicYN="N">foot and ankle surgery</Keyword><Keyword MajorTopicYN="N">pulmonary embolism</Keyword><Keyword MajorTopicYN="N">surgical pharmacological prophylaxis</Keyword><Keyword MajorTopicYN="N">venous thromboembolism</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>7</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2021</Year><Month>3</Month><Day>31</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>3</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>6</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>12</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>6</Month><Day>6</Day><Hour>10</Hour><Minute>28</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35659160</ArticleId><ArticleId IdType="doi">10.1053/j.jfas.2022.03.008</ArticleId><ArticleId IdType="pii">S1067-2516(22)00104-1</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">31522961</PMID><DateCompleted><Year>2020</Year><Month>05</Month><Day>15</Day></DateCompleted><DateRevised><Year>2020</Year><Month>05</Month><Day>15</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1424-3911</ISSN><JournalIssue CitedMedium="Internet"><Volume>19</Volume><Issue>7</Issue><PubDate><Year>2019</Year><Month>Oct</Month></PubDate></JournalIssue><Title>Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.]</Title><ISOAbbreviation>Pancreatology</ISOAbbreviation></Journal><ArticleTitle>Incidental pulmonary embolism in pancreatic ductal adenocarcinoma: Impact of tumor and AJCC stages at initial staging CT.</ArticleTitle><Pagination><StartPage>979</StartPage><EndPage>984</EndPage><MedlinePgn>979-984</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.pan.2019.09.002</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S1424-3903(19)30723-9</ELocationID><Abstract><AbstractText Label="BACKGROUND/OBJECTIVES" NlmCategory="OBJECTIVE">To determine the prevalence of incidental pulmonary embolism (PE) detected during initial staging CT among patients with newly diagnosed pancreatic ductal adenocarcinoma (PDAC) and assess their association with underlying tumor burden.</AbstractText><AbstractText Label="MATERIALS AND METHODS" NlmCategory="METHODS">This retrospective cohort study evaluated staging chest CT scans (2013-2017) to identify PE among patients with treatment na&#xef;ve, biopsy-proven PDAC. Data included age, sex, T stage, AJCC stage, presence/absence of metastases and their location at diagnosis. The association of PE with tumor (T1-T4) and AJCC stage were assessed using Pearson Chi-square and Fischer's exact test. A threshold p-value of &lt;0.05 indicated statistical significance.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">A total of 174 patients (90 female, mean age, 68 years; range: 34-93) were identified, of which 10 patients harbored incidental PE (prevalence, 5.7%). In the PE group, two patients presented with distant metastasis (liver, 20%), while eight patients had T4 tumors (80%). No statistical association was detected between PE and age, sex, and the presence/absence or location of distant metastasis (p&#x202f;=&#x202f;0.065, p&#x202f;=&#x202f;0.59, p&#x202f;=&#x202f;0.687 and p&#x202f;=&#x202f;0.933, respectively). Patients with T4 tumors and higher AJCC stages (stage III/IV) were significantly more likely to present with PE than those with lower T stage (p&#x202f;=&#x202f;0.045) and AJCC stage (stage I/II; p&#x202f;=&#x202f;0.017).</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">The prevalence of incidental PE among PDAC patients undergoing initial CT staging is 5.7%. Patients with T4 and AJCC stages III/IV are at higher risk of PE. Caution should be exercised during radiographic interpretation of initial staging chest CTs, as incidental PE may be lurking and require treatment.</AbstractText><CopyrightInformation>Published by Elsevier B.V.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Schawkat</LastName><ForeName>Khoschy</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Division of Abdominal Imaging, Department of Radiology, Beth Israel Deaconess Medical Center, Harvard Medical School, 330 Brookline Avenue, Boston, MA, 02215, USA; Institute of Diagnostic and Interventional Radiology, University Hospital Zurich, Zurich, Switzerland. Electronic address: kschawka@bidmc.harvard.edu.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tabah</LastName><ForeName>Nicolas</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Division of Abdominal Imaging, Department of Radiology, Beth Israel Deaconess Medical Center, Harvard Medical School, 330 Brookline Avenue, Boston, MA, 02215, USA. Electronic address: ntabah@bidmc.harvard.edu.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tridente</LastName><ForeName>Daniela</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Division of Thoracic Imaging, Department of Radiology, Beth Israel Deaconess Medical Center, Harvard Medical School, 330 Brookline Avenue, Boston, MA, 02215, USA. Electronic address: dtrident@bidmc.harvard.edu.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schlechter</LastName><ForeName>Benjamin L</ForeName><Initials>BL</Initials><AffiliationInfo><Affiliation>Division of Hematology and Oncology, Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, 330 Brookline Avenue, Boston, MA, 02215, USA. Electronic address: bschlech@bidmc.harvard.edu.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Singer</LastName><ForeName>Tori</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Pancreas and Liver Institute, Department of Surgery, Beth Israel Deaconess Medical Center, Harvard Medical School, 185 Pilgrim road, Palmer 6, Boston, MA, 02215, USA. Electronic address: tsinger@bidmc.harvard.edu.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Decicco</LastName><ForeName>Corinne</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Pancreas and Liver Institute, Department of Surgery, Beth Israel Deaconess Medical Center, Harvard Medical School, 185 Pilgrim road, Palmer 6, Boston, MA, 02215, USA. Electronic address: cdecicco@bidmc.harvard.edu.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Moser</LastName><ForeName>A James</ForeName><Initials>AJ</Initials><AffiliationInfo><Affiliation>Pancreas and Liver Institute, Department of Surgery, Beth Israel Deaconess Medical Center, Harvard Medical School, 185 Pilgrim road, Palmer 6, Boston, MA, 02215, USA. Electronic address: ajmoser@bidmc.harvard.edu.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mortele</LastName><ForeName>Koenraad J</ForeName><Initials>KJ</Initials><AffiliationInfo><Affiliation>Division of Abdominal Imaging, Department of Radiology, Beth Israel Deaconess Medical Center, Harvard Medical School, 330 Brookline Avenue, Boston, MA, 02215, USA. Electronic address: kmortele@bidmc.harvard.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2019</Year><Month>09</Month><Day>09</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Pancreatology</MedlineTA><NlmUniqueID>100966936</NlmUniqueID><ISSNLinking>1424-3903</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D021441" MajorTopicYN="N">Carcinoma, Pancreatic Ductal</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName><QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004617" MajorTopicYN="N">Embolism</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName><QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010190" MajorTopicYN="N">Pancreatic Neoplasms</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName><QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Computed tomography</Keyword><Keyword MajorTopicYN="N">Pancreas</Keyword><Keyword MajorTopicYN="N">Pancreatic ductal adenocarcinoma</Keyword><Keyword MajorTopicYN="N">Pulmonary embolism</Keyword><Keyword MajorTopicYN="N">Staging</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2019</Year><Month>8</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2019</Year><Month>9</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>9</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>5</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>9</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31522961</ArticleId><ArticleId IdType="doi">10.1016/j.pan.2019.09.002</ArticleId><ArticleId IdType="pii">S1424-3903(19)30723-9</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">32571889</PMID><DateCompleted><Year>2022</Year><Month>02</Month><Day>07</Day></DateCompleted><DateRevised><Year>2025</Year><Month>04</Month><Day>28</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1525-1438</ISSN><JournalIssue CitedMedium="Internet"><Volume>32</Volume><Issue>1</Issue><PubDate><Year>2022</Year><Month>Jan</Month></PubDate></JournalIssue><Title>International journal of gynecological cancer : official journal of the International Gynecological Cancer Society</Title><ISOAbbreviation>Int J Gynecol Cancer</ISOAbbreviation></Journal><ArticleTitle>Dual mechanical and pharmacological thromboprophylaxis decreases risk of pulmonary embolus after laparotomy for gynecologic malignancies.</ArticleTitle><Pagination><StartPage>55</StartPage><EndPage>61</EndPage><MedlinePgn>55-61</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1136/ijgc-2020-001205</ELocationID><Abstract><AbstractText Label="OBJECTIVES">Patients with gynecologic malignancies have high rates of post-operative venous thromboembolism. Currently, there is no consensus for peri-operative thromboprophylaxis specific to gynecologic oncology. We aimed to compare rates of symptomatic pulmonary embolus within 30 days post-operatively, and to identify risk factors for pulmonary embolus.</AbstractText><AbstractText Label="METHODS">The Division of Gynecologic Oncology at Sunnybrook Health Sciences Centre implemented dual thromboprophylaxis for laparotomies in December 2017. We conducted a prospective study of laparotomies for gynecologic malignancies from December 2017 to October 2018, with comparison to historical cohort from January 2016 to November 2017 using the institutional National Surgical Quality Improvement Program database (NSQIP). Pre-intervention, patients received low molecular weight heparin during admission and extended 28-day prophylaxis was continued at the surgeon's discretion. Post-intervention, all patients received both mechanical thromboprophylaxis with sequential compression devices during admission and 28-day prophylaxis with low molecular weight heparin.</AbstractText><AbstractText Label="RESULTS">There were 371 and 163 laparotomies pre- and post-intervention, respectively. Patient characteristics (age, body mass index, diabetes, smoking, tumor stage), rate of malignant cases, operative blood loss and duration, and length of stay were similar between groups. After implementation, pulmonary emboli rates decreased from 5.1% to 0% (p=0.001). There were more cytoreductive procedures pre-intervention (p&#x2264;0.0001) but surgical complexity scores were similar (p=0.82). Univariate analysis revealed that surgery pre-intervention (OR 4.25, 95%&#x2009;CI 1.04 to 17.43, p=0.04), length of stay &#x2265;5 days (OR 11.94, 95%&#x2009;CI 2.65 to 53.92, p=0.002), and operative blood loss &#x2265;500&#x2009;mL (OR 2.85, 95%&#x2009;CI 1.05 to 7.8, p=0.04) increased risk of pulmonary embolus. On multivariable analysis, surgery pre-intervention remained associated with more pulmonary emboli (OR 4.16, 95%&#x2009;CI 1.03 to 16.79, p=0.045), when adjusting for operative blood loss.</AbstractText><AbstractText Label="CONCLUSION">Dual thromboprophylaxis after laparotomy significantly reduced rates of pulmonary embolus in this high-risk patient population.</AbstractText><CopyrightInformation>&#xa9; IGCS and ESGO 2022. No commercial re-use. See rights and permissions. Published by BMJ.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Nguyen</LastName><ForeName>Julie My Van</ForeName><Initials>JMV</Initials><AffiliationInfo><Affiliation>Gynecologic Oncology, University of Toronto, Toronto, Ontario, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gien</LastName><ForeName>Lilian T</ForeName><Initials>LT</Initials><AffiliationInfo><Affiliation>Gynecologic Oncology, Odette Cancer Centre, Toronto, Ontario, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Covens</LastName><ForeName>Allan</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Gynecologic Oncology, Odette Cancer Centre, Toronto, Ontario, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kupets</LastName><ForeName>Rachel</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Gynecologic Oncology, Odette Cancer Centre, Toronto, Ontario, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Osborne</LastName><ForeName>Raymond J</ForeName><Initials>RJ</Initials><AffiliationInfo><Affiliation>Gynecologic Oncology, Odette Cancer Centre, Toronto, Ontario, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sadeghi</LastName><ForeName>Mahsa</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Division of Surgery, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nathens</LastName><ForeName>Avery B</ForeName><Initials>AB</Initials><AffiliationInfo><Affiliation>Division of General Surgery, Department of Surgery, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vicus</LastName><ForeName>Danielle</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Gynecologic Oncology, Odette Cancer Centre, Toronto, Ontario, Canada danielle.vicus@sunnybrook.ca.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D018848">Controlled Clinical Trial</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>06</Month><Day>22</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Int J Gynecol Cancer</MedlineTA><NlmUniqueID>9111626</NlmUniqueID><ISSNLinking>1048-891X</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000925">Anticoagulants</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D006495">Heparin, Low-Molecular-Weight</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000925" MajorTopicYN="N">Anticoagulants</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="Y">administration &amp; dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005833" MajorTopicYN="N">Genital Neoplasms, Female</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006495" MajorTopicYN="N">Heparin, Low-Molecular-Weight</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="Y">administration &amp; dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D048228" MajorTopicYN="N">Intermittent Pneumatic Compression Devices</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007813" MajorTopicYN="N">Laparotomy</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011655" MajorTopicYN="N">Pulmonary Embolism</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">postoperative care</Keyword><Keyword MajorTopicYN="N">pulmonary embolism</Keyword><Keyword MajorTopicYN="N">venous thromboembolism</Keyword></KeywordList><CoiStatement>Competing interests: None declared.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>2</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2020</Year><Month>5</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>5</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>6</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>2</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>6</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32571889</ArticleId><ArticleId IdType="doi">10.1136/ijgc-2020-001205</ArticleId><ArticleId IdType="pii">S1048-891X(24)00559-0</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">19329075</PMID><DateCompleted><Year>2009</Year><Month>07</Month><Day>22</Day></DateCompleted><DateRevised><Year>2020</Year><Month>12</Month><Day>16</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1878-7487</ISSN><JournalIssue CitedMedium="Internet"><Volume>16</Volume><Issue>4</Issue><PubDate><Year>2009</Year><Month>May</Month></PubDate></JournalIssue><Title>Journal of forensic and legal medicine</Title><ISOAbbreviation>J Forensic Leg Med</ISOAbbreviation></Journal><ArticleTitle>Pulmonary embolism and sudden-unexpected death: prospective study on 2477 forensic autopsies performed at the Institute of Legal Medicine in Seville.</ArticleTitle><Pagination><StartPage>196</StartPage><EndPage>201</EndPage><MedlinePgn>196-201</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jflm.2008.08.015</ELocationID><Abstract><AbstractText>Pulmonary embolism (PE) and deep venous thrombosis (DVT) are clinical manifestations of the same entity, venous thromboembolic disease (VTD). In approximately 25% of patients, the first manifestation of PE is sudden-unexpected death. We carried out a prospective study at the forensic pathology service of the Institute of Legal Medicine in Seville with the aim to know the incidence of PE as well as to describe the epidemiological, pathological and clinical characteristics of these deaths and associated risk factors. In the study period (32 months) 32 cases of PE were registered from a total of 2447 completed autopsies. Three cases were considered accidental deaths and the remaining 29 cases were sudden natural deaths, which represents 1.3% of the total autopsies, 2.6% of natural deaths and 4.3% of sudden deaths. Nineteen cases (59%) were men (mean age 50.3+/-13.8, range 22-74 years) and 13 cases (41%) were women (mean age 50.3+/-13.8, range 18-87 years). In 78% of cases death occurred at home or during transfer to a health care centre, mainly during the fall or winter (69%) and between 8a.m. and 4p.m. (47%). Pulmonary infarction was associated only in two cases (6%). Nine cases (28%) had been immobilized but only three (9%) received anticoagulant therapy. Surgical interventions had occurred in seven cases (22%). A history of psychiatric pathology was found in 31%. Overweight or obesity was found in 75%. The most frequent symptoms prior to death were dyspnea (31%) and chest pain (19%), and 19% of patients were examined in an Emergencies Department for symptoms compatible with deep vein thrombosis and/or PE, but this diagnosis was not suspected in any case. PE frequently makes its first appearance as sudden death. In addition to the classic risk factors, this study highlights that 75% of the cases were overweight/obese as well as 31% having had a history of psychiatric disorders and treatment as to support that this association should be considered as a risk factor. PE continues to be under diagnosed in Emergencies Department patients, which hinders the application of adequate therapeutic measures to prevent these deaths.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Lucena</LastName><ForeName>Joaqu&#xed;n</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Forensic Pathology Service, Institute of Legal Medicine, Avenida Sanchez Pizju&#xe1;n s/n. 41009, Seville, Spain. joaquin.lucena@gmail.com</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rico</LastName><ForeName>Antonio</ForeName><Initials>A</Initials></Author><Author ValidYN="Y"><LastName>V&#xe1;zquez</LastName><ForeName>Rafael</ForeName><Initials>R</Initials></Author><Author ValidYN="Y"><LastName>Mar&#xed;n</LastName><ForeName>Roc&#xed;o</ForeName><Initials>R</Initials></Author><Author ValidYN="Y"><LastName>Mart&#xed;nez</LastName><ForeName>Carmen</ForeName><Initials>C</Initials></Author><Author ValidYN="Y"><LastName>Salguero</LastName><ForeName>Manuel</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Miguel</LastName><ForeName>Luciana</ForeName><Initials>L</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2008</Year><Month>10</Month><Day>25</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>J Forensic Leg Med</MedlineTA><NlmUniqueID>101300022</NlmUniqueID><ISSNLinking>1752-928X</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000925">Anticoagulants</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017677" MajorTopicYN="N">Age Distribution</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000925" MajorTopicYN="N">Anticoagulants</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002637" MajorTopicYN="N">Chest Pain</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003645" MajorTopicYN="N">Death, Sudden</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004417" MajorTopicYN="N">Dyspnea</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D049429" MajorTopicYN="N">Forensic Pathology</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007103" MajorTopicYN="N">Immobilization</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015994" MajorTopicYN="N">Incidence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001523" MajorTopicYN="N">Mental Disorders</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D050177" MajorTopicYN="N">Overweight</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011655" MajorTopicYN="N">Pulmonary Embolism</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName><QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D054060" MajorTopicYN="N">Pulmonary Infarction</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012621" MajorTopicYN="N">Seasons</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017678" MajorTopicYN="N">Sex Distribution</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013030" MajorTopicYN="N" Type="Geographic">Spain</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013514" MajorTopicYN="N">Surgical Procedures, Operative</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020246" MajorTopicYN="N">Venous Thrombosis</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2008</Year><Month>4</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2008</Year><Month>8</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2008</Year><Month>8</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2009</Year><Month>3</Month><Day>31</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2009</Year><Month>3</Month><Day>31</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2009</Year><Month>7</Month><Day>23</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">19329075</ArticleId><ArticleId IdType="doi">10.1016/j.jflm.2008.08.015</ArticleId><ArticleId IdType="pii">S1752-928X(08)00182-0</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">34507273</PMID><DateRevised><Year>2023</Year><Month>11</Month><Day>08</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Print">1929-0748</ISSN><JournalIssue CitedMedium="Print"><Volume>10</Volume><Issue>11</Issue><PubDate><Year>2021</Year><Month>Nov</Month><Day>26</Day></PubDate></JournalIssue><Title>JMIR research protocols</Title><ISOAbbreviation>JMIR Res Protoc</ISOAbbreviation></Journal><ArticleTitle>Outcomes After Receipt of Neuraxial or Regional Anesthesia Instead of General Anesthesia for Lower Limb Revascularization Surgery: Protocol for a Systematic Review and Meta-analysis.</ArticleTitle><Pagination><StartPage>e32170</StartPage><MedlinePgn>e32170</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e32170</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.2196/32170</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Patients undergoing lower limb revascularization surgery for peripheral artery disease (PAD) have a high risk of perioperative morbidity and mortality and often have long hospital stays. Use of neuraxial or regional anesthesia instead of general anesthesia may represent one approach to improving outcomes and reducing resource use among these patients.</AbstractText><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">The aim is to conduct a systematic review and meta-analysis to determine whether receipt of neuraxial or regional anesthesia instead of general anesthesia in adults undergoing lower limb revascularization surgery for PAD results in improved health outcomes and costs and a shorter length of hospitalization.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">We will search electronic bibliographic databases (MEDLINE, EMBASE, the seven databases in Evidence-Based Medicine Reviews, medRxiv, bioRxiv, and Google Scholar), review papers identified during the search, and included article bibliographies. We will include randomized and nonrandomized studies comparing the use of neuraxial or regional anesthesia instead of general anesthesia in adults undergoing lower limb revascularization surgery for PAD. Two investigators will independently evaluate the risk of bias. The primary outcome will be short-term (in-hospital or 30-day) mortality. Secondary outcomes will include longer-term mortality; major adverse cardiovascular, pulmonary, renal, and limb events; delirium; deep vein thrombosis or pulmonary embolism; neuraxial or regional anesthesia-related complications; graft-related outcomes; length of operation and hospital stay; costs; and patient-reported or functional outcomes. We will calculate summary odds ratios (ORs) and standardized mean differences (SMDs) using random-effects models. Heterogeneity will be explored using stratified meta-analyses and meta-regression. We will assess for publication bias using the Begg and Egger tests and use the trim-and-fill method to estimate the potential influence of this bias on summary estimates. Finally, we will use Grading of Recommendations, Assessment, Development, and Evaluation (GRADE) methodology to make an overall rating of the quality of evidence in our effect estimates.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">The protocol was registered in the International Prospective Register of Systematic Reviews (PROSPERO). We executed the peer-reviewed search strategy on March 2, 2021. We completed the review of titles and abstracts on July 30, 2021, and plan to complete the review of full-text papers by September 30, 2021. We will complete full-text study data extraction and the risk-of-bias assessment by November 15, 2021, and conduct qualitative and then quantitative data synthesis and GRADE assessment of results by January 1, 2022, before drafting the manuscript. We anticipate that we will be able to submit the manuscript for peer review by the end of February 2022.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">This study will synthesize existing evidence regarding whether receipt of neuraxial or regional anesthesia instead of general anesthesia in adults undergoing lower limb revascularization surgery for PAD results in improved health outcomes, graft patency, and costs and a shorter length of hospital stay. Study results will be used to inform practice and future research, including creation of a pilot and then multicenter randomized controlled trial.</AbstractText><AbstractText Label="TRIAL REGISTRATION" NlmCategory="BACKGROUND">Prospero CRD42021237060; https://www.crd.york.ac.uk/prospero/display_record.php?RecordID=237060.</AbstractText><AbstractText Label="INTERNATIONAL REGISTERED REPORT IDENTIFIER (IRRID)" NlmCategory="UNASSIGNED">PRR1-10.2196/32170.</AbstractText><CopyrightInformation>&#xa9;Derek J Roberts, Hannah Dreksler, Sudhir K Nagpal, Allen Li, Jeanna Parsons Leigh, Timothy Brandys, Prasad Jetty, Luc Dubois, Henry T Stelfox, Daniel I McIsaac. Originally published in JMIR Research Protocols (https://www.researchprotocols.org), 26.11.2021.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Roberts</LastName><ForeName>Derek J</ForeName><Initials>DJ</Initials><Identifier Source="ORCID">0000-0001-6111-6291</Identifier><AffiliationInfo><Affiliation>Division of Vascular and Endovascular Surgery, Department of Surgery, University of Ottawa, Ottawa, ON, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Clinical Epidemiology Program, Ottawa Hospital Research Institute, Ottawa Hospital, Ottawa, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dreksler</LastName><ForeName>Hannah</ForeName><Initials>H</Initials><Identifier Source="ORCID">0000-0003-3879-1728</Identifier><AffiliationInfo><Affiliation>Division of Vascular and Endovascular Surgery, Department of Surgery, University of Ottawa, Ottawa, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nagpal</LastName><ForeName>Sudhir K</ForeName><Initials>SK</Initials><Identifier Source="ORCID">0000-0002-4584-8975</Identifier><AffiliationInfo><Affiliation>Division of Vascular and Endovascular Surgery, Department of Surgery, University of Ottawa, Ottawa, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Allen</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0001-6615-7295</Identifier><AffiliationInfo><Affiliation>Division of Vascular and Endovascular Surgery, Department of Surgery, University of Ottawa, Ottawa, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Parsons Leigh</LastName><ForeName>Jeanna</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0002-8408-674X</Identifier><AffiliationInfo><Affiliation>School of Health Administration, Faculty of Health, Dalhousie University, Halifax, NS, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Brandys</LastName><ForeName>Timothy</ForeName><Initials>T</Initials><Identifier Source="ORCID">0000-0002-4569-7636</Identifier><AffiliationInfo><Affiliation>Division of Vascular and Endovascular Surgery, Department of Surgery, University of Ottawa, Ottawa, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jetty</LastName><ForeName>Prasad</ForeName><Initials>P</Initials><Identifier Source="ORCID">0000-0003-0538-4456</Identifier><AffiliationInfo><Affiliation>Division of Vascular and Endovascular Surgery, Department of Surgery, University of Ottawa, Ottawa, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dubois</LastName><ForeName>Luc</ForeName><Initials>L</Initials><Identifier Source="ORCID">0000-0002-8828-6896</Identifier><AffiliationInfo><Affiliation>Division of Vascular Surgery, Department of Surgery, Western University, London, ON, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Epidemiology and Biostatistics, Faculty of Medicine, Western University, London, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Stelfox</LastName><ForeName>Henry T</ForeName><Initials>HT</Initials><Identifier Source="ORCID">0000-0003-1231-1490</Identifier><AffiliationInfo><Affiliation>Department of Critical Care Medicine, University of Calgary, Calgary, AB, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>O'Brien Institute for Public Health, University of Calgary, Calgary, AB, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>McIsaac</LastName><ForeName>Daniel I</ForeName><Initials>DI</Initials><Identifier Source="ORCID">0000-0002-8543-1859</Identifier><AffiliationInfo><Affiliation>Clinical Epidemiology Program, Ottawa Hospital Research Institute, Ottawa Hospital, Ottawa, ON, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Anesthesiology and Pain Medicine, University of Ottawa, Ottawa, ON, Canada.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>11</Month><Day>26</Day></ArticleDate></Article><MedlineJournalInfo><Country>Canada</Country><MedlineTA>JMIR Res Protoc</MedlineTA><NlmUniqueID>101599504</NlmUniqueID><ISSNLinking>1929-0748</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">anesthesia</Keyword><Keyword MajorTopicYN="N">artery</Keyword><Keyword MajorTopicYN="N">cardiovascular</Keyword><Keyword MajorTopicYN="N">epidural anesthesia</Keyword><Keyword MajorTopicYN="N">hospital</Keyword><Keyword MajorTopicYN="N">limb</Keyword><Keyword MajorTopicYN="N">lower limb revascularization surgery</Keyword><Keyword MajorTopicYN="N">nerves</Keyword><Keyword MajorTopicYN="N">neuraxial anesthesia</Keyword><Keyword MajorTopicYN="N">outcome</Keyword><Keyword MajorTopicYN="N">peripheral artery disease</Keyword><Keyword MajorTopicYN="N">protocol</Keyword><Keyword MajorTopicYN="N">review</Keyword><Keyword MajorTopicYN="N">spinal anesthesia</Keyword><Keyword MajorTopicYN="N">spine</Keyword><Keyword MajorTopicYN="N">surgery</Keyword><Keyword MajorTopicYN="N">vascular surgery</Keyword></KeywordList><CoiStatement>Conflicts of Interest: The authors declare that they have no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>7</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>9</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2021</Year><Month>9</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>9</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>9</Month><Day>11</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>9</Month><Day>10</Day><Hour>20</Hour><Minute>31</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2021</Year><Month>11</Month><Day>26</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34507273</ArticleId><ArticleId IdType="pmc">PMC8665382</ArticleId><ArticleId IdType="doi">10.2196/32170</ArticleId><ArticleId IdType="pii">v10i11e32170</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Roberts DJ, Nagpal SK, Kubelik D, Brandys T, Stelfox HT, Lalu MM, Forster AJ, McCartney CJ, McIsaac DI. Association between neuraxial anaesthesia or general anaesthesia for lower limb revascularisation surgery in adults and clinical outcomes: population based comparative effectiveness study. BMJ. 2020 Nov 25;371:m4104. doi: 10.1136/bmj.m4104. 
 
</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.m4104</ArticleId><ArticleId IdType="pmc">PMC7687020</ArticleId><ArticleId IdType="pubmed">33239330</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh N, Sidawy AN, Dezee K, Neville RF, Weiswasser J, Arora S, Aidinian G, Abularrage C, Adams E, Khuri S, Henderson WG. The effects of the type of anesthesia on outcomes of lower extremity infrainguinal bypass. J Vasc Surg. 2006 Nov;44(5):964&#x2013;68. doi: 10.1016/j.jvs.2006.06.035. 
 
S0741-5214(06)01207-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jvs.2006.06.035</ArticleId><ArticleId IdType="pubmed">17000075</ArticleId></ArticleIdList></Reference><Reference><Citation>Ghanami RJ, Hurie J, Andrews JS, Harrington RN, Corriere MA, Goodney PP, Hansen KJ, Edwards MS. Anesthesia-based evaluation of outcomes of lower-extremity vascular bypass procedures. Ann Vasc Surg. 2013 Feb;27(2):199&#x2013;207. doi: 10.1016/j.avsg.2012.04.006. 
 
S0890-5096(12)00262-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.avsg.2012.04.006</ArticleId><ArticleId IdType="pmc">PMC4279240</ArticleId><ArticleId IdType="pubmed">22944010</ArticleId></ArticleIdList></Reference><Reference><Citation>LaMuraglia GM, Conrad MF, Chung T, Hutter M, Watkins MT, Cambria RP. Significant perioperative morbidity accompanies contemporary infrainguinal bypass surgery: an NSQIP report. J Vasc Surg. 2009 Aug;50(2):299&#x2013;304, 304.e1. doi: 10.1016/j.jvs.2009.01.043. 
 
S0741-5214(09)00070-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jvs.2009.01.043</ArticleId><ArticleId IdType="pubmed">19631864</ArticleId></ArticleIdList></Reference><Reference><Citation>Mustapha JA, Katzen BT, Neville RF, Lookstein RA, Zeller T, Miller LE, Jaff MR. Determinants of long-term outcomes and costs in the management of critical limb ischemia: a population-based cohort study. J Am Heart Assoc. 2018 Aug 21;7(16):e009724. doi: 10.1161/JAHA.118.009724. 
 
</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/JAHA.118.009724?url_ver=Z39.88-2003&amp;rfr_id=ori:rid:crossref.org&amp;rfr_dat=cr_pub%3dpubmed</ArticleId><ArticleId IdType="doi">10.1161/JAHA.118.009724</ArticleId><ArticleId IdType="pmc">PMC6201392</ArticleId><ArticleId IdType="pubmed">30369325</ArticleId></ArticleIdList></Reference><Reference><Citation>Nejim BJ, Wang S, Arhuidese I, Obeid T, Alshaikh HN, Dakour Aridi H, Locham S, Malas MB. Regional variation in the cost of infrainguinal lower extremity bypass surgery in the United States. J Vasc Surg. 2018 Apr;67(4):1170&#x2013;1180.e4. doi: 10.1016/j.jvs.2017.08.055. 
 
S0741-5214(17)32099-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jvs.2017.08.055</ArticleId><ArticleId IdType="pubmed">29074114</ArticleId></ArticleIdList></Reference><Reference><Citation>Adam DJ, Beard JD, Cleveland T, Bell J, Bradbury AW, Forbes JF, Fowkes FGR, Gillepsie I, Ruckley CV, Raab G, Storkey H, BASIL trial participants Bypass versus angioplasty in severe ischaemia of the leg (BASIL): multicentre, randomised controlled trial. Lancet. 2005 Dec 03;366(9501):1925&#x2013;34. doi: 10.1016/S0140-6736(05)67704-5.S0140-6736(05)67704-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(05)67704-5</ArticleId><ArticleId IdType="pubmed">16325694</ArticleId></ArticleIdList></Reference><Reference><Citation>Smolderen KG, Bell A, Lei Y, Cohen EA, Gabriel Steg P, Bhatt DL, Mahoney EM. One-year costs associated with cardiovascular disease in Canada: insights from the REduction of Atherothrombosis for Continued Health (REACH) registry. Can J Cardiol. 2010 Oct;26(8):e297&#x2013;e305. doi: 10.1016/s0828-282x(10)70437-2. 
 
S0828-282X(10)70437-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0828-282x(10)70437-2</ArticleId><ArticleId IdType="pmc">PMC2954538</ArticleId><ArticleId IdType="pubmed">20931098</ArticleId></ArticleIdList></Reference><Reference><Citation>Bonaca M, Bauersachs R, Anand S, Debus E, Nehler M, Patel M. Rivaroxaban in peripheral artery disease after revascularization. J Vasc Surg. 2020 Jul;72(1):368. doi: 10.1016/j.jvs.2020.04.470.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jvs.2020.04.470</ArticleId><ArticleId IdType="pubmed">32222135</ArticleId></ArticleIdList></Reference><Reference><Citation>Moriarty JP, Murad MH, Shah ND, Prasad C, Montori VM, Erwin PJ, Forbes TL, Meissner MH, Stoner MC, Society for Vascular Surgery Committee on Comparative Effectiveness  A systematic review of lower extremity arterial revascularization economic analyses. J Vasc Surg. 2011 Oct;54(4):1131&#x2013;1144.e1. doi: 10.1016/j.jvs.2011.04.058. 
 
S0741-5214(11)01065-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jvs.2011.04.058</ArticleId><ArticleId IdType="pubmed">21971093</ArticleId></ArticleIdList></Reference><Reference><Citation>Fereydooni A, O'Meara T, Popescu WM, Dardik A, Ochoa Chaar CI. Use of neuraxial anesthesia for hybrid lower extremity revascularization is associated with reduced perioperative morbidity. J Vasc Surg. 2020 Apr;71(4):1296&#x2013;1304.e7. doi: 10.1016/j.jvs.2019.07.072.S0741-5214(19)31937-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jvs.2019.07.072</ArticleId><ArticleId IdType="pubmed">31708304</ArticleId></ArticleIdList></Reference><Reference><Citation>Kikuchi S, Yamaguchi T, Miyake K, Uchida D, Koya A, Iida T, Kurosawa A, Sasakawa T, Kunisawa T, Azuma N. Effectiveness and safety of ultrasound guided lower extremity nerve blockade in infragenicular bypass grafting for high risk patients with chronic limb threatening ischaemia. Eur J Vasc Endovasc Surg. 2019 Aug;58(2):206&#x2013;13. doi: 10.1016/j.ejvs.2019.03.023. 
 
S1078-5884(19)30203-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejvs.2019.03.023</ArticleId><ArticleId IdType="pubmed">31272780</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosenfeld BA, Beattie C, Christopherson R, Norris EJ, Frank SM, Breslow MJ, Rock P, Parker SD, Gottlieb SO, Perler BA. The effects of different anesthetic regimens on fibrinolysis and the development of postoperative arterial thrombosis. Perioperative Ischemia Randomized Anesthesia Trial Study Group. Anesthesiology. 1993 Sep;79(3):435&#x2013;43. doi: 10.1097/00000542-199309000-00005. 
 
</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00000542-199309000-00005</ArticleId><ArticleId IdType="doi">10.1097/00000542-199309000-00005</ArticleId><ArticleId IdType="pubmed">8363067</ArticleId></ArticleIdList></Reference><Reference><Citation>Tuman KJ, McCarthy RJ, March RJ, DeLaria GA, Patel RV, Ivankovich AD. Effects of epidural anesthesia and analgesia on coagulation and outcome after major vascular surgery. Anesth Analg. 1991 Dec;73(6):696&#x2013;704. doi: 10.1213/00000539-199112000-00005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1213/00000539-199112000-00005</ArticleId><ArticleId IdType="pubmed">1952169</ArticleId></ArticleIdList></Reference><Reference><Citation>Breslow MJ, Parker SD, Frank SM, Norris EJ, Yates H, Raff H, Rock P, Christopherson R, Rosenfeld BA, Beattie C. Determinants of catecholamine and cortisol responses to lower extremity revascularization. The PIRAT Study Group. Anesthesiology. 1993 Dec;79(6):1202&#x2013;9. doi: 10.1097/00000542-199312000-00010. 
 
</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00000542-199312000-00010</ArticleId><ArticleId IdType="doi">10.1097/00000542-199312000-00010</ArticleId><ArticleId IdType="pubmed">8267195</ArticleId></ArticleIdList></Reference><Reference><Citation>Parker SD, Breslow MJ, Frank SM, Rosenfeld BA, Norris EJ, Christopherson R, Rock P, Gottlieb SO, Raff H, Perler BA. Catecholamine and cortisol responses to lower extremity revascularization: correlation with outcome variables. Perioperative Ischemia Randomized Anesthesia Trial Study Group. Crit Care Med. 1995 Dec;23(12):1954&#x2013;61. doi: 10.1097/00003246-199512000-00003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00003246-199512000-00003</ArticleId><ArticleId IdType="pubmed">7497717</ArticleId></ArticleIdList></Reference><Reference><Citation>Aitken E, Jackson A, Kearns R, Steven M, Kinsella J, Clancy M, Macfarlane A. Effect of regional versus local anaesthesia on outcome after arteriovenous fistula creation: a randomised controlled trial. Lancet. 2016 Sep 10;388(10049):1067&#x2013;74. doi: 10.1016/S0140-6736(16)30948-5.S0140-6736(16)30948-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(16)30948-5</ArticleId><ArticleId IdType="pubmed">27492881</ArticleId></ArticleIdList></Reference><Reference><Citation>Guay J, Choi PT, Suresh S, Albert N, Kopp S, Pace NL. Neuraxial anesthesia for the prevention of postoperative mortality and major morbidity. Anesth Analg. 2014;119(3):716&#x2013;25. doi: 10.1213/ane.0000000000000339.</Citation><ArticleIdList><ArticleId IdType="doi">10.1213/ane.0000000000000339</ArticleId><ArticleId IdType="pubmed">24977635</ArticleId></ArticleIdList></Reference><Reference><Citation>Sgroi MD, McFarland G, Mell MW. Utilization of regional versus general anesthesia and its impact on lower extremity bypass outcomes. J Vasc Surg. 2019 Jun;69(6):1874&#x2013;79. doi: 10.1016/j.jvs.2018.08.190. 
 
S0741-5214(18)32266-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jvs.2018.08.190</ArticleId><ArticleId IdType="pubmed">30792062</ArticleId></ArticleIdList></Reference><Reference><Citation>Sox HC, Goodman SN. The methods of comparative effectiveness research. Annu Rev Public Health. 2012 Apr;33:425&#x2013;45. doi: 10.1146/annurev-publhealth-031811-124610.</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev-publhealth-031811-124610</ArticleId><ArticleId IdType="pubmed">22224891</ArticleId></ArticleIdList></Reference><Reference><Citation>Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, Shamseer L, Tetzlaff JM, Akl EA, Brennan SE, Chou R, Glanville J, Grimshaw JM, Hr&#xf3;bjartsson A, Lalu MM, Li T, Loder EW, Mayo-Wilson E, McDonald S, McGuinness LA, Stewart LA, Thomas J, Tricco AC, Welch VA, Whiting P, Moher D. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021 Mar 29;372:n71. doi: 10.1136/bmj.n71. 
 
</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.n71</ArticleId><ArticleId IdType="pmc">PMC8005924</ArticleId><ArticleId IdType="pubmed">33782057</ArticleId></ArticleIdList></Reference><Reference><Citation>Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D, Moher D, Becker BJ, Sipe TA, Thacker SB. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA. 2000 Apr 19;283(15):2008&#x2013;12. doi: 10.1001/jama.283.15.2008.jst00003</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.283.15.2008</ArticleId><ArticleId IdType="pubmed">10789670</ArticleId></ArticleIdList></Reference><Reference><Citation>Moher D, Shamseer L, Clarke M, Ghersi D, Liberati A, Petticrew M, Shekelle P, Stewart LA, PRISMA-P Group  Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement. Syst Rev. 2015 Jan 01;4:1. doi: 10.1186/2046-4053-4-1. 
 
2046-4053-4-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/2046-4053-4-1</ArticleId><ArticleId IdType="doi">10.1186/2046-4053-4-1</ArticleId><ArticleId IdType="pmc">PMC4320440</ArticleId><ArticleId IdType="pubmed">25554246</ArticleId></ArticleIdList></Reference><Reference><Citation>Shamseer L, Moher D, Clarke M, Ghersi D, Liberati A, Petticrew M, Shekelle P, Stewart LA, PRISMA-P Group  Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation. BMJ. 2015 Jan 02;350:g7647. doi: 10.1136/bmj.g7647. 
 
</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.g7647</ArticleId><ArticleId IdType="pubmed">25555855</ArticleId></ArticleIdList></Reference><Reference><Citation>Gropper M, Eriksson L, Fleisher L, Wiener-Kronish J, Cohen N, Leslie K, editors. Miller's Anesthesia. PA: Elsevier; 2019.</Citation></Reference><Reference><Citation>Anand SS, Bosch J, Eikelboom JW, Connolly SJ, Diaz R, Widimsky P, Aboyans V, Alings M, Kakkar AK, Keltai K, Maggioni AP, Lewis BS, St&#xf6;rk S, Zhu J, Lopez-Jaramillo P, O'Donnell M, Commerford PJ, Vinereanu D, Pogosova N, Ryden L, Fox KAA, Bhatt DL, Misselwitz F, Varigos JD, Vanassche T, Avezum AA, Chen E, Branch K, Leong DP, Bangdiwala SI, Hart RG, Yusuf S, COMPASS Investigators Rivaroxaban with or without aspirin in patients with stable peripheral or carotid artery disease: an international, randomised, double-blind, placebo-controlled trial. Lancet. 2018;391(10117):219&#x2013;29. doi: 10.1016/S0140-6736(17)32409-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(17)32409-1</ArticleId><ArticleId IdType="pubmed">29132880</ArticleId></ArticleIdList></Reference><Reference><Citation>Anand SS, Caron F, Eikelboom JW, Bosch J, Dyal L, Aboyans V, Abola MT, Branch KR, Keltai K, Bhatt DL, Verhamme P, Fox KA, Cook-Bruns N, Lanius V, Connolly SJ, Yusuf S. Major adverse limb events and mortality in patients with peripheral artery disease: the COMPASS trial. J Am Coll Cardiol. 2018 May 22;71(20):2306&#x2013;15. doi: 10.1016/j.jacc.2018.03.008. 
 
S0735-1097(18)33502-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2018.03.008</ArticleId><ArticleId IdType="pubmed">29540326</ArticleId></ArticleIdList></Reference><Reference><Citation>Stoner MC, Calligaro KD, Chaer RA, Dietzek AM, Farber A, Guzman RJ, Hamdan AD, Landry GJ, Yamaguchi DJ, Society for Vascular Surgery  Reporting standards of the Society for Vascular Surgery for endovascular treatment of chronic lower extremity peripheral artery disease. J Vasc Surg. 2016 Jul;64(1):e1&#x2013;e21. doi: 10.1016/j.jvs.2016.03.420. 
 
S0741-5214(16)30002-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jvs.2016.03.420</ArticleId><ArticleId IdType="pubmed">27345516</ArticleId></ArticleIdList></Reference><Reference><Citation>Higgins JPT, Altman DG, G&#xf8;tzsche PC, J&#xfc;ni P, Moher D, Oxman AD, Savovic J, Schulz KF, Weeks L, Sterne JAC, Cochrane Bias Methods Group. Cochrane Statistical Methods Group  The Cochrane Collaboration's tool for assessing risk of bias in randomised trials. BMJ. 2011 Oct 18;343:d5928. doi: 10.1136/bmj.d5928. 
 
</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.d5928</ArticleId><ArticleId IdType="pmc">PMC3196245</ArticleId><ArticleId IdType="pubmed">22008217</ArticleId></ArticleIdList></Reference><Reference><Citation>Sterne JA, Hern&#xe1;n MA, Reeves BC, Savovi&#x107; J, Berkman ND, Viswanathan M, Henry D, Altman DG, Ansari MT, Boutron I, Carpenter JR, Chan A, Churchill R, Deeks JJ, Hr&#xf3;bjartsson A, Kirkham J, J&#xfc;ni P, Loke YK, Pigott TD, Ramsay CR, Regidor D, Rothstein HR, Sandhu L, Santaguida PL, Sch&#xfc;nemann HJ, Shea B, Shrier I, Tugwell P, Turner L, Valentine JC, Waddington H, Waters E, Wells GA, Whiting PF, Higgins JP. ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions. BMJ. 2016 Oct 12;355:i4919. doi: 10.1136/bmj.i4919. 
 
</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.i4919</ArticleId><ArticleId IdType="pmc">PMC5062054</ArticleId><ArticleId IdType="pubmed">27733354</ArticleId></ArticleIdList></Reference><Reference><Citation>Riley RD, Moons KGM, Snell KIE, Ensor J, Hooft L, Altman DG, Hayden J, Collins GS, Debray TPA. A guide to systematic review and meta-analysis of prognostic factor studies. BMJ. 2019 Jan 30;364:k4597. doi: 10.1136/bmj.k4597.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.k4597</ArticleId><ArticleId IdType="pubmed">30700442</ArticleId></ArticleIdList></Reference><Reference><Citation>Altman DG. Systematic reviews of evaluations of prognostic variables. BMJ. 2001 Jul 28;323(7306):224&#x2013;28. doi: 10.1136/bmj.323.7306.224. 
 
</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.323.7306.224</ArticleId><ArticleId IdType="pmc">PMC1120839</ArticleId><ArticleId IdType="pubmed">11473921</ArticleId></ArticleIdList></Reference><Reference><Citation>Sterne JAC, Savovi&#x107; J, Page MJ, Elbers RG, Blencowe NS, Boutron I, Cates CJ, Cheng H, Corbett MS, Eldridge SM, Emberson JR, Hern&#xe1;n MA, Hopewell S, Hr&#xf3;bjartsson A, Junqueira DR, J&#xfc;ni P, Kirkham JJ, Lasserson T, Li T, McAleenan A, Reeves BC, Shepperd S, Shrier I, Stewart LA, Tilling K, White IR, Whiting PF, Higgins JPT. RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ. 2019 Aug 28;366:l4898. doi: 10.1136/bmj.l4898.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.l4898</ArticleId><ArticleId IdType="pubmed">31462531</ArticleId></ArticleIdList></Reference><Reference><Citation>Langan D, Higgins JPT, Jackson D, Bowden J, Veroniki AA, Kontopantelis E, Viechtbauer W, Simmonds M. A comparison of heterogeneity variance estimators in simulated random-effects meta-analyses. Res Synth Methods. 2019 Mar;10(1):83&#x2013;98. doi: 10.1002/jrsm.1316.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jrsm.1316</ArticleId><ArticleId IdType="pubmed">30067315</ArticleId></ArticleIdList></Reference><Reference><Citation>Higgins JPT, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med. 2002 Jun 15;21(11):1539&#x2013;58. doi: 10.1002/sim.1186.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/sim.1186</ArticleId><ArticleId IdType="pubmed">12111919</ArticleId></ArticleIdList></Reference><Reference><Citation>Higgins JPT, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ. 2003 Sep 06;327(7414):557&#x2013;60. doi: 10.1136/bmj.327.7414.557. 
 
327/7414/557</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.327.7414.557</ArticleId><ArticleId IdType="pmc">PMC192859</ArticleId><ArticleId IdType="pubmed">12958120</ArticleId></ArticleIdList></Reference><Reference><Citation>Egger M, Davey Smith G, Altman DG, editors. Systematic Reviews in Health Care: Meta&#x2010;Analysis in Context. London, UK: BMJ Publishing Group; 2001.</Citation></Reference><Reference><Citation>Begg CB, Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics. 1994 Dec;50(4):1088&#x2013;101.</Citation><ArticleIdList><ArticleId IdType="pubmed">7786990</ArticleId></ArticleIdList></Reference><Reference><Citation>Duval S, Tweedie R. A nonparametric &#x201c;trim and fill&#x201d; method of accounting for publication bias in meta-analysis. J Am Stat Assoc. 2000 Mar;95(449):89&#x2013;98. doi: 10.1080/01621459.2000.10473905.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/01621459.2000.10473905</ArticleId></ArticleIdList></Reference><Reference><Citation>Cosic N, Roberts DJ, Stelfox HT. Efficacy and safety of damage control in experimental animal models of injury: protocol for a systematic review and meta-analysis. Syst Rev. 2014 Nov 22;3(1):136&#x2013;136. doi: 10.1186/2046-4053-3-136. 
 
2046-4053-3-136</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/2046-4053-3-136</ArticleId><ArticleId IdType="doi">10.1186/2046-4053-3-136</ArticleId><ArticleId IdType="pmc">PMC4285082</ArticleId><ArticleId IdType="pubmed">25416175</ArticleId></ArticleIdList></Reference><Reference><Citation>Duval S, Tweedie R. Trim and fill: a simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis. Biometrics. 2000 Jun;56(2):455&#x2013;63. doi: 10.1111/j.0006-341x.2000.00455.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.0006-341x.2000.00455.x</ArticleId><ArticleId IdType="pubmed">10877304</ArticleId></ArticleIdList></Reference><Reference><Citation>Balshem H, Helfand M, Sch&#xfc;nemann HJ, Oxman AD, Kunz R, Brozek J, Vist GE, Falck-Ytter Y, Meerpohl J, Norris S, Guyatt GH. GRADE guidelines: 3. Rating the quality of evidence. J Clin Epidemiol. 2011 Apr;64(4):401&#x2013;6. doi: 10.1016/j.jclinepi.2010.07.015.S0895-4356(10)00332-X</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jclinepi.2010.07.015</ArticleId><ArticleId IdType="pubmed">21208779</ArticleId></ArticleIdList></Reference><Reference><Citation>Guyatt G, Oxman AD, Sultan S, Brozek J, Glasziou P, Alonso-Coello P, Atkins D, Kunz R, Montori V, Jaeschke R, Rind D, Dahm P, Akl EA, Meerpohl J, Vist G, Berliner E, Norris S, Falck-Ytter Y, Sch&#xfc;nemann Holger J. GRADE guidelines: 11. Making an overall rating of confidence in effect estimates for a single outcome and for all outcomes. J Clin Epidemiol. 2013 Feb;66(2):151&#x2013;57. doi: 10.1016/j.jclinepi.2012.01.006.S0895-4356(12)00025-X</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jclinepi.2012.01.006</ArticleId><ArticleId IdType="pubmed">22542023</ArticleId></ArticleIdList></Reference><Reference><Citation>Guyatt GH, Oxman AD, Vist G, Kunz R, Brozek J, Alonso-Coello P, Montori V, Akl EA, Djulbegovic B, Falck-Ytter Y, Norris SL, Williams JW, Atkins D, Meerpohl J, Sch&#xfc;nemann HJ. GRADE guidelines: 4. Rating the quality of evidence--study limitations (risk of bias) J Clin Epidemiol. 2011 Apr;64(4):407&#x2013;15. doi: 10.1016/j.jclinepi.2010.07.017.S0895-4356(10)00413-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jclinepi.2010.07.017</ArticleId><ArticleId IdType="pubmed">21247734</ArticleId></ArticleIdList></Reference><Reference><Citation>Guyatt GH, Oxman AD, Montori V, Vist G, Kunz R, Brozek J, Alonso-Coello P, Djulbegovic B, Atkins D, Falck-Ytter Y, Williams JW, Meerpohl J, Norris SL, Akl EA, Sch&#xfc;nemann HJ. GRADE guidelines: 5. Rating the quality of evidence--publication bias. J Clin Epidemiol. 2011 Dec;64(12):1277&#x2013;82. doi: 10.1016/j.jclinepi.2011.01.011.S0895-4356(11)00181-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jclinepi.2011.01.011</ArticleId><ArticleId IdType="pubmed">21802904</ArticleId></ArticleIdList></Reference><Reference><Citation>Guyatt GH, Oxman AD, Kunz R, Brozek J, Alonso-Coello P, Rind D, Devereaux PJ, Montori VM, Freyschuss B, Vist G, Jaeschke R, Williams JW, Murad MH, Sinclair D, Falck-Ytter Y, Meerpohl J, Whittington C, Thorlund K, Andrews J, Sch&#xfc;nemann HJ. GRADE guidelines 6. Rating the quality of evidence--imprecision. J Clin Epidemiol. 2011 Dec;64(12):1283&#x2013;93. doi: 10.1016/j.jclinepi.2011.01.012.S0895-4356(11)00206-X</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jclinepi.2011.01.012</ArticleId><ArticleId IdType="pubmed">21839614</ArticleId></ArticleIdList></Reference><Reference><Citation>Guyatt GH, Oxman AD, Kunz R, Woodcock J, Brozek J, Helfand M, Alonso-Coello P, Glasziou P, Jaeschke R, Akl EA, Norris S, Vist G, Dahm P, Shukla VK, Higgins J, Falck-Ytter Y, Sch&#xfc;nemann HJ, GRADE Working Group GRADE guidelines: 7. Rating the quality of evidence--inconsistency. J Clin Epidemiol. 2011 Dec;64(12):1294&#x2013;302. doi: 10.1016/j.jclinepi.2011.03.017.S0895-4356(11)00182-X</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jclinepi.2011.03.017</ArticleId><ArticleId IdType="pubmed">21803546</ArticleId></ArticleIdList></Reference><Reference><Citation>Guyatt GH, Oxman AD, Kunz R, Woodcock J, Brozek J, Helfand M, Alonso-Coello P, Falck-Ytter Y, Jaeschke R, Vist G, Akl EA, Post PN, Norris S, Meerpohl J, Shukla VK, Nasser M, Sch&#xfc;nemann HJ, GRADE Working Group GRADE guidelines: 8. Rating the quality of evidence--indirectness. J Clin Epidemiol. 2011 Dec;64(12):1303&#x2013;10. doi: 10.1016/j.jclinepi.2011.04.014.S0895-4356(11)00183-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jclinepi.2011.04.014</ArticleId><ArticleId IdType="pubmed">21802903</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">25860675</PMID><DateCompleted><Year>2015</Year><Month>06</Month><Day>05</Day></DateCompleted><DateRevised><Year>2015</Year><Month>04</Month><Day>11</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0041-4131</ISSN><JournalIssue CitedMedium="Print"><Volume>92</Volume><Issue>10</Issue><PubDate><Year>2014</Year><Month>Oct</Month></PubDate></JournalIssue><Title>La Tunisie medicale</Title><ISOAbbreviation>Tunis Med</ISOAbbreviation></Journal><ArticleTitle>Sudden death due to pulmonary embolism in north Tunisia: 37 cases study.</ArticleTitle><Pagination><StartPage>610</StartPage><EndPage>614</EndPage><MedlinePgn>610-4</MedlinePgn></Pagination><Abstract><AbstractText Label="AIM" NlmCategory="OBJECTIVE">To determine frequency of pulmonary embolism as the cause of sudden death and to study clinical, epidemiological characteristics and risk factors.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Prospective study of cases of sudden death secondary to pulmonary embolism, whose autopsy was performed in the forensic department of Tunis, between October 2009 and of September, 2011.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">During study period, 37 cases of pulmonary embolism were recorded. They represented 6.8 % of all cases of sudden cardiovascular deaths. Victims were male in most cases (65 %). Victims were aged between 21 and 87 years with an average age of about 52 years. Pathological histories were noted in 9 cases: three cases of recent surgery, four cases of pelvic trauma, a case of ovarian tumor and a case of which the PE arose in post-partum. Concerning other risk factors of pulmonary embolism, confinement to bed was noted in 24 cases (64.8 %), obesity in 12 cases (32.4 %), an arterial high blood pressure in 4 cases. Histories of psychiatric pathology were noted in 5 cases (13.5 %). Symptomatology preceding death was dominated by sudden death (35 %) followed by dyspnoea (30 %) and thoracic pains (16 %). In 8 cases , victims consulted emergencies within 48 hours preceding death, for a varied symptomatology without diagnosis of pulmonary embolism is suspected. At autopsy, in 30 cases embolism was massive. In 29 % of the cases, a deep venous thrombosis was revealing in particular at the primitive iliac veins.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Pulmonary embolism is an affection that still kills a lot. It can benefit from prevention and from an effective treatment. This testifies the major importance of clinical diagnosis of pulmonary embolism as well as the technical means for the diagnosis.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Shimi</LastName><ForeName>Maha</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Allouche</LastName><ForeName>Mohamed</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Ben Ahmed</LastName><ForeName>Habib</ForeName><Initials>H</Initials></Author><Author ValidYN="Y"><LastName>Zoghlemi</LastName><ForeName>Bilel</ForeName><Initials>B</Initials></Author><Author ValidYN="Y"><LastName>Gloulou</LastName><ForeName>Fatma</ForeName><Initials>F</Initials></Author><Author ValidYN="Y"><LastName>Ben Khelil</LastName><ForeName>Mahdi</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Banasr</LastName><ForeName>Ahmed</ForeName><Initials>A</Initials></Author><Author ValidYN="Y"><LastName>Zhioua</LastName><ForeName>Mongi</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Benzarti</LastName><ForeName>Anis</ForeName><Initials>A</Initials></Author><Author ValidYN="Y"><LastName>Hamdoun</LastName><ForeName>Moncef</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Baccar</LastName><ForeName>H&#xe9;di</ForeName><Initials>H</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>Tunisia</Country><MedlineTA>Tunis Med</MedlineTA><NlmUniqueID>0413766</NlmUniqueID><ISSNLinking>0041-4131</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001344" MajorTopicYN="N">Autopsy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003645" MajorTopicYN="N">Death, Sudden</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011655" MajorTopicYN="N">Pulmonary Embolism</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000401" MajorTopicYN="Y">mortality</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014416" MajorTopicYN="N" Type="Geographic">Tunisia</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2015</Year><Month>4</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2015</Year><Month>4</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2015</Year><Month>6</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">25860675</ArticleId><ArticleId IdType="pii">/article-medicale-tunisie.php?article=2647</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">25224956</PMID><DateCompleted><Year>2015</Year><Month>03</Month><Day>03</Day></DateCompleted><DateRevised><Year>2022</Year><Month>03</Month><Day>30</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1365-2168</ISSN><JournalIssue CitedMedium="Internet"><Volume>101</Volume><Issue>12</Issue><PubDate><Year>2014</Year><Month>Nov</Month></PubDate></JournalIssue><Title>The British journal of surgery</Title><ISOAbbreviation>Br J Surg</ISOAbbreviation></Journal><ArticleTitle>Outcomes after surgery in patients with previous stroke.</ArticleTitle><Pagination><StartPage>1616</StartPage><EndPage>1622</EndPage><MedlinePgn>1616-22</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1002/bjs.9639</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Limited information is available on the association between a medical history of stroke and postoperative outcomes. This study investigated the outcomes following non-neurological surgery in patients with previous stroke.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Using Taiwan's National Health Insurance Research Database, a nationwide cohort study was conducted of patients who underwent non-neurological surgery between 2008 and 2010 with a medical history of stroke in the 24-month period before operation. Patients who had non-neurological surgeries without previous stroke were selected as controls by the propensity score-matched pair method. Thirty-day postoperative complications and in-hospital mortality were compared between the two groups.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Some 1&#x2009;426&#x2009;795 adults underwent major inpatient non-neurological surgery, of whom 45&#x2009;420 had a medical history of previous stroke. Patients with previous stroke who underwent surgery had an increased risk of postoperative pneumonia, septicaemia, acute renal failure, acute myocardial infarction, pulmonary embolism and 30-day in-hospital mortality (adjusted rate ratio (RR) 1&#xb7;79, 95 per cent c.i. 1&#xb7;61 to 1&#xb7;99). Compared with controls, patients with previous stroke due to intracerebral haemorrhage (RR 3&#xb7;41, 2&#xb7;97 to 3&#xb7;91), and those who were treated in intensive care (RR 2&#xb7;55, 2&#xb7;24 to 2&#xb7;90) or underwent neurosurgery (RR 2&#xb7;49, 2&#xb7;12 to 2&#xb7;92), had an increased 30-day in-hospital mortality rate. Postoperative mortality also increased with stroke-related co-morbidities, and with stroke 1-6&#x2009;months before surgery (RR 3&#xb7;31, 2&#xb7;91 to 3&#xb7;75).</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Patients with previous stroke had a higher risk of adverse postoperative outcomes; their 30-day in-hospital mortality rate was nearly twice that of patients without previous stroke.</AbstractText><CopyrightInformation>&#xa9; 2014 BJS Society Ltd. Published by John Wiley &amp; Sons Ltd.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Liao</LastName><ForeName>C C</ForeName><Initials>CC</Initials><AffiliationInfo><Affiliation>Department of Anaesthesiology, Health Policy Research Centre, Taipei Medical University Hospital, Taipei, Taiwan; Health Policy Research Centre, Taipei Medical University Hospital, Taipei, Taiwan; School of Medicine, Taipei Medical University, Taipei, Taiwan; Department of School of Chinese Medicine, College of Chinese Medicine, China Medical University, Taichung, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chang</LastName><ForeName>P Y</ForeName><Initials>PY</Initials></Author><Author ValidYN="Y"><LastName>Yeh</LastName><ForeName>C C</ForeName><Initials>CC</Initials></Author><Author ValidYN="Y"><LastName>Hu</LastName><ForeName>C J</ForeName><Initials>CJ</Initials></Author><Author ValidYN="Y"><LastName>Wu</LastName><ForeName>C H</ForeName><Initials>CH</Initials></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>T L</ForeName><Initials>TL</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2014</Year><Month>09</Month><Day>16</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Br J Surg</MedlineTA><NlmUniqueID>0372553</NlmUniqueID><ISSNLinking>0007-1323</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016022" MajorTopicYN="N">Case-Control Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002543" MajorTopicYN="N">Cerebral Hemorrhage</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003422" MajorTopicYN="N">Critical Care</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017052" MajorTopicYN="N">Hospital Mortality</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019635" MajorTopicYN="N">Neurosurgical Procedures</DescriptorName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D024162" MajorTopicYN="N">Second-Look Surgery</DescriptorName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020521" MajorTopicYN="N">Stroke</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013624" MajorTopicYN="N" Type="Geographic">Taiwan</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2014</Year><Month>4</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2014</Year><Month>6</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2014</Year><Month>7</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2014</Year><Month>9</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2014</Year><Month>9</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2015</Year><Month>3</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">25224956</ArticleId><ArticleId IdType="doi">10.1002/bjs.9639</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">33818010</PMID><DateCompleted><Year>2021</Year><Month>11</Month><Day>08</Day></DateCompleted><DateRevised><Year>2021</Year><Month>11</Month><Day>08</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1757-7861</ISSN><JournalIssue CitedMedium="Internet"><Volume>13</Volume><Issue>3</Issue><PubDate><Year>2021</Year><Month>May</Month></PubDate></JournalIssue><Title>Orthopaedic surgery</Title><ISOAbbreviation>Orthop Surg</ISOAbbreviation></Journal><ArticleTitle>Risk Factors and Outcomes for Preoperative Asymptomatic Pulmonary Embolism in Patients Aged 60&#x2009;Years and Over with Hip Fracture.</ArticleTitle><Pagination><StartPage>958</StartPage><EndPage>965</EndPage><MedlinePgn>958-965</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1111/os.12983</ELocationID><Abstract><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">To investigate the risk factors for, and outcomes of, preoperative asymptomatic pulmonary embolism (PE) in patients &#x2265;60&#x2009;years old following delayed operation for hip fracture.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">From March 2017 to December 2018, 90 patients aged &#x2265;60&#x2009;years with hip fracture who suffered a delay in surgery were recruited to this prospective study following admission to our hospital. Computed tomography pulmonary angiography (CTPA) was used to detect preoperative asymptomatic PE and calculated its incidence. Time from injury to admission, baseline characteristics, medical comorbidities, and blood biomarker levels were evaluated as potential risk factors. Logistic regression analysis was used to identify risk factors. Mortality and major bleeding events were recorded and compared between individuals with PE and without. Data were analyzed by t-test, Mann-Whitney U test, &#x3c7;<sup>2</sup> test, Fisher's exact test, and logistic regression analysis.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">The incidence of preoperative asymptomatic PE was 18.9% (17/90 patients). In the univariate analysis, the risk factors for preoperative asymptomatic PE were male sex, hypertension, cerebrovascular accident, smoking, plasma D-dimer level, potassium level, urea level, creatinine level, and cysteine level. Multivariate logistic regression analysis showed that the risk of preoperative asymptomatic PE was higher in patients with hypertension (odds ratio [OR] = 10.048; 95% confidence interval [CI], 1.118-90.333), cerebrovascular accident (OR = 20.135; 95% CI, 1.875-216.164), smoking (OR = 48.741; 95% CI, 4.155-571.788), high plasma D-dimer levels (OR = 1.200; 95% CI, 1.062-157.300), and high plasma potassium levels (OR = 12.928; 95% CI, 1.062-157.300). All patients were followed up for 21.0&#x2009;months (range, 2 to 36&#x2009;months). Mortality within the first year postoperatively was higher in patients with PE (29.41% vs 9.59%, P = 0.046).</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">In view of the high incidence of preoperative asymptomatic PE and the inferior prognosis in individuals with PE, routine CTPA examination for preoperative asymptomatic PE could be useful for patients aged &#x2265;60&#x2009;years with hip fracture for whom surgery is delayed.</AbstractText><CopyrightInformation>&#xa9; 2021 The Authors. Orthopaedic Surgery published by Chinese Orthopaedic Association and John Wiley &amp; Sons Australia, Ltd.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Zhou</LastName><ForeName>Fang-Lun</ForeName><Initials>FL</Initials><Identifier Source="ORCID">0000-0003-3753-2708</Identifier><AffiliationInfo><Affiliation>Department of Arthrology, Dongyang People's Hospital, Wenzhou Medical University Affiliated Dongyang Hospital, Dongyang, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Li-Hong</ForeName><Initials>LH</Initials><Identifier Source="ORCID">0000-0002-4404-8589</Identifier><AffiliationInfo><Affiliation>Department of Arthrology, Dongyang People's Hospital, Wenzhou Medical University Affiliated Dongyang Hospital, Dongyang, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dai</LastName><ForeName>Cheng-Qian</ForeName><Initials>CQ</Initials><Identifier Source="ORCID">0000-0001-5759-3415</Identifier><AffiliationInfo><Affiliation>Department of Arthrology, Dongyang People's Hospital, Wenzhou Medical University Affiliated Dongyang Hospital, Dongyang, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shentu</LastName><ForeName>Guo-Jian</ForeName><Initials>GJ</Initials><Identifier Source="ORCID">0000-0002-5983-0354</Identifier><AffiliationInfo><Affiliation>Department of Arthrology, Dongyang People's Hospital, Wenzhou Medical University Affiliated Dongyang Hospital, Dongyang, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xu</LastName><ForeName>Guo-Hong</ForeName><Initials>GH</Initials><Identifier Source="ORCID">0000-0002-9279-8093</Identifier><AffiliationInfo><Affiliation>Department of Arthrology, Dongyang People's Hospital, Wenzhou Medical University Affiliated Dongyang Hospital, Dongyang, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>2018KY864</GrantID><Agency>Health Commission of Zhejiang Province</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>04</Month><Day>04</Day></ArticleDate></Article><MedlineJournalInfo><Country>Australia</Country><MedlineTA>Orthop Surg</MedlineTA><NlmUniqueID>101501666</NlmUniqueID><ISSNLinking>1757-7853</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015415">Biomarkers</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058070" MajorTopicYN="N">Asymptomatic Diseases</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015415" MajorTopicYN="N">Biomarkers</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006620" MajorTopicYN="N">Hip Fractures</DescriptorName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015994" MajorTopicYN="N">Incidence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057234" MajorTopicYN="N">Preoperative Period</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011655" MajorTopicYN="N">Pulmonary Embolism</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D061665" MajorTopicYN="N">Time-to-Treatment</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Hip fractures</Keyword><Keyword MajorTopicYN="N">Preoperative</Keyword><Keyword MajorTopicYN="N">Pulmonary embolism</Keyword></KeywordList><CoiStatement>No benefits in any form have been received or will be received from a commercial party related directly or indirectly to the subject of this article.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="revised"><Year>2021</Year><Month>2</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>7</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>2</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>4</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>11</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>4</Month><Day>5</Day><Hour>6</Hour><Minute>33</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2021</Year><Month>4</Month><Day>4</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33818010</ArticleId><ArticleId IdType="pmc">PMC8126953</ArticleId><ArticleId IdType="doi">10.1111/os.12983</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Sheikh HQ, Hossain FS, Aqil A, Akinbamijo B, Mushtaq V, Kapoor H. A comprehensive analysis of the causes and predictors of 30&#x2010;day mortality following hip fracture surgery. Clin Orthop Surg, 2017, 9: 10&#x2013;18.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5334018</ArticleId><ArticleId IdType="pubmed">28261422</ArticleId></ArticleIdList></Reference><Reference><Citation>Perez JV, Warwick DJ, Case CP, Bannister GC. Death after proximal femoral fracture&#x2014;an autopsy study. Injury, 1995, 26: 237&#x2013;240.</Citation><ArticleIdList><ArticleId IdType="pubmed">7649622</ArticleId></ArticleIdList></Reference><Reference><Citation>Bengoa F, Vicencio G, Schweitzer D, Lira MJ, Zamora T, Klaber I. High prevalence of deep vein thrombosis in elderly hip fracture patients with delayed hospital admission. European Journal of Trauma and Emergency Surgery. 2020, 46: 913&#x2013;917.</Citation><ArticleIdList><ArticleId IdType="pubmed">30523360</ArticleId></ArticleIdList></Reference><Reference><Citation>Song K, Yao Y, Rong Z, Shen Y, Zheng M, Jiang Q. The preoperative incidence of deep vein thrombosis (DVT) and its correlation with postoperative DVT in patients undergoing elective surgery for femoral neck fractures. Arch Orthop Trauma Surg, 2016, 136: 1459&#x2013;1464.</Citation><ArticleIdList><ArticleId IdType="pubmed">27535672</ArticleId></ArticleIdList></Reference><Reference><Citation>Cho YH, Byun YS, Jeong DG, Han IH, Park YB. Preoperative incidence of deep vein thrombosis after hip fractures in Korean. Clin Orthop Surg, 2015, 7: 298&#x2013;302.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4553276</ArticleId><ArticleId IdType="pubmed">26330950</ArticleId></ArticleIdList></Reference><Reference><Citation>Boc A, Vene N, Ko&#x161;melj K, Mavri A. Impact of asymptomatic pulmonary embolism on the long&#x2010;term prognosis of patients with deep venous thrombosis. Semin Thromb Hemost, 2017, 43: 24&#x2013;29.</Citation><ArticleIdList><ArticleId IdType="pubmed">27336690</ArticleId></ArticleIdList></Reference><Reference><Citation>Roche JJ, Wenn RT, Sahota O, Moran CG. Effect of comorbidities and postoperative complications on mortality after hip fracture in elderly people: prospective observational cohort study. BMJ, 2005, 331: 1374.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1309645</ArticleId><ArticleId IdType="pubmed">16299013</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith EB, Parvizi J, Purtill JJ. Delayed surgery for patients with femur and hip fractures&#x2010;risk of deep venous thrombosis. J Trauma, 2011, 70: E113&#x2013;E116.</Citation><ArticleIdList><ArticleId IdType="pubmed">21817966</ArticleId></ArticleIdList></Reference><Reference><Citation>Hefley FG, Nelson CL, Puskarich&#x2010;May CL. Effect of delayed admission to the hospital on the preoperative prevalence of deep&#x2010;vein thrombosis associated with fractures about the hip. J Bone Joint Surg Am, 1996, 78: 581&#x2013;583.</Citation><ArticleIdList><ArticleId IdType="pubmed">8609137</ArticleId></ArticleIdList></Reference><Reference><Citation>Shin WC, Lee SM, Suh KT. Recent updates of the diagnosis and prevention of venous thromboembolism in patients with a hip fracture. Hip Pelvis, 2017, 29: 159&#x2013;167.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5612975</ArticleId><ArticleId IdType="pubmed">28955681</ArticleId></ArticleIdList></Reference><Reference><Citation>Nam JH, Kim DH, Yoo JH, Hwang JH, Chang JD. Does preoperative mechanical prophylaxis have additional effectiveness in preventing postoperative venous thromboembolism in elderly patients with hip fracture?&#x2010;retrospective case&#x2010;control study. PLoS One, 2017, 12: e0187337.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5679592</ArticleId><ArticleId IdType="pubmed">29121664</ArticleId></ArticleIdList></Reference><Reference><Citation>Xia ZN, Xiao K, Zhu W, et al. Risk assessment and management of preoperative venous thromboembolism following femoral neck fracture. J Orthop Surg Res, 2018, 13: 291.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6245713</ArticleId><ArticleId IdType="pubmed">30458869</ArticleId></ArticleIdList></Reference><Reference><Citation>Shin WC, Woo SH, Lee SJ, Lee JS, Kim C, Suh KT. Preoperative prevalence of and risk factors for venous thromboembolism in patients with a hip fracture: an indirect multidetector CT venography study. J Bone Joint Surg Am, 2016, 98: 2089&#x2013;2095.</Citation><ArticleIdList><ArticleId IdType="pubmed">28002372</ArticleId></ArticleIdList></Reference><Reference><Citation>Park JS, Jang JH, Park KY, Moon NH. High energy injury is a risk factor for preoperative venous thromboembolism in the patients with hip fractures: a prospective observational study. Injury, 2018, 49: 1155&#x2013;1161.</Citation><ArticleIdList><ArticleId IdType="pubmed">29709377</ArticleId></ArticleIdList></Reference><Reference><Citation>Roberts KC, Brox WT. AAOS clinical practice guideline: Management of hip Fractures in the elderly. J Am Acad Orthop Surg, 2015, 23: 138&#x2013;140.</Citation><ArticleIdList><ArticleId IdType="pubmed">25624366</ArticleId></ArticleIdList></Reference><Reference><Citation>Garc&#xed;a&#x2010;Fuster MJ, Fabia MJ, Furi&#xf3; E, et al. Should we look for silent pulmonary embolism in patients with deep venous thrombosis. BMC Cardiovasc Disord, 2014, 14: 178.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4292826</ArticleId><ArticleId IdType="pubmed">25487168</ArticleId></ArticleIdList></Reference><Reference><Citation>Schulman S, Anger&#xe5;s U, Bergqvist D, et al. Definition of major bleeding in clinical investigations of antihemostatic medicinal products in surgical patients. J Thromb Haemost, 2010, 8: 202&#x2013;204.</Citation><ArticleIdList><ArticleId IdType="pubmed">19878532</ArticleId></ArticleIdList></Reference><Reference><Citation>Charlson M, Szatrowski TP, Peterson J, Gold J. Validation of a combined comorbidity index. J Clin Epidemiol, 1994, 47: 1245&#x2013;1251.</Citation><ArticleIdList><ArticleId IdType="pubmed">7722560</ArticleId></ArticleIdList></Reference><Reference><Citation>Koppie TM, Serio AM, Vickers AJ, et al. Age&#x2010;adjusted Charlson comorbidity score is associated with treatment decisions and clinical outcomes for patients undergoing radical cystectomy for bladder cancer. Cancer, 2008, 112: 2384&#x2013;2392.</Citation><ArticleIdList><ArticleId IdType="pubmed">18404699</ArticleId></ArticleIdList></Reference><Reference><Citation>Zahn HR, Skinner JA, Porteous MJ. The preoperative prevalence of deep vein thrombosis in patients with femoral neck fractures and delayed operation. Injury, 1999, 30: 605&#x2013;607.</Citation><ArticleIdList><ArticleId IdType="pubmed">10707228</ArticleId></ArticleIdList></Reference><Reference><Citation>Meignan M, Rosso J, Gauthier H, et al. Systematic lung scans reveal a high frequency of silent pulmonary embolism in patients with proximal deep venous thrombosis. Arch Intern Med, 2000, 160: 159&#x2013;164.</Citation><ArticleIdList><ArticleId IdType="pubmed">10647753</ArticleId></ArticleIdList></Reference><Reference><Citation>Hughes MJ, Stein PD, Matta F. Silent pulmonary embolism in patients with distal deep venous thrombosis: systematic review. Thromb Res, 2014, 134: 1182&#x2013;1185.</Citation><ArticleIdList><ArticleId IdType="pubmed">25312342</ArticleId></ArticleIdList></Reference><Reference><Citation>Stein PD, Matta F, Musani MH, Diaczok B. Silent pulmonary embolism in patients with deep venous thrombosis: a systematic review. Am J Med, 2010, 123: 426&#x2013;431.</Citation><ArticleIdList><ArticleId IdType="pubmed">20399319</ArticleId></ArticleIdList></Reference><Reference><Citation>Tzoran I, Saharov G, Brenner B, et al. Silent pulmonary embolism in patients with proximal deep vein thrombosis in the lower limbs. J Thromb Haemost, 2012, 10: 564&#x2013;571.</Citation><ArticleIdList><ArticleId IdType="pubmed">22288520</ArticleId></ArticleIdList></Reference><Reference><Citation>Tagalakis V, Kondal D, Ji Y, et al. Men had a higher risk of recurrent venous thromboembolism than women: a large population study. Gend Med, 2012, 9: 33&#x2013;43.</Citation><ArticleIdList><ArticleId IdType="pubmed">22333521</ArticleId></ArticleIdList></Reference><Reference><Citation>Tan L, Qi B, Yu T, Wang C. Incidence and risk factors for venous thromboembolism following surgical treatment of fractures below the hip: a meta&#x2010;analysis. Int Wound J, 2016, 13: 1359&#x2013;1371.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7949783</ArticleId><ArticleId IdType="pubmed">26936798</ArticleId></ArticleIdList></Reference><Reference><Citation>Goldhaber SZ, Grodstein F, Stampfer MJ, et al. A prospective study of risk factors for pulmonary embolism in women. JAMA, 1997, 277: 642&#x2013;645.</Citation><ArticleIdList><ArticleId IdType="pubmed">9039882</ArticleId></ArticleIdList></Reference><Reference><Citation>Goldhaber SZ. Pulmonary embolism. Lancet, 2004, 363: 1295&#x2013;1305.</Citation><ArticleIdList><ArticleId IdType="pubmed">15094276</ArticleId></ArticleIdList></Reference><Reference><Citation>Gregson J, Kaptoge S, Bolton T, et al. Cardiovascular risk factors associated with venous thromboembolism. JAMA Cardiol, 2019, 4: 163&#x2013;173.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6386140</ArticleId><ArticleId IdType="pubmed">30649175</ArticleId></ArticleIdList></Reference><Reference><Citation>Gambhir S, Grigorian A, Ashbaugh A, et al. Early versus late pulmonary embolism in trauma patients: not all pulmonary embolisms are created similarly. J Surg Res, 2019, 239: 174&#x2013;179.</Citation><ArticleIdList><ArticleId IdType="pubmed">30836300</ArticleId></ArticleIdList></Reference><Reference><Citation>Salahuddin S, Prabhakaran D, Roy A. Pathophysiological mechanisms of tobacco&#x2010;related CVD. Glob Heart, 2012, 7: 113&#x2013;120.</Citation><ArticleIdList><ArticleId IdType="pubmed">25691307</ArticleId></ArticleIdList></Reference><Reference><Citation>Nielsen VG, Hafner DT, Steinbrenner EB. Tobacco smoke&#x2010;induced hypercoagulation in human plasma: role of carbon monoxide. Blood Coagul Fibrinolysis, 2013, 24: 405&#x2013;410.</Citation><ArticleIdList><ArticleId IdType="pubmed">23429254</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheng YJ, Liu ZH, Yao FJ, et al. Current and former smoking and risk for venous thromboembolism: a systematic review and meta&#x2010;analysis. PLoS Med, 2013, 10: e1001515.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3775725</ArticleId><ArticleId IdType="pubmed">24068896</ArticleId></ArticleIdList></Reference><Reference><Citation>Bakhshi H, Alavi&#x2010;Moghaddam M, Wu KC, Imami M. Banasiri M. D&#x2010;dimer as an applicable test for detection of posttraumatic deep vein thrombosis in lower limb fracture. Am J Orthop, 2012, 41: E78&#x2013;E80.</Citation><ArticleIdList><ArticleId IdType="pubmed">22837995</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang Y, Zan P, Gong J. Cai M. d&#x2010;dimer as a screening marker for venous thromboembolism after surgery among patients younger than 50 with lower limb fractures. Clin Appl Thromb Hemost, 2017, 23: 78&#x2013;83.</Citation><ArticleIdList><ArticleId IdType="pubmed">26045546</ArticleId></ArticleIdList></Reference><Reference><Citation>Janvrin SB, Davies G, Greenhalgh RM. Postoperative deep vein thrombosis caused by intravenous fluids during surgery. Br J Surg, 1980, 67: 690&#x2013;693.</Citation><ArticleIdList><ArticleId IdType="pubmed">7000224</ArticleId></ArticleIdList></Reference><Reference><Citation>Martin G, Bennett&#x2010;Guerrero E, Wakeling H, et al. A prospective, randomized comparison of thromboelastographic coagulation profile in patients receiving lactated Ringer's solution, 6% hetastarch in a balanced&#x2010;saline vehicle, or 6% hetastarch in saline during major surgery. J Cardiothorac Vasc Anesth, 2002, 16: 441&#x2013;446.</Citation><ArticleIdList><ArticleId IdType="pubmed">12154422</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">22440631</PMID><DateCompleted><Year>2012</Year><Month>06</Month><Day>20</Day></DateCompleted><DateRevised><Year>2025</Year><Month>06</Month><Day>26</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1097-6809</ISSN><JournalIssue CitedMedium="Internet"><Volume>55</Volume><Issue>5</Issue><PubDate><Year>2012</Year><Month>May</Month></PubDate></JournalIssue><Title>Journal of vascular surgery</Title><ISOAbbreviation>J Vasc Surg</ISOAbbreviation></Journal><ArticleTitle>Treatment of acute iliofemoral deep vein thrombosis.</ArticleTitle><Pagination><StartPage>1463</StartPage><EndPage>1473</EndPage><MedlinePgn>1463-73</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jvs.2011.12.082</ELocationID><Abstract><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">The objective of this systematic review and meta-analysis was to compare the efficacy of three available treatments for acute iliofemoral deep vein thrombosis (DVT): systemic anticoagulation, surgical thrombectomy, and catheter-directed thrombolysis.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">We searched electronic databases (MEDLINE, EMBASE, Cochrane CENTRAL, Web of Science, and Scopus) and sought additional references from experts. Eligible studies enrolled participants with acute iliofemoral DVT and measured the outcomes of interest. Reviewers working independently in duplicate extracted study characteristics, quality, and outcome data (death, pulmonary embolism, local complications, hemorrhagic complications, postthrombotic syndrome, pain, quality of life, and surrogate markers of venous function such as valve competence and patency). We pooled relative risks (RRs) from each study using the random effects model and estimated the 95% confidence intervals (CIs). Bayesian indirect comparison techniques were used to compare thrombectomy to catheter-directed thrombolysis.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">We found 15 unique studies that fulfilled eligibility criteria. When compared to systemic anticoagulation, thrombectomy was associated with a statistically significant reduction in the risk of developing postthrombotic syndrome (RR, 0.67; 95% CI, 0.52-0.87), venous reflux (RR, 0.68; 95% CI, 0.46-0.99), and a trend for reduction in the risk of venous obstruction (RR, 0.84; 95% CI, 0.60-1.19). When compared to systemic anticoagulation, pharmacologic catheter-directed thrombolysis was associated with statistically significant reduction in the risk of postthrombotic syndrome (RR, 0.19; 95% CI, 0.07-0.48), venous obstruction (RR, 0.38; 95% CI, 0.18-0.37), and a trend for reduction in the risk of venous reflux (RR, 0.39; 95% CI, 0.16-1.00). Overall, the quality of evidence was low; downgraded due to the observational nature of the majority of studies, lack of comparability of study cohorts at baseline, loss to follow-up, imprecision, and indirectness of outcomes (surrogacy). There were insufficient data to compare the outcomes of thrombectomy to catheter-directed thrombolysis.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Low-quality evidence suggests that surgical thrombectomy decreases the incidence of postthrombotic syndrome and venous reflux. Catheter-directed pharmacologic thrombolysis decreases the incidence of postthrombotic syndrome and venous obstruction.</AbstractText><CopyrightInformation>Copyright &#xa9; 2012 Society for Vascular Surgery. Published by Mosby, Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Casey</LastName><ForeName>Edward T</ForeName><Initials>ET</Initials><AffiliationInfo><Affiliation>Knowledge and Evaluation Research Unit, Mayo Clinic, Rochester, MN 55905, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Murad</LastName><ForeName>M Hassan</ForeName><Initials>MH</Initials></Author><Author ValidYN="Y"><LastName>Zumaeta-Garcia</LastName><ForeName>Magaly</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Elamin</LastName><ForeName>Mohamed B</ForeName><Initials>MB</Initials></Author><Author ValidYN="Y"><LastName>Shi</LastName><ForeName>Qian</ForeName><Initials>Q</Initials></Author><Author ValidYN="Y"><LastName>Erwin</LastName><ForeName>Patricia J</ForeName><Initials>PJ</Initials></Author><Author ValidYN="Y"><LastName>Montori</LastName><ForeName>Victor M</ForeName><Initials>VM</Initials></Author><Author ValidYN="Y"><LastName>Gloviczki</LastName><ForeName>Peter</ForeName><Initials>P</Initials></Author><Author ValidYN="Y"><LastName>Meissner</LastName><ForeName>Mark</ForeName><Initials>M</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2012</Year><Month>03</Month><Day>21</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Vasc Surg</MedlineTA><NlmUniqueID>8407742</NlmUniqueID><ISSNLinking>0741-5214</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000925">Anticoagulants</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D005343">Fibrinolytic Agents</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000925" MajorTopicYN="N">Anticoagulants</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001499" MajorTopicYN="N">Bayes Theorem</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019317" MajorTopicYN="N">Evidence-Based Medicine</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005268" MajorTopicYN="Y">Femoral Vein</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005343" MajorTopicYN="N">Fibrinolytic Agents</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="Y">administration &amp; dosage</QualifierName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007084" MajorTopicYN="Y">Iliac Vein</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D054070" MajorTopicYN="N">Postthrombotic Syndrome</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018570" MajorTopicYN="N">Risk Assessment</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017131" MajorTopicYN="Y">Thrombectomy</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015912" MajorTopicYN="Y">Thrombolytic Therapy</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020246" MajorTopicYN="N">Venous Thrombosis</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2011</Year><Month>12</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2011</Year><Month>12</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2011</Year><Month>12</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2012</Year><Month>3</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2012</Year><Month>3</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2012</Year><Month>6</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">22440631</ArticleId><ArticleId IdType="doi">10.1016/j.jvs.2011.12.082</ArticleId><ArticleId IdType="pii">S0741-5214(12)00019-5</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">35094570</PMID><DateCompleted><Year>2022</Year><Month>02</Month><Day>04</Day></DateCompleted><DateRevised><Year>2022</Year><Month>02</Month><Day>04</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">2049-4408</ISSN><JournalIssue CitedMedium="Internet"><Volume>104-B</Volume><Issue>2</Issue><PubDate><Year>2022</Year><Month>Feb</Month></PubDate></JournalIssue><Title>The bone &amp; joint journal</Title><ISOAbbreviation>Bone Joint J</ISOAbbreviation></Journal><ArticleTitle>Assessment of deep vein thrombosis using routine pre- and postoperative duplex Doppler ultrasound in patients with pelvic trauma : a prospective study.</ArticleTitle><Pagination><StartPage>283</StartPage><EndPage>289</EndPage><MedlinePgn>283-289</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1302/0301-620X.104B2.BJJ-2021-0764.R2</ELocationID><Abstract><AbstractText Label="AIMS" NlmCategory="OBJECTIVE">The aims of this study were to assess the pre- and postoperative incidence of deep vein thrombosis (DVT) using routine duplex Doppler ultrasound (DUS), to assess the incidence of pulmonary embolism (PE) using CT angiography, and to identify the factors that predict postoperative DVT in patients with a pelvic and/or acetabular fracture.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">All patients treated surgically for a pelvic and/or acetabular fracture between October 2016 and January 2020 were enrolled into this prospective single-centre study. The demographic, medical, and surgical details of the patients were recorded. DVT screening of the lower limbs was routinely performed using DUS before and at six to ten days after surgery. CT angiography was used in patients who were suspected of having PE. Age-adjusted univariate and stepwise multiple logistic regression analysis were used to determine the association between explanatory variables and postoperative DVT.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">A total of 191 patients were included. A DVT was found preoperatively in 12 patients (6.3%), of which six were proximal. A postoperative DVT was found in 42 patients (22%), of which 27 were proximal. Eight patients (4.2%) had a PE, which was secondary to a DVT in three. None of the 12 patients in whom a vena cava filter was implanted prophylactically had a PE. Multivariate logistic regression analysis indicated that the association with the need for spinal surgery (odds ratio (OR) 19.78 (95% confidence interval (CI) 1.12 to 348.08); p = 0.041), intramedullary nailing of a long bone fracture (OR 4.44 (95% CI 1.05 to 18.86); p = 0.043), an operating time &gt; two hours (OR 3.28 (95% CI 1.09 to 9.88); p = 0.035), and additional trauma surgery (OR 3.1 (95% CI 1.03 to 9.45); p = 0.045) were statistically the most relevant independent predictors of a postoperative DVT.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">The acknowledgement of the risk factors for the development of a DVT and their weight is crucial to set a threshold for the index of suspicion for this diagnosis by medical staff. We suggest the routine use of the DUS screening for DVT in patients with a pelvic and/or acetabular fracture before and six to ten days after surgery. Cite this article: <i>Bone Joint J</i>&#xa0;2022;104-B(2):283-289.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Cerbasi</LastName><ForeName>Simone</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0002-4171-9076</Identifier><AffiliationInfo><Affiliation>Department of Surgery, Orthopedic and Trauma Unit, Ospedali Riuniti, Ancona, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bernasconi</LastName><ForeName>Alessio</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-9427-3178</Identifier><AffiliationInfo><Affiliation>Orthopaedic and Traumatology Unit, University Federico II, Naples, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Balato</LastName><ForeName>Giovanni</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Orthopaedic and Traumatology Unit, University Federico II, Naples, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dimitri</LastName><ForeName>Federica</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Cardiovascular Sciences, Section of Vascular Medicine, Ospedali Riuniti, Ancona, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zingaretti</LastName><ForeName>Oriana</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>Department of Cardiovascular Sciences, Section of Vascular Medicine, Ospedali Riuniti, Ancona, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Orabona</LastName><ForeName>Gianclaudio</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Surgery, Orthopedic and Trauma Unit, Ospedali Riuniti, Ancona, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pascarella</LastName><ForeName>Raffaele</ForeName><Initials>R</Initials><Identifier Source="ORCID">0000-0001-5159-4206</Identifier><AffiliationInfo><Affiliation>Department of Surgery, Orthopedic and Trauma Unit, Ospedali Riuniti, Ancona, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mariconda</LastName><ForeName>Massimo</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-9906-5124</Identifier><AffiliationInfo><Affiliation>Orthopaedic and Traumatology Unit, University Federico II, Naples, Italy.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016430">Clinical Trial</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Bone Joint J</MedlineTA><NlmUniqueID>101599229</NlmUniqueID><ISSNLinking>2049-4394</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000077" MajorTopicYN="N">Acetabulum</DescriptorName><QualifierName UI="Q000293" MajorTopicYN="Y">injuries</QualifierName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000072226" MajorTopicYN="Y">Computed Tomography Angiography</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005592" MajorTopicYN="N">Fracture Fixation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D050723" MajorTopicYN="N">Fractures, Bone</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015994" MajorTopicYN="N">Incidence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016015" MajorTopicYN="N">Logistic Models</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016017" MajorTopicYN="N">Odds Ratio</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010384" MajorTopicYN="N">Pelvic Bones</DescriptorName><QualifierName UI="Q000293" MajorTopicYN="Y">injuries</QualifierName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019990" MajorTopicYN="N">Perioperative Care</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011655" MajorTopicYN="N">Pulmonary Embolism</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="Y">diagnostic imaging</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018616" MajorTopicYN="Y">Ultrasonography, Doppler, Duplex</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020246" MajorTopicYN="N">Venous Thrombosis</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="Y">diagnostic imaging</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Acetabular</Keyword><Keyword MajorTopicYN="N">CT angiography</Keyword><Keyword MajorTopicYN="N">Deep vein thrombosis (DVT)</Keyword><Keyword MajorTopicYN="N">Doppler</Keyword><Keyword MajorTopicYN="N">Doppler ultrasound</Keyword><Keyword MajorTopicYN="N">Embolism</Keyword><Keyword MajorTopicYN="N">Logistic regression analysis</Keyword><Keyword MajorTopicYN="N">Lower limbs</Keyword><Keyword MajorTopicYN="N">Multivariate logistic regression analysis</Keyword><Keyword MajorTopicYN="N">Orthopedic and Trauma</Keyword><Keyword MajorTopicYN="N">Pelvic</Keyword><Keyword MajorTopicYN="N">Pelvic and acetabular fractures</Keyword><Keyword MajorTopicYN="N">Pulmonary embolism (PE)</Keyword><Keyword MajorTopicYN="N">Thrombosis</Keyword><Keyword MajorTopicYN="N">Trauma surgery</Keyword><Keyword MajorTopicYN="N">Ultrasound</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>1</Month><Day>31</Day><Hour>5</Hour><Minute>33</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>2</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>2</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35094570</ArticleId><ArticleId IdType="doi">10.1302/0301-620X.104B2.BJJ-2021-0764.R2</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">38995206</PMID><DateCompleted><Year>2024</Year><Month>12</Month><Day>11</Day></DateCompleted><DateRevised><Year>2025</Year><Month>05</Month><Day>22</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1550-9109</ISSN><JournalIssue CitedMedium="Internet"><Volume>47</Volume><Issue>12</Issue><PubDate><Year>2024</Year><Month>Dec</Month><Day>11</Day></PubDate></JournalIssue><Title>Sleep</Title><ISOAbbreviation>Sleep</ISOAbbreviation></Journal><ArticleTitle>STOP-Bang questionnaire in patients hospitalized with acute symptomatic pulmonary embolism.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">zsae158</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1093/sleep/zsae158</ELocationID><Abstract><AbstractText Label="STUDY OBJECTIVES">The STOP-Bang questionnaire is a validated screening tool for obstructive sleep apnea (OSA). We conducted this study to validate it among patients hospitalized with acute symptomatic pulmonary embolism (PE).</AbstractText><AbstractText Label="METHODS">This prospective cohort study enrolled consecutive stable patients with acute PE who underwent an overnight sleep study within 7 days after diagnosis. Our outcomes were: (1) the STOP-Bang questionnaire's utility for risk stratification, (2) the discrimination of the STOP-Bang questionnaire categories, (3) the false negative rate of STOP-Bang questionnaire prediction, and (4) the clinical utility of the STOP-Bang questionnaire to exclude OSA. We also calculated the test performance characteristics to predict OSA.</AbstractText><AbstractText Label="RESULTS">During the study period, 268 patients completed a sleep study. OSA was found in 47% of patients. OSA incidence in low-, moderate-, and high-risk STOP-Bang groups was 22.4%, 48.2%, and 61.5%, respectively (p&#x2005;&lt;&#x2005;.001). The area under the receiver operating characteristics curve of the STOP-Bang questionnaire for risk of OSA was 0.65. The false negative rate of a low-risk STOP-Bang questionnaire result to rule out OSA was 22.4% and the clinical utility was 21.6%. The sensitivity was 89.8% (97.2% for men and 80.4% for women).</AbstractText><AbstractText Label="CONCLUSIONS">The STOP-Bang questionnaire showed poor discrimination for the risk of OSA in hospitalized patients with acute symptomatic PE. It had a high false negative rate and a low clinical utility. The STOP-Bang questionnaire had a good sensitivity in men, and might be used to rule out OSA in this population.</AbstractText><CopyrightInformation>&#xa9; The Author(s) 2024. Published by Oxford University Press on behalf of Sleep Research Society. All rights reserved. For commercial re-use, please contact reprints@oup.com for reprints and translation rights for reprints. All other permissions can be obtained through our RightsLink service via the Permissions link on the article page on our site&#x2014;for further information please contact journals.permissions@oup.com.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Brice&#xf1;o</LastName><ForeName>Winnifer</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Respiratory Department, Hospital Ram&#xf3;n y Cajal, IRYCIS, Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Barbero</LastName><ForeName>Esther</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Respiratory Department, Hospital Ram&#xf3;n y Cajal, IRYCIS, Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ma&#xf1;as</LastName><ForeName>Eva</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Respiratory Department, Hospital Ram&#xf3;n y Cajal, IRYCIS, Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gonz&#xe1;lez</LastName><ForeName>Sara</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Respiratory Department, Hospital Ram&#xf3;n y Cajal, IRYCIS, Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Garc&#xed;a-Ortega</LastName><ForeName>Alberto</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Respiratory Department, Hospital Doctor Peset, Valencia, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Oscullo</LastName><ForeName>Grace</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Respiratory Department, Hospital La Fe, Valencia, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Garc&#xed;a-S&#xe1;nchez</LastName><ForeName>Aldara</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Respiratory Department, Hospital Ram&#xf3;n y Cajal, IRYCIS, Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cano-Pumarega</LastName><ForeName>Irene</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Respiratory Department, Hospital Ram&#xf3;n y Cajal, IRYCIS, Madrid, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>CIBER Enfermedades Respiratorias (CIBERES), Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Martinez-Garcia</LastName><ForeName>Miguel &#xc1;ngel</ForeName><Initials>M&#xc1;</Initials><Identifier Source="ORCID">0000-0002-7321-1891</Identifier><AffiliationInfo><Affiliation>Respiratory Department, Hospital La Fe, Valencia, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>CIBER Enfermedades Respiratorias (CIBERES), Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jimenez</LastName><ForeName>David</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Respiratory Department, Hospital Ram&#xf3;n y Cajal, IRYCIS, Madrid, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>CIBER Enfermedades Respiratorias (CIBERES), Madrid, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Medicine Department, Alcala University, IRYCIS, Madrid, Spain.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><Agency>The Spanish Society of Pneumology and Thoracic Surgery</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Sleep</MedlineTA><NlmUniqueID>7809084</NlmUniqueID><ISSNLinking>0161-8105</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Sleep. 2024 Dec 11;47(12):zsae176. doi: 10.1093/sleep/zsae176.</RefSource><PMID Version="1">39093666</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011655" MajorTopicYN="Y">Pulmonary Embolism</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020181" MajorTopicYN="Y">Sleep Apnea, Obstructive</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011795" MajorTopicYN="N">Surveys and Questionnaires</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006760" MajorTopicYN="N">Hospitalization</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000208" MajorTopicYN="N">Acute Disease</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017286" MajorTopicYN="N">Polysomnography</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012680" MajorTopicYN="N">Sensitivity and Specificity</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">pulmonary embolism</Keyword><Keyword MajorTopicYN="N">questionnaire</Keyword><Keyword MajorTopicYN="N">screening</Keyword><Keyword MajorTopicYN="N">sleep apnea</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>4</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>6</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>12</Month><Day>11</Day><Hour>6</Hour><Minute>24</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>7</Month><Day>12</Day><Hour>12</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>7</Month><Day>12</Day><Hour>10</Hour><Minute>12</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38995206</ArticleId><ArticleId IdType="doi">10.1093/sleep/zsae158</ArticleId><ArticleId IdType="pii">7712737</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">28108403</PMID><DateCompleted><Year>2018</Year><Month>01</Month><Day>12</Day></DateCompleted><DateRevised><Year>2022</Year><Month>04</Month><Day>10</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1878-1632</ISSN><JournalIssue CitedMedium="Internet"><Volume>17</Volume><Issue>6</Issue><PubDate><Year>2017</Year><Month>Jun</Month></PubDate></JournalIssue><Title>The spine journal : official journal of the North American Spine Society</Title><ISOAbbreviation>Spine J</ISOAbbreviation></Journal><ArticleTitle>Risk of cement leakage and pulmonary embolism by bone cement-augmented pedicle screw fixation of the thoracolumbar spine.</ArticleTitle><Pagination><StartPage>837</StartPage><EndPage>844</EndPage><MedlinePgn>837-844</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.spinee.2017.01.009</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S1529-9430(17)30021-9</ELocationID><Abstract><AbstractText Label="BACKGROUND">Cement-augmented pedicle screw instrumentation (CAPSI) of the thoracolumbar spine is indicated in osteoporosis or osteopenia to improve pullout strength and biomechanical stability of pedicle screws (PS). Only a few studies report on the incidence of pulmonary cement embolism or other complications associated with CAPSI.</AbstractText><AbstractText Label="PURPOSE">The aim of this retrospective study was to assess the rate of CAPSI-associated complications.</AbstractText><AbstractText Label="STUDY DESIGN">Retrospective cohort study.</AbstractText><AbstractText Label="PATIENT SAMPLE">Patients who underwent CAPSI due to spinal tumors or degenerative spine disease.</AbstractText><AbstractText Label="OUTCOME MEASURES">Cement leakage, pulmonary cement embolism (PCE), mortality rate.</AbstractText><AbstractText Label="METHODS">Our clinical database was reviewed for patients who underwent CAPSI between January 2012 and June 2015. A total of 165 patients (mean age 71&#xb1;11.2; range: 46 to 93 years; m=62, f=103) were included. Indications were osteoporotic fractures (n=40), spinal metastases (n=57), degenerative (n=49) or infectious spine disease (n=5), and traumatic vertebral fractures (n=14) with an associated osteoporosis. Every patient received between 2 and 21 (mean 8&#xb1;3.3) cement-augmented pedicle screws in the thoracolumbar and lumbosacral spine. Both intraoperative cement leakage in prevertebral veins, the inferior vena cava, and/or pulmonary arteries, and leakage detected on postoperative imaging were evaluated. We assessed the incidence of clinically symptomatic and asymptomatic events.</AbstractText><AbstractText Label="RESULTS">In 29 of 31 patients with intraoperative suspicion of cement leakage into prevertebral veins or the inferior vena cava on lateral fluoroscopy, which were without hemodynamic relevance, cement extrusion was confirmed on postoperative X-ray or computed tomography (CT) scan. In three of eight patients with suspicion of PCE, PCE was verified on thoracic CT. Four patients experienced life-threatening intraoperative hemodynamic reactions, either due to cement embolism (n=2; 1.2%) or anaphylactic shock (n=2; 1.2%) with need for intraoperative cardiopulmonary resuscitation in three cases. Two patients died due to fulminant PCE. Three patients with dyspnea 1 day after surgery were also confirmed with PCE on chest CT. In five patients, an asymptomatic PCE was found incidentally on postoperative imaging. In addition, 68 patients with cement leakage into prevertebral veins or the ascending cava vein were found incidentally on postoperative spine X-ray or CT. Two of 10 patients with intraspinal epidural cement leakage required revision surgery. One hundred ten of 165 patients (66.7%) had clinically asymptomatic cement leakage. Thirteen patients had PCE (7.9%), of whom five (3.0%) were symptomatic. Two patients experienced intraoperative cement-induced anaphylaxis (1.2%). The overall symptomatic complication rate was 5.5% (n=9). The 30-day mortality rate was 1.8% (n=3).</AbstractText><AbstractText Label="CONCLUSIONS">CAPSI bears a high risk of asymptomatic cement leakage. The risk for associated severe complications was also relatively high and probably underestimated considering the retrospective nature of the present study. A strict indication for cement augmentation, especially in patients with cardiac predisposition, should be the consequence. We doubt that technical aspects of cement application and/or different types of cement are capable of reducing the risk of these complications substantially.</AbstractText><CopyrightInformation>Copyright &#xa9; 2017 Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Janssen</LastName><ForeName>Insa</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Department of Neurosurgery, Klinikum rechts der Isar, Technical University Munich, Ismaninger Stra&#xdf;e 22, 81675 Munich, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ryang</LastName><ForeName>Yu-Mi</ForeName><Initials>YM</Initials><AffiliationInfo><Affiliation>Department of Neurosurgery, Klinikum rechts der Isar, Technical University Munich, Ismaninger Stra&#xdf;e 22, 81675 Munich, Germany. Electronic address: yu.ryang@tum.de.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gempt</LastName><ForeName>Jens</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Neurosurgery, Klinikum rechts der Isar, Technical University Munich, Ismaninger Stra&#xdf;e 22, 81675 Munich, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bette</LastName><ForeName>Stefanie</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Neuroradiology, Klinikum rechts der Isar, Technical University Munich, Ismaninger Stra&#xdf;e 22, 81675 Munich, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gerhardt</LastName><ForeName>Julia</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Neurosurgery, Klinikum rechts der Isar, Technical University Munich, Ismaninger Stra&#xdf;e 22, 81675 Munich, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kirschke</LastName><ForeName>Jan S</ForeName><Initials>JS</Initials><AffiliationInfo><Affiliation>Department of Neuroradiology, Klinikum rechts der Isar, Technical University Munich, Ismaninger Stra&#xdf;e 22, 81675 Munich, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Meyer</LastName><ForeName>Bernhard</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Neurosurgery, Klinikum rechts der Isar, Technical University Munich, Ismaninger Stra&#xdf;e 22, 81675 Munich, Germany.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2017</Year><Month>01</Month><Day>17</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Spine J</MedlineTA><NlmUniqueID>101130732</NlmUniqueID><ISSNLinking>1529-9430</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D001843">Bone Cements</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001843" MajorTopicYN="N">Bone Cements</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008159" MajorTopicYN="N">Lumbar Vertebrae</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058866" MajorTopicYN="N">Osteoporotic Fractures</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D065289" MajorTopicYN="N">Pedicle Screws</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011655" MajorTopicYN="N">Pulmonary Embolism</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016103" MajorTopicYN="N">Spinal Fractures</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013123" MajorTopicYN="N">Spinal Fusion</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Bone mineral density</Keyword><Keyword MajorTopicYN="N">Cement-augmented pedicle screw instrumentation</Keyword><Keyword MajorTopicYN="N">Osteoporosis</Keyword><Keyword MajorTopicYN="N">Osteoporotic fractures</Keyword><Keyword MajorTopicYN="N">Pulmonary cement embolism</Keyword><Keyword MajorTopicYN="N">Thoracolumbar spine</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2016</Year><Month>5</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2016</Year><Month>12</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2017</Year><Month>1</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2017</Year><Month>1</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>1</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2017</Year><Month>1</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">28108403</ArticleId><ArticleId IdType="doi">10.1016/j.spinee.2017.01.009</ArticleId><ArticleId IdType="pii">S1529-9430(17)30021-9</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">38717479</PMID><DateCompleted><Year>2024</Year><Month>05</Month><Day>08</Day></DateCompleted><DateRevised><Year>2025</Year><Month>01</Month><Day>10</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1432-1262</ISSN><JournalIssue CitedMedium="Internet"><Volume>39</Volume><Issue>1</Issue><PubDate><Year>2024</Year><Month>May</Month><Day>08</Day></PubDate></JournalIssue><Title>International journal of colorectal disease</Title><ISOAbbreviation>Int J Colorectal Dis</ISOAbbreviation></Journal><ArticleTitle>Evaluating postoperative hernia incidence and risk factors following pelvic exenteration.</ArticleTitle><Pagination><StartPage>70</StartPage><MedlinePgn>70</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">70</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1007/s00384-024-04638-3</ELocationID><Abstract><AbstractText Label="UNLABELLED">Pelvic exenteration (PE) is a technically challenging surgical procedure. More recently, quality of life and survivorship following PEs are being increasingly acknowledged as important patient outcomes. This includes evaluating major long-term complications such as hernias, defined as the protrusion of internal organs through a facial defect (The PelvEx Collaborative in Br J Surg&#xa0;109:1251-1263, 2022), for which there is currently limited literature. The aim of this paper is to ascertain the incidence and risk factors for postoperative hernia formation among our PE cohort managed at a quaternary centre.</AbstractText><AbstractText Label="METHOD" NlmCategory="METHODS">A retrospective cohort study examining hernia formation following PE for locally advanced rectal carcinoma and locally recurrent rectal carcinoma between June 2010 and August 2022 at a quaternary cancer centre was performed. Baseline data evaluating patient characteristics, surgical techniques and outcomes was collated among a PE cohort of 243 patients. Postoperative hernia incidence was evaluated via independent radiological screening and clinical examination.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">A total of 79 patients (32.5%) were identified as having developed a hernia. Expectantly, those undergoing flap reconstruction had a lower incidence of postoperative hernias. Of the 79 patients who developed postoperative hernias, 16.5% reported symptoms with the most common symptom reported being pain. Reintervention was required in 18 patients (23%), all of which were operative.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">This study found over one-third of PE patients developed a hernia postoperatively. This paper highlights the importance of careful perioperative planning and optimization of patients to minimize morbidity.</AbstractText><CopyrightInformation>&#xa9; 2024. Crown.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Milanko</LastName><ForeName>Nicole Anais</ForeName><Initials>NA</Initials><AffiliationInfo><Affiliation>Peter MacCallum Comprehensive Cancer Centre, Department of Surgical Oncology with the University of Melbourne, Melbourne, Australia. nicole8milanko@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kelly</LastName><ForeName>Michael Eamon</ForeName><Initials>ME</Initials><AffiliationInfo><Affiliation>Peter MacCallum Comprehensive Cancer Centre, Department of Surgical Oncology with the University of Melbourne, Melbourne, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Trinity St James Cancer Institute, Dublin, Ireland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Turner</LastName><ForeName>Greg</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Peter MacCallum Comprehensive Cancer Centre, Department of Surgical Oncology with the University of Melbourne, Melbourne, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Auckland District Health Board, Auckland, New Zealand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kong</LastName><ForeName>Joeseph</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Peter MacCallum Comprehensive Cancer Centre, Department of Surgical Oncology with the University of Melbourne, Melbourne, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Behrenbruch</LastName><ForeName>Cori</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Peter MacCallum Comprehensive Cancer Centre, Department of Surgical Oncology with the University of Melbourne, Melbourne, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mohan</LastName><ForeName>Helen</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Peter MacCallum Comprehensive Cancer Centre, Department of Surgical Oncology with the University of Melbourne, Melbourne, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Guerra</LastName><ForeName>Glen</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Peter MacCallum Comprehensive Cancer Centre, Department of Surgical Oncology with the University of Melbourne, Melbourne, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Warrier</LastName><ForeName>Satish</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Peter MacCallum Comprehensive Cancer Centre, Department of Surgical Oncology with the University of Melbourne, Melbourne, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>McCormick</LastName><ForeName>Jacob</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Peter MacCallum Comprehensive Cancer Centre, Department of Surgical Oncology with the University of Melbourne, Melbourne, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of General Surgery, Royal Melbourne Hospital, Melbourne, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Heriot</LastName><ForeName>Alexander</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Peter MacCallum Comprehensive Cancer Centre, Department of Surgical Oncology with the University of Melbourne, Melbourne, Australia. Alexander.Heriot@petermac.org.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>05</Month><Day>08</Day></ArticleDate></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>Int J Colorectal Dis</MedlineTA><NlmUniqueID>8607899</NlmUniqueID><ISSNLinking>0179-1958</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015994" MajorTopicYN="N">Incidence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010385" MajorTopicYN="Y">Pelvic Exenteration</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="Y">Postoperative Complications</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006547" MajorTopicYN="N">Hernia</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Advanced rectal cancer</Keyword><Keyword MajorTopicYN="N">Hernia</Keyword><Keyword MajorTopicYN="N">Pelvic exenteration</Keyword><Keyword MajorTopicYN="N">Postoperative complications</Keyword><Keyword MajorTopicYN="N">Surgical outcomes</Keyword></KeywordList><CoiStatement>The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>4</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>5</Month><Day>8</Day><Hour>12</Hour><Minute>45</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>5</Month><Day>8</Day><Hour>12</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>5</Month><Day>8</Day><Hour>11</Hour><Minute>3</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>5</Month><Day>8</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38717479</ArticleId><ArticleId IdType="pmc">PMC11078832</ArticleId><ArticleId IdType="doi">10.1007/s00384-024-04638-3</ArticleId><ArticleId IdType="pii">10.1007/s00384-024-04638-3</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>The PelvEx Collaborative (2022) Minimum standards of pelvic exenterative practice: PelvEx Collaborative guideline. Br J Surg 109:1251&#x2013;1263. 10.1093/bjs/znac317</Citation><ArticleIdList><ArticleId IdType="pubmed">36170347</ArticleId></ArticleIdList></Reference><Reference><Citation>Pleth Nielsen C, Sorensen M, Christensen H, Funder J (2022) Complications and survival after total pelvic exenteration. Eur J Surg Oncol 48:1362&#x2013;1367. 10.1016/j.ejso.2021.12.472</Citation><ArticleIdList><ArticleId IdType="pubmed">34998633</ArticleId></ArticleIdList></Reference><Reference><Citation>Brunschwig A (1948) Complete excision of pelvic viscera for advanced carcinoma; a one-stage abdominoperineal operation with end colostomy and bilateral ureteral implantation into the colon above the colostomy. Cancer 1:177&#x2013;183. 10.1002/1097-0142(194807)1:2%3c177::aid-cncr2820010203%3e3.0.co;2-a</Citation><ArticleIdList><ArticleId IdType="pubmed">18875031</ArticleId></ArticleIdList></Reference><Reference><Citation>The PelvEx Collaborative (2018) Factors affecting outcomes following pelvic exenteration for locally recurrent rectal cancer. Br J Surg 105:650&#x2013;657. 10.1002/bjs.10734</Citation><ArticleIdList><ArticleId IdType="pubmed">29529336</ArticleId></ArticleIdList></Reference><Reference><Citation>Heger U, Koch M, Buchler M, Weitz J (2010) Total pelvic exenteration. Chirurg 81:897&#x2013;901. 10.1007/s00104-010-1945-z</Citation><ArticleIdList><ArticleId IdType="pubmed">20835694</ArticleId></ArticleIdList></Reference><Reference><Citation>Boland P, Kelly M (2022) Advanced colorectal cancer: redefining the outcome paradigm; balancing cure with quality of life. Colorectal Dis 24:155&#x2013;156. 10.1111/codi.15950</Citation><ArticleIdList><ArticleId IdType="pubmed">34694054</ArticleId></ArticleIdList></Reference><Reference><Citation>The PelvEx Collaborative (2022) Contemporary management of locally advanced and recurrent rectal cancer: views from the PelvEx Collaborative. Cancers (Basel). 10.3390/cancers14051161</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8909015</ArticleId><ArticleId IdType="pubmed">35267469</ArticleId></ArticleIdList></Reference><Reference><Citation>Milne T, Solomon M, Lee P, Young J, Stalley P, Harrison J (2013) Assessing the impact of a sacral resection on morbidity and survival after extended radical surgery for locally recurrent rectal cancer. Ann Surg 258:1007&#x2013;1013. 10.1097/sla.0b013e318283a5b6</Citation><ArticleIdList><ArticleId IdType="pubmed">23364701</ArticleId></ArticleIdList></Reference><Reference><Citation>Venchiarutti R, Solomon M, Koh C, Young J, Steffens D (2019) Pushing the boundaries of pelvic exenteration by maintaining survival at the cost of morbidity. Br J Surg 106:1393&#x2013;1403. 10.1002/bjs.11203</Citation><ArticleIdList><ArticleId IdType="pubmed">31282571</ArticleId></ArticleIdList></Reference><Reference><Citation>Pawlik T, Skibber J, Rodriguez-Bigas M (2006) Pelvic exenteration for advanced pelvic malignancies. Ann Surg Oncol 13:612&#x2013;623. 10.1245/aso.2006.03.082</Citation><ArticleIdList><ArticleId IdType="pubmed">16538402</ArticleId></ArticleIdList></Reference><Reference><Citation>The PelvEx Collaborative (2019) Surgical and survival outcomes following pelvic exenteration for locally advanced primary rectal cancer: results from an international collaboration. Ann Surg 269:315&#x2013;321. 10.1097/sla.0000000000002528</Citation><ArticleIdList><ArticleId IdType="pubmed">28938268</ArticleId></ArticleIdList></Reference><Reference><Citation>Bhangu A, Ali S, Brown G, Nicholls R, Tekkis P (2014) Indications and outcome of pelvic exenteration for locally advanced primary and recurrent rectal cancer. Ann Surg 259:315&#x2013;322. 10.1097/sla.0b013e31828a0d22</Citation><ArticleIdList><ArticleId IdType="pubmed">23478530</ArticleId></ArticleIdList></Reference><Reference><Citation>The PelvEx Collaborative (2019) Pelvic exenteration for advanced nonrectal pelvic malignancy. Ann Surg 270:899&#x2013;905. 10.1097/SLA.0000000000003533</Citation><ArticleIdList><ArticleId IdType="pubmed">31634184</ArticleId></ArticleIdList></Reference><Reference><Citation>Harris C, Solomon M, Heriot A, Sagar P, Tekkis P, Dixon L, Pascoe R, Dobbs B, Frampton C, Harji D, Kontovounisios C, Austin K, Koh C, Lee P, Lynch A, Warrier S, Frizelle F (2016) The outcomes and patterns of treatment failure after surgery for locally recurrent rectal cancer. Ann Surg 264:323&#x2013;329. 10.1097/sla.0000000000001524</Citation><ArticleIdList><ArticleId IdType="pubmed">26692078</ArticleId></ArticleIdList></Reference><Reference><Citation>The PelvEx Collaborative (2019) Changing outcomes following pelvic exenteration for locally advanced and recurrent rectal cancer. BJS Open 3:516&#x2013;520. 10.1002/bjs5.50153</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6677093</ArticleId><ArticleId IdType="pubmed">31388644</ArticleId></ArticleIdList></Reference><Reference><Citation>Palmer G, Martling A, Cedermark B, Holm T (2007) A population-based study on the management and outcome in patients with locally recurrent rectal cancer. Ann Surg Oncol 14:447&#x2013;454. 10.1245/s10434-006-9256-9</Citation><ArticleIdList><ArticleId IdType="pubmed">17139457</ArticleId></ArticleIdList></Reference><Reference><Citation>Tortorella L, Casarin J, Mara K, Weaver A, Multinu F, Glaser G, Cliby W, Scambia G, Mariani A, Kumar A (2019) Prediction of short-term surgical complications in women undergoing pelvic exenteration for gynecological malignancies. Gynecol Oncol 152:151&#x2013;156. 10.1016/j.ygyno.2018.10.036</Citation><ArticleIdList><ArticleId IdType="pubmed">30414740</ArticleId></ArticleIdList></Reference><Reference><Citation>Camilleri-Brennan J, Steele R (2001) The impact of recurrent rectal cancer on quality of life. Eur J Surg Oncol 27:349&#x2013;353. 10.1053/ejso.2001.1115</Citation><ArticleIdList><ArticleId IdType="pubmed">11417978</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim E, Fernando C, McCombie A, Bailey W, Frizelle F, Glyn T, Porter C, Wakeman C, Creagh T (2022) Abdominal and perineal hernia rates following vertical rectus abdominis myocutaneous (VRAM) flap reconstruction - a supraregional experience. J Plast Reconstr Aesthet Surg 75:1158&#x2013;1163. 10.1016/j.bjps.2021.11.002</Citation><ArticleIdList><ArticleId IdType="pubmed">34895852</ArticleId></ArticleIdList></Reference><Reference><Citation>Nielsen M, Rasmussen P, Lindegaard J, Laurberg S (2012) A 10-year experience of total pelvic exenteration for primary advanced and locally recurrent rectal cancer based on a prospective database. Colorectal Dis 14:1076&#x2013;1083. 10.1111/j.1463-1318.2011.02893.x</Citation><ArticleIdList><ArticleId IdType="pubmed">22107085</ArticleId></ArticleIdList></Reference><Reference><Citation>Heriot A, Kumar (2000) Rectal cancer recurrence: factors and mechanisms. Colorectal Dis 2:126&#x2013;136. 10.1046/j.1463-1318.2000.00148.x</Citation><ArticleIdList><ArticleId IdType="pubmed">23578036</ArticleId></ArticleIdList></Reference><Reference><Citation>Chokshi R, Kuhrt M, Arrese D, Martin EJ (2013) Reconstruction of total pelvic exenteration defects with rectus abdominus myocutaneous flaps versus primary closure. Am J Surg 205:64&#x2013;70. 10.1016/j.amjsurg.2012.04.010</Citation><ArticleIdList><ArticleId IdType="pubmed">22854008</ArticleId></ArticleIdList></Reference><Reference><Citation>Waters P, Peacock O, Warrier S, Wakeman C, Eglinton T, Lynch A, Frizelle F, Heriot A, McCormick J (2019) Evolution of pelvic exenteration surgery&#x2013; resectional trends and survival outcomes over three decades. Eur J Surg Oncol 45:2325&#x2013;2333. 10.1016/j.ejso.2019.07.015</Citation><ArticleIdList><ArticleId IdType="pubmed">31303376</ArticleId></ArticleIdList></Reference><Reference><Citation>Chauhan A, Morrison E, Lonie S, Sham E, Heriot A (2020) The inferior gluteal artery myocutaneous flap is preferable for reconstructing the complex perineal defect following pelvic exenteration. Plast Reconstr Surg 8:73&#x2013;74. 10.1097/2F01.GOX.0000720672.09757.be</Citation></Reference><Reference><Citation>Alizai P, Andert A, Lelaona E, Neumann U, Klink C, Jansen M (2017) Impact of obesity on postoperative complications after laparoscopic and open incisional hernia repair - a prospective cohort study. Int J Surg 48:220&#x2013;224. 10.1016/j.ijsu.2017.11.006</Citation><ArticleIdList><ArticleId IdType="pubmed">29146269</ArticleId></ArticleIdList></Reference><Reference><Citation>The PelvEx Collaborative (2020) The global cost of pelvic exenteration: in-hospital perioperative costs. Br J Surg 107:e470&#x2013;e471. 10.1002/bjs.11924</Citation><ArticleIdList><ArticleId IdType="pubmed">33460051</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37681564</PMID><DateCompleted><Year>2023</Year><Month>09</Month><Day>11</Day></DateCompleted><DateRevised><Year>2025</Year><Month>06</Month><Day>26</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1469-493X</ISSN><JournalIssue CitedMedium="Internet"><Volume>9</Volume><Issue>9</Issue><PubDate><Year>2023</Year><Month>Sep</Month><Day>08</Day></PubDate></JournalIssue><Title>The Cochrane database of systematic reviews</Title><ISOAbbreviation>Cochrane Database Syst Rev</ISOAbbreviation></Journal><ArticleTitle>Cell salvage for minimising perioperative allogeneic blood transfusion in adults undergoing elective surgery.</ArticleTitle><Pagination><StartPage>CD001888</StartPage><MedlinePgn>CD001888</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">CD001888</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1002/14651858.CD001888.pub5</ELocationID><Abstract><AbstractText Label="BACKGROUND">Concerns regarding the safety and availability of transfused donor blood have prompted research into a range of techniques to minimise allogeneic transfusion requirements. Cell salvage (CS) describes the recovery of blood from the surgical field, either during or after surgery, for reinfusion back to the patient.</AbstractText><AbstractText Label="OBJECTIVES">To examine the effectiveness of CS in minimising perioperative allogeneic red blood cell transfusion and on other clinical outcomes in adults undergoing elective or non-urgent surgery.</AbstractText><AbstractText Label="SEARCH METHODS">We searched CENTRAL, MEDLINE, Embase, three other databases and two clinical trials registers for randomised controlled trials (RCTs) and systematic reviews from 2009 (date of previous search) to 19 January 2023, without restrictions on language or publication status.</AbstractText><AbstractText Label="SELECTION CRITERIA">We included RCTs assessing the use of CS compared to no CS in adults (participants aged 18 or over, or using the study's definition of adult) undergoing elective (non-urgent) surgery only.</AbstractText><AbstractText Label="DATA COLLECTION AND ANALYSIS">We used standard methodological procedures expected by Cochrane.</AbstractText><AbstractText Label="MAIN RESULTS">We included 106 RCTs, incorporating data from 14,528 participants, reported in studies conducted in 24 countries. Results were published between 1978 and 2021. We analysed all data according to a single comparison: CS versus no CS. We separated analyses by type of surgery. The certainty of the evidence varied from very low certainty to high certainty. Reasons for downgrading the certainty included imprecision (small sample sizes below the optimal information size required to detect a difference, and wide confidence intervals), inconsistency (high statistical heterogeneity), and risk of bias (high risk from domains including sequence generation, blinding, and baseline imbalances). Aggregate analysis (all surgeries combined: primary outcome only) Very low-certainty evidence means we are uncertain if there is a reduction in the risk of allogeneic transfusion with CS (risk ratio (RR) 0.65, 95% confidence interval (CI) 0.59 to 0.72; 82 RCTs, 12,520 participants). Cancer: 2 RCTs (79 participants) Very low-certainty evidence means we are uncertain whether there is a difference for mortality, blood loss, infection, or deep vein thrombosis (DVT). There were no analysable data reported for the remaining outcomes. Cardiovascular (vascular): 6 RCTs (384 participants) Very low- to low-certainty evidence means we are uncertain whether there is a difference for most outcomes. No data were reported for major adverse cardiovascular events (MACE). Cardiovascular (no bypass): 6 RCTs (372 participants) Moderate-certainty evidence suggests there is probably a reduction in risk of allogeneic transfusion with CS (RR 0.82, 95% CI 0.69 to 0.97; 3 RCTs, 169 participants). Very low- to low-certainty evidence means we are uncertain whether there is a difference for volume transfused, blood loss, mortality, re-operation for bleeding, infection, wound complication, myocardial infarction (MI), stroke, and hospital length of stay (LOS). There were no analysable data reported for thrombosis, DVT, pulmonary embolism (PE), and MACE. Cardiovascular (with bypass): 29 RCTs (2936 participants) Low-certainty evidence suggests there may be a reduction in the risk of allogeneic transfusion with CS, and suggests there may be no difference in risk of infection and hospital LOS. Very low- to moderate-certainty evidence means we are uncertain whether there is a reduction in volume transfused because of CS, or if there is any difference for mortality, blood loss, re-operation for bleeding, wound complication, thrombosis, DVT, PE, MACE, and MI, and probably no difference in risk of stroke. Obstetrics: 1 RCT (1356 participants) High-certainty evidence shows there is no difference between groups for mean volume of allogeneic blood transfused (mean difference (MD) -0.02 units, 95% CI -0.08 to 0.04; 1 RCT, 1349 participants). Low-certainty evidence suggests there may be no difference for risk of allogeneic transfusion. There were no analysable data reported for the remaining outcomes. Orthopaedic (hip only): 17 RCTs (2055 participants) Very low-certainty evidence means we are uncertain if CS reduces the risk of allogeneic transfusion, and the volume transfused, or if there is any difference between groups for mortality, blood loss, re-operation for bleeding, infection, wound complication, prosthetic joint infection (PJI), thrombosis, DVT, PE, stroke, and hospital LOS. There were no analysable data reported for MACE and MI. Orthopaedic (knee only): 26 RCTs (2568 participants) Very low- to low-certainty evidence means we are uncertain if CS reduces the risk of allogeneic transfusion, and the volume transfused, and whether there is a difference for blood loss, re-operation for bleeding, infection, wound complication, PJI, DVT, PE, MI, MACE, stroke, and hospital LOS. There were no analysable data reported for mortality and thrombosis. Orthopaedic (spine only): 6 RCTs (404 participants) Moderate-certainty evidence suggests there is probably a reduction in the need for allogeneic transfusion with CS (RR 0.44, 95% CI 0.31 to 0.63; 3 RCTs, 194 participants). Very low- to moderate-certainty evidence suggests there may be no difference for volume transfused, blood loss, infection, wound complication, and PE. There were no analysable data reported for mortality, re-operation for bleeding, PJI, thrombosis, DVT, MACE, MI, stroke, and hospital LOS. Orthopaedic (mixed): 14 RCTs (4374 participants) Very low- to low-certainty evidence means we are uncertain if there is a reduction in the need for allogeneic transfusion with CS, or if there is any difference between groups for volume transfused, mortality, blood loss, infection, wound complication, PJI, thrombosis, DVT, MI, and hospital LOS. There were no analysable data reported for re-operation for bleeding, MACE, and stroke.</AbstractText><AbstractText Label="AUTHORS' CONCLUSIONS">In some types of elective surgery, cell salvage may reduce the need for and volume of allogeneic transfusion, alongside evidence of no difference in adverse events, when compared to no cell salvage. Further research is required to establish why other surgeries show no benefit from CS, through further analysis of the current evidence. More large RCTs in under-reported specialities are needed to expand the evidence base for exploring the impact of CS.</AbstractText><CopyrightInformation>Copyright &#xa9; 2023 The Authors. Cochrane Database of Systematic Reviews published by John Wiley &amp; Sons, Ltd. on behalf of The Cochrane Collaboration.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Lloyd</LastName><ForeName>Thomas D</ForeName><Initials>TD</Initials><AffiliationInfo><Affiliation>Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Geneen</LastName><ForeName>Louise J</ForeName><Initials>LJ</Initials><AffiliationInfo><Affiliation>Systematic Review Initiative, NHS Blood and Transplant, Oxford, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Nuffield Department of Clinical Laboratory Sciences, University of Oxford, Oxford, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bernhardt</LastName><ForeName>Keeley</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Medical Sciences Division, University of Oxford, Oxford, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>McClune</LastName><ForeName>William</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Medical Sciences Division, University of Oxford, Oxford, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fernquest</LastName><ForeName>Scott J</ForeName><Initials>SJ</Initials><AffiliationInfo><Affiliation>Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Brown</LastName><ForeName>Tamara</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>School of Health, Leeds Beckett University, Leeds, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dor&#xe9;e</LastName><ForeName>Carolyn</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Systematic Review Initiative, NHS Blood and Transplant, Oxford, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Nuffield Department of Clinical Laboratory Sciences, University of Oxford, Oxford, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Brunskill</LastName><ForeName>Susan J</ForeName><Initials>SJ</Initials><AffiliationInfo><Affiliation>Systematic Review Initiative, NHS Blood and Transplant, Oxford, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Nuffield Department of Clinical Laboratory Sciences, University of Oxford, Oxford, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Murphy</LastName><ForeName>Michael F</ForeName><Initials>MF</Initials><AffiliationInfo><Affiliation>NHS Blood and Transplant, Oxford University Hospitals NHS Foundation Trust and University of Oxford, Oxford, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Blood and Transplant Research Unit in Data Driven Transfusion, NIHR, Oxford, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Palmer</LastName><ForeName>Antony Jr</ForeName><Initials>AJ</Initials><AffiliationInfo><Affiliation>Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Blood and Transplant Research Unit in Data Driven Transfusion, NIHR, Oxford, UK.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D000078182">Systematic Review</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>09</Month><Day>08</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Cochrane Database Syst Rev</MedlineTA><NlmUniqueID>100909747</NlmUniqueID><ISSNLinking>1361-6137</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="UpdateOf"><RefSource>Cochrane Database Syst Rev. 2010 Apr 14;(4):CD001888. doi: 10.1002/14651858.CD001888.pub4.</RefSource><PMID Version="1">20393932</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011247" MajorTopicYN="N">Pregnancy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017558" MajorTopicYN="N">Elective Surgical Procedures</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001803" MajorTopicYN="N">Blood Transfusion</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020521" MajorTopicYN="Y">Stroke</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009203" MajorTopicYN="Y">Myocardial Infarction</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011655" MajorTopicYN="Y">Pulmonary Embolism</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001170" MajorTopicYN="Y">Arthritis, Infectious</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014946" MajorTopicYN="Y">Wound Infection</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018380" MajorTopicYN="Y">Hematopoietic Stem Cell Transplantation</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement><b>Tom D Lloyd (TDL):</b> none known. <b>Louise J Geneen (LJG):</b> none known. <b>Keeley Bernhardt (KB):</b> none known. <b>William McClune (WM):</b> none known. <b>Scott J Fernquest (SJF):</b> none known. <b>Tamara Brown (TB):</b> none known. <b>Carolyn Dor&#xe9;e (CD):</b> none known. <b>Susan J Brunskill (SJB):</b> none. SJB is a Cochrane editor (with Cochrane Haematology) and was not involved with the editorial process for this review. <b>Michael F Murphy (MFM):</b> MFM is in receipt of consulting fees as a Member of the Scientific Advisory Council from Haemonetics Corporation. However, MFM was not involved in the extraction, assessment of bias, or analysis of this review. <b>Antony JR Palmer (AJRP):</b> none known</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>9</Month><Day>11</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>9</Month><Day>8</Day><Hour>12</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>9</Month><Day>8</Day><Hour>7</Hour><Minute>24</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>9</Month><Day>8</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37681564</ArticleId><ArticleId IdType="pmc">PMC10486190</ArticleId><ArticleId IdType="doi">10.1002/14651858.CD001888.pub5</ArticleId></ArticleIdList><ReferenceList><Title>References to studies included in this review</Title><ReferenceList><Title>Abuzakuk 2007 {published data only}</Title><Reference><Citation>Abuzakuk T, Senthil KV, Shenava Y, Bulstrode C, Skinner JA, Cannon SR, et al. Autotransfusion drains in total knee replacement. Are they alternatives to homologous transfusion? International Orthopaedics 2007;31(2):235-9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2267563</ArticleId><ArticleId IdType="pubmed">16761149</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Adalberth 1998 {published data only}</Title><Reference><Citation>Adalberth G, Bystrom S, Kolstad K, Mallmin H, Milbrink J. Postoperative drainage of knee arthroplasty is not necessary - A randomised study of 90 patients. Acta Orthopaedica Scandinavica 1998;69(5):475-8.</Citation><ArticleIdList><ArticleId IdType="pubmed">9855227</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Adan 1988 {published data only}</Title><Reference><Citation>Adan A, la Rivi&#xe8;re AB, Haas F, Zalk A, Nooij E. Autotransfusion of drained mediastinal blood after cardiac surgery: a reappraisal. Thoracic and Cardiovascular Surgery 1988;36(1):10-14.</Citation><ArticleIdList><ArticleId IdType="pubmed">3259732</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Altinel 2007 {published data only}</Title><Reference><Citation>Altinel L, Kaya E, Kose KC, Fidan F, Ergan V, Fidan H. Effect of shed blood retransfusion on pulmonary perfusion after total knee arthroplasty: a prospective controlled study. International Orthopaedics 2007;31(6):837-44.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2266671</ArticleId><ArticleId IdType="pubmed">17115155</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Amin 2008 {published data only}</Title><Reference><Citation>Amin A, Watson A, Mangwani J, Nawabi D, Ahluwalia R, Loeffler M. A prospective randomised controlled trial of autologous retransfusion in total knee replacement. Journal of Bone &amp; Joint Surgery. British Volume 2008;90(4):451-4.</Citation><ArticleIdList><ArticleId IdType="pubmed">18378918</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Atay 2010 {published data only (unpublished sought but not used)}</Title><Reference><Citation>Atay EF, G&#xfc;ven M, Altina&#x15f; F, Kadio&#x11f;lu B, Ceviz E, Ipek S. Allogeneic blood transfusion decreases with postoperative autotransfusion in hip and knee arthroplasty. Acta Orthopaedica et Traumatologica Turcica 2010;44(4):306-12. [DOI: 10.3944/AOTT.2010.2417]</Citation><ArticleIdList><ArticleId IdType="doi">10.3944/AOTT.2010.2417</ArticleId><ArticleId IdType="pubmed">21252608</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Axford 1994 {published data only}</Title><Reference><Citation>Axford TC, Dearani JA, Ragno G, MacGregor H, Patel MA, Valeri CR, et al. Safety and therapeutic effectiveness of reinfused shed blood after open heart surgery. Annals of Thoracic Surgery 1994;57(3):615-22.</Citation><ArticleIdList><ArticleId IdType="pubmed">8147630</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Ayers 1995 {published data only}</Title><Reference><Citation>Ayers DC, Murray DG, Duerr DM. Blood salvage after total hip arthroplasty. Journal of Bone and Joint Surgery. American Volume 1995;77(9):1347-51.</Citation><ArticleIdList><ArticleId IdType="pubmed">7673284</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Blatsoukas 2010 {published data only}</Title><Reference><Citation>Blatsoukas KS, Drosos GI, Kazakos K, Papaioakim M, Gioka T, Chloropoulou P, et al. Prospective comparative study of two different autotransfusion methods versus control group in total knee replacement. Archives of Orthopaedic and Trauma Surgery 2010;130:733-37.</Citation><ArticleIdList><ArticleId IdType="pubmed">20165861</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Breakwell 2000 {published data only}</Title><Reference><Citation>Breakwell LM, Getty CJM, Dobson P. The efficacy of autologous blood transfusion in bilateral total knee arthroplasty. Knee 2000;7(3):145-7.</Citation><ArticleIdList><ArticleId IdType="pubmed">10927206</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Cheng 2005 {published data only}</Title><Reference><Citation>Cheng SC, Hung TS, Tse PY. Investigation of the use of drained blood reinfusion after total knee arthroplasty: a prospective randomised controlled study. Journal of Orthopaedic Surgery 2005;13(2):120-4.</Citation><ArticleIdList><ArticleId IdType="pubmed">16131672</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Cheung 2010 {published data only}</Title><Reference><Citation>Cheung G, Carmont MR, Bing AJF, Kuiper JH, Alcock RJ, Graham NM. No drain, autologous transfusion drain or suction drain? A randomised prospective study in total hip replacement surgery of 168 patients. Acta Orthopaedica Belgica 2010;76:619-27.</Citation><ArticleIdList><ArticleId IdType="pubmed">21138217</ArticleId></ArticleIdList></Reference><Reference><Citation>ISRCTN71177341. The role of reinfusion drains in reducing transfusion requirements following primary total hip arthroplasty. www.isrctn.com/ISRCTN71177341 Submission date: 29 September 2006; Registration date: 29 September 2006 (retrospective). [DOI: ]</Citation></Reference></ReferenceList><ReferenceList><Title>Cip 2013 {published data only}</Title><Reference><Citation>Cip J, Widemschek M, Benesch T, Waibel R, Martin A. Does single use of an autologous transfusion system in TKA reduce the need for allogenic blood? A prospective randomized trial. Clinical Orthopaedics and Related Research 2013;471:1319-25.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3586038</ArticleId><ArticleId IdType="pubmed">23229426</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Clagett 1999 {published data only}</Title><Reference><Citation>Clagett GP, Valentine RJ, Jackson MR, Mathison C, Kakish HB, Bengtson TD. A randomised trial of intraoperative autotransfusion during aortic surgery. Journal of Vascular Surgery 1999;29(1):22-31.</Citation><ArticleIdList><ArticleId IdType="pubmed">9882786</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Dalrymple&#x2010;Hay 1999 {published data only}</Title><Reference><Citation>Dalrymple-Hay MJ, Pack L, Deakin CD, Shepherd S, Ohri SK, Haw MP, et al. Autotransfusion of washed shed mediastinal fluid decreases requirement for autologous blood transfusion following cardiac surgery: a prospective randomized trial. European Journal of Cardio-thoracic Surgery 1999;15:830-4.</Citation><ArticleIdList><ArticleId IdType="pubmed">10431866</ArticleId></ArticleIdList></Reference><Reference><Citation>Dalrymple-Hay MJR, Dawkins S, Pack L, Deakin CD, Sheppard S, Ohri SK, et al. Autotransfusion decreases blood usage following cardiac surgery - A prospective randomized trial. Cardiovascular Surgery 2001;9(2):184-7.</Citation><ArticleIdList><ArticleId IdType="pubmed">11250189</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Damgaard 2006 {published data only}</Title><Reference><Citation>Damgaard S, Steinbruchel DA. Autotransfusion with cell saver for off-pump coronary artery bypass surgery: a randomized trial. Scandinavian Cardiovascular Journal 2006;40(3):194-8.</Citation><ArticleIdList><ArticleId IdType="pubmed">16798668</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Davies 1987 {published data only}</Title><Reference><Citation>Davies MJ, Cronin KC, Moran P, Mears L, Booth RJ. Autologous blood transfusion for major vascular surgery using the Sorenson Receptal Device. Anaesthesia and Intensive Care 1987;15(3):282-8.</Citation><ArticleIdList><ArticleId IdType="pubmed">3661961</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Djurasovic 2018 {published data only}</Title><Reference><Citation>Djurasovic M, McGraw KE, Bratcher K, Crawford CH, Dimar JR, Puno RM, et al. Randomized trial of Cell Saver in 2- to 3-level lumbar instrumented posterior fusions. Journal of Neurosurgery Spine 2018;29:582-7.</Citation><ArticleIdList><ArticleId IdType="pubmed">30117795</ArticleId></ArticleIdList></Reference><Reference><Citation>NCT01453309. Cost effectiveness and clinical utility of cell saver use for two to three level lumbar fusions. clinicaltrials.gov/ct2/show/NCT01453309 First posted: 17 October 2011 (prospective).</Citation></Reference><Reference><Citation>Ogura Y, Dimar JR, Gum JL, Crawford CH, Djurasovic M, Glassman SD, et al. Hidden blood loss following 2- to 3-level posterior lumbar fusion. Spine Journal: Official Journal of the North American Spine Society 2019;19 (12):P2003-6. [DOI: 10.1016/j.spinee.2019.07.010]</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.spinee.2019.07.010</ArticleId><ArticleId IdType="pubmed">31326629</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Dramis 2006 {published data only}</Title><Reference><Citation>Dramis A, Plewes J. Autologous blood transfusion after primary unilateral total knee replacement surgery. Acta Orthopaedica Belgica 2006;72(1):15-7.</Citation><ArticleIdList><ArticleId IdType="pubmed">16570888</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Dutton 2012 {published data only}</Title><Reference><Citation>Dutton T, De Souza R, Parsons N, Costa ML. The timing of tourniquet release and &#x2018;retransfusion&#x2019; drains in total knee arthroplasty: a stratified randomised pilot investigation. Knee 2012;19:190-2.</Citation><ArticleIdList><ArticleId IdType="pubmed">21440444</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Ekback 1995 {published data only}</Title><Reference><Citation>Ekback G, Schott U, Axelsson K, Carberg M. Perioperative autotransfusion and functional coagulation analysis in total hip replacement. Acta Anaesthesiologica Scandinavica 1995;39:390-5. [MEDLINE: ]</Citation><ArticleIdList><ArticleId IdType="pubmed">7793222</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Elawad 1991 {published data only}</Title><Reference><Citation>Elawad AA, Ohlin AK, Berntorp E, Nilsson IM, Fredin H. Intraoperative autotransfusion in primary hip arthroplasty. A randomized comparison with homologous blood. Acta Orthopaedica Scandinavica 1991;62(6):557-62.</Citation><ArticleIdList><ArticleId IdType="pubmed">1767648</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Eng 1990 {published data only}</Title><Reference><Citation>Eng J, Kay PH, Murday AJ, Shreiti I, Harrison DP, Norfolk DR, et al. Postoperative autologous transfusion in cardiac surgery. A prospective, randomised study. European Journal of Cardiothorac Surgery 1990;4(11):595-600.</Citation><ArticleIdList><ArticleId IdType="pubmed">2268438</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Feiner 2015 {published data only}</Title><Reference><Citation>Feiner JR, Gropper MA, Toy P, Lieberman J, Twiford J, Weiskopf RB. A clinical trial to detect subclinical transfusion-induced lung injury during surgery. Anaesthesiology 2015;123(1):126-35.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4626309</ArticleId><ArticleId IdType="pubmed">25946480</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>G&#xe4;bel 2013a {published data only}</Title><Reference><Citation>G&#xe4;bel J, Hakimi CS, Westerberg M, Radulovic V, Jeppsson A. Retransfusion of cardiotomy suction blood impairs haemostasis: ex vivo and in vivo studies. Scandinavian Cardiovascular Journal 2013;47:368-76.</Citation><ArticleIdList><ArticleId IdType="pubmed">24040767</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Galaal 2019 (TIC TOC) {published data only}</Title><Reference><Citation>Galaal K, Lopes A, Pritchard C, Barton A, Wingham J, Marques EM, et al. Trial of intraoperative cell salvage versus transfusion in ovarian cancer (TIC TOC): a multi-centre randomised controlled feasibility study. International Journal of Gynaecological Cancer 2019;29 (Supp 4):A33. [DOI: 10.1136/ijgc-2019-ESGO.34]</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/ijgc-2019-ESGO.34</ArticleId></ArticleIdList></Reference><Reference><Citation>Galaal K, Lopes A, Pritchard C, Barton A, Wingham J, Marques EMR, et al. Trial of intraoperative cell salvage versus transfusion in ovarian cancer (TIC TOC): protocol for a randomised controlled feasibility study. BMJ Open 2018;8(11):e024108. [DOI: 10.1136/bmjopen-2018-024108]</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjopen-2018-024108</ArticleId><ArticleId IdType="pmc">PMC6224724</ArticleId><ArticleId IdType="pubmed">30389760</ArticleId></ArticleIdList></Reference><Reference><Citation>ISRCTN19517317. Intraoperative cell salvage vs transfusion in ovarian cancer. www.isrctn.com/ISRCTN19517317 Submission date: 07 November 2016. Registration date: 11 November 2016 (prospective). [DOI: 10.1186/ISRCTN19517317]</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/ISRCTN19517317</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Gannon 1991 {published data only}</Title><Reference><Citation>Gannon DM, Lombardi AV Jr, Mallory TH, Vaughn BK, Finney, CR, Niemcryk S. An evaluation of the efficacy of postoperative blood salvage after total joint arthroplasty. A prospective randomized trial. Journal of Arthroplasty 1991;6(2):109-14.</Citation><ArticleIdList><ArticleId IdType="pubmed">1875200</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Goel 2007 {published data only}</Title><Reference><Citation>Goel P, Pannu H, Mohan D, Arora R. Efficacy of cell saver in reducing homologous blood transfusions during OPCAB surgery: a prospective randomized trial. Transfusion Medicine 2007;17(4):285-9.</Citation><ArticleIdList><ArticleId IdType="pubmed">17680954</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Healy 1994 {published data only}</Title><Reference><Citation>Healy WL, Pfeifer BA, Kurtz SR, Johnson C, Johnson W, Johnston R, et al. Evaluation of autologous shed blood for autotransfusion after orthopaedic surgery. Clinical Orthopaedics and Related Research 1994;299:53-9.</Citation><ArticleIdList><ArticleId IdType="pubmed">8119037</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Heddle 1992 {published data only}</Title><Reference><Citation>Heddle NM, Brox WT, Klama LL, Dickson LL, Levine MN. A randomized trial on the efficacy of an autologous blood drainage and transfusion device in patients undergoing elective knee arthroplasty. Transfusion 1992;32:742-6.</Citation><ArticleIdList><ArticleId IdType="pubmed">1412681</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Horstmann 2012 {published data only}</Title><Reference><Citation>Horstmann WG, Kuipers BM, Slappendel R, Castelein RM, Kollen BJ, Verheyen CC. Postoperative autologous blood transfusion drain or no drain in primary total hip arthroplasty? A randomised controlled trial. International Orthopaedics 2012;36(10):2033-9. [DOI: 10.1007/s00264-012-1613-7]</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00264-012-1613-7</ArticleId><ArticleId IdType="pmc">PMC3460103</ArticleId><ArticleId IdType="pubmed">22790978</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Horstmann 2013 {published data only}</Title><Reference><Citation>Horstmann WG, Swierstra MJ, Ohanis D, Castelein RM, Kollen BJ, Verheyen CC. Reduction of blood loss with the use of a new combined intra-operative and post-operative autologous blood transfusion system compared with no drainage in primary total hip replacement. Bone and Joint Journal 2013;95-B(5):616-22. [DOI: 10.1302/0301-620X.95B5.30472]</Citation><ArticleIdList><ArticleId IdType="doi">10.1302/0301-620X.95B5.30472</ArticleId><ArticleId IdType="pubmed">23632670</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Horstmann 2014a {published data only}</Title><Reference><Citation>Horstmann WG, Swierstra MJ, Ohanis D, Rolink R, Kollen BJ, Verheyen CC. Favourable results of a new intraoperative and postoperative filtered autologous blood re-transfusion system in total hip arthroplasty: a randomised controlled trial. International Orthopaedics 2014;38(1):13-18. [DOI: 10.1007/s00264-013-2084-1]</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00264-013-2084-1</ArticleId><ArticleId IdType="pmc">PMC3890134</ArticleId><ArticleId IdType="pubmed">24077886</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Horstmann 2014b {published data only}</Title><Reference><Citation>Horstmann W, Kuipers B, Ohanis D, Slappendel R, Kollen B, Verheyen C. Autologous re-transfusion drain compared with no drain in total knee arthroplasty: a randomised controlled trial. Blood Transfusion 2014;12(Suppl 1):S176-81. [DOI: ]</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3934246</ArticleId><ArticleId IdType="pubmed">24120589</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Jacobi 1997 {published data only}</Title><Reference><Citation>Jacobi K, Walther A, Kuhn R, Dworak O, Neidhardt B, Rugheimer E. Advantages and limitations of intraoperative mechanical autotransfusion in radical prostatectomies. Anaesthetist 1997;46(2):101-7.</Citation><ArticleIdList><ArticleId IdType="pubmed">9133170</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Kelley&#x2010;Patteson 1993 {published data only}</Title><Reference><Citation>Kelley-Patteson C, Ammar AD, Kelley H. Should the Cell Saver Autotransfusion Device be used routinely in all infrarenal abdominal aortic bypass operations? Journal of Vascular Surgery 1993;18(2):261-5.</Citation><ArticleIdList><ArticleId IdType="pubmed">8350435</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Khan 2017 (SALVO) {published data only}</Title><Reference><Citation>Geoghegan J, Middleton L, Moore P, Subseson G, Khan K, Daniels J. Routine cell salvage during elective caesarean section: a pilot randomised trial. International Journal of Obstetric Anesthesia 2015;24(1):86-7. [DOI: 10.1016/j.ijoa.2014.08.003]</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijoa.2014.08.003</ArticleId><ArticleId IdType="pubmed">25499013</ArticleId></ArticleIdList></Reference><Reference><Citation>ISRCTN66118656. Cell salvage in obstetrics. www.isrctn.com/ISRCTN66118656 Submission date: 18 June 2012. Registration date: 25 June 2012 (prospective).</Citation></Reference><Reference><Citation>Khan KS, Moore PAS, Wilson MJ, Hooper R, Allard S, Wrench I, et al, on behalf of the SALVO study group. Cell salvage and donor blood transfusion during cesarean section: a pragmatic, multicentre randomised controlled trial (SALVO). PLoS Medicine 2017;14(12):e1002471. [DOI: 10.1371/journal.pmed.1002471]</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pmed.1002471</ArticleId><ArticleId IdType="pmc">PMC5736174</ArticleId><ArticleId IdType="pubmed">29261655</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Kirkos 2006 {published data only}</Title><Reference><Citation>Kirkos JM, Krystallis CT, Konstantinidis PA, Papavasiliou KA, Kyrkos MJ, Ikonomidis LG. Postoperative re-perfusion of drained blood in patients undergoing total knee arthroplasty: is it effective and cost-efficient? Acta Orthopaedica Belgica 2006;72(1):18-23.</Citation><ArticleIdList><ArticleId IdType="pubmed">16570889</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Klein 2008 {published data only}</Title><Reference><Citation>Klein AA, Nashef SA, Sharples L, Bottrill F, Dyer M, Armstrong J, et al. A randomized controlled trial of cell salvage in routine cardiac surgery. Anesthesia and Analgesia 2008;107(5):1487-95.</Citation><ArticleIdList><ArticleId IdType="pubmed">18931203</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Kleinert 2012 {published data only}</Title><Reference><Citation>Kleinert K, Werner C, Mamisch-Saupe N, Kalberer F, Dora C. Closed suction drainage with or without re-transfusion of filtered shed blood does not offer advantages in primary non-cemented total hip replacement using a direct anterior approach. Archives of Orthopaedic and Trauma Surgery 2012;132(1):131-6. [DOI: 10.1007/s00402-011-1387-1]</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00402-011-1387-1</ArticleId><ArticleId IdType="pubmed">21874574</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Koopman&#x2010;van Gemert 1993a {published data only}</Title><Reference><Citation>Koopman-van Germert AW. Chapter 5: Processed autotransfusion and homologous red cell requirement in elective cardiac and orthopaedic surgery: a randomised prospective study. In: Peri-operative Autotransfusion by Means of a Blood Cell Separator [PhD thesis]. The Hague (Den Haag): Cip-Data Koninklijke Bibliotheek, 1993:96-112. [ISBN: 9090057552]</Citation></Reference></ReferenceList><ReferenceList><Title>Koopman&#x2010;van Gemert 1993b {published data only}</Title><Reference><Citation>Koopman-van Germert AW. Chapter 5: Processed autotransfusion and homologous red cell requirement in elective cardiac and orthopaedic surgery: a randomised prospective study. In: Peri-operative Autotransfusion by Means of a Blood Cell Separator (PhD thesis). The Hague (Den Haag): Cip-Data Koninklijke Bibliotheek, 1993:96-112. [ISBN: 9090057552]</Citation></Reference></ReferenceList><ReferenceList><Title>Kristensen 1992 {published data only}</Title><Reference><Citation>Kristensen PW, S&#xf8;rensen LS, Thyregod HC. Autotransfusion of drainage blood in arthroplasty. A prospective, controlled study of 31 operations. Acta Orthopaedica Scandinavica 1992;63(4):377-80.</Citation><ArticleIdList><ArticleId IdType="pubmed">1529683</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Laszczyca 2015 {published data only}</Title><Reference><Citation>&#x141;aszczyca M, Kusz D, Wojciechowski P, Szmigiel A, W&#xf3;jcik M, Kusz M. Medical and economic advantages of postoperative blood salvage in total knee replacement [Ocena korzy&#x15b;ci medycznych i ekonomicznych re transfuzji krwi z drena&#x17c;u po aloplastyce kolana]. Ortopedia Traumatologia Rehabilitacja 2015;17(6):603-10. [DOI: 10.5604/15093492.1193017]</Citation><ArticleIdList><ArticleId IdType="doi">10.5604/15093492.1193017</ArticleId><ArticleId IdType="pubmed">27053392</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Lepore 1989 {published data only}</Title><Reference><Citation>Lepore V, Radegran K. Autotransfusion of mediastinal blood in cardiac surgery. Scandinavian Journal of Thoracic and Cardiovascular Surgery 1989;23(1):47-9.</Citation><ArticleIdList><ArticleId IdType="pubmed">2727646</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Lorentz 1991 {published data only}</Title><Reference><Citation>Lorentz A, Osswald PM, Schilling M, Jani L. A comparison of autologous transfusion procedures in hip surgery. Anaesthesist 1991;40(4):205-13.</Citation><ArticleIdList><ArticleId IdType="pubmed">2058822</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Luo 2016 {published data only}</Title><Reference><Citation>Luo C, Luo X, He Y, Li J, Huang B, Lin L, et al. Impact of postoperative drainage autologous blood re-transfusion on the coagulation parameters and D-dimer levels of patients after total hip arthroplasty. Transfusion and Apheresis Science 2016;55(1):109-13. [DOI: 10.1016/j.transci.2016.04.001]</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.transci.2016.04.001</ArticleId><ArticleId IdType="pubmed">27118495</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Mac 1993 {published data only}</Title><Reference><Citation>Mac HL, Reynolds MA, Treston-Aurand J, Henke JA. Comparison of autoreinfusion and standard drainage systems in total joint arthroplasty patients. Orthopaedic Nursing 1993;12(3):19-25.</Citation><ArticleIdList><ArticleId IdType="pubmed">8321561</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Mah 1995 {published data only}</Title><Reference><Citation>Mah ET, Davis R, Seshadri P, Nyman TLM, Seshadri R. The role of autologous blood transfusion in joint replacement. Anaesthesia and Intensive Care 1995;23:472-7.</Citation><ArticleIdList><ArticleId IdType="pubmed">7485940</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Majkowski 1991 {published data only}</Title><Reference><Citation>Majkowski RS, Currie IC, Newman JH. Postoperative collection and reinfusion of autologous blood in total knee arthroplasty. Annals of the Royal College of Surgeons of England 1991;73(6):381-4.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2499479</ArticleId><ArticleId IdType="pubmed">1759769</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Marberg 2010 {published data only}</Title><Reference><Citation>Marberg H, Jeppsson A, Brandrup-Wognsen G. Postoperative autotransfusion of mediastinal shed blood does not influence haemostasis after elective coronary artery bypass grafting. European Journal of Cardio-Thoracic Surgery 2010;38(6):767-72. [DOI: 10.1016/j.ejcts.2010.03.043]</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejcts.2010.03.043</ArticleId><ArticleId IdType="pubmed">20667439</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Martin 2000 {published data only}</Title><Reference><Citation>Martin J, Robitaille D, Perrault LP, Pellerin M, Page P, Searle N et al. Reinfusion of mediastinal blood after heart surgery. Journal of Thoracic and Cardiovascular Surgery 2000;120(3):499-504.</Citation><ArticleIdList><ArticleId IdType="pubmed">10962411</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Mauerhan 1993 {published data only}</Title><Reference><Citation>Mauerhan DR, Nussman D, Mokris JG, Beaver WB. Effect of postoperative reinfusion systems on hemoglobin levels in primary total hip and total knee arthroplasties. A prospective randomized study. Journal of Arthroplasty 1993;8(5):523-7.</Citation><ArticleIdList><ArticleId IdType="pubmed">8245998</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>McShane 1987 {published data only}</Title><Reference><Citation>McShane AJ, Power C, Jackson JF, Murphy DF, MacDonald A, Moriarty DC, et al. Autotransfusion: quality of blood prepared with a red cell processing device. British Journal of Anaesthesia 1987;59(8):1035-9.</Citation><ArticleIdList><ArticleId IdType="pubmed">3651272</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Menges 1992 {published data only}</Title><Reference><Citation>Menges T, Rupp D, Lessen A, Hempelmann G. Effects on coagulation parameters of different methods of autologous blood transfusion. Anaesthesist 1992;41:27-33.</Citation><ArticleIdList><ArticleId IdType="pubmed">1536438</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Mercer 2004 {published data only}</Title><Reference><Citation>Mercer KG, Spark JI, Berridge DC, Kent PJ, Scott DJ. Randomized clinical trial of intraoperative autotransfusion in surgery for abdominal aortic aneurysm. British Journal of Surgery 2004;91(11):1443-8.</Citation><ArticleIdList><ArticleId IdType="pubmed">15499651</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Moonen 2007 {published data only}</Title><Reference><Citation>Moonen AF, Knoors NT, Os JJ, Verburg AD, Pilot P. Retransfusion of filtered shed blood in primary total hip and knee arthroplasty: a prospective randomized clinical trial. Transfusion 2007;47(3):379-84.</Citation><ArticleIdList><ArticleId IdType="pubmed">17319816</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Munteanu 2009 {published data only}</Title><Reference><Citation>Munteanu AM. Efficacy of the methods to reduce the allogenic transfusion in primary knee arthroplasty. Jurnalul Roman de Anestezie Terapie Intensiva 2009;16(2):107-13.</Citation></Reference></ReferenceList><ReferenceList><Title>Murphy 2005 {published data only}</Title><Reference><Citation>Murphy GJ, Rogers CS, Lansdowne WB, Channon I, Alwair H, Cohen A, et al. Safety, efficacy, and cost of intraoperative cell salvage and autotransfusion after off-pump coronary artery bypass surgery: a randomized trial. Journal of Thoracic and Cardiovascular Surgery 2005;130(1):20-8.</Citation><ArticleIdList><ArticleId IdType="pubmed">15999036</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>NCT00839241 {published data only}</Title><Reference><Citation>NCT00839241. A clinical study to investigate if transfusion of patients own shed blood improves the immunological status in comparison to transfusion of donor blood ("bank blood"). clinicaltrials.gov/ct2/show/NCT00839241 First posted: 9 February 2009 (retrospective).</Citation></Reference></ReferenceList><ReferenceList><Title>NCT01251042 {published data only}</Title><Reference><Citation>NCT01251042. A prospective, randomized, controlled study on intra-operative autologous transfusion with the Sangvia&#xae; blood salvage system in spinal surgery. clinicaltrials.gov/ct2/show/NCT01251042 First posted: 1 December 2010 (retrospective).</Citation></Reference></ReferenceList><ReferenceList><Title>Nemani 2019 {published data only}</Title><Reference><Citation>Nemani VM, Kim HJ, Mina CA, Sheha ED, Ross T, Boachie-Adjei O. Postoperative blood salvage and autotransfusion for adult spinal deformity: a randomized controlled trial. Spine 2020;45(18):1247-52. [DOI: 10.1097/BRS.0000000000003176]</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/BRS.0000000000003176</ArticleId><ArticleId IdType="pubmed">31361726</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Newman 1997 {published data only}</Title><Reference><Citation>Newman JH, Bowers M, Murphy J. The clinical advantages of autologous transfusion. A randomized, controlled study after knee replacement. Journal of Bone and Joint Surgery. British Volume 1997;79(4):630-2.</Citation><ArticleIdList><ArticleId IdType="pubmed">9250753</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Niranjan 2006 {published data only}</Title><Reference><Citation>Niranjan G, Asimakopoulos G, Karagounis A, Cockerill G, Thompson M, Chandrasekaran V. Effects of cell saver autologous blood transfusion on blood loss and homologous blood transfusion requirements in patients undergoing cardiac surgery on- versus off-cardiopulmonary bypass: a randomised trial. European Journal of Cardio-thoracic Surgery 2006;30(2):271-7.</Citation><ArticleIdList><ArticleId IdType="pubmed">16829083</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Page 1989 {published data only}</Title><Reference><Citation>Page R, Russell GN, Fox MA, Fabri BM, Lewis I, Williets T. Hard-shell cardiotomy reservoir for reinfusion of shed mediastinal blood. Annals of Thoracic Surgery 1989;48(4):514-7.</Citation><ArticleIdList><ArticleId IdType="pubmed">2802852</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Parrot 1991 {published data only}</Title><Reference><Citation>Parrot D, Lancon JP, Merle JP, Rerolle A, Bernard A, Obadia JF, et al. Blood salvage in cardiac surgery. Journal of Cardiothoracic and Vascular Anesthesia 1991;5(5):454-6.</Citation><ArticleIdList><ArticleId IdType="pubmed">1932650</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Pavelescu 2014 {published data only}</Title><Reference><Citation>Pavelescu D, Mirea L, Grintescu I. Combined perioperative use of tranexamic acid with a postoperative reinfusion/autotransfusion drainage system dramatically decrease the allogenic transfusion needs in total knee arthroplasty (TKA). European Journal of Anaesthesiology 2014;52:103-4 (Abstract 6AP5-4).</Citation></Reference></ReferenceList><ReferenceList><Title>Pleym 2005 {published data only}</Title><Reference><Citation>Pleym H, Tjomsland O, Asberg A, Lydersen S, Wahba A, Bjella L, et al. Effects of autotransfusion of mediastinal shed blood on biochemical markers of myocardial damage in coronary surgery. Acta Anaesthesiologica Scandinavica 2005;49(9):1248-54.</Citation><ArticleIdList><ArticleId IdType="pubmed">16146460</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Reyes 2011 {published data only}</Title><Reference><Citation>Reyes G, Prieto MA, Alvarez P, Orts M, Bustamante J, Santos G, et al. Cell saving systems do not reduce the need of transfusion in low-risk patients undergoing cardiac surgery. Interactive Cardiovascular and Thoracic Surgery 2011;12(2):189-93. [DOI: 10.1510/icvts.2010.251538]</Citation><ArticleIdList><ArticleId IdType="doi">10.1510/icvts.2010.251538</ArticleId><ArticleId IdType="pubmed">21118833</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Riou 1994 {published data only}</Title><Reference><Citation>Riou B, Arock M, Guerrero M, Ramos M, Thoreux P, Guillosson JJ, et al. Haematological effects of postoperative autotransfusion in spinal surgery. Acta Anaesthesiologica Scandinavica 1994;38(4):336-41.</Citation><ArticleIdList><ArticleId IdType="pubmed">8067219</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Rollo 1995 {published data only}</Title><Reference><Citation>Rollo VJ, Hozack WJ, Rothman RH, Chao W, Eng KO. Prospective randomized evaluation of blood salvage techniques for primary total hip arthroplasty. Journal of Arthroplasty 1995;10(4):532-9.</Citation><ArticleIdList><ArticleId IdType="pubmed">8523015</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Rosencher 1994 {published data only}</Title><Reference><Citation>Rosencher N, Vassilieff V, Tallet F, Toulon P, Leoni J, Tomeno B, et al. Comparison of Orth-Evac and Solcotrans Plus devices for the autotransfusion of blood drained after total knee joint arthroplasty. Annales Fran&#xe7;aises d'Anesth&#xe9;sie et de R&#xe9;animation 1994;13(3):318-25.</Citation><ArticleIdList><ArticleId IdType="pubmed">7992939</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Sait 1999 {published data only}</Title><Reference><Citation>Sait MS, Earnshaw P. Autotransfusion in total knee arthroplasty. Is it worth the effort? Journal of Bone and Joint Surgery. British Volume 1999;81 (Suppl 2):244.</Citation></Reference></ReferenceList><ReferenceList><Title>&#x160;arkanovi&#xfc; 2013 {published data only}</Title><Reference><Citation>&#x160;arkanovi&#xfc; ML, Gvozdenovi&#xfc; L, Savi&#xfc; D, Ili&#xfc; MP, Jovanovi&#xfc; G. Autologous blood transfusion in total knee replacement surgery. Vojnosanitetski Pregled 2013;70(3):274-8. [DOI: 10.2298/VSP1303274L]</Citation><ArticleIdList><ArticleId IdType="doi">10.2298/VSP1303274L</ArticleId><ArticleId IdType="pubmed">23607238</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Savvidou 2009 {published data only}</Title><Reference><Citation>Savvidou C, Chatziioannou SN, Pilichou A, Pneumaticos SG. Efficacy and cost-effectiveness of cell saving blood autotransfusion in adult lumbar fusion. Transfusion Medicine 2009;19(4):202-6. [DOI: 10.1111/j.1365-3148.2009.00929.x]</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1365-3148.2009.00929.x</ArticleId><ArticleId IdType="pubmed">19706137</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Schaff 1978 {published data only}</Title><Reference><Citation>Schaff HV, Hauer JM, Bell WR, Gardner TJ, Donahoo JS, Gott VL, et al. Autotransfusion of shed mediastinal blood after cardiac surgery. A prospective study. Journal of Thoracic and Cardiovascular Surgery 1978;75(4):632-41.</Citation><ArticleIdList><ArticleId IdType="pubmed">642556</ArticleId></ArticleIdList></Reference><Reference><Citation>Schaff HV, Hauer JM, Brawley RK. Autotransfusion in cardiac surgical patients after operation. Surgery 1978;84(5):713-8.</Citation><ArticleIdList><ArticleId IdType="pubmed">715689</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Schmidt 1996 {published data only}</Title><Reference><Citation>Schmidt H, F&#xf8;lsgaard S, Mortensen PE, Jensen E. Cardiac enzymes and autotransfusion of shed mediastinal blood after myocardial revascularization. Annals of Thoracic Surgery 1997;63:1288-92.</Citation><ArticleIdList><ArticleId IdType="pubmed">9146316</ArticleId></ArticleIdList></Reference><Reference><Citation>Schmidt H, F&#xf8;lsgaard S, Mortensen PE, Jensen E. Impact of autotransfusion after coronary artery bypass grafting on oxygen transport. Acta Anaesthesiologica Scandinavica 1997;41(8):995-1001.</Citation><ArticleIdList><ArticleId IdType="pubmed">9311397</ArticleId></ArticleIdList></Reference><Reference><Citation>Schmidt H, Mortensen PE, F&#xf8;lsgaard SL, Jensen EA. Autotransfusion after coronary artery bypass grafting halves the number of patients needing blood transfusion. Annals of Thoracic Surgery 1996;61(4):1177-81. [DOI: 10.1016/0003-4975(96)00002-1.]</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0003-4975(96)00002-1.</ArticleId><ArticleId IdType="pubmed">8607679</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Schnurr 2018 {published data only}</Title><Reference><Citation>Schnurr C, Giannakopoulos I, Arbab D, Dargel J, Beckmann J, Eyse P. No benefit of autologous transfusion drains in total knee arthroplasty. Knee Surgery Sports Traumatology and Arthroscopy 2018;26(5):1557-63. [DOI: 10.1007/s00167-017-4585-8]</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00167-017-4585-8</ArticleId><ArticleId IdType="pubmed">28577064</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Sch&#xf6;nberger 1993 {published data only}</Title><Reference><Citation>Sch&#xf6;nberger JP, Bred&#xe9;e J, Speekenbrink RG, Everts PA, Wildevuur ChR. Autotransfusion of shed blood contributes additionally to blood saving in patients receiving aprotinin (2 million KIU). European Journal of Cardio-thoracic Surgery 1993;7(9):474-7.</Citation><ArticleIdList><ArticleId IdType="pubmed">7692899</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Scrascia 2012 {published data only}</Title><Reference><Citation>Scrascia G, Rotunno C, Nanna D, Rociola R, Guida P, Rubino G, et al. Pump blood processing, salvage and re-transfusion improves hemoglobin levels after coronary artery bypass grafting, but affects coagulative and fibrinolytic systems. Perfusion 2012;27(4):270-7. [DOI: 10.1177/0267659112442236]</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0267659112442236</ArticleId><ArticleId IdType="pubmed">22440640</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Shen 2016 {published data only}</Title><Reference><Citation>ChiCTR-TRC-13003268. Application of autologous blood reinfusion in open-heart surgery with extracorporeal circulation at high risk of blood transfusion. www.chictr.org.cn/showproj.aspx?proj=6291 Date of registration: 09 June 2013 (prospective).</Citation></Reference><Reference><Citation>Shen S, Zhang J, Wang W, Zheng J, Xie Y. Impact of intra-operative cell salvage on blood coagulation in high-bleeding-risk patients undergoing cardiac surgery with cardiopulmonary bypass: a prospective randomized and controlled trial. Journal of Translational Medicine 2016;14(1):228. [DOI: 10.1186/s12967-016-0986-6]</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12967-016-0986-6</ArticleId><ArticleId IdType="pmc">PMC4966771</ArticleId><ArticleId IdType="pubmed">27473326</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Shenolikar 1997 {published data only}</Title><Reference><Citation>Shenolikar A, Wareham K, Newington D, Thomas D, Hughes J, Downes M. Cell salvage auto transfusion in total knee replacement surgery. Transfusion Medicine 1997;7(4):277-80.</Citation><ArticleIdList><ArticleId IdType="pubmed">9510924</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Shirvani 1991 {published data only}</Title><Reference><Citation>Shirvani R. An evaluation of clinical aspects of post-operative autotransfusion, either alone or in conjunction with pre-operative aspirin, in cardiac surgery. British Journal of Clinical Practice 1991;45(2):105-8.</Citation><ArticleIdList><ArticleId IdType="pubmed">1793694</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Smith 2007 {published data only}</Title><Reference><Citation>Smith LK, Williams DH, Langkamer VG. Post-operative blood salvage with autologous retransfusion in primary total hip replacement. The Journal of Bone and Joint Surgery. British Volume 2007;89(8):1092-7.</Citation><ArticleIdList><ArticleId IdType="pubmed">17785752</ArticleId></ArticleIdList></Reference><Reference><Citation>Williams D, Smith L, Langkamer VG. A randomised prospective study of post operative blood salvage with autologous retransfusion in primary total hip replacement. In: The Journal of Bone and Joint Surgery. British Volume (Proceedings). Vol. 91-B Suppl 1. 2009:102-10d.</Citation><ArticleIdList><ArticleId IdType="pubmed">17785752</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>So&#x2010;Osman 2006 {published data only}</Title><Reference><Citation>So-Osman C, Nelissen RG, Eikenboom HC, Brand A. Efficacy, safety and user-friendliness of two devices for postoperative autologous shed red blood cell re-infusion in elective orthopaedic surgery patients: a randomized pilot study. Transfusion Medicine 2006;16(5):321-8.</Citation><ArticleIdList><ArticleId IdType="pubmed">16999754</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>So&#x2010;Osman 2014 {published data only}</Title><Reference><Citation>ISRCTN96327523. Optimal blood management in elective orthopaedic surgery: the Transfusion "Op Maat" (TOMaat) study. www.isrctn.com/ISRCTN96327523 Submission date: 20 December 2005. Registration date: 20 December 2005 (retrospective).</Citation></Reference><Reference><Citation>NCT00998088. Blood management in orthopedic surgery (TOMaat). clinicaltrials.gov/ct2/show/NCT00998088 First posted: 20 October 2009 (retrospective).</Citation></Reference><Reference><Citation>NTR303. Optimal blood management in elective orthopaedic surgery. The Transfusion "Op Maat" (TOMaat) study. trialregister.nl/trial/265 Date of registration: 12/09/2005 (retrospective).</Citation></Reference><Reference><Citation>So-Osman C, Balradj J, Koopman-van Gemert AWMM, Onstenk R, Van Den Hout WB, Brand R, et al. Patient blood management in elective orthopaedic hip-and knee replacement surgery-a report on clinical outcome. Vox Sanguinis 2016;111 (Suppl 1):282. [DOI: 10.1111/vox.12429]</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/vox.12429</ArticleId></ArticleIdList></Reference><Reference><Citation>So-Osman C, Nelissen RG, Koopman-van Gemert AM, Kluyver E, P&#xf6;ll R, Onstenk R, et al. A randomised controlled trial on erythropoietin and blood salvage as transfusion alternatives in orthopaedic surgery using a restrictive transfusion policy. Transfusion Alternatives in Transfusion Medicine 2011;12 (1):25-6. [DOI: 10.1111/j.1778-428X.2011.01149.x]</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1778-428X.2011.01149.x</ArticleId></ArticleIdList></Reference><Reference><Citation>So-Osman C, Nelissen RG, Koopman-van Gemert AW, Kluyver E, P&#xf6;ll RG, Onstenk R, et al. Patient blood management in elective total hip- and knee-replacement surgery (part 2): a randomized controlled trial on blood salvage as transfusion alternative using a restrictive transfusion policy in patients with a preoperative hemoglobin above 13 g/dl. Anaesthesiology 2014;120(4):852-60.</Citation><ArticleIdList><ArticleId IdType="pubmed">24434302</ArticleId></ArticleIdList></Reference><Reference><Citation>So-Osman C, Nelissen RGHH, Koopman-van Gemert AWMM, Kluyver E, P&#xf6;ll RG, Onstenk R et al. Patient blood management in elective total hip- and knee-replacement surgery (Part 1) A randomized controlled trial on erythropoietin and blood salvage as transfusion alternatives using a restrictive transfusion policy in erythropoietin-eligible patients. Anaesthesiology 2014;120(4):839-60.</Citation><ArticleIdList><ArticleId IdType="pubmed">24424070</ArticleId></ArticleIdList></Reference><Reference><Citation>So-Osman C. Cost effectiveness of patient blood management methods. Vox Sanguinis 2014;1:11-12.</Citation></Reference><Reference><Citation>So-Osman C. Cost-effectiveness of patient blood management methods in elective orthopaedic surgery. ISBT Science Series 2015;10(Suppl 1):146-9. [DOI: 10.1111/voxs.12154]</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/voxs.12154</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Spark 1997 {published data only}</Title><Reference><Citation>Farrer A, Spark JI, Scott DJ. Autologous blood transfusion: the benefits to the patient undergoing abdominal aortic aneurysm repair. Journal of Vascular Nursing 1997;15(4):111-5.</Citation><ArticleIdList><ArticleId IdType="pubmed">9429379</ArticleId></ArticleIdList></Reference><Reference><Citation>Spark JI, Chetter IC, Kester RC, Scott DJ. Allogeneic versus autologous blood during abdominal aortic aneurysm surgery. European Journal of Vascular and Endovascular Surgery 1997;14(6):482-6.</Citation><ArticleIdList><ArticleId IdType="pubmed">9467524</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Springer 2016 {published data only}</Title><Reference><Citation>NCT01636414. Reinfusion drains vs tranexamic acid in total joint arthroplasty. clinicaltrials.gov/ct2/show/NCT01636414 First posted: 10 July 2012 (retrospective).</Citation></Reference><Reference><Citation>Springer BD, Odum SM, Fehring TK. What is the benefit of tranexamic acid vs reinfusion drains in total joint arthroplasty? Journal of Arthroplasty 2016;31(1):76-80. [DOI: 10.1016/j.arth.2015.08.006]</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.arth.2015.08.006</ArticleId><ArticleId IdType="pubmed">26387037</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Teetzman 2014 {published data only}</Title><Reference><Citation>NCT01725724. Effects of the Sangvia blood collection system on postoperative infections in orthopedic patients. clinicaltrials.gov/ct2/show/NCT01725724 First posted: 14 November 2012 (retrospective).</Citation></Reference><Reference><Citation>Teetzmann R, S&#xf8;rensen B, Liseth K, Opheim E, Hervig T. Effects of the Sangvia blood collection system on patients undergoing elective hip surgery. Transfusion and Apheresis Science 2014;51(2):91-6. [DOI: 10.1016/j.transci.2014.08.004]</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.transci.2014.08.004</ArticleId><ArticleId IdType="pubmed">25151098</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Thomas 2001 {published data only}</Title><Reference><Citation>Thomas D, Wareham K, Cohen D, Hutchings H. Autologous blood transfusion in total knee replacement surgery. British Journal of Anaesthesia 2001;86(5):669-73. [DOI: 10.1093/bja/86.5.669] [PMID: ]</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bja/86.5.669</ArticleId><ArticleId IdType="pubmed">11575343</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Thomassen 2011 {published data only}</Title><Reference><Citation>NCT00822588. Comparison in need for bank blood between patients undergoing total hip surgery that either receive their own blood back or not. clinicaltrials.gov/ct2/show/NCT00822588 First posted: 14 January 2009 (prospective).</Citation></Reference><Reference><Citation>Thomassen BJ, Pilot P, Grohs J, Holen K, Bisbe E, Poolman RW. A prospective, randomized, controlled trial of retransfusion of intra-operatively collected filtered whole blood in total hip surgery with the sangvia blood reinfusion system. Vox Sanguinis 2011;1:191.</Citation></Reference></ReferenceList><ReferenceList><Title>Thomassen 2014 {published data only}</Title><Reference><Citation>NTR2501. The effect of duration of wound drainage on allogeneic blood transfusions using a postoperative retransfusion system after major orthopaedic surgery. trialsearch.who.int/Trial2.aspx?TrialID=NTR2501 Date of registration: 09 September 2010 (retrospective).</Citation></Reference><Reference><Citation>Thomassen BJ, Pilot P, Scholtes VA, Grohs JG, Holen K, Bisbe E, Poolman RW. Limit allogeneic blood use with routine re-use of patient&#x2019;s own blood: a prospective, randomized, controlled trial in total hip surgery. PLoS One 2012;7(9):E44503 (1-9).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3441549</ArticleId><ArticleId IdType="pubmed">23028549</ArticleId></ArticleIdList></Reference><Reference><Citation>Thomassen BJ, den Hollander PH, Kaptijn HH, Nelissen RG, Pilot P. Autologous wound drains have no effect on allogeneic blood transfusions in primary total hip and knee replacement: a three-arm randomised trial. Bone and Joint Journal 2014;96-B(6):765-71. [DOI: 10.1302/0301-620X.96B6.33021]</Citation><ArticleIdList><ArticleId IdType="doi">10.1302/0301-620X.96B6.33021</ArticleId><ArticleId IdType="pubmed">24891576</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Thompson 1990 {published data only}</Title><Reference><Citation>Thompson JF, Webster JH, Chant AD. Prospective randomised evaluation of a new cell saving device in elective aortic reconstruction. European Journal of Vascular Surgery 1990;4(5):507-12.</Citation><ArticleIdList><ArticleId IdType="pubmed">2226884</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Thurer 1979 {published data only}</Title><Reference><Citation>Thurer RL, Lytle BW, Cosgrove DM, Loop FD. Autotransfusion following cardiac operations: a randomized, prospective study. Annals of Thoracic Surgery 1979;27(6):500-7.</Citation><ArticleIdList><ArticleId IdType="pubmed">454027</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Touzopoulos 2021 {published data only}</Title><Reference><Citation>NCT04505748. Is self-transfusion safe after total knee arthroplasty in terms of nephrotoxicity of gentamicin from bone cement? clinicaltrials.gov/ct2/show/NCT04505748 First posted: 10 August 2020 (retrospective).</Citation></Reference><Reference><Citation>Touzopouos P, Arvanitidis K, Filidou E, Tikeridis K, Karanikas M, Kolios G, et al. Is serum gentamicin concentration modified with autologous cell-saved blood transfusion after total knee arthroplasty using tranexamic acid? A randomised control trial. Orthopaedics &amp; Traumatology: Surgery &amp; Research 2021;107(3):102794. [DOI: 10.1016/j.otsr.2020.102794] [PMID: ]</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.otsr.2020.102794</ArticleId><ArticleId IdType="pubmed">33333277</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Tripkovic 2008 {published data only}</Title><Reference><Citation>Tripkovic B, Bukovic D, Sakic K, Sakic S, Bukovic N, Radakovic B. Quality of the blood sampled from surgical drainage after total hip arthroplasty. Collegium Antropologicum 2008;32(1):153-60.</Citation><ArticleIdList><ArticleId IdType="pubmed">18494201</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Unsworth 1996 {published data only}</Title><Reference><Citation>Unsworth-White MJ, Kallis P, Cowan D, Tooze JA, Bevan DH, Treasure T. A prospective randomised controlled trial of postoperative autotransfusion with and without a heparin-bonded circuit. European Journal of Cardio-thoracic Surgery 1996;10(1):38-47.</Citation><ArticleIdList><ArticleId IdType="pubmed">8776184</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Vermeijden 2015 {published data only}</Title><Reference><Citation>De Vries AJ, Vermeijden WJ, Van Pelt LJ, Van den Heuvel ER, Van Oeveren W. Additional filtering of blood from a cell salvage device is not likely to show important additional benefits in outcome in cardiac surgery. Transfusion 2019;59(3):989-94. [DOI: 10.1111/trf.15130] [PMID: ]</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/trf.15130</ArticleId><ArticleId IdType="pubmed">30610759</ArticleId></ArticleIdList></Reference><Reference><Citation>ISRCTN58333401. The clinical effects of leukocyte removal filters, cell savers and their combination on blood transfusion and organ damage during cardiac surgery. www.isrctn.com/ISRCTN58333401 Submission date: 20 December 2005. Registration date: 20 December 2005 (retrospective). [DOI: 10.1186/ISRCTN58333401]</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/ISRCTN58333401</ArticleId></ArticleIdList></Reference><Reference><Citation>NTR244. The clinical effects of leukocyte removal filters, cellsavers and their combination on blood transfusion and organ damage during cardiac surgery. trialregister.nl/trial/207 Date of registration: 07 September 2005 (retrospective).</Citation></Reference><Reference><Citation>Van Klarenbosch J, Van den Heuvel ER, Van Oeveren W, De Vries AJ. Does intraoperative cell salvage reduce postoperative infection rates in cardiac surgery? Journal of Cardiothoracic and Vascular Anesthesia 2020;34:1457-63. [DOI: 10.1053/j.jvca.2020.01.023]</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.jvca.2020.01.023</ArticleId><ArticleId IdType="pubmed">32144053</ArticleId></ArticleIdList></Reference><Reference><Citation>Vermeijden WJ, Van Klarenbosch J, Gu YJ, Mariani MA, Buhre WF, Scheeren TWL, et al. Effects of cell-saving devices and filters on transfusion in cardiac surgery: a multicenter randomized study. Annals of Thoracic Surgery 2015;99(1):26-32. [DOI: 10.1016/j.athoracsur.2014.08.027]</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.athoracsur.2014.08.027</ArticleId><ArticleId IdType="pubmed">25440265</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Ward 1993 {published data only}</Title><Reference><Citation>Ward HB, Smith RR, Landis KP, Nemzek TG, Dalmasso AP, Swaim WR. Prospective, randomized trial of autotransfusion after routine cardiac operations. Annals of Thoracic Surgery 1993;56(1):137-41.</Citation><ArticleIdList><ArticleId IdType="pubmed">8328844</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Westerberg 2004 {published data only}</Title><Reference><Citation>Westerberg M, Bengtsson A, Jeppsson A. Coronary surgery without cardiotomy suction and autotransfusion reduces the postoperative systemic inflammatory response. Annals of Thoracic Surgery 2004;78(1):54-9.</Citation><ArticleIdList><ArticleId IdType="pubmed">15223402</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Xie 2015 {published data only}</Title><Reference><Citation>ChiCTR-TRC-13003209. Efficacy and safety of intraoperative Cell Saver in cardiac surgery associated with cardiopulmonary bypass circuit. www.chictr.org.cn/showprojen.aspx?proj=6350 Date of registration: 05 May 2013 (prospective).</Citation></Reference><Reference><Citation>Xie Y, Shen S, Zhang J, Wang W, Zheng J. The efficacy, safety and cost-effectiveness of intra-operative cell salvage in high-bleeding-risk cardiac surgery with cardiopulmonary bypass: a prospective randomized and controlled trial. International Journal of Medical Sciences 2015;12(4):322-8. [DOI: 10.7150/ijms.11227]</Citation><ArticleIdList><ArticleId IdType="doi">10.7150/ijms.11227</ArticleId><ArticleId IdType="pmc">PMC4402435</ArticleId><ArticleId IdType="pubmed">25897293</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Zhang 2008 {published data only}</Title><Reference><Citation>Zhang XF, Dong JM, Gong ML, Shen SM, Zhou Y, Pan YF, Mao J. Effectiveness of preoperative autologous plateletpheresis combined with intraoperative autotransfusion on the blood coagulation in orthopaedic patients. Chung-Hua Wai Ko Tsa Chih [Chinese Journal of Surgery] 2008;46(2):118-21.</Citation><ArticleIdList><ArticleId IdType="pubmed">18509970</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Zhao 1996 {published data only}</Title><Reference><Citation>Zhao K, Xiao M, Deng S. Autotransfusion of shed medistinal blood after open heart operation. Chinese Journal of Surgery 1996;34(8):497-9.</Citation><ArticleIdList><ArticleId IdType="pubmed">9594199</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Zhao 2003 {published data only}</Title><Reference><Citation>Zhao K, Xu J, Hu S, Wu Q, Wei Y, Liu Y. Autotransfusion of shed mediastinal blood after open heart surgery. Chinese Medical Journal 2003;116:1179-82.</Citation><ArticleIdList><ArticleId IdType="pubmed">12935406</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Zhao 2016 {published data only}</Title><Reference><Citation>Zhao JT, Jiang Z, Chen JF, Cao XD, Luo Y, Shen WZ. Safety and effectiveness of autologous blood transfusion after total hip arthroplasty. Chinese Journal of Tissue Engineering Research 2016;20(4):465-9. [URL: www.cjter.com/EN/abstract/abstract11187.shtml]</Citation></Reference></ReferenceList><ReferenceList><Title>Zhao 2017 {published data only}</Title><Reference><Citation>Zhao H, Ma H, Meng L, Zhao Z, Quan X, Cheng Z. Application of autologous blood cell salvage in off-pump coronary artery bypass graft operation. Heart Surgery Forum 2017;20(3):E107-110. [DOI: 10.1532/hsf.1609]</Citation><ArticleIdList><ArticleId IdType="doi">10.1532/hsf.1609</ArticleId><ArticleId IdType="pubmed">28671866</ArticleId></ArticleIdList></Reference></ReferenceList></ReferenceList><ReferenceList><Title>References to studies excluded from this review</Title><ReferenceList><Title>Albano 2010 {published data only}</Title><Reference><Citation>Albano G, Inghilleri G, Parinello M, Roscitano C, Borromeo U. Efficacy and safety in post-operative autologous blood reinfusion. Transfusion Medicine 2010;1:49 (Abstract no. PO54). [DOI: 10.1111/j.1365-3148.2010.01029.x]</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1365-3148.2010.01029.x</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Barbara 2010 {published data only}</Title><Reference><Citation>Barbara E, Di Spigno N, Perazzo P, Scardino M. A new concept in the post-operative autologous blood reinfusion in orthopaedic surgery. Regional Anesthesia and Pain Medicine 2010;35(5):E67 (Abstract no. 122). [DOI: 10.1097/AAP.0b013e3181f3582c]</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/AAP.0b013e3181f3582c</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Bartels 1996 {published data only}</Title><Reference><Citation>Bartels C, Bechtel JV, Winkler C, Horsch S. Intraoperative autotransfusion in aortic surgery: comparison of whole blood autotransfusion versus cell separation. Journal of Vascular Surgery 1996;24(1):102-8. [DOI: ]</Citation><ArticleIdList><ArticleId IdType="pubmed">8691512</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Bisleri 2016 {published data only}</Title><Reference><Citation>Bisleri G, Tononi L, Morgan JA, Bordonali T, Cheema FH, Siddiqui OT, et al. Separation of mediastinal shed blood during aortic valve surgery elicits a reduced inflammatory response. Journal of Cardiovascular Medicine 2016;17(1):62-8. [DOI: ]</Citation><ArticleIdList><ArticleId IdType="pubmed">24933196</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Bosboom 2022 {published data only}</Title><Reference><Citation>Bosboom JJ, Klanderman RB, Terwindt LE, Bulle EB, Wijnberge M, Eberl S, et al. Autologous red blood cell transfusion does not result in a more profound increase in pulmonary capillary wedge pressure compared to saline in critically ill patients: a randomized crossover trial. Vox Sanguinis 2022;117(8):1035-42. [DOI: ]</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9540110</ArticleId><ArticleId IdType="pubmed">35560234</ArticleId></ArticleIdList></Reference><Reference><Citation>NCT03135457. TACO crossover trial. clinicaltrials.gov/ct2/show/study/NCT03135457 First posted: 1 May 2017 (prospective).</Citation></Reference></ReferenceList><ReferenceList><Title>Boyle 2019 {published data only}</Title><Reference><Citation>Boyle G, Kuffel A, Parmar K, Gibson K, Smith M, Grehan A, et al. A comparison of haemostatic biomarkers during low-risk patients undergoing cardiopulmonary bypass using either conventional centrifugal cell salvage or the HemoSep device. Perfusion 2019;34(1):76-83. [DOI: ]</Citation><ArticleIdList><ArticleId IdType="pubmed">30067140</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Campbell 2012b {published data only}</Title><Reference><Citation>Campbell J, Holland C, Richens D, Skinner H. Impact of cell salvage during cardiac surgery on the thrombelastomeric coagulation profile: a pilot study. Perfusion 2012;27(3):221-4. [DOI: ]</Citation><ArticleIdList><ArticleId IdType="pubmed">22185951</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Chen 2020 {published data only}</Title><Reference><Citation>Chen H, Tan H, Luo PX, Shen YF, Lyu CC, Qian XW, et al. Comparison of cell salvage with one and two suction devices during cesarean section in patients with placenta previa and/or accrete: a randomized controlled trial. Chinese Medical Journal 2020;133(6):638-43. [DOI: ] [URL: https://journals.lww.com/cmj/Fulltext/2020/03200/Comparison_of_cell_salvage_with_one_and_two.2.aspx]</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7190236</ArticleId><ArticleId IdType="pubmed">32097203</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Cheng 2014 {published data only}</Title><Reference><Citation>Cheng W, Xu H, Xiao Z, Ren Y, Zheng Q, Kan W. Effect of autologous drained blood reinfusion on hidden blood loss and limb swelling following rivaroxaban anticoagulation for primary total hip arthroplasty. Nan Fang Yi Ke Da Xue Xue Bao [Journal of Southern Medical University] 2014;34(3):438-40. [DOI: 10.3969/j.issn.1673-4254.2014.03.32]</Citation><ArticleIdList><ArticleId IdType="doi">10.3969/j.issn.1673-4254.2014.03.32</ArticleId><ArticleId IdType="pubmed">24670467</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>ChiCTR1800016656 {published data only}</Title><Reference><Citation>ChiCTR1800016656. The application study of apheresis autologous red blood cell on spinal surgery. www.chictr.org.cn/showproj.aspx?proj=28050 Date of registration: 14 June 2018 (prospective).</Citation></Reference></ReferenceList><ReferenceList><Title>ChiCTR1800018689 {published data only}</Title><Reference><Citation>ChiCTR1800018689. Clinical study for intraoperative cell salvage in Caesarean section. www.chictr.org.cn/com/25/showproj.aspx?proj=31610 Date of registration: 03 October 2018 (retrospective).</Citation></Reference></ReferenceList><ReferenceList><Title>ChiCTR&#x2010;OCC&#x2010;15006016 {published data only}</Title><Reference><Citation>ChiCTR-OCC-15006016. Comparison of prognosis between intraoperative cell salvage and allogeneic transfusion for operation patients. www.chictr.org.cn/showproj.aspx?proj=10482 Date of registration: 29 October 2014 (prospective).</Citation></Reference></ReferenceList><ReferenceList><Title>ChiCTR&#x2010;ORN&#x2010;17013372 {published data only}</Title><Reference><Citation>ChiCTR-ORN-17013372. Intraoperative cell salvage during caesarean section for placenta accreta. www.chictr.org.cn/showproj.aspx?proj=22899 Date of registration: 14 November 2017 (retrospective).</Citation></Reference></ReferenceList><ReferenceList><Title>Choi 2019 {published data only}</Title><Reference><Citation>Choi HY, Hyun SJ, Kim KJ, Jahng TA, Kim HJ. Clinical efficacy of intra-operative cell salvage system in major spinal deformity surgery. Journal of Korean Neurosurgical Society 2019;62(1):53-60. [DOI: 10.3340/jkns.2017.0287]</Citation><ArticleIdList><ArticleId IdType="doi">10.3340/jkns.2017.0287</ArticleId><ArticleId IdType="pmc">PMC6328795</ArticleId><ArticleId IdType="pubmed">30486624</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Conn 2018 {published data only}</Title><Reference><Citation>Conn C, Johnson PM, Van Buskirk C, Santrach P. Utilizing box plots to monitor and investigate quality control results for multiple blood salvage devices. Transfusion 2018;58:157A-157A (abstract no. QT9).</Citation></Reference></ReferenceList><ReferenceList><Title>Deramoudt 1991 {published data only}</Title><Reference><Citation>Deramoudt V, Menestret P, Melledant Y, Chartier M, Sellin M, Le Couls H, et al. Autologous transfusion in cardiac surgery [Transfusion autologue en chirurgie cardiaque (&#xe0; propos de 74 patients)]. Cahiers d'Anesth&#xe9;siologie 1991;39(3):153-9.</Citation><ArticleIdList><ArticleId IdType="pubmed">1884268</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Dickenson 2022 (WHITE&#x2010;9) {published data only}</Title><Reference><Citation>Dickenson E, Griffin XL, Achten J, Mironov K, O'Connor H, Parsons N, et al. Randomised controlled trial comparing intraoperative cell salvage and autotransfusion with standard care in the treatment of hip fractures: a protocol for the WHITE 9 study. BMJ Open 2022;12(6):e062338. [DOI: 10.1136/bmjopen-2022-062338]</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjopen-2022-062338</ArticleId><ArticleId IdType="pmc">PMC9185657</ArticleId><ArticleId IdType="pubmed">35676006</ArticleId></ArticleIdList></Reference><Reference><Citation>ISRCTN15945622. A multi centre randomised controlled trial comparing intra operative cell salvage with standard care in the treatment of hip fractures. www.isrctn.com/ISRCTN15945622 Submission date: 27 August 2019; registration date: 10 September 2019 (prospective). [DOI: 10.1186/ISRCTN15945622]</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/ISRCTN15945622</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Djaiani 2012 (NCT00296985) {published data only}</Title><Reference><Citation>Djaiani G, Fedorko L, Borger MA, Green R, Carroll J, Marcon M, et al. Continuous-flow cell saver reduces cognitive decline in elderly patients after coronary bypass surgery. Circulation 2007;116(17):1888-95. [DOI: 10.1161/CIRCULATIONAHA.107.698001] [PMID: ]</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.107.698001</ArticleId><ArticleId IdType="pubmed">17923575</ArticleId></ArticleIdList></Reference><Reference><Citation>Djaiani G, Katznelson R, Fedorko L, Rao V, Green R, Carroll J, et al. Early benefit of preserved cognitive function is not sustained at one-year after cardiac surgery: a longitudinal follow-up of the randomized controlled trial. Canadian Journal of Anaesthesia 2012;59(5):449-55. [DOI: 10.1007/s12630-012-9675-y]</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12630-012-9675-y</ArticleId><ArticleId IdType="pubmed">22290354</ArticleId></ArticleIdList></Reference><Reference><Citation>NCT00296985. Continuous cellsaver and neurocognitive decline post cardiac surgery. clinicaltrials.gov/ct2/show/study/NCT00296985 First posted: 27 February 2006 (retrospective).</Citation></Reference></ReferenceList><ReferenceList><Title>DRKS00025454 {published data only}</Title><Reference><Citation>DRKS00025454. Comparative study of vacuum drainage associated hemolysis during cell salvage of cardiotomy suction blood [Vergleichende Untersuchung der vakuumbedingten H&#xe4;molyse bei der Evakuation von Kardiotomieblut]. drks.de/search/de/trial/DRKS00025454 Date of registration in DRKS: 06 January 2021 (prospective).</Citation></Reference></ReferenceList><ReferenceList><Title>Duramaz 2018 {published data only}</Title><Reference><Citation>Duramaz A, Bilgili MG, Bayram B, Ziro&#x11f;lu N, Edipo&#x11f;lu E, &#xd6;ne&#x15f; HN, et al. The role of intraoperative cell salvage system on blood management in major orthopedic surgeries: a cost-benefit analysis. European Journal of Orthopaedic Surgery &amp; Traumatology 2018;28(5):991-7. [DOI: 10.1007/s00590-017-2098-2]</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00590-017-2098-2</ArticleId><ArticleId IdType="pubmed">29214459</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Ela 2009 {published data only}</Title><Reference><Citation>Ela Y, Emmiler M, Kocogullari CU, Terzi Y, Sivaci RG, Cekirdekci A. Advantages of autologous blood transfusion in off-pump coronary artery bypass. Heart Surgery Forum 2009;12(5):E261-5. [DOI: ]</Citation><ArticleIdList><ArticleId IdType="pubmed">19833592</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Elawad 1992 {published data only}</Title><Reference><Citation>Elawad AA, Ohlin AK, Berntorp E, Nilsson IM, Fredin H. Autologous blood transfusion in revision hip arthroplasty. A prospective, controlled study of 30 patients. Acta Orthopaedica Scandinavica 1992;63(4):373-6.</Citation><ArticleIdList><ArticleId IdType="pubmed">1529682</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>G&#xe4;bel 2013b {published data only}</Title><Reference><Citation>G&#xe4;bel J, Westerberg M, Bengtsson A, Jeppsson A. Cell salvage of cardiotomy suction blood improves the balance between pro- and anti-inflammatory cytokines after cardiac surgery. European Journal of Cardio-Thoracic Surgery 2013;44(3):506-11. [DOI: ]</Citation><ArticleIdList><ArticleId IdType="pubmed">23404689</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Garg 2015 {published data only}</Title><Reference><Citation>Garg P, Malhotra A, Desai M, Sharma P, Bishnoi AK, Tripathi P et al. Pretransfusion comparison of dialyser-based hemoconcentrator with cell saver system for perioperative cell salvage. Innovations: Technology &amp; Techniques in Cardiothoracic &amp; Vascular Surgery 2015;10(5):334-41. [DOI: ]</Citation><ArticleIdList><ArticleId IdType="pubmed">26418303</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Gorki 2017 (HEPCON II) {published data only}</Title><Reference><Citation>DRKS00008832. Influence of fluid balance and recirculation of pericardial fluids during coronary artery bypass grafting on protamine dosing and on markers of coagulation. drks.de/search/en/trial/DRKS00008832 Date of registration in DRKS: 24 June 2015 (prospective).</Citation></Reference><Reference><Citation>Gorki H, Nakamura J, Kunert A, Hoenicka M, Liebold A. Pericardial fluids or cardiopulmonary bypass: Is there a major culprit for changes in coagulation and inflammation? In: Thoracic and Cardiovascular Surgeon. Conference: 46th Annual Meeting of the German Society for Thoracic and Cardiovascular Surgery, DGTHG. Vol. 65 (Supp 1). 2017:S1-S110. [DOI: 10.1055/s-0037-1598913]</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/s-0037-1598913</ArticleId><ArticleId IdType="pubmed">30727012</ArticleId></ArticleIdList></Reference><Reference><Citation>Gorki H, Nakamura J, Kunert A, Hoenicka M, Liebold A. Pericardial fluids or cardiopulmonary bypass: Is there a major culprit for changes in coagulation and inflammation? Thoracic and Cardiovascular Surgeon 2020;68:219-22. [DOI: ]</Citation><ArticleIdList><ArticleId IdType="pubmed">30727012</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Gu 2009 {published data only}</Title><Reference><Citation>Gu YJ, Vries AJ, Hagenaars JA, Oeveren W. Leucocyte filtration of salvaged blood during cardiac surgery: effect on red blood cell function in concentrated blood compared with diluted blood. European Journal of Cardio-Thoracic Surgery 2009;36(5):877-82. [DOI: ]</Citation><ArticleIdList><ArticleId IdType="pubmed">19608429</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Gunaydin 2013 {published data only}</Title><Reference><Citation>Gunaydin S, Gourlay T. Novel ultrafiltration technique for blood conservation in cardiac operations. Annals of Thoracic Surgery 2013;95(6):2148-51. [DOI: ]</Citation><ArticleIdList><ArticleId IdType="pubmed">23706433</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Gunaydin 2018 {published data only}</Title><Reference><Citation>Gunaydin S, Robertson C, Budak AB, Gourlay T. Comparative evaluation of blood salvage techniques in patients undergoing cardiac surgery with cardiopulmonary bypass. Perfusion 2018;33(2):105-9. [DOI: ]</Citation><ArticleIdList><ArticleId IdType="pubmed">28856967</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Han 2021 {published data only}</Title><Reference><Citation>Han Z, Wang M, Yu S. Effects of stored autotransfusion on electrolytes and postoperative complications in patients undergoing elective orthopedic surgery. American Journal of Translational Research 2021;13(6):7200-6. [PMID: ]</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8290778</ArticleId><ArticleId IdType="pubmed">34306482</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Harlaar 2012 {published data only}</Title><Reference><Citation>Busch O, Hop W, Pependrecht MH, Marquet RL, Jeekel J. Blood transfusions and prognosis in colorectal cancer. New England Journal of Medicine 1993;328:1372-6. [DOI: 10.1056/NEJM199305133281902]</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJM199305133281902</ArticleId><ArticleId IdType="pubmed">8292113</ArticleId></ArticleIdList></Reference><Reference><Citation>Harlaar JJ, Gosselink MP, Hop WC, Lange JF, Busch OR, Jeekel H. Blood transfusions and prognosis in colorectal cancer: long-term results of a randomized controlled trial. Annals of Surgery 2012;256(5):681&#x2010;7. [DOI: ]</Citation><ArticleIdList><ArticleId IdType="pubmed">23095610</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Hasan 2017 {published data only}</Title><Reference><Citation>Hasan MS, Choe NC, Chan CYW, Chiu CK, Kwan MK. Effect of intraoperative autologous transfusion techniques on perioperative hemoglobin level in idiopathic scoliosis patients undergoing posterior spinal fusion: A prospective randomized trial. Journal of Orthopaedic Surgery 2017;25(2):2309499017718951. [DOI: ]</Citation><ArticleIdList><ArticleId IdType="pubmed">28675975</ArticleId></ArticleIdList></Reference><Reference><Citation>NCT02112409. Intraoperative cell salvage and hemodilution technique in scoliosis surgery. clinicaltrials.gov/ct2/show/study/NCT02112409 First posted: 14 April 2014 (retrospective).</Citation></Reference></ReferenceList><ReferenceList><Title>Hogan 2014 {published data only}</Title><Reference><Citation>Hogan M, Needham A, Ortmann E, Bottrill F, Besser M, Klein A. A randomized controlled trial of the effect of concentrating residual cardiopulmonary bypass blood using Hemosep on patient haematocrit after cardiac surgery. Applied Cardiopulmonary Pathophysiology 2014;18 (Suppl):51-2 (Abstract no. O-49).</Citation></Reference></ReferenceList><ReferenceList><Title>Hogan 2015 {published data only}</Title><Reference><Citation>Hogan M, Needham A, Ortmann E, Bottrill F, Collier TJ, Besser MW, et al. Haemoconcentration of residual cardiopulmonary bypass blood using Hemosep: a randomised controlled trial. Anaesthesia 2015;70(5):563-70. [DOI: ]</Citation><ArticleIdList><ArticleId IdType="pubmed">25692545</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>ISRCTN59539154 (MASS III) {published data only}</Title><Reference><Citation>ISRCTN59539154. Off-pump vs on-pump surgery in patients with stable coronary artery disease. https://www.isrctn.com/ISRCTN59539154 Submission date 21/02/2008; registration date 10/03/2008 (retrospective). [DOI: ]</Citation></Reference><Reference><Citation>Vieira de Melo RM, Hueb W, Rezende PC, Alves da Costa LM, Oikawa FT, Lima EG, et al. Comparison between off-pump and on-pump coronary artery bypass grafting in patients with severe lesions at the circumflex artery territory: 5-year follow-up of the MASS III trial. European Journal of Cardiothoracic Surgery 2015;47(3):455-8. [DOI: 10.1093/ejcts/ezu216] [PMID: ]</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ejcts/ezu216</ArticleId><ArticleId IdType="pubmed">24855193</ArticleId></ArticleIdList></Reference><Reference><Citation>Vieira de Melo RM, Hueb W, Rezende PC, Lima EG, Hueb AC, Ramires JA, et al. On-pump versus off-pump coronary artery bypass surgery in patients older than 60 years: five-year follow-up of MASS III trial. Journal of Cardiothoracic Surgery 2014;9:127. [DOI: 10.1186/1749-8090-9-136] [PMID: ]</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1749-8090-9-136</ArticleId><ArticleId IdType="pmc">PMC4304776</ArticleId><ArticleId IdType="pubmed">25096030</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>ISRCTN85756518 {published data only}</Title><Reference><Citation>ISRCTN85756518. Autologous transfusion in surgery: a randomised clinical trial. www.isrctn.com/ISRCTN85756518 Submission date: 23 January 2004; registration date: 23 January 2004 (retrospective). [DOI: 10.1186/ISRCTN85756518]</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/ISRCTN85756518</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>ISRCTN87590585 {published data only}</Title><Reference><Citation>Boodhwani M, Nathan HJ, Mesana TG, Rubens FD, on behalf of Cardiotomy Investigators. Effects of shed mediastinal blood on cardiovascular and pulmonary function: a randomized, double-blind study. Annals of Thoracic Surgery 2008;86(4):1167-73. [DOI: 10.1016/j.athoracsur.2008.06.029] [PMID: ]</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.athoracsur.2008.06.029</ArticleId><ArticleId IdType="pubmed">18805154</ArticleId></ArticleIdList></Reference><Reference><Citation>ISRCTN87590585. Clinical relevance of cardiotomy blood salvage during cardiopulmonary bypass. www.isrctn.com/ISRCTN87590585 Submission date: 26 September 2005; registration date 26 September 2005 (retrospective). [DOI: 10.1186/ISRCTN87590585]</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/ISRCTN87590585</ArticleId></ArticleIdList></Reference><Reference><Citation>Rubens FD, Boodhwani M, Mesana T, Wozny D, Wells G, Nathan HJ, Cardiotomy Investigators. The cardiotomy trial: a randomized, double-blind study to assess the effect of processing of shed blood during cardiopulmonary bypass on transfusion and neurocognitive function. Circulation 2007;116(11 (Suppl)):i89-97. [DOI: 10.1161/CIRCULATIONAHA.106.678987] [PMID: ]</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.106.678987</ArticleId><ArticleId IdType="pubmed">17846332</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Jenni 2011 {published data only}</Title><Reference><Citation>Jenni H, Rheinberger J, Czerny M, Gygax E, Rieben R, Krahenbuhl E, et al. Autotransfusion system or integrated automatic suction device in minimized extracorporeal circulation: influence on coagulation and inflammatory response. European Journal of Cardio-Thoracic Surgery 2011;39(5):e139-43. [DOI: ]</Citation><ArticleIdList><ArticleId IdType="pubmed">21334912</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>JPRN UMIN 000019726 {published data only}</Title><Reference><Citation>UMIN000019726. Coagulation and fibrinolytic function in use of intraoperative blood salvage for cardiovascular surgery. center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000022782 Registered date: 10 November 2015 (prospective).</Citation></Reference></ReferenceList><ReferenceList><Title>JPRN UMIN 000022227 {published data only}</Title><Reference><Citation>UMIN000022227. Differences in biological responses between open and closed system cardiopulmonary bypass for adult cardiac surgery. center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000022145 Registered date: 6 May 2016 (retrospective).</Citation></Reference></ReferenceList><ReferenceList><Title>JPRN UMIN 000025157 {published data only}</Title><Reference><Citation>UMIN000025157. Coagulation and fibrinolytic function in use of intraoperative blood salvage for cardiovascular surgery/comparative test with other infusion. center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000028939 Registered date: 6 December 2016 (prospective).</Citation></Reference></ReferenceList><ReferenceList><Title>JPRN UMIN 000043920 {published data only}</Title><Reference><Citation>JPRN-UMIN000043920. Efficacy of cell saver system during cesarean section. center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000047046 Date of disclosure of the study information: 15 April 2021 (retrospective).</Citation></Reference></ReferenceList><ReferenceList><Title>Karlsson 2019 {published data only}</Title><Reference><Citation>Karlsson M, Hannuksela M, Appelblad M, Hallgren O, Johagen D, Wahba A, et al. Cardiopulmonary bypass and dual antiplatelet therapy: a strategy to minimise transfusions and blood loss. Perfusion 2019;35(3):236-45. [DOI: ]</Citation><ArticleIdList><ArticleId IdType="pubmed">31446845</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Khan 2022 {published data only}</Title><Reference><Citation>Khan MI, Ashraf M, Iqbal H. Normovolumetric haemodilution and auto transfusion in major operations prevents transfusion-related complications. Bangladesh Journal of Medical Science 2022;21(3):547-52. [DOI: ]</Citation></Reference></ReferenceList><ReferenceList><Title>Khanuja 2023 {published data only}</Title><Reference><Citation>Khanuja K, Iyer N, Roman A, Al-Kouatly HB. Use of cell salvage at time of cesarean section: a systematic review and meta-analysis. American Journal of Obstetrics and Gynecology 2023;228 (Suppl 1):s509-s510. [DOI: 10.1016/j.ajog.2022.11.872]</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajog.2022.11.872</ArticleId><ArticleId IdType="pubmed">38109996</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Laub 1993 {published data only}</Title><Reference><Citation>Laub GW, Dharan M, Riebman JB, Chen C, Moore R, Bailey BM, et al. The impact of intraoperative autotransfusion on cardiac surgery. A prospective randomized double-blind study. Chest 1993;104(3):686-9.</Citation><ArticleIdList><ArticleId IdType="pubmed">8365276</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Mayer 1985 {published data only}</Title><Reference><Citation>Mayer ED, Welsch M, Tanzeem A, Saggau W, Spath J, Hummels R, et al. Reduction of postoperative donor blood requirement by use of the cell separator. Scandinavian Journal of Thoracic Cardiovascular Surgery 1985;19(2):165-71.</Citation><ArticleIdList><ArticleId IdType="pubmed">4048888</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>McGill 2002 {published data only}</Title><Reference><Citation>McGill N, O'Shaughnessy D, Pickering R, Herbertson M, Gill R. Mechanical methods of reducing blood transfusion in cardiac surgery: randomised controlled trial. BMJ 2002;324(7349):1299. Erratum in: BMJ 2002; 20;325(7356):142.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC113763</ArticleId><ArticleId IdType="pubmed">12039820</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>McNair 2013 {published data only}</Title><Reference><Citation>McNair E, McKay W, Qureshi AM, Rosin M, Gamble J, Dalshaug G, et al. Outcomes and biochemical parameters following cardiac surgery: effects of transfusion of residual blood using centrifugation and multiple-pass hemoconcentration. Journal of Cardiothoracic &amp; Vascular Anesthesia 2013;27(6):1174-80. [DOI: ]</Citation><ArticleIdList><ArticleId IdType="pubmed">23988781</ArticleId></ArticleIdList></Reference><Reference><Citation>NCT01416792. Centrifugation vs. multiple-pass hemofiltration of the residual cardiopulmonary bypass volume. clinicaltrials.gov/ct2/show/study/NCT01416792 First posted: 15 August 2011 (retrospective).</Citation></Reference></ReferenceList><ReferenceList><Title>McNair 2020 {published data only}</Title><Reference><Citation>McNair ED, McKay WP, Mondal PK, Bryce RDT. Transfusion use and hemoglobin levels by blood conservation method after cardiopulmonary bypass. Annals of Thoracic Surgery 2020;110(5):1520-26. [DOI: ]</Citation><ArticleIdList><ArticleId IdType="pubmed">32289301</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Morisaki 2013 {published data only}</Title><Reference><Citation>Morisaki A, Nakahira A, Sasaki Y, Hirai H, Okada Y, Suehiro S, et al. Is elimination of cardiotomy suction preferable in aortic valve replacement? Assessment of perioperative coagulation, fibrinolysis and inflammation. Interactive Cardiovascular and Thoracic Surgery 2013;17(3):507-14. [DOI: ]</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3745149</ArticleId><ArticleId IdType="pubmed">23728087</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Murtha&#x2010;Lemekhova 2022 {published data only}</Title><Reference><Citation>Murtha-Lemekhova A, Fuchs J, Ritscher E, Hoffmann K. Effect of autotransfusion in HCC surgery on survival and recurrence: a systematic review and meta-analysis. Cancers 2022;14(9):4837. [DOI: ]</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9564172</ArticleId><ArticleId IdType="pubmed">36230760</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Naumenko 2003 {published data only}</Title><Reference><Citation>Naumenko SE, Pokrovskii MG, Belavin AS, Kim SF. Blood-saving effectiveness of preoperative reservation of autoblood for surgical treatment of ischaemic heart disease. Vestnik khirurgii imeni I. I. Grekova [Grekov's Bulletin of Surgery] 2003;162:59-64.</Citation><ArticleIdList><ArticleId IdType="pubmed">14606149</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>NCT00176657 {published data only}</Title><Reference><Citation>NCT00176657. The use of HEMOBAG to salvage blood after cardiac surgery. clinicaltrials.gov/ct2/show/NCT00176657 First posted: 15 September 2005 (retrospective).</Citation></Reference></ReferenceList><ReferenceList><Title>NCT01435304 {published data only}</Title><Reference><Citation>NCT01435304. The effect of the Hemobag&#xae; ultrafiltration system on blood conservation and coagulation after cardiopulmonary bypass. clinicaltrials.gov/ct2/show/study/NCT01435304 First posted: 16 September 2011 (prospective).</Citation></Reference></ReferenceList><ReferenceList><Title>NCT02338947 {published data only}</Title><Reference><Citation>NCT02338947. Off-pump versus on-pump coronary artery bypass grafting in frail patients (FRAGILE). clinicaltrials.gov/ct2/show/NCT02338947 First posted: 15 January 2015 (prospective).</Citation></Reference></ReferenceList><ReferenceList><Title>NCT02654028 {published data only}</Title><Reference><Citation>NCT02654028. Association between autologous transfusion and recurrence among patients with HCC after resection (AT/HCC). clinicaltrials.gov/ct2/show/study/NCT02654028 First posted: 13 January 2016 (prospective).</Citation></Reference></ReferenceList><ReferenceList><Title>NCT03995160 {published data only}</Title><Reference><Citation>NCT03995160. Influence of closed suction drainage after total knee replacement. clinicaltrials.gov/ct2/show/NCT03995160 First posted: 21 June 2019 (prospective).</Citation></Reference></ReferenceList><ReferenceList><Title>NCT04304287 {published data only}</Title><Reference><Citation>NCT04304287. The benefit of autologous blood transfusion in total hip arthroplasty. clinicaltrials.gov/ct2/show/NCT04304287 First posted: 11 March 2020 (retrospective).</Citation></Reference></ReferenceList><ReferenceList><Title>NCT04588350 {published data only}</Title><Reference><Citation>NCT04588350. Clinical investigation evaluating a new autotransfusion device in cardiac surgery (i-TRANSEP). clinicaltrials.gov/ct2/show/NCT04588350 First posted: 19 October 2020 (retrospective).</Citation></Reference></ReferenceList><ReferenceList><Title>NCT05164406 {published data only}</Title><Reference><Citation>NCT05164406. Impact of blood salvage therapy during oncologic liver surgeries on allogenic transfusion events, survival and recurrence. clinicaltrials.gov/ct2/show/NCT05164406 First posted: 20 December 2021 (retrospective).</Citation></Reference></ReferenceList><ReferenceList><Title>NCT05401175 {published data only}</Title><Reference><Citation>NCT05401175. Application of stored autologous blood transfusion therapy for bone marrow protection. clinicaltrials.gov/ct2/show/NCT05401175 First posted: 2 June 2022 (retrospective).</Citation></Reference></ReferenceList><ReferenceList><Title>NCT05545930 {published data only}</Title><Reference><Citation>NCT05545930. Analysis of red blood cell integrity and efficiency of recovery using a novel surgical sponge-blood recovery device (ProCell): immediate impact. clinicaltrials.gov/ct2/show/NCT05545930 First posted: 19 September 2022 (prospective).</Citation></Reference></ReferenceList><ReferenceList><Title>NTR1589 {published data only}</Title><Reference><Citation>NTR1589. Does have autologous bloodwithdrawal with or without sequestration effect on the usage of allogeneic blood products during heartsurgery? trialsearch.who.int/Trial2.aspx?TrialID=NTR1589 Date of registration: 15 December 2008 (prospective).</Citation></Reference></ReferenceList><ReferenceList><Title>NTR2712 {published data only}</Title><Reference><Citation>NTR2712. Quality assessment of cell saved blood. trialsearch.who.int/Trial2.aspx?TrialID=NTR2712 Date of registration: 25 January 2011 (prospective). [URL: trialregister.nl/trial/2587]</Citation></Reference></ReferenceList><ReferenceList><Title>Nunes 2019 {published data only}</Title><Reference><Citation>Nunes NG, Oliveira JAA, Bezerra FMP, Nascimento VDD, Dumaresq DMH, Patrocinio MCA. Is intraoperative blood cell salvage effective in hip surgery? Revista Brasileira de Ortopedia (Sao Paulo) 2019;54(4):377-81. [DOI: ]</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6702029</ArticleId><ArticleId IdType="pubmed">31435101</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Quispe&#x2010;Fern&#xe1;ndez 2020 {published data only}</Title><Reference><Citation>Quispe-Fern&#xe1;ndez LA, Carrillo-Gonz&#xe1;lez ML, Guti&#xe9;rrez-Ospina A, G&#xf3;mez Leandro II. Blood products with autologous transfusion versus allogeneic transfusion in cardiac surgery patients. Revista Medica del Instituto Mexicano del Seguro Social 2020;58(4):417-27.</Citation><ArticleIdList><ArticleId IdType="pubmed">34543547</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Santiago&#x2010;Lopez 2021 {published data only}</Title><Reference><Citation>Santiago-Lopez J, Leon-Ramirez V, Barragan-Zamora JA, Merino-Machuca YA. Effect of the use of operative blood salvage on the pulmonary gas exchange in patients undergoing cardiac surgery [Efecto del uso del recuperador celular en el intercambio gaseoso en pacientes sometidos a cirug&#xed;a card&#xed;aca]. Revista Mexicana de Anestesiologia 2021;44(3):173-7. [DOI: ]</Citation></Reference></ReferenceList><ReferenceList><Title>Schmidt 1997 {published data only}</Title><Reference><Citation>Schmidt H, Lund JO, Nielsen SL. Autotransfused shed mediastinal blood has normal erythrocyte survival. Annals of Thoracic Surgery 1996;62(1):105-8.</Citation><ArticleIdList><ArticleId IdType="pubmed">8678627</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Sirvinskas 2007 {published data only}</Title><Reference><Citation>Sirvinskas E, Veikutiene A, Benetis R, Grybauskas P, Andrejaitiene J, Veikutis V, et al. Influence of early re-infusion of autologous shed mediastinal blood on clinical outcome after cardiac surgery. Perfusion 2007;22(5):345-52.</Citation><ArticleIdList><ArticleId IdType="pubmed">18416221</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Slagis 1991 {published data only}</Title><Reference><Citation>Slagis SV, Benjamin JB, Volz RG, Giordano GF. Postoperative blood salvage in total hip and knee arthroplasty. A randomised controlled trial. Journal of Bone and Joint Surgery. British Volume 1991;73(4):591-4.</Citation><ArticleIdList><ArticleId IdType="pubmed">1906472</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Soliman 2022 {published data only}</Title><Reference><Citation>Soliman R, Saad D, Abukhudair W, Abdeldayem S. The neurocognitive outcomes of hemodilution in adult patients undergoing coronary artery bypass grafting using cardiopulmonary bypass. Annals of Cardiac Anaesthesia 2022;25(2):133-40. [DOI: ] [PMID: ]</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9244259</ArticleId><ArticleId IdType="pubmed">35417957</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Sridhar 2019 {published data only}</Title><Reference><Citation>Sridhar S, Abdelmonem M. Prospective study comparing usage of closed-suction drains in elective total hip replacement (THR) procedures at an NHS district general hospital. In: Soci&#xe9;t&#xe9; Internationale de Chirurgie Orthop&#xe9;dique et de Traumatologie (SICOT) 40th Orthopaedic World Congress. 2019.</Citation></Reference></ReferenceList><ReferenceList><Title>Starlinger 2016 {published data only}</Title><Reference><Citation>Starlinger J, Schmidt R, Machold W. Post-operative retransfusion of unwashed filtered shed blood reduces allogenic blood demand in hip hemiarthroplasty in traumatic femoral neck fractures-a prospective randomized trial. International Orthopaedics 2016;40(12):2575-9. [DOI: ] [PMID: ]</Citation><ArticleIdList><ArticleId IdType="pubmed">26932780</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Tachias 2022 {published data only}</Title><Reference><Citation>Tachias F, Samara E, Petrou A, Karakosta A, Siminelakis S, Apostolakis E, et al. The effect of cell salvage on bleeding and transfusion needs in cardiac surgery. Anesthesiology Research and Practice 2022;2022:Article ID 3993452. [DOI: ]</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9458370</ArticleId><ArticleId IdType="pubmed">36092853</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Tempe 1996 {published data only}</Title><Reference><Citation>Tempe D, Bajwa R, Cooper A, Nag B, Tomar AS, Khanna SK, et al. Blood conservation in small adults undergoing valve surgery. Journal of Cardiothoracic and Vascular Anesthesia 1996;10(4):502-6.</Citation><ArticleIdList><ArticleId IdType="pubmed">8776645</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Tempe 2001 {published data only}</Title><Reference><Citation>Tempe DK, Banerjee A, Virmani S, Mehta N, Panwar S, Tomar AS, et al. Comparison of the effects of a cell saver and low dose aprotinin on blood loss and homologous blood usage in patients undergoing valve surgery. Journal of Cardiothoracic and Vascular Anesthesia 2001;15(3):326-30.</Citation><ArticleIdList><ArticleId IdType="pubmed">11426363</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Trubel 1995 {published data only}</Title><Reference><Citation>Trubel W, Gunen E, Wuppinger G, Tschernko E, Gunen-Frank A, Staudacher M, et al. Recovery of intraoperatively shed blood in aortoiliac surgery: comparison of cell washing with simple filtration. Thoracic and Cardiovascular Surgeon 1995;43(3):165-70.</Citation><ArticleIdList><ArticleId IdType="pubmed">7570569</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Ubee 2010 {published data only}</Title><Reference><Citation>Ubee SS, Manikandan R, Gudimetla AR, Singh G. Cost benefits of intraoperative cell salvage in radical cystectomy. Indian Journal of Urology 2010;26(2):196-9. [DOI: 10.4103/0970-1591.65386]</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/0970-1591.65386</ArticleId><ArticleId IdType="pmc">PMC2938542</ArticleId><ArticleId IdType="pubmed">20877596</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Ulrich 2014 {published data only}</Title><Reference><Citation>Ulrich C, Bauer A, Eberle T, Schaarschmidt J, Lucy J, Hausmann H. Effects of cell salvaged and directly retransfused mediastinal shed blood on the postoperative competency of the coagulation system after coronary artery bypass graft surgery. Interactive Cardiovascular and Thoracic Surgery 2014;19 (4):S719 (Abstract no. 005). [DOI: 10.1093/icvts/ivu292]</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/icvts/ivu292</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Vertrees 1996 {published data only}</Title><Reference><Citation>Vertrees RA, Conti VR, Lick SD, Zwischenberger JB, McDaniel LB, Shulman G. Adverse effects of postoperative infusion of shed mediastinal blood. Annals of Thoracic Surgery 1996;62(3):717-23.</Citation><ArticleIdList><ArticleId IdType="pubmed">8783998</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Vonk 2012 {published data only}</Title><Reference><Citation>Vonk AB, Muntajit W, Bhagirath P, Barneveld LJ, Romijn JW, Vroege R, et al. Residual blood processing by centrifugation, cell salvage or ultrafiltration in cardiac surgery: effects on clinical hemostatic and ex-vivo rheological parameters. Blood Coagulation &amp; Fibrinolysis 2012;23(7):622-8. [DOI: ]</Citation><ArticleIdList><ArticleId IdType="pubmed">22828598</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Wang 2012 {published data only}</Title><Reference><Citation>Wang X, Ji B, Zhang Y, Zhu X, Liu J, Long C, et al. Comparison of the effects of three cell saver devices on erythrocyte function during cardiopulmonary bypass procedure - a pilot study. Artificial Organs 2012;36(10):931-5. [DOI: ]</Citation><ArticleIdList><ArticleId IdType="pubmed">22835059</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang X. Comparison of the effects of three autotransfusion devices on erythrocyte function and clinical indicator during cardiopulmonary bypass procedure. Cardiology 2012;123 (Suppl 1):[no pagination]. [DOI: 10.1159/000341270]</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000341270</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Wang 2022 {published data only}</Title><Reference><Citation>Wang Z, Li S, Jia Y, Liu M, Yang K, Sui M, et al. Clinical prognosis of intraoperative blood salvage autotransfusion in liver transplantation for hepatocellular carcinoma: A systematic review and meta-analysis. Frontiers in Oncology 2022;12:985281. [DOI: ]</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9622948</ArticleId><ArticleId IdType="pubmed">36330502</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Weltert 2013 {published data only}</Title><Reference><Citation>Weltert L, Nardella S, Rondinelli MB, Pierelli L, De Paulis R. Reduction of allogeneic red blood cell usage during cardiac surgery by an integrated intra- and postoperative blood salvage strategy: results of a randomized comparison. Transfusion 2013;53(4):790-7. [DOI: ]</Citation><ArticleIdList><ArticleId IdType="pubmed">22882381</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Whitlock 2013 {published data only}</Title><Reference><Citation>NCT01173822. Processed residual pump blood in cardiac surgery: the PRBC trial (PRBC). clinicaltrials.gov/ct2/show/NCT01173822 First posted: 2 August 2010 (retrospective).</Citation></Reference><Reference><Citation>Whitlock R, Mathew J, Eikelboom J, Al-Saleh AM, Yuan F, Teoh K. Processed residual pump blood in cardiac surgery: the Processed Residual Blood in Cardiac surgery trial. Transfusion 2013;53(7):1487-92. [DOI: 10.1111/j.1537-2995.2012.03958.x.] [PMID: ]</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1537-2995.2012.03958.x.</ArticleId><ArticleId IdType="pubmed">23176311</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Wong 2002 {published data only}</Title><Reference><Citation>Wong JCL, Torella F, Haynes SL, Dalrymple K, Mortimer AJ, McCollum CN, on behalf of ATIS investigators. Autologous versus allogeneic transfusion in aortic surgery: a multicenter randomized clinical trial. Annals of Surgery 2002;235(1):145-51.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1422408</ArticleId><ArticleId IdType="pubmed">11753054</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Wu 2019 {published data only}</Title><Reference><Citation>Wu X, Ma X, Feng H, Huo J, Xing Z, Chen C, et al. Application of autologous blood transfusion in spine surgery and its influence on hemorheology and inflammatory factors. International Journal of Clinical and Experimental Medicine 2019;12(8):10579-87.</Citation></Reference></ReferenceList><ReferenceList><Title>Xing 2014 {published data only}</Title><Reference><Citation>Xing YL, Wang YC. Influence of autologous and homologous blood transfusion on interleukins and tumor necrosis factor-alpha in peri-operative patients with esophageal cancer. Asian Pacific Journal of Cancer Prevention: APJCP 2014;15(18):7831-4. [DOI: ]</Citation><ArticleIdList><ArticleId IdType="pubmed">25292072</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Zacharopoulos 2007 {published data only}</Title><Reference><Citation>Zacharopoulos A, Apostolopoulos A, Kyriakidis A. The effectiveness of reinfusion after total knee replacement. A prospective randomised controlled study. International Orthopaedics 2007;31(3):303-8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2267590</ArticleId><ArticleId IdType="pubmed">16810542</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Zacharowski 2022 {published data only}</Title><Reference><Citation>Zacharowski K, Zoller H, Steinbicker AU. Patient blood management and patient safety. Current Opinion in Anaesthesiology 2022;35(6):733-7. [DOI: 10.1097/ACO.0000000000001196]</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/ACO.0000000000001196</ArticleId><ArticleId IdType="pubmed">36194140</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Zhou 2014 {published data only}</Title><Reference><Citation>Zhou LW, Li MQ, Wang XS, Wu Y, Ye F, Ye X. Application of controlled hypotension combined with autotransfusion in spinal orthomorphia. Anesthesia: Essays and Researches 2014;8(2):145-9. [DOI: ]</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4173619</ArticleId><ArticleId IdType="pubmed">25886217</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Zhou 2020 {published data only}</Title><Reference><Citation>Zhou XY, Xu LF, Chang X, Sun L, Guo Z. Application of autologous platelet-rich plasma separation in cardiac valve replacement: a random clinical trial. Zhonghua wai ke za zhi [Chinese Journal of Surgery] 2020;58(12):924-8. [DOI: 10.3760/cma.j.cn112139-20191231-00647] [PMID: ]</Citation><ArticleIdList><ArticleId IdType="doi">10.3760/cma.j.cn112139-20191231-00647</ArticleId><ArticleId IdType="pubmed">33249810</ArticleId></ArticleIdList></Reference></ReferenceList></ReferenceList><ReferenceList><Title>References to studies awaiting assessment</Title><ReferenceList><Title>Aghdaii 2012 {published data only (unpublished sought but not used)}</Title><Reference><Citation>Aghdaii N, Kabiri M, Yazdanian F, Ghaffarinejad MH. Effect of retransfusion of heparin remaining in the salvaged blood on postoperative blood loss in coronary artery bypass grafting: comparison with homologous blood transfusion. Iranian Heart Journal 2012;13(2):24-34.</Citation></Reference></ReferenceList><ReferenceList><Title>Bell 1992 {published data only}</Title><Reference><Citation>Bell K, Stott K, Sinclair CJ, Walker WS, Gillon J. A controlled trial of intra-operative autologous transfusion in cardiothoracic surgery measuring effect on transfusion requirements and clinical outcome. Transfusion Medicine 1992;2(4):295-300. [DOI: ] [PMID: ]</Citation><ArticleIdList><ArticleId IdType="pubmed">1285042</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Bouboulis 1994 {published data only}</Title><Reference><Citation>Bouboulis N, Kardara M, Kesteven PJ, Jayakrishnan AG. Autotransfusion after coronary artery bypass surgery: is there any benefit? Journal of Cardiac Surgery 1994;9(3):314-21.</Citation><ArticleIdList><ArticleId IdType="pubmed">8054726</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Cavolli 2011 {published data only}</Title><Reference><Citation>Cavolli R, Uymaz B, Memishaj S, Eren NT. Cell saver in off-pump surgery. Heart Surgery Forum 2011;1:s35.</Citation></Reference></ReferenceList><ReferenceList><Title>ChiCTR&#x2010;IOR&#x2010;17010508 {published data only}</Title><Reference><Citation>ChiCTR-IOR-17010508. Perioperative lung protection of leucocyte filter with autologous blood cell salvage technology for elderly patients undergoing spinal surgery. www.chictr.org.cn/showprojen.aspx?proj=17884 Date of registration: 24 January 2017 (prospective).</Citation></Reference></ReferenceList><ReferenceList><Title>Damgaard 2010 {published data only}</Title><Reference><Citation>Damgaard S, Nielsen CH, Andersen LW, Bendtzen K, Tvede M, Steinbr&#xfc;chel DA. Cell saver for on-pump coronary operations reduces systemic inflammatory markers: a randomized trial. Annals of Thoracic Surgery 2010;89:1511-17.</Citation><ArticleIdList><ArticleId IdType="pubmed">20417770</ArticleId></ArticleIdList></Reference><Reference><Citation>NCT00159926. Cleansing of suction blood in cardiac surgery for reduced inflammatory response. www.clinicaltrials.gov/ct2/show/NCT00159926 First posted: 12 September 2005 (retrospective).</Citation></Reference></ReferenceList><ReferenceList><Title>Dietrich 1989 {published data only}</Title><Reference><Citation>Dietrich W, Barankay A, Dilthey G, Mitto HP, Richter JA. Reduction of blood utilization during myocardial revascularization. Journal of Thoracic and Cardiovascular Surgery 1989;97(2):213-9.</Citation><ArticleIdList><ArticleId IdType="pubmed">2783753</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Fragnito 1995 {published data only}</Title><Reference><Citation>Fragnito C, Beghi C, Cavozza C, Saccani S, Contini SA, Barboso G. Autotransfusion of the blood drained from mediastinum in the course of myocardial revascularization. Acta Bio Medica: Atenei Parmensis 1995;66(5):195-201.</Citation><ArticleIdList><ArticleId IdType="pubmed">8928582</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>G&#xfc;zel 2016 {published data only}</Title><Reference><Citation>G&#xfc;zel Y, G&#xfc;rcan OT, G&#xf6;lge UH, D&#xfc;lgero&#x11f;lu TC, Metineren H. Topical tranexamic acid versus autotransfusion after total knee arthroplasty. Journal of Orthopaedic Surgery 2016;24(2):179-82. [DOI: ] [PMID: ]</Citation><ArticleIdList><ArticleId IdType="pubmed">27574259</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>ISRCTN24531848 {published data only}</Title><Reference><Citation>ISRCTN24531848. Blood transfusion in lower limb arthroplasty: the safe and economical future. www.isrctn.com/ISRCTN24531848 Submission date: 12 September 2003 (retrospective). [DOI: 10.1186/ISRCTN24531848]</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/ISRCTN24531848</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>ISRCTN55488814 {published data only}</Title><Reference><Citation>ISRCTN55488814. Reduction of allogenic blood transfusion and increased activation of coagulation by re-infusion of post-operative autologous wound blood in patients undergoing total knee and total hip replacement. www.isrctn.com/ISRCTN55488814 Submission date 10 October 2011; registration date 12 March 2012 (retrospective). [DOI: 10.1186/ISRCTN55488814]</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/ISRCTN55488814</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Lei 2022 {published data only}</Title><Reference><Citation>Lei B, Guo M, Deng X, He S, Lu X, Wang Y et al. Intraoperative cell salvage as an effective intervention for postpartum hemorrhage- evidence from a prospective randomized controlled trial. Frontiers in Immunology 2022;13:953334. [DOI: ]</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9589269</ArticleId><ArticleId IdType="pubmed">36300123</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Liang 2015 {published data only}</Title><Reference><Citation>Liang J, Shen J, Chua S, Fan Y, Zhai J, Feng B, et al. Does intraoperative cell salvage system effectively decrease the need for allogeneic transfusions in scoliotic patients undergoing posterior spinal fusion? A prospective randomized study. European Spine Journal 2015;24(2):270-5. [DOI: ]</Citation><ArticleIdList><ArticleId IdType="pubmed">24682378</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Liu 2020 {published data only}</Title><Reference><Citation>ChiCTR-ICC-15007096. Intraoperative cell salvage in high bleeding risk cesarean section: a prospective randomized controlled multi-center clinical trial. www.chictr.org.cn/showproj.aspx?proj=11283 Date of registration: 18 September 2015 (prospective).</Citation></Reference><Reference><Citation>Liu Y, Li X, Che X, Zhao G, Xu M. Intraoperative cell salvage for obstetrics: a prospective randomized controlled clinical trial. BMC Pregnancy and Childbirth 2020;20(1):452. [DOI: ]</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7412832</ArticleId><ArticleId IdType="pubmed">32767971</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Martin 2009 {published data only}</Title><Reference><Citation>Martin A, Prenn M, Wohlgenannt O, Strempel A. Blood transfusion from reinfusion systems in TKA - comparison of different wound drainage techniques. Journal of Bone and Joint Surgery. British volume (Proceedings) 2009;91-B (Suppl I):5-b. [URL: online.boneandjoint.org.uk/doi/abs/10.1302/0301-620X.91BSUPP_I.0910005b]</Citation></Reference></ReferenceList><ReferenceList><Title>Matkovic 2010 {published data only}</Title><Reference><Citation>Matkovic M, Vuksanovic M, Putnik S. The efficacy of intraoperative cell salvage during coronary artery bypass grafting. European Journal of Medical Research 2010;1:223 (ESC-ID: 1242).</Citation></Reference></ReferenceList><ReferenceList><Title>Morgenschweis 2011 {published data only}</Title><Reference><Citation>Morgenschweis K, Gierth T, Hering R. Effects of cell saver autologous blood transfusion on allogeneic blood transfusion in patients undergoing primary hip and knee replacement. Transfusion Alternatives in Transfusion Medicine 2011;12(1):Poster no. 26. [DOI: 10.1111/j.1778-428X.2011.01149.x]</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1778-428X.2011.01149.x</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Murphy 2004 {published data only}</Title><Reference><Citation>Murphy GJ, Allen SM, Unsworth-White J, Lewis CT, Dalrymple-Hay MJ. Safety and efficacy of perioperative cell salvage and autotransfusion after coronary artery bypass grafting: a randomized trial. Annals of Thoracic Surgery 2004;77(5):1553-9.</Citation><ArticleIdList><ArticleId IdType="pubmed">15111142</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Narula 2015 {published data only}</Title><Reference><Citation>Narula J, Kiran U, Kapoor PM, Choudhury M, Chowdhury UK. Intra-operative autologous donation regulates increase in thoracic fluid content in patients undergoing heart valve replacement on cardiopulmonary bypass. Vox Sanguinis 2015;109 (Suppl 1):373-4.</Citation></Reference></ReferenceList><ReferenceList><Title>NCT00950547 {published data only}</Title><Reference><Citation>NCT00950547. ICU cell saver to reduce blood transfusions in cardiac. www.clinicaltrials.gov/ct2/show/NCT00950547 First posted: 31 July 2009 (prospective).</Citation></Reference></ReferenceList><ReferenceList><Title>NCT01468129 {published data only}</Title><Reference><Citation>NCT01468129. Cell saver use in bilateral total hip Arthroplasty (THA). clinicaltrials.gov/ct2/show/NCT01468129 First posted: 9 November 2011 (prospective).</Citation></Reference></ReferenceList><ReferenceList><Title>NCT02058134 {published data only}</Title><Reference><Citation>NCT02058134. The CardioPAT project: a randomized trial. clinicaltrials.gov/ct2/show/NCT02058134 First posted: 7 February 2014 (retrospective).</Citation></Reference></ReferenceList><ReferenceList><Title>Rainaldi 1998 {published data only}</Title><Reference><Citation>Rainaldi MP, Tazzari PL, Scagliarini G, Borghi B, Conte R. Blood salvage during caesarean section. British Journal of Anaesthesia 1998;80(2):195-8. [DOI: 10.1093/bja/80.2.195] [PMID: ]</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bja/80.2.195</ArticleId><ArticleId IdType="pubmed">9602584</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Ritter 1994 {published data only}</Title><Reference><Citation>Ritter MA, Keating EM, Faris PM. Closed wound drainage in total hip or total knee replacement. A prospective, randomized study. Journal of Bone and Joint Surgery. American Volume 1994;76(1):35-8.</Citation><ArticleIdList><ArticleId IdType="pubmed">8288663</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Shen 2013 {published data only}</Title><Reference><Citation>Shen J, Liang J, Chua S. Does intraoperative cell salvage system effectively decrease the need for allogeneic transfusions in scoliotic patients undergoing posterior spinal fusion: a prospective randomized study. European Spine Journal 2013;1:s758-s759 (P101). [DOI: 10.1007/s00586-013-2947-6]</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00586-013-2947-6</ArticleId><ArticleId IdType="pubmed">24682378</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Simpson 1994 {published data only}</Title><Reference><Citation>Simpson MB, Murphy KP, Chambers HG, Bucknell AL. The effect of postoperative wound drainage reinfusion in reducing the need for blood transfusions in elective total joint arthroplasty: a prospective, randomized study. Orthopedics 1994;17(2):133-7.</Citation><ArticleIdList><ArticleId IdType="pubmed">8190677</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Sintes 2009 {published data only}</Title><Reference><Citation>Sintes D, Pijoan M, Mansilla R, Esteva E, Martinez L. The quality and safety of reinfused drainage blood after total knee arthroplasty. European Journal of Anaesthesiology 2009;45:85.</Citation></Reference></ReferenceList><ReferenceList><Title>Skoura 1997 {published data only}</Title><Reference><Citation>Skoura H, Anastasiou E, Moshou A, Katsioulas A, Kostaki S. Value of autologous blood for intra-operative massive bleeding. European Journal of Anaesthesiology 1997;14(1):74-5.</Citation></Reference></ReferenceList><ReferenceList><Title>Srndic 2014 {published data only}</Title><Reference><Citation>Srndic E, Kiessling AH, Guo F, Keller H, Beiras-Fernandez A, et al. Coronary artery revascularization with a minimized extracorporeal circulation system (MECC): the inflammatory response in comparison to conventional cardiopulmonary bypass. Thoracic and Cardiovascular Surgeon 2014;62 (Suppl 1):[no pagination]. [DOI: 10.1055/s-0034-1367384]</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/s-0034-1367384</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Stamenic 2009 {published data only}</Title><Reference><Citation>Stamenic S, Mitkovic M, Stanojlovic M, Jevtic R, Velickovic K. Postoperative autotransfusion in total hip arthroplasty. European Journal of Anaesthesiology 2009;45:87 (6AP2-9).</Citation></Reference></ReferenceList><ReferenceList><Title>Washington 2009 {published data only}</Title><Reference><Citation>Washington B, Liakonis C, Pagnanelli R, Salerno C, Barnett L, Lonquist J, et al. Post-operative cell salvage reduces allogeneic RBC transfusion rate in patients undergoing cardiovascular surgery. Transfusion 2009;49(10):2257-8.</Citation></Reference></ReferenceList><ReferenceList><Title>Wiefferink 2007 {published data only}</Title><Reference><Citation>Wiefferink A, Weerwind PW, Heerde W, Teerenstra S, Noyez L, Pauw BE, et al. Autotransfusion management during and after cardiopulmonary bypass alters fibrin degradation and transfusion requirements. Journal of Extra-Corporeal Technology 2007;39(2):66-70.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4680668</ArticleId><ArticleId IdType="pubmed">17672185</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Yu 2022 {published data only}</Title><Reference><Citation>Yu YF, Cao YD. Effect of intraoperative cell rescue on bleeding related indexes after cesarean section. World Journal of Clinical Cases 2022;10(8):2439-46. [DOI: ]</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8968603</ArticleId><ArticleId IdType="pubmed">35434071</ArticleId></ArticleIdList></Reference></ReferenceList></ReferenceList><ReferenceList><Title>References to ongoing studies</Title><ReferenceList><Title>ChiCTR1800018118 {published data only}</Title><Reference><Citation>ChiCTR1800018118. A multicenter prospective randomized controlled trial for the safety of intraoperative salvaged blood in the spinal metastasis surgery. www.chictr.org.cn/showprojen.aspx?proj=30606 Date of registration: 31 August 2018 (prospective).</Citation></Reference></ReferenceList><ReferenceList><Title>DRKS00021914 {published data only}</Title><Reference><Citation>DRKS00021914. Haemodynamic relevance of cardiotomy suction blood for the systemic vascular resistance and requirement of catecholamines. drks.de/search/en/trial/DRKS00021914 Date of registration in DRKS: 04 June 2020 (retrospective).</Citation></Reference></ReferenceList><ReferenceList><Title>NCT02595385 (CONSERVE) {published data only}</Title><Reference><Citation>NCT02595385. Blood conservation in adult cardiac surgery, what is the way forward in today's practice? (CONSERVE). clinicaltrials.gov/ct2/show/study/NCT02595385 First posted: 3 November 2015 (retrospective).</Citation></Reference></ReferenceList><ReferenceList><Title>NCT03429790 {published data only}</Title><Reference><Citation>NCT03429790. Cell salvage during Caesarean section (CSCS). clinicaltrials.gov/ct2/show/NCT03429790 First posted: 12 February 2018 (prospective).</Citation></Reference></ReferenceList><ReferenceList><Title>NCT04574128 {published data only}</Title><Reference><Citation>NCT04574128. Retransfusion or not of cardiotomy blood. www.clinicaltrials.gov/ct2/show/NCT04574128 First posted: 5 October 2020 (prospective).</Citation></Reference></ReferenceList><ReferenceList><Title>NCT04922307 (RESTRICT) {published data only}</Title><Reference><Citation>NCT04922307. Reduction of allogenic blood transfusion in locally advanced kidney cancer (RESTRICT). www.clinicaltrials.gov/ct2/show/NCT04922307 First posted: 10 June 10 2021 (prospective).</Citation></Reference></ReferenceList><ReferenceList><Title>NCT05612477 {published data only}</Title><Reference><Citation>NCT05612477. Blood salvage in orthotopic liver transplantation with HCC (SOLT). clinicaltrials.gov/ct2/show/NCT05612477 First posted: 10 November 2022 (prospective).</Citation></Reference></ReferenceList></ReferenceList><ReferenceList><Title>Additional references</Title><ReferenceList><Title>Ashworth 2010</Title><Reference><Citation>Ashworth A, Klein AA. Cell salvage as part of a blood conservation strategy in anaesthesia. British Journal of Anaesthesia 2010;105(4):401-16. [DOI: 10.1093/bja/aeq244]</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bja/aeq244</ArticleId><ArticleId IdType="pubmed">20802228</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Bellamy 2021</Title><Reference><Citation>Bellamy M, Narayan S, Davies J, Poles D, Milser E, Carter-Graham S, et al. UK Serious Hazards of Transfusion (SHOT) Annual Report 2021; November 2021. Available at: www.shotuk.org/wp-content/uploads/myimages/SHOT-REPORT-2021-FINAL-bookmarked-V3-November.pdf (accessed 25 March 2023).</Citation></Reference></ReferenceList><ReferenceList><Title>Bosco 2021</Title><Reference><Citation>Bosco E, Hsueh L, McConeghy KW, Gravenstein S, Saade E. Major adverse cardiovascular event definitions used in observational analysis of administrative databases: a systematic review. BMC Medical Research Methodology 2021;21:241. [DOI: 10.1186/s12874-021-01440-5]</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12874-021-01440-5</ArticleId><ArticleId IdType="pmc">PMC8571870</ArticleId><ArticleId IdType="pubmed">34742250</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Boutron 2022</Title><Reference><Citation>Boutron I, Page MJ, Higgins JP, Altman DG, Lundh A, Hr&#xf3;bjartsson A. Chapter 7: Considering bias and conflicts of interest among the included studies. In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 6.3 (updated February 2022). Available from handbook.cochrane.org.</Citation></Reference></ReferenceList><ReferenceList><Title>Broughton 2021</Title><Reference><Citation>Broughton SL, Wilkinson J, Bero L. When beauty is but skin deep: dealing with problematic studies in systematic reviews (Editorial). Cochrane Database of Systematic Reviews 2021;6:ED000152. [DOI: 10.1002/14651858.ED000152] [PMID: ]</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/14651858.ED000152</ArticleId><ArticleId IdType="pmc">PMC10285350</ArticleId><ArticleId IdType="pubmed">34081324</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Campbell 2012</Title><Reference><Citation>Campbell JP, Mackenzie MJ, Yentis SM, Sooranna SR, Johnson MR. An evaluation of the ability of leucocyte depletion filters to remove components of amniotic fluid. Anaesthesia 2012;67(10):1152-7. [DOI: 10.1111/j.1365-2044.2012.07247.x]</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1365-2044.2012.07247.x</ArticleId><ArticleId IdType="pubmed">22804692</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Carlisle 2021</Title><Reference><Citation>Carlisle JB. False individual patient data and zombie randomised controlled trials submitted to Anaesthesia. Anaesthesia 2021;76(4):472-9. [DOI: 10.1111/anae.15263]</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/anae.15263</ArticleId><ArticleId IdType="pubmed">33040331</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Carson 2021</Title><Reference><Citation>Carson JL, Stanworth SJ, Dennis JA, Trivella M, Roubinian N, Fergusson DA, et al. Transfusion thresholds for guiding red blood cell transfusion. Cochrane Database of Systematic Reviews 2021, Issue 12. Art. No: CD002042. [DOI: 10.1002/14651858.CD002042.pub5]</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/14651858.CD002042.pub5</ArticleId><ArticleId IdType="pmc">PMC8691808</ArticleId><ArticleId IdType="pubmed">34932836</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Catling 2008</Title><Reference><Citation>Catling S, Williams S, Freites O, Rees M, Davies C, Hopkins L. Use of a leucocyte filter to remove tumour cells from intra-operative cell salvage blood. Anaesthesia 2008;63(12):1332-8. [DOI: 10.1111/j.1365-2044.2008.05637.x]</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1365-2044.2008.05637.x</ArticleId><ArticleId IdType="pubmed">19032302</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Cochrane Policy 2020</Title><Reference><Citation>Cochrane Editors. Managing potentially problematic studies. Cochrane Database of Systematic Reviews: Editorial Policies 2020 (www.cochranelibrary.com/cdsr/editorial-policies#problematic-studies) (accessed 26 March 2023).</Citation></Reference></ReferenceList><ReferenceList><Title>Deeks 2022</Title><Reference><Citation>Deeks JJ, Higgins JP, Altman DG (editors). Chapter 10: Analysing data and undertaking meta-analyses. In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 6.3 (updated February 2022). Available from handbook.cochrane.org.</Citation></Reference></ReferenceList><ReferenceList><Title>Dobbs 2021</Title><Reference><Citation>Dobbs TD, Gibson JAG, Fowler AJ, Abbott TE, Shahid T, Torabi F, et al. Surgical activity in England and Wales during the COVID-19 pandemic: a nationwide observational cohort study. British Journal of Anaesthesia 2021;127(2):196-204. [DOI: 10.1016/j.bja.2021.05.001]</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bja.2021.05.001</ArticleId><ArticleId IdType="pmc">PMC8277602</ArticleId><ArticleId IdType="pubmed">34148732</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Esper 2011</Title><Reference><Citation>Esper SA, Waters JH. Intra-operative cell salvage: a fresh look at the indications and contraindications. Blood Transfusion 2011;9(2):139-47. [DOI: 10.2450/2011.0081-10]</Citation><ArticleIdList><ArticleId IdType="doi">10.2450/2011.0081-10</ArticleId><ArticleId IdType="pmc">PMC3096856</ArticleId><ArticleId IdType="pubmed">21251468</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>EU Clinical Trial Directive 2001</Title><Reference><Citation>European Commission. Clinical trials - Directive 2001/20/EC. health.ec.europa.eu/medicinal-products/clinical-trials/clinical-trials-directive-200120ec_en 2001 (accessed 26 March 2023). [health.ec.europa.eu/medicinal-products/clinical-trials/clinical-trials-directive-200120ec_en#guidelines]</Citation></Reference></ReferenceList><ReferenceList><Title>EU Regulations 2014</Title><Reference><Citation>European Parliament and the Council of the European Union. REGULATION (EU) No 536/2014 OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL of 16 April 2014 on clinical trials on medicinal products for human use, and repealing Directive 2001/20/EC. Official Journal of the European Union, 2014.</Citation></Reference></ReferenceList><ReferenceList><Title>Farrer 1997</Title><Reference><Citation>Farrer A, Spark JI, Scott DJ. Autologous blood transfusion: the benefits to the patient undergoing abdominal aortic aneurysm repair. Journal of Vascular Nursing 1997;15(4):111-5. [DOI: 10.1016/S1062-0303(97)90028-5]</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1062-0303(97)90028-5</ArticleId><ArticleId IdType="pubmed">9429379</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Ferraris 2011</Title><Reference><Citation>Ferraris VA, Brown JR, Despotis GJ, Hammon JW, Reece TB, Saha SP, et al. 2011 update to the Society of Thoracic Surgeons and the Society of Cardiovascular Anesthesiologists blood conservation clinical practice guidelines. Annals of Thoracic Surgery 2011;91(3):944-82. [DOI: 10.1016/j.athoracsur.2010.11.078]</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.athoracsur.2010.11.078</ArticleId><ArticleId IdType="pubmed">21353044</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Fong 2007</Title><Reference><Citation>Fong J, Gurewitsch ED, Kang HJ, Kump, L, Mack PF, Birnbach DJ. An analysis of transfusion practice and the role of intraoperative red blood cell salvage during cesarean delivery. Anesthesia and Analgesia 2007;104(3):666-72. [DOI: 10.1213/01.ane.0000253232.45403.e5]</Citation><ArticleIdList><ArticleId IdType="doi">10.1213/01.ane.0000253232.45403.e5</ArticleId><ArticleId IdType="pubmed">17312227</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Fowler 2015</Title><Reference><Citation>Fowler AJ, Ahmad T, Phull MK, Allard S, Gillies MA, Pearse RM. Meta-analysis of the association between preoperative anaemia and mortality after surgery. British Journal of Surgery 2015;102:1314&#x2013;24. [DOI: 10.1002/bjs.9861]</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/bjs.9861</ArticleId><ArticleId IdType="pubmed">26349842</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Frietsch 2020</Title><Reference><Citation>Frietsch T, Steinbicker AU, Hackbusch M, Nguyen XD, Dietrich G. Safety of cell salvage in tumor surgery: systematic review with meta-analysis. Anaesthetist 2020;69(5):331-51. [DOI: 10.1007/s00101-020-00751-4]</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00101-020-00751-4</ArticleId><ArticleId IdType="pubmed">32221621</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Goel 2018</Title><Reference><Citation>Goel R, Buckley P, Sterbis E, Parvizi J. Patients with infected total hip arthroplasty undergoing 2-stage exchange arthroplasty experience massive blood loss. Journal of Arthroplasty 2018;33(11):3547-50. [DOI: 10.1016/j.arth.2018.06.032]</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.arth.2018.06.032</ArticleId><ArticleId IdType="pubmed">30100135</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Goel 2019</Title><Reference><Citation>Goel R, Shi PA. Chapter 59: Patient blood management. In: Transfusion Medicine and Haemostasis: Clinical and Laboratory Aspects. 3rd edition. Elsevier, 2019:371-8. [DOI: 10.1016/B978-0-12-813726-0.00059-3]</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/B978-0-12-813726-0.00059-3</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>GRADEpro GDT [Computer program]</Title><Reference><Citation>GRADEpro GDT. Hamilton (ON): McMaster University (developed by Evidence Prime), 2015 (version accessed 30 September 2019). Available at gradepro.org.</Citation></Reference></ReferenceList><ReferenceList><Title>Haien 2013</Title><Reference><Citation>Haien Z, Yong J, Baoan M, Mingjun G, Qingyu F. Post-operative auto-transfusion in total hip or knee arthroplasty: a meta-analysis of randomized controlled trials. PLoS One 2013;8(1):e55073. [DOI: 10.1371/journal.pone.0055073]</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0055073</ArticleId><ArticleId IdType="pmc">PMC3555861</ArticleId><ArticleId IdType="pubmed">23372816</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Hibbs 2015</Title><Reference><Citation>Hibbs SP, Nielsen ND, Brunskill S, Dor&#xe9;e C, Yazer MH, Kaufman RM, et al. The impact of electronic decision support on transfusion practice: a systematic review. Transfusion Medicine Reviews 2015;29(1):14-23. [DOI: 10.1016/j.tmrv.2014.10.002]</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tmrv.2014.10.002</ArticleId><ArticleId IdType="pubmed">25535095</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Hicks 2018</Title><Reference><Citation>Hicks KA, Mahaffey KW, Mehran R, Nissen SE, Wiviott SD, Dunn B, et al, on behalf of the Standardized Data Collection for Cardiovascular Trials Initiative (SCTI). 2017 Cardiovascular and Stroke Endpoint Definitions for Clinical Trials. Circulation 2018;137:961-72. [DOI: 10.1161/CIRCULATIONAHA.117.033502] [Originally published27 Feb 2018https://doi.org/10.1161/CIRCULATIONAHA.117.033502]</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.117.033502</ArticleId><ArticleId IdType="pubmed">29483172</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Higgins 2011</Title><Reference><Citation>Higgins JP, Altman DG, G&#xf8;tzsche PC, J&#xfc;ni P, Moher D, Oxman AD et al. The Cochrane Collaboration&#x2019;s tool for assessing risk of bias in randomised trials. BMJ 2011;343:d528. [DOI: 10.1136/bmj.d5928]</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.d5928</ArticleId><ArticleId IdType="pmc">PMC3196245</ArticleId><ArticleId IdType="pubmed">22008217</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Higgins 2017</Title><Reference><Citation>Higgins JP, Altman DG, Sterne JA (editors). Chapter 8: Assessing risk of bias in included studies. In: Higgins JP, Churchill R, Chandler J, Cumpston MS (editors), Cochrane Handbook for Systematic Reviews of Interventions Version 5.2.0 (updated June 2017). Available from www.training.cochrane.org/handbook 2017. [URL: https://training.cochrane.org/handbook/PDF/v5.2/chapter-08]</Citation></Reference></ReferenceList><ReferenceList><Title>Higgins 2022</Title><Reference><Citation>Higgins JP, Eldridge S, Li T (editors). Chapter 23: Including variants on randomized trials. In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 63 (updated February 2022). Available from www.training.cochrane.org/handbook 2022.</Citation></Reference></ReferenceList><ReferenceList><Title>Huet 1999</Title><Reference><Citation>Huet C, Salmi LR, Fergusson D, Koopman-van Gemert AW, Rubens F, Laupacis A. A meta-analysis of the effectiveness of cell salvage to minimize perioperative allogeneic blood transfusion in cardiac and orthopedic surgery. International Study of Perioperative Transfusion (ISPOT) Investigators. Anesthesia and Analgesia 1999;89(4):861-9.</Citation><ArticleIdList><ArticleId IdType="pubmed">10512256</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>ICJME</Title><Reference><Citation>International Committee of Medical Journal Editors (ICJME). Recommendations (Clinical Trials). www.icmje.org/recommendations/browse/publishing-and-editorial-issues/clinical-trial-registration.html accessed 24 March 2023.</Citation></Reference></ReferenceList><ReferenceList><Title>Kim 2017</Title><Reference><Citation>Kim JL, Park J-H, Han S-B, Cho IY, Jang K-M. Allogeneic blood transfusion is a significant risk factor for surgical-site infection following total hip and knee arthroplasty: a meta-analaysis. Journal of Arthroplasty 2017;32(1):320-5. [DOI: 10.1016/j.arth.2016.08.026]</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.arth.2016.08.026</ArticleId><ArticleId IdType="pubmed">27682006</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Kip 2008</Title><Reference><Citation>Kip K, Hollabaugh K, Marroquin OC, Williams DO. The problem with composite end points in cardiovascular studies: the story of major adverse cardiac events and percutaneous coronary intervention. Journal of the American College of Cardiology 2008;51(7):701-7. [DOI: 10.1016/j.jacc.2007.10.034]</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2007.10.034</ArticleId><ArticleId IdType="pubmed">18279733</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Klein 2018</Title><Reference><Citation>Klein AA, Bailey CR, Charlton AJ, Evans E, Guckian-Fisher M, McCrossan R, et al. Association of Anaesthetists guidelines: cell salvage for peri-operative blood conservation 2018. Anaesthesia 2018;73(9):1141-50. [DOI: 10.1111/anae.14331]</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/anae.14331</ArticleId><ArticleId IdType="pubmed">29989144</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Kumar 2016</Title><Reference><Citation>Kumar N, Zaw AS, Khoo BL, Nandi S, Lai Z, Singh G, et al. Intraoperative cell salvage in metastatic spine tumour surgery reduces potential for reinfusion of viable cancer cells. European Spine Journal 2016;25:4008-15. [DOI: 10.1007/s00586-016-4478-4]</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00586-016-4478-4</ArticleId><ArticleId IdType="pubmed">26951173</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Li 2015</Title><Reference><Citation>Li J, Sun SL, Tian JH, Yang K, Liu R, Li J. Cell salvage in emergency trauma surgery. Cochrane Database of Systematic Reviews 2015, Issue 1. Art. No: CD007379. [DOI: 10.1002/14651858.CD007379.pub2] [PMID: ]</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/14651858.CD007379.pub2</ArticleId><ArticleId IdType="pmc">PMC8406788</ArticleId><ArticleId IdType="pubmed">25613473</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Li 2020</Title><Reference><Citation>Li T, Higgins JP, Deeks JJ (editors). Chapter 5: Collecting data. In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 6.3 (updated February 2022). Available from www.training.cochrane.org/handbook 2022.</Citation></Reference></ReferenceList><ReferenceList><Title>Lloyd 2020</Title><Reference><Citation>Lloyd TD, Neal-Smith G, Fennelly J, Claireaux H, Bretherton C, Carr AJ, et al. Peri-operative administration of tranexamic acid in lower limb arthroplasty: a multicentre, prospective cohort study. Anaesthesia 2020;75(8):1050-8. [DOI: 10.1111/anae.15056]</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/anae.15056</ArticleId><ArticleId IdType="pubmed">32500530</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Mack 2004</Title><Reference><Citation>Mack MJ, Pfister A, Bachand D, Emery R, Magee MJ, Connolly M, et al. Comparison of coronary bypass surgery with and without cardiopulmonary bypass in patients with multivessel disease. Journal of Thoracic and Cardiovascular Surgery 2004;127(1):167-73. [DOI: 10.1016/j.jtcvs.2003.08.032]</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jtcvs.2003.08.032</ArticleId><ArticleId IdType="pubmed">14752427</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Meybohm 2016</Title><Reference><Citation>Meybohm P, Choorapoikayil S, Wessels A, Eva H, Zacharowski K, Spahn DR. Washed cell salvage in surgical patients: a review and meta-analysis of prospective randomized trials under PRISMA. Medicine 2016;95(31):e4490. [DOI: 10.1097/MD.0000000000004490]</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MD.0000000000004490</ArticleId><ArticleId IdType="pmc">PMC4979849</ArticleId><ArticleId IdType="pubmed">27495095</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Moher 2009</Title><Reference><Citation>Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Journal of Clinical Epidemiology 2009;62(10):1006-12.</Citation><ArticleIdList><ArticleId IdType="pubmed">19631508</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Moran 1978</Title><Reference><Citation>Moran JM, Babka R, Silberman S, Rice PL, Pifarre R, Sullivan HJ, et al. Immediate centrifugation of oxygenator contents after cardiopulmonary bypass. Journal of Thoracic and Cardiovascular Research 1978;76(4):510-7. [DOI: 10.1016/S0022-5223(19)41081-7]</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0022-5223(19)41081-7</ArticleId><ArticleId IdType="pubmed">703358</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Mueller 2018</Title><Reference><Citation>Mueller MM, Van Remoortel H, Meybohm P, Aranko K, Aubron C, Burger R, et al, on behalf of ICC PBM Frankfurt 2018 Group. Patient Blood Management: recommendations from the 2018 Frankfurt Consensus Conference. Journal of the American Medical Association 2019;321(10):983-97. [DOI: 10.1001/jama.2019.0554]</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2019.0554</ArticleId><ArticleId IdType="pubmed">30860564</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Murphy 2020</Title><Reference><Citation>Murphy M, Metcalf L, Reagon S, Walsh T, Richards T, Pulford C, et al. The James Lind Alliance Blood Transfusion and Blood Donation Priority Setting Partnership. James Lind Alliance (www.jla.nihr.ac.uk/priority-setting-partnerships/blood-transfusion-and-blood-donation/) (accessed prior to 21 August 2023).</Citation></Reference></ReferenceList><ReferenceList><Title>Murphy 2021</Title><Reference><Citation>Murphy M, Uprichard J, Cort J, Estcourt L, Sorour Y, McSporran W, et al. National comparative audit of NICW Quality Standard QS138: national comparative audit of blood transfusion. National Health Service Blood and Transplant; 2022. Available at: hospital.blood.co.uk/audits/national-comparative-audit/reports-grouped-by-year/2021-national-comparative-audit-of-nice-quality-standard-qs138/;(accessed 26 March 2023).</Citation></Reference></ReferenceList><ReferenceList><Title>Musallam 2011</Title><Reference><Citation>Musallam KM, Tamim HM, Richards T, Spahn DR, Rosendaal FR, Habbal A, et al. Preoperative anaemia and postoperative outcomes in non-cardiac surgery: a retrospective cohort study. Lancet 2011;378(9800):1396-407. [DOI: 10.1016/S0140-6736(11)61381-0]</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(11)61381-0</ArticleId><ArticleId IdType="pubmed">21982521</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>NICE 2015</Title><Reference><Citation>National Institute for Health and Clinical Excellence. Section 1.2 Red blood cells. In: Blood Transfusion. NICE guideline NG24; November 2015. Available at: www.nice.org.uk/guidance/ng24/chapter/Recommendations#red-blood-cells-2 (accessed prior to 21 August 2023).</Citation></Reference></ReferenceList><ReferenceList><Title>NICE 2020</Title><Reference><Citation>National Institute for Health and Clinical Excellence. Section 1.4: Tranexamic acid to minimise blood loss. In: Joint replacement (primary): hip, knee and shoulder. NICE guideline 157; June 2020. Available at: www.nice.org.uk/guidance/ng157/chapter/Recommendations#tranexamic-acid-to-minimise-blood-loss (accessed prior to 21 August 2023).</Citation><ArticleIdList><ArticleId IdType="pubmed">32881462</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Palmer 2020a</Title><Reference><Citation>Palmer AJ, Lloyd TD, Gibbs VN, Shah A, Dhiman P, Booth R, et al. The role of intra-operative cell salvage in patient blood management for revision hip arthroplasty: a prospective cohort study. Anaesthesia 2020;75(4):479-86. [DOI: 10.1111/anae.14989]</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/anae.14989</ArticleId><ArticleId IdType="pubmed">32037522</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Palmer 2020b</Title><Reference><Citation>Palmer AJ, Gagn&#xe9; S, Fergusson DA, Murphy MF, Grammatopoulos G. Blood management for elective orthopaedic surgery. Journal of Bone and Joint Surgery American Volume 2020;102(17):1552-64. [DOI: 10.2106/JBJS.19.01417]</Citation><ArticleIdList><ArticleId IdType="doi">10.2106/JBJS.19.01417</ArticleId><ArticleId IdType="pubmed">32558663</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Parker 2007</Title><Reference><Citation>Parker MJ, Livingstone V, Clifton R, McKee A. Closed suction surgical wound drainage after orthopaedic surgery. Cochrane Database of Systematic Reviews 2007;3:CD001825. [DOI: 10.1002/14651858.CD001825.pub2.]</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/14651858.CD001825.pub2.</ArticleId><ArticleId IdType="pmc">PMC8408575</ArticleId><ArticleId IdType="pubmed">17636687</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Poudel 2019</Title><Reference><Citation>Poudel I, Tejpal C, Rashid H, Jahan N. Major adverse cardiovascular events: an inevitable outcome of ST-elevation myocardial infarction? A literature review. Cureus 2019;11(7):e5280. [DOI: 10.7759/cureus.5280]</Citation><ArticleIdList><ArticleId IdType="doi">10.7759/cureus.5280</ArticleId><ArticleId IdType="pmc">PMC6695291</ArticleId><ArticleId IdType="pubmed">31423405</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Rajasekaran 2021</Title><Reference><Citation>Rajasekaran RB, Palmer AJ, Whitwell D, Cosker TD, Pigott D, Zsolt O, et al. The role of intraoperative cell salvage for musculoskeletal sarcoma surgery. Journal of Bone Oncology 2021;30:100390. [DOI: 10.1016/j.jbo.2021.100390]</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jbo.2021.100390</ArticleId><ArticleId IdType="pmc">PMC8458974</ArticleId><ArticleId IdType="pubmed">34589408</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Rasouli 2016</Title><Reference><Citation>Rasouli MR, Maltenfort MG, Erkocak OF, Austin MS, Waters JH, Parvizi J. Blood management after total joint arthroplasty in the United States: 19-year trend analysis. Transfusion 2016;56(5):1112-20. [DOI: 10.1111/trf.13518]</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/trf.13518</ArticleId><ArticleId IdType="pubmed">26898972</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Reed 2022</Title><Reference><Citation>Reed M, Brittain R, Howard P, Lawrence S, Stonadge J, Wilkinson M, et al. UK National Joint Registry 19th Annual Report; 2022. National Joint Registry. Available at: reports.njrcentre.org.uk/Portals/0/PDFdownloads/NJR%2019th%20Annual%20Report%202022.pdf (accessed 25 March 2023).</Citation></Reference></ReferenceList><ReferenceList><Title>Review Manager 2020 [Computer program]</Title><Reference><Citation>Review Manager 5 (RevMan 5). Version 5.4. Copenhagen: The Cochrane Collaboration, 2020.</Citation></Reference></ReferenceList><ReferenceList><Title>Roberts 2015</Title><Reference><Citation>Roberts I, Edwards P, Beecher D, Manno D, Sydenham E. The knowledge system underpinning healthcare is not fit for purpose and must change. BMJ 2015;350:h2463. [DOI: 10.1136/bmj.h2463]</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.h2463</ArticleId><ArticleId IdType="pubmed">26041754</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Rubens 2007</Title><Reference><Citation>Rubens F, Boodhwani M, Mesana T, Wozny D, Wells G, Nathan HJ, Cardiotomy Investigators. The cardiotomy trial: a randomised double-blind study to assess the effect of processing of shed blood during cardiopulmonary bypass on transfusion and neurocognitive function. Circulation 2007;116(11):I-89-I-97. [DOI: 10.1161/CIRCULATIONAHA.106.678987]</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.106.678987</ArticleId><ArticleId IdType="pubmed">17846332</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Saleh 2014</Title><Reference><Citation>Saleh A, Small T, Pillai AL, Schiltz NK, Klika AK, Barsoum WK. Allogenic blood transfusion following total hip arthroplasty: results from the nationwide inpatient sample, 2000 to 2009. Journal of Bone and Joint Surgery, American volume 2014;96(18):1-10. [DOI: 10.2106/JBJS.M.00825]</Citation><ArticleIdList><ArticleId IdType="doi">10.2106/JBJS.M.00825</ArticleId><ArticleId IdType="pmc">PMC4159964</ArticleId><ArticleId IdType="pubmed">25232085</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Sch&#xfc;nemann 2022</Title><Reference><Citation>Sch&#xfc;nemann HJ, Higgins JP, Vist GE, Glasziou P, Akl EA, Skoetz N, et al. Chapter 14: Completing &#x2018;Summary of findings&#x2019; tables and grading the certainty of the evidence. In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 6.3 (updated February 2022). Available from www.cochrane-handbook.org 2022.</Citation></Reference></ReferenceList><ReferenceList><Title>Shah 2020</Title><Reference><Citation>Shah A, Palmer AJ, Klein AA. Strategies to minimize intraoperative blood loss during major surgery. British Journal of Surgery 2020;107(2):e26-e38. [DOI: 10.1002/bjs.11393]</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/bjs.11393</ArticleId><ArticleId IdType="pubmed">31903592</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Shah 2022</Title><Reference><Citation>Shah F, Toh C-H. NHSBT Red Cell Shortage - Amber Alert Notice: Letter to Royal Colleges; 12 October 2022. National Health Service Blood and Transplant &amp; Royal College of Pathologists (available at: www.rcpath.org/asset/4EDCCD82-8DB4-4C8A-813224D5B0A3B8EF). (accessed on 25 March 2023). [URL: HTTPS://WWW.RCPATH.ORG/ASSET/4EDCCD82-8DB4-4C8A-813224D5B0A3B8EF/: Accessed on 25/03/2023]</Citation></Reference></ReferenceList><ReferenceList><Title>Shander 2004</Title><Reference><Citation>Shander A, Knight K, Thurer R, Adamson J, Spence R. Prevalence and outcomes of anemia in surgery: a systematic review of the literature. American Journal of Medicine 2004;116(7 (Suppl 1)):58-9. [DOI: 10.1016/j.amjmed.2003.12.013]</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amjmed.2003.12.013</ArticleId><ArticleId IdType="pubmed">15050887</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Son 2020</Title><Reference><Citation>Son K, Yamada T, Tarao K, Kitamura Y, Okazaki J, Sato Y, Isono S. Effects of cardiac surgery and salvaged blood transfusion on coagulation function assessed by thromboelastometry. Journal of Cardiothoracic and Vascular Anaesthesia 2020;34:2375-82. [DOI: 10.1053/j.jvca.2020.02.009]</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.jvca.2020.02.009</ArticleId><ArticleId IdType="pubmed">32178956</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Sterne 2011</Title><Reference><Citation>Sterne JA, Egger M, Moher D, on behalf of the Cochrane Bias Methods Group, editor(s). Chapter 10: Addressing reporting biases. In: Higgins JP, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). Available from handbook-5-1.cochrane.org/ 2011.</Citation></Reference></ReferenceList><ReferenceList><Title>Takagi 2007</Title><Reference><Citation>Takagi H, Sekino S, Kato T, Matsuno Y, Umemoto T. Intraoperative autotransfusion in abdominal aortic aneurysm surgery: meta-analysis of randomized controlled trials. Archives of Surgery 2007;142(11):1098-1101. [DOI: 10.1001/archsurg.142.11.1098.]</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archsurg.142.11.1098.</ArticleId><ArticleId IdType="pubmed">18025340</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Tinegate 2016</Title><Reference><Citation>Tinegate H, Pendry K, Murphy M, Babra P, Grant-Casey J, Hopkinsin C, et al. Where do all the red blood cells (RBCs) go? Results of a survey of RBC use in England and North Wales in 2014. Transfusion Practice 2016;56(1):139-45.</Citation><ArticleIdList><ArticleId IdType="pubmed">26442481</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Van Bodegom&#x2010;Vos 2015</Title><Reference><Citation>Van Bodegom-Vos L, Voorn VM, So-Osman C, Vliet Vlieland TP, Dahan A, Koopman-van Gemert AW, et al. Cell salvage in hip and knee arthroplasty: a meta-analysis of randomized controlled trials. Journal of Bone and Joint Surgery, American volume 2015;97:1012-21. [DOI: 10.2106/JBJS.N.00315]</Citation><ArticleIdList><ArticleId IdType="doi">10.2106/JBJS.N.00315</ArticleId><ArticleId IdType="pubmed">26085536</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Wang 2009</Title><Reference><Citation>Wang G, Bainbridge D, Martin J, Cheng D. The efficacy of an intraoperative cell saver during cardiac surgery: a meta-analysis of randomized trials. Anaesthesia and Analgesia 2009;109(2):320-30. [DOI: 10.1213/ane.0b013e3181aa084c]</Citation><ArticleIdList><ArticleId IdType="doi">10.1213/ane.0b013e3181aa084c</ArticleId><ArticleId IdType="pubmed">19608798</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Waters 2003</Title><Reference><Citation>Waters JH, Tuohy MJ, Hobson DF, Procop G. Bacterial reduction by cell salvage washing and leukocyte depletion filtration. Anesthesiology 2003;99(3):652-5. [DOI: 10.1097/00000542-200309000-00021]</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00000542-200309000-00021</ArticleId><ArticleId IdType="pubmed">12960550</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Weiser 2015</Title><Reference><Citation>Weiser TG, Haynes AB, Molina G, Lipsitz SR, Esquivel MM, Uribe-Leitz T, et al. Estimate of the global volume of surgery in 2012: an assessment supporting improved health outcomes. Lancet 2015;385(Suppl 2):S11. [DOI: 10.1016/S0140-6736(15)60806-6]</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(15)60806-6</ArticleId><ArticleId IdType="pubmed">26313057</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>WHO 1968</Title><Reference><Citation>World Health Organisation (WHO) Scientific Group. Nutritional Anaemias: WHO Technical Report Series no.45. Geneva, Switzerland: World Health Organisation, 1968.</Citation><ArticleIdList><ArticleId IdType="pubmed">4975372</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Williamson 2013</Title><Reference><Citation>Williamson LM, Devine D V. Challenges in the management of the blood supply. Lancet 2013;381(9880):1866-75. [DOI: 10.1016/S0140-6736(13)60631-5]</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(13)60631-5</ArticleId><ArticleId IdType="pubmed">23706803</ArticleId></ArticleIdList></Reference></ReferenceList></ReferenceList><ReferenceList><Title>References to other published versions of this review</Title><ReferenceList><Title>Carless 2010</Title><Reference><Citation>Carless PA, Henry DA, Moxey AJ, O'Connell D, Brown T, Fergusson DA. Cell salvage for minimising perioperative allogeneic blood transfusion. Cochrane Database of Systematic Reviews 2010, Issue 4. Art. No: CD001888. [COCHRANE: CD001888] [DOI: 10.1002/14651858.CD001888.pub4]</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/14651858.CD001888.pub4</ArticleId><ArticleId IdType="pubmed">17054147</ArticleId></ArticleIdList></Reference></ReferenceList></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">18948602</PMID><DateCompleted><Year>2009</Year><Month>02</Month><Day>20</Day></DateCompleted><DateRevised><Year>2022</Year><Month>03</Month><Day>11</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1524-4628</ISSN><JournalIssue CitedMedium="Internet"><Volume>40</Volume><Issue>1</Issue><PubDate><Year>2009</Year><Month>Jan</Month></PubDate></JournalIssue><Title>Stroke</Title><ISOAbbreviation>Stroke</ISOAbbreviation></Journal><ArticleTitle>Embolic potential of cardiac tumors and outcome after resection: a case-control study.</ArticleTitle><Pagination><StartPage>156</StartPage><EndPage>162</EndPage><MedlinePgn>156-62</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1161/STROKEAHA.108.525709</ELocationID><Abstract><AbstractText Label="BACKGROUND AND PURPOSE" NlmCategory="OBJECTIVE">Embolic events have long been thought to occur in patients with cardiac tumors secondary to embolization of tumor fragments; however, there are no large studies examining the epidemiology and occurrence of embolism in this group of patients.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">From 1957 to 2006, 323 consecutive patients with primary cardiac tumors were treated surgically at our institution. Of these, patients who experienced an embolic event included 80 (cerebrovascular accident 31 [9.7%], transient ischemic attack 30 [9.3%], and other 19 [6%]). Those with no history of an embolic event (n=243 [75%]) were defined as control subjects.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Age was similar between the case and control groups (mean 54.5 versus 53.9 years, P=0.8). A multivariate logistic regression model including tumor location, tumor burden, tumor histology, and cerebrovascular risk factors, indicated that left atrial tumors (OR, 1.95; P=0.04), aortic valve tumors (OR, 4.17; P=0.002), and smaller tumor burden (OR, 2.20; P=0.01) were the most significant factors in the occurrence of embolism (P&lt;0.001). The presence of mitral regurgitation (OR, 0.12; P=0.006) and decreased functional status (New York Heart Association III/IV; OR, 0.31; P&lt;0.001) were protective against the occurrence of embolism. Follow-up was obtained in 82% at a mean follow-up time of 6.17+/-6.9 years. There were no recurrent embolic events at follow-up. A Kaplan-Meier survival curve demonstrated no difference in survival between both groups (P=0.78).</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Aortic valve and left atrial tumors have the greatest anatomic risk for embolism. Furthermore, patients with smaller tumors, minimal symptomatology, and no evidence of mitral regurgitation have a high risk of embolism. Cardiac tumors can be resected with low early mortality, and late survival after operation in the context of an embolic event is similar to patients with cardiac tumors who undergo resection for other indications.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Elbardissi</LastName><ForeName>Andrew W</ForeName><Initials>AW</Initials><AffiliationInfo><Affiliation>Brigham and Women's Hospital, 75 Francis Street, Boston, MA 02115, USA. aelbardissi@partners.org</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dearani</LastName><ForeName>Joseph A</ForeName><Initials>JA</Initials></Author><Author ValidYN="Y"><LastName>Daly</LastName><ForeName>Richard C</ForeName><Initials>RC</Initials></Author><Author ValidYN="Y"><LastName>Mullany</LastName><ForeName>Charles J</ForeName><Initials>CJ</Initials></Author><Author ValidYN="Y"><LastName>Orszulak</LastName><ForeName>Thomas A</ForeName><Initials>TA</Initials></Author><Author ValidYN="Y"><LastName>Puga</LastName><ForeName>Francisco J</ForeName><Initials>FJ</Initials></Author><Author ValidYN="Y"><LastName>Schaff</LastName><ForeName>Hartzell V</ForeName><Initials>HV</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2008</Year><Month>10</Month><Day>23</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Stroke</MedlineTA><NlmUniqueID>0235266</NlmUniqueID><ISSNLinking>0039-2499</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017677" MajorTopicYN="N">Age Distribution</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001021" MajorTopicYN="N">Aortic Valve</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006348" MajorTopicYN="N">Cardiac Surgical Procedures</DescriptorName><QualifierName UI="Q000401" MajorTopicYN="Y">mortality</QualifierName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016022" MajorTopicYN="N">Case-Control Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002561" MajorTopicYN="N">Cerebrovascular Disorders</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015897" MajorTopicYN="N">Comorbidity</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004617" MajorTopicYN="N">Embolism</DescriptorName><QualifierName UI="Q000401" MajorTopicYN="Y">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006325" MajorTopicYN="N">Heart Atria</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006338" MajorTopicYN="N">Heart Neoplasms</DescriptorName><QualifierName UI="Q000401" MajorTopicYN="Y">mortality</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020766" MajorTopicYN="N">Intracranial Embolism</DescriptorName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008944" MajorTopicYN="N">Mitral Valve Insufficiency</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011655" MajorTopicYN="N">Pulmonary Embolism</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018570" MajorTopicYN="N">Risk Assessment</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015996" MajorTopicYN="N">Survival Rate</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2008</Year><Month>10</Month><Day>25</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2009</Year><Month>2</Month><Day>21</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2008</Year><Month>10</Month><Day>25</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">18948602</ArticleId><ArticleId IdType="doi">10.1161/STROKEAHA.108.525709</ArticleId><ArticleId IdType="pii">STROKEAHA.108.525709</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">23677493</PMID><DateCompleted><Year>2014</Year><Month>03</Month><Day>07</Day></DateCompleted><DateRevised><Year>2013</Year><Month>07</Month><Day>01</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2567-689X</ISSN><JournalIssue CitedMedium="Internet"><Volume>110</Volume><Issue>1</Issue><PubDate><Year>2013</Year><Month>Jul</Month></PubDate></JournalIssue><Title>Thrombosis and haemostasis</Title><ISOAbbreviation>Thromb Haemost</ISOAbbreviation></Journal><ArticleTitle>Factors associated with diagnosis and operability of chronic thromboembolic pulmonary hypertension. A case-control study.</ArticleTitle><Pagination><StartPage>83</StartPage><EndPage>91</EndPage><MedlinePgn>83-91</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1160/TH13-02-0097</ELocationID><Abstract><AbstractText>Chronic thromboembolic pulmonary hypertension (CTEPH) and idiopathic pulmonary hypertension (IPAH) share a similar clinical presentation, and a differential diagnosis requires a thorough workup. Once CTEPH is confirmed, patients who can be safely operated have to be identified. We investigated risk factors associated with CTEPH and IPAH, and the criteria for the selection of operable CTEPH patients. This case-control study included 436 consecutive patients with CTEPH and 158 with IPAH in eight European centres, between 2006 and 2010. Conditions identified as risk factors for CTEPH included history of acute venous thromboembolism (p &lt; 0.0001), large size of previous pulmonary embolism (p = 0.0040 in univariate analysis), blood groups non-O (p&#xa0;&lt;&#xa0;0.0001 in univariate analysis), and older age (p&#xa0;=&#xa0;0.0198), whereas diabetes mellitus (p&#xa0;=&#xa0;0.0006), female gender (p&#xa0;=&#xa0;0.0197) and higher mean pulmonary artery pressure (p = 0.0103) were associated with increased likelihood for an IPAH diagnosis. Operability of CTEPH patients was associated with younger age (p&#xa0;=&#xa0;0.0108), proximal lesions (p &#x2264; 0.0001), and pulmonary vascular resistance below 1200 dyn.s.cm&#x207b;&#x2075; (p&#xa0;=&#xa0;0.0080). Non-operable CTEPH patients tended to be less differentiable from IPAH patients by risk factor analysis than operable patients. This study confirmed the association of CTEPH with history of acute venous thromboembolism and blood groups non-O, and identified diabetes mellitus and higher mean pulmonary artery pressure as factors suggesting an IPAH diagnosis. Non-operable CTEPH is more similar to IPAH than operable CTEPH regarding risk factors.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Lang</LastName><ForeName>Irene M</ForeName><Initials>IM</Initials><AffiliationInfo><Affiliation>Irene Lang, Department of Cardiology, Medical University of Vienna, W&#xe4;hringer G&#xfc;rtel 18 - 20, 1090 Vienna, Austria. irene.lang@meduniwien.ac.at</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Simonneau</LastName><ForeName>G&#xe9;rald</ForeName><Initials>G</Initials></Author><Author ValidYN="Y"><LastName>Pepke-Zaba</LastName><ForeName>Joanna W</ForeName><Initials>JW</Initials></Author><Author ValidYN="Y"><LastName>Mayer</LastName><ForeName>Eckhard</ForeName><Initials>E</Initials></Author><Author ValidYN="Y"><LastName>Ambro&#x17e;</LastName><ForeName>David</ForeName><Initials>D</Initials></Author><Author ValidYN="Y"><LastName>Blanco</LastName><ForeName>Isabel</ForeName><Initials>I</Initials></Author><Author ValidYN="Y"><LastName>Torbicki</LastName><ForeName>Adam</ForeName><Initials>A</Initials></Author><Author ValidYN="Y"><LastName>Mellemkjaer</LastName><ForeName>S&#xf6;ren</ForeName><Initials>S</Initials></Author><Author ValidYN="Y"><LastName>Yaici</LastName><ForeName>Azzedine</ForeName><Initials>A</Initials></Author><Author ValidYN="Y"><LastName>Delcroix</LastName><ForeName>Marion</ForeName><Initials>M</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016448">Multicenter Study</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2013</Year><Month>05</Month><Day>16</Day></ArticleDate></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>Thromb Haemost</MedlineTA><NlmUniqueID>7608063</NlmUniqueID><ISSNLinking>0340-6245</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D001789">Blood Group Antigens</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000367" MajorTopicYN="N">Age Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001789" MajorTopicYN="N">Blood Group Antigens</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016022" MajorTopicYN="N">Case-Control Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002908" MajorTopicYN="N">Chronic Disease</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003920" MajorTopicYN="N">Diabetes Mellitus</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005060" MajorTopicYN="N" Type="Geographic">Europe</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006976" MajorTopicYN="N">Hypertension, Pulmonary</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018579" MajorTopicYN="N">Patient Selection</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011655" MajorTopicYN="N">Pulmonary Embolism</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012737" MajorTopicYN="N">Sex Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019616" MajorTopicYN="N">Thoracic Surgical Procedures</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D054556" MajorTopicYN="N">Venous Thromboembolism</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2013</Year><Month>2</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2013</Year><Month>4</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2013</Year><Month>5</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2013</Year><Month>5</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2014</Year><Month>3</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">23677493</ArticleId><ArticleId IdType="doi">10.1160/TH13-02-0097</ArticleId><ArticleId IdType="pii">13-02-0097</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">39032608</PMID><DateCompleted><Year>2024</Year><Month>10</Month><Day>31</Day></DateCompleted><DateRevised><Year>2024</Year><Month>10</Month><Day>31</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1878-1632</ISSN><JournalIssue CitedMedium="Internet"><Volume>24</Volume><Issue>11</Issue><PubDate><Year>2024</Year><Month>Nov</Month></PubDate></JournalIssue><Title>The spine journal : official journal of the North American Spine Society</Title><ISOAbbreviation>Spine J</ISOAbbreviation></Journal><ArticleTitle>Immediate vs delayed venous thromboembolism prophylaxis following spine surgery: increased rate of unplanned reoperation for postoperative hematoma with immediate prophylaxis.</ArticleTitle><Pagination><StartPage>2019</StartPage><EndPage>2025</EndPage><MedlinePgn>2019-2025</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.spinee.2024.06.568</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S1529-9430(24)00894-5</ELocationID><Abstract><AbstractText Label="BACKGROUND CONTEXT" NlmCategory="BACKGROUND">There is significant variability in postoperative chemoprophylaxis protocols amongst spine providers due to perceived risks and benefits, but limited data on the topic. At our institution, both orthopaedic spine and neurosurgery departments utilize unfractionated subcutaneous heparin in identical dosages and frequency, with the only difference being time to initiation postoperatively.</AbstractText><AbstractText Label="PURPOSE" NlmCategory="OBJECTIVE">To evaluate the rate of symptomatic venous thromboembolism (VTEs) and unplanned reoperation for hematoma based on timing of chemoprophylaxis initiation.</AbstractText><AbstractText Label="STUDY DESIGN/SETTING" NlmCategory="METHODS">Single institution retrospective cohort study.</AbstractText><AbstractText Label="PATIENT SAMPLE" NlmCategory="METHODS">Patients undergoing elective spine surgery, excluding patients undergoing surgery in the setting of trauma, malignancy, or infection.</AbstractText><AbstractText Label="OUTCOME MEASURES" NlmCategory="METHODS">Outcome measures included the diagnosis of a venous thromboembolism within 90 days of surgery and unplanned reoperation for a hematoma.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Patients undergoing elective spine surgery from 2017 to 2021 were grouped based on chemoprophylaxis protocol. In the "immediate" group, patients received subcutaneous heparin 5000 units every 8 hours starting immediately after surgery, and in the "delayed" group, patients received chemoprophylaxis starting postoperative day (POD)-2 for any decompressions and/or fusions involving a spinal cord level (ie, L2 and above) and POD-1 for those involving only levels below the spinal cord (ie, L3 to pelvis). A cox proportional hazards model was created to assess independent predictors of venous thromboembolic events, while a logistic regression was utilized for unplanned reoperations for hematoma.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Of 8,704 patients, a total of 98 (1.13%) VTE events occurred, of which 43 (0.49%) were pulmonary embolism. Fifty-four patients (0.62%) had unplanned reoperations for postoperative hematomas. On cox proportional hazards model analysis, immediate chemoprophylaxis was not protective of a venous thromboembolism (Hazard Ratio: 1.18, p=.436), but, it was a significant independent predictor for unplanned reoperation for hematoma on multivariable logistic regression modeling (Odds Ratio: 3.29, p&lt;.001).</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Both chemoprophylaxis protocols in our study resulted in low rates of VTE and postoperative hematoma. However, our findings suggest that the delayed chemoprophylaxis protocol may mitigate postoperative hematoma formation without increasing the risk for a thrombotic event.</AbstractText><CopyrightInformation>Copyright &#xa9; 2024 The Author(s). Published by Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Lambrechts</LastName><ForeName>Mark J</ForeName><Initials>MJ</Initials><AffiliationInfo><Affiliation>Department of Orthopaedic Surgery, Rothman Orthopaedic Institute, Thomas Jefferson University Hospital, Philadelphia, PA, USA; Department of Orthopedic Surgery, Washington University in St. Louis School of Medicine, St. Louis, MO, USA. Electronic address: lambrechts@wustl.edu.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Toci</LastName><ForeName>Gregory R</ForeName><Initials>GR</Initials><AffiliationInfo><Affiliation>Department of Orthopaedic Surgery, Rothman Orthopaedic Institute, Thomas Jefferson University Hospital, Philadelphia, PA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Issa</LastName><ForeName>Tariq Z</ForeName><Initials>TZ</Initials><AffiliationInfo><Affiliation>Department of Orthopaedic Surgery, Rothman Orthopaedic Institute, Thomas Jefferson University Hospital, Philadelphia, PA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Narayanan</LastName><ForeName>Rajkishen</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Orthopaedic Surgery, Rothman Orthopaedic Institute, Thomas Jefferson University Hospital, Philadelphia, PA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Yunsoo</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Orthopaedic Surgery, Rothman Orthopaedic Institute, Thomas Jefferson University Hospital, Philadelphia, PA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schaefer</LastName><ForeName>Joseph</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Neurosurgery, Thomas Jefferson University Hospital, Philadelphia, PA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hilibrand</LastName><ForeName>Alan S</ForeName><Initials>AS</Initials><AffiliationInfo><Affiliation>Department of Orthopaedic Surgery, Rothman Orthopaedic Institute, Thomas Jefferson University Hospital, Philadelphia, PA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vaccaro</LastName><ForeName>Alexander R</ForeName><Initials>AR</Initials><AffiliationInfo><Affiliation>Department of Orthopaedic Surgery, Rothman Orthopaedic Institute, Thomas Jefferson University Hospital, Philadelphia, PA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Harrop</LastName><ForeName>James S</ForeName><Initials>JS</Initials><AffiliationInfo><Affiliation>Department of Neurosurgery, Thomas Jefferson University Hospital, Philadelphia, PA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schroeder</LastName><ForeName>Gregory D</ForeName><Initials>GD</Initials><AffiliationInfo><Affiliation>Department of Orthopaedic Surgery, Rothman Orthopaedic Institute, Thomas Jefferson University Hospital, Philadelphia, PA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kepler</LastName><ForeName>Christopher K</ForeName><Initials>CK</Initials><AffiliationInfo><Affiliation>Department of Orthopaedic Surgery, Rothman Orthopaedic Institute, Thomas Jefferson University Hospital, Philadelphia, PA, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>07</Month><Day>18</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Spine J</MedlineTA><NlmUniqueID>101130732</NlmUniqueID><ISSNLinking>1529-9430</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>9005-49-6</RegistryNumber><NameOfSubstance UI="D006493">Heparin</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000925">Anticoagulants</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D054556" MajorTopicYN="Y">Venous Thromboembolism</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012086" MajorTopicYN="Y">Reoperation</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="Y">Postoperative Complications</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006493" MajorTopicYN="Y">Heparin</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006406" MajorTopicYN="Y">Hematoma</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000925" MajorTopicYN="Y">Anticoagulants</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013131" MajorTopicYN="N">Spine</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Blood clots</Keyword><Keyword MajorTopicYN="N">Chemoprophylaxis</Keyword><Keyword MajorTopicYN="N">Deep vein thrombosis</Keyword><Keyword MajorTopicYN="N">Hematoma</Keyword><Keyword MajorTopicYN="N">Prophylaxis</Keyword><Keyword MajorTopicYN="N">Pulmonary embolism</Keyword><Keyword MajorTopicYN="N">Reoperation</Keyword><Keyword MajorTopicYN="N">Spine surgery</Keyword><Keyword MajorTopicYN="N">Venous thromboembolism</Keyword></KeywordList><CoiStatement>Declaration of competing interest One or more of the authors declare financial or professional relationships on ICMJE-TSJ disclosure forms.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>3</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>6</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>6</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>11</Month><Day>1</Day><Hour>0</Hour><Minute>22</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>7</Month><Day>21</Day><Hour>15</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>7</Month><Day>20</Day><Hour>19</Hour><Minute>27</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39032608</ArticleId><ArticleId IdType="doi">10.1016/j.spinee.2024.06.568</ArticleId><ArticleId IdType="pii">S1529-9430(24)00894-5</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">32040790</PMID><DateCompleted><Year>2021</Year><Month>02</Month><Day>26</Day></DateCompleted><DateRevised><Year>2021</Year><Month>07</Month><Day>08</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1590-3478</ISSN><JournalIssue CitedMedium="Internet"><Volume>41</Volume><Issue>6</Issue><PubDate><Year>2020</Year><Month>Jun</Month></PubDate></JournalIssue><Title>Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology</Title><ISOAbbreviation>Neurol Sci</ISOAbbreviation></Journal><ArticleTitle>Seizures as the first clinical manifestation of acute pulmonary embolism: an underestimate issue in neurocritical care.</ArticleTitle><Pagination><StartPage>1427</StartPage><EndPage>1436</EndPage><MedlinePgn>1427-1436</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s10072-020-04275-y</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">The aim of the present review is to analyze the clinical characteristics of patients with acute pulmonary embolism (PE) which seizures were the first clinical manifestation of the disease.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">After screening 258 articles in PubMed, Scopus, Cochrane Library, and Google Scholar databases, we identified 16 case reports meeting the inclusion criteria.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">The mean age of the population was 48.4&#x2009;&#xb1;&#x2009;19.8&#xa0;years (9 males and 7 females). About three of four patients (68.7%) were hemodynamically stable at admission, having a systolic blood pressure &gt;&#x2009;90&#xa0;mmHg. Intriguingly, the doubt of acute PE was based on clinical suspicion or on instrumental findings in 62.5% and 18.7% of patients, respectively. In 3 subjects (18.7%), the acute cardiovascular disease was not suspected. Half of patients had an unremarkable previous medical history while neurological comorbidities were present in 4 patients (25.0%). During seizures, a transient loss of consciousness (TLOC) was reported in 6 cases. Seizures were retrospectively classified according to the 2017 ILAE classification, whenever possible. A focal and generalized onset was reported in 37.5% and 50% of cases, respectively, in 12.5% of patient's data that were insufficient to classify the events. The mean number of seizure episodes in the population enrolled was 2.0&#x2009;&#xb1;&#x2009;1.1. Mortality rate was 54.5% but one investigation did not report the patient's outcome.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">The relationship between seizures and acute PE is probably underrecognized. Identifying patients that have a high probability of acute PE is fundamental to avoid any treatment delay and ameliorate their outcomes.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Zuin</LastName><ForeName>Marco</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>School of Medicine, University of Ferrara, Ferrara, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rigatelli</LastName><ForeName>Gianluca</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Cardiovascular Diagnosis and Endoluminal Interventions Unit, Rovigo General Hospital, Rovigo, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zuliani</LastName><ForeName>Giovanni</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Morphology, Surgery and Experimental Medicine, Section of Internal Medicine, University of Ferrara, Ferrara, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Adami</LastName><ForeName>Alessandro</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Division of Neurology, Stroke Center, Sacro Cuore-Don Calabria Hospital, Negrar, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zonzin</LastName><ForeName>Pietro</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Division of Cardiology, Rovigo General Hospital, Santa Maria della Misericordia Hospital, Via Tre Martiri 140, 45100, Rovigo, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Roncon</LastName><ForeName>Loris</ForeName><Initials>L</Initials><Identifier Source="ORCID">0000-0001-9164-9160</Identifier><AffiliationInfo><Affiliation>Division of Cardiology, Rovigo General Hospital, Santa Maria della Misericordia Hospital, Via Tre Martiri 140, 45100, Rovigo, Italy. roncon.loris@gmail.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>02</Month><Day>10</Day></ArticleDate></Article><MedlineJournalInfo><Country>Italy</Country><MedlineTA>Neurol Sci</MedlineTA><NlmUniqueID>100959175</NlmUniqueID><ISSNLinking>1590-1874</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000208" MajorTopicYN="N">Acute Disease</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003422" MajorTopicYN="N">Critical Care</DescriptorName><QualifierName UI="Q000592" MajorTopicYN="Y">standards</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011655" MajorTopicYN="N">Pulmonary Embolism</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012640" MajorTopicYN="N">Seizures</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName><QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Diagnosis</Keyword><Keyword MajorTopicYN="N">Management</Keyword><Keyword MajorTopicYN="N">Pulmonary embolism</Keyword><Keyword MajorTopicYN="N">Seizures</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2019</Year><Month>7</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>2</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>2</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>2</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>2</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32040790</ArticleId><ArticleId IdType="doi">10.1007/s10072-020-04275-y</ArticleId><ArticleId IdType="pii">10.1007/s10072-020-04275-y</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Goldhaber SZ, Bounameaux H (2012) Pulmonary embolism and deep vein thrombosis. Lancet 379:1835&#x2013;1846. https://doi.org/10.1016/S0140-6736(11)61904-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(11)61904-1</ArticleId><ArticleId IdType="pubmed">22494827</ArticleId></ArticleIdList></Reference><Reference><Citation>Elliott JO, Lu B, Shneker B, Charyton C, Layne Moore J (2009) Comorbidity, health screening, and quality of life among persons with a history of epilepsy. Epilepsy Behav 14:125&#x2013;129. https://doi.org/10.1016/j.yebeh.2008.10.013</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.yebeh.2008.10.013</ArticleId><ArticleId IdType="pubmed">18983943</ArticleId></ArticleIdList></Reference><Reference><Citation>Martz GU, Wilson DA, Malek AM, Selassie AW (2014) Risk of venous thromboembolism in people with epilepsy. Epilepsia 55:1800&#x2013;1807. https://doi.org/10.1111/epi.12796</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/epi.12796</ArticleId><ArticleId IdType="pubmed">25270297</ArticleId></ArticleIdList></Reference><Reference><Citation>Dunn MJ, Breen DP, Davenport RJ, Gray AJ (2005) Early management of adults with an uncomplicated first generalised seizure. Emerg Med J 22:237&#x2013;242. https://doi.org/10.1136/emj.2004.015651</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/emj.2004.015651</ArticleId><ArticleId IdType="pubmed">15788819</ArticleId><ArticleId IdType="pmc">1726732</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organization (2015) Epilepsy. Last updated, May 2015. Retrieved from http://www.who.int/mediacentre/factsheets/fs999/en/</Citation></Reference><Reference><Citation>Shohet C, Yelloly J, Bingham P, Lyratzopoulos G (2007) The association between the quality of epilepsy management in primary care, general practice population deprivation status and epilepsy-related emergency hospitalisations. Seizure 16:351&#x2013;355. https://doi.org/10.1016/j.seizure.2007.02.005</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.seizure.2007.02.005</ArticleId><ArticleId IdType="pubmed">17395500</ArticleId></ArticleIdList></Reference><Reference><Citation>Huff JS1, Morris DL, Kothari RU, Gibbs MA; Emergency Medicine Seizure Study Group (2001) Emergency department management of patients with seizures: a multicenter study. Acad Emerg Med 8:622&#x2013;628. https://doi.org/10.1111/j.1553-2712.2001.tb00175.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1553-2712.2001.tb00175.x</ArticleId></ArticleIdList></Reference><Reference><Citation>Hamilton M, Thompson EN (1963) Unusual manifestations of pulmonary embolic disease. Postgrad Med J 39:348&#x2013;353. https://doi.org/10.1136/pgmj.39.452.348</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/pgmj.39.452.348</ArticleId><ArticleId IdType="pubmed">13952344</ArticleId><ArticleId IdType="pmc">2482255</ArticleId></ArticleIdList></Reference><Reference><Citation>Fred HL, Willerson JT, Alexander JK (1967) Neurological manifestations of pulmonary thromboembolism. Arch Intern Med 120:33&#x2013;37. https://doi.org/10.1001/archinte.1967.00300010035006</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archinte.1967.00300010035006</ArticleId><ArticleId IdType="pubmed">6028695</ArticleId></ArticleIdList></Reference><Reference><Citation>Fred HL, Yang m (1995) Sudden loss of consciousness, dyspnea and hypoxaemia in a previously healthy young man. Circulation 91:3017&#x2013;3019. https://doi.org/10.1161/01.CIR.91.12.3017</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/01.CIR.91.12.3017</ArticleId><ArticleId IdType="pubmed">7796514</ArticleId></ArticleIdList></Reference><Reference><Citation>Marine JE, Goldhaber SZ (1997) Pulmonary embolism presenting as seizures. Chest 112:840&#x2013;842. https://doi.org/10.1378/chest.112.3.840</Citation><ArticleIdList><ArticleId IdType="doi">10.1378/chest.112.3.840</ArticleId><ArticleId IdType="pubmed">9315823</ArticleId></ArticleIdList></Reference><Reference><Citation>Kupnik D, Grmec S (2004) Pulmonary thromboembolism presenting as epileptiform generalized seizure. Eur J Emerg Med 11:346&#x2013;347. https://doi.org/10.1097/00063110-200412000-00009</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00063110-200412000-00009</ArticleId><ArticleId IdType="pubmed">15542993</ArticleId></ArticleIdList></Reference><Reference><Citation>Meyer MA (2009) Seizure as the presenting sign for massive pulmonary embolism: case report and review of the literature. Seizure 18:76&#x2013;78. https://doi.org/10.1016/j.seizure.2008.06.008</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.seizure.2008.06.008</ArticleId><ArticleId IdType="pubmed">18656385</ArticleId></ArticleIdList></Reference><Reference><Citation>Shah AK, Darwent M (2009) Acute pulmonary embolism presenting as seizures. Emerg Med J 26:299&#x2013;300. https://doi.org/10.1136/emj.2007.046151</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/emj.2007.046151</ArticleId><ArticleId IdType="pubmed">19307400</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang JW, Xu MW, Luo BY (2013) Pulmonary embolism presenting as recurrent transient loss of consciousness: syncope and seizure. Chin Med J 126:193&#x2013;194</Citation><ArticleIdList><ArticleId IdType="pubmed">23286503</ArticleId></ArticleIdList></Reference><Reference><Citation>Kimura K, Mori H, Kitaguchi H, Yamao F, Shindo K (2013) Pulmonary embolism as a cause of seizure. Am J Emerg Med 31:1525&#x2013;1527. https://doi.org/10.1016/j.ajem.2013.06.024</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajem.2013.06.024</ArticleId><ArticleId IdType="pubmed">23932122</ArticleId></ArticleIdList></Reference><Reference><Citation>Volz EE, Jasani N (2014) Seizure as a presentation of pulmonary embolism. J Emerg Med 46:e1&#x2013;e4. https://doi.org/10.1016/j.jemermed.2013.08.057</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jemermed.2013.08.057</ArticleId><ArticleId IdType="pubmed">24188600</ArticleId></ArticleIdList></Reference><Reference><Citation>Ching YH, Alvey EN, Omar HR, Lynch CM, Mangar D, Camporesi EM (2015) Pulmonary embolism presenting as a seizure in the immediate postpartum period. J Obstet Gynaecol 35:92&#x2013;93</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/01443615.2014.936842</ArticleId></ArticleIdList></Reference><Reference><Citation>Hashmani S, Tipoo Sultan FA, Kazmi M, Yasmeen A (2016) Massive pulmonary embolism presenting as seizures. J Pak Med Assoc 66:1656&#x2013;1658</Citation><ArticleIdList><ArticleId IdType="pubmed">28179706</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu SH, Wang YC, Wu YS, Huang SC, Lin CS (2016) A rare cause of pulmonary embolism and seizure in a young man: antiphospholipid syndrome. Acta Cardiol Sin 32:247&#x2013;249. https://doi.org/10.6515/acs20150413a</Citation><ArticleIdList><ArticleId IdType="doi">10.6515/acs20150413a</ArticleId><ArticleId IdType="pubmed">27122957</ArticleId><ArticleId IdType="pmc">4816925</ArticleId></ArticleIdList></Reference><Reference><Citation>Pourshahid S, Dedhia S, Hakim S, Barakat M, Genin D (2017) Seizure and pulmonary embolism: a differential that can save a life. Case Rep Pulmonol 2017:3408795</Citation><ArticleIdList><ArticleId IdType="pubmed">29391962</ArticleId><ArticleId IdType="pmc">5748118</ArticleId></ArticleIdList></Reference><Reference><Citation>Scheffer IE, Berkovic S, Capovilla G, Connolly MB, French J, Guilhoto L, Hirsch E, Jain S, Mathern GW, Mosh&#xe9; SL, Nordli DR, Perucca E, Tomson T, Wiebe S, Zhang YH, Zuberi SM (2017) ILAE classification of the epilepsies: position paper of the ILAE Commission for Classification and Terminology. Epilepsia 58:512&#x2013;521. https://doi.org/10.1111/epi.13709</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/epi.13709</ArticleId><ArticleId IdType="pubmed">28276062</ArticleId><ArticleId IdType="pmc">28276062</ArticleId></ArticleIdList></Reference><Reference><Citation>Konstantinides SV, Torbicki A, Agnelli G, Danchin N, Fitzmaurice D, Gali&#xe8; N, Gibbs JS, Huisman MV, Humbert M, Kucher N, Lang I, Lankeit M, Lekakis J, Maack C, Mayer E, Meneveau N, Perrier A, Pruszczyk P, Rasmussen LH, Schindler TH, Svitil P, Vonk Noordegraaf A, Zamorano JL, Zompatori M, Task Force for the Diagnosis and Management of Acute Pulmonary Embolism of the European Society of Cardiology (ESC (2014) 2014 ESC guidelines on the diagnosis and management of acute pulmonary embolism. Eur Heart J 35:3033&#x2013;3069</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehu243</ArticleId></ArticleIdList></Reference><Reference><Citation>Wells PS, Anderson DR, Rodger M, Ginsberg JS, Kearon C, Gent M, Turpie AG, Bormanis J, Weitz J, Chamberlain M, Bowie D, Barnes D, Hirsh J (2000) Derivation of a simple clinical model to categorize patients probability of pulmonary embolism: increasing the models utility with the SimpliRED D-dimer. Thromb Haemost 83:416&#x2013;420</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/s-0037-1613830</ArticleId></ArticleIdList></Reference><Reference><Citation>Le Gal G, Righini M, Roy PM, Sanchez O, Aujesky D, Bounameaux H, Perrier A (2006) Prediction of pulmonary embolism in the emergency department: the revised Geneva score. Ann Intern Med 144:165&#x2013;171. https://doi.org/10.7326/0003-4819-144-3-200602070-00004</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/0003-4819-144-3-200602070-00004</ArticleId><ArticleId IdType="pubmed">16461960</ArticleId></ArticleIdList></Reference><Reference><Citation>Petkar S, Cooper P, Fitzpatrick AP (2006) How to avoid a misdiagnosis in patients presenting with transient loss of consciousness. Postgrad Med J 82:630&#x2013;641. https://doi.org/10.1136/pgmj.2006.046565</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/pgmj.2006.046565</ArticleId><ArticleId IdType="pubmed">17068273</ArticleId><ArticleId IdType="pmc">2653900</ArticleId></ArticleIdList></Reference><Reference><Citation>Reuber M, Chen M, Jamnadas-Khoda J, Broadhurst M, Wall M, Gr&#xfc;newald RA, Howell SJ, Koepp M, Parry S, Sisodiya S, Walker M, Hesdorffer D (2016) Value of patient-reported symptoms in the diagnosis of transient loss of consciousness. Neurology 87:625&#x2013;633</Citation><ArticleIdList><ArticleId IdType="pubmed">27385741</ArticleId><ArticleId IdType="pmc">4977366</ArticleId></ArticleIdList></Reference><Reference><Citation>Chadwick D, Smith D (2002) The misdiagnosis of epilepsy. BMJ 324:495&#x2013;496. https://doi.org/10.1136/bmj.324.7336.495</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.324.7336.495</ArticleId><ArticleId IdType="pubmed">11872532</ArticleId><ArticleId IdType="pmc">1122430</ArticleId></ArticleIdList></Reference><Reference><Citation>Leach JP, Lauder R, Nicolson A, Smith DF (2005) Epilepsy in the UK: misdiagnosis, mistreatment, and undertreatment? The Wrexham area epilepsy project. Seizure 14:514&#x2013;520. https://doi.org/10.1016/j.seizure.2005.08.008</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.seizure.2005.08.008</ArticleId><ArticleId IdType="pubmed">16188464</ArticleId></ArticleIdList></Reference><Reference><Citation>Zaidi A, Clough P, Cooper P, Scheepers B, Fitzpatrick AP (2000) Misdiagnosis of epilepsy: many seizure-like attacks have a cardiovascular cause. J Am Coll Cardiol 36:181&#x2013;184</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0735-1097(00)00700-2</ArticleId></ArticleIdList></Reference><Reference><Citation>Vozoris NT (2014) Do benzodiazepines contribute to respiratory problems? Expert Rev Respir Med 8:661&#x2013;663. https://doi.org/10.1586/17476348.2014.957186</Citation><ArticleIdList><ArticleId IdType="doi">10.1586/17476348.2014.957186</ArticleId><ArticleId IdType="pubmed">25193249</ArticleId></ArticleIdList></Reference><Reference><Citation>Kearon C, Akl EA, Ornelas J, Blaivas A, Jimenez D, Bounameaux H, Huisman M, King CS, Morris TA, Sood N, Stevens SM, Vintch JRE, Wells P, Woller SC, Moores L (2016) Antithrombotic therapy for. https://doi.org/10.1182/asheducation-2016.1.397</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">16549851</PMID><DateCompleted><Year>2006</Year><Month>04</Month><Day>11</Day></DateCompleted><DateRevised><Year>2022</Year><Month>03</Month><Day>18</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1539-3704</ISSN><JournalIssue CitedMedium="Internet"><Volume>144</Volume><Issue>6</Issue><PubDate><Year>2006</Year><Month>Mar</Month><Day>21</Day></PubDate></JournalIssue><Title>Annals of internal medicine</Title><ISOAbbreviation>Ann Intern Med</ISOAbbreviation></Journal><ArticleTitle>Pulmonary embolism in patients with unexplained exacerbation of chronic obstructive pulmonary disease: prevalence and risk factors.</ArticleTitle><Pagination><StartPage>390</StartPage><EndPage>396</EndPage><MedlinePgn>390-6</MedlinePgn></Pagination><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Diagnosis of pulmonary embolism (PE) is difficult in patients with chronic obstructive pulmonary disease (COPD) and exacerbation.</AbstractText><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">To evaluate PE in patients with COPD and exacerbation of unknown origin and explore factors associated with PE.</AbstractText><AbstractText Label="DESIGN" NlmCategory="METHODS">Prospective cohort study.</AbstractText><AbstractText Label="SETTING" NlmCategory="METHODS">University-affiliated hospital in France.</AbstractText><AbstractText Label="PATIENTS" NlmCategory="METHODS">211 consecutive patients, all current or former smokers with COPD, who were admitted to the hospital for severe exacerbation of unknown origin and did not require invasive mechanical ventilation.</AbstractText><AbstractText Label="MEASUREMENTS" NlmCategory="METHODS">Spiral computed tomography angiography (CTA) and ultrasonography within 48 hours of admission and assessment of the Geneva score. Patients were classified as PE positive (positive results on CTA or negative results on CTA and positive results on ultrasonography) or PE negative (negative results on CTA and negative results on ultrasonography or negative results on CTA and no recurrence of PE at follow-up 3 months later).</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">49 of 197 patients (25% [95% CI, 19% to 32%]) met the diagnostic criteria for PE. Clinical factors associated with PE were previous thromboembolic disease (risk ratio, 2.43 [CI, 1.49 to 3.94]), malignant disease (risk ratio, 1.82 [CI, 1.13 to 2.92]), and decrease in PaCO2 of at least 5 mm Hg (risk ratio, 2.10 [CI, 1.23 to 3.58]). A total of 9.2% (CI, 4.7% to 15.9%) of patients with a low-probability Geneva score received a diagnosis of PE. An exploratory analysis suggested that substituting malignant disease for recent surgery in the Geneva score might improve its performance in excluding PE in this sample who were more likely to have malignant disease than to have had recent surgery. However, this improvement seems insufficient to exclude PE with enough certainty to withhold therapy for low-risk patients on the basis of the modified score.</AbstractText><AbstractText Label="LIMITATIONS" NlmCategory="CONCLUSIONS">This study was done in only 1 center. Patients with COPD requiring invasive mechanical ventilation in the intensive care unit were not included. The upper bound of the 95% CI for the low probability of PE according to the Geneva score is too high to rule out PE. The classification of COPD exacerbation of unknown origin was based on the clinician's assessment, not on a standard evaluation for all patients.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">This study showed a 25% prevalence of PE in patients with COPD hospitalized for severe exacerbation of unknown origin. Three clinical factors are associated with the increased risk for PE. The Geneva score and the modified Geneva score should be prospectively evaluated in patients with COPD.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Tillie-Leblond</LastName><ForeName>Isabelle</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Lung Department, University Hospital A Calmette, Lille, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Marquette</LastName><ForeName>Charles-Hugo</ForeName><Initials>CH</Initials></Author><Author ValidYN="Y"><LastName>Perez</LastName><ForeName>Thierry</ForeName><Initials>T</Initials></Author><Author ValidYN="Y"><LastName>Scherpereel</LastName><ForeName>Arnaud</ForeName><Initials>A</Initials></Author><Author ValidYN="Y"><LastName>Zanetti</LastName><ForeName>Christophe</ForeName><Initials>C</Initials></Author><Author ValidYN="Y"><LastName>Tonnel</LastName><ForeName>Andr&#xe9;-Bernard</ForeName><Initials>AB</Initials></Author><Author ValidYN="Y"><LastName>Remy-Jardin</LastName><ForeName>Martine</ForeName><Initials>M</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Ann Intern Med</MedlineTA><NlmUniqueID>0372351</NlmUniqueID><ISSNLinking>0003-4819</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>142M471B3J</RegistryNumber><NameOfSubstance UI="D002245">Carbon Dioxide</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Ann Intern Med. 2006 Aug 15;145(4):310; author reply 310. doi: 10.7326/0003-4819-145-4-200608150-00015.</RefSource><PMID Version="1">16908927</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000792" MajorTopicYN="N">Angiography</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002245" MajorTopicYN="N">Carbon Dioxide</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007866" MajorTopicYN="N">Leg</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009369" MajorTopicYN="N">Neoplasms</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015995" MajorTopicYN="N">Prevalence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D029424" MajorTopicYN="N">Pulmonary Disease, Chronic Obstructive</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011655" MajorTopicYN="N">Pulmonary Embolism</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013923" MajorTopicYN="N">Thromboembolism</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D036542" MajorTopicYN="N">Tomography, Spiral Computed</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018615" MajorTopicYN="N">Ultrasonography, Doppler, Color</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2006</Year><Month>3</Month><Day>22</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2006</Year><Month>4</Month><Day>12</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2006</Year><Month>3</Month><Day>22</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">16549851</ArticleId><ArticleId IdType="doi">10.7326/0003-4819-144-6-200603210-00005</ArticleId><ArticleId IdType="pii">144/6/390</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">27284980</PMID><DateCompleted><Year>2017</Year><Month>04</Month><Day>13</Day></DateCompleted><DateRevised><Year>2022</Year><Month>03</Month><Day>17</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1879-2472</ISSN><JournalIssue CitedMedium="Internet"><Volume>144</Volume><PubDate><Year>2016</Year><Month>Aug</Month></PubDate></JournalIssue><Title>Thrombosis research</Title><ISOAbbreviation>Thromb Res</ISOAbbreviation></Journal><ArticleTitle>Risk factors for venous thromboembolism after acute trauma: A population-based case-cohort study.</ArticleTitle><Pagination><StartPage>40</StartPage><EndPage>45</EndPage><MedlinePgn>40-5</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.thromres.2016.03.026</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0049-3848(16)30085-8</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Predictors of venous thromboembolism (VTE) after trauma are uncertain.</AbstractText><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">To identify independent predictors of VTE after acute trauma.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Using Rochester Epidemiology Project (REP) resources, we identified all Olmsted County, MN residents with objectively-diagnosed incident VTE within 92days after hospitalization for acute trauma over the 18-year period, 1988-2005. We also identified all Olmsted County residents hospitalized for acute trauma over this time period and chose one to two residents frequency-matched to VTE cases on sex, event year group and ICD-9-CM trauma code predictive of surgery. In a case-cohort study, demographic, baseline and time-dependent characteristics were tested as predictors of VTE after trauma using Cox proportional hazards modeling.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Among 200 incident VTE cases, the median (interquartile range) time from trauma to VTE was 18 (6, 41) days. Of these, 62% cases developed VTE after hospital discharge. In a multiple variable model including 370 cohort members, patient age at injury, male sex, increasing injury severity as reflected by the Trauma Mortality Prediction Model (TMPM) Mortality Score, immobility prior to trauma, soft tissue leg injury, and prior superficial vein thrombosis were independent predictors of VTE (C-statistic=0.78).</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">We have identified clinical characteristics which can identify patients at increased risk for VTE after acute trauma, independent of surgery. Almost two thirds of all incident VTE events occurred after initial hospital discharge (18day median time from trauma to VTE) which questions current practice of not extending VTE prophylaxis beyond hospital discharge.</AbstractText><CopyrightInformation>Copyright &#xa9; 2016. Published by Elsevier Ltd.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Park</LastName><ForeName>Myung S</ForeName><Initials>MS</Initials><AffiliationInfo><Affiliation>Mayo Clinic, 200 First Street, SW, Rochester, MN 55905, United States. Electronic address: park.myung@mayo.edu.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Perkins</LastName><ForeName>Sarah E</ForeName><Initials>SE</Initials><AffiliationInfo><Affiliation>Mayo Clinic, 200 First Street, SW, Rochester, MN 55905, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Spears</LastName><ForeName>Grant M</ForeName><Initials>GM</Initials><AffiliationInfo><Affiliation>Mayo Clinic, 200 First Street, SW, Rochester, MN 55905, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ashrani</LastName><ForeName>Aneel A</ForeName><Initials>AA</Initials><AffiliationInfo><Affiliation>Mayo Clinic, 200 First Street, SW, Rochester, MN 55905, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Leibson</LastName><ForeName>Cynthia L</ForeName><Initials>CL</Initials><AffiliationInfo><Affiliation>Mayo Clinic, 200 First Street, SW, Rochester, MN 55905, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Boos</LastName><ForeName>Christine M</ForeName><Initials>CM</Initials><AffiliationInfo><Affiliation>Mayo Clinic, 200 First Street, SW, Rochester, MN 55905, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Harmsen</LastName><ForeName>William S</ForeName><Initials>WS</Initials><AffiliationInfo><Affiliation>Mayo Clinic, 200 First Street, SW, Rochester, MN 55905, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jenkins</LastName><ForeName>Donald H</ForeName><Initials>DH</Initials><AffiliationInfo><Affiliation>Mayo Clinic, 200 First Street, SW, Rochester, MN 55905, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bailey</LastName><ForeName>Kent R</ForeName><Initials>KR</Initials><AffiliationInfo><Affiliation>Mayo Clinic, 200 First Street, SW, Rochester, MN 55905, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ballman</LastName><ForeName>Karla V</ForeName><Initials>KV</Initials><AffiliationInfo><Affiliation>Mayo Clinic, 200 First Street, SW, Rochester, MN 55905, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Heit</LastName><ForeName>John A</ForeName><Initials>JA</Initials><AffiliationInfo><Affiliation>Mayo Clinic, 200 First Street, SW, Rochester, MN 55905, United States.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>K08 GM093133</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 AG034676</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 HL066216</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2016</Year><Month>03</Month><Day>29</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Thromb Res</MedlineTA><NlmUniqueID>0326377</NlmUniqueID><ISSNLinking>0049-3848</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000208" MajorTopicYN="N">Acute Disease</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016022" MajorTopicYN="N">Case-Control Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006760" MajorTopicYN="N">Hospitalization</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010351" MajorTopicYN="N">Patient Discharge</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016016" MajorTopicYN="N">Proportional Hazards Models</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015599" MajorTopicYN="N">Trauma Severity Indices</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D054556" MajorTopicYN="N">Venous Thromboembolism</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014947" MajorTopicYN="N">Wounds and Injuries</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Deep vein thrombosis</Keyword><Keyword MajorTopicYN="N">Epidemiology</Keyword><Keyword MajorTopicYN="N">Fracture</Keyword><Keyword MajorTopicYN="N">Pulmonary embolism</Keyword><Keyword MajorTopicYN="N">Trauma</Keyword><Keyword MajorTopicYN="N">Venous thromboembolism</Keyword></KeywordList><CoiStatement>All authors report no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2015</Year><Month>6</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2016</Year><Month>2</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2016</Year><Month>3</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2016</Year><Month>6</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2016</Year><Month>6</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2017</Year><Month>4</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2017</Year><Month>8</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">27284980</ArticleId><ArticleId IdType="mid">NIHMS801842</ArticleId><ArticleId IdType="pmc">PMC5124558</ArticleId><ArticleId IdType="doi">10.1016/j.thromres.2016.03.026</ArticleId><ArticleId IdType="pii">S0049-3848(16)30085-8</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Heit JA, Silverstein MD, Mohr DN, Petterson TM, O&#x2019;Fallon WM, Melton LJ., III Risk factors for deep vein thrombosis and pulmonary embolism: a population-based case-control study. Arch Intern Med. 2000;160:809&#x2013;815.</Citation><ArticleIdList><ArticleId IdType="pubmed">10737280</ArticleId></ArticleIdList></Reference><Reference><Citation>Heit JA, O&#x2019;Fallon WM, Petterson TM, Lohse CM, Silverstein MD, Mohr DN, Melton LJ., III Relative impact of risk factors for deep vein thrombosis and pulmonary embolism: a population-based study. Arch Intern Med. 2002;162:1245&#x2013;1248.</Citation><ArticleIdList><ArticleId IdType="pubmed">12038942</ArticleId></ArticleIdList></Reference><Reference><Citation>US Department of Health and Human Services.  [Accessed June 16, 2015];The Surgeon General&#x2019;s Call to Action to prevent deep vein thrombosis and pulmonary embolism 2008.  Available at:  http://www.ncbi.nlm.nih.gov/books/NBK44178/</Citation><ArticleIdList><ArticleId IdType="pubmed">20669525</ArticleId></ArticleIdList></Reference><Reference><Citation>Geerts WH, Code KI, Jay RM, Chen E, Szalai JP. A prospective study of venous thromboembolism after major trauma. N Engl J Med. 1994;331:1601&#x2013;1606.</Citation><ArticleIdList><ArticleId IdType="pubmed">7969340</ArticleId></ArticleIdList></Reference><Reference><Citation>Knudson MM, Dangara GI, Khaw L, Morabito D, Speetzman LS. Thromboembolism after trauma. Ann Surg. 2004;240:490&#x2013;498.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1356439</ArticleId><ArticleId IdType="pubmed">15319720</ArticleId></ArticleIdList></Reference><Reference><Citation>Gearhart MM, Luchette FA, Proctor MC, Lutomski DM, Witsken C, James L, et al. The risk assessment profile score identifies trauma patients at risk for deep vein thrombosis. Surgery. 2000;128:631&#x2013;640.</Citation><ArticleIdList><ArticleId IdType="pubmed">11015097</ArticleId></ArticleIdList></Reference><Reference><Citation>Rogers FB, Shackford SR, Horst MA, Horst MA, Miller JA, Wu D, et al. J Trauma Acute Care Surg. 2012;73:511&#x2013;515.</Citation><ArticleIdList><ArticleId IdType="pubmed">23019680</ArticleId></ArticleIdList></Reference><Reference><Citation>Rogers FB, Cipolle MD, Velmahos G, Rozycki G, Luchette FA. Practice management guidelines for the prevention of venous thromboembolism in trauma patients: the EAST practice management guidelines workgroup. J Trauma. 2002;53(1):142&#x2013;164.</Citation><ArticleIdList><ArticleId IdType="pubmed">12131409</ArticleId></ArticleIdList></Reference><Reference><Citation>Melton LJ., III History of the Rochester Epidemiology Project. Mayo Clin Proc. 1996;71:266&#x2013;274.</Citation><ArticleIdList><ArticleId IdType="pubmed">8594285</ArticleId></ArticleIdList></Reference><Reference><Citation>St Sauver JL, Grossardt BR, Yawn BP, Melton LJ, 3rd, Rocca WA. Use of a medical records linkage system to enumerate a dynamic population over time: The Rochester Epidemiology Project. American Journal of Epidemiology. 2011;173:1059&#x2013;1068.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3105274</ArticleId><ArticleId IdType="pubmed">21430193</ArticleId></ArticleIdList></Reference><Reference><Citation>Rocca WA, Yawn BP, St Sauver JL, Grossardt BR, Melton LJ., 3rd History of the Rochester Epidemiology Project: Half a century of medical records linkage in a us population. Mayo Clin Proc. 2012;87:1202&#x2013;1213.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3541925</ArticleId><ArticleId IdType="pubmed">23199802</ArticleId></ArticleIdList></Reference><Reference><Citation>Silverstein MD, Heit JA, Mohr DN, Petterson TM, O&#x2019;Fallon WM, Melton LJ., III Trends in the incidence of deep vein thrombosis and pulmonary embolism: a 25-year population-based study. Arch Intern Med. 1998;158:585&#x2013;593.</Citation><ArticleIdList><ArticleId IdType="pubmed">9521222</ArticleId></ArticleIdList></Reference><Reference><Citation>Heit JA. Venous thromboembolism: Disease burden, outcomes and risk factors. J Thromb Haemost. 2005;3:1611&#x2013;1617.</Citation><ArticleIdList><ArticleId IdType="pubmed">16102026</ArticleId></ArticleIdList></Reference><Reference><Citation>Kurland LT, Molgaard CA. The patient record in epidemiology. Scientific American. 1981;245(4):54&#x2013;63.</Citation><ArticleIdList><ArticleId IdType="pubmed">7027437</ArticleId></ArticleIdList></Reference><Reference><Citation>Heit JA, Silverstein MD, Mohr DN, Petterson TM, O&#x2019;Fallon WM, Melton LJ., III Predictors of survival after deep vein thrombosis and pulmonary embolism: A population-based, cohort study. Arch Intern Med. 1999;159:445&#x2013;453.</Citation><ArticleIdList><ArticleId IdType="pubmed">10074952</ArticleId></ArticleIdList></Reference><Reference><Citation>Osler T, Glance L, Buzas JS, Mukamel D, Wagner J, Dick A. A Trauma Mortality Prediction Model Based on the Anatomic Injury Scale. Ann Surg. 2008;247(6):1041&#x2013;1047.</Citation><ArticleIdList><ArticleId IdType="pubmed">18520233</ArticleId></ArticleIdList></Reference><Reference><Citation>Godat LN, Kobayashi L, Chang DC, Coimbra R. Can we ever stop worrying about thromboembolism after trauma. J Trauma Acute Care Surg. 2015;78(3):475&#x2013;481.</Citation><ArticleIdList><ArticleId IdType="pubmed">25710416</ArticleId></ArticleIdList></Reference><Reference><Citation>White RT, Zhou H, Romano PS. Incidence of symptomatic venous thromboembolism after different elective or urgent surgical procedures. Thromb Haemost. 2003;90:446&#x2013;455.</Citation><ArticleIdList><ArticleId IdType="pubmed">12958614</ArticleId></ArticleIdList></Reference><Reference><Citation>Eikelboom JW, Quinlan DJ, Doukertis JD. Extended- duration prophylaxis against venous thromboembolism after total hip or knee replacement: a metaanalysis of the randomized trials. Lancet. 2001;358:9&#x2013;15.</Citation><ArticleIdList><ArticleId IdType="pubmed">11454370</ArticleId></ArticleIdList></Reference><Reference><Citation>Liew A, Eikerlboom JW, O&#x2019; Donnell M. Extended-duration of new oral anticoagulants for venous thromboprophylaxis in patients undergoing total hip arthroplasty: a meta-analysis of the randomized controlled trials. J Thromb Hemost. 2014;12:107&#x2013;19.</Citation><ArticleIdList><ArticleId IdType="pubmed">24305087</ArticleId></ArticleIdList></Reference><Reference><Citation>Gould MK, Garcia DA, Wren SM, Karanicolas PJ, Heit JA, Samama CM. Prevention of VTE in nonorthopedic surgical patients: Antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2012;141(2(suppl)):e227S&#x2013;e277S.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3278061</ArticleId><ArticleId IdType="pubmed">22315263</ArticleId></ArticleIdList></Reference><Reference><Citation>van Stralen KJ, Rosendaal FR, Doggen CJM. Minor injuries as a risk factor for venous thrombosis. Arch Intern Med. 2008;168(1):21&#x2013;26.</Citation><ArticleIdList><ArticleId IdType="pubmed">18195191</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">32838596</PMID><DateCompleted><Year>2021</Year><Month>07</Month><Day>07</Day></DateCompleted><DateRevised><Year>2021</Year><Month>07</Month><Day>07</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">2058-7384</ISSN><JournalIssue CitedMedium="Internet"><Volume>34</Volume><PubDate><Year>2020</Year><Season>Jan-Dec</Season></PubDate></JournalIssue><Title>International journal of immunopathology and pharmacology</Title><ISOAbbreviation>Int J Immunopathol Pharmacol</ISOAbbreviation></Journal><ArticleTitle>Concordance between clinical diagnosis of pulmonary thromboembolism at hospital discharge and anatomopathological diagnosis.</ArticleTitle><Pagination><StartPage>2058738420942390</StartPage><MedlinePgn>2058738420942390</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">2058738420942390</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1177/2058738420942390</ELocationID><Abstract><AbstractText>Half of the cases of pulmonary thromboembolism (PTE) are not diagnosed because of its unspecific clinical presentation; in Mexico, autopsy data reveal a similar incidence to that of developed countries. The objective of this work was to know the concordance between the clinical diagnosis of PTE at hospital discharge and its autopsy diagnosis. The method used was a retrospective cohort study of cases with PTE diagnosis who attended from January 2005 to December 2013. Information was obtained from the autopsies registry and clinical charts. From 177,368 hospital discharges, there were 412 (6.74%) with PTE diagnosis. There were 13,559 deaths, with PTE diagnosis in 139 (1%) patients. There were 479 autopsies, and in 66 (14%) of whom PTE diagnosis was documented, the mean age was 55&#x2009;years (range, 18-89&#x2009;years). The premortem diagnosis of PTE at discharge was confirmed in 412 cases. Postmortem diagnosis of principal disease was medical in 49 (74%) and medical-surgical in 17 (26%) patients. We found that nine patients had the clinical diagnosis of PTE, unlike the postmortem diagnosis, which was reported in 66 autopsies. The above allows establishing a 1:7 ratio that represents 14%. D-dimer was determined in 11 cases (16%) and was positive in 8 (73%). Thromboprophylaxis was applied in 15 cases (23%). The study of necropsies and identification of discrepancies is needed to improve the diagnostic accuracy and healthcare quality. The evaluation of hemostasis biomarkers besides D-dimer can better describe the pro-thrombotic state, the risk of thrombosis, and its association with morbidity and mortality.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Rubio-Jurado</LastName><ForeName>Benjam&#xed;n</ForeName><Initials>B</Initials><Identifier Source="ORCID">0000-0002-5138-8063</Identifier><AffiliationInfo><Affiliation>Servicio de Hematolog&#xed;a UMAE, HE, CMNO, Instituto Mexicano del Seguro Social, Guadalajara, M&#xe9;xico.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Unidad de Investigaci&#xf3;n Biom&#xe9;dica 02, UMAE, HE, CMNO, Instituto Mexicano del Seguro Social, Guadalajara, M&#xe9;xico.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Extensi&#xf3;n, Consulting and Research Division, Universidad de Monterrey, San Pedro Garza Garc&#xed;a, M&#xe9;xico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Albores-Arguijo</LastName><ForeName>Roc&#xed;o Concepci&#xf3;n</ForeName><Initials>RC</Initials><AffiliationInfo><Affiliation>Unidad de Investigaci&#xf3;n Biom&#xe9;dica 02, UMAE, HE, CMNO, Instituto Mexicano del Seguro Social, Guadalajara, M&#xe9;xico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Guerra-Soto</LastName><ForeName>Antonio</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Unidad de Investigaci&#xf3;n Biom&#xe9;dica 02, UMAE, HE, CMNO, Instituto Mexicano del Seguro Social, Guadalajara, M&#xe9;xico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Plasencia-Ortiz</LastName><ForeName>Teresita</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Departamento de Patolog&#xed;a, UMAE, HE, CMNO, Instituto Mexicano del Seguro Social, Guadalajara, M&#xe9;xico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tavarez-Mac&#xed;as</LastName><ForeName>Ger&#xf3;nimo</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Departamento de Patolog&#xed;a, UMAE, HE, CMNO, Instituto Mexicano del Seguro Social, Guadalajara, M&#xe9;xico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Huerta-Hern&#xe1;ndez</LastName><ForeName>Jennifer</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Departamento de Patolog&#xed;a, UMAE, HE, CMNO, Instituto Mexicano del Seguro Social, Guadalajara, M&#xe9;xico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Riebeling-Navarro</LastName><ForeName>Carlos</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Unidad de Investigaci&#xf3;n en Epidemiolog&#xed;a Cl&#xed;nica, UMAE, Hospital de Pediatr&#xed;a CMNS-XXI, Instituto Mexicano del Seguro Social/UNAM, M&#xe9;xico City, M&#xe9;xico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nava-Zavala</LastName><ForeName>Arnulfo Hern&#xe1;n</ForeName><Initials>AH</Initials><Identifier Source="ORCID">0000-0003-3061-521X</Identifier><AffiliationInfo><Affiliation>Unidad de Investigaci&#xf3;n Biom&#xe9;dica 02, UMAE, HE, CMNO, Instituto Mexicano del Seguro Social, Guadalajara, M&#xe9;xico.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Programa Internacional de la Facultad de Medicina, Universidad Aut&#xf3;noma de Guadalajara, Zapopan, M&#xe9;xico.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Divisi&#xf3;n de Medicina Interna, Servicio de Inmunolog&#xed;a y Reumatolog&#xed;a, Hospital General de Occidente, Secretaria de Salud Jalisco, Zapopan, M&#xe9;xico.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Int J Immunopathol Pharmacol</MedlineTA><NlmUniqueID>8911335</NlmUniqueID><ISSNLinking>0394-6320</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015415">Biomarkers</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D005338">Fibrin Fibrinogen Degradation Products</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C036309">fibrin fragment D</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001344" MajorTopicYN="N">Autopsy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015415" MajorTopicYN="N">Biomarkers</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002423" MajorTopicYN="N">Cause of Death</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005338" MajorTopicYN="N">Fibrin Fibrinogen Degradation Products</DescriptorName><QualifierName UI="Q000032" MajorTopicYN="Y">analysis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008800" MajorTopicYN="N" Type="Geographic">Mexico</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010351" MajorTopicYN="Y">Patient Discharge</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011237" MajorTopicYN="N">Predictive Value of Tests</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011655" MajorTopicYN="N">Pulmonary Embolism</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015203" MajorTopicYN="N">Reproducibility of Results</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Autopsy</Keyword><Keyword MajorTopicYN="N">D-dimer</Keyword><Keyword MajorTopicYN="N">deep venous thrombosis</Keyword><Keyword MajorTopicYN="N">pulmonary embolism thromboprophylaxis</Keyword><Keyword MajorTopicYN="N">thrombosis</Keyword></KeywordList><CoiStatement><b>Declaration of conflicting interests:</b> The author(s) declared no potential conflicts of interest with respect to the
research, authorship, and/or publication of this article.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>8</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>8</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>7</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2020</Year><Month>8</Month><Day>24</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32838596</ArticleId><ArticleId IdType="pmc">PMC7450291</ArticleId><ArticleId IdType="doi">10.1177/2058738420942390</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Morris TA. (2011) Natural history of venous thromboembolism. Crit Care Clin 27: 869&#x2013;884.</Citation><ArticleIdList><ArticleId IdType="pubmed">22082518</ArticleId></ArticleIdList></Reference><Reference><Citation>Roy PM, Meyer G, Vielle B, et al. (2006) Appropriateness of diagnostic management and outcomes of suspected pulmonary embolism. Ann Intern Med 144: 157&#x2013;164.</Citation><ArticleIdList><ArticleId IdType="pubmed">16461959</ArticleId></ArticleIdList></Reference><Reference><Citation>Nordstrom M, Lindblad B. (1998) Autopsy-verified venous thromboembolism within a defined urban population&#x2013;the city of Malmo, Sweden. APMIS 106: 378&#x2013;384.</Citation><ArticleIdList><ArticleId IdType="pubmed">9548426</ArticleId></ArticleIdList></Reference><Reference><Citation>Heit JA. (2006) The epidemiology of venous thromboembolism in the community: Implications for prevention and management. J Thromb Thrombol 21(1): 23&#x2013;29.</Citation><ArticleIdList><ArticleId IdType="pubmed">16475038</ArticleId></ArticleIdList></Reference><Reference><Citation>Torbicki A, Perrier A, Konstantinides S, et al. (2008) Guidelines on the diagnosis and management of acute pulmonary embolism: The Task Force for the Diagnosis and Management of Acute Pulmonary Embolism of the European Society of Cardiology (ESC). Eur Heart J 29: 2276&#x2013;2315.</Citation><ArticleIdList><ArticleId IdType="pubmed">18757870</ArticleId></ArticleIdList></Reference><Reference><Citation>Torbicki A, Perrier A, Konstantinides S, et al. (2000) Guidelines on diagnosis and management of acute pulmonary embolism. Task Force on Pulmonary Embolism, European Society of Cardiology. Eur Heart J 21: 1301&#x2013;1336.</Citation><ArticleIdList><ArticleId IdType="pubmed">10952823</ArticleId></ArticleIdList></Reference><Reference><Citation>Nijkeuter M, Hovens MM, Davidson BL, et al. (2006) Resolution of thromboemboli in patients with acute pulmonary embolism: A systematic review. Chest 129(1): 192&#x2013;197.</Citation><ArticleIdList><ArticleId IdType="pubmed">16424432</ArticleId></ArticleIdList></Reference><Reference><Citation>Ornelas-Aguirre JM, Vazquez-Camacho G, Gonzalez-Lopez L, et al. (2003) Concordance between premortem and postmortem diagnosis in the autopsy: Results of a 10-year study in a tertiary care center. Ann Diagn Pathol 7(4): 223&#x2013;230.</Citation><ArticleIdList><ArticleId IdType="pubmed">12913844</ArticleId></ArticleIdList></Reference><Reference><Citation>Zavaleta Mart&#xed;nez EO, Morales Blanhir JE. (2006) Tromboembolia pulmonar. Neumolog&#xed;a Cirug&#xed;a T&#xf3;rax 65: 24&#x2013;39.</Citation></Reference><Reference><Citation>Anderson JA, Weitz JI. (2011) Hypercoagulable states. Crit Care Clin 27: 933&#x2013;952.</Citation><ArticleIdList><ArticleId IdType="pubmed">22082521</ArticleId></ArticleIdList></Reference><Reference><Citation>Timp JF, Braekkan SK, Versteeg HH, et al. (2013) Epidemiology of cancer-associated venous thrombosis. Blood 122: 1712&#x2013;1723.</Citation><ArticleIdList><ArticleId IdType="pubmed">23908465</ArticleId></ArticleIdList></Reference><Reference><Citation>Falanga A, Marchetti M. (2009) Venous thromboembolism in the hematologic malignancies. J Clin Oncol 27: 4848&#x2013;4857.</Citation><ArticleIdList><ArticleId IdType="pubmed">19752334</ArticleId></ArticleIdList></Reference><Reference><Citation>Turnbull A, Osborn M, Nicholas N. (2015) Hospital autopsy: Endangered or extinct? J Clin Pathol 68: 601&#x2013;604.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4518760</ArticleId><ArticleId IdType="pubmed">26076965</ArticleId></ArticleIdList></Reference><Reference><Citation>Tadlock MD, Chouliaras K, Kennedy M, et al. (2015) The origin of fatal pulmonary emboli: A postmortem analysis of 500 deaths from pulmonary embolism in trauma, surgical, and medical patients. Am J Surg 209(6): 959&#x2013;968.</Citation><ArticleIdList><ArticleId IdType="pubmed">25669120</ArticleId></ArticleIdList></Reference><Reference><Citation>Tejerina E, Esteban A, Fernandez-Segoviano P, et al. (2012) Clinical diagnoses and autopsy findings: Discrepancies in critically ill patients. Crit Care Med 40(3): 842&#x2013;846.</Citation><ArticleIdList><ArticleId IdType="pubmed">22001588</ArticleId></ArticleIdList></Reference><Reference><Citation>Goldman L, Sayson R, Robbins S, et al. (1983) The value of the autopsy in three medical eras. N Engl J Med 308: 1000&#x2013;1005.</Citation><ArticleIdList><ArticleId IdType="pubmed">6835306</ArticleId></ArticleIdList></Reference><Reference><Citation>Malatino LCA, Cardella AM, Puccia G, et al. (2016) Testing clinical scores to diagnose incident deep vein thrombosis in patients hospitalized in a department of medicine: Can biomarkers improve accuracy. Angiology 67(3): 245&#x2013;251.</Citation><ArticleIdList><ArticleId IdType="pubmed">25991607</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">24253138</PMID><DateCompleted><Year>2014</Year><Month>05</Month><Day>05</Day></DateCompleted><DateRevised><Year>2022</Year><Month>04</Month><Day>10</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1528-1140</ISSN><JournalIssue CitedMedium="Internet"><Volume>259</Volume><Issue>4</Issue><PubDate><Year>2014</Year><Month>Apr</Month></PubDate></JournalIssue><Title>Annals of surgery</Title><ISOAbbreviation>Ann Surg</ISOAbbreviation></Journal><ArticleTitle>A randomized study on 1-week versus 4-week prophylaxis for venous thromboembolism after laparoscopic surgery for colorectal cancer.</ArticleTitle><Pagination><StartPage>665</StartPage><EndPage>669</EndPage><MedlinePgn>665-9</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1097/SLA.0000000000000340</ELocationID><Abstract><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">To compare the efficacy and safety of antithrombotic prophylaxis given for 1 week or 4 weeks in patients undergoing laparoscopic surgery for colorectal cancer.</AbstractText><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Extending antithrombotic prophylaxis beyond 1 week reduces the incidence of venous thromboembolism (VTE) after open abdominal surgery for cancer.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">In consecutive patients who underwent laparoscopic surgery for colorectal cancer, complete compression ultrasonography of the lower limbs was performed after 8 &#xb1; 2 days of antithrombotic prophylaxis. Patients with no evidence of VTE were randomized to short (heparin withdrawal) or to extended (heparin continued for 3 additional weeks) prophylaxis. Complete compression ultrasonography was repeated at day 28 &#xb1; 2 after surgery by investigators blinded to treatment allocation. The primary outcome of the study was the composite of symptomatic and ultrasonography-detected VTE at day 28 &#xb1; 2 after surgery.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Overall, 301 patients were evaluated for inclusion in the study and 225 were randomized. VTE occurred in 11 of 113 patients randomized to short (9.7%) and in none of the 112 patients randomized to extended heparin prophylaxis (P = 0.001). The incidence of VTE at 3 months was 9.7% and 0.9% in patients randomized to short or to extended heparin prophylaxis, respectively (relative risk reduction: 91%, 95% confidence interval: 30%-99%; P = 0.005). The rate of bleeding was similar in the 2 treatment groups. Two patients died during the study period, 1 in each treatment group.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">After laparoscopic surgery for colorectal cancer, extended antithrombotic prophylaxis is safe and reduces the risk for VTE as compared with 1-week prophylaxis (NCT01589146).</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Vedovati</LastName><ForeName>Maria Cristina</ForeName><Initials>MC</Initials><AffiliationInfo><Affiliation>*Internal and Cardiovascular Medicine-Stroke Unit, University of Perugia, Perugia, Italy &#x2020;Oncology Surgery, University of Perugia, Perugia, Italy &#x2021;General Surgery, S. Maria della Misericordia Hospital, Perugia, Italy &#xa7;Unit of Angiology, University Hospital of Padua, Padua, Italy &#xb6;General Surgery, Niguarda Hospital, Milan, Italy &#x2016;General Surgery, S. Giovanni Battista Hospital, Foligno, Italy **Unit of Angiology, S. Giovanni Battista Hospital, Foligno, Italy &#x2020;&#x2020;Department of Surgical, Oncological and Gastroenterological Sciences, Section of Surgical Clinic I, University Hospital of Padua, Padua, Italy &#x2021;&#x2021;General and Emergency Surgery, University of Perugia, Perugia, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Becattini</LastName><ForeName>Cecilia</ForeName><Initials>C</Initials></Author><Author ValidYN="Y"><LastName>Rondelli</LastName><ForeName>Fabio</ForeName><Initials>F</Initials></Author><Author ValidYN="Y"><LastName>Boncompagni</LastName><ForeName>Michela</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Camporese</LastName><ForeName>Giuseppe</ForeName><Initials>G</Initials></Author><Author ValidYN="Y"><LastName>Balzarotti</LastName><ForeName>Ruben</ForeName><Initials>R</Initials></Author><Author ValidYN="Y"><LastName>Mariani</LastName><ForeName>Enrico</ForeName><Initials>E</Initials></Author><Author ValidYN="Y"><LastName>Flamini</LastName><ForeName>Otello</ForeName><Initials>O</Initials></Author><Author ValidYN="Y"><LastName>Pucciarelli</LastName><ForeName>Salvatore</ForeName><Initials>S</Initials></Author><Author ValidYN="Y"><LastName>Donini</LastName><ForeName>Annibale</ForeName><Initials>A</Initials></Author><Author ValidYN="Y"><LastName>Agnelli</LastName><ForeName>Giancarlo</ForeName><Initials>G</Initials></Author></AuthorList><Language>eng</Language><DataBankList CompleteYN="Y"><DataBank><DataBankName>ClinicalTrials.gov</DataBankName><AccessionNumberList><AccessionNumber>NCT01589146</AccessionNumber></AccessionNumberList></DataBank></DataBankList><PublicationTypeList><PublicationType UI="D003160">Comparative Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016448">Multicenter Study</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Ann Surg</MedlineTA><NlmUniqueID>0372354</NlmUniqueID><ISSNLinking>0003-4932</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D005343">Fibrinolytic Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D006495">Heparin, Low-Molecular-Weight</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Ann Surg. 2015 Dec;262(6):e120. doi: 10.1097/SLA.0000000000000770.</RefSource><PMID Version="1">24887974</PMID></CommentsCorrections><CommentsCorrections RefType="CommentIn"><RefSource>Ann Surg. 2015 Dec;262(6):e123-4. doi: 10.1097/SLA.0000000000000800.</RefSource><PMID Version="1">24950286</PMID></CommentsCorrections><CommentsCorrections RefType="CommentIn"><RefSource>Ann Surg. 2016 Apr;263(4):e62. doi: 10.1097/SLA.0000000000000901.</RefSource><PMID Version="1">25211266</PMID></CommentsCorrections><CommentsCorrections RefType="CommentIn"><RefSource>Ann Surg. 2016 Apr;263(4):e63. doi: 10.1097/SLA.0000000000000904.</RefSource><PMID Version="1">25502469</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003082" MajorTopicYN="N">Colectomy</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015179" MajorTopicYN="N">Colorectal Neoplasms</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004334" MajorTopicYN="N">Drug Administration Schedule</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005343" MajorTopicYN="N">Fibrinolytic Agents</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005500" MajorTopicYN="N">Follow-Up Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006495" MajorTopicYN="N">Heparin, Low-Molecular-Weight</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015994" MajorTopicYN="N">Incidence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010535" MajorTopicYN="Y">Laparoscopy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011182" MajorTopicYN="N">Postoperative Care</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016016" MajorTopicYN="N">Proportional Hazards Models</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011655" MajorTopicYN="N">Pulmonary Embolism</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016037" MajorTopicYN="N">Single-Blind Method</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014463" MajorTopicYN="N">Ultrasonography</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D054556" MajorTopicYN="N">Venous Thromboembolism</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020246" MajorTopicYN="N">Venous Thrombosis</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2013</Year><Month>11</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2013</Year><Month>11</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2014</Year><Month>5</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">24253138</ArticleId><ArticleId IdType="doi">10.1097/SLA.0000000000000340</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">23778403</PMID><DateCompleted><Year>2014</Year><Month>01</Month><Day>22</Day></DateCompleted><DateRevised><Year>2024</Year><Month>03</Month><Day>18</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1980-5322</ISSN><JournalIssue CitedMedium="Internet"><Volume>68</Volume><Issue>5</Issue><PubDate><Year>2013</Year><Month>May</Month></PubDate></JournalIssue><Title>Clinics (Sao Paulo, Brazil)</Title><ISOAbbreviation>Clinics (Sao Paulo)</ISOAbbreviation></Journal><ArticleTitle>Fatal pulmonary embolism in hospitalized patients: a large autopsy-based matched case-control study.</ArticleTitle><Pagination><StartPage>679</StartPage><EndPage>685</EndPage><MedlinePgn>679-85</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.6061/clinics/2013(05)16</ELocationID><Abstract><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">Pulmonary embolism is an underdiagnosed major cause of death for hospitalized patients. The objective of this study was to identify the conditions associated with fatal pulmonary embolism in this population.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">A total of 13,074 autopsy records were evaluated in a case-control study. Patients were matched by age, sex, and year of death, and factors potentially associated with fatal pulmonary embolism were analyzed using univariate and multivariate conditional logistic regression.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Pulmonary embolism was considered fatal in 328 (2.5%) patients. In the multivariate analysis, conditions that were more common in patients who died of pulmonary embolism were atherosclerosis, congestive heart failure, and neurological surgery. Some conditions were negatively associated with fatal pulmonary embolism, including hemorrhagic stroke, aortic aneurism, cirrhosis, acquired immune deficiency syndrome, and pneumonia. In the control group, patients with hemorrhagic stroke and aortic aneurism had short hospital stays (8.5 and 8.8 days, respectively), and the hemorrhage itself was the main cause of death in most of them (90.6% and 68.4%, respectively), which may have prevented the development of pulmonary embolism. Cirrhotic patients in the control group also had short hospital stays (7 days), and 50% died from bleeding complications.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">In this large autopsy study, atherosclerosis, congestive heart failure, and neurological surgery were diagnoses associated with fatal pulmonary embolism.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Carvalho Bricola</LastName><ForeName>Solange Aparecida Petilo</ForeName><Initials>SA</Initials><AffiliationInfo><Affiliation>Faculdade de Medicina da Universidade de S&#xe3;o Paulo, Department of Medicine, S&#xe3;o Paulo/SP, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Paiva</LastName><ForeName>Edison Ferreira</ForeName><Initials>EF</Initials></Author><Author ValidYN="Y"><LastName>Lichtenstein</LastName><ForeName>Arnaldo</ForeName><Initials>A</Initials></Author><Author ValidYN="Y"><LastName>Gianini</LastName><ForeName>Reinaldo Jos&#xe9;</ForeName><Initials>RJ</Initials></Author><Author ValidYN="Y"><LastName>Duarte</LastName><ForeName>Jurandir Godoy</ForeName><Initials>JG</Initials></Author><Author ValidYN="Y"><LastName>Shinjo</LastName><ForeName>Samuel Katsuyuki</ForeName><Initials>SK</Initials></Author><Author ValidYN="Y"><LastName>Eluf-Neto</LastName><ForeName>Jose</ForeName><Initials>J</Initials></Author><Author ValidYN="Y"><LastName>Arruda Martins</LastName><ForeName>Milton</ForeName><Initials>M</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Clinics (Sao Paulo)</MedlineTA><NlmUniqueID>101244734</NlmUniqueID><ISSNLinking>1807-5932</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001344" MajorTopicYN="N">Autopsy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016022" MajorTopicYN="N">Case-Control Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017052" MajorTopicYN="Y">Hospital Mortality</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011655" MajorTopicYN="N">Pulmonary Embolism</DescriptorName><QualifierName UI="Q000401" MajorTopicYN="Y">mortality</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>No potential conflict of interest was reported.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2012</Year><Month>11</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2013</Year><Month>2</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2013</Year><Month>6</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2013</Year><Month>6</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2014</Year><Month>1</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2013</Year><Month>5</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">23778403</ArticleId><ArticleId IdType="pmc">PMC3654296</ArticleId><ArticleId IdType="doi">10.6061/clinics/2013(05)16</ArticleId><ArticleId IdType="pii">S1807-5932(22)01728-8</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Alpert JS, Dalen JE. Epidemiology and natural history of venous thromboembolism. Prog Cardiovasc Dis. 1994;36(6):417&#x2013;22.</Citation><ArticleIdList><ArticleId IdType="pubmed">8184095</ArticleId></ArticleIdList></Reference><Reference><Citation>Sandler DA, Martin JF. Autopsy proven pulmonary embolism in hospital patients: are we detecting enough deep vein thrombosis. J&#xa0;R&#xa0;Soc Med. 1989;82(4):203&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1292084</ArticleId><ArticleId IdType="pubmed">2716016</ArticleId></ArticleIdList></Reference><Reference><Citation>Geerts WH, Bergqvist D, Pineo GF, Heit JA, Samama CM, Lassen MR, et al. Prevention of venous thromboembolism: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th edition) Chest. 2008;133(6 Suppl):381S&#x2013;453S.</Citation><ArticleIdList><ArticleId IdType="pubmed">18574271</ArticleId></ArticleIdList></Reference><Reference><Citation>Rocha AT, Paiva EF, Lichtenstein A, Milani R, Jr, Cavalheiro CF, Maffei FH. Risk-assessment algorithm and recommendations for venous thromboembolism prophylaxis in medical patients. Vasc Health Risk Manag. 2007;3(4):533&#x2013;53.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2291339</ArticleId><ArticleId IdType="pubmed">17969384</ArticleId></ArticleIdList></Reference><Reference><Citation>Perrier A, Roy PM, Sanchez O, Le Gal G, Meyer G, Gourdier AL, et al. Multidetector-row computed tomography in suspected pulmonary embolism. N&#xa0;Engl&#xa0;J&#xa0;Med. 2005;352(17):1760&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">15858185</ArticleId></ArticleIdList></Reference><Reference><Citation>Goodman LR, Curtin JJ, Mewissen MW, Foley WD, Lipchik RJ, Crain MR, et al. Detection of pulmonary embolism in patients with unresolved clinical and scintigraphic diagnosis: helical CT versus angiography. AJR Am&#xa0;J&#xa0;Roentgenol. 1995;164(6):1369&#x2013;74.</Citation><ArticleIdList><ArticleId IdType="pubmed">7754875</ArticleId></ArticleIdList></Reference><Reference><Citation>Michiels JJ, Gadisseur A, van der Planken M, Schroyens W, De Maeseneer M, Hermsen JT, et al. Screening for deep vein thrombosis and pulmonary embolism in outpatients with suspected DVT or PE by the sequential use of clinical score: a sensitive quantitative D-dimer test and noninvasive diagnostic tools. Semin Vasc Med. 2005;5(4):351&#x2013;64.</Citation><ArticleIdList><ArticleId IdType="pubmed">16302156</ArticleId></ArticleIdList></Reference><Reference><Citation>Michiels JJ, Gadisseur A, Van Der Planken M, Schroyens W, De Maeseneer M, Hermsen JT, et al. A critical appraisal of non-invasive diagnosis and exclusion of deep vein thrombosis and pulmonary embolism in outpatients with suspected deep vein thrombosis or pulmonary embolism: how many tests do we need. Int Angiol. 2005;24(1):27&#x2013;39.</Citation><ArticleIdList><ArticleId IdType="pubmed">15876996</ArticleId></ArticleIdList></Reference><Reference><Citation>Lindblad B, Sternby NH, Bergqvist D. Incidence of venous thromboembolism verified by necropsy over 30 years. BMJ. 1991;302(6778):709&#x2013;11.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1669118</ArticleId><ArticleId IdType="pubmed">2021744</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosenbaum GE, Burns J, Johnson J, Mitchell C, Robinson M, Truog RD. Autopsy consent practice at US teaching hospitals: results of a national survey. Arch Intern Med. 2000;160(3):374&#x2013;80.</Citation><ArticleIdList><ArticleId IdType="pubmed">10668840</ArticleId></ArticleIdList></Reference><Reference><Citation>Goldman L, Sayson R, Robbins S, Cohn LH, Bettmann M, Weisberg M. The value of the autopsy in three medical eras. N&#xa0;Engl&#xa0;J&#xa0;Med. 1983;308(17):1000&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="pubmed">6835306</ArticleId></ArticleIdList></Reference><Reference><Citation>Ayoub T, Chow J. The conventional autopsy in modern medicine. J&#xa0;R&#xa0;Soc Med. 2008;101(4):177&#x2013;81.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2312379</ArticleId><ArticleId IdType="pubmed">18387908</ArticleId></ArticleIdList></Reference><Reference><Citation>Shojania KG, Burton EC, McDonald KM, Goldman L. Changes in rates of autopsy-detected diagnostic errors over time: a systematic review. JAMA. 2003;289(21):2849&#x2013;56.</Citation><ArticleIdList><ArticleId IdType="pubmed">12783916</ArticleId></ArticleIdList></Reference><Reference><Citation>Coradazzi AL, Morganti AL, Montenegro MR. Discrepancies between clinical diagnoses and autopsy findings. Braz&#xa0;J&#xa0;Med Biol Res. 2003;36(3):385&#x2013;91.</Citation><ArticleIdList><ArticleId IdType="pubmed">12640504</ArticleId></ArticleIdList></Reference><Reference><Citation>Perkins GD, McAuley DF, Davies S, Gao F. Discrepancies between clinical and postmortem diagnoses in critically ill patients: an observational study. Crit Care. 2003;7(6):R129&#x2013;32.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC374369</ArticleId><ArticleId IdType="pubmed">14624686</ArticleId></ArticleIdList></Reference><Reference><Citation>Nicolaides AN, Breddin HK, Fareed J, Goldhaber S, Haas S, Hull R, et al. Prevention of venous thromboembolism. International Consensus Statement. Guidelines compiled in accordance with the scientific evidence. Int Angiol. 2001;20(10):1&#x2013;37.</Citation><ArticleIdList><ArticleId IdType="pubmed">11342993</ArticleId></ArticleIdList></Reference><Reference><Citation>Goldhaber SZ. Pulmonary embolism. Lancet. 2004;363(9417):1295&#x2013;305.</Citation><ArticleIdList><ArticleId IdType="pubmed">15094276</ArticleId></ArticleIdList></Reference><Reference><Citation>Cohen AT, Tapson VF, Bergmann JF, Goldhaber SZ, Kakkar AK, Deslandes B, et al. Venous thromboembolism risk and prophylaxis in the acute hospital care setting (ENDORSE study): a multinational cross-sectional study. Lancet. 2008;2008;371(9610)371(9628):387&#x2013;94. 1914. Erratum in: Lancet.</Citation><ArticleIdList><ArticleId IdType="pubmed">18242412</ArticleId></ArticleIdList></Reference><Reference><Citation>Deheinzelin D, Braga AL, Martins LC, Martins MA, Hernandez A, Yoshida WB, et al. Incorrect use of thromboprophylaxis for venous thromboembolism in medical and surgical patients: results of a multicentric, observational and cross-sectional study in Brazil. J&#xa0;Thromb Haemost. 2006;4(6):1266&#x2013;70.</Citation><ArticleIdList><ArticleId IdType="pubmed">16706970</ArticleId></ArticleIdList></Reference><Reference><Citation>Pineda LA, Hathwar VS, Grant BJ. Clinical suspicion of fatal pulmonary embolism. Chest. 2001;120(3):791&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="pubmed">11555511</ArticleId></ArticleIdList></Reference><Reference><Citation>Goldhaber SZ, Hennekens CH, Evans DA, Newton EC, Godleski JJ. Factors associated with correct antemortem diagnosis of major pulmonary embolism. Am&#xa0;J&#xa0;Med. 1982;73(6):822&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">7148876</ArticleId></ArticleIdList></Reference><Reference><Citation>Kotovicz F, Mauad T, Saldiva PH. Clinico-pathological discrepancies in a general university hospital in S&#xe3;o Paulo, Brazil. Clinics (Sao Paulo) 2008;63(5):581&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2664713</ArticleId><ArticleId IdType="pubmed">18925315</ArticleId></ArticleIdList></Reference><Reference><Citation>Morpurgo M, Schmid C, Mandelli V. Factors influencing the clinical diagnosis of pulmonary embolism: analysis of 229 postmortem cases. Int&#xa0;J&#xa0;Cardiol. 1998;65(Suppl 1):S79&#x2013;82.</Citation><ArticleIdList><ArticleId IdType="pubmed">9706833</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoyert DL, Kung HC, Xu J. Autopsy patterns in 2003. National Center for Health Statistics. Vital Health Stat. 2007;20(32):1&#x2013;21.</Citation><ArticleIdList><ArticleId IdType="pubmed">25314591</ArticleId></ArticleIdList></Reference><Reference><Citation>Stein PD, Beemath A, Meyers FA, Skaf E, Sanchez J, Olson RE. Incidence of venous thromboembolism in patients hospitalized with cancer. Am&#xa0;J&#xa0;Med. 2006;119(1):60&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">16431186</ArticleId></ArticleIdList></Reference><Reference><Citation>Beemath A, Stein PD, Skaf E, Al Sibae MR, Alesh I. Risk of venous thromboembolism in patients hospitalized with heart failure. Am&#xa0;J&#xa0;Cardiol. 2006;98(6):793&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="pubmed">16950187</ArticleId></ArticleIdList></Reference><Reference><Citation>Rizkallah J, Man SF, Sin DD. Prevalence of pulmonary embolism in acute exacerbations of COPD: a systematic review and metaanalysis. Chest. 2009;135(3):786&#x2013;93.</Citation><ArticleIdList><ArticleId IdType="pubmed">18812453</ArticleId></ArticleIdList></Reference><Reference><Citation>Thodiyil PA, Kakkar AK. Variation in relative risk of venous thromboembolism in different cancers. Thromb Haemost. 2002;87(6):1076&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">12083490</ArticleId></ArticleIdList></Reference><Reference><Citation>Khaldi A, Helo N, Schneck MJ, Origitano TC. Venous thromboembolism: deep venous thrombosis and pulmonary embolism in a neurosurgical population. J&#xa0;Neurosurg. 2011;114(1):40&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">20815694</ArticleId></ArticleIdList></Reference><Reference><Citation>Prandoni P, Bilora F, Marchiori A, Bernardi E, Petrobelli F, Lensing AW, et al. An association between atherosclerosis and venous thrombosis. N&#xa0;Engl&#xa0;J&#xa0;Med. 2003;348(15):1435&#x2013;41.</Citation><ArticleIdList><ArticleId IdType="pubmed">12686699</ArticleId></ArticleIdList></Reference><Reference><Citation>Prandoni P. Venous thromboembolism and atherosclerosis: is there a link. Thromb Haemost. 2007;5(Suppl 1):270&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="pubmed">17635736</ArticleId></ArticleIdList></Reference><Reference><Citation>Glynn RJ, Danielson E, Fonseca FA, Genest J, Gotto AM, Jr, Kastelein JJ, et al. A randomized trial of rosuvastatin in the prevention of venous thromboembolism. N&#xa0;Engl&#xa0;J&#xa0;Med. 2009;360(18):1851&#x2013;61.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2710995</ArticleId><ArticleId IdType="pubmed">19329822</ArticleId></ArticleIdList></Reference><Reference><Citation>Pai M, Evans NS, Shah SJ, Green D, Cook D, Crowther MA. Statins in the prevention of venous thromboembolism: A meta-analysis of observational studies. Thromb Res. 2011;128(5):422&#x2013;30.</Citation><ArticleIdList><ArticleId IdType="pubmed">21641019</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahonkhai AA, Gebo KA, Streiff MB, Moore RD, Segal JB. Venous thromboembolism in patients with HIV/AIDS: a case-control study. J&#xa0;Acquir Immune Defic Syndr. 2008;48(3):310&#x2013;4.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2597553</ArticleId><ArticleId IdType="pubmed">18197123</ArticleId></ArticleIdList></Reference><Reference><Citation>Cortez-Escalante JJ, Castro C, Romero GAS, Matos L, Saif MW. Pulmonary thromboembolism in AIDS patients with chronic venous insufficiency, pulmonary tuberculosis and breast cancer: a case report and pathophysiology review. Rev Inst Med Trop. 2006;48(2):105&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">16699634</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">40306698</PMID><DateCompleted><Year>2025</Year><Month>05</Month><Day>01</Day></DateCompleted><DateRevised><Year>2025</Year><Month>04</Month><Day>30</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2049-4408</ISSN><JournalIssue CitedMedium="Internet"><Volume>107-B</Volume><Issue>5</Issue><PubDate><Year>2025</Year><Month>May</Month><Day>01</Day></PubDate></JournalIssue><Title>The bone &amp; joint journal</Title><ISOAbbreviation>Bone Joint J</ISOAbbreviation></Journal><ArticleTitle>Outcomes of patellofemoral joint arthroplasty compared with total knee arthroplasty for osteoarthritis : a population-based cohort study using data from the National Joint Registry and Hospital Episode Statistics for England.</ArticleTitle><Pagination><StartPage>514</StartPage><EndPage>521</EndPage><MedlinePgn>514-521</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1302/0301-620X.107B5.BJJ-2024-1273.R2</ELocationID><Abstract><AbstractText Label="AIMS" NlmCategory="UNASSIGNED">The surgical options for patients with osteoarthritis (OA) of the patellofemoral joint (PFJ) involve a patellofemoral joint arthroplasty (PFA) or a total knee arthroplasy (TKA). The aim of this study was to describe and compare the safety profile and risk of revision of these two procedures.</AbstractText><AbstractText Label="METHODS" NlmCategory="UNASSIGNED">The records of patients from the UK National Joint Registry who underwent PFA or TKA between April 2003 and December 2021 were linked to the Hospital Episode Statistics database. Using Poisson regression, a 30-day safety profile was created by plotting risk ratios, absolute risk, and the differences in risk of myocardial infarction, respiratory tract infection, urinary tract infection (UTI), stroke, delirium, deep vein thrombosis/pulmonary embolism (DVT/PE), wound infection, and death. A parametric survival model was used to model the survival of a PFA compared with a TKA over the course of the postoperative time period. Differences in hazard ratios were plotted by sex for PFA. Confounding was handled by inverse proportional treatment weighting. The indications for revision and the length of stay in hospital were compared between the procedures.</AbstractText><AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">A total of 7,819 PFAs and 662,141 TKAs were analyzed. Patients who underwnt PFA were significantly less likely to have complications than those who underwent TKA: respiratory tract infection (risk ratio (RR) 0.65 (95% CI 0.47 to 0.90); p = 0.011), DVT/PE (RR 0.35 (95% CI 0.24 to 0.52); p &lt; 0.001), UTI (RR 0.59 (95% CI 0.40 to 0.88); p = 0.001), wound infection (RR 0.73 (95% CI 0.57 to 0.91); p = 0.006), and death within 30 days postoperatively (RR 0.36 (95% CI 0.14 to 0.98); p = 0.045). Over ten years, PFAs had an 85% survival (95% CI 0.84 to 0.86) and TKAs had a 95% survival (95% CI 0.95 to 0.96). Within two years, the indication for revision of a PFA was most likely to be pain, while infection was the most common indication for revision of a TKA at this time.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="UNASSIGNED">PFA may be a safer procedure than TKA, being less likely to have complications, with a reduced length of stay. Despite an increased risk of revision, patients should still be counselled about the advantages of undergoing a PFA.</AbstractText><CopyrightInformation>&#xa9; 2025 Vella-Baldacchino et al.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Vella-Baldacchino</LastName><ForeName>Martinique</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Surgery &amp; Cancer, MSk Lab, Imperial College, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bottle</LastName><ForeName>Alex</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>School of Public Health, Imperial College London, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cobb</LastName><ForeName>Justin</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Surgery &amp; Cancer, MSk Lab, Imperial College, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liddle</LastName><ForeName>Alexander D</ForeName><Initials>AD</Initials><AffiliationInfo><Affiliation>Department of Surgery &amp; Cancer, MSk Lab, Imperial College, London, UK.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D003160">Comparative Study</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>05</Month><Day>01</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Bone Joint J</MedlineTA><NlmUniqueID>101599229</NlmUniqueID><ISSNLinking>2049-4394</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019645" MajorTopicYN="Y">Arthroplasty, Replacement, Knee</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020370" MajorTopicYN="Y">Osteoarthritis, Knee</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012042" MajorTopicYN="N">Registries</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004739" MajorTopicYN="N" Type="Geographic">England</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012086" MajorTopicYN="N">Reoperation</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D057071" MajorTopicYN="Y">Patellofemoral Joint</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007902" MajorTopicYN="N">Length of Stay</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>M. Vella-Baldacchino is an Orthopaedic Research UK Early Career Research Fellow (project no: 551), unrelated to this study. A. Bottle reports grants or contracts from the Royal College of Surgeons of England, unrelated to this study.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>5</Month><Day>1</Day><Hour>6</Hour><Minute>28</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>5</Month><Day>1</Day><Hour>0</Hour><Minute>27</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>4</Month><Day>30</Day><Hour>20</Hour><Minute>13</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">40306698</ArticleId><ArticleId IdType="doi">10.1302/0301-620X.107B5.BJJ-2024-1273.R2</ArticleId><ArticleId IdType="pii">BJJ-2024-1273.R2</ArticleId></ArticleIdList><ReferenceList><Title>References</Title><Reference><Citation>Price AJ , Alvand A , Troelsen A , et al. Knee replacement . Lancet . 2018 ; 392 ( 10158 ): 1672 &#x2013; 1682 . 10.1016/S0140-6736(18)32344-4 30496082</Citation></Reference><Reference><Citation>Evans JT , Walker RW , Evans JP , Blom AW , Sayers A , Whitehouse MR . How long does a knee replacement last? A systematic review and meta-analysis of case series and national registry reports with more than 15 years of follow-up . Lancet . 2019 ; 393 ( 10172 ): 655 &#x2013; 663 . 10.1016/S0140-6736(18)32531-5 30782341</Citation></Reference><Reference><Citation>No authors listed . American Joint Replacement Registry 2023 Annual Report . American Academy of Orthopaedic Surgeons . 2023 . https://connect.registryapps.net/2023-ajrr-annual-report ( date last accessed 14 March 2025 ).</Citation></Reference><Reference><Citation>No authors listed . 2023 Annual Report: Hip, Knee and Shoulder Arthroplasty . Australian Orthopaedic Association National Joint Replacement Registry . 2023 . https://aoanjrr.sahmri.com/documents/10180/1579982/AOA_NJRR_AR23.pdf ( date last accessed 14 March 2025 ).</Citation></Reference><Reference><Citation>Registry Management Committee . The New Zealand Joint Registry Twenty-Four Year Report 24 January 1999 to December 2022 . The New Zealand Joint Registry . 2023 . https://www.nzoa.org.nz/sites/default/files/NZJR%20Twenty%20Four%20Year%20Report__29Aug2023.pdf ( date last accessed 2 April 2024 ).</Citation></Reference><Reference><Citation>Achakri H , Ben-Shlomo Y , Blom A , et al. 20th Annual Report . National Joint Registry . 2023 . https://www.ncbi.nlm.nih.gov/books/NBK559966 ( date last accessed 2 April 2025 ).</Citation></Reference><Reference><Citation>Bennett A , Esler C , Harper W . Trends in knee arthroplasty 1990&#x2013;2003: results from a UK joint register . Orthop Procs . 2005 ; 87-B : 325 &#x2013; 326 . 10.1302/0301-620X.87BSUPP_III.0870325d</Citation></Reference><Reference><Citation>Stoddart JC , Dandridge O , Garner A , Cobb J , van Arkel RJ . The compartmental distribution of knee osteoarthritis &#x2013; a systematic review and meta-analysis . Osteoarthritis Cartilage . 2021 ; 29 ( 4 ): 445 &#x2013; 455 . 10.1016/j.joca.2020.10.011 33253887</Citation></Reference><Reference><Citation>Duncan RC , Hay EM , Saklatvala J , Croft PR . Prevalence of radiographic osteoarthritis--it all depends on your point of view . Rheumatology (Oxford) . 2006 ; 45 ( 6 ): 757 &#x2013; 760 . 10.1093/rheumatology/kei270 16418199</Citation></Reference><Reference><Citation>McAlindon TE , Snow S , Cooper C , Dieppe PA . Radiographic patterns of osteoarthritis of the knee joint in the community: the importance of the patellofemoral joint . Ann Rheum Dis . 1992 ; 51 ( 7 ): 844 &#x2013; 849 . 10.1136/ard.51.7.844 1632657</Citation></Reference><Reference><Citation>Ajnin S , Buchanan D , Arbuthnot J , Fernandes R . Patellofemoral joint replacement - mean five year follow-up . Knee . 2018 ; 25 ( 6 ): 1272 &#x2013; 1277 . 10.1016/j.knee.2018.08.014 30193976</Citation></Reference><Reference><Citation>Coolican M , Budhiparama NC , Lustig S , Maestu R , Price A , Wascher DC . Knee registries . J ISAKOS . 2022 ; 7 ( 5 ): 87 &#x2013; 89 . 10.1016/j.jisako.2022.04.007 35569795</Citation></Reference><Reference><Citation>Garner AJ , Edwards TC , Liddle AD , Jones GG , Cobb JP . The revision partial knee classification system: understanding the causative pathology and magnitude of further surgery following partial knee arthroplasty . Bone Jt Open . 2021 ; 2 ( 8 ): 638 &#x2013; 645 . 10.1302/2633-1462.28.BJO-2021-0086.R1 34392701</Citation></Reference><Reference><Citation>Lonner JH . Patellofemoral arthroplasty: pros, cons, and design considerations . Clin Orthop Relat Res . 2004 ; 428 : 158 &#x2013; 165 . 15534537</Citation></Reference><Reference><Citation>Sabatini L , Giachino M , Risitano S , Atzori F , San Luigi A . Bicompartmental knee arthroplasty . Ann Transl Med . 2016 ; 4 ( 1 ): 5 . 10.3978/j.issn.2305-5839.2015.12.24 26855941</Citation></Reference><Reference><Citation>Kuwabara A , Cinque M , Ray T , Sherman SL . Treatment options for patellofemoral arthritis . Curr Rev Musculoskelet Med . 2022 ; 15 ( 2 ): 90 &#x2013; 106 . 10.1007/s12178-022-09740-z 35118631</Citation></Reference><Reference><Citation>Schneider BL , Ling DI , Kleebad LJ , Strickland S , Pearle A . Comparing return to sports after patellofemoral and knee arthroplasty in an age- and sex-matched cohort . Orthop J Sports Med . 2020 ; 8 ( 10 ): 2325967120957425 . 10.1177/2325967120957425 33088840</Citation></Reference><Reference><Citation>Lewis PL , Graves SE , Cuthbert A , Parker D , Myers P . What is the risk of repeat revision when patellofemoral replacement is revised to TKA? An analysis of 482 cases from a large national arthroplasty registry . Clin Orthop Relat Res . 2019 ; 477 ( 6 ): 1402 &#x2013; 1410 . 10.1097/CORR.0000000000000541 31136442</Citation></Reference><Reference><Citation>Liddle AD , Judge A , Pandit H , Murray DW . Adverse outcomes after total and unicompartmental knee replacement in 101&#x2008;330 matched patients: a study of data from the National Joint Registry for England and Wales . Lancet . 2014 ; 384 ( 9952 ): 1437 &#x2013; 1445 . 10.1016/S0140-6736(14)60419-0 25012116</Citation></Reference><Reference><Citation>Charlson ME , Pompei P , Ales KL , MacKenzie CR . A new method of classifying prognostic comorbidity in longitudinal studies: development and validation . J Chronic Dis . 1987 ; 40 ( 5 ): 373 &#x2013; 383 . 10.1016/0021-9681(87)90171-8 3558716</Citation></Reference><Reference><Citation>Bottle A , Aylin P . Comorbidity scores for administrative data benefited from adaptation to local coding and diagnostic practices . J Clin Epidemiol . 2011 ; 64 ( 12 ): 1426 &#x2013; 1433 . 10.1016/j.jclinepi.2011.04.004 21764557</Citation></Reference><Reference><Citation>No authors listed . International Statistical Classification of Diseases and Related Health Problems 10th Revision . World Health Organization . 2019 . https://icd.who.int/browse10/2019/en ( date last accessed 3 March 2025 ).</Citation></Reference><Reference><Citation>Saklad M . Grading of patients for surgical procedures . Anesthesiol . 1941 ; 2 ( 3 ): 281 &#x2013; 284 .</Citation></Reference><Reference><Citation>No authors listed . English indices of deprivation . Department for Levelling Up, Housing and Communities . 2020 . https://www.gov.uk/government/collections/english-indices-of-deprivation ( date last accessed 14 March 2025 ).</Citation></Reference><Reference><Citation>Lambert PC , Royston P . Further development of flexible parametric models for survival analysis . Stata J . 2009 ; 9 ( 2 ): 265 &#x2013; 290 . 10.1177/1536867X0900900206</Citation></Reference><Reference><Citation>Lambert P . STPM2: Stata Module to Estimate Flexible Parametric Survival Models, Revised 18 Jan 2023 . Statistical Software Components. Boston College Department of Economics , 2010 .</Citation></Reference><Reference><Citation>Dickman PW . Comparing Cox and flexible parametric models . 2019 . https://www.pauldickman.com/software/stata/sex-differences-cox ( date last accessed 3 March 2025 ).</Citation></Reference><Reference><Citation>Lewis P . Knee Replacement Revision: An International Comparison . Lund, Sweden : Lund University , 2022 .</Citation></Reference><Reference><Citation>Towne JB , Bernhard VM . The relationship of postoperative hypertension to complications following carotid endarterectomy . Surgery . 1980 ; 88 ( 4 ): 575 &#x2013; 580 . 7423377</Citation></Reference><Reference><Citation>Goldberg ME , Larijani GE . Perioperative hypertension . Pharmacotherapy . 1998 ; 18 ( 5 ): 911 &#x2013; 914 . 9758305</Citation></Reference><Reference><Citation>Zhou Y , Luo D , Shao L , et al. Risk factors for acute postoperative hypertension in non-cardiac major surgery: a case control study . BMC Anesthesiol . 2023 ; 23 ( 1 ): 167 . 10.1186/s12871-023-02121-0 37193947</Citation></Reference><Reference><Citation>Wolfe S , Varacallo M , Thomas JD , Carroll JJ , Kahwaji CI . Patellar Instability . In : StatPearls . Treasure Island, Florida, USA : StatPearls Publishing , 2023 .</Citation></Reference><Reference><Citation>Mont MA , Haas S , Mullick T , Hungerford DS . Total knee arthroplasty for patellofemoral arthritis . J Bone Joint Surg Am . 2002 ; 84-A ( 11 ): 1977 &#x2013; 1981 . 10.2106/00004623-200211000-00011 12429758</Citation></Reference><Reference><Citation>Parvizi J , Stuart MJ , Pagnano MW , Hanssen AD . Total knee arthroplasty in patients with isolated patellofemoral arthritis . Clin Orthop Relat Res . 2001 ; 392 ( 392 ): 147 &#x2013; 152 . 10.1097/00003086-200111000-00018 11716376</Citation></Reference><Reference><Citation>Tay ML , Monk AP , Frampton CM , Hooper GJ , Young SW . A comparison of clinical thresholds for revision following total and unicompartmental knee arthroplasty . Bone Joint J . 2023 ; 105-B ( 3 ): 269 &#x2013; 276 . 10.1302/0301-620X.105B3.BJJ-2022-0872.R2 36854342</Citation></Reference><Reference><Citation>Lewis PL , Graves SE , Cuthbert A , Parker D , Myers P . What is the risk of repeat revision when patellofemoral replacement is revised to TKA? An analysis of 482 cases from a large national arthroplasty registry . Clin Orthop Relat Res . 2019 ; 477 ( 6 ): 1402 &#x2013; 1410 . 10.1097/CORR.0000000000000541 31136442</Citation></Reference><Reference><Citation>Lenguerrand E , Whitehouse MR , Beswick AD , et al. Risk factors associated with revision for prosthetic joint infection following knee replacement: an observational cohort study from England and Wales . Lancet Infect Dis . 2019 ; 19 ( 6 ): 589 &#x2013; 600 . 10.1016/S1473-3099(18)30755-2 31005559</Citation></Reference><Reference><Citation>Li CY , Ng Cheong Chung KJ , Ali OME , Chung NDH , Li CH . Literature review of the causes of pain following total knee replacement surgery: prosthesis, inflammation and arthrofibrosis . EFORT Open Rev . 2020 ; 5 ( 9 ): 534 &#x2013; 543 . 10.1302/2058-5241.5.200031 33072405</Citation></Reference><Reference><Citation>Scuderi GR , Insall JN , Scott NW . Patellofemoral pain after total knee arthroplasty . J Am Acad Orthop Surg . 1994 ; 2 ( 5 ): 239 &#x2013; 246 . 10.5435/00124635-199409000-00001 10709015</Citation></Reference><Reference><Citation>Dahm DL , Kalisvaart MM , Stuart MJ , Slettedahl SW . Patellofemoral arthroplasty: outcomes and factors associated with early progression of tibiofemoral arthritis . Knee Surg Sports Traumatol Arthrosc . 2014 ; 22 ( 10 ): 2554 &#x2013; 2559 . 10.1007/s00167-014-3202-3 25079134</Citation></Reference><Reference><Citation>Stefanik JJ , Guermazi A , Roemer FW , et al. Changes in patellofemoral and tibiofemoral joint cartilage damage and bone marrow lesions over 7 years: the Multicenter Osteoarthritis Study . Osteoarthr Cartil . 2016 ; 24 ( 7 ): 1160 &#x2013; 1166 . 10.1016/j.joca.2016.01.981 26836287</Citation></Reference><Reference><Citation>Koelling S , Miosge N . Sex differences of chondrogenic progenitor cells in late stages of osteoarthritis . Arthritis Rheum . 2010 ; 62 ( 4 ): 1077 &#x2013; 1087 . 10.1002/art.27311 20131243</Citation></Reference><Reference><Citation>Peshkova M , Lychagin A , Lipina M , et al. Gender-related aspects in osteoarthritis development and progression: a review . Int J Mol Sci . 2022 ; 23 ( 5 ): 2767 . 10.3390/ijms23052767 35269906</Citation></Reference><Reference><Citation>Wise J . Women&#x2019;s health: specific assessments to become mandatory in medical training . BMJ . 2022 ; o1820 . 10.1136/bmj.o1820 35858692</Citation></Reference><Reference><Citation>Stone B , Nugent M , Young SW , Frampton C , Hooper GJ . The lifetime risk of revision following total knee arthroplasty . Bone Joint J . 2022 ; 104-B ( 2 ): 235 &#x2013; 241 . 10.1302/0301-620X.104B2.BJJ-2021-0890.R1 35094573</Citation></Reference><Reference><Citation>Kennedy JA , Mohammad HR , Mellon SJ , Dodd CAF , Murray DW . Age stratified, matched comparison of unicompartmental and total knee replacement . Knee . 2020 ; 27 ( 5 ): 1332 &#x2013; 1342 . 10.1016/j.knee.2020.06.004 33010745</Citation></Reference><Reference><Citation>Vella-Baldacchino M , Davies AR , Bottle A , Cobb J , Liddle AD . Association between surgeon volume and patient outcomes after elective patellofemoral arthroplasty: a population-based cohort study using data from the National Joint Registry and Hospital Episode Statistics for England . J Bone Joint Surg Am . 2025 ; Online ahead of print . 10.2106/JBJS.24.00703 39899649</Citation></Reference><Reference><Citation>No authors listed . UN Decade of Healthy Ageing . World Health Organization . 2022 . https://www.who.int/initiatives/decade-of-healthy-ageing ( date last accessed 15 March 2025 ).</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">39979813</PMID><DateCompleted><Year>2025</Year><Month>02</Month><Day>20</Day></DateCompleted><DateRevised><Year>2025</Year><Month>05</Month><Day>16</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1471-2253</ISSN><JournalIssue CitedMedium="Internet"><Volume>25</Volume><Issue>1</Issue><PubDate><Year>2025</Year><Month>Feb</Month><Day>20</Day></PubDate></JournalIssue><Title>BMC anesthesiology</Title><ISOAbbreviation>BMC Anesthesiol</ISOAbbreviation></Journal><ArticleTitle>Cerebral oxygenation and hemodynamic changes during ephedrine and phenylephrine administration for transient intraoperative hypotension in patients undergoing major abdominal surgery: a randomized controlled trial.</ArticleTitle><Pagination><StartPage>87</StartPage><MedlinePgn>87</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">87</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s12871-025-02944-z</ELocationID><Abstract><AbstractText Label="BACKGROUND">Phenylephrine and ephedrine are frequently used vasopressors for treating intraoperative hypotension. However, their impact on cerebral oxygenation and blood flow remains a subject of debate. This study aims to understand their effects on cerebral oxygen saturation and hemodynamics when used for treatment of intraoperative hypotension.</AbstractText><AbstractText Label="METHODS">The adult patients undergoing major abdominal surgery under general anesthesia were randomly assigned into ephedrine (ED) group or phenylephrine (PE) group. They received an intravenous bolus of either ephedrine or phenylephrine for treating intraoperative transient hypotension. The primary outcome was their effects on regional cerebral oxygen saturation (rScO<sub>2</sub>). The secondary outcomes included cerebral hemodynamics middle cerebral artery velocity (MCAvm), pulsatility index (PI), and resistance index (RI), as well as systemic hemodynamics arterial blood pressure (ABP), heart rate (HR), cardiac output (CO), cardiac index (CI), stroke volume (SV) and stroke volume index (SVI). Additionally, two indices of cerebral autoregulation, mean flow index (Mx<sub>a</sub>) and cerebral oximetry index (CO<sub>X</sub>), were calculated in real-time via ICM&#x2009;+&#x2009;software.</AbstractText><AbstractText Label="RESULTS">Forty patients were included in this study. The initial results showed ephedrine increased rScO<sub>2</sub> (p&#x2009;&lt;&#x2009;0.001), while phenylephrine increased Mx<sub>a</sub> (p&#x2009;&lt;&#x2009;0.02) and CO<sub>X</sub> (p&#x2009;&lt;&#x2009;0.007), respectively. However, upon further linear-mix model analysis, the effects of both drugs on rScO<sub>2</sub> (p&#x2009;=&#x2009;0.944), Mx<sub>a</sub> (p&#x2009;=&#x2009;0.093) and CO<sub>X</sub> (p&#x2009;=&#x2009;0.084) were found to be non-significant. Compared with the hemodynamic parameters during hypotension, the systolic blood pressure (SBP) (p&#x2009;&lt;&#x2009;0.001), diastolic blood pressure (DBP) (p&#x2009;&lt;&#x2009;0.001), mean arterial pressure (MAP) (p&#x2009;&lt;&#x2009;0.001), and MCAvm (p&#x2009;&lt;&#x2009;0.001) significantly increased after both ephedrine and phenylephrine administration. However, no significant differences were found between the two groups in terms of the changes in MAP (p&#x2009;=&#x2009;0.549) and MCAvm (p&#x2009;=&#x2009;0.173). And there were significant increases in CO (p&#x2009;&lt;&#x2009;0.001), HR (p&#x2009;&lt;&#x2009;0.001), and CI (p&#x2009;&lt;&#x2009;0.001) following ephedrine administration, while decreases in HR (p&#x2009;&lt;&#x2009;0.001), CO (p&#x2009;&lt;&#x2009;0.001), and CI (p&#x2009;&lt;&#x2009;0.001) after phenylephrine administration.</AbstractText><AbstractText Label="CONCLUSION">In the management of intraoperative hypotension, both phenylephrine and ephedrine effectively increase MAP and MCAvm, albeit with their differential effects on CO and HR. It seems that neither vasopressor has a significant impact on cerebral oxygenation and cerebral autoregulation.</AbstractText><CopyrightInformation>&#xa9; 2025. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Li</LastName><ForeName>Xueyan</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Anaesthesia and Critical Care, Fudan University Shanghai Cancer Center, Shanghai, 200032, PR China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Zheng</LastName><ForeName>Yijun</ForeName><Initials>Y</Initials><Identifier Source="ORCID">0000-0002-0163-6401</Identifier><AffiliationInfo><Affiliation>Department of Anaesthesia and Critical Care, Fudan University Shanghai Cancer Center, Shanghai, 200032, PR China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of oncology, Shanghai Medical College, Fudan University, Shanghai, 200032, PR China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Intensive Care Unit, Fudan University Shanghai Cancer Center, Shanghai, 200032, P.R. China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Jun</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Anaesthesia and Critical Care, Fudan University Shanghai Cancer Center, Shanghai, 200032, PR China. snapzhang@aliyun.com.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of oncology, Shanghai Medical College, Fudan University, Shanghai, 200032, PR China. snapzhang@aliyun.com.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Anesthesiology, Fudan University Shanghai Cancer Center, and Shanghai Medical College, Fudan University, 270 Dong An Road, Shanghai, 200032, P.R. China. snapzhang@aliyun.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>No. 22Y11904200</GrantID><Agency>Science and Technology Innovation Plan Of Shanghai Science and Technology Commission</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>02</Month><Day>20</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>BMC Anesthesiol</MedlineTA><NlmUniqueID>100968535</NlmUniqueID><ISSNLinking>1471-2253</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>GN83C131XS</RegistryNumber><NameOfSubstance UI="D004809">Ephedrine</NameOfSubstance></Chemical><Chemical><RegistryNumber>1WS297W6MV</RegistryNumber><NameOfSubstance UI="D010656">Phenylephrine</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D014662">Vasoconstrictor Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>S88TT14065</RegistryNumber><NameOfSubstance UI="D010100">Oxygen</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004809" MajorTopicYN="Y">Ephedrine</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010656" MajorTopicYN="Y">Phenylephrine</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007022" MajorTopicYN="Y">Hypotension</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014662" MajorTopicYN="Y">Vasoconstrictor Agents</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006439" MajorTopicYN="Y">Hemodynamics</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000005" MajorTopicYN="Y">Abdomen</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002560" MajorTopicYN="N">Cerebrovascular Circulation</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007431" MajorTopicYN="Y">Intraoperative Complications</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010100" MajorTopicYN="N">Oxygen</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Cardiac output</Keyword><Keyword MajorTopicYN="N">Cerebral autoregulation</Keyword><Keyword MajorTopicYN="N">Cerebral blood flow velocity</Keyword><Keyword MajorTopicYN="N">Ephedrine</Keyword><Keyword MajorTopicYN="N">Hypotension</Keyword><Keyword MajorTopicYN="N">Phenylephrine</Keyword></KeywordList><CoiStatement>Declarations. Conflict of interest: All authors declare that they have no competing interests. Competing interests: The authors declare no competing interests. Ethical approval: The study received approval from the Institutional Review Board at Fudan University Shanghai Cancer Center (approval number:2211265-7; Nov 28, 2022). Consent for publication: The manuscript contains no individual person&#x2019;s data in any form. Consent to participate: All patients gave written informed consent. Declaration of the use of Generative AI in writing: The authors declare that they have not used generative AI in writing.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>10</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2025</Year><Month>2</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>2</Month><Day>21</Day><Hour>0</Hour><Minute>22</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>2</Month><Day>21</Day><Hour>0</Hour><Minute>21</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>2</Month><Day>20</Day><Hour>23</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2025</Year><Month>2</Month><Day>20</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39979813</ArticleId><ArticleId IdType="pmc">PMC11841356</ArticleId><ArticleId IdType="doi">10.1186/s12871-025-02944-z</ArticleId><ArticleId IdType="pii">10.1186/s12871-025-02944-z</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Gregory A, Stapelfeldt WH, Khanna AK, Smischney NJ, Boero IJ, Chen Q, Stevens M, Shaw AD. Intraoperative Hypotension Is Associated With Adverse Clinical Outcomes After Noncardiac Surgery. Anesth Analg. 2021;132(6):1654&#x2013;1665.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8115733</ArticleId><ArticleId IdType="pubmed">33177322</ArticleId></ArticleIdList></Reference><Reference><Citation>D&#x2019;Amico F, Fominskiy EV, Turi S, Pruna A, Fresilli S, Triulzi M, Zangrillo A, Landoni G. Intraoperative hypotension and postoperative outcomes: a meta-analysis of randomised trials. Br J Anaesth. 2023;131(5):823&#x2013;831.</Citation><ArticleIdList><ArticleId IdType="pubmed">37739903</ArticleId></ArticleIdList></Reference><Reference><Citation>Chaix I, Manquat E, Liu N, Casadio MC, Ludes PO, Tantot A, Lopes JP, Touchard C, Mateo J, Mebazaa A, Gayat E, Vall&#xe9;e F. Impact of hypotension on cerebral perfusion during general anesthesia induction: A prospective observational study in adults. Acta Anaesthesiol Scand. 2020;64(5):592&#x2013;601.</Citation><ArticleIdList><ArticleId IdType="pubmed">31883375</ArticleId></ArticleIdList></Reference><Reference><Citation>Nissen P, Brassard P, J&#xf8;rgensen TB, Secher NH. Phenylephrine but not ephedrine reduces frontal lobe oxygenation following anesthesia-induced hypotension. Neurocrit Care. 2010;12(1):17&#x2013;23.</Citation><ArticleIdList><ArticleId IdType="pubmed">19957053</ArticleId></ArticleIdList></Reference><Reference><Citation>Soeding PF, Hoy S, Hoy G, Evans M, Royse CF. (2013) Effect of phenylephrine on the haemodynamic state and cerebral oxygen saturation during anaesthesia in the upright position. Br J Anaesth. 2013; 111(2):229&#x2013;&#x2009;34.</Citation><ArticleIdList><ArticleId IdType="pubmed">23518801</ArticleId></ArticleIdList></Reference><Reference><Citation>Larson S, Anderson L, Thomson S. Effect of phenylephrine on cerebral oxygen saturation and cardiac output in adults when used to treat intraoperative hypotension: a systematic review. JBI Evid Synth. 2021;19(1):34&#x2013;58.</Citation><ArticleIdList><ArticleId IdType="pubmed">32941358</ArticleId></ArticleIdList></Reference><Reference><Citation>Ogoh S, Sato K, Fisher JP, Seifert T, Overgaard M, Secher NH. The effect of phenylephrine on arterial and venous cerebral blood flow in healthy subjects. Clin Physiol Funct Imaging. 2011;31(6):445&#x2013;&#x2009;51.</Citation><ArticleIdList><ArticleId IdType="pubmed">21981455</ArticleId></ArticleIdList></Reference><Reference><Citation>Aliane J, Dual&#xe9; C, Guesmi N, et al. Compared effects on cerebral oxygenation of ephedrine vs phenylephrine to treat hypotension during carotid endarterectomy. Clin Exp Pharmacol Physiol. 2017;44(7):739&#x2013;48.</Citation><ArticleIdList><ArticleId IdType="pubmed">28378467</ArticleId></ArticleIdList></Reference><Reference><Citation>Vanpeteghem CM, Bruneel BY, Lecoutere IM, De Hert SG, Moerman AT. Ephedrine and phenylephrine induce opposite changes in cerebral and paraspinal tissue oxygen saturation, measured with near-infrared spectroscopy: a randomized controlled trial. J Clin Monit Comput. 2020;34(2):253&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">31165350</ArticleId></ArticleIdList></Reference><Reference><Citation>Kitchen CC, Nissen P, Secher NH, Nielsen HB. Preserved frontal lobe oxygenation following calcium chloride for treatment of anesthesia-induced hypotension. Front Physiol. 2014; 5:407.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4205832</ArticleId><ArticleId IdType="pubmed">25374543</ArticleId></ArticleIdList></Reference><Reference><Citation>Ma H, Ahrens E, Wachtendorf LJ, Suleiman A, Shay D, Munoz-Acuna R, Tartler TM, Teja B, Wagner S, Subramaniam B, Rhee J, Schaefer MS. Intraoperative Use of Phenylephrine versus Ephedrine and Postoperative Delirium: A Multicenter Retrospective Cohort Study. Anesthesiology. 2024;140(4):657&#x2013;667.</Citation><ArticleIdList><ArticleId IdType="pubmed">37725759</ArticleId></ArticleIdList></Reference><Reference><Citation>Umgelter, Andreas MD; Schmid, Roland M. MD; Huber, Wolfgang MD. Questionable Design to Validate the ProAQT/Pulsioflex Device. Anesth Analg. 2017;125(4):1417&#x2013;1420.</Citation><ArticleIdList><ArticleId IdType="pubmed">28759497</ArticleId></ArticleIdList></Reference><Reference><Citation>Brady K, Joshi B, Zweifel C, Smielewski P, Czosnyka M, Easley RB, Hogue CW Jr.Real-time continuous monitoring of cerebral blood flow autoregulation using near-infrared spectroscopy in patients undergoing cardiopulmonary bypass. Stroke. 2010; 41:1951-6.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5544901</ArticleId><ArticleId IdType="pubmed">20651274</ArticleId></ArticleIdList></Reference><Reference><Citation>Dony P, Seidel L, Pirson M, Haller G. Common clinical thresholds of intraoperative hypotension and 30-day mortality following surgery: a retrospective cohort study. Acta Anaesthesiol Scand. 2020;64(10):1388&#x2013;96.</Citation><ArticleIdList><ArticleId IdType="pubmed">32659863</ArticleId></ArticleIdList></Reference><Reference><Citation>Meng L, Cannesson M, Alexander BS, Yu Z, Kain ZN, Cerussi AE, Tromberg BJ, Mantulin WW. Effect of phenylephrine and ephedrine bolus treatment on cerebral oxygenation in anaesthetized patients. Br J Anaesth. 2011; 107:209&#x2013;&#x2009;17.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3136202</ArticleId><ArticleId IdType="pubmed">21642644</ArticleId></ArticleIdList></Reference><Reference><Citation>Meng L, Sun Y, Zhao X, Meng DM, Liu Z, Adams DC, McDonagh DL, Rasmussen M. Effects of phenylephrine on systemic and cerebral circulations in humans: a systematic review with mechanistic explanations. Anaesthesia. 2024; 79(1):71&#x2013;85.</Citation><ArticleIdList><ArticleId IdType="pubmed">37948131</ArticleId></ArticleIdList></Reference><Reference><Citation>Moppett IK, Wild MJ, Sherman RW, Latter JA, Miller K, Mahajan RP. Effects of ephedrine, dobutamine and dopexamine on cerebral haemodynamics: transcranial Doppler studies in healthy volunteers. Br J Anaesth. 2004; 92(1):39&#x2013;44.</Citation><ArticleIdList><ArticleId IdType="pubmed">14665551</ArticleId></ArticleIdList></Reference><Reference><Citation>Cho SY, Kim SJ, Jeong CW, Jeong CY, Chung SS, Lee J, Yoo KY. Under general anesthesia arginine vasopressin prevents hypotension but impairs cerebral oxygenation during arthroscopic shoulder surgery in the beach chair position. Anesth Analg. 2013;117(6):1436-43.</Citation><ArticleIdList><ArticleId IdType="pubmed">24257393</ArticleId></ArticleIdList></Reference><Reference><Citation>Bombardieri AM, Singh NP, Yaeger L, Athiraman U, Tsui BCH, Singh PM. The regional cerebral oxygen saturation effect of inotropes/vasopressors administered to treat intraoperative hypotension: a Bayesian network meta-analysis. J Neurosurg Anesthesiol. 2023; 35:31&#x2013;40.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9142214</ArticleId><ArticleId IdType="pubmed">34116546</ArticleId></ArticleIdList></Reference><Reference><Citation>S&#xf8;rensen H, Rasmussen P, Sato K, Persson S, Olesen ND, Nielsen HB, Olsen NV, Ogoh S, Secher NH. External carotid artery flow maintains near infrared spectroscopy-determined frontal lobe oxygenation during ephedrine administration. Br J Anaesth. 2014;113(3):452-8.</Citation><ArticleIdList><ArticleId IdType="pubmed">24508985</ArticleId></ArticleIdList></Reference><Reference><Citation>Moerman AT, Vandenheuvel M, Tuybens PJ, Van Gompel C, De Hert SG. Incongruous effect of phenylephrine on changes in cerebral blood volume measured by near-infrared spectroscopy (NIRS) indicating extracranial contamination. J Clin Monit Comput. 2022;36(3):745&#x2013;50.</Citation><ArticleIdList><ArticleId IdType="pubmed">33846886</ArticleId></ArticleIdList></Reference><Reference><Citation>Strandgaard S, Sigurdsson S. Point-counterpoint: sympathetic activity does/does not influence cerebral blood flow. J Appl Physiol. 2008;105:1366&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">18838509</ArticleId></ArticleIdList></Reference><Reference><Citation>Kubo Y, Kubo T, Toki T, Yokota I, Morimoto Y. Effects of ephedrine and phenylephrine on cerebral oxygenation: observational prospective study using near-infrared time-resolved spectroscopy. J Clin Monit Comput. 2023;37(5):1171&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">37243955</ArticleId></ArticleIdList></Reference><Reference><Citation>Koch KU, Mikkelsen IK, Aanerud J, Espelund US, Tietze A, Oettingen GV, Juul N, Nikolajsen L, &#xd8;stergaard L, Rasmussen M. Ephedrine versus Phenylephrine Effect on Cerebral Blood Flow and Oxygen Consumption in anesthetized brain tumor patients: a Randomized Clinical Trial. Anesthesiology. 2020;133(2):304&#x2013;17.</Citation><ArticleIdList><ArticleId IdType="pubmed">32482999</ArticleId></ArticleIdList></Reference><Reference><Citation>Vanpeteghem CM, De Hert SG, Moerman AT. Blood pressure control with phenylephrine or dobutamine: a randomized controlled trial comparing effects on cerebral and paravertebral tissue oxygen saturation measured with near-infrared spectroscopy. J Clin Monit Comput. 2023;37(5):1161&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">37195621</ArticleId></ArticleIdList></Reference><Reference><Citation>Davie SN, Grocott HP. Impact of extracranial contamination on regional cerebral oxygen saturation: a comparison of three cerebral oximetry technologies. Anesthesiology. 2012; 116:834&#x2013;&#x2009;40.</Citation><ArticleIdList><ArticleId IdType="pubmed">22343469</ArticleId></ArticleIdList></Reference><Reference><Citation>Chuan A, Short TG, Peng AZY, Wen SYB, Sun AX, Ting TH, Wan AS, Pope L, Jaeger M, Aneman A. Is cerebrovascular autoregulation associated with outcomes after major noncardiac surgery? A prospective observational pilot study. Acta Anaesthesiol Scand. 2019;;63(1):8&#x2013;17.</Citation><ArticleIdList><ArticleId IdType="pubmed">30079514</ArticleId></ArticleIdList></Reference><Reference><Citation>Goettel N, Burkhart CS, Rossi A, Cabella BC, Berres M, Monsch AU, Czosnyka M, Steiner LA. Associations between impaired cerebral blood Flow Autoregulation, cerebral oxygenation, and biomarkers of Brain Injury and Postoperative Cognitive Dysfunction in Elderly patients after major noncardiac surgery. Anesth Analg. 2017;;124(3):934&#x2013;42.</Citation><ArticleIdList><ArticleId IdType="pubmed">28151820</ArticleId></ArticleIdList></Reference><Reference><Citation>Ortega-Gutierrez S, Petersen N, Masurkar A, Reccius A, Huang A, Li M, Choi JH, Marshall RS. Reliability, asymmetry, and age influence on dynamic cerebral autoregulation measured by spontaneous fluctuations of blood pressure and cerebral blood flow velocities in healthy individuals. J Neuroimaging. 2014;;24(4):379&#x2013;86.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4812577</ArticleId><ArticleId IdType="pubmed">23607680</ArticleId></ArticleIdList></Reference><Reference><Citation>Olsen MH, Riberholt CG, Mehlsen J, Berg RM, M&#xf8;ller K. Reliability and validity of the mean flow index (Mx) for assessing cerebral autoregulation in humans: a systematic review of the methodology. J Cereb Blood Flow Metab. 2022;;42(1):27&#x2013;38.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8721771</ArticleId><ArticleId IdType="pubmed">34617816</ArticleId></ArticleIdList></Reference><Reference><Citation>Czosnyka M, Smielewski P, Kirkpatrick P, Menon DK, Pickard JD. Monitoring of cerebral autoregulation in head-injured patients. Stroke. 1996; 27(10):1829-34.</Citation><ArticleIdList><ArticleId IdType="pubmed">8841340</ArticleId></ArticleIdList></Reference><Reference><Citation>Brady KM, Lee JK, Kibler KK, Smielewski P, Czosnyka M, Easley RB, Koehler RC, Shaffner DH. Continuous time-domain analysis of cerebrovascular autoregulation using near-infrared spectroscopy. Stroke. 2007;38(10):2818&#x2013;25.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2377358</ArticleId><ArticleId IdType="pubmed">17761921</ArticleId></ArticleIdList></Reference><Reference><Citation>Hori D, Brown C, Ono M, Rappold T, Sieber F, Gottschalk A, Neufeld KJ, Gottesman R, Adachi H, Hogue CW. Arterial pressure above the upper cerebral autoregulation limit during cardiopulmonary bypass is associated with postoperative delirium. Br J Anaesth. 2014;113(6):1009&#x2013;17.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4235573</ArticleId><ArticleId IdType="pubmed">25256545</ArticleId></ArticleIdList></Reference><Reference><Citation>Froese L, Hammarlund E, &#xc5;kerlund CAI, Tjerkaski J, Hong E, Lindblad C, Nelson DW, Thelin EP, Zeiler FA. The impact of sedative and vasopressor agents on cerebrovascular reactivity in severe traumatic brain injury. Intensive Care Med Exp. 2023;11(1):54.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10403459</ArticleId><ArticleId IdType="pubmed">37541993</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">22278852</PMID><DateCompleted><Year>2012</Year><Month>08</Month><Day>20</Day></DateCompleted><DateRevised><Year>2021</Year><Month>10</Month><Day>21</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1528-1132</ISSN><JournalIssue CitedMedium="Internet"><Volume>470</Volume><Issue>6</Issue><PubDate><Year>2012</Year><Month>Jun</Month></PubDate></JournalIssue><Title>Clinical orthopaedics and related research</Title><ISOAbbreviation>Clin Orthop Relat Res</ISOAbbreviation></Journal><ArticleTitle>Which is the best alternative for displaced femoral neck fractures in the elderly?: A meta-analysis.</ArticleTitle><Pagination><StartPage>1782</StartPage><EndPage>1791</EndPage><MedlinePgn>1782-91</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s11999-012-2250-6</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Treatment of displaced femoral neck fractures includes internal fixation and arthroplasty. However, whether arthroplasty or internal fixation is the primary treatment for displaced femoral neck fractures in elderly patients remains a subject for debate. The literature contains conflicting evidence regarding rates of mortality, revision surgery, major postoperative complications, and function in elderly patients with displaced femoral neck fractures treated either by internal fixation or arthroplasty (either hemiarthroplasty or THA).</AbstractText><AbstractText Label="QUESTIONS/PURPOSE" NlmCategory="OBJECTIVE">We determined mortality, revision surgery rates, major surgical complications (which include infection, nonunion or early redisplacement, avascular necrosis, dislocation, loosening of the prosthesis, acetabular erosion, fracture below or around the implant, and other severe general complications such as deep vein thrombosis and pulmonary embolism), and function in patients treated with either internal fixation or arthroplasty for displaced femoral neck fractures in the elderly.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">We searched PubMed, Embase, and the Cochrane Library for randomized controlled trials (RCTs) comparing internal fixation and arthroplasty. We identified 20 RCTs with 4508 patients meeting all the criteria for eligibility. We performed a meta-analysis of the major complications, reoperations, function, pain, and mortality.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Compared with internal fixation, arthroplasty reduced the risk of the major complications (95% CI, 0.21-0.54 for 1&#xa0;year; 95% CI, 0.16-0.31 for 5&#xa0;years) and the incidence of reoperation 1 to 5&#xa0;years after surgery (95% CI, 0.15-0.34 for 1&#xa0;year; 95% CI, 0.08-0.24 for 5&#xa0;years), and provided better pain relief (95% CI, 0.34-0.72). Function was superior (RR&#xa0;=&#xa0;0.59; 95% CI, 0.44-0.79) for patients treated with arthroplasty than for patients treated by internal fixation. However, mortality 1 to 3&#xa0;years after surgery was similar (95% CI, 0.96-1.23, p&#xa0;=&#xa0;0.20 for 1&#xa0;year; 95% CI, 0.91-1.17, p&#xa0;=&#xa0;0.63 for 3&#xa0;years).</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Arthroplasty can reduce the risk of major complications and the incidence of reoperation compared with internal fixation, and provide better pain relief and function, but it does not reduce mortality.</AbstractText><AbstractText Label="LEVEL OF EVIDENCE" NlmCategory="METHODS">Level II, prognostic study. See the Guidelines for Authors for a complete description of levels of evidence.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Gao</LastName><ForeName>Hongwei</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Orthopaedics, The Second Hospital of Shandong University, 247 Beiyuan Street, Shandong, 250033, Jinan, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Zhonghao</ForeName><Initials>Z</Initials></Author><Author ValidYN="Y"><LastName>Xing</LastName><ForeName>Deguo</ForeName><Initials>D</Initials></Author><Author ValidYN="Y"><LastName>Gong</LastName><ForeName>Mingzhi</ForeName><Initials>M</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D003160">Comparative Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2012</Year><Month>01</Month><Day>26</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Clin Orthop Relat Res</MedlineTA><NlmUniqueID>0075674</NlmUniqueID><ISSNLinking>0009-921X</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019644" MajorTopicYN="Y">Arthroplasty, Replacement, Hip</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005265" MajorTopicYN="N">Femoral Neck Fractures</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005593" MajorTopicYN="Y">Fracture Fixation, Internal</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2011</Year><Month>6</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2012</Year><Month>1</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2012</Year><Month>1</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2012</Year><Month>1</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2012</Year><Month>8</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2013</Year><Month>6</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">22278852</ArticleId><ArticleId IdType="pmc">PMC3348330</ArticleId><ArticleId IdType="doi">10.1007/s11999-012-2250-6</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Berry DJ, Knoch M, Schleck CD, Harmsen WS. Effect of femoral head diameter and operative approach on risk of dislocation after primary total hip arthroplasty. J Bone Joint Surg Am. 2005;87:2456&#x2013;2463. doi: 10.2106/JBJS.D.02860.</Citation><ArticleIdList><ArticleId IdType="doi">10.2106/JBJS.D.02860</ArticleId><ArticleId IdType="pubmed">16264121</ArticleId></ArticleIdList></Reference><Reference><Citation>Bhandari M, Devereaux PJ, Swiontkowski MF, Tornetta P, 3rd, Obremskey W, Koval KJ, Nork S, Sprague S, Schemitsch EH, Guyatt GH. Internal fixation compared with arthroplasty for displaced fractures of the femoral neck: a meta-analysis. J Bone Joint Surg Am. 2003;85:1673&#x2013;1681.</Citation><ArticleIdList><ArticleId IdType="pubmed">12954824</ArticleId></ArticleIdList></Reference><Reference><Citation>Bjorgul K, Reikeras O. Hemiarthroplasty in worst cases is better than internal fixation in best cases of displaced femoral neck fractures: a prospective study of 683 patients treated with hemiarthroplasty or internal fixation. Acta Orthop. 2006;77:368&#x2013;374. doi: 10.1080/17453670610046271.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/17453670610046271</ArticleId><ArticleId IdType="pubmed">16819673</ArticleId></ArticleIdList></Reference><Reference><Citation>Cummings SR, Melton LJ. Epidemiology and outcomes of osteoporotic fractures. Lancet. 2002;359:1761&#x2013;1767. doi: 10.1016/S0140-6736(02)08657-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(02)08657-9</ArticleId><ArticleId IdType="pubmed">12049882</ArticleId></ArticleIdList></Reference><Reference><Citation>Davison JN, Calder SJ, Anderson GH, Ward G, Jagger C, Harper WM, Gregg PJ. Treatment for displaced intracapsular fracture of the proximal femur: a prospective randomised trial in patients aged 65 to 79&#xa0;years. J Bone Joint Surg Br. 2001;83:206&#x2013;212. doi: 10.1302/0301-620X.83B2.11128.</Citation><ArticleIdList><ArticleId IdType="doi">10.1302/0301-620X.83B2.11128</ArticleId><ArticleId IdType="pubmed">11284567</ArticleId></ArticleIdList></Reference><Reference><Citation>Frihagen F, Nordsletten L, Madsen JE. Hemiarthroplasty or internal fixation for intracapsular displaced femoral neck fractures: randomised controlled trial. BMJ. 2007;335:1251&#x2013;1254. doi: 10.1136/bmj.39399.456551.25.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.39399.456551.25</ArticleId><ArticleId IdType="pmc">PMC2137068</ArticleId><ArticleId IdType="pubmed">18056740</ArticleId></ArticleIdList></Reference><Reference><Citation>Guyatt GH, Oxman AD, Vist GE, Kunz R, Falck-Ytter Y, Alonso-Coello P. GRADE Working Group. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ. 2008;336:924&#x2013;926. doi: 10.1136/bmj.39489.470347.AD.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.39489.470347.AD</ArticleId><ArticleId IdType="pmc">PMC2335261</ArticleId><ArticleId IdType="pubmed">18436948</ArticleId></ArticleIdList></Reference><Reference><Citation>Hedlund R, Lindgren U, Ahlbom A. Age- and sex-specific incidence of femoral neck and trochanteric fractures: an analysis based on 20,538 fractures in Stockholm County, Sweden, 1972&#x2013;1981. Clin Orthop Relat Res. 1987;222:132&#x2013;139.</Citation><ArticleIdList><ArticleId IdType="pubmed">3621713</ArticleId></ArticleIdList></Reference><Reference><Citation>Heetveld MJ, Raaymakers EL, Luitse JS, Nijhof M, Gouma DJ. Femoral neck fractures: can physiologic status determine treatment choice? Clin Orthop Relat Res. 2007;461:203&#x2013;212.</Citation><ArticleIdList><ArticleId IdType="pubmed">17414163</ArticleId></ArticleIdList></Reference><Reference><Citation>Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ. 2003;327:557&#x2013;560. doi: 10.1136/bmj.327.7414.557.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.327.7414.557</ArticleId><ArticleId IdType="pmc">PMC192859</ArticleId><ArticleId IdType="pubmed">12958120</ArticleId></ArticleIdList></Reference><Reference><Citation>Hudson JI, Kenzora JE, Hebel JR, Gardner JF, Scherlis L, Epstein RS, Magaziner JS. Eight-year outcome associated with clinical options in the management of femoral neck fractures. Clin Orthop Relat Res. 1998;348:59&#x2013;66. doi: 10.1097/00003086-199803000-00011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00003086-199803000-00011</ArticleId><ArticleId IdType="pubmed">9553534</ArticleId></ArticleIdList></Reference><Reference><Citation>Johansson T, Jacobsson SA, Ivarsson I, Knutsson A, Wahlstr&#xf6;m O. Internal fixation versus total hip arthroplasty in the treatment of displaced femoral neck fractures: a prospective randomized study of 100 hips. Acta Orthop Scand. 2000;71:597&#x2013;602. doi: 10.1080/000164700317362235.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/000164700317362235</ArticleId><ArticleId IdType="pubmed">11145387</ArticleId></ArticleIdList></Reference><Reference><Citation>J&#xf3;nsson B, Sernbo I, Carlsson A, Fredin H, Johnell O. Social function after cervical hip fracture: a comparison of hook-pins and total hip replacement in 47 patients. Acta Orthop Scand. 1996;67:431&#x2013;434. doi: 10.3109/17453679608996662.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/17453679608996662</ArticleId><ArticleId IdType="pubmed">8948244</ArticleId></ArticleIdList></Reference><Reference><Citation>J&#xfc;ni P, Altman DG, Egger M. Systematic reviews in health care: assessing the quality of controlled clinical trials. BMJ. 2001;323:42&#x2013;46. doi: 10.1136/bmj.323.7303.42.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.323.7303.42</ArticleId><ArticleId IdType="pmc">PMC1120670</ArticleId><ArticleId IdType="pubmed">11440947</ArticleId></ArticleIdList></Reference><Reference><Citation>Keating JF, Grant A, Masson M, Scott NW, Forbes JF. Randomized comparison of reduction and fixation, bipolar hemiarthroplasty, and total hip arthroplasty: treatment of displaced intracapsular hip fractures in healthy older people. J Bone Joint Surg Am. 2006;88:249&#x2013;260. doi: 10.2106/JBJS.E.00215.</Citation><ArticleIdList><ArticleId IdType="doi">10.2106/JBJS.E.00215</ArticleId><ArticleId IdType="pubmed">16452734</ArticleId></ArticleIdList></Reference><Reference><Citation>Leonardsson O, Sernbo I, Carlsson A, Akesson K, Rogmark C. Long-term follow-up of replacement compared with internal fixation for displaced femoral neck fractures: results at ten years in a randomised study of 450 patients. J Bone Joint Surg Br. 2010;92:406&#x2013;412. doi: 10.1302/0301-620X.92B3.23036.</Citation><ArticleIdList><ArticleId IdType="doi">10.1302/0301-620X.92B3.23036</ArticleId><ArticleId IdType="pubmed">20190313</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu-Yao GL, Keller RB, Littenberg B, Wennberg JE. Outcomes after displaced fractures of the femoral neck: a meta analysis of one hundred and six published reports. J Bone Joint Surg Am. 1994;76:15&#x2013;25.</Citation><ArticleIdList><ArticleId IdType="pubmed">8288658</ArticleId></ArticleIdList></Reference><Reference><Citation>Mahoney FI, Barthel DW. Functional evaluation: the Barthel index. Md State Med J. 1965;14:61&#x2013;65.</Citation><ArticleIdList><ArticleId IdType="pubmed">14258950</ArticleId></ArticleIdList></Reference><Reference><Citation>Neander G, Adolphson P, Sivers K, Dahlborn M, Dal&#xe9;n N. Bone and muscle mass after femoral neck fracture: a controlled quantitative computed tomography study of osteosynthesis versus primary total hip arthroplasty. Arch Orthop Trauma Surg. 1997;116:470&#x2013;474. doi: 10.1007/BF00387579.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/BF00387579</ArticleId><ArticleId IdType="pubmed">9352040</ArticleId></ArticleIdList></Reference><Reference><Citation>Parker M, Johansen A. Hip fracture. BMJ. 2006;333:27&#x2013;30.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1488757</ArticleId><ArticleId IdType="pubmed">16809710</ArticleId></ArticleIdList></Reference><Reference><Citation>Parker MJ, Khan RJ, Crawford J, Pryor GA. Hemiarthroplasty versus internal fixation for displaced intracapsular hip fractures in the elderly: a randomized trial of 455 patients. J Bone Joint Surg Br. 2002;84:1150&#x2013;1155. doi: 10.1302/0301-620X.84B8.13522.</Citation><ArticleIdList><ArticleId IdType="doi">10.1302/0301-620X.84B8.13522</ArticleId><ArticleId IdType="pubmed">12463661</ArticleId></ArticleIdList></Reference><Reference><Citation>Puolakka TJ, Laine HJ, Tarvainen T, Aho H. Thompson hemiarthroplasty is superior to Ullevaal screws in treating displaced femoral neck fractures in patient over 75&#xa0;years: a prospective randomized study with two-year follow-up. Ann Chir Gynaecol. 2001;90:225&#x2013;228.</Citation><ArticleIdList><ArticleId IdType="pubmed">11695801</ArticleId></ArticleIdList></Reference><Reference><Citation>Ravikumar KJ, Marsh G. Internal fixation versus hemiarthroplasty versus total hip arthroplasty for displaced subcapital fractures of femur: 13&#xa0;year results of a prospective randomised study. Injury. 2000;31:793&#x2013;797. doi: 10.1016/S0020-1383(00)00125-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0020-1383(00)00125-X</ArticleId><ArticleId IdType="pubmed">11154750</ArticleId></ArticleIdList></Reference><Reference><Citation>R&#xf6;d&#xe9;n M, Sch&#xf6;n M, Fredin H. Treatment of displaced femoral neck fractures: a randomized minimum 5-year follow-up study of screws and bipolar hemiprostheses in l00 patients. Acta Orthop Scand. 2003;74:42&#x2013;44. doi: 10.1080/00016470310013635.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/00016470310013635</ArticleId><ArticleId IdType="pubmed">12635791</ArticleId></ArticleIdList></Reference><Reference><Citation>Rogmark C, Carlsson A, Johnell O, Sernbo I. A prospective randomised trial of internal fixation versus arthroplasty for displaced fractures of the neck of the femur: functional outcome for 450 patients at two years. J Bone Joint Surg Br. 2002;84:183&#x2013;188. doi: 10.1302/0301-620X.84B2.11923.</Citation><ArticleIdList><ArticleId IdType="doi">10.1302/0301-620X.84B2.11923</ArticleId><ArticleId IdType="pubmed">11922358</ArticleId></ArticleIdList></Reference><Reference><Citation>Rogmark C, Johnell O. Primary arthroplasty is better than internal fixation of displaced femoral neck fractures: a meta-analysis of 14 randomized studies with 2,289 patients. Acta Orthop. 2006;77:359&#x2013;367. doi: 10.1080/17453670610046262.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/17453670610046262</ArticleId><ArticleId IdType="pubmed">16819672</ArticleId></ArticleIdList></Reference><Reference><Citation>Schulz KF, Chalmers I, Hayes RJ, Altman DG. Empirical evidence of bias: dimensions of methodological quality associated with estimates of treatment effects in controlled trials. JAMA. 1995;273:408&#x2013;412. doi: 10.1001/jama.1995.03520290060030.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.1995.03520290060030</ArticleId><ArticleId IdType="pubmed">7823387</ArticleId></ArticleIdList></Reference><Reference><Citation>Shepherd SM, Prescott RJ. Use of standardised assessment scales in elderly hip fracture patients. J R Coll Physicians Lond. 1996;30:335&#x2013;343.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5401580</ArticleId><ArticleId IdType="pubmed">8875380</ArticleId></ArticleIdList></Reference><Reference><Citation>Sierra RJ, Raposo JM, Trousdale RT, Cabanela ME. Dislocation of primary THA done through a posterolateral approach in the elderly. Clin Orthop Relat Res. 2005;441:262&#x2013;267. doi: 10.1097/01.blo.0000194308.23105.f4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.blo.0000194308.23105.f4</ArticleId><ArticleId IdType="pubmed">16331013</ArticleId></ArticleIdList></Reference><Reference><Citation>Sikorski JM, Barrington R. Internal fixation versus hemiarthroplasty for the displaced subcapital fracture of the femur: a prospective randomised study. J Bone Joint Surg Br. 1981;63:357&#x2013;361.</Citation><ArticleIdList><ArticleId IdType="pubmed">7263746</ArticleId></ArticleIdList></Reference><Reference><Citation>Skinner P, Riley D, Ellery J, Beaumont A, Coumine R, Shafighian B. Displaced subcapital fractures of the femur: a prospective randomized comparison of internal fixation, hemiarthroplasty and total hip replacement. Injury. 1989;20:291&#x2013;293. doi: 10.1016/0020-1383(89)90171-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0020-1383(89)90171-X</ArticleId><ArticleId IdType="pubmed">2693355</ArticleId></ArticleIdList></Reference><Reference><Citation>S&#xf6;derman P, Malchau H. Is the Harris hip score system useful to study the outcome of total hip replacement? Clin Orthop Relat Res. 2001;384:189&#x2013;197. doi: 10.1097/00003086-200103000-00022.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00003086-200103000-00022</ArticleId><ArticleId IdType="pubmed">11249165</ArticleId></ArticleIdList></Reference><Reference><Citation>S&#xf6;reide O, M&#xf6;lster A, Raugstad TS. Internal fixation versus primary prosthetic replacement in acute femoral neck fractures: a prospective, randomized clinical study. Br J Surg. 1979;66:56&#x2013;60. doi: 10.1002/bjs.1800660118.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/bjs.1800660118</ArticleId><ArticleId IdType="pubmed">369644</ArticleId></ArticleIdList></Reference><Reference><Citation>Svenningsen S, Benum P, Nesse O, Furset OI. [Femoral neck fractures in the elderly: a comparison of 3 methods of treatment] [in Norwegian. Nord Med. 1985;100:256&#x2013;259.</Citation><ArticleIdList><ArticleId IdType="pubmed">3913899</ArticleId></ArticleIdList></Reference><Reference><Citation>The EuroQol Group EuroQol: a new facility for the measurement of health-related quality of life. The EuroQol Group. Health Policy. 1990;16:199&#x2013;208.</Citation><ArticleIdList><ArticleId IdType="pubmed">10109801</ArticleId></ArticleIdList></Reference><Reference><Citation>Thomsen NO, Jensen CM, Skovgaard N, Pedersen MS, Pallesen P, Soe-Nielsen NH, Rosenklint A. Observer variation in the radiographic classification of fractures of the neck of the femur using Garden&#x2019;s system. Int Orthop. 1996;20:326&#x2013;329. doi: 10.1007/s002640050087.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s002640050087</ArticleId><ArticleId IdType="pubmed">8930727</ArticleId></ArticleIdList></Reference><Reference><Citation>Tidermark J, Ponzer S, Svensson O, S&#xf6;derqvist A, T&#xf6;rnkvist H. Internal fixation compared with total hip replacement for displaced femoral neck fractures in the elderly: a randomised, controlled trial. J Bone Joint Surg Br. 2003;85:380&#x2013;388. doi: 10.1302/0301-620X.85B3.13609.</Citation><ArticleIdList><ArticleId IdType="doi">10.1302/0301-620X.85B3.13609</ArticleId><ArticleId IdType="pubmed">12729114</ArticleId></ArticleIdList></Reference><Reference><Citation>Vugt AB, Oosterwijk WM, Goris RJ. Osteosynthesis versus endoprosthesis in the treatment of unstable intracapsular hip fractures in the elderly: a randomised clinical trial. Arch Orthop Trauma Surg. 1993;113:39&#x2013;45. doi: 10.1007/BF00440593.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/BF00440593</ArticleId><ArticleId IdType="pubmed">8117509</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang J, Jiang B, Marshall RJ, Zhang P. Arthroplasty or internal fixation for displaced femoral neck fractures: which is the optimal alternative for elderly patients? A meta-analysis. Int Orthop. 2009;33:1179&#x2013;1187. doi: 10.1007/s00264-009-0763-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00264-009-0763-8</ArticleId><ArticleId IdType="pmc">PMC2899139</ArticleId><ArticleId IdType="pubmed">19343344</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">31287237</PMID><DateCompleted><Year>2020</Year><Month>02</Month><Day>10</Day></DateCompleted><DateRevised><Year>2020</Year><Month>02</Month><Day>10</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1752-699X</ISSN><JournalIssue CitedMedium="Internet"><Volume>13</Volume><Issue>8</Issue><PubDate><Year>2019</Year><Month>Aug</Month></PubDate></JournalIssue><Title>The clinical respiratory journal</Title><ISOAbbreviation>Clin Respir J</ISOAbbreviation></Journal><ArticleTitle>Pulmonary embolism in intensive care units: More frequent or more Known? Prospective study of 75 cases.</ArticleTitle><Pagination><StartPage>513</StartPage><EndPage>520</EndPage><MedlinePgn>513-520</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1111/crj.13053</ELocationID><Abstract><AbstractText Label="PURPOSE" NlmCategory="OBJECTIVE">to evaluate the current rate of pulmonary embolism (PE) in our medico-surgical intensive care unit (ICU), to identify risk factors, and to determine the outcome of PE in ICU.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">We performed a prospective cohort study of consecutive patients requiring intensive care admission during a one-year period. We included, in this prospective study, all the patients with confirmed PE admitted in ICU with more than 18 years of age, and expected to stay in ICU for more than 48 hours. Only the patients who had a clinical suspicion (unexplained hypoxemia and/or shock) for PE underwent diagnostic studies.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">During the study period, 842 patients were admitted in our ICU. One hundred and two patients were excluded. The diagnosis of PE was confirmed in 75 patients (10.1%). In our study, all patients (100%) had received some forms of pharmaceutical prophylaxis (PP) during ICU stay. The median time from ICU admission to diagnosis of PE was 6 days. The diagnosis of PE was made by spiral CT in 74 patients (98.7%), and by echocardiography in 1 case (1.3%). The mean ICU stay was 26.3 &#xb1; 26.5 days (median: 20 days). During their ICU stay, 73 patients (97.3%) developed one, or more, organ failure. Respiratory failure was the most observed (97.3%). Moreover, 38 patients (50.6%) developed nosocomial infections and 29 (38.6%) died. The multivariate analysis showed that the risk factors associated with mortality were the presence of shock the day of PE diagnosis and the presence of right ventricular dilatation on echocardiography.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Our findings confirm that subjects in the ICU are at high risk of PE, due to a high number of risk-factors. PE was associated with higher ICU mortality and a significantly higher ICU LOS. Our results invite to revise the preventive strategies of deep venous thrombosis and PE in patients requiring ICU admission.</AbstractText><CopyrightInformation>&#xa9; 2019 John Wiley &amp; Sons Ltd.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Bahloul</LastName><ForeName>Mabrouk</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-6488-8294</Identifier><AffiliationInfo><Affiliation>Department of Intensive Care, Habib Bourguiba University Hospital, Sfax, Tunisia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Facult&#xe9; de medicine de Sfax, Sfax University, Sfax, Tunisia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Regaieg</LastName><ForeName>Kais</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Intensive Care, Habib Bourguiba University Hospital, Sfax, Tunisia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Facult&#xe9; de medicine de Sfax, Sfax University, Sfax, Tunisia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dlela</LastName><ForeName>Mariem</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Intensive Care, Habib Bourguiba University Hospital, Sfax, Tunisia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Facult&#xe9; de medicine de Sfax, Sfax University, Sfax, Tunisia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Turki</LastName><ForeName>Olfa</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>Department of Intensive Care, Habib Bourguiba University Hospital, Sfax, Tunisia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Facult&#xe9; de medicine de Sfax, Sfax University, Sfax, Tunisia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nouri</LastName><ForeName>Hana</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Intensive Care, Habib Bourguiba University Hospital, Sfax, Tunisia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Facult&#xe9; de medicine de Sfax, Sfax University, Sfax, Tunisia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bradaii</LastName><ForeName>Sabrine</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Intensive Care, Habib Bourguiba University Hospital, Sfax, Tunisia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Facult&#xe9; de medicine de Sfax, Sfax University, Sfax, Tunisia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ben Hamida</LastName><ForeName>Chokri</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Intensive Care, Habib Bourguiba University Hospital, Sfax, Tunisia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Facult&#xe9; de medicine de Sfax, Sfax University, Sfax, Tunisia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bouaziz</LastName><ForeName>Nadia Khlaf</ForeName><Initials>NK</Initials><AffiliationInfo><Affiliation>Centre Interm&#xe9;diaire, Rte El MATAR Km 4, Sfax, Tunisia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chabchoub</LastName><ForeName>Imen</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Department of Pediatrics Hedi Chaker University Hospital, Sfax University, Sfax, Tunisia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Haddar</LastName><ForeName>Sondes</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Radiology Habib Bourguiba University Hospital, Sfax University, Sfax, Tunisia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chelly</LastName><ForeName>Hedi</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Intensive Care, Habib Bourguiba University Hospital, Sfax, Tunisia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Facult&#xe9; de medicine de Sfax, Sfax University, Sfax, Tunisia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bouaziz</LastName><ForeName>Mounir</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Intensive Care, Habib Bourguiba University Hospital, Sfax, Tunisia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Facult&#xe9; de medicine de Sfax, Sfax University, Sfax, Tunisia.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D003160">Comparative Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D064888">Observational Study</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2019</Year><Month>07</Month><Day>31</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Clin Respir J</MedlineTA><NlmUniqueID>101315570</NlmUniqueID><ISSNLinking>1752-6981</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003428" MajorTopicYN="N">Cross Infection</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004452" MajorTopicYN="N">Echocardiography</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017380" MajorTopicYN="N">Hypertrophy, Right Ventricular</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007362" MajorTopicYN="N">Intensive Care Units</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007902" MajorTopicYN="N">Length of Stay</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017063" MajorTopicYN="N">Outcome Assessment, Health Care</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011655" MajorTopicYN="N">Pulmonary Embolism</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="Y">diagnostic imaging</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000401" MajorTopicYN="Y">mortality</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012131" MajorTopicYN="N">Respiratory Insufficiency</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D036542" MajorTopicYN="N">Tomography, Spiral Computed</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020246" MajorTopicYN="N">Venous Thrombosis</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">intensive care unit</Keyword><Keyword MajorTopicYN="N">outcome</Keyword><Keyword MajorTopicYN="N">pulmonary embolism</Keyword><Keyword MajorTopicYN="N">shock index</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2018</Year><Month>8</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2019</Year><Month>1</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2019</Year><Month>7</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>7</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>2</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>7</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31287237</ArticleId><ArticleId IdType="doi">10.1111/crj.13053</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">39593144</PMID><DateCompleted><Year>2024</Year><Month>11</Month><Day>27</Day></DateCompleted><DateRevised><Year>2025</Year><Month>01</Month><Day>10</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1471-2482</ISSN><JournalIssue CitedMedium="Internet"><Volume>24</Volume><Issue>1</Issue><PubDate><Year>2024</Year><Month>Nov</Month><Day>26</Day></PubDate></JournalIssue><Title>BMC surgery</Title><ISOAbbreviation>BMC Surg</ISOAbbreviation></Journal><ArticleTitle>Application of RhBMP-2 in Percutaneous Endoscopic Posterior Lumbar Interbody Fusion.</ArticleTitle><Pagination><StartPage>376</StartPage><MedlinePgn>376</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">376</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s12893-024-02674-y</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">To investigate the application of recombinant human bone morphogenetic protein-2 (RhBMP-2) in Percutaneous Endoscopic Posterior Lumbar Interbody Fusion (PE-PLIF).</AbstractText><AbstractText Label="MATERIALS AND METHODS" NlmCategory="METHODS">The study randomly included 102 patients with lumbar spondylosis who underwent PE-PLIF at our hospital from April 2020 to August 2022. Following the random number table method, these subjects were graded as a study group of 51 cases and a control group of 51 cases. Posterior pedicle screw fixation treatment with RhBMP-2 or autologous bone was given respectively. The surgical status and perioperative complications, as well as lumbar spine function before surgery and at 1 and 12 months after surgery [Prolo score and Japanese Orthopaedic Association (JOA) score] of patients in the two groups were observed, and the postoperative fusion rate and cage displacement rate at 1 and 12 months after surgery were compared between the two groups. The degree of vertebral body slippage, intervertebral space height, and changes in quality of life were compared between the two groups before and 12 months after surgery.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">There was no significant difference in hospital stay, surgical time, bleeding volume, and incidence of complications between the two groups (P&#x2009;&gt;&#x2009;0.05)0.12 months post-operation, the Prolo and JOA scores of both groups largely increased, which were significantly higher in the RhBMP-2 group than the control (P&#x2009;&lt;&#x2009;0.05). 12 months post-operation, the fusion rate in the RhBMP-2 group was 86.27%, which was significantly higher than that of 54.90% in the control group (P&#x2009;&lt;&#x2009;0.05). 12 months post-operation, the Cage displacement rate in the RhBMP-2 group was 5.88%, which was lower than that of 21.57% in the control group (P&#x2009;&lt;&#x2009;0.05). 12 months post-operation, the height of the intervertebral space in both groups largely increased, which was significantly higher in the RhBMP-2 group than in the control (P&#x2009;&lt;&#x2009;0.05). The degree of vertebral body slippage was significantly reduced in both groups, and the RhBMP-2 group was significantly lower than the control (P&#x2009;&lt;&#x2009;0.05). The cognitive function, social function, physiological function, and mental health were evidently improved in both groups 12 months post-operation and were significantly higher in the RhBMP-2 group than in the control (P&#x2009;&lt;&#x2009;0.05).</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">RhBMP-2 material in PE-PLIF could significantly restore lumbar function, promote postoperative fusion, reduce Cage displacement and vertebral slippage, accelerate recovery of lumbar intervertebral space, and improve patient quality of life.</AbstractText><CopyrightInformation>&#xa9; 2024. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Yunsheng</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Spinal Surgery, Ganzhou People's Hospital, No. 16 Meiguan Avenue, Zhanggong District, Ganzhou City, Jiangxi Province, 341000, China. cysheng2024@21cn.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xu</LastName><ForeName>Canhua</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Spinal Surgery, Ganzhou People's Hospital, No. 16 Meiguan Avenue, Zhanggong District, Ganzhou City, Jiangxi Province, 341000, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wu</LastName><ForeName>Yaohong</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Spinal Surgery, Ganzhou People's Hospital, No. 16 Meiguan Avenue, Zhanggong District, Ganzhou City, Jiangxi Province, 341000, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shi</LastName><ForeName>Jiangyou</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Spinal Surgery, Ganzhou People's Hospital, No. 16 Meiguan Avenue, Zhanggong District, Ganzhou City, Jiangxi Province, 341000, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Rongchun</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Spinal Surgery, Ganzhou People's Hospital, No. 16 Meiguan Avenue, Zhanggong District, Ganzhou City, Jiangxi Province, 341000, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>202212489</GrantID><Agency>Science and Technology Plan of Jiangxi Provincial Health Commission</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>11</Month><Day>26</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>BMC Surg</MedlineTA><NlmUniqueID>100968567</NlmUniqueID><ISSNLinking>1471-2482</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D055396">Bone Morphogenetic Protein 2</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D011994">Recombinant Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C499469">recombinant human bone morphogenetic protein-2</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016212">Transforming Growth Factor beta</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="ErratumIn"><RefSource>BMC Surg. 2025 Jan 10;25(1):16. doi: 10.1186/s12893-024-02732-5.</RefSource><PMID Version="1">39794793</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013123" MajorTopicYN="Y">Spinal Fusion</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D055396" MajorTopicYN="Y">Bone Morphogenetic Protein 2</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011994" MajorTopicYN="Y">Recombinant Proteins</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008159" MajorTopicYN="Y">Lumbar Vertebrae</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055009" MajorTopicYN="N">Spondylosis</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004724" MajorTopicYN="N">Endoscopy</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016212" MajorTopicYN="N">Transforming Growth Factor beta</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D065289" MajorTopicYN="N">Pedicle Screws</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Autologous bone</Keyword><Keyword MajorTopicYN="N">Lumbar function</Keyword><Keyword MajorTopicYN="N">Lumbar interbody fusion surgery</Keyword><Keyword MajorTopicYN="N">Quality of life</Keyword><Keyword MajorTopicYN="N">RhBMP-2</Keyword></KeywordList><CoiStatement>Declarations. Ethics approval and consent to participate: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. All procedures performed in studies involving humans were in accordance with the ethical standards of the ethics committee of the Ganzhou People&#x2019;s Hospital (approval number: 2023-09-07). Consent for publication: Informed consent was obtained from all individual participants included in the study. The patients participating in the study all agree to publish the research results. Competing interests: The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>6</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>11</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>11</Month><Day>27</Day><Hour>6</Hour><Minute>21</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>11</Month><Day>27</Day><Hour>6</Hour><Minute>20</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>11</Month><Day>27</Day><Hour>0</Hour><Minute>3</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>11</Month><Day>26</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39593144</ArticleId><ArticleId IdType="pmc">PMC11590271</ArticleId><ArticleId IdType="doi">10.1186/s12893-024-02674-y</ArticleId><ArticleId IdType="pii">10.1186/s12893-024-02674-y</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Lacroix M, Nguyen C, Burns R, Laporte A, Rannou F, Feydy A. Degenerative lumbar spine disease: imaging and Biomechanics. Semin Musculoskelet Radiol. 2022;26(4):424&#x2013;38.</Citation><ArticleIdList><ArticleId IdType="pubmed">36103885</ArticleId></ArticleIdList></Reference><Reference><Citation>Mohd Isa IL, Teoh SL, Mohd Nor NH, Mokhtar SA. Discogenic low back Pain: anatomy, pathophysiology and treatments of intervertebral disc degeneration. Int J Mol Sci. 2022;24(1):208.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9820240</ArticleId><ArticleId IdType="pubmed">36613651</ArticleId></ArticleIdList></Reference><Reference><Citation>Ravindra VM, Senglaub SS, Rattani A, et al. Degenerative lumbar spine disease: estimating Global Incidence and Worldwide volume. Global Spine J. 2018;8(8):784&#x2013;94.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6293435</ArticleId><ArticleId IdType="pubmed">30560029</ArticleId></ArticleIdList></Reference><Reference><Citation>Jacobi S, Beynon A, Dombrowski SU, Wedderkopp N, Witherspoon R, H&#xe9;bert JJ. Effectiveness of Conservative Nonpharmacologic therapies for Pain, disability, physical capacity, and physical activity behavior in patients with degenerative lumbar spinal stenosis: a systematic review and Meta-analysis. Arch Phys Med Rehabil. 2021;102(11):2247&#x2013;e22607.</Citation><ArticleIdList><ArticleId IdType="pubmed">33933439</ArticleId></ArticleIdList></Reference><Reference><Citation>Fenton-White HA. Trailblazing: the historical development of the posterior lumbar interbody fusion (PLIF). Spine Journal: Official J North Am Spine Soc. 2021;21(9):1528&#x2013;41.</Citation><ArticleIdList><ArticleId IdType="pubmed">33757870</ArticleId></ArticleIdList></Reference><Reference><Citation>Qureshi R, Puvanesarajah V, Jain A, et al. A comparison of anterior and posterior lumbar interbody fusions: complications, readmissions, Discharge dispositions, and costs. Spine. 2017;42(24):1865&#x2013;70.</Citation><ArticleIdList><ArticleId IdType="pubmed">28549000</ArticleId></ArticleIdList></Reference><Reference><Citation>Urist MR. Bone: formation by autoinduction. Sci (New York NY). 1965;150(3698):893&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">5319761</ArticleId></ArticleIdList></Reference><Reference><Citation>Carlisle P, Guda T, Silliman DT, et al. Localized low-dose rhBMP-2 is effective at promoting bone regeneration in mandibular segmental defects. J Biomedical Mater Res Part B Appl Biomaterials. 2019;107(5):1491&#x2013;503.</Citation><ArticleIdList><ArticleId IdType="pubmed">30265782</ArticleId></ArticleIdList></Reference><Reference><Citation>Raina DB, Larsson D, Mrkonjic F, et al. Gelatin- hydroxyapatite- calcium sulphate based biomaterial for long term sustained delivery of bone morphogenic protein-2 and zoledronic acid for increased bone formation: In-vitro and in-vivo carrier properties. J Controlled Release: Official J Controlled Release Soc. 2018;272:83&#x2013;96.</Citation><ArticleIdList><ArticleId IdType="pubmed">29329716</ArticleId></ArticleIdList></Reference><Reference><Citation>Chan CY, Kwan MK, Saw LB, et al. Feasibility of percutaneous posterolateral spinal Fusion with recombinant bone morphogenetic Protein-2 (rhBMP-2): a comparison with Standard methods using an animal Model Study. Clin Spine Surg. 2017;30(2):E138&#x2013;47.</Citation><ArticleIdList><ArticleId IdType="pubmed">28207623</ArticleId></ArticleIdList></Reference><Reference><Citation>Ver MLP, Gum JL, Crawford CH et al. Index episode-of-care propensity-matched comparison of transforaminal lumbar interbody fusion (TLIF) techniques: open traditional TLIF versus midline lumbar interbody fusion (MIDLIF) versus robot-assisted MIDLIF. J Neurosurg Spine 2020 Jan 24:1&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">31978884</ArticleId></ArticleIdList></Reference><Reference><Citation>Kawakami M, Takeshita K, Inoue G, et al. Japanese Orthopaedic Association (JOA) clinical practice guidelines on the management of lumbar spinal stenosis, 2021 - secondary publication. J Orthop Science: Official J Japanese Orthop Association. 2023;28(1):46&#x2013;91.</Citation><ArticleIdList><ArticleId IdType="pubmed">35597732</ArticleId></ArticleIdList></Reference><Reference><Citation>Dalitz K, Vitzthum HE. Evaluation of five scoring systems for cervical spondylogenic myelopathy. Spine Journal: Official J North Am Spine Soc. 2019;19(2):e41&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">18774750</ArticleId></ArticleIdList></Reference><Reference><Citation>Pan Y, Barnhart HX. Methods for assessing the reliability of quality of life based on SF-36. Stat Med. 2016;35(30):5656&#x2013;65.</Citation><ArticleIdList><ArticleId IdType="pubmed">27554251</ArticleId></ArticleIdList></Reference><Reference><Citation>Lo WC, Tsai LW, Yang YS et al. Understanding the Future Prospects of Synergizing Minimally Invasive Transforaminal Lumbar Interbody Fusion Surgery with Ceramics and Regenerative Cellular Therapies. International journal of molecular sciences. 2021;22(7).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8037583</ArticleId><ArticleId IdType="pubmed">33807361</ArticleId></ArticleIdList></Reference><Reference><Citation>He LM, Li JR, Wu HR, et al. Percutaneous endoscopic posterior lumbar Interbody Fusion with unilateral laminotomy for bilateral decompression Vs. open posterior lumbar Interbody Fusion for the Treatment of Lumbar Spondylolisthesis. Front Surg. 2022;9:915522.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9174668</ArticleId><ArticleId IdType="pubmed">35693306</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang JC, Li ZZ, Cao Z, et al. Technical Notes of full endoscopic lumbar Interbody Fusion with Anterior Expandable Cylindrical Fusion Cage: clinical and radiographic outcomes at 1-Year Follow-Up. World Neurosurg. 2022;158:e618&#x2013;26.</Citation><ArticleIdList><ArticleId IdType="pubmed">34775095</ArticleId></ArticleIdList></Reference><Reference><Citation>Shah DS, Fisher MWA, Hurley RK, et al. Role of rhBMP-2 in posterior lumbar Fusion. Clin Spine Surg. 2022;35(6):229&#x2013;32.</Citation><ArticleIdList><ArticleId IdType="pubmed">34321391</ArticleId></ArticleIdList></Reference><Reference><Citation>Um IW, Ku JK, Kim YK, et al. Histological review of demineralized dentin matrix as a carrier of rhBMP-2. Tissue Eng Part B Reviews. 2020;26(3):284&#x2013;93.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7310192</ArticleId><ArticleId IdType="pubmed">31928139</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim SH, Choi HJ, Yoon DS, et al. Serial administration of rhBMP-2 and alendronate enhances the differentiation of osteoblasts. Int J Rheum Dis. 2021;24(10):1266&#x2013;72.</Citation><ArticleIdList><ArticleId IdType="pubmed">34324274</ArticleId></ArticleIdList></Reference><Reference><Citation>On SW, Park SY, Yi SM et al. Current Status of Recombinant Human Bone Morphogenetic Protein-2 (rhBMP-2) in Maxillofacial Surgery: Should It Be Continued? Bioengineering (Basel, Switzerland). 2023;10(9).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10525581</ArticleId><ArticleId IdType="pubmed">37760107</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee DD, Kim JY. A comparison of radiographic and clinical outcomes of anterior lumbar interbody fusion performed with either a cellular bone allograft containing multipotent adult progenitor cells or recombinant human bone morphogenetic protein-2. J Orthop Surg Res. 2017;12(1):126.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5574155</ArticleId><ArticleId IdType="pubmed">28841904</ArticleId></ArticleIdList></Reference><Reference><Citation>Esmail N, Buser Z, Cohen JR, et al. Postoperative complications Associated with rhBMP2 use in Posterior/Posterolateral lumbar Fusion. Global Spine J. 2018;8(2):142&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5898669</ArticleId><ArticleId IdType="pubmed">29662744</ArticleId></ArticleIdList></Reference><Reference><Citation>Weisbrod LJ, Arnold PM, Leever JD. Radiographic and CT evaluation of recombinant human bone morphogenetic protein-2-assisted cervical spinal Interbody Fusion. Clin Spine Surg. 2019;32(2):71&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">30234566</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Y, Hu L, Lin M, et al. RhBMP-2-Loaded PLGA/Titanium Nanotube Delivery System synergistically enhances osseointegration. ACS Omega. 2021;6(25):16364&#x2013;72.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8246472</ArticleId><ArticleId IdType="pubmed">34235307</ArticleId></ArticleIdList></Reference><Reference><Citation>Cho JH, Lee JH, Lee KM, et al. BMP-2 Induced Signaling pathways and phenotypes: comparisons between senescent and non-senescent bone marrow mesenchymal stem cells. Calcif Tissue Int. 2022;110(4):489&#x2013;503.</Citation><ArticleIdList><ArticleId IdType="pubmed">34714366</ArticleId></ArticleIdList></Reference><Reference><Citation>Um IW, Ku JK, Lee BK, et al. Postulated release profile of recombinant human bone morphogenetic protein-2 (rhBMP-2) from demineralized dentin matrix. J Korean Association Oral Maxillofacial Surg. 2019;45(3):123&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6620303</ArticleId><ArticleId IdType="pubmed">31334099</ArticleId></ArticleIdList></Reference><Reference><Citation>Fu TS, Wang IC, Lu ML, Hsieh MK, Chen LH, Chen WJ. The fusion rate of demineralized bone matrix compared with autogenous iliac bone graft for long multi-segment posterolateral spinal fusion. BMC Musculoskelet Disord. 2016;17:3.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4700670</ArticleId><ArticleId IdType="pubmed">26728876</ArticleId></ArticleIdList></Reference><Reference><Citation>Godlewski B, Bebenek A, Dominiak M, Bochniak M, Cieslik P, Pawelczyk T. Reliability and Utility of Various Methods for Evaluation of Bone Union after Anterior Cervical Discectomy and Fusion. J Clin Med. 2022;11(20):6066.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9605251</ArticleId><ArticleId IdType="pubmed">36294384</ArticleId></ArticleIdList></Reference><Reference><Citation>Kitchen D, Rao PJ, Zotti M, Woodman R, Sampson MJ, Allison D, Phan K, Selby M. Fusion Assessment by MRI in Comparison with CT in anterior lumbar Interbody Fusion: a prospective study. Global Spine J. 2018;8(6):586&#x2013;92.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6125925</ArticleId><ArticleId IdType="pubmed">30202712</ArticleId></ArticleIdList></Reference><Reference><Citation>Hasegawa T, Ushirozako H, Shigeto E, Ohba T, Oba H, Mukaiyama K, Shimizu S, Yamato Y, Ide K, Shibata Y, Ojima T, Takahashi J, Haro H, Matsuyama Y. The Titanium-coated PEEK cage maintains Better Bone Fusion with the Endplate Than the PEEK Cage 6 months after PLIF surgery: a Multicenter, prospective, randomized study. Spine (Phila Pa 1976). 2020;45(15):E892&#x2013;902.</Citation><ArticleIdList><ArticleId IdType="pubmed">32675599</ArticleId></ArticleIdList></Reference><Reference><Citation>Park MK, Park SA, Son SK, Park WW, Choi SH. Clinical and radiological outcomes of unilateral biportal endoscopic lumbar interbody fusion (ULIF) compared with conventional posterior lumbar interbody fusion (PLIF): 1-year follow-up. Neurosurg Rev. 2019;42(3):753&#x2013;61.</Citation><ArticleIdList><ArticleId IdType="pubmed">31144195</ArticleId></ArticleIdList></Reference><Reference><Citation>You X, Zhao B, Zhang T, Wang Y, Xu C, Yuan J, Liu R. Clinical efficacy of unilateral dual-channel endoscopic lumbar Interbody Fusion for lumbar spondylolisthesis with spinal scoliosis. Orthop Surg. 2024;16(5):1134&#x2013;42.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11062877</ArticleId><ArticleId IdType="pubmed">38520125</ArticleId></ArticleIdList></Reference><Reference><Citation>Steinhaus ME, Vaishnav AS, Shah SP, Clark NJ, Chaudhary CB, Othman YA, Urakawa H, Samuel AM, Lovecchio FC, Sheha ED, McAnany SJ, Qureshi SA. Does loss of spondylolisthesis reduction impact clinical and radiographic outcomes after minimally invasive transforaminal lumbar interbody fusion? Spine J. 2022;22(1):95&#x2013;103.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11980685</ArticleId><ArticleId IdType="pubmed">34118417</ArticleId></ArticleIdList></Reference><Reference><Citation>Phan K, Lee NJ, Kothari P, Kim JS, Cho SK. Risk factors for readmissions following anterior lumbar Interbody Fusion. Spine (Phila Pa 1976). 2018;43(5):364&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">27163369</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">24244441</PMID><DateCompleted><Year>2014</Year><Month>08</Month><Day>18</Day></DateCompleted><DateRevised><Year>2021</Year><Month>10</Month><Day>21</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1932-6203</ISSN><JournalIssue CitedMedium="Internet"><Volume>8</Volume><Issue>11</Issue><PubDate><Year>2013</Year></PubDate></JournalIssue><Title>PloS one</Title><ISOAbbreviation>PLoS One</ISOAbbreviation></Journal><ArticleTitle>Reduction of thromboembolic events in meningioma surgery: a cohort study of 724 consecutive patients.</ArticleTitle><Pagination><StartPage>e79170</StartPage><MedlinePgn>e79170</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e79170</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1371/journal.pone.0079170</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Meningiomas are associated with the highest postoperative rate of venous thromboembolic events (VTE) among all intracranial tumors. The aim of this study is to compare two entirely different VTE prophylaxis regimens in 724 consecutive patients undergoing meningioma surgery.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Two cohorts at a single institution treated with different regimens to prevent VTE were reviewed retrospectively. Cohort A (n&#x200a;=&#x200a;482; 314 females, mean age 57 years, range: 11-87 years) received our institutional regimen during the years 1999-2006, consisting of low-molecular-weight heparin (LMWH) and compression stockings. For cohort B (n&#x200a;=&#x200a;242; 163 females, mean age 56.8 years, range: 16-90 years), during the years 2008-2010, the management included intraoperative 10&#xb0;-20&#xb0; leg elevation with intermittent pneumatic compression (IPC), heparin and LMWH administration. We compared the incidence of the endpoints pulmonary embolism (PE), deep venous thrombosis (DVT), hemorrhage and death, taking into account several known associated risk factors.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">For all endpoints, we observed a more favorable outcome with the new regimen. The difference in incidence of PEs (cohort A: 38/482, 8%; cohort B: 6/242, 2.5%) reached statistical significance (p&#x200a;=&#x200a;0.002). In general, patients with skull base meningiomas had a higher risk for PE (OR 2.77). Regarding VTE prophylaxis, an adjusted subgroup analysis suggests that the new regimen is particularly beneficial for patients with skull base meningiomas.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">We recommend perioperative prophylaxis using a management composed of intraoperative leg-elevation, IPC, early heparin administration and LMWH to reduce the risk for PE.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Eisenring</LastName><ForeName>Christian Valentin</ForeName><Initials>CV</Initials><AffiliationInfo><Affiliation>Klinik f&#xfc;r Neurochirurgie, Universit&#xe4;tsSpital Z&#xfc;rich, Z&#xfc;rich, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Neidert</LastName><ForeName>Marian Christoph</ForeName><Initials>MC</Initials></Author><Author ValidYN="Y"><LastName>Saban&#xe9;s Bov&#xe9;</LastName><ForeName>Daniel</ForeName><Initials>D</Initials></Author><Author ValidYN="Y"><LastName>Held</LastName><ForeName>Leonhard</ForeName><Initials>L</Initials></Author><Author ValidYN="Y"><LastName>Sarnthein</LastName><ForeName>Johannes</ForeName><Initials>J</Initials></Author><Author ValidYN="Y"><LastName>Krayenb&#xfc;hl</LastName><ForeName>Niklaus</ForeName><Initials>N</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2013</Year><Month>11</Month><Day>14</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>PLoS One</MedlineTA><NlmUniqueID>101285081</NlmUniqueID><ISSNLinking>1932-6203</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000925">Anticoagulants</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D006495">Heparin, Low-Molecular-Weight</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000925" MajorTopicYN="N">Anticoagulants</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="Y">administration &amp; dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006495" MajorTopicYN="N">Heparin, Low-Molecular-Weight</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="Y">administration &amp; dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008579" MajorTopicYN="Y">Meningioma</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="Y">Postoperative Complications</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D053828" MajorTopicYN="Y">Stockings, Compression</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013923" MajorTopicYN="Y">Thromboembolism</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading></MeshHeadingList><CoiStatement><b>Competing Interests: </b>The authors have declared that no competing interests exist.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2013</Year><Month>6</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2013</Year><Month>9</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2013</Year><Month>11</Month><Day>19</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2013</Year><Month>11</Month><Day>19</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2014</Year><Month>8</Month><Day>19</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2013</Year><Month>11</Month><Day>14</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">24244441</ArticleId><ArticleId IdType="pmc">PMC3828295</ArticleId><ArticleId IdType="doi">10.1371/journal.pone.0079170</ArticleId><ArticleId IdType="pii">PONE-D-13-25164</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Gerber DE, Segal JB, Salhotra A, Olivi A, Grossman SA, et al. (2007) Venous thromboembolism occurs infrequently in meningioma patients receiving combined modality prophylaxis. Cancer 109: 300&#x2013;305.</Citation><ArticleIdList><ArticleId IdType="pubmed">17154163</ArticleId></ArticleIdList></Reference><Reference><Citation>Porter KR, McCarthy BJ, Freels S, Kim Y, Davis FG (2010) Prevalence estimates for primary brain tumors in the United States by age, gender, behavior, and histology. Neuro Oncol 12: 520&#x2013;527.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2940648</ArticleId><ArticleId IdType="pubmed">20511189</ArticleId></ArticleIdList></Reference><Reference><Citation>Caroli M, Locatelli M, Prada F, Beretta F, Martinelli-Boneschi F, et al. (2005) Surgery for intracranial meningiomas in the elderly: a clinical-radiological grading system as a predictor of outcome. J Neurosurg 102: 290&#x2013;294.</Citation><ArticleIdList><ArticleId IdType="pubmed">15739557</ArticleId></ArticleIdList></Reference><Reference><Citation>Sawaya R, Decourteen-Meyers G, Copeland B (1984) Massive preoperative pulmonary embolism and suprasellar brain tumor: case report and review of the literature. Neurosurgery 15: 566&#x2013;571.</Citation><ArticleIdList><ArticleId IdType="pubmed">6493467</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Mefty O (1991) MENINGIOMAS. XXI+630P p.</Citation></Reference><Reference><Citation>Cage TA, Lamborn KR, Ware ML, Frankfurt A, Chakalian L, et al. (2009) Adjuvant enoxaparin therapy may decrease the incidence of postoperative thrombotic events though does not increase the incidence of postoperative intracranial hemorrhage in patients with meningiomas. Journal of Neuro-Oncology 93: 151&#x2013;156.</Citation><ArticleIdList><ArticleId IdType="pubmed">19430892</ArticleId></ArticleIdList></Reference><Reference><Citation>Koray &#xd6;zduman RF (2010) Meningiomas: A Comprehensive Text, Perioperative management of patients with meningiomas. In: M. Necmettin Pamir PMB, Rudolf Fahlbusch, editor. Acta Neurochirurgica. 800.</Citation></Reference><Reference><Citation>Sawaya R, Zuccarello M, Elkalliny M (1989) Brain-Tumors and Thromboembolism - Clinical, Hemostatic, and Biochemical Correlations. Journal of Neurosurgery 70: A314&#x2013;A314.</Citation></Reference><Reference><Citation>Whittle IR, Smith C, Navoo P, Collie D (2004) Meningiomas. Lancet 363: 1535&#x2013;1543.</Citation><ArticleIdList><ArticleId IdType="pubmed">15135603</ArticleId></ArticleIdList></Reference><Reference><Citation>Keller E (2011) Kapitel 20 Thromboembolieprophylaxe. In: Schwab S, Schellinger P, Werner C, Unterberg A, Hacke W, editors. NeuroIntensiv: Springer. 810.</Citation></Reference><Reference><Citation>Samandouras G (2010) The neurosurgeon's handbook. Oxford: Oxford University Press. xxix, 930 p., [912] p. of plates p.</Citation></Reference><Reference><Citation>Greenberg MSMD (2010) Handbook of neurosurgery. New York: Thieme. xiv, 1337 p. p.</Citation></Reference><Reference><Citation>Gerlach R, Krause M, Seifert V, Goerlinger K (2009) Hemostatic and hemorrhagic problems in neurosurgical patients. Acta Neurochirurgica 151: 873&#x2013;900.</Citation><ArticleIdList><ArticleId IdType="pubmed">19557305</ArticleId></ArticleIdList></Reference><Reference><Citation>Gerlach R, Scheuer T, Beck J, Woszczyk A, Seifert V, et al... (2003) Risk of postoperative hemorrhage after intracranial surgery after early nadroparin administration: results of a prospective study. Neurosurgery 53: 1028&#x2013;1034; discussion 1034&#x2013;1025.</Citation><ArticleIdList><ArticleId IdType="pubmed">14580268</ArticleId></ArticleIdList></Reference><Reference><Citation>Chibbaro S, Tacconi L (2008) Safety of deep venous thrombosis prophylaxis with low-molecular-weight heparin in brain surgery. Prospective study on 746 patients. Surgical Neurology 70: 117&#x2013;121.</Citation><ArticleIdList><ArticleId IdType="pubmed">18262633</ArticleId></ArticleIdList></Reference><Reference><Citation>Raslan AM, Fields JD, Bhardwaj A (2010) Prophylaxis for venous thrombo-embolism in neurocritical care: a critical appraisal. Neurocrit Care 12: 297&#x2013;309.</Citation><ArticleIdList><ArticleId IdType="pubmed">20033354</ArticleId></ArticleIdList></Reference><Reference><Citation>Carman TL, Kanner AA, Barnett GH, Deitcher SR (2003) Prevention of thromboembolism after neurosurgery for brain and spinal tumors. Southern Medical Journal 96: 17&#x2013;22.</Citation><ArticleIdList><ArticleId IdType="pubmed">12602707</ArticleId></ArticleIdList></Reference><Reference><Citation>Wong JM, Panchmatia JR, Ziewacz JE, Bader AM, Dunn IF, et al. (2012) Patterns in neurosurgical adverse events: intracranial neoplasm surgery. Neurosurg Focus 33: E16.</Citation><ArticleIdList><ArticleId IdType="pubmed">23116096</ArticleId></ArticleIdList></Reference><Reference><Citation>Wiemels J, Wrensch M, Claus EB (2010) Epidemiology and etiology of meningioma. J Neurooncol 99: 307&#x2013;314.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2945461</ArticleId><ArticleId IdType="pubmed">20821343</ArticleId></ArticleIdList></Reference><Reference><Citation>Agnelli G (1999) Prevention of venous thromboembolism after neurosurgery. Thrombosis and Haemostasis 82: 925&#x2013;930.</Citation><ArticleIdList><ArticleId IdType="pubmed">10605805</ArticleId></ArticleIdList></Reference><Reference><Citation>Kleindienst A, Harvey HB, Mater E, Bronst J, Flack J, et al. (2003) Early antithrombotic prophylaxis with low molecular weight heparin in neurosurgery. Acta Neurochirurgica 145: 1085&#x2013;1091.</Citation><ArticleIdList><ArticleId IdType="pubmed">14663565</ArticleId></ArticleIdList></Reference><Reference><Citation>Geerts WH, Bergqvist D, Pineo GF, Heit JA, Samama CM, et al. (2008) Prevention of venous thromboembolism: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest 133: 381S&#x2013;453S.</Citation><ArticleIdList><ArticleId IdType="pubmed">18574271</ArticleId></ArticleIdList></Reference><Reference><Citation>Chaichana KL, Pendleton C, Jackson C, Martinez-Gutierrez JC, Diaz-Stransky A, et al. (2013) Deep venous thrombosis and pulmonary embolisms in adult patients undergoing craniotomy for brain tumors. Neurol Res 35: 206&#x2013;211.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3991124</ArticleId><ArticleId IdType="pubmed">23336127</ArticleId></ArticleIdList></Reference><Reference><Citation>Schulman S, Beyth RJ, Kearon C, Levine MN, Physicians ACoC (2008) Hemorrhagic complications of anticoagulant and thrombolytic treatment: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest 133: 257S&#x2013;298S.</Citation><ArticleIdList><ArticleId IdType="pubmed">18574268</ArticleId></ArticleIdList></Reference><Reference><Citation>Raabe A, Gerlach R, Zimmermann M, Seifert V (2000) Practice of perioperative thromboembolic prophylaxis in neurosurgery: results of a German survey]. Zentralblatt f&#xfc;r Neurochirurgie 61: 103.</Citation><ArticleIdList><ArticleId IdType="pubmed">10986759</ArticleId></ArticleIdList></Reference><Reference><Citation>Macdonald RL, Amidei C, Lin G, Munshi I, Baron J, et al... (1999) Safety of perioperative subcutaneous heparin for prophylaxis of venous thromboembolism in patients undergoing craniotomy. Neurosurgery 45: 245&#x2013;251; discussion 251&#x2013;242.</Citation><ArticleIdList><ArticleId IdType="pubmed">10449068</ArticleId></ArticleIdList></Reference><Reference><Citation>Black P, Morokoff A, Zauberman J, Claus E, Carroll R (2007) Meningiomas: science and surgery. Clin Neurosurg 54: 91&#x2013;99.</Citation><ArticleIdList><ArticleId IdType="pubmed">18504903</ArticleId></ArticleIdList></Reference><Reference><Citation>Riffaud L, Mazzon A, Haegelen C, Hamlat A, Morandi X (2007) Surgery for intracranial meningiomas in patients older than 80 years. Presse Medicale 36: 197&#x2013;202.</Citation><ArticleIdList><ArticleId IdType="pubmed">17259027</ArticleId></ArticleIdList></Reference><Reference><Citation>Roser F, Ebner FH, Ritz R, Samii M, Tatagiba MS, et al. (2007) Management of skull based meningiomas in the elderly patient. Journal of Clinical Neuroscience 14: 224&#x2013;228.</Citation><ArticleIdList><ArticleId IdType="pubmed">17258130</ArticleId></ArticleIdList></Reference><Reference><Citation>Stienen MN, Lucke S, Fournier JY, Hildebrandt G, Gautschi OP (2010) [The intracranial meningioma - therapeutic possibilities and limitations]. Praxis (Bern 1994) 99: 1479&#x2013;1494.</Citation><ArticleIdList><ArticleId IdType="pubmed">21125533</ArticleId></ArticleIdList></Reference><Reference><Citation>Black P, Kathiresan S, Chung W (1998) Meningioma surgery in the elderly: A case-control study assessing morbidity and mortality. Acta Neurochirurgica 140: 1013&#x2013;+.</Citation><ArticleIdList><ArticleId IdType="pubmed">9856244</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen CM, Huang AP, Kuo LT, Tu YK (2011) Contemporary surgical outcome for skull base meningiomas. Neurosurg Rev 34: 281&#x2013;296; discussion 296.</Citation><ArticleIdList><ArticleId IdType="pubmed">21614426</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">28281226</PMID><DateCompleted><Year>2017</Year><Month>08</Month><Day>22</Day></DateCompleted><DateRevised><Year>2018</Year><Month>11</Month><Day>13</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2210-7711</ISSN><JournalIssue CitedMedium="Internet"><Volume>39</Volume><Issue>2</Issue><PubDate><Year>2017</Year><Month>Apr</Month></PubDate></JournalIssue><Title>International journal of clinical pharmacy</Title><ISOAbbreviation>Int J Clin Pharm</ISOAbbreviation></Journal><ArticleTitle>Polypharmacotherapy and blood products as risk factors for venous thromboembolism in postsurgical patients: a case-control study.</ArticleTitle><Pagination><StartPage>416</StartPage><EndPage>423</EndPage><MedlinePgn>416-423</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s11096-017-0441-7</ELocationID><Abstract><AbstractText>Background After surgical procedures, patients are at high risk of developing venous thromboembolism, clinically manifested as deep vein thrombosis (DVT) or pulmonary embolism (PE). Objective To evaluate the influence of polypharmacotherapy, comorbidity, drug treatments, packed red blood cells application, adequacy of thromboprophylaxis, and patient characteristics on the occurrence of DVT or PE in postsurgical patients. Setting The surgical department at Murska Sobota&#xa0;General Hospital, Slovenia. Methods In this retrospective case control study, the records of 286 surgical patients were analysed: DVT or PE group (n&#xa0;=&#xa0;144) and control group (n&#xa0;=&#xa0;142). The number of prescribed drugs and drug-drug interactions were reviewed, together with prescription of low-molecular-weight heparins. The odds ratios (OR) of risk factors for DVT or PE were calculated using a multivariable logistic regression model. Main outcome measure Risk factors assessment for the occurrence of DVT or PE in surgical patients. Results Polypharmacotherapy (OR 2.02, 95% CI 1.03-3.96, p&#xa0;=&#xa0;0.040) and packed red blood cells application (OR 3.44, 95% CI 1.46-8.10, p&#xa0;=&#xa0;0.005) were associated with an increased risk of PE or DVT after surgery. Inadequate thromboprophylaxis with low-molecular-weight heparins significantly increased the likelihood of DVT or PE (OR 2.50, 95% CI 1.41-4.43, p&#xa0;=&#xa0;0.002). There were no differences between the groups concerning the treatment with nonsteroidal anti-inflammatory drugs, benzodiazepines or antipsychotics. Conclusions Patients with polypharmacotherapy and patients receiving red blood cells should be monitored more closely after surgery as they are more likely to develop DVT or PE.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Premu&#x161; Maru&#x161;i&#x10d;</LastName><ForeName>Alenka</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Murska Sobota General Hospital, Raki&#x10d;an, Ulica dr. Vrbnjaka 6, 9000, Murska Sobota, Slovenia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Faculty of Pharmacy, University of Ljubljana, A&#x161;ker&#x10d;eva cesta 7, 1000, Ljubljana, Slovenia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Petrovi&#x10d;</LastName><ForeName>Daniel</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Faculty of Medicine, University of Ljubljana, Vrazov trg 2, 1104, Ljubljana, Slovenia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mrhar</LastName><ForeName>Ale&#x161;</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Faculty of Pharmacy, University of Ljubljana, A&#x161;ker&#x10d;eva cesta 7, 1000, Ljubljana, Slovenia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Locatelli</LastName><ForeName>Igor</ForeName><Initials>I</Initials><Identifier Source="ORCID">0000-0002-0052-8986</Identifier><AffiliationInfo><Affiliation>Faculty of Pharmacy, University of Ljubljana, A&#x161;ker&#x10d;eva cesta 7, 1000, Ljubljana, Slovenia. igor.locatelli@ffa.uni-lj.si.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2017</Year><Month>03</Month><Day>09</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Int J Clin Pharm</MedlineTA><NlmUniqueID>101554912</NlmUniqueID></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000925">Anticoagulants</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D006495">Heparin, Low-Molecular-Weight</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000925" MajorTopicYN="N">Anticoagulants</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016022" MajorTopicYN="N">Case-Control Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004912" MajorTopicYN="Y">Erythrocytes</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006495" MajorTopicYN="N">Heparin, Low-Molecular-Weight</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019338" MajorTopicYN="Y">Polypharmacy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011655" MajorTopicYN="N">Pulmonary Embolism</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017524" MajorTopicYN="N">Slovenia</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020246" MajorTopicYN="N">Venous Thrombosis</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Drug interactions</Keyword><Keyword MajorTopicYN="N">Packed red blood cells</Keyword><Keyword MajorTopicYN="N">Polypharmacotherapy</Keyword><Keyword MajorTopicYN="N">Prevention</Keyword><Keyword MajorTopicYN="N">Slovenia</Keyword><Keyword MajorTopicYN="N">VTE-prophylaxis</Keyword><Keyword MajorTopicYN="N">Venous tromboembolism</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2016</Year><Month>7</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2017</Year><Month>2</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2017</Year><Month>3</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2017</Year><Month>8</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2017</Year><Month>3</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">28281226</ArticleId><ArticleId IdType="doi">10.1007/s11096-017-0441-7</ArticleId><ArticleId IdType="pii">10.1007/s11096-017-0441-7</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Pathophysiol Haemost Thromb. 2003 Sep-2004 Dec;33(5-6):455-7</Citation><ArticleIdList><ArticleId IdType="pubmed">15692260</ArticleId></ArticleIdList></Reference><Reference><Citation>Pathophysiol Haemost Thromb. 2003 Sep-2004 Dec;33(5-6):445-8</Citation><ArticleIdList><ArticleId IdType="pubmed">15692258</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Psychiatry. 1990 Jul;147(7):948-9</Citation><ArticleIdList><ArticleId IdType="pubmed">2356883</ArticleId></ArticleIdList></Reference><Reference><Citation>Circulation. 2016 Jan 26;133(4):352-60</Citation><ArticleIdList><ArticleId IdType="pubmed">26673560</ArticleId></ArticleIdList></Reference><Reference><Citation>BMC Psychiatry. 2015 Apr 29;15:92</Citation><ArticleIdList><ArticleId IdType="pubmed">25924683</ArticleId></ArticleIdList></Reference><Reference><Citation>Circulation. 2003 Jun 17;107(23 Suppl 1):I4-8</Citation><ArticleIdList><ArticleId IdType="pubmed">12814979</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Intern Med. 1994 Mar 15;120(6):449-57</Citation><ArticleIdList><ArticleId IdType="pubmed">8311367</ArticleId></ArticleIdList></Reference><Reference><Citation>J Am Coll Cardiol. 1993 Dec;22(7):1830-4</Citation><ArticleIdList><ArticleId IdType="pubmed">7902370</ArticleId></ArticleIdList></Reference><Reference><Citation>Arch Intern Med. 2001 Jul 9;161(13):1629-34</Citation><ArticleIdList><ArticleId IdType="pubmed">11434795</ArticleId></ArticleIdList></Reference><Reference><Citation>J Thromb Haemost. 2013 Jan;11(1):116-23</Citation><ArticleIdList><ArticleId IdType="pubmed">23106832</ArticleId></ArticleIdList></Reference><Reference><Citation>J Am Geriatr Soc. 2014 Dec;62(12):2261-72</Citation><ArticleIdList><ArticleId IdType="pubmed">25516023</ArticleId></ArticleIdList></Reference><Reference><Citation>Int J Clin Pharm. 2014 Oct;36(5):1007-13</Citation><ArticleIdList><ArticleId IdType="pubmed">25087039</ArticleId></ArticleIdList></Reference><Reference><Citation>BMJ. 2015 Mar 11;350:h1059</Citation><ArticleIdList><ArticleId IdType="pubmed">25761379</ArticleId></ArticleIdList></Reference><Reference><Citation>CMAJ. 2015 Mar 3;187(4):E130-7</Citation><ArticleIdList><ArticleId IdType="pubmed">25646290</ArticleId></ArticleIdList></Reference><Reference><Citation>South Med J. 1996 Jun;89(6):612-4</Citation><ArticleIdList><ArticleId IdType="pubmed">8638202</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet. 1986 Jul 19;2(8499):143-6</Citation><ArticleIdList><ArticleId IdType="pubmed">2873407</ArticleId></ArticleIdList></Reference><Reference><Citation>Chest. 2001 Jan;119(1 Suppl):64S-94S</Citation><ArticleIdList><ArticleId IdType="pubmed">11157643</ArticleId></ArticleIdList></Reference><Reference><Citation>Q J Med. 1993 Aug;86(8):467-72</Citation><ArticleIdList><ArticleId IdType="pubmed">8210304</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet. 2002 Nov 9;360(9344):1438</Citation><ArticleIdList><ArticleId IdType="pubmed">12433507</ArticleId></ArticleIdList></Reference><Reference><Citation>Pathophysiol Haemost Thromb. 2003 Sep-2004 Dec;33(5-6):449-54</Citation><ArticleIdList><ArticleId IdType="pubmed">15692259</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Interv Aging. 2008;3(2):383-9</Citation><ArticleIdList><ArticleId IdType="pubmed">18686760</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Emerg Med. 1981 Dec;10(12):627-30</Citation><ArticleIdList><ArticleId IdType="pubmed">7305093</ArticleId></ArticleIdList></Reference><Reference><Citation>Chest. 2008 Jun;133(6 Suppl):381S-453S</Citation><ArticleIdList><ArticleId IdType="pubmed">18574271</ArticleId></ArticleIdList></Reference><Reference><Citation>Arterioscler Thromb Vasc Biol. 2008 Mar;28(3):370-2</Citation><ArticleIdList><ArticleId IdType="pubmed">18296591</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Respir Crit Care Med. 2010 Nov 1;182(9):1178-83</Citation><ArticleIdList><ArticleId IdType="pubmed">20595225</ArticleId></ArticleIdList></Reference><Reference><Citation>J Am Coll Cardiol. 2010 Jun 29;56(1):1-7</Citation><ArticleIdList><ArticleId IdType="pubmed">20620709</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Intern Med. 1977 Dec;87(6):722-3</Citation><ArticleIdList><ArticleId IdType="pubmed">931209</ArticleId></ArticleIdList></Reference><Reference><Citation>Chest. 2012 Feb;141(2 Suppl):e227S-e277S</Citation><ArticleIdList><ArticleId IdType="pubmed">22315263</ArticleId></ArticleIdList></Reference><Reference><Citation>Br J Haematol. 2008 Oct;143(2):180-90</Citation><ArticleIdList><ArticleId IdType="pubmed">18783400</ArticleId></ArticleIdList></Reference><Reference><Citation>Int J Clin Pharm. 2013 Jun;35(3):455-62</Citation><ArticleIdList><ArticleId IdType="pubmed">23483444</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Surg. 1972 Aug;124(2):169-76</Citation><ArticleIdList><ArticleId IdType="pubmed">5045886</ArticleId></ArticleIdList></Reference><Reference><Citation>Proc (Bayl Univ Med Cent). 2000 Jul;13(3):244-7</Citation><ArticleIdList><ArticleId IdType="pubmed">16389390</ArticleId></ArticleIdList></Reference><Reference><Citation>Crit Rev Oncol Hematol. 2003 Nov;48(2):133-43</Citation><ArticleIdList><ArticleId IdType="pubmed">14607376</ArticleId></ArticleIdList></Reference><Reference><Citation>Arch Intern Med. 1999 Feb 22;159(4):369-74</Citation><ArticleIdList><ArticleId IdType="pubmed">10030310</ArticleId></ArticleIdList></Reference><Reference><Citation>Pharmacotherapy. 2004 Oct;24(10 Pt 2):179S-183S</Citation><ArticleIdList><ArticleId IdType="pubmed">15624337</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS One. 2015 Jun 01;10(6):e0124611</Citation><ArticleIdList><ArticleId IdType="pubmed">26030195</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">33121228</PMID><DateCompleted><Year>2021</Year><Month>11</Month><Day>25</Day></DateCompleted><DateRevised><Year>2021</Year><Month>11</Month><Day>25</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2005-7563</ISSN><JournalIssue CitedMedium="Internet"><Volume>74</Volume><Issue>4</Issue><PubDate><Year>2021</Year><Month>Aug</Month></PubDate></JournalIssue><Title>Korean journal of anesthesiology</Title><ISOAbbreviation>Korean J Anesthesiol</ISOAbbreviation></Journal><ArticleTitle>Hemodynamic effects of norepinephrine versus phenylephrine infusion for prophylaxis against spinal anesthesia-induced hypotension in the elderly population undergoing hip fracture surgery: a randomized controlled trial.</ArticleTitle><Pagination><StartPage>308</StartPage><EndPage>316</EndPage><MedlinePgn>308-316</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.4097/kja.20519</ELocationID><Abstract><AbstractText Label="BACKGROUND">Elderly population are at increased risk of spinal anesthesia-induced hypotension increasing their risk for postoperative morbidity and mortality. This study aimed to compare the hemodynamic effects of prophylactic infusion of norepinephrine (NE) versus phenylephrine (PE) in elderly patients undergoing hip fracture surgery under spinal anesthesia.</AbstractText><AbstractText Label="METHODS">Elderly patients scheduled for hip fracture surgery were randomized to receive either NE infusion (8 &#xb5;g/min) (NE group, n = 31) or PE infusion (100 &#xb5;g/min) (PE group, n = 31) after spinal anesthesia. Outcomes included mean heart rate, mean blood pressure, cardiac output, incidence of spinal anesthesia-induced hypotension, incidence of bradycardia, and incidence of hypertension.</AbstractText><AbstractText Label="RESULTS">Sixty-two patients with a mean age of 71 &#xb1; 6 years were included in the final analysis (31 patients in each group). The NE group showed a higher mean heart rate and cardiac output than the PE group. The NE group had a lower incidence of reactive bradycardia (10% vs. 36%, P = 0.031) and hypertension (3% vs. 36%, P = 0.003) than the PE group. No study participant developed hypotension, and the mean blood pressure was comparable between the two groups.</AbstractText><AbstractText Label="CONCLUSIONS">Both NE and PE infusions effectively prevented spinal anesthesia-induced hypotension in elderly patients undergoing hip fracture surgery. However, NE provided more hemodynamic stability than PE; maintaining the heart rate, higher cardiac output, less reactive bradycardia, and hypertension.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Mostafa</LastName><ForeName>Maha</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Anesthesia and Critical Care Medicine, Cairo University, Cairo, Egypt.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hasanin</LastName><ForeName>Ahmed</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Anesthesia and Critical Care Medicine, Cairo University, Cairo, Egypt.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mostafa</LastName><ForeName>Mahmoud</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Anesthesia and Critical Care Medicine, Cairo University, Cairo, Egypt.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Taha</LastName><ForeName>Mai Y</ForeName><Initials>MY</Initials><AffiliationInfo><Affiliation>Department of Anesthesia and Critical Care Medicine, Cairo University, Cairo, Egypt.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Elsayad</LastName><ForeName>Mohamed</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Anesthesia and Critical Care Medicine, Cairo University, Cairo, Egypt.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Haggag</LastName><ForeName>Fatma Alzahraa</ForeName><Initials>FA</Initials><AffiliationInfo><Affiliation>Department of Anesthesia and Critical Care Medicine, Cairo University, Cairo, Egypt.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Taalab</LastName><ForeName>Omar</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>Department of Orthopedic Surgery, Cairo University, Cairo, Egypt.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rady</LastName><ForeName>Ashraf</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Anesthesia and Critical Care Medicine, Cairo University, Cairo, Egypt.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Abdelhamid</LastName><ForeName>Bassant</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Anesthesia and Critical Care Medicine, Cairo University, Cairo, Egypt.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>10</Month><Day>30</Day></ArticleDate></Article><MedlineJournalInfo><Country>Korea (South)</Country><MedlineTA>Korean J Anesthesiol</MedlineTA><NlmUniqueID>101502451</NlmUniqueID><ISSNLinking>2005-6419</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D014662">Vasoconstrictor Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>1WS297W6MV</RegistryNumber><NameOfSubstance UI="D010656">Phenylephrine</NameOfSubstance></Chemical><Chemical><RegistryNumber>X4W3ENH1CV</RegistryNumber><NameOfSubstance UI="D009638">Norepinephrine</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000775" MajorTopicYN="Y">Anesthesia, Spinal</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002585" MajorTopicYN="N">Cesarean Section</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006439" MajorTopicYN="N">Hemodynamics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007023" MajorTopicYN="Y">Hypotension, Controlled</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009638" MajorTopicYN="N">Norepinephrine</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010656" MajorTopicYN="N">Phenylephrine</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011247" MajorTopicYN="N">Pregnancy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014662" MajorTopicYN="N">Vasoconstrictor Agents</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Elderly</Keyword><Keyword MajorTopicYN="N">Hip fracture surgery</Keyword><Keyword MajorTopicYN="N">Hypotension</Keyword><Keyword MajorTopicYN="N">Norepinephrine</Keyword><Keyword MajorTopicYN="N">Phenylephrine</Keyword><Keyword MajorTopicYN="N">Spinal anesthesia</Keyword></KeywordList><CoiStatement><b>Conflicts of Interest</b>. No potential conflict of interest relevant to this article was reported.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>9</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>10</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>10</Month><Day>31</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>11</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>10</Month><Day>30</Day><Hour>3</Hour><Minute>7</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2021</Year><Month>8</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33121228</ArticleId><ArticleId IdType="pmc">PMC8342837</ArticleId><ArticleId IdType="doi">10.4097/kja.20519</ArticleId><ArticleId IdType="pii">kja.20519</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Ferr&#xe9; F, Marty P, Bruneteau L, Merlet V, Bataille B, Ferrier A, et al. Prophylactic phenylephrine infusion for the prevention of hypotension after spinal anesthesia in the elderly: a randomized controlled clinical trial. J Clin Anesth. 2016;35:99&#x2013;106.</Citation><ArticleIdList><ArticleId IdType="pubmed">27871603</ArticleId></ArticleIdList></Reference><Reference><Citation>White SM, Moppett IK, Griffiths R, Johansen A, Wakeman R, Boulton C, et al. Secondary analysis of outcomes after 11,085 hip fracture operations from the prospective UK Anaesthesia Sprint Audit of Practice (ASAP-2) Anaesthesia. 2016;71:506&#x2013;14.</Citation><ArticleIdList><ArticleId IdType="pubmed">26940645</ArticleId></ArticleIdList></Reference><Reference><Citation>Sessler DI, Bloomstone JA, Aronson S, Berry C, Gan TJ, Kellum JA, et al. Perioperative Quality Initiative consensus statement on intraoperative blood pressure, risk and outcomes for elective surgery. Br J Anaesth. 2019;122:563&#x2013;74.</Citation><ArticleIdList><ArticleId IdType="pubmed">30916004</ArticleId></ArticleIdList></Reference><Reference><Citation>Dobson PM, Caldicott LD, Gerrish SP, Cole JR, Channer KS. Changes in haemodynamic variables during transurethral resection of the prostate: comparison of general and spinal anaesthesia. Br J Anaesth. 1994;72:267&#x2013;71.</Citation><ArticleIdList><ArticleId IdType="pubmed">8130043</ArticleId></ArticleIdList></Reference><Reference><Citation>Gelman S. Venous function and central venous pressure: a physiologic story. Anesthesiology. 2008;108:735&#x2013;48.</Citation><ArticleIdList><ArticleId IdType="pubmed">18362606</ArticleId></ArticleIdList></Reference><Reference><Citation>Hofhuizen C, Lemson J, Snoeck M, Scheffer GJ. Spinal anesthesia-induced hypotension is caused by a decrease in stroke volume in elderly patients. Local Reg Anesth. 2019;12:19&#x2013;26.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6404676</ArticleId><ArticleId IdType="pubmed">30881108</ArticleId></ArticleIdList></Reference><Reference><Citation>Kinsella SM, Carvalho B, Dyer RA, Fernando R, McDonnell N, Mercier FJ, et al. International consensus statement on the management of hypotension with vasopressors during caesarean section under spinal anaesthesia. Anaesthesia. 2018;73:71&#x2013;92.</Citation><ArticleIdList><ArticleId IdType="pubmed">29090733</ArticleId></ArticleIdList></Reference><Reference><Citation>Ngan Kee WD, Lee SW, Ng FF, Tan PE, Khaw KS. Randomized double-blinded comparison of norepinephrine and phenylephrine for maintenance of blood pressure during spinal Anesthesia for cesarean delivery. Anesthesiology. 2015;122:736&#x2013;45.</Citation><ArticleIdList><ArticleId IdType="pubmed">25635593</ArticleId></ArticleIdList></Reference><Reference><Citation>Jakobsson J, Kalman SH, Lindeberg-Lindvet M, Bartha E. Is postspinal hypotension a sign of impaired cardiac performance in the elderly? An observational mechanistic study. Br J Anaesth. 2017;119:1178&#x2013;85.</Citation><ArticleIdList><ArticleId IdType="pubmed">29040402</ArticleId></ArticleIdList></Reference><Reference><Citation>Vall&#xe9;e F, Passouant O, Le Gall A, Joachim J, Mateo J, Mebazaa A, et al. Norepinephrine reduces arterial compliance less than phenylephrine when treating general anesthesia-induced arterial hypotension. Acta Anaesthesiol Scand. 2017;61:590&#x2013;600.</Citation><ArticleIdList><ArticleId IdType="pubmed">28543052</ArticleId></ArticleIdList></Reference><Reference><Citation>Sharkey AM, Siddiqui N, Downey K, Ye XY, Guevara J, Carvalho JC. Comparison of intermittent intravenous boluses of phenylephrine and norepinephrine to prevent and treat spinal-induced hypotension in cesarean deliveries: randomized controlled trial. Anesth Analg. 2019;129:1312&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">30113395</ArticleId></ArticleIdList></Reference><Reference><Citation>Hasanin AM, Amin SM, Agiza NA, Elsayed MK, Refaat S, Hussein HA, et al. Norepinephrine infusion for preventing postspinal anesthesia hypotension during cesarean delivery: a randomized dose-finding trial. Anesthesiology. 2019;130:55&#x2013;62.</Citation><ArticleIdList><ArticleId IdType="pubmed">30335625</ArticleId></ArticleIdList></Reference><Reference><Citation>Hasanin A. Fluid responsiveness in acute circulatory failure. J Intensive Care. 2015;3:50.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4653888</ArticleId><ArticleId IdType="pubmed">26594361</ArticleId></ArticleIdList></Reference><Reference><Citation>Hasanin A, Amin S, Refaat S, Habib S, Zayed M, Abdelwahab Y, et al. Norepinephrine versus phenylephrine infusion for prophylaxis against post-spinal anaesthesia hypotension during elective caesarean delivery: a randomised controlled trial. Anaesth Crit Care Pain Med. 2019;38:601&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">30935897</ArticleId></ArticleIdList></Reference><Reference><Citation>Stewart A, Fernando R, McDonald S, Hignett R, Jones T, Columb M. The dose-dependent effects of phenylephrine for elective cesarean delivery under spinal anesthesia. Anesth Analg. 2010;111:1230&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">20841418</ArticleId></ArticleIdList></Reference><Reference><Citation>Goertz AW, Schmidt M, Seefelder C, Lindner KH, Georgieff M. The effect of phenylephrine bolus administration on left ventricular function during isoflurane-induced hypotension. Anesth Analg. 1993;77:227&#x2013;31.</Citation><ArticleIdList><ArticleId IdType="pubmed">8346819</ArticleId></ArticleIdList></Reference><Reference><Citation>Allen TK, George RB, White WD, Muir HA, Habib AS. A double-blind, placebo-controlled trial of four fixed rate infusion regimens of phenylephrine for hemodynamic support during spinal anesthesia for cesarean delivery. Anesth Analg. 2010;111:1221&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">20495139</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiao F, Shen B, Xu WP, Feng Y, Ngan Kee WD, Chen XZ. Dose-response study of 4 weight-based phenylephrine infusion regimens for preventing hypotension during cesarean delivery under combined spinal-epidural anesthesia. Anesth Analg. 2020;130:187&#x2013;93.</Citation><ArticleIdList><ArticleId IdType="pubmed">30829668</ArticleId></ArticleIdList></Reference><Reference><Citation>Ngan Kee WD. A Random-allocation graded dose-response study of norepinephrine and phenylephrine for treating hypotension during spinal anesthesia for cesarean delivery. Anesthesiology. 2017;127:934&#x2013;41.</Citation><ArticleIdList><ArticleId IdType="pubmed">28872480</ArticleId></ArticleIdList></Reference><Reference><Citation>Bartha E, Arfwedson C, Imnell A, Fernlund ME, Andersson LE, Kalman S. Randomized controlled trial of goal-directed haemodynamic treatment in patients with proximal femoral fracture. Br J Anaesth. 2013;110:545&#x2013;53.</Citation><ArticleIdList><ArticleId IdType="pubmed">23274782</ArticleId></ArticleIdList></Reference><Reference><Citation>&#x17d;uni&#x107; M, Kr&#x10d;evski &#x160;kvar&#x10d; N, Kamenik M. The influence of the infusion of ephedrine and phenylephrine on the hemodynamic stability after subarachnoid anesthesia in senior adults - a controlled randomized trial. BMC Anesthesiol. 2019;19:207.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6849197</ArticleId><ArticleId IdType="pubmed">31711417</ArticleId></ArticleIdList></Reference><Reference><Citation>Kinsella SM, Carvalho B, Dyer RA, Fernando R, McDonnell N, Mercier FJ, et al. International consensus statement on the management of hypotension with vasopressors during caesarean section under spinal anaesthesia. Anaesthesia. 2018;73:71&#x2013;92.</Citation><ArticleIdList><ArticleId IdType="pubmed">29090733</ArticleId></ArticleIdList></Reference><Reference><Citation>Dai X, Hummel SL, Salazar JB, Taffet GE, Zieman S, Schwartz JB. Cardiovascular physiology in the older adults. J Geriatr Cardiol. 2015;12:196&#x2013;201.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4460159</ArticleId><ArticleId IdType="pubmed">26089840</ArticleId></ArticleIdList></Reference><Reference><Citation>Priebe HJ. The aged cardiovascular risk patient. Br J Anaesth. 2000;85:763&#x2013;78.</Citation><ArticleIdList><ArticleId IdType="pubmed">11094595</ArticleId></ArticleIdList></Reference><Reference><Citation>Hasanin A, Mukhtar A, Nassar H. Perfusion indices revisited. J Intensive Care. 2017;5:24.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5351209</ArticleId><ArticleId IdType="pubmed">28331621</ArticleId></ArticleIdList></Reference><Reference><Citation>Lairez O, Ferr&#xe9; F, Portet N, Marty P, Delmas C, Cognet T, et al. Cardiovascular effects of low-dose spinal anaesthesia as a function of age: an observational study using echocardiography. Anaesth Crit Care Pain Med. 2015;34:271&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">26388504</ArticleId></ArticleIdList></Reference><Reference><Citation>Sanders M, Servaas S, Slagt C. Accuracy and precision of non-invasive cardiac output monitoring by electrical cardiometry: a systematic review and meta-analysis. J Clin Monit Comput. 2020;34:433&#x2013;60.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7205855</ArticleId><ArticleId IdType="pubmed">31175501</ArticleId></ArticleIdList></Reference><Reference><Citation>Mazgaoker S, Ketko I, Yanovich R, Heled Y, Epstein Y. Measuring core body temperature with a non-invasive sensor. J Therm Biol. 2017;66:17&#x2013;20.</Citation><ArticleIdList><ArticleId IdType="pubmed">28477905</ArticleId></ArticleIdList></Reference><Reference><Citation>Hasanin A, Soryal R, Kaddah T, Raouf SA, Abdelwahab Y, Elshafaei K, et al. Hemodynamic effects of lateral tilt before and after spinal anesthesia during cesarean delivery: an observational study. BMC Anesthesiol. 2018;18:8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5769501</ArticleId><ArticleId IdType="pubmed">29334907</ArticleId></ArticleIdList></Reference><Reference><Citation>Fathy S, Hasanin A, Mostafa M, Ramzy E, Sarhan K, Almenesey T, et al. The benefit of adding lidocaine to ketamine during rapid sequence endotracheal intubation in patients with septic shock: a randomised controlled trial. Anaesth Crit Care Pain Med. 2021;40:100731.</Citation><ArticleIdList><ArticleId IdType="pubmed">32898698</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">31911130</PMID><DateCompleted><Year>2020</Year><Month>10</Month><Day>19</Day></DateCompleted><DateRevised><Year>2020</Year><Month>10</Month><Day>19</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1615-5947</ISSN><JournalIssue CitedMedium="Internet"><Volume>66</Volume><PubDate><Year>2020</Year><Month>Jul</Month></PubDate></JournalIssue><Title>Annals of vascular surgery</Title><ISOAbbreviation>Ann Vasc Surg</ISOAbbreviation></Journal><ArticleTitle>Predictive Model for Pulmonary Embolism in Patients with Deep Vein Thrombosis.</ArticleTitle><Pagination><StartPage>334</StartPage><EndPage>343</EndPage><MedlinePgn>334-343</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.avsg.2019.12.008</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0890-5096(19)31046-5</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">To develop and verify a risk predictive model/scoring system for pulmonary embolism (PE) among hospitalized patients with deep venous thrombosis of the lower extremities (LDVT).</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">776 patients with LDVT were enrolled in a case-control study between January 2016 and June 2017 from the Vascular Surgery Department of Shanxi Dayi Hospital, China. They were randomly divided into development (543 patients, 70%) and validation (233 patients, 30%) databases. Based on the results of pulmonary computed tomography arteriography, patients were divided into 2 categories; those with PE were designated as the case group, whereas those without comprised the controls. A logistic regression model and scoring system for PE in patients with LDVT was established in the development database and verified in the validation database. Scoring system (Shanxi Dayi Hospital score [SDH score]) was tabulated as follows: right lower extremity or bilateral lower extremities, 1; surgery or immobilization, 1; malignant tumor, 1; history of venous thromboembolism (VTE), 2; D-dimer &gt;1,000&#xa0;ng/mL, 2; and unprovoked, 2. Calibration and discrimination of the model were assessed by the Hosmer-Lemeshow goodness of fit test and the area under the receiver operating characteristic curve (AUC). Wells score, the Revised Geneva score, and the SDH score for predictive value of PE by AUC in the validation database were compared.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">776 patients with LDVT were divided into 2 risk categories based on the scores from the risk model as follows: PE unlikely (score &lt;3) and PE likely (score &#x2265;3). Sensitivity, specificity, and crude agreement of the SDH score in the development database were 76.39%, 55.89%, and 61.33%, respectively. In the validation database, the logistic regression model showed good calibration and discriminative power. The Hosmer-Lemeshow goodness of fit test P value was &gt;0.05, and the AUC was 0.705 (95% CI: 0.634-0.776, P&#xa0;&lt;&#xa0;0.001). The SDH score also showed good discriminative power, and the AUC was 0.702 (95% CI: 0.631-0.774, P&#xa0;&lt;&#xa0;0.001). Sensitivity, specificity, and crude agreement of the SDH score in the validation database were 67.61%, 61.73%, and 63.52%, respectively. AUC for the Wells score and the Revised Geneva score was 0.611 (95% CI: 0.533-0.688, P&#xa0;=&#xa0;0.007) and 0.585 (95% CI: 0.503-0.666, P&#xa0;=&#xa0;0.040), respectively. Difference of the AUC was not statistically significant between the Wells score and the SDH score (0.611 vs. 0.702, P&#xa0;=&#xa0;0.059) but was so between the Revised Geneva score and the SDH score (0.585 vs. 0.702, P&#xa0;=&#xa0;0.016). Sensitivity of the Wells score, Revised Geneva score, and the SDH score (64.79%, 67.61% vs. 67.61%) was not statistically significant. However, the specificity of the Wells score and Revised Geneva score was significantly lower than that of the SDH score (48.77%, 39.51% vs. 61.73%).</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Our logistic regression model and the SDH score based on 7 risk factors as right lower extremity, bilateral lower extremities, unprovoked, surgery or immobilization, malignant tumor, history of VTE, and D-dimer&gt;1,000&#xa0;ng/mL showed good calibration and discriminative power for the assessment of PE risk in patients with LDVT. The SDH score is more specific for PE prediction in the Chinese population, compared with the Wells score and the Revised Geneva score.</AbstractText><CopyrightInformation>Copyright &#xa9; 2019 Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Zhao</LastName><ForeName>Binliang</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Vascular Surgery, The Affiliated Da Yi Hospital of Shanxi Medical University, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hao</LastName><ForeName>Bin</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Vascular Surgery, The Affiliated Da Yi Hospital of Shanxi Medical University, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xu</LastName><ForeName>Huimin</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Vascular Surgery, The Affiliated Da Yi Hospital of Shanxi Medical University, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Premaratne</LastName><ForeName>Shyamal</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Hunter Holmes McGuire Veterans Administration Medical Center, Richmond, VA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Jiantao</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Vascular Surgery, The Affiliated Da Yi Hospital of Shanxi Medical University, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jiao</LastName><ForeName>Le</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Vascular Surgery, The Affiliated Da Yi Hospital of Shanxi Medical University, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Wenpei</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Department of Vascular Surgery, The Affiliated Da Yi Hospital of Shanxi Medical University, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Shengquan</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Vascular Surgery, The Affiliated Da Yi Hospital of Shanxi Medical University, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Su</LastName><ForeName>Xudong</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Vascular Surgery, The Affiliated Da Yi Hospital of Shanxi Medical University, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sun</LastName><ForeName>Lei</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Vascular Surgery, The Affiliated Da Yi Hospital of Shanxi Medical University, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yao</LastName><ForeName>Jie</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Vascular Surgery, The Affiliated Da Yi Hospital of Shanxi Medical University, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yu</LastName><ForeName>Ying</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Vascular Surgery, The Affiliated Da Yi Hospital of Shanxi Medical University, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>Tao</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Vascular Surgery, The Affiliated Da Yi Hospital of Shanxi Medical University, China. Electronic address: tao646808009@gmail.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D003160">Comparative Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D023361">Validation Study</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>01</Month><Day>03</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Ann Vasc Surg</MedlineTA><NlmUniqueID>8703941</NlmUniqueID><ISSNLinking>0890-5096</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016022" MajorTopicYN="N">Case-Control Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002681" MajorTopicYN="N" Type="Geographic">China</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000081415" MajorTopicYN="Y">Clinical Decision Rules</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016208" MajorTopicYN="N">Databases, Factual</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006760" MajorTopicYN="N">Hospitalization</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011237" MajorTopicYN="N">Predictive Value of Tests</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011655" MajorTopicYN="N">Pulmonary Embolism</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName><QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015203" MajorTopicYN="N">Reproducibility of Results</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018570" MajorTopicYN="N">Risk Assessment</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020246" MajorTopicYN="N">Venous Thrombosis</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2019</Year><Month>8</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2019</Year><Month>11</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2019</Year><Month>12</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>1</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>10</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>1</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31911130</ArticleId><ArticleId IdType="doi">10.1016/j.avsg.2019.12.008</ArticleId><ArticleId IdType="pii">S0890-5096(19)31046-5</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">31003781</PMID><DateCompleted><Year>2020</Year><Month>06</Month><Day>29</Day></DateCompleted><DateRevised><Year>2020</Year><Month>06</Month><Day>29</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1532-8406</ISSN><JournalIssue CitedMedium="Internet"><Volume>34</Volume><Issue>8</Issue><PubDate><Year>2019</Year><Month>Aug</Month></PubDate></JournalIssue><Title>The Journal of arthroplasty</Title><ISOAbbreviation>J Arthroplasty</ISOAbbreviation></Journal><ArticleTitle>Gender Differences for Hip and Knee Arthroplasty: Complications and Healthcare Utilization.</ArticleTitle><Pagination><StartPage>1593</StartPage><EndPage>1597.e1</EndPage><MedlinePgn>1593-1597.e1</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.arth.2019.03.064</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0883-5403(19)30320-1</ELocationID><Abstract><AbstractText Label="INTRODUCTION" NlmCategory="BACKGROUND">The influence of patient gender on complications and healthcare utilization remains unexplored. The purpose of the present study was to determine if patient gender significantly affected outcomes following total hip arthroplasty (THA) and total knee arthroplasty (TKA).</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Retrospective cohort study of THA and TKA patients was performed using the Nationwide Inpatient Sample from 2002 to 2011. Only patients who underwent elective procedures and those with complete perioperative data were included. Multivariate logistic regression was used to compare the rates of adverse events between male and female cohorts while controlling for baseline characteristics.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">A total of 6,123,637 patients were included in the study (31.2% THA and 68.8% TKA). The cohort was 61.1% female. While males had a lower rate of any adverse event (odds ratio [OR]&#xa0;= 0.8, P &lt; .001), urinary tract infection (OR&#xa0;= 0.4, P &lt; .001), deep vein thrombosis/pulmonary embolism (OR&#xa0;= 0.9, P&#xa0;&lt;&#xa0;.001), and blood transfusion (OR&#xa0;= 0.5, P &lt; .001), male gender was associated with statistically significant increases in the rates of death (OR&#xa0;= 1.6, P &lt; .001), acute kidney injury (OR&#xa0;= 1.6, P &lt; .001), cardiac arrest (OR&#xa0;= 1.7, P &lt; .001), myocardial infarction (OR&#xa0;= 1.6, P &lt; .001), pneumonia (OR&#xa0;= 1.1, P&#xa0;&lt;&#xa0;.001), sepsis (OR&#xa0;= 1.6, P &lt; .001), surgical site infection (OR&#xa0;= 1.4, P &lt; .001), and wound dehiscence (OR&#xa0;= 1.4, P &lt; .001).</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Males had increased rates of many individual adverse events. Females had higher rates of urinary tract infection, which translated to an overall higher rate of adverse events in females because of the rarity of the other individual adverse events.</AbstractText><CopyrightInformation>Copyright &#xa9; 2019 Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Basques</LastName><ForeName>Bryce A</ForeName><Initials>BA</Initials><AffiliationInfo><Affiliation>Department of Orthopaedic Surgery, Rush University Medical Center, Chicago, IL.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bell</LastName><ForeName>Joshua A</ForeName><Initials>JA</Initials><AffiliationInfo><Affiliation>Department of Orthopaedic Surgery, Rush University Medical Center, Chicago, IL.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fillingham</LastName><ForeName>Yale A</ForeName><Initials>YA</Initials><AffiliationInfo><Affiliation>Department of Orthopaedic Surgery, Dartmouth-Hitchcock Medical Center, Lebanon, NH.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Khan</LastName><ForeName>Jannat M</ForeName><Initials>JM</Initials><AffiliationInfo><Affiliation>Department of Orthopaedic Surgery, Rush University Medical Center, Chicago, IL.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Della Valle</LastName><ForeName>Craig J</ForeName><Initials>CJ</Initials><AffiliationInfo><Affiliation>Department of Orthopaedic Surgery, Rush University Medical Center, Chicago, IL.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2019</Year><Month>04</Month><Day>01</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Arthroplasty</MedlineTA><NlmUniqueID>8703515</NlmUniqueID><ISSNLinking>0883-5403</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019644" MajorTopicYN="N">Arthroplasty, Replacement, Hip</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019645" MajorTopicYN="N">Arthroplasty, Replacement, Knee</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001803" MajorTopicYN="N">Blood Transfusion</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006323" MajorTopicYN="N">Heart Arrest</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016015" MajorTopicYN="N">Logistic Models</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015999" MajorTopicYN="N">Multivariate Analysis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009203" MajorTopicYN="N">Myocardial Infarction</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016017" MajorTopicYN="N">Odds Ratio</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010342" MajorTopicYN="N">Patient Acceptance of Health Care</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="Y">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011014" MajorTopicYN="N">Pneumonia</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011655" MajorTopicYN="N">Pulmonary Embolism</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012737" MajorTopicYN="N">Sex Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013530" MajorTopicYN="N">Surgical Wound Infection</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014481" MajorTopicYN="N" Type="Geographic">United States</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014552" MajorTopicYN="N">Urinary Tract Infections</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020246" MajorTopicYN="N">Venous Thrombosis</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">complications</Keyword><Keyword MajorTopicYN="N">gender</Keyword><Keyword MajorTopicYN="N">healthcare utilization</Keyword><Keyword MajorTopicYN="N">total hip arthroplasty</Keyword><Keyword MajorTopicYN="N">total knee arthroplasty</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2018</Year><Month>12</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2019</Year><Month>3</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2019</Year><Month>3</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>4</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>7</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>4</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31003781</ArticleId><ArticleId IdType="doi">10.1016/j.arth.2019.03.064</ArticleId><ArticleId IdType="pii">S0883-5403(19)30320-1</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">31448795</PMID><DateCompleted><Year>2020</Year><Month>02</Month><Day>06</Day></DateCompleted><DateRevised><Year>2022</Year><Month>04</Month><Day>10</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">2444-054X</ISSN><JournalIssue CitedMedium="Internet"><Volume>87</Volume><Issue>5</Issue><PubDate><Year>2019</Year></PubDate></JournalIssue><Title>Cirugia y cirujanos</Title><ISOAbbreviation>Cir Cir</ISOAbbreviation></Journal><ArticleTitle>Results and complications of carotid endarterectomy in a hospital from Madrid, Spain.</ArticleTitle><Pagination><StartPage>501</StartPage><EndPage>507</EndPage><MedlinePgn>501-507</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.24875/CIRU.19000529</ELocationID><Abstract><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">To study the incidence of cerebrovascular (transient ischemic attacks and stroke) and myocardial events (myocardial infarction) as well as early survival related to carotid endarterectomy. Our secondary aim is to establish possible risk factors associated with complications.</AbstractText><AbstractText Label="METHOD" NlmCategory="METHODS">Retrospective observational case-control study within a cohort. All patients who underwent carotid endarterectomy by the angiology and vascular surgery service at the Hospital Universitario La Paz, in Madrid (Spain), in the period between January 2011 and December 2017 were included. Chi square was used to calculate differences. Kaplan-Meier and Cox regression was used for the survival analysis and patency.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">111 procedures were performed on 108 patients, 95 (87,9%) male with an average age of 68.5 &#xb1; 8.75. The mean time of follow-up was 2.9 years. There was no 30-day post-surgical mortality, with a 30-day postoperative cerebral vascular event rate of 2.7%. Statistically significant correlation was found between the presence of 30-day postoperative cerebral vascular event and primary closure (p = 0.005) as well as between the smoking habit and 30-day postoperative myocardial infarction (p = 0.036) and restenosis (p = 0.008). In mid-term follow-up, the event rate for cerebral vascular events and myocardial infarction was 1.8%.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">carotid endarterectomy is the procedure of choice in carotid stenosis. The low rates of perioperative mortality, morbidity and complications have been demonstrated.</AbstractText><CopyrightInformation>Copyright: &#xa9; 2019 Permanyer.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Mart&#xed;n-Morales</LastName><ForeName>Elena</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Departamento de Cirug&#xed;a, Facultad de Medicina, Universidad Aut&#xf3;noma de Madrid.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jim&#xe9;nez-Rom&#xe1;n</LastName><ForeName>Renato</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Servicio de Angiolog&#xed;a y Cirug&#xed;a Vascular. Hospital Universitario La Paz. Madrid, Espa&#xf1;a.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Paluso-Montero</LastName><ForeName>Alexia</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Servicio de Angiolog&#xed;a y Cirug&#xed;a Vascular. Hospital Universitario La Paz. Madrid, Espa&#xf1;a.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hern&#xe1;ndez-Ruiz</LastName><ForeName>Teresa</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Servicio de Angiolog&#xed;a y Cirug&#xed;a Vascular. Hospital Universitario La Paz. Madrid, Espa&#xf1;a.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mendieta-Azcona</LastName><ForeName>Covadonga</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Servicio de Angiolog&#xed;a y Cirug&#xed;a Vascular. Hospital Universitario La Paz. Madrid, Espa&#xf1;a.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Moral</LastName><ForeName>Luis F Riera-Del</ForeName><Initials>LFR</Initials><AffiliationInfo><Affiliation>Servicio de Angiolog&#xed;a y Cirug&#xed;a Vascular. Hospital Universitario La Paz. Madrid, Espa&#xf1;a.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D064888">Observational Study</PublicationType></PublicationTypeList><VernacularTitle>Resultados y complicaciones de la endarterectom&#xed;a carot&#xed;dea en un Hospital de Madrid, Espa&#xf1;a.</VernacularTitle></Article><MedlineJournalInfo><Country>Mexico</Country><MedlineTA>Cir Cir</MedlineTA><NlmUniqueID>0372736</NlmUniqueID><ISSNLinking>0009-7411</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016893" MajorTopicYN="N">Carotid Stenosis</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016022" MajorTopicYN="N">Case-Control Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016894" MajorTopicYN="Y">Endarterectomy, Carotid</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005500" MajorTopicYN="N">Follow-Up Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006785" MajorTopicYN="N">Hospitals, University</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D053208" MajorTopicYN="N">Kaplan-Meier Estimate</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009203" MajorTopicYN="N">Myocardial Infarction</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010523" MajorTopicYN="N">Peripheral Nervous System Diseases</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016016" MajorTopicYN="N">Proportional Hazards Models</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011655" MajorTopicYN="N">Pulmonary Embolism</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013030" MajorTopicYN="N" Type="Geographic">Spain</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020521" MajorTopicYN="N">Stroke</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013530" MajorTopicYN="N">Surgical Wound Infection</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading></MeshHeadingList><OtherAbstract Type="Publisher" Language="spa"><AbstractText Label="OBJETIVO" NlmCategory="OBJECTIVE">Conocer la incidencia de eventos cerebrovasculares y mioc&#xe1;rdicos, y la supervivencia temprana, relacionados con la endarterectom&#xed;a carot&#xed;dea, y como objetivo secundario establecer los posibles factores de riesgo asociados a las complicaciones.</AbstractText><AbstractText Label="M&#xc9;TODO" NlmCategory="UNASSIGNED">Estudio observacional de casos y controles anidado en una cohorte retrospectiva. Se incluyeron todos los pacientes que se sometieron a endarterectom&#xed;a carot&#xed;dea en el servicio de angiolog&#xed;a y cirug&#xed;a vascular del Hospital Universitario La Paz, de Madrid (Espa&#xf1;a), en el periodo de enero de 2011 a diciembre de 2017. Para la estimaci&#xf3;n de diferencias se utiliz&#xf3; la prueba de ji al cuadrado. El an&#xe1;lisis de supervivencia y permeabilidad se realiz&#xf3; mediante Kaplan-Meier y regresi&#xf3;n de Cox.</AbstractText><AbstractText Label="RESULTADOS" NlmCategory="RESULTS">Se realizaron 111 procedimientos en 108 pacientes, 95 (87.9%) de ellos varones, con una edad media de 68.5 &#xb1; 8.75 a&#xf1;os. La media de seguimiento fue de 2.9 a&#xf1;os. No hubo mortalidad posquir&#xfa;rgica a 30 d&#xed;as, y la tasa global de eventos vasculares cerebrales posoperatorios a 30 d&#xed;as fue del 2.7%. Se encontr&#xf3; asociaci&#xf3;n entre la presencia de eventos vasculares cerebrales posquir&#xfa;rgicos a 30 d&#xed;as y el cierre arterial primario (p = 0.005), y del infarto agudo de miocardio posoperatorio a 30 d&#xed;as y la reestenosis carot&#xed;dea con el h&#xe1;bito tab&#xe1;quico (p = 0.036 y p = 0.008, respectivamente). En el seguimiento a mediano plazo se encontr&#xf3; una tasa de enfermedad vascular cerebral y de infarto agudo de miocardio del 1,8%.</AbstractText><AbstractText Label="CONCLUSI&#xd3;N" NlmCategory="UNASSIGNED">La endarterectom&#xed;a carot&#xed;dea es el procedimiento de elecci&#xf3;n en la estenosis carot&#xed;dea por enfermedad ateroscler&#xf3;tica. En nuestro estudio se demuestran sus bajas tasas de mortalidad, de morbilidad y de complicaciones perioperatorias.</AbstractText><CopyrightInformation>Copyright: &#xa9; 2019 Permanyer.</CopyrightInformation></OtherAbstract><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Carotid stenosis</Keyword><Keyword MajorTopicYN="N">Complicaci&#xf3;n posquir&#xfa;rgica</Keyword><Keyword MajorTopicYN="N">Complication postoperative</Keyword><Keyword MajorTopicYN="N">Endarterectomy carotid</Keyword><Keyword MajorTopicYN="N">Endarterectom&#xed;a carot&#xed;dea</Keyword><Keyword MajorTopicYN="N">Estenosis carot&#xed;dea</Keyword><Keyword MajorTopicYN="N">Ictus</Keyword><Keyword MajorTopicYN="N">Infarto de miocardio</Keyword><Keyword MajorTopicYN="N">Mortalidad</Keyword><Keyword MajorTopicYN="N">Mortality</Keyword><Keyword MajorTopicYN="N">Myocardial infarction</Keyword><Keyword MajorTopicYN="N">Stroke</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>8</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>8</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>2</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31448795</ArticleId><ArticleId IdType="doi">10.24875/CIRU.19000529</ArticleId><ArticleId IdType="pii">j87/5/501</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">39734000</PMID><DateCompleted><Year>2025</Year><Month>02</Month><Day>23</Day></DateCompleted><DateRevised><Year>2025</Year><Month>06</Month><Day>04</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1615-5947</ISSN><JournalIssue CitedMedium="Internet"><Volume>112</Volume><PubDate><Year>2025</Year><Month>Mar</Month></PubDate></JournalIssue><Title>Annals of vascular surgery</Title><ISOAbbreviation>Ann Vasc Surg</ISOAbbreviation></Journal><ArticleTitle>Flush Endovenous Laser Ablation (fEVLA) in the Treatment of Lower Limb Venous Insufficiency a Systematic Review and Meta-Analysis.</ArticleTitle><Pagination><StartPage>352</StartPage><EndPage>362</EndPage><MedlinePgn>352-362</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.avsg.2024.12.041</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0890-5096(24)00861-6</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">To assess the safety and efficacy of flush endovenous laser ablation (fEVLA) in the treatment of chronic venous insufficiency (CVI).</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) 2020 guidelines, a systematic review aiming to identify studies published from inception to March 2024 was conducted. The investigation covered single-arm studies and studies comparing fEVLA to standard EVLA (sEVLA). The primary endpoint was endovenous heat-induced thrombosis (EHIT) class&#xa0;&#x2265;&#xa0;II.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Eleven studies encompassing 2738 patients and 3147 truncal veins were included. The pooled EHIT&#xa0;&#x2265;&#xa0;II was 1.37% (95% CI: 0.57-3.28). Meta-regression identified an association between linear endovenous energy density (LEED) applied at the saphenofemoral junction (SFJ) and EHIT&#xa0;&#x2265;&#xa0;II outcomes (&#x3b2;&#xa0;=&#xa0;0.011, P&#xa0;&lt;&#xa0;0.01). The pooled medium-term great saphenous vein (GSV) occlusion was 97.59% (95% CI: 94.89-98.88). The pooled and crude deep vein thrombosis (DVT) and pulmonary embolism (PE) estimates were 0.97% (95% CI: 0.64-1.47) and 0.04%. The comparative analysis regarding GSV occlusion, odds ratio (OR) 3.26 (95% CI: 0.76-13.97) and refluxing anterior accessory saphenous vein (AASV), risk ratio (RR) 0.45 (95% CI: 0.11-1.77) suggested a nonstatistically significant trend favoring fEVLA. Nonstatistically significant differences were identified in terms of EHIT&#xa0;&#x2265;&#xa0;II between the techniques, RR 1.00(95% CI: 0.18-5.53). Statistically significant differences favoring fEVLA were identified in terms of proximal groin recurrence RR 0.35 (95% CI: 0.16-0.80) and stump length (mean difference) MD -7.23 (95% CI: -11.59to-2.88).</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">This review has demonstrated the safety of fEVLA while also suggesting a potentially improved efficacy of fEVLA over sEVLA in terms of proximal groin recurrence. Moreover, the trend indicating fEVLA's superiority in terms of GSV occlusion and the occurrence of new-onset AASV reflux merits further research.</AbstractText><CopyrightInformation>Copyright &#xa9; 2024 Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Bontinis</LastName><ForeName>Vangelis</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Department of Vascular Surgery, Aristotle University of Thessaloniki, AHEPA University General Hospital, Thessaloniki, Greece. Electronic address: vangelisbont@hotmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bontinis</LastName><ForeName>Alkis</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Vascular Surgery, Aristotle University of Thessaloniki, AHEPA University General Hospital, Thessaloniki, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Giannopoulos</LastName><ForeName>Argirios</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Vascular Surgery, Aristotle University of Thessaloniki, AHEPA University General Hospital, Thessaloniki, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pitoulias</LastName><ForeName>Apostolos G</ForeName><Initials>AG</Initials><AffiliationInfo><Affiliation>Division of Vascular Surgery - 2nd Department of Surgery, "G. Gennimatas" Hospital, Thessaloniki, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chorti</LastName><ForeName>Angeliki</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Surgery, Aristotle University of Thessaloniki, AHEPA University Hospital, Thessaloniki, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ktenidis</LastName><ForeName>Kiriakos</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Vascular Surgery, Aristotle University of Thessaloniki, AHEPA University General Hospital, Thessaloniki, Greece.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>12</Month><Day>27</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Ann Vasc Surg</MedlineTA><NlmUniqueID>8703941</NlmUniqueID><ISSNLinking>0890-5096</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002908" MajorTopicYN="N">Chronic Disease</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057510" MajorTopicYN="Y">Endovascular Procedures</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D053685" MajorTopicYN="Y">Laser Therapy</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D035002" MajorTopicYN="Y">Lower Extremity</DescriptorName><QualifierName UI="Q000098" MajorTopicYN="N">blood supply</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018570" MajorTopicYN="N">Risk Assessment</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014689" MajorTopicYN="Y">Venous Insufficiency</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020246" MajorTopicYN="N">Venous Thrombosis</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>10</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>12</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>12</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>2</Month><Day>24</Day><Hour>2</Hour><Minute>10</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>12</Month><Day>30</Day><Hour>0</Hour><Minute>19</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>12</Month><Day>29</Day><Hour>19</Hour><Minute>52</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39734000</ArticleId><ArticleId IdType="doi">10.1016/j.avsg.2024.12.041</ArticleId><ArticleId IdType="pii">S0890-5096(24)00861-6</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">28723807</PMID><DateCompleted><Year>2017</Year><Month>08</Month><Day>08</Day></DateCompleted><DateRevised><Year>2021</Year><Month>01</Month><Day>09</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1536-5964</ISSN><JournalIssue CitedMedium="Internet"><Volume>96</Volume><Issue>29</Issue><PubDate><Year>2017</Year><Month>Jul</Month></PubDate></JournalIssue><Title>Medicine</Title><ISOAbbreviation>Medicine (Baltimore)</ISOAbbreviation></Journal><ArticleTitle>Can patients with femoral neck fracture benefit from preoperative thromboprophylaxis?: A prospective randomized controlled trial.</ArticleTitle><Pagination><StartPage>e7604</StartPage><MedlinePgn>e7604</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e7604</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1097/MD.0000000000007604</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">The effectiveness of preoperative thromboprophylaxis remains obscure in patients with femoral neck fracture. The purpose of the current study was to investigate whether these patients benefit from preoperative thromboprophylaxis.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">In this prospective, randomized controlled trial, a total of 80 patients with femoral neck fracture were randomly assigned to receive either rivaroxaban or conservative treatment before surgery. For all patients, color Doppler ultrasound of both lower extremities was performed immediately after admission. The primary efficacy outcome was venous thromboembolism (VTE) defined as deep vein thrombosis (DVT) or pulmonary embolism (PE). The primary safety outcome was major bleeding.</AbstractText><AbstractText Label="RESULT" NlmCategory="RESULTS">Compared with conservative treatment, rivaroxaban could significantly reduce the incidence of DVT from 19.5% (8/41) to 2.6% (1/39) (P&#x200a;=&#x200a;.016). Preoperatively, there were a total of 9 occurrences of DVT including 8 DVT in the conservative treatment group and 1 in the oral rivaroxaban group. All cases of DVT were asymptomatic, with 8 of them diagnosed as isolated muscular calf vein thromboses. There were no differences between the 2 groups in terms of the overall incidence of major bleeding.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Thromboprophylaxis with rivaroxaban prior to surgery can effectively reduce the risk of preoperative DVT for patients with femoral neck fracture without increasing the risk of bleeding.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Qiangqiang</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>Department of Sports Medicine and Adult Reconstructive Surgery, Nanjing Drum Tower Hospital, Clinical College of Nanjing Medical University Laboratory for Bone and Joint Diseases, Model Animal Research Center, Nanjing University Department of Sports Medicine and Adult Reconstructive Surgery, Nanjing Drum Tower Hospital Affiliated with the Medical School of Nanjing University, Nanjing, Jiangsu Department of Orthopedics, The first Affiliated Hospital of Nantong University, Nantong NingBo No.6 Hospital, Ningbo, P.R. China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dai</LastName><ForeName>Bingyang</ForeName><Initials>B</Initials></Author><Author ValidYN="Y"><LastName>Xu</LastName><ForeName>Jiacheng</ForeName><Initials>J</Initials></Author><Author ValidYN="Y"><LastName>Yao</LastName><ForeName>Yao</ForeName><Initials>Y</Initials></Author><Author ValidYN="Y"><LastName>Song</LastName><ForeName>Kai</ForeName><Initials>K</Initials></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Haojun</ForeName><Initials>H</Initials></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Dongyang</ForeName><Initials>D</Initials></Author><Author ValidYN="Y"><LastName>Jiang</LastName><ForeName>Qing</ForeName><Initials>Q</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D003160">Comparative Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Medicine (Baltimore)</MedlineTA><NlmUniqueID>2985248R</NlmUniqueID><ISSNLinking>0025-7974</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D065427">Factor Xa Inhibitors</NameOfSubstance></Chemical><Chemical><RegistryNumber>9NDF7JZ4M3</RegistryNumber><NameOfSubstance UI="D000069552">Rivaroxaban</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000284" MajorTopicYN="N">Administration, Oral</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000072700" MajorTopicYN="N">Conservative Treatment</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D065427" MajorTopicYN="N">Factor Xa Inhibitors</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="Y">administration &amp; dosage</QualifierName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005265" MajorTopicYN="N">Femoral Neck Fractures</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName><QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006470" MajorTopicYN="N">Hemorrhage</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015994" MajorTopicYN="N">Incidence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011300" MajorTopicYN="N">Preoperative Care</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011655" MajorTopicYN="N">Pulmonary Embolism</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000069552" MajorTopicYN="N">Rivaroxaban</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="Y">administration &amp; dosage</QualifierName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018615" MajorTopicYN="N">Ultrasonography, Doppler, Color</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020246" MajorTopicYN="N">Venous Thrombosis</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName></MeshHeading></MeshHeadingList><CoiStatement>The authors declare that they have no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2017</Year><Month>7</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2017</Year><Month>7</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2017</Year><Month>8</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2017</Year><Month>7</Month><Day>21</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">28723807</ArticleId><ArticleId IdType="pmc">PMC5521947</ArticleId><ArticleId IdType="doi">10.1097/MD.0000000000007604</ArticleId><ArticleId IdType="pii">00005792-201707210-00072</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Eriksson BI, Lassen MR. Duration of prophylaxis against venous thromboembolism with fondaparinux after hip fracture surgery: a multicenter, randomized, placebo-controlled, double-blind study. Arch Int Med 2003;163:1337&#x2013;42.</Citation><ArticleIdList><ArticleId IdType="pubmed">12796070</ArticleId></ArticleIdList></Reference><Reference><Citation>Geerts WH, Pineo GF, Heit JA, et al. Prevention of venous thromboembolism: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 2004;126(Suppl):338S&#x2013;400S.</Citation><ArticleIdList><ArticleId IdType="pubmed">15383478</ArticleId></ArticleIdList></Reference><Reference><Citation>Agnelli G, Cosmi B, Di FP, et al. A randomised, double-blind, placebo-controlled trial of dermatan sulphate for prevention of deep vein thrombosis in hip fracture. Thromb Haemost 1992;67:203.</Citation><ArticleIdList><ArticleId IdType="pubmed">1621239</ArticleId></ArticleIdList></Reference><Reference><Citation>Lowe G DO, Meek DR, Campbell AF, et al. Subcutaneous ancrod in prevention of deep-vein thrombosis after operation for fractured neck of femur. Lancet 1978;2:698.</Citation><ArticleIdList><ArticleId IdType="pubmed">80632</ArticleId></ArticleIdList></Reference><Reference><Citation>Powers PJ, Gent M, Jay RM, et al. A randomized trial of less intense postoperative warfarin or aspirin therapy in the prevention of venous thromboembolism after surgery for fractured hip. Arch Inter Med 1989;149:771.</Citation><ArticleIdList><ArticleId IdType="pubmed">2650646</ArticleId></ArticleIdList></Reference><Reference><Citation>Rogers PH, Walsh PN, Marder VJ, et al. Controlled trial of low-dose heparin and sulfinpyrazone to prevent venous thromboembolism after operation on the hip. J Bone Joint Surg 1978;60:758.</Citation><ArticleIdList><ArticleId IdType="pubmed">359562</ArticleId></ArticleIdList></Reference><Reference><Citation>Falckytter Y, Francis CW, Johanson NA, et al. Prevention of VTE in orthopedic surgery patients. Chest 2012;141(Part):400&#x2013;12.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3278063</ArticleId><ArticleId IdType="pubmed">22315265</ArticleId></ArticleIdList></Reference><Reference><Citation>Chan YK, Chiu KY, Cheng SW, et al. The incidence of deep vein thrombosis in elderly Chinese suffering hip fracture is low without prophylaxis: a prospective study using serial duplex ultrasound. J Orthop Surg 2005;12:178.</Citation><ArticleIdList><ArticleId IdType="pubmed">15621903</ArticleId></ArticleIdList></Reference><Reference><Citation>Cho YH, Byun YS, Jeong DG, et al. Preoperative incidence of deep vein thrombosis after hip fractures in Korean. Clin Orthop Surg 2015;7:298.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4553276</ArticleId><ArticleId IdType="pubmed">26330950</ArticleId></ArticleIdList></Reference><Reference><Citation>Roberts TS, Nelson CL, Barnes CL, et al. The preoperative prevalence and postoperative incidence of thromboembolism in patients with hip fractures treated with dextran prophylaxis. Clin Orthop Relat R 1990;255:198.</Citation><ArticleIdList><ArticleId IdType="pubmed">1693325</ArticleId></ArticleIdList></Reference><Reference><Citation>Hull RD, Pineo GF, Stein PD, et al. Timing of initial administration of low-molecular-weight heparin prophylaxis against deep vein thrombosis in patients following elective hip arthroplasty: a systematic review. Arch Inter Med 2001;161:1952.</Citation><ArticleIdList><ArticleId IdType="pubmed">11525697</ArticleId></ArticleIdList></Reference><Reference><Citation>Sharnoff JG, Deblasio G. Prevention of fatal postoperative thromboembolism by heparin prophylaxis. Lancet 1970;2:1006.</Citation><ArticleIdList><ArticleId IdType="pubmed">4098043</ArticleId></ArticleIdList></Reference><Reference><Citation>Gallus AS, Hirsh J, Tutle RJ, et al. Small subcutaneous doses of heparin in prevention of venous thrombosis. N Engl J Med 1973;288:545.</Citation><ArticleIdList><ArticleId IdType="pubmed">4568221</ArticleId></ArticleIdList></Reference><Reference><Citation>Strebel N, Prins M, Agnelli G, et al. Preoperative or postoperative start of prophylaxis for venous thromboembolism with low-molecular-weight heparin in elective hip surgery? Arch Inter Med 2002;162:145.</Citation><ArticleIdList><ArticleId IdType="pubmed">12090880</ArticleId></ArticleIdList></Reference><Reference><Citation>Dahl OE, Aspelin T, Lyberg T. The role of bone traumatization in the initiation of proximal deep vein thrombosis during cemented hip replacement surgery in pigs. Blood Coagul Fibrin 1996;6:709.</Citation><ArticleIdList><ArticleId IdType="pubmed">8825220</ArticleId></ArticleIdList></Reference><Reference><Citation>Perka C. Preoperative versus postoperative initiation of thromboprophylaxis following major orthopedic surgery: safety and efficacy of postoperative administration supported by recent trials of new oral anticoagulants. Thromb J 2011;9:17.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3228673</ArticleId><ArticleId IdType="pubmed">22087515</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Z, Na H, Xu H, et al. Incidence of venous thromboembolism and hemorrhage related safety studies of preoperative anticoagulation therapy in hip fracture patients undergoing surgical treatment: a case&#x2013;control study. BMC Musculoskel Dis 2016;17:1.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4752756</ArticleId><ArticleId IdType="pubmed">26873584</ArticleId></ArticleIdList></Reference><Reference><Citation>Kirazli Y, Akkoc Y, Kanyilmaz S. Spinal epidural hematoma associated with oral anticoagulation therapy. Am J Phys Med Rehab 2004;83:220.</Citation><ArticleIdList><ArticleId IdType="pubmed">15043358</ArticleId></ArticleIdList></Reference><Reference><Citation>Tran T, Delluc A, Wit CD, et al. The impact of oral anticoagulation on time to surgery in patients hospitalized with hip fracture. Thromb Res 2015;136:962.</Citation><ArticleIdList><ArticleId IdType="pubmed">26428416</ArticleId></ArticleIdList></Reference><Reference><Citation>Eriksson BI, Borris LC, Friedman RJ, et al. Rivaroxaban versus enoxaparin for thromboprophylaxis after hip arthroplasty. N Engl J Med 2008;358:2765.</Citation><ArticleIdList><ArticleId IdType="pubmed">18579811</ArticleId></ArticleIdList></Reference><Reference><Citation>Agnelli G, Gallus A, Goldhaber SZ. Treatment of proximal deep-vein thrombosis with the oral direct factor Xa inhibitor Rivaroxaban (BAY 59-7939): The ODIXa-DVT (oral direct factor Xa inhibitor BAY 59-7939 in patients with acute symptomatic deep-vein thrombosis) study. Dig World Core Med J 2007;116:180&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">17576867</ArticleId></ArticleIdList></Reference><Reference><Citation>Kakkar AK, Brenner B, Dahl OE, et al. Extended duration rivaroxaban versus short-term enoxaparin for the prevention of venous thromboembolism after total hip arthroplasty: a double-blind, randomised controlled trial. Lancet 2008;372:31.</Citation><ArticleIdList><ArticleId IdType="pubmed">18582928</ArticleId></ArticleIdList></Reference><Reference><Citation>Turpie AG, Lassen MR, Davidson BL, et al. Rivaroxaban versus enoxaparin for thromboprophylaxis after total knee arthroplasty (RECORD4): a randomised trial. Lancet 2009;373:1673&#x2013;80.</Citation><ArticleIdList><ArticleId IdType="pubmed">19411100</ArticleId></ArticleIdList></Reference><Reference><Citation>Lensing AW, Doris CI, Mcgrath FP, et al. A comparison of compression ultrasound with color Doppler ultrasound for the diagnosis of symptomless postoperative deep vein thrombosis. Arch Int Med 1997;157:765&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">9125008</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith EB, Parvizi J, Purtill JJ. Delayed surgery for patients with femur and hip fractures-risk of deep venous thrombosis. J Trauma 2011;70:113.</Citation><ArticleIdList><ArticleId IdType="pubmed">21817966</ArticleId></ArticleIdList></Reference><Reference><Citation>Hefley FG, Jr, Nelson CL, Puskarich-May CL. Effect of delayed admission to the hospital on the preoperative prevalence of deep-vein thrombosis associated with fractures about the hip. J Bone Joint Surg 1996;78:581.</Citation><ArticleIdList><ArticleId IdType="pubmed">8609137</ArticleId></ArticleIdList></Reference><Reference><Citation>Zahn HR, Skinner JA, Porteous MJ. The preoperative prevalence of deep vein thrombosis in patients with femoral neck fractures and delayed operation. Injury 1999;30:605.</Citation><ArticleIdList><ArticleId IdType="pubmed">10707228</ArticleId></ArticleIdList></Reference><Reference><Citation>Geerts WH, Bergqvist D, Pineo GF, et al. Prevention of venous thromboembolism: American College of chest physicians evidence-based clinical practice guidelines (8th Edition). Chest 2008;133:381S.</Citation><ArticleIdList><ArticleId IdType="pubmed">18574271</ArticleId></ArticleIdList></Reference><Reference><Citation>Borgen PO, Dahl OE, Reikeras O. Preoperative versus postoperative initiation of dalteparin thromboprophylaxis in THA. Hip Int 2010;20:301.</Citation><ArticleIdList><ArticleId IdType="pubmed">20640994</ArticleId></ArticleIdList></Reference><Reference><Citation>Knesek D, Peterson TC, Markel DC. Thromboembolic prophylaxis in total joint arthroplasty. Thrombosis 2012;2012:837896.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3458274</ArticleId><ArticleId IdType="pubmed">23029611</ArticleId></ArticleIdList></Reference><Reference><Citation>Hull RD, Brant RF, Pineo GF, et al. Preoperative vs postoperative initiation of low-molecular-weight heparin prophylaxis against venous thromboembolism in patients undergoing elective hip replacement. Arch Int Med 1999;159:137.</Citation><ArticleIdList><ArticleId IdType="pubmed">9927095</ArticleId></ArticleIdList></Reference><Reference><Citation>J&#xf8;rgensen PS, Strandberg C, Wille-J&#xf8;rgensen P, et al. Early preoperative thromboprophylaxis with Klexane&#xae; in hip fracture surgery: a placebo-controlled study. Clin Appl Thromb-Hem 1998;4:140.</Citation></Reference><Reference><Citation>Warwick D. New concepts in orthopaedic thromboprophylaxis. J Bone Joint Surg Br 2004;86:788.</Citation><ArticleIdList><ArticleId IdType="pubmed">15330015</ArticleId></ArticleIdList></Reference><Reference><Citation>Rd LE, Miller RS, Rd CW, et al. Prophylactic inferior vena cava filters in trauma patients at high risk: follow-up examination and risk/benefit assessment. J Vasc Surg 1999;30:484.</Citation><ArticleIdList><ArticleId IdType="pubmed">10477641</ArticleId></ArticleIdList></Reference><Reference><Citation>Mismetti P, Laporte S, Pellerin O. Effect of a retrievable inferior vena cava filter plus anticoagulation vs anticoagulation alone on risk of recurrent pulmonary embolism: a randomized clinical trial. JAMA 2015;313:1627.</Citation><ArticleIdList><ArticleId IdType="pubmed">25919526</ArticleId></ArticleIdList></Reference><Reference><Citation>Singhal R, Brimble KS. Thromboembolic complications in the nephrotic syndrome: pathophysiology and clinical management. Thromb Res 2006;118:397.</Citation><ArticleIdList><ArticleId IdType="pubmed">15990160</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">29498571</PMID><DateCompleted><Year>2019</Year><Month>10</Month><Day>18</Day></DateCompleted><DateRevised><Year>2024</Year><Month>08</Month><Day>05</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1933-0693</ISSN><JournalIssue CitedMedium="Internet"><Volume>130</Volume><Issue>1</Issue><PubDate><Year>2019</Year><Month>Jan</Month><Day>01</Day></PubDate></JournalIssue><Title>Journal of neurosurgery</Title><ISOAbbreviation>J Neurosurg</ISOAbbreviation></Journal><ArticleTitle>The role of preoperative deep vein thrombosis screening in neurooncology.</ArticleTitle><Pagination><StartPage>38</StartPage><EndPage>43</EndPage><MedlinePgn>38-43</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.3171/2017.9.JNS17176</ELocationID><ELocationID EIdType="pii" ValidYN="Y">2017.9.JNS17176</ELocationID><Abstract><AbstractText>OBJECTIVEVenous thromboembolism (VTE) is a major cause of morbidity in patients undergoing neurosurgical intervention. The authors postulate that the introduction of a routine preoperative deep vein thrombosis (DVT) screening protocol for patients undergoing neurosurgical intervention for brain tumors would result in a more effective diagnosis of DVT in this high-risk subgroup, and subsequent appropriate management of the condition would reduce pulmonary embolism (PE) rates and improve patient outcomes.METHODSThe authors conducted a prospective study of 115 adult patients who were undergoing surgical intervention for a brain tumor. All patients underwent preoperative lower-limb Doppler ultrasonography scanning for DVT screening. Patients with confirmed DVT underwent a period of anticoagulation therapy, which was stopped prior to surgery. An inferior vena cava (IVC) filter was inserted to cover the perioperative period during which anticoagulation therapy was avoided due to bleeding risk before restarting the therapy at a later date. Patients underwent follow-up performed by a neurooncology multidisciplinary team, and subsequent complications and outcomes were recorded.RESULTSSeven (6%) of the 115 screened patients had DVT. Of these patients, one developed postoperative PE, and another had bilateral DVT postoperatively. None of the patients without preoperative DVT developed VTE postoperatively. Age, symptoms of DVT, and previous history of VTE were significantly higher in the group with preoperative DVT. There were no deaths and no complications from the anticoagulation or IVC filter insertion.CONCLUSIONSPreoperative screening for DVT is a worthwhile endeavor in patients undergoing neurosurgical intervention. A multidisciplinary approach in management of anticoagulation and IVC filter insertion is safe and can minimize further VTE in such patients.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Pandey</LastName><ForeName>Anmol</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Departments of1Neurosurgery and.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Thakur</LastName><ForeName>Bhaskar</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Departments of1Neurosurgery and.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hogg</LastName><ForeName>Florence</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Departments of1Neurosurgery and.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Brogna</LastName><ForeName>Christian</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Departments of1Neurosurgery and.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Logan</LastName><ForeName>Jamie</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Departments of1Neurosurgery and.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Arya</LastName><ForeName>Roopen</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>2Haematology, King's College Hospital, London, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gullan</LastName><ForeName>Richard</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Departments of1Neurosurgery and.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bhangoo</LastName><ForeName>Ranjeev</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Departments of1Neurosurgery and.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ashkan</LastName><ForeName>Keyoumars</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Departments of1Neurosurgery and.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>03</Month><Day>02</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Neurosurg</MedlineTA><NlmUniqueID>0253357</NlmUniqueID><ISSNLinking>0022-3085</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000925">Anticoagulants</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>J Neurosurg. 2019 Jul 12;131(3):984-985. doi: 10.3171/2019.3.JNS19665.</RefSource><PMID Version="1">31299648</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000925" MajorTopicYN="N">Anticoagulants</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001932" MajorTopicYN="N">Brain Neoplasms</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011300" MajorTopicYN="Y">Preoperative Care</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018608" MajorTopicYN="N">Ultrasonography, Doppler</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016306" MajorTopicYN="N">Vena Cava Filters</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D054556" MajorTopicYN="N">Venous Thromboembolism</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020246" MajorTopicYN="N">Venous Thrombosis</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000000981" MajorTopicYN="Y">diagnostic imaging</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">CCI = Charlson Comorbidity Index</Keyword><Keyword MajorTopicYN="N">DVT = deep vein thrombosis</Keyword><Keyword MajorTopicYN="N">IVC = inferior vena cava</Keyword><Keyword MajorTopicYN="N">MDT = multidisciplinary team</Keyword><Keyword MajorTopicYN="N">PE = pulmonary embolism</Keyword><Keyword MajorTopicYN="N">VTE = venous thromboembolism</Keyword><Keyword MajorTopicYN="N">brain tumor</Keyword><Keyword MajorTopicYN="N">deep vein thrombosis</Keyword><Keyword MajorTopicYN="N">neurooncology</Keyword><Keyword MajorTopicYN="N">oncology</Keyword><Keyword MajorTopicYN="N">pulmonary embolus</Keyword><Keyword MajorTopicYN="N">screening</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>1</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2017</Year><Month>9</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>3</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>10</Month><Day>19</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>3</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29498571</ArticleId><ArticleId IdType="doi">10.3171/2017.9.JNS17176</ArticleId><ArticleId IdType="pii">2017.9.JNS17176</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">32826053</PMID><DateCompleted><Year>2021</Year><Month>06</Month><Day>17</Day></DateCompleted><DateRevised><Year>2021</Year><Month>06</Month><Day>17</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1879-0267</ISSN><JournalIssue CitedMedium="Internet"><Volume>51</Volume><Issue>11</Issue><PubDate><Year>2020</Year><Month>Nov</Month></PubDate></JournalIssue><Title>Injury</Title><ISOAbbreviation>Injury</ISOAbbreviation></Journal><ArticleTitle>Morbid obesity and short-term complications following acetabular fracture surgery: A comparative cohort study.</ArticleTitle><Pagination><StartPage>2622</StartPage><EndPage>2627</EndPage><MedlinePgn>2622-2627</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.injury.2020.08.021</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0020-1383(20)30694-X</ELocationID><Abstract><AbstractText Label="INTRODUCTION" NlmCategory="BACKGROUND">Obesity is an epidemic facing the United States affecting nearly 40% of the population (93.3 million adults). The objective of this study was to compare early perioperative complications in patients with a normal BMI to patients who are pre-obese, obese, and morbidly obese.</AbstractText><AbstractText Label="MATERIALS AND METHODS" NlmCategory="METHODS">The study was conducted at a Level-I trauma center. Patients were separated into 4 groups based on their BMI. Group 1 had a BMI &lt; 25 (normal), Group 2 had a BMI between 25-29.9 (pre-obesity), Group 3 had a BMI between 30-39.9 (obese), and Group 4 had a BMI &#x2265;40 (morbidly obese). Outcome variables included total operative time (OT), estimated blood loss (EBL), length of stay (LOS), and early medical and surgical complications. A comparison between groups was performed for each outcome variable and surgical complication.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">We identified 333 patients and the number of patients in Groups 1-4 were 86, 96, 121, and 30, respectively. The average BMI for Groups 1-4 was 22.3, 27.3, 35.9, and 44.9, respectively (p &lt; 0.001). OT, EBL, and LOS did not differ between groups or between the surgical approach utilized. There were no significant relationships when comparing complication rates between groups. Patients in Group 4 experienced significantly more PE compared to patients in Group 2 (p=0.01). Additionally, patients in Group 4 experienced a significantly more PE than patients in Groups 1 and 2 combined (p&lt;.01). The relative risk of having a PE if BMI is &#x2265;40, compared to a BMI &lt;30 is 18.40 (95% CI&#xa0;=&#xa0;1.98 - 171.13). The PEs were not fatal in all cases.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">In the treatment of the obese and morbidly obese with acetabular fractures, we find that these cohorts are not at a greater risk of wound complications or infection. The higher rate of pulmonary embolism seen in the morbidly obese should be considered when evaluating these patients for appropriate thromboembolic prophylaxis.</AbstractText><CopyrightInformation>Copyright &#xa9; 2020 Elsevier Ltd. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Shaath</LastName><ForeName>M Kareem</ForeName><Initials>MK</Initials><AffiliationInfo><Affiliation>Orlando Health Orthopaedic Institute, Florida State College of Medicine, University of Central Florida College of Medicine, 122 S Orange Ave, 5 Floor, Orlando, FL, 32806, USA. Electronic address: mkshaathmd@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lim</LastName><ForeName>Philip K</ForeName><Initials>PK</Initials><AffiliationInfo><Affiliation>University of California Irvine, Department of Orthopedic Surgery, Irvine, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Andrews</LastName><ForeName>Reid</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>McGovern Medical School at UTHealth, Department of Orthopedic Surgery, Houston, TX, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chip Routt</LastName><ForeName>Milton L</ForeName><Initials>ML</Initials><AffiliationInfo><Affiliation>Orlando Health Orthopaedic Institute, Florida State College of Medicine, University of Central Florida College of Medicine, 122 S Orange Ave, 5 Floor, Orlando, FL, 32806, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>08</Month><Day>14</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Injury</MedlineTA><NlmUniqueID>0226040</NlmUniqueID><ISSNLinking>0020-1383</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015992" MajorTopicYN="N">Body Mass Index</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007902" MajorTopicYN="N">Length of Stay</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009767" MajorTopicYN="Y">Obesity, Morbid</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014481" MajorTopicYN="N" Type="Geographic">United States</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Acetabular fractures</Keyword><Keyword MajorTopicYN="N">Complications</Keyword><Keyword MajorTopicYN="N">Morbid obesity</Keyword><Keyword MajorTopicYN="N">Obesity</Keyword><Keyword MajorTopicYN="N">Surgical outcomes</Keyword></KeywordList><CoiStatement>Declaration of Competing Interest None.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>6</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2020</Year><Month>8</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>8</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>8</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>6</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>8</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32826053</ArticleId><ArticleId IdType="doi">10.1016/j.injury.2020.08.021</ArticleId><ArticleId IdType="pii">S0020-1383(20)30694-X</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">27984007</PMID><DateCompleted><Year>2017</Year><Month>05</Month><Day>09</Day></DateCompleted><DateRevised><Year>2017</Year><Month>05</Month><Day>09</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1555-7162</ISSN><JournalIssue CitedMedium="Internet"><Volume>130</Volume><Issue>3</Issue><PubDate><Year>2017</Year><Month>Mar</Month></PubDate></JournalIssue><Title>The American journal of medicine</Title><ISOAbbreviation>Am J Med</ISOAbbreviation></Journal><ArticleTitle>Inferior Vena Cava Filters in Elderly Patients with Stable Acute Pulmonary Embolism.</ArticleTitle><Pagination><StartPage>356</StartPage><EndPage>364</EndPage><MedlinePgn>356-364</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.amjmed.2016.09.033</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0002-9343(16)31071-3</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Patients aged &gt;60 years with pulmonary embolism who were stable and did not require thrombolytic therapy were shown to have a somewhat lower in-hospital all-cause mortality with vena cava filters. In this investigation we further assess mortality with filters in stable elderly patients.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">In-hospital all-cause mortality according to use of inferior vena cava filters was assessed from the National (Nationwide) Inpatient Sample, 2003-2012, in: 1) All patients with pulmonary embolism; 2) All with pulmonary embolism who had none of the comorbid conditions listed in the Charlson Comorbidity Index; 3) Patients with a primary (first-listed) diagnosis of pulmonary embolism, and 4) Patients with a primary diagnosis of pulmonary embolism and none of the comorbid conditions listed in the Charlson Comorbidity Index.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">From 2003-2012, 2,621,575 stable patients with pulmonary embolism were hospitalized in the US. Patients aged &gt;80 years showed lower mortality with vena cava filters (all pulmonary embolism, 6.1% vs 10.5%; all pulmonary embolism with no comorbid conditions, 3.3% vs 6.3%; primary pulmonary embolism, 4.1% vs 5.7%; primary pulmonary embolism with no comorbid conditions, 2.1% vs 3.7%; all P&#xa0;&lt;.0001). In the all-patient category, patients aged 71-80 years showed somewhat lower mortality with filters, 6.3% vs 7.4% (P &lt;.0001), and those without comorbid conditions, 2.5% vs 2.8% (P&#xa0;= .04). Those aged 71-80 years with primary pulmonary embolism, irrespective of comorbid conditions, did not show lower mortality with filters.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">At present, in the absence of a randomized controlled trial, it seems prudent to consider a vena cava filter in very elderly (aged &gt;80 years) stable patients with acute pulmonary embolism.</AbstractText><CopyrightInformation>Copyright &#xa9; 2016 Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Stein</LastName><ForeName>Paul D</ForeName><Initials>PD</Initials><AffiliationInfo><Affiliation>Department of Osteopathic Medical Specialties, College of Osteopathic Medicine, Michigan State University, East Lansing. Electronic address: steinp@msu.edu.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Matta</LastName><ForeName>Fadi</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Osteopathic Medical Specialties, College of Osteopathic Medicine, Michigan State University, East Lansing.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hughes</LastName><ForeName>Mary J</ForeName><Initials>MJ</Initials><AffiliationInfo><Affiliation>Department of Osteopathic Medical Specialties, College of Osteopathic Medicine, Michigan State University, East Lansing.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2016</Year><Month>10</Month><Day>29</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Am J Med</MedlineTA><NlmUniqueID>0267200</NlmUniqueID><ISSNLinking>0002-9343</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000208" MajorTopicYN="N">Acute Disease</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000367" MajorTopicYN="N">Age Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019917" MajorTopicYN="N">Blood Vessel Prosthesis Implantation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017052" MajorTopicYN="N">Hospital Mortality</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011655" MajorTopicYN="N">Pulmonary Embolism</DescriptorName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014481" MajorTopicYN="N">United States</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016306" MajorTopicYN="Y">Vena Cava Filters</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Elderly</Keyword><Keyword MajorTopicYN="N">Mortality</Keyword><Keyword MajorTopicYN="N">Pulmonary embolism</Keyword><Keyword MajorTopicYN="N">Vena cava filters</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2016</Year><Month>7</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2016</Year><Month>9</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2016</Year><Month>9</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2016</Year><Month>12</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2017</Year><Month>5</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2016</Year><Month>12</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">27984007</ArticleId><ArticleId IdType="doi">10.1016/j.amjmed.2016.09.033</ArticleId><ArticleId IdType="pii">S0002-9343(16)31071-3</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">27455158</PMID><DateCompleted><Year>2017</Year><Month>05</Month><Day>23</Day></DateCompleted><DateRevised><Year>2017</Year><Month>05</Month><Day>23</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1528-1140</ISSN><JournalIssue CitedMedium="Internet"><Volume>264</Volume><Issue>4</Issue><PubDate><Year>2016</Year><Month>Oct</Month></PubDate></JournalIssue><Title>Annals of surgery</Title><ISOAbbreviation>Ann Surg</ISOAbbreviation></Journal><ArticleTitle>Timing of Chemical Thromboprophylaxis and Deep Vein Thrombosis in Major Colorectal Surgery: A Randomized Clinical Trial.</ArticleTitle><Pagination><StartPage>632</StartPage><EndPage>639</EndPage><MedlinePgn>632-9</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1097/SLA.0000000000001856</ELocationID><Abstract><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">To identify the optimal timing of perioperative chemical thromboprophylaxis (CTP) and incidence of occult preoperative deep vein thrombosis (OP-DVT) in patients undergoing major colorectal surgery.</AbstractText><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">There is limited Level 1 data regarding the optimal timing of CTP in major colorectal surgery and the incidence of OP-DVT remains unclear. Both issues influence the occurrence of venous thromboembolism (VTE) and may impact Medicare reimbursement because of penalties for hospital-acquired conditions.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Patients undergoing major colorectal surgery underwent preoperative lower extremity venous duplex (LEVD) immediately before surgery. Those without OP-DVT were randomized to preoperative or postoperative CTP with 5000 units of subcutaneous heparin. Patients underwent repeat LEVD in the recovery room and on postoperative day 2. Outcome measures included early (48-hrs) and overall (30-days) postoperative VTE, bleeding complications, and OP-DVT.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Eighteen patients (4.2%) had OP-DVT and were excluded. The randomized group included 376 patients (51.6% female) with mean age of 52.7&#x200a;&#xb1;&#x200a;17.6 years. No pulmonary embolism occurred. There was no significant difference in preoperative versus postoperative CTP with respect to early postoperative DVT [3/184 (1.6%) vs 5/192 (2.6%); P = 0.72], DVT at 30 days (1.6% vs 3.6%; P = 0.34) or bleeding complications requiring reoperation (0.5% vs 1.6%; P = 0.62).</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">The risk of OP-DVT is higher than that of perioperative DVT after colorectal surgery and preoperative screening LEVD should be considered to identify and treat patients at risk for pulmonary embolism. Preoperative and postoperative CTP are equally safe in protecting against VTE. CMS should account for these factors when assigning financial disincentives for perioperative VTE.</AbstractText><AbstractText Label="TRIAL REGISTRATION" NlmCategory="BACKGROUND">Clinicaltrials.gov #NCT01976988.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Zaghiyan</LastName><ForeName>Karen N</ForeName><Initials>KN</Initials><AffiliationInfo><Affiliation>*Divisions of Colorectal Surgery, Cedars Sinai Medical Center, Los Angeles, CA &#x2020;Department of Surgery, Cedars Sinai Medical Center, Los Angeles, CA &#x2021;Division of Vascular Surgery, Cedars Sinai Medical Center, Los Angeles, CA &#xa7;Biostatistics and Bioinformatics Research Center, Cedars Sinai Medical Center, Los Angeles, CA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sax</LastName><ForeName>Harry C</ForeName><Initials>HC</Initials></Author><Author ValidYN="Y"><LastName>Miraflor</LastName><ForeName>Emily</ForeName><Initials>E</Initials></Author><Author ValidYN="Y"><LastName>Cossman</LastName><ForeName>David</ForeName><Initials>D</Initials></Author><Author ValidYN="Y"><LastName>Wagner</LastName><ForeName>Willis</ForeName><Initials>W</Initials></Author><Author ValidYN="Y"><LastName>Mirocha</LastName><ForeName>James</ForeName><Initials>J</Initials></Author><Author ValidYN="Y"><LastName>Gewertz</LastName><ForeName>Bruce</ForeName><Initials>B</Initials></Author><Author ValidYN="Y"><LastName>Fleshner</LastName><ForeName>Phillip</ForeName><Initials>P</Initials></Author><Author ValidYN="Y"><CollectiveName>Cedars-Sinai DVT Study Group</CollectiveName></Author></AuthorList><Language>eng</Language><DataBankList CompleteYN="Y"><DataBank><DataBankName>ClinicalTrials.gov</DataBankName><AccessionNumberList><AccessionNumber>NCT01976988</AccessionNumber></AccessionNumberList></DataBank></DataBankList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Ann Surg</MedlineTA><NlmUniqueID>0372354</NlmUniqueID><ISSNLinking>0003-4932</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D005343">Fibrinolytic Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>9005-49-6</RegistryNumber><NameOfSubstance UI="D006493">Heparin</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003108" MajorTopicYN="N">Colonic Diseases</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005343" MajorTopicYN="N">Fibrinolytic Agents</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006493" MajorTopicYN="N">Heparin</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011292" MajorTopicYN="Y">Premedication</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011655" MajorTopicYN="N">Pulmonary Embolism</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012002" MajorTopicYN="N">Rectal Diseases</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020246" MajorTopicYN="N">Venous Thrombosis</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2016</Year><Month>7</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2016</Year><Month>7</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2017</Year><Month>5</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">27455158</ArticleId><ArticleId IdType="doi">10.1097/SLA.0000000000001856</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">25891841</PMID><DateCompleted><Year>2016</Year><Month>03</Month><Day>25</Day></DateCompleted><DateRevised><Year>2018</Year><Month>11</Month><Day>13</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1879-2472</ISSN><JournalIssue CitedMedium="Internet"><Volume>135</Volume><Issue>6</Issue><PubDate><Year>2015</Year><Month>Jun</Month></PubDate></JournalIssue><Title>Thrombosis research</Title><ISOAbbreviation>Thromb Res</ISOAbbreviation></Journal><ArticleTitle>Is lipid lowering therapy an independent risk factor for venous thromboembolism? A population-based case-control study.</ArticleTitle><Pagination><StartPage>1110</StartPage><EndPage>1116</EndPage><MedlinePgn>1110-6</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.thromres.2015.04.005</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0049-3848(15)00160-7</ELocationID><Abstract><AbstractText Label="INTRODUCTION" NlmCategory="BACKGROUND">The independent effect of lipid lowering therapy (LLT) on venous thromboembolism (VTE) risk is uncertain.</AbstractText><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">To test statin and non-statin LLT as potential VTE risk factors.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Using Rochester Epidemiology Project resources, we identified all Olmsted County, MN residents with objectively diagnosed incident VTE (cases) over the 13-year period, 1988-2000 (n=1340), and one to two matched controls (n=1538). We reviewed their complete medical records for baseline characteristics previously identified as independent VTE risk factors, and for statin and non-statin LLT. Using conditional logistic regression, we tested the overall effect of LLT on VTE risk and also separately explored the role of statin versus that of non-statin LLT, adjusting for other baseline characteristics.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Among cases and controls, 74 and 111 received statin LLT, and 32 and 50 received non-statin LLT, respectively. Univariately, and after individually controlling for other potential VTE risk factors (i.e., BMI, trauma/fracture, leg paresis, hospitalization for surgery or medical illness, nursing home residence, active cancer, central venous catheter, varicose veins, prior superficial vein thrombosis, diabetes, congestive heart failure, angina/myocardial infarction, stroke, peripheral vascular disease, smoking, anticoagulation), LLT was associated with decreased odds of VTE (unadjusted OR=0.73; p=0.03). When considered separately, statin and non-statin LLT were each associated with moderate, non-significant lower odds of VTE. After adjusting for angina/myocardial infarction, each was significantly associated with decreased odds of VTE (OR=0.63, p&lt;0.01 and OR=0.61, p=0.04, respectively).</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">LLT is associated with decreased VTE risk after adjusting for known risk factors.</AbstractText><CopyrightInformation>Copyright &#xa9; 2015 Elsevier Ltd. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ashrani</LastName><ForeName>Aneel A</ForeName><Initials>AA</Initials><AffiliationInfo><Affiliation>Division of Hematology, Department of Internal Medicine, College of Medicine, Mayo Clinic, Rochester, MN, United States. Electronic address: ashrani.aneel@mayo.edu.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Barsoum</LastName><ForeName>Michel K</ForeName><Initials>MK</Initials><AffiliationInfo><Affiliation>Division of Cardiovascular Diseases, Department of Internal Medicine, College of Medicine, Mayo Clinic, Rochester, MN, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Crusan</LastName><ForeName>Daniel J</ForeName><Initials>DJ</Initials><AffiliationInfo><Affiliation>Division of Biomedical Statistics and Informatics, Department of Health Sciences Research, College of Medicine, Mayo Clinic, Rochester, MN, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Petterson</LastName><ForeName>Tanya M</ForeName><Initials>TM</Initials><AffiliationInfo><Affiliation>Division of Biomedical Statistics and Informatics, Department of Health Sciences Research, College of Medicine, Mayo Clinic, Rochester, MN, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bailey</LastName><ForeName>Kent R</ForeName><Initials>KR</Initials><AffiliationInfo><Affiliation>Division of Biomedical Statistics and Informatics, Department of Health Sciences Research, College of Medicine, Mayo Clinic, Rochester, MN, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Heit</LastName><ForeName>John A</ForeName><Initials>JA</Initials><AffiliationInfo><Affiliation>Division of Hematology, Department of Internal Medicine, College of Medicine, Mayo Clinic, Rochester, MN, United States; Division of Cardiovascular Diseases, Department of Internal Medicine, College of Medicine, Mayo Clinic, Rochester, MN, United States; Division of Epidemiology, Department of Health Sciences Research, College of Medicine, Mayo Clinic, Rochester, MN, United States.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01 AG034676</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 HL066216</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>K12HL83797</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01HL66216</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>K12 HL083797</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01AG034676</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2015</Year><Month>04</Month><Day>11</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Thromb Res</MedlineTA><NlmUniqueID>0326377</NlmUniqueID><ISSNLinking>0049-3848</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D019161">Hydroxymethylglutaryl-CoA Reductase Inhibitors</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D008055">Lipids</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016022" MajorTopicYN="N">Case-Control Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003327" MajorTopicYN="N">Coronary Disease</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019161" MajorTopicYN="N">Hydroxymethylglutaryl-CoA Reductase Inhibitors</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006949" MajorTopicYN="N">Hyperlipidemias</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008055" MajorTopicYN="N">Lipids</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016015" MajorTopicYN="N">Logistic Models</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008137" MajorTopicYN="N">Longitudinal Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016017" MajorTopicYN="N">Odds Ratio</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011655" MajorTopicYN="N">Pulmonary Embolism</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D054556" MajorTopicYN="N">Venous Thromboembolism</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName><QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020246" MajorTopicYN="N">Venous Thrombosis</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Epidemiology</Keyword><Keyword MajorTopicYN="N">Hydroxymethylglutaryl-CoA Reductase Inhibitors</Keyword><Keyword MajorTopicYN="N">Hypolipidemic Agents</Keyword><Keyword MajorTopicYN="N">Pulmonary Embolism</Keyword><Keyword MajorTopicYN="N">Venous Thrombosis</Keyword><Keyword MajorTopicYN="N">Venous thromboembolism</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2014</Year><Month>12</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2015</Year><Month>4</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2015</Year><Month>4</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2015</Year><Month>4</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2015</Year><Month>4</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2016</Year><Month>3</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2016</Year><Month>6</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">25891841</ArticleId><ArticleId IdType="mid">NIHMS680402</ArticleId><ArticleId IdType="pmc">PMC4437851</ArticleId><ArticleId IdType="doi">10.1016/j.thromres.2015.04.005</ArticleId><ArticleId IdType="pii">S0049-3848(15)00160-7</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Falk E, Fuster V. Atherothrombosis: Disease burden, activity, and vulnerability. In: Fuster V, Walsh RA, Harrington RA, et al., editors. Hurst's The Heart. 13th ed. New York: McGraw-Hill; 2011. pp. 1215&#x2013;1223.</Citation></Reference><Reference><Citation>Kawasaki T, Kambayashi J, Ariyoshi H, Sakon M, Suehisa E, Monden M. Hypercholesterolemia as a risk factor for deep-vein thrombosis. Thromb Res. 1997;88(1):67&#x2013;73.</Citation><ArticleIdList><ArticleId IdType="pubmed">9336875</ArticleId></ArticleIdList></Reference><Reference><Citation>Griffin JH, Fernandez JA, Deguchi H. Plasma lipoproteins, hemostasis and thrombosis. Thromb Haemost. 2001;86(1):386&#x2013;394.</Citation><ArticleIdList><ArticleId IdType="pubmed">11487028</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaya A, Mira Y, Ferrando F, Contreras M, Estelles A, Espana F, et al. Hyperlipidaemia and venous thromboembolism in patients lacking thrombophilic risk factors. Br J Haematol. 2002;118(1):255&#x2013;259.</Citation><ArticleIdList><ArticleId IdType="pubmed">12100157</ArticleId></ArticleIdList></Reference><Reference><Citation>Goldhaber SZ, Grodstein F, Stampfer MJ, Manson JE, Colditz GA, Speizer FE, et al. A prospective study of risk factors for pulmonary embolism in women. Jama. 1997;277(8):642&#x2013;645.</Citation><ArticleIdList><ArticleId IdType="pubmed">9039882</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsai AW, Cushman M, Rosamond WD, Heckbert SR, Polak JF, Folsom AR. Cardiovascular risk factors and venous thromboembolism incidence: the longitudinal investigation of thromboembolism etiology. Arch Intern Med. 2002;162(10):1182&#x2013;1189.</Citation><ArticleIdList><ArticleId IdType="pubmed">12020191</ArticleId></ArticleIdList></Reference><Reference><Citation>Linnemann B, Zgouras D, Schindewolf M, Schwonberg J, Jarosch-Preusche M, Lindhoff-Last E. Impact of sex and traditional cardiovascular risk factors on the risk of recurrent venous thromboembolism: results from the German MAISTHRO Registry. Blood coagulation &amp; fibrinolysis : an international journal in haemostasis and thrombosis. 2008;19(2):159&#x2013;165.</Citation><ArticleIdList><ArticleId IdType="pubmed">18277138</ArticleId></ArticleIdList></Reference><Reference><Citation>Holst AG, Jensen G, Prescott E. Risk factors for venous thromboembolism: results from the Copenhagen City Heart Study. Circulation. 2010;121(17):1896&#x2013;1903.</Citation><ArticleIdList><ArticleId IdType="pubmed">20404252</ArticleId></ArticleIdList></Reference><Reference><Citation>de Man FH, Nieuwland R, van der Laarse A, Romijn F, Smelt AH, Gevers Leuven JA, et al. Activated platelets in patients with severe hypertriglyceridemia: effects of triglyceride-lowering therapy. Atherosclerosis. 2000;152(2):407&#x2013;414.</Citation><ArticleIdList><ArticleId IdType="pubmed">10998469</ArticleId></ArticleIdList></Reference><Reference><Citation>Pathansali R, Smith N, Bath P. Altered megakaryocyte-platelet haemostatic axis in hypercholesterolaemia. Platelets. 2001;12(5):292&#x2013;297.</Citation><ArticleIdList><ArticleId IdType="pubmed">11487381</ArticleId></ArticleIdList></Reference><Reference><Citation>Sattar N, Petrie JR, Jaap AJ. The atherogenic lipoprotein phenotype and vascular endothelial dysfunction. Atherosclerosis. 1998;138(2):229&#x2013;235.</Citation><ArticleIdList><ArticleId IdType="pubmed">9690905</ArticleId></ArticleIdList></Reference><Reference><Citation>Bladbjerg EM, Marckmann P, Sandstrom B, Jespersen J. Non-fasting factor VII coagulant activity (FVII:C) increased by high-fat diet. Thromb Haemost. 1994;71(6):755&#x2013;758.</Citation><ArticleIdList><ArticleId IdType="pubmed">7974344</ArticleId></ArticleIdList></Reference><Reference><Citation>Atsumi T, Khamashta MA, Andujar C, Leandro MJ, Amengual O, Ames PR, et al. Elevated plasma lipoprotein(a) level and its association with impaired fibrinolysis in patients with antiphospholipid syndrome. J Rheumatol. 1998;25(1):69&#x2013;73.</Citation><ArticleIdList><ArticleId IdType="pubmed">9458205</ArticleId></ArticleIdList></Reference><Reference><Citation>Caplice NM, Panetta C, Peterson TE, Kleppe LS, Mueske CS, Kostner GM, et al. Lipoprotein (a) binds and inactivates tissue factor pathway inhibitor: a novel link between lipoproteins and thrombosis. Blood. 2001;98(10):2980&#x2013;2987.</Citation><ArticleIdList><ArticleId IdType="pubmed">11698280</ArticleId></ArticleIdList></Reference><Reference><Citation>Cogo A, Bernardi E, Prandoni P, Girolami B, Noventa F, Simioni P, et al. Acquired risk factors for deep-vein thrombosis in symptomatic outpatients. Arch Intern Med. 1994;154(2):164&#x2013;168.</Citation><ArticleIdList><ArticleId IdType="pubmed">8285811</ArticleId></ArticleIdList></Reference><Reference><Citation>Libertiny G, Hands L. Deep venous thrombosis in peripheral vascular disease. Br J Surg. 1999;86(7):907&#x2013;910.</Citation><ArticleIdList><ArticleId IdType="pubmed">10417563</ArticleId></ArticleIdList></Reference><Reference><Citation>Prandoni P, Bilora F, Marchiori A, Bernardi E, Petrobelli F, Lensing AW, et al. An association between atherosclerosis and venous thrombosis. N Engl J Med. 2003;348(15):1435&#x2013;1441.</Citation><ArticleIdList><ArticleId IdType="pubmed">12686699</ArticleId></ArticleIdList></Reference><Reference><Citation>Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S) Lancet. 1994;344(8934):1383&#x2013;1389.</Citation><ArticleIdList><ArticleId IdType="pubmed">7968073</ArticleId></ArticleIdList></Reference><Reference><Citation>Shepherd J, Cobbe SM, Ford I, Isles CG, Lorimer AR, MacFarlane PW, et al. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group. N Engl J Med. 1995;333(20):1301&#x2013;1307.</Citation><ArticleIdList><ArticleId IdType="pubmed">7566020</ArticleId></ArticleIdList></Reference><Reference><Citation>Lewis SJ, Moye LA, Sacks FM, Johnstone DE, Timmis G, Mitchell J, et al. Effect of pravastatin on cardiovascular events in older patients with myocardial infarction and cholesterol levels in the average range. Results of the Cholesterol and Recurrent Events (CARE) trial. Ann Intern Med. 1998;129(9):681&#x2013;689.</Citation><ArticleIdList><ArticleId IdType="pubmed">9841599</ArticleId></ArticleIdList></Reference><Reference><Citation>Tonkin AM, Colquhoun D, Emberson J, Hague W, Keech A, Lane G, et al. Effects of pravastatin in 3260 patients with unstable angina: results from the LIPID study. Lancet. 2000;356(9245):1871&#x2013;1875.</Citation><ArticleIdList><ArticleId IdType="pubmed">11130382</ArticleId></ArticleIdList></Reference><Reference><Citation>Ridker PM, Danielson E, Fonseca FA, Genest J, Gotto AM, Jr, Kastelein JJ, et al. Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. The New England journal of medicine. 2008;359(21):2195&#x2013;2207.</Citation><ArticleIdList><ArticleId IdType="pubmed">18997196</ArticleId></ArticleIdList></Reference><Reference><Citation>Alonso R, Mata P, De Andres R, Villacastin BP, Martinez-Gonzalez J, Badimon L. Sustained long-term improvement of arterial endothelial function in heterozygous familial hypercholesterolemia patients treated with simvastatin. Atherosclerosis. 2001;157(2):423&#x2013;429.</Citation><ArticleIdList><ArticleId IdType="pubmed">11472743</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsunekawa T, Hayashi T, Kano H, Sumi D, Matsui-Hirai H, Thakur NK, et al. Cerivastatin, a hydroxymethylglutaryl coenzyme a reductase inhibitor, improves endothelial function in elderly diabetic patients within 3 days. Circulation. 2001;104(4):376&#x2013;379.</Citation><ArticleIdList><ArticleId IdType="pubmed">11468195</ArticleId></ArticleIdList></Reference><Reference><Citation>de Jongh S, Lilien MR, op't Roodt J, Stroes ES, Bakker HD, Kastelein JJ. Early statin therapy restores endothelial function in children with familial hypercholesterolemia. J Am Coll Cardiol. 2002;40(12):2117&#x2013;2121.</Citation><ArticleIdList><ArticleId IdType="pubmed">12505222</ArticleId></ArticleIdList></Reference><Reference><Citation>Wilson SH, Herrmann J, Lerman LO, Holmes DR, Jr, Napoli C, Ritman EL, et al. Simvastatin preserves the structure of coronary adventitial vasa vasorum in experimental hypercholesterolemia independent of lipid lowering. Circulation. 2002;105(4):415&#x2013;418.</Citation><ArticleIdList><ArticleId IdType="pubmed">11815421</ArticleId></ArticleIdList></Reference><Reference><Citation>Thompson PD, Moyna NM, White CM, Weber KM, Giri S, Waters DD. The effects of hydroxy-methyl-glutaryl co-enzyme A reductase inhibitors on platelet thrombus formation. Atherosclerosis. 2002;161(2):301&#x2013;306.</Citation><ArticleIdList><ArticleId IdType="pubmed">11888512</ArticleId></ArticleIdList></Reference><Reference><Citation>Ma LP, Nie DN, Hsu SX, Yin SM, Xu LZ, Nunes JV. Inhibition of platelet aggregation and expression of alpha granule membrane protein 140 and thromboxane B2 with pravastatin therapy for hypercholesterolemia. J Assoc Acad Minor Phys. 2002;13(1):23&#x2013;26.</Citation><ArticleIdList><ArticleId IdType="pubmed">11852667</ArticleId></ArticleIdList></Reference><Reference><Citation>Puccetti L, Pasqui AL, Pastorelli M, Bova G, Cercignani M, Palazzuoli A, et al. Time-dependent effect of statins on platelet function in hypercholesterolaemia. Eur J Clin Invest. 2002;32(12):901&#x2013;908.</Citation><ArticleIdList><ArticleId IdType="pubmed">12534449</ArticleId></ArticleIdList></Reference><Reference><Citation>Undas A, Brummel KE, Musial J, Mann KG, Szczeklik A. Simvastatin depresses blood clotting by inhibiting activation of prothrombin, factor V, and factor XIII and by enhancing factor Va inactivation. Circulation. 2001;103(18):2248&#x2013;2253.</Citation><ArticleIdList><ArticleId IdType="pubmed">11342472</ArticleId></ArticleIdList></Reference><Reference><Citation>Colli S, Eligini S, Lalli M, Camera M, Paoletti R, Tremoli E. Vastatins inhibit tissue factor in cultured human macrophages. A novel mechanism of protection against atherothrombosis. Arterioscler Thromb Vasc Biol. 1997;17(2):265&#x2013;272.</Citation><ArticleIdList><ArticleId IdType="pubmed">9081680</ArticleId></ArticleIdList></Reference><Reference><Citation>Baetta R, Camera M, Comparato C, Altana C, Ezekowitz MD, Tremoli E. Fluvastatin reduces tissue factor expression and macrophage accumulation in carotid lesions of cholesterol-fed rabbits in the absence of lipid lowering. Arterioscler Thromb Vasc Biol. 2002;22(4):692&#x2013;698.</Citation><ArticleIdList><ArticleId IdType="pubmed">11950712</ArticleId></ArticleIdList></Reference><Reference><Citation>Camera M, Toschi V, Comparato C, Baetta R, Rossi F, Fuortes M, et al. Cholesterol-induced thrombogenicity of the vessel wall: inhibitory effect of fluvastatin. Thromb Haemost. 2002;87(4):748&#x2013;755.</Citation><ArticleIdList><ArticleId IdType="pubmed">12008961</ArticleId></ArticleIdList></Reference><Reference><Citation>Adams NB, Lutsey PL, Folsom AR, Herrington DH, Sibley CT, Zakai NA, et al. Statin therapy and levels of hemostatic factors in a healthy population: the MultiEthnic Study of Atherosclerosis. Journal of thrombosis and haemostasis : JTH. 2013;11(6):1078&#x2013;1084.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3702638</ArticleId><ArticleId IdType="pubmed">23565981</ArticleId></ArticleIdList></Reference><Reference><Citation>Albert MA, Danielson E, Rifai N, Ridker PM. Effect of statin therapy on C-reactive protein levels: the pravastatin inflammation/CRP evaluation (PRINCE): a randomized trial and cohort study. Jama. 2001;286(1):64&#x2013;70.</Citation><ArticleIdList><ArticleId IdType="pubmed">11434828</ArticleId></ArticleIdList></Reference><Reference><Citation>van Haelst PL, van Doormaal JJ, May JF, Gans RO, Crijns HJ, Cohen Tervaert JW. Secondary prevention with fluvastatin decreases levels of adhesion molecules, neopterin and C-reactive protein. European Journal of Internal Medicine. 2001;12(6):503&#x2013;509.</Citation><ArticleIdList><ArticleId IdType="pubmed">11711273</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosenson RS, Tangney CC. Antiatherothrombotic properties of statins: implications for cardiovascular event reduction. Jama. 1998;279(20):1643&#x2013;1650.</Citation><ArticleIdList><ArticleId IdType="pubmed">9613915</ArticleId></ArticleIdList></Reference><Reference><Citation>Dangas G, Smith DA, Unger AH, Shao JH, Meraj P, Fier C, et al. Pravastatin: an antithrombotic effect independent of the cholesterol-lowering effect. Thromb Haemost. 2000;83(5):688&#x2013;692.</Citation><ArticleIdList><ArticleId IdType="pubmed">10823263</ArticleId></ArticleIdList></Reference><Reference><Citation>Seljeflot I, Tonstad S, Hjermann I, Arnesen H. Improved fibrinolysis after 1-year treatment with HMG CoA reductase inhibitors in patients with coronary heart disease. Thromb Res. 2002;105(4):285&#x2013;290.</Citation><ArticleIdList><ArticleId IdType="pubmed">12031821</ArticleId></ArticleIdList></Reference><Reference><Citation>Grady D, Wenger NK, Herrington D, Khan S, Furberg C, Hunninghake D, et al. Postmenopausal hormone therapy increases risk for venous thromboembolic disease. The Heart and Estrogen/progestin Replacement Study. Ann Intern Med. 2000;132(9):689&#x2013;696.</Citation><ArticleIdList><ArticleId IdType="pubmed">10787361</ArticleId></ArticleIdList></Reference><Reference><Citation>Herrington DM, Vittinghoff E, Lin F, Fong J, Harris F, Hunninghake D, et al. Statin therapy, cardiovascular events, and total mortality in the Heart and Estrogen/Progestin Replacement Study (HERS) Circulation. 2002;105(25):2962&#x2013;2967.</Citation><ArticleIdList><ArticleId IdType="pubmed">12081988</ArticleId></ArticleIdList></Reference><Reference><Citation>Ray JG, Mamdani M, Tsuyuki RT, Anderson DR, Yeo EL, Laupacis A. Use of statins and the subsequent development of deep vein thrombosis. Arch Intern Med. 2001;161(11):1405&#x2013;1410.</Citation><ArticleIdList><ArticleId IdType="pubmed">11386889</ArticleId></ArticleIdList></Reference><Reference><Citation>Doggen CJ, Lemaitre RN, Smith NL, Heckbert SR, Psaty BM. HMG CoA reductase inhibitors and the risk of venous thrombosis among postmenopausal women. J Thromb Haemost. 2004;2(5):700&#x2013;701.</Citation><ArticleIdList><ArticleId IdType="pubmed">15099273</ArticleId></ArticleIdList></Reference><Reference><Citation>Lacut K, Oger E, Le Gal G, Couturaud F, Louis S, Leroyer C, et al. Statins but not fibrates are associated with a reduced risk of venous thromboembolism: a hospital-based case-control study. Fundam Clin Pharmacol. 2004;18(4):477&#x2013;482.</Citation><ArticleIdList><ArticleId IdType="pubmed">15312155</ArticleId></ArticleIdList></Reference><Reference><Citation>Huerta C, Johansson S, Wallander MA, Garcia Rodriguez LA. Risk factors and short-term mortality of venous thromboembolism diagnosed in the primary care setting in the United Kingdom. Archives of internal medicine. 2007;167(9):935&#x2013;943.</Citation><ArticleIdList><ArticleId IdType="pubmed">17502535</ArticleId></ArticleIdList></Reference><Reference><Citation>Ramcharan AS, Van Stralen KJ, Snoep JD, Mantel-Teeuwisse AK, Rosendaal FR, Doggen CJ. HMG-CoA reductase inhibitors, other lipid-lowering medication, antiplatelet therapy, and the risk of venous thrombosis. Journal of thrombosis and haemostasis : JTH. 2009;7(4):514&#x2013;520.</Citation><ArticleIdList><ArticleId IdType="pubmed">19036068</ArticleId></ArticleIdList></Reference><Reference><Citation>Glynn RJ, Danielson E, Fonseca FA, Genest J, Gotto AM, Jr, Kastelein JJ, et al. A randomized trial of rosuvastatin in the prevention of venous thromboembolism. The New England journal of medicine. 2009;360(18):1851&#x2013;1861.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2710995</ArticleId><ArticleId IdType="pubmed">19329822</ArticleId></ArticleIdList></Reference><Reference><Citation>Sorensen HT, Horvath-Puho E, Sogaard KK, Christensen S, Johnsen SP, Thomsen RW, et al. Arterial cardiovascular events, statins, low-dose aspirin and subsequent risk of venous thromboembolism: a population-based case-control study. Journal of thrombosis and haemostasis : JTH. 2009;7(4):521&#x2013;528.</Citation><ArticleIdList><ArticleId IdType="pubmed">19192118</ArticleId></ArticleIdList></Reference><Reference><Citation>Agarwal V, Phung OJ, Tongbram V, Bhardwaj A, Coleman CI. Statin use and the prevention of venous thromboembolism: a meta-analysis. International journal of clinical practice. 2010;64(10):1375&#x2013;1383.</Citation><ArticleIdList><ArticleId IdType="pubmed">20716146</ArticleId></ArticleIdList></Reference><Reference><Citation>Squizzato A, Galli M, Romualdi E, Dentali F, Kamphuisen PW, Guasti L, et al. Statins, fibrates, and venous thromboembolism: a meta-analysis. European heart journal. 2010;31(10):1248&#x2013;1256.</Citation><ArticleIdList><ArticleId IdType="pubmed">20031958</ArticleId></ArticleIdList></Reference><Reference><Citation>Pai M, Evans NS, Shah SJ, Green D, Cook D, Crowther MA. Statins in the prevention of venous thromboembolism: a meta-analysis of observational studies. Thrombosis research. 2011;128(5):422&#x2013;430.</Citation><ArticleIdList><ArticleId IdType="pubmed">21641019</ArticleId></ArticleIdList></Reference><Reference><Citation>Rabinowich L, Steinvil A, Leshem-Rubinow E, Berliner S, Zeltser D, Rogowski O, et al. Adherence to statins is associated with reduced incidence of idiopathic venous thromboembolism: real-life data from a large healthcare maintenance organisation. Heart. 2012;98(24):1817&#x2013;1821.</Citation><ArticleIdList><ArticleId IdType="pubmed">23038788</ArticleId></ArticleIdList></Reference><Reference><Citation>Biere-Rafi S, Hutten BA, Squizzato A, Ageno W, Souverein PC, de Boer A, et al. Statin treatment and the risk of recurrent pulmonary embolism. European heart journal. 2013;34(24):1800&#x2013;1806.</Citation><ArticleIdList><ArticleId IdType="pubmed">23396492</ArticleId></ArticleIdList></Reference><Reference><Citation>Nguyen CD, Andersson C, Jensen TB, Gjesing A, Schjerning Olsen AM, Malta Hansen C, et al. Statin treatment and risk of recurrent venous thromboembolism: a nationwide cohort study. BMJ open. 2013;3(11):e003135.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3822311</ArticleId><ArticleId IdType="pubmed">24202053</ArticleId></ArticleIdList></Reference><Reference><Citation>Schmidt M, Cannegieter SC, Johannesdottir SA, Dekkers OM, Horvath-Puho E, Sorensen HT. Statin use and venous thromboembolism recurrence: a combined nationwide cohort and nested case-control study. Journal of thrombosis and haemostasis : JTH. 2014;12(8):1207&#x2013;1215.</Citation><ArticleIdList><ArticleId IdType="pubmed">24818818</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang CC, Jick SS, Jick H. Statins and the risk of idiopathic venous thromboembolism. Br J Clin Pharmacol. 2002;53(1):101&#x2013;105.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1874555</ArticleId><ArticleId IdType="pubmed">11849201</ArticleId></ArticleIdList></Reference><Reference><Citation>Smeeth L, Douglas I, Hall AJ, Hubbard R, Evans S. Effect of statins on a wide range of health outcomes: a cohort study validated by comparison with randomized trials. British journal of clinical pharmacology. 2009;67(1):99&#x2013;109.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2668090</ArticleId><ArticleId IdType="pubmed">19006546</ArticleId></ArticleIdList></Reference><Reference><Citation>Hippisley-Cox J, Coupland C. Unintended effects of statins in men and women in England and Wales: population based cohort study using the QResearch database. BMJ. 2010;340:c2197.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2874131</ArticleId><ArticleId IdType="pubmed">20488911</ArticleId></ArticleIdList></Reference><Reference><Citation>Freeman DJ, Robertson M, Brown EA, Rumley A, Tobias ES, Frolich M, et al. Incident venous thromboembolic events in the Prospective Study of Pravastatin in the Elderly at Risk (PROSPER) BMC geriatrics. 2011;11:18.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3053238</ArticleId><ArticleId IdType="pubmed">21342490</ArticleId></ArticleIdList></Reference><Reference><Citation>Delluc A, Tromeur C, Le Moigne E, Nowak E, Mottier D, Le Gal G, et al. Lipid lowering drugs and the risk of recurrent venous thromboembolism. Thrombosis research. 2012;130(6):859&#x2013;863.</Citation><ArticleIdList><ArticleId IdType="pubmed">22939687</ArticleId></ArticleIdList></Reference><Reference><Citation>Rahimi K, Bhala N, Kamphuisen P, Emberson J, Biere-Rafi S, Krane V, et al. Effect of statins on venous thromboembolic events: a meta-analysis of published and unpublished evidence from randomised controlled trials. PLoS medicine. 2012;9(9):e1001310.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3445446</ArticleId><ArticleId IdType="pubmed">23028261</ArticleId></ArticleIdList></Reference><Reference><Citation>Clofibrate and niacin in coronary heart disease. JAMA : the journal of the American Medical Association. 1975;231(4):360&#x2013;381.</Citation><ArticleIdList><ArticleId IdType="pubmed">1088963</ArticleId></ArticleIdList></Reference><Reference><Citation>Keech A, Simes RJ, Barter P, Best J, Scott R, Taskinen MR, et al. Effects of long-term fenofibrate therapy on cardiovascular events in 9795 people with type 2 diabetes mellitus (the FIELD study): randomised controlled trial. Lancet. 2005;366(9500):1849&#x2013;1861.</Citation><ArticleIdList><ArticleId IdType="pubmed">16310551</ArticleId></ArticleIdList></Reference><Reference><Citation>Becattini C, Agnelli G, Schenone A, Eichinger S, Bucherini E, Silingardi M, et al. Aspirin for preventing the recurrence of venous thromboembolism. The New England journal of medicine. 2012;366(21):1959&#x2013;1967.</Citation><ArticleIdList><ArticleId IdType="pubmed">22621626</ArticleId></ArticleIdList></Reference><Reference><Citation>Brighton TA, Eikelboom JW, Mann K, Mister R, Gallus A, Ockelford P, et al. Low-dose aspirin for preventing recurrent venous thromboembolism. The New England journal of medicine. 2012;367(21):1979&#x2013;1987.</Citation><ArticleIdList><ArticleId IdType="pubmed">23121403</ArticleId></ArticleIdList></Reference><Reference><Citation>Melton LJ., 3rd History of the Rochester Epidemiology Project. Mayo Clin Proc. 1996;71(3):266&#x2013;274.</Citation><ArticleIdList><ArticleId IdType="pubmed">8594285</ArticleId></ArticleIdList></Reference><Reference><Citation>Silverstein MD, Heit JA, Mohr DN, Petterson TM, O'Fallon WM, Melton LJ., 3rd Trends in the incidence of deep vein thrombosis and pulmonary embolism: a 25-year population-based study. Arch Intern Med. 1998;158(6):585&#x2013;593.</Citation><ArticleIdList><ArticleId IdType="pubmed">9521222</ArticleId></ArticleIdList></Reference><Reference><Citation>Heit JA, Farmer SA, Petterson TM, Bailey KR, Melton LJ., III Novel Risk Factors for Venous Thromboembolism (VTE): A Population-Based Case-Control Study. Blood. 2005;106(11):1618.</Citation></Reference><Reference><Citation>Heit JA, Silverstein MD, Mohr DN, Petterson TM, O'Fallon WM, Melton LJ., 3rd Risk factors for deep vein thrombosis and pulmonary embolism: a population-based case-control study. Arch Intern Med. 2000;160(6):809&#x2013;815.</Citation><ArticleIdList><ArticleId IdType="pubmed">10737280</ArticleId></ArticleIdList></Reference><Reference><Citation>Heit JA, Leibson CL, Ashrani AA, Petterson TM, Bailey KR, Melton LJ., 3rd Is diabetes mellitus an independent risk factor for venous thromboembolism?: a population-based case-control study. Arteriosclerosis, thrombosis, and vascular biology. 2009;29(9):1399&#x2013;1405.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2735343</ArticleId><ArticleId IdType="pubmed">19542020</ArticleId></ArticleIdList></Reference><Reference><Citation>Barsoum MK, Heit JA, Ashrani AA, Leibson CL, Petterson TM, Bailey KR. Is progestin an independent risk factor for incident venous thromboembolism? A population-based case-control study. Thrombosis research. 2010;126(5):373&#x2013;378.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2975753</ArticleId><ArticleId IdType="pubmed">20833412</ArticleId></ArticleIdList></Reference><Reference><Citation>Kurland LT, Molgaard CA. The patient record in epidemiology. Scientific American. 1981;245(4):54&#x2013;63.</Citation><ArticleIdList><ArticleId IdType="pubmed">7027437</ArticleId></ArticleIdList></Reference><Reference><Citation>St Sauver JL, Grossardt BR, Yawn BP, Melton LJ, 3rd, Rocca WA. Use of a medical records linkage system to enumerate a dynamic population over time: the Rochester epidemiology project. American journal of epidemiology. 2011;173(9):1059&#x2013;1068.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3105274</ArticleId><ArticleId IdType="pubmed">21430193</ArticleId></ArticleIdList></Reference><Reference><Citation>St Sauver JL, Grossardt BR, Leibson CL, Yawn BP, Melton LJ, 3rd, Rocca WA. Generalizability of epidemiological findings and public health decisions: an illustration from the Rochester Epidemiology Project. Mayo Clinic proceedings. 2012;87(2):151&#x2013;160.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3538404</ArticleId><ArticleId IdType="pubmed">22305027</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">32910409</PMID><DateCompleted><Year>2021</Year><Month>02</Month><Day>22</Day></DateCompleted><DateRevised><Year>2023</Year><Month>04</Month><Day>15</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1573-742X</ISSN><JournalIssue CitedMedium="Internet"><Volume>51</Volume><Issue>2</Issue><PubDate><Year>2021</Year><Month>Feb</Month></PubDate></JournalIssue><Title>Journal of thrombosis and thrombolysis</Title><ISOAbbreviation>J Thromb Thrombolysis</ISOAbbreviation></Journal><ArticleTitle>Pulmonary Embolism Response Team activation during the COVID-19 pandemic in a New York City Academic Hospital: a retrospective cohort analysis.</ArticleTitle><Pagination><StartPage>330</StartPage><EndPage>338</EndPage><MedlinePgn>330-338</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s11239-020-02264-8</ELocationID><Abstract><AbstractText>Coronavirus disease 2019 (COVID-19) is associated with increased rates of deep vein thrombosis (DVT) and pulmonary embolism (PE). Pulmonary Embolism Response Teams (PERT) have previously been associated with improved outcomes. We aimed&#xa0;to investigate whether PERT utilization, recommendations, and outcomes for patients diagnosed with acute PE changed during the COVID-19 pandemic. This is a retrospective cohort study of all adult patients with acute PE who received care at an academic hospital system in New York City between March 1st and April 30th, 2020. These patients were compared against historic controls between March 1st and April 30th, 2019. PE severity, PERT utilization, initial management, PERT recommendations, and outcomes were compared. There were more cases of PE during the pandemic (82 vs. 59), but less PERT activations (26.8% vs. 64.4%, p&#x2009;&lt;&#x2009;0.001) despite similar markers of PE severity. PERT recommendations were similar before and during the pandemic; anticoagulation was most recommended (89.5% vs. 86.4%, p&#x2009;=&#x2009;0.70). During the pandemic, those with PERT activations were more likely to be female (63.6% vs. 31.7%, p&#x2009;=&#x2009;0.01), have a history of DVT/PE (22.7% vs. 1.7%, p&#x2009;=&#x2009;0.01), and to be SARS-CoV-2 PCR negative (68.2% vs. 38.3% p&#x2009;=&#x2009;0.02). PERT activation during the pandemic is associated with decreased length of stay (7.7&#x2009;&#xb1;&#x2009;7.7 vs. 13.2&#x2009;&#xb1;&#x2009;12.7&#xa0;days, p&#x2009;=&#x2009;0.02). PERT utilization decreased during the COVID-19 pandemic and its activation was associated with different biases. PERT recommendations and outcomes were similar before and during the pandemic, and led to decreased length of stay during the pandemic.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Kwok</LastName><ForeName>Benjamin</ForeName><Initials>B</Initials><Identifier Source="ORCID">0000-0002-6331-2779</Identifier><AffiliationInfo><Affiliation>Division of Pulmonary, Critical Care and Sleep Medicine, New York University Langone Health, New York, NY, USA. benjamin.kwok@nyulangone.org.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Brosnahan</LastName><ForeName>Shari B</ForeName><Initials>SB</Initials><AffiliationInfo><Affiliation>Division of Pulmonary, Critical Care and Sleep Medicine, New York University Langone Health, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Amoroso</LastName><ForeName>Nancy E</ForeName><Initials>NE</Initials><AffiliationInfo><Affiliation>Division of Pulmonary, Critical Care and Sleep Medicine, New York University Langone Health, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Goldenberg</LastName><ForeName>Ronald M</ForeName><Initials>RM</Initials><AffiliationInfo><Affiliation>Division of Pulmonary, Critical Care and Sleep Medicine, New York University Langone Health, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Heyman</LastName><ForeName>Brooke</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Division of Pulmonary, Critical Care and Sleep Medicine, New York University Langone Health, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Horowitz</LastName><ForeName>James M</ForeName><Initials>JM</Initials><AffiliationInfo><Affiliation>Leon H. Charney Division of Cardiology, New York University Langone Health, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jamin</LastName><ForeName>Catherine</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Ronald O. Perelman Department of Emergency Medicine, New York University Langone Health, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sista</LastName><ForeName>Akhilesh K</ForeName><Initials>AK</Initials><AffiliationInfo><Affiliation>Division of Vascular and Interventional Radiology, New York University Langone Health, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Smith</LastName><ForeName>Deane E</ForeName><Initials>DE</Initials><AffiliationInfo><Affiliation>Department of Cardiothoracic Surgery, New York University Langone Health, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yuriditsky</LastName><ForeName>Eugene</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Leon H. Charney Division of Cardiology, New York University Langone Health, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Maldonado</LastName><ForeName>Thomas S</ForeName><Initials>TS</Initials><AffiliationInfo><Affiliation>Division of Vascular and Endovascular Surgery, New York University Langone Health, New York, NY, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016430">Clinical Trial</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>J Thromb Thrombolysis</MedlineTA><NlmUniqueID>9502018</NlmUniqueID><ISSNLinking>0929-5305</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000925">Anticoagulants</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000925" MajorTopicYN="N">Anticoagulants</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="Y">administration &amp; dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006785" MajorTopicYN="Y">Hospitals, University</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009519" MajorTopicYN="N" Type="Geographic">New York City</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D058873" MajorTopicYN="Y">Pandemics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017410" MajorTopicYN="N">Practice Guidelines as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011655" MajorTopicYN="Y">Pulmonary Embolism</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012720" MajorTopicYN="N">Severity of Illness Index</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000093485" MajorTopicYN="Y">COVID-19 Drug Treatment</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">Pulmonary Embolism Response Team</Keyword><Keyword MajorTopicYN="N">Pulmonary embolism</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword><Keyword MajorTopicYN="N">Venous thromboembolism</Keyword></KeywordList><CoiStatement>JMH receives funding from Penumbra, Inc and Inari Medical. BK, SBB, NEA, RMG, BH, CJ, AKS, DES, EY, and TSM have no conflicts of interest to disclose.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>9</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>2</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>9</Month><Day>10</Day><Hour>12</Hour><Minute>27</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2020</Year><Month>9</Month><Day>10</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32910409</ArticleId><ArticleId IdType="pmc">PMC7482370</ArticleId><ArticleId IdType="doi">10.1007/s11239-020-02264-8</ArticleId><ArticleId IdType="pii">10.1007/s11239-020-02264-8</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Tang N, Bai H, Chen X, Gong J, Li D, Sun Z. Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy. J Thromb Haemost. 2020;18(5):1094&#x2013;1099. doi: 10.1111/jth.14817.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jth.14817</ArticleId><ArticleId IdType="pmc">PMC9906401</ArticleId><ArticleId IdType="pubmed">32220112</ArticleId></ArticleIdList></Reference><Reference><Citation>Marginean A, Masic D, Brailovsky Y, Fareed J, Darki A. Difficulties of managing submassive and massive pulmonary embolism in the era of COVID-19. JACC Case Rep. 2020;2:523.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7236704</ArticleId><ArticleId IdType="pubmed">32835283</ArticleId></ArticleIdList></Reference><Reference><Citation>Bikdeli B, Madhavan MV, Jimenez D, et al. COVID-19 and thrombotic or thromboembolic disease: implications for prevention, antithrombotic therapy, and follow-up: JACC State-of-the-Art Review. J Am Coll Cardiol. 2020;75(23):2950&#x2013;2973. doi: 10.1016/j.jacc.2020.04.031.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2020.04.031</ArticleId><ArticleId IdType="pmc">PMC7164881</ArticleId><ArticleId IdType="pubmed">32311448</ArticleId></ArticleIdList></Reference><Reference><Citation>Schultz J, Giordano N, Zheng H, et al. EXPRESS: a multidisciplinary Pulmonary Embolism Response Team (PERT) - experience from a national multicenter consortium. Pulm Circ. 2019;9(3):2045894018824563. doi: 10.1177/2045894018824563.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/2045894018824563</ArticleId><ArticleId IdType="pmc">PMC6690111</ArticleId><ArticleId IdType="pubmed">30632901</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosovsky R, Zhao K, Sista A, Rivera-Lebron B, Kabrhel C. Pulmonary embolism response teams: purpose, evidence for efficacy, and future research directions. Res Pract Thromb Haemost. 2019;3(3):315&#x2013;330. doi: 10.1002/rth2.12216.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/rth2.12216</ArticleId><ArticleId IdType="pmc">PMC6611377</ArticleId><ArticleId IdType="pubmed">31294318</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosovsky R, Chang Y, Rosenfield K, et al. Changes in treatment and outcomes after creation of a pulmonary embolism response team (PERT), a 10-year analysis. J Thromb Thrombol. 2019;47(1):31&#x2013;40. doi: 10.1007/s11239-018-1737-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11239-018-1737-8</ArticleId><ArticleId IdType="pubmed">30242551</ArticleId></ArticleIdList></Reference><Reference><Citation>Chaudhury P, Gadre SK, Schneider E, et al. Impact of multidisciplinary Pulmonary Embolism Response Team availability on management and outcomes. Am J Cardiol. 2019;124(9):1465&#x2013;1469. doi: 10.1016/j.amjcard.2019.07.043.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amjcard.2019.07.043</ArticleId><ArticleId IdType="pubmed">31495443</ArticleId></ArticleIdList></Reference><Reference><Citation>Konstantinides SV, Meyer G, Becattini C, et al. 2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS) Eur Heart J. 2020;41(4):543&#x2013;603. doi: 10.1093/eurheartj/ehz405.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehz405</ArticleId><ArticleId IdType="pubmed">31504429</ArticleId></ArticleIdList></Reference><Reference><Citation>Panigada M, Bottino N, Tagliabue P, et al. Hypercoagulability of COVID-19 patients in Intensive Care Unit. A report of thromboelastography findings and other parameters of hemostasis. J Thromb Haemost. 2020;18:1738. doi: 10.1111/jth.14850.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jth.14850</ArticleId><ArticleId IdType="pmc">PMC9906150</ArticleId><ArticleId IdType="pubmed">32302438</ArticleId></ArticleIdList></Reference><Reference><Citation>Leonard-Lorant I, Delabranche X, Severac F, et al. Acute pulmonary embolism in COVID-19 patients on CT angiography and relationship to d-dimer levels. Radiology. 2020 doi: 10.1148/radiol.2020201561.</Citation><ArticleIdList><ArticleId IdType="doi">10.1148/radiol.2020201561</ArticleId><ArticleId IdType="pmc">PMC7233397</ArticleId><ArticleId IdType="pubmed">32324102</ArticleId></ArticleIdList></Reference><Reference><Citation>Yuriditsky E, Horowitz JM, Merchan C, et al. Thromboelastography profiles of critically ill patients with coronavirus disease 2019. Crit Care Med. 2020;48:1319.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7314320</ArticleId><ArticleId IdType="pubmed">32618696</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu S, Luo P, Tang M, et al. Providing pharmacy services during the coronavirus pandemic. Int J Clin Pharm. 2020;42(2):299&#x2013;304. doi: 10.1007/s11096-020-01017-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11096-020-01017-0</ArticleId><ArticleId IdType="pmc">PMC7101875</ArticleId><ArticleId IdType="pubmed">32222911</ArticleId></ArticleIdList></Reference><Reference><Citation>Badreldin HA, Atallah B. Global drug shortages due to COVID-19: impact on patient care and mitigation strategies. Res Soc Adm Pharm. 2020 doi: 10.1016/j.sapharm.2020.05.017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.sapharm.2020.05.017</ArticleId><ArticleId IdType="pmc">PMC7235598</ArticleId><ArticleId IdType="pubmed">32446652</ArticleId></ArticleIdList></Reference><Reference><Citation>Kicska G, Litmanovich DE, Ordovas KG, et al. Statement from the North American Society for Cardiovascular Imaging on imaging strategies to reduce the scarcity of healthcare resources during the COVID-19 outbreak. Int J Cardiovasc Imaging. 2020 doi: 10.1007/s10554-020-01861-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10554-020-01861-1</ArticleId><ArticleId IdType="pmc">PMC7261212</ArticleId><ArticleId IdType="pubmed">32474676</ArticleId></ArticleIdList></Reference><Reference><Citation>Sasangohar F, Jones SL, Masud FN, Vahidy FS, Kash BA. Provider burnout and fatigue during the COVID-19 pandemic: lessons learned from a high-volume Intensive Care Unit. Anesth Analg. 2020;131(1):106&#x2013;111. doi: 10.1213/ANE.0000000000004866.</Citation><ArticleIdList><ArticleId IdType="doi">10.1213/ANE.0000000000004866</ArticleId><ArticleId IdType="pmc">PMC7173087</ArticleId><ArticleId IdType="pubmed">32282389</ArticleId></ArticleIdList></Reference><Reference><Citation>Singer BD, Jain M, Budinger GRS, Wunderink RG. A Call for Rational Intensive Care in the era of COVID-19. Am J Respir Cell Mol Biol. 2020;63:132&#x2013;133. doi: 10.1165/rcmb.2020-0151LE.</Citation><ArticleIdList><ArticleId IdType="doi">10.1165/rcmb.2020-0151LE</ArticleId><ArticleId IdType="pmc">PMC7328253</ArticleId><ArticleId IdType="pubmed">32315548</ArticleId></ArticleIdList></Reference><Reference><Citation>Rice TW, Janz DR. In defense of evidence-based medicine for the treatment of COVID-19 ARDS. Ann Am Thorac Soc. 2020;17:787&#x2013;789. doi: 10.1513/AnnalsATS.202004-325IP.</Citation><ArticleIdList><ArticleId IdType="doi">10.1513/AnnalsATS.202004-325IP</ArticleId><ArticleId IdType="pmc">PMC7328187</ArticleId><ArticleId IdType="pubmed">32320268</ArticleId></ArticleIdList></Reference><Reference><Citation>Gniadek TJ, Mallek J, Wright G, et al. Expansion of hospital-based blood collections in the face of COVID-19 associated national blood shortage. Transfusion. 2020;60(7):1470&#x2013;1475. doi: 10.1111/trf.15869.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/trf.15869</ArticleId><ArticleId IdType="pmc">PMC7283630</ArticleId><ArticleId IdType="pubmed">32445417</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">33560104</PMID><DateCompleted><Year>2021</Year><Month>08</Month><Day>17</Day></DateCompleted><DateRevised><Year>2023</Year><Month>08</Month><Day>25</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">2163-0763</ISSN><JournalIssue CitedMedium="Internet"><Volume>90</Volume><Issue>5</Issue><PubDate><Year>2021</Year><Month>May</Month><Day>01</Day></PubDate></JournalIssue><Title>The journal of trauma and acute care surgery</Title><ISOAbbreviation>J Trauma Acute Care Surg</ISOAbbreviation></Journal><ArticleTitle>Trauma patients at risk for venous thromboembolism who undergo routine duplex ultrasound screening experience fewer pulmonary emboli: A prospective randomized trial.</ArticleTitle><Pagination><StartPage>787</StartPage><EndPage>796</EndPage><MedlinePgn>787-796</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1097/TA.0000000000003104</ELocationID><Abstract><AbstractText Label="BACKGROUND">Although guidelines are established for the prevention and management of venous thromboembolism (VTE) in trauma, no consensus exists regarding protocols for the diagnostic approach. We hypothesized that at-risk trauma patients who undergo duplex ultrasound (DUS) surveillance for lower extremity deep venous thrombosis (DVT) will have a lower rate of symptomatic or fatal pulmonary embolism (PE) than those who do not undergo routine surveillance.</AbstractText><AbstractText Label="METHODS">Prospective, randomized trial between March 2017 and September 2019 of trauma patients admitted to a single, level 1 trauma center, with a risk assessment profile score of &#x2265;5. Patients were randomized to receive either bilateral lower extremity DUS surveillance on days 1, 3, and 7 and weekly during hospitalization ultrasound group (US) or no surveillance no ultrasound group (NoUS). Rates of in-hospital and 90-day DVT and PE were reported as was DVT propagation and all-cause mortality. Standard care for the prevention and management of VTE per established institutional protocols was provided to all patients.</AbstractText><AbstractText Label="RESULTS">A total of 3,236 trauma service admissions were screened, and 1,989 moderate- and high-risk patients were randomized (US, 995; NoUS, 994). The mean &#xb1; SD age was 62 &#xb1; 20.1 years, Injury Severity Score was 14 &#xb1; 9.7, risk assessment profile was 7.1 &#xb1; 2.4, and 97% suffered blunt trauma. There was no difference in demographics or VTE risk factors between the groups. There were significantly fewer in-hospital PE in the US group than the NoUS group (1 [0.1%] vs. 9 [0.9%], p = 0.01). The US group experienced more in-hospital below-knee DVTs (124 [12.5%] vs. 8 [0.8%], p &lt; 0.001) and above-knee DVTs (19 [1.9%] vs. 8 [0.8%], p = 0.05). There was no difference in 90-day PE or DVT, or overall mortality.</AbstractText><AbstractText Label="CONCLUSION">The implementation of a selective routine DUS protocol was associated with significantly fewer in-hospital PE. More DVTs were identified with routine screening; however, surveillance bias appears to exist primarily with distal DVT. Larger trials are needed to further characterize the relationship between routine DUS screening and VTE outcomes in the high-risk trauma population.</AbstractText><AbstractText Label="LEVEL OF EVIDENCE">Therapeutic/care management, level II.</AbstractText><CopyrightInformation>Copyright &#xa9; 2021 Wolters Kluwer Health, Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Kay</LastName><ForeName>Annika B</ForeName><Initials>AB</Initials><AffiliationInfo><Affiliation>From the Division of Trauma Services and Surgical Critical Care (A.B.K., D.S.M., S.M.), Department of Medicine (S.C.W., S.M.S.), Intermountain Medical Center, Murray; Department of Medicine (S.C.W., S.M.S.), University of Utah School of Medicine, Salt Lake City; Department of Emergency Medicine (J.R.B.), Intermountain Medical Center, Murray; Medical Informatics (J.F.L.), Intermountain Medical Center; and Office of Research (D.S.C.), Intermountain Medical Center, Murray, Utah.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Morris</LastName><ForeName>David S</ForeName><Initials>DS</Initials></Author><Author ValidYN="Y"><LastName>Woller</LastName><ForeName>Scott C</ForeName><Initials>SC</Initials></Author><Author ValidYN="Y"><LastName>Stevens</LastName><ForeName>Scott M</ForeName><Initials>SM</Initials></Author><Author ValidYN="Y"><LastName>Bledsoe</LastName><ForeName>Joseph R</ForeName><Initials>JR</Initials></Author><Author ValidYN="Y"><LastName>Lloyd</LastName><ForeName>James F</ForeName><Initials>JF</Initials></Author><Author ValidYN="Y"><LastName>Collingridge</LastName><ForeName>Dave S</ForeName><Initials>DS</Initials></Author><Author ValidYN="Y"><LastName>Majercik</LastName><ForeName>Sarah</ForeName><Initials>S</Initials></Author></AuthorList><Language>eng</Language><DataBankList CompleteYN="Y"><DataBank><DataBankName>ClinicalTrials.gov</DataBankName><AccessionNumberList><AccessionNumber>NCT02978950</AccessionNumber></AccessionNumberList></DataBank></DataBankList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Trauma Acute Care Surg</MedlineTA><NlmUniqueID>101570622</NlmUniqueID><ISSNLinking>2163-0755</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015601" MajorTopicYN="N">Injury Severity Score</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D035002" MajorTopicYN="N">Lower Extremity</DescriptorName><QualifierName UI="Q000098" MajorTopicYN="Y">blood supply</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011655" MajorTopicYN="N">Pulmonary Embolism</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018570" MajorTopicYN="N">Risk Assessment</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013997" MajorTopicYN="N">Time Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014193" MajorTopicYN="N">Trauma Centers</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018616" MajorTopicYN="Y">Ultrasonography, Doppler, Duplex</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020246" MajorTopicYN="N">Venous Thrombosis</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014947" MajorTopicYN="N">Wounds and Injuries</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>2</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>8</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>2</Month><Day>9</Day><Hour>11</Hour><Minute>20</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33560104</ArticleId><ArticleId IdType="doi">10.1097/TA.0000000000003104</ArticleId><ArticleId IdType="pii">01586154-202105000-00003</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Geerts WH, Code KI, Jay RM, Chen E, Szalai JP. A prospective study of venous thromboembolism after major trauma. N Engl J Med . 1994;331(24):1601&#x2013;1606.</Citation></Reference><Reference><Citation>Adams RC, Hamrick M, Berenquer C, Senkowski C, Ochsner MG. Four years of an aggressive prophylaxis and screening protocol for venous thromboembolism in a large trauma population. J Trauma . 2008;65(2):300&#x2013;308.</Citation></Reference><Reference><Citation>Paffrath T, Wafaisade A, Lefering R, Simanski C, Bouillon B, Spanholtz T, Wutzler S, Maegele M. Venous thromboembolism after severe trauma: incidence, risk factors, and outcomes. Injury . 2010;41(1):97&#x2013;101.</Citation></Reference><Reference><Citation>Shackford SR, Cipolle MD, Badiee J, et al. Determining the magnitude of surveillance bias in the assessment of lower extremity deep venous thrombosis: a prospective observational study of two centers. J Trauma Acute Care Surg . 2016;80(5):734&#x2013;739.</Citation></Reference><Reference><Citation>Knudson MM, Ikossi DG, Khaw L, Morabito D, Speetzen LS. Thromboembolism after trauma: an analysis of 1602 episodes from the American College of Surgeons National Trauma Data Bank. Ann Surg . 2004;240(3):490&#x2013;496.</Citation></Reference><Reference><Citation>Thorson CM, Ryan ML, Van Haren RM, Cuira E, Barrera JM, Guarch GA, Busko AM, Namias N, Livingstone AS, Proctor KG. Venous thromboembolism after trauma: a never event? * . Crit Care Med . 2012;40(11):2967&#x2013;2973.</Citation></Reference><Reference><Citation>Karcutskie CA, Meizoso JP, Ray JJ, Horkan D, Ruiz XD, Schulman CI, Namias N, Proctor KG. Association of mechanism of injury with risk for venous thromboembolism after trauma. JAMA Surg . 2017;152(1):35&#x2013;40.</Citation></Reference><Reference><Citation>Hegsted D, Gritsiouk Y, Schlesinger P, Gardiner S, Gubler KD. Utility of the risk assessment profile for risk stratification of venous thrombotic events for trauma patients. Am J Surg . 2013;205(5):517&#x2013;520.</Citation></Reference><Reference><Citation>Anderson DR, Morgano GP, Bennett C, et al. American Society of Hematology 2019 guidelines for management of venous thromboembolism: prevention of venous thromboembolism in surgical hospitalized patients. Blood Adv . 2019;3(23):3898&#x2013;3944.</Citation></Reference><Reference><Citation>Centers for Medicare and Medicaid Services, HHS. Medicare Program; hospital inpatient prospective payment systems for acute care hospitals and the long-term care hospital prospective payment system changes and FY2011 rates; provider agreements and supplier approvals; and hospital conditions of participation for rehabilitation and respiratory care services: Medicaid program: accreditation for providers of inpatient psychiatric services. Final rules and interim final rule with comment period. Fed Regist . 2010;75:50041&#x2013;50681.</Citation></Reference><Reference><Citation>Kardooni DR, Haut ER, Chang DC, Pierce CA, Efron DT, Haider AH, Pronovost PJ, Cornwell EE. Hazards of benchmarking complications with the National Trauma Data Bank: numerators in search of denominators. J Trauma . 2008;64:273&#x2013;277.</Citation></Reference><Reference><Citation>American College of Surgeons, Committee on Trauma. ACS TQIP Benchmark Report: Spring 2020. Report ID . 305. https://www.acsdataplatform.com/login . Accessed August 7, 2020.</Citation></Reference><Reference><Citation>Rogers FB, Cipolle MD, Velmahos G, Rozycki G, Luchette FA. Practice management guidelines for the prevention of venous thromboembolism in trauma patients: the EAST practice management guidelines work group. J Trauma . 2002;53:142&#x2013;164.</Citation></Reference><Reference><Citation>Geerts WH, Bergqvist D, Pineo GF, Heit JA, Samama CM, Lassen MR, Colwell CW. Prevention of venous thromboembolism: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th edition). Chest . 2008;133(Suppl 6):381S&#x2013;453S.</Citation></Reference><Reference><Citation>Ley EJ, Brown CV, Moore EE, et al. Updated guidelines to reduce venous thromboembolism in trauma patients: a Western Trauma Association critical decisions algorithm. J Trauma Acute Care Surg . 2020;89(5):971&#x2013;981.</Citation></Reference><Reference><Citation>Joseph B, Pandit V, Harrison C, et al. Early thromboembolic prophylaxis in patients with blunt solid abdominal organ injuries undergoing nonoperative management: is it safe? Am J Surg . 2015;209(1):194&#x2013;198.</Citation></Reference><Reference><Citation>Byrne JP, Mason SA, Gomez D, Hoeft C, Subacius H, Xiong W, Neal M, Pirouzmand F, Nathans AB. Timing of pharmacologic venous thromboembolism prophylaxis in severe traumatic brain injury: a propensity-matched cohort study. J Am Coll Surg . 2016;223(4):621&#x2013;631.</Citation></Reference><Reference><Citation>Haut ER, Schneider EB, Patel A, et al. Duplex ultrasound screening for deep vein thrombosis in asymptomatic trauma patients: a survey of individual trauma surgeon opinions and current trauma center practices. J Trauma . 2011;70(1):27&#x2013;33.</Citation></Reference><Reference><Citation>Dietch ZC, Edwards B, Thames M, Shah P, Williams MD, Sawyer RG. Rate of lower extremity ultrasound in trauma patients is associated with rate of deep venous thrombosis but not pulmonary embolism. Surgery . 2015;158(2):379&#x2013;385.</Citation></Reference><Reference><Citation>Cipolle MD, Wojcik R, Seislove E, Wasser TE, Pasquale MD. The role of surveillance duplex scanning in preventing venous thromboembolism in trauma patients. J Trauma . 2002;52(3):453&#x2013;462.</Citation></Reference><Reference><Citation>Spain DA, Richardson JD, Polk HC, Bergamini TM, Wilson MA, Miller FB. Venous thromboembolism in the high-risk trauma patient: do risks justify aggressive screening and prophylaxis? J Trauma . 1997;42(3):463&#x2013;467.</Citation></Reference><Reference><Citation>Dietch ZC, Petroze RT, Thames M, Willis R, Sawyer RG, Williams MD. The &#x201c;high-risk&#x201d; DVT screening protocol for trauma patients &#x2014; is it practical? J Trauma Acute Care Surg . 2015;79(6):970&#x2013;975.</Citation></Reference><Reference><Citation>Brasel KJ, Borgstrom DC, Weigelt JA. Cost-effective prevention of pulmonary embolus in high-risk trauma patients. J Trauma . 1997;42(3):456&#x2013;460.</Citation></Reference><Reference><Citation>Baker JE, Niziolek GM, Elson NC, Pugh AM, Nomellini V, Makley AT, Pritts TA, Goodman MD. Optimizing lower extremity duplex ultrasound screening after traumatic injury. J Surg Res . 2019;243:143&#x2013;150.</Citation></Reference><Reference><Citation>Martin GE, Pugh A, Williams SG, Hanseman D, Nomellini V, Makley AT, Pritts TA, Goodman MD. Lower extremity duplex ultrasound screening protocol for moderate- and high-risk trauma patients. J Surg Res . 2019;235:280&#x2013;287.</Citation></Reference><Reference><Citation>Johnson AP, Koganti D, Wallace A, Stake S, Cowan SW, Cohen MJ, Marks JA. Asymptomatic trauma patients screened for venous thromboembolism have a higher risk profile with lower rate of pulmonary embolism: a five-year single-institution experience. Am Surg . 2020;86(2):104&#x2013;109.</Citation></Reference><Reference><Citation>Allen CJ, Murray CR, Meizoso JP, Ginzburg E, Schulman CI, Lineen EB, Namias N, Proctor KG. Surveillance and early management of deep vein thrombosis decreases rate of pulmonary embolism in high-risk trauma patients. J Am Coll Surg . 2016;222(1):65&#x2013;72.</Citation></Reference><Reference><Citation>Azarbal A, Rowell S, Lewis J, Urankar R, Moseley S, Landry G, Moneta G. Duplex ultrasound screening detects high rates of deep vein thrombosis in critically ill trauma patients. J Vasc Surg . 2011;54(3):743&#x2013;747.</Citation></Reference><Reference><Citation>Malhotra AK, Goldberg SR, McLay L, et al. DVT surveillance program in the ICU: analysis of the cost-effectiveness. PLoS One . 2014;9(9):e106793.</Citation></Reference><Reference><Citation>Gearhart MM, Luchette FA, Proctor MC, Lutomski DM, Witsken C, James L, Davis K Jr., Johannigman JA, Hurst JM, Frame SB. The risk assessment profile score identifies trauma patients at risk for deep vein thrombosis. Surgery . 2000;128(4):631&#x2013;640.</Citation></Reference><Reference><Citation>Modi S, Deisler R, Gozel K, Reicks P, Irwin E, Brunsvold M, Banton K, Beilman GJ. Wells criteria for DVT is a reliable clinical tool to assess the risk of deep vein thrombosis in trauma patients. World J Emerg Surg . 2016;11:24.</Citation></Reference><Reference><Citation>Schulman S, Kearon C; The Subcommittee on Control of Anticoagulation of the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis. Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non-surgical patients. J Thromb Haemost . 2005;3:692&#x2013;694.</Citation></Reference><Reference><Citation>Prandoni P, Lensing AW, Cogo A, Cuppini S, Villalta S, Carta M, Cattelan AM, Polistena P, Bernardi E, Prins MH. The long-term clinical course of acute deep venous thrombosis. Ann Intern Med . 1996;125(1):1&#x2013;7.</Citation></Reference><Reference><Citation>Coleman JR, Kay AB, Moore EE, Moore HB, Gonzalez E, Majercik S, Cohen MJ, White T, Pieracci FM. It&#x2019;s sooner than you think: blunt solid organ injury patients are already hypercoagulable upon hospital admission &#x2014; results of a bi-institutional, prospective study. Am J Surg . 2019;218(6):1065&#x2013;1073.</Citation></Reference><Reference><Citation>Kashuk JL, Moore EE, Sabel A, et al. Rapid thrombelastography (r-TEG) identifies hypercoagulability and predicts thromboembolic events in surgical patients. Surgery . 2009;146(4):764&#x2013;772.</Citation></Reference><Reference><Citation>Constantini TW, Min E, Box K, Tran V, Winfield RD, Fortlage D, Doucet J, Bansal V, Coimbra R. Dose adjusting enoxaparin is necessary to achieve adequate venous thromboembolism prophylaxis in trauma patients. J Trauma Acute Care Surg . 2013;74(1):128&#x2013;135.</Citation></Reference><Reference><Citation>Bandle J, Shackford SR, Kahl JE, Sise CB, Calvo RY, Shackford MC, Sise MJ. The value of lower extremity duplex ultrasound surveillance to detect deep vein thrombosis in trauma patients. J Trauma Acute Care Surg . 2013;74(2):575&#x2013;580.</Citation></Reference><Reference><Citation>Greenfield LJ, Proctor MC, Rodriguez JL, Luchette FA, Cipolle MD, Cho J. Posttrauma thromboembolism prophylaxis. J Trauma . 1997;42(1):100&#x2013;103.</Citation></Reference><Reference><Citation>Rogers FB, Shackford SR, Horst MA, Miller JA, Wu D, Bradburn E, Rogers A, Krasne M. Determining venous thromboembolic risk assessment for patients with trauma: the Trauma Embolic Scoring System. J Trauma Acute Care Surg . 2012;73(2):511&#x2013;515.</Citation></Reference><Reference><Citation>Zander AL, Van Gent JM, Olson EJ, Shackford SR, Badiee J, Dunne CE, Sise CB, Sise MJ. Venous thromboembolic risk assessment models should not solely guide prophylaxis and surveillance in trauma patients. J Trauma Acute Care Surg . 2015;79(2):194&#x2013;198.</Citation></Reference><Reference><Citation>Pierce CA, Haut ER, Kardooni S, Chang DC, Efron DT, Haider A, Pronovost PJ, Cornwell EE. Surveillance bias and deep vein thrombosis in the National Trauma Data Bank: the more we look, the more we find. J Trauma . 2008;64:932&#x2013;937.</Citation></Reference><Reference><Citation>Masuda EM, Kistner RL, Musikasinthorn C, Liquido F, Geling O, He Q. The controversy of managing calf vein thrombosis. J Vasc Surg . 2012;55(2):550&#x2013;561.</Citation></Reference><Reference><Citation>Lee TH, Alonzo BJ, Differding J, Underwood SJ, Hamilton G, Kremenevskiy I, McNamara S, Schreiber MA. The effects of location and low-molecular-weight heparin administration on deep vein thrombosis outcomes in trauma patients. J Trauma Acute Care Surg . 2013;74(2):476&#x2013;481.</Citation></Reference><Reference><Citation>Sharpe RP, Gupta R, Gracias VH, Pryor JP, Pieracci FM, Reilly PM, Schwab CW. Incidence and natural history of below-knee deep venous thrombosis in high-risk trauma patients. J Trauma . 2002;53:1048&#x2013;1052.</Citation></Reference><Reference><Citation>Olson EJ, Zander AL, Van Gent JM, Shackford SR, Badiee J, Sise CB, Sise MJ. Below-knee deep vein thrombosis: an opportunity to prevent pulmonary embolism? J Trauma Acute Care Surg . 2014;77:459&#x2013;463.</Citation></Reference><Reference><Citation>Van Gent JM, Zander AL, Olson EJ, Shackford SR, Dunne CE, Sise CB, Badiee J, Schechter M, Sise MJ. Pulmonary embolism without deep venous thrombosis: de novo or missed deep venous thrombosis? J Trauma Acute Care Surg . 2014;76(5):1270&#x2013;1274.</Citation></Reference><Reference><Citation>Velahmos G, Spaniolas K, Tabbara M, Abujudeh HH, de Moya M, Gervasini A, Alam HB. Pulmonary embolism and deep venous thrombosis in trauma: are they related? Arch Surg . 2009;144(10):928&#x2013;932.</Citation></Reference><Reference><Citation>Tadlock MD, Chouliaras K, Kennedy M, et al. The origin of fatal pulmonary emboli: a postmortem analysis of 500 deaths from pulmonary embolism in trauma, surgical, and medical patients. Am J Surg . 2015;209(6):959&#x2013;968.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">25956005</PMID><DateCompleted><Year>2016</Year><Month>08</Month><Day>16</Day></DateCompleted><DateRevised><Year>2018</Year><Month>11</Month><Day>13</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1552-9924</ISSN><JournalIssue CitedMedium="Internet"><Volume>123</Volume><Issue>12</Issue><PubDate><Year>2015</Year><Month>Dec</Month></PubDate></JournalIssue><Title>Environmental health perspectives</Title><ISOAbbreviation>Environ Health Perspect</ISOAbbreviation></Journal><ArticleTitle>Prospective Study of Ambient Particulate Matter Exposure and Risk of Pulmonary Embolism in the Nurses' Health Study Cohort.</ArticleTitle><Pagination><StartPage>1265</StartPage><EndPage>1270</EndPage><MedlinePgn>1265-70</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1289/ehp.1408927</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Pulmonary embolism (PE) is the most serious manifestation of venous thromboembolism and a leading cause of sudden death. Several studies have suggested associations of venous thromboembolism with short-term particulate matter (PM) exposure; evidence on long-term PM and traffic exposure is mixed.</AbstractText><AbstractText Label="OBJECTIVES" NlmCategory="OBJECTIVE">We examined the association of long-term exposure to PM2.5, PM2.5-10, and PM10 (PM with diameter of &#x2264; 2.5, 2.5-10, and &#x2264; 10 &#x3bc;m) and distance to roadways with overall incident PE and with PE subtypes in a cohort of U.S. women.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">The study included 115,745 women from the Nurses' Health Study, followed from 1992 through 2008. Incident PE cases were self-reported biennially. Nonidiopathic PE were cases for which the medical record revealed an underlying health condition related to PE (i.e., surgery, trauma, or malignancy); idiopathic PE were cases with no such history. We used spatiotemporal models combining spatial smoothing and geographic covariates to quantify exposure at residential addresses, and Cox proportional hazards models to calculate hazard ratios (HR) and 95% confidence intervals (CIs).</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">PM2.5 averaged over 1 month (HR = 1.22; 95% CI: 1.04, 1.44) or 12 months (HR = 1.17; 95% CI: 0.93, 1.48) was associated with incident PE, after adjusting for known risk factors and PM2.5-10. Equivalent analyses restricted to PE subtypes showed a positive association for PM2.5 with nonidiopathic PE, but not with idiopathic PE. We did not find evidence of an association between distance to roadways and PE risk.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">We provide evidence that PM in the prior 1 and 12 months is associated with PE risk. Our results also suggest that women with underlying health conditions may be more susceptible to PE after PM exposure.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Pun</LastName><ForeName>Vivian C</ForeName><Initials>VC</Initials><AffiliationInfo><Affiliation>Jockey Club School of Public Health and Primary Care, The Chinese University of Hong Kong, Shatin, Hong Kong.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hart</LastName><ForeName>Jaime E</ForeName><Initials>JE</Initials></Author><Author ValidYN="Y"><LastName>Kabrhel</LastName><ForeName>Christopher</ForeName><Initials>C</Initials></Author><Author ValidYN="Y"><LastName>Camargo</LastName><ForeName>Carlos A</ForeName><Initials>CA</Initials><Suffix>Jr</Suffix></Author><Author ValidYN="Y"><LastName>Baccarelli</LastName><ForeName>Andrea A</ForeName><Initials>AA</Initials></Author><Author ValidYN="Y"><LastName>Laden</LastName><ForeName>Francine</ForeName><Initials>F</Initials></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01 ES017017</GrantID><Acronym>ES</Acronym><Agency>NIEHS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P01 CA087969</GrantID><Acronym>CA</Acronym><Agency>NCI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 HL116854</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P01 CA87969</GrantID><Acronym>CA</Acronym><Agency>NCI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UM1 CA186107</GrantID><Acronym>CA</Acronym><Agency>NCI NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2015</Year><Month>05</Month><Day>08</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Environ Health Perspect</MedlineTA><NlmUniqueID>0330411</NlmUniqueID><ISSNLinking>0091-6765</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D052638">Particulate Matter</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000397" MajorTopicYN="N">Air Pollution</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004781" MajorTopicYN="N">Environmental Exposure</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010316" MajorTopicYN="N">Particle Size</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D052638" MajorTopicYN="N">Particulate Matter</DescriptorName><QualifierName UI="Q000633" MajorTopicYN="Y">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016016" MajorTopicYN="N">Proportional Hazards Models</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011655" MajorTopicYN="N">Pulmonary Embolism</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014481" MajorTopicYN="N" Type="Geographic">United States</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>The authors declare they have no actual or potential competing financial interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2014</Year><Month>7</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2015</Year><Month>5</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2015</Year><Month>5</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2015</Year><Month>5</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2016</Year><Month>8</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2015</Year><Month>12</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">25956005</ArticleId><ArticleId IdType="pmc">PMC4671228</ArticleId><ArticleId IdType="doi">10.1289/ehp.1408927</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Baccarelli A, Martinelli I, Pegoraro V, Melly S, Grillo P, Zanobetti A, et al. Living near major traffic roads and risk of deep vein thrombosis. Circulation. 2009;119:3118&#x2013;3124.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2895730</ArticleId><ArticleId IdType="pubmed">19506111</ArticleId></ArticleIdList></Reference><Reference><Citation>Baccarelli A, Martinelli I, Zanobetti A, Grillo P, Hou LF, Bertazzi PA, et al. Exposure to particulate air pollution and risk of deep vein thrombosis. Arch Intern Med. 2008;168:920&#x2013;927.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3093962</ArticleId><ArticleId IdType="pubmed">18474755</ArticleId></ArticleIdList></Reference><Reference><Citation>Baccarelli A, Zanobetti A, Martinelli I, Grillo P, Hou L, Giacomini S, et al. Effects of exposure to air pollution on blood coagulation. J Thromb Haemost. 2007;5:252&#x2013;260.</Citation><ArticleIdList><ArticleId IdType="pubmed">17083648</ArticleId></ArticleIdList></Reference><Reference><Citation>Brook RD, Franklin B, Cascio W, Hong Y, Howard G, Lipsett M, et al. Air pollution and cardiovascular disease: a statement for healthcare professionals from the Expert Panel on Population and Prevention Science of the American Heart Association. Circulation. 2004;109:2655&#x2013;2671.</Citation><ArticleIdList><ArticleId IdType="pubmed">15173049</ArticleId></ArticleIdList></Reference><Reference><Citation>Brook RD, Rajagopalan S, Pope CA, III, Brook JR, Bhatnagar A, Diez-Roux AV, et al. Particulate matter air pollution and cardiovascular disease: an update to the scientific statement from the American Heart Association. Circulation. 2010;121:2331&#x2013;2378.</Citation><ArticleIdList><ArticleId IdType="pubmed">20458016</ArticleId></ArticleIdList></Reference><Reference><Citation>Chiuve S, Fung T, Rimm E, Hu FB, McCullough ML, Wang M, et al. Alternative dietary indices both strongly predict risk of chronic disease. J Nutr. 2012;142:1009&#x2013;1018.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3738221</ArticleId><ArticleId IdType="pubmed">22513989</ArticleId></ArticleIdList></Reference><Reference><Citation>Colditz GA, Manson JE, Hankinson SE. The Nurses&#x2019; Health Study: 20-year contribution to the understanding of health among women. J Womens Health. 1997;6:49&#x2013;62.</Citation><ArticleIdList><ArticleId IdType="pubmed">9065374</ArticleId></ArticleIdList></Reference><Reference><Citation>Dales RE, Cakmak S, Vidal CB. Air pollution and hospitalization for venous thromboembolic disease in Chile. J Thromb Haemost. 2010;8:669&#x2013;674.</Citation><ArticleIdList><ArticleId IdType="pubmed">20088925</ArticleId></ArticleIdList></Reference><Reference><Citation>Dockery DW, Pope CA, III, Xu X, Spengler JD, Ware JH, Fay ME, et al. An association between air pollution and mortality in six U.S. cities. N Engl J Med. 1993;329:1753&#x2013;1759.</Citation><ArticleIdList><ArticleId IdType="pubmed">8179653</ArticleId></ArticleIdList></Reference><Reference><Citation>Esmon CT. Inflammation and thrombosis. J Thromb Haemost. 2003;1:1343&#x2013;1348.</Citation><ArticleIdList><ArticleId IdType="pubmed">12871267</ArticleId></ArticleIdList></Reference><Reference><Citation>Goldhaber SZ, Visani L, De Rosa M. Acute pulmonary embolism: clinical outcomes in the International Cooperative Pulmonary Embolism Registry (ICOPER). Lancet. 1999;353:1386&#x2013;1389.</Citation><ArticleIdList><ArticleId IdType="pubmed">10227218</ArticleId></ArticleIdList></Reference><Reference><Citation>Gryparis A, Paciorek CJ, Zeka A, Schwartz J, Coull BA. Measurement error caused by spatial misalignment in environmental epidemiology. Biostatistics. 2009;10:258&#x2013;274.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2733173</ArticleId><ArticleId IdType="pubmed">18927119</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoek G, Krishnan RM, Beelen R, Peters A, Ostro B, Brunekreef B, et al. 2013Long-term air pollution exposure and cardio- respiratory mortality: a review. Environ Health 1243; 10.1186/1476-069X-12-43</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1476-069X-12-43</ArticleId><ArticleId IdType="pmc">PMC3679821</ArticleId><ArticleId IdType="pubmed">23714370</ArticleId></ArticleIdList></Reference><Reference><Citation>IMPROVE (Interagency Monitoring of Protected Visual Environments). Interagency Monitoring of Protected Visual Environments Homepage. 2013.  Available:  http://vista.cira.colostate.edu/improve/ [accessed 8 January 2015]</Citation></Reference><Reference><Citation>IMPROVE. National Park Service&#x2019;s Stack Filter Unit Network (NPS-SFU) Homepage. 2015.  Available:  http://vista.cira.colostate.edu/improve/data/Other/Data_nps_sfu.htm [accessed 8 January 2015]</Citation></Reference><Reference><Citation>Kabrhel C, Varraso R, Goldhaber SZ, Rimm E, Camargo CA., Jr2011Physical inactivity and idiopathic pulmonary embolism in women: prospective study. BMJ 343d3867; 10.1136/bmj.d3867</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.d3867</ArticleId><ArticleId IdType="pmc">PMC3266839</ArticleId><ArticleId IdType="pubmed">21727169</ArticleId></ArticleIdList></Reference><Reference><Citation>Kan H, Folsom AR, Cushman M, Rose KM, Rosamond WD, Liao D, et al. Traffic exposure and incident venous thromboembolism in the Atherosclerosis Risk in Communities (ARIC) Study. J Thromb Haemost. 2011;9:672&#x2013;678.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3071427</ArticleId><ArticleId IdType="pubmed">21255249</ArticleId></ArticleIdList></Reference><Reference><Citation>Karner AA, Eisinger DS, Niemeier DA. Near-roadway air quality: synthesizing the findings from real-world data. Environ Sci Technol. 2010;44:5334&#x2013;5344.</Citation><ArticleIdList><ArticleId IdType="pubmed">20560612</ArticleId></ArticleIdList></Reference><Reference><Citation>K&#xfc;rkciyan I, Meron G, Sterz F, Janata K, Domanovits H, Holzer M, et al. Pulmonary embolism as cause of cardiac arrest: presentation and outcome. JAMA Intern Med. 2000;160:1529&#x2013;1535.</Citation><ArticleIdList><ArticleId IdType="pubmed">10826469</ArticleId></ArticleIdList></Reference><Reference><Citation>Martinelli N, Girelli D, Cigolini D, Sandri M, Ricci G, Rocca G, et al. 2012Access rate to the emergency department for venous thromboembolism in relationship with coarse and fine particulate matter air pollution. PLoS One 7e34831; 10.1371/journal.pone.0034831</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0034831</ArticleId><ArticleId IdType="pmc">PMC3324538</ArticleId><ArticleId IdType="pubmed">22509360</ArticleId></ArticleIdList></Reference><Reference><Citation>Miller KA, Siscovick DS, Sheppard L, Shepherd K, Sullivan JH, Anderson GL, et al. Long-term exposure to air pollution and incidence of cardiovascular events in women. N Engl J Med. 2007;356:447&#x2013;458.</Citation><ArticleIdList><ArticleId IdType="pubmed">17267905</ArticleId></ArticleIdList></Reference><Reference><Citation>Milojevic A, Wilkinson P, Armstrong B, Bhaskaran K, Smeeth L, Hajat S. Short-term effects of air pollution on a range of cardiovascular events in England and Wales: case-crossover analysis of the MINAP database, hospital admissions and mortality. Heart. 2014;100:1093&#x2013;1098.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4078678</ArticleId><ArticleId IdType="pubmed">24952943</ArticleId></ArticleIdList></Reference><Reference><Citation>Naess IA, Christiansen SC, Romundstad P, Cannegieter S, Rosendaal FR, Hammerstr&#xf8;m J. Incidence and mortality of venous thrombosis: a population-based study. J Thromb Haemost. 2007;5:692&#x2013;699.</Citation><ArticleIdList><ArticleId IdType="pubmed">17367492</ArticleId></ArticleIdList></Reference><Reference><Citation>Nemmar A, Hoylaerts MF, Nemery B. Effects of particulate air pollution on hemostasis. Clin Occup Environ Med. 2006;5:865&#x2013;881.</Citation><ArticleIdList><ArticleId IdType="pubmed">17110297</ArticleId></ArticleIdList></Reference><Reference><Citation>Office of the Surgeon General. Acting Surgeon General Issues &#x2018;Call to Action to Prevent Deep Vein Thrombosis and Pulmonary Embolism&#x2019; [Press release]. Washington, DC:U.S. Department of Health and Human Services. 2008.  Available:  http://www.nhlbi.nih.gov/news/press-releases/2014/acting-surgeon-general-issues-call-action-prevent-deep-vein-thrombosis-and [accessed 8 January 2015]</Citation><ArticleIdList><ArticleId IdType="pubmed">20669525</ArticleId></ArticleIdList></Reference><Reference><Citation>Oger E, EPI-GETBO Study Group. Incidence of venous thromboembolism: a community-based study in Western France. EPI-GETBP Study Group. Groupe d&#x2019;Etude de la Thrombose de Bretagne Occidentale. Thromb Haemost. 2000;83:657&#x2013;660.</Citation><ArticleIdList><ArticleId IdType="pubmed">10823257</ArticleId></ArticleIdList></Reference><Reference><Citation>Paciorek CJ, Yanosky JD, Puett RC, Laden F, Suh HH. Practical large-scale spatio-temporal modeling of particulate matter concentrations. Ann Appl Stat. 2009;3:370&#x2013;397.</Citation></Reference><Reference><Citation>Peled R. Air pollution exposure: who is at high risk? Atmos Environ. 2011;45:1781&#x2013;1785.</Citation></Reference><Reference><Citation>Piazza G, Goldhaber SZ. Acute pulmonary embolism: part I: epidemiology and diagnosis. Circulation. 2006;114:e28&#x2013;e32.</Citation><ArticleIdList><ArticleId IdType="pubmed">16831989</ArticleId></ArticleIdList></Reference><Reference><Citation>Pope CA, III, Burnett RT, Thun MJ, Calle EE, Krewski D, Ito K, et al. Lung cancer, cardiopulmonary mortality, and long-term exposure to fine particulate air pollution. JAMA. 2002;287:1132&#x2013;1141.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4037163</ArticleId><ArticleId IdType="pubmed">11879110</ArticleId></ArticleIdList></Reference><Reference><Citation>Previtali E, Bucciarelli P, Passamonti SM, Martinelli I. Risk factors for venous and arterial thrombosis. Blood Transfus. 2011;9:120&#x2013;138.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3096855</ArticleId><ArticleId IdType="pubmed">21084000</ArticleId></ArticleIdList></Reference><Reference><Citation>Puett RC, Hart JE, Yanosky JD, Paciorek C, Schwartz J, Suh H, et al. 2009Chronic fine and coarse particulate exposure, mortality, and coronary heart disease in the Nurses&#x2019; Health Study. Environ Health Perspect 1171697&#x2013;1701.; 10.1289/ehp.0900572</Citation><ArticleIdList><ArticleId IdType="doi">10.1289/ehp.0900572</ArticleId><ArticleId IdType="pmc">PMC2801178</ArticleId><ArticleId IdType="pubmed">20049120</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosendaal FR. Venous thrombosis: a multicausal disease. Lancet. 1999;353:1167&#x2013;1173.</Citation><ArticleIdList><ArticleId IdType="pubmed">10209995</ArticleId></ArticleIdList></Reference><Reference><Citation>R&#xfc;ckerl R, Ibald-Mulli A, Koenig W, Schneider A, Woelke G, Cyrys J, et al. Air pollution and markers of inflammation and coagulation in patients with coronary heart disease. Am J Respir Crit Care Med. 2006;173:432&#x2013;441.</Citation><ArticleIdList><ArticleId IdType="pubmed">16293802</ArticleId></ArticleIdList></Reference><Reference><Citation>Sacks JD, Stanek LW, Luben TJ, Johns DO, Buckley BJ, Brown JS, et al. 2011Particulate matter-induced health effects: who is susceptible? Environ Health Perspect 119446&#x2013;454.; 10.1289/ehp.1002255</Citation><ArticleIdList><ArticleId IdType="doi">10.1289/ehp.1002255</ArticleId><ArticleId IdType="pmc">PMC3080924</ArticleId><ArticleId IdType="pubmed">20961824</ArticleId></ArticleIdList></Reference><Reference><Citation>Shih RA, Griffin BA, Salkowski N, Jewell A, Eibner C, Bird CE, et al. 2011Ambient particulate matter air pollution and venous thromboembolism in the Women&#x2019;s Health Initiative Hormone Therapy trials. Environ Health Perspect 119326&#x2013;331.; 10.1289/ehp.1002256</Citation><ArticleIdList><ArticleId IdType="doi">10.1289/ehp.1002256</ArticleId><ArticleId IdType="pmc">PMC3059994</ArticleId><ArticleId IdType="pubmed">21036692</ArticleId></ArticleIdList></Reference><Reference><Citation>Spengler JD, Koutrakis P, Dockery DW, Raizenne M, Speizer FE. Health effects of acid aerosols on North American children: air pollution exposures. Environ Health Perspect. 1996;104:492&#x2013;499.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1469351</ArticleId><ArticleId IdType="pubmed">8743436</ArticleId></ArticleIdList></Reference><Reference><Citation>Suh HH, Nishioka Y, Allen GA, Koutrakis P, Burton RM. The metropolitan acid aerosol characterization study: results from the summer 1994 Washington, D.C. field study. Environ Health Perspect. 1997;105:826&#x2013;834.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1470204</ArticleId><ArticleId IdType="pubmed">9347898</ArticleId></ArticleIdList></Reference><Reference><Citation>U.S. Census Bureau. Census 2000 CD. Washington, DC:U.S. Government Printing Office. 2000.  Available:  https://bookstore.gpo.gov/ [accessed 8 January 2015]</Citation></Reference><Reference><Citation>U.S. EPA (U.S. Environmental Protection Agency). Air Quality System Homepage. 2015a.  Available:  http://www2.epa.gov/aqs [accessed 4 January 2015]</Citation></Reference><Reference><Citation>U.S. EPA. Clean Air Status and Trends Network (CASTNET) Homepage. 2015b.  Available:  http://www2.epa.gov/castnet [accessed 8 January 2015]</Citation></Reference><Reference><Citation>Utell MJ, Frampton MW, Zareba W, Devlin RB, Cascio WE. Cardiovascular effects associated with air pollution: potential mechanisms and methods of testing. Inhal Toxicol. 2002;14:1231&#x2013;1247.</Citation><ArticleIdList><ArticleId IdType="pubmed">12454788</ArticleId></ArticleIdList></Reference><Reference><Citation>VIEWS (Visibility Information Exchange Web System). Visibility Information Exchange Homepage. 2010.  Available:  http://views.cira.colostate.edu/web/ [accessed 6 January 2015]</Citation></Reference><Reference><Citation>Yanosky JD, Paciorek CJ, Laden F, Hart JE, Puett RC, Liao D, et al. 2014Spatio-temporal modeling of particulate air pollution in the conterminous United States using geographic and meteorological predictors. Environ Health 1363; 10.1186/1476-069X-13-63</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1476-069X-13-63</ArticleId><ArticleId IdType="pmc">PMC4137272</ArticleId><ArticleId IdType="pubmed">25097007</ArticleId></ArticleIdList></Reference><Reference><Citation>Yanosky JD, Paciorek CJ, Schwartz J, Laden F, Puett R, Suh HH. Spatio-temporal modeling of chronic PM10 exposure for the Nurses&#x2019; Health Study. Atmos Environ. 2008;42:4047&#x2013;4062.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2705904</ArticleId><ArticleId IdType="pubmed">19584946</ArticleId></ArticleIdList></Reference><Reference><Citation>Yanosky JD, Paciorek CJ, Suh HH.2009Predicting chronic fine and coarse particulate exposures using spatiotemporal models for the Northeastern and Midwestern United States. Environ Health Perspect 117522&#x2013;529.; 10.1289/ehp.11692</Citation><ArticleIdList><ArticleId IdType="doi">10.1289/ehp.11692</ArticleId><ArticleId IdType="pmc">PMC2679594</ArticleId><ArticleId IdType="pubmed">19440489</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">34269751</PMID><DateCompleted><Year>2021</Year><Month>11</Month><Day>25</Day></DateCompleted><DateRevised><Year>2023</Year><Month>09</Month><Day>29</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1536-0237</ISSN><JournalIssue CitedMedium="Internet"><Volume>36</Volume><Issue>5</Issue><PubDate><Year>2021</Year><Month>Sep</Month><Day>01</Day></PubDate></JournalIssue><Title>Journal of thoracic imaging</Title><ISOAbbreviation>J Thorac Imaging</ISOAbbreviation></Journal><ArticleTitle>Prevalence and Associated Risk Factors of Pulmonary Embolism in Children and Young Adults With Nephrotic Syndrome: A Chinese Large Cohort Study.</ArticleTitle><Pagination><StartPage>326</StartPage><EndPage>332</EndPage><MedlinePgn>326-332</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1097/RTI.0000000000000603</ELocationID><Abstract><AbstractText Label="PURPOSE" NlmCategory="OBJECTIVE">Nephrotic syndrome (NS) is highly associated with an increased risk of pulmonary embolism (PE) in children and young adults. However, few studies have specified the risk factors of PE in children and young adults with NS. We sought to determine the prevalence and associated factors of PE confirmed with computed tomography pulmonary angiography in Chinese children and young adults with NS.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Data from 444 children and young adults with NS who had computed tomography pulmonary angiography from December 2010 to October 2018 were retrospectively analyzed. The prevalence of PE was estimated for different age, sex, and histopathologic types of NS. Multivariable logistic regression was used to identify independent risk factors of PE in children and young adults with NS. Models incorporating the independent risk factors were evaluated using receiver operation characteristic curves. Area under the curve was used to determine the best-performing prognosticators for predicting PE.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">There were 444 patients in the study cohort (310 male patients, 134 female patients; mean age 19&#xb1;3&#x2009;y; range: 6 to 25&#x2009;y). PE was present in 24.8% of the participants (110 of 444, 18.2% female). Children and young adult NS patients with PE tend to be older, male, to have a previous thromboembolism history and smoking, and have a higher level of proteinuria, D-dimer, and serum albumin (P&lt;0.05 for all). Children and young adults with membranous nephropathy are likely to have a higher incidence of PE than those with other types of nephropathy. Membranous nephropathy and proteinuria were significant predictors of PE in children and young adults with NS (P&lt;0.05 for all). The area under the curves of each model for the presence of PE in children and young adults with NS based on biochemical parameters and clinical information (model 1), adjusted for proteinuria (model 2), and adjusted for membranous nephropathy (model 3) were 0.578, 0.657, and 0.709, respectively. Compared with model 1, model 2, and model 3 showed statistically significant differences (model 1 vs. model 2, P=0.0336; model 1 vs. model 3, P=0.0268). There was no statistically significant difference between model 2 and model 3 (P=0.2947).</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">This study identified membranous nephropathy and proteinuria as independent associated factors of PE in children and young adults with NS, which can be noted as a risk factor to guide clinician management in this population.</AbstractText><CopyrightInformation>Copyright &#xa9; 2021 Wolters Kluwer Health, Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Zhu</LastName><ForeName>Haitao</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Medical Imaging, Jinling Hospital, Medical School of Nanjing University, Nanjing, Jiangsu.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Affiliated Hospital of Jiangsu University, Jiangsu University, Zhenjiang, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Qi</LastName><ForeName>Jianchen</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Affiliated Hospital of Jiangsu University, Jiangsu University, Zhenjiang, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schoepf</LastName><ForeName>Joseph</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Medical Imaging, Jinling Hospital, Medical School of Nanjing University, Nanjing, Jiangsu.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Radiology and Radiological Science, Division of Cardiovascular Imaging, Medical University of South Carolina, Charleston, SC.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Savage</LastName><ForeName>Rock H</ForeName><Initials>RH</Initials><AffiliationInfo><Affiliation>Department of Medical Imaging, Jinling Hospital, Medical School of Nanjing University, Nanjing, Jiangsu.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Radiology and Radiological Science, Division of Cardiovascular Imaging, Medical University of South Carolina, Charleston, SC.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tang</LastName><ForeName>Chunxiang</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Medical Imaging, Jinling Hospital, Medical School of Nanjing University, Nanjing, Jiangsu.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lu</LastName><ForeName>Mengjie</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Medical Imaging, Jinling Hospital, Medical School of Nanjing University, Nanjing, Jiangsu.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhou</LastName><ForeName>Changsheng</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Medical Imaging, Jinling Hospital, Medical School of Nanjing University, Nanjing, Jiangsu.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lu</LastName><ForeName>Guangming</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Medical Imaging, Jinling Hospital, Medical School of Nanjing University, Nanjing, Jiangsu.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Dongqing</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Affiliated Hospital of Jiangsu University, Jiangsu University, Zhenjiang, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Longjiang</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Medical Imaging, Jinling Hospital, Medical School of Nanjing University, Nanjing, Jiangsu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Thorac Imaging</MedlineTA><NlmUniqueID>8606160</NlmUniqueID><ISSNLinking>0883-5993</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D005338">Fibrin Fibrinogen Degradation Products</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002681" MajorTopicYN="N" Type="Geographic">China</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005338" MajorTopicYN="N">Fibrin Fibrinogen Degradation Products</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009404" MajorTopicYN="Y">Nephrotic Syndrome</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015995" MajorTopicYN="N">Prevalence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011655" MajorTopicYN="Y">Pulmonary Embolism</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>The authors declare no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>7</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>11</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>7</Month><Day>16</Day><Hour>12</Hour><Minute>20</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34269751</ArticleId><ArticleId IdType="doi">10.1097/RTI.0000000000000603</ArticleId><ArticleId IdType="pii">00005382-202109000-00008</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Noone DG, Iijima K, Parekh R. Idiopathic nephrotic syndrome in children. Lancet. 2018;392:61&#x2013;74.</Citation></Reference><Reference><Citation>Mendonca AC, Oliveira EA, Froes BP, et al. A predictive model of progressive chronic kidney disease in idiopathic nephrotic syndrome. Pediatr Nephrol. 2015;30:2011&#x2013;2020.</Citation></Reference><Reference><Citation>Loscalzo J. Venous thrombosis in the nephrotic syndrome. N Engl J Med. 2013;368:956&#x2013;958.</Citation></Reference><Reference><Citation>Zhang LJ, Zhang Z, Li SJ, et al. Pulmonary embolism and renal vein thrombosis in patients with nephrotic syndrome: prospective evaluation of prevalence and risk factors with CT. Radiology. 2014;273:897&#x2013;906.</Citation></Reference><Reference><Citation>Remy-Jardin M, Pistolesi M, Goodman LR, et al. Management of suspected acute pulmonary embolism in the era of CT angiography: a statement from the Fleischner Society. Radiology. 2007;245:315&#x2013;329.</Citation></Reference><Reference><Citation>Lee EY, Tse SK, Zurakowski D, et al. Children suspected of having pulmonary embolism: multidetector CT pulmonary angiography&#x2212;thromboembolic risk factors and implications for appropriate use. Radiology. 2012;262:242&#x2013;251.</Citation></Reference><Reference><Citation>Mamlouk MD, vanSonnenberg E, Gosalia R, et al. Pulmonary embolism at CT angiography: implications for appropriateness, cost, and radiation exposure in 2003 patients. Radiology. 2010;256:625&#x2013;632.</Citation></Reference><Reference><Citation>Yang Y, Lv J, Zhou F, et al. Risk factors of pulmonary thrombosis/embolism in nephrotic syndrome. Am J Med Sci. 2014;348:394&#x2013;398.</Citation></Reference><Reference><Citation>Konstantinides S, Goldhaber SZ. Pulmonary embolism: risk assessment and management. Eur Heart J. 2012;33:3014&#x2013;3022.</Citation></Reference><Reference><Citation>Coresh J, Astor B, Sarnak MJ. Evidence for increased cardiovascular disease risk in patients with chronic kidney disease. Curr Opin Nephrol Hypertens. 2004;13:73&#x2013;81.</Citation></Reference><Reference><Citation>Tang CX, Zhou CS, Schoepf UJ, et al. Computer-assisted detection of acute pulmonary embolism at CT pulmonary angiography in children and young adults: a diagnostic performance analysis. Acta radiol. 2019;60:1011&#x2013;1019.</Citation></Reference><Reference><Citation>Orth SR, Ritz E. The nephrotic syndrome. N Engl J Med. 1998;338:1202&#x2013;1211.</Citation></Reference><Reference><Citation>Levey AS, Coresh J, Greene T, et al. Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate. Ann Intern Med. 2006;145:247&#x2013;254.</Citation></Reference><Reference><Citation>Lee EY, Kritsaneepaiboon S, Arellano CM, et al. Unsuspected pulmonary emboli in pediatric oncology patients: detection with MDCT. AJR Am J Roentgenol. 2010;194:1216&#x2013;1222.</Citation></Reference><Reference><Citation>Zhang LJ, Zhou CS, Lu GM. Dual energy computed tomography demonstrated lung ventilation/perfusion mismatch in a 19-year-old patient with pulmonary embolism. Circulation. 2012;126:2441&#x2013;2443.</Citation></Reference><Reference><Citation>Tang CX, Schoepf UJ, Chowdhury SM, et al. Multidetector computed tomography pulmonary angiography in childhood acute pulmonary embolism. Pediatr Radiol. 2015;45:1431&#x2013;1439.</Citation></Reference><Reference><Citation>Lee EY, Zurakowski D, Diperna S, et al. Parenchymal and pleural abnormalities in children with and without pulmonary embolism at MDCT pulmonary angiography. Pediatr Radiol. 2010;40:173&#x2013;181.</Citation></Reference><Reference><Citation>Gatewood OM, Fishman EK, Burrow CR, et al. Renal vein thrombosis in patients with nephrotic syndrome: CT diagnosis. Radiology. 1986;159:117&#x2013;122.</Citation></Reference><Reference><Citation>Katz MH. Multivariable analysis: a practical guide for clinicians and public health researchers. Cambridge University Press; 2011:1&#x2013;233.</Citation></Reference><Reference><Citation>Lionaki S, Derebail VK, Hogan SL, et al. Venous thromboembolism in patients with membranous nephropathy. Clin J Am Soc Nephrol. 2012;7:43&#x2013;51.</Citation></Reference><Reference><Citation>Lee EY, Neuman MI, Lee NJ, et al. Pulmonary embolism detected by pulmonary MDCT angiography in older children and young adults: risk factor assessment. AJR Am J Roentgenol. 2012;198:1431&#x2013;1437.</Citation></Reference><Reference><Citation>Romero-Diaz J, Garcia-Sosa I, Sanchez-Guerrero J. Thrombosis in systemic lupus erythematosus and other autoimmune diseases of recent onset. J Rheumatol. 2009;36:68&#x2013;75.</Citation></Reference><Reference><Citation>Tomasson G, Monach PA, Merkel PA. Thromboembolic disease in vasculitis. Curr Opin Rheumatol. 2009;21:41&#x2013;46.</Citation></Reference><Reference><Citation>Kerlin BA, Blatt NB, Fuh B, et al. Epidemiology and risk factors for thromboembolic complications of childhood nephrotic syndrome: a Midwest Pediatric Nephrology Consortium (MWPNC) study. J Pediatr. 2009;155:105&#x2013;110.</Citation></Reference><Reference><Citation>Christiansen CF, Schmidt M, Lamberg AL, et al. Kidney disease and risk of venous thromboembolism: a nationwide population-based case-control study. J Thromb Haemost. 2014;12:1449&#x2013;1454.</Citation></Reference><Reference><Citation>Yan C, Wang X, Su H, et al. Recent progress in research on the pathogenesis of pulmonary thromboembolism: an old story with new perspectives. Biomed Res Int. 2017;2017:6516791.</Citation></Reference><Reference><Citation>Barbour SJ, Greenwald A, Djurdjev O, et al. Disease-specific risk of venous thromboembolic events is increased in idiopathic glomerulonephritis. Kidney Int. 2012;81:190&#x2013;195.</Citation></Reference><Reference><Citation>Kumar S, Chapagain A, Nitsch D, et al. Proteinuria and hypoalbuminemia are risk factors for thromboembolic events in patients with idiopathic membranous nephropathy: an observational study. BMC Nephrol. 2012;13:107.</Citation></Reference><Reference><Citation>Li SJ, Guo JZ, Zuo K, et al. Thromboembolic complications in membranous nephropathy patients with nephrotic syndrome-a prospective study. Thromb Res. 2012;130:501&#x2013;505.</Citation></Reference><Reference><Citation>Barbar S, Noventa F, Rossetto V, et al. A risk assessment model for the identification of hospitalized medical patients at risk for venous thromboembolism: the Padua Prediction Score. J Thromb Haemost. 2010;8:2450&#x2013;2457.</Citation></Reference><Reference><Citation>Schulman S, Ageno W, Konstantinides SV. Venous thromboembolism: past, present and future. Thromb Haemost. 2017;117:1219&#x2013;1229.</Citation></Reference><Reference><Citation>Kayali F, Najjar R, Aswad F, et al. Venous thromboembolism in patients hospitalized with nephrotic syndrome. Am J Med. 2008;121:226&#x2013;230.</Citation></Reference><Reference><Citation>Mahmoodi BK, ten Kate MK, Waanders F, et al. High absolute risks and predictors of venous and arterial thromboembolic events in patients with nephrotic syndrome: results from a large retrospective cohort study. Circulation. 2008;117:224&#x2013;230.</Citation></Reference><Reference><Citation>Zaffanello M. Thromboembolism in childhood nephrotic syndrome: a rare but serious complication. Hematology. 2007;12:69&#x2013;73.</Citation></Reference><Reference><Citation>Righini M, Van Es J, Den Exter PL, et al. Age-adjusted D-dimer cutoff levels to rule out pulmonary embolism: the ADJUST-PE study. JAMA. 2014;311:1117&#x2013;1124.</Citation></Reference><Reference><Citation>Biss TT, Brandao LR, Kahr WH, et al. Clinical probability score and D-dimer estimation lack utility in the diagnosis of childhood pulmonary embolism. J Thromb Haemost. 2009;7:1633&#x2013;1638.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">34856931</PMID><DateCompleted><Year>2022</Year><Month>03</Month><Day>08</Day></DateCompleted><DateRevised><Year>2022</Year><Month>03</Month><Day>08</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1471-2253</ISSN><JournalIssue CitedMedium="Internet"><Volume>21</Volume><Issue>1</Issue><PubDate><Year>2021</Year><Month>Dec</Month><Day>03</Day></PubDate></JournalIssue><Title>BMC anesthesiology</Title><ISOAbbreviation>BMC Anesthesiol</ISOAbbreviation></Journal><ArticleTitle>Intraoperative hypotension, oliguria and operation time are associated with pulmonary embolism after radical resection of head and neck cancers: a case control study.</ArticleTitle><Pagination><StartPage>304</StartPage><MedlinePgn>304</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">304</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s12871-021-01521-4</ELocationID><Abstract><AbstractText Label="BACKGROUND">Postoperative pulmonary embolism (PE) is a serious thrombotic complication in the patients with otolaryngologic cancers. We investigated the risk factors associated with postoperative PE after radical resection of head and neck cancers.</AbstractText><AbstractText Label="METHODS">A total of 3512 patients underwent head and neck cancers radical resection from 2013 to 2019. A one-to-three control group without postoperative PE was selected matched by age, gender, and type of cancer. Univariate analyses were performed for the perioperative patient data including hemodynamic management factors. Conditional logistic regression was used to analyze the factors and their odds ratios.</AbstractText><AbstractText Label="RESULTS">Postoperative PE was prevalent in 0.85% (95%CI&#x2009;=&#x2009;0.56-1.14). Univariate analyses showed that a high ASA grade, high BMI, and smoking history may be related to postoperative PE. There was significantly difference in operation time between the two groups, especially for&gt;&#x2009;4&#x2009;h [22(78.6%) vs 43(51.2%), P&#x2009;=&#x2009;.011]. The urine output was lower [1.37(0.73-2.21) ml&#xb7;kg<sup>-&#x2009;1</sup>&#xb7;h<sup>-&#x2009;1</sup> vs 2.14(1.32-3.46) ml&#xb7;kg<sup>-&#x2009;1</sup>&#xb7;h<sup>-&#x2009;1</sup>, P&#x2009;=&#x2009;.006] and the incidence of oliguria was significantly increased (14.3% vs 1.2%, P&#x2009;=&#x2009;.004) in the PE group. Multivariable conditional logistic regression showed postoperative PE were associated with the cumulative duration for intraoperative hypotension (OR&#x2009;=&#x2009;2.330, 95%CI&#x2009;=&#x2009;1.428-3.801, P&#x2009;=&#x2009;.001), oliguria (OR&#x2009;=&#x2009;14.844, 95%CI&#x2009;=&#x2009;1.089-202.249, P&#x2009;=&#x2009;.043), and operation time&#x2009;&gt;&#x2009;4&#x2009;h (OR&#x2009;=&#x2009;4.801, 95%CI&#x2009;=&#x2009;1.054-21.866, P&#x2009;=&#x2009;.043).</AbstractText><AbstractText Label="CONCLUSIONS">The intraoperative hypotension, oliguria, and operation time&#x2009;&gt;&#x2009;4&#x2009;h are risk factors associated with postoperative PE after radical resection of head and neck cancers. Improving intraoperative hemodynamics management to ensure adequate blood pressure and urine output may reduce the occurrence of such complications.</AbstractText><CopyrightInformation>&#xa9; 2021. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Liang</LastName><ForeName>Xuan</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Beijing Tongren Hospital, Capital Medical University, Beijing, 100730, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Xiaohong</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Otolaryngology Head &amp; Neck surgery, Beijing Tongren Hospital, Capital Medical University, Beijing, 100730, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Guyan</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Beijing Tongren Hospital, Capital Medical University, Beijing, 100730, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Yue</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Beijing Tongren Hospital, Capital Medical University, Beijing, 100730, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shi</LastName><ForeName>Dongjing</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Beijing Tongren Hospital, Capital Medical University, Beijing, 100730, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhao</LastName><ForeName>Meiyi</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Beijing Tongren Hospital, Capital Medical University, Beijing, 100730, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zheng</LastName><ForeName>Huachuan</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Experimental Oncology, Shengjing Hospital of China Medical University, Shenyang, 110004, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cui</LastName><ForeName>Xu</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Beijing Tongren Hospital, Capital Medical University, Beijing, 100730, China. cuixubjtr@ccmu.edu.cn.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>12</Month><Day>03</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>BMC Anesthesiol</MedlineTA><NlmUniqueID>100968535</NlmUniqueID><ISSNLinking>1471-2253</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000068476" MajorTopicYN="N" Type="Geographic">Beijing</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016022" MajorTopicYN="N">Case-Control Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015984" MajorTopicYN="N">Causality</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015897" MajorTopicYN="N">Comorbidity</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006258" MajorTopicYN="N">Head and Neck Neoplasms</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007022" MajorTopicYN="N">Hypotension</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015994" MajorTopicYN="N">Incidence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007431" MajorTopicYN="N">Intraoperative Complications</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009846" MajorTopicYN="N">Oliguria</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D061646" MajorTopicYN="Y">Operative Time</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011655" MajorTopicYN="N">Pulmonary Embolism</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Anesthesia, general</Keyword><Keyword MajorTopicYN="N">Fluid therapy</Keyword><Keyword MajorTopicYN="N">Hypotension</Keyword><Keyword MajorTopicYN="N">Malignant head and neck tumors</Keyword><Keyword MajorTopicYN="N">Pulmonary embolism</Keyword></KeywordList><CoiStatement>Not applicable.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>1</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>11</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>12</Month><Day>3</Day><Hour>5</Hour><Minute>38</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>12</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>3</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2021</Year><Month>12</Month><Day>3</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34856931</ArticleId><ArticleId IdType="pmc">PMC8641205</ArticleId><ArticleId IdType="doi">10.1186/s12871-021-01521-4</ArticleId><ArticleId IdType="pii">10.1186/s12871-021-01521-4</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Pan R, Zhu M, Yu C, et al. Cancer incidence and mortality: a cohort study in China, 2008-2013. Int J Cancer. 2017;141(7):1315&#x2013;1323. doi: 10.1002/ijc.30825.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ijc.30825</ArticleId><ArticleId IdType="pubmed">28593646</ArticleId></ArticleIdList></Reference><Reference><Citation>Siegel RL, Miller KD, Jemal A. Cancer statistics, 2020. CA Cancer J Clin. 2020;70(1):7&#x2013;30. doi: 10.3322/caac.21590.</Citation><ArticleIdList><ArticleId IdType="doi">10.3322/caac.21590</ArticleId><ArticleId IdType="pubmed">31912902</ArticleId></ArticleIdList></Reference><Reference><Citation>Moreano EH, Hutchison JL, McCulloch TM, Graham SM, Funk GF, Hoffman HT. Incidence of deep venous thrombosis and pulmonary embolism in otolaryngology-head and neck surgery. Otolaryngol Head Neck Surg. 1998;118(6):777&#x2013;784. doi: 10.1016/S0194-5998(98)70268-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0194-5998(98)70268-2</ArticleId><ArticleId IdType="pubmed">9627236</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen CM, Disa JJ, Cordeiro PG, Pusic AL, McCarthy CM, Mehrara BJ. The incidence of venous thromboembolism after oncologic head and neck reconstruction. Ann Plast Surg. 2008;60(5):476&#x2013;479. doi: 10.1097/SAP.0b013e31816fd7e7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/SAP.0b013e31816fd7e7</ArticleId><ArticleId IdType="pubmed">18434817</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee J, Alexander A, Higgins K, Geerts W. The Sunnybrook experience: review of deep vein thrombosis and pulmonary embolism in otolaryngology. J Otolaryngol Head Neck Surg. 2008;37(4):547&#x2013;551.</Citation><ArticleIdList><ArticleId IdType="pubmed">19128591</ArticleId></ArticleIdList></Reference><Reference><Citation>Ali NS, Nawaz A, Junaid M, Kazi M, Akhtar S. Venous thromboembolism-incidence of deep venous thrombosis and pulmonary embolism in patients with head and neck Cancer: a tertiary care experience in Pakistan. Int Arch Otorhinolaryngol. 2015;19(3):200&#x2013;204. doi: 10.1055/s-0035-1549153.</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/s-0035-1549153</ArticleId><ArticleId IdType="pmc">PMC4490913</ArticleId><ArticleId IdType="pubmed">26157492</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou J, Chen XH, Qin MZ. Diagnosis and treatment of pulmonary embolism in patients after operation of head and neck malignant tumor. Chin Arch Otolaryngol Head Neck Surg. 2015;22(10):504&#x2013;506.</Citation></Reference><Reference><Citation>Cramer JD, Dilger AE, Schneider A, Smith SS, Samant S, Patel UA. Risk of venous thromboembolism among otolaryngology patients vs general surgery and plastic surgery patients. JAMA Otolaryngol Head Neck Surg. 2018;144(1):9&#x2013;17.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5833590</ArticleId><ArticleId IdType="pubmed">29049530</ArticleId></ArticleIdList></Reference><Reference><Citation>Clayburgh DR, Stott W, Cordiero T, et al. Prospective study of venous thromboembolism in patients with head and neck cancer after surgery. JAMA Otolaryngol Head Neck Surg. 2013;139(11):1143&#x2013;1150. doi: 10.1001/jamaoto.2013.4911.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaoto.2013.4911</ArticleId><ArticleId IdType="pubmed">24076972</ArticleId></ArticleIdList></Reference><Reference><Citation>Thai L, McCarn K, Stott W, et al. Venous thromboembolism in patients with head and neck cancer after surgery. Head Neck. 2013;35(1):4&#x2013;9. doi: 10.1002/hed.22920.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/hed.22920</ArticleId><ArticleId IdType="pubmed">22302625</ArticleId></ArticleIdList></Reference><Reference><Citation>Tham T, Rahman L, Persaud C, Olson C, Costantino P. Venous thromboembolism risk in head and neck Cancer: significance of the preoperative platelet-to-lymphocyte ratio. Otolaryngol Head Neck Surg. 2018;159(1):85&#x2013;91. doi: 10.1177/0194599818756851.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0194599818756851</ArticleId><ArticleId IdType="pubmed">29406795</ArticleId></ArticleIdList></Reference><Reference><Citation>Beswick DM, Vaezeafshar R, Ma Y, Hwang PH, Nayak JV, Patel ZM. Risk stratification for postoperative venous thromboembolism after endoscopic sinus surgery. Otolaryngol Head Neck Surg. 2018;158(4):767&#x2013;773. doi: 10.1177/0194599818755340.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0194599818755340</ArticleId><ArticleId IdType="pubmed">29460675</ArticleId></ArticleIdList></Reference><Reference><Citation>Meng LZ, Yu WF, Wang TL, Zhang LN, Heerdt PM, Gelb AW. Blood pressure targets in perioperative care. Hypertension. 2018;72(4):806&#x2013;817. doi: 10.1161/HYPERTENSIONAHA.118.11688.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/HYPERTENSIONAHA.118.11688</ArticleId><ArticleId IdType="pubmed">30354725</ArticleId></ArticleIdList></Reference><Reference><Citation>Rogers SO, Jr, Kilaru RK, Hosokawa P, Henderson WG, Zinner MJ, Khuri SF. Multivariable predictors of postoperative venous thromboembolic events after general and vascular surgery: results from the patient safety in surgery study. J Am Coll Surg. 2007;204(6):1211&#x2013;1221. doi: 10.1016/j.jamcollsurg.2007.02.072.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jamcollsurg.2007.02.072</ArticleId><ArticleId IdType="pubmed">17544079</ArticleId></ArticleIdList></Reference><Reference><Citation>Kandagatla P, Goranta S, Antoine H, Marashi SM, Schmoekel N, Gupta AH. PADUA score as a predictor for pulmonary embolism: a potential strategy for reducing unnecessary imaging. J Thromb Thrombolysis. 2019;47(4):566&#x2013;571. doi: 10.1007/s11239-018-01801-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11239-018-01801-w</ArticleId><ArticleId IdType="pubmed">30612328</ArticleId></ArticleIdList></Reference><Reference><Citation>Bilgi K, Muthusamy A, Subair M, et al. Assessing the risk for development of venous thromboembolism (VTE) in surgical patients using adapted Caprini scoring system. Int J Surg. 2016;30:68&#x2013;73. doi: 10.1016/j.ijsu.2016.04.030.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijsu.2016.04.030</ArticleId><ArticleId IdType="pubmed">27109201</ArticleId></ArticleIdList></Reference><Reference><Citation>Dashe J, Parisien RL, Pina M, De Giacomo AF, Tornetta P., 3rd Is the Caprini score predictive of Venothromboembolism events in Orthopaedic fracture patients? J Orthop Trauma. 2019;33(6):269&#x2013;275. doi: 10.1097/BOT.0000000000001451.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/BOT.0000000000001451</ArticleId><ArticleId IdType="pubmed">31124908</ArticleId></ArticleIdList></Reference><Reference><Citation>Bijker JB, Persoon S, Peelen LM, et al. Intraoperative hypotension and perioperative ischemic stroke after general surgery: a nested case-control study. Anesthesiology. 2012;116(3):658&#x2013;664. doi: 10.1097/ALN.0b013e3182472320.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/ALN.0b013e3182472320</ArticleId><ArticleId IdType="pubmed">22277949</ArticleId></ArticleIdList></Reference><Reference><Citation>Walsh M, Devereaux PJ, Garg AX, et al. Relationship between intraoperative mean arterial pressure and clinical outcomes after noncardiac surgery: toward an empirical definition of hypotension. Anesthesiology. 2013;119(3):507&#x2013;515. doi: 10.1097/ALN.0b013e3182a10e26.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/ALN.0b013e3182a10e26</ArticleId><ArticleId IdType="pubmed">23835589</ArticleId></ArticleIdList></Reference><Reference><Citation>Shiba A, Uchino S, Fujii T, Takinami M, Uezono S. Association between intraoperative oliguria and acute kidney injury after major noncardiac surgery. Anesth Analg. 2018;127(5):1229&#x2013;1235. doi: 10.1213/ANE.0000000000003576.</Citation><ArticleIdList><ArticleId IdType="doi">10.1213/ANE.0000000000003576</ArticleId><ArticleId IdType="pubmed">29933276</ArticleId></ArticleIdList></Reference><Reference><Citation>Mizota T, Yamamoto Y, Hamada M, Matsukawa S, Shimizu S, Kai S. Intraoperative oliguria predicts acute kidney injury after major abdominal surgery. Br J Anaesth. 2017;119(6):1127&#x2013;1134. doi: 10.1093/bja/aex255.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bja/aex255</ArticleId><ArticleId IdType="pubmed">29136086</ArticleId></ArticleIdList></Reference><Reference><Citation>Muller-Richter U, Betz C, Hartmann S, Brands RC. Nutrition management for head and neck cancer patients improves clinical outcome and survival. Nutr Res. 2017;48:1&#x2013;8. doi: 10.1016/j.nutres.2017.08.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nutres.2017.08.007</ArticleId><ArticleId IdType="pubmed">29246276</ArticleId></ArticleIdList></Reference><Reference><Citation>Bell EJ, Agarwal SK, Cushman M, Heckbert SR, Lutsey PL, Folsom AR. Orthostatic hypotension and risk of venous thromboembolism in 2 cohort studies. Am J Hypertens. 2016;29(5):634&#x2013;640. doi: 10.1093/ajh/hpv151.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ajh/hpv151</ArticleId><ArticleId IdType="pmc">PMC5014082</ArticleId><ArticleId IdType="pubmed">26306405</ArticleId></ArticleIdList></Reference><Reference><Citation>Sessler DI, Sigl JC, Kelley SD, et al. Hospital stay and mortality are increased in patients having a "triple low" of low blood pressure, low bispectral index, and low minimum alveolar concentration of volatile anesthesia. Anesthesiology. 2012;116(6):1195&#x2013;1203. doi: 10.1097/ALN.0b013e31825683dc.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/ALN.0b013e31825683dc</ArticleId><ArticleId IdType="pubmed">22546967</ArticleId></ArticleIdList></Reference><Reference><Citation>Kertai MD, White WD, Gan TJ. Cumulative duration of "triple low" state of low blood pressure, low bispectral index, and low minimum alveolar concentration of volatile anesthesia is not associated with increased mortality. Anesthesiology. 2014;121(1):18&#x2013;28. doi: 10.1097/ALN.0000000000000281.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/ALN.0000000000000281</ArticleId><ArticleId IdType="pubmed">24936920</ArticleId></ArticleIdList></Reference><Reference><Citation>Dooley BJ, Karassawa Zanoni D, McGill MR, et al. Intraoperative and postanesthesia care unit fluid administration as risk factors for postoperative complications in patients with head and neck cancer undergoing free tissue transfer. Head Neck. 2020;42(1):14&#x2013;24.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7544020</ArticleId><ArticleId IdType="pubmed">31593349</ArticleId></ArticleIdList></Reference><Reference><Citation>Patel RS, McCluskey SA, Goldstein DP, et al. Clinicopathologic and therapeutic risk factors for perioperative complications and prolonged hospital stay in free flap reconstruction of the head and neck. Head Neck. 2010;32(10):1345&#x2013;1353. doi: 10.1002/hed.21331.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/hed.21331</ArticleId><ArticleId IdType="pubmed">20091687</ArticleId></ArticleIdList></Reference><Reference><Citation>Clark JR, McCluskey SA, Hall F, et al. Predictors of morbidity following free flap reconstruction for cancer of the head and neck. Head Neck. 2007;29(12):1090&#x2013;1101. doi: 10.1002/hed.20639.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/hed.20639</ArticleId><ArticleId IdType="pubmed">17563889</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">27925452</PMID><DateCompleted><Year>2018</Year><Month>09</Month><Day>10</Day></DateCompleted><DateRevised><Year>2018</Year><Month>09</Month><Day>10</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1752-699X</ISSN><JournalIssue CitedMedium="Internet"><Volume>12</Volume><Issue>2</Issue><PubDate><Year>2018</Year><Month>Feb</Month></PubDate></JournalIssue><Title>The clinical respiratory journal</Title><ISOAbbreviation>Clin Respir J</ISOAbbreviation></Journal><ArticleTitle>Usefulness of admission red blood cell distribution width as a predictor of severity of acute pulmonary embolism.</ArticleTitle><Pagination><StartPage>786</StartPage><EndPage>794</EndPage><MedlinePgn>786-794</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1111/crj.12595</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Previous researches have represented a considerable relation between acute pulmonary embolism (PE) and red blood cell distribution width (RDW). To the authors' knowledge no research has been informed in subjects with PE severity. Pulmonary arterial obstruction index (PAOI) is associated with the severity of acute PE.</AbstractText><AbstractText Label="OBJECTIVES" NlmCategory="OBJECTIVE">In our investigation, we purposed to assess the relation between PAOI and RDW and the benefit of these factors in the detection of PE severity.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">We retrospectively investigated the demographic information, probability of clinical scores, laboratory parameters, serum D-dimer levels, and echocardiographic findings of systolic pulmonary artery pressure (PAP) in Acute PE individuals who were diagnosed by computed tomography of pulmonary arterial angiography. Right ventricular dysfunction (RVD) on CT was assessed by calculating the right ventricular/left ventricular (RV/LV) diameter ratios on transverse (RV/LVtrans).</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">The information of 131 patients with acute PE and 51 (64.6%) female and 28 (35.4%) male healthy control were evaluated. Acute PE group's RDW values were higher than control subjects (P&#x2009;&lt;&#x2009;.0001). RDW (%) level was remarkable higher in patients with massive PE than in patients with nonmassive PE. There were statistically considerable differences in terms of PAOI and systolic pulmonary arterial pressure (sPAP) between nonmassive and massive PE patients (P&#x2009;&lt;&#x2009;.0001 for all).</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">PAOI was correlated with PE severity, D-dimer level, sPAP and clinical probability scores. PAOI was correlated with RDW levels. RDW levels, an inexpensive and easily measurable laboratory factor, were considerable associated with the severity and presence of PE.</AbstractText><CopyrightInformation>&#xa9; 2016 John Wiley &amp; Sons Ltd.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Akgedik</LastName><ForeName>Recep</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Chest Diseases, Faculty of Medicine, Ordu University, Ordu, Turkey.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Karamanli</LastName><ForeName>Harun</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Chest Diseases, Ataturk Chest Diseases and Chest Surgery Education and Research State Hospital, Ankara, Turkey.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kurt</LastName><ForeName>Ali Bekir</ForeName><Initials>AB</Initials><AffiliationInfo><Affiliation>Department of Radiology, Faculty of Medicine, Ordu University, Ordu, Turkey.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>G&#xfc;nayd&#x131;n</LastName><ForeName>Zeki Y&#xfc;ksel</ForeName><Initials>ZY</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Faculty of Medicine, Ordu University, Ordu, Turkey.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D003160">Comparative Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2017</Year><Month>01</Month><Day>08</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Clin Respir J</MedlineTA><NlmUniqueID>101315570</NlmUniqueID><ISSNLinking>1752-6981</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015415">Biomarkers</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D005338">Fibrin Fibrinogen Degradation Products</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C036309">fibrin fragment D</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000208" MajorTopicYN="N">Acute Disease</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015415" MajorTopicYN="N">Biomarkers</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016022" MajorTopicYN="N">Case-Control Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000072226" MajorTopicYN="N">Computed Tomography Angiography</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018450" MajorTopicYN="N">Disease Progression</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015150" MajorTopicYN="N">Echocardiography, Doppler</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004906" MajorTopicYN="N">Erythrocyte Count</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004909" MajorTopicYN="N">Erythrocyte Indices</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004912" MajorTopicYN="N">Erythrocytes</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005338" MajorTopicYN="N">Fibrin Fibrinogen Degradation Products</DescriptorName><QualifierName UI="Q000032" MajorTopicYN="N">analysis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011237" MajorTopicYN="N">Predictive Value of Tests</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011379" MajorTopicYN="N">Prognosis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011655" MajorTopicYN="N">Pulmonary Embolism</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000503" MajorTopicYN="Y">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012016" MajorTopicYN="N">Reference Values</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012720" MajorTopicYN="N">Severity of Illness Index</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018709" MajorTopicYN="N">Statistics, Nonparametric</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015996" MajorTopicYN="N">Survival Rate</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014057" MajorTopicYN="N">Tomography, X-Ray Computed</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">multidetector computed tomography</Keyword><Keyword MajorTopicYN="N">pulmonary arterial obstruction index</Keyword><Keyword MajorTopicYN="N">pulmonary artery pressure</Keyword><Keyword MajorTopicYN="N">pulmonary embolism</Keyword><Keyword MajorTopicYN="N">red cell distribution width</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2016</Year><Month>5</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2016</Year><Month>11</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2016</Year><Month>11</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2016</Year><Month>12</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>9</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2016</Year><Month>12</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">27925452</ArticleId><ArticleId IdType="doi">10.1111/crj.12595</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">28347320</PMID><DateCompleted><Year>2018</Year><Month>04</Month><Day>30</Day></DateCompleted><DateRevised><Year>2022</Year><Month>03</Month><Day>31</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1466-609X</ISSN><JournalIssue CitedMedium="Internet"><Volume>21</Volume><Issue>1</Issue><PubDate><Year>2017</Year><Month>Mar</Month><Day>28</Day></PubDate></JournalIssue><Title>Critical care (London, England)</Title><ISOAbbreviation>Crit Care</ISOAbbreviation></Journal><ArticleTitle>Life-threatening massive pulmonary embolism rescued by venoarterial-extracorporeal membrane oxygenation.</ArticleTitle><Pagination><StartPage>76</StartPage><MedlinePgn>76</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">76</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s13054-017-1655-8</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Despite quick implementation of reperfusion therapies, a few patients with high-risk, acute, massive, pulmonary embolism (PE) remain highly hemodynamically unstable. Others have absolute contraindication to receive reperfusion therapies. Venoarterial-extracorporeal membrane oxygenation (VA-ECMO) might lower their right ventricular overload, improve hemodynamic status, and restore tissue oxygenation.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">ECMO-related complications and 90-day mortality were analyzed for 17 highly unstable, ECMO-treated, massive PE patients admitted to a tertiary-care center (2006-2015). Hospital- discharge survivors were assessed for long-term health-related quality of life. A systematic review of this topic was also conducted.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Seventeen high-risk PE patients [median age 51 (range 18-70) years, Simplified Acute Physiology Score II (SAPS II) 78 (45-95)] were placed on VA-ECMO for 4 (1-12) days. Among 15 (82%) patients with pre-ECMO cardiac arrest, seven (41%) were cannulated during cardiopulmonary resuscitation, and eight (47%) underwent pre-ECMO thrombolysis. Pre-ECMO median blood pressure, pH, and blood lactate were, respectively: 42 (0-106) mmHg, 6.99 (6.54-7.37) and 13 (4-19) mmol/L. Ninety-day survival was 47%. Fifteen (88%) patients suffered in-ICU severe hemorrhages with no impact on survival. Like other ECMO-treated patients, ours reported limitations of all physical domains but preserved mental health 19 (4-69) months post-ICU discharge.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">VA-ECMO could be a lifesaving rescue therapy for patients with high-risk, acute, massive PE when thrombolytic therapy fails or the patient is too sick to benefit from surgical thrombectomy. Because heparin-induced clot dissolution and spontaneous fibrinolysis allows ECMO weaning within several days, future studies should investigate whether VA-ECMO should be the sole therapy or completed by additional mechanical clot-removal therapies in this setting.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Corsi</LastName><ForeName>Fillipo</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Dipartimento di Anestesia e Rianimazione, Policlinico Universitario A. Gemelli, Universit&#xe0; Cattolica Del Sacro Cuore, Rome, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Medical Intensive Care Unit, iCAN, Institute of Cardiometabolism and Nutrition, H&#xf4;pital de la Piti&#xe9;-Salp&#xea;tri&#xe8;re, Assistance Publique-H&#xf4;pitaux de Paris, Universit&#xe9; Pierre-et-Marie-Curie, Paris 6, 47, bd de l'H&#xf4;pital, 75651, Paris Cedex 13, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lebreton</LastName><ForeName>Guillaume</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Cardiac Surgery Department, iCAN, Institute of Cardiometabolism and Nutrition, H&#xf4;pital de la Piti&#xe9;-Salp&#xea;tri&#xe8;re, Assistance Publique-H&#xf4;pitaux de Paris, Universit&#xe9; Pierre-et-Marie-Curie, Paris 6, 47, bd de l'H&#xf4;pital, 75651, Paris Cedex 13, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Br&#xe9;chot</LastName><ForeName>Nicolas</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Medical Intensive Care Unit, iCAN, Institute of Cardiometabolism and Nutrition, H&#xf4;pital de la Piti&#xe9;-Salp&#xea;tri&#xe8;re, Assistance Publique-H&#xf4;pitaux de Paris, Universit&#xe9; Pierre-et-Marie-Curie, Paris 6, 47, bd de l'H&#xf4;pital, 75651, Paris Cedex 13, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hekimian</LastName><ForeName>Guillaume</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Medical Intensive Care Unit, iCAN, Institute of Cardiometabolism and Nutrition, H&#xf4;pital de la Piti&#xe9;-Salp&#xea;tri&#xe8;re, Assistance Publique-H&#xf4;pitaux de Paris, Universit&#xe9; Pierre-et-Marie-Curie, Paris 6, 47, bd de l'H&#xf4;pital, 75651, Paris Cedex 13, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nieszkowska</LastName><ForeName>Ania</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Medical Intensive Care Unit, iCAN, Institute of Cardiometabolism and Nutrition, H&#xf4;pital de la Piti&#xe9;-Salp&#xea;tri&#xe8;re, Assistance Publique-H&#xf4;pitaux de Paris, Universit&#xe9; Pierre-et-Marie-Curie, Paris 6, 47, bd de l'H&#xf4;pital, 75651, Paris Cedex 13, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Trouillet</LastName><ForeName>Jean-Louis</ForeName><Initials>JL</Initials><AffiliationInfo><Affiliation>Medical Intensive Care Unit, iCAN, Institute of Cardiometabolism and Nutrition, H&#xf4;pital de la Piti&#xe9;-Salp&#xea;tri&#xe8;re, Assistance Publique-H&#xf4;pitaux de Paris, Universit&#xe9; Pierre-et-Marie-Curie, Paris 6, 47, bd de l'H&#xf4;pital, 75651, Paris Cedex 13, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Luyt</LastName><ForeName>Charles-Edouard</ForeName><Initials>CE</Initials><AffiliationInfo><Affiliation>Medical Intensive Care Unit, iCAN, Institute of Cardiometabolism and Nutrition, H&#xf4;pital de la Piti&#xe9;-Salp&#xea;tri&#xe8;re, Assistance Publique-H&#xf4;pitaux de Paris, Universit&#xe9; Pierre-et-Marie-Curie, Paris 6, 47, bd de l'H&#xf4;pital, 75651, Paris Cedex 13, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Leprince</LastName><ForeName>Pascal</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Cardiac Surgery Department, iCAN, Institute of Cardiometabolism and Nutrition, H&#xf4;pital de la Piti&#xe9;-Salp&#xea;tri&#xe8;re, Assistance Publique-H&#xf4;pitaux de Paris, Universit&#xe9; Pierre-et-Marie-Curie, Paris 6, 47, bd de l'H&#xf4;pital, 75651, Paris Cedex 13, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chastre</LastName><ForeName>Jean</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Medical Intensive Care Unit, iCAN, Institute of Cardiometabolism and Nutrition, H&#xf4;pital de la Piti&#xe9;-Salp&#xea;tri&#xe8;re, Assistance Publique-H&#xf4;pitaux de Paris, Universit&#xe9; Pierre-et-Marie-Curie, Paris 6, 47, bd de l'H&#xf4;pital, 75651, Paris Cedex 13, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Combes</LastName><ForeName>Alain</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Medical Intensive Care Unit, iCAN, Institute of Cardiometabolism and Nutrition, H&#xf4;pital de la Piti&#xe9;-Salp&#xea;tri&#xe8;re, Assistance Publique-H&#xf4;pitaux de Paris, Universit&#xe9; Pierre-et-Marie-Curie, Paris 6, 47, bd de l'H&#xf4;pital, 75651, Paris Cedex 13, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schmidt</LastName><ForeName>Matthieu</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Medical Intensive Care Unit, iCAN, Institute of Cardiometabolism and Nutrition, H&#xf4;pital de la Piti&#xe9;-Salp&#xea;tri&#xe8;re, Assistance Publique-H&#xf4;pitaux de Paris, Universit&#xe9; Pierre-et-Marie-Curie, Paris 6, 47, bd de l'H&#xf4;pital, 75651, Paris Cedex 13, France. matthieu.schmidt@aphp.fr.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Service de R&#xe9;animation M&#xe9;dicale, iCAN, Institute of Cardiometabolism and Nutrition, H&#xf4;pital de la Piti&#xe9;-Salp&#xea;tri&#xe8;re, 47, bd de l'H&#xf4;pital, 75651, Paris Cedex 13, France. matthieu.schmidt@aphp.fr.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2017</Year><Month>03</Month><Day>28</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Crit Care</MedlineTA><NlmUniqueID>9801902</NlmUniqueID><ISSNLinking>1364-8535</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015199" MajorTopicYN="N">Extracorporeal Membrane Oxygenation</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007362" MajorTopicYN="N">Intensive Care Units</DescriptorName><QualifierName UI="Q000458" MajorTopicYN="N">organization &amp; administration</QualifierName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010297" MajorTopicYN="N">Paris</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011655" MajorTopicYN="N">Pulmonary Embolism</DescriptorName><QualifierName UI="Q000401" MajorTopicYN="Y">mortality</QualifierName><QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012720" MajorTopicYN="N">Severity of Illness Index</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018709" MajorTopicYN="N">Statistics, Nonparametric</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016019" MajorTopicYN="N">Survival Analysis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017741" MajorTopicYN="N">Survivors</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D062606" MajorTopicYN="N">Tertiary Care Centers</DescriptorName><QualifierName UI="Q000458" MajorTopicYN="N">organization &amp; administration</QualifierName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Cardiogenic shock</Keyword><Keyword MajorTopicYN="N">Extracorporeal membrane oxygenation</Keyword><Keyword MajorTopicYN="N">Long-term quality of life</Keyword><Keyword MajorTopicYN="N">Massive pulmonary embolism</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2016</Year><Month>11</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2017</Year><Month>2</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2017</Year><Month>3</Month><Day>29</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2017</Year><Month>3</Month><Day>30</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>5</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2017</Year><Month>3</Month><Day>28</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">28347320</ArticleId><ArticleId IdType="pmc">PMC5369216</ArticleId><ArticleId IdType="doi">10.1186/s13054-017-1655-8</ArticleId><ArticleId IdType="pii">10.1186/s13054-017-1655-8</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Agnelli G, Becattini C. Acute pulmonary embolism. N Engl J Med. 2010;363(3):266&#x2013;74. doi: 10.1056/NEJMra0907731.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMra0907731</ArticleId><ArticleId IdType="pubmed">20592294</ArticleId></ArticleIdList></Reference><Reference><Citation>Kasper W, Konstantinides S, Geibel A, Olschewski M, Heinrich F, Grosser KD, Rauber K, Iversen S, Redecker M, Kienast J. Management strategies and determinants of outcome in acute major pulmonary embolism: results of a multicenter registry. J Am Coll Cardiol. 1997;30(5):1165&#x2013;71. doi: 10.1016/S0735-1097(97)00319-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0735-1097(97)00319-7</ArticleId><ArticleId IdType="pubmed">9350909</ArticleId></ArticleIdList></Reference><Reference><Citation>Konstantinides SV, Torbicki A, Agnelli G, Danchin N, Fitzmaurice D, Galie N, Gibbs JS, Huisman MV, Humbert M, Kucher N, et al. ESC guidelines on the diagnosis and management of acute pulmonary embolism. Eur Heart J. 2014;35(43):3033&#x2013;3069. doi: 10.1093/eurheartj/ehu283.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehu283</ArticleId><ArticleId IdType="pubmed">25173341</ArticleId></ArticleIdList></Reference><Reference><Citation>Maggio P, Hemmila M, Haft J, Bartlett R. Extracorporeal life support for massive pulmonary embolism. J Trauma. 2007;62(3):570&#x2013;6. doi: 10.1097/TA.0b013e318031cd0c.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/TA.0b013e318031cd0c</ArticleId><ArticleId IdType="pubmed">17414330</ArticleId></ArticleIdList></Reference><Reference><Citation>Malekan R, Saunders PC, Yu CJ, Brown KA, Gass AL, Spielvogel D, Lansman SL. Peripheral extracorporeal membrane oxygenation: comprehensive therapy for high-risk massive pulmonary embolism. Ann Thorac Surg. 2012;94(1):104&#x2013;8. doi: 10.1016/j.athoracsur.2012.03.052.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.athoracsur.2012.03.052</ArticleId><ArticleId IdType="pubmed">22542068</ArticleId></ArticleIdList></Reference><Reference><Citation>Pavlovic G, Banfi C, Tassaux D, Peter RE, Licker MJ, Bendjelid K, Giraud R. Peri-operative massive pulmonary embolism management: is veno-arterial ECMO a therapeutic option? Acta Anaesthesiol Scand. 2014;58(10):1280&#x2013;6. doi: 10.1111/aas.12411.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/aas.12411</ArticleId><ArticleId IdType="pubmed">25251898</ArticleId></ArticleIdList></Reference><Reference><Citation>Yusuff HO, Zochios V, Vuylsteke A. Extracorporeal membrane oxygenation in acute massive pulmonary embolism: a systematic review. Perfusion. 2015;30(8):611&#x2013;6. doi: 10.1177/0267659115583377.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0267659115583377</ArticleId><ArticleId IdType="pubmed">25910837</ArticleId></ArticleIdList></Reference><Reference><Citation>Aissaoui N, Luyt CE, Leprince P, Trouillet JL, Leger P, Pavie A, Diebold B, Chastre J, Combes A. Predictors of successful extracorporeal membrane oxygenation (ECMO) weaning after assistance for refractory cardiogenic shock. Intensive Care Med. 2011;37(11):1738&#x2013;45. doi: 10.1007/s00134-011-2358-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-011-2358-2</ArticleId><ArticleId IdType="pubmed">21965097</ArticleId></ArticleIdList></Reference><Reference><Citation>Combes A, Leprince P, Luyt CE, Bonnet N, Trouillet JL, Leger P, Pavie A, Chastre J. Outcomes and long-term quality-of-life of patients supported by extracorporeal membrane oxygenation for refractory cardiogenic shock. Crit Care Med. 2008;36(5):1404&#x2013;11. doi: 10.1097/CCM.0b013e31816f7cf7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CCM.0b013e31816f7cf7</ArticleId><ArticleId IdType="pubmed">18434909</ArticleId></ArticleIdList></Reference><Reference><Citation>Mirabel M, Luyt CE, Leprince P, Trouillet JL, Leger P, Pavie A, Chastre J, Combes A. Outcomes, long-term quality of life, and psychologic assessment of fulminant myocarditis patients rescued by mechanical circulatory support. Crit Care Med. 2011;39(5):1029&#x2013;35. doi: 10.1097/CCM.0b013e31820ead45.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CCM.0b013e31820ead45</ArticleId><ArticleId IdType="pubmed">21336134</ArticleId></ArticleIdList></Reference><Reference><Citation>Jackson GG, Arana-Sialer JA, Andersen Br Grieble HG, McCabe WR. Profiles of pyelonephritis. Arch Intern Med. 1962;110:63&#x2013;75. doi: 10.1001/archinte.1962.03620230109016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archinte.1962.03620230109016</ArticleId><ArticleId IdType="pubmed">13957202</ArticleId></ArticleIdList></Reference><Reference><Citation>Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40(5):373&#x2013;83. doi: 10.1016/0021-9681(87)90171-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0021-9681(87)90171-8</ArticleId><ArticleId IdType="pubmed">3558716</ArticleId></ArticleIdList></Reference><Reference><Citation>Le Gall JR, Lemeshow S, Saulnier F. A new Simplified Acute Physiology Score (SAPS II) based on a European/North American multicenter study. JAMA. 1993;270(24):2957&#x2013;63. doi: 10.1001/jama.1993.03510240069035.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.1993.03510240069035</ArticleId><ArticleId IdType="pubmed">8254858</ArticleId></ArticleIdList></Reference><Reference><Citation>Vincent JL, Moreno R, Takala J, Willatts S, De Mendonca A, Bruining H, Reinhart CK, Suter PM, Thijs LG. The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine. Intensive Care Med. 1996;22(7):707&#x2013;10. doi: 10.1007/BF01709751.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/BF01709751</ArticleId><ArticleId IdType="pubmed">8844239</ArticleId></ArticleIdList></Reference><Reference><Citation>Wernovsky G, Wypij D, Jonas RA, Mayer JE, Jr, Hanley FL, Hickey PR, Walsh AZ, Chang AC, Castaneda AR, Newburger JW, et al. Postoperative course and hemodynamic profile after the arterial switch operation in neonates and infants. A comparison of low-flow cardiopulmonary bypass and circulatory arrest. Circulation. 1995;92(8):2226&#x2013;35. doi: 10.1161/01.CIR.92.8.2226.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/01.CIR.92.8.2226</ArticleId><ArticleId IdType="pubmed">7554206</ArticleId></ArticleIdList></Reference><Reference><Citation>The effects of tissue plasminogen activator, streptokinase, or both on coronary-artery patency, ventricular function, and survival after acute myocardial infarction. The GUSTO Angiographic Investigators. N Engl J Med. 1993; 329(22):1615&#x2013;1622</Citation><ArticleIdList><ArticleId IdType="pubmed">8232430</ArticleId></ArticleIdList></Reference><Reference><Citation>Mehran R, Steg PG, White HD, Rao SV. Letter by Mehran et al regarding article, &#x201c;Bleeding academic research consortium consensus report: the food and drug administration perspective&#x201d;. Circulation. 2012;125(10):e460. doi: 10.1161/CIRCULATIONAHA.111.065888.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.111.065888</ArticleId><ArticleId IdType="pubmed">22412101</ArticleId></ArticleIdList></Reference><Reference><Citation>Leplege A, Ecosse E, Verdier A, Perneger TV. The French SF-36 Health Survey: translation, cultural adaptation and preliminary psychometric evaluation. J Clin Epidemiol. 1998;51(11):1013&#x2013;23. doi: 10.1016/S0895-4356(98)00093-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0895-4356(98)00093-6</ArticleId><ArticleId IdType="pubmed">9817119</ArticleId></ArticleIdList></Reference><Reference><Citation>Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand. 1983;67(6):361&#x2013;70. doi: 10.1111/j.1600-0447.1983.tb09716.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1600-0447.1983.tb09716.x</ArticleId><ArticleId IdType="pubmed">6880820</ArticleId></ArticleIdList></Reference><Reference><Citation>Horowitz M, Wilner N, Alvarez W. Impact of Event Scale: a measure of subjective stress. Psychosom Med. 1979;41(3):209&#x2013;18. doi: 10.1097/00006842-197905000-00004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00006842-197905000-00004</ArticleId><ArticleId IdType="pubmed">472086</ArticleId></ArticleIdList></Reference><Reference><Citation>Lawton MP, Brody EM. Assessment of older people: self-maintaining and instrumental activities of daily living. Gerontologist. 1969;9(3):179&#x2013;86. doi: 10.1093/geront/9.3_Part_1.179.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/geront/9.3_Part_1.179</ArticleId><ArticleId IdType="pubmed">5349366</ArticleId></ArticleIdList></Reference><Reference><Citation>Brechot N, Luyt CE, Schmidt M, Leprince P, Trouillet JL, Leger P, Pavie A, Chastre J, Combes A. Venoarterial extracorporeal membrane oxygenation support for refractory cardiovascular dysfunction during severe bacterial septic shock. Crit Care Med. 2013;41(7):1616&#x2013;26. doi: 10.1097/CCM.0b013e31828a2370.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CCM.0b013e31828a2370</ArticleId><ArticleId IdType="pubmed">23563585</ArticleId></ArticleIdList></Reference><Reference><Citation>Schmidt M, Zogheib E, Roze H, Repesse X, Lebreton G, Luyt CE, Trouillet JL, Brechot N, Nieszkowska A, Dupont H, et al. The PRESERVE mortality risk score and analysis of long-term outcomes after extracorporeal membrane oxygenation for severe acute respiratory distress syndrome. Intensive Care Med. 2013;39(10):1704&#x2013;13. doi: 10.1007/s00134-013-3037-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-013-3037-2</ArticleId><ArticleId IdType="pmc">PMC7094902</ArticleId><ArticleId IdType="pubmed">23907497</ArticleId></ArticleIdList></Reference><Reference><Citation>Konstantinides S, Geibel A, Heusel G, Heinrich F, Kasper W, Management S. Prognosis of Pulmonary Embolism-3 Trial I. Heparin plus alteplase compared with heparin alone in patients with submassive pulmonary embolism. N Engl J Med. 2002;347(15):1143&#x2013;50. doi: 10.1056/NEJMoa021274.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa021274</ArticleId><ArticleId IdType="pubmed">12374874</ArticleId></ArticleIdList></Reference><Reference><Citation>Kasirajan V, Smedira NG, McCarthy JF, Casselman F, Boparai N, McCarthy PM. Risk factors for intracranial hemorrhage in adults on extracorporeal membrane oxygenation. Eur J Cardiothorac Surg. 1999;15(4):508&#x2013;14. doi: 10.1016/S1010-7940(99)00061-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1010-7940(99)00061-5</ArticleId><ArticleId IdType="pubmed">10371130</ArticleId></ArticleIdList></Reference><Reference><Citation>Cengiz P, Seidel K, Rycus PT, Brogan TV, Roberts JS. Central nervous system complications during pediatric extracorporeal life support: incidence and risk factors. Crit Care Med. 2005;33(12):2817&#x2013;24. doi: 10.1097/01.CCM.0000189940.70617.C3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.CCM.0000189940.70617.C3</ArticleId><ArticleId IdType="pubmed">16352965</ArticleId></ArticleIdList></Reference><Reference><Citation>Schmidt M, Burrell A, Roberts L, Bailey M, Sheldrake J, Rycus PT, Hodgson C, Scheinkestel C, Cooper DJ, Thiagarajan RR, et al. Predicting survival after ECMO for refractory cardiogenic shock: the survival after veno-arterial-ECMO (SAVE)-score. Eur Heart J. 2015;36(33):2246&#x2013;56. doi: 10.1093/eurheartj/ehv194.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehv194</ArticleId><ArticleId IdType="pubmed">26033984</ArticleId></ArticleIdList></Reference><Reference><Citation>Beurtheret S, Mordant P, Paoletti X, Marijon E, Celermajer DS, Leger P, Pavie A, Combes A, Leprince P. Emergency circulatory support in refractory cardiogenic shock patients in remote institutions: a pilot study (the cardiac-RESCUE program) Eur Heart J. 2013;34(2):112&#x2013;20. doi: 10.1093/eurheartj/ehs081.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehs081</ArticleId><ArticleId IdType="pubmed">22513777</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu MY, Liu YC, Tseng YH, Chang YS, Lin PJ, Wu TI. Pulmonary embolectomy in high-risk acute pulmonary embolism: the effectiveness of a comprehensive therapeutic algorithm including extracorporeal life support. Resuscitation. 2013;84(10):1365&#x2013;70. doi: 10.1016/j.resuscitation.2013.03.032.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.resuscitation.2013.03.032</ArticleId><ArticleId IdType="pubmed">23583612</ArticleId></ArticleIdList></Reference><Reference><Citation>Munakata R, Yamamoto T, Hosokawa Y, Tokita Y, Akutsu K, Sato N, Murata S, Tajima H, Mizuno K, Tanaka K. Massive pulmonary embolism requiring extracorporeal life support treated with catheter-based interventions. Int Heart J. 2012;53(6):370&#x2013;4. doi: 10.1536/ihj.53.370.</Citation><ArticleIdList><ArticleId IdType="doi">10.1536/ihj.53.370</ArticleId><ArticleId IdType="pubmed">23258138</ArticleId></ArticleIdList></Reference><Reference><Citation>Lang IM, Pesavento R, Bonderman D, Yuan JX. Risk factors and basic mechanisms of chronic thromboembolic pulmonary hypertension: a current understanding. Eur Respir J. 2013;41(2):462&#x2013;8. doi: 10.1183/09031936.00049312.</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/09031936.00049312</ArticleId><ArticleId IdType="pubmed">22700839</ArticleId></ArticleIdList></Reference><Reference><Citation>Delcroix M, Lang I, Pepke-Zaba J, Jansa P, D&#x2019;Armini AM, Snijder R, Bresser P, Torbicki A, Mellemkjaer S, Lewczuk J, et al. Long-term outcome of patients with chronic thromboembolic pulmonary hypertension (CTEPH): results from an international prospective registry. Circulation. 2016;133(9):859&#x2013;71. doi: 10.1161/CIRCULATIONAHA.115.016522.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.115.016522</ArticleId><ArticleId IdType="pubmed">26826181</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen YS, Lin JW, Yu HY, Ko WJ, Jerng JS, Chang WT, Chen WJ, Huang SC, Chi NH, Wang CH, et al. Cardiopulmonary resuscitation with assisted extracorporeal life-support versus conventional cardiopulmonary resuscitation in adults with in-hospital cardiac arrest: an observational study and propensity analysis. Lancet. 2008;372(9638):554&#x2013;61. doi: 10.1016/S0140-6736(08)60958-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(08)60958-7</ArticleId><ArticleId IdType="pubmed">18603291</ArticleId></ArticleIdList></Reference><Reference><Citation>Le Guen M, Nicolas-Robin A, Carreira S, Raux M, Leprince P, Riou B, Langeron O. Extracorporeal life support following out-of-hospital refractory cardiac arrest. Crit Care. 2011;15(1):R29. doi: 10.1186/cc9976.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/cc9976</ArticleId><ArticleId IdType="pmc">PMC3222065</ArticleId><ArticleId IdType="pubmed">21244674</ArticleId></ArticleIdList></Reference><Reference><Citation>Kawahito K, Murata S, Adachi H, Ino T, Fuse K. Resuscitation and circulatory support using extracorporeal membrane oxygenation for fulminant pulmonary embolism. Artif Organs 2000;24(6):427&#x2013;30.</Citation><ArticleIdList><ArticleId IdType="pubmed">10886059</ArticleId></ArticleIdList></Reference><Reference><Citation>Sakuma M, Nakamura M, Yamada N, Nakano T, Shirato K. Percutaneous cardiopulmonary support for the treatment of acute pulmonary embolism: summarized review of the literature in Japan including our own experience. Annals of vascular diseases 2009;2(1):7&#x2013;16.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3595745</ArticleId><ArticleId IdType="pubmed">23555350</ArticleId></ArticleIdList></Reference><Reference><Citation>Omar HR, Miller J, Mangar D, Camporesi EM. Experience with extracorporeal membrane oxygenation in massive and submassive pulmonary embolism in a tertiary care center. Am J Emerg Med 2013;31(11):1616&#x2013;17.</Citation><ArticleIdList><ArticleId IdType="pubmed">24055248</ArticleId></ArticleIdList></Reference><Reference><Citation>Maj G, Melisurgo G, De Bonis M, Pappalardo F: ECLS management in pulmonary embolism with cardiac arrest: which strategy is better? Resuscitation 2014;85(10):e175&#x2013;76.</Citation><ArticleIdList><ArticleId IdType="pubmed">24709613</ArticleId></ArticleIdList></Reference><Reference><Citation>Swol J, Buchwald D, Strauch J, Schildhauer TA. Extracorporeal life support (ECLS) for cardiopulmonary resuscitation (CPR) with pulmonary embolism in surgical patients - a case series. Perfusion. 2016;31(1):54&#x2013;59.</Citation><ArticleIdList><ArticleId IdType="pubmed">25906777</ArticleId></ArticleIdList></Reference><Reference><Citation>Cho YH, Sung K, Kim WS, Jeong DS. Management of acute massive pulmonary embolism: Is surgical embolectomy inferior to thrombolysis? International Journal of Cardiology 2016;203:579&#x2013;83.</Citation><ArticleIdList><ArticleId IdType="pubmed">26569368</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>